Citrus Sinensis ID: 005427
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 697 | 2.2.26 [Sep-21-2011] | |||||||
| Q940A2 | 658 | Protein kinase and PP2C-l | yes | no | 0.938 | 0.993 | 0.692 | 0.0 | |
| Q5JJY4 | 657 | Protein kinase and PP2C-l | yes | no | 0.932 | 0.989 | 0.678 | 0.0 | |
| Q4PSE8 | 447 | Probable protein phosphat | no | no | 0.357 | 0.557 | 0.418 | 1e-46 | |
| Q8RXV3 | 311 | Probable protein phosphat | no | no | 0.352 | 0.790 | 0.413 | 2e-45 | |
| Q67UX7 | 348 | Probable protein phosphat | no | no | 0.354 | 0.709 | 0.406 | 7e-45 | |
| Q8LAY8 | 354 | Probable protein phosphat | no | no | 0.357 | 0.703 | 0.407 | 5e-43 | |
| Q5Z6F5 | 327 | Probable protein phosphat | no | no | 0.355 | 0.758 | 0.400 | 2e-42 | |
| Q6L5C4 | 491 | Probable protein phosphat | no | no | 0.347 | 0.492 | 0.411 | 3e-41 | |
| Q7XR06 | 282 | Probable protein phosphat | no | no | 0.341 | 0.843 | 0.401 | 8e-41 | |
| Q94AT1 | 420 | Probable protein phosphat | no | no | 0.341 | 0.566 | 0.422 | 5e-40 |
| >sp|Q940A2|P2C31_ARATH Protein kinase and PP2C-like domain-containing protein OS=Arabidopsis thaliana GN=At2g40860/At2g40870 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 972 bits (2513), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 459/663 (69%), Positives = 552/663 (83%), Gaps = 9/663 (1%)
Query: 39 MGLKVLEPNTCIRGCCSSQSIPLHLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPI 98
M +++++PNTCIRGCC+S+SIPLHLP SS+TLLSPIA+G+ESVVYEA LDGR+VA KKPI
Sbjct: 1 MVMEIVKPNTCIRGCCTSESIPLHLPSSSFTLLSPIAKGSESVVYEAILDGRRVAAKKPI 60
Query: 99 LSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWS 158
LSTS++LD FH+ LQL C L+HPG+AK +AAHAKPPNYMFFF+FYES LAEKLHVEEWS
Sbjct: 61 LSTSDDLDKFHRNLQLSCNLNHPGVAKLLAAHAKPPNYMFFFDFYESGTLAEKLHVEEWS 120
Query: 159 PSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI 218
PS+DQVL+I LAKALQYLHN GIVHRDVKPANVLLD P+LADFGLAEY++NL+E+
Sbjct: 121 PSIDQVLLITLHLAKALQYLHNNGIVHRDVKPANVLLDEKFFPYLADFGLAEYKKNLREV 180
Query: 219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
+L+NWRSSGKPTGGFHKKNMVGTLIYMAPEIL+K++++EK+D+YSFGI INELLTGVVPY
Sbjct: 181 NLQNWRSSGKPTGGFHKKNMVGTLIYMAPEILRKDMYTEKADIYSFGILINELLTGVVPY 240
Query: 279 TDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHN 338
TD RAEAQAHTVLEMNYTEQQLT A+VS GLRP LA + L LP S+LSLIQ CW+ +P
Sbjct: 241 TDRRAEAQAHTVLEMNYTEQQLTVAIVSSGLRPALAEIGLHLPKSLLSLIQNCWESDPSK 300
Query: 339 RPSFSDIALELDLVLEHRKSLKEEDLCAGKSYVTYD----DKLINSGNNMHTYHESINWT 394
RPS ++ LEL+ + E + ++ L S D D + NSG+ Y +++NW
Sbjct: 301 RPSSDNVVLELESIWEQVRGKQQGHLLEKTSNSQSDTDGADIIKNSGD----YRDTVNWF 356
Query: 395 AQGEHSSKKASHAAESDVKLWLESANDALTYYPVLSWGSFATCGRRETMEDTHFLMPHMY 454
+QGE SKK+S + DVKLW S ++ Y PV+S GSFATCGRRE+MEDTHF++PHM
Sbjct: 357 SQGECLSKKSSVSTVFDVKLWSSSTDEPSRYVPVISCGSFATCGRRESMEDTHFIIPHMC 416
Query: 455 NQKEIHMFGIFDGHRGSAAAEFSARALPGFLQNLGSTTRPTDALLEAFIRTDVAFRNELD 514
N++ IH+F IFDGHRG+AAAEFSA+ LPG +Q+L ST+ +AL +AF+RTD+AFR ELD
Sbjct: 417 NEESIHLFAIFDGHRGAAAAEFSAQVLPGLVQSLCSTS-AGEALSQAFVRTDLAFRQELD 475
Query: 515 SLRKSKRVVQKDWHPGCTAIAALIVRNRLFVANAGDCRAILCRGGHPFALSRDHVASCLE 574
S R+SKRV QKDWHPGCTAIA+L+V N+LFVAN GD RAILCR GHPFALS+ H+A+C++
Sbjct: 476 SHRQSKRVSQKDWHPGCTAIASLLVENKLFVANVGDSRAILCRAGHPFALSKAHLATCID 535
Query: 575 ERERVVSAGGNVNWQVDTWRVGPPALQVTRSIGDDDLKPAVTAEPEITETIMTPEDEYLV 634
ER RV+ GG + W VDTWRV P LQVTRSIGDDDLKPAVTAEPEI+ETI++ +DE+LV
Sbjct: 536 ERNRVIGEGGRIEWLVDTWRVAPAGLQVTRSIGDDDLKPAVTAEPEISETILSADDEFLV 595
Query: 635 MASDGLWDVVSHVEAVGIIKDTVKEPGMCSKRLATEAAERGSKDNITVIVVFLQPVSTAE 694
MASDGLWDV++ E +GII+DTVKEP MCSKRLATEAA RGS DNITVIVVFL+PVSTAE
Sbjct: 596 MASDGLWDVMNDEEVIGIIRDTVKEPSMCSKRLATEAAARGSGDNITVIVVFLRPVSTAE 655
Query: 695 RIY 697
RIY
Sbjct: 656 RIY 658
|
Arabidopsis thaliana (taxid: 3702) EC: 3EC: .EC: 1EC: .EC: 3EC: .EC: 1EC: 6 |
| >sp|Q5JJY4|P2C04_ORYSJ Protein kinase and PP2C-like domain-containing protein OS=Oryza sativa subsp. japonica GN=Os01g0541900 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 946 bits (2444), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 452/666 (67%), Positives = 540/666 (81%), Gaps = 16/666 (2%)
Query: 39 MGLKVL--EPNTCIRGCCSSQSIPLHLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKK 96
MG++V E N C+RGCC S +IPLHLPPSS++LLSPIA+G+ES VYEA L G +VA KK
Sbjct: 1 MGVEVPPEESNRCVRGCCRSAAIPLHLPPSSFSLLSPIAKGSESTVYEARLGGERVAAKK 60
Query: 97 PILSTSEELDNFHKELQLL-----CKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEK 151
P+LSTS++LD FH +LQLL +LDHPGLA+ VAAHA+PPNY+ FF+F+E NLA+K
Sbjct: 61 PVLSTSDDLDKFHYQLQLLWWVLPIELDHPGLARLVAAHARPPNYLMFFDFFEPPNLADK 120
Query: 152 LHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEY 211
+HVEEW+PSV QV+ IA LAKALQYL+ LGIVHRD+KPAN+L+D++ PHLADFGLA Y
Sbjct: 121 IHVEEWNPSVQQVVTIATDLAKALQYLNILGIVHRDIKPANILIDKDFHPHLADFGLAMY 180
Query: 212 RENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINEL 271
++++K +S++NWRSSGKPTGGFHKKNMVGTLIYMAPEIL+K+IH+EKSDVYSF ISINEL
Sbjct: 181 QKDIKHVSVENWRSSGKPTGGFHKKNMVGTLIYMAPEILRKDIHTEKSDVYSFAISINEL 240
Query: 272 LTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRC 331
LTGVVPYTDLRAEAQAHTVLEM YTEQQLTAA+VS GLRP LA E G P S+LSLIQRC
Sbjct: 241 LTGVVPYTDLRAEAQAHTVLEMTYTEQQLTAAIVSQGLRPALALPESGAPPSLLSLIQRC 300
Query: 332 WDGNPHNRPSFSDIALELDLVLEHRKSLKEEDLCAGKSYVTYDDKLINSGNNMHTYHESI 391
WD +P RPSF DI EL ++ +H + C S + +K N +H Y E++
Sbjct: 301 WDSDPQQRPSFKDITEELKIIEKHIAV----NSC---SLASPANKSQNGNTEVHHYQEAL 353
Query: 392 NWTAQGEHSSKKASHAAESDVKLWLESANDALTYYPVLSWGSFATCGRRETMEDTHFLMP 451
+W QGE +K + +S V W + + + Y P LSWGSFATCGRRETMEDTHF++P
Sbjct: 354 SWLNQGELFAK--GNKLDSTVDHWSDIFDQSSKYCPTLSWGSFATCGRRETMEDTHFMLP 411
Query: 452 HMYNQKEIHMFGIFDGHRGSAAAEFSARALPGFLQNLGSTTRPTDALLEAFIRTDVAFRN 511
HM +K++H FGIFDGHRGSAAAEFS RA+PGFL+ S T PTDAL EAF+RTD+AFR
Sbjct: 412 HMSEEKDLHAFGIFDGHRGSAAAEFSVRAVPGFLKQFNSNTSPTDALTEAFVRTDIAFRE 471
Query: 512 ELDSLRKSKRVVQKDWHPGCTAIAALIVRNRLFVANAGDCRAILCRGGHPFALSRDHVAS 571
EL +KSKR+ QK+WHPGCTA+ ALIVRN+LFVANAGDCRAIL R G PF ++RDHVAS
Sbjct: 472 ELILHQKSKRITQKNWHPGCTAVTALIVRNKLFVANAGDCRAILNRAGEPFPMTRDHVAS 531
Query: 572 CLEERERVVSAGGNVNWQVDTWRVGPPALQVTRSIGDDDLKPAVTAEPEITETIMTPEDE 631
C +ERER+V G V WQ+DTWRVG ALQVTRSIGDDDLKPAVTA+PE+ ETI++P+DE
Sbjct: 532 CPKERERIVKEGTEVKWQIDTWRVGAAALQVTRSIGDDDLKPAVTAQPEVIETILSPDDE 591
Query: 632 YLVMASDGLWDVVSHVEAVGIIKDTVKEPGMCSKRLATEAAERGSKDNITVIVVFLQPVS 691
+LVMASDGLWDV+S+ + + IIKDTVKEPGMCSKRLATEAA RGSKDNITVIVVFL+PVS
Sbjct: 592 FLVMASDGLWDVMSNEDVLSIIKDTVKEPGMCSKRLATEAAARGSKDNITVIVVFLRPVS 651
Query: 692 TAERIY 697
TAERIY
Sbjct: 652 TAERIY 657
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 3 EC: . EC: 1 EC: . EC: 3 EC: . EC: 1 EC: 6 |
| >sp|Q4PSE8|P2C71_ARATH Probable protein phosphatase 2C 71 OS=Arabidopsis thaliana GN=At5g24940 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 188 bits (478), Expect = 1e-46, Method: Compositional matrix adjust.
Identities = 115/275 (41%), Positives = 162/275 (58%), Gaps = 26/275 (9%)
Query: 422 ALTYYPVLSWGSFATCGRRETMEDTHFLMPHMYNQKEIHMFGIFDGHRGSAAAEFSARAL 481
L+ S+G ++ G+R +MED + + + +FG+FDGH GS AAE+ R L
Sbjct: 25 GLSQNGKFSYGYASSAGKRSSMEDFFETRIDGIDGEIVGLFGVFDGHGGSRAAEYVKRHL 84
Query: 482 -------PGFLQNLGSTTRPTDALLEAFIRTDVAFRNELDSLRKSKRVVQKDWHPGCTAI 534
P F+ + S A+ +A+ TD L KS+ +D G TA
Sbjct: 85 FSNLITHPKFISDTKS------AIADAYTHTD-------SELLKSENSHTRD--AGSTAS 129
Query: 535 AALIVRNRLFVANAGDCRAILCRGGHPFALSRDHVASCLEERERVVSAGGNVNWQVDTWR 594
A++V +RL VAN GD RA++CRGG+ FA+SRDH +ERER+ +AGG V W TWR
Sbjct: 130 TAILVGDRLLVANVGDSRAVICRGGNAFAVSRDHKPDQSDERERIENAGGFVMW-AGTWR 188
Query: 595 VGPPALQVTRSIGDDDLKPAVTAEPEITETIMTPEDEYLVMASDGLWDVVSHVEAVGIIK 654
VG L V+R+ GD LK V A+PEI E + E+L++ASDGLWDV S+ EAV ++K
Sbjct: 189 VG-GVLAVSRAFGDRLLKQYVVADPEIQEEKIDDSLEFLILASDGLWDVFSNEEAVAVVK 247
Query: 655 DTVKEPGMCSKRLATEAAERGSKDNITVIVV-FLQ 688
+ V++P +K+L EA +RGS DNIT +VV FL+
Sbjct: 248 E-VEDPEESTKKLVGEAIKRGSADNITCVVVRFLE 281
|
Arabidopsis thaliana (taxid: 3702) EC: 3 EC: . EC: 1 EC: . EC: 3 EC: . EC: 1 EC: 6 |
| >sp|Q8RXV3|P2C59_ARATH Probable protein phosphatase 2C 59 OS=Arabidopsis thaliana GN=WIN2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 184 bits (467), Expect = 2e-45, Method: Compositional matrix adjust.
Identities = 112/271 (41%), Positives = 159/271 (58%), Gaps = 25/271 (9%)
Query: 422 ALTYYPVLSWGSFATCGRRETMEDTHFLMPHMYNQKEIHMFGIFDGHRGSAAAEFSARAL 481
L+ S+G ++ G+R +MED + + + +FG+FDGH G+ AAE+ + L
Sbjct: 25 GLSQNGKFSYGYASSPGKRSSMEDFYETRIDGVEGEIVGLFGVFDGHGGARAAEYVKQNL 84
Query: 482 -------PGFLQNLGSTTRPTDALLEAFIRTDVAFRNELDSLRKSKRVVQKDWHPGCTAI 534
P F+ + T A+ +A+ +TD F KS+ +D G TA
Sbjct: 85 FSNLIRHPKFISD------TTAAIADAYNQTDSEFL-------KSENSQNRD--AGSTAS 129
Query: 535 AALIVRNRLFVANAGDCRAILCRGGHPFALSRDHVASCLEERERVVSAGGNVNWQVDTWR 594
A++V +RL VAN GD RA++CRGG+ A+SRDH +ER+R+ AGG V W TWR
Sbjct: 130 TAILVGDRLLVANVGDSRAVICRGGNAIAVSRDHKPDQSDERQRIEDAGGFVMW-AGTWR 188
Query: 595 VGPPALQVTRSIGDDDLKPAVTAEPEITETIMTPEDEYLVMASDGLWDVVSHVEAVGIIK 654
VG L V+R+ GD LK V A+PEI E + E+L++ASDGLWDVVS+ EAVG+IK
Sbjct: 189 VG-GVLAVSRAFGDRLLKQYVVADPEIQEEKVDSSLEFLILASDGLWDVVSNEEAVGMIK 247
Query: 655 DTVKEPGMCSKRLATEAAERGSKDNITVIVV 685
+++P +KRL EA +RGS DNIT +VV
Sbjct: 248 -AIEDPEEGAKRLMMEAYQRGSADNITCVVV 277
|
Protein phosphatase that modulates defense response to pathogenic bacteria, conferring resistance and promoting salicylic acid (SA) accumulation. Arabidopsis thaliana (taxid: 3702) EC: 3 EC: . EC: 1 EC: . EC: 3 EC: . EC: 1 EC: 6 |
| >sp|Q67UX7|P2C10_ORYSJ Probable protein phosphatase 2C 10 OS=Oryza sativa subsp. japonica GN=Os02g0149800 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 182 bits (462), Expect = 7e-45, Method: Compositional matrix adjust.
Identities = 111/273 (40%), Positives = 158/273 (57%), Gaps = 26/273 (9%)
Query: 429 LSWGSFATCGRRETMEDTHFLMPHMYNQKEIHMFGIFDGHRGSAAAEFSARAL------- 481
S+G + G+R +MED + + + I +FG+FDGH G+ AAE+ + L
Sbjct: 81 FSYGYASAPGKRASMEDFYETRIDGVDGETIGLFGVFDGHGGARAAEYVKQHLFSNLIKH 140
Query: 482 PGFLQNLGSTTRPTDALLEAFIRTDVAFRNELDSLRKSKRVVQKDWHPGCTAIAALIVRN 541
P F+ ++ S A+ E + TD F S + G TA A++V +
Sbjct: 141 PKFISDIKS------AIAETYNHTDSEFLKAESSHTRD---------AGSTASTAILVGD 185
Query: 542 RLFVANAGDCRAILCRGGHPFALSRDHVASCLEERERVVSAGGNVNWQVDTWRVGPPALQ 601
RL VAN GD RA++CRGG A+SRDH +ER+R+ AGG V W TWRVG L
Sbjct: 186 RLLVANVGDSRAVVCRGGDAIAVSRDHKPDQSDERQRIEDAGGFVMW-AGTWRVG-GVLA 243
Query: 602 VTRSIGDDDLKPAVTAEPEITETIMTPEDEYLVMASDGLWDVVSHVEAVGIIKDTVKEPG 661
V+R+ GD LK V A+PEI E I+ E+L++ASDGLWDVVS+ EAV +++ +++P
Sbjct: 244 VSRAFGDKLLKQYVVADPEIKEEIVDSSLEFLILASDGLWDVVSNKEAVDMVR-PIQDPE 302
Query: 662 MCSKRLATEAAERGSKDNITVIVV-FLQPVSTA 693
+KRL EA +RGS DNITV++V FL+ +T
Sbjct: 303 QAAKRLLQEAYQRGSADNITVVIVRFLEGTTTG 335
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 3 EC: . EC: 1 EC: . EC: 3 EC: . EC: 1 EC: 6 |
| >sp|Q8LAY8|P2C69_ARATH Probable protein phosphatase 2C 69 OS=Arabidopsis thaliana GN=At5g10740 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 176 bits (446), Expect = 5e-43, Method: Compositional matrix adjust.
Identities = 112/275 (40%), Positives = 158/275 (57%), Gaps = 26/275 (9%)
Query: 422 ALTYYPVLSWGSFATCGRRETMEDTHFLMPHMYNQKEIHMFGIFDGHRGSAAAEFSARAL 481
L+ S+G ++ G+R +MED N + + +FG+FDGH G+ AAE+ R L
Sbjct: 25 GLSQNGKFSYGYASSAGKRSSMEDFFETRIDGINGEIVGLFGVFDGHGGARAAEYVKRHL 84
Query: 482 -------PGFLQNLGSTTRPTDALLEAFIRTDVAFRNELDSLRKSKRVVQKDWHPGCTAI 534
P F+ + S A+ +A+ TD L KS+ +D G TA
Sbjct: 85 FSNLITHPKFISDTKS------AITDAYNHTD-------SELLKSENSHNRD--AGSTAS 129
Query: 535 AALIVRNRLFVANAGDCRAILCRGGHPFALSRDHVASCLEERERVVSAGGNVNWQVDTWR 594
A++V +RL VAN GD RA++ RGG A+SRDH +ERER+ +AGG V W TWR
Sbjct: 130 TAILVGDRLVVANVGDSRAVISRGGKAIAVSRDHKPDQSDERERIENAGGFVMW-AGTWR 188
Query: 595 VGPPALQVTRSIGDDDLKPAVTAEPEITETIMTPEDEYLVMASDGLWDVVSHVEAVGIIK 654
VG L V+R+ GD LK V A+PEI E + E+L++ASDGLWDV S+ AV ++K
Sbjct: 189 VG-GVLAVSRAFGDRLLKQYVVADPEIQEEKIDDTLEFLILASDGLWDVFSNEAAVAMVK 247
Query: 655 DTVKEPGMCSKRLATEAAERGSKDNITVIVV-FLQ 688
+ V++P +K+L EA +RGS DNIT +VV FL+
Sbjct: 248 E-VEDPEDSAKKLVGEAIKRGSADNITCVVVRFLE 281
|
Arabidopsis thaliana (taxid: 3702) EC: 3 EC: . EC: 1 EC: . EC: 3 EC: . EC: 1 EC: 6 |
| >sp|Q5Z6F5|P2C59_ORYSJ Probable protein phosphatase 2C 59 OS=Oryza sativa subsp. japonica GN=Os06g0698300 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 174 bits (442), Expect = 2e-42, Method: Compositional matrix adjust.
Identities = 105/262 (40%), Positives = 156/262 (59%), Gaps = 14/262 (5%)
Query: 429 LSWGSFATCGRRETMEDTHFLMPHMYNQKEIHMFGIFDGHRGSAAAEFSARAL-PGFLQN 487
S+G ++ G+R +MED + + + + +FG+FDGH G+ AAEF + L +++
Sbjct: 63 FSYGYASSPGKRSSMEDFYDTRIDGVDGETVGLFGVFDGHGGARAAEFVKQNLFTNLIKH 122
Query: 488 LGSTTRPTDALLEAFIRTDVAFRNELDSLRKSKRVVQKDWHPGCTAIAALIVRNRLFVAN 547
+ A+ E + TD L K++ +D G TA A++V +RL VAN
Sbjct: 123 PKLFSDTKSAIAETYTSTD-------SELLKAETSHNRD--AGSTASTAILVGDRLLVAN 173
Query: 548 AGDCRAILCRGGHPFALSRDHVASCLEERERVVSAGGNVNWQVDTWRVGPPALQVTRSIG 607
GD RA++CRGG A+SRDH +ER+R+ AGG V W TWRVG L V+R+ G
Sbjct: 174 VGDSRAVICRGGDAIAVSRDHKPDQSDERQRIEDAGGFVMW-AGTWRVGG-VLAVSRAFG 231
Query: 608 DDDLKPAVTAEPEITETIMTPEDEYLVMASDGLWDVVSHVEAVGIIKDTVKEPGMCSKRL 667
D LK V A+PEI E ++ E+L++ASDGLWDVV++ EAV ++K + + +K+L
Sbjct: 232 DKLLKQYVVADPEIKEEVVDSSLEFLILASDGLWDVVTNEEAVAMVK-PILDSEQAAKKL 290
Query: 668 ATEAAERGSKDNITVIVV-FLQ 688
EA++RGS DNIT +VV FL+
Sbjct: 291 LQEASQRGSADNITCLVVRFLE 312
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 3 EC: . EC: 1 EC: . EC: 3 EC: . EC: 1 EC: 6 |
| >sp|Q6L5C4|P2C52_ORYSJ Probable protein phosphatase 2C 52 OS=Oryza sativa subsp. japonica GN=Os05g0587100 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 170 bits (431), Expect = 3e-41, Method: Compositional matrix adjust.
Identities = 110/267 (41%), Positives = 151/267 (56%), Gaps = 25/267 (9%)
Query: 429 LSWGSFATCGRRETMEDTHFLMPHMYNQKEIHMFGIFDGHRGSAAAEFSARAL------- 481
LS G + G+R +MED + + + K+I +FGIFDGH GS AAE+ L
Sbjct: 228 LSCGYSSFRGKRASMEDFYDIKSSKIDDKQISLFGIFDGHGGSRAAEYLKEHLFENLMKH 287
Query: 482 PGFLQNLGSTTRPTDALLEAFIRTDVAFRNELDSLRKSKRVVQKDWHPGCTAIAALIVRN 541
P F+ N A+ E + +TD F LDS + R G TA A++V N
Sbjct: 288 PEFMTNTKL------AISETYKKTDSEF---LDSESHTHR------DDGSTASTAVLVGN 332
Query: 542 RLFVANAGDCRAILCRGGHPFALSRDHVASCLEERERVVSAGGNVNWQVDTWRVGPPALQ 601
L+VAN GD RA++ + G ALS DH + +ER+R+ SAGG V W TWRVG L
Sbjct: 333 HLYVANVGDSRAVISKAGKAIALSEDHKPNRSDERKRIESAGGVVMW-AGTWRVG-GVLA 390
Query: 602 VTRSIGDDDLKPAVTAEPEITETIMTPEDEYLVMASDGLWDVVSHVEAVGIIKDTVKEPG 661
++R+ G+ LK V A+PEI E + E E+L++ASDGLWDVV + +AV ++K +EP
Sbjct: 391 MSRAFGNRLLKQFVVADPEIQEQEIDDELEFLILASDGLWDVVPNEDAVSLVK-IEEEPE 449
Query: 662 MCSKRLATEAAERGSKDNITVIVVFLQ 688
+++L A RGS DNIT IVV Q
Sbjct: 450 AAARKLTETAFSRGSGDNITCIVVKFQ 476
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 3 EC: . EC: 1 EC: . EC: 3 EC: . EC: 1 EC: 6 |
| >sp|Q7XR06|P2C45_ORYSJ Probable protein phosphatase 2C 45 OS=Oryza sativa subsp. japonica GN=Os04g0659500 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 169 bits (427), Expect = 8e-41, Method: Compositional matrix adjust.
Identities = 106/264 (40%), Positives = 154/264 (58%), Gaps = 26/264 (9%)
Query: 429 LSWGSFATCGRRETMEDTHFLMPHMYNQKEIHMFGIFDGHRGSAAAEFSARAL------- 481
S+G ++ G+R +MED + + + I +FG+FDGH G+ AE+ + L
Sbjct: 26 FSYGYASSPGKRASMEDFYETRIDSVDGQIIGLFGVFDGHGGAKVAEYVKQNLFSHLLRH 85
Query: 482 PGFLQNLGSTTRPTDALLEAFIRTDVAFRNELDSLRKSKRVVQKDWHPGCTAIAALIVRN 541
P F+ S T+ A+ +A+ TD F E DS + G TA A++V +
Sbjct: 86 PKFI----SDTKV--AIDDAYKSTDSEFL-ESDSSQN---------QCGSTASTAVLVGD 129
Query: 542 RLFVANAGDCRAILCRGGHPFALSRDHVASCLEERERVVSAGGNVNWQVDTWRVGPPALQ 601
RLFVAN GD RAI+CRGG+ A+S+DH +ER+R+ AGG V W TWRVG L
Sbjct: 130 RLFVANVGDSRAIICRGGNAIAVSKDHKPDQTDERQRIEDAGGFVMW-AGTWRVGG-VLA 187
Query: 602 VTRSIGDDDLKPAVTAEPEITETIMTPEDEYLVMASDGLWDVVSHVEAVGIIKDTVKEPG 661
V+R+ GD LK V +PEI E ++ E+L++ASDGLWDVV++ EAV + + ++ +P
Sbjct: 188 VSRAFGDKLLKQYVVVDPEIREEVIDHSLEFLILASDGLWDVVTNEEAVDMTR-SIHDPE 246
Query: 662 MCSKRLATEAAERGSKDNITVIVV 685
+K+L EA +R S DNIT +VV
Sbjct: 247 EAAKKLLQEAYKRESSDNITCVVV 270
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 3 EC: . EC: 1 EC: . EC: 3 EC: . EC: 1 EC: 6 |
| >sp|Q94AT1|P2C76_ARATH Probable protein phosphatase 2C 76 OS=Arabidopsis thaliana GN=At5g53140 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 166 bits (420), Expect = 5e-40, Method: Compositional matrix adjust.
Identities = 112/265 (42%), Positives = 149/265 (56%), Gaps = 27/265 (10%)
Query: 429 LSWGSFATCGRRETMEDTHFLMPHMYNQKEIHMFGIFDGHRGSAAAEFSARAL------- 481
LS G + G+R TMED + + + + MFGIFDGH GS AAE+ L
Sbjct: 100 LSCGYCSFRGKRSTMEDFYDIKASTIEGQAVCMFGIFDGHGGSRAAEYLKEHLFNNLMKH 159
Query: 482 PGFLQNLGSTTRPTDALLEAFIRTDVAF-RNELDSLRKSKRVVQKDWHPGCTAIAALIVR 540
P FL T AL E + +TDVAF +E D+ R G TA AA++V
Sbjct: 160 PQFL------TDTKLALNETYKQTDVAFLESEKDTYRDD----------GSTASAAVLVG 203
Query: 541 NRLFVANAGDCRAILCRGGHPFALSRDHVASCLEERERVVSAGGNVNWQVDTWRVGPPAL 600
N L+VAN GD R I+ + G ALS DH + +ER+R+ SAGG + W TWRVG L
Sbjct: 204 NHLYVANVGDSRTIVSKAGKAIALSDDHKPNRSDERKRIESAGGVIMW-AGTWRVGG-VL 261
Query: 601 QVTRSIGDDDLKPAVTAEPEITETIMTPEDEYLVMASDGLWDVVSHVEAVGIIKDTVKEP 660
++R+ G+ LK V AEPEI + + E E LV+ASDGLWDVV + +AV + + + +EP
Sbjct: 262 AMSRAFGNRMLKQFVVAEPEIQDLEIDHEAELLVLASDGLWDVVPNEDAVALAQ-SEEEP 320
Query: 661 GMCSKRLATEAAERGSKDNITVIVV 685
+++L A RGS DNIT IVV
Sbjct: 321 EAAARKLTDTAFSRGSADNITCIVV 345
|
Arabidopsis thaliana (taxid: 3702) EC: 3 EC: . EC: 1 EC: . EC: 3 EC: . EC: 1 EC: 6 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 697 | ||||||
| 225440175 | 659 | PREDICTED: protein kinase and PP2C-like | 0.945 | 1.0 | 0.787 | 0.0 | |
| 225440177 | 669 | PREDICTED: protein kinase and PP2C-like | 0.945 | 0.985 | 0.772 | 0.0 | |
| 255570496 | 657 | protein kinase, putative [Ricinus commun | 0.942 | 1.0 | 0.783 | 0.0 | |
| 224139662 | 661 | predicted protein [Populus trichocarpa] | 0.944 | 0.995 | 0.776 | 0.0 | |
| 357439937 | 654 | Protein kinase and PP2C-like domain-cont | 0.936 | 0.998 | 0.720 | 0.0 | |
| 356500335 | 658 | PREDICTED: protein kinase and PP2C-like | 0.944 | 1.0 | 0.723 | 0.0 | |
| 297827721 | 661 | kinase family protein [Arabidopsis lyrat | 0.936 | 0.987 | 0.698 | 0.0 | |
| 30688440 | 658 | putative protein phosphatase 2C 31 [Arab | 0.938 | 0.993 | 0.692 | 0.0 | |
| 449505991 | 654 | PREDICTED: protein kinase and PP2C-like | 0.931 | 0.992 | 0.710 | 0.0 | |
| 449437706 | 649 | PREDICTED: protein kinase and PP2C-like | 0.923 | 0.992 | 0.706 | 0.0 |
| >gi|225440175|ref|XP_002283436.1| PREDICTED: protein kinase and PP2C-like domain-containing protein isoform 1 [Vitis vinifera] gi|297741696|emb|CBI32828.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1097 bits (2837), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 519/659 (78%), Positives = 588/659 (89%)
Query: 39 MGLKVLEPNTCIRGCCSSQSIPLHLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPI 98
MG+++++PNTC RGCCSS+SIPL LP S Y+LLSPIARGAESVVYEA LDG+KVAVKKPI
Sbjct: 1 MGVEIVQPNTCFRGCCSSESIPLCLPSSFYSLLSPIARGAESVVYEACLDGKKVAVKKPI 60
Query: 99 LSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWS 158
LSTS+++D FHKELQLLCKLDHPG+AK VAAHAKPPNYMFFFEFYES NLA+KLHVEEWS
Sbjct: 61 LSTSQDIDKFHKELQLLCKLDHPGIAKLVAAHAKPPNYMFFFEFYESGNLADKLHVEEWS 120
Query: 159 PSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI 218
P +DQ MI QLA+ALQYLHNLGI+HRDVKPANVLLD+ PHLADFGLAEY+ +LK++
Sbjct: 121 PGIDQAFMITVQLARALQYLHNLGIIHRDVKPANVLLDKKFYPHLADFGLAEYKADLKQV 180
Query: 219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
S +NWRSSGKPTGGFHKKNMVGTLIYMAPEIL+KEIH+EKSDVYSFG+SINELLTGVVPY
Sbjct: 181 STENWRSSGKPTGGFHKKNMVGTLIYMAPEILRKEIHTEKSDVYSFGVSINELLTGVVPY 240
Query: 279 TDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHN 338
TDLRAEAQAHTVLEMNYTEQQLTAAV S GLRP+LA LE PA +LSLIQRCWD NP N
Sbjct: 241 TDLRAEAQAHTVLEMNYTEQQLTAAVASEGLRPVLAGLESAAPARLLSLIQRCWDANPQN 300
Query: 339 RPSFSDIALELDLVLEHRKSLKEEDLCAGKSYVTYDDKLINSGNNMHTYHESINWTAQGE 398
RPSF +I +ELD +LEHRK++KE++ G+ + D+ IN N+ TY ESINW AQGE
Sbjct: 301 RPSFDEIVMELDPILEHRKTVKEKENILGEPSIFPADQHINDATNLRTYQESINWVAQGE 360
Query: 399 HSSKKASHAAESDVKLWLESANDALTYYPVLSWGSFATCGRRETMEDTHFLMPHMYNQKE 458
+ SK AS A+S V++W +S+ND LTY P+LSWGSFATCGRRETMEDTHFLMP+M+N+++
Sbjct: 361 NFSKIASSVADSSVEMWFDSSNDPLTYRPILSWGSFATCGRRETMEDTHFLMPNMFNEED 420
Query: 459 IHMFGIFDGHRGSAAAEFSARALPGFLQNLGSTTRPTDALLEAFIRTDVAFRNELDSLRK 518
IH+FGIFDGHRG+AAAEFSARALPG+L+ LGS + P DALLEAF++TDVAFRNELDS RK
Sbjct: 421 IHVFGIFDGHRGAAAAEFSARALPGYLKTLGSRSSPADALLEAFVKTDVAFRNELDSCRK 480
Query: 519 SKRVVQKDWHPGCTAIAALIVRNRLFVANAGDCRAILCRGGHPFALSRDHVASCLEERER 578
SK V+QKDWHPGCTA+AALIVRN+LFVANAGDCR ILCR G FALS+DHVASCLEERER
Sbjct: 481 SKGVIQKDWHPGCTAVAALIVRNKLFVANAGDCRTILCRAGCAFALSKDHVASCLEERER 540
Query: 579 VVSAGGNVNWQVDTWRVGPPALQVTRSIGDDDLKPAVTAEPEITETIMTPEDEYLVMASD 638
V +AGG V WQVDTWRVGP ALQVTRSIGDDDLKPAVTAEPEITETI++ EDE+LVMASD
Sbjct: 541 VTNAGGQVKWQVDTWRVGPAALQVTRSIGDDDLKPAVTAEPEITETILSVEDEFLVMASD 600
Query: 639 GLWDVVSHVEAVGIIKDTVKEPGMCSKRLATEAAERGSKDNITVIVVFLQPVSTAERIY 697
GLWDVVS+ E V II+DTVKEPGMCSKRLATEAAERGSKDNITVIV+FL+PVSTAERIY
Sbjct: 601 GLWDVVSNAEVVSIIRDTVKEPGMCSKRLATEAAERGSKDNITVIVIFLRPVSTAERIY 659
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225440177|ref|XP_002283443.1| PREDICTED: protein kinase and PP2C-like domain-containing protein isoform 2 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1081 bits (2795), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 517/669 (77%), Positives = 586/669 (87%), Gaps = 10/669 (1%)
Query: 39 MGLKVLEPNTCIRGCCSSQSIPLHLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPI 98
MG+++++PNTC RGCCSS+SIPL LP S Y+LLSPIARGAESVVYEA LDG+KVAVKKPI
Sbjct: 1 MGVEIVQPNTCFRGCCSSESIPLCLPSSFYSLLSPIARGAESVVYEACLDGKKVAVKKPI 60
Query: 99 LSTSEELDNFHKELQLL----------CKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNL 148
LSTS+++D FHKELQLL LDHPG+AK VAAHAKPPNYMFFFEFYES NL
Sbjct: 61 LSTSQDIDKFHKELQLLWSTFLSFCLFFFLDHPGIAKLVAAHAKPPNYMFFFEFYESGNL 120
Query: 149 AEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGL 208
A+KLHVEEWSP +DQ MI QLA+ALQYLHNLGI+HRDVKPANVLLD+ PHLADFGL
Sbjct: 121 ADKLHVEEWSPGIDQAFMITVQLARALQYLHNLGIIHRDVKPANVLLDKKFYPHLADFGL 180
Query: 209 AEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISI 268
AEY+ +LK++S +NWRSSGKPTGGFHKKNMVGTLIYMAPEIL+KEIH+EKSDVYSFG+SI
Sbjct: 181 AEYKADLKQVSTENWRSSGKPTGGFHKKNMVGTLIYMAPEILRKEIHTEKSDVYSFGVSI 240
Query: 269 NELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLI 328
NELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAV S GLRP+LA LE PA +LSLI
Sbjct: 241 NELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVASEGLRPVLAGLESAAPARLLSLI 300
Query: 329 QRCWDGNPHNRPSFSDIALELDLVLEHRKSLKEEDLCAGKSYVTYDDKLINSGNNMHTYH 388
QRCWD NP NRPSF +I +ELD +LEHRK++KE++ G+ + D+ IN N+ TY
Sbjct: 301 QRCWDANPQNRPSFDEIVMELDPILEHRKTVKEKENILGEPSIFPADQHINDATNLRTYQ 360
Query: 389 ESINWTAQGEHSSKKASHAAESDVKLWLESANDALTYYPVLSWGSFATCGRRETMEDTHF 448
ESINW AQGE+ SK AS A+S V++W +S+ND LTY P+LSWGSFATCGRRETMEDTHF
Sbjct: 361 ESINWVAQGENFSKIASSVADSSVEMWFDSSNDPLTYRPILSWGSFATCGRRETMEDTHF 420
Query: 449 LMPHMYNQKEIHMFGIFDGHRGSAAAEFSARALPGFLQNLGSTTRPTDALLEAFIRTDVA 508
LMP+M+N+++IH+FGIFDGHRG+AAAEFSARALPG+L+ LGS + P DALLEAF++TDVA
Sbjct: 421 LMPNMFNEEDIHVFGIFDGHRGAAAAEFSARALPGYLKTLGSRSSPADALLEAFVKTDVA 480
Query: 509 FRNELDSLRKSKRVVQKDWHPGCTAIAALIVRNRLFVANAGDCRAILCRGGHPFALSRDH 568
FRNELDS RKSK V+QKDWHPGCTA+AALIVRN+LFVANAGDCR ILCR G FALS+DH
Sbjct: 481 FRNELDSCRKSKGVIQKDWHPGCTAVAALIVRNKLFVANAGDCRTILCRAGCAFALSKDH 540
Query: 569 VASCLEERERVVSAGGNVNWQVDTWRVGPPALQVTRSIGDDDLKPAVTAEPEITETIMTP 628
VASCLEERERV +AGG V WQVDTWRVGP ALQVTRSIGDDDLKPAVTAEPEITETI++
Sbjct: 541 VASCLEERERVTNAGGQVKWQVDTWRVGPAALQVTRSIGDDDLKPAVTAEPEITETILSV 600
Query: 629 EDEYLVMASDGLWDVVSHVEAVGIIKDTVKEPGMCSKRLATEAAERGSKDNITVIVVFLQ 688
EDE+LVMASDGLWDVVS+ E V II+DTVKEPGMCSKRLATEAAERGSKDNITVIV+FL+
Sbjct: 601 EDEFLVMASDGLWDVVSNAEVVSIIRDTVKEPGMCSKRLATEAAERGSKDNITVIVIFLR 660
Query: 689 PVSTAERIY 697
PVSTAERIY
Sbjct: 661 PVSTAERIY 669
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255570496|ref|XP_002526206.1| protein kinase, putative [Ricinus communis] gi|223534484|gb|EEF36185.1| protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1064 bits (2751), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 516/659 (78%), Positives = 573/659 (86%), Gaps = 2/659 (0%)
Query: 39 MGLKVLEPNTCIRGCCSSQSIPLHLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPI 98
MG++++EPNTCIRGCCSS SIPLHLPPS YTLLSPIARG ESVVYE LDGR+VAVKKPI
Sbjct: 1 MGVEIMEPNTCIRGCCSSNSIPLHLPPSCYTLLSPIARGGESVVYEGILDGRRVAVKKPI 60
Query: 99 LSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWS 158
LSTSE++D FHKELQLLC LDHPG+A+ AAHAKPPNYMFFFE YES NLA KLHVEEWS
Sbjct: 61 LSTSEDIDKFHKELQLLCTLDHPGIARLAAAHAKPPNYMFFFELYESGNLAGKLHVEEWS 120
Query: 159 PSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI 218
PS+DQVL I+ QLAKALQYLHN GIVHRDVKPANVLLDRNLC HLADFGLAEYR+NLK +
Sbjct: 121 PSIDQVLRISIQLAKALQYLHNQGIVHRDVKPANVLLDRNLCAHLADFGLAEYRKNLKGV 180
Query: 219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
S++NWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIH+EKSDVYSFGISINELLTGVVPY
Sbjct: 181 SMENWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHTEKSDVYSFGISINELLTGVVPY 240
Query: 279 TDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHN 338
TDLRAEAQAHTVLEMNYTEQQLTAAVVSG LRP LA E G AS+LSLIQRCWD NP
Sbjct: 241 TDLRAEAQAHTVLEMNYTEQQLTAAVVSGNLRPALAGPESGASASMLSLIQRCWDENPQI 300
Query: 339 RPSFSDIALELDLVLEHRKSLKEEDLCAGKSYVTYDDKLINSGNNMHTYHESINWTAQGE 398
RPSF +I LEL VLEH+ E+ G+S + D+L + N + + ESINW+ QGE
Sbjct: 301 RPSFDNIVLELSTVLEHKLKTMGENQAGGESTI-LQDQLSDGANKVQIFRESINWSTQGE 359
Query: 399 HSSKKASHAAESDVKLWLESANDALTYYPVLSWGSFATCGRRETMEDTHFLMPHMYNQKE 458
SKK S A ++ WL+S+ND L Y+PVLSWGSFATCG+RETMED HFLMPHM ++K+
Sbjct: 360 ELSKKVSLAVNLGLRNWLDSSNDPLAYHPVLSWGSFATCGKRETMEDRHFLMPHMCDEKD 419
Query: 459 IHMFGIFDGHRGSAAAEFSARALPGFLQNLGSTTRPTDALLEAFIRTDVAFRNELDSLRK 518
IH+FGIFDGHRG+AAAEFSA+A+PGFL++L T P AL E FI TD+AFRNELDS RK
Sbjct: 420 IHVFGIFDGHRGAAAAEFSAQAMPGFLRSLAFVTSPKSALFEVFISTDLAFRNELDSHRK 479
Query: 519 SKRVVQKDWHPGCTAIAALIVRNRLFVANAGDCRAILCRGGHPFALSRDHVASCLEERER 578
S RV+QKDWHPGCTAIAALIVR++LF+ANAGDCR+ILCR G F+LS+DH+ASCLEERER
Sbjct: 480 S-RVIQKDWHPGCTAIAALIVRDKLFIANAGDCRSILCRSGRAFSLSKDHIASCLEERER 538
Query: 579 VVSAGGNVNWQVDTWRVGPPALQVTRSIGDDDLKPAVTAEPEITETIMTPEDEYLVMASD 638
VVSAGG V WQVDTWRVGP ALQVTRSIGDDDLKPAVTAEPEITET ++ EDE+LVMASD
Sbjct: 539 VVSAGGLVKWQVDTWRVGPAALQVTRSIGDDDLKPAVTAEPEITETTLSSEDEFLVMASD 598
Query: 639 GLWDVVSHVEAVGIIKDTVKEPGMCSKRLATEAAERGSKDNITVIVVFLQPVSTAERIY 697
GLWDVVS+ E V II+DTVKEPGMCSKRLATEAAERGSKDNITVIVVFL+PVSTAERIY
Sbjct: 599 GLWDVVSNEEVVDIIRDTVKEPGMCSKRLATEAAERGSKDNITVIVVFLRPVSTAERIY 657
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224139662|ref|XP_002323217.1| predicted protein [Populus trichocarpa] gi|222867847|gb|EEF04978.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1062 bits (2746), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 514/662 (77%), Positives = 577/662 (87%), Gaps = 4/662 (0%)
Query: 39 MGLKVLEPNTCIRGCCSSQSIPLHLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPI 98
MGL+++EPN+CIRGCC+S SIPLHLPPSSYTLLSPIA+GAESVVY A LDGRKVAVKKPI
Sbjct: 1 MGLEIVEPNSCIRGCCTSNSIPLHLPPSSYTLLSPIAKGAESVVYGAVLDGRKVAVKKPI 60
Query: 99 LSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWS 158
LSTSE++D FHKELQLLCKLDHPG+AK VAAHAKPPNYMFFFEFYES NL+EKLHVEEWS
Sbjct: 61 LSTSEDIDKFHKELQLLCKLDHPGIAKLVAAHAKPPNYMFFFEFYESGNLSEKLHVEEWS 120
Query: 159 PSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI 218
P++DQVLMI QLAKALQYLHN IVHRDVKPAN+LLD NLCPHLADFGLAEY++NLK +
Sbjct: 121 PNMDQVLMITVQLAKALQYLHNHEIVHRDVKPANILLDENLCPHLADFGLAEYQKNLKGV 180
Query: 219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
SL+NWRSSGKPTGGFHKKNMVGTLIYMAPEIL+KEIH+EKSDVYSFGISINELLTGVVPY
Sbjct: 181 SLENWRSSGKPTGGFHKKNMVGTLIYMAPEILRKEIHTEKSDVYSFGISINELLTGVVPY 240
Query: 279 TDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHN 338
TDLRAEAQAHTVLEMNYTEQQLTA+VVSG LRP LA L G ASILSLIQRCWD NP N
Sbjct: 241 TDLRAEAQAHTVLEMNYTEQQLTASVVSGKLRPALAGLGSGASASILSLIQRCWDDNPQN 300
Query: 339 RPSFSDIALELDLVLEHRKSLKEEDLCAGKSYVTYDDKLINSGNNMHTYHESINWTAQGE 398
RPSF+DI LELD +LE RK +D K +++ D+ +S N+ TY E INW+ QGE
Sbjct: 301 RPSFTDILLELDPILESRKKSIGKDFSLDKYSISHGDQPADSAKNLTTYQEIINWSTQGE 360
Query: 399 HSSKKASHAAESDVKLWLESANDALTYYPVLSWGSFATCGRRETMEDTHFLMPHMYNQKE 458
S KA A +S +++WL+ +N L Y P+LSWGSFATCG+RETMEDTHFLMPHM N+K+
Sbjct: 361 ILS-KAPPAVDSSLRIWLDCSNVGLAYRPILSWGSFATCGKRETMEDTHFLMPHMCNEKD 419
Query: 459 IHMFGIFDGHRGSAAAEFSARALPGFLQNLGSTTRPTDALLEAFIRTDVAFRNELDSLRK 518
IH FGIFDGHRG+AAAEFSARALPGFLQ+ GS + P +AL+EAF+ TD AFRNELD+ RK
Sbjct: 420 IHAFGIFDGHRGAAAAEFSARALPGFLQSTGSASSPRNALVEAFVSTDAAFRNELDTHRK 479
Query: 519 SKRVVQKDWHPGCTAIAALIVRNRLFVANAGDCRAILCRGGHPFALSRDHVASCLEERER 578
S+RVVQKDWHPGCTAI ALIV N+LFVANAGDC+ ILCR G + LS+DHVAS +EERER
Sbjct: 480 SRRVVQKDWHPGCTAIVALIVTNKLFVANAGDCKTILCRAGKAYPLSKDHVASYIEERER 539
Query: 579 VVSAGGNVNWQVDTWRVGPPALQ---VTRSIGDDDLKPAVTAEPEITETIMTPEDEYLVM 635
V+SAGG V WQ+DTWRVG ALQ VTRSIGDDDLKPAVTAEPEITET+++ EDE+LVM
Sbjct: 540 VLSAGGQVKWQIDTWRVGHAALQASSVTRSIGDDDLKPAVTAEPEITETVLSAEDEFLVM 599
Query: 636 ASDGLWDVVSHVEAVGIIKDTVKEPGMCSKRLATEAAERGSKDNITVIVVFLQPVSTAER 695
SDGLWDV+S + + IIKDTVKEPGMCSKRLATEAAERGSKDNITVIVVFL+PVSTAER
Sbjct: 600 GSDGLWDVMSSADVISIIKDTVKEPGMCSKRLATEAAERGSKDNITVIVVFLRPVSTAER 659
Query: 696 IY 697
IY
Sbjct: 660 IY 661
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357439937|ref|XP_003590246.1| Protein kinase and PP2C-like domain-containing protein [Medicago truncatula] gi|355479294|gb|AES60497.1| Protein kinase and PP2C-like domain-containing protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 1025 bits (2649), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 475/659 (72%), Positives = 562/659 (85%), Gaps = 6/659 (0%)
Query: 39 MGLKVLEPNTCIRGCCSSQSIPLHLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPI 98
+G +++EPNTCIRGCC+S SIPLHLPPSSY LL PIARGAESVVYE TL+G KVAVKKPI
Sbjct: 2 VGKEIVEPNTCIRGCCTSSSIPLHLPPSSYELLFPIARGAESVVYEGTLNGDKVAVKKPI 61
Query: 99 LSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWS 158
LS S+ ++NFHK+LQLLCKLDHPG+A +AAHAKPPNYMFFF+ YES NL KLHVEEW+
Sbjct: 62 LSLSQHINNFHKQLQLLCKLDHPGIATLIAAHAKPPNYMFFFKLYESSNLGHKLHVEEWA 121
Query: 159 PSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI 218
P+V+ LMI QLAKALQYLHNLGI+HRDVKP+N+LLD NLCPHL DFGLAEY+ ++K +
Sbjct: 122 PTVNDALMITMQLAKALQYLHNLGILHRDVKPSNILLDINLCPHLTDFGLAEYKSDIKGV 181
Query: 219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
SL+NW+SSGKPTGGFHKKNMVGTL+YMAPEILKKE+H+EKSDVYSFGISINELLTGVVPY
Sbjct: 182 SLENWKSSGKPTGGFHKKNMVGTLVYMAPEILKKELHTEKSDVYSFGISINELLTGVVPY 241
Query: 279 TDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHN 338
TDLRAEAQAHTVLEMNYTEQQLTAAVVS GLRP+LAS ELG+P+ ++S+I++CWD NP +
Sbjct: 242 TDLRAEAQAHTVLEMNYTEQQLTAAVVSDGLRPVLASEELGIPSRLVSMIRKCWDANPKS 301
Query: 339 RPSFSDIALELDLVLEHRKSLKEEDLCAGKSYVTYDDKLINSGNNMHTYHESINWTAQGE 398
RPSF DI ELD ++EHRK K ED+ ++ D+L++ TY ESI+W+AQGE
Sbjct: 302 RPSFDDIVKELDFIMEHRKVKKVEDMHIRPCNLSV-DQLVDK-----TYQESISWSAQGE 355
Query: 399 HSSKKASHAAESDVKLWLESANDALTYYPVLSWGSFATCGRRETMEDTHFLMPHMYNQKE 458
++ S + +S + W ES ++ Y P+LSWGS+ATCGRRE MEDTHF++PH++N+K+
Sbjct: 356 LLARNTSSSTDSGFRTWCESYDEPFAYRPILSWGSYATCGRREAMEDTHFILPHVFNEKD 415
Query: 459 IHMFGIFDGHRGSAAAEFSARALPGFLQNLGSTTRPTDALLEAFIRTDVAFRNELDSLRK 518
++ FGIFDGHRG+AAAEFS+RA+P LQ LG T P +AL+EAF+RTD AFR EL S RK
Sbjct: 416 VYAFGIFDGHRGAAAAEFSSRAVPAVLQTLGFKTSPANALVEAFLRTDTAFRKELASYRK 475
Query: 519 SKRVVQKDWHPGCTAIAALIVRNRLFVANAGDCRAILCRGGHPFALSRDHVASCLEERER 578
S R +QKDWHPGCTAIAA++ N+LFVAN+GDCRAIL R G+P ALS+DHVASCL+ERER
Sbjct: 476 SNRCIQKDWHPGCTAIAAIVSGNKLFVANSGDCRAILYRAGNPIALSKDHVASCLQERER 535
Query: 579 VVSAGGNVNWQVDTWRVGPPALQVTRSIGDDDLKPAVTAEPEITETIMTPEDEYLVMASD 638
V+ GG V+WQVDTWRVG PALQVTRSIGDDDLKPAVTAEPEITE + EDE+LVMASD
Sbjct: 536 VIRQGGQVHWQVDTWRVGLPALQVTRSIGDDDLKPAVTAEPEITENTLHAEDEFLVMASD 595
Query: 639 GLWDVVSHVEAVGIIKDTVKEPGMCSKRLATEAAERGSKDNITVIVVFLQPVSTAERIY 697
GLWDV+S ++ + IIKDTVKE GMCSKRLATEA ERGSKDNITVIVVFL+PVSTAERIY
Sbjct: 596 GLWDVMSSLDVINIIKDTVKEAGMCSKRLATEAVERGSKDNITVIVVFLRPVSTAERIY 654
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356500335|ref|XP_003518988.1| PREDICTED: protein kinase and PP2C-like domain-containing protein-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1014 bits (2623), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 477/659 (72%), Positives = 560/659 (84%), Gaps = 1/659 (0%)
Query: 39 MGLKVLEPNTCIRGCCSSQSIPLHLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPI 98
MG+++LEPNTCIRGCC+S SIPLHLPPSSYTLLSPIARG+ESVVYE TLDG +VAVKKPI
Sbjct: 1 MGIEILEPNTCIRGCCTSPSIPLHLPPSSYTLLSPIARGSESVVYEGTLDGTRVAVKKPI 60
Query: 99 LSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWS 158
LSTSE+++ FHKELQLLCKLDHPG+A +AAHAKPPNYMFFF+ +ES NLA+KLHVEEW
Sbjct: 61 LSTSEDINKFHKELQLLCKLDHPGIATPIAAHAKPPNYMFFFKLFESPNLAQKLHVEEWI 120
Query: 159 PSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI 218
P+++ LMIA QLAKALQYLHNLGIVHRDVKPAN+LLD+NLCPHL DFGLAEY+ +LK +
Sbjct: 121 PTLNDALMIAMQLAKALQYLHNLGIVHRDVKPANILLDKNLCPHLTDFGLAEYKNDLKRV 180
Query: 219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
S +NW+SSGKPTGGFHKKNMVGTLIYMAPEIL+KE+H+EKSDVYSFGISINELLTGVVPY
Sbjct: 181 STENWKSSGKPTGGFHKKNMVGTLIYMAPEILRKELHTEKSDVYSFGISINELLTGVVPY 240
Query: 279 TDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHN 338
TDLR EAQAHTVLEMNYTEQQLTAAVVS GLRP+LA+ +LG+P+ +LS+I++CWD +P+N
Sbjct: 241 TDLRTEAQAHTVLEMNYTEQQLTAAVVSDGLRPVLAAEDLGIPSRLLSMIKKCWDADPNN 300
Query: 339 RPSFSDIALELDLVLEHRKSLKEEDLCAGKSYVTYDDKLINSGNNMHTYHESINWTAQGE 398
RP+F DI ELDLV+EH K K ED+ + Y + + ++ Y ES +W +GE
Sbjct: 301 RPAFDDIVEELDLVMEHGKLKKAEDIHI-RPYNLHVVQPAGKTDHFKAYQESFSWFTRGE 359
Query: 399 HSSKKASHAAESDVKLWLESANDALTYYPVLSWGSFATCGRRETMEDTHFLMPHMYNQKE 458
++ AS A +S + ES++ Y+P +SWGS+ATCGRRETMEDTHF++PH+ ++K+
Sbjct: 360 LLARSASSANDSGLITRCESSDKPSAYHPTMSWGSYATCGRRETMEDTHFILPHICDEKD 419
Query: 459 IHMFGIFDGHRGSAAAEFSARALPGFLQNLGSTTRPTDALLEAFIRTDVAFRNELDSLRK 518
+ FGIFDGHRG+AAA FS+RA+P LQ P +AL EAFI+TD AFR ELDS RK
Sbjct: 420 AYAFGIFDGHRGAAAAAFSSRAVPAVLQTSDFMGSPANALAEAFIKTDAAFRKELDSYRK 479
Query: 519 SKRVVQKDWHPGCTAIAALIVRNRLFVANAGDCRAILCRGGHPFALSRDHVASCLEERER 578
S R +QKDWHPGCTAIA LIVRN+LFVAN GDCR ILCR G+P ALS+DHVASCL+ERER
Sbjct: 480 SNRCIQKDWHPGCTAIAILIVRNKLFVANIGDCRVILCRAGNPIALSKDHVASCLQERER 539
Query: 579 VVSAGGNVNWQVDTWRVGPPALQVTRSIGDDDLKPAVTAEPEITETIMTPEDEYLVMASD 638
V+ GG V+WQVDTWRVG PALQVTRSIGDDDLKPAVTAEPEITE+ + PEDE+LVMASD
Sbjct: 540 VIRQGGQVHWQVDTWRVGLPALQVTRSIGDDDLKPAVTAEPEITESTLCPEDEFLVMASD 599
Query: 639 GLWDVVSHVEAVGIIKDTVKEPGMCSKRLATEAAERGSKDNITVIVVFLQPVSTAERIY 697
GLWD +S +E + IIKDTVKEPGMCSKRLATEA ERGSKDNITVIVVFL+PVSTAERIY
Sbjct: 600 GLWDAISSMEVINIIKDTVKEPGMCSKRLATEAVERGSKDNITVIVVFLRPVSTAERIY 658
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297827721|ref|XP_002881743.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] gi|297327582|gb|EFH58002.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 974 bits (2517), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 466/667 (69%), Positives = 554/667 (83%), Gaps = 14/667 (2%)
Query: 39 MGLKVLEPNTCIRGCCSSQSIPLHLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPI 98
M +++++PNTCIRGCC+S+SIPLHLP SS+TLLSPIA+G+ESVVYEA LDGR+VA KKPI
Sbjct: 1 MVMEIVKPNTCIRGCCTSESIPLHLPSSSFTLLSPIAKGSESVVYEAILDGRRVAAKKPI 60
Query: 99 LSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWS 158
LSTS++LD FH+ LQLLC LDHPG+AK +AAHAKPPNYMFFFE YES LAEKLHVEEWS
Sbjct: 61 LSTSDDLDKFHRNLQLLCNLDHPGVAKLLAAHAKPPNYMFFFELYESGTLAEKLHVEEWS 120
Query: 159 PSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI 218
PS+DQVL+I LAKALQYLHN GIVHRDVKPANVLLD P+LADFGLAEY++NL+E+
Sbjct: 121 PSIDQVLVITLHLAKALQYLHNNGIVHRDVKPANVLLDEKFFPYLADFGLAEYKKNLREV 180
Query: 219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
+L+NWRSSGKPTGGFHKKNMVGTLIYMAPE+L+K++++EKSD+YSFGI INELLTGVVPY
Sbjct: 181 NLQNWRSSGKPTGGFHKKNMVGTLIYMAPELLRKDMYTEKSDIYSFGILINELLTGVVPY 240
Query: 279 TDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHN 338
TDLRAEAQAHTVLEMNYTEQQLTAA+VS GLRP LA L LP ++LSLIQ CW+ +P
Sbjct: 241 TDLRAEAQAHTVLEMNYTEQQLTAAIVSSGLRPALAETGLHLPKNLLSLIQNCWEADPSK 300
Query: 339 RPSFSDIALELDLVLEHRKSLKEEDLCAGKSYVTYDDK-----LINSGNNMHTYHESINW 393
RPS ++ LEL+ + E + K++ K+Y + D + NSG Y + +NW
Sbjct: 301 RPSSDNVGLELESIWEQVRG-KQQGHLLEKTYNSQSDTDGADIIKNSGE----YRDIVNW 355
Query: 394 TAQGEHSSKKASHAAESDVKLWLESANDALTYYPVLSWGSFATCGRRETMEDTHFLMPHM 453
++QGE SKK+S + DVKLW S +D +Y PV+S GSFATCGRRE+MEDTHFLMPHM
Sbjct: 356 SSQGECLSKKSSVSTVFDVKLWSTSIDDPSSYVPVISCGSFATCGRRESMEDTHFLMPHM 415
Query: 454 YNQKEIHMFGIFDGHRG---SAAAEFSARALPGFLQNLGSTTRPTDALLEAFIRTDVAFR 510
N++ IH+F IFDGHRG + AAEFSA+ LPG +Q+L ST+ +AL +AF+RTD+AFR
Sbjct: 416 CNEESIHLFAIFDGHRGIPTATAAEFSAQVLPGLVQSLCSTS-AGEALSQAFVRTDLAFR 474
Query: 511 NELDSLRKSKRVVQKDWHPGCTAIAALIVRNRLFVANAGDCRAILCRGGHPFALSRDHVA 570
ELDS R+SKRV QKDWHPGCTAIA+L+V N+LFVAN GD RAILCR GHPFALS+ H+A
Sbjct: 475 QELDSHRQSKRVSQKDWHPGCTAIASLLVENKLFVANVGDSRAILCRAGHPFALSKAHLA 534
Query: 571 SCLEERERVVSAGGNVNWQVDTWRVGPPALQVTRSIGDDDLKPAVTAEPEITETIMTPED 630
+C++ER RVV GG + W VDTWRV P LQVTRSIGDDDLKPAVTAEPEI+ETI++ +D
Sbjct: 535 TCIDERNRVVGEGGRIEWLVDTWRVAPAGLQVTRSIGDDDLKPAVTAEPEISETILSADD 594
Query: 631 EYLVMASDGLWDVVSHVEAVGIIKDTVKEPGMCSKRLATEAAERGSKDNITVIVVFLQPV 690
E+LVMASDGLWDVV+ E +GII+DTVKEP MCSKRLATEAA RGS DNITVIVVFL+PV
Sbjct: 595 EFLVMASDGLWDVVNDEEVIGIIRDTVKEPSMCSKRLATEAAARGSGDNITVIVVFLRPV 654
Query: 691 STAERIY 697
STAERIY
Sbjct: 655 STAERIY 661
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|30688440|ref|NP_850336.1| putative protein phosphatase 2C 31 [Arabidopsis thaliana] gi|75249489|sp|Q940A2.1|P2C31_ARATH RecName: Full=Protein kinase and PP2C-like domain-containing protein; Includes: RecName: Full=Probable serine/threonine protein kinase At2g40860; Includes: RecName: Full=Probable protein phosphatase 2C 31; Short=AtPP2C31 gi|15810225|gb|AAL07230.1| unknown protein [Arabidopsis thaliana] gi|22136688|gb|AAM91663.1| unknown protein [Arabidopsis thaliana] gi|330254797|gb|AEC09891.1| putative protein phosphatase 2C 31 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 972 bits (2513), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 459/663 (69%), Positives = 552/663 (83%), Gaps = 9/663 (1%)
Query: 39 MGLKVLEPNTCIRGCCSSQSIPLHLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPI 98
M +++++PNTCIRGCC+S+SIPLHLP SS+TLLSPIA+G+ESVVYEA LDGR+VA KKPI
Sbjct: 1 MVMEIVKPNTCIRGCCTSESIPLHLPSSSFTLLSPIAKGSESVVYEAILDGRRVAAKKPI 60
Query: 99 LSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWS 158
LSTS++LD FH+ LQL C L+HPG+AK +AAHAKPPNYMFFF+FYES LAEKLHVEEWS
Sbjct: 61 LSTSDDLDKFHRNLQLSCNLNHPGVAKLLAAHAKPPNYMFFFDFYESGTLAEKLHVEEWS 120
Query: 159 PSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI 218
PS+DQVL+I LAKALQYLHN GIVHRDVKPANVLLD P+LADFGLAEY++NL+E+
Sbjct: 121 PSIDQVLLITLHLAKALQYLHNNGIVHRDVKPANVLLDEKFFPYLADFGLAEYKKNLREV 180
Query: 219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
+L+NWRSSGKPTGGFHKKNMVGTLIYMAPEIL+K++++EK+D+YSFGI INELLTGVVPY
Sbjct: 181 NLQNWRSSGKPTGGFHKKNMVGTLIYMAPEILRKDMYTEKADIYSFGILINELLTGVVPY 240
Query: 279 TDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHN 338
TD RAEAQAHTVLEMNYTEQQLT A+VS GLRP LA + L LP S+LSLIQ CW+ +P
Sbjct: 241 TDRRAEAQAHTVLEMNYTEQQLTVAIVSSGLRPALAEIGLHLPKSLLSLIQNCWESDPSK 300
Query: 339 RPSFSDIALELDLVLEHRKSLKEEDLCAGKSYVTYD----DKLINSGNNMHTYHESINWT 394
RPS ++ LEL+ + E + ++ L S D D + NSG+ Y +++NW
Sbjct: 301 RPSSDNVVLELESIWEQVRGKQQGHLLEKTSNSQSDTDGADIIKNSGD----YRDTVNWF 356
Query: 395 AQGEHSSKKASHAAESDVKLWLESANDALTYYPVLSWGSFATCGRRETMEDTHFLMPHMY 454
+QGE SKK+S + DVKLW S ++ Y PV+S GSFATCGRRE+MEDTHF++PHM
Sbjct: 357 SQGECLSKKSSVSTVFDVKLWSSSTDEPSRYVPVISCGSFATCGRRESMEDTHFIIPHMC 416
Query: 455 NQKEIHMFGIFDGHRGSAAAEFSARALPGFLQNLGSTTRPTDALLEAFIRTDVAFRNELD 514
N++ IH+F IFDGHRG+AAAEFSA+ LPG +Q+L ST+ +AL +AF+RTD+AFR ELD
Sbjct: 417 NEESIHLFAIFDGHRGAAAAEFSAQVLPGLVQSLCSTS-AGEALSQAFVRTDLAFRQELD 475
Query: 515 SLRKSKRVVQKDWHPGCTAIAALIVRNRLFVANAGDCRAILCRGGHPFALSRDHVASCLE 574
S R+SKRV QKDWHPGCTAIA+L+V N+LFVAN GD RAILCR GHPFALS+ H+A+C++
Sbjct: 476 SHRQSKRVSQKDWHPGCTAIASLLVENKLFVANVGDSRAILCRAGHPFALSKAHLATCID 535
Query: 575 ERERVVSAGGNVNWQVDTWRVGPPALQVTRSIGDDDLKPAVTAEPEITETIMTPEDEYLV 634
ER RV+ GG + W VDTWRV P LQVTRSIGDDDLKPAVTAEPEI+ETI++ +DE+LV
Sbjct: 536 ERNRVIGEGGRIEWLVDTWRVAPAGLQVTRSIGDDDLKPAVTAEPEISETILSADDEFLV 595
Query: 635 MASDGLWDVVSHVEAVGIIKDTVKEPGMCSKRLATEAAERGSKDNITVIVVFLQPVSTAE 694
MASDGLWDV++ E +GII+DTVKEP MCSKRLATEAA RGS DNITVIVVFL+PVSTAE
Sbjct: 596 MASDGLWDVMNDEEVIGIIRDTVKEPSMCSKRLATEAAARGSGDNITVIVVFLRPVSTAE 655
Query: 695 RIY 697
RIY
Sbjct: 656 RIY 658
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449505991|ref|XP_004162623.1| PREDICTED: protein kinase and PP2C-like domain-containing protein-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 969 bits (2505), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 472/664 (71%), Positives = 550/664 (82%), Gaps = 15/664 (2%)
Query: 39 MGLKVLEPNTCIRGCCSSQSIPLHLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPI 98
MGL++++PNTCIRGCCS+ SIPLHL PS++TLLSPIARG ES VYE LDGRKVAVKKPI
Sbjct: 1 MGLEIMDPNTCIRGCCSTNSIPLHLQPSAFTLLSPIARGGESTVYEGRLDGRKVAVKKPI 60
Query: 99 LSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWS 158
LSTSEELD FHKELQLLC+LDHPG+ K VAA+AKPPNYMFFFE+YES NLAEKLHVEEW+
Sbjct: 61 LSTSEELDKFHKELQLLCELDHPGIVKLVAANAKPPNYMFFFEYYESPNLAEKLHVEEWN 120
Query: 159 PSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI 218
PS++QVLMI +LAK LQYLHNLGIVHRDVKPANVLLD++L P+LADFGLA +++ LKE+
Sbjct: 121 PSINQVLMITLELAKTLQYLHNLGIVHRDVKPANVLLDKDLHPYLADFGLAIHQKYLKEV 180
Query: 219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
S +NW+SSGKPTGGF+KK+MVGTLIYMAPEIL+KEIH++ SDVYSFGI +NELLTGVVPY
Sbjct: 181 SAENWKSSGKPTGGFYKKSMVGTLIYMAPEILRKEIHTDLSDVYSFGILMNELLTGVVPY 240
Query: 279 TDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHN 338
TDLR EAQAHTVLEMNYTEQ LTAA+VS GLRP L S E G P+ +LSLIQ CWD NP N
Sbjct: 241 TDLRTEAQAHTVLEMNYTEQLLTAAIVSDGLRPALPSDESGTPSRLLSLIQSCWDANPKN 300
Query: 339 RPSFSDIALELDLVLEHRKSLK-----EEDLCAGKSYVTYDDKLINSGNNMHTYHESINW 393
RPSFSDI ++L+ + E RKSL+ + DLC +L ++ + Y E INW
Sbjct: 301 RPSFSDIVMDLESIWESRKSLESVSSGQLDLCG---------RLSDANEHDCAYREEINW 351
Query: 394 TAQGEHSSKKASHAAESDVKLWLESANDALTYYPVLSWGSFATCGRRETMEDTHFLMPHM 453
+ QGEH S+K S + WL+ + D L Y P LS GSF+T G RETMED+HFL+PH
Sbjct: 352 SNQGEHCSQKFS-GDRCGLNEWLDHSTDQLAYRPTLSCGSFSTRGMRETMEDSHFLLPHF 410
Query: 454 YNQKEIHMFGIFDGHRGSAAAEFSARALPGFLQNLGSTTRPTDALLEAFIRTDVAFRNEL 513
+ + IH FGIFDGHRG+AAAEFSA+A+PGFLQ ST P D L+EAF++TD+ FR EL
Sbjct: 411 CSDENIHAFGIFDGHRGAAAAEFSAQAIPGFLQRAFSTRSPADVLMEAFVKTDIEFRKEL 470
Query: 514 DSLRKSKRVVQKDWHPGCTAIAALIVRNRLFVANAGDCRAILCRGGHPFALSRDHVASCL 573
+ RKSK++ QKDWHPGCTA+ ALIVR++LF ANAGDCRAILCR G P LS+DHVASCL
Sbjct: 471 EFFRKSKKLKQKDWHPGCTAVVALIVRDKLFAANAGDCRAILCRAGDPIVLSKDHVASCL 530
Query: 574 EERERVVSAGGNVNWQVDTWRVGPPALQVTRSIGDDDLKPAVTAEPEITETIMTPEDEYL 633
EERERV++ GG V WQVDTWRVGP ALQVTRSIGDDDLKPAVTAEPEITET++T +D+ L
Sbjct: 531 EERERVINNGGQVKWQVDTWRVGPAALQVTRSIGDDDLKPAVTAEPEITETVLTSQDDCL 590
Query: 634 VMASDGLWDVVSHVEAVGIIKDTVKEPGMCSKRLATEAAERGSKDNITVIVVFLQPVSTA 693
VMASDGLWDV+S+ E V II+DTVK+PGMCSKRLATEAA RGS+DNITVIVVFL PVST
Sbjct: 591 VMASDGLWDVLSNSEVVDIIRDTVKDPGMCSKRLATEAAARGSRDNITVIVVFLHPVSTI 650
Query: 694 ERIY 697
ERIY
Sbjct: 651 ERIY 654
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449437706|ref|XP_004136632.1| PREDICTED: protein kinase and PP2C-like domain-containing protein-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 960 bits (2482), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 469/664 (70%), Positives = 548/664 (82%), Gaps = 20/664 (3%)
Query: 39 MGLKVLEPNTCIRGCCSSQSIPLHLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPI 98
MGL++++PNTCIRGCCS+ SIPLHL PS++TLLSPIARG ES VYE LDGRKVAVKKPI
Sbjct: 1 MGLEIMDPNTCIRGCCSTNSIPLHLQPSAFTLLSPIARGGESTVYEGRLDGRKVAVKKPI 60
Query: 99 LSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWS 158
LSTSEELD FHKELQLLC+LDHPG+ K VAA+AKPPNYMFFFE+YES NLAEKLHVEEW+
Sbjct: 61 LSTSEELDKFHKELQLLCELDHPGIVKLVAANAKPPNYMFFFEYYESPNLAEKLHVEEWN 120
Query: 159 PSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI 218
PS++QVLMI +LAK LQYLHNLGIVHRDVKPANVLLD++L P+LADFGLA +++ LKE+
Sbjct: 121 PSINQVLMITLELAKTLQYLHNLGIVHRDVKPANVLLDKDLHPYLADFGLAIHQKYLKEV 180
Query: 219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
S +NW+SSGKPTGGF+KK+MVGTLIYMAPEIL+KEIH++ SDVYSFGI +NELLTGVVPY
Sbjct: 181 SAENWKSSGKPTGGFYKKSMVGTLIYMAPEILRKEIHTDLSDVYSFGILMNELLTGVVPY 240
Query: 279 TDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHN 338
TDLR EAQAHTVLEMNYTEQ LTAA+VS GLRP L + P+ +LSLIQ CWD NP N
Sbjct: 241 TDLRTEAQAHTVLEMNYTEQLLTAAIVSDGLRPALPT-----PSRLLSLIQSCWDANPKN 295
Query: 339 RPSFSDIALELDLVLEHRKSLK-----EEDLCAGKSYVTYDDKLINSGNNMHTYHESINW 393
RPSFSDI ++L+ + E RKSL+ + DLC +L ++ + Y E INW
Sbjct: 296 RPSFSDIVMDLESIWESRKSLESVSSGQLDLCG---------RLSDANEHDCAYREEINW 346
Query: 394 TAQGEHSSKKASHAAESDVKLWLESANDALTYYPVLSWGSFATCGRRETMEDTHFLMPHM 453
+ QGEH S+K S + WL+ + D L Y P LS GSF+T G RETMED+HFL+PH
Sbjct: 347 SNQGEHCSQKFS-GDRCGLNEWLDHSTDQLAYRPTLSCGSFSTRGMRETMEDSHFLLPHF 405
Query: 454 YNQKEIHMFGIFDGHRGSAAAEFSARALPGFLQNLGSTTRPTDALLEAFIRTDVAFRNEL 513
+ + IH FGIFDGHRG+AAAEFSA+A+PGFLQ ST P D L+EAF++TD+ FR EL
Sbjct: 406 CSDENIHAFGIFDGHRGAAAAEFSAQAIPGFLQRAFSTRSPADVLMEAFVKTDIEFRKEL 465
Query: 514 DSLRKSKRVVQKDWHPGCTAIAALIVRNRLFVANAGDCRAILCRGGHPFALSRDHVASCL 573
+ RKSK++ QKDWHPGCTA+ ALIVR++LF ANAGDCRAILCR G P LS+DHVASCL
Sbjct: 466 EFFRKSKKLKQKDWHPGCTAVVALIVRDKLFAANAGDCRAILCRAGDPIVLSKDHVASCL 525
Query: 574 EERERVVSAGGNVNWQVDTWRVGPPALQVTRSIGDDDLKPAVTAEPEITETIMTPEDEYL 633
EERERV++ GG V WQVDTWRVGP ALQVTRSIGDDDLKPAVTAEPEITET++T +D+ L
Sbjct: 526 EERERVINNGGQVKWQVDTWRVGPAALQVTRSIGDDDLKPAVTAEPEITETVLTSQDDCL 585
Query: 634 VMASDGLWDVVSHVEAVGIIKDTVKEPGMCSKRLATEAAERGSKDNITVIVVFLQPVSTA 693
VMASDGLWDV+S+ E V II+DTVK+PGMCSKRLATEAA RGS+DNITVIVVFL PVST
Sbjct: 586 VMASDGLWDVLSNSEVVDIIRDTVKDPGMCSKRLATEAAARGSRDNITVIVVFLHPVSTI 645
Query: 694 ERIY 697
ERIY
Sbjct: 646 ERIY 649
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 697 | ||||||
| TAIR|locus:2058495 | 658 | AT2G40860 [Arabidopsis thalian | 0.944 | 1.0 | 0.670 | 1.6e-244 | |
| TAIR|locus:2149363 | 447 | AT5G24940 [Arabidopsis thalian | 0.358 | 0.559 | 0.405 | 3.1e-40 | |
| TAIR|locus:2124784 | 311 | WIN2 "HOPW1-1-interacting 2" [ | 0.350 | 0.784 | 0.404 | 1.9e-39 | |
| TAIR|locus:2183695 | 354 | AT5G10740 [Arabidopsis thalian | 0.361 | 0.711 | 0.413 | 1.5e-37 | |
| TAIR|locus:2163781 | 420 | AT5G53140 [Arabidopsis thalian | 0.351 | 0.583 | 0.403 | 5.2e-35 | |
| TAIR|locus:2008545 | 445 | AT1G67820 [Arabidopsis thalian | 0.299 | 0.469 | 0.384 | 2.7e-33 | |
| TAIR|locus:2029172 | 371 | AT1G43900 [Arabidopsis thalian | 0.348 | 0.654 | 0.354 | 2e-30 | |
| ZFIN|ZDB-GENE-060929-136 | 351 | ppm1lb "protein phosphatase, M | 0.358 | 0.712 | 0.347 | 9.2e-30 | |
| TAIR|locus:2045678 | 396 | AT2G30020 [Arabidopsis thalian | 0.341 | 0.601 | 0.342 | 1.9e-29 | |
| UNIPROTKB|E1BTL4 | 360 | PPM1L "Uncharacterized protein | 0.364 | 0.705 | 0.347 | 2.5e-29 |
| TAIR|locus:2058495 AT2G40860 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2356 (834.4 bits), Expect = 1.6e-244, P = 1.6e-244
Identities = 442/659 (67%), Positives = 528/659 (80%)
Query: 39 MGLKVLEPNTCIRGCCSSQSIPLHLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPI 98
M +++++PNTCIRGCC+S+SIPLHLP SS+TLLSPIA+G+ESVVYEA LDGR+VA KKPI
Sbjct: 1 MVMEIVKPNTCIRGCCTSESIPLHLPSSSFTLLSPIAKGSESVVYEAILDGRRVAAKKPI 60
Query: 99 LSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWS 158
LSTS++LD FH+ LQL C L+HPG+AK +AAHAKPPNYMFFF+FYES LAEKLHVEEWS
Sbjct: 61 LSTSDDLDKFHRNLQLSCNLNHPGVAKLLAAHAKPPNYMFFFDFYESGTLAEKLHVEEWS 120
Query: 159 PSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI 218
PS+DQVL+I LAKALQYLHN GIVHRDVKPANVLLD P+LADFGLAEY++NL+E+
Sbjct: 121 PSIDQVLLITLHLAKALQYLHNNGIVHRDVKPANVLLDEKFFPYLADFGLAEYKKNLREV 180
Query: 219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
+L+NWRSSGKPTGGFHKKNMVGTLIYMAPEIL+K++++EK+D+YSFGI INELLTGVVPY
Sbjct: 181 NLQNWRSSGKPTGGFHKKNMVGTLIYMAPEILRKDMYTEKADIYSFGILINELLTGVVPY 240
Query: 279 TDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHN 338
TD RAEAQAHTVLEMNYTEQQLT A+VS GLRP LA + L LP S+LSLIQ CW+ +P
Sbjct: 241 TDRRAEAQAHTVLEMNYTEQQLTVAIVSSGLRPALAEIGLHLPKSLLSLIQNCWESDPSK 300
Query: 339 RPSFSDIALELDLVLEHRKSLKEEDLCAGKSYVTYDDKLINSGNNMHTYHESINWTAQGX 398
RPS ++ LEL+ + E + ++ L S D + N Y +++NW +QG
Sbjct: 301 RPSSDNVVLELESIWEQVRGKQQGHLLEKTSNSQSDTDGADIIKNSGDYRDTVNWFSQGE 360
Query: 399 XXXXXXXXXXXXDVKLWLESANDALTYYPVLSWGSFATCGRRETMEDTHFLMPHMYNQKE 458
DVKLW S ++ Y PV+S GSFATCGRRE+MEDTHF++PHM N++
Sbjct: 361 CLSKKSSVSTVFDVKLWSSSTDEPSRYVPVISCGSFATCGRRESMEDTHFIIPHMCNEES 420
Query: 459 IHMFGIFDGHRGSAAAEFSARALPGFLQNLGSTTRPTDALLEAFIRTDVAFRNELDSLRK 518
IH+F IFDGHRG+AAAEFSA+ LPG +Q+L ST+ +AL +AF+RTD+AFR ELDS R+
Sbjct: 421 IHLFAIFDGHRGAAAAEFSAQVLPGLVQSLCSTSAG-EALSQAFVRTDLAFRQELDSHRQ 479
Query: 519 SKRVVQKDWHPGCTAIAALIVRNRLFVANAGDCRAILCRGGHPFALSRDHVASCLEERER 578
SKRV QKDWHPGCTAIA+L+V N+LFVAN GD RAILCR GHPFALS+ H+A+C++ER R
Sbjct: 480 SKRVSQKDWHPGCTAIASLLVENKLFVANVGDSRAILCRAGHPFALSKAHLATCIDERNR 539
Query: 579 VVSAGGNVNWQVDTWRVGPPALQVTRSIGDDDLKPAVXXXXXXXXXXXXXXDEYLVMASD 638
V+ GG + W VDTWRV P LQVTRSIGDDDLKPAV DE+LVMASD
Sbjct: 540 VIGEGGRIEWLVDTWRVAPAGLQVTRSIGDDDLKPAVTAEPEISETILSADDEFLVMASD 599
Query: 639 GLWDVVSHVEAVGIIKDTVKEPGMCSKRLATEAAERGSKDNITVIVVFLQPVSTAERIY 697
GLWDV++ E +GII+DTVKEP MCSKRLATEAA RGS DNITVIVVFL+PVSTAERIY
Sbjct: 600 GLWDVMNDEEVIGIIRDTVKEPSMCSKRLATEAAARGSGDNITVIVVFLRPVSTAERIY 658
|
|
| TAIR|locus:2149363 AT5G24940 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 432 (157.1 bits), Expect = 3.1e-40, P = 3.1e-40
Identities = 107/264 (40%), Positives = 152/264 (57%)
Query: 430 SWGSFATCGRRETMEDTHFLMPHMYNQKEIHMFGIFDGHRGSAAAEFSARAL-PGFLQNL 488
S+G ++ G+R +MED + + + +FG+FDGH GS AAE+ R L + +
Sbjct: 33 SYGYASSAGKRSSMEDFFETRIDGIDGEIVGLFGVFDGHGGSRAAEYVKRHLFSNLITHP 92
Query: 489 GSTTRPTDALLEAFIRTDVAFRNELDSLRKSKRVVQKDWHPGCTAIAALIVRNRLFVANA 548
+ A+ +A+ TD L KS+ +D G TA A++V +RL VAN
Sbjct: 93 KFISDTKSAIADAYTHTD-------SELLKSENSHTRD--AGSTASTAILVGDRLLVANV 143
Query: 549 GDCRAILCRGGHPFALSRDHVASCLEERERVVSAGGNVNWQVDTWRVGPPALQVTRSIGD 608
GD RA++CRGG+ FA+SRDH +ERER+ +AGG V W TWRVG L V+R+ GD
Sbjct: 144 GDSRAVICRGGNAFAVSRDHKPDQSDERERIENAGGFVMW-AGTWRVGG-VLAVSRAFGD 201
Query: 609 DDLKPAVXXXXXXXXXXXXXXDEYLVMASDGLWDVVSHVEAVGIIKDTVKEPGMCSKRLA 668
LK V E+L++ASDGLWDV S+ EAV ++K+ V++P +K+L
Sbjct: 202 RLLKQYVVADPEIQEEKIDDSLEFLILASDGLWDVFSNEEAVAVVKE-VEDPEESTKKLV 260
Query: 669 TEAAERGSKDNITVIVV-FLQPVS 691
EA +RGS DNIT +VV FL+ S
Sbjct: 261 GEAIKRGSADNITCVVVRFLESKS 284
|
|
| TAIR|locus:2124784 WIN2 "HOPW1-1-interacting 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 425 (154.7 bits), Expect = 1.9e-39, P = 1.9e-39
Identities = 104/257 (40%), Positives = 150/257 (58%)
Query: 430 SWGSFATCGRRETMEDTHFLMPHMYNQKEIHMFGIFDGHRGSAAAEFSARAL-PGFLQNL 488
S+G ++ G+R +MED + + + +FG+FDGH G+ AAE+ + L +++
Sbjct: 33 SYGYASSPGKRSSMEDFYETRIDGVEGEIVGLFGVFDGHGGARAAEYVKQNLFSNLIRHP 92
Query: 489 GSTTRPTDALLEAFIRTDVAFRNELDSLRKSKRVVQKDWHPGCTAIAALIVRNRLFVANA 548
+ T A+ +A+ +TD F KS+ +D G TA A++V +RL VAN
Sbjct: 93 KFISDTTAAIADAYNQTDSEFL-------KSENSQNRD--AGSTASTAILVGDRLLVANV 143
Query: 549 GDCRAILCRGGHPFALSRDHVASCLEERERVVSAGGNVNWQVDTWRVGPPALQVTRSIGD 608
GD RA++CRGG+ A+SRDH +ER+R+ AGG V W TWRVG L V+R+ GD
Sbjct: 144 GDSRAVICRGGNAIAVSRDHKPDQSDERQRIEDAGGFVMW-AGTWRVGG-VLAVSRAFGD 201
Query: 609 DDLKPAVXXXXXXXXXXXXXXDEYLVMASDGLWDVVSHVEAVGIIKDTVKEPGMCSKRLA 668
LK V E+L++ASDGLWDVVS+ EAVG+IK +++P +KRL
Sbjct: 202 RLLKQYVVADPEIQEEKVDSSLEFLILASDGLWDVVSNEEAVGMIK-AIEDPEEGAKRLM 260
Query: 669 TEAAERGSKDNITVIVV 685
EA +RGS DNIT +VV
Sbjct: 261 MEAYQRGSADNITCVVV 277
|
|
| TAIR|locus:2183695 AT5G10740 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 408 (148.7 bits), Expect = 1.5e-37, P = 1.5e-37
Identities = 110/266 (41%), Positives = 150/266 (56%)
Query: 430 SWGSFATCGRRETMEDTHFLMPHMYNQKEIHMFGIFDGHRGSAAAEFSARALPGFLQNLG 489
S+G ++ G+R +MED N + + +FG+FDGH G+ AAE+ R L NL
Sbjct: 33 SYGYASSAGKRSSMEDFFETRIDGINGEIVGLFGVFDGHGGARAAEYVKRHL---FSNL- 88
Query: 490 STTRPTDALLEAFIRTDVAFRNELDS-LRKSKRVVQKDWHPGCTAIAALIVRNRLFVANA 548
T P TD A+ N DS L KS+ +D G TA A++V +RL VAN
Sbjct: 89 -ITHPKFISDTKSAITD-AY-NHTDSELLKSENSHNRD--AGSTASTAILVGDRLVVANV 143
Query: 549 GDCRAILCRGGHPFALSRDHVASCLEERERVVSAGGNVNWQVDTWRVGPPALQVTRSIGD 608
GD RA++ RGG A+SRDH +ERER+ +AGG V W TWRVG L V+R+ GD
Sbjct: 144 GDSRAVISRGGKAIAVSRDHKPDQSDERERIENAGGFVMW-AGTWRVGG-VLAVSRAFGD 201
Query: 609 DDLKPAVXXXXXXXXXXXXXXDEYLVMASDGLWDVVSHVEAVGIIKDTVKEPGMCSKRLA 668
LK V E+L++ASDGLWDV S+ AV ++K+ V++P +K+L
Sbjct: 202 RLLKQYVVADPEIQEEKIDDTLEFLILASDGLWDVFSNEAAVAMVKE-VEDPEDSAKKLV 260
Query: 669 TEAAERGSKDNITVIVV-FLQPVSTA 693
EA +RGS DNIT +VV FL+ S +
Sbjct: 261 GEAIKRGSADNITCVVVRFLEKKSAS 286
|
|
| TAIR|locus:2163781 AT5G53140 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 385 (140.6 bits), Expect = 5.2e-35, P = 5.2e-35
Identities = 104/258 (40%), Positives = 137/258 (53%)
Query: 429 LSWGSFATCGRRETMEDTHFLMPHMYNQKEIHMFGIFDGHRGSAAAEFSARALPGFLQNL 488
LS G + G+R TMED + + + + MFGIFDGH GS AAE+ L L
Sbjct: 100 LSCGYCSFRGKRSTMEDFYDIKASTIEGQAVCMFGIFDGHGGSRAAEYLKEHLFNNLMKH 159
Query: 489 GSTTRPTD-ALLEAFIRTDVAFRNELDSLRKSKRVVQKDWHPGCTAIAALIVRNRLFVAN 547
T AL E + +TDVAF L K + D G TA AA++V N L+VAN
Sbjct: 160 PQFLTDTKLALNETYKQTDVAF------LESEKDTYRDD---GSTASAAVLVGNHLYVAN 210
Query: 548 AGDCRAILCRGGHPFALSRDHVASCLEERERVVSAGGNVNWQVDTWRVGPPALQVTRSIG 607
GD R I+ + G ALS DH + +ER+R+ SAGG + W TWRVG L ++R+ G
Sbjct: 211 VGDSRTIVSKAGKAIALSDDHKPNRSDERKRIESAGGVIMW-AGTWRVGG-VLAMSRAFG 268
Query: 608 DDDLKPAVXXXXXXXXXXXXXXDEYLVMASDGLWDVVSHVEAVGIIKDTVKEPGMCSKRL 667
+ LK V E LV+ASDGLWDVV + +AV + + +EP +++L
Sbjct: 269 NRMLKQFVVAEPEIQDLEIDHEAELLVLASDGLWDVVPNEDAVALAQSE-EEPEAAARKL 327
Query: 668 ATEAAERGSKDNITVIVV 685
A RGS DNIT IVV
Sbjct: 328 TDTAFSRGSADNITCIVV 345
|
|
| TAIR|locus:2008545 AT1G67820 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 331 (121.6 bits), Expect = 2.7e-33, Sum P(2) = 2.7e-33
Identities = 85/221 (38%), Positives = 118/221 (53%)
Query: 431 WGSFATCGRRETMEDTHFLMPHMYNQKEIHMFGIFDGHRGSAAAEFSARALPGFLQNLGS 490
+G + G+++ MEDTH ++P + + FG++DGH G+ AAEF A L ++ +
Sbjct: 121 FGVVSRNGKKKFMEDTHRIVPCLVGNSKKSFFGVYDGHGGAKAAEFVAENLHKYVVEMME 180
Query: 491 TTRPTDALLEAFIRTDVAF-RNELDSLRKSKRVVQKDWHPGCTAIAALIVRNRLFVANAG 549
+ + +EAF AF R + D L K VV G + A+I + V+N G
Sbjct: 181 NCKGKEEKVEAF---KAAFLRTDRDFLEKG--VVS-----GACCVTAVIQDQEMIVSNLG 230
Query: 550 DCRAILCRGGHPFALSRDHVASCLEERERVVSAGGNVNWQVDTWRVGPPALQVTRSIGDD 609
DCRA+LCR G AL+ DH +E+ER+ S GG V+ WRV L V+RSIGD
Sbjct: 231 DCRAVLCRAGVAEALTDDHKPGRDDEKERIESQGGYVDNHQGAWRV-QGILAVSRSIGDA 289
Query: 610 DLKPAVXXXXXXXXXXXXXXDEYLVMASDGLWDVVSHVEAV 650
LK V E+LV+ASDGLWDVVS+ EAV
Sbjct: 290 HLKKWVVAEPETRVLELEQDMEFLVLASDGLWDVVSNQEAV 330
|
|
| TAIR|locus:2029172 AT1G43900 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 343 (125.8 bits), Expect = 2.0e-30, P = 2.0e-30
Identities = 91/257 (35%), Positives = 132/257 (51%)
Query: 430 SWGSFATCGRRETMEDTHFLMPHMYNQKEIHMFGIFDGHRGSAAAEFSARALPGFLQNLG 489
S+G + G+R TMED N + + FG+FDGH G+ AE+ L L +
Sbjct: 123 SYGYSSLKGKRATMEDYFETRISDVNGQMVAFFGVFDGHGGARTAEYLKNNLFKNLVSHD 182
Query: 490 STTRPTD-ALLEAFIRTDVAFRNELDSLRKSKRVVQKDWHPGCTAIAALIVRNRLFVANA 548
T A++E F +TD + ++ + K G TA A ++ ++L VAN
Sbjct: 183 DFISDTKKAIVEVFKQTDEEYL--IEEAGQPKNA-------GSTAATAFLIGDKLIVANV 233
Query: 549 GDCRAILCRGGHPFALSRDHVASCLEERERVVSAGGNVNWQVDTWRVGPPALQVTRSIGD 608
GD R + R G LS DH +ER+R+ AGG + W TWRVG L V+R+ GD
Sbjct: 234 GDSRVVASRNGSAVPLSDDHKPDRSDERQRIEDAGGFIIW-AGTWRVGG-ILAVSRAFGD 291
Query: 609 DDLKPAVXXXXXXXXXXXXXXDEYLVMASDGLWDVVSHVEAVGIIKDTVKEPGMCSKRLA 668
LKP V E++V+ASDGLW+V+S+ +AV I++D + + +++L
Sbjct: 292 KQLKPYVIAEPEIQEEDISTL-EFIVVASDGLWNVLSNKDAVAIVRD-ISDAETAARKLV 349
Query: 669 TEAAERGSKDNITVIVV 685
E RGS DNIT IVV
Sbjct: 350 QEGYARGSCDNITCIVV 366
|
|
| ZFIN|ZDB-GENE-060929-136 ppm1lb "protein phosphatase, Mg2+/Mn2+ dependent, 1Lb" [Danio rerio (taxid:7955)] | Back alignment and assigned GO terms |
|---|
Score = 337 (123.7 bits), Expect = 9.2e-30, P = 9.2e-30
Identities = 92/265 (34%), Positives = 138/265 (52%)
Query: 438 GRRETMEDTHFLMPHMYNQKEIHMFGIFDGHRGSAAAEFSARALPGFL-QNLGSTTRPTD 496
GRR+ MED ++ N+ +F I+DGH G AAAE++ LP L Q L R +
Sbjct: 89 GRRDHMEDRFDILTDTRNRSHPAIFSIYDGHGGEAAAEYAKAHLPIMLRQQLQRYERQKE 148
Query: 497 --ALL-EAFIRTDVAFRNELDSLRKSKRVVQKDWHPGCTAIAALIVRNRLFVANAGDCRA 553
A+ +A +R + +D K D G T + AL+ L VAN GD RA
Sbjct: 149 NSAVSRQAILRQQIL---NMDRELLEKLTASYD-EAGTTCLVALLSEKELTVANVGDSRA 204
Query: 554 ILC-RGGHPFALSRDHVASCLEERERVVSAGGNVNWQVDTWRVGPPALQVTRSIGD---D 609
+LC + G+ LS DH L+ER+R+ AGG +++ +WRV L ++RS+GD
Sbjct: 205 VLCDKDGNAIPLSHDHKPYQLKERKRIKKAGGFISFS-GSWRV-QGVLSMSRSLGDFPLK 262
Query: 610 DLKPAVXXXXXXXXXXXXXXDEYLVMASDGLWDVVSHVEAVGIIKDTVKEPGMCSKRLAT 669
LK + +++++ASDGLWD S+ EAV IK+ + EP +K +
Sbjct: 263 KLKVLIPDPDLMTFDLDTLQPQFMILASDGLWDTFSNEEAVHFIKERLDEPHFGAKSIVL 322
Query: 670 EAAERGSKDNITVIVV-FLQPVSTA 693
++ RG DNITV+VV F++ + A
Sbjct: 323 QSFYRGCPDNITVMVVKFMKGAAKA 347
|
|
| TAIR|locus:2045678 AT2G30020 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 334 (122.6 bits), Expect = 1.9e-29, P = 1.9e-29
Identities = 89/260 (34%), Positives = 139/260 (53%)
Query: 438 GRRETMEDTHFLMPHMYNQKEIHMFGIFDGHRGSAAAEFSARALPGFL--QNLGSTTRP- 494
GRRE MED + +++ ++ +FG++DGH G AAEF+A+ L + + +G
Sbjct: 147 GRREAMEDRFSAITNLHGDRKQAIFGVYDGHGGVKAAEFAAKNLDKNIVEEVVGKRDESE 206
Query: 495 -TDALLEAFIRTDVAFRNELDSLRKSKRVVQKDWHPGCTAIAALIVRNRLFVANAGDCRA 553
+A+ ++ TD +F E +D G + AL+ L V+NAGDCRA
Sbjct: 207 IAEAVKHGYLATDASFLKE------------EDVKGGSCCVTALVNEGNLVVSNAGDCRA 254
Query: 554 ILCRGGHPFALSRDHVASCLEERERVVSAGGNVNWQVDTWRVGPPALQVTRSIGDDDLKP 613
++ GG ALS DH S +ER+R+ + GG V+ WR+ +L V+R IGD LK
Sbjct: 255 VMSVGGVAKALSSDHRPSRDDERKRIETTGGYVDTFHGVWRI-QGSLAVSRGIGDAQLKK 313
Query: 614 AVXXXXXXXXXXXXXXDEYLVMASDGLWDVVSHVEAVGIIKDT---VKEPGMCS--KRLA 668
V E+L++ASDGLWD VS+ EAV I + ++P + + K+L
Sbjct: 314 WVIAEPETKISRIEHDHEFLILASDGLWDKVSNQEAVDIARPLCLGTEKPLLLAACKKLV 373
Query: 669 TEAAERGSKDNITVIVVFLQ 688
+A RGS D+I+V+++ L+
Sbjct: 374 DLSASRGSSDDISVMLIPLR 393
|
|
| UNIPROTKB|E1BTL4 PPM1L "Uncharacterized protein" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 333 (122.3 bits), Expect = 2.5e-29, P = 2.5e-29
Identities = 92/265 (34%), Positives = 139/265 (52%)
Query: 438 GRRETMEDTHFLMPHMYNQKEIHMFGIFDGHRGSAAAEFSARALPGFL-QNLGSTTRPTD 496
GRR+ MED ++ + N+ +FGIFDGH G +AAE+ LP L Q+L + +
Sbjct: 100 GRRDHMEDRFEVITDLVNKTHPSIFGIFDGHGGESAAEYVKSRLPEVLKQHLQDYEKDKE 159
Query: 497 ALLEAFIRTDVAFRN-ELDSLRKSKRVVQKDWHPGCTAIAALIVRNRLFVANAGDCRAIL 555
+ ++ +T + + +D K V D G T + AL+ L VAN GD R +L
Sbjct: 160 NSVMSY-QTILEQQILSIDREMLEKLTVSYD-EAGTTCLIALLSDKELTVANVGDSRGVL 217
Query: 556 C-RGGHPFALSRDHVASCLEERERVVSAGGNVNWQVDTWRVGPPALQVTRSIGDDDLKP- 613
C + G+ LS DH L+ER+R+ AGG +++ +WRV L ++RS+GD LK
Sbjct: 218 CDKDGNAIPLSHDHKPYQLKERKRIKRAGGFISFN-GSWRV-QGILAMSRSLGDYPLKNL 275
Query: 614 --AVXXXXXXXXXXXXXXDEYLVMASDGLWDVVSHVEAVGIIKDTVKEPGMCSKRLATEA 671
+ E++++ASDGLWD S+ EAV IK+ + EP +K + ++
Sbjct: 276 NVVIPDPDILTFDLDKLQPEFMILASDGLWDAFSNEEAVRFIKERLDEPHFGAKSIVLQS 335
Query: 672 AERGSKDNITVIVV-FLQPVSTAER 695
RG DNITV+VV F T E+
Sbjct: 336 FYRGCPDNITVMVVKFRNSSKTDEQ 360
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q5JJY4 | P2C04_ORYSJ | 3, ., 1, ., 3, ., 1, 6 | 0.6786 | 0.9325 | 0.9893 | yes | no |
| Q940A2 | P2C31_ARATH | 3, ., 1, ., 3, ., 1, 6 | 0.6923 | 0.9383 | 0.9939 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 3rd Layer | 3.1.3 | LOW CONFIDENCE prediction! |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | LOW CONFIDENCE prediction! |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | estExt_fgenesh4_pm.C_LG_XVI0076 | hypothetical protein (662 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 697 | |||
| cd00143 | 254 | cd00143, PP2Cc, Serine/threonine phosphatases, fam | 3e-79 | |
| smart00332 | 252 | smart00332, PP2Cc, Serine/threonine phosphatases, | 3e-78 | |
| pfam00481 | 252 | pfam00481, PP2C, Protein phosphatase 2C | 2e-72 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-51 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-49 | |
| PLN03145 | 365 | PLN03145, PLN03145, Protein phosphatase 2c; Provis | 2e-48 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-48 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 5e-46 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-45 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-44 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-42 | |
| COG0631 | 262 | COG0631, PTC1, Serine/threonine protein phosphatas | 1e-41 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-40 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 9e-37 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 4e-36 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-34 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 4e-32 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 5e-32 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 6e-29 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-28 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-28 | |
| PTZ00224 | 381 | PTZ00224, PTZ00224, protein phosphatase 2C; Provis | 4e-28 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 8e-27 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 8e-27 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-26 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 5e-26 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 8e-26 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-25 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-24 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-24 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-24 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 4e-24 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 5e-24 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 7e-24 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-23 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-23 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-23 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 5e-23 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 8e-23 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 8e-23 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-22 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 7e-22 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 7e-22 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 8e-22 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-21 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-21 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-21 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-21 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-21 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-21 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 4e-21 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-20 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-20 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 7e-20 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 7e-20 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-19 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-19 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-19 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-19 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-19 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-19 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-19 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-19 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-19 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-19 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 4e-19 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 4e-19 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 5e-19 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 6e-19 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 7e-19 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 8e-19 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-18 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-18 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-18 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-18 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-18 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-18 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-18 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-18 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-18 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-18 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 4e-18 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-18 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 4e-18 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 6e-18 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 6e-18 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 6e-18 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-17 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-17 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-17 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-17 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-17 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-17 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-17 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-17 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-17 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-17 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-17 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-17 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-17 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-17 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 5e-17 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 5e-17 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 5e-17 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 5e-17 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 6e-17 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 6e-17 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 6e-17 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 8e-17 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 9e-17 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 9e-17 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-16 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-16 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-16 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-16 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-16 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-16 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-16 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 5e-16 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 5e-16 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 5e-16 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 8e-16 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 8e-16 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-15 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-15 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-15 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-15 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-15 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-15 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 4e-15 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 4e-15 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-15 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 5e-15 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 5e-15 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 5e-15 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 6e-15 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 6e-15 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 6e-15 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-14 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-14 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-14 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-14 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-14 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-14 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-14 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-14 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-14 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-14 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-14 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 4e-14 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 4e-14 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 6e-14 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 6e-14 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 7e-14 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 7e-14 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 8e-14 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 9e-14 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-13 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-13 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-13 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-13 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-13 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-13 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-13 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-13 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-13 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-13 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-13 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-13 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 4e-13 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 4e-13 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 4e-13 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 4e-13 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 5e-13 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 5e-13 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 5e-13 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 6e-13 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 8e-13 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 9e-13 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 9e-13 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 9e-13 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-12 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-12 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-12 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-12 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-12 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-12 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-12 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-12 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-12 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 4e-12 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 4e-12 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 4e-12 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 4e-12 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 4e-12 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 4e-12 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 4e-12 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 5e-12 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 5e-12 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 6e-12 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 6e-12 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 7e-12 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 7e-12 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 7e-12 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 7e-12 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 8e-12 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-11 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-11 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-11 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-11 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-11 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-11 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-11 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-11 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-11 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-11 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-11 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-11 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-11 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-11 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-11 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 4e-11 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 5e-11 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 5e-11 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 5e-11 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 5e-11 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 5e-11 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 5e-11 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 5e-11 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 7e-11 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 7e-11 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 7e-11 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 8e-11 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 8e-11 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-10 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-10 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-10 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-10 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-10 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-10 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-10 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-10 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-10 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-10 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-10 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-10 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 3e-10 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-10 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-10 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-10 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-10 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-10 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 4e-10 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 4e-10 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 5e-10 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 5e-10 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 6e-10 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 7e-10 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 7e-10 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 7e-10 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 8e-10 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 9e-10 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 9e-10 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-09 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-09 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-09 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 1e-09 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-09 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-09 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-09 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 2e-09 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-09 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-09 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 3e-09 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 4e-09 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 4e-09 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 5e-09 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 5e-09 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 6e-09 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 6e-09 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 7e-09 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 8e-09 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 9e-09 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-08 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-08 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-08 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-08 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 3e-08 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 3e-08 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 3e-08 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-08 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-08 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-08 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 5e-08 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 5e-08 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 5e-08 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 5e-08 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 8e-08 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 9e-08 | |
| TIGR03724 | 199 | TIGR03724, arch_bud32, Kae1-associated kinase Bud3 | 1e-07 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-07 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 3e-07 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 6e-07 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 8e-07 | |
| PRK09605 | 535 | PRK09605, PRK09605, bifunctional UGMP family prote | 8e-07 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-06 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-06 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 2e-06 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 3e-06 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 4e-06 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 5e-06 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 3e-05 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 3e-05 | |
| smart00331 | 193 | smart00331, PP2C_SIG, Sigma factor PP2C-like phosp | 3e-05 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 4e-05 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 3e-04 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 4e-04 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 5e-04 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 0.002 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 0.003 |
| >gnl|CDD|238083 cd00143, PP2Cc, Serine/threonine phosphatases, family 2C, catalytic domain; The protein architecture and deduced catalytic mechanism of PP2C phosphatases are similar to the PP1, PP2A, PP2B family of protein Ser/Thr phosphatases, with which PP2C shares no sequence similarity | Back alignment and domain information |
|---|
Score = 252 bits (646), Expect = 3e-79
Identities = 108/264 (40%), Positives = 149/264 (56%), Gaps = 21/264 (7%)
Query: 432 GSFATCGRRETMEDTHFLMPHMYNQKEIHMFGIFDGHRGSAAAEFSARALPGFL------ 485
G G R+T ED + P++ N+ +FG+FDGH G AA EF+++ L L
Sbjct: 4 GVSDKGGDRKTNEDAVVIKPNLNNED-GGLFGVFDGHGGHAAGEFASKLLVEELLEELEE 62
Query: 486 QNLGSTTRPTDALLEAFIRTDVAFRNELDSLRKSKRVVQKDWHPGCTAIAALIVRNRLFV 545
S +AL +AF+R D E R G TA+ ALI N+L+V
Sbjct: 63 TLTLSEEDIEEALRKAFLRADEEILEEAQDEPDDARS-------GTTAVVALIRGNKLYV 115
Query: 546 ANAGDCRAILCRGGHPFALSRDHVASCLEERERVVSAGGNVNWQVDTWRVGPPALQVTRS 605
AN GD RA+LCR G L++DH EERER+ AGG +V RV P L VTR+
Sbjct: 116 ANVGDSRAVLCRNGEAVQLTKDHKPVNEEERERIEKAGG----RVSNGRV-PGVLAVTRA 170
Query: 606 IGDDDLKPAVTAEPEITETIMTPEDEYLVMASDGLWDVVSHVEAVGIIKDTVKE--PGMC 663
+GD DLKP V+AEP++T +T +D++L++ASDGLWDV+S+ EAV I++ + +
Sbjct: 171 LGDFDLKPGVSAEPDVTVVKLTEDDDFLILASDGLWDVLSNQEAVDIVRSELAKEDLQEA 230
Query: 664 SKRLATEAAERGSKDNITVIVVFL 687
++ L A RGS DNITV+VV L
Sbjct: 231 AQELVDLALRRGSHDNITVVVVRL 254
|
Length = 254 |
| >gnl|CDD|214625 smart00332, PP2Cc, Serine/threonine phosphatases, family 2C, catalytic domain | Back alignment and domain information |
|---|
Score = 249 bits (639), Expect = 3e-78
Identities = 106/265 (40%), Positives = 149/265 (56%), Gaps = 25/265 (9%)
Query: 427 PVLSWGSFATCGRRETMEDTHFLMPHMYNQKEIHMFGIFDGHRGSAAAEFSARALPGFLQ 486
L +G + G R+ MED H + P + FG+FDGH GS AA+F ++ LP L
Sbjct: 7 LGLRYGLSSMQGVRKPMEDAHVITPDL--SDSGGFFGVFDGHGGSEAAKFLSKNLPEILA 64
Query: 487 NL-----GSTTRPTDALLEAFIRTDVAFRNELDSLRKSKRVVQKDWHPGCTAIAALIVRN 541
+AL +AF+ TD + + + + G TA+ ALI N
Sbjct: 65 EELIKEKDELEDVEEALRKAFLSTD------------EEILEELEALSGSTAVVALISGN 112
Query: 542 RLFVANAGDCRAILCRGGHPFALSRDHVASCLEERERVVSAGGNVNWQVDTWRVGPPALQ 601
+L+VAN GD RA+LCR G L+ DH S +ER R+ +AGG V RV L
Sbjct: 113 KLYVANVGDSRAVLCRNGKAVQLTEDHKPSNEDERARIEAAGG----FVINGRV-NGVLA 167
Query: 602 VTRSIGDDDLKPAVTAEPEITETIMTPEDEYLVMASDGLWDVVSHVEAVGIIKDT-VKEP 660
++R+IGD LKP V+AEP++T +T +D++L++ASDGLWDV+S+ E V I++ K+P
Sbjct: 168 LSRAIGDFFLKPYVSAEPDVTVVELTEKDDFLILASDGLWDVLSNQEVVDIVRKHLSKDP 227
Query: 661 GMCSKRLATEAAERGSKDNITVIVV 685
+KRL A RGSKDNITV+VV
Sbjct: 228 KEAAKRLIDLALARGSKDNITVVVV 252
|
The protein architecture and deduced catalytic mechanism of PP2C phosphatases are similar to the PP1, PP2A, PP2B family of protein Ser/Thr phosphatases, with which PP2C shares no sequence similarity. Length = 252 |
| >gnl|CDD|215938 pfam00481, PP2C, Protein phosphatase 2C | Back alignment and domain information |
|---|
Score = 234 bits (600), Expect = 2e-72
Identities = 96/261 (36%), Positives = 137/261 (52%), Gaps = 24/261 (9%)
Query: 432 GSFATCGRRETMEDTHFLMPHMYN---QKEIHMFGIFDGHRGSAAAEFSARALPGFLQNL 488
G G R+ MED H ++ + F +FDGH GS AA+++ + L L
Sbjct: 4 GGPRMQGFRKFMEDAHIAGKNLNASSGKDSFGFFAVFDGHGGSQAAKYAGKHLETILALR 63
Query: 489 GS--TTRPTDALLEAFIRTDVAFRNELDSLRKSKRVVQKDWHPGCTAIAALIVRNRLFVA 546
S T DAL ++F+ D R S +D G TA+ ALI +L+VA
Sbjct: 64 RSFLTLDKLDALRKSFLEADEELR--------SDAANHEDLSSGSTAVVALIRGQKLYVA 115
Query: 547 NAGDCRAILCRGGHPF-ALSRDHVASCLEERERVVSAGGNVNWQVDTWRVGPPALQVTRS 605
N GD RA+LCR G+ L+ DH S +ER R+ AGG V+ RV L V+R+
Sbjct: 116 NVGDSRAVLCRNGNAIKQLTEDHKPSNEDERRRIRGAGGFVSRN---GRVNG-VLAVSRA 171
Query: 606 IGDDDLKP----AVTAEPEITETIMTPEDEYLVMASDGLWDVVSHVEAVGIIKDTVKE-- 659
GD +LK V+AEP++T +T DE+L++ASDGLWDV+S E V I++ + +
Sbjct: 172 FGDFELKKGKPQPVSAEPDVTSHKITESDEFLILASDGLWDVLSDQEVVDIVRSELSDGS 231
Query: 660 PGMCSKRLATEAAERGSKDNI 680
P +++L EA GS+DNI
Sbjct: 232 PMEAAEKLVDEAIAYGSEDNI 252
|
Protein phosphatase 2C is a Mn++ or Mg++ dependent protein serine/threonine phosphatase. Length = 252 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 179 bits (456), Expect = 1e-51
Identities = 75/281 (26%), Positives = 120/281 (42%), Gaps = 36/281 (12%)
Query: 68 YTLLSPIARGAESVVYEAT--LDGRKVAVKK-PILSTSEELDNFHKELQLLCKLDHPGLA 124
Y +L + G+ VY A G+ VA+K ++ + +E+++L KL HP +
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 125 KFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIV 184
+ E+ E +L + L + S D+ Q+ AL+YLH+ GIV
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLK-KRGRLSEDEARFYLRQILSALEYLHSKGIV 119
Query: 185 HRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIY 244
HRD+KP N+LLD + LADFGLA +++ G VGT Y
Sbjct: 120 HRDLKPENILLDEDGHVKLADFGLA------RQL-----------DPGEKLTTFVGTPEY 162
Query: 245 MAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAV 304
MAPE+L + + + D++S G+ + ELLTG P+ +Q L
Sbjct: 163 MAPEVLLGKGYGKAVDIWSLGVILYELLTGKPPFPGD---------------DQLLELFK 207
Query: 305 VSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
G +P E + LI++ +P R + +
Sbjct: 208 KIGKPKPPFPPPEWDISPEAKDLIRKLLVKDPEKRLTAEEA 248
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 173 bits (442), Expect = 1e-49
Identities = 87/285 (30%), Positives = 130/285 (45%), Gaps = 38/285 (13%)
Query: 68 YTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHK----ELQLLCKLDHP 121
Y LL + G+ VY+A G+ VAVK IL E + E+++L +L HP
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVK--ILKKRSEKSKKDQTARREIRILRRLSHP 58
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL 181
+ + + A + E+ E +L + L S D+ IA Q+ + L+YLH+
Sbjct: 59 NIVRLIDAFEDKDHLYLVMEYCEGGDLFDYL-SRGGPLSEDEAKKIALQILRGLEYLHSN 117
Query: 182 GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGT 241
GI+HRD+KP N+LLD N +ADFGLA+ +SS T VGT
Sbjct: 118 GIIHRDLKPENILLDENGVVKIADFGLAKKLL----------KSSSSLTT------FVGT 161
Query: 242 LIYMAPEILKKEI-HSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQL 300
YMAPE+L + K DV+S G+ + ELLTG P++ E + QL
Sbjct: 162 PWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSG-----------ENILDQLQL 210
Query: 301 TAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
++ L G LI++C + +P RP+ +I
Sbjct: 211 IRRILGPPLEFDEPKWSSG-SEEAKDLIKKCLNKDPSKRPTAEEI 254
|
Length = 260 |
| >gnl|CDD|215603 PLN03145, PLN03145, Protein phosphatase 2c; Provisional | Back alignment and domain information |
|---|
Score = 174 bits (442), Expect = 2e-48
Identities = 112/312 (35%), Positives = 165/312 (52%), Gaps = 36/312 (11%)
Query: 399 HSSKKASHAAESDVKLWLESANDALTYYPVLSWGSFATCGRRETMEDTHFLMPHM---YN 455
HSS + A++ V+ L N + PV+ G++A G R +MED + + + +
Sbjct: 35 HSSLVKTPASDISVENELTFENMDTEFIPVVRSGAWADIGSRSSMEDVYICVDNFMSDFG 94
Query: 456 QKEIH-----MFGIFDGHRGSAAAEFSARALPGFL-QNLGSTTRPTDALLEAFIRTDVAF 509
K +G+FDGH G AA+F+ LP F+ ++ + AF++TD AF
Sbjct: 95 LKNSEDGPSAFYGVFDGHGGKHAADFACYHLPRFIVEDEDFPREIEKVVSSAFLQTDTAF 154
Query: 510 RN--ELDSLRKSKRVVQKDWHPGCTAIAALIVRNRLFVANAGDCRAILCRGGHPFALSRD 567
LD+ S G TA+AAL+V L VANAGDCRA+LCR G +SRD
Sbjct: 155 AEACSLDASLAS----------GTTALAALVVGRSLVVANAGDCRAVLCRRGKAIEMSRD 204
Query: 568 HVASCLEERERVVSAGGNVNWQVDTWRVGPPALQVTRSIGD---DDLKPA----VTAEPE 620
H C +ER+R+ ++GG V D + G L V R++GD + +K + ++AEPE
Sbjct: 205 HKPMCSKERKRIEASGGYV---YDGYLNG--QLNVARALGDWHMEGMKGSDGGPLSAEPE 259
Query: 621 ITETIMTPEDEYLVMASDGLWDVVSHVEAVGIIKDTVKE---PGMCSKRLATEAAERGSK 677
+ T +T EDE+L++ DG+WDV AV + ++E P MCSK L EA +R S
Sbjct: 260 LMTTQLTEEDEFLIIGCDGIWDVFRSQNAVDFARRRLQEHNDPVMCSKELVDEALKRKSG 319
Query: 678 DNITVIVVFLQP 689
DN+ V+VV Q
Sbjct: 320 DNLAVVVVCFQS 331
|
Length = 365 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 168 bits (429), Expect = 3e-48
Identities = 77/277 (27%), Positives = 118/277 (42%), Gaps = 71/277 (25%)
Query: 74 IARGAESVVYEAT--LDGRKVAVKK-PILSTSEELDNFHKELQLLCKLDHPGLAKFVAAH 130
+ G VY A G+KVA+K +S L+ +E+++L KL+HP + K
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 131 AKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKP 190
+ E+ E +L + L E S D++L I Q+ + L+YLH+ GI+HRD+KP
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKP 120
Query: 191 ANVLLD-RNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEI 249
N+LLD N LADFGL++ + K + K +VGT YMAPE+
Sbjct: 121 ENILLDSDNGKVKLADFGLSKLLTSDKSLL----------------KTIVGTPAYMAPEV 164
Query: 250 LK-KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGG 308
L K +SEKSD++S G+ + E+
Sbjct: 165 LLGKGYYSEKSDIWSLGV----------------------ILYELP-------------- 188
Query: 309 LRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
+ LI++ +P RPS +I
Sbjct: 189 --------------ELKDLIRKMLQKDPEKRPSAKEI 211
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 163 bits (416), Expect = 5e-46
Identities = 77/296 (26%), Positives = 133/296 (44%), Gaps = 55/296 (18%)
Query: 69 TLLSPIARGAESVVYEATLDGR------KVAVKKPILSTSE-ELDNFHKELQLLCKLDHP 121
TL + GA VY+ L G+ +VAVK SE +++ F +E +++ KLDHP
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL 181
+ K + + E+ E +L L S+ +L A Q+A+ ++YL +
Sbjct: 62 NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESK 121
Query: 182 GIVHRDVKPANVLLDRNLCPHLADFGLAE-------YRENLKEISLKNWRSSGKPTGGFH 234
+HRD+ N L+ NL ++DFGL+ YR+ ++ ++ W
Sbjct: 122 NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIR-W----------- 169
Query: 235 KKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEM 293
MAPE LK+ + KSDV+SFG+ + E+ T G PY +
Sbjct: 170 ----------MAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGM------------ 207
Query: 294 NYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALEL 349
+ +++ + +G P + P + L+ +CW +P +RP+FS++ L
Sbjct: 208 --SNEEVLEYLKNGYRLPQPPN----CPPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 162 bits (412), Expect = 2e-45
Identities = 77/297 (25%), Positives = 131/297 (44%), Gaps = 56/297 (18%)
Query: 69 TLLSPIARGAESVVYEATLDGRK------VAVKKPILSTSE-ELDNFHKELQLLCKLDHP 121
TL + GA VY+ TL G+ VAVK SE +++ F +E +++ KLDHP
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHV-EEWSPSVDQVLMIAAQLAKALQYLHN 180
+ K + + M E+ +L + L S+ +L A Q+A+ ++YL +
Sbjct: 62 NIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES 121
Query: 181 LGIVHRDVKPANVLLDRNLCPHLADFGLA-------EYRENLKEISLKNWRSSGKPTGGF 233
+HRD+ N L+ NL ++DFGL+ Y+ ++ ++ W
Sbjct: 122 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIR-W---------- 170
Query: 234 HKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLE 292
MAPE LK+ + KSDV+SFG+ + E+ T G PY +
Sbjct: 171 -----------MAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGM----------- 208
Query: 293 MNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALEL 349
+ ++ + G P + P + L+ +CW +P +RP+FS++ L
Sbjct: 209 ---SNAEVLEYLKKGYRLPKPPN----CPPELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 159 bits (404), Expect = 3e-44
Identities = 78/298 (26%), Positives = 125/298 (41%), Gaps = 58/298 (19%)
Query: 69 TLLSPIARGAESVVYEATLDGR------KVAVKK-PILSTSEELDNFHKELQLLCKLDHP 121
L + GA VY+ TL G KVAVK ++ EE + F +E ++ KL HP
Sbjct: 2 ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHP 61
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL 181
+ + + + E+ +L + L ++ +L +A Q+AK ++YL +
Sbjct: 62 NIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLESK 121
Query: 182 GIVHRDVKPANVLLDRNLCPHLADFGLA-------EYRENLKEISLKNWRSSGKPTGGFH 234
VHRD+ N L+ NL ++DFGL+ YR+ W
Sbjct: 122 NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKW----------- 170
Query: 235 KKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEM 293
MAPE LK + KSDV+SFG+ + E+ T G PY + E
Sbjct: 171 ----------MAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNE--------- 211
Query: 294 NYTEQQLTAAVVSGG--LRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALEL 349
++ + G RP P + L+ +CW +P +RP+FS++ +L
Sbjct: 212 -----EVLELLEDGYRLPRPENC------PDELYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 153 bits (390), Expect = 2e-42
Identities = 78/297 (26%), Positives = 127/297 (42%), Gaps = 55/297 (18%)
Query: 73 PIARGAESVVYEATLDG-----RKVAVKKPILSTSE-ELDNFHKELQLLCKLDHPGLAKF 126
+ GA VY+ L G +VAVK SE E +F KE +++ KL HP + +
Sbjct: 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRL 61
Query: 127 VAAHAKPPNYMFFFEFYESRNLAEKL------HVEEWSP--SVDQVLMIAAQLAKALQYL 178
+ + E+ E +L + L S+ +L A Q+AK ++YL
Sbjct: 62 LGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYL 121
Query: 179 HNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNM 238
+ VHRD+ N L+ +L ++DFGL+ + +++K
Sbjct: 122 ASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD----------------DDYYRKKT 165
Query: 239 VGTLI--YMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNY 295
G L +MAPE LK I + KSDV+SFG+ + E+ T G PY L
Sbjct: 166 GGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN------------ 213
Query: 296 TEQQLTAAVVSGG--LRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350
+++ + G +P P + L+ CW +P +RP+FS++ L+
Sbjct: 214 --EEVLEYLRKGYRLPKPEYC------PDELYELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|223704 COG0631, PTC1, Serine/threonine protein phosphatase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 152 bits (385), Expect = 1e-41
Identities = 78/264 (29%), Positives = 118/264 (44%), Gaps = 22/264 (8%)
Query: 435 ATCGRRETMEDTHFLMPHMYNQKEIHMFGIFDGHRGSAAAEF-SARALPGFLQNLGSTTR 493
R+ ED + P+ N + +F + DG G AA E S A+ + T
Sbjct: 15 DVGTVRKHNEDAFLIKPN-ENGNLLLLFAVADGMGGHAAGEVASKLAVEALARLFDETNF 73
Query: 494 P--TDALLEAFIRTDVAFRNELDSLRKSKRVVQKDWHPGCTAIAALIVRNRLFVANAGDC 551
++L E + + + V+ G T + LI N+L+VAN GD
Sbjct: 74 NSLNESLEELLKEAILKANEAIAEEGQLNEDVRG---MGTTLVLLLIRGNKLYVANVGDS 130
Query: 552 RAILCRGGHPFALSRDHVASCLEERERVVSAGGNVNWQVDTWRVGPPALQVTRSIGDDDL 611
RA L R G L+ DH E+ +++ + P +TR++GD DL
Sbjct: 131 RAYLLRDGELKQLTEDHSLVNRLEQRGIITPEEARSH--------PRRNALTRALGDFDL 182
Query: 612 KPAVTAEPEITETIMTPEDEYLVMASDGLWDVVSHVEAVGIIKDTVKEPGMCSKRLATEA 671
EP+ITE + P ++L++ SDGLWDVVS E V I+K++ + P + +L A
Sbjct: 183 -----LEPDITELELEP-GDFLLLCSDGLWDVVSDDEIVDILKNS-ETPQEAADKLIELA 235
Query: 672 AERGSKDNITVIVVFLQPVSTAER 695
E G DNITV++V L R
Sbjct: 236 LEGGGPDNITVVLVRLNGEGETSR 259
|
Length = 262 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 148 bits (375), Expect = 3e-40
Identities = 83/291 (28%), Positives = 134/291 (46%), Gaps = 44/291 (15%)
Query: 68 YTLLSPIARGAESVVYEAT--LDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAK 125
+ +L I +G VY+A G++VA+K L + E+ + E+Q+L K HP + K
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 126 FVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVH 185
+ ++ K EF +L + L + + Q+ + +L K L+YLH+ GI+H
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIH 121
Query: 186 RDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYM 245
RD+K AN+LL + L DFGL+ ++S R MVGT +M
Sbjct: 122 RDIKAANILLTSDGEVKLIDFGLS------AQLSDTKAR-----------NTMVGTPYWM 164
Query: 246 APEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVV 305
APE++ + + K+D++S GI+ EL G PY++L + + A
Sbjct: 165 APEVINGKPYDYKADIWSLGITAIELAEGKPPYSEL------PPMKALFK-----IATNG 213
Query: 306 SGGLR-PILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH 355
GLR P S E +++C NP RP+ A +L L+H
Sbjct: 214 PPGLRNPEKWSDEF------KDFLKKCLQKNPEKRPT----AEQL---LKH 251
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 9e-37
Identities = 79/299 (26%), Positives = 127/299 (42%), Gaps = 52/299 (17%)
Query: 67 SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPG 122
+T + RG+ VY A G +AVK LS + EEL+ +E+++L L HP
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 123 LAKFVAAHAKPPNYMF--FFEFYESRNLAEKLH----VEEWSPSVDQVLMIAAQLAKALQ 176
+ ++ + F E+ +L+ L + E V + Q+ + L
Sbjct: 61 IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPE---PVIRKY--TRQILEGLA 115
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
YLH+ GIVHRD+K AN+L+D + LADFG A K +
Sbjct: 116 YLHSNGIVHRDIKGANILVDSDGVVKLADFGCA------KRLGDIETGEGTGS------- 162
Query: 237 NMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYT 296
+ GT +MAPE+++ E + +D++S G ++ E+ TG P+++L A
Sbjct: 163 -VRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAA--------- 212
Query: 297 EQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH 355
L SG I L +++C +P RP+ A EL L+H
Sbjct: 213 ---LYKIGSSGEPPEIPE----HLSEEAKDFLRKCLRRDPKKRPT----ADEL---LQH 257
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 140 bits (352), Expect = 4e-36
Identities = 92/380 (24%), Positives = 157/380 (41%), Gaps = 29/380 (7%)
Query: 67 SYTLLSPIARGAESVVYEATLDGRKVAVK---KPILSTSEELDNFHKELQLLCKLDHPG- 122
SY +L + G+ VY A D + VA+K K + S S+E++ F +E+Q+L L+HP
Sbjct: 1 SYRILRKLGEGSFGEVYLAR-DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPN 59
Query: 123 LAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSV--DQVLMIAAQLAKALQYLHN 180
+ K + E+ + +L + L + + L I AQ+ AL+YLH+
Sbjct: 60 IVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS 119
Query: 181 LGIVHRDVKPANVLLDRNLC-PHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMV 239
GI+HRD+KP N+LLDR+ L DFGLA+ + S V
Sbjct: 120 KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPAL----------PSTSV 169
Query: 240 GTLIYMAPEILKKEIH---SEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYT 296
GT YMAPE+L S SD++S GI++ ELLTG+ P+ + + L++
Sbjct: 170 GTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILE 229
Query: 297 EQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHR 356
P+ S + + L+++ +P NR S + +L H
Sbjct: 230 L------PTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRL--SSSSDLSHDLLAHL 281
Query: 357 KSLKEEDLCAGKSYVTYDDKLINSGNNMHTYHESINWTAQGEHSSKKASHAAESDVKLWL 416
K + + K + +L + + G S+ ++ +
Sbjct: 282 KLKESDLSDLLKPDDSAPLRLSLPPSLEALISSLNSLAISGSDLKLDDSNFSKELAPNGV 341
Query: 417 ESANDALTYYPVLSWGSFAT 436
S+ + + + S +
Sbjct: 342 SSSPHNSSSLLLSTASSKRS 361
|
Length = 384 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 2e-34
Identities = 72/292 (24%), Positives = 136/292 (46%), Gaps = 42/292 (14%)
Query: 68 YTLLSPIARGAESVVY--EATLDGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGL 123
Y ++ I +G+ VY DG+ +K+ LS + +E ++ E+++L KL+HP +
Sbjct: 2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNI 61
Query: 124 AKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWS---PSVDQVLMIAAQLAKALQYLHN 180
K+ + + E+ + +L++K+ ++ +Q+L QL AL+YLH+
Sbjct: 62 IKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS 121
Query: 181 LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
I+HRD+KP N+ L N L DFG+++ + + K +VG
Sbjct: 122 RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD----------------LAKTVVG 165
Query: 241 TLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQL 300
T Y++PE+ + + ++ KSD++S G + EL T P+ + +LE L
Sbjct: 166 TPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPF-------EGENLLE-------L 211
Query: 301 TAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352
++ G PI + + + +L+ +P RPS + I L+ +
Sbjct: 212 ALKILKGQYPPIPSQ----YSSELRNLVSSLLQKDPEERPSIAQI-LQSPFI 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 4e-32
Identities = 71/224 (31%), Positives = 105/224 (46%), Gaps = 33/224 (14%)
Query: 68 YTLLSPIARGAESVVYEA--TLDGRKVAVKKPILST--SEELDNFHKELQLLCKLDHPGL 123
Y L I RGA VVY+ G VA+K+ L E L + +E+ LL L HP +
Sbjct: 2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNI 61
Query: 124 AKFVAAHAKPPNYMFFFEFYESRNLA------EKLHVEEWSPSVDQVLMIAAQLAKALQY 177
K++ + + E+ E+ +L + V QVL + L Y
Sbjct: 62 VKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVL-------QGLAY 114
Query: 178 LHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKN 237
LH G++HRD+K AN+L ++ LADFG+A K + +S
Sbjct: 115 LHEQGVIHRDIKAANILTTKDGVVKLADFGVA-----TKLNDVSKDDAS----------- 158
Query: 238 MVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDL 281
+VGT +MAPE+++ S SD++S G ++ ELLTG PY DL
Sbjct: 159 VVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDL 202
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 5e-32
Identities = 73/291 (25%), Positives = 120/291 (41%), Gaps = 44/291 (15%)
Query: 70 LLSPIARGAESVVYEAT--LDGRKVAVKK-PILSTSEELDNFHKELQLLCKLDHPGLAKF 126
+ + +G+ VVY+ G+ A+KK + E +EL+ L + P + K
Sbjct: 5 RVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKC 64
Query: 127 VAAHAKPPNYMFFFEFYESRNLAEKL-HVEEWSPSVDQVLMIAAQLAKALQYLHN-LGIV 184
A K E+ + +LA+ L V + V + IA Q+ K L YLH I+
Sbjct: 65 YGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPV--LAYIARQILKGLDYLHTKRHII 122
Query: 185 HRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIY 244
HRD+KP+N+L++ +ADFG++ K ++ F VGT+ Y
Sbjct: 123 HRDIKPSNLLINSKGEVKIADFGIS-----------KVLENTLDQCNTF-----VGTVTY 166
Query: 245 MAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAV 304
M+PE ++ E +S +D++S G+++ E G P+ + + +
Sbjct: 167 MSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPS---- 222
Query: 305 VSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH 355
L S E I C +P RPS A EL L+H
Sbjct: 223 ----LPAEEFSPEF------RDFISACLQKDPKKRPS----AAEL---LQH 256
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 6e-29
Identities = 63/218 (28%), Positives = 104/218 (47%), Gaps = 15/218 (6%)
Query: 73 PIARGAESVVYEATL--DGRKVAVKKPILSTS----EELDNF-HKELQLLCKLD-HPGLA 124
I G+ S V A ++ A+K IL E+ + E ++L +L+ HPG+
Sbjct: 8 IIGEGSFSTVVLAKEKETNKEYAIK--ILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGII 65
Query: 125 KFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIV 184
K N F E+ + L + + + S AA++ AL+YLH+ GI+
Sbjct: 66 KLYYTFQDEENLYFVLEYAPNGELLQYIR-KYGSLDEKCTRFYAAEILLALEYLHSKGII 124
Query: 185 HRDVKPANVLLDRNLCPHLADFGLAE-YRENLKEISLK---NWRSSGKPTGGFHKKNMVG 240
HRD+KP N+LLD+++ + DFG A+ N S K S + VG
Sbjct: 125 HRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVG 184
Query: 241 TLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
T Y++PE+L ++ + SD+++ G I ++LTG P+
Sbjct: 185 TAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPF 222
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 74/299 (24%), Positives = 126/299 (42%), Gaps = 35/299 (11%)
Query: 69 TLLSPIARGAESVVYEATLD------GRKVAVKKPILSTSEE-LDNFHKELQLLCKLDHP 121
+ + G V D G +VAVK S E+ +F +E+++L LDH
Sbjct: 7 KFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHE 66
Query: 122 GLAKF--VAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLH 179
+ K+ V + E+ S +L + L ++ ++L+ ++Q+ K + YL
Sbjct: 67 NIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG 126
Query: 180 NLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMV 239
+ +HRD+ N+L++ ++DFGLA K + K G
Sbjct: 127 SQRYIHRDLAARNILVESEDLVKISDFGLA------KVLPEDKDYYYVKEPGES------ 174
Query: 240 GTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-----GVVPYTDLRAEAQAHTVLEMN 294
+ + APE L+ S SDV+SFG+++ EL T P LR A +
Sbjct: 175 -PIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQM--- 230
Query: 295 YTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL 353
+L + G P S P + L++ CW+ P +RPSF+D+ L +D +
Sbjct: 231 -IVTRLLELLKEGERLPRPPS----CPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 62/212 (29%), Positives = 96/212 (45%), Gaps = 14/212 (6%)
Query: 74 IARGAESVVYEA--TLDGRKVAVK---KPILSTSEELDNFHKELQLLCKLDHPGLAKFVA 128
I++GA V+ A G A+K K + ++D E +L + P + K
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 129 AHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDV 188
+ N E+ +LA L S D + A++ AL+YLH+ GI+HRD+
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLENVG-SLDEDVARIYIAEIVLALEYLHSNGIIHRDL 119
Query: 189 KPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPE 248
KP N+L+D N L DFGL++ L R K +VGT Y+APE
Sbjct: 120 KPDNILIDSNGHLKLTDFGLSKV-------GLVR-RQINLNDDEKEDKRIVGTPDYIAPE 171
Query: 249 ILKKEIHSEKSDVYSFGISINELLTGVVPYTD 280
++ + HS+ D +S G + E L G+ P+
Sbjct: 172 VILGQGHSKTVDWWSLGCILYEFLVGIPPFHG 203
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|240318 PTZ00224, PTZ00224, protein phosphatase 2C; Provisional | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 4e-28
Identities = 79/281 (28%), Positives = 134/281 (47%), Gaps = 40/281 (14%)
Query: 432 GSFATCGRRETMEDTHFLMPHMYNQKEIHMFGIFDGHRGSAAAEFSARALPGFLQNLGST 491
S G RE+MED H +Y + FG+FDGH +++ ARA P L+
Sbjct: 25 ASACVNGYRESMEDAHL----LYLTDDWGFFGVFDGHVNDECSQYLARAWPQALEKEPEP 80
Query: 492 TRPTDALLEAFIRTDVAFRNELDSLRKSKRVVQKDWHPGCTAIAALIVRN-RLFVANAGD 550
+ + E + D + +DS R+ G T +I+++ L V N GD
Sbjct: 81 MTD-ERMEELCLEIDEEW---MDSGREG----------GSTGTFCVIMKDVHLQVGNVGD 126
Query: 551 CRAILCRGGHPFALSRDHVASCLEERERVVSAGGNV-NWQVDTWRVGPPALQVTRSIGD- 608
R ++CR G + DH + ER+R+ + GG V + +VD L V+R+ GD
Sbjct: 127 SRVLVCRDGKLVFATEDHKPNNPGERQRIEACGGRVVSNRVDG------DLAVSRAFGDR 180
Query: 609 --------DDLKPAVTAEPEITETIMTPEDEYLVMASDGLWD-VVSHVEAVGIIKD---T 656
D L+ V A P++T D ++++A DG+++ S+ E V +K+ T
Sbjct: 181 SFKVKGTGDYLEQKVIAVPDVTHLTCQSND-FIILACDGVFEGNFSNEEVVAFVKEQLET 239
Query: 657 VKEPGMCSKRLATEAAERGSKDNITVIVVFLQPVSTAERIY 697
+ + + R+ EA RGSKDNI+ ++V L+ ++ +++
Sbjct: 240 CDDLAVVAGRVCDEAIRRGSKDNISCLIVQLKDGASYAKLF 280
|
Length = 381 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 8e-27
Identities = 60/223 (26%), Positives = 116/223 (52%), Gaps = 22/223 (9%)
Query: 64 PPSSYTLLSPIARGAESVVYEAT--LDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP 121
P + +L + G+ VY+A G+ VA+K ++ E+L KE+ +L + D P
Sbjct: 1 PEEVFDILEKLGEGSYGSVYKAIHKETGQVVAIK--VVPVEEDLQEIIKEISILKQCDSP 58
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL 181
+ K+ ++ K + E+ + ++++ + + + + +++ I Q K L+YLH+
Sbjct: 59 YIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSN 118
Query: 182 GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKN-MVG 240
+HRD+K N+LL+ LADFG+ SG+ T K+N ++G
Sbjct: 119 KKIHRDIKAGNILLNEEGQAKLADFGV-----------------SGQLTDTMAKRNTVIG 161
Query: 241 TLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRA 283
T +MAPE++++ ++ K+D++S GI+ E+ G PY+D+
Sbjct: 162 TPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHP 204
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 8e-27
Identities = 62/217 (28%), Positives = 102/217 (47%), Gaps = 32/217 (14%)
Query: 74 IARGAESVVYEA--TLDGR----KVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFV 127
+ +G+ V G+ KV KK I+ E E +L +++HP + K
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLT-ERNILSRINHPFIVKLH 59
Query: 128 AAHAKPPNYMFF-FEFYESRNLAEKLHVEEWSP-SVDQVLMIAAQLAKALQYLHNLGIVH 185
A + ++ E+ L H+ + S ++ AA++ AL+YLH+LGI++
Sbjct: 60 YAF-QTEEKLYLVLEYAPGGELFS--HLSKEGRFSEERARFYAAEIVLALEYLHSLGIIY 116
Query: 186 RDVKPANVLLDR--NLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLI 243
RD+KP N+LLD ++ L DFGLA KE+S + G GT
Sbjct: 117 RDLKPENILLDADGHIK--LTDFGLA------KELS----------SEGSRTNTFCGTPE 158
Query: 244 YMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTD 280
Y+APE+L + + + D +S G+ + E+LTG P+
Sbjct: 159 YLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYA 195
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 3e-26
Identities = 59/228 (25%), Positives = 109/228 (47%), Gaps = 24/228 (10%)
Query: 62 HLPPSSYTLLSPIARGAESVVYEAT--LDGRKVAVKKPILSTSEELDNFHKELQLLCKLD 119
P Y L I GA VY+AT G++VA+KK L + + E+ ++
Sbjct: 15 GDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRL-RKQNKELIINEILIMKDCK 73
Query: 120 HPGLAKFVAAHAKPPNYMFF-FEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYL 178
HP + + ++ + ++ E+ + +L + + + Q+ + ++ + L+YL
Sbjct: 74 HPNIVDYYDSY-LVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYL 132
Query: 179 HNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNM 238
H+ ++HRD+K N+LL ++ LADFG A +++ + ++
Sbjct: 133 HSQNVIHRDIKSDNILLSKDGSVKLADFGFA------AQLT----------KEKSKRNSV 176
Query: 239 VGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTD---LRA 283
VGT +MAPE++K++ + K D++S GI E+ G PY LRA
Sbjct: 177 VGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRA 224
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 5e-26
Identities = 76/291 (26%), Positives = 123/291 (42%), Gaps = 40/291 (13%)
Query: 63 LPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPG 122
+ L + I +G V G+KVAVK + S F E ++ L HP
Sbjct: 3 INSKELKLGATIGKGEFGDVMLGDYRGQKVAVKC-LKDDSTAAQAFLAEASVMTTLRHPN 61
Query: 123 LAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSV-DQVLMIAAQLAKALQYLHNL 181
L + + + E+ +L + L + Q L A + + ++YL
Sbjct: 62 LVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK 121
Query: 182 GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGT 241
VHRD+ NVL+ +L ++DFGLA KE S G+ +G K
Sbjct: 122 NFVHRDLAARNVLVSEDLVAKVSDFGLA------KEASQ------GQDSGKLPVK----- 164
Query: 242 LIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQL 300
+ APE L+++ S KSDV+SFGI + E+ + G VPY + + +
Sbjct: 165 --WTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI--------------PLKDV 208
Query: 301 TAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL 351
V G R + + E G P + +++ CW+ +P RP+F + +L L
Sbjct: 209 VPHVEK-GYR--MEAPE-GCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 106 bits (268), Expect = 8e-26
Identities = 74/262 (28%), Positives = 108/262 (41%), Gaps = 65/262 (24%)
Query: 111 ELQLLCKLDHPGLAKFVAAHAKPPN-----YMFFFEFYESRNLA--------EKLHVEEW 157
E+ +L +L HP + ++ N M E+ E +LA E+ ++EE
Sbjct: 49 EVNILRELKHPNIVRYYDRIIDRSNQTLYIVM---EYCEGGDLAQLIQKCKKERKYIEE- 104
Query: 158 SPSVDQVLMIAAQLAKALQYLHNLG-----IVHRDVKPANVLLDRNLCPHLADFGLAEYR 212
+ + I QL AL HN ++HRD+KPAN+ LD N L DFGLA
Sbjct: 105 ----EFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLA--- 157
Query: 213 ENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELL 272
K + K VGT YM+PE L + EKSD++S G I EL
Sbjct: 158 ---KIL----------GHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELC 204
Query: 273 TGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILA--SLELGLPASILSLIQR 330
P+T + QL + + G R I S EL +I+
Sbjct: 205 ALSPPFT--------------ARNQLQLASKIKEGKFRRIPYRYSSELN------EVIKS 244
Query: 331 CWDGNPHNRPSFSDIALELDLV 352
+ +P RPS ++ L+L L+
Sbjct: 245 MLNVDPDKRPSTEEL-LQLPLI 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 3e-25
Identities = 82/294 (27%), Positives = 125/294 (42%), Gaps = 58/294 (19%)
Query: 74 IARGAESVVYEA--TLDGRKVAVKKPIL-----STSEELDNFHKELQLLCKLDHPGLAKF 126
+ G+ VYE DG AVK+ L + E + +E+ LL KL HP + ++
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 127 VAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHR 186
+ + N F E +LA KL + S + + Q+ L+YLH+ VHR
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLA-KLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHR 126
Query: 187 DVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMA 246
D+K AN+L+D N LADFG+A+ K+ G+ +MA
Sbjct: 127 DIKGANILVDTNGVVKLADFGMAKQVVEFSFA-----------------KSFKGSPYWMA 169
Query: 247 PE-ILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVV 305
PE I ++ + +D++S G ++ E+ TG P +++ + AAV
Sbjct: 170 PEVIAQQGGYGLAADIWSLGCTVLEMATGKPP-----------------WSQLEGVAAVF 212
Query: 306 ----SGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH 355
S L PI L IL +QR +P RP+ A EL LEH
Sbjct: 213 KIGRSKELPPIPDHLSDEAKDFILKCLQR----DPSLRPT----AAEL---LEH 255
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 1e-24
Identities = 74/312 (23%), Positives = 132/312 (42%), Gaps = 63/312 (20%)
Query: 62 HLPPSSYTLLSPIARGAESVVYEATL------DGRKVAVKKPILSTSEE--LDNFHKELQ 113
P S+ ++ + RG V+ A G + + K + T +E F +EL
Sbjct: 1 AFPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELD 60
Query: 114 LLCKLDHPGLAKFVA-AHAKPPNYMFFFEFYESRNL-----AEKLHVEEWSP---SVDQV 164
+ KL H + + + P+YM E+ + +L A K E+ P S Q
Sbjct: 61 MFRKLSHKNVVRLLGLCREAEPHYMIL-EYTDLGDLKQFLRATKSKDEKLKPPPLSTKQK 119
Query: 165 LMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLA------EYRENLKEI 218
+ + Q+A + +L N VHRD+ N L+ ++ L+ EY
Sbjct: 120 VALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEY------- 172
Query: 219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVP 277
+ +N + L ++APE ++++ S KSDV+SFG+ + E+ T G +P
Sbjct: 173 --------------YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELP 218
Query: 278 YTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPH 337
+ L +++++ + +G L + G P+ + L+ RCW NP
Sbjct: 219 FYGL--------------SDEEVLNRLQAGKLELPVPE---GCPSRLYKLMTRCWAVNPK 261
Query: 338 NRPSFSDIALEL 349
+RPSFS++ L
Sbjct: 262 DRPSFSELVSAL 273
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 88/302 (29%), Positives = 124/302 (41%), Gaps = 59/302 (19%)
Query: 63 LPPSSYTLLSPIARGAESVVYEAT-LDGRKVAVKKPILSTSEEL--DNFHKELQLLCKLD 119
P +TL + G V+E + +VA+K IL + + L +F KE+Q L +L
Sbjct: 3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIK--ILKSDDLLKQQDFQKEVQALKRLR 60
Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHV-EEWSPSVDQVLMIAAQLAKALQYL 178
H L A + E E +L L E V ++ +A Q+A+ + YL
Sbjct: 61 HKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYL 120
Query: 179 HNLGIVHRDVKPANVLLDRNLCPHLADFGLAE------YRENLKEISLKNWRSSGKPTGG 232
+HRD+ N+L+ +L +ADFGLA Y + K+I K
Sbjct: 121 EEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYK----------- 169
Query: 233 FHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVL 291
+ APE S KSDV+SFGI + E+ T G VPY
Sbjct: 170 -----------WTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPG----------- 207
Query: 292 EMNYTE--QQLTAAVVSGGLR-PILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALE 348
MN E Q+TA G R P A P I ++ CW P +RPSF + E
Sbjct: 208 -MNNHEVYDQITA-----GYRMPCPAK----CPQEIYKIMLECWAAEPEDRPSFKALREE 257
Query: 349 LD 350
LD
Sbjct: 258 LD 259
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 77/320 (24%), Positives = 128/320 (40%), Gaps = 78/320 (24%)
Query: 63 LPPSSYTLLSPIARGAESVVYEATLDG-------RKVAVKKPILS---TSEELDNFHKEL 112
LP TL+ + +G+ +VYE G +VA+K ++ + E F E
Sbjct: 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIK--TVNENASMRERIEFLNEA 60
Query: 113 QLLCKLDHPGLAKF--VAAHAKPPNYMFFFEFYESRNLAEKL--HVEE-------WSPSV 161
++ + + + + V + +P + E +L L E P++
Sbjct: 61 SVMKEFNCHHVVRLLGVVSTGQPT--LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTL 118
Query: 162 DQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLA------EYRENL 215
+ + +AA++A + YL VHRD+ N ++ +L + DFG+ +Y
Sbjct: 119 QKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDY---- 174
Query: 216 KEISLKNWRSSGKPTGGFHKKNMVGTLI--YMAPEILKKEIHSEKSDVYSFGISINELLT 273
+R GK G L +MAPE LK + + KSDV+SFG+ + E+ T
Sbjct: 175 -------YRKGGK-----------GLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
Query: 274 -GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGL--RPILASLELGLPASILSLIQR 330
PY L E ++ V+ GG P P +L L++
Sbjct: 217 LAEQPYQGLSNE--------------EVLKFVIDGGHLDLPE------NCPDKLLELMRM 256
Query: 331 CWDGNPHNRPSFSDIALELD 350
CW NP RP+F +I L
Sbjct: 257 CWQYNPKMRPTFLEIVSSLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 4e-24
Identities = 88/291 (30%), Positives = 128/291 (43%), Gaps = 51/291 (17%)
Query: 63 LPPSSYTLLSPIARGAESVVYEATLDGR-KVAVK--KPILSTSEELDNFHKELQLLCKLD 119
+P S L + G V+ T +G KVAVK KP + + F +E Q++ KL
Sbjct: 3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKP---GTMSPEAFLQEAQIMKKLR 59
Query: 120 HPGLAKFVAAHA----KPPNYMFFFEFYESRNLAEKLHVEEWSP-SVDQVLMIAAQLAKA 174
H K V +A + P Y+ E+ +L + L E + Q++ +AAQ+A+
Sbjct: 60 HD---KLVQLYAVCSEEEPIYIVT-EYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEG 115
Query: 175 LQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFH 234
+ YL + +HRD+ N+L+ NL +ADFGLA L E R K F
Sbjct: 116 MAYLESRNYIHRDLAARNILVGENLVCKIADFGLAR----LIEDDEYTAREGAK----FP 167
Query: 235 KKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEM 293
K + APE + KSDV+SFGI + E++T G VPY + VLE
Sbjct: 168 IK-------WTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGM----TNREVLEQ 216
Query: 294 NYTEQQLTAAVVSGGLR-PILASLELGLPASILSLIQRCWDGNPHNRPSFS 343
V G R P P + L+ +CWD +P RP+F
Sbjct: 217 -----------VERGYRMPRPP----NCPEELYDLMLQCWDKDPEERPTFE 252
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 5e-24
Identities = 53/199 (26%), Positives = 84/199 (42%), Gaps = 41/199 (20%)
Query: 91 KVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAE 150
K K+ + + N E ++L +L+HP L ++ F + N+
Sbjct: 31 KYMNKQKCVEK-GSVRNVLNERRILQELNHPFLVNL------------WYSFQDEENMYL 77
Query: 151 KL----------HVEEWSP-SVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNL 199
+ H+ + S +QV ++ AL+YLH+ GI+HRD+KP N+LLD
Sbjct: 78 VVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQG 137
Query: 200 CPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKS 259
H+ DF +A T GT YMAPE+L ++ +S
Sbjct: 138 HVHITDFNIA-----------TKVTPDTLTTS------TSGTPGYMAPEVLCRQGYSVAV 180
Query: 260 DVYSFGISINELLTGVVPY 278
D +S G++ E L G PY
Sbjct: 181 DWWSLGVTAYECLRGKRPY 199
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 7e-24
Identities = 82/292 (28%), Positives = 124/292 (42%), Gaps = 48/292 (16%)
Query: 74 IARGAESVVYEA-TLD-GRKVAVKKPILSTSEE--LDNFHKELQLLCKLDHPGLAKFVAA 129
I G VY A LD G +AVK+ + ++ + E+++L L HP L K+
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67
Query: 130 HAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMI---AAQLAKALQYLHNLGIVHR 186
F E+ L E L + +I QL + L YLH+ GIVHR
Sbjct: 68 EVHREKVYIFMEYCSGGTLEELLE----HGRILDEHVIRVYTLQLLEGLAYLHSHGIVHR 123
Query: 187 DVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMA 246
D+KPAN+ LD N L DFG A ++ ++ +++ GT YMA
Sbjct: 124 DIKPANIFLDHNGVIKLGDFGCA------VKLK----NNTTTMGEEV--QSLAGTPAYMA 171
Query: 247 PEILKKEIHSEK---SDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAA 303
PE++ +D++S G + E+ TG P+++L E Q+
Sbjct: 172 PEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELD-------------NEFQIMFH 218
Query: 304 VVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH 355
V +G PI SL+L + RC + +P RP+ A EL L+H
Sbjct: 219 VGAGHKPPIPDSLQLSPEG--KDFLDRCLESDPKKRPT----ASEL---LQH 261
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 65/227 (28%), Positives = 109/227 (48%), Gaps = 28/227 (12%)
Query: 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST-SEELDNFHKELQLLCKLDHPG 122
Y L+ I GA +VVY A + KVA+K+ L +D KE+Q + + +HP
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPN 60
Query: 123 LAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLA---KALQYLH 179
+ K+ + + +L + + +D+ + IA L K L+YLH
Sbjct: 61 VVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAI-IATVLKEVLKGLEYLH 119
Query: 180 NLGIVHRDVKPANVLLDRNLCPHLADFG----LAEYRENLKEISLKNWRSSGKPTGGFHK 235
+ G +HRD+K N+LL + +ADFG LA+ + +++ +
Sbjct: 120 SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKV----------------R 163
Query: 236 KNMVGTLIYMAPEILKKEI-HSEKSDVYSFGISINELLTGVVPYTDL 281
K VGT +MAPE++++ + K+D++SFGI+ EL TG PY+
Sbjct: 164 KTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKY 210
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 80/307 (26%), Positives = 128/307 (41%), Gaps = 62/307 (20%)
Query: 63 LPPSSYTLLSPIARGAESVVYEATLDGRK-------VAVKK-PILSTSEELDNFHKELQL 114
+P S TLL + GA VYE GR VAVK P + ++ +F E +
Sbjct: 3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALI 62
Query: 115 LCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQ--------VLM 166
+ K +H + + + + E +L K + E P ++ +L
Sbjct: 63 MSKFNHQNIVRLIGVSFERLPRFILLELMAGGDL--KSFLRENRPRPERPSSLTMKDLLF 120
Query: 167 IAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCP------HLADFGLAEYRENLKEISL 220
A +AK +YL +HRD+ N LL C +ADFG+A ++I
Sbjct: 121 CARDVAKGCKYLEENHFIHRDIAARNCLLT---CKGPGRVAKIADFGMA------RDI-- 169
Query: 221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYT 279
+R+S GG + M+ + +M PE I + K+DV+SFG+ + E+ + G +PY
Sbjct: 170 --YRASYYRKGG---RAML-PIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYP 223
Query: 280 DLRAEAQAHTVLEMNYTEQQLTAAVVSGG-LRPILASLELGLPASILSLIQRCWDGNPHN 338
+ V+E V GG L P G P + ++ CW P +
Sbjct: 224 GRTNQ----EVMEF----------VTGGGRLDP-----PKGCPGPVYRIMTDCWQHTPED 264
Query: 339 RPSFSDI 345
RP+F+ I
Sbjct: 265 RPNFATI 271
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 66/223 (29%), Positives = 107/223 (47%), Gaps = 29/223 (13%)
Query: 66 SSYTLLSPIARGAESVVYEAT--LDGRKVAVKKPIL-STSEELDNFHKELQLLCKLDHPG 122
+TLL I +G+ VY+A + VA+K L +E+++ +E+Q L + P
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPY 60
Query: 123 LAKFVAAHAKPPNYMFFFEFYES---RNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLH 179
+ K+ + K E+ +L + ++E + I ++ L+YLH
Sbjct: 61 ITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDE-----TYIAFILREVLLGLEYLH 115
Query: 180 NLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKN-M 238
G +HRD+K AN+LL LADFG+ SG+ T K+N
Sbjct: 116 EEGKIHRDIKAANILLSEEGDVKLADFGV-----------------SGQLTSTMSKRNTF 158
Query: 239 VGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDL 281
VGT +MAPE++K+ + EK+D++S GI+ EL G P +DL
Sbjct: 159 VGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDL 201
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.5 bits (249), Expect = 5e-23
Identities = 70/217 (32%), Positives = 101/217 (46%), Gaps = 29/217 (13%)
Query: 68 YTLLSPIARGAESVVYEA--TLDGRKVAVKKPILSTSEELDNFH----KELQLLCKLDHP 121
Y ++ I G VY+A G VA+KK + E + F +E++LL KL HP
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKK--IRMENEKEGFPITAIREIKLLQKLRHP 58
Query: 122 ---GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYL 178
L + V + K YM F E+ + +L L E + Q+ QL + LQYL
Sbjct: 59 NIVRLKEIVTSKGKGSIYMVF-EYMD-HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYL 116
Query: 179 HNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNM 238
H+ GI+HRD+K +N+L++ + LADFGLA R+S T N
Sbjct: 117 HSNGILHRDIKGSNILINNDGVLKLADFGLARPYTK---------RNSADYT------NR 161
Query: 239 VGTLIYMAPEILKKEIH-SEKSDVYSFGISINELLTG 274
V TL Y PE+L + D++S G + EL G
Sbjct: 162 VITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLG 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.6 bits (246), Expect = 8e-23
Identities = 65/213 (30%), Positives = 98/213 (46%), Gaps = 22/213 (10%)
Query: 68 YTLLSPIARGAESVVYEA--TLDGRKVAVKKPILSTSEELDNFH--KELQLLCKLDHPGL 123
Y L I G VVY+A L G VA+KK L E +E++LL +L+HP +
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60
Query: 124 AKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGI 183
K + + FEF ++ +L + + + + QL + L + H+ GI
Sbjct: 61 IKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGI 119
Query: 184 VHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLI 243
+HRD+KP N+L++ LADFGLA RS G P + + V T
Sbjct: 120 LHRDLKPENLLINTEGVLKLADFGLA--------------RSFGSPVRPY--THYVVTRW 163
Query: 244 YMAPEIL-KKEIHSEKSDVYSFGISINELLTGV 275
Y APE+L + +S D++S G ELL+
Sbjct: 164 YRAPELLLGDKGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 98.9 bits (247), Expect = 8e-23
Identities = 65/213 (30%), Positives = 95/213 (44%), Gaps = 21/213 (9%)
Query: 68 YTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEE--LDNFHKELQLLCKLDHPGL 123
Y +L I GA +V++A G VA+KK L E + +E++ L HP +
Sbjct: 2 YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYV 61
Query: 124 AKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGI 183
K + ++ E Y +L+E L EE QV L K + Y+H GI
Sbjct: 62 VKLLDVFPHGSGFVLVME-YMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGI 120
Query: 184 VHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLI 243
+HRD+KPAN+L+ + +ADFGLA R S +P H+ V T
Sbjct: 121 MHRDLKPANLLISADGVLKIADFGLA--RLF----------SEEEPRLYSHQ---VATRW 165
Query: 244 YMAPEIL-KKEIHSEKSDVYSFGISINELLTGV 275
Y APE+L + D+++ G ELL G
Sbjct: 166 YRAPELLYGARKYDPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 1e-22
Identities = 70/255 (27%), Positives = 118/255 (46%), Gaps = 37/255 (14%)
Query: 90 RKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLA 149
KVA+K + S + F E L+ +L HP L + A + P Y+ E+ E+ +L
Sbjct: 31 TKVAIKS-LKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQEPIYIIT-EYMENGSLV 88
Query: 150 EKLHVEEWSP-SVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGL 208
+ L E ++++++ +AAQ+A+ + ++ +HRD++ AN+L+ LC +ADFGL
Sbjct: 89 DFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGL 148
Query: 209 AEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISI 268
A E+ + + R K F K + APE + + KSDV+SFGI +
Sbjct: 149 ARLIEDNEYTA----REGAK----FPIK-------WTAPEAINYGTFTIKSDVWSFGILL 193
Query: 269 NELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSL 327
E++T G +PY + + LE Y + P + L
Sbjct: 194 TEIVTYGRIPYPGMT-NPEVIQNLERGYRMPRPD-----------------NCPEELYEL 235
Query: 328 IQRCWDGNPHNRPSF 342
++ CW P RP+F
Sbjct: 236 MRLCWKEKPEERPTF 250
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.4 bits (238), Expect = 7e-22
Identities = 59/223 (26%), Positives = 99/223 (44%), Gaps = 21/223 (9%)
Query: 64 PPSSYTLLSPIARGAESVVYEA--TLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP 121
P Y L+ I G VY+A G VA+K L ++ + +E+ +L + HP
Sbjct: 1 PQEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHP 60
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL 181
+ + ++ + E+ +L + V S Q+ + + K L YLH
Sbjct: 61 NIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHET 120
Query: 182 GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGT 241
G +HRD+K AN+LL + LADFG++ +++ + K +K+ +GT
Sbjct: 121 GKIHRDIKGANILLTEDGDVKLADFGVS------AQLT----ATIAK------RKSFIGT 164
Query: 242 LIYMAPEILKKEIHS---EKSDVYSFGISINELLTGVVPYTDL 281
+MAPE+ E K D+++ GI+ EL P DL
Sbjct: 165 PYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDL 207
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 95.4 bits (238), Expect = 7e-22
Identities = 54/170 (31%), Positives = 79/170 (46%), Gaps = 20/170 (11%)
Query: 111 ELQLLCKLDHPGLAKFVAAHAKPPNYMFF-FEFYESRNLAEKLHVEEWSPSVDQVLMIAA 169
E ++L + +HP + K K Y++ E+ L L + A
Sbjct: 43 EKEILEECNHPFIVKLYRTF-KDKKYIYMLMEYCLGGELWTILR-DRGLFDEYTARFYIA 100
Query: 170 QLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKP 229
+ A +YLHN GI++RD+KP N+LLD N L DFG A K++ SG+
Sbjct: 101 CVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFA------KKL------KSGQK 148
Query: 230 TGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYT 279
T F GT Y+APEI+ + + D +S GI + ELLTG P+
Sbjct: 149 TWTF-----CGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFG 193
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 8e-22
Identities = 63/223 (28%), Positives = 105/223 (47%), Gaps = 30/223 (13%)
Query: 74 IARGAESVVYEA--TLDGRKVAVKKPILSTSEE---------LDNFHKELQLLCKLDHPG 122
I G+ VY G +AVK+ L + LD +E+ LL +L H
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 123 LAKFVAAHAKPPNYMFFFEFYESRNLAEKLH----VEEWSPSVDQVLMIAAQLAKALQYL 178
+ +++ + + F E+ ++A L+ EE V Q+ K L YL
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEE-----TLVRNFVRQILKGLNYL 122
Query: 179 HNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNM 238
HN GI+HRD+K AN+L+D ++DFG IS K +S + ++
Sbjct: 123 HNRGIIHRDIKGANILVDNKGGIKISDFG----------ISKKLEANSLSTKTNGARPSL 172
Query: 239 VGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDL 281
G++ +MAPE++K+ ++ K+D++S G + E+LTG P+ D
Sbjct: 173 QGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDC 215
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 1e-21
Identities = 67/278 (24%), Positives = 119/278 (42%), Gaps = 39/278 (14%)
Query: 68 YTLLSPIARGAESVVYEAT--LDGRKVAVKKPILSTSEELDNFH--KELQLLCKLDHPGL 123
+ +L+ I +G+ VV++ D R A+K+ LS + E ++L KLD +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 124 AKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSP-SVDQVLMIAAQLAKALQYLHNLG 182
++ + E+ E+ +L + L ++ P DQV Q+ L +LH+
Sbjct: 62 IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK 121
Query: 183 IVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTL 242
I+HRD+K N+ LD + D G+A K +S +VGT
Sbjct: 122 ILHRDIKSLNLFLDAYDNVKIGDLGVA------KLLSDNT----------NFANTIVGTP 165
Query: 243 IYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTA 302
Y++PE+ + + ++EKSDV++ G+ + E TG P+ A Q +L+
Sbjct: 166 YYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFD---ANNQGALILK---------- 212
Query: 303 AVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRP 340
++ G P+ + LI +C + RP
Sbjct: 213 -IIRGVFPPVSQ----MYSQQLAQLIDQCLTKDYRQRP 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 1e-21
Identities = 63/263 (23%), Positives = 110/263 (41%), Gaps = 38/263 (14%)
Query: 92 VAVKKPILST---SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNL 148
VAVK L + S+ +D+F KE ++ LDH L + P M E +L
Sbjct: 26 VAVK--CLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLTHP-LMMVTELAPLGSL 82
Query: 149 AEKLHVEEWSP-SVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFG 207
++L + + + A Q+A ++YL + +HRD+ N+LL + + DFG
Sbjct: 83 LDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFG 142
Query: 208 LAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGIS 267
L ++ ++ H K + APE L+ S SDV+ FG++
Sbjct: 143 LMRALPQNED----HYVME------EHLKV---PFAWCAPESLRTRTFSHASDVWMFGVT 189
Query: 268 INELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILS 326
+ E+ T G P+ L + + ++L RP + I +
Sbjct: 190 LWEMFTYGEEPWAGLSGSQILKKI-DKEG--ERLE--------RPEACPQD------IYN 232
Query: 327 LIQRCWDGNPHNRPSFSDIALEL 349
++ +CW NP +RP+F+ + L
Sbjct: 233 VMLQCWAHNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 2e-21
Identities = 86/307 (28%), Positives = 127/307 (41%), Gaps = 81/307 (26%)
Query: 68 YTLLSPIARGAESVVYEA--TLDGRKVAVKK-PI--LSTSEELDNFHKELQLLCKLDHPG 122
+ + I +G SVVY+A LDGR VA+KK I + ++ + KE+ LL +LDHP
Sbjct: 4 FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPN 63
Query: 123 LAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIA-------------- 168
+ K++A+ F E+ L V E + + D MI
Sbjct: 64 VIKYLAS------------FIENNEL---NIVLELADAGDLSRMIKHFKKQKRLIPERTI 108
Query: 169 ----AQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWR 224
QL AL+++H+ I+HRD+KPANV + L D GL +
Sbjct: 109 WKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRF------------- 155
Query: 225 SSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVP-YTDLRA 283
S K T VGT YM+PE + + ++ KSD++S G + E+ P Y D
Sbjct: 156 FSSKTTAAHSL---VGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD--- 209
Query: 284 EAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILS-----LIQRCWDGNPHN 338
+MN L + P LPA S L+ RC + +P
Sbjct: 210 --------KMNLYS--LCKKIEKCDYPP--------LPADHYSEELRDLVSRCINPDPEK 251
Query: 339 RPSFSDI 345
RP S +
Sbjct: 252 RPDISYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 2e-21
Identities = 75/228 (32%), Positives = 114/228 (50%), Gaps = 31/228 (13%)
Query: 66 SSYTLLSPIARGAESVVYEA--TLDGRKVAVKKPILST-SEELDNFHKELQLLCKLDH-- 120
S Y L I RGA VY GR VA+K L T +++ + +E+ LL +L
Sbjct: 1 SLYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQ 60
Query: 121 -PGLAKFVAAHAKPPNYMFFFEFYES---RNLAEKLHVEEWSPSVDQVLMIAAQLAKALQ 176
P + K+ ++ K P E+ E R L + + E SV I ++ AL+
Sbjct: 61 PPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISV-----IIREVLVALK 115
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
Y+H +G++HRD+K AN+L+ L DFG+A L + S K RS+
Sbjct: 116 YIHKVGVIHRDIKAANILVTNTGNVKLCDFGVA---ALLNQNSSK--RST---------- 160
Query: 237 NMVGTLIYMAPE-ILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRA 283
VGT +MAPE I + + + K+D++S GI+I E+ TG PY+D+ A
Sbjct: 161 -FVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDA 207
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 2e-21
Identities = 68/288 (23%), Positives = 120/288 (41%), Gaps = 49/288 (17%)
Query: 68 YTLLSPIARGA--ESVVYEATLDGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGL 123
Y + + +GA E+ +Y T D V K+ L+ + +E + E+ +L L HP +
Sbjct: 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNI 61
Query: 124 AKFVAAHAKPPNYMFFFEFYESRNLAEKL------HVEEWSPSVDQVLMIAAQLAKALQY 177
+ + E+ L +K+ EE + VL Q+ A+ Y
Sbjct: 62 IAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEE-----EMVLWYLFQIVSAVSY 116
Query: 178 LHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKN 237
+H GI+HRD+K N+ L + L DFG++ K + + +
Sbjct: 117 IHKAGILHRDIKTLNIFLTKAGLIKLGDFGIS------KILG----------SEYSMAET 160
Query: 238 MVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTE 297
+VGT YM+PE+ + ++ KSD+++ G + ELLT L+ A L
Sbjct: 161 VVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLT-------LKRTFDATNPLN----- 208
Query: 298 QQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
L +V G P+++ L +SL+ +P RP+ ++
Sbjct: 209 --LVVKIVQGNYTPVVSVYSSEL----ISLVHSLLQQDPEKRPTADEV 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 2e-21
Identities = 77/273 (28%), Positives = 129/273 (47%), Gaps = 31/273 (11%)
Query: 89 GRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKF--VAAHAKPPNYMFFFEFYESR 146
G VAVKK ST+E L +F +E+++L L H + K+ V A N E+
Sbjct: 33 GEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYG 92
Query: 147 NLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADF 206
+L + L ++L+ A+Q+ K ++YL + VHRD+ N+L++ + DF
Sbjct: 93 SLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDF 152
Query: 207 GLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGI 266
GL + KE R G+ + + APE L + S SDV+SFG+
Sbjct: 153 GLTKVLPQDKEYYKV--REPGE-----------SPIFWYAPESLTESKFSVASDVWSFGV 199
Query: 267 SINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVV-------SGGLRPILASLELG 319
+ EL T Y+D ++ + + M ++Q V + G P G
Sbjct: 200 VLYELFT----YSD-KSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRLPA----PPG 250
Query: 320 LPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352
PA I ++++ CW+ +P RPSFS++AL+++ +
Sbjct: 251 CPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 4e-21
Identities = 79/297 (26%), Positives = 131/297 (44%), Gaps = 43/297 (14%)
Query: 63 LPPSSYTLLSPIARGAESVVYEATLD--GRK---VAVK--KPILSTSEELDNFHKELQLL 115
+ PS T+ I G V L G+K VA+K K S + LD F E ++
Sbjct: 1 IDPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLD-FLTEASIM 59
Query: 116 CKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKAL 175
+ DHP + + K M E+ E+ +L + L + +V Q++ + +A +
Sbjct: 60 GQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGM 119
Query: 176 QYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK-PTGGFH 234
+YL + VHRD+ N+L++ NL ++DFGL+ E+ + GK P
Sbjct: 120 KYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTK---GGKIP----- 171
Query: 235 KKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEM 293
+ + APE + + SDV+SFGI + E+++ G PY D+
Sbjct: 172 -------IRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDM------------ 212
Query: 294 NYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350
+ Q + AV G P + P+++ L+ CW + + RP+FS I LD
Sbjct: 213 --SNQDVIKAVEDGYRLPP----PMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLD 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 1e-20
Identities = 65/229 (28%), Positives = 113/229 (49%), Gaps = 23/229 (10%)
Query: 65 PSSYTLLSPIARGAESVVYEA-TLD-GRKVAVKK-PI----LSTSEELDNFHKELQLLCK 117
P+++ + +GA VY +D GR++AVK+ P T +E++ E+QLL
Sbjct: 1 PTNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKN 60
Query: 118 LDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVL-MIAAQLAKALQ 176
L H + ++ F E+ ++ + ++ + + V Q+ + ++
Sbjct: 61 LQHERIVQYYGCLRDDETLSIFMEYMPGGSVKD--QLKAYGALTETVTRKYTRQILEGVE 118
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
YLH+ IVHRD+K AN+L D L DFG ++ L+ SSG TG K
Sbjct: 119 YLHSNMIVHRDIKGANILRDSAGNVKLGDFGASK--------RLQTICSSG--TG---MK 165
Query: 237 NMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEA 285
++ GT +M+PE++ E + K+DV+S G ++ E+LT P+ + A A
Sbjct: 166 SVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMA 214
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 2e-20
Identities = 80/286 (27%), Positives = 131/286 (45%), Gaps = 46/286 (16%)
Query: 74 IARGAESVVYEA--TLDGRKVAVK--KPILSTSEELDN----FHKELQLLCKLDHPGLAK 125
+ GA S Y+A G +AVK + +TS E + KE++L+ +L+HP + +
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 126 FVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLM-IAAQLAKALQYLHNLGIV 184
+ A + ++ F E+ +++ L ++ + V++ QL + L YLH I+
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLLS--KYGAFKEAVIINYTEQLLRGLSYLHENQII 125
Query: 185 HRDVKPANVLLD---RNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTG-GFHKKNMVG 240
HRDVK AN+L+D + L +ADFG A R + K TG G + ++G
Sbjct: 126 HRDVKGANLLIDSTGQRL--RIADFGAAA-------------RLAAKGTGAGEFQGQLLG 170
Query: 241 TLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQL 300
T+ +MAPE+L+ E + DV+S G I E+ T P+ A+ H+ L
Sbjct: 171 TIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWN-----AEKHS------NHLAL 219
Query: 301 TAAVVSG-GLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
+ S I L GL L RC + P +RP ++
Sbjct: 220 IFKIASATTAPSIPEHLSPGLRDVTL----RCLELQPEDRPPSREL 261
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 7e-20
Identities = 79/287 (27%), Positives = 132/287 (45%), Gaps = 36/287 (12%)
Query: 65 PSSYTLLSPIARGAESVVYEAT-LDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGL 123
PS TL+ I G +V+ L+ RKVA+K I + ++F +E Q++ KL HP L
Sbjct: 3 PSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKT-IREGAMSEEDFIEEAQVMMKLSHPKL 61
Query: 124 AKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGI 183
+ + FEF E L++ L + S + +L + + + + YL + +
Sbjct: 62 VQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNV 121
Query: 184 VHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLI 243
+HRD+ N L+ N ++DFG+ L + +S T F K
Sbjct: 122 IHRDLAARNCLVGENQVVKVSDFGMTR-------FVLDDQYTSSTGTK-FPVK------- 166
Query: 244 YMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTA 302
+ +PE+ +S KSDV+SFG+ + E+ + G PY + R+ ++ V+E +L
Sbjct: 167 WSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPY-ENRSNSE---VVETINAGFRL-- 220
Query: 303 AVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALEL 349
+P LA S+ L+Q CW P +RPSFS + +L
Sbjct: 221 ------YKPRLA------SQSVYELMQHCWKERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 7e-20
Identities = 74/298 (24%), Positives = 125/298 (41%), Gaps = 45/298 (15%)
Query: 69 TLLSPIARGAESVVYEATLDGRK-----VAVKK-PILSTSEELDNFHKELQLLCKLDHPG 122
TL I G VY+ + VAVK ++ + F +E ++ + DHP
Sbjct: 9 TLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPH 68
Query: 123 LAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLG 182
+ K + + P ++ E L L V ++S + +++ + QL+ AL YL +
Sbjct: 69 IVKLIGVITENPVWIVM-ELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR 127
Query: 183 IVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTL 242
VHRD+ NVL+ C L DFGL+ Y E+ + K G L
Sbjct: 128 FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES-----------------YYKASKGKL 170
Query: 243 --IYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQ 299
+MAPE + + SDV+ FG+ + E+L GV P+ + +
Sbjct: 171 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGV---------------KNN 215
Query: 300 LTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHRK 357
+ G R + P ++ SL+ +CW +P RP F+++ +L +L+ K
Sbjct: 216 DVIGRIENGERLPMPPN---CPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQEEK 270
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 1e-19
Identities = 73/288 (25%), Positives = 119/288 (41%), Gaps = 51/288 (17%)
Query: 74 IARGAESVVYEATL-DGRKVAVKKPILSTSEEL-DNFHKELQLLCKLDHPGLAKFVAAHA 131
I +G VY+ L +VAVK + +L F +E ++L + DHP + K +
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV 62
Query: 132 KPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPA 191
+ E +L L ++ +V ++L ++ A ++YL + +HRD+
Sbjct: 63 QKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAAR 122
Query: 192 NVLLDRNLCPHLADFGLAEYREN--------LKEISLKNWRSSGKPTGGFHKKNMVGTLI 243
N L+ N ++DFG++ E LK+I +K
Sbjct: 123 NCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIK---------------------- 160
Query: 244 YMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTA 302
+ APE L ++ +SDV+S+GI + E + G PY + QQ
Sbjct: 161 WTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYP--------------GMSNQQTRE 206
Query: 303 AVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350
+ SG P P I L+ +CW +P NRPSFS+I EL
Sbjct: 207 RIESGYRMPA----PQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 1e-19
Identities = 76/276 (27%), Positives = 121/276 (43%), Gaps = 44/276 (15%)
Query: 82 VYEATLD--GRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFF 139
VYE VAVK + + E++ F KE ++ ++ HP L + + + P +
Sbjct: 22 VYEGVWKKYSLTVAVKT-LKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 80
Query: 140 FEFYESRNLAEKLHV--EEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDR 197
EF NL + L + +V + M A Q++ A++YL +HRD+ N L+
Sbjct: 81 TEFMTYGNLLDYLRECNRQEVNAVVLLYM-ATQISSAMEYLEKKNFIHRDLAARNCLVGE 139
Query: 198 NLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSE 257
N +ADFGL+ + + F K + APE L S
Sbjct: 140 NHLVKVADFGLSRL--------MTGDTYTAHAGAKFPIK-------WTAPESLAYNKFSI 184
Query: 258 KSDVYSFGISINELLT-GVVPY--TDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILA 314
KSDV++FG+ + E+ T G+ PY DL +Q + +LE Y + RP
Sbjct: 185 KSDVWAFGVLLWEIATYGMSPYPGIDL---SQVYELLEKGYRME-----------RP--- 227
Query: 315 SLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350
G P + L++ CW NP +RPSF++I +
Sbjct: 228 ---EGCPPKVYELMRACWQWNPSDRPSFAEIHQAFE 260
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 2e-19
Identities = 85/285 (29%), Positives = 130/285 (45%), Gaps = 42/285 (14%)
Query: 63 LPPSSYTLLSPIARGAESVVYEATLDGR-KVAVK--KPILSTSEELDNFHKELQLLCKLD 119
+P S L+ + G V+ T +G KVAVK KP + E +F +E Q++ KL
Sbjct: 3 IPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPE---SFLEEAQIMKKLR 59
Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSP-SVDQVLMIAAQLAKALQYL 178
H L + A ++ P Y+ E+ +L + L E + ++ +AAQ+A + Y+
Sbjct: 60 HDKLVQLYAVVSEEPIYIVT-EYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYI 118
Query: 179 HNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNM 238
+ +HRD++ AN+L+ L +ADFGLA E+ + + R K F K
Sbjct: 119 ERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA----RQGAK----FPIK-- 168
Query: 239 VGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTE 297
+ APE + KSDV+SFGI + EL+T G VPY + VLE
Sbjct: 169 -----WTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM----NNREVLEQ---- 215
Query: 298 QQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSF 342
V G R P S+ L+ +CW +P RP+F
Sbjct: 216 -------VERGYR---MPCPQDCPISLHELMLQCWKKDPEERPTF 250
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 89.0 bits (220), Expect = 2e-19
Identities = 68/226 (30%), Positives = 114/226 (50%), Gaps = 31/226 (13%)
Query: 64 PPSSYTLLSPIARGAESVVYEATLDGRK---VAVKKPILSTSE-ELDNFHKELQLLCKLD 119
P +T L I +G+ V++ +D R VA+K L +E E+++ +E+ +L + D
Sbjct: 2 PEELFTKLEKIGKGSFGEVFKG-IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCD 60
Query: 120 HPGLAKFVAAHAKPPNYMFFFEFY---ESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQ 176
P + K+ ++ K E+ + +L E ++E Q+ I ++ K L
Sbjct: 61 SPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDE-----TQIATILREILKGLD 115
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
YLH+ +HRD+K ANVLL + LADFG+A G+ T K+
Sbjct: 116 YLHSEKKIHRDIKAANVLLSEHGEVKLADFGVA-----------------GQLTDTQIKR 158
Query: 237 N-MVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDL 281
N VGT +MAPE++K+ + K+D++S GI+ EL G P+++L
Sbjct: 159 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSEL 204
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 2e-19
Identities = 79/288 (27%), Positives = 131/288 (45%), Gaps = 38/288 (13%)
Query: 74 IARGAESVVYEATL---DGRKV--AVKK-PILSTSEELDNFHKELQLLCKLDHPGLAKFV 127
I +G VY TL DG+K+ AVK ++ EE++ F KE ++ HP + +
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 128 AAHAKPPNY-MFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHR 186
+ + + +L + E +P+V ++ Q+AK ++YL + VHR
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHR 122
Query: 187 DVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMA 246
D+ N +LD + +ADFGLA ++I K + S TG K V +MA
Sbjct: 123 DLAARNCMLDESFTVKVADFGLA------RDIYDKEYYSVHNHTGA---KLPVK---WMA 170
Query: 247 PEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVV 305
E L+ + + KSDV+SFG+ + EL+T G PY D+ + +L+
Sbjct: 171 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQ------------- 217
Query: 306 SGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL 353
G R L E P + ++ CW P RP+FS++ ++ +
Sbjct: 218 --GRR--LLQPEY-CPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 2e-19
Identities = 63/283 (22%), Positives = 133/283 (46%), Gaps = 39/283 (13%)
Query: 68 YTLLSPIARGA--ESVVYEATLDGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGL 123
Y + I G+ ++++ ++ DG++ +K+ +S + +E + KE+ +L + HP +
Sbjct: 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNI 61
Query: 124 AKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSP-SVDQVLMIAAQLAKALQYLHNLG 182
++ + + N ++ E +L +K++ + DQ+L Q+ AL+++H+
Sbjct: 62 VQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK 121
Query: 183 IVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTL 242
I+HRD+K N+ L ++ L DFG+A + E++ + +GT
Sbjct: 122 ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELA----------------RTCIGTP 165
Query: 243 IYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTA 302
Y++PEI + ++ KSD+++ G + E+ T L+ +A + + L
Sbjct: 166 YYLSPEICENRPYNNKSDIWALGCVLYEMCT-------LKHAFEAGNM-------KNLVL 211
Query: 303 AVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
++ G P+ + L + L +R NP +RPS + I
Sbjct: 212 KIIRGSYPPVSSHYSYDLRNLVSQLFKR----NPRDRPSVNSI 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 2e-19
Identities = 60/225 (26%), Positives = 103/225 (45%), Gaps = 23/225 (10%)
Query: 64 PPSSYTLLSPIARGAESVVYEAT--LDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP 121
P + ++ + GA VY+A G A K + + EEL++F E+ +L + HP
Sbjct: 3 PNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHP 62
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL 181
+ A+ EF + L + E + Q+ + Q+ +AL +LH+
Sbjct: 63 NIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSH 122
Query: 182 GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGT 241
++HRD+K N+LL + LADFG +S KN + K + +GT
Sbjct: 123 KVIHRDLKAGNILLTLDGDVKLADFG----------VSAKNKSTLQK------RDTFIGT 166
Query: 242 LIYMAPEILKKEIHSE-----KSDVYSFGISINELLTGVVPYTDL 281
+MAPE++ E + K+D++S GI++ EL P+ +L
Sbjct: 167 PYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHEL 211
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 3e-19
Identities = 82/310 (26%), Positives = 136/310 (43%), Gaps = 61/310 (19%)
Query: 88 DGRKVAVKKPIL---STSEELDNFHKELQLLCKL-DHPGLAKFVAAHAKPPNYMFF-FEF 142
DG K+ +L ++ + +F EL++LCKL HP + + A + Y++ E+
Sbjct: 26 DGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGA-CENRGYLYIAIEY 84
Query: 143 YESRNLAE---KLHVEEWSP------------SVDQVLMIAAQLAKALQYLHNLGIVHRD 187
NL + K V E P + Q+L A+ +A +QYL +HRD
Sbjct: 85 APYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRD 144
Query: 188 VKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLI--YM 245
+ NVL+ NL +ADFGL+ E + K +G L +M
Sbjct: 145 LAARNVLVGENLASKIADFGLSRGEE-------------------VYVKKTMGRLPVRWM 185
Query: 246 APEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAV 304
A E L +++ KSDV+SFG+ + E+++ G PY + A+ + L Y ++
Sbjct: 186 AIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC-AELYEKLPQGYRMEK----- 239
Query: 305 VSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHRKSLKEEDL 364
P E + L+++CW P+ RP F+ I+++L +LE RK+ L
Sbjct: 240 ------PRNCDDE------VYELMRQCWRDRPYERPPFAQISVQLSRMLEARKAYVNMAL 287
Query: 365 CAGKSYVTYD 374
+Y D
Sbjct: 288 FENFTYAGID 297
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 3e-19
Identities = 79/285 (27%), Positives = 128/285 (44%), Gaps = 42/285 (14%)
Query: 63 LPPSSYTLLSPIARGAESVVYEATLDGR-KVAVK--KPILSTSEELDNFHKELQLLCKLD 119
+P S L + G V+ AT + KVAVK KP S ++ F E ++ L
Sbjct: 3 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKP---GSMSVEAFLAEANVMKTLQ 59
Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSP-SVDQVLMIAAQLAKALQYL 178
H L K A K P Y+ EF +L + L +E S + +++ +AQ+A+ + ++
Sbjct: 60 HDKLVKLHAVVTKEPIYIIT-EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI 118
Query: 179 HNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNM 238
+HRD++ AN+L+ +L +ADFGLA E+ + + R K F K
Sbjct: 119 EQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTA----REGAK----FPIK-- 168
Query: 239 VGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTE 297
+ APE + + KSDV+SFGI + E++T G +PY + + + LE Y
Sbjct: 169 -----WTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM-SNPEVIRALERGYRM 222
Query: 298 QQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSF 342
+ P + +++ RCW P RP+F
Sbjct: 223 PRPENC-----------------PEELYNIMMRCWKNRPEERPTF 250
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 3e-19
Identities = 65/225 (28%), Positives = 107/225 (47%), Gaps = 29/225 (12%)
Query: 64 PPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSE---ELDNFHKELQLLCKLDH 120
P +T L I +G+ VY+ + K V I+ E E+++ +E+ +L + D
Sbjct: 2 PEELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS 61
Query: 121 PGLAKFVAAHAKPPNYMFFFEFY---ESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQY 177
P + ++ ++ K E+ + +L + +EE + I ++ K L Y
Sbjct: 62 PYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEE-----TYIATILREILKGLDY 116
Query: 178 LHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKN 237
LH+ +HRD+K ANVLL LADFG+A G+ T K+N
Sbjct: 117 LHSERKIHRDIKAANVLLSEQGDVKLADFGVA-----------------GQLTDTQIKRN 159
Query: 238 -MVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDL 281
VGT +MAPE++K+ + K+D++S GI+ EL G P +DL
Sbjct: 160 TFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDL 204
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 88.0 bits (219), Expect = 4e-19
Identities = 54/197 (27%), Positives = 89/197 (45%), Gaps = 27/197 (13%)
Query: 89 GRKVAVKKPILSTSE-----ELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFY 143
G+ A+K ILS ++ ++++ E ++L + HP L + N E+
Sbjct: 26 GKYYALK--ILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYV 83
Query: 144 ESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHL 203
L + AAQ+ AL+YLH+L IV+RD+KP N+LLD + +
Sbjct: 84 PGGELFS-HLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKI 142
Query: 204 ADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYS 263
DFG A K + + + + GT Y+APEI+ + + + D ++
Sbjct: 143 TDFGFA------KRVKGRTY-------------TLCGTPEYLAPEIILSKGYGKAVDWWA 183
Query: 264 FGISINELLTGVVPYTD 280
GI I E+L G P+ D
Sbjct: 184 LGILIYEMLAGYPPFFD 200
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 4e-19
Identities = 72/297 (24%), Positives = 126/297 (42%), Gaps = 63/297 (21%)
Query: 82 VYEATL---DGR--KVAVK--KPILSTSEELDNFHKELQLLCKLDHPGLAKFV------A 128
V E L DG KVAVK K + T E++ F E + DHP + K + +
Sbjct: 15 VMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEAS 74
Query: 129 AHAKPPNYMFFFEFYESRNL-----AEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGI 183
+ K P M F + +L +L + +L +A ++YL N
Sbjct: 75 SLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNF 134
Query: 184 VHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTL- 242
+HRD+ N +L ++ +ADFGL+ K+I +G ++++ + +
Sbjct: 135 IHRDLAARNCMLREDMTVCVADFGLS------KKIY----------SGDYYRQGRIAKMP 178
Query: 243 -IYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQL 300
++A E L +++ KSDV++FG+++ E+ T G PY + H + +
Sbjct: 179 VKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPY----PGVENHEIYDY------- 227
Query: 301 TAAVVSGGLRPILASLELGLPASILS----LIQRCWDGNPHNRPSFSDIALELDLVL 353
+ G R L P L L+ CW +P +RP+F+ + L+ +L
Sbjct: 228 ----LRHGNR-------LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENIL 273
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 5e-19
Identities = 79/290 (27%), Positives = 123/290 (42%), Gaps = 43/290 (14%)
Query: 74 IARGAESVVYEA-TLDGRKVAVKKPILSTSEEL------DNFHKELQLLCKLDHPGLAKF 126
+ +GA VY T G+ +AVK+ L TS L + +E+ LL L H + ++
Sbjct: 8 LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67
Query: 127 VAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVL-MIAAQLAKALQYLHNLGIVH 185
+ F EF +++ L + P + V Q+ + YLHN +VH
Sbjct: 68 LGTCLDDNTISIFMEFVPGGSISSIL--NRFGPLPEPVFCKYTKQILDGVAYLHNNCVVH 125
Query: 186 RDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYM 245
RD+K NV+L N L DFG A L + L S+ K+M GT +M
Sbjct: 126 RDIKGNNVMLMPNGIIKLIDFGCAR---RLAWVGLHGTHSN-------MLKSMHGTPYWM 175
Query: 246 APEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVV 305
APE++ + + KSD++S G ++ E+ TG P + +L A
Sbjct: 176 APEVINESGYGRKSDIWSIGCTVFEMATGKPPLASM----------------DRLAAMFY 219
Query: 306 SGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH 355
G R ++ L A+ + + C + H RPS AL+L L H
Sbjct: 220 IGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPS----ALQL---LRH 262
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 6e-19
Identities = 68/285 (23%), Positives = 120/285 (42%), Gaps = 43/285 (15%)
Query: 68 YTLLSPIARGAESVVYEAT--LDGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGL 123
+ +L + +G+ VY+ D + A+K+ L + +E ++ E+++L ++HP +
Sbjct: 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNI 61
Query: 124 AKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSV---DQVLMIAAQLAKALQYLHN 180
+ A E+ +L++ + + + ++ I QL + LQ LH
Sbjct: 62 ISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE 121
Query: 181 LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
I+HRD+K AN+LL N + D G++ K K +G
Sbjct: 122 QKILHRDLKSANILLVANDLVKIGDLGIS------------------KVLKKNMAKTQIG 163
Query: 241 TLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQL 300
T YMAPE+ K +S KSD++S G + E+ T P+ +A ++ ++ Y
Sbjct: 164 TPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPF-------EARSMQDLRYK---- 212
Query: 301 TAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
V G PI L I S++Q P RP+ I
Sbjct: 213 ---VQRGKYPPIPPIYSQDLQNFIRSMLQV----KPKLRPNCDKI 250
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 7e-19
Identities = 66/219 (30%), Positives = 98/219 (44%), Gaps = 35/219 (15%)
Query: 68 YTLLSPIARGAESVVYE----ATLDGRKVAVKKPILSTSEELDNFHK----ELQLLCKLD 119
Y +L + GA VV + AT G VA+KK SE+ ++ K E+++L +L
Sbjct: 3 YEVLGVVGEGAYGVVLKCRNKAT--GEIVAIKK--FKESEDDEDVKKTALREVKVLRQLR 58
Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSP---SVDQVLMIAAQLAKALQ 176
H + A + FE+ E R L L + E SP D V QL +A+
Sbjct: 59 HENIVNLKEAFRRKGRLYLVFEYVE-RTL---LELLEASPGGLPPDAVRSYIWQLLQAIA 114
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
Y H+ I+HRD+KP N+L+ + L DFG A + R+
Sbjct: 115 YCHSHNIIHRDIKPENILVSESGVLKLCDFGFA-----------RALRARPAS----PLT 159
Query: 237 NMVGTLIYMAPEILKKEIHSEKS-DVYSFGISINELLTG 274
+ V T Y APE+L + + K DV++ G + ELL G
Sbjct: 160 DYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDG 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 86.9 bits (215), Expect = 8e-19
Identities = 69/307 (22%), Positives = 136/307 (44%), Gaps = 55/307 (17%)
Query: 68 YTLLSPIARGAESVVYEATL-----DGRKVAVK--KPILSTSEELDNFHKELQLLCKLDH 120
+TL + +G V EA L +KVAVK K + +S +++ F +E + + DH
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 121 PGLAKF--VAAHAKP----PNYMFFFEFYESRNL-----AEKLHVEEWSPSVDQVLMIAA 169
P + K V+ ++ P M F + +L ++ E ++ + ++
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 170 QLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKP 229
+A ++YL + +HRD+ N +L+ N+ +ADFGL+ K+I
Sbjct: 121 DIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS------KKIY---------- 164
Query: 230 TGGFHKKNMVGTL--IYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQ 286
+G ++++ L ++A E L +++ SDV++FG+++ E++T G PY +
Sbjct: 165 SGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEI 224
Query: 287 AHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIA 346
+ +++ N +Q + L+ +CW P RPSF +
Sbjct: 225 YNYLIKGNRLKQPPDC------------------LEDVYELMCQCWSPEPKCRPSFQHLR 266
Query: 347 LELDLVL 353
+L+L+
Sbjct: 267 DQLELIW 273
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 1e-18
Identities = 73/286 (25%), Positives = 117/286 (40%), Gaps = 50/286 (17%)
Query: 74 IARGAESVVYEATL-DGRKVAVKKPILSTSEELD-NFHKELQLLCKLDHPGLAKFVAAHA 131
+ +G V++ TL D VAVK +EL F E ++L + DHP + K +
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 132 KPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPA 191
+ E + L ++ Q++ A A + YL + +HRD+
Sbjct: 63 QRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAAR 122
Query: 192 NVLLDRNLCPHLADFGLAEYREN-------LKEISLKNWRSSGKPTGGFHKKNMVGTLIY 244
N L+ N ++DFG++ ++ LK+I +K +
Sbjct: 123 NCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIK----------------------W 160
Query: 245 MAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAA 303
APE L +S +SDV+S+GI + E + GV PY + + QA +E Y
Sbjct: 161 TAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ-QAREQVEKGYR------- 212
Query: 304 VVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALEL 349
S P + ++QRCWD P NRP FS++ EL
Sbjct: 213 ----------MSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKEL 248
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 1e-18
Identities = 75/295 (25%), Positives = 129/295 (43%), Gaps = 58/295 (19%)
Query: 100 STSEELDNFHKELQLLCKL-DHPGLAKFVAAHAKPPNYMFF-FEFYESRNLAE---KLHV 154
++ ++ +F EL++LCKL HP + + A + Y++ E+ NL + K V
Sbjct: 46 ASKDDHRDFAGELEVLCKLGHHPNIINLLGA-CEHRGYLYLAIEYAPHGNLLDFLRKSRV 104
Query: 155 EEWSP------------SVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPH 202
E P S Q+L AA +A+ + YL +HRD+ N+L+ N
Sbjct: 105 LETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAK 164
Query: 203 LADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLI--YMAPEILKKEIHSEKSD 260
+ADFGL+ +E + K +G L +MA E L +++ SD
Sbjct: 165 IADFGLSRGQE-------------------VYVKKTMGRLPVRWMAIESLNYSVYTTNSD 205
Query: 261 VYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELG 319
V+S+G+ + E+++ G PY + A+ + L Y ++ L
Sbjct: 206 VWSYGVLLWEIVSLGGTPYCGMTC-AELYEKLPQGYRLEK-----------------PLN 247
Query: 320 LPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHRKSLKEEDLCAGKSYVTYD 374
+ L+++CW P+ RPSF+ I + L+ +LE RK+ L +Y D
Sbjct: 248 CDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTLYEKFTYAGID 302
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 2e-18
Identities = 62/222 (27%), Positives = 108/222 (48%), Gaps = 23/222 (10%)
Query: 64 PPSSYTLLSPIARGAESVVYEATLDGRK---VAVKKPILSTSE-ELDNFHKELQLLCKLD 119
P +T L I +G+ V++ +D R VA+K L +E E+++ +E+ +L + D
Sbjct: 2 PEELFTKLERIGKGSFGEVFKG-IDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCD 60
Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLH 179
P + K+ ++ K E+ + + L + Q+ + ++ K L YLH
Sbjct: 61 SPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEF--QIATMLKEILKGLDYLH 118
Query: 180 NLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMV 239
+ +HRD+K ANVLL LADFG+A L + +K + V
Sbjct: 119 SEKKIHRDIKAANVLLSEQGDVKLADFGVA---GQLTDTQIK-------------RNTFV 162
Query: 240 GTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDL 281
GT +MAPE++++ + K+D++S GI+ EL G P +D+
Sbjct: 163 GTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDM 204
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 85.7 bits (213), Expect = 2e-18
Identities = 83/310 (26%), Positives = 123/310 (39%), Gaps = 59/310 (19%)
Query: 68 YTLLSPIARGAESVVYEA--TLDGRKVAVKKPILSTSEELD---NFH--KELQLLCKLDH 120
Y + G +VVY+A GR VA+KK L +E NF +E++LL +L H
Sbjct: 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKH 61
Query: 121 PGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHN 180
P + + N FEF E+ +L + + + + + + L+YLH+
Sbjct: 62 PNIIGLLDVFGHKSNINLVFEFMET-DLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHS 120
Query: 181 LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNM-- 238
I+HRD+KP N+L+ + LADFGLA RS G P + M
Sbjct: 121 NWILHRDLKPNNLLIASDGVLKLADFGLA--------------RSFGSP-----NRKMTH 161
Query: 239 -VGTLIYMAPEIL-KKEIHSEKSDVYSFGISINELLTGVVPY----TDLR---------- 282
V T Y APE+L + D++S G ELL VP+ +D+
Sbjct: 162 QVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLR-VPFLPGDSDIDQLGKIFEALG 220
Query: 283 ----AEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHN 338
T L +Y E + L + L L+QR NP+
Sbjct: 221 TPTEENWPGVTSL-PDYVEFKPFPP-------TPLKQIFPAASDDALDLLQRLLTLNPNK 272
Query: 339 RPSFSDIALE 348
R + ALE
Sbjct: 273 RITARQ-ALE 281
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 3e-18
Identities = 68/263 (25%), Positives = 114/263 (43%), Gaps = 54/263 (20%)
Query: 89 GRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNL 148
G K +V+K IL +ELQ++ + P + F A N EF + +L
Sbjct: 41 GAKSSVRKQIL----------RELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSL 90
Query: 149 AEKLHVEEWSPSVDQVLMIAAQLAKALQYLHN-LGIVHRDVKPANVLLDRNLCPHLADFG 207
++++ + V+ + IA + + L YL+N I+HRD+KP+N+L++ L DFG
Sbjct: 91 -DRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFG 149
Query: 208 LAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGIS 267
++ E + I+ VGT YM+PE ++ ++ KSDV+S GIS
Sbjct: 150 VSG--ELINSIA----------------DTFVGTSTYMSPERIQGGKYTVKSDVWSLGIS 191
Query: 268 INELLTGVVPYT----DLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPAS 323
I EL G P+ D + +L++ L+ I+ LP+S
Sbjct: 192 IIELALGKFPFAFSNIDDDGQDDPMGILDL---------------LQQIVQEPPPRLPSS 236
Query: 324 ILS-----LIQRCWDGNPHNRPS 341
+ C +P RP+
Sbjct: 237 DFPEDLRDFVDACLLKDPTERPT 259
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 3e-18
Identities = 49/172 (28%), Positives = 80/172 (46%), Gaps = 20/172 (11%)
Query: 109 HKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIA 168
H E ++L ++ HP + + E+ L L S L A
Sbjct: 49 HNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSG-RFSNSTGLFYA 107
Query: 169 AQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK 228
+++ AL+YLH+ IV+RD+KP N+LLD+ L DFG A K++ + W
Sbjct: 108 SEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFA------KKLRDRTW----- 156
Query: 229 PTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTD 280
+ GT Y+APE+++ + H++ D ++ GI I E+L G P+ D
Sbjct: 157 --------TLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFD 200
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 3e-18
Identities = 84/301 (27%), Positives = 126/301 (41%), Gaps = 52/301 (17%)
Query: 73 PIARGAESVVYEAT--LDGRKVAVKK------PILSTSEELDNFHKELQLLCKLDHPGLA 124
PI GA VV+ T DG++VA+KK ++S +EL++LC H +
Sbjct: 7 PIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVF----RELKMLCFFKHDNVL 62
Query: 125 KFVAAHAKPPNYMFFFEFYESRNLAEK-LH---VEEWSPSVDQVLMIAAQLAKALQYLHN 180
+ +PP+ F E Y L + LH V S D V + Q+ + L+YLH+
Sbjct: 63 SALDI-LQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHS 121
Query: 181 LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
GI+HRD+KP N+L++ N + DFGLA E P H V
Sbjct: 122 AGILHRDIKPGNLLVNSNCVLKICDFGLARVEE---------------PDESKHMTQEVV 166
Query: 241 TLIYMAPEILKKEIH-SEKSDVYSFGISINELLTGVVPY------------TDLRAEAQA 287
T Y APEIL H + D++S G ELL + + TDL
Sbjct: 167 TQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTP-- 224
Query: 288 HTVLEMNYTEQQLTAAVVSGGLRPILASLELGL--PAS--ILSLIQRCWDGNPHNRPSFS 343
++ M + A ++ G +P + L A+ + L+ R +P R S +
Sbjct: 225 -SLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAA 283
Query: 344 D 344
D
Sbjct: 284 D 284
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 3e-18
Identities = 62/185 (33%), Positives = 88/185 (47%), Gaps = 38/185 (20%)
Query: 167 IAAQLAKALQYLHN-LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRS 225
IA KAL YL L I+HRDVKP+N+LLDRN L DFG++ + S+ R
Sbjct: 112 IAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD----SIAKTRD 167
Query: 226 SG-KPTGGFHKKNMVGTLIYMAPEIL---KKEIHSEKSDVYSFGISINELLTGVVPYTDL 281
+G +P YMAPE + ++ + +SDV+S GI++ E+ TG PY
Sbjct: 168 AGCRP--------------YMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYP-- 211
Query: 282 RAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILA-SLELGLPASILSLIQRCWDGNPHNRP 340
+ N QLT VV G PIL+ S E S ++ I C + RP
Sbjct: 212 ----------KWNSVFDQLT-QVVKGD-PPILSNSEEREFSPSFVNFINLCLIKDESKRP 259
Query: 341 SFSDI 345
+ ++
Sbjct: 260 KYKEL 264
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 3e-18
Identities = 70/281 (24%), Positives = 124/281 (44%), Gaps = 43/281 (15%)
Query: 74 IARGAESVVYEA--TLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHA 131
+ +G +VY A ++A+K+ S + H+E+ L L H + +++ + +
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 132 KPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIA---AQLAKALQYLHNLGIVHRDV 188
+ + F E +L+ L +W P D I Q+ + L+YLH+ IVHRD+
Sbjct: 76 ENGFFKIFMEQVPGGSLSALLR-SKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDI 134
Query: 189 KPANVLLD--RNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMA 246
K NVL++ + ++DFG ++ + + + GTL YMA
Sbjct: 135 KGDNVLVNTYSGVV-KISDFGTSKRLAGINPCT----------------ETFTGTLQYMA 177
Query: 247 PEILKKEI--HSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAV 304
PE++ K + +D++S G +I E+ TG P+ +L E Q AA+
Sbjct: 178 PEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIEL-GEPQ---------------AAM 221
Query: 305 VSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
G+ I + L A + I RC++ +P R S D+
Sbjct: 222 FKVGMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDL 262
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 3e-18
Identities = 82/288 (28%), Positives = 130/288 (45%), Gaps = 42/288 (14%)
Query: 63 LPPSSYTLLSPIARGAESVVYEATLDGR-KVAVK--KPILSTSEELDNFHKELQLLCKLD 119
+P S L + +G V+ T +G KVA+K KP E F +E Q++ KL
Sbjct: 3 IPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEA---FLQEAQIMKKLR 59
Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSP-SVDQVLMIAAQLAKALQYL 178
H L A ++ P Y+ EF +L + L + + Q++ +AAQ+A + Y+
Sbjct: 60 HDKLVPLYAVVSEEPIYIVT-EFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYI 118
Query: 179 HNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNM 238
+ +HRD++ AN+L+ NL +ADFGLA E+ + + + + K
Sbjct: 119 ERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIK---------- 168
Query: 239 VGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTE 297
+ APE + KSDV+SFGI + EL+T G VPY +
Sbjct: 169 -----WTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM--------------VN 209
Query: 298 QQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
+++ V G P G P S+ L++ CW +P RP+F I
Sbjct: 210 REVLEQVERGYRMPC----PQGCPESLHELMKLCWKKDPDERPTFEYI 253
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 4e-18
Identities = 73/282 (25%), Positives = 129/282 (45%), Gaps = 58/282 (20%)
Query: 100 STSEELDNFHKELQLLCKLDHPGLAKFVAA--HAKPPNYMFFFEFYES------------ 145
++S EL + E LL +++HP + K A P + + Y S
Sbjct: 42 ASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVG 101
Query: 146 ---------RNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLD 196
RN + + +E + ++ ++ A Q+++ +QYL + +VHRD+ NVL+
Sbjct: 102 PSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVA 161
Query: 197 RNLCPHLADFGLAEYRENLKEIS-LKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIH 255
++DFGL+ R+ +E S +K RS G+ + +MA E L I+
Sbjct: 162 EGRKMKISDFGLS--RDVYEEDSYVK--RSKGRI-----------PVKWMAIESLFDHIY 206
Query: 256 SEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILA 314
+ +SDV+SFG+ + E++T G PY + E + +L+ Y + RP
Sbjct: 207 TTQSDVWSFGVLLWEIVTLGGNPYPGIAPE-RLFNLLKTGYRME-----------RPENC 254
Query: 315 SLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHR 356
S E + +L+ CW P RP+F+DI+ EL+ ++
Sbjct: 255 SEE------MYNLMLTCWKQEPDKRPTFADISKELEKMMVKS 290
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 4e-18
Identities = 54/169 (31%), Positives = 86/169 (50%), Gaps = 17/169 (10%)
Query: 110 KELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAA 169
E +L +++HP + K A +F +L +L +E + + V A
Sbjct: 47 MERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLS-KEVMFTEEDVKFYLA 105
Query: 170 QLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKP 229
+LA AL +LH+LGI++RD+KP N+LLD L DFGL+ K K
Sbjct: 106 ELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLS-----------KESIDHEKK 154
Query: 230 TGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
F GT+ YMAPE++ + H++ +D +SFG+ + E+LTG +P+
Sbjct: 155 AYSF-----CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPF 198
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.8 bits (211), Expect = 4e-18
Identities = 69/216 (31%), Positives = 99/216 (45%), Gaps = 30/216 (13%)
Query: 68 YTLLSPIARGAESVVYEAT--LDGRKVAVKKPILSTSEE------LDNFHKELQLLCKLD 119
Y L + G VVY+A G VA+KK L EE L +E+ LL +L
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTAL----REISLLKELK 56
Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLH 179
HP + K + FE+ + +L + L S + + I QL + L Y H
Sbjct: 57 HPNIVKLLDVIHTERKLYLVFEYCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH 115
Query: 180 NLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMV 239
+ I+HRD+KP N+L++R+ LADFGLA R+ G P + + V
Sbjct: 116 SHRILHRDLKPQNILINRDGVLKLADFGLA--------------RAFGIPLRTYTHE--V 159
Query: 240 GTLIYMAPEILKKEIHSEKS-DVYSFGISINELLTG 274
TL Y APEIL H + D++S G E++TG
Sbjct: 160 VTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITG 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.4 bits (208), Expect = 6e-18
Identities = 69/267 (25%), Positives = 114/267 (42%), Gaps = 56/267 (20%)
Query: 107 NFHKELQLLCKL-DHPGLAKFVAAHAKPPNYMFFFEFYESRNLAE---KLHVEEWSP--- 159
+F EL++LCKL HP + + A E+ NL + K V E P
Sbjct: 41 DFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFA 100
Query: 160 ---------SVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAE 210
S Q+L AA +A+ + YL +HRD+ N+L+ N +ADFGL+
Sbjct: 101 IANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 160
Query: 211 YRENLKEISLKNWRSSGKPTGGFHKKNMVGTLI--YMAPEILKKEIHSEKSDVYSFGISI 268
+E + K +G L +MA E L +++ SDV+S+G+ +
Sbjct: 161 GQE-------------------VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLL 201
Query: 269 NELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSL 327
E+++ G PY + A+ + L Y ++ L + L
Sbjct: 202 WEIVSLGGTPYCGMTC-AELYEKLPQGYRLEK-----------------PLNCDDEVYDL 243
Query: 328 IQRCWDGNPHNRPSFSDIALELDLVLE 354
+++CW P+ RPSF+ I + L+ +LE
Sbjct: 244 MRQCWREKPYERPSFAQILVSLNRMLE 270
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 6e-18
Identities = 80/285 (28%), Positives = 128/285 (44%), Gaps = 42/285 (14%)
Query: 63 LPPSSYTLLSPIARGAESVVYEATLDGR-KVAVK--KPILSTSEELDNFHKELQLLCKLD 119
+P S L + +G V+ T +G +VA+K KP + E F +E Q++ KL
Sbjct: 3 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLR 59
Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSP-SVDQVLMIAAQLAKALQYL 178
H L + A ++ P Y+ E+ +L + L E + Q++ +AAQ+A + Y+
Sbjct: 60 HEKLVQLYAVVSEEPIYIVT-EYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV 118
Query: 179 HNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNM 238
+ VHRD++ AN+L+ NL +ADFGLA E+ + + + + K
Sbjct: 119 ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK---------- 168
Query: 239 VGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTE 297
+ APE + KSDV+SFGI + EL T G VPY +
Sbjct: 169 -----WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM--------------VN 209
Query: 298 QQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSF 342
+++ V G P P S+ L+ +CW P RP+F
Sbjct: 210 REVLDQVERGYRMPCPPE----CPESLHDLMCQCWRKEPEERPTF 250
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 6e-18
Identities = 78/288 (27%), Positives = 125/288 (43%), Gaps = 46/288 (15%)
Query: 67 SYTLLSPIARGA--ESVVYEATLDGRKVAVKKPIL--STSEELDNFHKELQLLCKLDHPG 122
+Y + + +G+ E + DG++ +KK L ++ E +E QLL +L HP
Sbjct: 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPN 60
Query: 123 LAKFVAAHAKPPNYMFF-FEFYESRNLAEKLHVE--EWSPSVDQVLMIAAQLAKALQYLH 179
+ + + ++ F E +L KL + + P +QV+ Q+A ALQYLH
Sbjct: 61 IVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPE-NQVVEWFVQIAMALQYLH 119
Query: 180 NLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMV 239
I+HRD+K NV L R + D G+A EN +++ ++
Sbjct: 120 EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMA----------------STLI 163
Query: 240 GTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQ 299
GT YM+PE+ + ++ KSDV++ G + E+ T L+ A +MN
Sbjct: 164 GTPYYMSPELFSNKPYNYKSDVWALGCCVYEMAT-------LK---HAFNAKDMN----S 209
Query: 300 LTAAVVSGGLRPILA--SLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
L ++ G L P+ S ELG LI P RPS I
Sbjct: 210 LVYRIIEGKLPPMPKDYSPELG------ELIATMLSKRPEKRPSVKSI 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 1e-17
Identities = 47/140 (33%), Positives = 73/140 (52%), Gaps = 17/140 (12%)
Query: 153 HVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYR 212
+V E +++V+ +AQ+ + +LH++ IV+RD+KP NVLLD L+D GLA
Sbjct: 86 NVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLA--- 142
Query: 213 ENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELL 272
+ LK+ GK GT YMAPEILK+E +S D ++ G SI E++
Sbjct: 143 -----VELKD----GKTI-----TQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMV 188
Query: 273 TGVVPYTDLRAEAQAHTVLE 292
G P+ D + + +
Sbjct: 189 AGRTPFKDHKEKVAKEELKR 208
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 1e-17
Identities = 71/284 (25%), Positives = 127/284 (44%), Gaps = 40/284 (14%)
Query: 68 YTLLSPIARGAESVVY--EATLDGRKVAVKKPILSTS--EELDNFHKELQLLCKLDHPGL 123
Y ++ I G+ +Y +A D +K+ L+ +E + KE+ LL K+ HP +
Sbjct: 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNI 61
Query: 124 AKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSP-SVDQVLMIAAQLAKALQYLHNLG 182
F A+ + E+ + +L ++++ + S DQ+L Q++ L+++H+
Sbjct: 62 VTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK 121
Query: 183 IVHRDVKPANVLLDRN-LCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGT 241
I+HRD+K N+ L +N + L DFG+A + E++ VGT
Sbjct: 122 ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELA----------------YTCVGT 165
Query: 242 LIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLT 301
Y++PEI + ++ K+D++S G + EL T P+ E N QL
Sbjct: 166 PYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPF-------------EGN-NLHQLV 211
Query: 302 AAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
+ G PI + SLI + + +P +RPS + I
Sbjct: 212 LKICQGYFAPI----SPNFSRDLRSLISQLFKVSPRDRPSITSI 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 1e-17
Identities = 57/235 (24%), Positives = 93/235 (39%), Gaps = 25/235 (10%)
Query: 66 SSYTLLSPIARGAESVVYEATLDG--RKVAVKKPILSTSEELDNFHK---ELQLLCKLDH 120
+ + + +G V+ L G + A+K + + + E ++L LDH
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDH 60
Query: 121 PGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSP----SVDQVLMIAAQLAKALQ 176
P L A+ ++ L L + P S + AA++ AL+
Sbjct: 61 PFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQ---PGKCLSEEVARFYAAEVLLALE 117
Query: 177 YLHNLGIVHRDVKPANVLL---------DRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
YLH LGIV+RD+KP N+LL D +L + K + S
Sbjct: 118 YLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIP 177
Query: 228 KPT----GGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
T F + VGT Y+APE++ + H D ++ GI + E+L G P+
Sbjct: 178 SETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPF 232
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 62/240 (25%), Positives = 99/240 (41%), Gaps = 44/240 (18%)
Query: 64 PPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPIL-STSEELDNFHKELQLLCKL-D 119
P + L+ I G VY+A G+ VA+K I+ +E + +E +L K +
Sbjct: 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIK--IMDIIEDEEEEIKEEYNILRKYSN 61
Query: 120 HPGLAKFVAAHAKPPNYM------FFFEFYES---RNLAEKLHVEEWSPSVDQVLMIAAQ 170
HP +A F A K E +L + L + + + I +
Sbjct: 62 HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRE 121
Query: 171 LAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPT 230
+ L YLH ++HRD+K N+LL +N L DFG++ L + G+
Sbjct: 122 TLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVS---AQLD-------STLGR-- 169
Query: 231 GGFHKKNMVGTLIYMAPEILKKEIHSE---------KSDVYSFGISINELLTGVVPYTDL 281
+ +GT +MAPE+ I + +SDV+S GI+ EL G P D+
Sbjct: 170 ----RNTFIGTPYWMAPEV----IACDEQPDASYDARSDVWSLGITAIELADGKPPLCDM 221
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 1e-17
Identities = 67/289 (23%), Positives = 110/289 (38%), Gaps = 44/289 (15%)
Query: 63 LPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPG 122
+ P T L + G VV G+ K I S D F +E +++ KL H
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEK 60
Query: 123 LAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLG 182
L + K E+ + L L Q+L + + + + YL +
Sbjct: 61 LVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ 120
Query: 183 IVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGT- 241
+HRD+ N L+D C ++DFGL+ Y + + SS VG+
Sbjct: 121 FIHRDLAARNCLVDDQGCVKVSDFGLSRY------VLDDEYTSS------------VGSK 162
Query: 242 --LIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQ 298
+ + PE+L S KSDV++FG+ + E+ + G +PY +
Sbjct: 163 FPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYE--------------RFNNS 208
Query: 299 QLTAAVVSGG--LRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
+ V G RP LAS + +++ CW RP+F +
Sbjct: 209 ETVEKVSQGLRLYRPHLAS------EKVYAIMYSCWHEKAEERPTFQQL 251
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 82.7 bits (205), Expect = 1e-17
Identities = 67/214 (31%), Positives = 101/214 (47%), Gaps = 26/214 (12%)
Query: 71 LSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDN-FHKELQLLCKLDHPGLAKFV 127
L + G VV + G+ +AVK L +E + +EL +L K + P + F
Sbjct: 6 LGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFY 65
Query: 128 AAHAKPPNYMFFFEFYESRNLAEKL-HVEEWSPSVDQVL-MIAAQLAKALQYLHN-LGIV 184
A + E+ + +L + L V+ P +++L IA + K L YLH I+
Sbjct: 66 GAFYNNGDISICMEYMDGGSLDKILKEVQGRIP--ERILGKIAVAVLKGLTYLHEKHKII 123
Query: 185 HRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIY 244
HRDVKP+N+L++ L DFG+ SG+ K VGT Y
Sbjct: 124 HRDVKPSNILVNSRGQIKLCDFGV-----------------SGQLVNSLAKTF-VGTSSY 165
Query: 245 MAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
MAPE ++ +S KSD++S G+S+ EL TG PY
Sbjct: 166 MAPERIQGNDYSVKSDIWSLGLSLIELATGRFPY 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 1e-17
Identities = 78/283 (27%), Positives = 118/283 (41%), Gaps = 37/283 (13%)
Query: 63 LPPSSYTLLSPIARGAESVVYEATLDGR-KVAVKKPILSTSEELDNFHKELQLLCKLDHP 121
+ +S LL + G V+E + VAVK + + + +F E Q++ KL HP
Sbjct: 3 IDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKT-LKPGTMDPKDFLAEAQIMKKLRHP 61
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSP-SVDQVLMIAAQLAKALQYLHN 180
L + A E + +L E L + Q++ +AAQ+A + YL
Sbjct: 62 KLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEA 121
Query: 181 LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
+HRD+ NVL+ N +ADFGLA +KE + R K F K
Sbjct: 122 QNYIHRDLAARNVLVGENNICKVADFGLARV---IKE-DIYEAREGAK----FPIK---- 169
Query: 241 TLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQ 299
+ APE S KSDV+SFGI + E++T G +PY T +
Sbjct: 170 ---WTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYP--------------GMTNAE 212
Query: 300 LTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSF 342
+ V G P G P + ++ CW +P +RP+F
Sbjct: 213 VLQQVDQGYRMPCPP----GCPKELYDIMLDCWKEDPDDRPTF 251
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 2e-17
Identities = 57/218 (26%), Positives = 101/218 (46%), Gaps = 22/218 (10%)
Query: 64 PPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP 121
P S I G+ +V AT GR+VAVKK L + + E+ ++ HP
Sbjct: 17 PRSYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHP 76
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL 181
+ + +++ EF E L + V + +Q+ + + KAL +LH
Sbjct: 77 NIVEMYSSYLVGDELWVVMEFLEGGALTDI--VTHTRMNEEQIATVCLAVLKALSFLHAQ 134
Query: 182 GIVHRDVKPANVLLDRNLCPHLADFGL-AEYRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
G++HRD+K ++LL + L+DFG A+ + + +K++VG
Sbjct: 135 GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR-----------------RKSLVG 177
Query: 241 TLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
T +MAPE++ + + + D++S GI + E++ G PY
Sbjct: 178 TPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 2e-17
Identities = 67/217 (30%), Positives = 104/217 (47%), Gaps = 27/217 (12%)
Query: 108 FHKELQLLCKLDHPGLAKFVAAHAKPPNYMF-FFEFYESRNLAEKLHVEEWSPSVDQV-L 165
F +E L +L HP + + + PP +F FE+ R L E L + P+ + L
Sbjct: 25 FRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVLAADGALPAGETGRL 84
Query: 166 MIAAQLAKALQYLHNLGIVHRDVKPANVLLD-RNLCPH--LADFGLAEYRENLKEISLKN 222
M Q+ AL HN GIVHRD+KP N+++ + PH + DFG+ +++ +
Sbjct: 85 M--LQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVAT 142
Query: 223 WRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLR 282
+ + ++GT Y APE L+ E + SD+Y++G+ E LTG +
Sbjct: 143 LTRTTE---------VLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTG-------Q 186
Query: 283 AEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELG 319
Q +V E+ Y QQL+ VS L P +A LG
Sbjct: 187 RVVQGASVAEILY--QQLSPVDVS--LPPWIAGHPLG 219
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 2e-17
Identities = 76/281 (27%), Positives = 121/281 (43%), Gaps = 38/281 (13%)
Query: 74 IARGAESVVYEATL--DGRKVAVKKPILSTSEEL-DNFHKELQLLCKLDHPGLAKFVAA- 129
I RG V+ L D VAVK + +L F +E ++L + HP + + +
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 130 HAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVK 189
K P Y+ E + + L E V +++ + A ++YL + +HRD+
Sbjct: 63 TQKQPIYIVM-ELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLA 121
Query: 190 PANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEI 249
N L+ ++DFG++ E+ S TGG + + T APE
Sbjct: 122 ARNCLVTEKNVLKISDFGMSREEEDGVYAS----------TGGMKQIPVKWT----APEA 167
Query: 250 LKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGG 308
L +S +SDV+SFGI + E + G VPY +L + QQ A+ G
Sbjct: 168 LNYGRYSSESDVWSFGILLWEAFSLGAVPYANL--------------SNQQTREAIEQGV 213
Query: 309 LRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALEL 349
P P ++ L++RCW+ +P RPSFS + EL
Sbjct: 214 RLPCPELC----PDAVYRLMERCWEYDPGQRPSFSTVHQEL 250
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 2e-17
Identities = 72/287 (25%), Positives = 123/287 (42%), Gaps = 44/287 (15%)
Query: 65 PSSYTLLSPIARGAESVVYEATLDGR-KVAVKKPILSTSEELDNFHKELQLLCKLDHPGL 123
PS T + + G VV+ + KVA+K I + ++F +E +++ KL HP L
Sbjct: 3 PSELTFMKELGSGQFGVVHLGKWRAQIKVAIKA-INEGAMSEEDFIEEAKVMMKLSHPKL 61
Query: 124 AKF--VAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL 181
+ V KP EF E+ L L + S D +L + + + ++YL
Sbjct: 62 VQLYGVCTQQKP--LYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERN 119
Query: 182 GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGT 241
+HRD+ N L+ ++DFG+ Y + + S SSG F K
Sbjct: 120 SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS-----SSG---AKFPVK----- 166
Query: 242 LIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQL 300
+ PE+ +S KSDV+SFG+ + E+ T G +P+ + ++
Sbjct: 167 --WSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFE--------------KKSNYEV 210
Query: 301 TAAVVSGG--LRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
+ G RP LAS+ ++ ++ CW P RP+F+++
Sbjct: 211 VEMISRGFRLYRPKLASM------TVYEVMYSCWHEKPEGRPTFAEL 251
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 3e-17
Identities = 62/253 (24%), Positives = 114/253 (45%), Gaps = 36/253 (14%)
Query: 101 TSEELDNFHKELQLLCKLDHPGLAKF--VAAHAKPPNYMFFFEFYESRNLAEKLHVEEWS 158
T ++ +F E ++ + DHP + V +KP M E+ E+ +L L +
Sbjct: 45 TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKP--VMIVTEYMENGSLDAFLRKHDGQ 102
Query: 159 PSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI 218
+V Q++ + +A ++YL ++G VHRD+ N+L++ NL ++DFGL+ E+
Sbjct: 103 FTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLED---- 158
Query: 219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVP 277
P + + + + APE + + SDV+S+GI + E+++ G P
Sbjct: 159 ---------DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 209
Query: 278 YTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPH 337
Y ++ + Q + A+ G P + PA++ L+ CW + +
Sbjct: 210 YWEM--------------SNQDVIKAIEEGYRLPA----PMDCPAALHQLMLDCWQKDRN 251
Query: 338 NRPSFSDIALELD 350
RP F I LD
Sbjct: 252 ERPKFEQIVSILD 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 82.7 bits (205), Expect = 3e-17
Identities = 57/200 (28%), Positives = 85/200 (42%), Gaps = 24/200 (12%)
Query: 66 SSYTLLSPIARGAESVVYEAT--LDGRKVAVKKPILSTSEELDNFH----KELQLLCKLD 119
Y +L + G VY+A GR VA+KK ++ E D F +E+++L KL
Sbjct: 8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHN--EKDGFPITALREIKILKKLK 65
Query: 120 HPGLAKFV-------AAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLA 172
HP + + + ++ Y +L+ L + Q+ QL
Sbjct: 66 HPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLL 125
Query: 173 KALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAE-YRENLKEISLKNWRSSGKPTG 231
+ + YLH I+HRD+K AN+L+D +ADFGLA Y G G
Sbjct: 126 EGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPP-------NPKGGGGG 178
Query: 232 GFHK-KNMVGTLIYMAPEIL 250
G K N+V T Y PE+L
Sbjct: 179 GTRKYTNLVVTRWYRPPELL 198
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 3e-17
Identities = 65/241 (26%), Positives = 101/241 (41%), Gaps = 44/241 (18%)
Query: 111 ELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKL----HVEEWSPSVDQVLM 166
E QLL KLDHP + KF A+ + + E+ E R+L KL H + +QV
Sbjct: 52 EAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSE-NQVCE 110
Query: 167 IAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSS 226
QL + Y+H I+HRD+K N+ L NL + DFG++ +++
Sbjct: 111 WFIQLLLGVHYMHQRRILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGSCDLA------- 162
Query: 227 GKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQ 286
GT YM+PE LK + + KSD++S G + E+
Sbjct: 163 ---------TTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEM--------------- 198
Query: 287 AHTVLEMNYTEQQLTAAVVS--GGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSD 344
L + Q + V+ G P SL + S++Q + +P RPS ++
Sbjct: 199 --CCLAHAFEGQNFLSVVLRIVEGPTP---SLPETYSRQLNSIMQSMLNKDPSLRPSAAE 253
Query: 345 I 345
I
Sbjct: 254 I 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 5e-17
Identities = 75/281 (26%), Positives = 128/281 (45%), Gaps = 44/281 (15%)
Query: 77 GAESVVYEATLDG-------RKVAVK--KPILSTSEELDNFHKELQLLCKL-DHPGLAKF 126
GA V EAT G KVAVK KP +SE + EL+++ L +H +
Sbjct: 46 GAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSER-EALMSELKIMSHLGNHENIVNL 104
Query: 127 VAAHAKPPNYMFFFEFYESRNLAEKLHVEEWS-PSVDQVLMIAAQLAKALQYLHNLGIVH 185
+ A + E+ +L L + S +++ +L + Q+AK + +L + +H
Sbjct: 105 LGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIH 164
Query: 186 RDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYM 245
RD+ NVLL + DFGLA R+ + + N+ G N + +M
Sbjct: 165 RDLAARNVLLTHGKIVKICDFGLA--RDIMND---SNYVVKG---------NARLPVKWM 210
Query: 246 APEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAV 304
APE + +++ +SDV+S+GI + E+ + G PY + +++ + +++ Y Q
Sbjct: 211 APESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQ----- 265
Query: 305 VSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
P A PA I +++ CWD +P RP+F I
Sbjct: 266 ------PEHA------PAEIYDIMKTCWDADPLKRPTFKQI 294
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 5e-17
Identities = 68/279 (24%), Positives = 116/279 (41%), Gaps = 45/279 (16%)
Query: 83 YEATLD--GRKVAVKKPILSTSEEL-DNFHKELQLLCKLDHPGLAKF--VAAHAKPPNYM 137
Y+ D G VAVK ++ + KE+ +L L H + K+ +
Sbjct: 25 YDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQ 84
Query: 138 FFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDR 197
E+ +L + L + ++ Q+L+ A Q+ + + YLH+ +HRD+ NVLLD
Sbjct: 85 LIMEYVPLGSLRDYL--PKHKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDN 142
Query: 198 NLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFH---KKNMVGTLIYMAPEILKKEI 254
+ + DFGLA K + P G + +++ + + A E LK+
Sbjct: 143 DRLVKIGDFGLA------KAV----------PEGHEYYRVREDGDSPVFWYAVECLKENK 186
Query: 255 HSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILA 314
S SDV+SFG+++ ELLT + EM +Q V ++
Sbjct: 187 FSYASDVWSFGVTLYELLTHCDSKQSPPKK-----FEEMIGPKQGQMTVV------RLIE 235
Query: 315 SLELGL--------PASILSLIQRCWDGNPHNRPSFSDI 345
LE G+ P + L++ CW+ RP+F +
Sbjct: 236 LLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSL 274
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 5e-17
Identities = 75/272 (27%), Positives = 120/272 (44%), Gaps = 40/272 (14%)
Query: 92 VAVKKPILS-TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAE 150
VAVK + ++F KE+++L +L P +A+ + P E+ E+ +L +
Sbjct: 49 VAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQ 108
Query: 151 KL--HVEE--------WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLC 200
L HV E S S +L +A Q+A ++YL +L VHRD+ N L+ +N
Sbjct: 109 FLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYT 168
Query: 201 PHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSD 260
+ADFG+ R NL S +R G+ + +MA E + + KSD
Sbjct: 169 IKIADFGM--SR-NL--YSSDYYRVQGRA---------PLPIRWMAWESVLLGKFTTKSD 214
Query: 261 VYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQL---TAAVVSGGLRPILASLE 317
V++FG+++ E+LT Q + L T+QQ+ R I
Sbjct: 215 VWAFGVTLWEILT--------LCREQPYEHL----TDQQVIENAGHFFRDDGRQIYLPRP 262
Query: 318 LGLPASILSLIQRCWDGNPHNRPSFSDIALEL 349
P I L+ CW + +RP+F +I L L
Sbjct: 263 PNCPKDIYELMLECWRRDEEDRPTFREIHLFL 294
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 5e-17
Identities = 77/297 (25%), Positives = 129/297 (43%), Gaps = 40/297 (13%)
Query: 65 PSSYTLLSPIARGAESVVYEATLD--GRK---VAVK--KPILSTSEELDNFHKELQLLCK 117
PS T I G V+ L GRK VA+K KP + + D F E ++ +
Sbjct: 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQD-FLSEASIMGQ 62
Query: 118 LDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQY 177
H + + K M E+ E+ L + L + S Q++ + +A ++Y
Sbjct: 63 FSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKY 122
Query: 178 LHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKN 237
L ++ VHRD+ N+L++ NL ++DFGL+ E+ E + S GK
Sbjct: 123 LSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTT--SGGKI-------- 172
Query: 238 MVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYT 296
+ + APE + + SDV+SFGI + E+++ G PY D+ +
Sbjct: 173 ---PIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDM--------------S 215
Query: 297 EQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL 353
++ A+ G P + P+++ L+ +CW + RP F DI LD +L
Sbjct: 216 NHEVMKAINDGFRLPA----PMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL 268
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 6e-17
Identities = 60/197 (30%), Positives = 82/197 (41%), Gaps = 39/197 (19%)
Query: 167 IAAQLAKALQYLH-NLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRS 225
IA + KAL+YLH L ++HRDVKP+NVL++RN L DFG+
Sbjct: 108 IAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGI----------------- 150
Query: 226 SGKPTGGFHKKNMVGTLIYMAPEILKKEIHSE----KSDVYSFGISINELLTGVVPYTDL 281
SG K G YMAPE + E++ + KSDV+S GI++ EL TG PY
Sbjct: 151 SGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPY--- 207
Query: 282 RAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPS 341
T QQL V P L + +C N RP+
Sbjct: 208 ---DSWKTPF------QQLKQVV--EEPSPQLP--AEKFSPEFQDFVNKCLKKNYKERPN 254
Query: 342 FSDIALELDLVLEHRKS 358
+ ++ L+ H
Sbjct: 255 YPEL-LQHPFFELHLSK 270
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 6e-17
Identities = 75/270 (27%), Positives = 120/270 (44%), Gaps = 39/270 (14%)
Query: 89 GRKVAVK--KPILSTSEELDNFHKELQLLCKLDHPGLAKF--VAAHAKPPNYMFFFEFYE 144
G +VAVK KP S + + KE+++L L H + K+ + EF
Sbjct: 33 GEQVAVKSLKP-ESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLP 91
Query: 145 SRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLA 204
S +L E L + ++ Q L A Q+ K + YL + VHRD+ NVL++ +
Sbjct: 92 SGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIG 151
Query: 205 DFGLAEYRENLKE-ISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSE---KSD 260
DFGL + E KE ++K+ S + + APE L I S+ SD
Sbjct: 152 DFGLTKAIETDKEYYTVKDDLDS--------------PVFWYAPECL---IQSKFYIASD 194
Query: 261 VYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAA----VVSGGLR-PILAS 315
V+SFG+++ ELLT Y D + + + T Q+T V+ G R P +
Sbjct: 195 VWSFGVTLYELLT----YCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLPRPPN 250
Query: 316 LELGLPASILSLIQRCWDGNPHNRPSFSDI 345
P + L+++CW+ P R +F ++
Sbjct: 251 ----CPEEVYQLMRKCWEFQPSKRTTFQNL 276
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 6e-17
Identities = 42/145 (28%), Positives = 69/145 (47%), Gaps = 17/145 (11%)
Query: 153 HVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYR 212
+V E + + AAQ+ L++LH IV+RD+KP NVLLD + ++D GLA
Sbjct: 86 NVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLA--- 142
Query: 213 ENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELL 272
+ LK GK G GT YMAPE+L+ E++ D ++ G ++ E++
Sbjct: 143 -----VELK----GGKKIKGR-----AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMI 188
Query: 273 TGVVPYTDLRAEAQAHTVLEMNYTE 297
G P+ + + + +
Sbjct: 189 AGRSPFRQRKEKVEKEELKRRTLEM 213
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 8e-17
Identities = 84/297 (28%), Positives = 124/297 (41%), Gaps = 61/297 (20%)
Query: 74 IARGAESVVYEATL-----DGR---KVAVKKPIL---STSEELDNFHKELQLLCKLDHPG 122
+ GA VYE T G +VAVK L +T +E F KE L+ +HP
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKT--LRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 123 LAKFVAAHAKPPNYMFFFEFYESRNLAEKLH---VEEWSP---SVDQVLMIAAQLAKALQ 176
+ K + E E +L L VE + P ++ ++L I +AK
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 177 YLHNLGIVHRDVKPANVLL-----DRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTG 231
YL + +HRD+ N L+ D + + DFGLA ++I K+
Sbjct: 121 YLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA------RDI-YKS--------- 164
Query: 232 GFHKKNMVGTLI--YMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAH 288
+++K G L +MAPE L + +SDV+SFG+ + E+LT G PY L
Sbjct: 165 DYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPAL------- 217
Query: 289 TVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
Q++ V +GG L E P I L+ CW +P RP+F I
Sbjct: 218 -------NNQEVLQHVTAGGR---LQKPEN-CPDKIYQLMTNCWAQDPSERPTFDRI 263
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 81.8 bits (203), Expect = 9e-17
Identities = 71/230 (30%), Positives = 100/230 (43%), Gaps = 51/230 (22%)
Query: 68 YTLLSPIARGAESVVYEA--TLDGRKVAVKKPILSTSEELDNFH--KELQLLCKLDHPGL 123
Y LL PI GA VV A GRKVA+KK + +D +E++LL L H +
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENI 61
Query: 124 AKFVAAHA--KPPNYMFFFEFYESRNLAEK-LHVEEWSP---SVDQVLMIAAQLAKALQY 177
+ +PP+ F + Y L E LH SP + D + Q+ + L+Y
Sbjct: 62 ---IGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQYFLYQILRGLKY 118
Query: 178 LHNLGIVHRDVKPANVLLDRN----LCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGF 233
LH+ ++HRD+KP+N+L++ N +C DFGLA R
Sbjct: 119 LHSANVIHRDLKPSNILVNSNCDLKIC----DFGLA--------------RGVD--PDED 158
Query: 234 HKKNM---VGTLIYMAPEIL------KKEIHSEKSDVYSFGISINELLTG 274
K + V T Y APE+L K I D++S G ELLT
Sbjct: 159 EKGFLTEYVVTRWYRAPELLLSSSRYTKAI-----DIWSVGCIFAELLTR 203
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 9e-17
Identities = 59/214 (27%), Positives = 93/214 (43%), Gaps = 26/214 (12%)
Query: 66 SSYTLLSPIARGAESVVYEA--TLDGRKVAVKKPI--LSTSEELDNFHKELQLLCKLDHP 121
+ Y L P+ GA +V A L G+ VA+KK + ST ++EL+LL L H
Sbjct: 10 NRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHE 69
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL 181
+ P ++F +L L Q + Q+ + L+Y+H+
Sbjct: 70 NIISLSDIFISPLEDIYFVTELLGTDLHRLLTSRPLEKQFIQYFLY--QILRGLKYVHSA 127
Query: 182 GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGT 241
G+VHRD+KP+N+L++ N + DFGLA ++ V T
Sbjct: 128 GVVHRDLKPSNILINENCDLKICDFGLARIQDP-------------------QMTGYVST 168
Query: 242 LIYMAPEI-LKKEIHSEKSDVYSFGISINELLTG 274
Y APEI L + + + D++S G E+L G
Sbjct: 169 RYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEG 202
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 1e-16
Identities = 71/286 (24%), Positives = 122/286 (42%), Gaps = 46/286 (16%)
Query: 65 PSSYTLLSPIARGAESVVYEATLDG-RKVAVKKPILSTSEELDNFHKELQLLCKLDHPGL 123
PS T L + G VV+ G VA+K I + D+F +E +++ KL HP L
Sbjct: 3 PSELTFLKELGSGQFGVVHLGKWRGKIDVAIKM-IREGAMSEDDFIEEAKVMMKLSHPNL 61
Query: 124 AKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGI 183
+ K E+ + L L + + +L + + + +A++YL + G
Sbjct: 62 VQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGF 121
Query: 184 VHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGT-- 241
+HRD+ N L+ + ++DFGLA Y + + SS GT
Sbjct: 122 IHRDLAARNCLVGEDNVVKVSDFGLARY------VLDDQYTSSQ------------GTKF 163
Query: 242 -LIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQ 299
+ + PE+ S KSDV+SFG+ + E+ + G +PY ++ +
Sbjct: 164 PVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYE--------------RFSNSE 209
Query: 300 LTAAVVSGGL--RPILASLELGLPASILSLIQRCWDGNPHNRPSFS 343
+ +V +G RP LA P + +++ CW P +RP+F
Sbjct: 210 VVESVSAGYRLYRPKLA------PTEVYTIMYSCWHEKPEDRPAFK 249
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 2e-16
Identities = 61/225 (27%), Positives = 103/225 (45%), Gaps = 23/225 (10%)
Query: 64 PPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILST--SEELDNFHKELQLLCKLDHP 121
P + ++ + GA VY+A V ++ T EEL+++ E+ +L DHP
Sbjct: 3 PEEFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHP 62
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL 181
+ K + A N EF + + E + Q+ ++ Q +AL YLH
Sbjct: 63 NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHEN 122
Query: 182 GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGT 241
I+HRD+K N+L + LADFG +S KN R+ + + + +GT
Sbjct: 123 KIIHRDLKAGNILFTLDGDIKLADFG----------VSAKNTRTIQR------RDSFIGT 166
Query: 242 LIYMAPEILKKEIHSE-----KSDVYSFGISINELLTGVVPYTDL 281
+MAPE++ E + K+DV+S GI++ E+ P+ +L
Sbjct: 167 PYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHEL 211
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 2e-16
Identities = 69/209 (33%), Positives = 94/209 (44%), Gaps = 28/209 (13%)
Query: 74 IARGAESVVYEA--TLDGRKVAVKKPILSTSEELD-NFHKELQLLCKLDHPGLAKFVAAH 130
+ G VY+A L R +AVK L + EL EL++L K D P + F A
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 131 AKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVL-MIAAQLAKALQYLHNLGIVHRDVK 189
EF + +L + E VL IA + K L YL +L I+HRDVK
Sbjct: 69 FVENRISICTEFMDGGSLDVYRKIPE------HVLGRIAVAVVKGLTYLWSLKILHRDVK 122
Query: 190 PANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEI 249
P+N+L++ L DFG++ + + I+ K VGT YMAPE
Sbjct: 123 PSNMLVNTRGQVKLCDFGVS--TQLVNSIA----------------KTYVGTNAYMAPER 164
Query: 250 LKKEIHSEKSDVYSFGISINELLTGVVPY 278
+ E + SDV+S GIS EL G PY
Sbjct: 165 ISGEQYGIHSDVWSLGISFMELALGRFPY 193
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 2e-16
Identities = 57/219 (26%), Positives = 88/219 (40%), Gaps = 37/219 (16%)
Query: 71 LSPIARGAESVVYEA--TLDGRKVAVK---KPILSTSEELDNFHKELQ-LLCKLDHPGLA 124
L PI++GA VY A G A+K K + ++ N E ++ + + P +A
Sbjct: 1 LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVA 60
Query: 125 KFVAAHAKPPNYMFFFEFYESRNLAEKLHV-----EEWSPSVDQVLMIAAQLAKALQYLH 179
K + E+ + A + E+W A++ ++ LH
Sbjct: 61 KLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDW------AKQYIAEVVLGVEDLH 114
Query: 180 NLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMV 239
GI+HRD+KP N+L+D+ L DFGL+ G K V
Sbjct: 115 QRGIIHRDIKPENLLIDQTGHLKLTDFGLSR--------------------NGLENKKFV 154
Query: 240 GTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
GT Y+APE + + SD +S G I E L G P+
Sbjct: 155 GTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPF 193
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 2e-16
Identities = 64/240 (26%), Positives = 99/240 (41%), Gaps = 37/240 (15%)
Query: 66 SSYTLLSPIARGAESVVYEAT--LDGRKVAVK---KPILSTSEELDNFHKELQLLCKLDH 120
+ ++ I RGA V+ G+ A+K K + ++ + E +L D
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 121 PGLAKFVAAHAKPPNYMFFFEFY---ESRNLAEKLHV--EEWSPSVDQVLMIAAQLAKAL 175
P + K + + E+ + NL + V EE A+L AL
Sbjct: 61 PWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEET------ARFYIAELVLAL 114
Query: 176 QYLHNLGIVHRDVKPANVLLDRNLCPH--LADFGLA---------EYRENLKEISLKNWR 224
+H LG +HRD+KP N+L+D H LADFGL EY N L R
Sbjct: 115 DSVHKLGFIHRDIKPDNILIDA--DGHIKLADFGLCKKMNKAKDREYYLNDSHNLLF--R 170
Query: 225 SSGKPTGGFHKKNM------VGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
+ HK+ VGT Y+APE+L+ + + D +S G+ + E+L G P+
Sbjct: 171 DNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPF 230
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 2e-16
Identities = 57/244 (23%), Positives = 104/244 (42%), Gaps = 44/244 (18%)
Query: 111 ELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLH----VEEWSPSVDQVLM 166
E++ L LDH + +++ F E+ ++ L EE V
Sbjct: 58 EIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEE-----QLVRF 112
Query: 167 IAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSS 226
Q+ + L YLH+ GI+HRD+K N+L+D + ++DFG+++ +++
Sbjct: 113 FTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDI----------- 161
Query: 227 GKPTGGFHKKNMVGTLIYMAPEI--LKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAE 284
+M G++ +MAPE+ + +S K D++S G + E+ G P++D
Sbjct: 162 ---YDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSD---- 214
Query: 285 AQAHTVLEMNYTEQQLTAAVVSGGLR---PILASLELGLPASILSLIQRCWDGNPHNRPS 341
E+ + A G R PI + + L L + C+ NP NRP+
Sbjct: 215 ------------EEAIAAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPT 262
Query: 342 FSDI 345
++
Sbjct: 263 AREL 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 80.3 bits (199), Expect = 3e-16
Identities = 88/323 (27%), Positives = 136/323 (42%), Gaps = 92/323 (28%)
Query: 68 YTLLSPIARGAESVVYEATLD---GRKVAVKKPILSTSEELDNF---------HKELQLL 115
Y +L + +GA +V++A +D VA+KK I D F +E+ L
Sbjct: 9 YEILQKLGKGAYGIVWKA-IDRRTKEVVALKK-IF------DAFRNATDAQRTFREIMFL 60
Query: 116 CKL-DHPGLAKFVAAHAKPPN----YMFFFEFYES-------RNLAEKLHVEEWSPSVDQ 163
+L DHP + K + K N Y+ F E+ E+ N+ E +H
Sbjct: 61 QELGDHPNIVKLLNVI-KAENDKDIYLVF-EYMETDLHAVIRANILEDVHKR-------- 110
Query: 164 VLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLA----EYRENLKEIS 219
I QL KAL+Y+H+ ++HRD+KP+N+LL+ + LADFGLA E EN +
Sbjct: 111 --YIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPV 168
Query: 220 LKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKS-DVYSFGISINELLTG--VV 276
L ++ V T Y APEIL K D++S G + E+L G +
Sbjct: 169 LTDY---------------VATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLF 213
Query: 277 PYTDLRAEAQAHTV--LE--MNYTE---QQLTAAVVSGGLRPILAS--------LELGLP 321
P T T+ LE + + ++ S +L S L+ LP
Sbjct: 214 PGTS--------TLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLP 265
Query: 322 ---ASILSLIQRCWDGNPHNRPS 341
L L+++ NP+ R +
Sbjct: 266 KASDDALDLLKKLLVFNPNKRLT 288
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 79.0 bits (194), Expect = 5e-16
Identities = 60/225 (26%), Positives = 104/225 (46%), Gaps = 23/225 (10%)
Query: 64 PPSSYTLLSPIARGAESVVYEAT--LDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP 121
P YT I +GA V+ A G++VA+K+ L + + E+ ++ +L +P
Sbjct: 17 PKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNP 76
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL 181
+ F+ + E+ +L + V E Q+ + + +AL++LH
Sbjct: 77 NIVNFLDSFLVGDELFVVMEYLAGGSLTDV--VTETCMDEAQIAAVCRECLQALEFLHAN 134
Query: 182 GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGT 241
++HRD+K NVLL + L DFG +I+ + + S MVGT
Sbjct: 135 QVIHRDIKSDNVLLGMDGSVKLTDFGFC------AQITPEQSKRS----------TMVGT 178
Query: 242 LIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTD---LRA 283
+MAPE++ ++ + K D++S GI E++ G PY + LRA
Sbjct: 179 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA 223
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 5e-16
Identities = 68/275 (24%), Positives = 110/275 (40%), Gaps = 55/275 (20%)
Query: 88 DGRKVAVKKPILSTSEELDN---FHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYE 144
G++V V L F +E ++ +LDHP + + + P M E
Sbjct: 20 SGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKGEP-LMLVMELAP 78
Query: 145 SRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLA 204
L + L P D + +A Q+A + YL + VHRD+ NVLL ++
Sbjct: 79 LGPLLKYLKKRREIPVSD-LKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKIS 137
Query: 205 DFGLA--------EYRENLKEISLKNWRSSGK-PTGGFHKKNMVGTLIYMAPEILKKEIH 255
DFG++ YR ++G+ P L + APE +
Sbjct: 138 DFGMSRALGAGSDYYRA----------TTAGRWP------------LKWYAPECINYGKF 175
Query: 256 SEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILA 314
S KSDV+S+G+++ E + G PY +++ V+ M + G R L
Sbjct: 176 SSKSDVWSYGVTLWEAFSYGAKPYGEMKGA----EVIAM-----------LESGER--LP 218
Query: 315 SLELGLPASILSLIQRCWDGNPHNRPSFSDIALEL 349
E P I S++ CW P +RP+FS++
Sbjct: 219 RPE-ECPQEIYSIMLSCWKYRPEDRPTFSELESTF 252
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 5e-16
Identities = 63/222 (28%), Positives = 107/222 (48%), Gaps = 26/222 (11%)
Query: 66 SSYTLLSPIARGAESVVYEAT--LDGRKVAVKK----PILSTSEELDNFHKELQLLCKLD 119
+++ + I RG S VY AT LDG VA+KK ++ D KE+ LL +L+
Sbjct: 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCI-KEIDLLKQLN 60
Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKL-HVEEWSPSVDQ--VLMIAAQLAKALQ 176
HP + K+ A+ + E ++ +L+ + H ++ + + V QL AL+
Sbjct: 61 HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALE 120
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
++H+ ++HRD+KPANV + L D GL + S K T
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRF-------------FSSKTTAA---H 164
Query: 237 NMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
++VGT YM+PE + + ++ KSD++S G + E+ P+
Sbjct: 165 SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 8e-16
Identities = 59/225 (26%), Positives = 105/225 (46%), Gaps = 23/225 (10%)
Query: 64 PPSSYTLLSPIARGAESVVYEAT--LDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP 121
P YT I +GA VY A G++VA+K+ L + + E+ ++ + HP
Sbjct: 17 PKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHP 76
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL 181
+ ++ ++ E+ +L + V E Q+ + + +AL++LH+
Sbjct: 77 NIVNYLDSYLVGDELWVVMEYLAGGSLTDV--VTETCMDEGQIAAVCRECLQALEFLHSN 134
Query: 182 GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGT 241
++HRD+K N+LL + L DFG +I+ + + S MVGT
Sbjct: 135 QVIHRDIKSDNILLGMDGSVKLTDFGFC------AQITPEQSKRS----------TMVGT 178
Query: 242 LIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTD---LRA 283
+MAPE++ ++ + K D++S GI E++ G PY + LRA
Sbjct: 179 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA 223
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 8e-16
Identities = 63/230 (27%), Positives = 98/230 (42%), Gaps = 29/230 (12%)
Query: 62 HLPPSSYTLLSPIARGAESVVYEAT--LDGRKVAVKKPILS---TSEELDNFHKELQLLC 116
P +T L I G+ VY A VA+KK S ++E+ + KE++ L
Sbjct: 11 DDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 70
Query: 117 KLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQ 176
+L HP ++ + + E Y + ++ L V + ++ I + L
Sbjct: 71 QLRHPNTIEYKGCYLREHTAWLVME-YCLGSASDILEVHKKPLQEVEIAAICHGALQGLA 129
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
YLH+ +HRD+K N+LL LADFG A SL + P F
Sbjct: 130 YLHSHERIHRDIKAGNILLTEPGTVKLADFGSA---------SLVS------PANSF--- 171
Query: 237 NMVGTLIYMAPEI---LKKEIHSEKSDVYSFGISINELLTGVVPYTDLRA 283
VGT +MAPE+ + + + K DV+S GI+ EL P ++ A
Sbjct: 172 --VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 219
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 1e-15
Identities = 73/291 (25%), Positives = 122/291 (41%), Gaps = 55/291 (18%)
Query: 68 YTLLSPIARGAESVVYEATLDGRKVAVKKPILS-------TSEELDNFHKELQLLCKLDH 120
Y + + RGA +V+ L RK K I+ T +E E Q+L L H
Sbjct: 2 YEKIRVVGRGAFGIVH---LCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSH 58
Query: 121 PGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLH--VEEWSPSVDQVLMIAAQLAKALQYL 178
P + ++ + M E+ LAE + D +L Q+ AL ++
Sbjct: 59 PNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDE-DTILHFFVQILLALHHV 117
Query: 179 HNLGIVHRDVKPANVLLDRN-LCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKN 237
H I+HRD+K N+LLD++ + + DFG++ K +S K+ +
Sbjct: 118 HTKLILHRDLKTQNILLDKHKMVVKIGDFGIS------KILSSKSKAYT----------- 160
Query: 238 MVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTE 297
+VGT Y++PE+ + + +++KSD+++ G + EL + L+ +
Sbjct: 161 VVGTPCYISPELCEGKPYNQKSDIWALGCVLYELAS-----------------LKRAFEA 203
Query: 298 QQLTAAVV---SGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
L A V+ SG PI L ILS++ +P RP S I
Sbjct: 204 ANLPALVLKIMSGTFAPISDRYSPDLRQLILSMLNL----DPSKRPQLSQI 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 1e-15
Identities = 74/316 (23%), Positives = 125/316 (39%), Gaps = 66/316 (20%)
Query: 62 HLPPSSYTLLSPIARGAESVVYEATL-------DGRKVAVKKPILSTSEEL-DNFHKELQ 113
H+ + L + GA V+ D VAVK + S + +F +E +
Sbjct: 1 HVQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAE 60
Query: 114 LLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLH---------VEEWSP----S 160
LL H + KF + + FE+ E +L + L SP +
Sbjct: 61 LLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELT 120
Query: 161 VDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI-S 219
+ Q+L IA Q+A + YL + VHRD+ N L+ +L + DFG++ +++ +
Sbjct: 121 LSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMS------RDVYT 174
Query: 220 LKNWRSSGKPTGGFHKKNMVGTLI---YMAPEILKKEIHSEKSDVYSFGISINELLT-GV 275
+R G T++ +M PE + + +SDV+SFG+ + E+ T G
Sbjct: 175 TDYYRVGGH------------TMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGK 222
Query: 276 VPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGL--RPILASLELGLPASILSLIQRCWD 333
P+ L V+E + G L RP P+ + ++ CW
Sbjct: 223 QPWYGL----SNEEVIEC----------ITQGRLLQRP------RTCPSEVYDIMLGCWK 262
Query: 334 GNPHNRPSFSDIALEL 349
+P R + DI L
Sbjct: 263 RDPQQRINIKDIHERL 278
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 2e-15
Identities = 59/184 (32%), Positives = 85/184 (46%), Gaps = 27/184 (14%)
Query: 161 VDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAE-----YRENL 215
VD M A+ AL+YLHN GIVHRD+KP N+L+ L DFGL++ NL
Sbjct: 100 VDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNL 159
Query: 216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGV 275
E ++ K T F K + GT Y+APE++ ++ + + D ++ GI + E L G
Sbjct: 160 YEGHIE------KDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGC 213
Query: 276 VPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGN 335
VP+ T ++L V+S + + LPA LI R N
Sbjct: 214 VPF--------------FGDTPEELFGQVISDDI--EWPEGDEALPADAQDLISRLLRQN 257
Query: 336 PHNR 339
P R
Sbjct: 258 PLER 261
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 2e-15
Identities = 68/264 (25%), Positives = 115/264 (43%), Gaps = 40/264 (15%)
Query: 91 KVAVK--KPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNL 148
KVAVK KP + + F +E L+ L H L + A K E+ +L
Sbjct: 32 KVAVKTLKP---GTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSL 88
Query: 149 AEKLHVEEWSP-SVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFG 207
+ L +E + +++ +AQ+A+ + Y+ +HRD++ ANVL+ +L +ADFG
Sbjct: 89 LDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFG 148
Query: 208 LAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGIS 267
LA E+ + + R K F K + APE + + KSDV+SFGI
Sbjct: 149 LARVIEDNEYTA----REGAK----FPIK-------WTAPEAINFGSFTIKSDVWSFGIL 193
Query: 268 INELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILS 326
+ E++T G +PY + + + L+ Y ++ P +
Sbjct: 194 LYEIVTYGKIPYPG-MSNSDVMSALQRGYRMPRMENC-----------------PDELYD 235
Query: 327 LIQRCWDGNPHNRPSFSDIALELD 350
+++ CW RP+F + LD
Sbjct: 236 IMKTCWKEKAEERPTFDYLQSVLD 259
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 2e-15
Identities = 73/287 (25%), Positives = 117/287 (40%), Gaps = 44/287 (15%)
Query: 66 SSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAK 125
TL I G V + G+KVAVK + F +E ++ KL H L +
Sbjct: 6 QKLTLGEIIGEGEFGAVLQGEYTGQKVAVK--NIKCDVTAQAFLEETAVMTKLHHKNLVR 63
Query: 126 FVAAHAKPPNYMFFFEFYESRNLAEKLHVE-EWSPSVDQVLMIAAQLAKALQYLHNLGIV 184
+ Y+ E NL L SV Q+L + +A+ ++YL + +V
Sbjct: 64 LLGVILHNGLYIVM-ELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLV 122
Query: 185 HRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIY 244
HRD+ N+L+ + ++DFGLA + +S P +
Sbjct: 123 HRDLAARNILVSEDGVAKVSDFGLAR-------VGSMGVDNSKLPVK------------W 163
Query: 245 MAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAA 303
APE LK + S KSDV+S+G+ + E+ + G PY + + +++
Sbjct: 164 TAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKM--------------SLKEVKEC 209
Query: 304 VVSG-GLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALEL 349
V G + P G PA + L+ CW+ P RPSF + +L
Sbjct: 210 VEKGYRMEP-----PEGCPADVYVLMTSCWETEPKKRPSFHKLREKL 251
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 3e-15
Identities = 76/306 (24%), Positives = 124/306 (40%), Gaps = 70/306 (22%)
Query: 74 IARGAESVVYEATLDG-------RKVAVKKPILSTSEELD---NFHKELQLLCKLDHPGL 123
I +GA V++A G VAVK +L D +F +E L+ + DHP +
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVK--MLKEEASADMQADFQREAALMAEFDHPNI 70
Query: 124 AKF--VAAHAKPPNYMFFFEFYESRNLAEKLH--VEEWSPSVDQV--------------- 164
K V A KP FE+ +L E L S+
Sbjct: 71 VKLLGVCAVGKP--MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLS 128
Query: 165 ----LMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL 220
L IA Q+A + YL VHRD+ N L+ N+ +ADFGL+ S
Sbjct: 129 CTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSR-----NIYSA 183
Query: 221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYT 279
+++S N + +M PE + ++ +SDV+++G+ + E+ + G+ PY
Sbjct: 184 DYYKASE---------NDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYY 234
Query: 280 DLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNR 339
+ E + V + N +L+ + P + +L++ CW P +R
Sbjct: 235 GMAHEEVIYYVRDGN-----------------VLSCPD-NCPLELYNLMRLCWSKLPSDR 276
Query: 340 PSFSDI 345
PSF+ I
Sbjct: 277 PSFASI 282
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 4e-15
Identities = 55/216 (25%), Positives = 88/216 (40%), Gaps = 39/216 (18%)
Query: 149 AEKLHVEEWSPSVDQVL-MIAAQLAKALQYL-HNLGIVHRDVKPANVLLDRNLCPHLADF 206
+KL P + +L + + KAL YL G++HRDVKP+N+LLD + L DF
Sbjct: 100 LDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDF 159
Query: 207 GLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPE-ILKKEIHSE---KSDVY 262
G+ SG+ K G YMAPE I + + + ++DV+
Sbjct: 160 GI-----------------SGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVW 202
Query: 263 SFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPA 322
S GIS+ EL TG PY + TE ++ ++ P G
Sbjct: 203 SLGISLVELATGQFPY-------------KNCKTEFEVLTKILQ--EEPPSLPPNEGFSP 247
Query: 323 SILSLIQRCWDGNPHNRPSFSDIALELDLVLEHRKS 358
S + C + RP + ++ L+ + + +
Sbjct: 248 DFCSFVDLCLTKDHRKRPKYREL-LQHPFIRRYETA 282
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 4e-15
Identities = 59/225 (26%), Positives = 107/225 (47%), Gaps = 23/225 (10%)
Query: 64 PPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILST--SEELDNFHKELQLLCKLDHP 121
P + ++ + GA VY+A ++ T EEL+++ E+++L +HP
Sbjct: 10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHP 69
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL 181
+ K + A EF + + + + Q+ +I Q+ +ALQYLH++
Sbjct: 70 YIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSM 129
Query: 182 GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGT 241
I+HRD+K NVLL + LADFG +S KN ++ + + + +GT
Sbjct: 130 KIIHRDLKAGNVLLTLDGDIKLADFG----------VSAKNVKTLQR------RDSFIGT 173
Query: 242 LIYMAPEI-----LKKEIHSEKSDVYSFGISINELLTGVVPYTDL 281
+MAPE+ +K + K+D++S GI++ E+ P+ +L
Sbjct: 174 PYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL 218
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 4e-15
Identities = 64/231 (27%), Positives = 110/231 (47%), Gaps = 25/231 (10%)
Query: 65 PSSYTLLSPIARGAESVVYEA--TLDGRKVAVKKPILS-----TSEELDNFHKELQLLCK 117
P+++ L + +GA VY GR++AVK+ TS+E++ E+QLL
Sbjct: 1 PTNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKN 60
Query: 118 LDHPGLAKFVAAHAKPPNYMF--FFEFYESRNLAEKLHVEEWSPSVDQVL-MIAAQLAKA 174
L H + ++ P F E ++ ++L + + + V Q+ +
Sbjct: 61 LLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL--KSYGALTENVTRKYTRQILEG 118
Query: 175 LQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFH 234
+ YLH+ IVHRD+K AN+L D L DFG ++ L+ I L G
Sbjct: 119 VSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASK---RLQTICLS----------GTG 165
Query: 235 KKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEA 285
K++ GT +M+PE++ E + K+D++S G ++ E+LT P+ + A A
Sbjct: 166 MKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA 216
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 5e-15
Identities = 57/225 (25%), Positives = 105/225 (46%), Gaps = 23/225 (10%)
Query: 64 PPSSYTLLSPIARGAESVVYEA--TLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP 121
P YT I +GA VY A G++VA+++ L + + E+ ++ + +P
Sbjct: 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNP 77
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL 181
+ ++ ++ E+ +L + V E Q+ + + +AL++LH+
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTDV--VTETCMDEGQIAAVCRECLQALEFLHSN 135
Query: 182 GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGT 241
++HRD+K N+LL + L DFG +I+ + + S MVGT
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFC------AQITPEQSKRS----------TMVGT 179
Query: 242 LIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTD---LRA 283
+MAPE++ ++ + K D++S GI E++ G PY + LRA
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA 224
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 5e-15
Identities = 60/223 (26%), Positives = 110/223 (49%), Gaps = 28/223 (12%)
Query: 66 SSYTLLSPIARGAESVVYEAT--LDGRKVAVKKPILSTSEELD-----NFHKELQLLCKL 118
+++ + I RG S VY AT LD + VA+KK + E +D + KE+ LL +L
Sbjct: 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKK--VQIFEMMDAKARQDCVKEIDLLKQL 59
Query: 119 DHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKL-HVEEWSPSVDQ--VLMIAAQLAKAL 175
+HP + K++ + + E ++ +L++ + + ++ + + V QL A+
Sbjct: 60 NHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAV 119
Query: 176 QYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHK 235
+++H+ ++HRD+KPANV + L D GL + S K T
Sbjct: 120 EHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRF-------------FSSKTTAA--- 163
Query: 236 KNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
++VGT YM+PE + + ++ KSD++S G + E+ P+
Sbjct: 164 HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 5e-15
Identities = 59/226 (26%), Positives = 106/226 (46%), Gaps = 25/226 (11%)
Query: 64 PPSSYTLLSPIARGAESVVYEATLD---GRKVAVKKPILSTSEELDNFHKELQLLCKLDH 120
P YT I +GA VY A +D G++VA+K+ L + + E+ ++ + +
Sbjct: 17 PKKKYTRFEKIGQGASGTVYTA-IDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKN 75
Query: 121 PGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHN 180
P + ++ ++ E+ +L + V E Q+ + + +AL +LH+
Sbjct: 76 PNIVNYLDSYLVGDELWVVMEYLAGGSLTDV--VTETCMDEGQIAAVCRECLQALDFLHS 133
Query: 181 LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
++HRD+K N+LL + L DFG +I+ + + S MVG
Sbjct: 134 NQVIHRDIKSDNILLGMDGSVKLTDFGFC------AQITPEQSKRS----------TMVG 177
Query: 241 TLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTD---LRA 283
T +MAPE++ ++ + K D++S GI E++ G PY + LRA
Sbjct: 178 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA 223
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 6e-15
Identities = 64/254 (25%), Positives = 111/254 (43%), Gaps = 36/254 (14%)
Query: 101 TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPS 160
T ++ +F E ++ + DHP + K M EF E+ L L + +
Sbjct: 45 TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFT 104
Query: 161 VDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL 220
V Q++ + +A ++YL + VHRD+ N+L++ NL ++DFGL+ + E+
Sbjct: 105 VIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED------ 158
Query: 221 KNWRSSGKPTGGFHKKNMVGTLI---YMAPEILKKEIHSEKSDVYSFGISINELLT-GVV 276
+ PT + +G I + APE + + SDV+S+GI + E+++ G
Sbjct: 159 ----DTSDPT----YTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGER 210
Query: 277 PYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNP 336
PY D+ + +N EQ L P + P ++ L+ CW +
Sbjct: 211 PYWDMSNQDV------INAIEQDYR-------LPP-----PMDCPTALHQLMLDCWQKDR 252
Query: 337 HNRPSFSDIALELD 350
+ RP F I LD
Sbjct: 253 NARPKFGQIVSTLD 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 6e-15
Identities = 64/222 (28%), Positives = 99/222 (44%), Gaps = 41/222 (18%)
Query: 68 YTLLSPIARGAESVVYEA--TLDGRKVAVKKPILSTSEE------LDNFHKELQLLCKLD 119
Y L+ I GA VY+A GR VA+KK + SEE L +E+ LL +L+
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTL----REIALLKQLE 56
Query: 120 ---HPGLAKFVAAHAKPPNY-----MFFFEFYESRNLAEKL-HVEEWSPSVDQVLMIAAQ 170
HP + + + P FE + ++LA L + + + + Q
Sbjct: 57 SFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQ 115
Query: 171 LAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAE-YRENLKEISLKNWRSSGKP 229
L + + +LH+ IVHRD+KP N+L+ + +ADFGLA Y + S+
Sbjct: 116 LLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSV--------- 166
Query: 230 TGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINEL 271
V TL Y APE+L + ++ D++S G EL
Sbjct: 167 ---------VVTLWYRAPEVLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 6e-15
Identities = 67/275 (24%), Positives = 124/275 (45%), Gaps = 43/275 (15%)
Query: 88 DGRKVAVKKPIL---STSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYE 144
DG+ V V +L T ++F KE++++ +L +P + + + E+ E
Sbjct: 41 DGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYME 100
Query: 145 SRNLAEKLHVEEW-----------SPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANV 193
+ +L + L E S S+ +L +A Q+A ++YL +L VHRD+ N
Sbjct: 101 NGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNC 160
Query: 194 LLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKE 253
L+ + +ADFG++ NL S +R G+ V + +MA E +
Sbjct: 161 LVGNHYTIKIADFGMS---RNL--YSGDYYRIQGRA---------VLPIRWMAWESILLG 206
Query: 254 IHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQL---TAAVVSGGLR 310
+ SDV++FG+++ E+ T + Q +++L +++Q+ T R
Sbjct: 207 KFTTASDVWAFGVTLWEMFT--------LCKEQPYSLL----SDEQVIENTGEFFRNQGR 254
Query: 311 PILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
I S P+ + L+ RCW + +RP+F+ I
Sbjct: 255 QIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKI 289
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 1e-14
Identities = 77/319 (24%), Positives = 118/319 (36%), Gaps = 70/319 (21%)
Query: 62 HLPPSSYTLLSPIARGAESVVYEA---TLDGRKVAVKKPILSTSEEL-----DNFHKELQ 113
+P S+ L + GA VY+ + R A I + E F +E +
Sbjct: 1 EIPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAE 60
Query: 114 LLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKL-------------HVEEWSPS 160
L+ L HP + + K FE+ +L E L E S
Sbjct: 61 LMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSS 120
Query: 161 VDQ--VLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAE-------Y 211
+D L IA Q+A ++YL + VHRD+ N L+ L ++DFGL+ Y
Sbjct: 121 LDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYY 180
Query: 212 RENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINEL 271
R K + W M PE + + +SD++SFG+ + E+
Sbjct: 181 RVQSKSLLPVRW---------------------MPPEAILYGKFTTESDIWSFGVVLWEI 219
Query: 272 LT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQR 330
+ G+ PY + V+EM + Q L PA + +L+
Sbjct: 220 FSYGLQPYYGFSNQ----EVIEMIRSRQLLPCPE--------------DCPARVYALMIE 261
Query: 331 CWDGNPHNRPSFSDIALEL 349
CW+ P RP F DI L
Sbjct: 262 CWNEIPARRPRFKDIHTRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 1e-14
Identities = 42/111 (37%), Positives = 63/111 (56%), Gaps = 16/111 (14%)
Query: 169 AQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK 228
++++ AL++LH GI++RD+KP N+LLD L DFGL +E++ E G
Sbjct: 107 SEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLC--KESIHE---------GT 155
Query: 229 PTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYT 279
T F GT+ YMAPEIL + H + D +S G + ++LTG P+T
Sbjct: 156 VTHTF-----CGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFT 201
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 75.4 bits (186), Expect = 1e-14
Identities = 69/226 (30%), Positives = 104/226 (46%), Gaps = 43/226 (19%)
Query: 65 PSSYTLLSPIARGAESVVYEA--TLDGRKVAVKK---PILSTSEELDNFHKELQLLCKLD 119
P Y LSP+ GA V A T GRKVA+KK P S ++EL+LL +D
Sbjct: 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSA-IHAKRTYRELRLLKHMD 72
Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNLA----------EKLHVEEWSPSVDQVLMIAA 169
H + + + F + Y +L +KL S D + +
Sbjct: 73 HENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKL-------SDDHIQFLVY 125
Query: 170 QLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKP 229
Q+ + L+Y+H+ GI+HRD+KP+N+ ++ + + DFGLA R E+
Sbjct: 126 QILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA--RHTDDEM----------- 172
Query: 230 TGGFHKKNMVGTLIYMAPEILKKEIHSEKS-DVYSFGISINELLTG 274
TG V T Y APEI+ +H ++ D++S G + ELLTG
Sbjct: 173 TG------YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 212
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 1e-14
Identities = 66/235 (28%), Positives = 111/235 (47%), Gaps = 31/235 (13%)
Query: 68 YTLLSPIARGAESVVYEA--TLDGRKVAVKK--PILSTSEELDN-FHKELQLLCKLDHPG 122
Y ++ I +G VY A + R+VA+KK LS + L F +E ++ L HPG
Sbjct: 4 YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPG 63
Query: 123 LAK-FVAAHAKPPNY--MFFFEFY----------ESRNLAEKLHVEEWSPSVDQVLMIAA 169
+ + P Y M + E Y + +L+++L + SV L I
Sbjct: 64 IVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKT---SVGAFLSIFH 120
Query: 170 QLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKP 229
++ ++Y+H+ G++HRD+KP N+LL + D+G A +++ +E L +
Sbjct: 121 KICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLD--IDVDER 178
Query: 230 TGGFHKKNM------VGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
+ +M VGT YMAPE L SE +D+Y+ G+ + ++LT PY
Sbjct: 179 NICYS--SMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY 231
|
Length = 932 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 1e-14
Identities = 70/226 (30%), Positives = 97/226 (42%), Gaps = 40/226 (17%)
Query: 64 PPSSYTLLSPIARGAESVVYEA--TLDGRKVAVKK----------PILSTSEELDNFHKE 111
+ + L+ I G +VY A T G VA+KK PI S +E
Sbjct: 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSL--------RE 56
Query: 112 LQLLCKLDHPGLA--KFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAA 169
+ LL L HP + K V + E+ E ++LA L S QV +
Sbjct: 57 ITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCE-QDLASLLDNMPTPFSESQVKCLML 115
Query: 170 QLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKP 229
QL + LQYLH I+HRD+K +N+LL C +ADFGLA R+ G P
Sbjct: 116 QLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLA--------------RTYGLP 161
Query: 230 TGGFHKKNMVGTLIYMAPEIL-KKEIHSEKSDVYSFGISINELLTG 274
K V TL Y APE+L ++ D+++ G + ELL
Sbjct: 162 AKPMTPK--VVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAH 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 1e-14
Identities = 77/320 (24%), Positives = 128/320 (40%), Gaps = 65/320 (20%)
Query: 63 LPPSSYTLLSPIARGAESVVYEATLDG-------RKVAVKKPILSTSE-ELDNFHKELQL 114
LP TL P+ GA V +A G VAVK +E +L + E+++
Sbjct: 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEM 68
Query: 115 LCKL-DHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHV-----EEWSPSVDQVLM-- 166
+ + H + + + E+ NL + L E SP +
Sbjct: 69 MKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEET 128
Query: 167 --------IAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI 218
A Q+A+ +++L + +HRD+ NVL+ + +ADFGLA ++ I
Sbjct: 129 LTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLA---RDIHHI 185
Query: 219 SLKNWRSSGKPTGGFHKKNMVGTLIY--MAPEILKKEIHSEKSDVYSFGISINELLT-GV 275
+++K G L MAPE L +++ +SDV+SFG+ + E+ T G
Sbjct: 186 D-------------YYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGG 232
Query: 276 VPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGL--RPILASLELGLPASILSLIQRCWD 333
PY + E +L + G +P + EL L++ CW
Sbjct: 233 SPYPGIPVE--------------ELFKLLKEGYRMEKPQNCTQEL------YHLMRDCWH 272
Query: 334 GNPHNRPSFSDIALELDLVL 353
P RP+F + +LD +L
Sbjct: 273 EVPSQRPTFKQLVEDLDRML 292
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 2e-14
Identities = 64/287 (22%), Positives = 124/287 (43%), Gaps = 45/287 (15%)
Query: 73 PIARGAESVVYEA--TLDGRK----VAVKKPILSTSEELDN-FHKELQLLCKLDHPGLAK 125
+ GA VY+ +G K VA+K TS + + E ++ +DHP + +
Sbjct: 14 VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVR 73
Query: 126 FVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMI--AAQLAKALQYLHNLGI 183
+ + L + +V ++ ++ Q+AK + YL +
Sbjct: 74 LLGI-CLSSQVQLITQLMPLGCLLD--YVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRL 130
Query: 184 VHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLI 243
VHRD+ NVL+ + DFGLA+ L ++ K + + G +
Sbjct: 131 VHRDLAARNVLVKTPQHVKITDFGLAK----LLDVDEKEYHAEGGKV----------PIK 176
Query: 244 YMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTA 302
+MA E + I++ KSDV+S+G+++ EL+T G PY + A + +LE ++L
Sbjct: 177 WMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA-VEIPDLLEKG---ERLP- 231
Query: 303 AVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALEL 349
+P + +++ + ++ +CW + +RP+F ++ E
Sbjct: 232 -------QPPICTID------VYMVLVKCWMIDAESRPTFKELINEF 265
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 55/207 (26%), Positives = 97/207 (46%), Gaps = 20/207 (9%)
Query: 74 IARGAESVVYEAT--LDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHA 131
I G+ +V AT G++VAVKK L + + E+ ++ H + ++
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 132 KPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPA 191
EF E L + V + +Q+ + + +AL YLHN G++HRD+K
Sbjct: 90 VGDELWVVMEFLEGGALTDI--VTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSD 147
Query: 192 NVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILK 251
++LL + L+DFG + KE+ +K++VGT +MAPE++
Sbjct: 148 SILLTSDGRIKLSDFGFCA--QVSKEVP--------------KRKSLVGTPYWMAPEVIS 191
Query: 252 KEIHSEKSDVYSFGISINELLTGVVPY 278
+ + + D++S GI + E++ G PY
Sbjct: 192 RLPYGTEVDIWSLGIMVIEMIDGEPPY 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 2e-14
Identities = 63/221 (28%), Positives = 99/221 (44%), Gaps = 34/221 (15%)
Query: 65 PSSYTLLSPIARGAESVVYEAT--LDGRKVAVKKPILSTSEELDNFHK----ELQLLCKL 118
P YT L + GA V A G KVA+KK LS + + F K EL LL +
Sbjct: 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKK--LSRPFQSEIFAKRAYRELTLLKHM 71
Query: 119 DHPGLAKFVAAHAKPPNYMFFFEFY----ESRNLAEKLHVEEWSPSVDQVLMIAAQLAKA 174
H + + + F +FY + +K+ S D+V + Q+
Sbjct: 72 QHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSE--DKVQYLVYQMLCG 129
Query: 175 LQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFH 234
L+Y+H+ GI+HRD+KP N+ ++ + + DFGLA R + G+
Sbjct: 130 LKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLA--------------RHADAEMTGY- 174
Query: 235 KKNMVGTLIYMAPEILKKEIHSEKS-DVYSFGISINELLTG 274
V T Y APE++ +H ++ D++S G + E+LTG
Sbjct: 175 ----VVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTG 211
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 3e-14
Identities = 48/122 (39%), Positives = 67/122 (54%), Gaps = 18/122 (14%)
Query: 160 SVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLA-EYRENLKEI 218
S D+V + ++ AL++LH LGIV+RD+K N+LLD L DFGL+ E+ KE
Sbjct: 103 SEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKER 162
Query: 219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILK-KEIHSEKSDVYSFGISINELLTGVVP 277
+ + GT+ YMAPEI++ K H + D +S GI I ELLTG P
Sbjct: 163 TY----------------SFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASP 206
Query: 278 YT 279
+T
Sbjct: 207 FT 208
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 3e-14
Identities = 53/224 (23%), Positives = 95/224 (42%), Gaps = 21/224 (9%)
Query: 66 SSYTLLSPIARGAESV-VYEATLDGRKVAVKKPILST--SEELDNFHKELQLLCKLDHPG 122
TL+ V + + VAVKK L + E+L +E+ +L HP
Sbjct: 1 ELLTLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPN 60
Query: 123 LAKFVAAHAKPPNYMF----FFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYL 178
+ +V + + ++ + +L + E + I + AL Y+
Sbjct: 61 ILPYVTSFIVD-SELYVVSPLMAYGSCEDLLKTHFPEGLPELA--IAFILKDVLNALDYI 117
Query: 179 HNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNM 238
H+ G +HR VK +++LL + L+ R ++ I + K+
Sbjct: 118 HSKGFIHRSVKASHILLSGDGKVVLSGL-----RYSVSMIKHGKR----QRVVHDFPKSS 168
Query: 239 VGTLIYMAPEILKKEIH--SEKSDVYSFGISINELLTGVVPYTD 280
V L +++PE+L++ + +EKSD+YS GI+ EL G VP+ D
Sbjct: 169 VKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 73.4 bits (181), Expect = 4e-14
Identities = 68/221 (30%), Positives = 103/221 (46%), Gaps = 36/221 (16%)
Query: 67 SYTLLSPIARGAESVVYEA--TLDGRKVAVKKPILSTSEELDNFH----KELQLLCKLDH 120
Y L+ I G VVY A G VA+KK L +E + F +E+ +L KL H
Sbjct: 6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKK--LKMEKEKEGFPITSLREINILLKLQH 63
Query: 121 P---GLAKFVAAHAKPPNYMF--FFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKAL 175
P + + V YM + E ++ ++L E + + + S + LM+ QL +
Sbjct: 64 PNIVTVKEVVVGSNLDKIYMVMEYVE-HDLKSLMETMK-QPFLQSEVKCLML--QLLSGV 119
Query: 176 QYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLA-EYRENLKEISLKNWRSSGKPTGGFH 234
+LH+ I+HRD+K +N+LL+ + DFGLA EY LK +
Sbjct: 120 AHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQ-------------- 165
Query: 235 KKNMVGTLIYMAPEIL-KKEIHSEKSDVYSFGISINELLTG 274
+V TL Y APE+L + +S D++S G ELLT
Sbjct: 166 ---LVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTK 203
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 4e-14
Identities = 72/284 (25%), Positives = 129/284 (45%), Gaps = 42/284 (14%)
Query: 68 YTLLSPIARGA--ESVVYEATLDGRKVAVKKPIL-STSEELDNFHKELQLLCKLDHPGLA 124
Y +L + G+ +++ + +K A+K+ L +S +++ KE LL K+ HP +
Sbjct: 2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIV 61
Query: 125 KFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSP-SVDQVLMIAAQLAKALQYLHNLGI 183
F + + E+ + +L +K+ ++ D +L Q+ +Q++H +
Sbjct: 62 AFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRV 121
Query: 184 VHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLI 243
+HRD+K N+ L +N L DFG A R P G + VGT
Sbjct: 122 LHRDIKSKNIFLTQNGKVKLGDFGSA--------------RLLTSP--GAYACTYVGTPY 165
Query: 244 YMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAA 303
Y+ PEI + ++ KSD++S G + EL T P+ +A + + +L+
Sbjct: 166 YVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPF---QANSWKNLILK----------- 211
Query: 304 VVSGGLRPILA--SLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
V G +P+ + S EL SLI++ + NP +RPS + I
Sbjct: 212 VCQGSYKPLPSHYSYELR------SLIKQMFKRNPRSRPSATTI 249
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 6e-14
Identities = 68/286 (23%), Positives = 120/286 (41%), Gaps = 64/286 (22%)
Query: 91 KVAVK--KPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKP------PNYMFFFEF 142
KVAVK K + T E+++F E + + DHP + + + + P+ + F
Sbjct: 28 KVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPF 87
Query: 143 YESRNLAEKLHVEEWSPSVDQVLMIAAQ--------LAKALQYLHNLGIVHRDVKPANVL 194
+ +L L +S D + Q +A ++YL + +HRD+ N +
Sbjct: 88 MKHGDLHSFLL---YSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCM 144
Query: 195 LDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTL--IYMAPEILKK 252
L+ N+ +ADFGL++ N G ++++ + + ++A E L
Sbjct: 145 LNENMNVCVADFGLSKKIYN----------------GDYYRQGRIAKMPVKWIAIESLAD 188
Query: 253 EIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRP 311
+++ KSDV+SFG+++ E+ T G PY + + + N +Q
Sbjct: 189 RVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQ------------- 235
Query: 312 ILASLELGLPASIL----SLIQRCWDGNPHNRPSFSDIALELDLVL 353
P L SL+ CW NP +RPSF + EL+ L
Sbjct: 236 ---------PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKAL 272
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 6e-14
Identities = 39/111 (35%), Positives = 64/111 (57%), Gaps = 16/111 (14%)
Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
AA++ LQ+LH GI++RD+K NVLLD++ +ADFG+ + + ++ + S+
Sbjct: 102 AAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCK-----ENMNGEGKAST- 155
Query: 228 KPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
GT Y+APEILK + ++E D +SFG+ + E+L G P+
Sbjct: 156 ----------FCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 7e-14
Identities = 60/225 (26%), Positives = 99/225 (44%), Gaps = 26/225 (11%)
Query: 64 PPSSYTLLSPIARGAESVVYEA--TLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP 121
P + L+ I G VY+A G A+K L E+ +E+ ++ H
Sbjct: 7 PQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHS 66
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSP-SVDQVLMIAAQLAKALQYLHN 180
+ + ++ + EF +L + HV P S Q+ ++ + + L YLH+
Sbjct: 67 NIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVT--GPLSESQIAYVSRETLQGLYYLHS 124
Query: 181 LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHK-KNMV 239
G +HRD+K AN+LL N LADFG+ S + T K K+ +
Sbjct: 125 KGKMHRDIKGANILLTDNGHVKLADFGV-----------------SAQITATIAKRKSFI 167
Query: 240 GTLIYMAPEIL---KKEIHSEKSDVYSFGISINELLTGVVPYTDL 281
GT +MAPE+ +K +++ D+++ GI+ EL P DL
Sbjct: 168 GTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDL 212
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 7e-14
Identities = 59/190 (31%), Positives = 83/190 (43%), Gaps = 21/190 (11%)
Query: 91 KVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAE 150
KV KK IL EE + LL + HP L + F ++ L
Sbjct: 26 KVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFY 85
Query: 151 KLHVEE--WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGL 208
L E P + AA++A AL YLH+L IV+RD+KP N+LLD L DFGL
Sbjct: 86 HLQRERCFLEP---RARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGL 142
Query: 209 AEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISI 268
+EN+ + G GT Y+APE+L K+ + D + G +
Sbjct: 143 C--KENI------------EHNGT--TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVL 186
Query: 269 NELLTGVVPY 278
E+L G+ P+
Sbjct: 187 YEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 8e-14
Identities = 51/162 (31%), Positives = 79/162 (48%), Gaps = 21/162 (12%)
Query: 119 DHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQ--VLMIAAQLAKALQ 176
+HP L + P F EF +L H+++ S D+ AA++ AL
Sbjct: 54 NHPFLTQLYCCFQTPDRLFFVMEFVNGGDLM--FHIQK-SRRFDEARARFYAAEITSALM 110
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
+LH+ GI++RD+K NVLLD LADFG+ +E + GK T F
Sbjct: 111 FLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMC--KEGIFN---------GKTTSTF--- 156
Query: 237 NMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
GT Y+APEIL++ ++ D ++ G+ + E+L G P+
Sbjct: 157 --CGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 9e-14
Identities = 67/209 (32%), Positives = 102/209 (48%), Gaps = 29/209 (13%)
Query: 74 IARGAESVVYEA--TLDGRKVAVKKPILSTSEE--LDNFHKELQLLCKLDHPGLAKFV-A 128
I G VVY+A L G VA+KK L T E +E+ LL +L+HP + K +
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 67
Query: 129 AHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAA---QLAKALQYLHNLGIVH 185
H + Y+ F EF ++L K ++ S + +I + QL + L + H+ ++H
Sbjct: 68 IHTENKLYLVF-EFL-HQDL--KKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLH 123
Query: 186 RDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYM 245
RD+KP N+L++ LADFGLA R+ G P + + V TL Y
Sbjct: 124 RDLKPQNLLINTEGAIKLADFGLA--------------RAFGVPVRTYTHE--VVTLWYR 167
Query: 246 APEI-LKKEIHSEKSDVYSFGISINELLT 273
APEI L + +S D++S G E++T
Sbjct: 168 APEILLGCKYYSTAVDIWSLGCIFAEMVT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 1e-13
Identities = 63/231 (27%), Positives = 109/231 (47%), Gaps = 25/231 (10%)
Query: 65 PSSYTLLSPIARGAESVVYEA--TLDGRKVAVKKPIL-----STSEELDNFHKELQLLCK 117
P ++ L + RGA VY GR++AVK+ TS+E++ E+QLL
Sbjct: 1 PVNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKN 60
Query: 118 LDHPGLAKFVAAHAKPPN--YMFFFEFYESRNLAEKLHVEEWSPSVDQVL-MIAAQLAKA 174
L H + ++ P F E+ ++ ++L + + + V Q+ +
Sbjct: 61 LRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQL--KAYGALTENVTRRYTRQILQG 118
Query: 175 LQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFH 234
+ YLH+ IVHRD+K AN+L D L DFG ++ ++ I + G
Sbjct: 119 VSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASK---RIQTICMS----------GTG 165
Query: 235 KKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEA 285
K++ GT +M+PE++ E + K+DV+S ++ E+LT P+ + A A
Sbjct: 166 IKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA 216
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 1e-13
Identities = 59/196 (30%), Positives = 87/196 (44%), Gaps = 21/196 (10%)
Query: 87 LDGR----KVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF 142
LDG+ KV KK +L+ E+ + LL + HP L + F +F
Sbjct: 18 LDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDF 77
Query: 143 YESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPH 202
L L E P + AA++A AL YLH++ IV+RD+KP N+LLD
Sbjct: 78 VNGGELFFHLQRERSFPE-PRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVV 136
Query: 203 LADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVY 262
L DFGL K + T F GT Y+APE+++K+ + D +
Sbjct: 137 LTDFGLC-----------KEGIAQSDTTTTF-----CGTPEYLAPEVIRKQPYDNTVDWW 180
Query: 263 SFGISINELLTGVVPY 278
G + E+L G+ P+
Sbjct: 181 CLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 1e-13
Identities = 38/112 (33%), Positives = 56/112 (50%), Gaps = 18/112 (16%)
Query: 167 IAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSS 226
IA + K L YLH+ I+HRD+KP+N+LL R L DFG+ S
Sbjct: 110 IAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGV-----------------S 152
Query: 227 GKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
G+ GT YMAPE ++ + +S SDV+S G+++ E+ P+
Sbjct: 153 GELVNSL-AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPF 203
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.4 bits (176), Expect = 1e-13
Identities = 65/213 (30%), Positives = 97/213 (45%), Gaps = 26/213 (12%)
Query: 68 YTLLSPIARGAESVVYEAT--LDGRKVAVKKPI--LSTSEELDNFHKELQLLCKL-DHPG 122
Y ++ + G VY A G VA+KK + EE N +E++ L KL +HP
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNL-REVKSLRKLNEHPN 59
Query: 123 LAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSP-SVDQVLMIAAQLAKALQYLHNL 181
+ K + F FE+ E NL + + + P S + I Q+ + L ++H
Sbjct: 60 IVKLKEVFRENDELYFVFEYME-GNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH 118
Query: 182 GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGT 241
G HRD+KP N+L+ +ADFGLA +EI RS T + V T
Sbjct: 119 GFFHRDLKPENLLVSGPEVVKIADFGLA------REI-----RSRPPYT------DYVST 161
Query: 242 LIYMAPEI-LKKEIHSEKSDVYSFGISINELLT 273
Y APEI L+ +S D+++ G + EL T
Sbjct: 162 RWYRAPEILLRSTSYSSPVDIWALGCIMAELYT 194
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 2e-13
Identities = 62/271 (22%), Positives = 107/271 (39%), Gaps = 63/271 (23%)
Query: 93 AVKKPILSTSEELDNFHKELQLLCK-LDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAE- 150
A K + + + E+ ++ + L HP + ++ + + E L E
Sbjct: 40 AFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEH 99
Query: 151 -------KLHVEEWSPSVDQVLMIAAQLAKALQYLHNLG-IVHRDVKPANVLLDRNLCPH 202
K E +++ I Q+ AL+YLH IVHRD+ P N++L +
Sbjct: 100 FNSLKEKKQRFTE-----ERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVT 154
Query: 203 LADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVY 262
+ DFGLA ++ E L + +VGT++Y PEI+K E + EK+DV+
Sbjct: 155 ITDFGLA--KQKQPESKLTS---------------VVGTILYSCPEIVKNEPYGEKADVW 197
Query: 263 SFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAA--VVSGGLRPILASLELGL 320
+FG + ++ T P+ Y+ L+ A +V P L
Sbjct: 198 AFGCILYQMCTLQPPF----------------YSTNMLSLATKIVEAVYEP--------L 233
Query: 321 PASILS-----LIQRCWDGNPHNRPSFSDIA 346
P + S +I C + RP ++
Sbjct: 234 PEGMYSEDVTDVITSCLTPDAEARPDIIQVS 264
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 20/207 (9%)
Query: 74 IARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHA 131
I G+ +V AT+ G+ VAVKK L + + E+ ++ H + + ++
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 132 KPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPA 191
EF E L + V + +Q+ + + KAL LH G++HRD+K
Sbjct: 88 VGDELWVVMEFLEGGALTDI--VTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSD 145
Query: 192 NVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILK 251
++LL + L+DFG + KE+ +K++VGT +MAPE++
Sbjct: 146 SILLTHDGRVKLSDFGFCA--QVSKEVP--------------RRKSLVGTPYWMAPELIS 189
Query: 252 KEIHSEKSDVYSFGISINELLTGVVPY 278
+ + + D++S GI + E++ G PY
Sbjct: 190 RLPYGPEVDIWSLGIMVIEMVDGEPPY 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 57/188 (30%), Positives = 84/188 (44%), Gaps = 17/188 (9%)
Query: 91 KVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAE 150
KV KK IL E+ + LL L HP L + F ++ L
Sbjct: 26 KVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFF 85
Query: 151 KLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAE 210
L E + AA++A A+ YLH+L I++RD+KP N+LLD L DFGL
Sbjct: 86 HLQRER-CFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLC- 143
Query: 211 YRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINE 270
+E ++ + T F GT Y+APE+L+KE + D + G + E
Sbjct: 144 -KEGVEP---------EETTSTF-----CGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYE 188
Query: 271 LLTGVVPY 278
+L G+ P+
Sbjct: 189 MLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 3e-13
Identities = 66/214 (30%), Positives = 99/214 (46%), Gaps = 27/214 (12%)
Query: 68 YTLLSPIARGAESVVYEA--TLDGRKVAVKKPILSTSEE--LDNFHKELQLLCKLDHPGL 123
Y + I G VVY+A L G VA+KK L T +E +E+ LL +L+HP +
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNI 60
Query: 124 AK-FVAAHAKPPNYMFFFEFYESRNLAEKL-HVEEWSPSVDQVLMIAAQLAKALQYLHNL 181
+ H++ Y+ F EF + +L + + + QL + + Y H+
Sbjct: 61 VRLLDVVHSENKLYLVF-EFLDL-DLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH 118
Query: 182 GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGF-HKKNMVG 240
++HRD+KP N+L+DR LADFGLA R+ G P + H+ V
Sbjct: 119 RVLHRDLKPQNLLIDREGALKLADFGLA--------------RAFGVPVRTYTHE---VV 161
Query: 241 TLIYMAPEILKKEIH-SEKSDVYSFGISINELLT 273
TL Y APEIL S D++S G E++
Sbjct: 162 TLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVN 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-13
Identities = 71/283 (25%), Positives = 121/283 (42%), Gaps = 54/283 (19%)
Query: 91 KVAVKKPILSTSE-ELDNFHKELQLLCKL-DHPGLAKFVAAHAKPPNYMFFFEFYESRNL 148
KVAVK +E +L + E++++ + H + + A + E+ NL
Sbjct: 52 KVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 111
Query: 149 AEKL---------------HVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANV 193
E L V E S ++ A Q+A+ ++YL + +HRD+ NV
Sbjct: 112 REYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 171
Query: 194 LLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTL--IYMAPEILK 251
L+ + +ADFGLA ++ I ++KK G L +MAPE L
Sbjct: 172 LVTEDNVMKIADFGLA---RDIHHID-------------YYKKTTNGRLPVKWMAPEALF 215
Query: 252 KEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLR 310
I++ +SDV+SFG+ + E+ T G PY + E + E + + +
Sbjct: 216 DRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMD------------K 263
Query: 311 PILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL 353
P + EL + +++ CW P RP+F + +LD +L
Sbjct: 264 PSNCTNELYM------MMRDCWHAVPSQRPTFKQLVEDLDRIL 300
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 3e-13
Identities = 63/221 (28%), Positives = 101/221 (45%), Gaps = 33/221 (14%)
Query: 65 PSSYTLLSPIARGAESVVYEATLDGR---KVAVKKPILSTSEEL--DNFHKELQLLCKLD 119
P Y L + GA V A LD R KVA+KK EL ++EL+LL +
Sbjct: 14 PDRYRDLKQVGSGAYGTVCSA-LDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMK 72
Query: 120 HPGLAKFVAAHAKPPNYMFFFEFY-----ESRNLAEKLHVEEWSPSVDQVLMIAAQLAKA 174
H + + + F +FY +L + + E+ S D++ + Q+ K
Sbjct: 73 HENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSE--DRIQFLVYQMLKG 130
Query: 175 LQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFH 234
L+Y+H GI+HRD+KP N+ ++ + + DFGLA R + G+
Sbjct: 131 LKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA--------------RQTDSEMTGY- 175
Query: 235 KKNMVGTLIYMAPEILKKEIH-SEKSDVYSFGISINELLTG 274
V T Y APE++ +H ++ D++S G + E+LTG
Sbjct: 176 ----VVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTG 212
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 3e-13
Identities = 41/120 (34%), Positives = 60/120 (50%), Gaps = 17/120 (14%)
Query: 162 DQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLK 221
+V + A++ AL +LH LGI++RD+K N+LLD L DFGL+ KE
Sbjct: 105 SEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLS------KEFL-- 156
Query: 222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEI--HSEKSDVYSFGISINELLTGVVPYT 279
+ GT+ YMAPE+++ H + D +S G+ ELLTG P+T
Sbjct: 157 -------AEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFT 209
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 3e-13
Identities = 37/111 (33%), Positives = 56/111 (50%), Gaps = 16/111 (14%)
Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
AA++ LQ+LH GI++RD+K NVLLD +ADFG+ +E +
Sbjct: 102 AAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMC--KEGI------------ 147
Query: 228 KPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
GG GT Y+APEIL + + D ++ G+ + E+L G P+
Sbjct: 148 --LGGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPF 196
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 4e-13
Identities = 63/241 (26%), Positives = 106/241 (43%), Gaps = 38/241 (15%)
Query: 118 LDHPGLAKFVAAHAKPPNYMFFFEFY----ESRNLAEKLHVEEWSPSVDQVLMIAAQLAK 173
D G K+ A + NY ++ Y R + L E + S ++ + Q+A
Sbjct: 193 QDMKGTVKY--ADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVAN 250
Query: 174 ALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGF 233
+++L + VHRD+ NVL+ + DFGLA R+ +++ N+ S G
Sbjct: 251 GMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLA--RDIMRD---SNYISKG------ 299
Query: 234 HKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLE 292
+ L +MAPE + +++ SDV+SFGI + E+ T G PY +L Q + ++
Sbjct: 300 ---STFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIK 356
Query: 293 MNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352
Y + P AS E I ++Q+CW+ RP FS + + +
Sbjct: 357 RGYRMAK-----------PAHASDE------IYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399
Query: 353 L 353
L
Sbjct: 400 L 400
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 4e-13
Identities = 64/224 (28%), Positives = 106/224 (47%), Gaps = 35/224 (15%)
Query: 65 PSSYTLLSPIARGAESVVYEAT--LDGRKVAVKKPILSTSEELDNFH--------KELQL 114
Y LS I GA +V AT G KVA+KK +S E H +E+++
Sbjct: 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKK--ISPFE-----HQTFCQRTLREIKI 56
Query: 115 LCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEK-LH--VEEWSPSVDQVLMIAAQL 171
L + H + + +PP++ F + Y + L E L+ ++ S D + Q+
Sbjct: 57 LRRFKHENIIGILDI-IRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQI 115
Query: 172 AKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTG 231
+ L+Y+H+ ++HRD+KP+N+LL+ N + DFGLA I+ +G T
Sbjct: 116 LRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLA-------RIADPEHDHTGFLT- 167
Query: 232 GFHKKNMVGTLIYMAPEI-LKKEIHSEKSDVYSFGISINELLTG 274
V T Y APEI L + +++ D++S G + E+L+
Sbjct: 168 -----EYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSN 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 4e-13
Identities = 49/190 (25%), Positives = 85/190 (44%), Gaps = 21/190 (11%)
Query: 91 KVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAE 150
K K+ IL +++ + +E +L +L HP + + + F EF L
Sbjct: 49 KCLKKREILKM-KQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFT 107
Query: 151 KLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAE 210
L P+ D A+L A +YLH+ I++RD+KP N+LLD + DFG A
Sbjct: 108 HLRKAGRFPN-DVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFA- 165
Query: 211 YRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINE 270
K++ + + G P Y+APE+++ + H + D ++ G+ + E
Sbjct: 166 -----KKVPDRTFTLCGTPE-------------YLAPEVIQSKGHGKAVDWWTMGVLLYE 207
Query: 271 LLTGVVPYTD 280
+ G P+ D
Sbjct: 208 FIAGYPPFFD 217
|
Length = 329 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 4e-13
Identities = 67/219 (30%), Positives = 101/219 (46%), Gaps = 29/219 (13%)
Query: 65 PSSYTLLSPIARGAESVVYEA--TLDGRKVAVKK---PILSTSEELDNFHKELQLLCKLD 119
P Y L+P+ GA V A T +KVAVKK P S + +EL+LL +
Sbjct: 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTY-RELRLLKHMK 72
Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNL-AEKLH--VEEWSPSVDQVLMIAAQLAKALQ 176
H + + + F E Y NL L+ V+ S + V + QL + L+
Sbjct: 73 HENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLK 132
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
Y+H+ GI+HRD+KP+NV ++ + + DFGLA R + G+
Sbjct: 133 YIHSAGIIHRDLKPSNVAVNEDCELRILDFGLA--------------RQADDEMTGY--- 175
Query: 237 NMVGTLIYMAPEILKKEIHSEKS-DVYSFGISINELLTG 274
V T Y APEI+ +H ++ D++S G + ELL G
Sbjct: 176 --VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKG 212
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 5e-13
Identities = 71/313 (22%), Positives = 122/313 (38%), Gaps = 60/313 (19%)
Query: 63 LPPSSYTLLSPIARGAESVVYEATL------DGRKVAVKK-PILSTSEELDNFHKELQLL 115
LP S+ + + A +Y+ L + VA+K ++ ++ F +E L+
Sbjct: 2 LPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLM 61
Query: 116 CKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVD------------- 162
+L HP + + + FE+ +L E L + SP D
Sbjct: 62 AELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMR--SPHSDVGCSSDEDGTVKS 119
Query: 163 -----QVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKE 217
L IA Q+A ++YL + VH+D+ N+L+ L ++D GL+ +E
Sbjct: 120 SLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLS------RE 173
Query: 218 ISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVV 276
I ++ + + + +M PE + S SD++SFG+ + E+ + G+
Sbjct: 174 IYSADYYRV--------QPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQ 225
Query: 277 PYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNP 336
PY + V+EM Q L + P + SL+ CW P
Sbjct: 226 PYYGFSNQ----EVIEMVRKRQLLPCSE--------------DCPPRMYSLMTECWQEGP 267
Query: 337 HNRPSFSDIALEL 349
RP F DI L
Sbjct: 268 SRRPRFKDIHTRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 5e-13
Identities = 66/267 (24%), Positives = 109/267 (40%), Gaps = 48/267 (17%)
Query: 90 RKVAVKKPILSTSE-ELDNFHKELQLLCKLDHPGLAKFVAA----HAKPPNYMFFFEFYE 144
+V VK SE ++ +E LL L H + + P + +
Sbjct: 36 EEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP---FVLYPYMN 92
Query: 145 SRNLAEKL----HVEEWSP---SVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDR 197
NL L E +P S Q++ +A Q+A + YLH G++H+D+ N ++D
Sbjct: 93 WGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDE 152
Query: 198 NLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSE 257
L + D L+ +++ ++ G N + +MA E L + +S
Sbjct: 153 ELQVKITDNALS------RDLFPMDYHCLG--------DNENRPVKWMALESLVNKEYSS 198
Query: 258 KSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASL 316
SDV+SFG+ + EL+T G PY ++ A L+ Y Q PI
Sbjct: 199 ASDVWSFGVLLWELMTLGQTPYVEIDPFEMAA-YLKDGYRLAQ-----------PI---- 242
Query: 317 ELGLPASILSLIQRCWDGNPHNRPSFS 343
P + +++ CW +P RPSFS
Sbjct: 243 --NCPDELFAVMACCWALDPEERPSFS 267
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 5e-13
Identities = 52/187 (27%), Positives = 88/187 (47%), Gaps = 37/187 (19%)
Query: 170 QLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKP 229
Q+A+ ++YL + +HRD+ NVL+ N +ADFGLA N+
Sbjct: 145 QVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNID------------- 191
Query: 230 TGGFHKKNMVGTL--IYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQ 286
++KK G L +MAPE L +++ +SDV+SFG+ + E+ T G PY + E
Sbjct: 192 ---YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 248
Query: 287 AHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIA 346
+ E + + +P + EL + +++ CW P +RP+F +
Sbjct: 249 FKLLKEGHRMD------------KPANCTNELYM------MMRDCWHAIPSHRPTFKQLV 290
Query: 347 LELDLVL 353
+LD +L
Sbjct: 291 EDLDRIL 297
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 6e-13
Identities = 67/227 (29%), Positives = 105/227 (46%), Gaps = 31/227 (13%)
Query: 65 PSSYTLLSPIARGAESVVYEA--TLDGRKVAVKK---PILSTSEELDNFHKELQLLCKLD 119
P Y LSP+ GA V A T G +VAVKK P S + +EL+LL +
Sbjct: 16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMK 74
Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNL-AEKLH--VEEWSPSVDQVLMIAAQLAKALQ 176
H + + + F + Y +L L+ V+ + D V + Q+ + L+
Sbjct: 75 HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 134
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
Y+H+ I+HRD+KP+N+ ++ + + DFGLA R + G+
Sbjct: 135 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLA--------------RHTDDEMTGY--- 177
Query: 237 NMVGTLIYMAPEILKKEIHSEKS-DVYSFGISINELLTG--VVPYTD 280
V T Y APEI+ +H ++ D++S G + ELLTG + P TD
Sbjct: 178 --VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 222
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 8e-13
Identities = 54/192 (28%), Positives = 92/192 (47%), Gaps = 34/192 (17%)
Query: 157 WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLK 216
W +D +L ++Q+A+ + +L + +HRDV NVLL + DFGLA N
Sbjct: 207 WPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDS 266
Query: 217 EISLK-NWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-G 274
+K N R K +MAPE + +++ +SDV+S+GI + E+ + G
Sbjct: 267 NYVVKGNARLPVK---------------WMAPESIFDCVYTVQSDVWSYGILLWEIFSLG 311
Query: 275 VVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDG 334
PY + ++ + +++ Y Q++ RP A E I S+++ CW+
Sbjct: 312 KSPYPGILVNSKFYKMVKRGY---QMS--------RPDFAPPE------IYSIMKMCWNL 354
Query: 335 NPHNRPSFSDIA 346
P RP+FS I+
Sbjct: 355 EPTERPTFSQIS 366
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 9e-13
Identities = 64/214 (29%), Positives = 97/214 (45%), Gaps = 26/214 (12%)
Query: 68 YTLLSPIARGAESVVYEAT--LDGRKVAVKKPILSTSEE--LDNFHKELQLLCKLDHPGL 123
YT + I G VVY+ G+ VA+KK L + EE +E+ LL +L HP +
Sbjct: 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNI 61
Query: 124 AKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIA--AQLAKALQYLHNL 181
+ FEF S +L + L +D L+ + Q+ + + + H+
Sbjct: 62 VCLQDVLMQESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR 120
Query: 182 GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGF-HKKNMVG 240
++HRD+KP N+L+D LADFGLA R+ G P + H+ V
Sbjct: 121 RVLHRDLKPQNLLIDNKGVIKLADFGLA--------------RAFGIPVRVYTHE---VV 163
Query: 241 TLIYMAPEIL-KKEIHSEKSDVYSFGISINELLT 273
TL Y APE+L +S D++S G E+ T
Sbjct: 164 TLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMAT 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 9e-13
Identities = 75/321 (23%), Positives = 133/321 (41%), Gaps = 65/321 (20%)
Query: 63 LPPSSYTLLSPIARG-------AESVVYEATLDGRKVAVKKPIL---STSEELDNFHKEL 112
L + TL P+ G AE++ + + V V +L +T ++L + E+
Sbjct: 9 LSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEM 68
Query: 113 QLLCKL-DHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVD--------- 162
+++ + H + + A + E+ NL E L P +D
Sbjct: 69 EMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARR-PPGMDYSFDTCKLP 127
Query: 163 -------QVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL 215
++ A Q+A+ ++YL + +HRD+ NVL+ + +ADFGLA N+
Sbjct: 128 EEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNI 187
Query: 216 KEISLKNWRSSGKPTGGFHKKNMVGTL--IYMAPEILKKEIHSEKSDVYSFGISINELLT 273
++KK G L +MAPE L +++ +SDV+SFG+ + E+ T
Sbjct: 188 D----------------YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
Query: 274 -GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCW 332
G PY + E + E + + +P + EL + +++ CW
Sbjct: 232 LGGSPYPGIPVEELFKLLKEGHRMD------------KPANCTHELYM------IMRECW 273
Query: 333 DGNPHNRPSFSDIALELDLVL 353
P RP+F + +LD VL
Sbjct: 274 HAVPSQRPTFKQLVEDLDRVL 294
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 68.6 bits (167), Expect = 9e-13
Identities = 57/206 (27%), Positives = 99/206 (48%), Gaps = 25/206 (12%)
Query: 89 GRKVAVKKPIL-----STSEELDNFHKELQLLCKLDHPGLAKFVAA---HAKPPNYMFFF 140
GR++A K+ TS+E+ E+QLL L H + ++ A+ F
Sbjct: 27 GRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEK-TLTIFM 85
Query: 141 EFYESRNLAEKLHVE-EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNL 199
E+ ++ ++L + SV + Q+ + + YLH+ IVHRD+K AN+L D
Sbjct: 86 EYMPGGSVKDQLKAYGALTESVTR--KYTRQILEGMSYLHSNMIVHRDIKGANILRDSAG 143
Query: 200 CPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKS 259
L DFG ++ L+ I + G +++ GT +M+PE++ E + K+
Sbjct: 144 NVKLGDFGASK---RLQTICMS----------GTGIRSVTGTPYWMSPEVISGEGYGRKA 190
Query: 260 DVYSFGISINELLTGVVPYTDLRAEA 285
DV+S G ++ E+LT P+ + A A
Sbjct: 191 DVWSLGCTVVEMLTEKPPWAEYEAMA 216
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 1e-12
Identities = 60/188 (31%), Positives = 86/188 (45%), Gaps = 17/188 (9%)
Query: 91 KVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAE 150
KV KK IL E+ + LL + HP L + F ++ L
Sbjct: 26 KVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFF 85
Query: 151 KLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAE 210
L E P + AA++A AL YLH+L I++RD+KP N+LLD L DFGL
Sbjct: 86 HLQRERSFPEP-RARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLC- 143
Query: 211 YRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINE 270
+E + E S K T F GT Y+APE+L+K+ + D + G + E
Sbjct: 144 -KEGI-EHS--------KTTSTF-----CGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYE 188
Query: 271 LLTGVVPY 278
+L G+ P+
Sbjct: 189 MLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 47/191 (24%), Positives = 93/191 (48%), Gaps = 20/191 (10%)
Query: 89 GRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNL 148
GR+VAVK L + + E+ ++ H + + ++ EF + L
Sbjct: 46 GRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105
Query: 149 AEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGL 208
+ V + + +Q+ + + +AL YLH+ G++HRD+K ++LL + L+DFG
Sbjct: 106 TDI--VSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGF 163
Query: 209 -AEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGIS 267
A+ +++ + +K++VGT +MAPE++ + + + D++S GI
Sbjct: 164 CAQISKDVPK-----------------RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIM 206
Query: 268 INELLTGVVPY 278
+ E++ G PY
Sbjct: 207 VIEMVDGEPPY 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 1e-12
Identities = 36/116 (31%), Positives = 56/116 (48%), Gaps = 19/116 (16%)
Query: 169 AQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK 228
A++ AL +H++G +HRDVKP N+LLD++ LADFG +
Sbjct: 149 AEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA-------------- 194
Query: 229 PTGGFHKKNMVGTLIYMAPEILKKEIHS----EKSDVYSFGISINELLTGVVPYTD 280
G VGT Y++PE+LK + + D +S G+ + E+L G P+
Sbjct: 195 -NGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA 249
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-12
Identities = 73/285 (25%), Positives = 117/285 (41%), Gaps = 42/285 (14%)
Query: 69 TLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVA 128
LL I +G V G KVAVK + F E ++ +L H L + +
Sbjct: 9 KLLQTIGKGEFGDVMLGDYRGNKVAVK--CIKNDATAQAFLAEASVMTQLRHSNLVQLLG 66
Query: 129 AHAKPPNYMFFF-EFYESRNLAEKLHVEEWSP-SVDQVLMIAAQLAKALQYLHNLGIVHR 186
+ ++ E+ +L + L S D +L + + +A++YL VHR
Sbjct: 67 VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHR 126
Query: 187 DVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMA 246
D+ NVL+ + ++DFGL KE SS + TG K + A
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLT------KEA------SSTQDTGKLPVK-------WTA 167
Query: 247 PEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVV 305
PE L+++ S KSDV+SFGI + E+ + G VPY + + V E Y
Sbjct: 168 PEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV-EKGYKMDAPD---- 222
Query: 306 SGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350
G P + ++++CW + RPSF + +L+
Sbjct: 223 -------------GCPPVVYDVMKQCWHLDAATRPSFLQLREQLE 254
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 42/120 (35%), Positives = 66/120 (55%), Gaps = 19/120 (15%)
Query: 163 QVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLA-EYRENLKEISLK 221
+V + + ++ AL++LH LGI++RD+K N+LLD N L DFGL+ E+ E+ E
Sbjct: 106 EVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE---- 161
Query: 222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILK--KEIHSEKSDVYSFGISINELLTGVVPYT 279
+ GT+ YMAP+I++ H + D +S G+ + ELLTG P+T
Sbjct: 162 ------------RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFT 209
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 2e-12
Identities = 40/139 (28%), Positives = 70/139 (50%), Gaps = 27/139 (19%)
Query: 169 AQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAE----------YREN--LK 216
A+L A++ +H +G +HRD+KP N+L+DR+ L DFGL Y++ +
Sbjct: 108 AELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHR 167
Query: 217 EISLKNW-------RSSGKPTGGFHKK--------NMVGTLIYMAPEILKKEIHSEKSDV 261
+ S++ R KP K+ ++VGT Y+APE+L + +++ D
Sbjct: 168 QDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDW 227
Query: 262 YSFGISINELLTGVVPYTD 280
+S G+ + E+L G P+
Sbjct: 228 WSVGVILYEMLVGQPPFLA 246
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 53/200 (26%), Positives = 93/200 (46%), Gaps = 20/200 (10%)
Query: 93 AVKKPILSTSEELDNFHKELQLLC-KLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEK 151
A+KK ++ ++++ E ++L +HP L N F E+ +L
Sbjct: 27 ALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGGDLM-- 84
Query: 152 LHVEEWSP-SVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAE 210
H++ + + AA++ LQ+LH+ GIV+RD+K N+LLD + +ADFG+
Sbjct: 85 FHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMC- 143
Query: 211 YRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINE 270
KE L + ++ GT Y+APEIL + ++ D +SFG+ + E
Sbjct: 144 -----KENMLGDAKTC----------TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYE 188
Query: 271 LLTGVVPYTDLRAEAQAHTV 290
+L G P+ E ++
Sbjct: 189 MLIGQSPFHGHDEEELFQSI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 3e-12
Identities = 61/267 (22%), Positives = 109/267 (40%), Gaps = 45/267 (16%)
Query: 92 VAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEK 151
VAVK ++ +FH+E +LL L H + KF + + FE+ + +L +
Sbjct: 38 VAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKF 97
Query: 152 LH--------VEEWSPSVD----QVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNL 199
L + E + + Q+L IA Q+A + YL + VHRD+ N L+ NL
Sbjct: 98 LRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL 157
Query: 200 CPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKS 259
+ DFG++ +++ ++ G T + + +M PE + + +S
Sbjct: 158 LVKIGDFGMS------RDVYSTDYYRVGGHT--------MLPIRWMPPESIMYRKFTTES 203
Query: 260 DVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLEL 318
DV+S G+ + E+ T G P+ L + + ++ T
Sbjct: 204 DVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQRPRTC---------------- 247
Query: 319 GLPASILSLIQRCWDGNPHNRPSFSDI 345
P + L+ CW PH R + +I
Sbjct: 248 --PKEVYDLMLGCWQREPHMRLNIKEI 272
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 3e-12
Identities = 66/220 (30%), Positives = 100/220 (45%), Gaps = 30/220 (13%)
Query: 68 YTLLSPIARGAESVVYEA--TLDGRKVAVKKPILSTSEELDNFHK---ELQLLCKLDHPG 122
Y + I +G+ VV A T G KVA+KK I E + + + E++LL L HP
Sbjct: 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKK-INDVFEHVSDATRILREIKLLRLLRHPD 60
Query: 123 LAKFVAAHAKPPNYMFFFEFYESRNLAEK-LHV-----EEWSPSVDQVLMIAAQLAKALQ 176
+ + + PP+ F + Y L E LH ++ +P Q + QL +AL+
Sbjct: 61 IVE-IKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLY--QLLRALK 117
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
Y+H + HRD+KP N+L + + + DFGLA N PT F
Sbjct: 118 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN------------DTPTAIFW-T 164
Query: 237 NMVGTLIYMAPEILKK--EIHSEKSDVYSFGISINELLTG 274
+ V T Y APE+ ++ D++S G E+LTG
Sbjct: 165 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG 204
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 4e-12
Identities = 36/112 (32%), Positives = 54/112 (48%), Gaps = 21/112 (18%)
Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
A++ +A+ LH LG +HRD+KP N L+D + L DFGL+
Sbjct: 107 MAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLS------------------ 148
Query: 228 KPTGGFHKKN-MVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
G N +VG+ YMAPE+L+ + + D +S G + E L G P+
Sbjct: 149 --KGIVTYANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPF 198
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 4e-12
Identities = 52/192 (27%), Positives = 88/192 (45%), Gaps = 41/192 (21%)
Query: 159 PSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI 218
PS+ +++ +A ++A + YL+ VHRD+ N ++ + + DFG+ ++ E
Sbjct: 116 PSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMT---RDIYET 172
Query: 219 SLKNWRSSGKPTGGFHKKNMVGTLI--YMAPEILKKEIHSEKSDVYSFGISINELLT-GV 275
+R GK G L +M+PE LK + + SDV+SFG+ + E+ T
Sbjct: 173 DY--YRKGGK-----------GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE 219
Query: 276 VPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGL--RPILASLELGLPASILSLIQRCWD 333
PY + + +Q+ V+ GGL +P P + L++ CW
Sbjct: 220 QPYQGM--------------SNEQVLRFVMEGGLLDKPD------NCPDMLFELMRMCWQ 259
Query: 334 GNPHNRPSFSDI 345
NP RPSF +I
Sbjct: 260 YNPKMRPSFLEI 271
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 4e-12
Identities = 66/218 (30%), Positives = 100/218 (45%), Gaps = 26/218 (11%)
Query: 65 PSSYTLLSPIARGAESVVYEAT--LDGRKVAVKKPILSTSEELDNFH--KELQLLCKLDH 120
+ Y + PI RGA +V A KVA+KK + +D +E++LL LDH
Sbjct: 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDH 63
Query: 121 PGLAKFVAAHAKPPNYMFFFEFYESRNLAEK-LHVEEWSP---SVDQVLMIAAQLAKALQ 176
+ + PP+ F + Y L + LH S S D QL + L+
Sbjct: 64 ENVIA-IKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLK 122
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
Y+H+ ++HRD+KP+N+LL+ N + DFGLA R++ + G F +
Sbjct: 123 YIHSANVLHRDLKPSNLLLNANCDLKICDFGLA--------------RTTSE-KGDFMTE 167
Query: 237 NMVGTLIYMAPE-ILKKEIHSEKSDVYSFGISINELLT 273
+V T Y APE +L ++ DV+S G ELL
Sbjct: 168 YVV-TRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLG 204
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 4e-12
Identities = 51/186 (27%), Positives = 86/186 (46%), Gaps = 18/186 (9%)
Query: 94 VKKPILSTSEELDNFHKELQLLCKL-DHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKL 152
VKK +++ E++D E + + +HP L + F E+ +L +
Sbjct: 28 VKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHM 87
Query: 153 HVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYR 212
+ P + +A+++ AL YLH GI++RD+K NVLLD L D+G+ +
Sbjct: 88 QRQRKLPE-EHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMC--K 144
Query: 213 ENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELL 272
E L+ G T F GT Y+APEIL+ E + D ++ G+ + E++
Sbjct: 145 EGLR---------PGDTTSTF-----CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMM 190
Query: 273 TGVVPY 278
G P+
Sbjct: 191 AGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 4e-12
Identities = 44/139 (31%), Positives = 72/139 (51%), Gaps = 22/139 (15%)
Query: 160 SVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLA-EYRENLKEI 218
S ++ AA++ L+++HN +V+RD+KPAN+LLD + ++D GLA ++
Sbjct: 95 SEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF------- 147
Query: 219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKS-DVYSFGISINELLTGVVP 277
S KP VGT YMAPE+L+K + + S D +S G + +LL G P
Sbjct: 148 ------SKKKPHAS------VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 195
Query: 278 YTDLRAEAQAHTVLEMNYT 296
+ + + + H + M T
Sbjct: 196 FRQHKTKDK-HEIDRMTLT 213
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 4e-12
Identities = 54/191 (28%), Positives = 89/191 (46%), Gaps = 25/191 (13%)
Query: 92 VAVK---KPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFF-FEFYESRN 147
VA+K K + +++D+ E ++L ++HP + K +Y++ EF
Sbjct: 59 VAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSF-KDESYLYLVLEFVIGGE 117
Query: 148 LAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFG 207
L + P+ D AAQ+ +YL +L IV+RD+KP N+LLD++ + DFG
Sbjct: 118 FFTFLRRNKRFPN-DVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFG 176
Query: 208 LAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGIS 267
A K + + + G P Y+APEIL H + +D ++ GI
Sbjct: 177 FA------KVVDTRTYTLCGTPE-------------YIAPEILLNVGHGKAADWWTLGIF 217
Query: 268 INELLTGVVPY 278
I E+L G P+
Sbjct: 218 IYEILVGCPPF 228
|
Length = 340 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 4e-12
Identities = 54/189 (28%), Positives = 87/189 (46%), Gaps = 37/189 (19%)
Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
A Q+A+ ++YL + +HRD+ NVL+ + +ADFGLA ++
Sbjct: 140 AYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDID----------- 188
Query: 228 KPTGGFHKKNMVGTL--IYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAE 284
++KK G L +MAPE L +++ +SDV+SFGI + E+ T G PY + E
Sbjct: 189 -----YYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE 243
Query: 285 AQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSD 344
+ E + + +P + EL + L++ CW P RP+F
Sbjct: 244 ELFKLLREGHRMD------------KPSNCTHELYM------LMRECWHAVPTQRPTFKQ 285
Query: 345 IALELDLVL 353
+ LD VL
Sbjct: 286 LVEALDKVL 294
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 5e-12
Identities = 67/271 (24%), Positives = 115/271 (42%), Gaps = 51/271 (18%)
Query: 92 VAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNL--- 148
VAVK ++ +F +E +LL L H + +F + + FE+ +L
Sbjct: 38 VAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRF 97
Query: 149 -------AEKLHVEEWSP----SVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDR 197
A+ L E ++ Q+L IA+Q+A + YL +L VHRD+ N L+ +
Sbjct: 98 LRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQ 157
Query: 198 NLCPHLADFGLAEYRENLKEI-SLKNWRSSGKPTGGFHKKNMVGTLIYMAPE-ILKKEIH 255
L + DFG++ ++I S +R G + M+ + +M PE IL ++
Sbjct: 158 GLVVKIGDFGMS------RDIYSTDYYRVGG--------RTML-PIRWMPPESILYRKFT 202
Query: 256 SEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILA 314
+E SD++SFG+ + E+ T G P+ L + + E+ T
Sbjct: 203 TE-SDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGRELERPRTC------------ 249
Query: 315 SLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
P + +++Q CW P R DI
Sbjct: 250 ------PPEVYAIMQGCWQREPQQRMVIKDI 274
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 5e-12
Identities = 69/280 (24%), Positives = 119/280 (42%), Gaps = 48/280 (17%)
Query: 89 GRKVAVKKPIL---STSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYES 145
GR + V IL + ++F KE+++L +L P + + + E+ E+
Sbjct: 44 GRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMEN 103
Query: 146 RNLAEKL---HVEEWS---------------PSVDQVLMIAAQLAKALQYLHNLGIVHRD 187
+L + L H+++ S +L +A Q+A ++YL +L VHRD
Sbjct: 104 GDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRD 163
Query: 188 VKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAP 247
+ N L+ NL +ADFG++ NL + +R G+ V + +MA
Sbjct: 164 LATRNCLVGENLTIKIADFGMS---RNL--YAGDYYRIQGRA---------VLPIRWMAW 209
Query: 248 EILKKEIHSEKSDVYSFGISINELLT--GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVV 305
E + + SDV++FG+++ E+L PY +L E E + +Q
Sbjct: 210 ECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEF-FRDQG------ 262
Query: 306 SGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
R + P + L+ +CW + RPSFSDI
Sbjct: 263 ----RQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDI 298
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 6e-12
Identities = 53/205 (25%), Positives = 88/205 (42%), Gaps = 22/205 (10%)
Query: 68 YTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFV 127
YT++ + G+E V+ AT G+ V I L E LL ++HP + +
Sbjct: 68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTTL----IEAMLLQNVNHPSVIRMK 123
Query: 128 AAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRD 187
Y S +L L +DQ L+I Q+ + L+YLH I+HRD
Sbjct: 124 DTLVSGAITCMVLPHYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRD 182
Query: 188 VKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAP 247
VK N+ ++ + D G A++ P + GT+ AP
Sbjct: 183 VKTENIFINDVDQVCIGDLGAAQF-----------------PVVAPAFLGLAGTVETNAP 225
Query: 248 EILKKEIHSEKSDVYSFGISINELL 272
E+L ++ ++ K+D++S GI + E+L
Sbjct: 226 EVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 6e-12
Identities = 50/186 (26%), Positives = 90/186 (48%), Gaps = 32/186 (17%)
Query: 170 QLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKP 229
Q+A+ +++L + +HRD+ N+LL N + DFGLA R+ K+ + P
Sbjct: 181 QVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLA--RDIYKDPDYVRKGDARLP 238
Query: 230 TGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAH 288
L +MAPE + ++++ +SDV+SFG+ + E+ + G PY ++ + +
Sbjct: 239 ------------LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFC 286
Query: 289 TVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALE 348
L+ G R + + E P I S++ CW NP +RP+FS++
Sbjct: 287 RRLKE--------------GTR--MRAPEYATP-EIYSIMLDCWHNNPEDRPTFSELVEI 329
Query: 349 LDLVLE 354
L +L+
Sbjct: 330 LGDLLQ 335
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 7e-12
Identities = 53/201 (26%), Positives = 87/201 (43%), Gaps = 33/201 (16%)
Query: 66 SSYTLLSPIARGAESVVYEA--TLDGRKVAVKKPILSTSEELDNFH----KELQLLCKLD 119
S Y L+ I +G V++A + VA+KK ++ +E F +E+++L L
Sbjct: 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKE--GFPITALREIKILQLLK 69
Query: 120 HPGLAKFVA-AHAKP-------PNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQL 171
H + + K ++ FEF E +LA L + ++ ++ + L
Sbjct: 70 HENVVNLIEICRTKATPYNRYKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKML 128
Query: 172 AKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTG 231
L Y+H I+HRD+K AN+L+ ++ LADFGLA R+
Sbjct: 129 LNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLA--------------RAFSLSKN 174
Query: 232 GFHKK--NMVGTLIYMAPEIL 250
+ N V TL Y PE+L
Sbjct: 175 SKPNRYTNRVVTLWYRPPELL 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 7e-12
Identities = 60/221 (27%), Positives = 99/221 (44%), Gaps = 33/221 (14%)
Query: 66 SSYTLLSPIARGAESVVYEA--TLDGRKVAVKKPILSTSEELDN---FHKELQLLCKLDH 120
S Y + I GA VV A T G+KVA+KK I + +EL++L H
Sbjct: 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKK-IPHAFDVPTLAKRTLRELKILRHFKH 63
Query: 121 PGLAK----FVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSP-SVDQVLMIAAQLAKAL 175
+ A + + ES +L +H ++ P + + + QL + L
Sbjct: 64 DNIIAIRDILRPPGADFKDVYVVMDLMES-DLHHIIHSDQ--PLTEEHIRYFLYQLLRGL 120
Query: 176 QYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHK 235
+Y+H+ ++HRD+KP+N+L++ + + DFG+A + + S PT HK
Sbjct: 121 KYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMA------RGL-------SSSPTE--HK 165
Query: 236 KNM---VGTLIYMAPEIL-KKEIHSEKSDVYSFGISINELL 272
M V T Y APE+L ++ D++S G E+L
Sbjct: 166 YFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 7e-12
Identities = 51/193 (26%), Positives = 91/193 (47%), Gaps = 28/193 (14%)
Query: 89 GRKVAVKKPILSTSEELDNFHK----ELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYE 144
G+ VA+KK + SE+ K E+++L +L H L + + FEF +
Sbjct: 26 GQIVAIKKFL--ESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVD 83
Query: 145 SRNLAEKLHVEEWSPSVDQ--VLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPH 202
L + +E++ +D+ V Q+ + +++ H+ I+HRD+KP N+L+ ++
Sbjct: 84 HTVLDD---LEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVK 140
Query: 203 LADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKS-DV 261
L DFG A R+ P G + V T Y APE+L + ++ D+
Sbjct: 141 LCDFGFA--------------RTLAAP--GEVYTDYVATRWYRAPELLVGDTKYGRAVDI 184
Query: 262 YSFGISINELLTG 274
++ G + E+LTG
Sbjct: 185 WAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 7e-12
Identities = 60/227 (26%), Positives = 107/227 (47%), Gaps = 34/227 (14%)
Query: 66 SSYTLLSPIARGAESVVYEATLD---GRKVAVKKPILSTSEELDNFHKELQLLCKLDHPG 122
S Y L P+ G+ +V+ A +D ++VAVKK +L+ + + + +E++++ +LDH
Sbjct: 5 SRYMDLRPLGCGSNGLVFSA-VDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDN 63
Query: 123 LAK-----FVAAHAKPPNYMFFFEF--------YESRNLAEKLHVEEWSPSVDQVLMIAA 169
+ K + + E Y +LA L E+ S + +
Sbjct: 64 IVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVL--EQGPLSEEHARLFMY 121
Query: 170 QLAKALQYLHNLGIVHRDVKPANVLLD-RNLCPHLADFGLAEYRENLKEISLKNWRSSGK 228
QL + L+Y+H+ ++HRD+KPANV ++ +L + DFGLA + S K + S G
Sbjct: 122 QLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVD--PHYSHKGYLSEG- 178
Query: 229 PTGGFHKKNMVGTLIYMAPEILKKEIHSEKS-DVYSFGISINELLTG 274
+ T Y +P +L + K+ D+++ G E+LTG
Sbjct: 179 ----------LVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG 215
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 8e-12
Identities = 67/235 (28%), Positives = 97/235 (41%), Gaps = 35/235 (14%)
Query: 64 PPSSYTLLSPIARGAESVVYEAT--LDGRKVAVK--KPILSTSEELDNFHKELQLLCKLD 119
P ++ ++ I +G VY+ T DG AVK PI EE++ + LQ L +
Sbjct: 20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLP--N 77
Query: 120 HPGLAKFVAAHAKPPNYM-----FFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKA 174
HP + KF K + E ++ E + MI+ L A
Sbjct: 78 HPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGA 137
Query: 175 L---QYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTG 231
L Q+LHN I+HRDVK N+LL L DFG+ S+ +
Sbjct: 138 LLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGV----------------SAQLTST 181
Query: 232 GFHKKNMVGTLIYMAPEILKKEIHSEKS-----DVYSFGISINELLTGVVPYTDL 281
+ VGT +MAPE++ E + S DV+S GI+ EL G P D+
Sbjct: 182 RLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDM 236
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 1e-11
Identities = 63/256 (24%), Positives = 114/256 (44%), Gaps = 37/256 (14%)
Query: 106 DNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYE--------SRNLAEKLHVEEW 157
++F KE++++ +L P + + +A E+ E SR+ ++ +
Sbjct: 64 NDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKAD 123
Query: 158 SPSVD--QVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL 215
++ ++ +A Q+A ++YL +L VHRD+ N L+ +N +ADFG++ NL
Sbjct: 124 VVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMS---RNL 180
Query: 216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGV 275
S +R G+ V + +M+ E + + SDV++FG+++ E+LT
Sbjct: 181 --YSGDYYRIQGRA---------VLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLC 229
Query: 276 --VPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWD 333
PY+ L E E + +Q + +P L P S+ L+ CW
Sbjct: 230 KEQPYSQLSDEQVIENTGEF-FRDQGRQVYL----PKPALC------PDSLYKLMLSCWR 278
Query: 334 GNPHNRPSFSDIALEL 349
N RPSF +I L
Sbjct: 279 RNAKERPSFQEIHATL 294
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 1e-11
Identities = 47/188 (25%), Positives = 83/188 (44%), Gaps = 17/188 (9%)
Query: 93 AVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKL 152
++K + + E+ + E +L +++ P + + P F L L
Sbjct: 25 TIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHL 84
Query: 153 HVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYR 212
E + + A+L AL+ LH +++RD+KP N+LLD L DFGL +
Sbjct: 85 Q-REGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKL- 142
Query: 213 ENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELL 272
N+K+ N GT Y+APE+L +++ D ++ G+ + E+L
Sbjct: 143 -NMKDDDKTN--------------TFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEML 187
Query: 273 TGVVPYTD 280
TG+ P+ D
Sbjct: 188 TGLPPFYD 195
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 39/111 (35%), Positives = 62/111 (55%), Gaps = 16/111 (14%)
Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
AA++A L +LH+ GI++RD+K NV+LD +ADFG+ +EN+ G
Sbjct: 107 AAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMC--KENIFG---------G 155
Query: 228 KPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
K T F GT Y+APEI+ + + + D ++FG+ + E+L G P+
Sbjct: 156 KTTRTF-----CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPF 201
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 65.3 bits (160), Expect = 1e-11
Identities = 39/120 (32%), Positives = 54/120 (45%), Gaps = 21/120 (17%)
Query: 160 SVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCP-HLADFGLAEYRENLKEI 218
S +V I QL +AL LH I+H D+K NVL DR +L D+GL
Sbjct: 107 SEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLC--------- 157
Query: 219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
+ G P+ GTL Y +PE +K + D ++ G+ ELLTG P+
Sbjct: 158 -----KIIGTPS------CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPF 206
|
Length = 267 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 61/217 (28%), Positives = 93/217 (42%), Gaps = 30/217 (13%)
Query: 68 YTLLSPIARGAESVVYEA--TLDGRKVAVKKPILSTSEELDNFHK----ELQLLCKLDHP 121
Y LS I G+ VV++ G+ VA+KK + SE+ K E+++L +L HP
Sbjct: 3 YEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFV--ESEDDPVIKKIALREIRMLKQLKHP 60
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLM--IAAQLAKALQYLH 179
L + + FE+ + L E +E+ V + L+ I Q +A+ + H
Sbjct: 61 NLVNLIEVFRRKRKLHLVFEYCDHTVLNE---LEKNPRGVPEHLIKKIIWQTLQAVNFCH 117
Query: 180 NLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMV 239
+HRDVKP N+L+ + L DFG A G + V
Sbjct: 118 KHNCIHRDVKPENILITKQGQIKLCDFGFARILT----------------GPGDDYTDYV 161
Query: 240 GTLIYMAPEILKKEI-HSEKSDVYSFGISINELLTGV 275
T Y APE+L + + DV++ G ELLTG
Sbjct: 162 ATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 57/249 (22%), Positives = 102/249 (40%), Gaps = 42/249 (16%)
Query: 106 DNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYE----SRNLAEKLHVEEWSPSV 161
D +E ++ +LD+P + + + + ++M E E ++ L + HV E
Sbjct: 41 DELLREANVMQQLDNPYIVRMIGI-CEAESWMLVMELAELGPLNKFLQKNKHVTE----- 94
Query: 162 DQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLK 221
+ + Q++ ++YL VHRD+ NVLL ++DFGL+ K +
Sbjct: 95 KNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLS------KALGAD 148
Query: 222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTD 280
K G + K + APE + S KSDV+SFG+ + E + G PY
Sbjct: 149 ENYYKAKTHGKWPVK-------WYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKG 201
Query: 281 LRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRP 340
++ + V +M + +++ P + L++ CW RP
Sbjct: 202 MK----GNEVTQMIESGERMECPQ--------------RCPPEMYDLMKLCWTYGVDERP 243
Query: 341 SFSDIALEL 349
F+ + L L
Sbjct: 244 GFAVVELRL 252
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 39/127 (30%), Positives = 67/127 (52%), Gaps = 16/127 (12%)
Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
AA++A L +LH+ GI++RD+K NV+LD +ADFG+ +EN+ +
Sbjct: 107 AAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMC--KENMWD---------- 154
Query: 228 KPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQA 287
G K GT Y+APEI+ + + + D ++FG+ + E+L G P+ +
Sbjct: 155 ----GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF 210
Query: 288 HTVLEMN 294
+++E N
Sbjct: 211 QSIMEHN 217
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 2e-11
Identities = 54/195 (27%), Positives = 83/195 (42%), Gaps = 25/195 (12%)
Query: 94 VKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLH 153
+KK +L E + F +E +L + P + + A N E+ +L L+
Sbjct: 34 MKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLN 93
Query: 154 VEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRE 213
E D A+L A+ +H +G VHRD+KP NVL+DR LADFG
Sbjct: 94 RYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFG------ 147
Query: 214 NLKEISLKNWRSSGKPTGGFH--KKNMVGTLIYMAPEILK------KEIHSEKSDVYSFG 265
S+ + T K VGT Y+APE+L K + + D +S G
Sbjct: 148 -----------SAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLG 196
Query: 266 ISINELLTGVVPYTD 280
+ E++ G P+ +
Sbjct: 197 VIAYEMIYGRSPFHE 211
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 49/190 (25%), Positives = 85/190 (44%), Gaps = 37/190 (19%)
Query: 159 PSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI 218
P++ +++ +AA++A + YL+ VHRD+ N ++ + + DFG+ ++ E
Sbjct: 116 PTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMT---RDIYET 172
Query: 219 SLKNWRSSGKPTGGFHKKNMVGTLI--YMAPEILKKEIHSEKSDVYSFGISINELLT-GV 275
+R GK G L +MAPE LK + + SD++SFG+ + E+ +
Sbjct: 173 DY--YRKGGK-----------GLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAE 219
Query: 276 VPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGN 335
PY L E V++ Y +Q P + L++ CW N
Sbjct: 220 QPYQGLSNEQVLKFVMDGGYLDQPDNC------------------PERVTDLMRMCWQFN 261
Query: 336 PHNRPSFSDI 345
P RP+F +I
Sbjct: 262 PKMRPTFLEI 271
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 3e-11
Identities = 55/211 (26%), Positives = 87/211 (41%), Gaps = 19/211 (9%)
Query: 68 YTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFV 127
Y +LS + G+E V+ T G KK I+ +E+ +L + H + +
Sbjct: 94 YNILSSLTPGSEGEVFVCTKHG-DEQRKKVIVKAVTGGKTPGREIDILKTISHRAIINLI 152
Query: 128 AAHAKPPNYMFFFEFYESRNLAEKLHVEEWSP-SVDQVLMIAAQLAKALQYLHNLGIVHR 186
A+ Y+ +V+ P ++Q + I +L +AL YLH GI+HR
Sbjct: 153 HAYRWKSTVCMVMPKYKCDLFT---YVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHR 209
Query: 187 DVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMA 246
DVK N+ LD L DFG A K P GTL +
Sbjct: 210 DVKTENIFLDEPENAVLGDFGAA----------CKLDAHPDTP----QCYGWSGTLETNS 255
Query: 247 PEILKKEIHSEKSDVYSFGISINELLTGVVP 277
PE+L + + K+D++S G+ + E+ V
Sbjct: 256 PELLALDPYCAKTDIWSAGLVLFEMSVKNVT 286
|
Length = 392 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 3e-11
Identities = 62/215 (28%), Positives = 93/215 (43%), Gaps = 24/215 (11%)
Query: 66 SSYTLLSPIARGAESVVYEATLDGRK--VAVKKPILSTSEELDNFH----KELQLLCKLD 119
+ + +L + GA VV + K VA+KK SEE + +EL++L L
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKK--FKDSEENEEVKETTLRELKMLRTLK 58
Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLH 179
+ + A + FE+ E +N+ E L ++V QL KA+ + H
Sbjct: 59 QENIVELKEAFRRRGKLYLVFEYVE-KNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCH 117
Query: 180 NLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMV 239
IVHRD+KP N+L+ N L DFG A NL E S N+ V
Sbjct: 118 KNDIVHRDIKPENLLISHNDVLKLCDFGFA---RNLSEGSNANY------------TEYV 162
Query: 240 GTLIYMAPEILKKEIHSEKSDVYSFGISINELLTG 274
T Y +PE+L + + D++S G + EL G
Sbjct: 163 ATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 3e-11
Identities = 61/264 (23%), Positives = 109/264 (41%), Gaps = 44/264 (16%)
Query: 100 STSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLH----VE 155
+T +E F +E+Q +L+HP + + + + Y+ EF +L L +
Sbjct: 34 ATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMV 93
Query: 156 EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLA--EYRE 213
D + +A ++A L +LH +H D+ N L +L + D+GLA +Y E
Sbjct: 94 AQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPE 153
Query: 214 NLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEI-------LKKEIHSEKSDVYSFGI 266
+ + L ++APE+ L + ++KS+++S G+
Sbjct: 154 DYYITKDCHAVP----------------LRWLAPELVEIRGQDLLPKDQTKKSNIWSLGV 197
Query: 267 SINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASIL 325
++ EL T PY DL E VL+ EQ + +P L+L
Sbjct: 198 TMWELFTAADQPYPDLSDE----QVLKQVVREQDIKLP------KP---QLDLKYSDRWY 244
Query: 326 SLIQRCWDGNPHNRPSFSDIALEL 349
++Q CW +P RP+ ++ L
Sbjct: 245 EVMQFCW-LDPETRPTAEEVHELL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 63/238 (26%), Positives = 104/238 (43%), Gaps = 35/238 (14%)
Query: 68 YTLLSPIARGAESVVYEA--TLDGRKVAVKK---PILSTSEELDNFHKELQLLCKLDHPG 122
Y L PI GA+ +V A T+ G VAVKK P + + ++EL LL ++H
Sbjct: 23 YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHA-KRAYRELVLLKCVNHKN 81
Query: 123 LAKFVAAHAKPPNYMFFFEFY-----ESRNLAEKLHVEEWSPSVDQVLM--IAAQLAKAL 175
+ + + F + Y NL + +H+E +D M + Q+ +
Sbjct: 82 IISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHME-----LDHERMSYLLYQMLCGI 136
Query: 176 QYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHK 235
++LH+ GI+HRD+KP+N+++ + + DFGLA F
Sbjct: 137 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-----------------TACTNFMM 179
Query: 236 KNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEM 293
V T Y APE++ + E D++S G + EL+ G V + Q + V+E
Sbjct: 180 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQ 237
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 3e-11
Identities = 51/188 (27%), Positives = 91/188 (48%), Gaps = 20/188 (10%)
Query: 93 AVKKPILSTSEELDNFHKELQLLC-KLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEK 151
A+KK ++ ++++ E ++L ++P L + F EF +L
Sbjct: 27 ALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGGDLM-- 84
Query: 152 LHVEEWSP-SVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAE 210
H+++ + + AA++ LQ+LH+ GI++RD+K NV+LDR+ +ADFG+
Sbjct: 85 FHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMC- 143
Query: 211 YRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINE 270
+EN+ G GT Y+APEIL+ ++ D +SFG+ + E
Sbjct: 144 -KENV--------------FGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYE 188
Query: 271 LLTGVVPY 278
+L G P+
Sbjct: 189 MLIGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 3e-11
Identities = 60/230 (26%), Positives = 105/230 (45%), Gaps = 37/230 (16%)
Query: 65 PSSYTLLSPIARGAESVVYEA--TLDGRKVAVKK---PILSTSEELDNFHKELQLLCKLD 119
Y L PI GA+ +V A T+ G+ VA+KK P + + + +EL L+ ++
Sbjct: 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAY-RELVLMKLVN 73
Query: 120 HPGLAKFVAAHAKPPNYMFFFEFY-----ESRNLAEKLHVEEWSPSVDQVLM--IAAQLA 172
H + + + F + Y NL + + ++ +D M + Q+
Sbjct: 74 HKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMD-----LDHERMSYLLYQML 128
Query: 173 KALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGG 232
+++LH+ GI+HRD+KP+N+++ + + DFGLA R++G
Sbjct: 129 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA--------------RTAG---TS 171
Query: 233 FHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVV--PYTD 280
F V T Y APE++ + E D++S G + E++ G V P TD
Sbjct: 172 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTD 221
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 4e-11
Identities = 38/128 (29%), Positives = 66/128 (51%), Gaps = 18/128 (14%)
Query: 153 HVEEWSPSVDQ--VLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAE 210
+V+E +P + AQ+ L++LH I++RD+KP NVLLD + ++D GLA
Sbjct: 86 NVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLA- 144
Query: 211 YRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINE 270
+ LK+ +S K GT +MAPE+L+ E + D ++ G+++ E
Sbjct: 145 -------VELKDGQSK--------TKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYE 189
Query: 271 LLTGVVPY 278
++ P+
Sbjct: 190 MIAARGPF 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 5e-11
Identities = 79/291 (27%), Positives = 122/291 (41%), Gaps = 51/291 (17%)
Query: 71 LSPIARGAESVVYEA--TLDGRKVAVKKPILSTSE-ELDNFHKELQLLCKLDHPGLAKFV 127
L + +G VY+ G +A+K+ L E + + EL +L K P + F
Sbjct: 6 LDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFY 65
Query: 128 AAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSV---DQVLMIAAQLAKALQYL---HNL 181
A E+ ++ +L +KL+ + D + I + K L++L HN
Sbjct: 66 GAFFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN- 123
Query: 182 GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGT 241
I+HRDVKP NVL++ N L DFG+ SG K N +G
Sbjct: 124 -IIHRDVKPTNVLVNGNGQVKLCDFGV-----------------SGNLVASLAKTN-IGC 164
Query: 242 LIYMAPEILKKE------IHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNY 295
YMAPE +K ++ +SDV+S G+SI E+ G PY E A+
Sbjct: 165 QSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYP---PETYANIF----- 216
Query: 296 TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIA 346
QL+A V G P L S G + +C + P+ RP+++ +
Sbjct: 217 --AQLSAIV--DGDPPTLPS---GYSDDAQDFVAKCLNKIPNRRPTYAQLL 260
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 5e-11
Identities = 37/116 (31%), Positives = 59/116 (50%), Gaps = 17/116 (14%)
Query: 163 QVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKN 222
+ + AA++ L+ LH IV+RD+KP N+LLD ++D GLA + +
Sbjct: 103 RAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLA--------VEIPE 154
Query: 223 WRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
G+ G VGT+ YMAPE++K E ++ D + G I E++ G P+
Sbjct: 155 ----GETIRG-----RVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 5e-11
Identities = 63/258 (24%), Positives = 112/258 (43%), Gaps = 38/258 (14%)
Query: 92 VAVKKPILSTSEE---LDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNL 148
VA+K +L E D +E +++ +LD+P + + + + M E L
Sbjct: 25 VAIK--VLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGV-CEAEALMLVMEMASGGPL 81
Query: 149 AEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGL 208
+ L ++ +V V+ + Q++ ++YL VHRD+ NVLL ++DFGL
Sbjct: 82 NKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGL 141
Query: 209 AEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISI 268
++ + S RS+GK L + APE + S +SDV+S+GI++
Sbjct: 142 SKALG--ADDSYYKARSAGK-----------WPLKWYAPECINFRKFSSRSDVWSYGITM 188
Query: 269 NELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSL 327
E + G PY ++ M++ EQ G R P + +L
Sbjct: 189 WEAFSYGQKPYKKMKGPEV------MSFIEQ---------GKR---LDCPAECPPEMYAL 230
Query: 328 IQRCWDGNPHNRPSFSDI 345
++ CW +RP+F+ +
Sbjct: 231 MKDCWIYKWEDRPNFAKV 248
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 5e-11
Identities = 61/269 (22%), Positives = 109/269 (40%), Gaps = 51/269 (18%)
Query: 93 AVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKL 152
A+K P L+ ++ F +E +LL L H + KF + FE+ + +L + L
Sbjct: 42 ALKDPTLAARKD---FQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFL 98
Query: 153 HVE--------EWSP-------SVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDR 197
+ P + Q+L IA+Q+A + YL + VHRD+ N L+
Sbjct: 99 RAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGA 158
Query: 198 NLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSE 257
NL + DFG++ +++ ++ G T + + +M PE + +
Sbjct: 159 NLLVKIGDFGMS------RDVYSTDYYRVGGHT--------MLPIRWMPPESIMYRKFTT 204
Query: 258 KSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASL 316
+SDV+SFG+ + E+ T G P+ L + + E RP +
Sbjct: 205 ESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVLE------------RPRVC-- 250
Query: 317 ELGLPASILSLIQRCWDGNPHNRPSFSDI 345
P + ++ CW P R + +I
Sbjct: 251 ----PKEVYDIMLGCWQREPQQRLNIKEI 275
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 5e-11
Identities = 40/132 (30%), Positives = 62/132 (46%), Gaps = 22/132 (16%)
Query: 169 AQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGL---------AEYRENLKEIS 219
A+ A+ +H LG +HRD+KP N+LLD L+DFGL E+ L
Sbjct: 108 AETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHAL 167
Query: 220 LKNWRS-SGKP---TGGFH--KKN-------MVGTLIYMAPEILKKEIHSEKSDVYSFGI 266
N+ KP K+N VGT Y+APE+ + ++++ D +S G+
Sbjct: 168 PSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGV 227
Query: 267 SINELLTGVVPY 278
+ E+L G P+
Sbjct: 228 IMYEMLVGYPPF 239
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 5e-11
Identities = 51/206 (24%), Positives = 94/206 (45%), Gaps = 34/206 (16%)
Query: 142 FYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCP 201
+ + +E L +E + + +L + Q+AK + +L + +HRD+ N+LL
Sbjct: 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRIT 253
Query: 202 HLADFGLAEYRENLKEISLK-NWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSD 260
+ DFGLA N +K N R K +MAPE + +++ +SD
Sbjct: 254 KICDFGLARDIRNDSNYVVKGNARLPVK---------------WMAPESIFNCVYTFESD 298
Query: 261 VYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELG 319
V+S+GI + E+ + G PY + +++ + +++ Y L P A
Sbjct: 299 VWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRM-----------LSPECA----- 342
Query: 320 LPASILSLIQRCWDGNPHNRPSFSDI 345
P+ + +++ CWD +P RP+F I
Sbjct: 343 -PSEMYDIMKSCWDADPLKRPTFKQI 367
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 5e-11
Identities = 64/236 (27%), Positives = 99/236 (41%), Gaps = 37/236 (15%)
Query: 64 PPSSYTLLSPIARGAESVVYEA--TLDGRKVAVK--KPILSTSEELDNFHKELQLLCKLD 119
P ++ ++ I +G V++ +G K AVK PI EE++ + L+ L D
Sbjct: 16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALS--D 73
Query: 120 HPGLAKFVAAHAKPP-----NYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKA 174
HP + KF + K E ++ + + + +IA L +A
Sbjct: 74 HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEA 133
Query: 175 L---QYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTG 231
L Q+LH +HRDVK N+LL L DFG+ S + T
Sbjct: 134 LMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGV-----------------SAQLTS 176
Query: 232 GFHKKNM-VGTLIYMAPEILKKE-----IHSEKSDVYSFGISINELLTGVVPYTDL 281
++N VGT +MAPE++ E + + DV+S GI+ EL G P DL
Sbjct: 177 TRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADL 232
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 7e-11
Identities = 49/188 (26%), Positives = 85/188 (45%), Gaps = 32/188 (17%)
Query: 170 QLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKP 229
Q+A+ +++L + +HRD+ N+LL N + DFGLA R K
Sbjct: 182 QVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLA--------------RDIYKD 227
Query: 230 TGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAH 288
K + L +MAPE + ++++ +SDV+SFG+ + E+ + G PY ++ +
Sbjct: 228 PDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFC 287
Query: 289 TVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALE 348
L+ G R + + E P I ++ CW G+P RP+FS +
Sbjct: 288 QRLK--------------DGTR--MRAPENATPE-IYRIMLACWQGDPKERPTFSALVEI 330
Query: 349 LDLVLEHR 356
L +L+
Sbjct: 331 LGDLLQEN 338
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 7e-11
Identities = 36/117 (30%), Positives = 56/117 (47%), Gaps = 17/117 (14%)
Query: 162 DQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLK 221
++ L AA++ L+ LH V+RD+KP N+LLD ++D GLA
Sbjct: 102 ERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAV----------- 150
Query: 222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
K G + VGT+ YMAPE+L + ++ D + G I E++ G P+
Sbjct: 151 ------KIPEGESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 7e-11
Identities = 40/131 (30%), Positives = 64/131 (48%), Gaps = 31/131 (23%)
Query: 160 SVDQVLM------------IAAQLAKALQYLH-NLGIVHRDVKPANVLLDRNLCPHLADF 206
S+DQVL I+ + + L YL I+HRDVKP+N+L++ L DF
Sbjct: 85 SLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDF 144
Query: 207 GLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGI 266
G++ + S+ N + VGT YM+PE L+ ++ +SD++S G+
Sbjct: 145 GVSGQLID----SMAN--------------SFVGTRSYMSPERLQGTHYTVQSDIWSLGL 186
Query: 267 SINELLTGVVP 277
S+ E+ G P
Sbjct: 187 SLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 64.0 bits (155), Expect = 8e-11
Identities = 56/213 (26%), Positives = 98/213 (46%), Gaps = 27/213 (12%)
Query: 68 YTLLSPIARGAESVV---YEATLDGRKVAVKK---PILSTSEELDNFHKELQLLCKLDHP 121
Y L PI GA+ +V Y+A LD R VA+KK P + + ++EL L+ ++H
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHA-KRAYRELVLMKCVNHK 76
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLM--IAAQLAKALQYLH 179
+ + + F + Y L + + +D M + Q+ +++LH
Sbjct: 77 NIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 136
Query: 180 NLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMV 239
+ GI+HRD+KP+N+++ + + DFGLA R++G F V
Sbjct: 137 SAGIIHRDLKPSNIVVKSDCTLKILDFGLA--------------RTAGT---SFMMTPYV 179
Query: 240 GTLIYMAPEILKKEIHSEKSDVYSFGISINELL 272
T Y APE++ + E D++S G + E++
Sbjct: 180 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 8e-11
Identities = 55/231 (23%), Positives = 94/231 (40%), Gaps = 34/231 (14%)
Query: 61 LHLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDN-----FHKELQLL 115
L + Y ++ I RGA V + +LS E + F +E ++
Sbjct: 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIM 97
Query: 116 CKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLH----VEEWSPSVDQVLMIAAQL 171
+ P + + A E+ +L + E+W+ A++
Sbjct: 98 AFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAK------FYTAEV 151
Query: 172 AKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTG 231
AL +H++G++HRDVKP N+LLD++ LADFG + TG
Sbjct: 152 VLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE---------------TG 196
Query: 232 GFHKKNMVGTLIYMAPEILKKE----IHSEKSDVYSFGISINELLTGVVPY 278
VGT Y++PE+LK + + + D +S G+ + E+L G P+
Sbjct: 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 58/225 (25%), Positives = 97/225 (43%), Gaps = 26/225 (11%)
Query: 94 VKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLH 153
++K + E++ + E +L + D + K + N EF ++ L
Sbjct: 34 LRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLM 93
Query: 154 VEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGL----- 208
++ + S + A+ A+ +H LG +HRD+KP N+LLD L+DFGL
Sbjct: 94 KKD-TLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLK 152
Query: 209 ----AEYRENL-----KEISLKNWRSSGKPTGGFHKKN-------MVGTLIYMAPEILKK 252
E+ NL + S +N S K KKN VGT Y+APE+ +
Sbjct: 153 KAHRTEFYRNLTHNPPSDFSFQNMNSKRKAET--WKKNRRQLAYSTVGTPDYIAPEVFMQ 210
Query: 253 EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTE 297
+++ D +S G+ + E+L G P+ + V MN+ E
Sbjct: 211 TGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKV--MNWKE 253
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 78/301 (25%), Positives = 120/301 (39%), Gaps = 47/301 (15%)
Query: 64 PPSSYTLLSPIARGAESVVYEAT--LDGRKVAVKKPILS---TSEELDNFHKELQLLCKL 118
P + L I G+ VY AT VAVKK S T+E+ + KE++ L +L
Sbjct: 19 PEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQL 78
Query: 119 DHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYL 178
HP ++ + K E Y + ++ L V + ++ I + L YL
Sbjct: 79 KHPNTIEYKGCYLKEHTAWLVME-YCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYL 137
Query: 179 HNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNM 238
H+ ++HRD+K N+LL LADFG A S P F
Sbjct: 138 HSHNMIHRDIKAGNILLTEPGQVKLADFGSA---------------SKSSPANSF----- 177
Query: 239 VGTLIYMAPEI---LKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNY 295
VGT +MAPE+ + + + K DV+S GI+ EL P ++ A + + + + +
Sbjct: 178 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQND- 236
Query: 296 TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH 355
P L S E S + C P RP+ +++ L D V
Sbjct: 237 --------------SPTLQSNE--WTDSFRGFVDYCLQKIPQERPASAEL-LRHDFVRRD 279
Query: 356 R 356
R
Sbjct: 280 R 280
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 1e-10
Identities = 73/309 (23%), Positives = 122/309 (39%), Gaps = 53/309 (17%)
Query: 64 PPSSYTLLSPIARGAESVVYEA--TLDGRKVAVKKPILS---TSEELDNFHKELQLLCKL 118
P ++ L I G+ VY A + VA+KK S ++E+ + KE++ L KL
Sbjct: 13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL 72
Query: 119 DHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYL 178
HP ++ + + E Y + ++ L V + ++ + + L YL
Sbjct: 73 RHPNTIQYRGCYLREHTAWLVME-YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYL 131
Query: 179 HNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNM 238
H+ ++HRDVK N+LL L DFG A S P F
Sbjct: 132 HSHNMIHRDVKAGNILLSEPGLVKLGDFGSA---------------SIMAPANXF----- 171
Query: 239 VGTLIYMAPEI---LKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNY 295
VGT +MAPE+ + + + K DV+S GI+ EL P ++ A + + + +
Sbjct: 172 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE- 230
Query: 296 TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH 355
P L S + + C P +RP+ +++L+H
Sbjct: 231 --------------SPALQSGHWS--EYFRNFVDSCLQKIPQDRPTS-------EVLLKH 267
Query: 356 RKSLKEEDL 364
R L+E
Sbjct: 268 RFVLRERPP 276
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 1e-10
Identities = 59/238 (24%), Positives = 102/238 (42%), Gaps = 42/238 (17%)
Query: 64 PPSSYTLLSPIARGAESVVYEAT-LDGRKVAVKKPILSTSEELDNFHKELQLLCKLDH-P 121
P + L+ + G VY+ + ++A K + T +E + +E+ +L K H
Sbjct: 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHR 63
Query: 122 GLAKFVAAHAK--PP----NYMFFFEFYES-------RNLAEKLHVEEWSPSVDQVLMIA 168
+A + A K PP EF + +N EEW + I
Sbjct: 64 NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEW------IAYIC 117
Query: 169 AQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK 228
++ + L +LH ++HRD+K NVLL N L DFG++ + R+ G+
Sbjct: 118 REILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD----------RTVGR 167
Query: 229 PTGGFHKKNMVGTLIYMAPEILKKEIHSE-----KSDVYSFGISINELLTGVVPYTDL 281
+ +GT +MAPE++ + + + KSD++S GI+ E+ G P D+
Sbjct: 168 ------RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM 219
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 2e-10
Identities = 61/232 (26%), Positives = 101/232 (43%), Gaps = 38/232 (16%)
Query: 68 YTLLSPIARGAESVVYEATL----DGRKVAVKKPILSTSEELDNFH----KELQLLCKLD 119
Y + I RG VY+A DG++ A+KK E+ +E+ LL +L
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKK-FKGDKEQYTGISQSACREIALLRELK 60
Query: 120 HPGLAKFVAAHAKPPN---YMFFFEFYESRNLAE--KLHVEEWSPSVDQ--VLMIAAQLA 172
H + V + + Y+ F ++ E +L + K H + S+ V + Q+
Sbjct: 61 HENVVSLVEVFLEHADKSVYLLF-DYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQIL 118
Query: 173 KALQYLHNLGIVHRDVKPANVLLDRNLCPH----LADFGLAE-YRENLKEISLKNWRSSG 227
+ YLH+ ++HRD+KPAN+L+ + D GLA + LK + +
Sbjct: 119 NGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPL------ADL 172
Query: 228 KPTGGFHKKNMVGTLIYMAPEILKKEIHSEKS-DVYSFGISINELLTGVVPY 278
P +V T+ Y APE+L H K+ D+++ G ELLT +
Sbjct: 173 DP--------VVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIF 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 2e-10
Identities = 48/185 (25%), Positives = 82/185 (44%), Gaps = 17/185 (9%)
Query: 94 VKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLH 153
+KK ++ +E+ + E ++L HP L + F E+ L L
Sbjct: 28 LKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLS 87
Query: 154 VEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRE 213
E S D+ A++ AL YLH+ IV+RD+K N++LD++ + DFGL +E
Sbjct: 88 RERVF-SEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLC--KE 144
Query: 214 NLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT 273
+ T K GT Y+APE+L+ + D + G+ + E++
Sbjct: 145 GI--------------TDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC 190
Query: 274 GVVPY 278
G +P+
Sbjct: 191 GRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 49/186 (26%), Positives = 85/186 (45%), Gaps = 18/186 (9%)
Query: 94 VKKPILSTSEELDNFHKELQLL-CKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKL 152
+KK +++ E++D E + +HP L + F EF +L +
Sbjct: 28 IKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHM 87
Query: 153 HVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYR 212
+ P + +A+++ AL +LH GI++RD+K NVLLD L D+G+ +
Sbjct: 88 QRQRKLPE-EHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMC--K 144
Query: 213 ENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELL 272
E ++ G T F GT Y+APEIL+ E + D ++ G+ + E++
Sbjct: 145 EGIRP---------GDTTSTF-----CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMM 190
Query: 273 TGVVPY 278
G P+
Sbjct: 191 AGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 2e-10
Identities = 60/223 (26%), Positives = 103/223 (46%), Gaps = 29/223 (13%)
Query: 68 YTLLSPIARGAESVV---YEATLDGRKVAVKK---PILSTSEELDNFHKELQLLCKLDHP 121
Y L PI GA+ +V Y+A L+ R VA+KK P + + ++EL L+ ++H
Sbjct: 26 YQNLKPIGSGAQGIVCAAYDAILE-RNVAIKKLSRPFQNQTHA-KRAYRELVLMKCVNHK 83
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLM--IAAQLAKALQYLH 179
+ + + F + Y L + + +D M + Q+ +++LH
Sbjct: 84 NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 180 NLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMV 239
+ GI+HRD+KP+N+++ + + DFGLA R++G F V
Sbjct: 144 SAGIIHRDLKPSNIVVKSDCTLKILDFGLA--------------RTAGT---SFMMTPYV 186
Query: 240 GTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVV--PYTD 280
T Y APE++ + E D++S G + E++ G V P TD
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 229
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 36/132 (27%), Positives = 68/132 (51%), Gaps = 16/132 (12%)
Query: 163 QVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKN 222
Q + AA+++ L +LH GI++RD+K NV+LD +ADFG+ +E++ +
Sbjct: 102 QAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMC--KEHMVD----- 154
Query: 223 WRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLR 282
G + GT Y+APEI+ + + + D +++G+ + E+L G P+
Sbjct: 155 ---------GVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGED 205
Query: 283 AEAQAHTVLEMN 294
+ +++E N
Sbjct: 206 EDELFQSIMEHN 217
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 46/136 (33%), Positives = 66/136 (48%), Gaps = 24/136 (17%)
Query: 169 AQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK 228
A++ A+ +H LG VHRD+KP NVLLD+N LADFG L+
Sbjct: 109 AEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFG-----SCLRL----------L 153
Query: 229 PTGGFHKKNMVGTLIYMAPEILK-----KEIHSEKSDVYSFGISINELLTGVVPYTDLRA 283
G VGT Y++PEIL+ K + + D +S G+ + E+L G P+ A
Sbjct: 154 ADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFY---A 210
Query: 284 EAQAHTVLE-MNYTEQ 298
E+ T + MN+ E
Sbjct: 211 ESLVETYGKIMNHKEH 226
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 2e-10
Identities = 45/172 (26%), Positives = 78/172 (45%), Gaps = 32/172 (18%)
Query: 170 QLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKP 229
Q+ A+ ++H+ ++HRD+K AN+LL N L DFG ++ +
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAA----------TVSDD 200
Query: 230 TGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHT 289
G + GT Y+APEI +++ +S+K+D++S G+ + ELLT P+ E H
Sbjct: 201 VG----RTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHK 256
Query: 290 VLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPS 341
L +G P+ S+ + + +L+ +P RPS
Sbjct: 257 TL--------------AGRYDPLPPSISPEMQEIVTALLS----SDPKRRPS 290
|
Length = 496 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 75/319 (23%), Positives = 119/319 (37%), Gaps = 70/319 (21%)
Query: 56 SQSIPLHLPPSSYTLLSP------------------------IARGAESVVYEA--TLDG 89
S ++PL LPP S + S I GA VY+ G
Sbjct: 40 SLAVPLPLPPPSSSSSSSSSSSASGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTG 99
Query: 90 RKVAVKKPILSTSEE--LDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRN 147
R A+K I E+ +E+++L ++HP + K EF + +
Sbjct: 100 RLYALKV-IYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGS 158
Query: 148 LAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFG 207
L E H+ + D +A Q+ + YLH IVHRD+KP+N+L++ +ADFG
Sbjct: 159 L-EGTHIADEQFLAD----VARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFG 213
Query: 208 LAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEK-----SDVY 262
++ ++ SS VGT+ YM+PE + +++ D++
Sbjct: 214 VSRILAQ----TMDPCNSS------------VGTIAYMSPERINTDLNHGAYDGYAGDIW 257
Query: 263 SFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPA 322
S G+SI E G P+ R A + + ++ A S R
Sbjct: 258 SLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASREFR------------ 305
Query: 323 SILSLIQRCWDGNPHNRPS 341
I C P R S
Sbjct: 306 ---HFISCCLQREPAKRWS 321
|
Length = 353 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 3e-10
Identities = 48/194 (24%), Positives = 87/194 (44%), Gaps = 35/194 (18%)
Query: 160 SVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEIS 219
+ +L Q+A+ +++L + VHRD+ NVLL + + DFGLA R+ + +
Sbjct: 235 TTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLA--RDIMHD-- 290
Query: 220 LKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPY 278
N+ S G + + +MAPE + +++ SDV+S+GI + E+ + G PY
Sbjct: 291 -SNYVSKG---------STFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPY 340
Query: 279 TDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHN 338
+ ++ + ++ Y + A + ++ +CW+ P
Sbjct: 341 PGMIVDSTFYNKIKSGYRMAKPDHA-----------------TQEVYDIMVKCWNSEPEK 383
Query: 339 RPSF---SDIALEL 349
RPSF SDI L
Sbjct: 384 RPSFLHLSDIVESL 397
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 3e-10
Identities = 36/111 (32%), Positives = 58/111 (52%), Gaps = 16/111 (14%)
Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
AA++ AL +LH G+++RD+K N+LLD LADFG+ +E + G
Sbjct: 102 AAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMC--KEGILN---------G 150
Query: 228 KPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
T F GT Y+APEIL++ + D ++ G+ + E++ G P+
Sbjct: 151 VTTTTF-----CGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-10
Identities = 43/181 (23%), Positives = 82/181 (45%), Gaps = 33/181 (18%)
Query: 170 QLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKP 229
Q+AK + YL + +VHRD+ NVL+ + DFGLA L +I + + G
Sbjct: 117 QIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLAR----LLDIDETEYHADGGK 172
Query: 230 TGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAH 288
+ +MA E + + +SDV+S+G+++ EL+T G PY + A
Sbjct: 173 V----------PIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGI----PAR 218
Query: 289 TVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALE 348
+ ++ ++L +P + +++ + ++ +CW + RP F ++ E
Sbjct: 219 EIPDLLEKGERLP--------QPPICTID------VYMIMVKCWMIDSECRPRFRELVDE 264
Query: 349 L 349
Sbjct: 265 F 265
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 3e-10
Identities = 38/111 (34%), Positives = 57/111 (51%), Gaps = 17/111 (15%)
Query: 169 AQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK 228
A+L AL++LH IV+RD+KP N+LLD L DFGL+ + NL + N
Sbjct: 103 AELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLS--KANLTDNKTTN------ 154
Query: 229 PTGGFHKKNMVGTLIYMAPEILKKEI-HSEKSDVYSFGISINELLTGVVPY 278
GT Y+APE+L E +++ D +S G+ + E+ G P+
Sbjct: 155 --------TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPF 197
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 3e-10
Identities = 54/223 (24%), Positives = 100/223 (44%), Gaps = 22/223 (9%)
Query: 94 VKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLH 153
++K + E++ + E +L + D + K + N EF ++ L
Sbjct: 34 LRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLM 93
Query: 154 VEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGL----- 208
++ + + ++ A+ A+ +H LG +HRD+KP N+LLD L+DFGL
Sbjct: 94 KKD-TLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLK 152
Query: 209 ----AEYRENLK-----EISLKNWRSSGKP-TGGFHKKNM----VGTLIYMAPEILKKEI 254
E+ NL + + +N S K T +++ + VGT Y+APE+ +
Sbjct: 153 KAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTG 212
Query: 255 HSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTE 297
+++ D +S G+ + E+L G P+ + V MN+ E
Sbjct: 213 YNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKV--MNWKE 253
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 3e-10
Identities = 59/225 (26%), Positives = 97/225 (43%), Gaps = 26/225 (11%)
Query: 64 PPSSYTLLSPIARGAESVVYEA--TLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP 121
P Y L+ + G VY+A G AVK L ++ +E+ ++ + H
Sbjct: 7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHC 66
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVD-QVLMIAAQLAKALQYLHN 180
+ + ++ E+ +L + HV P + Q+ + + + L YLH+
Sbjct: 67 NIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLAYLHS 124
Query: 181 LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHK-KNMV 239
G +HRD+K AN+LL N LADFG+A K T K K+ +
Sbjct: 125 KGKMHRDIKGANILLTDNGDVKLADFGVA-----------------AKITATIAKRKSFI 167
Query: 240 GTLIYMAPEILKKEI---HSEKSDVYSFGISINELLTGVVPYTDL 281
GT +MAPE+ E +++ D+++ GI+ EL P DL
Sbjct: 168 GTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDL 212
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 4e-10
Identities = 62/222 (27%), Positives = 91/222 (40%), Gaps = 33/222 (14%)
Query: 68 YTLLSPIARGAESVVYEA--TLDGRKVAVKKPILSTSEELDNFH----KELQLLCKLDHP 121
+ ++ I G VY+A G VA+KK + E + F +E+++L +L+H
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKK--VRLDNEKEGFPITAIREIKILRQLNHR 66
Query: 122 GLA--------KFVAAHAKPPNYMFFFEF-YESRNLAEKLHVEEWSPSVDQVLMIAAQLA 172
+ K A K F+ F Y +L L S D + QL
Sbjct: 67 NIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLL 126
Query: 173 KALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGG 232
+ L Y H +HRD+K +N+LL+ LADFGLA +P
Sbjct: 127 EGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYN----------SEESRPY-- 174
Query: 233 FHKKNMVGTLIYMAPE-ILKKEIHSEKSDVYSFGISINELLT 273
N V TL Y PE +L +E + DV+S G + EL T
Sbjct: 175 ---TNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFT 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 4e-10
Identities = 55/218 (25%), Positives = 91/218 (41%), Gaps = 21/218 (9%)
Query: 74 IARGAESVVYEA--TLDGRKVAVKK--------PILSTSEELD----NFH--KELQLLCK 117
+ G V +A TL G+ VA+KK + + + +F +EL+++ +
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 118 LDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQY 177
+ H + V + + + S +L K+ + + QV I Q+ L
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMDIMAS-DLK-KVVDRKIRLTESQVKCILLQILNGLNV 134
Query: 178 LHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKN 237
LH +HRD+ PAN+ ++ +ADFGLA + + + K
Sbjct: 135 LHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSK- 193
Query: 238 MVGTLIYMAPEIL-KKEIHSEKSDVYSFGISINELLTG 274
V TL Y APE+L E + D++S G ELLTG
Sbjct: 194 -VVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTG 230
|
Length = 335 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 5e-10
Identities = 47/159 (29%), Positives = 72/159 (45%), Gaps = 18/159 (11%)
Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLH 179
HP L A + F E+ +L +H + +S + + AA + LQYLH
Sbjct: 61 HPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEP--RAVFYAACVVLGLQYLH 118
Query: 180 NLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMV 239
IV+RD+K N+LLD +ADFGL +E + G T F
Sbjct: 119 ENKIVYRDLKLDNLLLDTEGFVKIADFGLC--KEGM---------GFGDRTSTF-----C 162
Query: 240 GTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
GT ++APE+L + ++ D + G+ I E+L G P+
Sbjct: 163 GTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPF 201
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 5e-10
Identities = 48/196 (24%), Positives = 91/196 (46%), Gaps = 32/196 (16%)
Query: 160 SVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEIS 219
+++ ++ + Q+AK +++L + +HRD+ N+LL N + DFGLA
Sbjct: 177 TLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLA---------- 226
Query: 220 LKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPY 278
R K K + L +MAPE + +++ +SDV+SFG+ + E+ + G PY
Sbjct: 227 ----RDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 282
Query: 279 TDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHN 338
++ + + L+ G R + + + P +++ CW G P
Sbjct: 283 PGVKIDEEFCRRLKE--------------GTR--MRAPDYTTPEMYQTMLD-CWHGEPSQ 325
Query: 339 RPSFSDIALELDLVLE 354
RP+FS++ L +L+
Sbjct: 326 RPTFSELVEHLGNLLQ 341
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 6e-10
Identities = 47/152 (30%), Positives = 71/152 (46%), Gaps = 20/152 (13%)
Query: 68 YTLLSPIARGAESVVYEA--TLDGRKVAVK--KPILSTSEELDNFHKELQLLCKL-DHPG 122
Y +L I G S V +A G+ A+K K + E+++N +E+Q L +L HP
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNL-REIQALRRLSPHPN 59
Query: 123 LAKFVAAH--AKPPNYMFFFEFYESRNLAE-----KLHVEEWSPSVDQVLMIAAQLAKAL 175
+ + + K FE + NL E K + E +V QL K+L
Sbjct: 60 ILRLIEVLFDRKTGRLALVFELMDM-NLYELIKGRKRPLPE-----KRVKSYMYQLLKSL 113
Query: 176 QYLHNLGIVHRDVKPANVLLDRNLCPHLADFG 207
++H GI HRD+KP N+L+ + LADFG
Sbjct: 114 DHMHRNGIFHRDIKPENILIKDD-ILKLADFG 144
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 7e-10
Identities = 69/249 (27%), Positives = 101/249 (40%), Gaps = 30/249 (12%)
Query: 68 YTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDN-----FHKELQLLCKLDHPG 122
+ +L I RGA V L IL+ E L F +E +L D+
Sbjct: 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQW 62
Query: 123 LAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLG 182
+ A N ++Y +L L E D A++ A+ +H L
Sbjct: 63 ITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH 122
Query: 183 IVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTL 242
VHRD+KP N+L+D N LADFG LK + G VGT
Sbjct: 123 YVHRDIKPDNILMDMNGHIRLADFG-----SCLKLME----------DGTVQSSVAVGTP 167
Query: 243 IYMAPEILK-----KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLE-MNYT 296
Y++PEIL+ K + + D +S G+ + E+L G P+ AE+ T + MN+
Sbjct: 168 DYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFY---AESLVETYGKIMNHK 224
Query: 297 EQ-QLTAAV 304
E+ Q A V
Sbjct: 225 ERFQFPAQV 233
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 7e-10
Identities = 49/193 (25%), Positives = 87/193 (45%), Gaps = 20/193 (10%)
Query: 89 GRKVAVK---KPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYES 145
GR A+K K ++ +E+ + E ++L HP L A F E+
Sbjct: 20 GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANG 79
Query: 146 RNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLAD 205
L L E + ++ A++ AL+YLH+ +V+RD+K N++LD++ + D
Sbjct: 80 GELFFHLSRERVF-TEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITD 138
Query: 206 FGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFG 265
FGL +E + + G K GT Y+APE+L+ + D + G
Sbjct: 139 FGLC--KEGI--------------SDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLG 182
Query: 266 ISINELLTGVVPY 278
+ + E++ G +P+
Sbjct: 183 VVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 7e-10
Identities = 36/111 (32%), Positives = 58/111 (52%), Gaps = 17/111 (15%)
Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
AA++ L+ LH IV+RD+KP N+LLD + ++D GLA + + I
Sbjct: 108 AAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTI--------- 158
Query: 228 KPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
K VGT+ YMAPE++K E ++ D ++ G + E++ G P+
Sbjct: 159 --------KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 8e-10
Identities = 60/231 (25%), Positives = 91/231 (39%), Gaps = 47/231 (20%)
Query: 67 SYTLLSPIARGAESVVYEAT--LDGRKVAVKKPILSTSEE--LDNFHKELQLLCKLDH-P 121
+Y L I G VY+A G+ VA+KK L EE +E+ LL L
Sbjct: 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESI 61
Query: 122 GLAKFVAA-HAK----PPNYMFFFEFYES----------RNLAEKLHVEEWSPSVDQVLM 166
+ + + H + P+ FE+ +S R L + M
Sbjct: 62 YIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPL-----PAKTIKSFM 116
Query: 167 IAAQLAKALQYLHNLGIVHRDVKPANVLLDRNL-CPHLADFGLAEYRENLKEISLKNWRS 225
QL K + + H G++HRD+KP N+L+D+ +AD GL R+
Sbjct: 117 Y--QLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLG--------------RA 160
Query: 226 SGKPTGGF-HKKNMVGTLIYMAPEILKKEIH-SEKSDVYSFGISINELLTG 274
P + H+ + TL Y APE+L H S D++S G E+
Sbjct: 161 FSIPVKSYTHE---IVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 9e-10
Identities = 61/216 (28%), Positives = 99/216 (45%), Gaps = 30/216 (13%)
Query: 68 YTLLSPIARGAESVVYEAT--LDGRKVAVKKPILSTSEE--LDNFHKELQLLCKLDHPGL 123
Y + I G VVY+A + +A+KK L +E +E+ LL ++ H +
Sbjct: 4 YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNI 63
Query: 124 AKFV-AAHAKPPNYMFFFEFYESRNLAEKLHVE---EWSPSVDQVLMIAAQLAKALQYLH 179
+ H++ Y+ F E +L K H++ +++ + + Q+ + + Y H
Sbjct: 64 VRLQDVVHSEKRLYLVF----EYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH 119
Query: 180 NLGIVHRDVKPANVLLDR-NLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNM 238
+ ++HRD+KP N+L+DR LADFGLA R+ G P F +
Sbjct: 120 SHRVLHRDLKPQNLLIDRRTNALKLADFGLA--------------RAFGIPVRTFTHE-- 163
Query: 239 VGTLIYMAPEILKKEIH-SEKSDVYSFGISINELLT 273
V TL Y APEIL H S D++S G E++
Sbjct: 164 VVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVN 199
|
Length = 294 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 9e-10
Identities = 56/212 (26%), Positives = 97/212 (45%), Gaps = 27/212 (12%)
Query: 87 LDGRKVAVKK-PILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYES 145
LD +++ +K+ L+ +E + L L+ D P + A P F +
Sbjct: 27 LDKKRIKMKQGETLALNERI-----MLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNG 81
Query: 146 RNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLAD 205
+L L + S ++ A ++ L+++HN +V+RD+KPAN+LLD + ++D
Sbjct: 82 GDLHYHLS-QHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISD 140
Query: 206 FGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSF 264
GLA + S K +S VGT YMAPE+L+K + +D +S
Sbjct: 141 LGLA------CDFSKKKPHAS------------VGTHGYMAPEVLQKGTAYDSSADWFSL 182
Query: 265 GISINELLTGVVPYTDLRAEAQAHTVLEMNYT 296
G + +LL G P+ + + + H + M T
Sbjct: 183 GCMLFKLLRGHSPFRQHKTKDK-HEIDRMTLT 213
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 45/158 (28%), Positives = 71/158 (44%), Gaps = 35/158 (22%)
Query: 138 FFFEFYESRNLAEKLHVEEWSPSVDQVLMIA-------------AQLAKALQYLHNLGIV 184
F+ F + R L V E+ P D V +++ A++ AL +H++G +
Sbjct: 108 LFYAFQDDRYL---YMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFI 164
Query: 185 HRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIY 244
HRDVKP N+LLD++ LADFG G VGT Y
Sbjct: 165 HRDVKPDNMLLDKSGHLKLADFGTC---------------MKMNKEGMVRCDTAVGTPDY 209
Query: 245 MAPEILKKE----IHSEKSDVYSFGISINELLTGVVPY 278
++PE+LK + + + D +S G+ + E+L G P+
Sbjct: 210 ISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 1e-09
Identities = 63/229 (27%), Positives = 99/229 (43%), Gaps = 31/229 (13%)
Query: 64 PPSSYTLLSPIARGAESVVYEATLDGRK---VAVKKPILS---TSEELDNFHKELQLLCK 117
P +T L I G+ VY A D R VA+KK S ++E+ + KE++ L +
Sbjct: 23 PEKLFTDLREIGHGSFGAVYFAR-DVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQR 81
Query: 118 LDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQY 177
+ HP ++ + + E Y + ++ L V + ++ I + L Y
Sbjct: 82 IKHPNSIEYKGCYLREHTAWLVME-YCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAY 140
Query: 178 LHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKN 237
LH+ ++HRD+K N+LL LADFG A S P F
Sbjct: 141 LHSHNMIHRDIKAGNILLTEPGQVKLADFGSA---------------SIASPANSF---- 181
Query: 238 MVGTLIYMAPEI---LKKEIHSEKSDVYSFGISINELLTGVVPYTDLRA 283
VGT +MAPE+ + + + K DV+S GI+ EL P ++ A
Sbjct: 182 -VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 229
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 57/214 (26%), Positives = 97/214 (45%), Gaps = 23/214 (10%)
Query: 67 SYTLLSPIARGAESVVYEA--TLDGRKVAVKKPILSTSEELDNFH-KELQLLCKLDHPGL 123
++ L + G + VY+ G VA+K+ L E + +E+ L+ +L H +
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 124 AKFVAAHAKPPNYMFFFEFYESRNLAEKL--HVEEWSPSVDQVLMIAAQLAKALQYLHNL 181
+ M FE+ + ++L + + H + + V QL K + + H
Sbjct: 61 VRLHDVIHTENKLMLVFEYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN 119
Query: 182 GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGT 241
++HRD+KP N+L+++ LADFGLA R+ G P F N V T
Sbjct: 120 RVLHRDLKPQNLLINKRGELKLADFGLA--------------RAFGIPVNTF--SNEVVT 163
Query: 242 LIYMAPEIL-KKEIHSEKSDVYSFGISINELLTG 274
L Y AP++L +S D++S G + E++TG
Sbjct: 164 LWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITG 197
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 1e-09
Identities = 68/271 (25%), Positives = 114/271 (42%), Gaps = 38/271 (14%)
Query: 83 YEATLDGRKVAVKKPILSTSEELD-NFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFE 141
+ G++V+V +L + F + L+ +L H L K + N M E
Sbjct: 22 LDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVRDENIMVE-E 80
Query: 142 FYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCP 201
+ + L LH E+ + S+ L +A QLA AL YL + +VH +V N+L+ R
Sbjct: 81 YVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVAR---- 136
Query: 202 HLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKS-- 259
+GL E + I L + G P ++ V + ++APE ++ S
Sbjct: 137 ----YGLNE--GYVPFIKLSD---PGIPITVLSREERVERIPWIAPECIRNGQASLTIAA 187
Query: 260 DVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLEL 318
D +SFG ++ E+ + G P + L + + + +L P+ EL
Sbjct: 188 DKWSFGTTLLEICSNGEEPLSTLSSSEK----ERFYQDQHRL----------PMPDCAEL 233
Query: 319 GLPASILSLIQRCWDGNPHNRPSFSDIALEL 349
+LI +CW +P RPSF I +L
Sbjct: 234 A------NLINQCWTYDPTKRPSFRAILRDL 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 2e-09
Identities = 63/255 (24%), Positives = 114/255 (44%), Gaps = 23/255 (9%)
Query: 68 YTLLSPIARGAESVVYEAT---LDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLA 124
Y L + + R + + AT KV K +L+ + EL L DH G+
Sbjct: 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIV 128
Query: 125 KFVAAHAKPPNYMFFFEFYESRNLAE--KLHVEEWSPSVD-QVLMIAAQLAKALQYLHNL 181
K + E+ +L + K ++E P + +V ++ Q+ AL +H+
Sbjct: 129 KHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR 188
Query: 182 GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGT 241
++HRD+K AN+ L L DFG + ++ +SL S GT
Sbjct: 189 KMMHRDLKSANIFLMPTGIIKLGDFGFS--KQYSDSVSLDVASS------------FCGT 234
Query: 242 LIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLT 301
Y+APE+ +++ +S+K+D++S G+ + ELLT P+ + +Q + ++ Y +
Sbjct: 235 PYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPF---KGPSQREIMQQVLYGKYDPF 291
Query: 302 AAVVSGGLRPILASL 316
VS G++ +L L
Sbjct: 292 PCPVSSGMKALLDPL 306
|
Length = 478 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 57/218 (26%), Positives = 95/218 (43%), Gaps = 26/218 (11%)
Query: 67 SYTLLSPIARGAESVVYEAT--LDGRKVAVKKPILSTSEE--LDNFHKELQLLCKLDHPG 122
Y L I G V++A VA+K+ L +E + +E+ LL +L H
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 60
Query: 123 LAKFVAAHAKPPNYMFFFEFYESRNLAEKLHV--EEWSPSVDQVLMIAAQLAKALQYLHN 180
+ + FE+ + ++L + + P + + M QL K L + H+
Sbjct: 61 IVRLYDVLHSDKKLTLVFEYCD-QDLKKYFDSCNGDIDPEIVKSFMF--QLLKGLAFCHS 117
Query: 181 LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
++HRD+KP N+L+++N LADFGLA R+ G P + + V
Sbjct: 118 HNVLHRDLKPQNLLINKNGELKLADFGLA--------------RAFGIPVRCYSAE--VV 161
Query: 241 TLIYMAPEIL-KKEIHSEKSDVYSFGISINELLTGVVP 277
TL Y P++L +++S D++S G EL P
Sbjct: 162 TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 59/236 (25%), Positives = 104/236 (44%), Gaps = 38/236 (16%)
Query: 64 PPSSYTLLSPIARGAESVVYEATLDGRKV-----AVKKPILSTSEELDNFHKELQLLCKL 118
P + L+ + G VY+ GR V A K + T +E + E+ +L K
Sbjct: 14 PAGIFELVEVVGNGTYGQVYK----GRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKY 69
Query: 119 DH-PGLAKFVAAHAK--PPNY----MFFFEFYESRNLAEKL-HVEEWSPSVDQVLMIAAQ 170
H +A + A K PP + EF + ++ + + + + + D + I +
Sbjct: 70 SHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICRE 129
Query: 171 LAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPT 230
+ + L +LH ++HRD+K NVLL N L DFG +S + R+ G+
Sbjct: 130 ILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFG----------VSAQLDRTVGR-- 177
Query: 231 GGFHKKNMVGTLIYMAPEILKKE-----IHSEKSDVYSFGISINELLTGVVPYTDL 281
+ +GT +MAPE++ + + +SD++S GI+ E+ G P D+
Sbjct: 178 ----RNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDM 229
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 65/234 (27%), Positives = 112/234 (47%), Gaps = 40/234 (17%)
Query: 70 LLSPIARGAESVV------YEATLDGRKVAVKKPIL-STSEELDNF-HKELQLLCKLDHP 121
LL+ I RG E ++ Y+ T G V V++ L + + E+ F EL + +HP
Sbjct: 2 LLTVIGRGFEDLMTVNLARYKPT--GEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHP 59
Query: 122 GL----AKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLM--IAAQLAKAL 175
+ A F+A N ++ + + A+ L + + ++ + I + KAL
Sbjct: 60 NIVPYRATFIA-----DNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKAL 114
Query: 176 QYLHNLGIVHRDVKPANVL--LDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGF 233
Y+H++G VHR VK +++L +D + L+ R NL I + G+
Sbjct: 115 DYIHHMGYVHRSVKASHILISVDGKVY-------LSGLRSNLSMI------NHGQRLRVV 161
Query: 234 HK--KNMVGTLIYMAPEILKKEI--HSEKSDVYSFGISINELLTGVVPYTDLRA 283
H K V L +++PE+L++ + + KSD+YS GI+ EL G VP+ D+ A
Sbjct: 162 HDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPA 215
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 46/181 (25%), Positives = 85/181 (46%), Gaps = 33/181 (18%)
Query: 170 QLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKP 229
Q+AK + YL +VHRD+ NVL+ + DFGLA+ L K + + G
Sbjct: 117 QIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAK----LLGADEKEYHAEGGK 172
Query: 230 TGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAH 288
+ +MA E + I++ +SDV+S+G+++ EL+T G PY + A ++
Sbjct: 173 V----------PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEIS 221
Query: 289 TVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALE 348
++LE Q P + +++ + ++ +CW + +RP F ++ +E
Sbjct: 222 SILEKGERLPQ-----------PPICTID------VYMIMVKCWMIDADSRPKFRELIIE 264
Query: 349 L 349
Sbjct: 265 F 265
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 49/186 (26%), Positives = 82/186 (44%), Gaps = 18/186 (9%)
Query: 94 VKKPILSTSEELDNFHKELQLLCKLD-HPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKL 152
VKK ++ E++D E + + +P L + E+ +L +
Sbjct: 28 VKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHM 87
Query: 153 HVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYR 212
+ P + AA++ AL +LH GI++RD+K NVLLD + L D+G+ +
Sbjct: 88 QRQRKLPE-EHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMC--K 144
Query: 213 ENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELL 272
E L G T F GT Y+APEIL+ E + D ++ G+ + E++
Sbjct: 145 EGLG---------PGDTTSTF-----CGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMM 190
Query: 273 TGVVPY 278
G P+
Sbjct: 191 AGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 3e-09
Identities = 46/162 (28%), Positives = 73/162 (45%), Gaps = 19/162 (11%)
Query: 111 ELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQ 170
E +LL +L HP + + Y S +L L + QV +A Q
Sbjct: 210 EARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYRS-DLYTYLGARLRPLGLAQVTAVARQ 268
Query: 171 LAKALQYLHNLGIVHRDVKPANVLLD--RNLCPHLADFGLAEYRENLKEISLKNWRSSGK 228
L A+ Y+H GI+HRD+K NVL++ ++C L DFG A + + S+
Sbjct: 269 LLSAIDYIHGEGIIHRDIKTENVLVNGPEDIC--LGDFGAACF--------ARGSWSTPF 318
Query: 229 PTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINE 270
G + GT+ APE+L + ++ D++S G+ I E
Sbjct: 319 HYG------IAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 4e-09
Identities = 57/243 (23%), Positives = 101/243 (41%), Gaps = 34/243 (13%)
Query: 108 FHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMI 167
F E ++ +DHP L + + P + L + +H + + +L
Sbjct: 56 FMDEALIMASMDHPHLVRLLGV-CLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNW 114
Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
Q+AK + YL +VHRD+ NVL+ + DFGLA L E K + + G
Sbjct: 115 CVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLAR----LLEGDEKEYNADG 170
Query: 228 KPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQ 286
+ +MA E + + +SDV+S+G++I EL+T G PY + +
Sbjct: 171 GKM----------PIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR-E 219
Query: 287 AHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIA 346
+LE Q P + +++ + ++ +CW + +RP F ++A
Sbjct: 220 IPDLLEKGERLPQ-----------PPICTID------VYMVMVKCWMIDADSRPKFKELA 262
Query: 347 LEL 349
E
Sbjct: 263 AEF 265
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 4e-09
Identities = 59/256 (23%), Positives = 104/256 (40%), Gaps = 48/256 (18%)
Query: 106 DNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKL-----HVEEWSPS 160
+ F E + +L HP + + K F + +L E L H + S
Sbjct: 53 EEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTD 112
Query: 161 VDQV----------LMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAE 210
D+ + I Q+A +++L + +VH+D+ NVL+ L ++D GL
Sbjct: 113 DDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGL-- 170
Query: 211 YRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINE 270
+RE K +S P + +M+PE + S SD++S+G+ + E
Sbjct: 171 FREVYAADYYKLMGNSLLP------------IRWMSPEAIMYGKFSIDSDIWSYGVVLWE 218
Query: 271 LLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQ 329
+ + G+ PY Y+ Q + + + R +L + PA + +L+
Sbjct: 219 VFSYGLQPYC--------------GYSNQDVIEMIRN---RQVLPCPD-DCPAWVYTLML 260
Query: 330 RCWDGNPHNRPSFSDI 345
CW+ P RP F DI
Sbjct: 261 ECWNEFPSRRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 5e-09
Identities = 47/185 (25%), Positives = 83/185 (44%), Gaps = 17/185 (9%)
Query: 94 VKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLH 153
+KK ++ +E+ + E ++L HP L + F E+ L L
Sbjct: 28 LKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLS 87
Query: 154 VEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRE 213
E S D+ A++ AL YLH+ +V+RD+K N++LD++ + DFGL +E
Sbjct: 88 -RERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLC--KE 144
Query: 214 NLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT 273
+ + G K GT Y+APE+L+ + D + G+ + E++
Sbjct: 145 GISD--------------GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC 190
Query: 274 GVVPY 278
G +P+
Sbjct: 191 GRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 5e-09
Identities = 57/240 (23%), Positives = 95/240 (39%), Gaps = 36/240 (15%)
Query: 108 FHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMI 167
F E L + DH + + + M E+ + L L E Q++ +
Sbjct: 53 FLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGM 112
Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFG-LAEYRENLKEISLKNWRSS 226
LA ++YL +G VH+ + VL++ +L ++ F L E + ++ S
Sbjct: 113 LPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTM-----S 167
Query: 227 GKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEA 285
GK +++ APE ++ S SDV+SFGI + E+++ G PY D+
Sbjct: 168 GK-----------SPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDM---- 212
Query: 286 QAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
+ Q + AV G P + P + L+ CW RP FS I
Sbjct: 213 ----------SGQDVIKAVEDGFRLPAPRN----CPNLLHQLMLDCWQKERGERPRFSQI 258
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 6e-09
Identities = 73/275 (26%), Positives = 117/275 (42%), Gaps = 47/275 (17%)
Query: 91 KVAVKKPILSTS-EELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLA 149
+V VK+ +S S +E F +E Q L H L + + + Y+ EF +L
Sbjct: 24 QVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLK 83
Query: 150 EKLH----VEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLAD 205
L E +P + +A ++A L +LH +H D+ N LL +L + D
Sbjct: 84 GYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGD 143
Query: 206 FGLA--EYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIH-------- 255
+GL+ +Y+E+ + W L ++APE++ E+H
Sbjct: 144 YGLSHNKYKEDYYVTPDQLWVP----------------LRWIAPELV-DEVHGNLLVVDQ 186
Query: 256 SEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILA 314
+++S+V+S G++I EL G PY L E VL EQQL +P
Sbjct: 187 TKESNVWSLGVTIWELFELGSQPYRHLSDE----QVLTYTVREQQLKLP------KPR-- 234
Query: 315 SLELGLPASILSLIQRCWDGNPHNRPSFSDIALEL 349
L+L L ++Q CW P RPS ++ L L
Sbjct: 235 -LKLPLSDRWYEVMQFCWL-QPEQRPSAEEVHLLL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 6e-09
Identities = 57/228 (25%), Positives = 95/228 (41%), Gaps = 44/228 (19%)
Query: 68 YTLLSPIARGAESVV----YEATLDGRKVAVKKPILSTSEE------------LDNF--H 109
Y L+ + +GA +V T + VA+KK S++ L +F H
Sbjct: 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGH 61
Query: 110 KELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVD-QVLMIA 168
K + L +D F N ++ +E +L + + + P D
Sbjct: 62 KNITCLYDMDIVFPGNF--------NELYLYEELMEADLHQIIRSGQ--PLTDAHFQSFI 111
Query: 169 AQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAE-YRENLKEISLKNWRSSG 227
Q+ L+Y+H+ ++HRD+KP N+L++ + + DFGLA + EN E +
Sbjct: 112 YQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAG------- 164
Query: 228 KPTGGFHKKNMVGTLIYMAPEI-LKKEIHSEKSDVYSFGISINELLTG 274
V T Y APEI L + +++ DV+S G + ELL
Sbjct: 165 ------FMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGR 206
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 7e-09
Identities = 58/218 (26%), Positives = 99/218 (45%), Gaps = 31/218 (14%)
Query: 68 YTLLSPIARGAESVVYEAT--LDGRKVAVKKPILSTSEE---LDNFHKELQLLCKL---D 119
Y ++ I GA VY+A G VA+K + T+E+ L +E+ LL +L D
Sbjct: 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTV-REVALLKRLEAFD 60
Query: 120 HPGLAKF--VAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPS---VDQVLMIAAQLAKA 174
HP + + V A ++ +E + + ++++ P + + + Q +
Sbjct: 61 HPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRG 120
Query: 175 LQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFH 234
L +LH IVHRD+KP N+L+ LADFGLA + + + + P
Sbjct: 121 LDFLHANCIVHRDLKPENILVTSGGQVKLADFGLAR---------IYSCQMALTP----- 166
Query: 235 KKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELL 272
+V TL Y APE+L + ++ D++S G E+
Sbjct: 167 ---VVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 8e-09
Identities = 45/141 (31%), Positives = 66/141 (46%), Gaps = 31/141 (21%)
Query: 169 AQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGL----------AEYRENLKEI 218
A+ A++ +H LG +HRD+KP N+L+DR L+DFGL A Y++ L+
Sbjct: 108 AECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGK 167
Query: 219 SLKNWRS--------------SGKPTGGFHKKN-------MVGTLIYMAPEILKKEIHSE 257
S KN S K KKN VGT Y+APEI ++ + +
Sbjct: 168 SNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQ 227
Query: 258 KSDVYSFGISINELLTGVVPY 278
+ D +S G + E L G P+
Sbjct: 228 ECDWWSLGAIMFECLIGWPPF 248
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 9e-09
Identities = 48/186 (25%), Positives = 84/186 (45%), Gaps = 18/186 (9%)
Query: 94 VKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLH 153
+KK ++ +E+ + E ++L HP L + F E+ L L
Sbjct: 28 LKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLS 87
Query: 154 VEEWSPSVDQVLMIAAQLAKALQYLHN-LGIVHRDVKPANVLLDRNLCPHLADFGLAEYR 212
E S D+ A++ AL YLH+ +V+RD+K N++LD++ + DFGL +
Sbjct: 88 RERVF-SEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLC--K 144
Query: 213 ENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELL 272
E +K+ G K GT Y+APE+L+ + D + G+ + E++
Sbjct: 145 EGIKD--------------GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM 190
Query: 273 TGVVPY 278
G +P+
Sbjct: 191 CGRLPF 196
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-08
Identities = 32/113 (28%), Positives = 55/113 (48%), Gaps = 19/113 (16%)
Query: 164 VLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDR--NLCPHLADFGLAEYRENLKEISLK 221
+L I + +A+QYLH I+HRD+K N+ ++ ++C L DFG A + ++
Sbjct: 184 ILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVC--LGDFGAACFPVDINANKYY 241
Query: 222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTG 274
W GT+ APE+L ++ + D++S GI + E+ T
Sbjct: 242 GW---------------AGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATC 279
|
Length = 391 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 58/221 (26%), Positives = 95/221 (42%), Gaps = 23/221 (10%)
Query: 67 SYTLLSPIARGAESVVYE--ATLDGRKVAVKKPILSTSEELDNFH--KELQLLCKLDHPG 122
SY L + G+ + VY+ + ++G+ VA+K I EE F +E LL L H
Sbjct: 6 SYEKLEKLGEGSYATVYKGKSKVNGKLVALKV-IRLQEEEGTPFTAIREASLLKGLKHAN 64
Query: 123 LAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLG 182
+ FE+ + +L + + + V + QL + L Y+H
Sbjct: 65 IVLLHDIIHTKETLTLVFEYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY 123
Query: 183 IVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTL 242
I+HRD+KP N+L+ LADFGLA R+ P+ + N V TL
Sbjct: 124 ILHRDLKPQNLLISDTGELKLADFGLA--------------RAKSVPSHTY--SNEVVTL 167
Query: 243 IYMAPEILKKEI-HSEKSDVYSFGISINELLTGVVPYTDLR 282
Y P++L +S D++ G E++ GV + ++
Sbjct: 168 WYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMK 208
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 41/142 (28%), Positives = 72/142 (50%), Gaps = 33/142 (23%)
Query: 169 AQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGL---------AEY-------R 212
A+L A++ +H +G +HRD+KP N+L+DR+ L DFGL ++Y R
Sbjct: 108 AELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVR 167
Query: 213 ENLKEISLKNWRSSG--------KP----TGGFHKK----NMVGTLIYMAPEILKKEIHS 256
++ + S + W KP H++ ++VGT Y+APE+L + ++
Sbjct: 168 QDSMDFSNE-WGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT 226
Query: 257 EKSDVYSFGISINELLTGVVPY 278
+ D +S G+ + E+L G P+
Sbjct: 227 QLCDWWSVGVILYEMLVGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 41/131 (31%), Positives = 63/131 (48%), Gaps = 20/131 (15%)
Query: 151 KLHVEEW-SPSVDQ--VLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFG 207
K H+ +P D+ + AA+L L+ L IV+RD+KP N+LLD ++D G
Sbjct: 88 KFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLG 147
Query: 208 LAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGIS 267
LA +I P G + VGT+ YMAPE++ E ++ D + G
Sbjct: 148 LA------VQI----------PEGE-TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCL 190
Query: 268 INELLTGVVPY 278
I E++ G P+
Sbjct: 191 IYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 3e-08
Identities = 49/203 (24%), Positives = 94/203 (46%), Gaps = 39/203 (19%)
Query: 173 KALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGG 232
+ L YLH G +HR++K +++L+ + L+ GL+ SL K
Sbjct: 112 RGLNYLHQNGYIHRNIKASHILISGDGLVSLS--GLSHLY------SLVRNGQKAKVVYD 163
Query: 233 FHKKNMVGTLIYMAPEILKKEIH--SEKSDVYSFGISINELLTGVVPYTDL--------R 282
F + + L +++PE+L+++++ + KSD+YS GI+ EL TG VP+ D+ +
Sbjct: 164 FPQFS-TSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQK 222
Query: 283 AEAQAHTVLEMNYTEQQ--------------LTAAVVSGGLRPILASLELGLPAS----- 323
+ ++ L++ + + +VV+ G+ + S L P+S
Sbjct: 223 LKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSP 282
Query: 324 -ILSLIQRCWDGNPHNRPSFSDI 345
+L++ C +P RPS S +
Sbjct: 283 AFQNLVELCLQQDPEKRPSASSL 305
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 3e-08
Identities = 49/202 (24%), Positives = 87/202 (43%), Gaps = 22/202 (10%)
Query: 76 RGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPN 135
RG S R +A K + + S E+ L +L+H + K + +
Sbjct: 180 RGVNSTNQGKPKCERLIA--KRVKAGSRAAIQLENEILALGRLNHENILK-IEEILRSEA 236
Query: 136 YMFFFEFYESRNLAEKLHVE--EW--SPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPA 191
+ +L ++ E +W P + Q I QL A++Y+H+ ++HRD+K
Sbjct: 237 NTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLE 296
Query: 192 NVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILK 251
N+ L+ + L DFG A E +E W VGT+ +PEIL
Sbjct: 297 NIFLNCDGKIVLGDFGTAMPFEKEREAFDYGW---------------VGTVATNSPEILA 341
Query: 252 KEIHSEKSDVYSFGISINELLT 273
+ + E +D++S G+ + ++L+
Sbjct: 342 GDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.1 bits (131), Expect = 3e-08
Identities = 38/157 (24%), Positives = 69/157 (43%), Gaps = 18/157 (11%)
Query: 71 LSPIARGAESVVYEATLDGRKVAVKKPILSTS---EELDN-FHK-----ELQLLCKLDHP 121
+ I RGAE+ +Y G K +K I ELD + E +++ +
Sbjct: 1 MKLIKRGAEAEIYLGDFLGIKAVIKWRI-PKRYRHPELDERIRRERTRREARIMSRARKA 59
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL 181
G+ P N++ E+ E L + ++ ++ I + K LH+
Sbjct: 60 GVNVPAVYFVDPENFIIVMEYIEGEPLKDLINSNGM-EELELSREIGRLVGK----LHSA 114
Query: 182 GIVHRDVKPANVLL-DRNLCPHLADFGLAEYRENLKE 217
GI+H D+ +N++L + L DFGLAE+ ++L++
Sbjct: 115 GIIHGDLTTSNMILSGGKIY--LIDFGLAEFSKDLED 149
|
Length = 211 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 62/231 (26%), Positives = 97/231 (41%), Gaps = 21/231 (9%)
Query: 67 SYTLLSPIARGAESVVYE--ATLDGRKVAVKKPILSTSEELD-NFHKELQLLCKLDHPGL 123
+Y L + G + VY+ + L VA+K+ L E +E+ LL L H +
Sbjct: 7 TYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 66
Query: 124 AKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGI 183
+ FE Y ++L + L S ++ V + QL + L Y H +
Sbjct: 67 VTLHDIIHTEKSLTLVFE-YLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKV 125
Query: 184 VHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLI 243
+HRD+KP N+L++ LADFGLA R+ PT + N V TL
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLA--------------RAKSIPTKTY--SNEVVTLW 169
Query: 244 YMAPEILKKEI-HSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEM 293
Y P+IL +S + D++ G E+ TG + E Q H + +
Sbjct: 170 YRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRI 220
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 3e-08
Identities = 48/164 (29%), Positives = 73/164 (44%), Gaps = 28/164 (17%)
Query: 117 KLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQ 176
KL HP + K + E+ E +NL+E L W ++ IA +AKAL+
Sbjct: 739 KLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRNLSW----ERRRKIAIGIAKALR 794
Query: 177 YLH---NLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGF 233
+LH + +V ++ P +++D PHL L L K + SS
Sbjct: 795 FLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPG----LLCTDTKCFISSA------ 843
Query: 234 HKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVP 277
Y+APE + + +EKSD+Y FG+ + ELLTG P
Sbjct: 844 ----------YVAPETRETKDITEKSDIYGFGLILIELLTGKSP 877
|
Length = 968 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 48/170 (28%), Positives = 80/170 (47%), Gaps = 22/170 (12%)
Query: 110 KELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVL-MIA 168
+ELQ+L + + P + F A E + +L + L + P +++L ++
Sbjct: 52 RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIP--EEILGKVS 109
Query: 169 AQLAKALQYLHNL-GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
+ + L YL I+HRDVKP+N+L++ L DFG+ SG
Sbjct: 110 IAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGV-----------------SG 152
Query: 228 KPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVP 277
+ + VGT YM+PE L+ +S +SD++S G+S+ EL G P
Sbjct: 153 QLIDSM-ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 5e-08
Identities = 59/219 (26%), Positives = 97/219 (44%), Gaps = 32/219 (14%)
Query: 68 YTLLSPIARGAESVVYEA---TLDGRKVAVKKPILSTSEE---LDNFHKELQLLCKLD-- 119
Y ++ I GA V++A GR VA+K+ + T EE L +E+ +L L+
Sbjct: 3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTI-REVAVLRHLETF 61
Query: 120 -HPGLAKF-----VAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAK 173
HP + + V+ + FE + V E + + + QL +
Sbjct: 62 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLR 121
Query: 174 ALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGF 233
L +LH+ +VHRD+KP N+L+ + LADFGLA + S + +S
Sbjct: 122 GLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA------RIYSFQMALTS------- 168
Query: 234 HKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELL 272
+V TL Y APE+L + ++ D++S G E+
Sbjct: 169 ----VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 5e-08
Identities = 60/216 (27%), Positives = 95/216 (43%), Gaps = 27/216 (12%)
Query: 66 SSYTLLSPIARGAESVVYE--ATLDGRKVAVKKPILSTSEELD-NFHKELQLLCKLDHPG 122
+SY L + G+ + VY+ + ++G+ VA+K + T E + +E LL L H
Sbjct: 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKH-- 62
Query: 123 LAKFVAAH---AKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLH 179
A V H F FE+ + +LA+ + V + QL + L Y+H
Sbjct: 63 -ANIVLLHDIIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIH 120
Query: 180 NLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMV 239
I+HRD+KP N+L+ LADFGLA R+ P+ + + V
Sbjct: 121 GQHILHRDLKPQNLLISYLGELKLADFGLA--------------RAKSIPSQTYSSE--V 164
Query: 240 GTLIYMAPEILKKEI-HSEKSDVYSFGISINELLTG 274
TL Y P++L +S D++ G E+L G
Sbjct: 165 VTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 5e-08
Identities = 52/171 (30%), Positives = 76/171 (44%), Gaps = 25/171 (14%)
Query: 135 NYMFF-FEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANV 193
NY++ ++Y +L L E D A++ A+ +H L VHRD+KP NV
Sbjct: 74 NYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNV 133
Query: 194 LLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKE 253
LLD N LADFG LK G VGT Y++PEIL+
Sbjct: 134 LLDMNGHIRLADFG-----SCLKMNQ----------DGTVQSSVAVGTPDYISPEILQAM 178
Query: 254 -----IHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLE-MNYTEQ 298
+ + D +S G+ + E+L G P+ AE+ T + MN+ E+
Sbjct: 179 EDGMGKYGPECDWWSLGVCMYEMLYGETPFY---AESLVETYGKIMNHEER 226
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 5e-08
Identities = 49/170 (28%), Positives = 79/170 (46%), Gaps = 22/170 (12%)
Query: 110 KELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVL-MIA 168
+ELQ+L + + P + F A E + +L + L P +Q+L ++
Sbjct: 52 RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIP--EQILGKVS 109
Query: 169 AQLAKALQYLHNL-GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
+ K L YL I+HRDVKP+N+L++ L DFG+ SG
Sbjct: 110 IAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGV-----------------SG 152
Query: 228 KPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVP 277
+ + VGT YM+PE L+ +S +SD++S G+S+ E+ G P
Sbjct: 153 QLIDSM-ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 8e-08
Identities = 48/203 (23%), Positives = 97/203 (47%), Gaps = 41/203 (20%)
Query: 153 HVEEWSPSVDQVLMI--AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAE 210
HV + S+D ++ Q+AK + YL +VHR++ N+LL + +ADFG+A+
Sbjct: 98 HVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVAD 157
Query: 211 --YRENLKEISLKNWRSSGKPTGGFHKKNMVGTLI-YMAPEILKKEIHSEKSDVYSFGIS 267
Y ++ K + T I +MA E + ++ +SDV+S+G++
Sbjct: 158 LLYPDDKKYFY-----------------SEHKTPIKWMALESILFGRYTHQSDVWSYGVT 200
Query: 268 INELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILS 326
+ E+++ G PY +R H V ++ ++L +P + +++ +
Sbjct: 201 VWEMMSYGAEPYAGMR----PHEVPDLLEKGERLA--------QPQICTID------VYM 242
Query: 327 LIQRCWDGNPHNRPSFSDIALEL 349
++ +CW + + RP+F ++A E
Sbjct: 243 VMVKCWMIDENVRPTFKELANEF 265
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 9e-08
Identities = 54/222 (24%), Positives = 98/222 (44%), Gaps = 39/222 (17%)
Query: 91 KVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAE 150
K KK +L+ ++ + + E +L + D+ + K + N F ++ ++
Sbjct: 32 KTLRKKDVLNRNQ-VAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMS 90
Query: 151 KLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGL-- 208
L E P V IA +L A++ +H +G +HRD+KP N+L+D + L DFGL
Sbjct: 91 LLIRMEVFPEVLARFYIA-ELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCT 149
Query: 209 --------------AEYRENLKEIS--------------LKNWRSSGKPTGGFHKK---- 236
+ R++ E S LK H++
Sbjct: 150 GFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQ---HQRCLAH 206
Query: 237 NMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
++VGT Y+APE+L ++ +++ D +S G+ + E+L G P+
Sbjct: 207 SLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Score = 52.2 bits (126), Expect = 1e-07
Identities = 43/150 (28%), Positives = 66/150 (44%), Gaps = 23/150 (15%)
Query: 74 IARGAESVVYEATLDGRKVAVKKPILSTS---EELDN------FHKELQLLCKLDHPGLA 124
IA+GAE+++Y G K +K+ + S ELD E +LL + G+
Sbjct: 2 IAKGAEAIIYLGDFLGLKAVIKERV-PKSYRHPELDERIRRERTRNEARLLSRARKAGVN 60
Query: 125 KFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVL-MIAAQLAKALQYLHNLGI 183
V P N E+ E + L + + D++L I + K LH GI
Sbjct: 61 TPVVYDVDPDNKTIVMEYIEGKPLKDVI-----EEGNDELLREIGRLVGK----LHKAGI 111
Query: 184 VHRDVKPANVLL-DRNLCPHLADFGLAEYR 212
VH D+ +N+++ D L L DFGL +Y
Sbjct: 112 VHGDLTTSNIIVRDDKLY--LIDFGLGKYS 139
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 58/212 (27%), Positives = 90/212 (42%), Gaps = 21/212 (9%)
Query: 67 SYTLLSPIARGAESVVYE--ATLDGRKVAVKKPILSTSEELD-NFHKELQLLCKLDHPGL 123
+Y L + G + V++ + L VA+K+ L E +E+ LL L H +
Sbjct: 6 TYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANI 65
Query: 124 AKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGI 183
FE+ +S +L + L S+ V + QL + L Y H I
Sbjct: 66 VTLHDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKI 124
Query: 184 VHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLI 243
+HRD+KP N+L++ LADFGLA R+ PT + N V TL
Sbjct: 125 LHRDLKPQNLLINEKGELKLADFGLA--------------RAKSVPTKTY--SNEVVTLW 168
Query: 244 YMAPEILKKEI-HSEKSDVYSFGISINELLTG 274
Y P++L +S D++ G + E+ TG
Sbjct: 169 YRPPDVLLGSTEYSTPIDMWGVGCILYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-07
Identities = 62/234 (26%), Positives = 96/234 (41%), Gaps = 53/234 (22%)
Query: 64 PPSSYTLLSPIARGAESVVYEAT-LD-GRKVAVKKPILSTSEELDNFHKELQLLCKLDHP 121
P SY L + I G+ VVYEA +D KVA+KK + + ++EL ++ L+H
Sbjct: 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYK----NRELLIMKNLNHI 119
Query: 122 GLAKF-------------------VAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVD 162
+ V P + + Y N A L +
Sbjct: 120 NIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFL-------- 171
Query: 163 QVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLD-RNLCPHLADFGLAEYRENLKEISLK 221
V + + QL +AL Y+H+ I HRD+KP N+L+D L DFG A +NL
Sbjct: 172 -VKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSA---KNL------ 221
Query: 222 NWRSSGKPTGGFHKKNMVGTLIYMAPEI-LKKEIHSEKSDVYSFGISINELLTG 274
G + + + Y APE+ L ++ D++S G I E++ G
Sbjct: 222 --------LAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 6e-07
Identities = 60/221 (27%), Positives = 91/221 (41%), Gaps = 35/221 (15%)
Query: 66 SSYTLLSPIARGAESVVYEA--TLDGRKVAVKKPILSTSEELDNFH--KELQLLCKLDHP 121
+Y L + G+ + VY+ L G+ VA+K+ I EE F +E LL L H
Sbjct: 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKE-IRLEHEEGAPFTAIREASLLKDLKH- 62
Query: 122 GLAKFVAAH---AKPPNYMFFFEFYESRNLAEKLHVEEWSPSV---DQVLMIAAQLAKAL 175
A V H FE+ + +L + + + V + QL + L
Sbjct: 63 --ANIVTLHDIIHTKKTLTLVFEYLD-TDLKQYM---DDCGGGLSMHNVRLFLFQLLRGL 116
Query: 176 QYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHK 235
Y H ++HRD+KP N+L+ LADFGLA R+ P+ +
Sbjct: 117 AYCHQRRVLHRDLKPQNLLISERGELKLADFGLA--------------RAKSVPSKTY-- 160
Query: 236 KNMVGTLIYMAPEILKKEI-HSEKSDVYSFGISINELLTGV 275
N V TL Y P++L +S D++ G E+ TG
Sbjct: 161 SNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 8e-07
Identities = 41/146 (28%), Positives = 58/146 (39%), Gaps = 24/146 (16%)
Query: 148 LAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFG 207
+++ L++ E + V AA++ AL LH GIV RD+ P N+LLD L F
Sbjct: 76 ISKFLNIPE-----ECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFS 130
Query: 208 LAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGIS 267
W G +NM Y APE+ +E D +S G
Sbjct: 131 --------------RWSEVEDSCDGEAVENM-----YCAPEVGGISEETEACDWWSLGAI 171
Query: 268 INELLTGVVPYTDLRAEAQAHTVLEM 293
+ ELLTG + HT L +
Sbjct: 172 LFELLTGKTLVECHPSGINTHTTLNI 197
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Score = 51.8 bits (125), Expect = 8e-07
Identities = 36/146 (24%), Positives = 61/146 (41%), Gaps = 18/146 (12%)
Query: 74 IARGAESVVYEATLDGRKVAVKKPILST--SEELDN------FHKELQLLCKLDHPGLAK 125
I +GAE+ + + GR +K+ + ELD E +LL + G+
Sbjct: 341 IGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPT 400
Query: 126 FVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVH 185
V P E+ ++L + L + + V + +AK LH GIVH
Sbjct: 401 PVIYDVDPEEKTIVMEYIGGKDLKDVLE-----GNPELVRKVGEIVAK----LHKAGIVH 451
Query: 186 RDVKPANVLLDRNLCPHLADFGLAEY 211
D+ +N ++ + +L DFGL +Y
Sbjct: 452 GDLTTSNFIVRDDRL-YLIDFGLGKY 476
|
Length = 535 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 2e-06
Identities = 59/277 (21%), Positives = 117/277 (42%), Gaps = 39/277 (14%)
Query: 80 SVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFF 139
S +Y T R V + ++S+E + F ++ L HP + + + + Y+
Sbjct: 14 SEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLV 73
Query: 140 FEFYESRNLAEKLHVEEWSPSVDQVLMI---AAQLAKALQYLHNLGIVHRDVKPANVLLD 196
FE+ E +L L E+W Q+L++ A ++A + ++H +H D+ N L
Sbjct: 74 FEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLT 133
Query: 197 RNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILK----K 252
+L + D+G+ R I ++ + L ++APE++
Sbjct: 134 SDLTVKVGDYGIGPSRYKEDYIETED--------------DKCVPLRWLAPELVGEFHGG 179
Query: 253 EIHSEK---SDVYSFGISINELLTGVV-PYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGG 308
I +E+ S+V++ G+++ EL PY+ L + V++ +QQ+
Sbjct: 180 LITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIK----DQQVKL------ 229
Query: 309 LRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
+P LEL ++Q CW +P R + ++
Sbjct: 230 FKP---QLELPYSERWYEVLQFCWL-SPEKRATAEEV 262
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 2e-06
Identities = 24/64 (37%), Positives = 35/64 (54%), Gaps = 2/64 (3%)
Query: 169 AQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAE--YRENLKEISLKNWRSS 226
+++A AL YLH GI+HRD+KP N+L+ L DFGL++ L + + S
Sbjct: 111 SEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRELNMMDILTTPSM 170
Query: 227 GKPT 230
KP
Sbjct: 171 AKPK 174
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 40/148 (27%), Positives = 66/148 (44%), Gaps = 17/148 (11%)
Query: 160 SVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEIS 219
S+ V + Q+ + L Y H ++HRD+KP N+L++ LADFGLA
Sbjct: 102 SMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLA---------- 151
Query: 220 LKNWRSSGKPTGGFHKKNMVGTLIYMAPEI-LKKEIHSEKSDVYSFGISINELLTGVVPY 278
R+ PT + N V TL Y P++ L +S + D++ G E+ +G +
Sbjct: 152 ----RAKSVPTKTY--SNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLF 205
Query: 279 TDLRAEAQAHTVLEMNYTEQQLTAAVVS 306
E + H + + T + T +S
Sbjct: 206 PGSTVEDELHLIFRLLGTPTEETWPGIS 233
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 48.4 bits (116), Expect = 2e-06
Identities = 39/153 (25%), Positives = 62/153 (40%), Gaps = 21/153 (13%)
Query: 71 LSPIARGAESVVYEATLDGRKVAVKK--PILSTSEELDNFHK--------ELQLLCKLDH 120
+ I +GAE+++Y G VK+ P ELD K E ++L K
Sbjct: 1 MDLIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELD--EKLRRERTRREARILAKARE 58
Query: 121 PGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHN 180
G+ + P N + E+ E L + L D + + + K LH
Sbjct: 59 AGVPVPIVYDVDPDNGLIVMEYIEGELLKDAL----EEARPDLLREVGRLVGK----LHK 110
Query: 181 LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRE 213
GIVH D+ +N++L + DFGL E+ +
Sbjct: 111 AGIVHGDLTTSNIIL-SGGRIYFIDFGLGEFSD 142
|
Length = 204 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.5 bits (120), Expect = 3e-06
Identities = 50/204 (24%), Positives = 86/204 (42%), Gaps = 58/204 (28%)
Query: 111 ELQLLCKLDHPGLAKFVAAHAKPPNYMFF--FEFYESRNLAEKLH--------VEEWSPS 160
E+ ++ +L H + +++ N + EF ++ +L+ + +EE +
Sbjct: 62 EVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHA-- 119
Query: 161 VDQVLMIAAQLAKALQYLHNLG-------IVHRDVKPANVLLDRNL-------------- 199
++ I QL AL Y HNL ++HRD+KP N+ L +
Sbjct: 120 ---IVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLN 176
Query: 200 ---CPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHS 256
+ DFGL+ K I +++ S VGT Y +PE+L E S
Sbjct: 177 GRPIAKIGDFGLS------KNIGIESMAHS-----------CVGTPYYWSPELLLHETKS 219
Query: 257 --EKSDVYSFGISINELLTGVVPY 278
+KSD+++ G I EL +G P+
Sbjct: 220 YDDKSDMWALGCIIYELCSGKTPF 243
|
Length = 1021 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 4e-06
Identities = 22/109 (20%), Positives = 47/109 (43%), Gaps = 19/109 (17%)
Query: 239 VGTLIYMAPEILKK--EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYT 296
V ++Y + ++L ++ K D+YS G+ + E+ TG +P+ +L + ++ N +
Sbjct: 181 VNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNS 240
Query: 297 EQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
+ L L P I +++ C + RP+ +I
Sbjct: 241 LK-----------------LPLDCPLEIKCIVEACTSHDSIKRPNIKEI 272
|
Length = 283 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 5e-06
Identities = 36/148 (24%), Positives = 58/148 (39%), Gaps = 19/148 (12%)
Query: 71 LSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKE---LQLLCKLDHPGLAKFV 127
+ + G + VY +K I + E+ + +E LQLL + V
Sbjct: 3 IKLLKGGLTNRVYLLGTKDEDYVLK--INPSREKGADREREVAILQLLAR--KGLPVPKV 58
Query: 128 AAHAKPPNYMF-FFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL---GI 183
A + + + E+ E L E S ++ IA QLA+ L LH L +
Sbjct: 59 LASGESDGWSYLLMEWIEGETLDE--------VSEEEKEDIAEQLAELLAKLHQLPLLVL 110
Query: 184 VHRDVKPANVLLDRNLCPHLADFGLAEY 211
H D+ P N+L+D + D+ A Y
Sbjct: 111 CHGDLHPGNILVDDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 3e-05
Identities = 50/181 (27%), Positives = 78/181 (43%), Gaps = 33/181 (18%)
Query: 110 KELQLLCKLDHP---GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLM 166
+E+ LL +L HP L K +HA ++ F Y +L + S + + +
Sbjct: 47 REIALLRELKHPNVISLQKVFLSHADRKVWLLFD--YAEHDLWHIIKFHRASKANKKPVQ 104
Query: 167 IAAQLAKAL--------QYLHNLGIVHRDVKPANVLL-----DRNLCPHLADFGLAEYRE 213
+ + K+L YLH ++HRD+KPAN+L+ +R +AD G A
Sbjct: 105 LPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRV-KIADMGFARL-- 161
Query: 214 NLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKS-DVYSFGISINELL 272
+ S KP +V T Y APE+L H K+ D+++ G ELL
Sbjct: 162 ---------FNSPLKPLADLDP--VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 210
Query: 273 T 273
T
Sbjct: 211 T 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 3e-05
Identities = 49/181 (27%), Positives = 78/181 (43%), Gaps = 33/181 (18%)
Query: 110 KELQLLCKLDHP---GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLM 166
+E+ LL +L HP L K +H+ ++ F Y +L + S + + +
Sbjct: 47 REIALLRELKHPNVIALQKVFLSHSDRKVWLLFD--YAEHDLWHIIKFHRASKANKKPMQ 104
Query: 167 IAAQLAKAL--------QYLHNLGIVHRDVKPANVLL-----DRNLCPHLADFGLAEYRE 213
+ + K+L YLH ++HRD+KPAN+L+ +R +AD G A
Sbjct: 105 LPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRV-KIADMGFARL-- 161
Query: 214 NLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKS-DVYSFGISINELL 272
+ S KP +V T Y APE+L H K+ D+++ G ELL
Sbjct: 162 ---------FNSPLKPLADLDP--VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 210
Query: 273 T 273
T
Sbjct: 211 T 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|214624 smart00331, PP2C_SIG, Sigma factor PP2C-like phosphatases | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 3e-05
Identities = 39/216 (18%), Positives = 58/216 (26%), Gaps = 61/216 (28%)
Query: 462 FGIFDGH-RGSAAAEFSARALPGFLQNLGSTTRPTDALLEAFIRTDVAFRNELDSLRKSK 520
I D +G AAA + A L + L R + A +
Sbjct: 33 IAIADVMGKGLAAALAMSMARSALRTLLSEGISLSQIL----ERLNRAIYENGEDGM--- 85
Query: 521 RVVQKDWHPGCTAIAALI--VRNRLFVANAGDCRAILCRGGHPFALSRDHVASCLEERER 578
T AL L ANAG L R
Sbjct: 86 ---------FATLFLALYDFAGGTLSYANAGHSPPYLLRAD------------------- 117
Query: 579 VVSAGGNVNWQVDTWRVGPPALQVTRSIGDDDLKPAVTAEPEITETIMTPEDEYLVMASD 638
GG V D G P L E ++ E + P D L++ +D
Sbjct: 118 ----GGLVEDLDDL---GAP------------LGLEPDVEVDVRELTLEPGD-LLLLYTD 157
Query: 639 GLWDVVSHVEAVGIIKDTVKEPGMCSKRLATEAAER 674
GL + + ++++ + G +A E
Sbjct: 158 GLTEARNPERLEELLEELL---GSPPAEIAQRILEE 190
|
Length = 193 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 4e-05
Identities = 61/254 (24%), Positives = 94/254 (37%), Gaps = 55/254 (21%)
Query: 108 FHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNL-----AEKLHVE-EWSPSV 161
F + L+ ++ H LA + + EF E L EK V W
Sbjct: 63 FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWK--- 119
Query: 162 DQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLK 221
+ +A QLA AL YL + +VH +V N+LL R GLAE ++S
Sbjct: 120 ---ITVAQQLASALSYLEDKNLVHGNVCAKNILLARL--------GLAEGTSPFIKLS-- 166
Query: 222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIH-SEKSDVYSFGISINEL-LTGVVPYT 279
G ++ V + ++APE + S +D +SFG ++ E+ G VP
Sbjct: 167 ---DPGVSFTALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPL- 222
Query: 280 DLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLP----ASILSLIQRCWDGN 335
+ T E ++ + LP + +LI +C
Sbjct: 223 ------KERTPSEKERFYEK-----------------KHRLPEPSCKELATLISQCLTYE 259
Query: 336 PHNRPSFSDIALEL 349
P RPSF I +L
Sbjct: 260 PTQRPSFRTILRDL 273
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 3e-04
Identities = 16/45 (35%), Positives = 28/45 (62%)
Query: 167 IAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEY 211
I + L+Y+H GI H D+KP N+++D N ++ D+G+A +
Sbjct: 131 IMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIASH 175
|
Length = 294 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 4e-04
Identities = 16/30 (53%), Positives = 20/30 (66%)
Query: 167 IAAQLAKALQYLHNLGIVHRDVKPANVLLD 196
I Q+ AL LH+ GIVHRDVKP N++
Sbjct: 260 IMRQILFALDGLHSTGIVHRDVKPQNIIFS 289
|
Length = 566 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 5e-04
Identities = 34/137 (24%), Positives = 59/137 (43%), Gaps = 29/137 (21%)
Query: 147 NLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADF 206
+LA+ L V + +++ + Q AL+ LH R K N+LL + L
Sbjct: 2 SLADILEVRGRPLNEEEIWAVCLQCLGALRELH------RQAKSGNILLTWDG--LLKLD 53
Query: 207 GLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGI 266
G ++ +P F MAPE+++ + ++EK+D+YS GI
Sbjct: 54 GSVAFKT----------PEQSRPDPYF-----------MAPEVIQGQSYTEKADIYSLGI 92
Query: 267 SINELLTGVVPYTDLRA 283
++ E L +PY + R
Sbjct: 93 TLYEALDYELPYNEERE 109
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.002
Identities = 49/188 (26%), Positives = 79/188 (42%), Gaps = 34/188 (18%)
Query: 165 LMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWR 224
L +A QLA AL +L + G+ H +V NVLL R N I L +
Sbjct: 103 LEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIRE---------EDRKTGNPPFIKLSD-- 151
Query: 225 SSGKPTGGFHKKNMVGTLIYMAPEILKKEIH-SEKSDVYSFGISINELLTGV-VPYTDLR 282
G K+ ++ + ++ PE ++ + S +D +SFG ++ E+ +G P + L
Sbjct: 152 -PGISITVLPKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALD 210
Query: 283 AEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSF 342
++ + L+ QL A P L +LI +C D P RPSF
Sbjct: 211 SQKK----LQFYEDRHQLPA--------PKWTELA--------NLINQCMDYEPDFRPSF 250
Query: 343 SDIALELD 350
I +L+
Sbjct: 251 RAIIRDLN 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.003
Identities = 18/40 (45%), Positives = 26/40 (65%)
Query: 170 QLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLA 209
Q+ L+ LH +GIVHRD+KP N+L+ + + DFG A
Sbjct: 317 QVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAA 356
|
Length = 507 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 697 | |||
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| PLN03145 | 365 | Protein phosphatase 2c; Provisional | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0697 | 379 | consensus Protein phosphatase 1B (formerly 2C) [Si | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0698 | 330 | consensus Serine/threonine protein phosphatase [Si | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| COG0631 | 262 | PTC1 Serine/threonine protein phosphatase [Signal | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PTZ00224 | 381 | protein phosphatase 2C; Provisional | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| PRK14559 | 645 | putative protein serine/threonine phosphatase; Pro | 100.0 | |
| PF00481 | 254 | PP2C: Protein phosphatase 2C; InterPro: IPR001932 | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0699 | 542 | consensus Serine/threonine protein phosphatase [Si | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd00143 | 254 | PP2Cc Serine/threonine phosphatases, family 2C, ca | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0700 | 390 | consensus Protein phosphatase 2C/pyruvate dehydrog | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| smart00332 | 255 | PP2Cc Serine/threonine phosphatases, family 2C, ca | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.98 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.98 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.98 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.97 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.97 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.96 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.96 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.95 | |
| KOG1323 | 493 | consensus Serine/threonine phosphatase [Signal tra | 99.94 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.94 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.92 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.91 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.9 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.89 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.88 | |
| KOG1379 | 330 | consensus Serine/threonine protein phosphatase [Si | 99.88 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.87 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.86 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.85 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.85 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.84 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.84 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.84 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.82 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.81 | |
| PF13672 | 212 | PP2C_2: Protein phosphatase 2C; PDB: 2JFT_A 2JFS_A | 99.81 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.8 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.79 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.75 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.75 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.74 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.74 | |
| smart00331 | 193 | PP2C_SIG Sigma factor PP2C-like phosphatases. | 99.74 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.72 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.71 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.7 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.67 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.62 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.62 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.6 | |
| TIGR02865 | 764 | spore_II_E stage II sporulation protein E. Stage I | 99.58 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.41 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.41 | |
| PF07228 | 193 | SpoIIE: Stage II sporulation protein E (SpoIIE); I | 99.38 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.38 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.34 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.31 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.31 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.26 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.26 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.26 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.25 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.14 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.06 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.02 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.96 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.94 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.86 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.84 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.72 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.67 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.67 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.54 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.39 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.34 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.33 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.29 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.27 | |
| COG2208 | 367 | RsbU Serine phosphatase RsbU, regulator of sigma s | 98.21 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.21 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.18 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.13 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.91 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.86 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.82 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.69 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.68 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.51 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.46 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.45 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.34 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.28 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.19 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.12 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.11 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.95 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.9 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.87 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.43 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.41 |
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-52 Score=412.40 Aligned_cols=258 Identities=27% Similarity=0.384 Sum_probs=219.4
Q ss_pred CCCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCChH-------HHHHHHHHHHHHHhcCCCCceEEeeccccC
Q 005427 63 LPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSE-------ELDNFHKELQLLCKLDHPGLAKFVAAHAKP 133 (697)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~hpniv~l~~~~~~~ 133 (697)
.-.+.|.+.+.||.|+||.|-+|.. +++.||||++...... ......+|+++|++|+|||||+++++|..+
T Consensus 169 s~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ 248 (475)
T KOG0615|consen 169 SFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVP 248 (475)
T ss_pred hhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecC
Confidence 3456799999999999999999975 7899999986543211 123467999999999999999999999999
Q ss_pred CceEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCC---CCCeeeeeccch
Q 005427 134 PNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRN---LCPHLADFGLAE 210 (697)
Q Consensus 134 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~---~~~kL~Dfg~a~ 210 (697)
..+||||||+.||+|.+++-..+ .+.++..+.+++|++.|+.|||++||+||||||+|||++.+ ..+||+|||+|+
T Consensus 249 ds~YmVlE~v~GGeLfd~vv~nk-~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK 327 (475)
T KOG0615|consen 249 DSSYMVLEYVEGGELFDKVVANK-YLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAK 327 (475)
T ss_pred CceEEEEEEecCccHHHHHHhcc-ccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhh
Confidence 99999999999999999987665 68888999999999999999999999999999999999765 789999999998
Q ss_pred hhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccC---CCchhhHHHHHHHHHHHHhCCCCCCCchhHH-H
Q 005427 211 YRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEI---HSEKSDVYSFGISINELLTGVVPYTDLRAEA-Q 286 (697)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~-~ 286 (697)
.... +....+.||||.|.|||++.+.. +..++|||||||+||-+++|.+||++..... .
T Consensus 328 ~~g~-----------------~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl 390 (475)
T KOG0615|consen 328 VSGE-----------------GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSL 390 (475)
T ss_pred cccc-----------------ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccH
Confidence 7653 22467899999999999997644 3458899999999999999999999865544 4
Q ss_pred HHHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 005427 287 AHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL 353 (697)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~ 353 (697)
..++..+.+. +.+..+..++.+..+||.+||..||++|||+.|+++|+|+..
T Consensus 391 ~eQI~~G~y~---------------f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~ 442 (475)
T KOG0615|consen 391 KEQILKGRYA---------------FGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKD 442 (475)
T ss_pred HHHHhcCccc---------------ccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhc
Confidence 5555544443 233455679999999999999999999999999999999963
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-51 Score=400.75 Aligned_cols=292 Identities=25% Similarity=0.379 Sum_probs=242.9
Q ss_pred CCCCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCC---ChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCce
Q 005427 62 HLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNY 136 (697)
Q Consensus 62 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 136 (697)
...+++|+++++||+|+||.||+++. +++.+|+|++... ...+.+..++|..+|..++||+||+++..|+++.++
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kL 100 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKL 100 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeE
Confidence 35568999999999999999999976 6889999975433 335677899999999999999999999999999999
Q ss_pred EEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhh
Q 005427 137 MFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLK 216 (697)
Q Consensus 137 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~ 216 (697)
|||+||+.||.|...|.+++ .|+++.++.++.+|+.||.|||+.||+||||||+|||+|.+|+++|+|||+++....
T Consensus 101 ylVld~~~GGeLf~hL~~eg-~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~-- 177 (357)
T KOG0598|consen 101 YLVLDYLNGGELFYHLQREG-RFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK-- 177 (357)
T ss_pred EEEEeccCCccHHHHHHhcC-CcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhccc--
Confidence 99999999999999998666 899999999999999999999999999999999999999999999999999975432
Q ss_pred hhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhcccc
Q 005427 217 EISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYT 296 (697)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~ 296 (697)
.+..+.++|||+.|||||++.+.+|+.++|+||||+++|||++|.+||.+.+.......+....
T Consensus 178 --------------~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k-- 241 (357)
T KOG0598|consen 178 --------------DGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGK-- 241 (357)
T ss_pred --------------CCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCc--
Confidence 1224567899999999999999999999999999999999999999999988777766665433
Q ss_pred HHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCC----HHHHHHHHHHHHHHhcccccccccCCccccc
Q 005427 297 EQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPS----FSDIALELDLVLEHRKSLKEEDLCAGKSYVT 372 (697)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt----~~ell~~l~~~~~~~~~~~~~~~~~~~~~~~ 372 (697)
+...+..++.+.+++++++|+.||++|.. +.+|
T Consensus 242 ----------------~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~i--------------------------- 278 (357)
T KOG0598|consen 242 ----------------LPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEI--------------------------- 278 (357)
T ss_pred ----------------CCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHh---------------------------
Confidence 12234458999999999999999999974 3333
Q ss_pred ccccccccCCCCccccccccccccccccccccccccchhhHHHHhhcccccccCcccceE
Q 005427 373 YDDKLINSGNNMHTYHESINWTAQGEHSSKKASHAAESDVKLWLESANDALTYYPVLSWG 432 (697)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 432 (697)
..|.+...++|. ++......+|+.+.....++..++-..+...
T Consensus 279 ----------k~HpfF~~inW~-------~l~~k~l~PpF~P~~~~~~~~~~Fd~eft~~ 321 (357)
T KOG0598|consen 279 ----------KRHPFFKGINWE-------KLLAKKLSPPFKPNVTGLEDTSNFDNEFTSY 321 (357)
T ss_pred ----------hcCcccccCCHH-------HHHhcCCCCCeecCCCCccccccccHHHHhc
Confidence 345566777777 4444445667777777666666665554433
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-50 Score=416.29 Aligned_cols=250 Identities=28% Similarity=0.418 Sum_probs=227.4
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccC---CChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEE
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPIL---STSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFF 140 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 140 (697)
.+|...+.||+|||+.||++++ +|+.||+|++.. .+....+.+.+|++|.+.|+|||||+++++|++..+.|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 6799999999999999999987 799999998653 34556788999999999999999999999999999999999
Q ss_pred eecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhc
Q 005427 141 EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL 220 (697)
Q Consensus 141 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~ 220 (697)
|+|..++|..+++ ....++|.+++.+++||+.||.|||+++|+|||||..|++++++.+|||+|||||..++...
T Consensus 98 ELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~---- 172 (592)
T KOG0575|consen 98 ELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG---- 172 (592)
T ss_pred EecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcc----
Confidence 9999999999988 44589999999999999999999999999999999999999999999999999998876422
Q ss_pred ccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHH
Q 005427 221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQL 300 (697)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 300 (697)
....+.||||.|.|||++.+..++..+||||+||+||-||+|++||...+..+....|....+.
T Consensus 173 ------------Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~---- 236 (592)
T KOG0575|consen 173 ------------ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYS---- 236 (592)
T ss_pred ------------cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcc----
Confidence 2367899999999999999999999999999999999999999999998888777777665553
Q ss_pred HHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 005427 301 TAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL 351 (697)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~ 351 (697)
.|..++.++.+||.++|+.||.+|||+++|+.|.++
T Consensus 237 ---------------~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff 272 (592)
T KOG0575|consen 237 ---------------MPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFF 272 (592)
T ss_pred ---------------cccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhh
Confidence 245789999999999999999999999999998877
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-50 Score=390.86 Aligned_cols=260 Identities=26% Similarity=0.370 Sum_probs=222.3
Q ss_pred CCCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCCh-HHHHHHHHHHHHHHhcCCCCceEEeeccccCCc-eEE
Q 005427 63 LPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTS-EELDNFHKELQLLCKLDHPGLAKFVAAHAKPPN-YMF 138 (697)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~-~~l 138 (697)
+..++.+.++.||+|..|+||++++ +++.+|+|++..... ...+++.+|+++++..+||+||.+|+.|.++.. ..+
T Consensus 76 i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI 155 (364)
T KOG0581|consen 76 ISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISI 155 (364)
T ss_pred cCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEe
Confidence 4445788999999999999999998 588999999865543 446789999999999999999999999999995 999
Q ss_pred EEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCCCceeecCCCCCeeeeeccchhhhhhhh
Q 005427 139 FFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHN-LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKE 217 (697)
Q Consensus 139 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~ 217 (697)
+||||++|+|.+++...+ ++++.....++.++++||.|||+ ++|+||||||+|||++..|.|||||||.+..+.+.
T Consensus 156 ~mEYMDgGSLd~~~k~~g-~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-- 232 (364)
T KOG0581|consen 156 CMEYMDGGSLDDILKRVG-RIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-- 232 (364)
T ss_pred ehhhcCCCCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh--
Confidence 999999999999997664 79999999999999999999995 99999999999999999999999999999876541
Q ss_pred hhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccH
Q 005427 218 ISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTE 297 (697)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~ 297 (697)
...+++||..|||||.+.+..|+.++||||||++++|+++|+.||..... .....
T Consensus 233 ----------------~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~---------~~~~~ 287 (364)
T KOG0581|consen 233 ----------------IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNP---------PYLDI 287 (364)
T ss_pred ----------------hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCC---------CCCCH
Confidence 25678999999999999999999999999999999999999999987511 01122
Q ss_pred HHHHHHHHhCCCCCcccccccC-ChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 005427 298 QQLTAAVVSGGLRPILASLELG-LPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE 354 (697)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~ 354 (697)
-++...++.+ .. +.+|.+ +|+++++|+..||++||.+|||+.|+++|.|....
T Consensus 288 ~~Ll~~Iv~~-pp---P~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~ 341 (364)
T KOG0581|consen 288 FELLCAIVDE-PP---PRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKF 341 (364)
T ss_pred HHHHHHHhcC-CC---CCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhc
Confidence 2333333332 12 234444 99999999999999999999999999999988653
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-50 Score=377.16 Aligned_cols=253 Identities=26% Similarity=0.428 Sum_probs=215.4
Q ss_pred CCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCC--ChHHHHHHHHHHHHHHhcCCCCceEEee-ccccCCc-eE
Q 005427 64 PPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVA-AHAKPPN-YM 137 (697)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~-~~~~~~~-~~ 137 (697)
....|+++++||+|.||+||++.. ++..+|.|.+... +..+.+.+..|+.+|++|+|||||++++ .|..+.. ++
T Consensus 17 ~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evln 96 (375)
T KOG0591|consen 17 TLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLN 96 (375)
T ss_pred cHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhH
Confidence 345799999999999999999976 7899999987654 3456778999999999999999999998 5555555 89
Q ss_pred EEEeecCCCCHhhhhh---hcCCCCCHHHHHHHHHHHHHHHHHHHh--CC--cccccCCCCceeecCCCCCeeeeeccch
Q 005427 138 FFFEFYESRNLAEKLH---VEEWSPSVDQVLMIAAQLAKALQYLHN--LG--IVHRDVKPANVLLDRNLCPHLADFGLAE 210 (697)
Q Consensus 138 lv~e~~~~g~L~~~l~---~~~~~~~~~~~~~i~~qi~~~l~~LH~--~~--ivHrDlkp~Nill~~~~~~kL~Dfg~a~ 210 (697)
+|||+|.+|+|...++ +.+..+++.++|+++.|++.||..+|+ .. |+||||||.||+++.+|.|||+|||+++
T Consensus 97 ivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r 176 (375)
T KOG0591|consen 97 IVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGR 176 (375)
T ss_pred HHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHh
Confidence 9999999999999874 355689999999999999999999999 44 9999999999999999999999999999
Q ss_pred hhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHH
Q 005427 211 YRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTV 290 (697)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~ 290 (697)
.+..... ...+.+|||.||+||.+...+|+.+|||||+||++|||+.-.+||.+.+-.....+|
T Consensus 177 ~l~s~~t----------------fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI 240 (375)
T KOG0591|consen 177 FLSSKTT----------------FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKI 240 (375)
T ss_pred HhcchhH----------------HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHH
Confidence 8864332 356789999999999999999999999999999999999999999998665555555
Q ss_pred HhccccHHHHHHHHHhCCCCCcccccc-cCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 005427 291 LEMNYTEQQLTAAVVSGGLRPILASLE-LGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350 (697)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~ 350 (697)
.++.+ .| +| ..+|.++..||..|+..||..||+.-.++....
T Consensus 241 ~qgd~--------------~~----~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 241 EQGDY--------------PP----LPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred HcCCC--------------CC----CcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 54433 22 23 468999999999999999999998655544433
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-49 Score=389.16 Aligned_cols=249 Identities=26% Similarity=0.419 Sum_probs=217.1
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccCC--ChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEe
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFE 141 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 141 (697)
.+|.+.++||+|+||+||+|++ ++..||||.+... ..+..+.+..|+++|+.++|||||.|++++..++.+|||||
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME 89 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME 89 (429)
T ss_pred ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence 5799999999999999999987 6789999987766 55667889999999999999999999999999999999999
Q ss_pred ecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCC------CCCeeeeeccchhhhhh
Q 005427 142 FYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRN------LCPHLADFGLAEYRENL 215 (697)
Q Consensus 142 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~------~~~kL~Dfg~a~~~~~~ 215 (697)
||.||+|.++++..+ ++++++++.++.||+.||++||+++|+||||||+||||+.. -.+||+|||+|+.+...
T Consensus 90 yC~gGDLs~yi~~~~-~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~ 168 (429)
T KOG0595|consen 90 YCNGGDLSDYIRRRG-RLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPG 168 (429)
T ss_pred eCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCch
Confidence 999999999998776 89999999999999999999999999999999999999764 46899999999987632
Q ss_pred hhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccc
Q 005427 216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNY 295 (697)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~ 295 (697)
....+.||+|.|||||++....|+.|+|+||+|+++|++++|++||...+..+....+...
T Consensus 169 -----------------~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~-- 229 (429)
T KOG0595|consen 169 -----------------SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKG-- 229 (429)
T ss_pred -----------------hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcc--
Confidence 2357889999999999999999999999999999999999999999987766655533222
Q ss_pred cHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005427 296 TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALE 348 (697)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 348 (697)
...++..+..++..+.+|+...|+.+|..|.++.+-..+
T Consensus 230 --------------~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~ 268 (429)
T KOG0595|consen 230 --------------NEIVPVLPAELSNPLRELLISLLQRNPKDRISFEDFFDH 268 (429)
T ss_pred --------------ccccCchhhhccCchhhhhhHHHhcCccccCchHHhhhh
Confidence 122333444577778899999999999999998876544
|
|
| >PLN03145 Protein phosphatase 2c; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-48 Score=397.03 Aligned_cols=256 Identities=38% Similarity=0.667 Sum_probs=213.8
Q ss_pred cccCcccceEeeeccCCCCCCCceeEEcccccC--------CCceEEEEEecCCCChHHHHHHHHHhHHHHHhcCC-CCC
Q 005427 423 LTYYPVLSWGSFATCGRRETMEDTHFLMPHMYN--------QKEIHMFGIFDGHRGSAAAEFSARALPGFLQNLGS-TTR 493 (697)
Q Consensus 423 ~~~~~~~~~~~~s~~G~R~~neD~~~~~~~~~~--------~~~~~~~~V~DG~GG~~~~~~as~~~~~~l~~~~~-~~~ 493 (697)
..+.+.+.++.+|++|.|.+|||++++..++.. .....||||||||||+.+|++|++.+++.+.+... ...
T Consensus 59 ~~~~~~~~~~~~s~~G~R~~nED~~~~~~~~~~~~~~~~~~~~~~~lf~V~DGhGG~~age~as~~l~~~i~~~~~~~~~ 138 (365)
T PLN03145 59 TEFIPVVRSGAWADIGSRSSMEDVYICVDNFMSDFGLKNSEDGPSAFYGVFDGHGGKHAADFACYHLPRFIVEDEDFPRE 138 (365)
T ss_pred hhccCceEEEEEccccCCCCCCCceEecccccccccccccCCCCceEEEEEeCCCCHHHHHHHHHHHHHHHHhhhccchh
Confidence 356688999999999999999999987654321 22357999999999999999999999999876422 223
Q ss_pred hHHHHHHHHHHHHHHHHHHHHHHHhhhhcccCCCCCCceEEEEEEecCeEEEEEcCCeEEEEEECCeeeecCCCCCCCCH
Q 005427 494 PTDALLEAFIRTDVAFRNELDSLRKSKRVVQKDWHPGCTAIAALIVRNRLFVANAGDCRAILCRGGHPFALSRDHVASCL 573 (697)
Q Consensus 494 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GtT~~~~~i~~~~l~~anvGDSr~~l~~~~~~~~lt~dH~~~~~ 573 (697)
...++.++|..++..+..... ......||||+++++|.++++|||||||||+|++++|++++||+||++.++
T Consensus 139 ~~~al~~af~~~d~~~~~~~~--------~~~~~~~GTTavv~li~~~~l~vaNvGDSRayl~r~g~~~~LT~DH~~~~~ 210 (365)
T PLN03145 139 IEKVVSSAFLQTDTAFAEACS--------LDASLASGTTALAALVVGRSLVVANAGDCRAVLCRRGKAIEMSRDHKPMCS 210 (365)
T ss_pred HHHHHHHHHHHHhHHHHhhhc--------cccCCCCcCcEEEEEEECCeEEEEecCCceEEEEcCCeEEEecCCCCCCCH
Confidence 456788888888887654311 112234899999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHcCCeeeeccCcceeCCCcceeccccCCCCCCC-------CcccCCceEEEEeCCCCeEEEEEcCCcccCCCh
Q 005427 574 EERERVVSAGGNVNWQVDTWRVGPPALQVTRSIGDDDLKP-------AVTAEPEITETIMTPEDEYLVMASDGLWDVVSH 646 (697)
Q Consensus 574 ~e~~ri~~~g~~~~~~~~~~~~~~~~~~ltralG~~~~k~-------~v~~~p~v~~~~l~~~d~~lvl~SDGl~d~~~~ 646 (697)
.|++||.+.|+.+. ..+++ +.+.+||||||..+|. .++++|++..+.+.++|+|||||||||||+|++
T Consensus 211 ~E~~RI~~~Gg~v~----~g~v~-g~l~vTRalGD~~~k~~k~~~~~~vs~ePdv~~~~l~~~D~fLILaSDGLwdvls~ 285 (365)
T PLN03145 211 KERKRIEASGGYVY----DGYLN-GQLNVARALGDWHMEGMKGSDGGPLSAEPELMTTQLTEEDEFLIIGCDGIWDVFRS 285 (365)
T ss_pred HHHHHHHHcCCcee----cceEC-CccccccccccccccccccccCCCcceEEEEEEEECCCCCEEEEEeCCccccCcCH
Confidence 99999999998663 23444 5778999999987762 478999999999999999999999999999999
Q ss_pred HHHHHHHHhhc---CChhHHHHHHHHHHHhcCCCCCcEEEEEEeCCCC
Q 005427 647 VEAVGIIKDTV---KEPGMCSKRLATEAAERGSKDNITVIVVFLQPVS 691 (697)
Q Consensus 647 ~ei~~~~~~~~---~~~~~~a~~L~~~a~~~g~~DNiT~ivv~l~~~~ 691 (697)
+++++++++.. .+++++|+.|++.|+.+|+.||||||||+|++.+
T Consensus 286 ee~v~~i~~~l~~~~~p~~aa~~Lv~~Al~rgs~DNITvIVV~l~~~~ 333 (365)
T PLN03145 286 QNAVDFARRRLQEHNDPVMCSKELVDEALKRKSGDNLAVVVVCFQSQP 333 (365)
T ss_pred HHHHHHHHHHHhcCCCHHHHHHHHHHHHHhCCCCCCEEEEEEEeecCC
Confidence 99987775432 3789999999999999999999999999998643
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-49 Score=370.55 Aligned_cols=269 Identities=23% Similarity=0.313 Sum_probs=221.4
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccCCCh--HHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEe
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTS--EELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFE 141 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 141 (697)
++|+.+.++|+|+||+||++++ +|+.||||++..+.. .-.+...+|+++|++|+|||+|.|+.+|.....+++|+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 5799999999999999999986 799999998765543 224678999999999999999999999999999999999
Q ss_pred ecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhcc
Q 005427 142 FYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLK 221 (697)
Q Consensus 142 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~ 221 (697)
||+. ++.+-|.......+.+.+..+++|++.|+.|+|+++++||||||+||||+.+|.+||||||+|+.+...
T Consensus 82 ~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p------ 154 (396)
T KOG0593|consen 82 YCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAP------ 154 (396)
T ss_pred ecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCC------
Confidence 9998 555556666667888999999999999999999999999999999999999999999999999876521
Q ss_pred cccCCCCCCCCccccccccCccccchhhhcc-cCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHH
Q 005427 222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQL 300 (697)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 300 (697)
+...+.++.|.+|+|||.+.| ..|+..+||||+||++.||++|.+-|++.++.+++..|...-......
T Consensus 155 ----------gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~pr 224 (396)
T KOG0593|consen 155 ----------GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPR 224 (396)
T ss_pred ----------cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHH
Confidence 123567899999999999987 789999999999999999999999999999888888776543332221
Q ss_pred HHHHHhC--CC----CCccc------ccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 005427 301 TAAVVSG--GL----RPILA------SLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL 351 (697)
Q Consensus 301 ~~~~~~~--~~----~~~~~------~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~ 351 (697)
-..+-.. .+ -|... .--+.++..+.+|++.||+.||++|++.+|++.|.-+
T Consensus 225 hq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yF 287 (396)
T KOG0593|consen 225 HQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYF 287 (396)
T ss_pred HHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHH
Confidence 1111111 11 11111 1113467788999999999999999999999987654
|
|
| >KOG0697 consensus Protein phosphatase 1B (formerly 2C) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-47 Score=353.08 Aligned_cols=255 Identities=29% Similarity=0.489 Sum_probs=219.4
Q ss_pred CcccceEeeeccCCCCCCCceeEEcccccC-CCceEEEEEecCCCChHHHHHHHHHhHHHHHhc--C----CCC---ChH
Q 005427 426 YPVLSWGSFATCGRRETMEDTHFLMPHMYN-QKEIHMFGIFDGHRGSAAAEFSARALPGFLQNL--G----STT---RPT 495 (697)
Q Consensus 426 ~~~~~~~~~s~~G~R~~neD~~~~~~~~~~-~~~~~~~~V~DG~GG~~~~~~as~~~~~~l~~~--~----~~~---~~~ 495 (697)
...+.||..|++|+|.+|||++.....+.. -.++.||||||||.|+..+.++++++.+.|.+. + ... +..
T Consensus 19 GNglryg~SSMQGWR~eMEDah~A~~~l~~~l~dWSfFAVfDGHAGs~va~~c~~hLlehi~sse~F~~~~k~gsv~~~~ 98 (379)
T KOG0697|consen 19 GNGLRYGVSSMQGWRVEMEDAHTAVAGLPSPLEDWSFFAVFDGHAGSQVANHCAEHLLEHIISSEEFRGMTKNGSVENVE 98 (379)
T ss_pred CCceeeeeccccchhhhhhhhhhhhhcCCCCccCceEEEEEcCccchHHHHHHHHHHHHHhhhhHHHhhhccCCcHHHHH
Confidence 458999999999999999999987654443 357899999999999999999999999888654 1 112 345
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHhhhhcccCCCCCCceEEEEEEecCeEEEEEcCCeEEEEEECCeeeecCCCCCCCCHHH
Q 005427 496 DALLEAFIRTDVAFRNELDSLRKSKRVVQKDWHPGCTAIAALIVRNRLFVANAGDCRAILCRGGHPFALSRDHVASCLEE 575 (697)
Q Consensus 496 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GtT~~~~~i~~~~l~~anvGDSr~~l~~~~~~~~lt~dH~~~~~~e 575 (697)
..++..|.++++.+........ ....+|||++.+++...++|++|+||||++++|+|+.+.-|.||+|.+|.|
T Consensus 99 ~GIrtGFL~iDE~mr~~~~~~~-------~~drsGsTAVcv~vsp~h~y~~NcGDSRavl~rng~~~f~TqDHKP~~p~E 171 (379)
T KOG0697|consen 99 KGIRTGFLSIDEIMRTLSDISK-------GSDRSGSTAVCVFVSPTHIYIINCGDSRAVLCRNGEVVFSTQDHKPYLPKE 171 (379)
T ss_pred hhHhhcceeHHHHHhhhhhhhc-------ccccCCceEEEEEecCceEEEEecCcchhheecCCceEEeccCCCCCChHH
Confidence 6677788888776654422211 112379999999999999999999999999999999999999999999999
Q ss_pred HHHHHHcCCeeeeccCcceeCCCcceeccccCCCCCCC---------CcccCCceEEEEeCCCCeEEEEEcCCcccCCCh
Q 005427 576 RERVVSAGGNVNWQVDTWRVGPPALQVTRSIGDDDLKP---------AVTAEPEITETIMTPEDEYLVMASDGLWDVVSH 646 (697)
Q Consensus 576 ~~ri~~~g~~~~~~~~~~~~~~~~~~ltralG~~~~k~---------~v~~~p~v~~~~l~~~d~~lvl~SDGl~d~~~~ 646 (697)
++||.++||.+.++ |++ +.++++|||||.++|. .|+++|+|........|+||||||||+||+|++
T Consensus 172 keRIqnAGGSVMIq----RvN-GsLAVSRAlGDydyK~v~~kgp~eQlVSPEPev~~~~R~eedeFivlACDGIwDVMtn 246 (379)
T KOG0697|consen 172 KERIQNAGGSVMIQ----RVN-GSLAVSRALGDYDYKNVPGKGPTEQLVSPEPEVYIIERSEEDEFIVLACDGIWDVMTN 246 (379)
T ss_pred HHHHhcCCCeEEEE----Eec-ceeeeehhccCcccccCCCCCchhcccCCCCceEEeeccccCcEEEEEccchhhhccc
Confidence 99999999998875 555 7999999999999993 699999999998888888999999999999999
Q ss_pred HHHHHHHHhhc---CChhHHHHHHHHHHHhcCCCCCcEEEEEEeCCCCc
Q 005427 647 VEAVGIIKDTV---KEPGMCSKRLATEAAERGSKDNITVIVVFLQPVST 692 (697)
Q Consensus 647 ~ei~~~~~~~~---~~~~~~a~~L~~~a~~~g~~DNiT~ivv~l~~~~~ 692 (697)
+|++++++..+ .++.++|+..++.++-+||+||+|+|+|.++..+.
T Consensus 247 eelcefv~sRl~Vt~dL~~vcn~VvDtCLhKGSRDNMsivlvcfp~APk 295 (379)
T KOG0697|consen 247 EELCEFVKSRLEVTSDLEEVCNDVVDTCLHKGSRDNMSIVLVCFPGAPK 295 (379)
T ss_pred HHHHHHHHhhheecccHHHHHHHHHHHHHhccCccCceEEEEecCCCCC
Confidence 99999998876 38999999999999999999999999999986543
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-47 Score=392.79 Aligned_cols=267 Identities=36% Similarity=0.588 Sum_probs=229.0
Q ss_pred ccCCCCCCCcccccccccCCceEEEEEEECCee-EEEEeccCCCh--HHHHHHHHHHHHHHhcCCCCceEEeeccccCC-
Q 005427 59 IPLHLPPSSYTLLSPIARGAESVVYEATLDGRK-VAVKKPILSTS--EELDNFHKELQLLCKLDHPGLAKFVAAHAKPP- 134 (697)
Q Consensus 59 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~- 134 (697)
..+.+......+.+.||+|+||+||+|.+.|+. ||+|++..... ...+.|.+|+.+|.+|+|||||+|+|++.++.
T Consensus 34 ~~~~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~ 113 (362)
T KOG0192|consen 34 PEEEIDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPG 113 (362)
T ss_pred cceecChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 345666777888899999999999999999988 99998765432 22669999999999999999999999999988
Q ss_pred ceEEEEeecCCCCHhhhhhh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC-cccccCCCCceeecCCC-CCeeeeeccchh
Q 005427 135 NYMFFFEFYESRNLAEKLHV-EEWSPSVDQVLMIAAQLAKALQYLHNLG-IVHRDVKPANVLLDRNL-CPHLADFGLAEY 211 (697)
Q Consensus 135 ~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~-ivHrDlkp~Nill~~~~-~~kL~Dfg~a~~ 211 (697)
.+++||||+++|+|.++++. ....+++..+..++.||++||.|||+++ ||||||||+|||++.++ ++||+|||+++.
T Consensus 114 ~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~ 193 (362)
T KOG0192|consen 114 SLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSRE 193 (362)
T ss_pred ceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCcccee
Confidence 79999999999999999987 4668999999999999999999999999 99999999999999998 999999999976
Q ss_pred hhhhhhhhcccccCCCCCCCCccccccccCccccchhhhc--ccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHH
Q 005427 212 RENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILK--KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHT 289 (697)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~ 289 (697)
..... ...+...||+.|||||++. ...|+.++||||||++||||+||..||.+......
T Consensus 194 ~~~~~----------------~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~--- 254 (362)
T KOG0192|consen 194 KVISK----------------TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQV--- 254 (362)
T ss_pred ecccc----------------ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHH---
Confidence 54211 1233468999999999999 66999999999999999999999999998765332
Q ss_pred HHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhcc
Q 005427 290 VLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHRKS 358 (697)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~~~~ 358 (697)
...+...+.||.++. .+++.+..||..||..||.+||++.+++..|..+..+...
T Consensus 255 -----------~~~v~~~~~Rp~~p~---~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~ 309 (362)
T KOG0192|consen 255 -----------ASAVVVGGLRPPIPK---ECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS 309 (362)
T ss_pred -----------HHHHHhcCCCCCCCc---cCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence 233444555665443 5899999999999999999999999999999998876443
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-48 Score=391.93 Aligned_cols=266 Identities=24% Similarity=0.391 Sum_probs=229.5
Q ss_pred CCCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCC---ChHHHHHHHHHHHHHHhc-CCCCceEEeeccccCCce
Q 005427 63 LPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKL-DHPGLAKFVAAHAKPPNY 136 (697)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~ 136 (697)
-...+|.+++.||+|+|++|++|+. +++.+|||++... .....+-+..|-++|.+| .||.|++|+..|.+...+
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL 149 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence 3456899999999999999999986 6889999975322 223355678899999999 899999999999999999
Q ss_pred EEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhh
Q 005427 137 MFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLK 216 (697)
Q Consensus 137 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~ 216 (697)
|+|+||+++|+|.+++++.+ .|++..++.++.||+.||+|||++|||||||||+|||+|.++++||+|||.|+.+....
T Consensus 150 YFvLe~A~nGdll~~i~K~G-sfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~ 228 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIKKYG-SFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQ 228 (604)
T ss_pred EEEEEecCCCcHHHHHHHhC-cchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhh
Confidence 99999999999999998776 89999999999999999999999999999999999999999999999999999887543
Q ss_pred hhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhcccc
Q 005427 217 EISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYT 296 (697)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~ 296 (697)
.... + ............+++||..|.+||+|.....++.+|||+|||++|+|+.|.+||.+.+.-...++|+...+.
T Consensus 229 ~~~~-~--~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~ 305 (604)
T KOG0592|consen 229 KSQE-N--PVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYE 305 (604)
T ss_pred cccc-C--ccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhccc
Confidence 3211 0 001111112246799999999999999999999999999999999999999999999888888888877764
Q ss_pred HHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 005427 297 EQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL 351 (697)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~ 351 (697)
.++++|+.+.+|++++|..||++|+|..+|.+|+.+
T Consensus 306 -------------------fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF 341 (604)
T KOG0592|consen 306 -------------------FPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFF 341 (604)
T ss_pred -------------------CCCCCCHHHHHHHHHHHccCccccccHHHHhhCccc
Confidence 356889999999999999999999999999888754
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-47 Score=361.22 Aligned_cols=237 Identities=25% Similarity=0.352 Sum_probs=214.9
Q ss_pred CCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCC---hHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEE
Q 005427 64 PPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST---SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMF 138 (697)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 138 (697)
.-++|++++.||.|+||.|.+++. ++..+|+|++.... .+..+...+|..+|+.+.||+++++++.|.+...++|
T Consensus 42 ~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lym 121 (355)
T KOG0616|consen 42 SLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYM 121 (355)
T ss_pred chhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEE
Confidence 346899999999999999999986 68889999865442 3456788999999999999999999999999999999
Q ss_pred EEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhh
Q 005427 139 FFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI 218 (697)
Q Consensus 139 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~ 218 (697)
||||++||.|+.++++.+ +|++..++.++.||+.||+|||+.+|++|||||+|||+|.+|.+||+|||+|+....
T Consensus 122 vmeyv~GGElFS~Lrk~~-rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~---- 196 (355)
T KOG0616|consen 122 VMEYVPGGELFSYLRKSG-RFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG---- 196 (355)
T ss_pred EEeccCCccHHHHHHhcC-CCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecC----
Confidence 999999999999998766 899999999999999999999999999999999999999999999999999987653
Q ss_pred hcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHH
Q 005427 219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQ 298 (697)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~ 298 (697)
.+.+.||||.|+|||++...+|..++|.|||||++|||+.|.+||.+.+...+..+|++....
T Consensus 197 ---------------rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~-- 259 (355)
T KOG0616|consen 197 ---------------RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVK-- 259 (355)
T ss_pred ---------------cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCccc--
Confidence 356789999999999999999999999999999999999999999998887777777765543
Q ss_pred HHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCC
Q 005427 299 QLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNR 339 (697)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R 339 (697)
.|..++.++++|++++|+.|-++|
T Consensus 260 -----------------fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 260 -----------------FPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred -----------------CCcccCHHHHHHHHHHHhhhhHhh
Confidence 355789999999999999999999
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-47 Score=385.67 Aligned_cols=270 Identities=26% Similarity=0.340 Sum_probs=232.3
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccCCCh--HHHHHHHHHHHHHHhcCCCCceEEeeccccC--CceEEE
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTS--EELDNFHKELQLLCKLDHPGLAKFVAAHAKP--PNYMFF 139 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~~lv 139 (697)
+.|+.+++||+|+||.||+|++ +|+.||+|++..... .......+||.||++|+||||++|.+...+. ..+|||
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 4699999999999999999987 788999999887763 3466788999999999999999999988776 689999
Q ss_pred EeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhh
Q 005427 140 FEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEIS 219 (697)
Q Consensus 140 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~ 219 (697)
+|||+. +|.-++...+..|++.++..++.||+.||+|||++||+|||||.+|||||.+|.+||+|||||+++.....
T Consensus 197 FeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~-- 273 (560)
T KOG0600|consen 197 FEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGS-- 273 (560)
T ss_pred Eecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCCC--
Confidence 999998 99999988888999999999999999999999999999999999999999999999999999997763221
Q ss_pred cccccCCCCCCCCccccccccCccccchhhhccc-CCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHH
Q 005427 220 LKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKE-IHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQ 298 (697)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~ 298 (697)
...++.+-|.+|+|||.+.|. .|+.++|+||.||||.||+.|++.|.+.+..+++..|.+...++.
T Consensus 274 -------------~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~ 340 (560)
T KOG0600|consen 274 -------------APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPT 340 (560)
T ss_pred -------------cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCC
Confidence 125667889999999999875 599999999999999999999999999999999999998887776
Q ss_pred HHHHHHHh----CCCCCc------ccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 005427 299 QLTAAVVS----GGLRPI------LASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL 351 (697)
Q Consensus 299 ~~~~~~~~----~~~~~~------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~ 351 (697)
+..|.+.. ..++|. +.+.-..++....+|+..+|..||.+|.|+.+++.+-++
T Consensus 341 e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF 403 (560)
T KOG0600|consen 341 EDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYF 403 (560)
T ss_pred hhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccc
Confidence 66655211 112221 122234688999999999999999999999999876555
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-47 Score=390.55 Aligned_cols=263 Identities=29% Similarity=0.453 Sum_probs=225.5
Q ss_pred CccCCCCCCCcccccccccCCceEEEEEEECCe-eEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCce
Q 005427 58 SIPLHLPPSSYTLLSPIARGAESVVYEATLDGR-KVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNY 136 (697)
Q Consensus 58 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~-~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 136 (697)
..+++++.+.++++++||+|.||.||+|.+.+. .||+|.+... ....+.|.+|+.+|++|+|+|||+|+++|..+..+
T Consensus 198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~pi 276 (468)
T KOG0197|consen 198 RDPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPI 276 (468)
T ss_pred cCCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCce
Confidence 456788888999999999999999999999776 8999986544 33456788999999999999999999999998899
Q ss_pred EEEEeecCCCCHhhhhhh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhh
Q 005427 137 MFFFEFYESRNLAEKLHV-EEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL 215 (697)
Q Consensus 137 ~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~ 215 (697)
+|||||+..|+|.++|+. .+..+...+.+.++.||++|++||+++++|||||.++||||+++..+||+|||||+...+.
T Consensus 277 yIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~ 356 (468)
T KOG0197|consen 277 YIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDD 356 (468)
T ss_pred EEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCC
Confidence 999999999999999987 5567899999999999999999999999999999999999999999999999999955432
Q ss_pred hhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCCchhHHHHHHHHhcc
Q 005427 216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMN 294 (697)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~~~~~~~~~~~~~~~ 294 (697)
... ......-+..|.|||++....++.+||||||||+||||+| |+.||.+....+....+.+
T Consensus 357 ~Y~---------------~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~-- 419 (468)
T KOG0197|consen 357 EYT---------------ASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLER-- 419 (468)
T ss_pred cee---------------ecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhc--
Confidence 211 1122234678999999999999999999999999999999 9999998876665555432
Q ss_pred ccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 005427 295 YTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE 354 (697)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~ 354 (697)
+...| .|..+|+++.++|..||..+|++||||+.+...+..+..
T Consensus 420 ------------GyRlp----~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 420 ------------GYRLP----RPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred ------------cCcCC----CCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence 22222 256799999999999999999999999998887777654
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-46 Score=349.29 Aligned_cols=271 Identities=25% Similarity=0.322 Sum_probs=227.8
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccCCChHH--HHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEe
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEE--LDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFE 141 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 141 (697)
.+|...++||+|.||.||+|++ +|+.||+|++...+..+ .....+|++.|+.++||||+.|+++|.+...+.+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 5899999999999999999987 68999999987765443 3467899999999999999999999999999999999
Q ss_pred ecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhcc
Q 005427 142 FYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLK 221 (697)
Q Consensus 142 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~ 221 (697)
|++. +|..+++.....++..++..++.+++.||+|||++.|+||||||.|+||+.+|.+||+|||+++.+.....
T Consensus 82 fm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~---- 156 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR---- 156 (318)
T ss_pred eccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCc----
Confidence 9985 99999998888899999999999999999999999999999999999999999999999999988764221
Q ss_pred cccCCCCCCCCccccccccCccccchhhhccc-CCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHH
Q 005427 222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKKE-IHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQL 300 (697)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 300 (697)
..+..+-|.+|+|||.+.|. .|+..+||||.||++.||+.|.+-|.+.++.+++..+.+...++.+.
T Consensus 157 ------------~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~ 224 (318)
T KOG0659|consen 157 ------------IQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPD 224 (318)
T ss_pred ------------ccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcc
Confidence 12334789999999999875 58999999999999999999999999999999888887765544322
Q ss_pred HHHHHh--------CCC-CCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 005427 301 TAAVVS--------GGL-RPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL 353 (697)
Q Consensus 301 ~~~~~~--------~~~-~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~ 353 (697)
.|.... ..+ .+....+-...+.++.+|+.+||.+||.+|+|+.|+++|..+..
T Consensus 225 ~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~ 286 (318)
T KOG0659|consen 225 QWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKS 286 (318)
T ss_pred cCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhc
Confidence 211111 111 11112123456788899999999999999999999999877753
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-46 Score=381.90 Aligned_cols=274 Identities=25% Similarity=0.344 Sum_probs=225.9
Q ss_pred CCCCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCC---hHHHHHHHHHHHHHHhcCCCCceEEeeccccCCce
Q 005427 62 HLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST---SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNY 136 (697)
Q Consensus 62 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 136 (697)
.+..++|.++++||+|+||.||+|+. +|..+|+|++..+. ..+...++.|-++|....+|+||+|+..|.+...+
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L 216 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL 216 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence 45667999999999999999999975 79999999866542 34577889999999999999999999999999999
Q ss_pred EEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhh
Q 005427 137 MFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLK 216 (697)
Q Consensus 137 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~ 216 (697)
||||||++||++..+|...+ .++++.++.++.+++.|++-||+.|++||||||+|+|||..|++||+||||+.-+....
T Consensus 217 YLiMEylPGGD~mTLL~~~~-~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~ 295 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLMRKD-TLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKH 295 (550)
T ss_pred EEEEEecCCccHHHHHHhcC-cCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhh
Confidence 99999999999999998766 89999999999999999999999999999999999999999999999999996443211
Q ss_pred hhh-----------cccccCCCCC-----CCC---------------ccccccccCccccchhhhcccCCCchhhHHHHH
Q 005427 217 EIS-----------LKNWRSSGKP-----TGG---------------FHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFG 265 (697)
Q Consensus 217 ~~~-----------~~~~~~~~~~-----~~~---------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG 265 (697)
... .........+ ... ......+|||.|||||++.+..|+..+|+||||
T Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG 375 (550)
T KOG0605|consen 296 RIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLG 375 (550)
T ss_pred hhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHH
Confidence 111 0000000000 000 012346999999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCC---CH
Q 005427 266 ISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRP---SF 342 (697)
Q Consensus 266 ~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp---t~ 342 (697)
|||||||.|.+||.+.+..+.+.+++.+..... +| ....++++++|||.+||. ||.+|. ++
T Consensus 376 ~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~-----------fP----~~~~~s~eA~DLI~rll~-d~~~RLG~~G~ 439 (550)
T KOG0605|consen 376 CIMYEMLVGYPPFCSETPQETYRKIVNWRETLK-----------FP----EEVDLSDEAKDLITRLLC-DPENRLGSKGA 439 (550)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhcc-----------CC----CcCcccHHHHHHHHHHhc-CHHHhcCcccH
Confidence 999999999999999999999988876553211 11 123578999999999999 999997 58
Q ss_pred HHHHHHHHHH
Q 005427 343 SDIALELDLV 352 (697)
Q Consensus 343 ~ell~~l~~~ 352 (697)
+||.+|+|+-
T Consensus 440 ~EIK~HPfF~ 449 (550)
T KOG0605|consen 440 EEIKKHPFFK 449 (550)
T ss_pred HHHhcCCccc
Confidence 8888877763
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-47 Score=379.79 Aligned_cols=275 Identities=25% Similarity=0.268 Sum_probs=227.2
Q ss_pred CCCCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCCh-HHHHHHHHHHHHHHhcC-CCCceEEeeccccCC-ce
Q 005427 62 HLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTS-EELDNFHKELQLLCKLD-HPGLAKFVAAHAKPP-NY 136 (697)
Q Consensus 62 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~-~~ 136 (697)
.+..++|+++++||.|+||.||+|+. ++..||||+...+-. -+...=.+|+..|++|+ |||||+|.+++.+.. .+
T Consensus 6 ~~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L 85 (538)
T KOG0661|consen 6 VIFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRIL 85 (538)
T ss_pred hhHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceE
Confidence 44567999999999999999999975 688999997543211 11223468999999998 999999999999988 99
Q ss_pred EEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhh
Q 005427 137 MFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLK 216 (697)
Q Consensus 137 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~ 216 (697)
++|||||+. +|+++++.++..|++..++.|+.||+.||+|+|.+|++|||+||+|||+..+..+||+|||+|+.+...
T Consensus 86 ~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk- 163 (538)
T KOG0661|consen 86 YFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSK- 163 (538)
T ss_pred eeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccC-
Confidence 999999986 999999988889999999999999999999999999999999999999999999999999999876531
Q ss_pred hhhcccccCCCCCCCCccccccccCccccchhhhc-ccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccc
Q 005427 217 EISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILK-KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNY 295 (697)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~ 295 (697)
.+.+.++.|.+|+|||++. ...|+.+.|||++||+++|+.+-++-|.|.+..++..+|++...
T Consensus 164 ----------------pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLG 227 (538)
T KOG0661|consen 164 ----------------PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLG 227 (538)
T ss_pred ----------------CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhC
Confidence 1356788999999999875 67799999999999999999999999999999999998887655
Q ss_pred cHHHHHH---HHHhC---CCCCcc-----cccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 005427 296 TEQQLTA---AVVSG---GLRPIL-----ASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE 354 (697)
Q Consensus 296 ~~~~~~~---~~~~~---~~~~~~-----~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~ 354 (697)
++....+ ...+. -..|.. ..+-...+.++.++|..||.+||.+|||+.|.++|+.+...
T Consensus 228 tP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~ 297 (538)
T KOG0661|consen 228 TPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVG 297 (538)
T ss_pred CCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccc
Confidence 4422211 11111 111211 12224588999999999999999999999999998876543
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-46 Score=373.02 Aligned_cols=261 Identities=28% Similarity=0.452 Sum_probs=215.9
Q ss_pred CCCcccccccccCCceEEEEEEEC--CeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccccCC--ceEEEE
Q 005427 65 PSSYTLLSPIARGAESVVYEATLD--GRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPP--NYMFFF 140 (697)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~--~~~lv~ 140 (697)
..+|...+.||+|+||.||++.+. +...|||.....+....+.+.+|+.+|++|+|||||++++...... .++++|
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 357999999999999999999874 6899999877665555778999999999999999999999855544 699999
Q ss_pred eecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecC-CCCCeeeeeccchhhhhhhhhh
Q 005427 141 EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDR-NLCPHLADFGLAEYRENLKEIS 219 (697)
Q Consensus 141 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~-~~~~kL~Dfg~a~~~~~~~~~~ 219 (697)
||+.+|+|.+++...+..++++.+..++.|+++||.|||++||+||||||+|||++. ++.+||+|||++.......
T Consensus 96 Ey~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~--- 172 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG--- 172 (313)
T ss_pred eccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccc---
Confidence 999999999999877667999999999999999999999999999999999999999 7999999999997655200
Q ss_pred cccccCCCCCCCCccccccccCccccchhhhccc-CCCchhhHHHHHHHHHHHHhCCCCCCCc-hhHHHHHHHHhccccH
Q 005427 220 LKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKE-IHSEKSDVYSFGISINELLTGVVPYTDL-RAEAQAHTVLEMNYTE 297 (697)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~ell~g~~Pf~~~-~~~~~~~~~~~~~~~~ 297 (697)
..........||+.|||||++... ...+++|||||||++.||+||..||.+. ........
T Consensus 173 ----------~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~-------- 234 (313)
T KOG0198|consen 173 ----------TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLL-------- 234 (313)
T ss_pred ----------ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHH--------
Confidence 111123457899999999999853 3446999999999999999999999873 21111111
Q ss_pred HHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 005427 298 QQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH 355 (697)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~ 355 (697)
+..+. ..+.+|..+|+++.+|+.+|+..||.+||||+++++|++.....
T Consensus 235 ------ig~~~---~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~ 283 (313)
T KOG0198|consen 235 ------IGRED---SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNS 283 (313)
T ss_pred ------HhccC---CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence 11111 23356678999999999999999999999999999998876543
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=384.51 Aligned_cols=255 Identities=27% Similarity=0.370 Sum_probs=221.1
Q ss_pred CCCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCC----Ch-HHHHHHHHHHHHHHhcC-CCCceEEeeccccCC
Q 005427 63 LPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS----TS-EELDNFHKELQLLCKLD-HPGLAKFVAAHAKPP 134 (697)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~ 134 (697)
...++|.+.+.||+|+||.|++|.+ ++..||+|++... .. ...+.+.+|+.+++.++ ||||+++++++..+.
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 4457899999999999999999986 6899999965443 12 23456779999999998 999999999999999
Q ss_pred ceEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCC-CCCeeeeeccchhhh
Q 005427 135 NYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRN-LCPHLADFGLAEYRE 213 (697)
Q Consensus 135 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~-~~~kL~Dfg~a~~~~ 213 (697)
.+++|||||.||+|++++.. ..++.+..+..+++|++.|++|||++||+||||||+|||++.+ +++||+|||++....
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~ 172 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP 172 (370)
T ss_pred eEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccC
Confidence 99999999999999999988 5589999999999999999999999999999999999999999 999999999997653
Q ss_pred hhhhhhcccccCCCCCCCCccccccccCccccchhhhcccC-CC-chhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHH
Q 005427 214 NLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEI-HS-EKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVL 291 (697)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~ 291 (697)
. ......+.+||+.|+|||++.+.. |+ .++||||+||+||.|++|..||.+.+.......+.
T Consensus 173 ~----------------~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~ 236 (370)
T KOG0583|consen 173 G----------------EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIR 236 (370)
T ss_pred C----------------CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHh
Confidence 1 111357789999999999999876 74 88999999999999999999999976666655554
Q ss_pred hccccHHHHHHHHHhCCCCCcccccccCC-hHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 005427 292 EMNYTEQQLTAAVVSGGLRPILASLELGL-PASILSLIQRCWDGNPHNRPSFSDIALELDLVL 353 (697)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~ 353 (697)
...+. .|..+ |+++.+|+.+||..||.+|+|+.+|+.|.|+..
T Consensus 237 ~~~~~-------------------~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 237 KGEFK-------------------IPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred cCCcc-------------------CCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 43332 23456 999999999999999999999999999999875
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-45 Score=384.34 Aligned_cols=291 Identities=22% Similarity=0.332 Sum_probs=242.2
Q ss_pred CCCCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCC---ChHHHHHHHHHHHHHHhcC-CCCceEEeeccccCCc
Q 005427 62 HLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKLD-HPGLAKFVAAHAKPPN 135 (697)
Q Consensus 62 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~ 135 (697)
.+..++|.++++||+|+||+|+++.. +++.+|||++... ..++.+..+.|.+|+...+ ||++++|+..|.++.+
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 45567899999999999999999987 5778999975543 4567888999999999885 9999999999999999
Q ss_pred eEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhh
Q 005427 136 YMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL 215 (697)
Q Consensus 136 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~ 215 (697)
+|+||||+.||++..+. ....|++..+..++..++.||.|||++||+|||||.+|||+|..|++||+|||+++.--
T Consensus 444 l~fvmey~~Ggdm~~~~--~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m-- 519 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHHI--HTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM-- 519 (694)
T ss_pred EEEEEEecCCCcEEEEE--ecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccC--
Confidence 99999999999944443 33479999999999999999999999999999999999999999999999999996422
Q ss_pred hhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccc
Q 005427 216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNY 295 (697)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~ 295 (697)
..+..+.++||||.|||||++.+..|+.++|.|||||+|||||.|..||.+.+.++....|+....
T Consensus 520 --------------~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~ 585 (694)
T KOG0694|consen 520 --------------GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEV 585 (694)
T ss_pred --------------CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC
Confidence 123357899999999999999999999999999999999999999999999888888777765432
Q ss_pred cHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhcccccccccCCcccccccc
Q 005427 296 TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHRKSLKEEDLCAGKSYVTYDD 375 (697)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (697)
.+|..+|.+..++|+++|..+|++|....+=
T Consensus 586 -------------------~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~------------------------------ 616 (694)
T KOG0694|consen 586 -------------------RYPRFLSKEAIAIMRRLLRKNPEKRLGSGER------------------------------ 616 (694)
T ss_pred -------------------CCCCcccHHHHHHHHHHhccCcccccCCCCC------------------------------
Confidence 2466899999999999999999999865210
Q ss_pred cccccCCCCccccccccccccccccccccccccchhhHHHHhhcccccccCcc
Q 005427 376 KLINSGNNMHTYHESINWTAQGEHSSKKASHAAESDVKLWLESANDALTYYPV 428 (697)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 428 (697)
-...-..|.+...++|. ++....+.+|+.+...+..+...|-..
T Consensus 617 --d~~~i~~hpFFr~i~w~-------~L~~r~i~PPf~P~i~~~~D~snFd~e 660 (694)
T KOG0694|consen 617 --DAEDIKKHPFFRSIDWD-------DLLNRRIKPPFVPTIKGPEDVSNFDEE 660 (694)
T ss_pred --CchhhhhCCccccCCHH-------HHhhccCCCCCCcccCChhhhcccchh
Confidence 00012456677777887 566667788887777777775555433
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=379.17 Aligned_cols=255 Identities=25% Similarity=0.398 Sum_probs=222.4
Q ss_pred CCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEe
Q 005427 64 PPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFE 141 (697)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 141 (697)
+...|....+||+|+.|.||.++. +++.||||++.+......+.+.+|+.+|+.++|+|||.+++.|...+.+|.|||
T Consensus 271 P~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVME 350 (550)
T KOG0578|consen 271 PRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVME 350 (550)
T ss_pred hhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEe
Confidence 345799999999999999999976 678899999888877778889999999999999999999999999999999999
Q ss_pred ecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhcc
Q 005427 142 FYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLK 221 (697)
Q Consensus 142 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~ 221 (697)
|++||+|.+.+... .+++.++..++++++.||+|||.+||+|||||.+|||++.+|.+||+|||+|..+....
T Consensus 351 ym~ggsLTDvVt~~--~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~----- 423 (550)
T KOG0578|consen 351 YMEGGSLTDVVTKT--RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ----- 423 (550)
T ss_pred ecCCCchhhhhhcc--cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeecccccc-----
Confidence 99999999998654 58999999999999999999999999999999999999999999999999997765322
Q ss_pred cccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHHH
Q 005427 222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLT 301 (697)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 301 (697)
....+++|||.|||||++....|++++||||||++++||+-|++||-..+...-...+..
T Consensus 424 -----------~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~--------- 483 (550)
T KOG0578|consen 424 -----------SKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT--------- 483 (550)
T ss_pred -----------CccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhh---------
Confidence 146789999999999999999999999999999999999999999976444333332221
Q ss_pred HHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 302 AAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
...|.+. .+..+|+++++|+.+||+.||.+|+++.|||+|...-
T Consensus 484 ------ng~P~lk-~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~ 527 (550)
T KOG0578|consen 484 ------NGTPKLK-NPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLK 527 (550)
T ss_pred ------cCCCCcC-CccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhh
Confidence 1123222 2457999999999999999999999999999998773
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=381.00 Aligned_cols=249 Identities=23% Similarity=0.352 Sum_probs=221.4
Q ss_pred CcccccccccCCceEEEEEEE--CCeeEEEEeccCCC---hHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEe
Q 005427 67 SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST---SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFE 141 (697)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 141 (697)
-|++++.||.|+-|.|.+|++ +|+.+|||++.... ......+.+|+-+|+.+.||||++||+++++..++|+|.|
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE 92 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE 92 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence 588999999999999999987 89999999865441 2235678899999999999999999999999999999999
Q ss_pred ecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhcc
Q 005427 142 FYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLK 221 (697)
Q Consensus 142 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~ 221 (697)
|+++|.|++++..++ ++++.++.+++.||+.|+.|||..+|+||||||+|+|+|..+.+||+|||+|.....
T Consensus 93 yv~gGELFdylv~kG-~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~------- 164 (786)
T KOG0588|consen 93 YVPGGELFDYLVRKG-PLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVP------- 164 (786)
T ss_pred ecCCchhHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccC-------
Confidence 999999999998776 788899999999999999999999999999999999999999999999999965432
Q ss_pred cccCCCCCCCCccccccccCccccchhhhcccCC-CchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHH
Q 005427 222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIH-SEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQL 300 (697)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 300 (697)
+....+.||+|.|.|||++.|.+| +.++||||.||+||.||+|.+||++.+....+.++..+.+
T Consensus 165 ----------gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f----- 229 (786)
T KOG0588|consen 165 ----------GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVF----- 229 (786)
T ss_pred ----------CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcc-----
Confidence 234677899999999999999987 6899999999999999999999998766666655554443
Q ss_pred HHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 301 TAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
.+|..+|.++.+||++||..||.+|.|.+||++|+|..
T Consensus 230 --------------~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~ 267 (786)
T KOG0588|consen 230 --------------EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLS 267 (786)
T ss_pred --------------cCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhh
Confidence 24568999999999999999999999999999999875
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=358.10 Aligned_cols=279 Identities=28% Similarity=0.393 Sum_probs=229.1
Q ss_pred CCccCCCCCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCChH-HHHHHHHHHHHHHhcCCCCceEEeeccccC
Q 005427 57 QSIPLHLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSE-ELDNFHKELQLLCKLDHPGLAKFVAAHAKP 133 (697)
Q Consensus 57 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~ 133 (697)
....+....+.|++..+||.|.-++||+|+. .++.||||++.+.... +.+.+.+|+..|+.++||||++++..|...
T Consensus 17 ~~~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~ 96 (516)
T KOG0582|consen 17 SEKEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVD 96 (516)
T ss_pred ccccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEec
Confidence 3455677788999999999999999999987 6899999998876543 468999999999999999999999999999
Q ss_pred CceEEEEeecCCCCHhhhhhh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhh
Q 005427 134 PNYMFFFEFYESRNLAEKLHV-EEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYR 212 (697)
Q Consensus 134 ~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~ 212 (697)
..+|+||.||.+|++.+++.. -...+.+..+..|+++++.||.|||.+|.+|||||+.||||+.+|.|||+|||.+..+
T Consensus 97 ~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l 176 (516)
T KOG0582|consen 97 SELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASL 176 (516)
T ss_pred ceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeee
Confidence 999999999999999999864 3446899999999999999999999999999999999999999999999999987655
Q ss_pred hhhhhhhcccccCCCCCCCCccc-cccccCccccchhhhc--ccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHH
Q 005427 213 ENLKEISLKNWRSSGKPTGGFHK-KNMVGTLIYMAPEILK--KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHT 289 (697)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~ 289 (697)
.+ ++ ...... .+.+||++|||||++. ...|+.|+||||||++..||.+|..||....+...+..
T Consensus 177 ~~-----------~G--~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~ 243 (516)
T KOG0582|consen 177 FD-----------SG--DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLL 243 (516)
T ss_pred cc-----------cC--ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHH
Confidence 42 11 111112 6789999999999965 35689999999999999999999999998877666555
Q ss_pred HHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhc
Q 005427 290 VLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHRK 357 (697)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~~~ 357 (697)
.++....... . ... -......++..++.++..||+.||++|||++++++|.++-.....
T Consensus 244 tLqn~pp~~~-t-----~~~---~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~ 302 (516)
T KOG0582|consen 244 TLQNDPPTLL-T-----SGL---DKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSK 302 (516)
T ss_pred HhcCCCCCcc-c-----ccC---ChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccch
Confidence 5443332110 0 000 001123467799999999999999999999999999888655433
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-45 Score=358.32 Aligned_cols=253 Identities=24% Similarity=0.378 Sum_probs=225.4
Q ss_pred CCCcccccccccCCceEEEEEEE--CCeeEEEEeccCC---ChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEE
Q 005427 65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFF 139 (697)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 139 (697)
..+|++.+.||+|.||.|-+|+. .|+.||||.+... +..+.-.+.+|++||..|+||||+.+|.+|++.+.+.+|
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 45899999999999999999975 6999999976543 444566789999999999999999999999999999999
Q ss_pred EeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhh
Q 005427 140 FEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEIS 219 (697)
Q Consensus 140 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~ 219 (697)
|||..+|.|++++...+ .+++.+++.+++||..|+.|+|..+++|||||.+|||+|.++++||+|||++..+...+
T Consensus 132 MEYaS~GeLYDYiSer~-~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~k--- 207 (668)
T KOG0611|consen 132 MEYASGGELYDYISERG-SLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKK--- 207 (668)
T ss_pred EEecCCccHHHHHHHhc-cccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhcccc---
Confidence 99999999999998766 89999999999999999999999999999999999999999999999999998776432
Q ss_pred cccccCCCCCCCCccccccccCccccchhhhcccCC-CchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHH
Q 005427 220 LKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIH-SEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQ 298 (697)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~ 298 (697)
...++||+|.|.+||++.|.+| ++.+|-|||||+||-|+.|..||.+.+......+|..+.|.
T Consensus 208 --------------fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYr-- 271 (668)
T KOG0611|consen 208 --------------FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYR-- 271 (668)
T ss_pred --------------HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhccccc--
Confidence 3568899999999999999998 57899999999999999999999998877776666554442
Q ss_pred HHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 005427 299 QLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH 355 (697)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~ 355 (697)
.+.-|.+..-||++||..||++|.|+++|..|.|.....
T Consensus 272 ------------------EP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvNwgy 310 (668)
T KOG0611|consen 272 ------------------EPETPSDASGLIRWMLMVNPERRATIEDIASHWWVNWGY 310 (668)
T ss_pred ------------------CCCCCchHHHHHHHHHhcCcccchhHHHHhhhheeeccc
Confidence 234567889999999999999999999999999987654
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-45 Score=371.75 Aligned_cols=249 Identities=27% Similarity=0.392 Sum_probs=217.0
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccCC--ChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEe
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFE 141 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 141 (697)
++|-+.+.||+|.||.||+|+. +.+.||+|.+... ..++.+.+.+|++|++.|+|||||.++++|++..++|+|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 5799999999999999999975 6788999975433 44568889999999999999999999999999999999999
Q ss_pred ecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhcc
Q 005427 142 FYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLK 221 (697)
Q Consensus 142 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~ 221 (697)
||.| +|..++...+ .++++++..++.+++.||.|||+.+|+|||+||+|||++..|++|+||||+|+.+....
T Consensus 82 ~a~g-~L~~il~~d~-~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t----- 154 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDG-KLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT----- 154 (808)
T ss_pred hhhh-hHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCc-----
Confidence 9987 9999998766 79999999999999999999999999999999999999999999999999998765311
Q ss_pred cccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHHH
Q 005427 222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLT 301 (697)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 301 (697)
...+...|||.|||||++.+.+|+..+|+|||||++||+++|++||...........|..
T Consensus 155 -----------~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~--------- 214 (808)
T KOG0597|consen 155 -----------SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILK--------- 214 (808)
T ss_pred -----------eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhc---------
Confidence 134567899999999999999999999999999999999999999986554444443332
Q ss_pred HHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 005427 302 AAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL 351 (697)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~ 351 (697)
+..+ .|...+..+.+|++.+|.+||.+|.|..+++.|...
T Consensus 215 -----d~v~-----~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~ 254 (808)
T KOG0597|consen 215 -----DPVK-----PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFW 254 (808)
T ss_pred -----CCCC-----CcccccHHHHHHHHHHhhcChhhcccHHHHhcChHH
Confidence 2111 234789999999999999999999999999988754
|
|
| >KOG0698 consensus Serine/threonine protein phosphatase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=363.54 Aligned_cols=251 Identities=43% Similarity=0.675 Sum_probs=217.0
Q ss_pred eEeeeccCCCCCCCceeEEccccc----CCC-ceEEEEEecCCCChHHHHHHHHHhHHHHHhcCCCC----ChHHHHHHH
Q 005427 431 WGSFATCGRRETMEDTHFLMPHMY----NQK-EIHMFGIFDGHRGSAAAEFSARALPGFLQNLGSTT----RPTDALLEA 501 (697)
Q Consensus 431 ~~~~s~~G~R~~neD~~~~~~~~~----~~~-~~~~~~V~DG~GG~~~~~~as~~~~~~l~~~~~~~----~~~~~l~~~ 501 (697)
.+.++.+|.|..|||++.....+. ... ...+|||||||||+.+|+|+.++++..+.+..... ....++.++
T Consensus 42 ~~~~~~~~~r~~med~~~~~~~~~~~~~~~~~~~~ffgVfDGHGG~~~A~~~~~~L~~~l~~~~~~~~~~~~~~~a~~~~ 121 (330)
T KOG0698|consen 42 GSLLSIRGRRRKMEDRHVQLPDFLEEDVGGEQDTAFFGVFDGHGGDLAAKFAAKHLHKNLLEQLAFPKDRQDVKDALRRA 121 (330)
T ss_pred eEEEecCCCCCccCcceeecccccccccCCCCceEEEEEEeCCCCHHHHHHHHHHHHHHHHhhhhcccchHHHHHHHHHH
Confidence 445588888999999999876543 223 57899999999999999999999999998763322 367888888
Q ss_pred HH-HHHHHHHHHHHHHHhhhhcccCCCCCCceEEEEEEecC-eEEEEEcCCeEEEEEECC-eeeecCCCCCCCCHHHHHH
Q 005427 502 FI-RTDVAFRNELDSLRKSKRVVQKDWHPGCTAIAALIVRN-RLFVANAGDCRAILCRGG-HPFALSRDHVASCLEERER 578 (697)
Q Consensus 502 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~GtT~~~~~i~~~-~l~~anvGDSr~~l~~~~-~~~~lt~dH~~~~~~e~~r 578 (697)
|. +++..+... ..+...+|||++++++.++ ++||||+|||||++++.| .+++||.||+|+.+.|+.|
T Consensus 122 F~~~~D~~~~~~----------~~~~~~~gstav~~vi~~~~~l~vaN~GDSRaVl~~~~~~a~~Ls~DHkP~~~~E~~R 191 (330)
T KOG0698|consen 122 FLTKTDSEFLEK----------REDNRSGGSTAVVALIKKGRKLYVANVGDSRAVLSRKGGVAVQLSVDHKPDREDERER 191 (330)
T ss_pred HHHHHHHHHHhh----------ccCCCCCcceeeeeeEecCCEEEEEEcCCCcEEEecCCCeeeeCCCCCCCCcHHHHHH
Confidence 88 577777654 0112346889998888865 999999999999999865 8999999999999999999
Q ss_pred HHHcCCeeeeccCcceeCCCcceeccccCCCCCC-CCcccCCceEEEEeCCCCeEEEEEcCCcccCCChHHHHHHHHhh-
Q 005427 579 VVSAGGNVNWQVDTWRVGPPALQVTRSIGDDDLK-PAVTAEPEITETIMTPEDEYLVMASDGLWDVVSHVEAVGIIKDT- 656 (697)
Q Consensus 579 i~~~g~~~~~~~~~~~~~~~~~~ltralG~~~~k-~~v~~~p~v~~~~l~~~d~~lvl~SDGl~d~~~~~ei~~~~~~~- 656 (697)
|.++||.+......+|+. +.+++||+|||..+| ++|+++|++....+.+.|+||||+||||||+++++|++++|+..
T Consensus 192 I~~~GG~v~~~~~~~Rv~-G~LavsRa~GD~~~k~~~v~a~Pei~~~~~~~~deFLiLasDGiwDv~s~qeav~~V~~~~ 270 (330)
T KOG0698|consen 192 IEAAGGRVSNWGGVWRVN-GVLAVSRAFGDVELKSQGVIAEPEIQQVKINSDDEFLILASDGIWDVVSNQEAVDLVRDEL 270 (330)
T ss_pred HHHcCCEEEEcCCcceEe-ceEEEeeecCCHHhcCCcEecCCceEEEEcCCCCcEEEEeCCchhcccChHHHHHHHHHHh
Confidence 999999997666667887 699999999999999 89999999999999999999999999999999999999999984
Q ss_pred --cCChhHHHHHHHHHHHhcCCCCCcEEEEEEeCCCCc
Q 005427 657 --VKEPGMCSKRLATEAAERGSKDNITVIVVFLQPVST 692 (697)
Q Consensus 657 --~~~~~~~a~~L~~~a~~~g~~DNiT~ivv~l~~~~~ 692 (697)
...+..++..|...|..+++.||||||||+|.+...
T Consensus 271 ~~~~~~~~a~~~l~~~a~~~~s~DnitvvvV~l~~~~~ 308 (330)
T KOG0698|consen 271 ASISSPLAAAKLLATEALSRGSKDNITVVVVRLKSSPK 308 (330)
T ss_pred hccccHHHHHHHHHHHHhhcCCCCCeEEEEEEecCccc
Confidence 347899999999999999999999999999987764
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-46 Score=342.04 Aligned_cols=257 Identities=26% Similarity=0.353 Sum_probs=222.0
Q ss_pred CCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCC--hHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEE
Q 005427 65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST--SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFF 140 (697)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 140 (697)
.+.|.+.+.||+|.|+.||++.+ +|+.+|+|.+.... ....+.+.+|+.|.+.|+||||++|.+.+......|+|+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 46899999999999999999976 78899999765432 235678899999999999999999999999999999999
Q ss_pred eecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeec---CCCCCeeeeeccchhhhhhhh
Q 005427 141 EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLD---RNLCPHLADFGLAEYRENLKE 217 (697)
Q Consensus 141 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~---~~~~~kL~Dfg~a~~~~~~~~ 217 (697)
|++.|++|..-+-.+. -+++..+-.++.||+++|.|+|.+||||||+||+|+|+. ...-+||+|||+|..+.+
T Consensus 90 e~m~G~dl~~eIV~R~-~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~--- 165 (355)
T KOG0033|consen 90 DLVTGGELFEDIVARE-FYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVND--- 165 (355)
T ss_pred ecccchHHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCC---
Confidence 9999999977665442 568889999999999999999999999999999999994 345699999999976552
Q ss_pred hhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccH
Q 005427 218 ISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTE 297 (697)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~ 297 (697)
+......+|||.|||||+++..+|+..+|||+-||+||-|+.|.+||.+.+......+|....+..
T Consensus 166 --------------g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~ 231 (355)
T KOG0033|consen 166 --------------GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDY 231 (355)
T ss_pred --------------ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCC
Confidence 122456789999999999999999999999999999999999999999988877777777665532
Q ss_pred HHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 005427 298 QQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE 354 (697)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~ 354 (697)
. +..++.++++.++|+++||..||.+|.|+.|.++|+|....
T Consensus 232 ~---------------~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r 273 (355)
T KOG0033|consen 232 P---------------SPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICNR 273 (355)
T ss_pred C---------------CcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcch
Confidence 1 23456899999999999999999999999999999998643
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-45 Score=350.06 Aligned_cols=268 Identities=25% Similarity=0.275 Sum_probs=222.6
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccCCChHH--HHHHHHHHHHHHhcCCCCceEEeeccc--cCCceEEE
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEE--LDNFHKELQLLCKLDHPGLAKFVAAHA--KPPNYMFF 139 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~--~~~~~~lv 139 (697)
+.|+.+.+|++|+||.||+|++ +++.||+|++......+ .-...+|+.+|.+++|||||.+-.+.. +-+.+|+|
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 4699999999999999999987 68899999877665332 224689999999999999999977654 34679999
Q ss_pred EeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhh
Q 005427 140 FEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEIS 219 (697)
Q Consensus 140 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~ 219 (697)
||||+. +|..++...+.+|+..++..++.|++.|++|||...|+||||||+|+|++..|.+||+|||+|+.+....
T Consensus 156 Me~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~--- 231 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL--- 231 (419)
T ss_pred HHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCc---
Confidence 999997 9999999888899999999999999999999999999999999999999999999999999999776421
Q ss_pred cccccCCCCCCCCccccccccCccccchhhhcccC-CCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHH
Q 005427 220 LKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEI-HSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQ 298 (697)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~ 298 (697)
...+..+-|.+|+|||.+.+.. |+.+.|+||+||+|.||+++.+-|.+.....++.+|......+.
T Consensus 232 -------------k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPt 298 (419)
T KOG0663|consen 232 -------------KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPS 298 (419)
T ss_pred -------------ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCc
Confidence 1245678899999999998754 89999999999999999999999999999999998887655543
Q ss_pred HHHHHHHhC---------------CCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 299 QLTAAVVSG---------------GLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 299 ~~~~~~~~~---------------~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
+..|--... .++..++. ..++....+|+..+|.+||.+|.|++|.|+|-|+.
T Consensus 299 e~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~--~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~ 365 (419)
T KOG0663|consen 299 EAIWPGYSELPAVKKMTFSEHPYNNLRKKFGA--LSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFR 365 (419)
T ss_pred cccCCCccccchhhccccCCCCchhhhhhccc--cccchhHHHHHHHHhccCccccccHHHhhcccccc
Confidence 322211000 01111111 12668899999999999999999999999987764
|
|
| >COG0631 PTC1 Serine/threonine protein phosphatase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-44 Score=354.82 Aligned_cols=243 Identities=33% Similarity=0.466 Sum_probs=204.7
Q ss_pred cccceEeeeccCC-CCCCCceeEEcccccCCCceEEEEEecCCCChHHHHHHHHHhHHHHHhcCCCC-----C--hHHHH
Q 005427 427 PVLSWGSFATCGR-RETMEDTHFLMPHMYNQKEIHMFGIFDGHRGSAAAEFSARALPGFLQNLGSTT-----R--PTDAL 498 (697)
Q Consensus 427 ~~~~~~~~s~~G~-R~~neD~~~~~~~~~~~~~~~~~~V~DG~GG~~~~~~as~~~~~~l~~~~~~~-----~--~~~~l 498 (697)
..+.++..++.|. |.+|||++.+..+..... ..+|+|||||||+.+|++||+.+++.|.+.+... . ..+.+
T Consensus 6 ~~~~~~~~s~~g~~R~~NeD~~~~~~~~~~~~-~~l~~V~DG~GGh~~ge~aS~~~v~~l~~~~~~~~~~~~~~~~~~~l 84 (262)
T COG0631 6 LSLKVAGLSDVGTVRKHNEDAFLIKPNENGNL-LLLFAVADGMGGHAAGEVASKLAVEALARLFDETNFNSLNESLEELL 84 (262)
T ss_pred ceeeeeeeccCCCccCCCCcceeeccccCCcc-eeEEEEEeCccchhHHHHHHHHHHHHHHHHHHhccccccchhHHHHH
Confidence 4567888899998 999999999977433333 6799999999999999999999999998873221 1 35677
Q ss_pred HHHHHHHHHHHHHHHHHHHhhhhcccCCCCCCceEEEEEEecCeEEEEEcCCeEEEEEECCeeeecCCCCCCCCHHHHHH
Q 005427 499 LEAFIRTDVAFRNELDSLRKSKRVVQKDWHPGCTAIAALIVRNRLFVANAGDCRAILCRGGHPFALSRDHVASCLEERER 578 (697)
Q Consensus 499 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GtT~~~~~i~~~~l~~anvGDSr~~l~~~~~~~~lt~dH~~~~~~e~~r 578 (697)
.+++..++..+..... ...+..+||||++++++.++++|+|||||||+|++|+|.+++||+||++.+..+.++
T Consensus 85 ~~~~~~~n~~i~~~~~-------~~~~~~~mgtTl~~~~~~~~~l~~a~vGDSR~yl~~~~~~~~lT~DH~~~~~~~~~~ 157 (262)
T COG0631 85 KEAILKANEAIAEEGQ-------LNEDVRGMGTTLVLLLIRGNKLYVANVGDSRAYLLRDGELKQLTEDHSLVNRLEQRG 157 (262)
T ss_pred HHHHHHHHHHHHHhhh-------cccccCCCceeEEEEEEECCeEEEEEccCCeEEEEcCCceEEeccCCcHHHHHHHhc
Confidence 7777777777765521 233445799999999999999999999999999999999999999996666666555
Q ss_pred HHHcCCeeeeccCcceeCCCcceeccccCCCCCCCCcccCCceEEEEeCCCCeEEEEEcCCcccCCChHHHHHHHHhhcC
Q 005427 579 VVSAGGNVNWQVDTWRVGPPALQVTRSIGDDDLKPAVTAEPEITETIMTPEDEYLVMASDGLWDVVSHVEAVGIIKDTVK 658 (697)
Q Consensus 579 i~~~g~~~~~~~~~~~~~~~~~~ltralG~~~~k~~v~~~p~v~~~~l~~~d~~lvl~SDGl~d~~~~~ei~~~~~~~~~ 658 (697)
+ ..+.+++.+|.++++|||||+.. .++|++..+.+.++| |+|||||||||.+++++|.++++.. .
T Consensus 158 ~--------~~~~~~~~~~~~~~ltralG~~~-----~~~p~~~~~~~~~~d-~llL~SDGl~d~v~~~~i~~il~~~-~ 222 (262)
T COG0631 158 I--------ITPEEARSHPRRNALTRALGDFD-----LLEPDITELELEPGD-FLLLCSDGLWDVVSDDEIVDILKNS-E 222 (262)
T ss_pred C--------CCHHHHHhCccchhhhhhcCCCc-----ccceeEEEEEcCCCC-EEEEECCCCccCcCHHHHHHHHhcC-C
Confidence 5 44456777888999999999999 589999999999996 9999999999999999999999973 4
Q ss_pred ChhHHHHHHHHHHHhcCCCCCcEEEEEEeCCCCc
Q 005427 659 EPGMCSKRLATEAAERGSKDNITVIVVFLQPVST 692 (697)
Q Consensus 659 ~~~~~a~~L~~~a~~~g~~DNiT~ivv~l~~~~~ 692 (697)
+++++++.|++.|+.+|+.||+|+|+|.+....+
T Consensus 223 ~~~~~~~~li~~a~~~g~~DNiT~ilv~~~~~~~ 256 (262)
T COG0631 223 TPQEAADKLIELALEGGGPDNITVVLVRLNGEGE 256 (262)
T ss_pred CHHHHHHHHHHHHHhcCCCCceEEEEEEeecccc
Confidence 8999999999999999999999999999987653
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=360.39 Aligned_cols=261 Identities=23% Similarity=0.332 Sum_probs=213.4
Q ss_pred CCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCCh--------------HHHHHHHHHHHHHHhcCCCCceEEee
Q 005427 65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTS--------------EELDNFHKELQLLCKLDHPGLAKFVA 128 (697)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~hpniv~l~~ 128 (697)
-.+|++.+.||+|.||.|-+|++ +++.||+|++..... ...+...+|+.+|++|.|||||+|+.
T Consensus 96 lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiE 175 (576)
T KOG0585|consen 96 LNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIE 175 (576)
T ss_pred hhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEE
Confidence 35799999999999999999987 688999997543211 12568999999999999999999999
Q ss_pred ccccC--CceEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeee
Q 005427 129 AHAKP--PNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADF 206 (697)
Q Consensus 129 ~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Df 206 (697)
+..++ ..+|||+|||..|.+...-. ....++++++++++++++.||+|||.+||+||||||+|+||+.+|+|||+||
T Consensus 176 vLDDP~s~~~YlVley~s~G~v~w~p~-d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIsDF 254 (576)
T KOG0585|consen 176 VLDDPESDKLYLVLEYCSKGEVKWCPP-DKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKISDF 254 (576)
T ss_pred eecCcccCceEEEEEeccCCccccCCC-CcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEeecc
Confidence 99876 57999999999988776432 2223899999999999999999999999999999999999999999999999
Q ss_pred ccchhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccC----CCchhhHHHHHHHHHHHHhCCCCCCCch
Q 005427 207 GLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEI----HSEKSDVYSFGISINELLTGVVPYTDLR 282 (697)
Q Consensus 207 g~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~~l~ell~g~~Pf~~~~ 282 (697)
|.+..+..... ..........+|||.|+|||.+.++. .+.+.||||+||+||.|+.|+.||.+..
T Consensus 255 GVs~~~~~~~~-----------~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~ 323 (576)
T KOG0585|consen 255 GVSNEFPQGSD-----------EGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDF 323 (576)
T ss_pred ceeeecccCCc-----------cccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccch
Confidence 99976522100 00000123368999999999987632 4678999999999999999999999987
Q ss_pred hHHHHHHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 005427 283 AEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE 354 (697)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~ 354 (697)
......+|++.....+ ..+.+...+++||++||.+||++|.+..+|..|+|....
T Consensus 324 ~~~l~~KIvn~pL~fP-----------------~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 324 ELELFDKIVNDPLEFP-----------------ENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred HHHHHHHHhcCcccCC-----------------CcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 7777777765433221 123578899999999999999999999999999998754
|
|
| >PTZ00224 protein phosphatase 2C; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=362.15 Aligned_cols=244 Identities=30% Similarity=0.504 Sum_probs=202.7
Q ss_pred CcccceEeeeccCCCCCCCceeEEcccccCCCceEEEEEecCCCChHHHHHHHHHhHHHHHhcCCCCChHHHHHHHHHHH
Q 005427 426 YPVLSWGSFATCGRRETMEDTHFLMPHMYNQKEIHMFGIFDGHRGSAAAEFSARALPGFLQNLGSTTRPTDALLEAFIRT 505 (697)
Q Consensus 426 ~~~~~~~~~s~~G~R~~neD~~~~~~~~~~~~~~~~~~V~DG~GG~~~~~~as~~~~~~l~~~~~~~~~~~~l~~~~~~~ 505 (697)
...+.+|..+++|.|.+|||++++.. ..+..+|||||||||..+++++++.+...+..... ....+.+.+++..+
T Consensus 19 ~~~~~~g~~s~~G~R~~nED~~~v~~----~~~~~lfgVfDGHgG~~~S~~~~~~l~~~l~~~~~-~~~~~~l~~a~~~~ 93 (381)
T PTZ00224 19 NSIFRCASACVNGYRESMEDAHLLYL----TDDWGFFGVFDGHVNDECSQYLARAWPQALEKEPE-PMTDERMEELCLEI 93 (381)
T ss_pred CccEEEEEEeCCCCCCCCCCeeEecc----CCCceEEEEEeCCCcHHHHHHHHHHHHHHHHhccc-cccHHHHHHHHHHH
Confidence 45788999999999999999988643 22456999999999999999999999988865322 22345577888877
Q ss_pred HHHHHHHHHHHHhhhhcccCCCCCCceEEEEEEe-cCeEEEEEcCCeEEEEEECCeeeecCCCCCCCCHHHHHHHHHcCC
Q 005427 506 DVAFRNELDSLRKSKRVVQKDWHPGCTAIAALIV-RNRLFVANAGDCRAILCRGGHPFALSRDHVASCLEERERVVSAGG 584 (697)
Q Consensus 506 ~~~~~~~~~~~~~~~~~~~~~~~~GtT~~~~~i~-~~~l~~anvGDSr~~l~~~~~~~~lt~dH~~~~~~e~~ri~~~g~ 584 (697)
+..+.+.. ..+|||+++++|. +++++|+||||||+|++|+|++++||+||++.++.|+.||...|+
T Consensus 94 d~~i~~~~-------------~~~GsTatv~lI~~~~~l~vaNVGDSRayl~r~g~~~~LT~DH~~~~~~E~~RI~~~gg 160 (381)
T PTZ00224 94 DEEWMDSG-------------REGGSTGTFCVIMKDVHLQVGNVGDSRVLVCRDGKLVFATEDHKPNNPGERQRIEACGG 160 (381)
T ss_pred HHHHHhcc-------------cCCCCeEEEEEEEECCEEEEEEcccceEEEEECCEEEEcccCCCCCCHHHHhHHHHccC
Confidence 77765321 1259999998886 579999999999999999999999999999999999999999998
Q ss_pred eeeeccCcceeCCCcceeccccCCCCCC---------CCcccCCceEEEEeCCCCeEEEEEcCCccc-CCChHHHHHHHH
Q 005427 585 NVNWQVDTWRVGPPALQVTRSIGDDDLK---------PAVTAEPEITETIMTPEDEYLVMASDGLWD-VVSHVEAVGIIK 654 (697)
Q Consensus 585 ~~~~~~~~~~~~~~~~~ltralG~~~~k---------~~v~~~p~v~~~~l~~~d~~lvl~SDGl~d-~~~~~ei~~~~~ 654 (697)
.+.. .|+. +.+++||+|||..+| +.|+++||+..+.+.++| ||||||||||| +++++|+.+++.
T Consensus 161 ~v~~----~Rv~-G~l~vTRalGd~~~K~~~~~~~~~~~v~~~Pdi~~~~l~~~D-~llLaSDGL~d~~ls~eEi~~iv~ 234 (381)
T PTZ00224 161 RVVS----NRVD-GDLAVSRAFGDRSFKVKGTGDYLEQKVIAVPDVTHLTCQSND-FIILACDGVFEGNFSNEEVVAFVK 234 (381)
T ss_pred Eecc----cccc-CceeeecccCCcccccccccccccCcceeeeEEEEEECCCCC-EEEEECCCcCcCccCHHHHHHHHH
Confidence 6532 2443 578999999997655 246789999999999888 99999999999 899999999997
Q ss_pred hh---cCChhHHHHHHHHHHHhcCCCCCcEEEEEEeCCCCcc
Q 005427 655 DT---VKEPGMCSKRLATEAAERGSKDNITVIVVFLQPVSTA 693 (697)
Q Consensus 655 ~~---~~~~~~~a~~L~~~a~~~g~~DNiT~ivv~l~~~~~~ 693 (697)
+. ..+++.+|+.|+++|+.+|+.||||||||++......
T Consensus 235 ~~l~~~~~~~~aA~~Lv~~A~~rGs~DNITvIvV~~~~~~~~ 276 (381)
T PTZ00224 235 EQLETCDDLAVVAGRVCDEAIRRGSKDNISCLIVQLKDGASY 276 (381)
T ss_pred HHHhcCCCHHHHHHHHHHHHHhcCCCCCEEEEEEEeeCCCCh
Confidence 53 2478999999999999999999999999999765433
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-44 Score=349.18 Aligned_cols=271 Identities=26% Similarity=0.385 Sum_probs=224.9
Q ss_pred CCCcccccccccCCceEEEEEEE--CCeeEEEEecc--CCChHHHHHHHHHHHHHHhcCCCCceEEeecccc-----CCc
Q 005427 65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPI--LSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAK-----PPN 135 (697)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-----~~~ 135 (697)
+.+|..++.||+|+||.|+.+.+ +++.||+|++. ..+....++..+|+++|+.++|+||+.+.+++.. -..
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 35677789999999999999987 68999999877 5666778899999999999999999999999865 356
Q ss_pred eEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhh
Q 005427 136 YMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL 215 (697)
Q Consensus 136 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~ 215 (697)
.|+|+|+|+ .+|...++.+. .++.+.+..+++|+++||.|+|+.+|+||||||.|+|++.+..+||||||+|+.....
T Consensus 101 vYiV~elMe-tDL~~iik~~~-~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~ 178 (359)
T KOG0660|consen 101 VYLVFELME-TDLHQIIKSQQ-DLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKF 178 (359)
T ss_pred eEEehhHHh-hHHHHHHHcCc-cccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeecccc
Confidence 899999995 58999887654 6899999999999999999999999999999999999999999999999999876431
Q ss_pred hhhhcccccCCCCCCCCccccccccCccccchhhhc-ccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhcc
Q 005427 216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILK-KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMN 294 (697)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~ 294 (697)
......+.++-|.+|+|||++. ...|+.+.||||+||+|.||++|++-|.|.+...+...+.+..
T Consensus 179 --------------~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~l 244 (359)
T KOG0660|consen 179 --------------FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELL 244 (359)
T ss_pred --------------CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhc
Confidence 1111356788999999999875 5679999999999999999999999999999998888888766
Q ss_pred ccHHHHHH-HHHhC---------CCCCc--ccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 005427 295 YTEQQLTA-AVVSG---------GLRPI--LASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL 351 (697)
Q Consensus 295 ~~~~~~~~-~~~~~---------~~~~~--~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~ 351 (697)
.++.+... .+.+. ...|. +...-++.++.+.+|+.+||..||.+|+|++|.++|+-.
T Consensus 245 GtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl 313 (359)
T KOG0660|consen 245 GTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYL 313 (359)
T ss_pred CCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhh
Confidence 65533322 22211 11111 122235788999999999999999999999999988644
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-45 Score=363.07 Aligned_cols=252 Identities=28% Similarity=0.433 Sum_probs=219.2
Q ss_pred CCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCCh-HHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEE
Q 005427 64 PPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTS-EELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFF 140 (697)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 140 (697)
+...|+.+++||+|.||.||+|.+ +++.||+|++.+... .+++.+.+|+.+|..+++|||.++|+.|.....++++|
T Consensus 11 ~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiM 90 (467)
T KOG0201|consen 11 PELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIM 90 (467)
T ss_pred cccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHH
Confidence 345799999999999999999987 688999999877654 45788999999999999999999999999999999999
Q ss_pred eecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhc
Q 005427 141 EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL 220 (697)
Q Consensus 141 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~ 220 (697)
|||.||++.+.+.... .+.+..+..++++++.||.|||.++.+|||||+.|||+..+|.+||+|||.+..+.....
T Consensus 91 ey~~gGsv~~lL~~~~-~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~--- 166 (467)
T KOG0201|consen 91 EYCGGGSVLDLLKSGN-ILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK--- 166 (467)
T ss_pred HHhcCcchhhhhccCC-CCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhh---
Confidence 9999999999997654 448888899999999999999999999999999999999999999999999987664322
Q ss_pred ccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHH
Q 005427 221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQL 300 (697)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 300 (697)
...+++|||.|||||++.+..|+.++||||||++.+||++|.+||.+..+...+..|-
T Consensus 167 -------------rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIp--------- 224 (467)
T KOG0201|consen 167 -------------RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIP--------- 224 (467)
T ss_pred -------------ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEecc---------
Confidence 3478899999999999999999999999999999999999999999876633322221
Q ss_pred HHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 005427 301 TAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350 (697)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~ 350 (697)
+...|.+...+++.+++|+..||++||+.||+|.++++|-.
T Consensus 225 ---------k~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~F 265 (467)
T KOG0201|consen 225 ---------KSAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKF 265 (467)
T ss_pred ---------CCCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHH
Confidence 11223344579999999999999999999999999998753
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=365.81 Aligned_cols=251 Identities=31% Similarity=0.530 Sum_probs=214.2
Q ss_pred cCCCCCCCcccccccccCCceEEEEEEECCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEE
Q 005427 60 PLHLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFF 139 (697)
Q Consensus 60 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 139 (697)
-|+++-+...-++-||.|+.|.||+|+..++.||||+++.. -..+|+-|++|+||||+.|.++|...+.||+|
T Consensus 118 ~WeiPFe~IsELeWlGSGaQGAVF~Grl~netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIi 190 (904)
T KOG4721|consen 118 LWEIPFEEISELEWLGSGAQGAVFLGRLHNETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQSPCYCII 190 (904)
T ss_pred hccCCHHHhhhhhhhccCcccceeeeeccCceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecCCceeEEe
Confidence 35566566666788999999999999999999999985422 23578889999999999999999999999999
Q ss_pred EeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhh
Q 005427 140 FEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEIS 219 (697)
Q Consensus 140 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~ 219 (697)
||||..|.|..+|+... .++......+..+|+.|+.|||.+.|||||||.-||||+.+..|||+|||-++...+..
T Consensus 191 MEfCa~GqL~~VLka~~-~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~S--- 266 (904)
T KOG4721|consen 191 MEFCAQGQLYEVLKAGR-PITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKS--- 266 (904)
T ss_pred eeccccccHHHHHhccC-ccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhhh---
Confidence 99999999999997655 78888999999999999999999999999999999999999999999999887655321
Q ss_pred cccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHH
Q 005427 220 LKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQ 299 (697)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~ 299 (697)
..-.++||..|||||++++++.+.|+|||||||+|||||||..||.+.+...+..
T Consensus 267 --------------TkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIw----------- 321 (904)
T KOG4721|consen 267 --------------TKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIW----------- 321 (904)
T ss_pred --------------hhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEE-----------
Confidence 2456799999999999999999999999999999999999999998765433222
Q ss_pred HHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 300 LTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
.+-...+.- ..|..+|+.++-||++||+-.|..||+|.+|+.||+..
T Consensus 322 ---GVGsNsL~L---pvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 322 ---GVGSNSLHL---PVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred ---eccCCcccc---cCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence 122222221 23557999999999999999999999999999999764
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-44 Score=328.36 Aligned_cols=253 Identities=23% Similarity=0.340 Sum_probs=222.9
Q ss_pred CCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCCh---HHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEE
Q 005427 64 PPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTS---EELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMF 138 (697)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 138 (697)
..++|++++.||+|.||.||+|+. ++..||+|+...+.. ....++.+|++|-..|+||||+++|++|.+....|+
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 346899999999999999999987 466799998654432 225679999999999999999999999999999999
Q ss_pred EEeecCCCCHhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhh
Q 005427 139 FFEFYESRNLAEKLHVEE-WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKE 217 (697)
Q Consensus 139 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~ 217 (697)
++||...|+|+..|.... .++++..++.+..|++.||.|+|..+++||||||+|+|++..+.+||+|||-+....
T Consensus 100 ilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p---- 175 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---- 175 (281)
T ss_pred EEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC----
Confidence 999999999999997433 368999999999999999999999999999999999999999999999999886532
Q ss_pred hhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccH
Q 005427 218 ISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTE 297 (697)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~ 297 (697)
.....++|||..|.+||+..+..++..+|+|++|++.||++.|.+||......+....+.+....
T Consensus 176 --------------~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~- 240 (281)
T KOG0580|consen 176 --------------SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLK- 240 (281)
T ss_pred --------------CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHcccc-
Confidence 12467899999999999999999999999999999999999999999988777777666554432
Q ss_pred HHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 005427 298 QQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL 353 (697)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~ 353 (697)
.|..++.++.++|.+||..+|.+|.+..|+++|+|...
T Consensus 241 ------------------~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 241 ------------------FPSTISGGAADLISRLLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred ------------------CCcccChhHHHHHHHHhccCccccccHHHHhhhHHHHh
Confidence 24578999999999999999999999999999999764
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-44 Score=368.03 Aligned_cols=266 Identities=32% Similarity=0.536 Sum_probs=228.7
Q ss_pred ccCCCCCCCcccccccccCCceEEEEEEECCeeEEEEeccCC--ChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCce
Q 005427 59 IPLHLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNY 136 (697)
Q Consensus 59 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 136 (697)
-.|+++.+...+.+.||+|.||+||+|++.| .||||++... ..+..+.|++|+..|++-+|.||+-+.|++..++.
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~- 462 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL- 462 (678)
T ss_pred cccccCHHHhhccceeccccccceeeccccc-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-
Confidence 4588888999999999999999999999988 6899987655 44568899999999999999999999999998887
Q ss_pred EEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhh
Q 005427 137 MFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLK 216 (697)
Q Consensus 137 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~ 216 (697)
.+|+.+|+|.+|+.+++..+..|.+.+.+.|+.|+++|+.|||.++|+|||||..||++.+++.|||+|||++......
T Consensus 463 AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w- 541 (678)
T KOG0193|consen 463 AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRW- 541 (678)
T ss_pred eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeee-
Confidence 9999999999999999988888999999999999999999999999999999999999999999999999999654321
Q ss_pred hhhcccccCCCCCCCCccccccccCccccchhhhc---ccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhc
Q 005427 217 EISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILK---KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEM 293 (697)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~ 293 (697)
.+........|...|||||+++ ..+|++.+||||||+++|||++|..||.....+..
T Consensus 542 -------------~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqI------- 601 (678)
T KOG0193|consen 542 -------------SGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQI------- 601 (678)
T ss_pred -------------ccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhhe-------
Confidence 1122344567899999999986 45789999999999999999999999995433332
Q ss_pred cccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 005427 294 NYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE 354 (697)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~ 354 (697)
.+.+..+..+|.+......+++++++|+..||.+++++||.|.+|+..+..++.
T Consensus 602 -------ifmVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 602 -------IFMVGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred -------EEEecccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 223334445565555667899999999999999999999999999998877765
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=349.03 Aligned_cols=273 Identities=25% Similarity=0.324 Sum_probs=225.7
Q ss_pred CCCCCCCcccccccccCCceEEEEEEECC--eeEEEEeccCCC---hHHHHHHHHHHHHHHhcCCCCceEEeeccccCCc
Q 005427 61 LHLPPSSYTLLSPIARGAESVVYEATLDG--RKVAVKKPILST---SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPN 135 (697)
Q Consensus 61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 135 (697)
..+..++|++++.||.|.-|+||+++..+ ..+|+|++.... .+...+...|-+||+.++||.++.||..|+.+..
T Consensus 72 ~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~ 151 (459)
T KOG0610|consen 72 GSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKY 151 (459)
T ss_pred CccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccce
Confidence 44566789999999999999999999854 789999865432 3446678889999999999999999999999999
Q ss_pred eEEEEeecCCCCHhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhh
Q 005427 136 YMFFFEFYESRNLAEKLHVE-EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYREN 214 (697)
Q Consensus 136 ~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~ 214 (697)
.|++||||+||+|..+++++ +..|+++.++.++.+++.||+|||-.|||+|||||+||||.++|++-|+||.|+.....
T Consensus 152 ~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~ 231 (459)
T KOG0610|consen 152 SCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPV 231 (459)
T ss_pred eEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence 99999999999999998765 45799999999999999999999999999999999999999999999999999854321
Q ss_pred hhhhhc------------------cc-----ccCCC-----------------CCCCCccccccccCccccchhhhcccC
Q 005427 215 LKEISL------------------KN-----WRSSG-----------------KPTGGFHKKNMVGTLIYMAPEILKKEI 254 (697)
Q Consensus 215 ~~~~~~------------------~~-----~~~~~-----------------~~~~~~~~~~~~gt~~y~aPE~~~~~~ 254 (697)
...... .. ..... ....+.....++||-.|.|||++.|..
T Consensus 232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G 311 (459)
T KOG0610|consen 232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG 311 (459)
T ss_pred CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence 111000 00 00000 022344566789999999999999999
Q ss_pred CCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccC
Q 005427 255 HSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDG 334 (697)
Q Consensus 255 ~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 334 (697)
.+.++|+|+|||++|||+.|..||.+.+..+.+.+++..... ++.. +.++..++|||+++|.+
T Consensus 312 HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~----------------Fp~~-~~vs~~akDLIr~LLvK 374 (459)
T KOG0610|consen 312 HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLK----------------FPEE-PEVSSAAKDLIRKLLVK 374 (459)
T ss_pred CCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCc----------------CCCC-CcchhHHHHHHHHHhcc
Confidence 999999999999999999999999999988888887654332 2222 26789999999999999
Q ss_pred CCCCCCC----HHHHHHHHH
Q 005427 335 NPHNRPS----FSDIALELD 350 (697)
Q Consensus 335 dP~~Rpt----~~ell~~l~ 350 (697)
||++|.. ++||.+|..
T Consensus 375 dP~kRlg~~rGA~eIK~HpF 394 (459)
T KOG0610|consen 375 DPSKRLGSKRGAAEIKRHPF 394 (459)
T ss_pred ChhhhhccccchHHhhcCcc
Confidence 9999998 888877763
|
|
| >PRK14559 putative protein serine/threonine phosphatase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=359.81 Aligned_cols=439 Identities=19% Similarity=0.201 Sum_probs=288.2
Q ss_pred CCCceEEeeccccCCceEEEEeecCC-CCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCC
Q 005427 120 HPGLAKFVAAHAKPPNYMFFFEFYES-RNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRN 198 (697)
Q Consensus 120 hpniv~l~~~~~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~ 198 (697)
+.||..+|+++..+..-++++|+... ..|.+..... ..+.-+.+.++.||+.--.-|...|+.-.=|.++|+-++.+
T Consensus 179 ~~~iP~v~~~~~~~~~~i~Lle~~~~~~~l~~~w~~~--~~~~l~~l~Wl~q~~~LW~~l~~~~~~~sll~~~nlrv~~~ 256 (645)
T PRK14559 179 PTEIPKIHDAWQDGDLQVILLEDRSHWQPLLDLWQDQ--TLPTLQILYWLNQMTQLWKALEPWGCCQSLLELENLRVDED 256 (645)
T ss_pred cccCcchheeecCCCCcEEEeCCCCCCchHHHHhhhc--CCcHHHHHHHHHHHHHHHHHHHhcCeehhccchhheeeCCC
Confidence 45699999999888888888888743 2344444332 34567888999999999999999999999999999999876
Q ss_pred CCCeeeeeccchhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCC
Q 005427 199 LCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278 (697)
Q Consensus 199 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf 278 (697)
..+.|-.|-.- .|+ .+.+ +=.||-+--.++....|
T Consensus 257 ~~~~l~~l~~~------------------------------------~~~----~~~~----l~~Lg~~w~~l~~~~~~- 291 (645)
T PRK14559 257 QTLGLQQLYQD------------------------------------PPE----QPPS----LQDLGQVWQQLFTQSQR- 291 (645)
T ss_pred ceehHhhhhcC------------------------------------CCc----CCCC----HHHHHHHHHHHHhhcCh-
Confidence 66555443210 000 0111 11333333333332111
Q ss_pred CCchhHHHHHHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhcc
Q 005427 279 TDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHRKS 358 (697)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~~~~ 358 (697)
.+...+..|+..+- -.+=.+.++|...|+.+......
T Consensus 292 ----------------------------------------~~~~~l~~l~~~l~---~~~~~~~~~l~~~l~~~~~~~~~ 328 (645)
T PRK14559 292 ----------------------------------------TQFESLIPLLQDLQ---SGKIQTIAQLRLRLQELATELEA 328 (645)
T ss_pred ----------------------------------------hhHHHHHHHHHHHH---hcCCCCHHHHHHHHHHHHHHhcc
Confidence 12233444544442 23345788888888887754433
Q ss_pred cccccccCCcccccccccccccCCCCcc-ccccccccccccccccccccccchhhHHHHhhccc-cc-ccCcccceEeee
Q 005427 359 LKEEDLCAGKSYVTYDDKLINSGNNMHT-YHESINWTAQGEHSSKKASHAAESDVKLWLESAND-AL-TYYPVLSWGSFA 435 (697)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~-~~-~~~~~~~~~~~s 435 (697)
........ ..+.........++ ......++ ....+. .+ +....++++..|
T Consensus 329 ~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~lp~~l~~l~~a~~T 381 (645)
T PRK14559 329 EGEAEFES------TEGETTLAPSILQSDDSESPIHE---------------------TEDAPTAVLPMQLVSLEDAGRT 381 (645)
T ss_pred cccccccc------ccccccccccccccccccccccc---------------------cccCccccccccceeEEEEEEC
Confidence 22111100 00000000000000 00000000 000000 01 112358899999
Q ss_pred ccCC-CCCCCceeEEccccc-----CC---CceEEEEEecCCCChHHHHHHHHHhHHHHHhcCC----C-CChHHHHHHH
Q 005427 436 TCGR-RETMEDTHFLMPHMY-----NQ---KEIHMFGIFDGHRGSAAAEFSARALPGFLQNLGS----T-TRPTDALLEA 501 (697)
Q Consensus 436 ~~G~-R~~neD~~~~~~~~~-----~~---~~~~~~~V~DG~GG~~~~~~as~~~~~~l~~~~~----~-~~~~~~l~~~ 501 (697)
++|. |.+|||++.+...+. .. .+..+|+|||||||+.+|++||+.+++.|.+.+. . ....+.+.++
T Consensus 382 d~G~~R~~NEDa~~i~~~~~~~~~~~~~~~~~~~L~aVaDGmGGh~~GevAS~lAv~~L~~~~~~~~~~~~~~~~~L~~a 461 (645)
T PRK14559 382 DVGRQRHHNEDYFGINTRIQKLENPHGRIVQARGLYILCDGMGGHAAGEVASALAVETLQQYFQQHWQDELPDEETIREA 461 (645)
T ss_pred CCCCCCcccCCcccccccccccccccccccccceEEEEEeCCCCchhHHHHHHHHHHHHHHHHHhhhcccccHHHHHHHH
Confidence 9997 999999987754321 11 1356899999999999999999999888765421 1 1235668888
Q ss_pred HHHHHHHHHHHHHHHHhhhhcccCCCCCCceEEEEEEecCeEEEEEcCCeEEEEE-ECCeeeecCCCCCCCCHHHHHHHH
Q 005427 502 FIRTDVAFRNELDSLRKSKRVVQKDWHPGCTAIAALIVRNRLFVANAGDCRAILC-RGGHPFALSRDHVASCLEERERVV 580 (697)
Q Consensus 502 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~GtT~~~~~i~~~~l~~anvGDSr~~l~-~~~~~~~lt~dH~~~~~~e~~ri~ 580 (697)
+..++..+....... ...+...||||++++++.++++|++||||||+|++ |+|++++||+||++ .++++
T Consensus 462 i~~AN~~I~~~~~~~-----~~~~~~~MGTTlv~alI~~~~l~ianVGDSRaYli~r~g~l~QLT~DHs~-----~~~lv 531 (645)
T PRK14559 462 IYLANEAIYDLNQQN-----ARSGSGRMGTTLVMALVQDTQVAVAHVGDSRLYRVTRKGGLEQLTVDHEV-----GQREI 531 (645)
T ss_pred HHHHHHHHHHHhhhc-----ccccCCCCCceeeeEEEECCEEEEEEecCceEEEEecCCeEEEeCCCCCH-----HHHHH
Confidence 888888876542211 11123359999999999999999999999999998 57899999999954 45666
Q ss_pred HcCCeeeeccCcceeCCCcceeccccCCCCCCCCcccCCceEEEEeCCCCeEEEEEcCCccc--CCCh---HHHHHHHHh
Q 005427 581 SAGGNVNWQVDTWRVGPPALQVTRSIGDDDLKPAVTAEPEITETIMTPEDEYLVMASDGLWD--VVSH---VEAVGIIKD 655 (697)
Q Consensus 581 ~~g~~~~~~~~~~~~~~~~~~ltralG~~~~k~~v~~~p~v~~~~l~~~d~~lvl~SDGl~d--~~~~---~ei~~~~~~ 655 (697)
+.| ....++..+|.+++||||||+...+ ..+|++..+.+.++| +|||||||||| .+.. +++..++..
T Consensus 532 ~~G----i~~~~a~~~p~~~~LTrALG~~~~~---~l~Pdi~~~~L~~gD-~lLLCSDGL~D~~~ve~~~~~~l~~il~~ 603 (645)
T PRK14559 532 QRG----VEPQIAYARPDAYQLTQALGPRDNS---AIQPDIQFLEIEEDT-LLLLCSDGLSDNDLLETHWQTHLLPLLSS 603 (645)
T ss_pred HhC----CCHHHHhcCcccceeeeccCCCCCC---cccceEEEEEcCCCC-EEEEECCCCCCCcccchHHHHHHHHHHhc
Confidence 766 2334566678899999999997644 468999999999877 88899999999 4554 345556655
Q ss_pred hcCChhHHHHHHHHHHHhcCCCCCcEEEEEEeCCCCccc
Q 005427 656 TVKEPGMCSKRLATEAAERGSKDNITVIVVFLQPVSTAE 694 (697)
Q Consensus 656 ~~~~~~~~a~~L~~~a~~~g~~DNiT~ivv~l~~~~~~~ 694 (697)
. .++++++++|++.|+.+|+.||||+|||++...+..+
T Consensus 604 ~-~~l~~aa~~Li~~Al~~gg~DNITvIvV~l~~~p~~~ 641 (645)
T PRK14559 604 S-ANLDQGLNKLIDLANQYNGHDNITAILVRLKVRPQLS 641 (645)
T ss_pred C-CCHHHHHHHHHHHHHHcCCCCcEEEEEEEeccCCCCC
Confidence 4 3789999999999999999999999999998665543
|
|
| >PF00481 PP2C: Protein phosphatase 2C; InterPro: IPR001932 This domain is found in protein phosphatase 2C, as well as other proteins eg | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=352.71 Aligned_cols=239 Identities=44% Similarity=0.740 Sum_probs=196.6
Q ss_pred ceEeeeccCCCCCCCceeEEccccc---CCCceEEEEEecCCCChHHHHHHHHHhHHHHHhcC--CCC-ChHHHHHHHHH
Q 005427 430 SWGSFATCGRRETMEDTHFLMPHMY---NQKEIHMFGIFDGHRGSAAAEFSARALPGFLQNLG--STT-RPTDALLEAFI 503 (697)
Q Consensus 430 ~~~~~s~~G~R~~neD~~~~~~~~~---~~~~~~~~~V~DG~GG~~~~~~as~~~~~~l~~~~--~~~-~~~~~l~~~~~ 503 (697)
.+|+.+.+|.|..|||++++..++. ...+..+|+|||||||..+++++++.++..+.+.. ... ....++..+|.
T Consensus 1 ~~~~~~~~g~r~~~eD~~~~~~~~~~~~~~~~~~l~~V~DGhgG~~~a~~~~~~l~~~l~~~~~~~~~~~~~~al~~a~~ 80 (254)
T PF00481_consen 1 DYGVSSMQGVRKEMEDRHLIIQNFNSNSGNDNVSLFGVFDGHGGSEAAEYASQNLPEFLKENLSFNDGNDIEEALRQAFL 80 (254)
T ss_dssp EEEEEEEECTSSSHHEEEEEEEEETCCTTEEEEEEEEEEEEESSSHHHHHHHHHHHHHHHHHHHHHTCHHHHHHHHHHHH
T ss_pred CcCeecCCCCCCcccCEEEEecCccccCCCCCcEEEEEecCCCChhhHHHHHHHHHHHHHhhcccccccchhhcccceee
Confidence 3788999999999999999977653 34578899999999999999999999998877652 122 46778888888
Q ss_pred H-HHHHHHHHHHHHHhhhhcccCCCCCCceEEEEEEecCeEEEEEcCCeEEEEEECCeee-ecCCCCCCCCHHHHHHHHH
Q 005427 504 R-TDVAFRNELDSLRKSKRVVQKDWHPGCTAIAALIVRNRLFVANAGDCRAILCRGGHPF-ALSRDHVASCLEERERVVS 581 (697)
Q Consensus 504 ~-~~~~~~~~~~~~~~~~~~~~~~~~~GtT~~~~~i~~~~l~~anvGDSr~~l~~~~~~~-~lt~dH~~~~~~e~~ri~~ 581 (697)
. ++..+...... . ....+|||+++++|.++++|+|||||||+|+++.+... +||+||+|+++.|+.||.+
T Consensus 81 ~~~~~~~~~~~~~-------~-~~~~~GsTa~v~li~~~~l~vanvGDSravl~~~~~~~~~Lt~dH~~~~~~E~~RI~~ 152 (254)
T PF00481_consen 81 AFTDESLYSDSEN-------N-ESSKSGSTATVALIDGNKLYVANVGDSRAVLCRNGGIIKQLTRDHKPSNPDERERIRK 152 (254)
T ss_dssp HHHHHHHHHHHHH-------H-THTTSEEEEEEEEEETTEEEEEEESS-EEEEEETTEEEEESS---STTSHHHHHHHHH
T ss_pred ecccccccccccc-------c-ccccccccccccccccceeEEEeeeeeeeeeeeccccccccccccccchhhccceeec
Confidence 7 66666552211 1 22347999999999999999999999999999999888 9999999999999999999
Q ss_pred cCCeeeeccCcceeCCCcceeccccCCCCCCC----CcccCCceEEEEeCCCCeEEEEEcCCcccCCChHHHHHHHHhhc
Q 005427 582 AGGNVNWQVDTWRVGPPALQVTRSIGDDDLKP----AVTAEPEITETIMTPEDEYLVMASDGLWDVVSHVEAVGIIKDTV 657 (697)
Q Consensus 582 ~g~~~~~~~~~~~~~~~~~~ltralG~~~~k~----~v~~~p~v~~~~l~~~d~~lvl~SDGl~d~~~~~ei~~~~~~~~ 657 (697)
.|+.+.. ..|+. +.+++||+|||..+|+ +|+++|++..+.+.++|.|||||||||||+++++|+++++.+..
T Consensus 153 ~gg~v~~---~~rv~-g~l~~sRalGd~~~k~~~~~~v~~~P~i~~~~l~~~d~flvlaSDGlwd~l~~~ei~~~v~~~~ 228 (254)
T PF00481_consen 153 AGGRVSE---NGRVN-GVLAVSRALGDFDLKPPGKPGVIAEPDISEVDLTPDDEFLVLASDGLWDVLSNEEIVDIVRESL 228 (254)
T ss_dssp TT-GEEE---TEEET-TTBSSSB-EE-GGGTTCTSSSSB---EEEEEEEBTTEEEEEEE-HHHHTTSHHHHHHHHHHHHH
T ss_pred ccccccc---chhhh-hccccccccccccccccccceeeeecccccccccccceEEEEEcccccccCCHHHHHHHHHHHH
Confidence 9997764 56676 6789999999999998 99999999999999999999999999999999999999999876
Q ss_pred CC---hhHHHHHHHHHHHhcCCCCCc
Q 005427 658 KE---PGMCSKRLATEAAERGSKDNI 680 (697)
Q Consensus 658 ~~---~~~~a~~L~~~a~~~g~~DNi 680 (697)
.. ++.+|+.|++.|+++|+.|||
T Consensus 229 ~~~~~~~~~a~~L~~~A~~~gs~DNi 254 (254)
T PF00481_consen 229 NSGRSPQEAAEKLVDEAIARGSKDNI 254 (254)
T ss_dssp HHHSHHHHHHHHHHHHHHHTTHHSHE
T ss_pred hcCCcHHHHHHHHHHHHHhcCCCCCC
Confidence 43 899999999999999999997
|
pyruvate dehydrogenase (lipoamide)-phosphatase (3.1.3.43 from EC), adenylate cyclase (4.6.1.1 from EC) and some bacterial stage II sporulation E proteins (3.1.3.16 from EC). Protein phosphatase 2C (PP2C) is one of the four major classes of mammalian serine/threonine specific protein phosphatases (3.1.3.16 from EC). PP2C [] is a monomeric enzyme of about 42 Kd which shows broad substrate specificity and is dependent on divalent cations (mainly manganese and magnesium) for its activity. Its exact physiological role is still unclear. Three isozymes are currently known in mammals: PP2C-alpha, -beta and -gamma. In yeast, there are at least four PP2C homologs: phosphatase PTC1 [], which has weak tyrosine phosphatase activity in addition to its activity on serines, phosphatases PTC2 and PTC3, and hypothetical protein YBR125c. Isozymes of PP2C are also known from Arabidopsis thaliana (ABI1, PPH1), Caenorhabditis elegans (FEM-2, F42G9.1, T23F11.1), Leishmania chagasi and Paramecium tetraurelia. In A. thaliana, the kinase associated protein phosphatase (KAPP) [] is an enzyme that dephosphorylates the Ser/Thr receptor-like kinase RLK5 and which contains a C-terminal PP2C domain. PP2C does not seem to be evolutionary related to the main family of serine/ threonine phosphatases: PP1, PP2A and PP2B. However, it is significantly similar to the catalytic subunit of pyruvate dehydrogenase phosphatase 3.1.3.43 from EC (PDPC) [], which catalyzes dephosphorylation and concomitant reactivation of the alpha subunit of the E1 component of the pyruvate dehydrogenase complex. PDPC is a mitochondrial enzyme and, like PP2C, is magnesium-dependent.; GO: 0003824 catalytic activity; PDB: 2I0O_A 2POP_C 2POM_A 2J4O_A 2I44_B 3MQ3_A 3N3C_A 2PNQ_B 2P8E_A 2IQ1_A .... |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-43 Score=343.00 Aligned_cols=271 Identities=24% Similarity=0.279 Sum_probs=221.3
Q ss_pred CCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCChH--HHHHHHHHHHHHHhcCCCC-ceEEeeccccCC-----
Q 005427 65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSE--ELDNFHKELQLLCKLDHPG-LAKFVAAHAKPP----- 134 (697)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpn-iv~l~~~~~~~~----- 134 (697)
...|..+++||+|+||+||+|+. +|+.||+|++.....+ ......+|+.+|+.|+|+| |+.|++++.+..
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 45699999999999999999986 7889999998877553 2456789999999999999 999999998877
Q ss_pred -ceEEEEeecCCCCHhhhhhhcC---CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccch
Q 005427 135 -NYMFFFEFYESRNLAEKLHVEE---WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAE 210 (697)
Q Consensus 135 -~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~ 210 (697)
.+++|+||++. +|..++.... ...+...++.++.||+.||+|||+++|+||||||+||||+.+|.+||+|||+|+
T Consensus 90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAr 168 (323)
T KOG0594|consen 90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLAR 168 (323)
T ss_pred ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHH
Confidence 78999999986 9999987655 356778999999999999999999999999999999999999999999999998
Q ss_pred hhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhccc-CCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHH
Q 005427 211 YRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKE-IHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHT 289 (697)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~ 289 (697)
.+.-.. ...+..++|.+|+|||++.+. .|+...||||+||+++||+++++-|.+.....+...
T Consensus 169 a~~ip~----------------~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~ 232 (323)
T KOG0594|consen 169 AFSIPM----------------RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFR 232 (323)
T ss_pred HhcCCc----------------ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHH
Confidence 544211 124566899999999999987 689999999999999999999999999998888888
Q ss_pred HHhccccHHHHHH--HHHhCCCCCccccc---------ccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 290 VLEMNYTEQQLTA--AVVSGGLRPILASL---------ELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 290 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
|.+...++.+..| ......+++.++.. .+..+++..+++.+||+++|.+|.|+...+.|..+.
T Consensus 233 If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~ 306 (323)
T KOG0594|consen 233 IFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFS 306 (323)
T ss_pred HHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhc
Confidence 8776555433222 11111222111111 122335899999999999999999999999886553
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=355.65 Aligned_cols=254 Identities=26% Similarity=0.371 Sum_probs=225.1
Q ss_pred CCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCC--hHHHHHHHHHHHHHHhcCCCCceEEeeccccCCc-eEEE
Q 005427 65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST--SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPN-YMFF 139 (697)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~-~~lv 139 (697)
.++|.+++++|+|+||.++++++ .++.+++|++.... ..+.+...+|+.++++++|||||.+.+.|..++. .++|
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 46899999999999999999876 57789999877654 3445578999999999999999999999999988 9999
Q ss_pred EeecCCCCHhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhh
Q 005427 140 FEFYESRNLAEKLHVEE-WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI 218 (697)
Q Consensus 140 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~ 218 (697)
|+||+||++.+.+.+.+ ..|+++.++.++.|++.|+.|||+..|+|||||+.||+++.++.|||+|||+|+.+.....
T Consensus 83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~- 161 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDS- 161 (426)
T ss_pred EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCchh-
Confidence 99999999999997665 6789999999999999999999999999999999999999999999999999998875332
Q ss_pred hcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHH
Q 005427 219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQ 298 (697)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~ 298 (697)
...+.+|||.||+||++.+.+|..|+|||||||++|||++-+++|...+-.....++.+..+
T Consensus 162 ---------------~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~--- 223 (426)
T KOG0589|consen 162 ---------------LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLY--- 223 (426)
T ss_pred ---------------hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccC---
Confidence 25678999999999999999999999999999999999999999998877766666654332
Q ss_pred HHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 299 QLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
..++..++.++..+++.||+.+|..||++.+++.++...
T Consensus 224 ---------------~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~ 262 (426)
T KOG0589|consen 224 ---------------SPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLL 262 (426)
T ss_pred ---------------CCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhh
Confidence 235668999999999999999999999999999985443
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=358.34 Aligned_cols=248 Identities=23% Similarity=0.300 Sum_probs=212.1
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccCCC---hHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEE
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST---SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFF 140 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 140 (697)
++|++.++||+|+||.||+|.+ +++.||+|++.... ....+.+.+|+.+|+.++||||+++++++.+...+++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 3799999999999999999987 48899999865432 234567889999999999999999999999999999999
Q ss_pred eecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhc
Q 005427 141 EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL 220 (697)
Q Consensus 141 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~ 220 (697)
||+.+|+|.+++...+ .+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~------ 153 (291)
T cd05612 81 EYVPGGELFSYLRNSG-RFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD------ 153 (291)
T ss_pred eCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccC------
Confidence 9999999999987654 688999999999999999999999999999999999999999999999999875432
Q ss_pred ccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHH
Q 005427 221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQL 300 (697)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 300 (697)
......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.........+.....
T Consensus 154 -------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~----- 215 (291)
T cd05612 154 -------------RTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKL----- 215 (291)
T ss_pred -------------CcccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCc-----
Confidence 12245789999999999999999999999999999999999999987655444333322111
Q ss_pred HHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCC-----HHHHHHHHHHH
Q 005427 301 TAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPS-----FSDIALELDLV 352 (697)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt-----~~ell~~l~~~ 352 (697)
..+..+++.+.+||++||+.||.+||+ ++++++|.|..
T Consensus 216 --------------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~ 258 (291)
T cd05612 216 --------------EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFK 258 (291)
T ss_pred --------------CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCcccc
Confidence 123457889999999999999999995 99999998874
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=363.29 Aligned_cols=263 Identities=27% Similarity=0.434 Sum_probs=211.2
Q ss_pred CCCCCCCcccccccccCCceEEEEEEE-------CCeeEEEEeccCCC-hHHHHHHHHHHHHHHhc-CCCCceEEeeccc
Q 005427 61 LHLPPSSYTLLSPIARGAESVVYEATL-------DGRKVAVKKPILST-SEELDNFHKELQLLCKL-DHPGLAKFVAAHA 131 (697)
Q Consensus 61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~-------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~ 131 (697)
|+++.++|++.++||+|+||.||+|.+ .++.||+|++.... ......+.+|+.+|+.+ +||||+++++++.
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 81 (338)
T cd05102 2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACT 81 (338)
T ss_pred cccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEec
Confidence 577889999999999999999999974 23579999865433 33456789999999999 8999999999887
Q ss_pred cCC-ceEEEEeecCCCCHhhhhhhcC------------------------------------------------------
Q 005427 132 KPP-NYMFFFEFYESRNLAEKLHVEE------------------------------------------------------ 156 (697)
Q Consensus 132 ~~~-~~~lv~e~~~~g~L~~~l~~~~------------------------------------------------------ 156 (697)
.+. .++++|||+++|+|.+++....
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (338)
T cd05102 82 KPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ 161 (338)
T ss_pred CCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence 654 5889999999999999886432
Q ss_pred -------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhcccccCCCCC
Q 005427 157 -------WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKP 229 (697)
Q Consensus 157 -------~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~ 229 (697)
..+++.++..++.|++.||+|||+.||+||||||+|||++.++.+||+|||+++.......
T Consensus 162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~------------ 229 (338)
T cd05102 162 ETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD------------ 229 (338)
T ss_pred hccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcc------------
Confidence 2367788999999999999999999999999999999999999999999999875432110
Q ss_pred CCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCCchhHHHHHHHHhccccHHHHHHHHHhCC
Q 005427 230 TGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGG 308 (697)
Q Consensus 230 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (697)
........+++.|+|||++.+..++.++|||||||++|||++ |..||.+..........+ . .+
T Consensus 230 --~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~-------------~-~~ 293 (338)
T cd05102 230 --YVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRL-------------K-DG 293 (338)
T ss_pred --hhcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHH-------------h-cC
Confidence 001223456788999999999999999999999999999997 999998754322211111 1 11
Q ss_pred CCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 005427 309 LRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE 354 (697)
Q Consensus 309 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~ 354 (697)
.++ ..+..+++++.+|+.+||+.||.+|||+.++++.|..++.
T Consensus 294 ~~~---~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 294 TRM---RAPENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred CCC---CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 111 1244678999999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=328.28 Aligned_cols=255 Identities=25% Similarity=0.364 Sum_probs=221.8
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccCCCh--------HHHHHHHHHHHHHHhc-CCCCceEEeeccccCC
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTS--------EELDNFHKELQLLCKL-DHPGLAKFVAAHAKPP 134 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~ 134 (697)
..|.-.+.||+|..++|-++.+ ++..+|+|++..... +-.+.-.+|+.||+++ .||+|+++.++|+++.
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 4688889999999999998865 678899997543211 1245678899999998 6999999999999999
Q ss_pred ceEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhh
Q 005427 135 NYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYREN 214 (697)
Q Consensus 135 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~ 214 (697)
..++|+|.|+.|.|+|+|...- .+++...+.|++|+++|+.|||.++||||||||+|||++++.++||+|||+++.++.
T Consensus 97 F~FlVFdl~prGELFDyLts~V-tlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~ 175 (411)
T KOG0599|consen 97 FVFLVFDLMPRGELFDYLTSKV-TLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLEP 175 (411)
T ss_pred hhhhhhhhcccchHHHHhhhhe-eecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccCC
Confidence 9999999999999999997554 789999999999999999999999999999999999999999999999999988764
Q ss_pred hhhhhcccccCCCCCCCCccccccccCccccchhhhcc------cCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHH
Q 005427 215 LKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK------EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAH 288 (697)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~ 288 (697)
.. .....||||+|.|||.+.. ..|+..+|+|++||+||.|+.|.+||.......++.
T Consensus 176 Ge-----------------kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR 238 (411)
T KOG0599|consen 176 GE-----------------KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLR 238 (411)
T ss_pred ch-----------------hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHH
Confidence 33 3567899999999999853 357889999999999999999999999887777777
Q ss_pred HHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 005427 289 TVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL 353 (697)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~ 353 (697)
.|.++.++.. ...+.+++.+.++||.+||+.||.+|.|++|.+.|+|++.
T Consensus 239 ~ImeGkyqF~---------------speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q 288 (411)
T KOG0599|consen 239 MIMEGKYQFR---------------SPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQ 288 (411)
T ss_pred HHHhcccccC---------------CcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHH
Confidence 7777776542 2345689999999999999999999999999999999864
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-43 Score=349.53 Aligned_cols=251 Identities=25% Similarity=0.376 Sum_probs=225.5
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccCCChHH--HHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEe
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEE--LDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFE 141 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 141 (697)
.-|.+.+.||+|.|+.|.+|++ +|..||||++....-++ ...+.+|++.|+.++|||||+||.+..+...+|||+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 3599999999999999999986 89999999876654444 4578999999999999999999999999999999999
Q ss_pred ecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceee-cCCCCCeeeeeccchhhhhhhhhhc
Q 005427 142 FYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLL-DRNLCPHLADFGLAEYRENLKEISL 220 (697)
Q Consensus 142 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill-~~~~~~kL~Dfg~a~~~~~~~~~~~ 220 (697)
.-++|+|++++.+....+.++.+.+++.||+.|+.|+|+..+|||||||+||.+ ..-|.|||+|||++..+..
T Consensus 98 LGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P------ 171 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP------ 171 (864)
T ss_pred ecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCC------
Confidence 999999999998888889999999999999999999999999999999999876 6679999999999876543
Q ss_pred ccccCCCCCCCCccccccccCccccchhhhcccCCC-chhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHH
Q 005427 221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHS-EKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQ 299 (697)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~ 299 (697)
|....+.||+..|-|||++.|..|+ +++|||||||+||.|++|++||...++.+.+..|+...|+
T Consensus 172 -----------G~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYt--- 237 (864)
T KOG4717|consen 172 -----------GKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYT--- 237 (864)
T ss_pred -----------cchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhccccc---
Confidence 3346788999999999999998875 6889999999999999999999998888888888877765
Q ss_pred HHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 300 LTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
.|..++.++++||..||..||.+|.+.++|..+.|..
T Consensus 238 ----------------vPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq 274 (864)
T KOG4717|consen 238 ----------------VPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQ 274 (864)
T ss_pred ----------------CchhhhHHHHHHHHHHHhcCchhhccHHHHhcccccc
Confidence 3457899999999999999999999999999888864
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=353.13 Aligned_cols=268 Identities=23% Similarity=0.266 Sum_probs=211.7
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccCCCh-HHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEee
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTS-EELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF 142 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 142 (697)
++|++.++||.|+||.||+|.. +++.||+|++..... .....+.+|+.+++.++||||+++++++.+....++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 5799999999999999999987 578899998754432 2345678999999999999999999999999999999999
Q ss_pred cCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhccc
Q 005427 143 YESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKN 222 (697)
Q Consensus 143 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 222 (697)
+.+ +|.+++...+..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 85 ~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~------ 157 (288)
T cd07871 85 LDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPT------ 157 (288)
T ss_pred CCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCC------
Confidence 985 8999887666567899999999999999999999999999999999999999999999999986432110
Q ss_pred ccCCCCCCCCccccccccCccccchhhhcc-cCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHHH
Q 005427 223 WRSSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLT 301 (697)
Q Consensus 223 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 301 (697)
.......|++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+...........
T Consensus 158 ----------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 227 (288)
T cd07871 158 ----------KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEET 227 (288)
T ss_pred ----------ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHH
Confidence 01234568999999999875 5689999999999999999999999988766655554443222111111
Q ss_pred HHHH--hCCC----CCc-----ccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 005427 302 AAVV--SGGL----RPI-----LASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350 (697)
Q Consensus 302 ~~~~--~~~~----~~~-----~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~ 350 (697)
+... ...+ .|. .......++.++.+||.+||+.||.+|||++|+++|.|
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~ 287 (288)
T cd07871 228 WPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSY 287 (288)
T ss_pred hhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCC
Confidence 1000 0000 000 01112357889999999999999999999999998876
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=357.88 Aligned_cols=253 Identities=27% Similarity=0.412 Sum_probs=222.3
Q ss_pred CCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCCh---HHHHHHHHHHHHHHhcC-CCCceEEeeccccCCceEE
Q 005427 65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTS---EELDNFHKELQLLCKLD-HPGLAKFVAAHAKPPNYMF 138 (697)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~l 138 (697)
...|++.+.||+|.||.||+++. +|+.+|+|.+..... .+...+.+|+.+|+++. |||||.++++|+++..+++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 45799999999999999999987 588999997654332 34578999999999998 9999999999999999999
Q ss_pred EEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecC----CCCCeeeeeccchhhhh
Q 005427 139 FFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDR----NLCPHLADFGLAEYREN 214 (697)
Q Consensus 139 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~----~~~~kL~Dfg~a~~~~~ 214 (697)
|||+|.||.|++.+... .+++..+..++.|++.+++|||+.||+||||||+|+|+.. ++.+|++|||++.....
T Consensus 114 vmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~ 191 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP 191 (382)
T ss_pred EEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC
Confidence 99999999999999766 3999999999999999999999999999999999999954 35799999999987653
Q ss_pred hhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhcc
Q 005427 215 LKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMN 294 (697)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~ 294 (697)
+......+||+.|+|||++...+|+..+||||+|+++|.|++|.+||.+.+.......+....
T Consensus 192 -----------------~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~ 254 (382)
T KOG0032|consen 192 -----------------GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGD 254 (382)
T ss_pred -----------------CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCC
Confidence 224667899999999999999999999999999999999999999999987776666665544
Q ss_pred ccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 005427 295 YTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL 351 (697)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~ 351 (697)
+. +....++.++..++++++.||..||.+|+|+.++++|+|.
T Consensus 255 ~~---------------f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi 296 (382)
T KOG0032|consen 255 FD---------------FTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWI 296 (382)
T ss_pred CC---------------CCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccc
Confidence 42 2233456789999999999999999999999999999994
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=362.21 Aligned_cols=249 Identities=22% Similarity=0.330 Sum_probs=211.8
Q ss_pred CCCcccccccccCCceEEEEEEE--CCeeEEEEeccCC---ChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEE
Q 005427 65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFF 139 (697)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 139 (697)
.++|++.+.||+|+||.||+|++ +++.||+|++... .....+.+.+|+.+|+.++||||+++++++..+..+++|
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence 46899999999999999999987 5788999986532 223456788999999999999999999999999999999
Q ss_pred EeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhh
Q 005427 140 FEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEIS 219 (697)
Q Consensus 140 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~ 219 (697)
|||+.+|+|.+.+.... .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 97 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~----- 170 (329)
T PTZ00263 97 LEFVVGGELFTHLRKAG-RFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD----- 170 (329)
T ss_pred EcCCCCChHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCC-----
Confidence 99999999999987654 688999999999999999999999999999999999999999999999999865431
Q ss_pred cccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHH
Q 005427 220 LKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQ 299 (697)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~ 299 (697)
......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.........+..
T Consensus 171 --------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~------- 229 (329)
T PTZ00263 171 --------------RTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILA------- 229 (329)
T ss_pred --------------CcceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhc-------
Confidence 12345799999999999999999999999999999999999999987654433333221
Q ss_pred HHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCC-----HHHHHHHHHHH
Q 005427 300 LTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPS-----FSDIALELDLV 352 (697)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt-----~~ell~~l~~~ 352 (697)
+. . ..+..++..+.+||++||+.||.+||+ +++++.|.|+.
T Consensus 230 -------~~--~---~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~ 275 (329)
T PTZ00263 230 -------GR--L---KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFH 275 (329)
T ss_pred -------CC--c---CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccC
Confidence 11 1 123457889999999999999999997 79999998763
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=370.02 Aligned_cols=266 Identities=28% Similarity=0.448 Sum_probs=226.9
Q ss_pred CCccCCCCCCCcccccccccCCceEEEEEEEC-------CeeEEEEeccCCChH-HHHHHHHHHHHHHhcCCCCceEEee
Q 005427 57 QSIPLHLPPSSYTLLSPIARGAESVVYEATLD-------GRKVAVKKPILSTSE-ELDNFHKELQLLCKLDHPGLAKFVA 128 (697)
Q Consensus 57 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~ 128 (697)
..-..+++..+.++.+.||+|+||.||+|... ...||||.++..... ....|++|+++|..|+|||||+|+|
T Consensus 477 ~~~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlG 556 (774)
T KOG1026|consen 477 DLKVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLG 556 (774)
T ss_pred ccceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEE
Confidence 34456778888999999999999999999752 356999987666555 6789999999999999999999999
Q ss_pred ccccCCceEEEEeecCCCCHhhhhhhcC---------C----CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceee
Q 005427 129 AHAKPPNYMFFFEFYESRNLAEKLHVEE---------W----SPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLL 195 (697)
Q Consensus 129 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------~----~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill 195 (697)
+|...+..|||+|||..|+|.++|.... . .++..+.+.|+.||+.|++||-++.+|||||-.+|+||
T Consensus 557 VC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLV 636 (774)
T KOG1026|consen 557 VCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLV 636 (774)
T ss_pred EEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhcee
Confidence 9999999999999999999999986432 1 26788999999999999999999999999999999999
Q ss_pred cCCCCCeeeeeccchhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-C
Q 005427 196 DRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-G 274 (697)
Q Consensus 196 ~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g 274 (697)
+++..|||+||||++.+-..+... ....-.-+.+|||||.+..+.++.+|||||+||+|||+++ |
T Consensus 637 ge~l~VKIsDfGLsRdiYssDYYk--------------~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG 702 (774)
T KOG1026|consen 637 GENLVVKISDFGLSRDIYSSDYYK--------------VRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYG 702 (774)
T ss_pred ccceEEEecccccchhhhhhhhhc--------------ccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccc
Confidence 999999999999998665433321 1123356789999999999999999999999999999999 9
Q ss_pred CCCCCCchhHHHHHHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 005427 275 VVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE 354 (697)
Q Consensus 275 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~ 354 (697)
..||.+..+.+....+.... . + +.|+++|.++.+||..||+.+|.+||+|.||-..|....+
T Consensus 703 ~QPy~glSn~EVIe~i~~g~--------------l---L-~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~ 764 (774)
T KOG1026|consen 703 KQPYYGLSNQEVIECIRAGQ--------------L---L-SCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ 764 (774)
T ss_pred cCcccccchHHHHHHHHcCC--------------c---c-cCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence 99999987776665554322 2 1 2467999999999999999999999999999888877654
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=346.10 Aligned_cols=252 Identities=19% Similarity=0.297 Sum_probs=208.2
Q ss_pred CCCcccc--cccccCCceEEEEEEECCeeEEEEeccCCChH---HHHHHHHHHHHHHhcCCCCceEEeecccc----CCc
Q 005427 65 PSSYTLL--SPIARGAESVVYEATLDGRKVAVKKPILSTSE---ELDNFHKELQLLCKLDHPGLAKFVAAHAK----PPN 135 (697)
Q Consensus 65 ~~~y~~~--~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~----~~~ 135 (697)
.+++... ..||+|++|.||+|.++++.||||.+...... ..+.+.+|+.+|++++||||+++++++.+ ...
T Consensus 17 ~~~i~~~~~~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~ 96 (283)
T PHA02988 17 SDDIDKYTSVLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPR 96 (283)
T ss_pred HHHcCCCCCeEEeeCCceEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCc
Confidence 3344444 67999999999999999999999987654322 25778899999999999999999998866 457
Q ss_pred eEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccccCCCCceeecCCCCCeeeeeccchhhhh
Q 005427 136 YMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL-GIVHRDVKPANVLLDRNLCPHLADFGLAEYREN 214 (697)
Q Consensus 136 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~ 214 (697)
++++|||+.+|+|.+++.... .+++.....++.|++.||.|||+. +++||||||+|||++.++.+||+|||++.....
T Consensus 97 ~~lv~Ey~~~g~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~ 175 (283)
T PHA02988 97 LSLILEYCTRGYLREVLDKEK-DLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSS 175 (283)
T ss_pred eEEEEEeCCCCcHHHHHhhCC-CCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcc
Confidence 899999999999999997654 688899999999999999999984 999999999999999999999999999865432
Q ss_pred hhhhhcccccCCCCCCCCccccccccCccccchhhhcc--cCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHh
Q 005427 215 LKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK--EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLE 292 (697)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~ 292 (697)
......|++.|+|||++.+ ..++.++|||||||++|||++|..||.+.+.......+.
T Consensus 176 -------------------~~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~- 235 (283)
T PHA02988 176 -------------------PPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLII- 235 (283)
T ss_pred -------------------ccccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHH-
Confidence 0123468899999999976 678999999999999999999999998765443333222
Q ss_pred ccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 005427 293 MNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL 353 (697)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~ 353 (697)
....++. .+..+++++.+|+.+||+.||++|||+.++++.|..+.
T Consensus 236 -------------~~~~~~~---~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 236 -------------NKNNSLK---LPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred -------------hcCCCCC---CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 1222222 23467899999999999999999999999999887764
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-42 Score=360.32 Aligned_cols=252 Identities=23% Similarity=0.309 Sum_probs=213.5
Q ss_pred CCCCCCCcccccccccCCceEEEEEEEC---CeeEEEEeccCC---ChHHHHHHHHHHHHHHhcCCCCceEEeeccccCC
Q 005427 61 LHLPPSSYTLLSPIARGAESVVYEATLD---GRKVAVKKPILS---TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPP 134 (697)
Q Consensus 61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~---~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 134 (697)
..+..++|++.+.||+|+||.||+|.+. +..||+|++... .....+.+.+|+.+++.++||||+++++++.+..
T Consensus 25 ~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~ 104 (340)
T PTZ00426 25 NKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDES 104 (340)
T ss_pred CCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCC
Confidence 3445578999999999999999999762 357999976432 2334567889999999999999999999999999
Q ss_pred ceEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhh
Q 005427 135 NYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYREN 214 (697)
Q Consensus 135 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~ 214 (697)
.+++||||+.+|+|.+++.... .+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 105 ~~~lv~Ey~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 105 YLYLVLEFVIGGEFFTFLRRNK-RFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred EEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 9999999999999999997654 689999999999999999999999999999999999999999999999999865431
Q ss_pred hhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhcc
Q 005427 215 LKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMN 294 (697)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~ 294 (697)
......||+.|+|||++.+..++.++|||||||++|||++|..||.+.+.......+....
T Consensus 184 -------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~ 244 (340)
T PTZ00426 184 -------------------RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGI 244 (340)
T ss_pred -------------------CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCC
Confidence 1234579999999999999889999999999999999999999998766544444333211
Q ss_pred ccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCC-----CHHHHHHHHHH
Q 005427 295 YTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRP-----SFSDIALELDL 351 (697)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~ell~~l~~ 351 (697)
. ..+..+++.+.++|++||+.||.+|+ +++++++|+|+
T Consensus 245 ~-------------------~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f 287 (340)
T PTZ00426 245 I-------------------YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWF 287 (340)
T ss_pred C-------------------CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCc
Confidence 1 12456789999999999999999995 89999998876
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=336.61 Aligned_cols=265 Identities=24% Similarity=0.332 Sum_probs=213.9
Q ss_pred CcccccccccCCceEEEEEEE--CCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccccCC-----ceEEE
Q 005427 67 SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPP-----NYMFF 139 (697)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-----~~~lv 139 (697)
+|.-.+++|+|+||.||+|.. +++.||||+...... --.+|+.+|+.++|||||+|..+|.... ...+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 588899999999999999976 578999998654332 2248999999999999999988875432 35689
Q ss_pred EeecCCCCHhhhhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCC-CCCeeeeeccchhhhhh
Q 005427 140 FEFYESRNLAEKLHV---EEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRN-LCPHLADFGLAEYRENL 215 (697)
Q Consensus 140 ~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~-~~~kL~Dfg~a~~~~~~ 215 (697)
|||++. +|.++++. .+..++.-.++-+..||++||.|||+.||+||||||+|+|+|.+ |.+||||||.|+.+...
T Consensus 101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~ 179 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKG 179 (364)
T ss_pred HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeeccC
Confidence 999986 99998874 24467788899999999999999999999999999999999976 99999999999876531
Q ss_pred hhhhcccccCCCCCCCCccccccccCccccchhhhcc-cCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhcc
Q 005427 216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMN 294 (697)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~ 294 (697)
.+..++..|..|+|||.+.| ..|+.+.||||.||++.||+-|++-|.+.+...++..+.+..
T Consensus 180 -----------------epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~l 242 (364)
T KOG0658|consen 180 -----------------EPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVL 242 (364)
T ss_pred -----------------CCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHh
Confidence 13456788999999999886 468999999999999999999999999999888888887766
Q ss_pred ccHHHHHHHHHhCCC----CCccc-----c-cccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 005427 295 YTEQQLTAAVVSGGL----RPILA-----S-LELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL 353 (697)
Q Consensus 295 ~~~~~~~~~~~~~~~----~~~~~-----~-~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~ 353 (697)
..+...........+ .|.+. . ....+++++.+|+.++|+++|.+|.++.|++.|..+-.
T Consensus 243 G~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFde 311 (364)
T KOG0658|consen 243 GTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDE 311 (364)
T ss_pred CCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHH
Confidence 554333222222211 11111 1 23468899999999999999999999999998876643
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=348.53 Aligned_cols=254 Identities=20% Similarity=0.230 Sum_probs=207.5
Q ss_pred CcccccccccCCceEEEEEEE--CCeeEEEEeccCCC---hHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEe
Q 005427 67 SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST---SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFE 141 (697)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 141 (697)
.|++.+.||+|+||.||++.+ +++.||+|.+.... ......+.+|+.+++.++|+||+++++++.+...++++||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 378899999999999999986 68899999765332 2233467889999999999999999999999999999999
Q ss_pred ecCCCCHhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhc
Q 005427 142 FYESRNLAEKLHVEE-WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL 220 (697)
Q Consensus 142 ~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~ 220 (697)
|+.+|+|.+.+.... ..+++..++.++.|++.||+|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~---- 156 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE---- 156 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC----
Confidence 999999988875433 358899999999999999999999999999999999999999999999999986542110
Q ss_pred ccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHH
Q 005427 221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQL 300 (697)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 300 (697)
......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+.
T Consensus 157 -------------~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~--------- 214 (285)
T cd05631 157 -------------TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVD--------- 214 (285)
T ss_pred -------------eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHH---------
Confidence 1234578999999999999999999999999999999999999998754322111111
Q ss_pred HHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCC-----HHHHHHHHHHH
Q 005427 301 TAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPS-----FSDIALELDLV 352 (697)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt-----~~ell~~l~~~ 352 (697)
..+. ......+..++.++.+|+++||+.||.+||+ ++++++|.|+.
T Consensus 215 -~~~~-----~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~ 265 (285)
T cd05631 215 -RRVK-----EDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFK 265 (285)
T ss_pred -HHhh-----cccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhc
Confidence 0000 1111234568899999999999999999997 89999988764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-42 Score=358.10 Aligned_cols=244 Identities=23% Similarity=0.319 Sum_probs=205.8
Q ss_pred cccccCCceEEEEEEE--CCeeEEEEeccCC---ChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEeecCCC
Q 005427 72 SPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESR 146 (697)
Q Consensus 72 ~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g 146 (697)
+.||+|+||.||++++ +++.||+|++... .......+.+|+.+|+.++||||+++++++.....+++||||+.+|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999986 6789999986532 2334567889999999999999999999999999999999999999
Q ss_pred CHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhcccccCC
Q 005427 147 NLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSS 226 (697)
Q Consensus 147 ~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~ 226 (697)
+|.+++.... .+++.++..++.||+.||+|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 81 ~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~------------ 147 (323)
T cd05571 81 ELFFHLSRER-VFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGIS------------ 147 (323)
T ss_pred cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCccccc------------
Confidence 9999987654 789999999999999999999999999999999999999999999999999864221
Q ss_pred CCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHHHHHHHh
Q 005427 227 GKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVS 306 (697)
Q Consensus 227 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (697)
.+......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+.......+..
T Consensus 148 ----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~-------------- 209 (323)
T cd05571 148 ----DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM-------------- 209 (323)
T ss_pred ----CCCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHc--------------
Confidence 01123456799999999999999999999999999999999999999987654433333221
Q ss_pred CCCCCcccccccCChHHHHHHHHHhccCCCCCCC-----CHHHHHHHHHH
Q 005427 307 GGLRPILASLELGLPASILSLIQRCWDGNPHNRP-----SFSDIALELDL 351 (697)
Q Consensus 307 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~ell~~l~~ 351 (697)
+. ...+..+++++.+||++||+.||++|| ++.++++|.|+
T Consensus 210 ~~-----~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f 254 (323)
T cd05571 210 EE-----IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFF 254 (323)
T ss_pred CC-----CCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCc
Confidence 11 112456899999999999999999999 89999998876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=358.03 Aligned_cols=256 Identities=24% Similarity=0.325 Sum_probs=214.0
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccCC---ChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEE
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFF 140 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 140 (697)
++|++.++||+|+||.||+|++ +++.||+|++... .......+.+|+.+++.++||||+++++++......++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 3799999999999999999987 5789999986533 2234567889999999999999999999999999999999
Q ss_pred eecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhc
Q 005427 141 EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL 220 (697)
Q Consensus 141 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~ 220 (697)
||+++|+|.+++.... .+++.+++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~------ 153 (333)
T cd05600 81 EYVPGGDFRTLLNNLG-VLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT------ 153 (333)
T ss_pred eCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc------
Confidence 9999999999997554 688999999999999999999999999999999999999999999999999865432
Q ss_pred ccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHH
Q 005427 221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQL 300 (697)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 300 (697)
......||+.|+|||++.+..++.++|||||||++|||++|..||...+.......+......
T Consensus 154 -------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~---- 216 (333)
T cd05600 154 -------------YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKET---- 216 (333)
T ss_pred -------------ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcccc----
Confidence 134567999999999999999999999999999999999999999876655444333221100
Q ss_pred HHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 301 TAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
...|........+++++.++|.+||..+|.+||++.++++|.|+.
T Consensus 217 -------~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~ 261 (333)
T cd05600 217 -------LQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFK 261 (333)
T ss_pred -------ccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccC
Confidence 011111111235789999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=350.13 Aligned_cols=269 Identities=23% Similarity=0.299 Sum_probs=214.9
Q ss_pred CCCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCC-hHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEE
Q 005427 63 LPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST-SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFF 139 (697)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 139 (697)
+..++|++.+.||+|+||.||++++ ++..+|+|...... ......+.+|+++|+.++||||+++++++...+.+++|
T Consensus 2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (331)
T cd06649 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 81 (331)
T ss_pred CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 4567999999999999999999987 47789999876543 33456799999999999999999999999999999999
Q ss_pred EeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccccCCCCceeecCCCCCeeeeeccchhhhhhhhh
Q 005427 140 FEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL-GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI 218 (697)
Q Consensus 140 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~ 218 (697)
|||+++++|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 82 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--- 157 (331)
T cd06649 82 MEHMDGGSLDQVLKEAK-RIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 157 (331)
T ss_pred eecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc---
Confidence 99999999999987654 688999999999999999999986 6999999999999999999999999998644310
Q ss_pred hcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccc---
Q 005427 219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNY--- 295 (697)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~--- 295 (697)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+-....
T Consensus 158 ---------------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 222 (331)
T cd06649 158 ---------------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGE 222 (331)
T ss_pred ---------------ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccc
Confidence 12345789999999999999999999999999999999999999976554332211110000
Q ss_pred -----------------------------cHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHH
Q 005427 296 -----------------------------TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIA 346 (697)
Q Consensus 296 -----------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell 346 (697)
........+... .++..+ ...+++++.+||.+||+.||++|||+.+++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~l~~li~~~L~~~P~~Rpt~~ell 299 (331)
T cd06649 223 EGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNE-PPPKLP--NGVFTPDFQEFVNKCLIKNPAERADLKMLM 299 (331)
T ss_pred cCCccccCcccccccccccccccccccchhHHHHHHHHHhC-CCcCCC--CccccHHHHHHHHHHccCCcccCCCHHHHh
Confidence 000111111111 111111 124788999999999999999999999999
Q ss_pred HHHHHHH
Q 005427 347 LELDLVL 353 (697)
Q Consensus 347 ~~l~~~~ 353 (697)
+|.|...
T Consensus 300 ~h~~~~~ 306 (331)
T cd06649 300 NHTFIKR 306 (331)
T ss_pred cChHHhh
Confidence 9998764
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=347.80 Aligned_cols=269 Identities=23% Similarity=0.266 Sum_probs=209.5
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccCCC--hHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEe
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST--SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFE 141 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 141 (697)
++|++.+.||+|+||.||++++ +++.||+|+..... ....+.+.+|+.+++.++||||+++++++.....+++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 3799999999999999999987 47789999865432 2235678899999999999999999999999999999999
Q ss_pred ecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhcc
Q 005427 142 FYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLK 221 (697)
Q Consensus 142 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~ 221 (697)
|+.++.+..+. .....+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||++........
T Consensus 81 ~~~~~~l~~~~-~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~---- 155 (287)
T cd07848 81 YVEKNMLELLE-EMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN---- 155 (287)
T ss_pred cCCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccc----
Confidence 99987665544 3444689999999999999999999999999999999999999999999999999875432110
Q ss_pred cccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccc--cHHH
Q 005427 222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNY--TEQQ 299 (697)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~--~~~~ 299 (697)
.......|++.|+|||++.+..++.++|||||||++|+|++|++||.+.+.......+..... ....
T Consensus 156 -----------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 224 (287)
T cd07848 156 -----------ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQ 224 (287)
T ss_pred -----------ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHH
Confidence 012345789999999999998899999999999999999999999988665444433332211 1111
Q ss_pred HHHHHHhCCC----CCcc-------cccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 005427 300 LTAAVVSGGL----RPIL-------ASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350 (697)
Q Consensus 300 ~~~~~~~~~~----~~~~-------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~ 350 (697)
.......... .+.. ......+|.++.+||++||+.||++|||++++++|.|
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~ 286 (287)
T cd07848 225 MKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPA 286 (287)
T ss_pred HHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCC
Confidence 1110000000 0000 0112247889999999999999999999999998876
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=351.19 Aligned_cols=243 Identities=23% Similarity=0.326 Sum_probs=203.9
Q ss_pred cccCCceEEEEEEE--CCeeEEEEeccCC---ChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEeecCCCCH
Q 005427 74 IARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNL 148 (697)
Q Consensus 74 lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L 148 (697)
||+|+||.||++++ +++.||+|++... .......+.+|+.+|++++||||+++++++..+...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 79999999999987 5778999976432 233456788999999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhcccccCCCC
Q 005427 149 AEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK 228 (697)
Q Consensus 149 ~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~ 228 (697)
.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 ~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~------------- 146 (312)
T cd05585 81 FHHLQREG-RFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD------------- 146 (312)
T ss_pred HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccC-------------
Confidence 99987654 6899999999999999999999999999999999999999999999999998643210
Q ss_pred CCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHHHHHHHhCC
Q 005427 229 PTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGG 308 (697)
Q Consensus 229 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (697)
........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.........+....
T Consensus 147 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~-------------- 209 (312)
T cd05585 147 ---DDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEP-------------- 209 (312)
T ss_pred ---CCccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCC--------------
Confidence 011345679999999999999999999999999999999999999998765544333332211
Q ss_pred CCCcccccccCChHHHHHHHHHhccCCCCCCC---CHHHHHHHHHHH
Q 005427 309 LRPILASLELGLPASILSLIQRCWDGNPHNRP---SFSDIALELDLV 352 (697)
Q Consensus 309 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp---t~~ell~~l~~~ 352 (697)
...+..+++++.++|.+||+.||.+|| ++.+++.|+|+.
T Consensus 210 -----~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~ 251 (312)
T cd05585 210 -----LRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFS 251 (312)
T ss_pred -----CCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcC
Confidence 123456889999999999999999997 578888887753
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=351.00 Aligned_cols=271 Identities=24% Similarity=0.327 Sum_probs=206.9
Q ss_pred CcccccccccCCceEEEEEEE--CCeeEEEEeccCC--ChHHHHHHHHHHHHHHhcCCCCceEEeeccccC-----CceE
Q 005427 67 SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKP-----PNYM 137 (697)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-----~~~~ 137 (697)
+|++.++||+|+||.||+|.+ +++.||+|++... .......+.+|+.+++.++||||+++++++... ..++
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 589999999999999999987 5789999986532 223455788999999999999999999987543 3489
Q ss_pred EEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhh
Q 005427 138 FFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKE 217 (697)
Q Consensus 138 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~ 217 (697)
+||||+. ++|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 81 lv~e~~~-~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 158 (338)
T cd07859 81 VVFELME-SDLHQVIKAND-DLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 158 (338)
T ss_pred EEEecCC-CCHHHHHHhcc-cCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccC
Confidence 9999996 58988886544 689999999999999999999999999999999999999999999999999875432110
Q ss_pred hhcccccCCCCCCCCccccccccCccccchhhhcc--cCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccc
Q 005427 218 ISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK--EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNY 295 (697)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~ 295 (697)
.........||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.........+.....
T Consensus 159 -------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~ 225 (338)
T cd07859 159 -------------TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLG 225 (338)
T ss_pred -------------ccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhC
Confidence 0011234579999999999876 6789999999999999999999999987654433322221111
Q ss_pred c-HHHHHHHHHh-----------CCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 296 T-EQQLTAAVVS-----------GGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 296 ~-~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
. .......+.. ......+......+++++.+++.+||+.||++|||++++++|.|+.
T Consensus 226 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~ 294 (338)
T cd07859 226 TPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFK 294 (338)
T ss_pred CCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhh
Confidence 1 1111111100 0001111111235788899999999999999999999999998874
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=343.86 Aligned_cols=263 Identities=25% Similarity=0.352 Sum_probs=207.2
Q ss_pred CCCCCcccccccccCCceEEEEEEEC------------------CeeEEEEeccCCC-hHHHHHHHHHHHHHHhcCCCCc
Q 005427 63 LPPSSYTLLSPIARGAESVVYEATLD------------------GRKVAVKKPILST-SEELDNFHKELQLLCKLDHPGL 123 (697)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~~------------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpni 123 (697)
++..+|++.++||+|+||.||+|.+. +..||+|.+.... ......+.+|+.+|..++||||
T Consensus 2 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 81 (304)
T cd05096 2 FPRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNI 81 (304)
T ss_pred CchhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCe
Confidence 55679999999999999999999742 3369999876543 3345678999999999999999
Q ss_pred eEEeeccccCCceEEEEeecCCCCHhhhhhhcC------------------CCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 005427 124 AKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEE------------------WSPSVDQVLMIAAQLAKALQYLHNLGIVH 185 (697)
Q Consensus 124 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~------------------~~~~~~~~~~i~~qi~~~l~~LH~~~ivH 185 (697)
+++++++.+....+++|||+.+|+|.+++.... ..+++.+++.++.|++.||.|||+.||+|
T Consensus 82 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH 161 (304)
T cd05096 82 IRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVH 161 (304)
T ss_pred eEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 999999999999999999999999999885432 23577889999999999999999999999
Q ss_pred ccCCCCceeecCCCCCeeeeeccchhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHH
Q 005427 186 RDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFG 265 (697)
Q Consensus 186 rDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG 265 (697)
|||||+|||++.++.+||+|||++........ ........++..|+|||++.+..++.++||||||
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~--------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG 227 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDY--------------YRIQGRAVLPIRWMAWECILMGKFTTASDVWAFG 227 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCce--------------eEecCcCCCCccccCHHHHhcCCCCchhhhHHHH
Confidence 99999999999999999999999865432110 0012234567899999999988899999999999
Q ss_pred HHHHHHHh--CCCCCCCchhHHHHHHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHH
Q 005427 266 ISINELLT--GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFS 343 (697)
Q Consensus 266 ~~l~ell~--g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ 343 (697)
|++|+|++ +..||.+.............. ...........+..+|..+.+|+.+||+.||.+|||+.
T Consensus 228 ~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~ 296 (304)
T cd05096 228 VTLWEILMLCKEQPYGELTDEQVIENAGEFF-----------RDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFS 296 (304)
T ss_pred HHHHHHHHccCCCCCCcCCHHHHHHHHHHHh-----------hhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHH
Confidence 99999986 678888765443332221100 01111111122346789999999999999999999999
Q ss_pred HHHHHHH
Q 005427 344 DIALELD 350 (697)
Q Consensus 344 ell~~l~ 350 (697)
+|.+.|.
T Consensus 297 ~i~~~l~ 303 (304)
T cd05096 297 DIHAFLT 303 (304)
T ss_pred HHHHHHh
Confidence 9977653
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=347.33 Aligned_cols=271 Identities=24% Similarity=0.295 Sum_probs=206.7
Q ss_pred CCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCChH-HHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEe
Q 005427 65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSE-ELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFE 141 (697)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 141 (697)
.++|++.++||+|+||.||+|+. +++.||+|++...... ....+.+|+.+++.++||||+++++++.++...++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 36899999999999999999987 5788999987644322 23457789999999999999999999999999999999
Q ss_pred ecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhcc
Q 005427 142 FYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLK 221 (697)
Q Consensus 142 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~ 221 (697)
|+. ++|.+++......++++.+..++.|++.||+|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~------ 156 (303)
T cd07869 84 YVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVP------ 156 (303)
T ss_pred CCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCC------
Confidence 996 5888888766667889999999999999999999999999999999999999999999999998643210
Q ss_pred cccCCCCCCCCccccccccCccccchhhhcc-cCCCchhhHHHHHHHHHHHHhCCCCCCCchhHH-HHHHHHhcccc--H
Q 005427 222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLTGVVPYTDLRAEA-QAHTVLEMNYT--E 297 (697)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~-~~~~~~~~~~~--~ 297 (697)
........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+..... ....+...... .
T Consensus 157 ----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 226 (303)
T cd07869 157 ----------SHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNE 226 (303)
T ss_pred ----------CccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCCh
Confidence 011234568999999999875 457889999999999999999999998754322 22221111000 0
Q ss_pred HHHHHHHHhCCCCC---------ccc--ccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 298 QQLTAAVVSGGLRP---------ILA--SLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 298 ~~~~~~~~~~~~~~---------~~~--~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
..+........+.+ .+. .....+++++.+|+.+||+.||++|||+.|+++|.|+.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~ 292 (303)
T cd07869 227 DTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFS 292 (303)
T ss_pred hhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccc
Confidence 00000000000000 000 00113567899999999999999999999999998874
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=352.14 Aligned_cols=245 Identities=23% Similarity=0.321 Sum_probs=205.6
Q ss_pred cccccCCceEEEEEEE--CCeeEEEEeccCC---ChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEeecCCC
Q 005427 72 SPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESR 146 (697)
Q Consensus 72 ~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g 146 (697)
+.||+|+||.||+++. +++.||+|++... .......+.+|+.+++.++||||+++++.+.....+++||||+.+|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 4699999999999986 5789999986532 2334567788999999999999999999999999999999999999
Q ss_pred CHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhcccccCC
Q 005427 147 NLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSS 226 (697)
Q Consensus 147 ~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~ 226 (697)
+|..++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 ~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~----------- 148 (323)
T cd05595 81 ELFFHLSRER-VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD----------- 148 (323)
T ss_pred cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCC-----------
Confidence 9998886554 6899999999999999999999999999999999999999999999999988642110
Q ss_pred CCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHHHHHHHh
Q 005427 227 GKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVS 306 (697)
Q Consensus 227 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (697)
........||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+...
T Consensus 149 -----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~------------- 210 (323)
T cd05595 149 -----GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME------------- 210 (323)
T ss_pred -----CCccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-------------
Confidence 01123457999999999999999999999999999999999999999876554443333211
Q ss_pred CCCCCcccccccCChHHHHHHHHHhccCCCCCCC-----CHHHHHHHHHHH
Q 005427 307 GGLRPILASLELGLPASILSLIQRCWDGNPHNRP-----SFSDIALELDLV 352 (697)
Q Consensus 307 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~ell~~l~~~ 352 (697)
.. ..+..+++++.++|.+||+.||.+|| ++.++++|.|+.
T Consensus 211 -~~-----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~ 255 (323)
T cd05595 211 -EI-----RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL 255 (323)
T ss_pred -CC-----CCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcC
Confidence 11 12456899999999999999999998 899999987664
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=313.71 Aligned_cols=266 Identities=22% Similarity=0.387 Sum_probs=212.6
Q ss_pred cCCCCCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccccCC---
Q 005427 60 PLHLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPP--- 134 (697)
Q Consensus 60 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~--- 134 (697)
...++.+||++.++||+|||+-||++.. ++..+|+|++.+...++.+..++|++..++++|||+++++++.....
T Consensus 15 tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~ 94 (302)
T KOG2345|consen 15 TVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDG 94 (302)
T ss_pred cEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccC
Confidence 4567889999999999999999999984 78899999999999899999999999999999999999998875543
Q ss_pred --ceEEEEeecCCCCHhhhhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccccCCCCceeecCCCCCeeeeec
Q 005427 135 --NYMFFFEFYESRNLAEKLHV---EEWSPSVDQVLMIAAQLAKALQYLHNLG--IVHRDVKPANVLLDRNLCPHLADFG 207 (697)
Q Consensus 135 --~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~~~~kL~Dfg 207 (697)
..|++++|+..|+|.+.+.. ++..+++.+++.++.++++||++||+.. ++||||||.|||++..+.++|.|||
T Consensus 95 ~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~G 174 (302)
T KOG2345|consen 95 KHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLG 174 (302)
T ss_pred ceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEecc
Confidence 48999999999999998754 3446899999999999999999999998 9999999999999999999999999
Q ss_pred cchhhhh-----hhhhhcccccCCCCCCCCccccccccCccccchhhhc---ccCCCchhhHHHHHHHHHHHHhCCCCCC
Q 005427 208 LAEYREN-----LKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILK---KEIHSEKSDVYSFGISINELLTGVVPYT 279 (697)
Q Consensus 208 ~a~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~~l~ell~g~~Pf~ 279 (697)
.++...- .+......| ..-..|..|+|||.+. +...+.++|||||||+||.|+.|..||.
T Consensus 175 S~~~a~i~i~~~~~a~~lQe~------------a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe 242 (302)
T KOG2345|consen 175 SATQAPIQIEGSRQALRLQEW------------AEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFE 242 (302)
T ss_pred CccccceEeechHHHHHHHHH------------HHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcch
Confidence 9865431 111111111 1224688999999985 4456889999999999999999999996
Q ss_pred CchhHHHHHHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 280 DLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
..-. .. ..+..++.++.+ .++.. ..+|..+.++++.||+.||.+||++.+++.+++.+
T Consensus 243 ~~~~---------~G---gSlaLAv~n~q~--s~P~~-~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 243 RIYQ---------QG---GSLALAVQNAQI--SIPNS-SRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred HHhh---------cC---CeEEEeeecccc--ccCCC-CCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 4211 00 000001111111 11111 23899999999999999999999999999888765
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=352.67 Aligned_cols=244 Identities=24% Similarity=0.308 Sum_probs=204.9
Q ss_pred cccccCCceEEEEEEE--CCeeEEEEeccCC---ChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEeecCCC
Q 005427 72 SPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESR 146 (697)
Q Consensus 72 ~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g 146 (697)
+.||+|+||.||++++ +++.||+|++... .......+.+|+.+|+.++||||+++++.+.....+++||||+.+|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 4689999999999987 5789999986532 2334567889999999999999999999999999999999999999
Q ss_pred CHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhcccccCC
Q 005427 147 NLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSS 226 (697)
Q Consensus 147 ~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~ 226 (697)
+|.+.+.... .+++.+++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 81 ~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~----------- 148 (328)
T cd05593 81 ELFFHLSRER-VFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD----------- 148 (328)
T ss_pred CHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCc-----------
Confidence 9998886554 6899999999999999999999999999999999999999999999999998643210
Q ss_pred CCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHHHHHHHh
Q 005427 227 GKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVS 306 (697)
Q Consensus 227 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (697)
.......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+....
T Consensus 149 -----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~------------ 211 (328)
T cd05593 149 -----AATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMED------------ 211 (328)
T ss_pred -----ccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCC------------
Confidence 011234579999999999999999999999999999999999999998765443333222111
Q ss_pred CCCCCcccccccCChHHHHHHHHHhccCCCCCCC-----CHHHHHHHHHH
Q 005427 307 GGLRPILASLELGLPASILSLIQRCWDGNPHNRP-----SFSDIALELDL 351 (697)
Q Consensus 307 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~ell~~l~~ 351 (697)
...+..+++++.++|++||+.||.+|| ++.++++|.|+
T Consensus 212 -------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~ 254 (328)
T cd05593 212 -------IKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFF 254 (328)
T ss_pred -------ccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCc
Confidence 113456889999999999999999997 89999998775
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=360.57 Aligned_cols=288 Identities=24% Similarity=0.418 Sum_probs=244.5
Q ss_pred ccCCCcccCCCCCCCCccCCCCCCCcccccccccCCceEEEEEEEC-----CeeEEEEeccCCC-hHHHHHHHHHHHHHH
Q 005427 43 VLEPNTCIRGCCSSQSIPLHLPPSSYTLLSPIARGAESVVYEATLD-----GRKVAVKKPILST-SEELDNFHKELQLLC 116 (697)
Q Consensus 43 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~ 116 (697)
+.+|.+....+.....+..+++.+..+|.++||.|.||+|++|+.+ ...||||.++..- .+....|..|+.||-
T Consensus 606 YiDP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMG 685 (996)
T KOG0196|consen 606 YIDPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMG 685 (996)
T ss_pred ecCCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcc
Confidence 5566666665555556667888899999999999999999999862 3469999766553 445778999999999
Q ss_pred hcCCCCceEEeeccccCCceEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeec
Q 005427 117 KLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLD 196 (697)
Q Consensus 117 ~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~ 196 (697)
+++||||++|.++.......++|+|||++|+|..+|+.+...|+..++..+++.|+.|++||-+.++|||||..+|||++
T Consensus 686 QFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVN 765 (996)
T KOG0196|consen 686 QFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVN 765 (996)
T ss_pred cCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeec
Confidence 99999999999999999999999999999999999999988999999999999999999999999999999999999999
Q ss_pred CCCCCeeeeeccchhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CC
Q 005427 197 RNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GV 275 (697)
Q Consensus 197 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~ 275 (697)
.+..+|++|||+++.+++.. ...+.+....-+.+|.|||.+....++.+|||||+|++|||.++ |+
T Consensus 766 snLvCKVsDFGLSRvledd~-------------~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGE 832 (996)
T KOG0196|consen 766 SNLVCKVSDFGLSRVLEDDP-------------EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGE 832 (996)
T ss_pred cceEEEeccccceeecccCC-------------CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCC
Confidence 99999999999999876522 11122223344689999999999999999999999999999998 99
Q ss_pred CCCCCchhHHHHHHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 005427 276 VPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH 355 (697)
Q Consensus 276 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~ 355 (697)
.||.+..+.+....+.+ ++|- ..|.++|..|.+||..||++|-.+||.|.||+..|+++..+
T Consensus 833 RPYWdmSNQdVIkaIe~---------------gyRL---PpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 833 RPYWDMSNQDVIKAIEQ---------------GYRL---PPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred CcccccchHHHHHHHHh---------------ccCC---CCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 99998776665554432 2221 13568999999999999999999999999999999999987
Q ss_pred hccccc
Q 005427 356 RKSLKE 361 (697)
Q Consensus 356 ~~~~~~ 361 (697)
..+++.
T Consensus 895 P~SLk~ 900 (996)
T KOG0196|consen 895 PNSLKT 900 (996)
T ss_pred chhhcc
Confidence 666653
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=351.51 Aligned_cols=255 Identities=25% Similarity=0.386 Sum_probs=220.5
Q ss_pred CCcccccccccCCceEEEEEEECC--eeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEeec
Q 005427 66 SSYTLLSPIARGAESVVYEATLDG--RKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFY 143 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 143 (697)
+-|.|+..||.|+||.||+|.... -..|.|++.....++.+.+.-|++||..+.||+||+|++.|...+.+|++.|||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 458999999999999999997643 345778888888889999999999999999999999999999999999999999
Q ss_pred CCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhcccc
Q 005427 144 ESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNW 223 (697)
Q Consensus 144 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~ 223 (697)
.||-+..++-.-+..++++++..+++|++.||.|||+.+|+|||||..|||++-+|.++|+|||.+........
T Consensus 112 ~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~q------ 185 (1187)
T KOG0579|consen 112 GGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQ------ 185 (1187)
T ss_pred CCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHHh------
Confidence 99999999888787899999999999999999999999999999999999999999999999998754322111
Q ss_pred cCCCCCCCCccccccccCccccchhhhc-----ccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHH
Q 005427 224 RSSGKPTGGFHKKNMVGTLIYMAPEILK-----KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQ 298 (697)
Q Consensus 224 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~ 298 (697)
...++.|||+|||||++. ..+|+.++||||||++|.||..+.+|-...+....+.++....
T Consensus 186 ----------kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSe---- 251 (1187)
T KOG0579|consen 186 ----------KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE---- 251 (1187)
T ss_pred ----------hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcC----
Confidence 245789999999999874 6789999999999999999999999998877666555543221
Q ss_pred HHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 299 QLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
.|.+ ..|..++..+.+|++.||..||..||++.+|++|+|..
T Consensus 252 -----------PPTL-lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~ 293 (1187)
T KOG0579|consen 252 -----------PPTL-LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQ 293 (1187)
T ss_pred -----------CCcc-cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccc
Confidence 1222 12456889999999999999999999999999998874
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=354.11 Aligned_cols=265 Identities=25% Similarity=0.397 Sum_probs=212.9
Q ss_pred CCCccCCCCCCCcccccccccCCceEEEEEEE-------CCeeEEEEeccCCC-hHHHHHHHHHHHHHHhc-CCCCceEE
Q 005427 56 SQSIPLHLPPSSYTLLSPIARGAESVVYEATL-------DGRKVAVKKPILST-SEELDNFHKELQLLCKL-DHPGLAKF 126 (697)
Q Consensus 56 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~l 126 (697)
+....+.++.++|++.++||+|+||.||+|++ .+..||||++.... ....+.+.+|+.+|+.+ +||||+++
T Consensus 25 ~~~~~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l 104 (375)
T cd05104 25 PYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNL 104 (375)
T ss_pred CCccccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeee
Confidence 33446677888999999999999999999963 34579999865432 34456789999999999 89999999
Q ss_pred eeccccCCceEEEEeecCCCCHhhhhhhcC--------------------------------------------------
Q 005427 127 VAAHAKPPNYMFFFEFYESRNLAEKLHVEE-------------------------------------------------- 156 (697)
Q Consensus 127 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-------------------------------------------------- 156 (697)
++++......++||||+++|+|.+++....
T Consensus 105 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 184 (375)
T cd05104 105 LGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKAD 184 (375)
T ss_pred eeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccc
Confidence 999999999999999999999999886432
Q ss_pred ------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhh
Q 005427 157 ------------------------WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYR 212 (697)
Q Consensus 157 ------------------------~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~ 212 (697)
..+++..++.++.|++.||+|||+.||+||||||+|||++.++.+||+|||++...
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~ 264 (375)
T cd05104 185 KRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDI 264 (375)
T ss_pred cccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceec
Confidence 13677889999999999999999999999999999999999999999999998754
Q ss_pred hhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCCchhHHHHHHHH
Q 005427 213 ENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVL 291 (697)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~~~~~~~~~~~~ 291 (697)
...... .......++..|+|||++.+..++.++|||||||++|||++ |..||............+
T Consensus 265 ~~~~~~--------------~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~ 330 (375)
T cd05104 265 RNDSNY--------------VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMI 330 (375)
T ss_pred cCcccc--------------cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHH
Confidence 321110 01122345678999999999999999999999999999998 899998754332222221
Q ss_pred hccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 005427 292 EMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL 351 (697)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~ 351 (697)
..+.++. .+...+.++.+|+..||+.||++|||+.+|++.|+.
T Consensus 331 --------------~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 331 --------------KEGYRML---SPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred --------------HhCccCC---CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 1222221 223467899999999999999999999999988875
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=335.77 Aligned_cols=256 Identities=22% Similarity=0.351 Sum_probs=210.5
Q ss_pred CCCCCcccccccccCCceEEEEEEE-----CCeeEEEEeccCCC-hHHHHHHHHHHHHHHhcCCCCceEEeeccccCCce
Q 005427 63 LPPSSYTLLSPIARGAESVVYEATL-----DGRKVAVKKPILST-SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNY 136 (697)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 136 (697)
+..++|++.+.||+|+||.||+|.+ .+..||+|...... ......+.+|+.+++.++||||+++++++......
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 81 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTM 81 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCc
Confidence 4567899999999999999999975 25689999866543 23456789999999999999999999999999999
Q ss_pred EEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhh
Q 005427 137 MFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLK 216 (697)
Q Consensus 137 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~ 216 (697)
++||||+.+|+|.+++......+++.+++.++.|++.||+|||++|++||||||+|||++.++.+||+|||.+.......
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~ 161 (266)
T cd05064 82 MIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEA 161 (266)
T ss_pred EEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccccc
Confidence 99999999999999997765678999999999999999999999999999999999999999999999999875432100
Q ss_pred hhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCCchhHHHHHHHHhccc
Q 005427 217 EISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNY 295 (697)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~~~~~~~~~~~~~~~~ 295 (697)
........++..|+|||++.+..++.++|||||||++||+++ |..||.+.........+.
T Consensus 162 ---------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~---- 222 (266)
T cd05064 162 ---------------IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVE---- 222 (266)
T ss_pred ---------------hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHH----
Confidence 001122345678999999999999999999999999999875 999998765443332221
Q ss_pred cHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 005427 296 TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL 351 (697)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~ 351 (697)
.+.++ ..+..++..+.+++.+||+.+|.+||++.+|++.+..
T Consensus 223 -----------~~~~~---~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~ 264 (266)
T cd05064 223 -----------DGFRL---PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSK 264 (266)
T ss_pred -----------CCCCC---CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence 11111 1245688999999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=344.13 Aligned_cols=269 Identities=24% Similarity=0.320 Sum_probs=212.5
Q ss_pred CCCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCC-hHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEE
Q 005427 63 LPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST-SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFF 139 (697)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 139 (697)
+..++|++.++||+|+||.||++.+ ++..+|+|.+.... ......+.+|+++|+.++||||+++++++.....+++|
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 81 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEE
Confidence 4568999999999999999999987 57789999766543 33456789999999999999999999999999999999
Q ss_pred EeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccccCCCCceeecCCCCCeeeeeccchhhhhhhhh
Q 005427 140 FEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL-GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI 218 (697)
Q Consensus 140 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~ 218 (697)
|||+.+++|.+++...+ .+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 82 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--- 157 (333)
T cd06650 82 MEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 157 (333)
T ss_pred EecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh---
Confidence 99999999999987654 678899999999999999999985 7999999999999999999999999998654321
Q ss_pred hcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHH---hccc
Q 005427 219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVL---EMNY 295 (697)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~---~~~~ 295 (697)
......|++.|+|||++.+..++.++|+|||||++|+|++|..||...........+. ....
T Consensus 158 ---------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 222 (333)
T cd06650 158 ---------------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDP 222 (333)
T ss_pred ---------------ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCc
Confidence 1223468999999999999889999999999999999999999997654322211110 0000
Q ss_pred c---------------------------HHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005427 296 T---------------------------EQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALE 348 (697)
Q Consensus 296 ~---------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 348 (697)
. .......+.. ...+..+ ...++.++.+|+.+||+.||++|||+.|++.|
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~--~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h 299 (333)
T cd06650 223 AESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVN-EPPPKLP--SGVFGAEFQDFVNKCLIKNPAERADLKQLMVH 299 (333)
T ss_pred cccccCcccCCccchhhhhcccccccccHHHHHHHHhc-CCCccCC--CCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence 0 0000011111 1111111 12367899999999999999999999999999
Q ss_pred HHHHH
Q 005427 349 LDLVL 353 (697)
Q Consensus 349 l~~~~ 353 (697)
.|...
T Consensus 300 ~~~~~ 304 (333)
T cd06650 300 AFIKR 304 (333)
T ss_pred HHHhc
Confidence 88753
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=352.79 Aligned_cols=263 Identities=27% Similarity=0.412 Sum_probs=211.8
Q ss_pred cCCCCCCCcccccccccCCceEEEEEEEC-------CeeEEEEeccCCC-hHHHHHHHHHHHHHHhc-CCCCceEEeecc
Q 005427 60 PLHLPPSSYTLLSPIARGAESVVYEATLD-------GRKVAVKKPILST-SEELDNFHKELQLLCKL-DHPGLAKFVAAH 130 (697)
Q Consensus 60 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~l~~~~ 130 (697)
.+.++.++|++.+.||+|+||.||+|++. +..||+|++.... ......+.+|+.+++.+ +||||+++++++
T Consensus 32 ~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~ 111 (374)
T cd05106 32 KWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGAC 111 (374)
T ss_pred cccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEe
Confidence 45677789999999999999999999751 2479999876543 34466789999999999 899999999999
Q ss_pred ccCCceEEEEeecCCCCHhhhhhhcC------------------------------------------------------
Q 005427 131 AKPPNYMFFFEFYESRNLAEKLHVEE------------------------------------------------------ 156 (697)
Q Consensus 131 ~~~~~~~lv~e~~~~g~L~~~l~~~~------------------------------------------------------ 156 (697)
......++||||+.+|+|.+++....
T Consensus 112 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (374)
T cd05106 112 THGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSS 191 (374)
T ss_pred cCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccc
Confidence 99999999999999999999885421
Q ss_pred ---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhcc
Q 005427 157 ---------------WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLK 221 (697)
Q Consensus 157 ---------------~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~ 221 (697)
.++++.+++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 192 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~---- 267 (374)
T cd05106 192 SQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSN---- 267 (374)
T ss_pred cccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcc----
Confidence 2467888999999999999999999999999999999999999999999999865432110
Q ss_pred cccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCCchhHHHHHHHHhccccHHHH
Q 005427 222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQL 300 (697)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 300 (697)
.....+..+++.|+|||++.+..++.++|||||||++|+|++ |..||.............
T Consensus 268 ----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~--------- 328 (374)
T cd05106 268 ----------YVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMV--------- 328 (374)
T ss_pred ----------eeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHH---------
Confidence 001123345678999999999899999999999999999997 999998654322222111
Q ss_pred HHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 005427 301 TAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL 353 (697)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~ 353 (697)
..+.++. .+..+++++.+++.+||+.||.+|||+.++++.|..++
T Consensus 329 -----~~~~~~~---~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 329 -----KRGYQMS---RPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred -----HcccCcc---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 1122221 23356899999999999999999999999999887754
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=360.98 Aligned_cols=268 Identities=23% Similarity=0.285 Sum_probs=205.4
Q ss_pred CCCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccccC-------
Q 005427 63 LPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKP------- 133 (697)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~------- 133 (697)
....+|++.++||+|+||.||+|.+ +++.||||++.... ....+|+.+|+.++||||+++++++...
T Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~ 138 (440)
T PTZ00036 63 SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEK 138 (440)
T ss_pred CcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCC
Confidence 3456899999999999999999987 57899999764322 2345799999999999999998876432
Q ss_pred -CceEEEEeecCCCCHhhhhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCC-CCeeeeecc
Q 005427 134 -PNYMFFFEFYESRNLAEKLHV---EEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNL-CPHLADFGL 208 (697)
Q Consensus 134 -~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~-~~kL~Dfg~ 208 (697)
..+++||||+++ +|.+++.. ....+++..++.++.|++.||+|||+.||+||||||+|||++.++ .+||+|||+
T Consensus 139 ~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGl 217 (440)
T PTZ00036 139 NIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGS 217 (440)
T ss_pred ceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeecccc
Confidence 246789999985 67666542 344688999999999999999999999999999999999998664 799999999
Q ss_pred chhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhccc-CCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHH
Q 005427 209 AEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKE-IHSEKSDVYSFGISINELLTGVVPYTDLRAEAQA 287 (697)
Q Consensus 209 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~ 287 (697)
++.+... .......||+.|+|||++.+. .++.++|||||||++|||++|.+||.+.......
T Consensus 218 a~~~~~~-----------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~ 280 (440)
T PTZ00036 218 AKNLLAG-----------------QRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQL 280 (440)
T ss_pred chhccCC-----------------CCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 9754321 112345789999999998764 6899999999999999999999999987766655
Q ss_pred HHHHhccccHHHHHHHHHhCCC-----C-----CcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 288 HTVLEMNYTEQQLTAAVVSGGL-----R-----PILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~-----~-----~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
..+......+...........+ . ......+...|+++.+||.+||++||.+|||+.|+++|.|+.
T Consensus 281 ~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~ 355 (440)
T PTZ00036 281 VRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFD 355 (440)
T ss_pred HHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHH
Confidence 5554432221111111111000 0 011112445788999999999999999999999999999874
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=350.19 Aligned_cols=268 Identities=26% Similarity=0.442 Sum_probs=226.3
Q ss_pred CCccCCCCCCCcccccccccCCceEEEEEEE--C-C--ee-EEEEeccC---CChHHHHHHHHHHHHHHhcCCCCceEEe
Q 005427 57 QSIPLHLPPSSYTLLSPIARGAESVVYEATL--D-G--RK-VAVKKPIL---STSEELDNFHKELQLLCKLDHPGLAKFV 127 (697)
Q Consensus 57 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~-~--~~-vavK~~~~---~~~~~~~~~~~E~~~l~~l~hpniv~l~ 127 (697)
...+|++..++..+.++||+|+||.||+|+. . + .. ||+|.... ...+.+..+.+|+++|++++|||||++|
T Consensus 148 ~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~y 227 (474)
T KOG0194|consen 148 PRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFY 227 (474)
T ss_pred cccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEE
Confidence 3446888899999999999999999999976 2 1 23 89998764 3356788999999999999999999999
Q ss_pred eccccCCceEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeec
Q 005427 128 AAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFG 207 (697)
Q Consensus 128 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg 207 (697)
|+......+++|||+|.||+|.++|.+.+..++..+...++.+++.||+|||+.+++||||-.+|+|++.++.+||+|||
T Consensus 228 GVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFG 307 (474)
T KOG0194|consen 228 GVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFG 307 (474)
T ss_pred EEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccc
Confidence 99999999999999999999999999888779999999999999999999999999999999999999999999999999
Q ss_pred cchhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCCchhHHH
Q 005427 208 LAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQ 286 (697)
Q Consensus 208 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~~~~~~~ 286 (697)
+++.-.... .......-+..|+|||.+....|++++|||||||++||+++ |..||.+......
T Consensus 308 Ls~~~~~~~----------------~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v 371 (474)
T KOG0194|consen 308 LSRAGSQYV----------------MKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEV 371 (474)
T ss_pred cccCCccee----------------eccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHH
Confidence 986432100 00112245789999999999999999999999999999999 8999998876655
Q ss_pred HHHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhc
Q 005427 287 AHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHRK 357 (697)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~~~ 357 (697)
...+. ..+++... +...|.++..++.+||..+|+.|||+.++.+.+..+.....
T Consensus 372 ~~kI~--------------~~~~r~~~---~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 372 KAKIV--------------KNGYRMPI---PSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred HHHHH--------------hcCccCCC---CCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 44443 23333322 34678999999999999999999999999999988876543
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=363.22 Aligned_cols=254 Identities=24% Similarity=0.347 Sum_probs=212.7
Q ss_pred CCcccccccccCCceEEEEEEE--C-CeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEee
Q 005427 66 SSYTLLSPIARGAESVVYEATL--D-GRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF 142 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 142 (697)
..|.+.+.||+|+||.||+|.. + ++.||+|............+.+|+.+|+.++||||+++++++...+.+++||||
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~ 146 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY 146 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence 4599999999999999999976 3 577899977666666667788999999999999999999999999999999999
Q ss_pred cCCCCHhhhhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhh
Q 005427 143 YESRNLAEKLHV---EEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEIS 219 (697)
Q Consensus 143 ~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~ 219 (697)
+++|+|.+++.. ....+++.++..++.|++.||.|||+++|+||||||+|||++.++.+||+|||++..+.....
T Consensus 147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~-- 224 (478)
T PTZ00267 147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS-- 224 (478)
T ss_pred CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc--
Confidence 999999988753 234678999999999999999999999999999999999999999999999999976532110
Q ss_pred cccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHH
Q 005427 220 LKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQ 299 (697)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~ 299 (697)
.......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.........+..
T Consensus 225 ------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~------- 285 (478)
T PTZ00267 225 ------------LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLY------- 285 (478)
T ss_pred ------------cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-------
Confidence 0113456799999999999999999999999999999999999999987654443333322
Q ss_pred HHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 005427 300 LTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL 351 (697)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~ 351 (697)
+...+ .+..++.++.++|.+||..||++||++.+++.+.+.
T Consensus 286 -------~~~~~----~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~ 326 (478)
T PTZ00267 286 -------GKYDP----FPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFL 326 (478)
T ss_pred -------CCCCC----CCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHH
Confidence 22221 234678999999999999999999999999877554
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-41 Score=349.29 Aligned_cols=245 Identities=25% Similarity=0.374 Sum_probs=204.4
Q ss_pred ccccccCCceEEEEEEE-----CCeeEEEEeccCC----ChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEe
Q 005427 71 LSPIARGAESVVYEATL-----DGRKVAVKKPILS----TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFE 141 (697)
Q Consensus 71 ~~~lg~G~~g~V~~~~~-----~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 141 (697)
+++||+|+||.||+++. .++.||+|++... .......+.+|+.+|+.++||||+++++++..+..+++|||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 36899999999999975 4678999986532 22334567899999999999999999999999999999999
Q ss_pred ecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhcc
Q 005427 142 FYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLK 221 (697)
Q Consensus 142 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~ 221 (697)
|+.+++|.+.+...+ .+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~------ 153 (323)
T cd05584 81 YLSGGELFMHLEREG-IFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE------ 153 (323)
T ss_pred CCCCchHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccC------
Confidence 999999999987654 6788999999999999999999999999999999999999999999999998643210
Q ss_pred cccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHHH
Q 005427 222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLT 301 (697)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 301 (697)
........||+.|+|||++.+..++.++|||||||++|||++|..||.+.........+....
T Consensus 154 ----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~------- 216 (323)
T cd05584 154 ----------GTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGK------- 216 (323)
T ss_pred ----------CCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-------
Confidence 111234579999999999999889999999999999999999999998765544333332211
Q ss_pred HHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCC-----CHHHHHHHHHH
Q 005427 302 AAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRP-----SFSDIALELDL 351 (697)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~ell~~l~~ 351 (697)
...+..+++++.++|.+||+.||++|| +++++++|.|+
T Consensus 217 ------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~ 259 (323)
T cd05584 217 ------------LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFF 259 (323)
T ss_pred ------------CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCc
Confidence 123456789999999999999999999 89999988775
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=342.40 Aligned_cols=267 Identities=23% Similarity=0.305 Sum_probs=206.0
Q ss_pred CCcccccccccCCceEEEEEEE---CCeeEEEEeccCCCh--HHHHHHHHHHHHHHhc---CCCCceEEeeccc-----c
Q 005427 66 SSYTLLSPIARGAESVVYEATL---DGRKVAVKKPILSTS--EELDNFHKELQLLCKL---DHPGLAKFVAAHA-----K 132 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~---~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~hpniv~l~~~~~-----~ 132 (697)
.+|++.+.||+|+||.||+|++ .++.||+|.+..... .....+.+|+.+++.+ +||||+++++++. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 3799999999999999999986 357899997654322 2234566788777766 6999999999874 3
Q ss_pred CCceEEEEeecCCCCHhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchh
Q 005427 133 PPNYMFFFEFYESRNLAEKLHVEE-WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEY 211 (697)
Q Consensus 133 ~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~ 211 (697)
...++++|||+. ++|.+++.... ..+++.+++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||++..
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 159 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI 159 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEe
Confidence 456899999997 58988886532 3578999999999999999999999999999999999999999999999999865
Q ss_pred hhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHH
Q 005427 212 RENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVL 291 (697)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~ 291 (697)
.... .......||+.|+|||++.+..++.++|||||||++|||++|.+||.+.........+.
T Consensus 160 ~~~~-----------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~ 222 (290)
T cd07862 160 YSFQ-----------------MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKIL 222 (290)
T ss_pred ccCC-----------------cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHH
Confidence 4321 11334578999999999998899999999999999999999999999877666555554
Q ss_pred hccccH--HHHHHHH------HhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 005427 292 EMNYTE--QQLTAAV------VSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350 (697)
Q Consensus 292 ~~~~~~--~~~~~~~------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~ 350 (697)
...... ..+.... ........+......++..+.+++.+||+.||++|||+.++++|.|
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~ 289 (290)
T cd07862 223 DVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 289 (290)
T ss_pred HHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCC
Confidence 322111 1110000 0000111112233467889999999999999999999999998865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=352.08 Aligned_cols=266 Identities=21% Similarity=0.315 Sum_probs=205.8
Q ss_pred CCCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEE
Q 005427 63 LPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFF 140 (697)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 140 (697)
+...+|+++++||+|+||.||++.+ +++.||+|... ...+.+|+.+|+.|+||||+++++++......++++
T Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~ 162 (391)
T PHA03212 89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLIL 162 (391)
T ss_pred cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEE
Confidence 4456899999999999999999987 57889999632 245679999999999999999999999999999999
Q ss_pred eecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhc
Q 005427 141 EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL 220 (697)
Q Consensus 141 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~ 220 (697)
|++. ++|..++.... .+++.+++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 163 e~~~-~~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~---- 236 (391)
T PHA03212 163 PRYK-TDLYCYLAAKR-NIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN---- 236 (391)
T ss_pred ecCC-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccccc----
Confidence 9996 68888876544 68899999999999999999999999999999999999999999999999986432211
Q ss_pred ccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCch-------hHHHHHHHHhc
Q 005427 221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLR-------AEAQAHTVLEM 293 (697)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~-------~~~~~~~~~~~ 293 (697)
........||+.|+|||++.+..++.++|||||||++|||++|..||.... .......+...
T Consensus 237 -----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~ 305 (391)
T PHA03212 237 -----------ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRR 305 (391)
T ss_pred -----------ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHH
Confidence 011234679999999999999999999999999999999999998875422 11222222211
Q ss_pred ccc--------H----HHHHHHHHhC-CC----CCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 294 NYT--------E----QQLTAAVVSG-GL----RPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 294 ~~~--------~----~~~~~~~~~~-~~----~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
... . .......... .. ++... ....++.++.+||.+||+.||.+|||+.|+++|.|+.
T Consensus 306 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~ 380 (391)
T PHA03212 306 SGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWT-NLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQ 380 (391)
T ss_pred hcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHH-HHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhc
Confidence 100 0 0000011111 00 11111 1124677899999999999999999999999999874
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-41 Score=356.17 Aligned_cols=269 Identities=23% Similarity=0.318 Sum_probs=211.7
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccCC---ChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEE
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFF 140 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 140 (697)
++|++.+.||+|+||.||+|++ +++.||||++... .......+.+|+.+|+.++||||+++++++.++..+++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 3799999999999999999987 5789999986532 2234566889999999999999999999999999999999
Q ss_pred eecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhc
Q 005427 141 EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL 220 (697)
Q Consensus 141 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~ 220 (697)
||+.+|+|.+++...+ .+++..++.++.|++.||+|||+.||+||||||+|||++.++.+||+|||++..+........
T Consensus 81 E~~~~g~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~ 159 (364)
T cd05599 81 EYLPGGDMMTLLMKKD-TFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEF 159 (364)
T ss_pred CCCCCcHHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceeccccccccc
Confidence 9999999999987654 689999999999999999999999999999999999999999999999999875432111000
Q ss_pred ccccCCC----------CC------------CCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCC
Q 005427 221 KNWRSSG----------KP------------TGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278 (697)
Q Consensus 221 ~~~~~~~----------~~------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf 278 (697)
....... .+ .........+||+.|+|||++.+..++.++|||||||++|||++|..||
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf 239 (364)
T cd05599 160 YRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPF 239 (364)
T ss_pred cccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCC
Confidence 0000000 00 0000112357999999999999999999999999999999999999999
Q ss_pred CCchhHHHHHHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCC---HHHHHHHHHH
Q 005427 279 TDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPS---FSDIALELDL 351 (697)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt---~~ell~~l~~ 351 (697)
.+.........+..... ....+ ....+++++.+||.+||. +|.+|++ +.++++|.|+
T Consensus 240 ~~~~~~~~~~~i~~~~~--------------~~~~~-~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~ 299 (364)
T cd05599 240 CSDNPQETYRKIINWKE--------------TLQFP-DEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFF 299 (364)
T ss_pred CCCCHHHHHHHHHcCCC--------------ccCCC-CCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCc
Confidence 87665444333332110 11111 122578999999999997 9999998 9999999876
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=324.55 Aligned_cols=253 Identities=22% Similarity=0.383 Sum_probs=218.8
Q ss_pred CCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEee
Q 005427 65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF 142 (697)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 142 (697)
.+-|.++++||+|+||.||++.+ .|..+|+|++... .+.+.+..|+.+|++++.|++|++|+.|.....+|+||||
T Consensus 32 EEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEY 109 (502)
T KOG0574|consen 32 EEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEY 109 (502)
T ss_pred HHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhh
Confidence 34589999999999999999976 7899999986544 4678899999999999999999999999999999999999
Q ss_pred cCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhccc
Q 005427 143 YESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKN 222 (697)
Q Consensus 143 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 222 (697)
|..|++.+.++.+..+++++++..+++..+.||+|||...-+|||||..|||++.+|..||+|||.+..+.+...
T Consensus 110 CGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA----- 184 (502)
T KOG0574|consen 110 CGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA----- 184 (502)
T ss_pred cCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHH-----
Confidence 999999999998888999999999999999999999999999999999999999999999999999987765332
Q ss_pred ccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHHHH
Q 005427 223 WRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTA 302 (697)
Q Consensus 223 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 302 (697)
...+..|||.|||||++..-.|..++||||||++..||..|++||.+..+..-...+-
T Consensus 185 -----------KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIP----------- 242 (502)
T KOG0574|consen 185 -----------KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIP----------- 242 (502)
T ss_pred -----------hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEecc-----------
Confidence 3567899999999999999999999999999999999999999999864432211110
Q ss_pred HHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 005427 303 AVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL 351 (697)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~ 351 (697)
....|.+ ..|...|.++-+++++||-.+|++|.|+.++++|...
T Consensus 243 ----T~PPPTF-~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~Fi 286 (502)
T KOG0574|consen 243 ----TKPPPTF-KKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFI 286 (502)
T ss_pred ----CCCCCCC-CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhh
Confidence 0111111 1245678999999999999999999999999988644
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=354.32 Aligned_cols=270 Identities=20% Similarity=0.265 Sum_probs=209.4
Q ss_pred CcccccccccCCceEEEEEEE--CCeeEEEEeccCC---ChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEe
Q 005427 67 SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFE 141 (697)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 141 (697)
.|+++++||+|+||+||+|++ +++.||+|++... .......+.+|+.+|+.++||||+++++++.++..+++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 689999999999999999987 5778999986543 23345678999999999999999999999999999999999
Q ss_pred ecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhcc
Q 005427 142 FYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLK 221 (697)
Q Consensus 142 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~ 221 (697)
|+++|+|.+++.... .+++..++.++.|++.||+|||+.||+||||||+|||++.++.+||+|||++..+.........
T Consensus 82 ~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~ 160 (381)
T cd05626 82 YIPGGDMMSLLIRME-VFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYY 160 (381)
T ss_pred cCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccc
Confidence 999999999987654 6889999999999999999999999999999999999999999999999998643211000000
Q ss_pred ---------cccC------C----------------CCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHH
Q 005427 222 ---------NWRS------S----------------GKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINE 270 (697)
Q Consensus 222 ---------~~~~------~----------------~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~e 270 (697)
.... . ............+||+.|+|||++.+..++.++|||||||++||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~e 240 (381)
T cd05626 161 QKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFE 240 (381)
T ss_pred cccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHH
Confidence 0000 0 00000011234689999999999999899999999999999999
Q ss_pred HHhCCCCCCCchhHHHHHHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhc--cCCCCCCCCHHHHHHH
Q 005427 271 LLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCW--DGNPHNRPSFSDIALE 348 (697)
Q Consensus 271 ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l--~~dP~~Rpt~~ell~~ 348 (697)
|++|..||...........+..... ....+ ....+++++.+||.+|+ ..+|..||++.+++.|
T Consensus 241 lltG~~Pf~~~~~~~~~~~i~~~~~--------------~~~~~-~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~h 305 (381)
T cd05626 241 MLVGQPPFLAPTPTETQLKVINWEN--------------TLHIP-PQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAH 305 (381)
T ss_pred HHhCCCCCcCCCHHHHHHHHHcccc--------------ccCCC-CCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 9999999987655443333322110 00011 12357899999999954 5566669999999999
Q ss_pred HHHH
Q 005427 349 LDLV 352 (697)
Q Consensus 349 l~~~ 352 (697)
.|+-
T Consensus 306 p~f~ 309 (381)
T cd05626 306 PFFS 309 (381)
T ss_pred cccC
Confidence 8863
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=348.16 Aligned_cols=247 Identities=25% Similarity=0.342 Sum_probs=204.6
Q ss_pred cccccccccCCceEEEEEEE--CCeeEEEEeccCC---ChHHHHHHHHHHHHH---HhcCCCCceEEeeccccCCceEEE
Q 005427 68 YTLLSPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLL---CKLDHPGLAKFVAAHAKPPNYMFF 139 (697)
Q Consensus 68 y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l---~~l~hpniv~l~~~~~~~~~~~lv 139 (697)
|++++.||+|+||.||+|.+ +++.||||++... .....+.+.+|++++ +.++||||+++++++.+...+|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 78899999999999999987 5789999986532 223455677777665 456799999999999999999999
Q ss_pred EeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhh
Q 005427 140 FEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEIS 219 (697)
Q Consensus 140 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~ 219 (697)
|||+.+++|...+.. ..+++.+++.++.|++.||+|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 81 ~E~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~----- 153 (324)
T cd05589 81 MEYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG----- 153 (324)
T ss_pred EcCCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCC-----
Confidence 999999999988754 3689999999999999999999999999999999999999999999999999864221
Q ss_pred cccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHH
Q 005427 220 LKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQ 299 (697)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~ 299 (697)
.+......+|++.|+|||++.+..++.++|||||||++|+|++|..||.+.........+...
T Consensus 154 -----------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~------ 216 (324)
T cd05589 154 -----------FGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVND------ 216 (324)
T ss_pred -----------CCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC------
Confidence 011234567999999999999999999999999999999999999999876554443333221
Q ss_pred HHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCC-----CHHHHHHHHHH
Q 005427 300 LTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRP-----SFSDIALELDL 351 (697)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~ell~~l~~ 351 (697)
.. ..+..+++++.++|.+||+.||.+|| ++.++++|.|+
T Consensus 217 --------~~-----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f 260 (324)
T cd05589 217 --------EV-----RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFF 260 (324)
T ss_pred --------CC-----CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCc
Confidence 11 12446889999999999999999999 68888887765
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=359.87 Aligned_cols=267 Identities=22% Similarity=0.323 Sum_probs=214.6
Q ss_pred cCCCCCCCcccccccccCCceEEEEEEE-CC-eeEEEEeccCCChHHHHHHHHHHHHHHhcC-CCCceEEeecc-cc---
Q 005427 60 PLHLPPSSYTLLSPIARGAESVVYEATL-DG-RKVAVKKPILSTSEELDNFHKELQLLCKLD-HPGLAKFVAAH-AK--- 132 (697)
Q Consensus 60 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~-~~--- 132 (697)
.+.+..-++++.+.|.+|||+.||+|++ .+ ..+|+|+....+....+.+++|+++|++|+ |+|||.+++.. ..
T Consensus 31 ~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~ 110 (738)
T KOG1989|consen 31 TFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSS 110 (738)
T ss_pred EEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccC
Confidence 4566777899999999999999999997 33 899999988888888999999999999996 99999999932 21
Q ss_pred ---CCceEEEEeecCCCCHhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC--cccccCCCCceeecCCCCCeeeee
Q 005427 133 ---PPNYMFFFEFYESRNLAEKLHVE-EWSPSVDQVLMIAAQLAKALQYLHNLG--IVHRDVKPANVLLDRNLCPHLADF 206 (697)
Q Consensus 133 ---~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~~~~kL~Df 206 (697)
.-.++|+||||.||.|.+++..+ ..+|++.++++|+.|+++|+++||... |||||||-+||||+.++..|||||
T Consensus 111 ~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDF 190 (738)
T KOG1989|consen 111 NNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDF 190 (738)
T ss_pred CCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcc
Confidence 13578999999999999999643 346999999999999999999999997 999999999999999999999999
Q ss_pred ccchhhhhhh-hhhcccccCCCCCCCCccccccccCccccchhhh---cccCCCchhhHHHHHHHHHHHHhCCCCCCCch
Q 005427 207 GLAEYRENLK-EISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEIL---KKEIHSEKSDVYSFGISINELLTGVVPYTDLR 282 (697)
Q Consensus 207 g~a~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~ 282 (697)
|.++..-... ......+. ...-...-|+.|+|||++ .+.+.++|+|||+|||+||-||....||.+..
T Consensus 191 GSatt~~~~~~~~~e~~~v--------e~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg 262 (738)
T KOG1989|consen 191 GSATTKILSPTSAQEVNYV--------EEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG 262 (738)
T ss_pred cccccccCCCccHHHHHHH--------HHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc
Confidence 9985322100 00000000 000112468999999986 58889999999999999999999999998753
Q ss_pred hHHHHHHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 005427 283 AEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH 355 (697)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~ 355 (697)
.. .|+...|.. +. .+.++..+.+||+.||+.||.+||++.|++.++..+...
T Consensus 263 ~l----aIlng~Y~~----------------P~-~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~ 314 (738)
T KOG1989|consen 263 KL----AILNGNYSF----------------PP-FPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK 314 (738)
T ss_pred ce----eEEeccccC----------------CC-CccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence 22 223333321 11 246899999999999999999999999999999888754
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=348.30 Aligned_cols=268 Identities=23% Similarity=0.283 Sum_probs=218.1
Q ss_pred CcccccccccCCceEEEEEEE--CCeeEEEEeccCCChHHHHHHHHHHHHHHhcC-C-----CCceEEeeccccCCceEE
Q 005427 67 SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLD-H-----PGLAKFVAAHAKPPNYMF 138 (697)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----pniv~l~~~~~~~~~~~l 138 (697)
+|.+++.||+|+||.|-+|.+ +++.||||+++.. ..-..+...|+.+|..|+ | -|+|+++++|...++.|+
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 789999999999999999987 6889999986543 344566788999999996 4 389999999999999999
Q ss_pred EEeecCCCCHhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecC--CCCCeeeeeccchhhhhh
Q 005427 139 FFEFYESRNLAEKLHVEE-WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDR--NLCPHLADFGLAEYRENL 215 (697)
Q Consensus 139 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~--~~~~kL~Dfg~a~~~~~~ 215 (697)
|+|.+.. +|+++++.+. ..++...++.|+.||+.||.+||+.||||+||||+||||.. ...|||+|||++++...
T Consensus 266 VfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q- 343 (586)
T KOG0667|consen 266 VFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQ- 343 (586)
T ss_pred eehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccccCC-
Confidence 9999975 9999998655 35789999999999999999999999999999999999954 34799999999987543
Q ss_pred hhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccc
Q 005427 216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNY 295 (697)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~ 295 (697)
...+++.+..|+|||++.|.+|+.+.|||||||+++||++|.+-|.+.+..+++..|.+...
T Consensus 344 ------------------~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG 405 (586)
T KOG0667|consen 344 ------------------RVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLG 405 (586)
T ss_pred ------------------cceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhC
Confidence 23377889999999999999999999999999999999999999999998888888776554
Q ss_pred cHHHHHHHHHhC---------------------------------------CCCC-ccccc----ccCChHHHHHHHHHh
Q 005427 296 TEQQLTAAVVSG---------------------------------------GLRP-ILASL----ELGLPASILSLIQRC 331 (697)
Q Consensus 296 ~~~~~~~~~~~~---------------------------------------~~~~-~~~~~----~~~~~~~l~~li~~~ 331 (697)
.++........+ ...| ..... +..-...+.++|++|
T Consensus 406 ~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~ 485 (586)
T KOG0667|consen 406 LPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRC 485 (586)
T ss_pred CCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHH
Confidence 332221111000 0000 00000 112235689999999
Q ss_pred ccCCCCCCCCHHHHHHHHHHHHHH
Q 005427 332 WDGNPHNRPSFSDIALELDLVLEH 355 (697)
Q Consensus 332 l~~dP~~Rpt~~ell~~l~~~~~~ 355 (697)
|.+||.+|+|+.+.++|.|.-...
T Consensus 486 L~~dP~~R~tp~qal~Hpfl~~~~ 509 (586)
T KOG0667|consen 486 LEWDPAERITPAQALNHPFLTGTS 509 (586)
T ss_pred hccCchhcCCHHHHhcCccccccc
Confidence 999999999999999999987544
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=351.33 Aligned_cols=269 Identities=22% Similarity=0.308 Sum_probs=209.2
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccCC---ChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEE
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFF 140 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 140 (697)
++|++.+.||+|+||+||++.+ +++.||+|++... .......+.+|+.++..++||||+++++.+.+...+++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 4799999999999999999987 5789999986532 2233467889999999999999999999999999999999
Q ss_pred eecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhc
Q 005427 141 EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL 220 (697)
Q Consensus 141 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~ 220 (697)
||+++|+|.+++...+ .+++.++..++.|++.||+|||+.||+||||||+|||++.++.+||+|||+++..........
T Consensus 81 E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~ 159 (363)
T cd05628 81 EFLPGGDMMTLLMKKD-TLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEF 159 (363)
T ss_pred cCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccccccccccc
Confidence 9999999999997654 789999999999999999999999999999999999999999999999999875432110000
Q ss_pred ccccCCCCC-------------------CCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCc
Q 005427 221 KNWRSSGKP-------------------TGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDL 281 (697)
Q Consensus 221 ~~~~~~~~~-------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~ 281 (697)
........+ .........+||+.|+|||++.+..++.++|||||||++|||++|..||.+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~ 239 (363)
T cd05628 160 YRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE 239 (363)
T ss_pred cccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCC
Confidence 000000000 0000123458999999999999999999999999999999999999999876
Q ss_pred hhHHHHHHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCC---CCCCHHHHHHHHHH
Q 005427 282 RAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPH---NRPSFSDIALELDL 351 (697)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~---~Rpt~~ell~~l~~ 351 (697)
........+..... ...++. ...+++++.++|.+|+. +|. .||+++||++|.|+
T Consensus 240 ~~~~~~~~i~~~~~--------------~~~~p~-~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f 296 (363)
T cd05628 240 TPQETYKKVMNWKE--------------TLIFPP-EVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFF 296 (363)
T ss_pred CHHHHHHHHHcCcC--------------cccCCC-cCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCC
Confidence 65554444432211 111111 12478899999998664 344 56899999999766
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=346.66 Aligned_cols=244 Identities=25% Similarity=0.360 Sum_probs=203.4
Q ss_pred cccccCCceEEEEEEE--CCeeEEEEeccCC---ChHHHHHHHHHHHHHHhc-CCCCceEEeeccccCCceEEEEeecCC
Q 005427 72 SPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKL-DHPGLAKFVAAHAKPPNYMFFFEFYES 145 (697)
Q Consensus 72 ~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~ 145 (697)
+.||+|+||.||+|++ +++.||+|++... .......+..|..++..+ +||||+++++++.....+++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999987 5788999986532 223456678888888876 799999999999999999999999999
Q ss_pred CCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhcccccC
Q 005427 146 RNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRS 225 (697)
Q Consensus 146 g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~ 225 (697)
|+|.+++.... .+++..++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 81 g~L~~~i~~~~-~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~----------- 148 (320)
T cd05590 81 GDLMFHIQKSR-RFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIF----------- 148 (320)
T ss_pred chHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCc-----------
Confidence 99999887554 689999999999999999999999999999999999999999999999999864221
Q ss_pred CCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHHHHHHH
Q 005427 226 SGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVV 305 (697)
Q Consensus 226 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (697)
.+.......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+.....
T Consensus 149 -----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~---------- 213 (320)
T cd05590 149 -----NGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV---------- 213 (320)
T ss_pred -----CCCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCC----------
Confidence 01123345799999999999999999999999999999999999999988765544443332111
Q ss_pred hCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCH------HHHHHHHHH
Q 005427 306 SGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSF------SDIALELDL 351 (697)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~------~ell~~l~~ 351 (697)
..+..++.++.+++++||+.||.+||++ ++++.|.|+
T Consensus 214 ---------~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f 256 (320)
T cd05590 214 ---------VYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFF 256 (320)
T ss_pred ---------CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCc
Confidence 1234578999999999999999999998 778877765
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=347.04 Aligned_cols=249 Identities=23% Similarity=0.339 Sum_probs=206.3
Q ss_pred CcccccccccCCceEEEEEEE--CCeeEEEEeccCC---ChHHHHHHHHHHHHHHhcCCC-CceEEeeccccCCceEEEE
Q 005427 67 SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKLDHP-GLAKFVAAHAKPPNYMFFF 140 (697)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hp-niv~l~~~~~~~~~~~lv~ 140 (697)
+|++.+.||+|+||.||+|.+ +++.||+|++... .....+.+..|..++..++|+ +|+.+++++...+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 488999999999999999987 4678999986532 234456788899999999765 5888999999999999999
Q ss_pred eecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhc
Q 005427 141 EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL 220 (697)
Q Consensus 141 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~ 220 (697)
||+.+|+|.+++.... .+++.+++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 81 E~~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~------ 153 (324)
T cd05587 81 EYVNGGDLMYHIQQVG-KFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF------ 153 (324)
T ss_pred cCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCC------
Confidence 9999999999886554 688999999999999999999999999999999999999999999999999853211
Q ss_pred ccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHH
Q 005427 221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQL 300 (697)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 300 (697)
........+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.........+....
T Consensus 154 ----------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~------ 217 (324)
T cd05587 154 ----------GGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHN------ 217 (324)
T ss_pred ----------CCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC------
Confidence 0011234579999999999999999999999999999999999999998766554444332211
Q ss_pred HHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCH-----HHHHHHHHH
Q 005427 301 TAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSF-----SDIALELDL 351 (697)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~-----~ell~~l~~ 351 (697)
...+..++.++.+++.+||..||.+|++. +++++|.++
T Consensus 218 -------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~ 260 (324)
T cd05587 218 -------------VSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFF 260 (324)
T ss_pred -------------CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCc
Confidence 12345688999999999999999999986 677776654
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=359.44 Aligned_cols=259 Identities=23% Similarity=0.323 Sum_probs=213.0
Q ss_pred CCCCCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCC--ChHHHHHHHHHHHHHHhcCCCCceEEeeccccCC--
Q 005427 61 LHLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPP-- 134 (697)
Q Consensus 61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-- 134 (697)
.....++|++.+.||+|+||+||+|++ +++.||||++... .......+.+|+.+|..++|+||++++..+....
T Consensus 27 ~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~ 106 (496)
T PTZ00283 27 AKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPR 106 (496)
T ss_pred ccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccccc
Confidence 345567999999999999999999986 6889999986544 3445667889999999999999999987765432
Q ss_pred ------ceEEEEeecCCCCHhhhhhhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeee
Q 005427 135 ------NYMFFFEFYESRNLAEKLHVE---EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLAD 205 (697)
Q Consensus 135 ------~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~D 205 (697)
.+++||||+.+|+|.+++... ...+++..+..++.|++.||.|||+.+|+||||||+|||++.++.+||+|
T Consensus 107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~D 186 (496)
T PTZ00283 107 NPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGD 186 (496)
T ss_pred CcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEe
Confidence 368999999999999988643 23678999999999999999999999999999999999999999999999
Q ss_pred eccchhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHH
Q 005427 206 FGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEA 285 (697)
Q Consensus 206 fg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~ 285 (697)
||+++.+.... ........+||+.|+|||++.+..++.++|||||||++|||++|..||.+.....
T Consensus 187 FGls~~~~~~~--------------~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~ 252 (496)
T PTZ00283 187 FGFSKMYAATV--------------SDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEE 252 (496)
T ss_pred cccCeeccccc--------------cccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH
Confidence 99987543211 0112345679999999999999999999999999999999999999998765443
Q ss_pred HHHHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 005427 286 QAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL 351 (697)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~ 351 (697)
....+. .+... ..+..+++++.+++.+||+.||.+||++.+++++.+.
T Consensus 253 ~~~~~~--------------~~~~~----~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~ 300 (496)
T PTZ00283 253 VMHKTL--------------AGRYD----PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPIC 300 (496)
T ss_pred HHHHHh--------------cCCCC----CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHH
Confidence 333222 12222 2345789999999999999999999999999998764
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=366.57 Aligned_cols=263 Identities=31% Similarity=0.486 Sum_probs=221.9
Q ss_pred CCCCCcccccccccCCceEEEEEEEC---Ce----eEEEEeccCC-ChHHHHHHHHHHHHHHhcCCCCceEEeeccccCC
Q 005427 63 LPPSSYTLLSPIARGAESVVYEATLD---GR----KVAVKKPILS-TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPP 134 (697)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~~---~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 134 (697)
++.+..++...||+|.||.||.|+.. +. .||+|.+... +..+...|.+|..+|+.++|||||+++|++.+..
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~ 768 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG 768 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC
Confidence 56778899999999999999999862 32 4888875443 4566889999999999999999999999999999
Q ss_pred ceEEEEeecCCCCHhhhhhhc------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeecc
Q 005427 135 NYMFFFEFYESRNLAEKLHVE------EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGL 208 (697)
Q Consensus 135 ~~~lv~e~~~~g~L~~~l~~~------~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~ 208 (697)
.+++++|||.||+|..+|++. ...++....+.++.||+.|++||+++++|||||..+|+|++....|||+||||
T Consensus 769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccch
Confidence 999999999999999999887 66789999999999999999999999999999999999999999999999999
Q ss_pred chhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCCchhHHHH
Q 005427 209 AEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQA 287 (697)
Q Consensus 209 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~~~~~~~~ 287 (697)
|+.+...+... ..+ ...-+..|||||.+....++.++|||||||++||+++ |..||.+.++....
T Consensus 849 ArDiy~~~yyr-----~~~---------~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~ 914 (1025)
T KOG1095|consen 849 ARDIYDKDYYR-----KHG---------EAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVL 914 (1025)
T ss_pred hHhhhhchhee-----ccC---------ccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHH
Confidence 98544322211 110 1234578999999999999999999999999999999 99999987665544
Q ss_pred HHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhc
Q 005427 288 HTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHRK 357 (697)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~~~ 357 (697)
.... .++.- ..|..+|..+.++|..||+.+|++||+|..|++.+..+.....
T Consensus 915 ~~~~--------------~ggRL----~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~ 966 (1025)
T KOG1095|consen 915 LDVL--------------EGGRL----DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAAL 966 (1025)
T ss_pred HHHH--------------hCCcc----CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhc
Confidence 4333 23311 2356899999999999999999999999999998888776543
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=355.26 Aligned_cols=270 Identities=23% Similarity=0.309 Sum_probs=209.3
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccCC---ChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEE
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFF 140 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 140 (697)
++|+++++||+|+||.||++.. +++.||||++... .......+.+|+++++.++||||+++++++.++..+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 3799999999999999999986 6789999986432 2234567889999999999999999999999999999999
Q ss_pred eecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhc
Q 005427 141 EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL 220 (697)
Q Consensus 141 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~ 220 (697)
||+++|+|.+++...+ .+++..++.++.|++.||+|||+.||+||||||+|||++.++.+||+|||+++.+........
T Consensus 81 E~~~gg~L~~~l~~~~-~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 159 (377)
T cd05629 81 EFLPGGDLMTMLIKYD-TFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAY 159 (377)
T ss_pred eCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccccccccccccc
Confidence 9999999999987554 688999999999999999999999999999999999999999999999999964322110000
Q ss_pred -ccccCCCCCC------------------------------CCccccccccCccccchhhhcccCCCchhhHHHHHHHHH
Q 005427 221 -KNWRSSGKPT------------------------------GGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISIN 269 (697)
Q Consensus 221 -~~~~~~~~~~------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ 269 (697)
.......... ........+||+.|+|||++.+..++.++|||||||++|
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ 239 (377)
T cd05629 160 YQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMF 239 (377)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhh
Confidence 0000000000 000011357999999999999999999999999999999
Q ss_pred HHHhCCCCCCCchhHHHHHHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCC---CCHHHHH
Q 005427 270 ELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNR---PSFSDIA 346 (697)
Q Consensus 270 ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R---pt~~ell 346 (697)
||++|..||.+.........+..... ...++ ....++.++.+||.+||. +|.+| +|+.+++
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~~~--------------~~~~p-~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l 303 (377)
T cd05629 240 ECLIGWPPFCSENSHETYRKIINWRE--------------TLYFP-DDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIK 303 (377)
T ss_pred hhhcCCCCCCCCCHHHHHHHHHccCC--------------ccCCC-CCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHh
Confidence 99999999987655444433332110 01111 112478999999999998 67765 5999999
Q ss_pred HHHHHH
Q 005427 347 LELDLV 352 (697)
Q Consensus 347 ~~l~~~ 352 (697)
.|.|+.
T Consensus 304 ~hp~~~ 309 (377)
T cd05629 304 SHPFFR 309 (377)
T ss_pred cCCCcC
Confidence 998763
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=344.02 Aligned_cols=264 Identities=27% Similarity=0.439 Sum_probs=212.0
Q ss_pred cCCCCCCCcccccccccCCceEEEEEEEC-------CeeEEEEeccCCC-hHHHHHHHHHHHHHHhc-CCCCceEEeecc
Q 005427 60 PLHLPPSSYTLLSPIARGAESVVYEATLD-------GRKVAVKKPILST-SEELDNFHKELQLLCKL-DHPGLAKFVAAH 130 (697)
Q Consensus 60 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~l~~~~ 130 (697)
.|+++.++|++.+.||+|+||.||+|... ++.||+|++.... ......+..|+.+++++ +||||+++++++
T Consensus 1 ~~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~ 80 (337)
T cd05054 1 KWEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGAC 80 (337)
T ss_pred CcccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeE
Confidence 36788899999999999999999999642 3679999876443 33456788999999999 899999999987
Q ss_pred ccC-CceEEEEeecCCCCHhhhhhhcC-----------------------------------------------------
Q 005427 131 AKP-PNYMFFFEFYESRNLAEKLHVEE----------------------------------------------------- 156 (697)
Q Consensus 131 ~~~-~~~~lv~e~~~~g~L~~~l~~~~----------------------------------------------------- 156 (697)
..+ ..++++|||+++++|.+++....
T Consensus 81 ~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (337)
T cd05054 81 TKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDE 160 (337)
T ss_pred ecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccch
Confidence 654 56889999999999999885421
Q ss_pred -------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhcccccCCCCC
Q 005427 157 -------WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKP 229 (697)
Q Consensus 157 -------~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~ 229 (697)
..+++..+..++.|++.||+|||+.||+||||||+|||++.++.+||+|||++..+.....
T Consensus 161 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~------------ 228 (337)
T cd05054 161 EGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD------------ 228 (337)
T ss_pred hhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcc------------
Confidence 2568899999999999999999999999999999999999999999999999976532110
Q ss_pred CCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCCchhHHHHHHHHhccccHHHHHHHHHhCC
Q 005427 230 TGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGG 308 (697)
Q Consensus 230 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (697)
........++..|+|||++.+..++.++|||||||++|||++ |..||.+.......... ....
T Consensus 229 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~--------------~~~~ 292 (337)
T cd05054 229 --YVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRR--------------LKEG 292 (337)
T ss_pred --hhhccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHH--------------Hhcc
Confidence 011223456778999999999999999999999999999998 99999864332221111 1111
Q ss_pred CCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 005427 309 LRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE 354 (697)
Q Consensus 309 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~ 354 (697)
.++ ..+..+++++.+++.+||+.+|++||++.+++++|..+++
T Consensus 293 ~~~---~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 293 TRM---RAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred CCC---CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 122 1234678899999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=341.63 Aligned_cols=272 Identities=21% Similarity=0.257 Sum_probs=212.7
Q ss_pred CCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCCh-HHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEe
Q 005427 65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTS-EELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFE 141 (697)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 141 (697)
.++|.+.++||+|+||.||+|++ +++.||+|.+..... .....+.+|+.+++.++||||+++++++..+...++|||
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 84 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFE 84 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence 36799999999999999999987 577899998654432 223467789999999999999999999999999999999
Q ss_pred ecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhcc
Q 005427 142 FYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLK 221 (697)
Q Consensus 142 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~ 221 (697)
|+.+ +|.+++...+..+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 85 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~----- 158 (309)
T cd07872 85 YLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPT----- 158 (309)
T ss_pred CCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCc-----
Confidence 9985 8888887666568899999999999999999999999999999999999999999999999986432110
Q ss_pred cccCCCCCCCCccccccccCccccchhhhcc-cCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHH
Q 005427 222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQL 300 (697)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 300 (697)
.......+++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+..........
T Consensus 159 -----------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 227 (309)
T cd07872 159 -----------KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEE 227 (309)
T ss_pred -----------cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 01223467899999999865 457899999999999999999999998876655544443322111110
Q ss_pred HHHH----------HhCCCCCc-ccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 005427 301 TAAV----------VSGGLRPI-LASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL 353 (697)
Q Consensus 301 ~~~~----------~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~ 353 (697)
.+.. ......+. .......+++++.+||.+||+.||.+|||+.|+++|.|+..
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 291 (309)
T cd07872 228 TWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRS 291 (309)
T ss_pred HHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhh
Confidence 0000 00000000 00112357889999999999999999999999999998864
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=352.11 Aligned_cols=259 Identities=20% Similarity=0.265 Sum_probs=211.3
Q ss_pred CCCCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCC---ChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCce
Q 005427 62 HLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNY 136 (697)
Q Consensus 62 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 136 (697)
.+..++|++.++||+|+||.||++++ +++.||+|++... .......+.+|+.+++.++||||+++++++.++..+
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~ 118 (370)
T cd05596 39 RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYL 118 (370)
T ss_pred CCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 45567899999999999999999987 5788999986432 223345678899999999999999999999999999
Q ss_pred EEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhh
Q 005427 137 MFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLK 216 (697)
Q Consensus 137 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~ 216 (697)
++||||+++|+|.+++... .+++..+..++.|++.||+|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 119 ~lv~Ey~~gg~L~~~l~~~--~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~ 196 (370)
T cd05596 119 YMVMEYMPGGDLVNLMSNY--DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANG 196 (370)
T ss_pred EEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCC
Confidence 9999999999999988653 57889999999999999999999999999999999999999999999999986543210
Q ss_pred hhhcccccCCCCCCCCccccccccCccccchhhhccc----CCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHh
Q 005427 217 EISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKE----IHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLE 292 (697)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~ 292 (697)
.......+||+.|+|||++.+. .++.++|||||||++|||++|..||.+.........+..
T Consensus 197 ---------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~ 261 (370)
T cd05596 197 ---------------MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMD 261 (370)
T ss_pred ---------------cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHc
Confidence 0112345799999999998753 478899999999999999999999987655444333322
Q ss_pred ccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCC--CCCHHHHHHHHHHH
Q 005427 293 MNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHN--RPSFSDIALELDLV 352 (697)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~--Rpt~~ell~~l~~~ 352 (697)
.. ....++ ....+|.++.+||.+||+.+|.+ |+|++++++|.|..
T Consensus 262 ~~--------------~~~~~~-~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~ 308 (370)
T cd05596 262 HK--------------NSLTFP-DDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFK 308 (370)
T ss_pred CC--------------CcCCCC-CcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccC
Confidence 11 011111 12357899999999999999988 99999999998763
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=349.70 Aligned_cols=245 Identities=24% Similarity=0.318 Sum_probs=204.4
Q ss_pred cccccCCceEEEEEEE--CCeeEEEEeccCC---ChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEeecCCC
Q 005427 72 SPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESR 146 (697)
Q Consensus 72 ~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g 146 (697)
+.||+|+||.||++.+ +++.||+|++... .......+..|+.+++.++||||+++++++.....+++||||+.+|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999986 6789999986532 2234567788999999999999999999999999999999999999
Q ss_pred CHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhcccccC
Q 005427 147 NLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHN-LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRS 225 (697)
Q Consensus 147 ~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~ 225 (697)
+|..++.... .+++.+++.++.||+.||.|||+ .||+||||||+|||++.++.+||+|||++......
T Consensus 81 ~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~---------- 149 (325)
T cd05594 81 ELFFHLSRER-VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD---------- 149 (325)
T ss_pred cHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCC----------
Confidence 9999886554 68999999999999999999997 79999999999999999999999999998642210
Q ss_pred CCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHHHHHHH
Q 005427 226 SGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVV 305 (697)
Q Consensus 226 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (697)
........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.........+....
T Consensus 150 ------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~----------- 212 (325)
T cd05594 150 ------GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE----------- 212 (325)
T ss_pred ------CcccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCC-----------
Confidence 011234579999999999999999999999999999999999999998765444333322111
Q ss_pred hCCCCCcccccccCChHHHHHHHHHhccCCCCCCC-----CHHHHHHHHHHH
Q 005427 306 SGGLRPILASLELGLPASILSLIQRCWDGNPHNRP-----SFSDIALELDLV 352 (697)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~ell~~l~~~ 352 (697)
...+..+++++.++|.+||+.||++|+ ++.++++|.|+.
T Consensus 213 --------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~ 256 (325)
T cd05594 213 --------IRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFA 256 (325)
T ss_pred --------CCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcC
Confidence 112456889999999999999999996 899999987753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=354.82 Aligned_cols=268 Identities=21% Similarity=0.298 Sum_probs=209.4
Q ss_pred CcccccccccCCceEEEEEEE--CCeeEEEEeccCCC---hHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEe
Q 005427 67 SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST---SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFE 141 (697)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 141 (697)
+|+++++||+|+||.||+|++ +++.||+|++.... ......+.+|+.+++.++||||+++++.+.++..+++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 689999999999999999987 57889999865332 2345678899999999999999999999999999999999
Q ss_pred ecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhcc
Q 005427 142 FYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLK 221 (697)
Q Consensus 142 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~ 221 (697)
|+++|+|.+++...+ .+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||++..+.........
T Consensus 82 ~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~ 160 (382)
T cd05625 82 YIPGGDMMSLLIRMG-IFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (382)
T ss_pred CCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccccc
Confidence 999999999987654 6889999999999999999999999999999999999999999999999998543210000000
Q ss_pred ---------------cccC----------------CCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHH
Q 005427 222 ---------------NWRS----------------SGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINE 270 (697)
Q Consensus 222 ---------------~~~~----------------~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~e 270 (697)
.+.. .............+||+.|+|||++.+..++.++|||||||++||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~e 240 (382)
T cd05625 161 QSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 240 (382)
T ss_pred ccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHH
Confidence 0000 000000111234579999999999999999999999999999999
Q ss_pred HHhCCCCCCCchhHHHHHHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCC---HHHHHH
Q 005427 271 LLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPS---FSDIAL 347 (697)
Q Consensus 271 ll~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt---~~ell~ 347 (697)
|++|..||.+.+.......+..... ....+ ....+++++.++|.+|+ .+|.+|++ +.++++
T Consensus 241 lltG~~Pf~~~~~~~~~~~i~~~~~--------------~~~~p-~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~ 304 (382)
T cd05625 241 MLVGQPPFLAQTPLETQMKVINWQT--------------SLHIP-PQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKA 304 (382)
T ss_pred HHhCCCCCCCCCHHHHHHHHHccCC--------------CcCCC-CcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhc
Confidence 9999999987655444333332111 11111 12357899999999976 59999997 999998
Q ss_pred HHHH
Q 005427 348 ELDL 351 (697)
Q Consensus 348 ~l~~ 351 (697)
|.|+
T Consensus 305 hp~f 308 (382)
T cd05625 305 HPFF 308 (382)
T ss_pred CCCc
Confidence 8775
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=345.70 Aligned_cols=244 Identities=23% Similarity=0.319 Sum_probs=203.9
Q ss_pred cccccCCceEEEEEEE--CCeeEEEEeccCC---ChHHHHHHHHHHHHHHhc-CCCCceEEeeccccCCceEEEEeecCC
Q 005427 72 SPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKL-DHPGLAKFVAAHAKPPNYMFFFEFYES 145 (697)
Q Consensus 72 ~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~ 145 (697)
+.||+|+||.||+|++ +++.||+|++... .......+..|.+++..+ +||||+++++++.++..+|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 4699999999999987 4678999986532 233456678899999876 799999999999999999999999999
Q ss_pred CCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhcccccC
Q 005427 146 RNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRS 225 (697)
Q Consensus 146 g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~ 225 (697)
|+|...+.... .+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~---------- 149 (321)
T cd05591 81 GDLMFQIQRSR-KFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILN---------- 149 (321)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccC----------
Confidence 99999886554 6889999999999999999999999999999999999999999999999998643210
Q ss_pred CCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHHHHHHH
Q 005427 226 SGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVV 305 (697)
Q Consensus 226 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (697)
........||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+.....
T Consensus 150 ------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~---------- 213 (321)
T cd05591 150 ------GVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDV---------- 213 (321)
T ss_pred ------CccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC----------
Confidence 1113345799999999999999999999999999999999999999988765554444332111
Q ss_pred hCCCCCcccccccCChHHHHHHHHHhccCCCCCCC-------CHHHHHHHHHH
Q 005427 306 SGGLRPILASLELGLPASILSLIQRCWDGNPHNRP-------SFSDIALELDL 351 (697)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-------t~~ell~~l~~ 351 (697)
..+..++.++.+++.+||+.||++|| ++.++++|+|+
T Consensus 214 ---------~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~ 257 (321)
T cd05591 214 ---------LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFF 257 (321)
T ss_pred ---------CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCcc
Confidence 12335789999999999999999999 89999988876
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=348.50 Aligned_cols=254 Identities=25% Similarity=0.354 Sum_probs=204.9
Q ss_pred CcccccccccCCceEEEEEEE-----CCeeEEEEeccCC----ChHHHHHHHHHHHHHHhc-CCCCceEEeeccccCCce
Q 005427 67 SYTLLSPIARGAESVVYEATL-----DGRKVAVKKPILS----TSEELDNFHKELQLLCKL-DHPGLAKFVAAHAKPPNY 136 (697)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~-----~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~ 136 (697)
+|+++++||+|+||.||+++. +++.||+|++... .....+.+..|+.+++.+ +||||+++++++.....+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 488999999999999999975 4678999976432 223356788999999999 599999999999999999
Q ss_pred EEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhh
Q 005427 137 MFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLK 216 (697)
Q Consensus 137 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~ 216 (697)
++||||+.+|+|.+++.... .+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~ 159 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRD-NFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE 159 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccC
Confidence 99999999999999987554 68999999999999999999999999999999999999999999999999986543211
Q ss_pred hhhcccccCCCCCCCCccccccccCccccchhhhccc-CCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccc
Q 005427 217 EISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKE-IHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNY 295 (697)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~ 295 (697)
........||+.|+|||++.+. .++.++|||||||++|||++|..||...........
T Consensus 160 ---------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~------ 218 (332)
T cd05614 160 ---------------KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSE------ 218 (332)
T ss_pred ---------------CCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHH------
Confidence 0112345799999999999865 478899999999999999999999975322111111
Q ss_pred cHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCC-----CHHHHHHHHHH
Q 005427 296 TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRP-----SFSDIALELDL 351 (697)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~ell~~l~~ 351 (697)
....+.. ..+ ..+..+++.+.+++.+||+.||++|| +++++++|.|.
T Consensus 219 ----~~~~~~~--~~~---~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~ 270 (332)
T cd05614 219 ----VSRRILK--CDP---PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFF 270 (332)
T ss_pred ----HHHHHhc--CCC---CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCc
Confidence 1111111 111 23446889999999999999999999 78899998876
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=343.55 Aligned_cols=244 Identities=25% Similarity=0.370 Sum_probs=199.4
Q ss_pred cccccCCceEEEEEEE--CCeeEEEEeccCC---ChHHHHHHHHHHHHHHhc-CCCCceEEeeccccCCceEEEEeecCC
Q 005427 72 SPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKL-DHPGLAKFVAAHAKPPNYMFFFEFYES 145 (697)
Q Consensus 72 ~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~ 145 (697)
++||+|+||.||+|++ +++.||+|.+... .....+.+..|..++..+ +||||+++++++.....+++||||+.+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999999987 5678999976532 223345566677777654 899999999999999999999999999
Q ss_pred CCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhcccccC
Q 005427 146 RNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRS 225 (697)
Q Consensus 146 g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~ 225 (697)
|+|.+++.... .+++.++..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 81 g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~---------- 149 (316)
T cd05592 81 GDLMFHIQSSG-RFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNG---------- 149 (316)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCC----------
Confidence 99999887654 6899999999999999999999999999999999999999999999999998643210
Q ss_pred CCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHHHHHHH
Q 005427 226 SGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVV 305 (697)
Q Consensus 226 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (697)
.......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+...
T Consensus 150 ------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~------------ 211 (316)
T cd05592 150 ------EGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILND------------ 211 (316)
T ss_pred ------CCccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC------------
Confidence 01233457999999999999999999999999999999999999999876654433332211
Q ss_pred hCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHH-HHHHHHHH
Q 005427 306 SGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFS-DIALELDL 351 (697)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~-ell~~l~~ 351 (697)
.+ ..+..++.++.+++.+||+.||++||++. ++++|.|+
T Consensus 212 ----~~---~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~ 251 (316)
T cd05592 212 ----RP---HFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFF 251 (316)
T ss_pred ----CC---CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCccc
Confidence 11 23456889999999999999999999875 66666554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=349.00 Aligned_cols=256 Identities=25% Similarity=0.316 Sum_probs=211.3
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccCCC---hHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEE
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST---SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFF 140 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 140 (697)
++|.+.+.||+|+||.||++.+ +++.||+|++.... ......+.+|+.+++.++||||+++++++.+...+++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 3699999999999999999987 57899999865432 234567889999999999999999999999999999999
Q ss_pred eecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhc
Q 005427 141 EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL 220 (697)
Q Consensus 141 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~ 220 (697)
||+++|+|.+++......+++..+..++.|++.||+|||+.||+||||||+|||++.++.+||+|||++..+.....
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~--- 157 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM--- 157 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc---
Confidence 99999999999987656789999999999999999999999999999999999999999999999999875432110
Q ss_pred ccccCCCCCCCCccccccccCccccchhhhc------ccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhcc
Q 005427 221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILK------KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMN 294 (697)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~ 294 (697)
.......||+.|+|||++. +..++.++|||||||++|+|++|..||...........+....
T Consensus 158 ------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~ 225 (330)
T cd05601 158 ------------VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQ 225 (330)
T ss_pred ------------eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCC
Confidence 0123347899999999986 4567889999999999999999999998765544443333211
Q ss_pred ccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 295 YTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
.....+ ....+++++.+|+..||+ +|.+|||+.+++.|.|+.
T Consensus 226 --------------~~~~~~-~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~ 267 (330)
T cd05601 226 --------------RFLKFP-EDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFS 267 (330)
T ss_pred --------------CccCCC-CCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcC
Confidence 000111 123578999999999998 999999999999998763
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=328.65 Aligned_cols=252 Identities=23% Similarity=0.373 Sum_probs=207.3
Q ss_pred CCCCcccccccccCCceEEEEEEEC-CeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEee
Q 005427 64 PPSSYTLLSPIARGAESVVYEATLD-GRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF 142 (697)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 142 (697)
+.++|++.+.||+|+||.||++... +..+|+|...... .....+.+|+.+|+.++||||+++++++......+++|||
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 80 (256)
T cd05114 2 NPSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEF 80 (256)
T ss_pred CHHHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEc
Confidence 3467999999999999999999874 4589999755332 2346788999999999999999999999999999999999
Q ss_pred cCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhccc
Q 005427 143 YESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKN 222 (697)
Q Consensus 143 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 222 (697)
+++|+|.+++......+++..++.++.|++.||+|||+.||+||||||+||+++.++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~----- 155 (256)
T cd05114 81 MENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY----- 155 (256)
T ss_pred CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCce-----
Confidence 999999999876555688999999999999999999999999999999999999999999999998865432110
Q ss_pred ccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCCchhHHHHHHHHhccccHHHHH
Q 005427 223 WRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLT 301 (697)
Q Consensus 223 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 301 (697)
.......++..|+|||++.+..++.++|+||||+++|+|++ |..||...+.......+...
T Consensus 156 ----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~-------- 217 (256)
T cd05114 156 ----------TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRG-------- 217 (256)
T ss_pred ----------eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC--------
Confidence 01122345678999999998889999999999999999999 99999876554443333221
Q ss_pred HHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 005427 302 AAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALEL 349 (697)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l 349 (697)
.++. .+...+..+.+++.+||+.+|++|||+.++++.|
T Consensus 218 -------~~~~---~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 218 -------FRLY---RPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred -------CCCC---CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 1111 1234678899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=352.16 Aligned_cols=269 Identities=23% Similarity=0.335 Sum_probs=214.6
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccCC---ChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEE
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFF 140 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 140 (697)
++|.+.+.||+|+||+||+|++ +++.||+|++... .......+.+|+.++..++||||+++++++.++..+++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 4799999999999999999987 4889999986533 2234567889999999999999999999999999999999
Q ss_pred eecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhc
Q 005427 141 EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL 220 (697)
Q Consensus 141 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~ 220 (697)
||+.+++|.+++... ..+++..++.++.|++.||+|||+.||+||||||+|||++.++.+||+|||++...........
T Consensus 81 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~ 159 (350)
T cd05573 81 EYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREY 159 (350)
T ss_pred cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcccc
Confidence 999999999999766 4789999999999999999999999999999999999999999999999999976543220000
Q ss_pred ccc-------------cCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHH
Q 005427 221 KNW-------------RSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQA 287 (697)
Q Consensus 221 ~~~-------------~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~ 287 (697)
... ................||+.|+|||++.+..++.++|||||||++|+|++|..||.........
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~ 239 (350)
T cd05573 160 YLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETY 239 (350)
T ss_pred cccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHHH
Confidence 000 0000000111234567999999999999999999999999999999999999999887655444
Q ss_pred HHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCC-HHHHHHHHHH
Q 005427 288 HTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPS-FSDIALELDL 351 (697)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt-~~ell~~l~~ 351 (697)
..+..... . ..++ ....+++++.+||.+||. ||.+||+ ++++++|+|.
T Consensus 240 ~~i~~~~~------------~--~~~p-~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~ 288 (350)
T cd05573 240 NKIINWKE------------S--LRFP-PDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFF 288 (350)
T ss_pred HHHhccCC------------c--ccCC-CCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCc
Confidence 44332110 0 0011 112378999999999998 9999999 9999999876
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=355.38 Aligned_cols=270 Identities=21% Similarity=0.270 Sum_probs=210.2
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccCCC---hHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEE
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST---SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFF 140 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 140 (697)
++|+++++||+|+||.||+++. +++.||+|++.... ......+.+|+++|+.++||||+++++.+.+++.+++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 3799999999999999999987 57899999864321 223567889999999999999999999999999999999
Q ss_pred eecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhh-
Q 005427 141 EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEIS- 219 (697)
Q Consensus 141 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~- 219 (697)
||+++|+|.+++...+ .+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||++..+.......
T Consensus 81 E~~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~ 159 (376)
T cd05598 81 DYIPGGDMMSLLIRLG-IFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 159 (376)
T ss_pred eCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccccc
Confidence 9999999999997654 67889999999999999999999999999999999999999999999999985332100000
Q ss_pred --c------ccccCC------------------CCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh
Q 005427 220 --L------KNWRSS------------------GKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT 273 (697)
Q Consensus 220 --~------~~~~~~------------------~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~ 273 (697)
. ...... ............+||+.|+|||++.+..++.++|||||||++|||++
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~ 239 (376)
T cd05598 160 YQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLV 239 (376)
T ss_pred cccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhh
Confidence 0 000000 00000011234589999999999999999999999999999999999
Q ss_pred CCCCCCCchhHHHHHHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCC---CHHHHHHHHH
Q 005427 274 GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRP---SFSDIALELD 350 (697)
Q Consensus 274 g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp---t~~ell~~l~ 350 (697)
|..||.+.........+..... ....+ ....+++++.++|.+|+ .+|.+|+ |+.++++|.|
T Consensus 240 G~~Pf~~~~~~~~~~~i~~~~~--------------~~~~~-~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~ 303 (376)
T cd05598 240 GQPPFLADTPAETQLKVINWET--------------TLHIP-SQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPF 303 (376)
T ss_pred CCCCCCCCCHHHHHHHHhccCc--------------cccCC-CCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCC
Confidence 9999987665444333322110 00011 12357899999999977 5999999 9999999988
Q ss_pred HH
Q 005427 351 LV 352 (697)
Q Consensus 351 ~~ 352 (697)
+.
T Consensus 304 ~~ 305 (376)
T cd05598 304 FK 305 (376)
T ss_pred cC
Confidence 63
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=347.09 Aligned_cols=256 Identities=23% Similarity=0.343 Sum_probs=204.3
Q ss_pred CCCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCCh-HHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEE
Q 005427 63 LPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTS-EELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFF 139 (697)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 139 (697)
...++|+++++||+|+||.||+|++ +++.||||++..... .....+.+|+++|+.++||||+++++++.....+++|
T Consensus 71 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 150 (353)
T PLN00034 71 KSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVL 150 (353)
T ss_pred CCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEE
Confidence 3446799999999999999999987 578999998754433 3356789999999999999999999999999999999
Q ss_pred EeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhh
Q 005427 140 FEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEIS 219 (697)
Q Consensus 140 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~ 219 (697)
|||+.+|+|.+.. ...+..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++..+.....
T Consensus 151 ~e~~~~~~L~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-- 223 (353)
T PLN00034 151 LEFMDGGSLEGTH-----IADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD-- 223 (353)
T ss_pred EecCCCCcccccc-----cCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccccc--
Confidence 9999999986532 345678889999999999999999999999999999999999999999999875532110
Q ss_pred cccccCCCCCCCCccccccccCccccchhhhcc-----cCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhcc
Q 005427 220 LKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-----EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMN 294 (697)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~ 294 (697)
......||..|+|||++.. ...+.++|||||||++|||++|+.||.........
T Consensus 224 --------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~------- 282 (353)
T PLN00034 224 --------------PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWA------- 282 (353)
T ss_pred --------------cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHH-------
Confidence 1234579999999998743 33456899999999999999999999743211110
Q ss_pred ccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 005427 295 YTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE 354 (697)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~ 354 (697)
.....+.. .. ....+..++.++.+||.+||+.||++|||+.|+++|.|....
T Consensus 283 ----~~~~~~~~-~~---~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~ 334 (353)
T PLN00034 283 ----SLMCAICM-SQ---PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRA 334 (353)
T ss_pred ----HHHHHHhc-cC---CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccC
Confidence 01111110 11 112344688999999999999999999999999999887654
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=342.66 Aligned_cols=266 Identities=29% Similarity=0.475 Sum_probs=204.3
Q ss_pred CCcccccccccCCceEEEEEEECC-eeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccccCC-ceEEEEeec
Q 005427 66 SSYTLLSPIARGAESVVYEATLDG-RKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPP-NYMFFFEFY 143 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-~~~lv~e~~ 143 (697)
++|.-...||+|+||.||+|...+ +.||||+...........|.+|+.+|.+++|||+|+|+|+|.+.+ +.+||+||+
T Consensus 75 ~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEym 154 (361)
T KOG1187|consen 75 NNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYEYM 154 (361)
T ss_pred hCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEEcc
Confidence 456677899999999999998854 899999766544331344999999999999999999999999988 599999999
Q ss_pred CCCCHhhhhhhcCC-CCCHHHHHHHHHHHHHHHHHHHhCC---cccccCCCCceeecCCCCCeeeeeccchhhhhhhhhh
Q 005427 144 ESRNLAEKLHVEEW-SPSVDQVLMIAAQLAKALQYLHNLG---IVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEIS 219 (697)
Q Consensus 144 ~~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~ 219 (697)
.+|+|.++|+.... .++|.++++|+.+++.||+|||+.. |+||||||+|||+|.++.+||+|||+|+..... .
T Consensus 155 ~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~-~-- 231 (361)
T KOG1187|consen 155 PNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEG-D-- 231 (361)
T ss_pred CCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCcc-c--
Confidence 99999999987766 8899999999999999999999864 999999999999999999999999999543310 0
Q ss_pred cccccCCCCCCCCcccccc-ccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHH
Q 005427 220 LKNWRSSGKPTGGFHKKNM-VGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQ 298 (697)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~ 298 (697)
....+. .||..|+|||.+..+..+.++|||||||+|.||++|+.|........... +..+. ..
T Consensus 232 -------------~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~-l~~w~--~~ 295 (361)
T KOG1187|consen 232 -------------TSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELS-LVEWA--KP 295 (361)
T ss_pred -------------cceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCccccc-HHHHH--HH
Confidence 011122 79999999999998889999999999999999999998887543111100 11100 00
Q ss_pred HHHHHHHhCCCCCcccccccCCh-----HHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 299 QLTAAVVSGGLRPILASLELGLP-----ASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~-----~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
.+......+-..|.+.. ...+ ..+..+...|++.+|.+||++.|+++.|..+
T Consensus 296 ~~~~~~~~eiiD~~l~~--~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~ 352 (361)
T KOG1187|consen 296 LLEEGKLREIVDPRLKE--GEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGI 352 (361)
T ss_pred HHHCcchhheeCCCccC--CCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhh
Confidence 01000111122232221 1222 3366889999999999999999998888443
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=332.92 Aligned_cols=257 Identities=27% Similarity=0.447 Sum_probs=210.0
Q ss_pred CCCCCcccccccccCCceEEEEEEECC-------eeEEEEeccCCCh-HHHHHHHHHHHHHHhcCCCCceEEeeccccCC
Q 005427 63 LPPSSYTLLSPIARGAESVVYEATLDG-------RKVAVKKPILSTS-EELDNFHKELQLLCKLDHPGLAKFVAAHAKPP 134 (697)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 134 (697)
+..++|++.+.||+|+||.||+|...+ ..|++|....... .....+.+|+.+++.++||||+++++++....
T Consensus 2 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~ 81 (283)
T cd05048 2 IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQ 81 (283)
T ss_pred CChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCC
Confidence 344689999999999999999997632 5699998654433 34567899999999999999999999999999
Q ss_pred ceEEEEeecCCCCHhhhhhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCC
Q 005427 135 NYMFFFEFYESRNLAEKLHVEE---------------WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNL 199 (697)
Q Consensus 135 ~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~ 199 (697)
..+++|||+++++|.+++.... ..+++.+++.++.|++.||.|||+.|++||||||+||+++.++
T Consensus 82 ~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 82 PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGL 161 (283)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCC
Confidence 9999999999999999986532 3567889999999999999999999999999999999999999
Q ss_pred CCeeeeeccchhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCC
Q 005427 200 CPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPY 278 (697)
Q Consensus 200 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf 278 (697)
.+||+|||++........ ........+++.|+|||.+.+..++.++|||||||++|||++ |..||
T Consensus 162 ~~~L~dfg~~~~~~~~~~--------------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~ 227 (283)
T cd05048 162 TVKISDFGLSRDIYSADY--------------YRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPY 227 (283)
T ss_pred cEEECCCcceeecccccc--------------ccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCC
Confidence 999999999865432110 001233457889999999998889999999999999999998 99999
Q ss_pred CCchhHHHHHHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 005427 279 TDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL 351 (697)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~ 351 (697)
.+.........+. .+.. ...+..+|+++.+|+.+||+.||.+||++.+|+++|..
T Consensus 228 ~~~~~~~~~~~i~--------------~~~~----~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 228 YGFSNQEVIEMIR--------------SRQL----LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred CCCCHHHHHHHHH--------------cCCc----CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 8765443322221 1111 12345789999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=343.24 Aligned_cols=249 Identities=22% Similarity=0.331 Sum_probs=205.8
Q ss_pred CcccccccccCCceEEEEEEE--CCeeEEEEeccCC---ChHHHHHHHHHHHHHHhc-CCCCceEEeeccccCCceEEEE
Q 005427 67 SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKL-DHPGLAKFVAAHAKPPNYMFFF 140 (697)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv~ 140 (697)
+|.+.+.||+|+||.||+|++ +++.||+|++... .......+..|..++..+ .||+|+++++++...+.+++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 488999999999999999987 4678999986532 223345667788888877 5899999999999999999999
Q ss_pred eecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhc
Q 005427 141 EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL 220 (697)
Q Consensus 141 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~ 220 (697)
||+++|+|.+.+.... .+++.+++.++.|++.||+|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 81 E~~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~------ 153 (323)
T cd05616 81 EYVNGGDLMYQIQQVG-RFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW------ 153 (323)
T ss_pred cCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCC------
Confidence 9999999999886554 688999999999999999999999999999999999999999999999999864221
Q ss_pred ccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHH
Q 005427 221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQL 300 (697)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 300 (697)
.+......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.........+.....
T Consensus 154 ----------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~----- 218 (323)
T cd05616 154 ----------DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV----- 218 (323)
T ss_pred ----------CCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-----
Confidence 01123456799999999999999999999999999999999999999988765554444332111
Q ss_pred HHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCH-----HHHHHHHHH
Q 005427 301 TAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSF-----SDIALELDL 351 (697)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~-----~ell~~l~~ 351 (697)
..+..++.++.+++.+||+.||.+|++. .++++|.++
T Consensus 219 --------------~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~ 260 (323)
T cd05616 219 --------------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFF 260 (323)
T ss_pred --------------CCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCc
Confidence 1244688999999999999999999985 677766543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=343.06 Aligned_cols=244 Identities=23% Similarity=0.327 Sum_probs=200.4
Q ss_pred cccccCCceEEEEEEE--CCeeEEEEeccCCC---hHHHHHHHHHHHHHHhc-CCCCceEEeeccccCCceEEEEeecCC
Q 005427 72 SPIARGAESVVYEATL--DGRKVAVKKPILST---SEELDNFHKELQLLCKL-DHPGLAKFVAAHAKPPNYMFFFEFYES 145 (697)
Q Consensus 72 ~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~ 145 (697)
++||+|+||.||+|++ +++.||+|.+.... ......+..|..++..+ +||||+++++++.+...+++||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 4799999999999987 57889999865321 23445677788888765 899999999999999999999999999
Q ss_pred CCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhcccccC
Q 005427 146 RNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRS 225 (697)
Q Consensus 146 g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~ 225 (697)
|+|..++.... .+++.++..++.|++.||+|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 81 g~L~~~i~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---------- 149 (316)
T cd05620 81 GDLMFHIQDKG-RFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG---------- 149 (316)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccC----------
Confidence 99999887543 6889999999999999999999999999999999999999999999999998532110
Q ss_pred CCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHHHHHHH
Q 005427 226 SGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVV 305 (697)
Q Consensus 226 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (697)
.......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+..
T Consensus 150 ------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~------------- 210 (316)
T cd05620 150 ------DNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRV------------- 210 (316)
T ss_pred ------CCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh-------------
Confidence 0123456799999999999999999999999999999999999999987654433332211
Q ss_pred hCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCH-HHHHHHHHH
Q 005427 306 SGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSF-SDIALELDL 351 (697)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~-~ell~~l~~ 351 (697)
. . +..+..++.++.++|.+||+.||++||++ +++++|.|+
T Consensus 211 -~--~---~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f 251 (316)
T cd05620 211 -D--T---PHYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFF 251 (316)
T ss_pred -C--C---CCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCc
Confidence 1 1 12234578999999999999999999998 577777665
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=349.13 Aligned_cols=260 Identities=21% Similarity=0.282 Sum_probs=209.9
Q ss_pred CCCCCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCC---ChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCc
Q 005427 61 LHLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPN 135 (697)
Q Consensus 61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 135 (697)
..+..++|++.+.||+|+||.||++++ +++.+|+|++... .......+.+|+.+++.++||||+++++++.++..
T Consensus 38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (370)
T cd05621 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY 117 (370)
T ss_pred cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence 345567899999999999999999987 5778999976421 22334568899999999999999999999999999
Q ss_pred eEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhh
Q 005427 136 YMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL 215 (697)
Q Consensus 136 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~ 215 (697)
+++||||+++|+|.+++... .+++.++..++.||+.||+|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~~--~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~ 195 (370)
T cd05621 118 LYMVMEYMPGGDLVNLMSNY--DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDET 195 (370)
T ss_pred EEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccC
Confidence 99999999999999998644 5788999999999999999999999999999999999999999999999998754321
Q ss_pred hhhhcccccCCCCCCCCccccccccCccccchhhhcccC----CCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHH
Q 005427 216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEI----HSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVL 291 (697)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~ 291 (697)
. .......+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.........+.
T Consensus 196 ~---------------~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~ 260 (370)
T cd05621 196 G---------------MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIM 260 (370)
T ss_pred C---------------ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 0 01123567999999999997643 7889999999999999999999998765544433332
Q ss_pred hccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCC--CCCHHHHHHHHHHH
Q 005427 292 EMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHN--RPSFSDIALELDLV 352 (697)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~--Rpt~~ell~~l~~~ 352 (697)
... ....++ ....++..+.+++..||..+|.+ |+|+.++++|.|+.
T Consensus 261 ~~~--------------~~~~~p-~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~ 308 (370)
T cd05621 261 DHK--------------NSLNFP-EDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFK 308 (370)
T ss_pred hCC--------------cccCCC-CcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccC
Confidence 211 111111 12357899999999999865544 89999999998863
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=342.37 Aligned_cols=244 Identities=25% Similarity=0.336 Sum_probs=203.7
Q ss_pred cccccCCceEEEEEEE--CCeeEEEEeccCC---ChHHHHHHHHHHHHHHhc-CCCCceEEeeccccCCceEEEEeecCC
Q 005427 72 SPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKL-DHPGLAKFVAAHAKPPNYMFFFEFYES 145 (697)
Q Consensus 72 ~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~ 145 (697)
+.||+|+||.||+|++ +++.||+|++... .......+..|..+++.+ +||||+++++++.....+++||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999987 5678999986532 233456778899999888 799999999999999999999999999
Q ss_pred CCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhcccccC
Q 005427 146 RNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRS 225 (697)
Q Consensus 146 g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~ 225 (697)
|+|...+.... .+++.++..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 81 ~~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~----------- 148 (318)
T cd05570 81 GDLMFHIQRSG-RFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGIL----------- 148 (318)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCc-----------
Confidence 99999887654 789999999999999999999999999999999999999999999999999853211
Q ss_pred CCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHHHHHHH
Q 005427 226 SGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVV 305 (697)
Q Consensus 226 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (697)
........+|++.|+|||++.+..++.++|||||||++|+|++|..||.+.........+...
T Consensus 149 -----~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~------------ 211 (318)
T cd05570 149 -----GGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILED------------ 211 (318)
T ss_pred -----CCCcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC------------
Confidence 011123457999999999999999999999999999999999999999876554433332211
Q ss_pred hCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCH-----HHHHHHHHH
Q 005427 306 SGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSF-----SDIALELDL 351 (697)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~-----~ell~~l~~ 351 (697)
. + ..+..++.++.+||++||..||.+|||+ .++++|.|.
T Consensus 212 --~--~---~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~ 255 (318)
T cd05570 212 --E--V---RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFF 255 (318)
T ss_pred --C--C---CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCc
Confidence 1 1 1234688999999999999999999999 999888766
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=333.64 Aligned_cols=248 Identities=19% Similarity=0.255 Sum_probs=200.7
Q ss_pred cccCCceEEEEEEE--CCeeEEEEeccCCCh---HHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEeecCCCCH
Q 005427 74 IARGAESVVYEATL--DGRKVAVKKPILSTS---EELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNL 148 (697)
Q Consensus 74 lg~G~~g~V~~~~~--~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L 148 (697)
||+|+||+||++.+ +++.+|+|++..... ...+.+..|+.+++.++||||+++++++.....+++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 79999999999986 578999998653322 2345678899999999999999999999999999999999999999
Q ss_pred hhhhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhcccccC
Q 005427 149 AEKLHV---EEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRS 225 (697)
Q Consensus 149 ~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~ 225 (697)
.+.+.. ....+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~--------- 151 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ--------- 151 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCC---------
Confidence 887743 23468999999999999999999999999999999999999999999999999986543211
Q ss_pred CCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHHHHHHH
Q 005427 226 SGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVV 305 (697)
Q Consensus 226 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (697)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||............. ....
T Consensus 152 -------~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~----------~~~~ 214 (280)
T cd05608 152 -------SKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK----------QRIL 214 (280)
T ss_pred -------ccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHH----------Hhhc
Confidence 11234578999999999999999999999999999999999999997643221111111 0000
Q ss_pred hCCCCCcccccccCChHHHHHHHHHhccCCCCCCC-----CHHHHHHHHHHH
Q 005427 306 SGGLRPILASLELGLPASILSLIQRCWDGNPHNRP-----SFSDIALELDLV 352 (697)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~ell~~l~~~ 352 (697)
.. ....+..++.++.+++.+||+.||++|| +++++++|.|+.
T Consensus 215 ----~~-~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~ 261 (280)
T cd05608 215 ----ND-SVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFR 261 (280)
T ss_pred ----cc-CCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhh
Confidence 00 0123446889999999999999999999 789999998874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=344.08 Aligned_cols=267 Identities=24% Similarity=0.324 Sum_probs=206.1
Q ss_pred CCCcccccccccCCceEEEEEEE--CCeeEEEEeccCC--ChHHHHHHHHHHHHHHhcCCCCceEEeeccccCC------
Q 005427 65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPP------ 134 (697)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~------ 134 (697)
.++|++.+.||+|+||.||++.+ +++.||+|++... .......+.+|+.+++.++||||+++++++....
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 46899999999999999999986 5789999986533 3344567889999999999999999999886543
Q ss_pred ceEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhh
Q 005427 135 NYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYREN 214 (697)
Q Consensus 135 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~ 214 (697)
.+++||||+.+ +|...+.. .+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 100 ~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 175 (359)
T cd07876 100 DVYLVMELMDA-NLCQVIHM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACT 175 (359)
T ss_pred eeEEEEeCCCc-CHHHHHhc---cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcccccc
Confidence 47999999976 66666532 478889999999999999999999999999999999999999999999999864321
Q ss_pred hhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhcc
Q 005427 215 LKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMN 294 (697)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~ 294 (697)
........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+....
T Consensus 176 -----------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~ 238 (359)
T cd07876 176 -----------------NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQL 238 (359)
T ss_pred -----------------CccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 011234578999999999999999999999999999999999999998876554444333221
Q ss_pred ccHH-HHH-------HHHHhCC--CC-------------CcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 005427 295 YTEQ-QLT-------AAVVSGG--LR-------------PILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL 351 (697)
Q Consensus 295 ~~~~-~~~-------~~~~~~~--~~-------------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~ 351 (697)
.... ... ....... .. +.........++++.+||.+||..||++|||+.|+++|+|.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~ 318 (359)
T cd07876 239 GTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYI 318 (359)
T ss_pred CCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchh
Confidence 1110 000 0000000 00 00001112346789999999999999999999999999987
Q ss_pred H
Q 005427 352 V 352 (697)
Q Consensus 352 ~ 352 (697)
.
T Consensus 319 ~ 319 (359)
T cd07876 319 T 319 (359)
T ss_pred h
Confidence 5
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=345.99 Aligned_cols=264 Identities=25% Similarity=0.370 Sum_probs=212.7
Q ss_pred ccCCCCCCCcccccccccCCceEEEEEEEC-------CeeEEEEeccCCC-hHHHHHHHHHHHHHHhcC-CCCceEEeec
Q 005427 59 IPLHLPPSSYTLLSPIARGAESVVYEATLD-------GRKVAVKKPILST-SEELDNFHKELQLLCKLD-HPGLAKFVAA 129 (697)
Q Consensus 59 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-hpniv~l~~~ 129 (697)
..++++.++|+++++||+|+||.||+|.+. +..||||++.... ....+.+.+|+.+|+++. ||||++++++
T Consensus 30 ~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~ 109 (400)
T cd05105 30 SRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGA 109 (400)
T ss_pred CceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEE
Confidence 356778889999999999999999999752 2469999876443 334568999999999996 9999999999
Q ss_pred cccCCceEEEEeecCCCCHhhhhhhcC-----------------------------------------------------
Q 005427 130 HAKPPNYMFFFEFYESRNLAEKLHVEE----------------------------------------------------- 156 (697)
Q Consensus 130 ~~~~~~~~lv~e~~~~g~L~~~l~~~~----------------------------------------------------- 156 (697)
+......++|||||++|+|.+++....
T Consensus 110 ~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (400)
T cd05105 110 CTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYV 189 (400)
T ss_pred EccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccc
Confidence 999999999999999999999875421
Q ss_pred ------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcee
Q 005427 157 ------------------------------------------WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVL 194 (697)
Q Consensus 157 ------------------------------------------~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nil 194 (697)
..+++.+++.++.|++.||.|||+.+|+||||||+|||
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nil 269 (400)
T cd05105 190 PMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVL 269 (400)
T ss_pred hhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEE
Confidence 13677888999999999999999999999999999999
Q ss_pred ecCCCCCeeeeeccchhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-
Q 005427 195 LDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT- 273 (697)
Q Consensus 195 l~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~- 273 (697)
++.++.+||+|||+++....... ........+++.|+|||++.+..++.++|||||||++|+|++
T Consensus 270 l~~~~~~kL~DfGla~~~~~~~~--------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~ 335 (400)
T cd05105 270 LAQGKIVKICDFGLARDIMHDSN--------------YVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSL 335 (400)
T ss_pred EeCCCEEEEEeCCcceecccccc--------------ccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHC
Confidence 99999999999999875432110 011223457788999999999999999999999999999997
Q ss_pred CCCCCCCchhHHHHHHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 005427 274 GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL 353 (697)
Q Consensus 274 g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~ 353 (697)
|..||............. ..+.++ ..+..++.++.+++.+||+.||++|||+.+|.+.+..++
T Consensus 336 g~~P~~~~~~~~~~~~~~--------------~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 336 GGTPYPGMIVDSTFYNKI--------------KSGYRM---AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred CCCCCcccchhHHHHHHH--------------hcCCCC---CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 999998653322211111 111121 123468899999999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-40 Score=335.81 Aligned_cols=254 Identities=20% Similarity=0.234 Sum_probs=208.1
Q ss_pred CcccccccccCCceEEEEEEE--CCeeEEEEeccCCCh---HHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEe
Q 005427 67 SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTS---EELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFE 141 (697)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 141 (697)
.|++.++||+|+||.||++.+ +++.||+|++..... .....+.+|+.+++.++||||+++++.+..+...++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 488999999999999999987 578999998654322 223457789999999999999999999999999999999
Q ss_pred ecCCCCHhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhc
Q 005427 142 FYESRNLAEKLHVEE-WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL 220 (697)
Q Consensus 142 ~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~ 220 (697)
|+.+|+|.+++.... ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~---- 156 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE---- 156 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC----
Confidence 999999998876543 358999999999999999999999999999999999999999999999999986543110
Q ss_pred ccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHH
Q 005427 221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQL 300 (697)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 300 (697)
......|++.|+|||++.+..++.++||||+||++|+|++|..||.+.........+..
T Consensus 157 -------------~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~-------- 215 (285)
T cd05605 157 -------------TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVER-------- 215 (285)
T ss_pred -------------ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHH--------
Confidence 12234789999999999988899999999999999999999999987543322211111
Q ss_pred HHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCC-----CHHHHHHHHHHH
Q 005427 301 TAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRP-----SFSDIALELDLV 352 (697)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~ell~~l~~~ 352 (697)
.+. ......+..++..+.+|+.+||..||.+|| +++++++|.|+.
T Consensus 216 --~~~-----~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~ 265 (285)
T cd05605 216 --RVK-----EDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFR 265 (285)
T ss_pred --Hhh-----hcccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCcc
Confidence 010 011123345889999999999999999999 899999988775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=327.67 Aligned_cols=257 Identities=26% Similarity=0.422 Sum_probs=211.8
Q ss_pred CCCCCCCcccccccccCCceEEEEEEE-CCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEE
Q 005427 61 LHLPPSSYTLLSPIARGAESVVYEATL-DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFF 139 (697)
Q Consensus 61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 139 (697)
|.+..++|++.++||+|+||.||+|.. .++.||+|..... ....+.+.+|+.+++.++||||+++++.+......+++
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 79 (261)
T cd05072 1 WEIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYII 79 (261)
T ss_pred CcCchHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCC-chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEE
Confidence 456778999999999999999999986 5677999975543 23457889999999999999999999999999999999
Q ss_pred EeecCCCCHhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhh
Q 005427 140 FEFYESRNLAEKLHVE-EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI 218 (697)
Q Consensus 140 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~ 218 (697)
|||+.+++|.+++... ...+++.+++.++.|++.||+|||+.+++||||||+||+++.++.+||+|||++........
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~- 158 (261)
T cd05072 80 TEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY- 158 (261)
T ss_pred EecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCce-
Confidence 9999999999998653 34678899999999999999999999999999999999999999999999999976542110
Q ss_pred hcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCCchhHHHHHHHHhccccH
Q 005427 219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTE 297 (697)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~ 297 (697)
.......++..|+|||++.+..++.++|||||||++|+|++ |..||...........+..
T Consensus 159 --------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~----- 219 (261)
T cd05072 159 --------------TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQR----- 219 (261)
T ss_pred --------------eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHc-----
Confidence 01122345778999999998889999999999999999998 9999987654433322211
Q ss_pred HHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 005427 298 QQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL 351 (697)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~ 351 (697)
..+. .....++.++.+++.+||..+|++|||++++.+.|+.
T Consensus 220 ----------~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 220 ----------GYRM---PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred ----------CCCC---CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 1111 1223578999999999999999999999999887753
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=343.42 Aligned_cols=253 Identities=24% Similarity=0.352 Sum_probs=202.0
Q ss_pred cccccCCceEEEEEEE--CCeeEEEEeccCC---ChHHHHHHHHHHHHHHhc-CCCCceEEeeccccCCceEEEEeecCC
Q 005427 72 SPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKL-DHPGLAKFVAAHAKPPNYMFFFEFYES 145 (697)
Q Consensus 72 ~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~ 145 (697)
+.||+|+||.||++++ +++.||+|++... .......+..|..+++.+ +||||+++++++.+...+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4689999999999987 5788999986532 233456788999999998 799999999999999999999999999
Q ss_pred CCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhcccccC
Q 005427 146 RNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRS 225 (697)
Q Consensus 146 g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~ 225 (697)
|+|.+++...+ .+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 81 g~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~----------- 148 (329)
T cd05588 81 GDLMFHMQRQR-KLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIR----------- 148 (329)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCcccccccc-----------
Confidence 99998886554 789999999999999999999999999999999999999999999999999863211
Q ss_pred CCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHHHHHHH
Q 005427 226 SGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVV 305 (697)
Q Consensus 226 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (697)
.+......+||+.|+|||++.+..++.++|+|||||++|+|++|..||.......... ..........+.
T Consensus 149 -----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~-----~~~~~~~~~~~~ 218 (329)
T cd05588 149 -----PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPD-----QNTEDYLFQVIL 218 (329)
T ss_pred -----CCCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccccccccccc-----ccchHHHHHHHH
Confidence 0112345679999999999999999999999999999999999999996422110000 000011111111
Q ss_pred hCCCCCcccccccCChHHHHHHHHHhccCCCCCCCC------HHHHHHHHHH
Q 005427 306 SGGLRPILASLELGLPASILSLIQRCWDGNPHNRPS------FSDIALELDL 351 (697)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt------~~ell~~l~~ 351 (697)
... ...+..++.++.++|++||+.||.+||| ++++++|.|+
T Consensus 219 ~~~-----~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~ 265 (329)
T cd05588 219 EKQ-----IRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFF 265 (329)
T ss_pred cCC-----CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCC
Confidence 111 1234568899999999999999999997 7899988877
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=316.73 Aligned_cols=253 Identities=23% Similarity=0.322 Sum_probs=217.9
Q ss_pred CCCCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCC---ChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCce
Q 005427 62 HLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNY 136 (697)
Q Consensus 62 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 136 (697)
.+-.++|.++++||+|.||.|-+++. +++.+|+|++... ..++...-..|-++|+..+||++..|-..|...+++
T Consensus 164 kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drl 243 (516)
T KOG0690|consen 164 KVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRL 243 (516)
T ss_pred eeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceE
Confidence 34456899999999999999999986 6889999975432 345667778899999999999999999999999999
Q ss_pred EEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhh
Q 005427 137 MFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLK 216 (697)
Q Consensus 137 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~ 216 (697)
|+||||..||.|+-.|.... .|+++.++.+..+|+.||.|||+++||.||||.+|+|+|.+|++||+|||+++.-
T Consensus 244 CFVMeyanGGeLf~HLsrer-~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~---- 318 (516)
T KOG0690|consen 244 CFVMEYANGGELFFHLSRER-VFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEE---- 318 (516)
T ss_pred EEEEEEccCceEeeehhhhh-cccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhc----
Confidence 99999999999999987654 7999999999999999999999999999999999999999999999999999632
Q ss_pred hhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhcccc
Q 005427 217 EISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYT 296 (697)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~ 296 (697)
...+....++||||.|.|||++....|+.++|.|.+||+||||++|+.||...+.......|+-...
T Consensus 319 ------------I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~- 385 (516)
T KOG0690|consen 319 ------------IKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDL- 385 (516)
T ss_pred ------------ccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhc-
Confidence 1223357789999999999999999999999999999999999999999998777666555543222
Q ss_pred HHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCC-----CHHHHHHHHH
Q 005427 297 EQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRP-----SFSDIALELD 350 (697)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~ell~~l~ 350 (697)
..|..++++++.|+..+|..||.+|. ++.||.+|-.
T Consensus 386 ------------------kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~F 426 (516)
T KOG0690|consen 386 ------------------KFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRF 426 (516)
T ss_pred ------------------cCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhh
Confidence 13567999999999999999999995 4666665543
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-41 Score=340.19 Aligned_cols=249 Identities=25% Similarity=0.357 Sum_probs=215.9
Q ss_pred CCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCC---hHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEE
Q 005427 65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST---SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFF 139 (697)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 139 (697)
.+.|.=++.||.|+||.||.|++ +.+.||||+...+. .+.+..+..|+..|.+++|||+|.+-++|..+...|||
T Consensus 25 Eklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLV 104 (948)
T KOG0577|consen 25 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLV 104 (948)
T ss_pred HHHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHH
Confidence 34588899999999999999987 67889999877653 45688899999999999999999999999999999999
Q ss_pred EeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhh
Q 005427 140 FEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEIS 219 (697)
Q Consensus 140 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~ 219 (697)
||||-| +-.|++.....++.+.++..|+.+.+.||+|||+.+.||||||..|||+++.|.|||+|||.|....
T Consensus 105 MEYClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~------ 177 (948)
T KOG0577|consen 105 MEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMA------ 177 (948)
T ss_pred HHHHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcC------
Confidence 999975 8888877766788999999999999999999999999999999999999999999999999987654
Q ss_pred cccccCCCCCCCCccccccccCccccchhhhc---ccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhcccc
Q 005427 220 LKNWRSSGKPTGGFHKKNMVGTLIYMAPEILK---KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYT 296 (697)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~ 296 (697)
+..+++|||.|||||++. .+.|+-++||||||++..||.-+++|+-..+...-+.-|-..
T Consensus 178 --------------PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQN--- 240 (948)
T KOG0577|consen 178 --------------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN--- 240 (948)
T ss_pred --------------chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhc---
Confidence 356789999999999985 466899999999999999999999998877766555544321
Q ss_pred HHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 005427 297 EQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL 351 (697)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~ 351 (697)
-.|.++ ...+|..+.+|+..||+.-|.+|||.++++.|...
T Consensus 241 ------------esPtLq--s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv 281 (948)
T KOG0577|consen 241 ------------ESPTLQ--SNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFV 281 (948)
T ss_pred ------------CCCCCC--CchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchh
Confidence 123333 34688999999999999999999999999987644
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=326.83 Aligned_cols=252 Identities=24% Similarity=0.393 Sum_probs=207.1
Q ss_pred CCCCcccccccccCCceEEEEEEECC-eeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEee
Q 005427 64 PPSSYTLLSPIARGAESVVYEATLDG-RKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF 142 (697)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 142 (697)
..++|++.+.||+|+||.||++.+.+ ..+|+|.+.... ...+.+.+|+.+++.++||||+++++++......+++|||
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05113 2 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEY 80 (256)
T ss_pred ChHHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEc
Confidence 45689999999999999999998754 459999765432 2346789999999999999999999999999999999999
Q ss_pred cCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhccc
Q 005427 143 YESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKN 222 (697)
Q Consensus 143 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 222 (697)
+.+|+|.+++......+++.+++.++.|++.||+|||+.|++|+||||+||+++.++.+||+|||++........
T Consensus 81 ~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~----- 155 (256)
T cd05113 81 MSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY----- 155 (256)
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCce-----
Confidence 999999999976555789999999999999999999999999999999999999999999999999865432110
Q ss_pred ccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCCchhHHHHHHHHhccccHHHHH
Q 005427 223 WRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLT 301 (697)
Q Consensus 223 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 301 (697)
.......++..|+|||++.+..++.++|||||||++|+|++ |..||...........+..
T Consensus 156 ----------~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~--------- 216 (256)
T cd05113 156 ----------TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQ--------- 216 (256)
T ss_pred ----------eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhc---------
Confidence 01112345678999999998889999999999999999998 9999987654433332221
Q ss_pred HHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 005427 302 AAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALEL 349 (697)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l 349 (697)
..++. .+...+..+.+++.+||+.+|.+|||+.+|+..+
T Consensus 217 ------~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~ 255 (256)
T cd05113 217 ------GLRLY---RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSI 255 (256)
T ss_pred ------CCCCC---CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhh
Confidence 11111 2234688999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=339.86 Aligned_cols=244 Identities=24% Similarity=0.357 Sum_probs=199.5
Q ss_pred cccccCCceEEEEEEE--CCeeEEEEeccCCC---hHHHHHHHHHHHHHHhc-CCCCceEEeeccccCCceEEEEeecCC
Q 005427 72 SPIARGAESVVYEATL--DGRKVAVKKPILST---SEELDNFHKELQLLCKL-DHPGLAKFVAAHAKPPNYMFFFEFYES 145 (697)
Q Consensus 72 ~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~ 145 (697)
+.||+|+||.||+|++ +++.||+|++.... ......+..|..+++.+ +||||+++++++.+...+++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 4799999999999987 46789999765431 23345667788888764 999999999999999999999999999
Q ss_pred CCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhcccccC
Q 005427 146 RNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRS 225 (697)
Q Consensus 146 g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~ 225 (697)
|+|.+++.... .+++.++..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 81 g~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~----------- 148 (316)
T cd05619 81 GDLMFHIQSCH-KFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENML----------- 148 (316)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCC-----------
Confidence 99999987543 688999999999999999999999999999999999999999999999999853211
Q ss_pred CCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHHHHHHH
Q 005427 226 SGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVV 305 (697)
Q Consensus 226 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (697)
.........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.........+..
T Consensus 149 -----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~------------- 210 (316)
T cd05619 149 -----GDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRM------------- 210 (316)
T ss_pred -----CCCceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-------------
Confidence 00112345799999999999999999999999999999999999999987654433332211
Q ss_pred hCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHH-HHHHHHHH
Q 005427 306 SGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFS-DIALELDL 351 (697)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~-ell~~l~~ 351 (697)
. .+ ..+..++.++.+++.+||+.||.+||++. ++++|.|+
T Consensus 211 -~--~~---~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~ 251 (316)
T cd05619 211 -D--NP---CYPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFF 251 (316)
T ss_pred -C--CC---CCCccCCHHHHHHHHHHhccCHhhcCCChHHHHcCccc
Confidence 1 11 12345788999999999999999999996 77776654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=346.25 Aligned_cols=245 Identities=27% Similarity=0.408 Sum_probs=203.0
Q ss_pred ccccccCCceEEEEEEE-----CCeeEEEEeccCCC--hHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEeec
Q 005427 71 LSPIARGAESVVYEATL-----DGRKVAVKKPILST--SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFY 143 (697)
Q Consensus 71 ~~~lg~G~~g~V~~~~~-----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 143 (697)
++.||+|+||.||+++. .++.+|+|++.... ......+..|+++|++++||||+++++++..+..+|+||||+
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence 36799999999999864 46889999865432 223456788999999999999999999999999999999999
Q ss_pred CCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhcccc
Q 005427 144 ESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNW 223 (697)
Q Consensus 144 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~ 223 (697)
.+|+|.+++.... .+++..++.++.|++.||+|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 81 ~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~------- 152 (318)
T cd05582 81 RGGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE------- 152 (318)
T ss_pred CCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-------
Confidence 9999999986544 68999999999999999999999999999999999999999999999999986543210
Q ss_pred cCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHHHHH
Q 005427 224 RSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAA 303 (697)
Q Consensus 224 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (697)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+....
T Consensus 153 ---------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~--------- 214 (318)
T cd05582 153 ---------KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAK--------- 214 (318)
T ss_pred ---------CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCC---------
Confidence 11234579999999999999889999999999999999999999998765544433332211
Q ss_pred HHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCC-----HHHHHHHHHH
Q 005427 304 VVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPS-----FSDIALELDL 351 (697)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt-----~~ell~~l~~ 351 (697)
...+..+++++.+||++||+.||.+||+ +.+++.|.|+
T Consensus 215 ----------~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~ 257 (318)
T cd05582 215 ----------LGMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFF 257 (318)
T ss_pred ----------CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCc
Confidence 1134468899999999999999999999 5667766554
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=329.87 Aligned_cols=259 Identities=25% Similarity=0.382 Sum_probs=213.3
Q ss_pred CCCCcccccccccCCceEEEEEEE-------CCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCce
Q 005427 64 PPSSYTLLSPIARGAESVVYEATL-------DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNY 136 (697)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~-------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 136 (697)
...+|.+.+.||+|+||.||++.. ++..+|+|............+.+|+.++++++||||+++++++.....+
T Consensus 3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (288)
T cd05093 3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 82 (288)
T ss_pred chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 456799999999999999999974 2356899987666556677899999999999999999999999999999
Q ss_pred EEEEeecCCCCHhhhhhhcC------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeee
Q 005427 137 MFFFEFYESRNLAEKLHVEE------------WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLA 204 (697)
Q Consensus 137 ~lv~e~~~~g~L~~~l~~~~------------~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~ 204 (697)
+++|||+.+++|.+++.... ..+++.+++.++.|++.||+|||+.|++||||||+|||++.++.+||+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~kl~ 162 (288)
T cd05093 83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIG 162 (288)
T ss_pred EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEec
Confidence 99999999999999986433 247899999999999999999999999999999999999999999999
Q ss_pred eeccchhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCCchh
Q 005427 205 DFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRA 283 (697)
Q Consensus 205 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~~~~ 283 (697)
|||++........ ........+++.|+|||++.+..++.++|||||||++|+|++ |..||.....
T Consensus 163 dfg~~~~~~~~~~--------------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~ 228 (288)
T cd05093 163 DFGMSRDVYSTDY--------------YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN 228 (288)
T ss_pred cCCccccccCCce--------------eecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 9999875432110 001123346788999999999889999999999999999998 9999987654
Q ss_pred HHHHHHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 005427 284 EAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE 354 (697)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~ 354 (697)
......+.. +... ..+..++.++.+|+.+||+.||.+|||+.+++..++.+..
T Consensus 229 ~~~~~~i~~--------------~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~ 281 (288)
T cd05093 229 NEVIECITQ--------------GRVL----QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK 281 (288)
T ss_pred HHHHHHHHc--------------CCcC----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 433333221 1111 1234578899999999999999999999999988887764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=346.56 Aligned_cols=259 Identities=21% Similarity=0.279 Sum_probs=209.4
Q ss_pred CCCCCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCC---ChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCc
Q 005427 61 LHLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPN 135 (697)
Q Consensus 61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 135 (697)
..+..++|++.+.||+|+||.||++++ +++.+|+|++... .......+.+|+.+++.++||||+++++.+.+...
T Consensus 38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (371)
T cd05622 38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 117 (371)
T ss_pred cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence 455668999999999999999999987 5788999986432 22334567899999999999999999999999999
Q ss_pred eEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhh
Q 005427 136 YMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL 215 (697)
Q Consensus 136 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~ 215 (697)
+++||||+++|+|.+++... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 118 ~~lv~Ey~~gg~L~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~ 195 (371)
T cd05622 118 LYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE 195 (371)
T ss_pred EEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcC
Confidence 99999999999999998654 5788999999999999999999999999999999999999999999999998754321
Q ss_pred hhhhcccccCCCCCCCCccccccccCccccchhhhcccC----CCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHH
Q 005427 216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEI----HSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVL 291 (697)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~ 291 (697)
. .......+||+.|+|||++.+.. ++.++|||||||++|||++|..||.+.+.......+.
T Consensus 196 ~---------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~ 260 (371)
T cd05622 196 G---------------MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 260 (371)
T ss_pred C---------------cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 0 01123567999999999997543 7889999999999999999999998766544444333
Q ss_pred hccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCC--CCCHHHHHHHHHH
Q 005427 292 EMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHN--RPSFSDIALELDL 351 (697)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~--Rpt~~ell~~l~~ 351 (697)
.... ...++ ....++.++.++|..||..++.+ |++++++++|+|+
T Consensus 261 ~~~~--------------~~~~~-~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~ 307 (371)
T cd05622 261 NHKN--------------SLTFP-DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFF 307 (371)
T ss_pred cCCC--------------cccCC-CcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCccc
Confidence 2111 00111 12368999999999999844433 7899999999876
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=343.09 Aligned_cols=244 Identities=26% Similarity=0.351 Sum_probs=199.5
Q ss_pred cccccCCceEEEEEEE--CCeeEEEEeccCCC---hHHHHHHHHHHH-HHHhcCCCCceEEeeccccCCceEEEEeecCC
Q 005427 72 SPIARGAESVVYEATL--DGRKVAVKKPILST---SEELDNFHKELQ-LLCKLDHPGLAKFVAAHAKPPNYMFFFEFYES 145 (697)
Q Consensus 72 ~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 145 (697)
+.||+|+||+||+|++ +++.||+|++.... ......+..|.. +++.++||||+++++.+.....+++||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 4699999999999987 67899999865321 223344555554 56789999999999999999999999999999
Q ss_pred CCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhcccccC
Q 005427 146 RNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRS 225 (697)
Q Consensus 146 g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~ 225 (697)
|+|..++.... .+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 81 g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~---------- 149 (323)
T cd05575 81 GELFFHLQRER-SFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH---------- 149 (323)
T ss_pred CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccC----------
Confidence 99999887654 7889999999999999999999999999999999999999999999999998642210
Q ss_pred CCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHHHHHHH
Q 005427 226 SGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVV 305 (697)
Q Consensus 226 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (697)
.......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+....
T Consensus 150 ------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~----------- 212 (323)
T cd05575 150 ------SKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKP----------- 212 (323)
T ss_pred ------CCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC-----------
Confidence 011334579999999999999999999999999999999999999998765544433332211
Q ss_pred hCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCH----HHHHHHHHH
Q 005427 306 SGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSF----SDIALELDL 351 (697)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~----~ell~~l~~ 351 (697)
...+..++.++.++|++||+.||.+||++ .++++|.|+
T Consensus 213 --------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~ 254 (323)
T cd05575 213 --------LRLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFF 254 (323)
T ss_pred --------CCCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCc
Confidence 11234678999999999999999999987 577777664
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=330.51 Aligned_cols=256 Identities=24% Similarity=0.354 Sum_probs=208.2
Q ss_pred CCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEe
Q 005427 64 PPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFE 141 (697)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 141 (697)
+.++|++.++||+|+||.||+|+. +++.||+|+...........+.+|+.+++.++||||+++++.+.....+++|||
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e 86 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICME 86 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEe
Confidence 346899999999999999999986 678899998766655566678899999999999999999999999999999999
Q ss_pred ecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhcc
Q 005427 142 FYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLK 221 (697)
Q Consensus 142 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~ 221 (697)
|+.+++|.+++.... .+++.++..++.|++.||.|||+.||+||||||+||+++.++.+||+|||++.......
T Consensus 87 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~----- 160 (267)
T cd06646 87 YCGGGSLQDIYHVTG-PLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI----- 160 (267)
T ss_pred CCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccc-----
Confidence 999999999987554 68899999999999999999999999999999999999999999999999987543100
Q ss_pred cccCCCCCCCCccccccccCccccchhhhc---ccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHH
Q 005427 222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILK---KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQ 298 (697)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~ 298 (697)
.......|++.|+|||.+. ...++.++|+|||||++|+|++|..||...........+..
T Consensus 161 -----------~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~------ 223 (267)
T cd06646 161 -----------AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSK------ 223 (267)
T ss_pred -----------cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeec------
Confidence 0123356889999999984 34577899999999999999999999975433221111100
Q ss_pred HHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 005427 299 QLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350 (697)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~ 350 (697)
..+.+........++..+.+++++||..+|++|||+++++++++
T Consensus 224 --------~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 224 --------SNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred --------CCCCCCCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 11111111112357889999999999999999999999998763
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=327.59 Aligned_cols=255 Identities=28% Similarity=0.431 Sum_probs=214.0
Q ss_pred CCCCCcccccccccCCceEEEEEEE-CCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEe
Q 005427 63 LPPSSYTLLSPIARGAESVVYEATL-DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFE 141 (697)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 141 (697)
.+..+|++.++||.|+||.||+|.+ .++.+++|.+..........+.+|+.+++.++||||+++++++.....++++||
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE 82 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence 3456799999999999999999987 467899998776666567789999999999999999999999999999999999
Q ss_pred ecCCCCHhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhc
Q 005427 142 FYESRNLAEKLHVE-EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL 220 (697)
Q Consensus 142 ~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~ 220 (697)
|+++++|.+++... +..+++.+++.++.|++.||.|||+.|++||||||+||+++.++.+||+|||++.......
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~---- 158 (261)
T cd05148 83 LMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV---- 158 (261)
T ss_pred ecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCcc----
Confidence 99999999999753 3467899999999999999999999999999999999999999999999999987553211
Q ss_pred ccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCCchhHHHHHHHHhccccHHH
Q 005427 221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQ 299 (697)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~ 299 (697)
.......++..|+|||++.+..++.++||||||+++|+|++ |..||.+.........+.
T Consensus 159 ------------~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~-------- 218 (261)
T cd05148 159 ------------YLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT-------- 218 (261)
T ss_pred ------------ccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHH--------
Confidence 11223346778999999998889999999999999999998 899998765443333222
Q ss_pred HHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 005427 300 LTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL 351 (697)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~ 351 (697)
...++ ..+..+++.+.+++.+||+.||.+|||+.+|++.|+.
T Consensus 219 -------~~~~~---~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 219 -------AGYRM---PCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred -------hCCcC---CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 11121 1235688999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=336.26 Aligned_cols=266 Identities=28% Similarity=0.452 Sum_probs=222.8
Q ss_pred cCCCCCCCcccccccccCCceEEEEEEEC----Cee--EEEEeccCC-ChHHHHHHHHHHHHHHhcCCCCceEEeecccc
Q 005427 60 PLHLPPSSYTLLSPIARGAESVVYEATLD----GRK--VAVKKPILS-TSEELDNFHKELQLLCKLDHPGLAKFVAAHAK 132 (697)
Q Consensus 60 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~----~~~--vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 132 (697)
..++..+..++.++||.|.||.||+|.++ |+. ||||..... ..++.+.|..|..+|+.++|||||+|+|+|.+
T Consensus 383 nyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e 462 (974)
T KOG4257|consen 383 NYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE 462 (974)
T ss_pred cceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec
Confidence 34555566677889999999999999863 343 677754432 34557899999999999999999999999976
Q ss_pred CCceEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhh
Q 005427 133 PPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYR 212 (697)
Q Consensus 133 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~ 212 (697)
...|+|||.++-|.|..+|+.+...++......++.||+.||.|||+..+|||||..+|||+.....|||+|||+++++
T Consensus 463 -~P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ 541 (974)
T KOG4257|consen 463 -QPMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYL 541 (974)
T ss_pred -cceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhc
Confidence 4678999999999999999999989999999999999999999999999999999999999999999999999999998
Q ss_pred hhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCCchhHHHHHHHH
Q 005427 213 ENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVL 291 (697)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~~~~~~~~~~~~ 291 (697)
++.... ......-+.-|||||.+.-..++.++|||-|||.|||++. |..||.+..+.+....+.
T Consensus 542 ed~~yY---------------kaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iE 606 (974)
T KOG4257|consen 542 EDDAYY---------------KASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIE 606 (974)
T ss_pred cccchh---------------hccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEec
Confidence 864432 2233445778999999999999999999999999999998 999999876554433332
Q ss_pred hccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhccc
Q 005427 292 EMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHRKSL 359 (697)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~~~~~ 359 (697)
+ +. |+ ..|+.+|+.+..|+.+||.++|.+||++.+|...|..+++..+..
T Consensus 607 n--------------Ge-Rl---P~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qeek~~ 656 (974)
T KOG4257|consen 607 N--------------GE-RL---PCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEEKIN 656 (974)
T ss_pred C--------------CC-CC---CCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHhhhh
Confidence 2 22 22 246689999999999999999999999999999999988754433
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=331.92 Aligned_cols=258 Identities=24% Similarity=0.391 Sum_probs=216.3
Q ss_pred CCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEe
Q 005427 64 PPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFE 141 (697)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 141 (697)
+.++|++++.||.|+||.||++.+ ++..+|+|..........+.+.+|+++++.++||||+++++.+..+..+++|||
T Consensus 3 ~~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd06611 3 PNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE 82 (280)
T ss_pred chhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence 346899999999999999999987 578899998877777777889999999999999999999999999999999999
Q ss_pred ecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhcc
Q 005427 142 FYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLK 221 (697)
Q Consensus 142 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~ 221 (697)
|+++++|.+++...+..+++.+++.++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++.......
T Consensus 83 ~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~----- 157 (280)
T cd06611 83 FCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL----- 157 (280)
T ss_pred ccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccc-----
Confidence 999999999987766678999999999999999999999999999999999999999999999999876543210
Q ss_pred cccCCCCCCCCccccccccCccccchhhhc-----ccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhcccc
Q 005427 222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILK-----KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYT 296 (697)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~ 296 (697)
.......|++.|+|||++. +.+++.++|+||||+++|+|++|..||...........+..
T Consensus 158 -----------~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---- 222 (280)
T cd06611 158 -----------QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILK---- 222 (280)
T ss_pred -----------cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhc----
Confidence 0123456899999999975 34567899999999999999999999987654333222211
Q ss_pred HHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 005427 297 EQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL 353 (697)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~ 353 (697)
...+.+ ..+..++.++.++|.+||+.+|.+||++.++++|.|...
T Consensus 223 -----------~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~ 267 (280)
T cd06611 223 -----------SEPPTL-DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSD 267 (280)
T ss_pred -----------CCCCCc-CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhcc
Confidence 111111 123467899999999999999999999999999988753
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=346.30 Aligned_cols=269 Identities=28% Similarity=0.365 Sum_probs=210.6
Q ss_pred CcccccccccCCceEEEEEEE--CCeeEEEEeccCC--ChHHHHHHHHHHHHHHhcCCCCceEEeeccccCC-----ceE
Q 005427 67 SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPP-----NYM 137 (697)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-----~~~ 137 (697)
+|++.++||+|+||.||++.+ +++.||+|++... .......+.+|+.+|+.++||||+++++++..+. ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 478899999999999999986 6889999986432 2334567889999999999999999999998776 789
Q ss_pred EEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhh
Q 005427 138 FFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKE 217 (697)
Q Consensus 138 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~ 217 (697)
+||||+. ++|.+.+.... .+++..++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 81 lv~e~~~-~~l~~~~~~~~-~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~- 157 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSPQ-PLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDE- 157 (372)
T ss_pred EEeeccc-cCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCc-
Confidence 9999997 47888775443 78999999999999999999999999999999999999999999999999987543211
Q ss_pred hhcccccCCCCCCCCccccccccCccccchhhhccc-CCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhcccc
Q 005427 218 ISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKE-IHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYT 296 (697)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~ 296 (697)
........+++.|+|||++.+. .++.++|||||||++|||++|+.||.+.+.......+......
T Consensus 158 --------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~ 223 (372)
T cd07853 158 --------------SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGT 223 (372)
T ss_pred --------------cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCC
Confidence 0112334688999999999874 4789999999999999999999999887766655554432211
Q ss_pred --HHHH-------HHHHHhCCCCC-ccc---ccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 297 --EQQL-------TAAVVSGGLRP-ILA---SLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 297 --~~~~-------~~~~~~~~~~~-~~~---~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
...+ ...+......+ ... ......++++.+||.+||+.||.+|||+.++++|.|..
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~ 292 (372)
T cd07853 224 PSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLD 292 (372)
T ss_pred CCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhC
Confidence 1111 11111111111 111 12345688999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=324.86 Aligned_cols=258 Identities=27% Similarity=0.439 Sum_probs=212.1
Q ss_pred CCCCCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEE
Q 005427 61 LHLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMF 138 (697)
Q Consensus 61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 138 (697)
+++....|.+.++||+|+||.||+|.+ .++.||+|.... .......+.+|+++++.++||||+++++++.....+++
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (263)
T cd05052 1 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 79 (263)
T ss_pred CCCchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecC-CchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEE
Confidence 355667899999999999999999986 478899998653 33446678999999999999999999999999999999
Q ss_pred EEeecCCCCHhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhh
Q 005427 139 FFEFYESRNLAEKLHVEE-WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKE 217 (697)
Q Consensus 139 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~ 217 (697)
+|||+++++|.+++.... ..+++..++.++.|++.||+|||+.|++||||||+||+++.++.+||+|||++........
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~ 159 (263)
T cd05052 80 ITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 159 (263)
T ss_pred EEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence 999999999999986533 3578899999999999999999999999999999999999999999999999875432110
Q ss_pred hhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCCchhHHHHHHHHhcccc
Q 005427 218 ISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYT 296 (697)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~~~~~~~~~~~~~~~~~ 296 (697)
.......+++.|+|||.+.+..++.++|||||||++|||++ |..||.+.........+.
T Consensus 160 ---------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~----- 219 (263)
T cd05052 160 ---------------TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE----- 219 (263)
T ss_pred ---------------eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-----
Confidence 00112234678999999999999999999999999999998 999998765443322221
Q ss_pred HHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 297 EQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
...++ ..+..+|.++.+++.+||+.||++|||+.++++.|..+
T Consensus 220 ----------~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 220 ----------KGYRM---ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred ----------CCCCC---CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 11111 23456889999999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=328.66 Aligned_cols=258 Identities=23% Similarity=0.408 Sum_probs=208.2
Q ss_pred CCCCCCCcccccccccCCceEEEEEEEC-------CeeEEEEeccCCC-hHHHHHHHHHHHHHHhcCCCCceEEeecccc
Q 005427 61 LHLPPSSYTLLSPIARGAESVVYEATLD-------GRKVAVKKPILST-SEELDNFHKELQLLCKLDHPGLAKFVAAHAK 132 (697)
Q Consensus 61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 132 (697)
|.+..++|++.+.||+|+||.||+|.+. +..||+|+..... ......+.+|+.+++.++||||+++++++..
T Consensus 1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~ 80 (277)
T cd05062 1 WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 80 (277)
T ss_pred CcccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 3456788999999999999999999753 3579999865332 2345678899999999999999999999999
Q ss_pred CCceEEEEeecCCCCHhhhhhhcC---------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCee
Q 005427 133 PPNYMFFFEFYESRNLAEKLHVEE---------WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHL 203 (697)
Q Consensus 133 ~~~~~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL 203 (697)
....++||||+++++|.+++.... ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 81 GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEE
Confidence 999999999999999999986532 23567889999999999999999999999999999999999999999
Q ss_pred eeeccchhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCCch
Q 005427 204 ADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLR 282 (697)
Q Consensus 204 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~~~ 282 (697)
+|||++......... .......+++.|+|||++.+..++.++|||||||++|||++ |..||.+..
T Consensus 161 ~dfg~~~~~~~~~~~--------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~ 226 (277)
T cd05062 161 GDFGMTRDIYETDYY--------------RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMS 226 (277)
T ss_pred CCCCCccccCCccee--------------ecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 999998654321110 00112356788999999999889999999999999999999 789998765
Q ss_pred hHHHHHHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 005427 283 AEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350 (697)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~ 350 (697)
.......+.. ... ...+..++..+.+++.+||+.||++|||+.++++++.
T Consensus 227 ~~~~~~~~~~--------------~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 227 NEQVLRFVME--------------GGL----LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred HHHHHHHHHc--------------CCc----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 4433322211 111 1223467889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=343.13 Aligned_cols=267 Identities=22% Similarity=0.299 Sum_probs=206.4
Q ss_pred CCCcccccccccCCceEEEEEEE--CCeeEEEEeccCC--ChHHHHHHHHHHHHHHhcCCCCceEEeeccccC------C
Q 005427 65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKP------P 134 (697)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~------~ 134 (697)
.++|++.+.||+|+||.||++.+ .++.||+|++... .......+.+|+.+++.++||||+++++++... .
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 95 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ 95 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence 36899999999999999999986 5788999986543 333456788999999999999999999987543 3
Q ss_pred ceEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhh
Q 005427 135 NYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYREN 214 (697)
Q Consensus 135 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~ 214 (697)
..+++|||+.+ +|.+.+.. .+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 96 ~~~lv~e~~~~-~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~ 171 (355)
T cd07874 96 DVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 171 (355)
T ss_pred eeEEEhhhhcc-cHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCCC
Confidence 57999999976 66666643 478889999999999999999999999999999999999999999999999865432
Q ss_pred hhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhcc
Q 005427 215 LKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMN 294 (697)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~ 294 (697)
. .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+....
T Consensus 172 ~-----------------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 234 (355)
T cd07874 172 S-----------------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQL 234 (355)
T ss_pred c-----------------cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 0 11234578999999999999999999999999999999999999998876554444333221
Q ss_pred ccH-HHH-------HHHHHhC---------------CCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 005427 295 YTE-QQL-------TAAVVSG---------------GLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL 351 (697)
Q Consensus 295 ~~~-~~~-------~~~~~~~---------------~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~ 351 (697)
... .+. ....... ...+.....+...+.++.+||.+||+.||++|||+.|+++|+|.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~ 314 (355)
T cd07874 235 GTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYI 314 (355)
T ss_pred CCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcch
Confidence 110 000 0000000 00000111122356788999999999999999999999999887
Q ss_pred H
Q 005427 352 V 352 (697)
Q Consensus 352 ~ 352 (697)
.
T Consensus 315 ~ 315 (355)
T cd07874 315 N 315 (355)
T ss_pred h
Confidence 4
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=343.56 Aligned_cols=248 Identities=26% Similarity=0.427 Sum_probs=212.1
Q ss_pred ccccCCceEEEEEEE--CCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEeecCCCCHhh
Q 005427 73 PIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAE 150 (697)
Q Consensus 73 ~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~ 150 (697)
+||+|.||+||.|++ +...+|||.+........+.++.|+.+.++|+|.|||+++|.+..++.+-+.||.++||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 699999999999987 456789999888888889999999999999999999999999999999999999999999999
Q ss_pred hhhhcCCCC--CHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeec-CCCCCeeeeeccchhhhhhhhhhcccccCCC
Q 005427 151 KLHVEEWSP--SVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLD-RNLCPHLADFGLAEYRENLKEISLKNWRSSG 227 (697)
Q Consensus 151 ~l~~~~~~~--~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~-~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~ 227 (697)
+|+..-+++ .+.++..+.+||++||.|||+..|||||||-+||||+ ..|.+||+|||-++.+....
T Consensus 662 LLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin----------- 730 (1226)
T KOG4279|consen 662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN----------- 730 (1226)
T ss_pred HHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCC-----------
Confidence 998766666 7889999999999999999999999999999999995 58999999999987665322
Q ss_pred CCCCCccccccccCccccchhhhcccC--CCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHHHHHHH
Q 005427 228 KPTGGFHKKNMVGTLIYMAPEILKKEI--HSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVV 305 (697)
Q Consensus 228 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (697)
..+.++.||.-|||||++-.++ |+.++|||||||++.||.||++||.......-..-.
T Consensus 731 -----P~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFk--------------- 790 (1226)
T KOG4279|consen 731 -----PCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFK--------------- 790 (1226)
T ss_pred -----ccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhh---------------
Confidence 2467889999999999997654 889999999999999999999999875433221111
Q ss_pred hCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 306 SGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
-++-..-+.+|..++.+++.+|.+|+..||.+||++.+++..+...
T Consensus 791 -VGmyKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq 836 (1226)
T KOG4279|consen 791 -VGMYKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQ 836 (1226)
T ss_pred -hcceecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccc
Confidence 1112223445667899999999999999999999999999765443
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=340.75 Aligned_cols=257 Identities=25% Similarity=0.282 Sum_probs=207.6
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccCC---ChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEE
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFF 140 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 140 (697)
++|++.+.||+|+||.||+++. +++.||+|++... .....+.+.+|+.+++.++||||+++++++.++..+++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 4799999999999999999987 5789999986532 2234566889999999999999999999999999999999
Q ss_pred eecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhc
Q 005427 141 EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL 220 (697)
Q Consensus 141 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~ 220 (697)
||+.+|+|.+++......+++.++..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~---- 156 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG---- 156 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCC----
Confidence 9999999999997656678999999999999999999999999999999999999999999999999986543211
Q ss_pred ccccCCCCCCCCccccccccCccccchhhhcc-----cCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccc
Q 005427 221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-----EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNY 295 (697)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~ 295 (697)
........||+.|+|||++.. ..++.++|||||||++|+|++|..||.+.........+...
T Consensus 157 -----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~-- 223 (331)
T cd05597 157 -----------TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH-- 223 (331)
T ss_pred -----------CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcC--
Confidence 011223469999999999863 45788999999999999999999999876544433333211
Q ss_pred cHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCC--CCCHHHHHHHHHH
Q 005427 296 TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHN--RPSFSDIALELDL 351 (697)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~--Rpt~~ell~~l~~ 351 (697)
.....++.....++.++.++|++||..++++ ||++.++++|.|+
T Consensus 224 ------------~~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~ 269 (331)
T cd05597 224 ------------KEHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFF 269 (331)
T ss_pred ------------CCcccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCC
Confidence 1111122223458899999999988664443 7899999999886
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-39 Score=325.02 Aligned_cols=257 Identities=27% Similarity=0.455 Sum_probs=211.9
Q ss_pred CCCCcccccccccCCceEEEEEEEC-----CeeEEEEeccCCC-hHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceE
Q 005427 64 PPSSYTLLSPIARGAESVVYEATLD-----GRKVAVKKPILST-SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYM 137 (697)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 137 (697)
..++|++.+.||+|+||.||+|... ...||+|...... ......+.+|+.+++.++||||+++++.+......+
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (266)
T cd05033 2 DPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVM 81 (266)
T ss_pred ChHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceE
Confidence 3568999999999999999999863 3478999865443 334567889999999999999999999999999999
Q ss_pred EEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhh
Q 005427 138 FFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKE 217 (697)
Q Consensus 138 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~ 217 (697)
++|||+.+++|.+++......+++.+++.++.|++.||.|||+.+|+||||||+|||++.++.+||+|||++........
T Consensus 82 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd05033 82 IITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEA 161 (266)
T ss_pred EEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccccccc
Confidence 99999999999999977666789999999999999999999999999999999999999999999999999976641110
Q ss_pred hhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCCchhHHHHHHHHhcccc
Q 005427 218 ISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYT 296 (697)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~~~~~~~~~~~~~~~~~ 296 (697)
........+++.|+|||.+.+..++.++||||||+++|+|++ |..||...........+..
T Consensus 162 --------------~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~---- 223 (266)
T cd05033 162 --------------TYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVED---- 223 (266)
T ss_pred --------------ceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHc----
Confidence 111122345678999999998889999999999999999998 9999976554433222211
Q ss_pred HHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 297 EQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
. .++ ..+..++..+.+++.+||+.+|++||++.+++++|..+
T Consensus 224 ----------~-~~~---~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 224 ----------G-YRL---PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred ----------C-CCC---CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1 111 12346789999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=339.17 Aligned_cols=249 Identities=22% Similarity=0.340 Sum_probs=204.7
Q ss_pred CcccccccccCCceEEEEEEE--CCeeEEEEeccCC---ChHHHHHHHHHHHHHHhcC-CCCceEEeeccccCCceEEEE
Q 005427 67 SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKLD-HPGLAKFVAAHAKPPNYMFFF 140 (697)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lv~ 140 (697)
+|++.+.||+|+||.||+|.+ +++.||+|++... .....+.+..|..++..+. ||+|+++++++.+.+.+++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 478899999999999999987 5788999986532 2234566788999998885 577888999999999999999
Q ss_pred eecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhc
Q 005427 141 EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL 220 (697)
Q Consensus 141 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~ 220 (697)
||+++|+|.+++.... .+++.+++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 81 Ey~~~g~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~------ 153 (323)
T cd05615 81 EYVNGGDLMYHIQQVG-KFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV------ 153 (323)
T ss_pred cCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCC------
Confidence 9999999999986554 689999999999999999999999999999999999999999999999999864321
Q ss_pred ccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHH
Q 005427 221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQL 300 (697)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 300 (697)
.+.......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.........+.....
T Consensus 154 ----------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~----- 218 (323)
T cd05615 154 ----------DGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNV----- 218 (323)
T ss_pred ----------CCccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-----
Confidence 01123345799999999999999999999999999999999999999988765544444332111
Q ss_pred HHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCH-----HHHHHHHHH
Q 005427 301 TAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSF-----SDIALELDL 351 (697)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~-----~ell~~l~~ 351 (697)
..+..++.++.+++.+||+.+|.+|++. +++++|.++
T Consensus 219 --------------~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f 260 (323)
T cd05615 219 --------------SYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFF 260 (323)
T ss_pred --------------CCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCccc
Confidence 1234678999999999999999999984 566665443
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=333.75 Aligned_cols=259 Identities=22% Similarity=0.393 Sum_probs=210.1
Q ss_pred CCCCCcccccccccCCceEEEEEEE--CCe----eEEEEeccCCC-hHHHHHHHHHHHHHHhcCCCCceEEeeccccCCc
Q 005427 63 LPPSSYTLLSPIARGAESVVYEATL--DGR----KVAVKKPILST-SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPN 135 (697)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 135 (697)
+...+|++.+.||+|+||.||+|.+ +++ .||+|...... ....+.+.+|+.+++.++||||+++++++... .
T Consensus 4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~ 82 (316)
T cd05108 4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T 82 (316)
T ss_pred cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-C
Confidence 4567899999999999999999975 333 48999865443 34466789999999999999999999998764 5
Q ss_pred eEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhh
Q 005427 136 YMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL 215 (697)
Q Consensus 136 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~ 215 (697)
.++++||+.+|+|.+++......+++..++.++.|++.||+|||+.||+||||||+|||++.++.+||+|||+++.....
T Consensus 83 ~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 162 (316)
T cd05108 83 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD 162 (316)
T ss_pred ceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccCC
Confidence 77999999999999999876667889999999999999999999999999999999999999999999999999765421
Q ss_pred hhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCCchhHHHHHHHHhcc
Q 005427 216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMN 294 (697)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~~~~~~~~~~~~~~~ 294 (697)
.. ........++..|+|||++.+..++.++|||||||++|||++ |..||.+....... .+.
T Consensus 163 ~~--------------~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~-~~~--- 224 (316)
T cd05108 163 EK--------------EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SIL--- 224 (316)
T ss_pred Cc--------------ceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH-HHH---
Confidence 11 001122335678999999999999999999999999999998 99999875433221 111
Q ss_pred ccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 005427 295 YTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE 354 (697)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~ 354 (697)
....++ ..+..++.++.+++.+||..+|.+||++.+++.++..+..
T Consensus 225 -----------~~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~ 270 (316)
T cd05108 225 -----------EKGERL---PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 270 (316)
T ss_pred -----------hCCCCC---CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence 111111 1234578899999999999999999999999998877754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=332.89 Aligned_cols=266 Identities=26% Similarity=0.413 Sum_probs=221.4
Q ss_pred CCCCCCCcccccccccCCceEEEEEEECC-eeEEEEeccCCChHH-HHHHHHHHHHHHhcCCCCceEEeeccccCCceEE
Q 005427 61 LHLPPSSYTLLSPIARGAESVVYEATLDG-RKVAVKKPILSTSEE-LDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMF 138 (697)
Q Consensus 61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 138 (697)
.+++.++..+.++||+|.||.|.++...+ .+||||.++...... ...|.+|+++|.+|+||||+.|+++|..++.+++
T Consensus 533 ~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicm 612 (807)
T KOG1094|consen 533 VEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCM 612 (807)
T ss_pred hhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHH
Confidence 35777889999999999999999998765 899999987765444 5889999999999999999999999999999999
Q ss_pred EEeecCCCCHhhhhhhcCCCC-CHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhh
Q 005427 139 FFEFYESRNLAEKLHVEEWSP-SVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKE 217 (697)
Q Consensus 139 v~e~~~~g~L~~~l~~~~~~~-~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~ 217 (697)
++||+++|+|.+++....... .......|+.||+.|++||.+.++|||||.++|+|++.++++||+|||+++-+-..+.
T Consensus 613 I~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~y 692 (807)
T KOG1094|consen 613 ITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDY 692 (807)
T ss_pred HHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCc
Confidence 999999999999998764332 4456778999999999999999999999999999999999999999999974432211
Q ss_pred hhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh--CCCCCCCchhHHHHHHHHhccc
Q 005427 218 ISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT--GVVPYTDLRAEAQAHTVLEMNY 295 (697)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~--g~~Pf~~~~~~~~~~~~~~~~~ 295 (697)
.. .....+-+.+|||||.+..+.++.++|+|+||+++||+++ ...||....++......-..
T Consensus 693 y~--------------vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~-- 756 (807)
T KOG1094|consen 693 YR--------------VQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEF-- 756 (807)
T ss_pred ee--------------eecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhh--
Confidence 10 1223466789999999999999999999999999999865 89999988776654443221
Q ss_pred cHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 005427 296 TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL 351 (697)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~ 351 (697)
....-+......|.-+|..+.++|..||+.|..+||+|+++..+|..
T Consensus 757 ---------~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~ 803 (807)
T KOG1094|consen 757 ---------FRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQE 803 (807)
T ss_pred ---------cCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHH
Confidence 22223344455577899999999999999999999999999777654
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=341.17 Aligned_cols=253 Identities=24% Similarity=0.360 Sum_probs=200.1
Q ss_pred cccccCCceEEEEEEE--CCeeEEEEeccCC---ChHHHHHHHHHHHHHHhc-CCCCceEEeeccccCCceEEEEeecCC
Q 005427 72 SPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKL-DHPGLAKFVAAHAKPPNYMFFFEFYES 145 (697)
Q Consensus 72 ~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~ 145 (697)
+.||+|+||.||++++ +++.||+|++... .......+..|+.++..+ +||||+++++++.....+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4699999999999987 5778999986532 334456788899998877 899999999999999999999999999
Q ss_pred CCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhcccccC
Q 005427 146 RNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRS 225 (697)
Q Consensus 146 g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~ 225 (697)
|+|..++.... .+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 ~~L~~~~~~~~-~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~---------- 149 (329)
T cd05618 81 GDLMFHMQRQR-KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP---------- 149 (329)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCC----------
Confidence 99998886554 7899999999999999999999999999999999999999999999999998642210
Q ss_pred CCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHHHHHHH
Q 005427 226 SGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVV 305 (697)
Q Consensus 226 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (697)
........||+.|+|||++.+..++.++|||||||++|+|++|..||.......... ..........+.
T Consensus 150 ------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~-----~~~~~~~~~~i~ 218 (329)
T cd05618 150 ------GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD-----QNTEDYLFQVIL 218 (329)
T ss_pred ------CCccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcc-----cccHHHHHHHHh
Confidence 111334679999999999999999999999999999999999999996321110000 000001111111
Q ss_pred hCCCCCcccccccCChHHHHHHHHHhccCCCCCCCC------HHHHHHHHHH
Q 005427 306 SGGLRPILASLELGLPASILSLIQRCWDGNPHNRPS------FSDIALELDL 351 (697)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt------~~ell~~l~~ 351 (697)
... ...+..++..+.++|++||+.||.+||+ +.++++|.|+
T Consensus 219 ~~~-----~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f 265 (329)
T cd05618 219 EKQ-----IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF 265 (329)
T ss_pred cCC-----CCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCC
Confidence 111 1234568899999999999999999998 4788887665
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=333.31 Aligned_cols=263 Identities=25% Similarity=0.343 Sum_probs=206.8
Q ss_pred ccCCCCCCCcccccccccCCceEEEEEEE-CCeeEEEEeccCC--ChHHHHHHHHHHHHHHhc-CCCCceEEeeccccCC
Q 005427 59 IPLHLPPSSYTLLSPIARGAESVVYEATL-DGRKVAVKKPILS--TSEELDNFHKELQLLCKL-DHPGLAKFVAAHAKPP 134 (697)
Q Consensus 59 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~ 134 (697)
.-+.+.+..|+++++||+||.+.||++.. +.+.+|+|++... +......|.+|+.+|.+| .|.+||+||++-..++
T Consensus 354 ~~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~ 433 (677)
T KOG0596|consen 354 EIIKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDG 433 (677)
T ss_pred eeEEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCc
Confidence 34567778899999999999999999987 4567788865433 445578999999999999 4999999999999999
Q ss_pred ceEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhh
Q 005427 135 NYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYREN 214 (697)
Q Consensus 135 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~ 214 (697)
.+||||||-+ .+|..+|......++.-.++.+..|++.|+.++|++||||.||||.|+|+- .|.+||+|||+|..+..
T Consensus 434 ~lYmvmE~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~ 511 (677)
T KOG0596|consen 434 YLYMVMECGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQP 511 (677)
T ss_pred eEEEEeeccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeechhcccCc
Confidence 9999999765 499999987765555458999999999999999999999999999999984 57899999999987653
Q ss_pred hhhhhcccccCCCCCCCCccccccccCccccchhhhccc-----------CCCchhhHHHHHHHHHHHHhCCCCCCCchh
Q 005427 215 LKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKE-----------IHSEKSDVYSFGISINELLTGVVPYTDLRA 283 (697)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DiwslG~~l~ell~g~~Pf~~~~~ 283 (697)
.+......+.+||+.||+||.+... ..++++|||||||+||+|+.|++||.....
T Consensus 512 --------------DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n 577 (677)
T KOG0596|consen 512 --------------DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN 577 (677)
T ss_pred --------------cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH
Confidence 1223345678999999999998532 246799999999999999999999987543
Q ss_pred HHHHHHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 284 EAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
.......+.. -+..-.++..+ -..++.++|+.||.+||++|||+.+||+|....
T Consensus 578 ~~aKl~aI~~-------------P~~~Iefp~~~--~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~ 631 (677)
T KOG0596|consen 578 QIAKLHAITD-------------PNHEIEFPDIP--ENDELIDVMKCCLARDPKKRWSIPELLQHPFLQ 631 (677)
T ss_pred HHHHHHhhcC-------------CCccccccCCC--CchHHHHHHHHHHhcCcccCCCcHHHhcCcccc
Confidence 3221111110 00000111111 123499999999999999999999999886543
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=334.32 Aligned_cols=270 Identities=23% Similarity=0.282 Sum_probs=211.7
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccCCCh-HHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEee
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTS-EELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF 142 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 142 (697)
++|++.++||+|+||.||+|++ +++.||+|.+..... .....+.+|+.+++.++||||+++++++..+..+++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 5799999999999999999987 578899998654432 2345677899999999999999999999999999999999
Q ss_pred cCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhccc
Q 005427 143 YESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKN 222 (697)
Q Consensus 143 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 222 (697)
+. ++|.+++......+++..++.++.|++.||+|||+.||+|+||||+|||++.++.+||+|||++.......
T Consensus 86 ~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~------ 158 (301)
T cd07873 86 LD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT------ 158 (301)
T ss_pred cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC------
Confidence 97 58988887666678899999999999999999999999999999999999999999999999986432110
Q ss_pred ccCCCCCCCCccccccccCccccchhhhcc-cCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHH-HH
Q 005427 223 WRSSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQ-QL 300 (697)
Q Consensus 223 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~-~~ 300 (697)
.......+++.|+|||++.+ ..++.++|||||||++|+|++|.+||...+.......+........ ..
T Consensus 159 ----------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~ 228 (301)
T cd07873 159 ----------KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEET 228 (301)
T ss_pred ----------CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhh
Confidence 01223457899999999875 4578899999999999999999999988765554443332211110 00
Q ss_pred HHHHHhC-CC---------CCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 301 TAAVVSG-GL---------RPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 301 ~~~~~~~-~~---------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
....... .+ ...+......+++.+.+||.+||+.||.+|||+.|+++|.|+.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~ 290 (301)
T cd07873 229 WPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFH 290 (301)
T ss_pred chhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccc
Confidence 0000000 00 0011122346788999999999999999999999999999884
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=327.74 Aligned_cols=249 Identities=36% Similarity=0.541 Sum_probs=201.5
Q ss_pred ccccccccCCceEEEEEEEC------CeeEEEEeccCCC-hHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEe
Q 005427 69 TLLSPIARGAESVVYEATLD------GRKVAVKKPILST-SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFE 141 (697)
Q Consensus 69 ~~~~~lg~G~~g~V~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 141 (697)
.+.+.||.|.||.||+|.+. +..|+||.+.... ....+.+.+|++.+++++||||+++++++.....+++|+|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e 81 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME 81 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence 46789999999999999876 6789999875543 3457899999999999999999999999998888999999
Q ss_pred ecCCCCHhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhc
Q 005427 142 FYESRNLAEKLHVE-EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL 220 (697)
Q Consensus 142 ~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~ 220 (697)
|+++|+|.+++... ...+++.+++.++.|++.||.|||+.+++|+||+++|||++.++.+||+|||++........
T Consensus 82 ~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~--- 158 (259)
T PF07714_consen 82 YCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK--- 158 (259)
T ss_dssp --TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS---
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---
Confidence 99999999999876 55789999999999999999999999999999999999999999999999999876521110
Q ss_pred ccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCCchhHHHHHHHHhccccHHH
Q 005427 221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQ 299 (697)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~ 299 (697)
........+...|+|||.+.+..++.++||||||+++|||++ |..||.+.........+.+..
T Consensus 159 -----------~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~----- 222 (259)
T PF07714_consen 159 -----------YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQ----- 222 (259)
T ss_dssp -----------EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTE-----
T ss_pred -----------cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-----
Confidence 011233457789999999999889999999999999999999 789998775554444332211
Q ss_pred HHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 005427 300 LTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALEL 349 (697)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l 349 (697)
+ ...+..++..+.++|..||..||.+|||+.++++.|
T Consensus 223 ----------~---~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 223 ----------R---LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ----------E---TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ----------c---ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 1 123456899999999999999999999999998765
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=329.15 Aligned_cols=255 Identities=25% Similarity=0.399 Sum_probs=209.4
Q ss_pred CCCCcccccccccCCceEEEEEEEC-------CeeEEEEeccCCChH-HHHHHHHHHHHHHhcCCCCceEEeeccccCCc
Q 005427 64 PPSSYTLLSPIARGAESVVYEATLD-------GRKVAVKKPILSTSE-ELDNFHKELQLLCKLDHPGLAKFVAAHAKPPN 135 (697)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 135 (697)
...+|.+.+.||+|+||.||+|... +..||+|........ ..+.+.+|+++|+.++||||+++++++.....
T Consensus 3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 82 (280)
T cd05049 3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDP 82 (280)
T ss_pred ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCC
Confidence 4568999999999999999999752 367999987655444 45789999999999999999999999999999
Q ss_pred eEEEEeecCCCCHhhhhhhcC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCe
Q 005427 136 YMFFFEFYESRNLAEKLHVEE-------------WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPH 202 (697)
Q Consensus 136 ~~lv~e~~~~g~L~~~l~~~~-------------~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~k 202 (697)
.+++|||+++++|.+++...+ ..+++.++..++.|++.||.|||+.|++||||||+||+++.++.+|
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~k 162 (280)
T cd05049 83 PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVK 162 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeEE
Confidence 999999999999999986542 2467889999999999999999999999999999999999999999
Q ss_pred eeeeccchhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCCc
Q 005427 203 LADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDL 281 (697)
Q Consensus 203 L~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~~ 281 (697)
|+|||++......... .......+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.
T Consensus 163 l~d~g~~~~~~~~~~~--------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~ 228 (280)
T cd05049 163 IGDFGMSRDVYTTDYY--------------RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGL 228 (280)
T ss_pred ECCcccceecccCcce--------------ecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCC
Confidence 9999998643211100 01123346789999999999999999999999999999998 99999876
Q ss_pred hhHHHHHHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 005427 282 RAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350 (697)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~ 350 (697)
........+. .+.. ...+..++..+.+++.+||+.||++||++.|+++.+.
T Consensus 229 ~~~~~~~~~~--------------~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 229 SNEEVIECIT--------------QGRL----LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred CHHHHHHHHH--------------cCCc----CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 5544333222 1111 1123468899999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=331.70 Aligned_cols=257 Identities=25% Similarity=0.372 Sum_probs=212.6
Q ss_pred CCCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEE
Q 005427 63 LPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFF 140 (697)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 140 (697)
.+.+.|+++++||.|+||.||+|+. +++.+++|............+.+|+.+++.++||||+++++.+..+..+++||
T Consensus 9 ~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 88 (292)
T cd06644 9 DPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMI 88 (292)
T ss_pred CcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEE
Confidence 3456799999999999999999987 57889999987777777888999999999999999999999999999999999
Q ss_pred eecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhc
Q 005427 141 EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL 220 (697)
Q Consensus 141 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~ 220 (697)
||+++++|..++......+++..++.++.|++.+|.|||+.|++||||||+||+++.++.+||+|||++......
T Consensus 89 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~----- 163 (292)
T cd06644 89 EFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT----- 163 (292)
T ss_pred ecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecccc-----
Confidence 999999999888765667899999999999999999999999999999999999999999999999987543210
Q ss_pred ccccCCCCCCCCccccccccCccccchhhhc-----ccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccc
Q 005427 221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILK-----KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNY 295 (697)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~ 295 (697)
........+++.|+|||++. ...++.++|+|||||++|+|++|..||...........+..
T Consensus 164 -----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~--- 229 (292)
T cd06644 164 -----------LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK--- 229 (292)
T ss_pred -----------ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhc---
Confidence 00123456889999999984 34567899999999999999999999977543332222211
Q ss_pred cHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 005427 296 TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL 351 (697)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~ 351 (697)
...+.. ..+..++.++.++|.+||..+|++||+++++++|.+.
T Consensus 230 ------------~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 272 (292)
T cd06644 230 ------------SEPPTL-SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFV 272 (292)
T ss_pred ------------CCCccC-CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccc
Confidence 111111 1234678899999999999999999999999988775
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=341.27 Aligned_cols=243 Identities=26% Similarity=0.328 Sum_probs=196.1
Q ss_pred cccccCCceEEEEEEE--CCeeEEEEeccCCC---hHHHHHHHHHH-HHHHhcCCCCceEEeeccccCCceEEEEeecCC
Q 005427 72 SPIARGAESVVYEATL--DGRKVAVKKPILST---SEELDNFHKEL-QLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYES 145 (697)
Q Consensus 72 ~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~---~~~~~~~~~E~-~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 145 (697)
+.||+|+||+||+|++ +++.||+|++.... ......+..|. .+++.++||||+++++++.....+++||||+.+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 4799999999999987 56789999865322 12223344444 457889999999999999999999999999999
Q ss_pred CCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhcccccC
Q 005427 146 RNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRS 225 (697)
Q Consensus 146 g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~ 225 (697)
|+|.+++.... .+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 81 ~~L~~~~~~~~-~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~---------- 149 (325)
T cd05602 81 GELFYHLQRER-CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH---------- 149 (325)
T ss_pred CcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccC----------
Confidence 99999987644 6788999999999999999999999999999999999999999999999998643210
Q ss_pred CCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHHHHHHH
Q 005427 226 SGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVV 305 (697)
Q Consensus 226 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (697)
.......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+....
T Consensus 150 ------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~----------- 212 (325)
T cd05602 150 ------NGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP----------- 212 (325)
T ss_pred ------CCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCC-----------
Confidence 011345679999999999999999999999999999999999999998766554433332211
Q ss_pred hCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHH----HHHHHHH
Q 005427 306 SGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFS----DIALELD 350 (697)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~----ell~~l~ 350 (697)
...+..++..+.+++.+||+.||.+||++. ++++|++
T Consensus 213 --------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~ 253 (325)
T cd05602 213 --------LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIF 253 (325)
T ss_pred --------cCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcc
Confidence 012346889999999999999999999876 4544443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=327.82 Aligned_cols=257 Identities=24% Similarity=0.365 Sum_probs=209.5
Q ss_pred CCCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEE
Q 005427 63 LPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFF 140 (697)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 140 (697)
.+.++|++.++||+|+||.||+|.+ +++.||+|............+.+|+.+++.++||||+++++.+.....++++|
T Consensus 6 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~ 85 (267)
T cd06645 6 NPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICM 85 (267)
T ss_pred CcHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Confidence 3456899999999999999999987 57889999877665556677889999999999999999999999999999999
Q ss_pred eecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhc
Q 005427 141 EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL 220 (697)
Q Consensus 141 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~ 220 (697)
||+.+++|.+++...+ .+++.+++.++.|++.||.|||+.|++|+||||+||+++.++.+||+|||++.......
T Consensus 86 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~---- 160 (267)
T cd06645 86 EFCGGGSLQDIYHVTG-PLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI---- 160 (267)
T ss_pred eccCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc----
Confidence 9999999999987554 68999999999999999999999999999999999999999999999999986443110
Q ss_pred ccccCCCCCCCCccccccccCccccchhhhc---ccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccH
Q 005427 221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILK---KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTE 297 (697)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~ 297 (697)
.......|++.|+|||++. ...++.++|+|||||++|+|++|..||..............
T Consensus 161 ------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~----- 223 (267)
T cd06645 161 ------------AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTK----- 223 (267)
T ss_pred ------------cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhc-----
Confidence 0123457899999999984 45678899999999999999999999976443222111111
Q ss_pred HHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 005427 298 QQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350 (697)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~ 350 (697)
....+........++..+.+++.+||+.+|++|||++++++|.|
T Consensus 224 ---------~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 224 ---------SNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred ---------cCCCCCcccccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 11111111112247788999999999999999999999988753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=340.61 Aligned_cols=267 Identities=25% Similarity=0.324 Sum_probs=206.6
Q ss_pred CCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCC--hHHHHHHHHHHHHHHhcCCCCceEEeeccccC------C
Q 005427 65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST--SEELDNFHKELQLLCKLDHPGLAKFVAAHAKP------P 134 (697)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~------~ 134 (697)
.++|++++.||+|+||.||+|.+ +++.||||++.... ......+.+|+.+|+.++||||+++++++... .
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFN 93 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccC
Confidence 47899999999999999999986 57789999865432 22345678899999999999999999987543 4
Q ss_pred ceEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhh
Q 005427 135 NYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYREN 214 (697)
Q Consensus 135 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~ 214 (697)
.++++++++ +++|.+++.. ..+++.++..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 94 ~~~~~~~~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~ 170 (343)
T cd07878 94 EVYLVTNLM-GADLNNIVKC--QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADD 170 (343)
T ss_pred cEEEEeecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecCC
Confidence 578899987 6789887753 3589999999999999999999999999999999999999999999999999865431
Q ss_pred hhhhhcccccCCCCCCCCccccccccCccccchhhhcc-cCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhc
Q 005427 215 LKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEM 293 (697)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~ 293 (697)
......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+...
T Consensus 171 -------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~ 231 (343)
T cd07878 171 -------------------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEV 231 (343)
T ss_pred -------------------CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHH
Confidence 1234578999999999877 56889999999999999999999999876655444443322
Q ss_pred ccc-HHHHHHHHHhCC-------C----CCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 005427 294 NYT-EQQLTAAVVSGG-------L----RPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL 353 (697)
Q Consensus 294 ~~~-~~~~~~~~~~~~-------~----~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~ 353 (697)
... .......+.... . ...+.......++.+.+|+.+||+.||.+|||+.|+++|.|+..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~ 303 (343)
T cd07878 232 VGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQ 303 (343)
T ss_pred hCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhc
Confidence 111 111111110000 0 00001112346778899999999999999999999999998864
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=332.87 Aligned_cols=266 Identities=26% Similarity=0.313 Sum_probs=202.8
Q ss_pred CcccccccccCCceEEEEEEE--CCeeEEEEeccCCChH--HHHHHHHHHHHHHhc---CCCCceEEeecccc-----CC
Q 005427 67 SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSE--ELDNFHKELQLLCKL---DHPGLAKFVAAHAK-----PP 134 (697)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~hpniv~l~~~~~~-----~~ 134 (697)
+|++.+.||+|+||+||+|++ +++.||+|.+...... ....+.+|+.+++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 589999999999999999987 5788999976543211 223456777777666 79999999998764 34
Q ss_pred ceEEEEeecCCCCHhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhh
Q 005427 135 NYMFFFEFYESRNLAEKLHVEE-WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRE 213 (697)
Q Consensus 135 ~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~ 213 (697)
.++++|||+.+ +|.+++.... ..+++.+++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||++....
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~ 159 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYS 159 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCcccccc
Confidence 58999999985 8888876543 357999999999999999999999999999999999999999999999999987543
Q ss_pred hhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhc
Q 005427 214 NLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEM 293 (697)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~ 293 (697)
... ......||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.........+...
T Consensus 160 ~~~-----------------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~ 222 (288)
T cd07863 160 CQM-----------------ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDL 222 (288)
T ss_pred Ccc-----------------cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHH
Confidence 210 122346899999999999989999999999999999999999999876655544444332
Q ss_pred ccc--HHHHHHHHH--hCCC----CCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 005427 294 NYT--EQQLTAAVV--SGGL----RPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350 (697)
Q Consensus 294 ~~~--~~~~~~~~~--~~~~----~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~ 350 (697)
... ...+..... ...+ ..........++..+.+++.+||+.||.+|||+.+++.|.|
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~ 287 (288)
T cd07863 223 IGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPF 287 (288)
T ss_pred hCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCC
Confidence 111 000000000 0000 01112223467889999999999999999999999998876
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=341.49 Aligned_cols=267 Identities=22% Similarity=0.298 Sum_probs=207.4
Q ss_pred CCCcccccccccCCceEEEEEEE--CCeeEEEEeccCC--ChHHHHHHHHHHHHHHhcCCCCceEEeeccccC------C
Q 005427 65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKP------P 134 (697)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~------~ 134 (697)
.++|++.+.||+|+||.||++.+ .++.||||++... .......+.+|+.+++.++||||+++++++... .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 46899999999999999999987 5788999986543 234456788999999999999999999887543 3
Q ss_pred ceEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhh
Q 005427 135 NYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYREN 214 (697)
Q Consensus 135 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~ 214 (697)
.+++||||+.+ +|.+.+.. .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 103 ~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 178 (364)
T cd07875 103 DVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 178 (364)
T ss_pred eEEEEEeCCCC-CHHHHHHh---cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCC
Confidence 57999999975 77776643 478889999999999999999999999999999999999999999999999965432
Q ss_pred hhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhcc
Q 005427 215 LKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMN 294 (697)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~ 294 (697)
. .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......++...
T Consensus 179 ~-----------------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 241 (364)
T cd07875 179 S-----------------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQL 241 (364)
T ss_pred C-----------------CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 0 11234578999999999999999999999999999999999999998877666555544322
Q ss_pred ccH-HHHHH-------HHHhCC---------------CCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 005427 295 YTE-QQLTA-------AVVSGG---------------LRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL 351 (697)
Q Consensus 295 ~~~-~~~~~-------~~~~~~---------------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~ 351 (697)
... ..... ...... ..+.........+..+.+||.+||+.||.+|||+.++++|.|.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~ 321 (364)
T cd07875 242 GTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 321 (364)
T ss_pred CCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccc
Confidence 111 00000 000000 0000011112245688999999999999999999999999887
Q ss_pred H
Q 005427 352 V 352 (697)
Q Consensus 352 ~ 352 (697)
.
T Consensus 322 ~ 322 (364)
T cd07875 322 N 322 (364)
T ss_pred c
Confidence 4
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=345.41 Aligned_cols=269 Identities=22% Similarity=0.306 Sum_probs=209.7
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccCC---ChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEE
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFF 140 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 140 (697)
++|++.+.||+|+||.||++.. +++.||+|++... .......+.+|+.++..++||||+++++.+.+...+++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 3689999999999999999987 5788999986532 2334567889999999999999999999999999999999
Q ss_pred eecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhc
Q 005427 141 EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL 220 (697)
Q Consensus 141 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~ 220 (697)
||+++|+|.+++.... .+++..+..++.|++.||+|||+.||+||||||+|||++.++.+||+|||++...........
T Consensus 81 E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~ 159 (360)
T cd05627 81 EFLPGGDMMTLLMKKD-TLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEF 159 (360)
T ss_pred eCCCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCccccccccccc
Confidence 9999999999987654 689999999999999999999999999999999999999999999999999875432110000
Q ss_pred ccccCCCC-------------------CCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCc
Q 005427 221 KNWRSSGK-------------------PTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDL 281 (697)
Q Consensus 221 ~~~~~~~~-------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~ 281 (697)
........ ..........+||+.|+|||++.+..++.++|||||||++|||++|..||.+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~ 239 (360)
T cd05627 160 YRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE 239 (360)
T ss_pred ccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCC
Confidence 00000000 00000122457999999999999999999999999999999999999999877
Q ss_pred hhHHHHHHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCC---HHHHHHHHHH
Q 005427 282 RAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPS---FSDIALELDL 351 (697)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt---~~ell~~l~~ 351 (697)
........+.... ....++ ....+++++.+||.+|+. ||.+|++ +.++++|.|+
T Consensus 240 ~~~~~~~~i~~~~--------------~~~~~p-~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f 296 (360)
T cd05627 240 TPQETYRKVMNWK--------------ETLVFP-PEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFF 296 (360)
T ss_pred CHHHHHHHHHcCC--------------CceecC-CCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCC
Confidence 6554444333211 011111 112478899999999874 9999984 7899888775
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=324.35 Aligned_cols=255 Identities=25% Similarity=0.394 Sum_probs=213.1
Q ss_pred CCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEee
Q 005427 65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF 142 (697)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 142 (697)
.++|++.+.||.|+||.||+|.. +++.+++|..........+.+.+|+.+++.++||||+++++.+.....++++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 46899999999999999999986 5678999987776666778899999999999999999999999999999999999
Q ss_pred cCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhccc
Q 005427 143 YESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKN 222 (697)
Q Consensus 143 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 222 (697)
+.+++|.+++......+++.+++.++.|++.||.|||+.+++|+||+|+||+++.++.+||+|||++........
T Consensus 82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~----- 156 (262)
T cd06613 82 CGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA----- 156 (262)
T ss_pred CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhh-----
Confidence 999999999877655789999999999999999999999999999999999999999999999999875542110
Q ss_pred ccCCCCCCCCccccccccCccccchhhhccc---CCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHH
Q 005427 223 WRSSGKPTGGFHKKNMVGTLIYMAPEILKKE---IHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQ 299 (697)
Q Consensus 223 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~ 299 (697)
......++..|+|||.+.+. .++.++|+|||||++|+|++|..||.+.........+..
T Consensus 157 -----------~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~------- 218 (262)
T cd06613 157 -----------KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISK------- 218 (262)
T ss_pred -----------ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-------
Confidence 12345688899999999776 788999999999999999999999987654333222211
Q ss_pred HHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 005427 300 LTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALEL 349 (697)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l 349 (697)
..+.+.....+..++.++.+++++||..+|.+|||+.+++.|.
T Consensus 219 -------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~ 261 (262)
T cd06613 219 -------SNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHP 261 (262)
T ss_pred -------ccCCCccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCC
Confidence 1111111112234678899999999999999999999998764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=327.92 Aligned_cols=260 Identities=25% Similarity=0.364 Sum_probs=213.8
Q ss_pred CCCCCcccccccccCCceEEEEEEE-------CCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCc
Q 005427 63 LPPSSYTLLSPIARGAESVVYEATL-------DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPN 135 (697)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~-------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 135 (697)
+...+|.+.+.||+|+||.||+|.. ....+++|..........+.+.+|+.+++.++||||+++++++.....
T Consensus 2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (291)
T cd05094 2 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDP 81 (291)
T ss_pred CchHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCc
Confidence 3456799999999999999999974 234688898766666666789999999999999999999999999999
Q ss_pred eEEEEeecCCCCHhhhhhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCC
Q 005427 136 YMFFFEFYESRNLAEKLHVEE---------------WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLC 200 (697)
Q Consensus 136 ~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~ 200 (697)
.++||||+++++|.+++.... ..+++.+++.++.|++.||+|||++||+||||||+|||++.++.
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 82 LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLL 161 (291)
T ss_pred eEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCc
Confidence 999999999999999986532 24788999999999999999999999999999999999999999
Q ss_pred CeeeeeccchhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCC
Q 005427 201 PHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYT 279 (697)
Q Consensus 201 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~ 279 (697)
+||+|||++........ ........++..|+|||++.+..++.++|||||||++|+|++ |..||.
T Consensus 162 ~~l~dfg~a~~~~~~~~--------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 227 (291)
T cd05094 162 VKIGDFGMSRDVYSTDY--------------YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWF 227 (291)
T ss_pred EEECCCCcccccCCCce--------------eecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99999999865432110 001223457889999999999999999999999999999998 999997
Q ss_pred CchhHHHHHHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 005427 280 DLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE 354 (697)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~ 354 (697)
..........+.. + .. ...+..+|..+.+++.+||+.+|++|||+.++++.+..+.+
T Consensus 228 ~~~~~~~~~~~~~--------------~-~~---~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 228 QLSNTEVIECITQ--------------G-RV---LERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred CCCHHHHHHHHhC--------------C-CC---CCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 7654433222211 1 11 11234578899999999999999999999999999988865
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=329.01 Aligned_cols=256 Identities=23% Similarity=0.351 Sum_probs=211.9
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEeec
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFY 143 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 143 (697)
+-|++.+.||.|+||.||++.+ .+..+++|............+.+|+++++.++||||+++++.+......++|+||+
T Consensus 5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~ 84 (282)
T cd06643 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 84 (282)
T ss_pred HHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEec
Confidence 4478999999999999999987 46788999876666667788999999999999999999999999999999999999
Q ss_pred CCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhcccc
Q 005427 144 ESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNW 223 (697)
Q Consensus 144 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~ 223 (697)
.+++|..++......+++..++.++.|++.||.|||+.|++||||||+|||++.++.+||+|||++.......
T Consensus 85 ~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~------- 157 (282)
T cd06643 85 AGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI------- 157 (282)
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccccc-------
Confidence 9999999887655578999999999999999999999999999999999999999999999999986543210
Q ss_pred cCCCCCCCCccccccccCccccchhhhc-----ccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHH
Q 005427 224 RSSGKPTGGFHKKNMVGTLIYMAPEILK-----KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQ 298 (697)
Q Consensus 224 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~ 298 (697)
.......+++.|+|||++. +..++.++|+|||||++|+|++|.+||...........+...
T Consensus 158 ---------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~----- 223 (282)
T cd06643 158 ---------QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS----- 223 (282)
T ss_pred ---------cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhc-----
Confidence 0123356899999999984 455778999999999999999999999876543332222111
Q ss_pred HHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 005427 299 QLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL 353 (697)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~ 353 (697)
..+. ...+..++.++.++|.+||+.||.+||++.++++|.|...
T Consensus 224 ----------~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 267 (282)
T cd06643 224 ----------EPPT-LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTV 267 (282)
T ss_pred ----------CCCC-CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEec
Confidence 1111 1123457899999999999999999999999999887654
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=323.90 Aligned_cols=254 Identities=24% Similarity=0.379 Sum_probs=209.2
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccCCC-----hHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEE
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST-----SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMF 138 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 138 (697)
+.|++.+.||+|+||.||++.. +++.+++|...... ......+.+|+.++++++||||+++++++......++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 5799999999999999999976 57899999765432 1234678899999999999999999999999999999
Q ss_pred EEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhh
Q 005427 139 FFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI 218 (697)
Q Consensus 139 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~ 218 (697)
++||+++++|.+.+.... .+++..++.++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++........
T Consensus 82 v~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~- 159 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYG-ALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICS- 159 (263)
T ss_pred EEEECCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccc-
Confidence 999999999999987654 678899999999999999999999999999999999999999999999999865432110
Q ss_pred hcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHH
Q 005427 219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQ 298 (697)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~ 298 (697)
.........|+..|+|||++.+..++.++||||||+++|+|++|..||.............
T Consensus 160 ------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~------- 220 (263)
T cd06625 160 ------------SGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIA------- 220 (263)
T ss_pred ------------ccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHh-------
Confidence 0000123467889999999999889999999999999999999999997654333222211
Q ss_pred HHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 005427 299 QLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350 (697)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~ 350 (697)
..... ...+..++..+.++|.+||..+|.+|||+.+++++.|
T Consensus 221 -------~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~ 262 (263)
T cd06625 221 -------TQPTN---PQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFF 262 (263)
T ss_pred -------ccCCC---CCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCC
Confidence 11111 2234568899999999999999999999999998876
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=328.93 Aligned_cols=262 Identities=28% Similarity=0.464 Sum_probs=210.0
Q ss_pred CCCCcccccccccCCceEEEEEEE--CCe--eEEEEeccCC-ChHHHHHHHHHHHHHHhc-CCCCceEEeeccccCCceE
Q 005427 64 PPSSYTLLSPIARGAESVVYEATL--DGR--KVAVKKPILS-TSEELDNFHKELQLLCKL-DHPGLAKFVAAHAKPPNYM 137 (697)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~ 137 (697)
..++|++.+.||+|+||.||+|.+ ++. .+++|..... .......+.+|+.++.++ +||||+++++++.....++
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~ 84 (303)
T cd05088 5 EWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 84 (303)
T ss_pred chhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCce
Confidence 345899999999999999999986 343 4577764432 334456788999999999 8999999999999999999
Q ss_pred EEEeecCCCCHhhhhhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCe
Q 005427 138 FFFEFYESRNLAEKLHVEE---------------WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPH 202 (697)
Q Consensus 138 lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~k 202 (697)
++|||+++++|.+++.... ..+++.+++.++.|++.||+|||+.|++||||||+|||++.++.+|
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~~k 164 (303)
T cd05088 85 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAK 164 (303)
T ss_pred EEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCcEE
Confidence 9999999999999986542 2468899999999999999999999999999999999999999999
Q ss_pred eeeeccchhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCCc
Q 005427 203 LADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDL 281 (697)
Q Consensus 203 L~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~~ 281 (697)
|+|||++....... ......++..|+|||++.+..++.++|||||||++|+|++ |..||.+.
T Consensus 165 l~dfg~~~~~~~~~-----------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 227 (303)
T cd05088 165 IADFGLSRGQEVYV-----------------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM 227 (303)
T ss_pred eCccccCcccchhh-----------------hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccC
Confidence 99999985322100 0112234678999999988889999999999999999998 99999765
Q ss_pred hhHHHHHHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhcccc
Q 005427 282 RAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHRKSLK 360 (697)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~~~~~~ 360 (697)
........+. ...++ ..+..++.++.+|+.+||+.+|++||++.+++..+..+++..+...
T Consensus 228 ~~~~~~~~~~---------------~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~~~~ 288 (303)
T cd05088 228 TCAELYEKLP---------------QGYRL---EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYV 288 (303)
T ss_pred ChHHHHHHHh---------------cCCcC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhhhhh
Confidence 4433222111 11111 1234578899999999999999999999999999998887655433
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=327.81 Aligned_cols=256 Identities=22% Similarity=0.359 Sum_probs=208.2
Q ss_pred CCCCCcccccccccCCceEEEEEEEC-------CeeEEEEeccCCChH-HHHHHHHHHHHHHhcCCCCceEEeeccccCC
Q 005427 63 LPPSSYTLLSPIARGAESVVYEATLD-------GRKVAVKKPILSTSE-ELDNFHKELQLLCKLDHPGLAKFVAAHAKPP 134 (697)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 134 (697)
+...+|++.++||+|+||.||+|... +..||+|+....... ..+.+.+|+.++..++||||+++++++....
T Consensus 2 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~ 81 (283)
T cd05091 2 INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQ 81 (283)
T ss_pred CCHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCC
Confidence 34457999999999999999999763 367999987654333 3467889999999999999999999999999
Q ss_pred ceEEEEeecCCCCHhhhhhhc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCC
Q 005427 135 NYMFFFEFYESRNLAEKLHVE---------------EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNL 199 (697)
Q Consensus 135 ~~~lv~e~~~~g~L~~~l~~~---------------~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~ 199 (697)
..++++||+.+++|.+++... ...+++..++.++.|++.||.|||++||+||||||+|||++.++
T Consensus 82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKL 161 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCC
Confidence 999999999999999988532 12467888999999999999999999999999999999999999
Q ss_pred CCeeeeeccchhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCC
Q 005427 200 CPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPY 278 (697)
Q Consensus 200 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf 278 (697)
.+||+|||+++........ .......+++.|+|||++.+..++.++|||||||++|||++ |..||
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~--------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~ 227 (283)
T cd05091 162 NVKISDLGLFREVYAADYY--------------KLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPY 227 (283)
T ss_pred ceEecccccccccccchhe--------------eeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCC
Confidence 9999999998754321110 01223356789999999988889999999999999999998 88999
Q ss_pred CCchhHHHHHHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 005427 279 TDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350 (697)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~ 350 (697)
.+.........+.. ... ...+.+++.++.+++..||+.+|.+||++.+|+..|.
T Consensus 228 ~~~~~~~~~~~i~~--------------~~~----~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~ 281 (283)
T cd05091 228 CGYSNQDVIEMIRN--------------RQV----LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLR 281 (283)
T ss_pred CCCCHHHHHHHHHc--------------CCc----CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhh
Confidence 87654433333221 111 1234578999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=327.53 Aligned_cols=257 Identities=28% Similarity=0.465 Sum_probs=208.0
Q ss_pred CCcccccccccCCceEEEEEEEC--Ce--eEEEEeccC-CChHHHHHHHHHHHHHHhc-CCCCceEEeeccccCCceEEE
Q 005427 66 SSYTLLSPIARGAESVVYEATLD--GR--KVAVKKPIL-STSEELDNFHKELQLLCKL-DHPGLAKFVAAHAKPPNYMFF 139 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~--~~--~vavK~~~~-~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv 139 (697)
++|++.+.||+|+||.||+|... +. .+++|.+.. ......+.+.+|+.++.++ +||||+++++++.....++++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 57999999999999999999763 32 468876553 2334456789999999999 799999999999999999999
Q ss_pred EeecCCCCHhhhhhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeee
Q 005427 140 FEFYESRNLAEKLHVEE---------------WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLA 204 (697)
Q Consensus 140 ~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~ 204 (697)
+||+++++|.+++.... ..+++.+++.++.|++.||+|||++||+||||||+|||++.++.+||+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~ 161 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIA 161 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEEEC
Confidence 99999999999986532 247888999999999999999999999999999999999999999999
Q ss_pred eeccchhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCCchh
Q 005427 205 DFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRA 283 (697)
Q Consensus 205 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~~~~ 283 (697)
|||++...... ........+..|+|||++.+..++.++|||||||++|||++ |..||.+...
T Consensus 162 dfg~~~~~~~~-----------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~ 224 (297)
T cd05089 162 DFGLSRGEEVY-----------------VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC 224 (297)
T ss_pred CcCCCccccce-----------------eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 99998532110 00111233567999999999889999999999999999997 9999987654
Q ss_pred HHHHHHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhc
Q 005427 284 EAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHRK 357 (697)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~~~ 357 (697)
......+. ....+ ..+..++.++.+|+.+||+.+|.+|||++++++.|..+.+..+
T Consensus 225 ~~~~~~~~---------------~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~ 280 (297)
T cd05089 225 AELYEKLP---------------QGYRM---EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARK 280 (297)
T ss_pred HHHHHHHh---------------cCCCC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 43322221 11111 2234688999999999999999999999999999988876543
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=320.34 Aligned_cols=250 Identities=27% Similarity=0.443 Sum_probs=211.1
Q ss_pred CCCCCcccccccccCCceEEEEEEECCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEee
Q 005427 63 LPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF 142 (697)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 142 (697)
+..++|++.+.||.|+||.||+|...++.||+|....... ..+.+.+|+.+++.++||||+++++++......++||||
T Consensus 3 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 81 (256)
T cd05039 3 INSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEY 81 (256)
T ss_pred cChhhccceeeeecCCCceEEEEEecCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEe
Confidence 4567899999999999999999999999999998765544 567899999999999999999999999999999999999
Q ss_pred cCCCCHhhhhhhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhcc
Q 005427 143 YESRNLAEKLHVEEW-SPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLK 221 (697)
Q Consensus 143 ~~~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~ 221 (697)
+++++|.+++..... .+++..++.++.|++.||.|||+.|++||||||+||+++.++.+||+|||++......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~------ 155 (256)
T cd05039 82 MAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG------ 155 (256)
T ss_pred cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccccc------
Confidence 999999999875542 5899999999999999999999999999999999999999999999999998754311
Q ss_pred cccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCCchhHHHHHHHHhccccHHHH
Q 005427 222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQL 300 (697)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 300 (697)
.....++..|+|||++.+..++.++|+||||+++|++++ |..||...........+.
T Consensus 156 -------------~~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~--------- 213 (256)
T cd05039 156 -------------QDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVE--------- 213 (256)
T ss_pred -------------cccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh---------
Confidence 112234567999999988889999999999999999997 999997654433222111
Q ss_pred HHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 005427 301 TAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350 (697)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~ 350 (697)
...++ ..+..+|+++.+++.+||..+|++|||+.++++.|.
T Consensus 214 ------~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 254 (256)
T cd05039 214 ------KGYRM---EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLA 254 (256)
T ss_pred ------cCCCC---CCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHh
Confidence 11111 223467899999999999999999999999998775
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=330.25 Aligned_cols=263 Identities=26% Similarity=0.403 Sum_probs=213.3
Q ss_pred CCCCCCCcccccccccCCceEEEEEEEC---------CeeEEEEeccCCC-hHHHHHHHHHHHHHHhc-CCCCceEEeec
Q 005427 61 LHLPPSSYTLLSPIARGAESVVYEATLD---------GRKVAVKKPILST-SEELDNFHKELQLLCKL-DHPGLAKFVAA 129 (697)
Q Consensus 61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~---------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~l~~~ 129 (697)
++++.++|.+.+.||+|+||.||++.+. ...+|+|...... ......+..|+.+++.+ +||||++++++
T Consensus 13 ~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~ 92 (307)
T cd05098 13 WEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA 92 (307)
T ss_pred ceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence 4566689999999999999999999752 2469999876442 34466788999999999 79999999999
Q ss_pred cccCCceEEEEeecCCCCHhhhhhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcee
Q 005427 130 HAKPPNYMFFFEFYESRNLAEKLHVEE---------------WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVL 194 (697)
Q Consensus 130 ~~~~~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nil 194 (697)
+......++||||+.+|+|.+++.... ..+++.+++.++.|++.||+|||+.|++||||||+|||
T Consensus 93 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nil 172 (307)
T cd05098 93 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 172 (307)
T ss_pred EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheE
Confidence 999999999999999999999997532 24688899999999999999999999999999999999
Q ss_pred ecCCCCCeeeeeccchhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-
Q 005427 195 LDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT- 273 (697)
Q Consensus 195 l~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~- 273 (697)
++.++.+||+|||++......... .......+++.|+|||++.+..++.++|+|||||++|+|++
T Consensus 173 l~~~~~~kL~dfg~a~~~~~~~~~--------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~ 238 (307)
T cd05098 173 VTEDNVMKIADFGLARDIHHIDYY--------------KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTL 238 (307)
T ss_pred EcCCCcEEECCCcccccccccchh--------------hccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcC
Confidence 999999999999998654321110 00112234578999999999889999999999999999998
Q ss_pred CCCCCCCchhHHHHHHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 005427 274 GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL 353 (697)
Q Consensus 274 g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~ 353 (697)
|..||.+.........+. ...+ ...+..++.++.+|+.+||..+|++|||+.++++++..++
T Consensus 239 g~~p~~~~~~~~~~~~~~---------------~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~ 300 (307)
T cd05098 239 GGSPYPGVPVEELFKLLK---------------EGHR---MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 300 (307)
T ss_pred CCCCCCcCCHHHHHHHHH---------------cCCC---CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence 899997654433222211 1111 1223467899999999999999999999999999999987
Q ss_pred HH
Q 005427 354 EH 355 (697)
Q Consensus 354 ~~ 355 (697)
..
T Consensus 301 ~~ 302 (307)
T cd05098 301 AL 302 (307)
T ss_pred HH
Confidence 64
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=322.27 Aligned_cols=252 Identities=25% Similarity=0.428 Sum_probs=206.1
Q ss_pred CCCCcccccccccCCceEEEEEEEC-CeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEee
Q 005427 64 PPSSYTLLSPIARGAESVVYEATLD-GRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF 142 (697)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 142 (697)
+..+|++.+.||+|+||.||++.+. +..+|+|...... .....+.+|+++++.++||||+++++++......+++|||
T Consensus 2 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05059 2 DPSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEY 80 (256)
T ss_pred ChHHcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEec
Confidence 3467999999999999999999874 4579999764332 2345688899999999999999999999999999999999
Q ss_pred cCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhccc
Q 005427 143 YESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKN 222 (697)
Q Consensus 143 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 222 (697)
+++++|.+++......+++..++.++.|++.||.|||+.|++||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~----- 155 (256)
T cd05059 81 MANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY----- 155 (256)
T ss_pred CCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccc-----
Confidence 999999999976655789999999999999999999999999999999999999999999999999865432110
Q ss_pred ccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCCchhHHHHHHHHhccccHHHHH
Q 005427 223 WRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLT 301 (697)
Q Consensus 223 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 301 (697)
.......++..|+|||.+.+..++.++|+||||+++|+|++ |..||...........+.
T Consensus 156 ----------~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~---------- 215 (256)
T cd05059 156 ----------TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVS---------- 215 (256)
T ss_pred ----------cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH----------
Confidence 00111234568999999998899999999999999999999 899998755443322221
Q ss_pred HHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 005427 302 AAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALEL 349 (697)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l 349 (697)
...++ ..+..+|.++.+++.+||..+|++|||+.++++.+
T Consensus 216 -----~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 216 -----AGYRL---YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred -----cCCcC---CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 11111 12345789999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=338.90 Aligned_cols=257 Identities=24% Similarity=0.284 Sum_probs=208.0
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccCC---ChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEE
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFF 140 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 140 (697)
++|++.++||+|+||.||+++. .++.+|+|++... .......+..|+.++..++||||+++++.+.++..+++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 4799999999999999999987 4678999976421 2223456888999999999999999999999999999999
Q ss_pred eecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhc
Q 005427 141 EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL 220 (697)
Q Consensus 141 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~ 220 (697)
||+.+|+|.+++......+++..++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~---- 156 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG---- 156 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCC----
Confidence 9999999999998766678999999999999999999999999999999999999999999999999986432110
Q ss_pred ccccCCCCCCCCccccccccCccccchhhhc-----ccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccc
Q 005427 221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILK-----KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNY 295 (697)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~ 295 (697)
.......+||+.|+|||++. ...++.++|||||||++|||++|..||...........+..
T Consensus 157 -----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~--- 222 (332)
T cd05623 157 -----------TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN--- 222 (332)
T ss_pred -----------cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhC---
Confidence 01123457999999999986 34578899999999999999999999987655444443322
Q ss_pred cHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCC--CCCHHHHHHHHHH
Q 005427 296 TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHN--RPSFSDIALELDL 351 (697)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~--Rpt~~ell~~l~~ 351 (697)
...+..++.....+++++.+|+++||..+|.+ |+++.++++|.|+
T Consensus 223 -----------~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f 269 (332)
T cd05623 223 -----------HKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFF 269 (332)
T ss_pred -----------CCccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCc
Confidence 11111222233468999999999999665544 6899999999775
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=340.64 Aligned_cols=244 Identities=26% Similarity=0.347 Sum_probs=198.5
Q ss_pred cccccCCceEEEEEEE--CCeeEEEEeccCC---ChHHHHHHHHHHH-HHHhcCCCCceEEeeccccCCceEEEEeecCC
Q 005427 72 SPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQ-LLCKLDHPGLAKFVAAHAKPPNYMFFFEFYES 145 (697)
Q Consensus 72 ~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~-~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 145 (697)
+.||+|+||.||+|.+ +++.+|+|++... .......+..|.. +++.++||||+++++.+..++.+++||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 4699999999999987 5789999986532 2223345555655 56779999999999999999999999999999
Q ss_pred CCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhcccccC
Q 005427 146 RNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRS 225 (697)
Q Consensus 146 g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~ 225 (697)
|+|...+.... .+++.++..++.||+.||+|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~---------- 149 (325)
T cd05604 81 GELFFHLQRER-SFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ---------- 149 (325)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCC----------
Confidence 99998886544 7899999999999999999999999999999999999999999999999998642110
Q ss_pred CCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHHHHHHH
Q 005427 226 SGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVV 305 (697)
Q Consensus 226 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (697)
.......+||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+....
T Consensus 150 ------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~----------- 212 (325)
T cd05604 150 ------SDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKP----------- 212 (325)
T ss_pred ------CCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCC-----------
Confidence 011335679999999999999999999999999999999999999998765544433332211
Q ss_pred hCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHH----HHHHHHHH
Q 005427 306 SGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFS----DIALELDL 351 (697)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~----ell~~l~~ 351 (697)
...++..+..+.+++++||+.+|.+||++. ++++|.|+
T Consensus 213 --------~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f 254 (325)
T cd05604 213 --------LVLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFF 254 (325)
T ss_pred --------ccCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCc
Confidence 012345789999999999999999999874 67776654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=325.28 Aligned_cols=255 Identities=25% Similarity=0.425 Sum_probs=207.0
Q ss_pred CCCCcccccccccCCceEEEEEEE------CCeeEEEEeccCC-ChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCce
Q 005427 64 PPSSYTLLSPIARGAESVVYEATL------DGRKVAVKKPILS-TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNY 136 (697)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 136 (697)
+-++|++.++||+|+||.||+|.. .+..+++|..... .......+.+|+.+++.++||||+++++++......
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 82 (283)
T cd05090 3 PLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPV 82 (283)
T ss_pred ChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCce
Confidence 346899999999999999999974 3568999986543 334456789999999999999999999999999999
Q ss_pred EEEEeecCCCCHhhhhhhcC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCC
Q 005427 137 MFFFEFYESRNLAEKLHVEE----------------WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLC 200 (697)
Q Consensus 137 ~lv~e~~~~g~L~~~l~~~~----------------~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~ 200 (697)
+++|||+.+++|.+++.... ..+++.++..++.|++.||.|||++|++||||||+|||++.++.
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~~ 162 (283)
T cd05090 83 CMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLH 162 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCCc
Confidence 99999999999999885321 24678889999999999999999999999999999999999999
Q ss_pred CeeeeeccchhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCC
Q 005427 201 PHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYT 279 (697)
Q Consensus 201 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~ 279 (697)
+||+|||+++....... ........++..|+|||++.+..++.++|+|||||++|||++ |..||.
T Consensus 163 ~kl~dfg~~~~~~~~~~--------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~ 228 (283)
T cd05090 163 VKISDLGLSREIYSADY--------------YRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYY 228 (283)
T ss_pred EEeccccccccccCCcc--------------eecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCC
Confidence 99999999875432110 001233446778999999998889999999999999999998 999997
Q ss_pred CchhHHHHHHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 005427 280 DLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350 (697)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~ 350 (697)
+.........+.. ... ...+..+++.+.+++.+||+.||.+||++.+|++++.
T Consensus 229 ~~~~~~~~~~~~~--------------~~~----~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 281 (283)
T cd05090 229 GFSNQEVIEMVRK--------------RQL----LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLR 281 (283)
T ss_pred CCCHHHHHHHHHc--------------CCc----CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhh
Confidence 7544332222211 111 1134568899999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=329.42 Aligned_cols=256 Identities=24% Similarity=0.398 Sum_probs=213.4
Q ss_pred CCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEe
Q 005427 64 PPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFE 141 (697)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 141 (697)
+..+|++.+.||+|+||.||+|.+ .++.|++|............+.+|+.+++.++||||+++++.+......++|||
T Consensus 18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e 97 (296)
T cd06654 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (296)
T ss_pred cccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeec
Confidence 346899999999999999999986 578999998776666666788999999999999999999999999999999999
Q ss_pred ecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhcc
Q 005427 142 FYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLK 221 (697)
Q Consensus 142 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~ 221 (697)
|+++++|.+++... .+++.++..++.|++.||.|||+.||+||||||+||+++.++.+||+|||++.......
T Consensus 98 ~~~~~~L~~~~~~~--~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~----- 170 (296)
T cd06654 98 YLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ----- 170 (296)
T ss_pred ccCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccc-----
Confidence 99999999998643 57889999999999999999999999999999999999999999999999986543211
Q ss_pred cccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHHH
Q 005427 222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLT 301 (697)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 301 (697)
.......|++.|+|||.+.+..++.++|||||||++|+|++|..||...........+..
T Consensus 171 -----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~--------- 230 (296)
T cd06654 171 -----------SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT--------- 230 (296)
T ss_pred -----------cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhc---------
Confidence 012334688999999999988889999999999999999999999976543222111110
Q ss_pred HHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 005427 302 AAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL 353 (697)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~ 353 (697)
.. .+.. ..+..++..+.+++.+||..+|.+|||+.+++++.|...
T Consensus 231 -----~~-~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~ 275 (296)
T cd06654 231 -----NG-TPEL-QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275 (296)
T ss_pred -----CC-CCCC-CCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhc
Confidence 11 1111 123467889999999999999999999999999888754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=337.84 Aligned_cols=264 Identities=27% Similarity=0.383 Sum_probs=213.2
Q ss_pred ccCCCCCCCcccccccccCCceEEEEEEEC-------CeeEEEEeccCCC-hHHHHHHHHHHHHHHhcC-CCCceEEeec
Q 005427 59 IPLHLPPSSYTLLSPIARGAESVVYEATLD-------GRKVAVKKPILST-SEELDNFHKELQLLCKLD-HPGLAKFVAA 129 (697)
Q Consensus 59 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-hpniv~l~~~ 129 (697)
..++++.++|.+.++||+|+||.||+|++. ++.||+|++.... ....+.+.+|+.+|.++. ||||++++++
T Consensus 30 ~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~ 109 (401)
T cd05107 30 SAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGA 109 (401)
T ss_pred CcceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEE
Confidence 347788889999999999999999999853 3579999876543 333557889999999997 9999999999
Q ss_pred cccCCceEEEEeecCCCCHhhhhhhcC-----------------------------------------------------
Q 005427 130 HAKPPNYMFFFEFYESRNLAEKLHVEE----------------------------------------------------- 156 (697)
Q Consensus 130 ~~~~~~~~lv~e~~~~g~L~~~l~~~~----------------------------------------------------- 156 (697)
+......++||||+.+|+|.++++...
T Consensus 110 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (401)
T cd05107 110 CTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADY 189 (401)
T ss_pred EccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCc
Confidence 999999999999999999999986432
Q ss_pred --------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCc
Q 005427 157 --------------------------------------------WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPAN 192 (697)
Q Consensus 157 --------------------------------------------~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~N 192 (697)
..+++..++.++.|++.||.|||+.+++||||||+|
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~N 269 (401)
T cd05107 190 VPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARN 269 (401)
T ss_pred cchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcce
Confidence 134667788999999999999999999999999999
Q ss_pred eeecCCCCCeeeeeccchhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHH
Q 005427 193 VLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELL 272 (697)
Q Consensus 193 ill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell 272 (697)
||++.++.+||+|||+++........ .......+++.|+|||++.+..++.++|||||||++|||+
T Consensus 270 iLl~~~~~~kL~DfGla~~~~~~~~~--------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l 335 (401)
T cd05107 270 VLICEGKLVKICDFGLARDIMRDSNY--------------ISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIF 335 (401)
T ss_pred EEEeCCCEEEEEecCcceeccccccc--------------ccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHH
Confidence 99999999999999998754321100 0112345788999999999888999999999999999999
Q ss_pred h-CCCCCCCchhHHHHHHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 005427 273 T-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL 351 (697)
Q Consensus 273 ~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~ 351 (697)
+ |..||............ ...+.++. .+..++.++.+|+.+||..+|.+||++.+|++.|..
T Consensus 336 ~~g~~P~~~~~~~~~~~~~--------------~~~~~~~~---~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~ 398 (401)
T cd05107 336 TLGGTPYPELPMNEQFYNA--------------IKRGYRMA---KPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGD 398 (401)
T ss_pred HcCCCCCCCCCchHHHHHH--------------HHcCCCCC---CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 8 89999765433222111 11222221 234678999999999999999999999999998876
Q ss_pred HH
Q 005427 352 VL 353 (697)
Q Consensus 352 ~~ 353 (697)
++
T Consensus 399 ~~ 400 (401)
T cd05107 399 LL 400 (401)
T ss_pred Hh
Confidence 54
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=325.95 Aligned_cols=247 Identities=23% Similarity=0.281 Sum_probs=195.3
Q ss_pred cccCCceEEEEEEE--CCeeEEEEeccCCC---hHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEeecCCCCH
Q 005427 74 IARGAESVVYEATL--DGRKVAVKKPILST---SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNL 148 (697)
Q Consensus 74 lg~G~~g~V~~~~~--~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L 148 (697)
||+|+||.||++.. +++.+|+|.+.... ......+..|+++++.++||||+++++.+.++..+++||||+.+++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 79999999999986 58899999864321 12234556799999999999999999999999999999999999999
Q ss_pred hhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhcccccCCC
Q 005427 149 AEKLHVEE-WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227 (697)
Q Consensus 149 ~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~ 227 (697)
.+++.... ..+++..+..++.|++.||+|||+.||+||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~----------- 149 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK----------- 149 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc-----------
Confidence 98875433 357889999999999999999999999999999999999999999999999986543210
Q ss_pred CCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHHHHHHHhC
Q 005427 228 KPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSG 307 (697)
Q Consensus 228 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (697)
......|++.|+|||++.+..++.++|||||||++|+|++|..||.+......... ........
T Consensus 150 ------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~----------~~~~~~~~ 213 (277)
T cd05607 150 ------TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEE----------LKRRTLED 213 (277)
T ss_pred ------eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHH----------HHHHhhcc
Confidence 12234689999999999998899999999999999999999999976432211111 11111111
Q ss_pred CCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHH----HHHHHHH
Q 005427 308 GLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSD----IALELDL 351 (697)
Q Consensus 308 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~e----ll~~l~~ 351 (697)
. .......+++++.+|+.+||+.||.+||++.| ++.|.|+
T Consensus 214 ~----~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f 257 (277)
T cd05607 214 E----VKFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFF 257 (277)
T ss_pred c----cccccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhh
Confidence 1 11112357899999999999999999999955 4455444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=334.79 Aligned_cols=263 Identities=27% Similarity=0.437 Sum_probs=209.2
Q ss_pred CCCCCCCcccccccccCCceEEEEEEE-------CCeeEEEEeccCCC-hHHHHHHHHHHHHHHhc-CCCCceEEeeccc
Q 005427 61 LHLPPSSYTLLSPIARGAESVVYEATL-------DGRKVAVKKPILST-SEELDNFHKELQLLCKL-DHPGLAKFVAAHA 131 (697)
Q Consensus 61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~-------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~ 131 (697)
|.++.++|++.++||+|+||.||+|.+ .++.||||++.... ......+.+|+.+|.++ +||||+++++++.
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 81 (343)
T cd05103 2 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT 81 (343)
T ss_pred cccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceee
Confidence 677888999999999999999999973 35789999876543 33456788999999999 6899999999876
Q ss_pred cC-CceEEEEeecCCCCHhhhhhhcC------------------------------------------------------
Q 005427 132 KP-PNYMFFFEFYESRNLAEKLHVEE------------------------------------------------------ 156 (697)
Q Consensus 132 ~~-~~~~lv~e~~~~g~L~~~l~~~~------------------------------------------------------ 156 (697)
.. ...+++|||+++|+|.+++....
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (343)
T cd05103 82 KPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV 161 (343)
T ss_pred cCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence 54 46789999999999999886421
Q ss_pred ------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhccccc
Q 005427 157 ------------WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWR 224 (697)
Q Consensus 157 ------------~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~ 224 (697)
..+++.++..++.|++.||+|||+.||+||||||+|||++.++.+||+|||++........
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~------- 234 (343)
T cd05103 162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD------- 234 (343)
T ss_pred hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcc-------
Confidence 1357788899999999999999999999999999999999999999999999875432110
Q ss_pred CCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCCchhHHHHHHHHhccccHHHHHHH
Q 005427 225 SSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAA 303 (697)
Q Consensus 225 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (697)
........+++.|+|||++.+..++.++||||||+++|+|++ |..||.+..........
T Consensus 235 -------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~------------- 294 (343)
T cd05103 235 -------YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR------------- 294 (343)
T ss_pred -------hhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHH-------------
Confidence 001123346678999999998889999999999999999997 99999765332211111
Q ss_pred HHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 005427 304 VVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE 354 (697)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~ 354 (697)
...+.++. .+...++++.+++..||+.||.+|||+.+|+++|..+++
T Consensus 295 -~~~~~~~~---~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 295 -LKEGTRMR---APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred -HhccCCCC---CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 11111211 223467899999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=338.10 Aligned_cols=257 Identities=24% Similarity=0.270 Sum_probs=208.1
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccCC---ChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEE
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFF 140 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 140 (697)
++|++.+.||+|+||.||++++ +++.||+|.+... .......+.+|+.++..++||||+++++++.+.+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 4799999999999999999987 5678999976432 2233456888999999999999999999999999999999
Q ss_pred eecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhc
Q 005427 141 EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL 220 (697)
Q Consensus 141 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~ 220 (697)
||+.+|+|.+++......+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~---- 156 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG---- 156 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCC----
Confidence 9999999999998755578999999999999999999999999999999999999999999999999986543211
Q ss_pred ccccCCCCCCCCccccccccCccccchhhhcc-----cCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccc
Q 005427 221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-----EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNY 295 (697)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~ 295 (697)
........||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+..
T Consensus 157 -----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~--- 222 (331)
T cd05624 157 -----------TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN--- 222 (331)
T ss_pred -----------ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHc---
Confidence 011234579999999999875 4678899999999999999999999987654433333221
Q ss_pred cHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCC--CCCHHHHHHHHHH
Q 005427 296 TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHN--RPSFSDIALELDL 351 (697)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~--Rpt~~ell~~l~~ 351 (697)
...+..++.....++.++.+++.+||..++++ |++++++++|.|+
T Consensus 223 -----------~~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f 269 (331)
T cd05624 223 -----------HEERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFF 269 (331)
T ss_pred -----------CCCcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCc
Confidence 11122222223457899999999999876654 5689999988765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=320.52 Aligned_cols=255 Identities=29% Similarity=0.444 Sum_probs=207.4
Q ss_pred CCCCCCCcccccccccCCceEEEEEEE-CCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEE
Q 005427 61 LHLPPSSYTLLSPIARGAESVVYEATL-DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFF 139 (697)
Q Consensus 61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 139 (697)
|+++.++|++.++||+|+||.||+|.. .+..+|+|....... ..+.+.+|+.++++++||||+++++++. ....+++
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv 78 (260)
T cd05070 1 WEIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIV 78 (260)
T ss_pred CCCchHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEE
Confidence 456778999999999999999999986 456799998654332 3456899999999999999999999875 4568899
Q ss_pred EeecCCCCHhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhh
Q 005427 140 FEFYESRNLAEKLHVE-EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI 218 (697)
Q Consensus 140 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~ 218 (697)
|||+.+++|.+++... ...+++.+++.++.|++.||.|||+.+++||||||+||+++.++.++|+|||++..+.....
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~- 157 (260)
T cd05070 79 TEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY- 157 (260)
T ss_pred EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCccc-
Confidence 9999999999998653 33578999999999999999999999999999999999999999999999999875432110
Q ss_pred hcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCCchhHHHHHHHHhccccH
Q 005427 219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTE 297 (697)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~ 297 (697)
.......++..|+|||++.+..++.++|+||||+++|+|++ |.+||.+.........+..
T Consensus 158 --------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~----- 218 (260)
T cd05070 158 --------------TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVER----- 218 (260)
T ss_pred --------------ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-----
Confidence 01122345678999999988889999999999999999999 9999987654433332211
Q ss_pred HHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 005427 298 QQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350 (697)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~ 350 (697)
..++ ..+...+..+.+++.+||..+|++|||+.++.+.|.
T Consensus 219 ----------~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 258 (260)
T cd05070 219 ----------GYRM---PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLE 258 (260)
T ss_pred ----------CCCC---CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHh
Confidence 1111 124567899999999999999999999999987665
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=321.63 Aligned_cols=257 Identities=28% Similarity=0.417 Sum_probs=210.6
Q ss_pred CCCCCCCcccccccccCCceEEEEEEE-CCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEE
Q 005427 61 LHLPPSSYTLLSPIARGAESVVYEATL-DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFF 139 (697)
Q Consensus 61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 139 (697)
+++..++|++.+.||+|+||.||+|.+ .++.||+|...... ...+.+.+|+.++++++||||+++++++......+++
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 79 (261)
T cd05068 1 WEIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIV 79 (261)
T ss_pred CccchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeee
Confidence 356778899999999999999999987 55679999865433 2346688999999999999999999999999999999
Q ss_pred EeecCCCCHhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhh
Q 005427 140 FEFYESRNLAEKLHVEE-WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI 218 (697)
Q Consensus 140 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~ 218 (697)
|||+.+++|.+++.... ..+++.++..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++........
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~- 158 (261)
T cd05068 80 TELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY- 158 (261)
T ss_pred eecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc-
Confidence 99999999999986543 4688999999999999999999999999999999999999999999999999876542100
Q ss_pred hcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCCchhHHHHHHHHhccccH
Q 005427 219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTE 297 (697)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~ 297 (697)
........+..|+|||++.+..++.++|+||||+++|+|++ |+.||.+.........+..
T Consensus 159 --------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~----- 219 (261)
T cd05068 159 --------------EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQ----- 219 (261)
T ss_pred --------------cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-----
Confidence 00111223468999999999899999999999999999999 9999987654433322211
Q ss_pred HHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 005427 298 QQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL 351 (697)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~ 351 (697)
..+. ..+..++..+.+++.+||+.+|.+||++.++++.|+.
T Consensus 220 ----------~~~~---~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 220 ----------GYRM---PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred ----------CCCC---CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 1111 1234678999999999999999999999999887753
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=324.65 Aligned_cols=256 Identities=25% Similarity=0.397 Sum_probs=209.4
Q ss_pred CCCCCcccccccccCCceEEEEEEE-------CCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCc
Q 005427 63 LPPSSYTLLSPIARGAESVVYEATL-------DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPN 135 (697)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~-------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 135 (697)
+..++|.+.++||+|+||.||++.. ++..+++|............+.+|+++++.++||||+++++++.....
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (280)
T cd05092 2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRP 81 (280)
T ss_pred CChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCc
Confidence 3456899999999999999999963 356789998766666667789999999999999999999999999999
Q ss_pred eEEEEeecCCCCHhhhhhhcC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCC
Q 005427 136 YMFFFEFYESRNLAEKLHVEE--------------WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCP 201 (697)
Q Consensus 136 ~~lv~e~~~~g~L~~~l~~~~--------------~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~ 201 (697)
.+++|||+.+++|.+++.... ..+++.+++.++.|++.||+|||+.|++||||||+|||++.++.+
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 82 LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCCE
Confidence 999999999999999986543 247889999999999999999999999999999999999999999
Q ss_pred eeeeeccchhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 005427 202 HLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTD 280 (697)
Q Consensus 202 kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~ 280 (697)
||+|||++........ ........+++.|+|||++.+..++.++|||||||++|+|++ |.+||..
T Consensus 162 kL~dfg~~~~~~~~~~--------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~ 227 (280)
T cd05092 162 KIGDFGMSRDIYSTDY--------------YRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQ 227 (280)
T ss_pred EECCCCceeEcCCCce--------------eecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCcc
Confidence 9999999864432110 001123345788999999999999999999999999999998 9999976
Q ss_pred chhHHHHHHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 005427 281 LRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350 (697)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~ 350 (697)
.........+.. +. .+ ..+..+|+.+.+++.+||+.||.+||++.+|++.+.
T Consensus 228 ~~~~~~~~~~~~--------------~~-~~---~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 228 LSNTEAIECITQ--------------GR-EL---ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred CCHHHHHHHHHc--------------Cc-cC---CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 544433222211 11 11 123468899999999999999999999999987664
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=321.27 Aligned_cols=250 Identities=25% Similarity=0.383 Sum_probs=209.8
Q ss_pred CcccccccccCCceEEEEEEE--CCeeEEEEeccCC--ChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEee
Q 005427 67 SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF 142 (697)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 142 (697)
+|.+.+.||+|+||.||++.. +++.|++|..... .......+.+|+++++.++||||+++++.+.....++++|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 478899999999999999987 5788999986543 344567889999999999999999999999999999999999
Q ss_pred cCCCCHhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhcc
Q 005427 143 YESRNLAEKLHVE-EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLK 221 (697)
Q Consensus 143 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~ 221 (697)
+.+++|.+++... ...+++.+++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~----- 155 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT----- 155 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCcc-----
Confidence 9999999998764 4568899999999999999999999999999999999999999999999999987554211
Q ss_pred cccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHHH
Q 005427 222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLT 301 (697)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 301 (697)
.......|++.|+|||++.+..++.++|+|||||++|+|++|..||...........+..
T Consensus 156 -----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--------- 215 (256)
T cd08529 156 -----------NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIR--------- 215 (256)
T ss_pred -----------chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc---------
Confidence 112344688999999999998899999999999999999999999987654433332221
Q ss_pred HHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 005427 302 AAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350 (697)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~ 350 (697)
+. .+ ..+..++.++.+++.+||+.+|++||++.+++++.|
T Consensus 216 -----~~-~~---~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~ 255 (256)
T cd08529 216 -----GV-FP---PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPS 255 (256)
T ss_pred -----CC-CC---CCccccCHHHHHHHHHHccCCcccCcCHHHHhhCCC
Confidence 11 11 223367899999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=320.54 Aligned_cols=257 Identities=29% Similarity=0.420 Sum_probs=207.8
Q ss_pred CCCCCCCcccccccccCCceEEEEEEE-CCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEE
Q 005427 61 LHLPPSSYTLLSPIARGAESVVYEATL-DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFF 139 (697)
Q Consensus 61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 139 (697)
|+++.++|++.++||+|+||.||+|.+ ....||+|+...... ..+.+.+|+.+++.++||||+++++.+.. ...+++
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv 78 (262)
T cd05071 1 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 78 (262)
T ss_pred CCCChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEE
Confidence 356778999999999999999999987 345799998654322 34578899999999999999999998754 568899
Q ss_pred EeecCCCCHhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhh
Q 005427 140 FEFYESRNLAEKLHVE-EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI 218 (697)
Q Consensus 140 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~ 218 (697)
|||+.+|+|.+++... ...+++..+..++.|++.||+|||+.+++||||||+||+++.++.+||+|||.+........
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~- 157 (262)
T cd05071 79 TEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY- 157 (262)
T ss_pred EEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeecccccc-
Confidence 9999999999999753 33578899999999999999999999999999999999999999999999999875542110
Q ss_pred hcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCCchhHHHHHHHHhccccH
Q 005427 219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTE 297 (697)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~ 297 (697)
.......++..|+|||++.+..++.++|||||||++|+|++ |..||.+.........+..
T Consensus 158 --------------~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~----- 218 (262)
T cd05071 158 --------------TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER----- 218 (262)
T ss_pred --------------ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhc-----
Confidence 01123346778999999998889999999999999999999 8999987644333222211
Q ss_pred HHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 298 QQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
.... ..+..++..+.+++.+||+.+|++||++.++++.|+..
T Consensus 219 ----------~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 219 ----------GYRM---PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred ----------CCCC---CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 1111 12346789999999999999999999999999887764
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG0699 consensus Serine/threonine protein phosphatase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=304.76 Aligned_cols=157 Identities=34% Similarity=0.577 Sum_probs=142.5
Q ss_pred CCCceEEEEEEecCeEEEEEcCCeEEEEEECCeeeecCCCCCCCCHHHHHHHHHcCCeeeeccCcceeCCCcceeccccC
Q 005427 528 HPGCTAIAALIVRNRLFVANAGDCRAILCRGGHPFALSRDHVASCLEERERVVSAGGNVNWQVDTWRVGPPALQVTRSIG 607 (697)
Q Consensus 528 ~~GtT~~~~~i~~~~l~~anvGDSr~~l~~~~~~~~lt~dH~~~~~~e~~ri~~~g~~~~~~~~~~~~~~~~~~ltralG 607 (697)
.+|||+++++|.+++++|||.||||+++.|.|+++-++.||+|...-|..||.++||+|.+. .|++ +++.|+||||
T Consensus 329 DSGtTAvVcLv~g~~liVANAGDSRcV~sr~GkAvdmS~DHKPEDevE~~RI~~AGG~vtlD---GRVN-GGLNLSRA~G 404 (542)
T KOG0699|consen 329 DSGTTAVVCLVGGDKLIVANAGDSRCVLSRNGKAVDMSVDHKPEDEVETNRIHAAGGQVTLD---GRVN-GGLNLSRAFG 404 (542)
T ss_pred CCCceEEEEEecCceEEEecCCCcceEEecCCceeecccCCCcccHHHHHHHHhcCCeEeec---ceec-Cccchhhhhh
Confidence 35999999999999999999999999999999999999999999999999999999988754 5666 7999999999
Q ss_pred CCCCCC---------CcccCCceEEEEeCCCCeEEEEEcCCcccCCChHHHHHHHHhhcC---ChhHHHHHHHHHHHhcC
Q 005427 608 DDDLKP---------AVTAEPEITETIMTPEDEYLVMASDGLWDVVSHVEAVGIIKDTVK---EPGMCSKRLATEAAERG 675 (697)
Q Consensus 608 ~~~~k~---------~v~~~p~v~~~~l~~~d~~lvl~SDGl~d~~~~~ei~~~~~~~~~---~~~~~a~~L~~~a~~~g 675 (697)
|..||. .|++-|||....|.+.|+|+||+|||||++|+.++++.+|+.... .+..+|++|.+.++.-.
T Consensus 405 DHaYK~N~~Lp~eEQMIsALPDiK~l~lTpedEFmVvACDGIWN~MsSqeVVdFvr~~l~~n~~ls~iceeL~D~CLAp~ 484 (542)
T KOG0699|consen 405 DHAYKKNQELPLEEQMISALPDIKILALTPEDEFMVVACDGIWNSMSSQEVVDFVRDLLAKNSSLSEICEELCDACLAPS 484 (542)
T ss_pred hhhhhcccCCChHHHHhhhcccceeEeecCcccEEEEEccchhhhccHHHHHHHHHHHHhcCchHHHHHHHHHHhhcCCC
Confidence 999994 589999999999999999999999999999999999999987553 57789999999988632
Q ss_pred ------CCCCcEEEEEEeC
Q 005427 676 ------SKDNITVIVVFLQ 688 (697)
Q Consensus 676 ------~~DNiT~ivv~l~ 688 (697)
+=||||||++.|.
T Consensus 485 T~GDGTGCDNMT~ii~~Fk 503 (542)
T KOG0699|consen 485 TDGDGTGCDNMTVIITTFK 503 (542)
T ss_pred CCCCCcCCCcceEEEEEec
Confidence 2299999999986
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=337.83 Aligned_cols=244 Identities=27% Similarity=0.341 Sum_probs=196.9
Q ss_pred cccccCCceEEEEEEE--CCeeEEEEeccCCC---hHHHHHHHHHHH-HHHhcCCCCceEEeeccccCCceEEEEeecCC
Q 005427 72 SPIARGAESVVYEATL--DGRKVAVKKPILST---SEELDNFHKELQ-LLCKLDHPGLAKFVAAHAKPPNYMFFFEFYES 145 (697)
Q Consensus 72 ~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 145 (697)
+.||+|+||.||+|++ +++.||+|++.... ......+..|.. +++.++||||+++++.+.+....++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999999987 57889999864321 223344555554 67889999999999999999999999999999
Q ss_pred CCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhcccccC
Q 005427 146 RNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRS 225 (697)
Q Consensus 146 g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~ 225 (697)
|+|...+.... .+++.++..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~---------- 149 (321)
T cd05603 81 GELFFHLQRER-CFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP---------- 149 (321)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCC----------
Confidence 99998886543 6888999999999999999999999999999999999999999999999998642110
Q ss_pred CCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHHHHHHH
Q 005427 226 SGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVV 305 (697)
Q Consensus 226 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (697)
.......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+.......+....
T Consensus 150 ------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~----------- 212 (321)
T cd05603 150 ------EETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKP----------- 212 (321)
T ss_pred ------CCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCC-----------
Confidence 011234579999999999999899999999999999999999999998765443333322110
Q ss_pred hCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHH----HHHHHHHH
Q 005427 306 SGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFS----DIALELDL 351 (697)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~----ell~~l~~ 351 (697)
...+...+.++.+++.+||+.||.+||++. ++++|+|.
T Consensus 213 --------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~ 254 (321)
T cd05603 213 --------LQLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFF 254 (321)
T ss_pred --------CCCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCc
Confidence 123446788999999999999999998764 66666554
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=320.93 Aligned_cols=256 Identities=24% Similarity=0.383 Sum_probs=207.7
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccC---CChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEE
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPIL---STSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFF 140 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 140 (697)
++|++.++||+|+||.||+|+. +++.||+|.... ........+.+|+.+++.++||||+++++++...+.+++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 5799999999999999999986 678999997543 23344567889999999999999999999999999999999
Q ss_pred eecCCCCHhhhhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhh
Q 005427 141 EFYESRNLAEKLHV---EEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKE 217 (697)
Q Consensus 141 e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~ 217 (697)
||+++++|.+++.. ....+++.+++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++........
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~ 161 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchhH
Confidence 99999999988753 233578899999999999999999999999999999999999999999999999876542111
Q ss_pred hhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccH
Q 005427 218 ISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTE 297 (697)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~ 297 (697)
......|++.|+|||.+.+..++.++|+||||+++|+|++|..||.......
T Consensus 162 ----------------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~------------ 213 (267)
T cd08228 162 ----------------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL------------ 213 (267)
T ss_pred ----------------HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH------------
Confidence 1223468899999999998888999999999999999999999996542211
Q ss_pred HHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 298 QQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
......+......+. ....++..+.+++.+||..+|++||++.++++.+..+
T Consensus 214 ~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 214 FSLCQKIEQCDYPPL---PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred HHHHHHHhcCCCCCC---ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 011111111122221 1235778999999999999999999999999887654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=324.01 Aligned_cols=258 Identities=26% Similarity=0.446 Sum_probs=210.4
Q ss_pred CCCCCCCcccccccccCCceEEEEEEEC-------CeeEEEEeccCCC-hHHHHHHHHHHHHHHhcCCCCceEEeecccc
Q 005427 61 LHLPPSSYTLLSPIARGAESVVYEATLD-------GRKVAVKKPILST-SEELDNFHKELQLLCKLDHPGLAKFVAAHAK 132 (697)
Q Consensus 61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 132 (697)
+++..++|++.+.||+|+||.||+|... +..||+|...... ......+.+|+.+|+.++||||+++++++..
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~ 80 (277)
T cd05032 1 WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVST 80 (277)
T ss_pred CccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC
Confidence 4567789999999999999999999763 2679999865443 3445678899999999999999999999999
Q ss_pred CCceEEEEeecCCCCHhhhhhhcC---------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCee
Q 005427 133 PPNYMFFFEFYESRNLAEKLHVEE---------WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHL 203 (697)
Q Consensus 133 ~~~~~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL 203 (697)
....+++|||+.+|+|.+++.... ..+++..++.++.|++.||.|||+.+++||||||+|||++.++.+||
T Consensus 81 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl 160 (277)
T cd05032 81 GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKI 160 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEE
Confidence 999999999999999999986422 23678899999999999999999999999999999999999999999
Q ss_pred eeeccchhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCCch
Q 005427 204 ADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLR 282 (697)
Q Consensus 204 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~~~ 282 (697)
+|||+++........ .......++..|+|||.+.+..++.++|||||||++||+++ |..||.+.+
T Consensus 161 ~dfg~~~~~~~~~~~--------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 226 (277)
T cd05032 161 GDFGMTRDIYETDYY--------------RKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLS 226 (277)
T ss_pred CCcccchhhccCccc--------------ccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCC
Confidence 999998755321110 01223456789999999988889999999999999999998 999998765
Q ss_pred hHHHHHHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 005427 283 AEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350 (697)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~ 350 (697)
.......+. .+. .+ ..+..++.++.+++.+||+.+|++|||+.++++.|.
T Consensus 227 ~~~~~~~~~--------------~~~-~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 227 NEEVLKFVI--------------DGG-HL---DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred HHHHHHHHh--------------cCC-CC---CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 443332221 111 11 224457899999999999999999999999987764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=327.06 Aligned_cols=262 Identities=26% Similarity=0.416 Sum_probs=213.7
Q ss_pred cCCCCCCCcccccccccCCceEEEEEEEC-------CeeEEEEeccCC-ChHHHHHHHHHHHHHHhc-CCCCceEEeecc
Q 005427 60 PLHLPPSSYTLLSPIARGAESVVYEATLD-------GRKVAVKKPILS-TSEELDNFHKELQLLCKL-DHPGLAKFVAAH 130 (697)
Q Consensus 60 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~ 130 (697)
.+++..++|++.+.||+|+||.||++... ...+|+|..... .......+.+|+.+++++ +||||+++++++
T Consensus 6 ~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 85 (293)
T cd05053 6 EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVC 85 (293)
T ss_pred ccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 46777889999999999999999999763 257899986643 234456789999999999 899999999999
Q ss_pred ccCCceEEEEeecCCCCHhhhhhhc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceee
Q 005427 131 AKPPNYMFFFEFYESRNLAEKLHVE---------------EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLL 195 (697)
Q Consensus 131 ~~~~~~~lv~e~~~~g~L~~~l~~~---------------~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill 195 (697)
.....++++|||+.+|+|.+++... ...+++..++.++.|++.||.|||+.+|+||||||+|||+
T Consensus 86 ~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~ 165 (293)
T cd05053 86 TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLV 165 (293)
T ss_pred cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEE
Confidence 9999999999999999999998642 2357889999999999999999999999999999999999
Q ss_pred cCCCCCeeeeeccchhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-C
Q 005427 196 DRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-G 274 (697)
Q Consensus 196 ~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g 274 (697)
+.++.+||+|||++..+...... .......++..|+|||++.+..++.++|||||||++|||++ |
T Consensus 166 ~~~~~~kL~Dfg~~~~~~~~~~~--------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g 231 (293)
T cd05053 166 TEDHVMKIADFGLARDIHHIDYY--------------RKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLG 231 (293)
T ss_pred cCCCeEEeCccccccccccccce--------------eccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCC
Confidence 99999999999998765421110 00112235678999999999899999999999999999998 9
Q ss_pred CCCCCCchhHHHHHHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 005427 275 VVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL 353 (697)
Q Consensus 275 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~ 353 (697)
..||.+.........+. ....+ ..+..++.++.+|+.+||..||++|||+.+++++|..+.
T Consensus 232 ~~p~~~~~~~~~~~~~~---------------~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 232 GSPYPGIPVEELFKLLK---------------EGYRM---EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred CCCCCCCCHHHHHHHHH---------------cCCcC---CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 99998765443332221 11111 123467889999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=326.92 Aligned_cols=263 Identities=26% Similarity=0.381 Sum_probs=207.1
Q ss_pred CCCCCcccccccccCCceEEEEEEECC----------------eeEEEEeccCC-ChHHHHHHHHHHHHHHhcCCCCceE
Q 005427 63 LPPSSYTLLSPIARGAESVVYEATLDG----------------RKVAVKKPILS-TSEELDNFHKELQLLCKLDHPGLAK 125 (697)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~~~----------------~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~ 125 (697)
++..+|++.++||+|+||.||+++..+ ..||+|..... .......+.+|++++++++||||++
T Consensus 2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~ 81 (295)
T cd05097 2 FPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIR 81 (295)
T ss_pred CchHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCe
Confidence 456789999999999999999987532 24899986654 2334567999999999999999999
Q ss_pred EeeccccCCceEEEEeecCCCCHhhhhhhcC-----------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCcee
Q 005427 126 FVAAHAKPPNYMFFFEFYESRNLAEKLHVEE-----------WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVL 194 (697)
Q Consensus 126 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----------~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nil 194 (697)
+++++......++||||+.+++|.+++.... ..+++.+++.++.|++.||+|||+.|++||||||+||+
T Consensus 82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil 161 (295)
T cd05097 82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL 161 (295)
T ss_pred EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEE
Confidence 9999999999999999999999999886432 13578899999999999999999999999999999999
Q ss_pred ecCCCCCeeeeeccchhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-
Q 005427 195 LDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT- 273 (697)
Q Consensus 195 l~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~- 273 (697)
++.++.+||+|||++........ ........+++.|+|||++.+..++.++|+|||||++|+|++
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~--------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~ 227 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDY--------------YRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTL 227 (295)
T ss_pred EcCCCcEEecccccccccccCcc--------------eeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHc
Confidence 99999999999999865432110 001123345788999999998889999999999999999988
Q ss_pred -CCCCCCCchhHHHHHHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 005427 274 -GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350 (697)
Q Consensus 274 -g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~ 350 (697)
+..||...........+.... ...........+..+|+.+.+|+.+||+.||++|||+++|++.|.
T Consensus 228 ~~~~p~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 228 CKEQPYSLLSDEQVIENTGEFF-----------RNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred CCCCCCcccChHHHHHHHHHhh-----------hhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 778888765444333221100 000011111223457899999999999999999999999987664
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=357.74 Aligned_cols=256 Identities=23% Similarity=0.331 Sum_probs=204.0
Q ss_pred CCCCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCC--ChHHHHHHHHHHHHHHhcCCCCceEEeecccc--CCc
Q 005427 62 HLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAK--PPN 135 (697)
Q Consensus 62 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~--~~~ 135 (697)
.....+|+++++||+|+||+||++.+ .+..+|+|.+... .......+..|+.+|+.|+||||++++++|.. ...
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 34456899999999999999999987 5678999976543 33456788999999999999999999998854 456
Q ss_pred eEEEEeecCCCCHhhhhhhc---CCCCCHHHHHHHHHHHHHHHHHHHhC-------CcccccCCCCceeecC--------
Q 005427 136 YMFFFEFYESRNLAEKLHVE---EWSPSVDQVLMIAAQLAKALQYLHNL-------GIVHRDVKPANVLLDR-------- 197 (697)
Q Consensus 136 ~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~-------~ivHrDlkp~Nill~~-------- 197 (697)
+|+||||+.+|+|.+++... ...+++..++.|+.||+.||.|||+. +|+||||||+||||+.
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 89999999999999998642 24689999999999999999999985 4999999999999954
Q ss_pred ---------CCCCeeeeeccchhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcc--cCCCchhhHHHHHH
Q 005427 198 ---------NLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK--EIHSEKSDVYSFGI 266 (697)
Q Consensus 198 ---------~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~ 266 (697)
.+.+||+|||++..+.... ......||+.|+|||++.+ ..++.++|||||||
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s-----------------~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ 231 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIES-----------------MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGC 231 (1021)
T ss_pred cccccccCCCCceEEccCCccccccccc-----------------cccccCCCccccCHHHHhccCCCCCchhHHHHHHH
Confidence 3458999999986543210 1234579999999999864 45789999999999
Q ss_pred HHHHHHhCCCCCCCchhHHHHHHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHH
Q 005427 267 SINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIA 346 (697)
Q Consensus 267 ~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell 346 (697)
+||+|++|..||............+. .. +.+ .....+.++.+||..||..+|.+||++.|++
T Consensus 232 ILYELLTGk~PF~~~~~~~qli~~lk--------------~~--p~l--pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL 293 (1021)
T PTZ00266 232 IIYELCSGKTPFHKANNFSQLISELK--------------RG--PDL--PIKGKSKELNILIKNLLNLSAKERPSALQCL 293 (1021)
T ss_pred HHHHHHHCCCCCCcCCcHHHHHHHHh--------------cC--CCC--CcCCCCHHHHHHHHHHhcCChhHCcCHHHHh
Confidence 99999999999976543322221111 01 111 1235689999999999999999999999999
Q ss_pred HHHHHH
Q 005427 347 LELDLV 352 (697)
Q Consensus 347 ~~l~~~ 352 (697)
.+.|..
T Consensus 294 ~h~~ik 299 (1021)
T PTZ00266 294 GYQIIK 299 (1021)
T ss_pred ccHHHh
Confidence 876653
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=327.64 Aligned_cols=254 Identities=21% Similarity=0.258 Sum_probs=205.9
Q ss_pred CcccccccccCCceEEEEEEE--CCeeEEEEeccCCC---hHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEe
Q 005427 67 SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST---SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFE 141 (697)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 141 (697)
.|++.+.||+|+||.||++.+ +++.||+|.+.... ......+.+|+.+++.++|+||+.+++.+.+.+.++++||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 377889999999999999987 57899999765332 2224567789999999999999999999999999999999
Q ss_pred ecCCCCHhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhc
Q 005427 142 FYESRNLAEKLHVEE-WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL 220 (697)
Q Consensus 142 ~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~ 220 (697)
|+.+++|.+++.... ..+++.++..++.|++.||.|||+.+|+||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~---- 156 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---- 156 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc----
Confidence 999999999885433 358899999999999999999999999999999999999999999999999986432100
Q ss_pred ccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHH
Q 005427 221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQL 300 (697)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 300 (697)
......|++.|+|||++.+..++.++|||||||++|+|++|..||..............
T Consensus 157 -------------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~-------- 215 (285)
T cd05630 157 -------------TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVER-------- 215 (285)
T ss_pred -------------cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHh--------
Confidence 12234789999999999999999999999999999999999999986432111110000
Q ss_pred HHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCC-----HHHHHHHHHHH
Q 005427 301 TAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPS-----FSDIALELDLV 352 (697)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt-----~~ell~~l~~~ 352 (697)
.. .......+..+++++.+|+.+||+.||.+||| ++|+++|.|+.
T Consensus 216 ---~~----~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~ 265 (285)
T cd05630 216 ---LV----KEVQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFK 265 (285)
T ss_pred ---hh----hhhhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhh
Confidence 00 00001123467899999999999999999999 89999998874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=319.37 Aligned_cols=250 Identities=26% Similarity=0.415 Sum_probs=206.3
Q ss_pred CCCCCcccccccccCCceEEEEEEECCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeecc-ccCCceEEEEe
Q 005427 63 LPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAH-AKPPNYMFFFE 141 (697)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~-~~~~~~~lv~e 141 (697)
+...+|++.+.||+|+||.||++...+..+++|..... ...+.+.+|+.++++++|||++++++++ ......+++||
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (256)
T cd05082 3 LNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 80 (256)
T ss_pred ccHHhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEE
Confidence 44568999999999999999999999999999986433 3356789999999999999999999875 45567899999
Q ss_pred ecCCCCHhhhhhhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhc
Q 005427 142 FYESRNLAEKLHVEEW-SPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL 220 (697)
Q Consensus 142 ~~~~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~ 220 (697)
|+++++|.+++..... .+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~----- 155 (256)
T cd05082 81 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----- 155 (256)
T ss_pred CCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceecccc-----
Confidence 9999999999876443 4788999999999999999999999999999999999999999999999998643210
Q ss_pred ccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCCchhHHHHHHHHhccccHHH
Q 005427 221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQ 299 (697)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~ 299 (697)
.....++..|+|||++.+..++.++|||||||++|+|++ |..||...........+.
T Consensus 156 --------------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~-------- 213 (256)
T cd05082 156 --------------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-------- 213 (256)
T ss_pred --------------CCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh--------
Confidence 122334568999999998889999999999999999997 999997654333222211
Q ss_pred HHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 005427 300 LTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL 351 (697)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~ 351 (697)
....+ ..+..+++.+.+++.+||+.+|++|||+.++++.|..
T Consensus 214 -------~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 214 -------KGYKM---DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred -------cCCCC---CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 11111 2335688999999999999999999999999987753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=327.41 Aligned_cols=256 Identities=25% Similarity=0.402 Sum_probs=215.0
Q ss_pred CCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEe
Q 005427 64 PPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFE 141 (697)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 141 (697)
+.++|++.+.||.|+||.||+|.+ +++.|++|.+........+.+.+|+.+++.++||||+++++.+.....+++|+|
T Consensus 17 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 96 (296)
T cd06655 17 PKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVME 96 (296)
T ss_pred CcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEE
Confidence 346799999999999999999986 688999998766655566788999999999999999999999999999999999
Q ss_pred ecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhcc
Q 005427 142 FYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLK 221 (697)
Q Consensus 142 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~ 221 (697)
|+.+++|..++... .+++.++..++.|++.||+|||+.|++||||||+||+++.++.+||+|||++.......
T Consensus 97 ~~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~----- 169 (296)
T cd06655 97 YLAGGSLTDVVTET--CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ----- 169 (296)
T ss_pred ecCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhccccc-----
Confidence 99999999988643 58899999999999999999999999999999999999999999999999986543211
Q ss_pred cccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHHH
Q 005427 222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLT 301 (697)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 301 (697)
.......+++.|+|||.+.+..++.++|+|||||++|+|++|..||...........+..
T Consensus 170 -----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~--------- 229 (296)
T cd06655 170 -----------SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT--------- 229 (296)
T ss_pred -----------ccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---------
Confidence 012345688999999999988899999999999999999999999987654333222211
Q ss_pred HHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 005427 302 AAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL 353 (697)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~ 353 (697)
.. .+.+ ..+..+++.+.++|.+||..||.+|||+.+++.|.|...
T Consensus 230 -----~~-~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~ 274 (296)
T cd06655 230 -----NG-TPEL-QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKL 274 (296)
T ss_pred -----cC-Cccc-CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhh
Confidence 00 1111 123468899999999999999999999999999998864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=322.86 Aligned_cols=256 Identities=26% Similarity=0.434 Sum_probs=206.2
Q ss_pred CCCCCcccccccccCCceEEEEEEEC-------CeeEEEEeccCCC-hHHHHHHHHHHHHHHhcCCCCceEEeeccccCC
Q 005427 63 LPPSSYTLLSPIARGAESVVYEATLD-------GRKVAVKKPILST-SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPP 134 (697)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 134 (697)
+..++|.+.+.||+|+||.||+|.+. +..|++|...... ......+.+|+.+++.++||||+++++++.+..
T Consensus 3 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (277)
T cd05036 3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERL 82 (277)
T ss_pred CCHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence 44568999999999999999999873 4678888765443 333457899999999999999999999999999
Q ss_pred ceEEEEeecCCCCHhhhhhhcC------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCC---CCeeee
Q 005427 135 NYMFFFEFYESRNLAEKLHVEE------WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNL---CPHLAD 205 (697)
Q Consensus 135 ~~~lv~e~~~~g~L~~~l~~~~------~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~---~~kL~D 205 (697)
..+++|||+.+++|.+++.... ..+++.+++.++.||+.||+|||+.+++||||||+|||++.++ .+||+|
T Consensus 83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~d 162 (277)
T cd05036 83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIAD 162 (277)
T ss_pred CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEecc
Confidence 9999999999999999986543 2578899999999999999999999999999999999998654 589999
Q ss_pred eccchhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCCchhH
Q 005427 206 FGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAE 284 (697)
Q Consensus 206 fg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~~~~~ 284 (697)
||+++........ ........+..|+|||++.+..++.++|||||||++|+|++ |..||.+....
T Consensus 163 fg~~~~~~~~~~~--------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~ 228 (277)
T cd05036 163 FGMARDIYRASYY--------------RKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ 228 (277)
T ss_pred CccccccCCccce--------------ecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 9998765321100 00112234578999999998889999999999999999997 99999876544
Q ss_pred HHHHHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 005427 285 AQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350 (697)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~ 350 (697)
.....+.. ..++ ..+..+|..+.+++.+||+.+|++|||+.++++++.
T Consensus 229 ~~~~~~~~---------------~~~~---~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 229 EVMEFVTG---------------GGRL---DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HHHHHHHc---------------CCcC---CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 33222211 1111 124567899999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=321.57 Aligned_cols=259 Identities=20% Similarity=0.337 Sum_probs=207.6
Q ss_pred CCCCCcccccccccCCceEEEEEEE--CCe----eEEEEeccCCCh-HHHHHHHHHHHHHHhcCCCCceEEeeccccCCc
Q 005427 63 LPPSSYTLLSPIARGAESVVYEATL--DGR----KVAVKKPILSTS-EELDNFHKELQLLCKLDHPGLAKFVAAHAKPPN 135 (697)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 135 (697)
+...+|++.+.||+|+||+||+|.+ .++ .+++|....... .....+..|+.+++.++||||+++++++.. ..
T Consensus 4 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~ 82 (279)
T cd05111 4 LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-AS 82 (279)
T ss_pred CCHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-Cc
Confidence 3456899999999999999999987 343 477887643322 335678888999999999999999998754 55
Q ss_pred eEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhh
Q 005427 136 YMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL 215 (697)
Q Consensus 136 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~ 215 (697)
.++++||+++|+|.+++......+++..++.++.|++.||+|||+.+++||||||+|||++.++.+||+|||+++.....
T Consensus 83 ~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T cd05111 83 LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPD 162 (279)
T ss_pred cEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence 78899999999999999876667899999999999999999999999999999999999999999999999998754321
Q ss_pred hhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCCchhHHHHHHHHhcc
Q 005427 216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMN 294 (697)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~~~~~~~~~~~~~~~ 294 (697)
. .........++..|+|||++.+..++.++|||||||++||+++ |..||.+.........+
T Consensus 163 ~--------------~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~---- 224 (279)
T cd05111 163 D--------------KKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLL---- 224 (279)
T ss_pred C--------------cccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH----
Confidence 1 0011233457788999999998889999999999999999998 99999876443321111
Q ss_pred ccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 005427 295 YTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE 354 (697)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~ 354 (697)
..+.++. .+..++.++.+++.+||..||.+|||+.++++.+..+..
T Consensus 225 -----------~~~~~~~---~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 225 -----------EKGERLA---QPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred -----------HCCCcCC---CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 1111111 223467889999999999999999999999988877654
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=323.72 Aligned_cols=260 Identities=24% Similarity=0.386 Sum_probs=208.3
Q ss_pred CCCCCCCcccccccccCCceEEEEEEEC-------CeeEEEEeccCCC-hHHHHHHHHHHHHHHhcCCCCceEEeecccc
Q 005427 61 LHLPPSSYTLLSPIARGAESVVYEATLD-------GRKVAVKKPILST-SEELDNFHKELQLLCKLDHPGLAKFVAAHAK 132 (697)
Q Consensus 61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 132 (697)
|++..++|++.++||+|+||.||+|... +..||+|...... ......+.+|+.+++.++||||+++++++..
T Consensus 1 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 80 (288)
T cd05061 1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSK 80 (288)
T ss_pred CcccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 4567789999999999999999999642 3479999765443 2334568899999999999999999999999
Q ss_pred CCceEEEEeecCCCCHhhhhhhcC---------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCee
Q 005427 133 PPNYMFFFEFYESRNLAEKLHVEE---------WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHL 203 (697)
Q Consensus 133 ~~~~~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL 203 (697)
....+++|||+.+|+|.+++.... ..++...+..++.|++.||.|||+++|+||||||+|||++.++.+||
T Consensus 81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 81 GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEE
Confidence 999999999999999999996532 23466788999999999999999999999999999999999999999
Q ss_pred eeeccchhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCCch
Q 005427 204 ADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLR 282 (697)
Q Consensus 204 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~~~ 282 (697)
+|||+++....... ........++..|+|||.+.+..++.++|+|||||++|||++ |..||.+..
T Consensus 161 ~Dfg~~~~~~~~~~--------------~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~ 226 (288)
T cd05061 161 GDFGMTRDIYETDY--------------YRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS 226 (288)
T ss_pred CcCCcccccccccc--------------ccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99999865432110 001122345778999999998889999999999999999998 899998765
Q ss_pred hHHHHHHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 283 AEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
.......+. .+... ..+..+++.+.+++.+||+.||++|||+.++++.+...
T Consensus 227 ~~~~~~~~~--------------~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 227 NEQVLKFVM--------------DGGYL----DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred HHHHHHHHH--------------cCCCC----CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 443322221 11111 12345788999999999999999999999998776654
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=320.04 Aligned_cols=247 Identities=26% Similarity=0.382 Sum_probs=206.5
Q ss_pred CcccccccccCCceEEEEEEE--CCeeEEEEeccCC-ChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEeec
Q 005427 67 SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS-TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFY 143 (697)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 143 (697)
+|++.++||+|+||.||++.+ +++.+|+|..... .....+.+.+|+.+++.++||||+++++.+.....++++|||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 588999999999999999986 5788999986543 3445677889999999999999999999999999999999999
Q ss_pred CCCCHhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhccc
Q 005427 144 ESRNLAEKLHVE-EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKN 222 (697)
Q Consensus 144 ~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 222 (697)
++++|.+++... ...++++.++.++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~------ 154 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG------ 154 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccc------
Confidence 999999988653 3457899999999999999999999999999999999999999999999999986543211
Q ss_pred ccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHHHH
Q 005427 223 WRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTA 302 (697)
Q Consensus 223 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 302 (697)
.......|++.|+|||++.+..++.++|+||||+++|+|++|..||...+.......+.
T Consensus 155 ----------~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~----------- 213 (255)
T cd08219 155 ----------AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVC----------- 213 (255)
T ss_pred ----------cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHh-----------
Confidence 11234568999999999998889999999999999999999999998654333222221
Q ss_pred HHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005427 303 AVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIAL 347 (697)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 347 (697)
.+...+ .+..++..+.+++.+||+.||.+|||+.+++.
T Consensus 214 ---~~~~~~----~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 251 (255)
T cd08219 214 ---QGSYKP----LPSHYSYELRSLIKQMFKRNPRSRPSATTILS 251 (255)
T ss_pred ---cCCCCC----CCcccCHHHHHHHHHHHhCCcccCCCHHHHhh
Confidence 122222 23457889999999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=326.31 Aligned_cols=267 Identities=25% Similarity=0.263 Sum_probs=205.9
Q ss_pred CcccccccccCCceEEEEEEE--CCeeEEEEeccCCCh--HHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEee
Q 005427 67 SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTS--EELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF 142 (697)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 142 (697)
+|++.+.||+|+||.||+|++ +++.||+|++..... .....+.+|+.+++.++||||+++++++.++..+++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 488999999999999999987 578899998654432 2245788999999999999999999999999999999999
Q ss_pred cCCCCHhhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhc
Q 005427 143 YESRNLAEKLHVEE--WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL 220 (697)
Q Consensus 143 ~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~ 220 (697)
+. ++|.+++.... ..+++.+++.++.|++.||+|||+.|++||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~---- 155 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV---- 155 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc----
Confidence 97 58888875432 468899999999999999999999999999999999999999999999999986443110
Q ss_pred ccccCCCCCCCCccccccccCccccchhhhccc-CCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccH--
Q 005427 221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKE-IHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTE-- 297 (697)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~-- 297 (697)
.......+++.|+|||++.+. .++.++|||||||++|+|++|.+||.+.................
T Consensus 156 ------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (285)
T cd07861 156 ------------RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTE 223 (285)
T ss_pred ------------ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 012234678899999998754 47889999999999999999999998765444333322211100
Q ss_pred HHH--------HHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 005427 298 QQL--------TAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350 (697)
Q Consensus 298 ~~~--------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~ 350 (697)
..+ ...................+++++.++|++||..||.+|||+.++++|.|
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~ 284 (285)
T cd07861 224 DVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPY 284 (285)
T ss_pred hhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCC
Confidence 000 00000000111112223458899999999999999999999999998765
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=335.36 Aligned_cols=251 Identities=23% Similarity=0.343 Sum_probs=199.7
Q ss_pred cccccCCceEEEEEEE--CCeeEEEEeccCC---ChHHHHHHHHHHHHHHhc-CCCCceEEeeccccCCceEEEEeecCC
Q 005427 72 SPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKL-DHPGLAKFVAAHAKPPNYMFFFEFYES 145 (697)
Q Consensus 72 ~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~ 145 (697)
++||+|+||.||+|.. .++.||+|++... .....+.+..|+.++.++ +||||+.+++++.....+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4799999999999987 5678999986543 233456788999999888 699999999999999999999999999
Q ss_pred CCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhcccccC
Q 005427 146 RNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRS 225 (697)
Q Consensus 146 g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~ 225 (697)
|+|..++.... .+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 ~~L~~~~~~~~-~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~---------- 149 (327)
T cd05617 81 GDLMFHMQRQR-KLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP---------- 149 (327)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCC----------
Confidence 99998886544 6899999999999999999999999999999999999999999999999998632110
Q ss_pred CCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHHHHHHH
Q 005427 226 SGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVV 305 (697)
Q Consensus 226 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (697)
+......+||+.|+|||++.+..++.++|||||||++|+|++|..||.......... ..........
T Consensus 150 ------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~-------~~~~~~~~~~ 216 (327)
T cd05617 150 ------GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMN-------TEDYLFQVIL 216 (327)
T ss_pred ------CCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccc-------cHHHHHHHHH
Confidence 111335679999999999999999999999999999999999999996432111000 0001111111
Q ss_pred hCCCCCcccccccCChHHHHHHHHHhccCCCCCCCC------HHHHHHHHHH
Q 005427 306 SGGLRPILASLELGLPASILSLIQRCWDGNPHNRPS------FSDIALELDL 351 (697)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt------~~ell~~l~~ 351 (697)
... ...+..++..+.+++++||+.||.+|++ ++++++|.|+
T Consensus 217 ~~~-----~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f 263 (327)
T cd05617 217 EKP-----IRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFF 263 (327)
T ss_pred hCC-----CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCC
Confidence 111 1134568899999999999999999998 4677777654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=327.06 Aligned_cols=265 Identities=22% Similarity=0.325 Sum_probs=210.7
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccCCC-hHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEee
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST-SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF 142 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 142 (697)
++|++.+.||+|+||.||++.+ ++..+|+|...... ......+.+|++++++++||||+++++++..++.++++|||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 3699999999999999999987 57788998765543 33456788999999999999999999999999999999999
Q ss_pred cCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhcc
Q 005427 143 YESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHN-LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLK 221 (697)
Q Consensus 143 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~ 221 (697)
+++++|.+++.... .+++..+..++.|++.||.|||+ .+++||||||+|||++.++.+||+|||++......
T Consensus 81 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~------ 153 (308)
T cd06615 81 MDGGSLDQVLKKAG-RIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS------ 153 (308)
T ss_pred cCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc------
Confidence 99999999997653 68899999999999999999997 59999999999999999999999999988643210
Q ss_pred cccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhcccc-----
Q 005427 222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYT----- 296 (697)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~----- 296 (697)
......|++.|+|||++.+..++.++|+|||||++|+|++|..||...+...... .......
T Consensus 154 ------------~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~ 220 (308)
T cd06615 154 ------------MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEA-MFGRPVSEGEAK 220 (308)
T ss_pred ------------ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHH-hhcCcccccccc
Confidence 1234578999999999988889999999999999999999999997654332221 1111100
Q ss_pred ------------------HHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 005427 297 ------------------EQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL 353 (697)
Q Consensus 297 ------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~ 353 (697)
......... ....|..+ ...++.++.+++.+||..+|++|||+.++++++|...
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~ 292 (308)
T cd06615 221 ESHRPVSGHPPDSPRPMAIFELLDYIV-NEPPPKLP--SGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKR 292 (308)
T ss_pred CCcccccCCCCCccchhhHHHHHHHHh-cCCCccCc--CcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhh
Confidence 000111111 11112111 1237889999999999999999999999999999854
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=320.64 Aligned_cols=259 Identities=27% Similarity=0.466 Sum_probs=211.8
Q ss_pred CCCCCCcccccccccCCceEEEEEEECC-----eeEEEEeccCCC-hHHHHHHHHHHHHHHhcCCCCceEEeeccccCCc
Q 005427 62 HLPPSSYTLLSPIARGAESVVYEATLDG-----RKVAVKKPILST-SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPN 135 (697)
Q Consensus 62 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 135 (697)
++...+|.+.++||+|+||.||+|.+.. ..|++|...... ....+.+.+|+.+++.++||||+++++++.+ ..
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~ 80 (270)
T cd05056 2 EIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NP 80 (270)
T ss_pred eechhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CC
Confidence 3556789999999999999999998632 368999766554 4456789999999999999999999998875 45
Q ss_pred eEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhh
Q 005427 136 YMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL 215 (697)
Q Consensus 136 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~ 215 (697)
.+++|||+++++|.+++......+++.+++.++.|++.||.|||+.|++||||||+||+++.++.+||+|||++......
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 160 (270)
T cd05056 81 VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE 160 (270)
T ss_pred cEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecccc
Confidence 77999999999999999776656899999999999999999999999999999999999999999999999998755421
Q ss_pred hhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCCchhHHHHHHHHhcc
Q 005427 216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMN 294 (697)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~~~~~~~~~~~~~~~ 294 (697)
.. .......+++.|+|||.+....++.++||||||+++|++++ |..||.+.........+..
T Consensus 161 ~~---------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~-- 223 (270)
T cd05056 161 SY---------------YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIEN-- 223 (270)
T ss_pred cc---------------eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc--
Confidence 10 01112235578999999988889999999999999999996 9999987655443322211
Q ss_pred ccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 005427 295 YTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE 354 (697)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~ 354 (697)
+.++ ..+..+|..+.+++.+||..+|++|||+.++++.|..+..
T Consensus 224 -------------~~~~---~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 224 -------------GERL---PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred -------------CCcC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 1111 1235688999999999999999999999999999888754
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=316.97 Aligned_cols=247 Identities=26% Similarity=0.427 Sum_probs=200.1
Q ss_pred cccccCCceEEEEEEE--CCeeEEEEeccCCC-hHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEeecCCCCH
Q 005427 72 SPIARGAESVVYEATL--DGRKVAVKKPILST-SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNL 148 (697)
Q Consensus 72 ~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L 148 (697)
++||+|+||.||+|++ +++.+|+|...... .+....+.+|+++++.++||||+++++++.....+++||||+.+++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 4799999999999986 68889999755332 34456799999999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhcccccCCCC
Q 005427 149 AEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK 228 (697)
Q Consensus 149 ~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~ 228 (697)
.+++......+++.+++.++.|++.||.|||+.|++||||||+||+++.++.+||+|||++........
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~----------- 149 (252)
T cd05084 81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVY----------- 149 (252)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccc-----------
Confidence 999976655688999999999999999999999999999999999999999999999999864331100
Q ss_pred CCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCCchhHHHHHHHHhccccHHHHHHHHHhC
Q 005427 229 PTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSG 307 (697)
Q Consensus 229 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (697)
........++..|+|||.+.+..++.++|||||||++|+|++ |..||...........+. .
T Consensus 150 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~---------------~ 211 (252)
T cd05084 150 ---ASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIE---------------Q 211 (252)
T ss_pred ---cccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHH---------------c
Confidence 000011123567999999998889999999999999999998 999997654332221111 1
Q ss_pred CCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 005427 308 GLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350 (697)
Q Consensus 308 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~ 350 (697)
..++ ..+..++..+.+++.+||+.+|++|||+.++++.|.
T Consensus 212 ~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 212 GVRL---PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CCCC---CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 1111 123467899999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=322.46 Aligned_cols=256 Identities=27% Similarity=0.402 Sum_probs=207.6
Q ss_pred CcccccccccCCceEEEEEEEC-------CeeEEEEeccCCC-hHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEE
Q 005427 67 SYTLLSPIARGAESVVYEATLD-------GRKVAVKKPILST-SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMF 138 (697)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 138 (697)
+|++.+.||+|+||.||+|... ...+++|...... ......+.+|+.+++.++||||+++++.+......++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4789999999999999999763 2468888765433 3446788999999999999999999999999999999
Q ss_pred EEeecCCCCHhhhhhhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceee
Q 005427 139 FFEFYESRNLAEKLHVEE-----------------------WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLL 195 (697)
Q Consensus 139 v~e~~~~g~L~~~l~~~~-----------------------~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill 195 (697)
++||+.+++|.+++.... ..+++.+++.++.|++.||.|||+.+++||||||+|||+
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill 160 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLV 160 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEE
Confidence 999999999999875421 246788999999999999999999999999999999999
Q ss_pred cCCCCCeeeeeccchhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-C
Q 005427 196 DRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-G 274 (697)
Q Consensus 196 ~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g 274 (697)
+.++.+||+|||+++........ .......++..|+|||++.+..++.++||||||+++|+|++ |
T Consensus 161 ~~~~~~kl~dfg~~~~~~~~~~~--------------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g 226 (290)
T cd05045 161 AEGRKMKISDFGLSRDVYEEDSY--------------VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLG 226 (290)
T ss_pred cCCCcEEeccccccccccCccch--------------hcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcC
Confidence 99999999999998754321110 01122345678999999988889999999999999999998 9
Q ss_pred CCCCCCchhHHHHHHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 005427 275 VVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE 354 (697)
Q Consensus 275 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~ 354 (697)
..||.+........... ...++ ..+..++.++.+++..||+.+|.+||++.++++.|+.++.
T Consensus 227 ~~p~~~~~~~~~~~~~~---------------~~~~~---~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 227 GNPYPGIAPERLFNLLK---------------TGYRM---ERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred CCCCCCCCHHHHHHHHh---------------CCCCC---CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 99998765433222111 11111 1235688999999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=338.39 Aligned_cols=271 Identities=24% Similarity=0.308 Sum_probs=207.3
Q ss_pred CCCCCcccccccccCCceEEEEEEE----CCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEE
Q 005427 63 LPPSSYTLLSPIARGAESVVYEATL----DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMF 138 (697)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 138 (697)
+...+|.+++.||+|+||.||++.. .+..|++|..... ....+|+++|+.++||||+++++++.....+++
T Consensus 89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l 163 (392)
T PHA03207 89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCM 163 (392)
T ss_pred hccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEE
Confidence 4456799999999999999999975 3467899975432 234689999999999999999999999999999
Q ss_pred EEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhh
Q 005427 139 FFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI 218 (697)
Q Consensus 139 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~ 218 (697)
+||++. ++|.+++.. ...+++.+++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++........
T Consensus 164 v~e~~~-~~l~~~l~~-~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~- 240 (392)
T PHA03207 164 VMPKYK-CDLFTYVDR-SGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD- 240 (392)
T ss_pred EehhcC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcccc-
Confidence 999996 588888843 34789999999999999999999999999999999999999999999999999875442110
Q ss_pred hcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhH---HHHHHHHhccc
Q 005427 219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAE---AQAHTVLEMNY 295 (697)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~---~~~~~~~~~~~ 295 (697)
........||+.|+|||++.+..++.++|||||||++|||++|..||.+.... .....+.+...
T Consensus 241 -------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~ 307 (392)
T PHA03207 241 -------------TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQ 307 (392)
T ss_pred -------------cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhc
Confidence 11123567999999999999999999999999999999999999999765322 11222211100
Q ss_pred ------cH---HHHHH--HHHhCCCCCccc--c--cccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 005427 296 ------TE---QQLTA--AVVSGGLRPILA--S--LELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE 354 (697)
Q Consensus 296 ------~~---~~~~~--~~~~~~~~~~~~--~--~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~ 354 (697)
.. ..+.. .......++... . ....++.++.++|++||..||++|||+.+++.|.|+...
T Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~ 381 (392)
T PHA03207 308 VHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKE 381 (392)
T ss_pred cCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhcc
Confidence 00 00000 000111111111 0 012467889999999999999999999999999988643
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=324.79 Aligned_cols=255 Identities=20% Similarity=0.230 Sum_probs=207.4
Q ss_pred CcccccccccCCceEEEEEEE--CCeeEEEEeccCCC---hHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEe
Q 005427 67 SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST---SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFE 141 (697)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 141 (697)
.|+..+.||.|+||+||++.+ +++.+|+|.+.... ......+.+|+.+|+.++|+||+.+++.+...+..+++||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 377889999999999999987 57899999865432 2234457889999999999999999999999999999999
Q ss_pred ecCCCCHhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhc
Q 005427 142 FYESRNLAEKLHVEE-WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL 220 (697)
Q Consensus 142 ~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~ 220 (697)
|+.+++|.+.+...+ ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~----- 155 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG----- 155 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCC-----
Confidence 999999998886543 36899999999999999999999999999999999999999999999999988643210
Q ss_pred ccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHH
Q 005427 221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQL 300 (697)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 300 (697)
.......|++.|+|||++.+..++.++|+|||||++|+|++|..||.+.........+..
T Consensus 156 ------------~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~-------- 215 (285)
T cd05632 156 ------------ESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDR-------- 215 (285)
T ss_pred ------------CcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH--------
Confidence 012345789999999999988999999999999999999999999987544332222111
Q ss_pred HHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCC-----HHHHHHHHHHHH
Q 005427 301 TAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPS-----FSDIALELDLVL 353 (697)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt-----~~ell~~l~~~~ 353 (697)
.+. ......+..++.++.+|+..||+.||.+||+ +.+++.|.|...
T Consensus 216 --~~~-----~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~ 266 (285)
T cd05632 216 --RVL-----ETEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRN 266 (285)
T ss_pred --hhh-----ccccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhc
Confidence 000 0011223467889999999999999999999 889988877643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=319.83 Aligned_cols=258 Identities=26% Similarity=0.434 Sum_probs=209.9
Q ss_pred CCCCcccccccccCCceEEEEEEEC-----CeeEEEEeccCCC-hHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceE
Q 005427 64 PPSSYTLLSPIARGAESVVYEATLD-----GRKVAVKKPILST-SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYM 137 (697)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 137 (697)
...+|++.+.||+|+||.||+|... +..+|+|...... ......+.+|+.+++.++||||+++++++......+
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (267)
T cd05066 2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVM 81 (267)
T ss_pred CHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 3468999999999999999999762 3368999765433 334568899999999999999999999999999999
Q ss_pred EEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhh
Q 005427 138 FFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKE 217 (697)
Q Consensus 138 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~ 217 (697)
++|||+++++|.+++......+++.+++.++.|++.||.|||+.+++||||||+|||++.++.++|+|||++..+.....
T Consensus 82 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd05066 82 IVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 161 (267)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccccccc
Confidence 99999999999999987666789999999999999999999999999999999999999999999999999876542110
Q ss_pred hhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCCchhHHHHHHHHhcccc
Q 005427 218 ISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYT 296 (697)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~~~~~~~~~~~~~~~~~ 296 (697)
.........++..|+|||.+.+..++.++|+|||||++|++++ |..||.+.........+..
T Consensus 162 -------------~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~---- 224 (267)
T cd05066 162 -------------AAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEE---- 224 (267)
T ss_pred -------------eeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhC----
Confidence 0001112234568999999998889999999999999999887 9999987654433222211
Q ss_pred HHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 297 EQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
..++ ..+..+++.+.+++.+||+.+|.+||++.++++.|..+
T Consensus 225 -----------~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 225 -----------GYRL---PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred -----------CCcC---CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 1111 12346789999999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=321.24 Aligned_cols=259 Identities=22% Similarity=0.345 Sum_probs=208.4
Q ss_pred CCCCCcccccccccCCceEEEEEEE--CCe----eEEEEeccCCC-hHHHHHHHHHHHHHHhcCCCCceEEeeccccCCc
Q 005427 63 LPPSSYTLLSPIARGAESVVYEATL--DGR----KVAVKKPILST-SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPN 135 (697)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 135 (697)
+...+|++.++||+|+||+||+|++ +++ .||+|...... ......+.+|+.+++.++||||+++++++.. ..
T Consensus 4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~ 82 (279)
T cd05109 4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-ST 82 (279)
T ss_pred cchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CC
Confidence 3456899999999999999999975 343 48999865443 3345678899999999999999999998875 45
Q ss_pred eEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhh
Q 005427 136 YMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL 215 (697)
Q Consensus 136 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~ 215 (697)
.++++||+++|+|.+++......+++.+++.++.|++.||+|||+.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 83 ~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~ 162 (279)
T cd05109 83 VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDID 162 (279)
T ss_pred cEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecccc
Confidence 77999999999999999876667899999999999999999999999999999999999999999999999998765421
Q ss_pred hhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCCchhHHHHHHHHhcc
Q 005427 216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMN 294 (697)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~~~~~~~~~~~~~~~ 294 (697)
.. ........+++.|+|||.+.+..++.++|||||||++|||++ |..||...........+.
T Consensus 163 ~~--------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~--- 225 (279)
T cd05109 163 ET--------------EYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLE--- 225 (279)
T ss_pred cc--------------eeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH---
Confidence 10 001122345678999999998889999999999999999998 999998654433222111
Q ss_pred ccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 005427 295 YTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE 354 (697)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~ 354 (697)
....+ ..+..++.++.+++.+||..||++||++.++++.+..+..
T Consensus 226 ------------~~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05109 226 ------------KGERL---PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR 270 (279)
T ss_pred ------------CCCcC---CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 11111 1234678999999999999999999999999988766643
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=338.30 Aligned_cols=244 Identities=23% Similarity=0.304 Sum_probs=197.2
Q ss_pred cccCCceEEEEEEE--CCeeEEEEeccCCC---hHHHHHHHHHHHHHHhc---CCCCceEEeeccccCCceEEEEeecCC
Q 005427 74 IARGAESVVYEATL--DGRKVAVKKPILST---SEELDNFHKELQLLCKL---DHPGLAKFVAAHAKPPNYMFFFEFYES 145 (697)
Q Consensus 74 lg~G~~g~V~~~~~--~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l---~hpniv~l~~~~~~~~~~~lv~e~~~~ 145 (697)
||+|+||+||+|++ +++.||+|++.... ......+..|..++..+ .||||+++++.+..+..+++||||+.+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 79999999999987 57899999864321 22334556677777665 699999999999999999999999999
Q ss_pred CCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhcccccC
Q 005427 146 RNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRS 225 (697)
Q Consensus 146 g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~ 225 (697)
|+|.+++.... .+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 81 g~L~~~l~~~~-~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~---------- 149 (330)
T cd05586 81 GELFWHLQKEG-RFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTD---------- 149 (330)
T ss_pred ChHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCC----------
Confidence 99999887544 7899999999999999999999999999999999999999999999999998643210
Q ss_pred CCCCCCCccccccccCccccchhhhccc-CCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHHHHHH
Q 005427 226 SGKPTGGFHKKNMVGTLIYMAPEILKKE-IHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAV 304 (697)
Q Consensus 226 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (697)
.......+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.........+..
T Consensus 150 ------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~------------ 211 (330)
T cd05586 150 ------NKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAF------------ 211 (330)
T ss_pred ------CCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHc------------
Confidence 0113356799999999999764 478999999999999999999999987654443333221
Q ss_pred HhCCCCCcccccccCChHHHHHHHHHhccCCCCCCC----CHHHHHHHHHHH
Q 005427 305 VSGGLRPILASLELGLPASILSLIQRCWDGNPHNRP----SFSDIALELDLV 352 (697)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp----t~~ell~~l~~~ 352 (697)
+..+ + ....+++++.+++++||+.||.+|| ++.++++|.|+.
T Consensus 212 --~~~~--~--~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~ 257 (330)
T cd05586 212 --GKVR--F--PKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFA 257 (330)
T ss_pred --CCCC--C--CCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCcccc
Confidence 1111 1 1124789999999999999999998 789999888763
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=341.00 Aligned_cols=267 Identities=22% Similarity=0.282 Sum_probs=202.4
Q ss_pred CCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEe
Q 005427 64 PPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFE 141 (697)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 141 (697)
....|.+.+.||+|+||.||++.+ .++.||||.... ..+.+|+++|++|+||||+++++++......+++||
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e 240 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLP 240 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEE
Confidence 345799999999999999999988 467899996322 235689999999999999999999999999999999
Q ss_pred ecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhcc
Q 005427 142 FYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLK 221 (697)
Q Consensus 142 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~ 221 (697)
++. ++|.+++......+++.+++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 241 ~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~---- 315 (461)
T PHA03211 241 KYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS---- 315 (461)
T ss_pred ccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccc----
Confidence 996 689888876655789999999999999999999999999999999999999999999999999875432110
Q ss_pred cccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchh-------HHHHHHHHh-c
Q 005427 222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRA-------EAQAHTVLE-M 293 (697)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~-------~~~~~~~~~-~ 293 (697)
........||+.|+|||++.+..++.++|||||||+||||++|..|+..... .....+++. .
T Consensus 316 ----------~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~ 385 (461)
T PHA03211 316 ----------TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQA 385 (461)
T ss_pred ----------cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhh
Confidence 0012245799999999999999999999999999999999997765432110 111112211 1
Q ss_pred cccH--------HHHHHHHH---hCCCCCccccc----ccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 005427 294 NYTE--------QQLTAAVV---SGGLRPILASL----ELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL 351 (697)
Q Consensus 294 ~~~~--------~~~~~~~~---~~~~~~~~~~~----~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~ 351 (697)
.... ..+..... ....++..... ...++.++.+||.+||+.||.+|||+.|+++|.|+
T Consensus 386 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f 458 (461)
T PHA03211 386 QVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLF 458 (461)
T ss_pred ccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCccc
Confidence 1100 00000000 01111111000 01356789999999999999999999999999886
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=319.21 Aligned_cols=255 Identities=26% Similarity=0.470 Sum_probs=208.7
Q ss_pred CCCCCCCcccccccccCCceEEEEEEE-CCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEE
Q 005427 61 LHLPPSSYTLLSPIARGAESVVYEATL-DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFF 139 (697)
Q Consensus 61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 139 (697)
+++..++|++.++||+|+||.||+|.. .++.||+|...... .....+.+|+.+++.++||||+++++++. ...++++
T Consensus 1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v 78 (260)
T cd05067 1 WEVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYII 78 (260)
T ss_pred CccchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEE
Confidence 456778999999999999999999986 56889999865433 23467889999999999999999999874 4678999
Q ss_pred EeecCCCCHhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhh
Q 005427 140 FEFYESRNLAEKLHVE-EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI 218 (697)
Q Consensus 140 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~ 218 (697)
|||+.+++|.+++... +..+++.+++.++.|++.||+|||+.|++||||||+||+++.++.++|+|||++........
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~- 157 (260)
T cd05067 79 TEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY- 157 (260)
T ss_pred EEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCc-
Confidence 9999999999988653 34678899999999999999999999999999999999999999999999999865431100
Q ss_pred hcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCCchhHHHHHHHHhccccH
Q 005427 219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTE 297 (697)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~ 297 (697)
.......++..|+|||++.+..++.++||||||+++|++++ |.+||.+.........+.
T Consensus 158 --------------~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~------ 217 (260)
T cd05067 158 --------------TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLE------ 217 (260)
T ss_pred --------------ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHH------
Confidence 01123346788999999998889999999999999999999 999998765444333221
Q ss_pred HHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 005427 298 QQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350 (697)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~ 350 (697)
...++ ..+..++.++.+++.+||+.+|++|||+++++..|.
T Consensus 218 ---------~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 258 (260)
T cd05067 218 ---------RGYRM---PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLE 258 (260)
T ss_pred ---------cCCCC---CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhh
Confidence 11111 123457889999999999999999999999987765
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=326.73 Aligned_cols=264 Identities=27% Similarity=0.411 Sum_probs=213.5
Q ss_pred cCCCCCCCcccccccccCCceEEEEEEE---------CCeeEEEEeccCC-ChHHHHHHHHHHHHHHhc-CCCCceEEee
Q 005427 60 PLHLPPSSYTLLSPIARGAESVVYEATL---------DGRKVAVKKPILS-TSEELDNFHKELQLLCKL-DHPGLAKFVA 128 (697)
Q Consensus 60 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~---------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~l~~ 128 (697)
.+.++.++|.+.++||+|+||.||+++. ....+|+|..... .......+.+|+.+++.+ +||||+++++
T Consensus 6 ~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 85 (314)
T cd05099 6 KWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLG 85 (314)
T ss_pred cccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEE
Confidence 3566778999999999999999999974 2346899976543 234567789999999999 6999999999
Q ss_pred ccccCCceEEEEeecCCCCHhhhhhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCce
Q 005427 129 AHAKPPNYMFFFEFYESRNLAEKLHVEE---------------WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANV 193 (697)
Q Consensus 129 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Ni 193 (697)
++.....++++|||+.+|+|.+++.... ..+++.++..++.|++.||.|||++|++||||||+||
T Consensus 86 ~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Ni 165 (314)
T cd05099 86 VCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNV 165 (314)
T ss_pred EEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeE
Confidence 9999999999999999999999986532 2478889999999999999999999999999999999
Q ss_pred eecCCCCCeeeeeccchhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh
Q 005427 194 LLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT 273 (697)
Q Consensus 194 ll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~ 273 (697)
|++.++.+||+|||+++........ .......+++.|+|||++.+..++.++|||||||++|+|++
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~--------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~ 231 (314)
T cd05099 166 LVTEDNVMKIADFGLARGVHDIDYY--------------KKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231 (314)
T ss_pred EEcCCCcEEEccccccccccccccc--------------cccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHh
Confidence 9999999999999999755321110 00112234568999999999889999999999999999999
Q ss_pred -CCCCCCCchhHHHHHHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 274 -GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 274 -g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
|..||.+.........+.. ... ...+..++.++.+++.+||+.+|++|||+.++++.++.+
T Consensus 232 ~g~~p~~~~~~~~~~~~~~~---------------~~~---~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~ 293 (314)
T cd05099 232 LGGSPYPGIPVEELFKLLRE---------------GHR---MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKV 293 (314)
T ss_pred CCCCCCCCCCHHHHHHHHHc---------------CCC---CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 8999987654333322211 111 112346788999999999999999999999999999888
Q ss_pred HHH
Q 005427 353 LEH 355 (697)
Q Consensus 353 ~~~ 355 (697)
...
T Consensus 294 ~~~ 296 (314)
T cd05099 294 LAA 296 (314)
T ss_pred HHH
Confidence 654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=324.02 Aligned_cols=263 Identities=26% Similarity=0.410 Sum_probs=209.1
Q ss_pred CCCCCcccccccccCCceEEEEEEECC------------------eeEEEEeccCCC-hHHHHHHHHHHHHHHhcCCCCc
Q 005427 63 LPPSSYTLLSPIARGAESVVYEATLDG------------------RKVAVKKPILST-SEELDNFHKELQLLCKLDHPGL 123 (697)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~~~------------------~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpni 123 (697)
+..++|++.++||+|+||.||++.... ..||+|.+.... ....+.+.+|+++++.++||||
T Consensus 2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i 81 (296)
T cd05051 2 FPRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNI 81 (296)
T ss_pred CchhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCE
Confidence 345789999999999999999997632 458999866543 3456788999999999999999
Q ss_pred eEEeeccccCCceEEEEeecCCCCHhhhhhhcC----------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCce
Q 005427 124 AKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEE----------WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANV 193 (697)
Q Consensus 124 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Ni 193 (697)
+++++++......+++||++.+++|.+++.... ..+++..++.++.|++.||.|||+.|++||||||+||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Ni 161 (296)
T cd05051 82 ARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNC 161 (296)
T ss_pred eEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhce
Confidence 999999999999999999999999999986543 2578999999999999999999999999999999999
Q ss_pred eecCCCCCeeeeeccchhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh
Q 005427 194 LLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT 273 (697)
Q Consensus 194 ll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~ 273 (697)
+++.++.++|+|||++......... .......+++.|+|||++.+..++.++|||||||++|||++
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~--------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~ 227 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSDYY--------------RVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227 (296)
T ss_pred eecCCCceEEccccceeecccCcce--------------eecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHh
Confidence 9999999999999998654321100 01223456789999999998889999999999999999998
Q ss_pred --CCCCCCCchhHHHHHHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 005427 274 --GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350 (697)
Q Consensus 274 --g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~ 350 (697)
+..||................. ....... ...+..+|.++.+++.+||+.||.+|||+.+|++.|.
T Consensus 228 ~~~~~p~~~~~~~~~~~~~~~~~~----------~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 228 LCREQPYEHLTDQQVIENAGHFFR----------DDGRQIY-LPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred cCCCCCCCCcChHHHHHHHHhccc----------ccccccc-CCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 7889876554443332221100 0011111 1123457899999999999999999999999987764
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=324.87 Aligned_cols=262 Identities=26% Similarity=0.397 Sum_probs=212.3
Q ss_pred cCCCCCCCcccccccccCCceEEEEEEE-------CCeeEEEEeccCCC-hHHHHHHHHHHHHHHhc-CCCCceEEeecc
Q 005427 60 PLHLPPSSYTLLSPIARGAESVVYEATL-------DGRKVAVKKPILST-SEELDNFHKELQLLCKL-DHPGLAKFVAAH 130 (697)
Q Consensus 60 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~-------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~l~~~~ 130 (697)
.+.+...+|.+.+.||+|+||.||++.. .+..+|+|...... ....+.+.+|+.+++++ +||||+++++.+
T Consensus 29 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 108 (302)
T cd05055 29 KWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGAC 108 (302)
T ss_pred cccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEE
Confidence 4566777899999999999999999974 23479999765442 34456789999999999 799999999999
Q ss_pred ccCCceEEEEeecCCCCHhhhhhhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccc
Q 005427 131 AKPPNYMFFFEFYESRNLAEKLHVEEW-SPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLA 209 (697)
Q Consensus 131 ~~~~~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a 209 (697)
...+..+++|||+.+|+|.+++..... .+++.+++.++.|++.||+|||+.+|+|+||||+|||++.++.+||+|||++
T Consensus 109 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~ 188 (302)
T cd05055 109 TIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLA 188 (302)
T ss_pred ecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCccc
Confidence 999999999999999999999875432 3799999999999999999999999999999999999999999999999998
Q ss_pred hhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCCchhHHHHH
Q 005427 210 EYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAH 288 (697)
Q Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~~~~~~~~~ 288 (697)
........ ........+++.|+|||++.+..++.++|||||||++|+|++ |..||.+........
T Consensus 189 ~~~~~~~~--------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~ 254 (302)
T cd05055 189 RDIMNDSN--------------YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFY 254 (302)
T ss_pred ccccCCCc--------------eeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHH
Confidence 65432110 001223356788999999999889999999999999999998 999998754433222
Q ss_pred HHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 289 TVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
... ..+.++ ..+...++++.+++.+||..+|++|||+.++++.+...
T Consensus 255 ~~~--------------~~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 255 KLI--------------KEGYRM---AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred HHH--------------HcCCcC---CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 211 111121 12345788999999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=321.67 Aligned_cols=255 Identities=31% Similarity=0.454 Sum_probs=206.2
Q ss_pred cccccccccCCceEEEEEEE--CCeeEEEEeccCCChHHHH--HHHHHHHHHHhcCCCCceEEeeccccCCceEEEEeec
Q 005427 68 YTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELD--NFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFY 143 (697)
Q Consensus 68 y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 143 (697)
|++.+.||+|+||+||++.. +++.+|+|........... ...+|+.++++++||||+++++++.+....+++||++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 78999999999999999998 4668999998776654433 3456999999999999999999999999999999999
Q ss_pred CCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhcccc
Q 005427 144 ESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNW 223 (697)
Q Consensus 144 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~ 223 (697)
.+++|.+++... ..+++.+++.++.|++.||.+||+.|++|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~-------- 151 (260)
T PF00069_consen 81 PGGSLQDYLQKN-KPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSEN-------- 151 (260)
T ss_dssp TTEBHHHHHHHH-SSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTST--------
T ss_pred cccccccccccc-ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--------
Confidence 999999999733 36899999999999999999999999999999999999999999999999998643110
Q ss_pred cCCCCCCCCccccccccCccccchhhhc-ccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHHHH
Q 005427 224 RSSGKPTGGFHKKNMVGTLIYMAPEILK-KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTA 302 (697)
Q Consensus 224 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 302 (697)
........+++.|+|||++. +..++.++|+||||+++|+|++|..||...........+...........
T Consensus 152 --------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~- 222 (260)
T PF00069_consen 152 --------NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSS- 222 (260)
T ss_dssp --------TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHH-
T ss_pred --------ccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccccccc-
Confidence 01234567899999999998 88899999999999999999999999998622222222111111000000
Q ss_pred HHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 005427 303 AVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL 351 (697)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~ 351 (697)
.......+.++.+++.+||+.||++|||+.++++|.|+
T Consensus 223 -----------~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 223 -----------SQQSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp -----------TTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred -----------ccccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 00011235899999999999999999999999988763
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=318.58 Aligned_cols=259 Identities=27% Similarity=0.431 Sum_probs=209.9
Q ss_pred CCCCCcccccccccCCceEEEEEEEC--C---eeEEEEeccCC-ChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCce
Q 005427 63 LPPSSYTLLSPIARGAESVVYEATLD--G---RKVAVKKPILS-TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNY 136 (697)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~~--~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 136 (697)
+...+|+..+.||+|+||.||+|... + ..+++|..... .....+.+..|+.+++.++||||+++.+++......
T Consensus 2 i~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (268)
T cd05063 2 IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPA 81 (268)
T ss_pred CChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCc
Confidence 34567899999999999999999862 3 36899986544 234467789999999999999999999999999999
Q ss_pred EEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhh
Q 005427 137 MFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLK 216 (697)
Q Consensus 137 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~ 216 (697)
+++|||+.+++|.+++......+++.++..++.|++.||+|||+.|++||||||+||+++.++.+||+|||++.......
T Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~ 161 (268)
T cd05063 82 MIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDP 161 (268)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceeccccc
Confidence 99999999999999997766678999999999999999999999999999999999999999999999999986543211
Q ss_pred hhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCCchhHHHHHHHHhccc
Q 005427 217 EISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNY 295 (697)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~~~~~~~~~~~~~~~~ 295 (697)
. ..........++.|+|||++.+..++.++|||||||++||+++ |..||...........+..
T Consensus 162 ~-------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~--- 225 (268)
T cd05063 162 E-------------GTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAIND--- 225 (268)
T ss_pred c-------------cceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhc---
Confidence 0 0001112233567999999998888999999999999999997 9999976554333322211
Q ss_pred cHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 296 TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
....| .+..++.++.+++.+||+.+|++||++.++++.|..+
T Consensus 226 -----------~~~~~----~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 226 -----------GFRLP----APMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred -----------CCCCC----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11111 1335789999999999999999999999999888654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=323.04 Aligned_cols=253 Identities=23% Similarity=0.364 Sum_probs=204.5
Q ss_pred CCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCChHHHHHHHHHHHHHHhc-CCCCceEEeeccccC------C
Q 005427 64 PPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKL-DHPGLAKFVAAHAKP------P 134 (697)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~------~ 134 (697)
+.+.|++.+.||+|+||.||+|.. .++.||+|...... .....+.+|+.+++.+ +||||+++++++... .
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 456799999999999999999987 57889999865443 3345788999999998 799999999988653 4
Q ss_pred ceEEEEeecCCCCHhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhh
Q 005427 135 NYMFFFEFYESRNLAEKLHVE-EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRE 213 (697)
Q Consensus 135 ~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~ 213 (697)
.++++|||+.+++|.+++... ...+++..++.++.|++.||.|||+++|+||||||+||+++.++.+||+|||++....
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~ 162 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 162 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceecc
Confidence 689999999999999998764 3468899999999999999999999999999999999999999999999999986543
Q ss_pred hhhhhhcccccCCCCCCCCccccccccCccccchhhhc-----ccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHH
Q 005427 214 NLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILK-----KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAH 288 (697)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~ 288 (697)
... .......|++.|+|||++. +..++.++|||||||++|+|++|..||..........
T Consensus 163 ~~~----------------~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~ 226 (272)
T cd06637 163 RTV----------------GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF 226 (272)
T ss_pred ccc----------------ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHH
Confidence 210 0123467899999999986 3457889999999999999999999997654332222
Q ss_pred HHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 005427 289 TVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350 (697)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~ 350 (697)
... ....+ ......++.++.+|+.+||..+|.+|||+.++++|.|
T Consensus 227 ~~~--------------~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 271 (272)
T cd06637 227 LIP--------------RNPAP---RLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPF 271 (272)
T ss_pred HHh--------------cCCCC---CCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCC
Confidence 111 01111 1123357889999999999999999999999998876
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=325.67 Aligned_cols=263 Identities=26% Similarity=0.414 Sum_probs=214.0
Q ss_pred cCCCCCCCcccccccccCCceEEEEEEE---------CCeeEEEEeccCC-ChHHHHHHHHHHHHHHhc-CCCCceEEee
Q 005427 60 PLHLPPSSYTLLSPIARGAESVVYEATL---------DGRKVAVKKPILS-TSEELDNFHKELQLLCKL-DHPGLAKFVA 128 (697)
Q Consensus 60 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~---------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~l~~ 128 (697)
.+++...+|.+.+.||+|+||.||+++. .+..||+|..... .......+.+|+.+++.+ +||||+++++
T Consensus 9 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~ 88 (304)
T cd05101 9 RWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLG 88 (304)
T ss_pred cccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeE
Confidence 3567778999999999999999999974 2346899976543 234567899999999999 8999999999
Q ss_pred ccccCCceEEEEeecCCCCHhhhhhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCce
Q 005427 129 AHAKPPNYMFFFEFYESRNLAEKLHVEE---------------WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANV 193 (697)
Q Consensus 129 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Ni 193 (697)
++......+++|||+.+|+|.+++.... ..+++.+++.++.|++.||.|||+.|++||||||+||
T Consensus 89 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Ni 168 (304)
T cd05101 89 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNV 168 (304)
T ss_pred EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceE
Confidence 9999999999999999999999986532 2467788999999999999999999999999999999
Q ss_pred eecCCCCCeeeeeccchhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh
Q 005427 194 LLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT 273 (697)
Q Consensus 194 ll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~ 273 (697)
|++.++.+||+|||+++........ .......+++.|+|||++.+..++.++||||||+++|+|++
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~~--------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~ 234 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDYY--------------KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234 (304)
T ss_pred EEcCCCcEEECCCccceeccccccc--------------ccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHc
Confidence 9999999999999998755321110 01223346778999999999889999999999999999998
Q ss_pred -CCCCCCCchhHHHHHHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 274 -GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 274 -g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
|..||.+.........+.. ..+. ..+..++.++.+|+.+||+.+|.+|||+.++++.|..+
T Consensus 235 ~g~~p~~~~~~~~~~~~~~~---------------~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~ 296 (304)
T cd05101 235 LGGSPYPGIPVEELFKLLKE---------------GHRM---DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRI 296 (304)
T ss_pred CCCCCcccCCHHHHHHHHHc---------------CCcC---CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHH
Confidence 8899987654443332211 1111 12346789999999999999999999999999999887
Q ss_pred HH
Q 005427 353 LE 354 (697)
Q Consensus 353 ~~ 354 (697)
..
T Consensus 297 ~~ 298 (304)
T cd05101 297 LT 298 (304)
T ss_pred HH
Confidence 65
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=319.50 Aligned_cols=257 Identities=26% Similarity=0.359 Sum_probs=208.9
Q ss_pred CcccccccccCCceEEEEEEE-CCeeEEEEeccCCC------hHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEE
Q 005427 67 SYTLLSPIARGAESVVYEATL-DGRKVAVKKPILST------SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFF 139 (697)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 139 (697)
+|++.+.||.|+||.||+|.. +++.+|+|.+.... ......+.+|+.+++.++||||+++++++.+...++++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 588999999999999999986 67889999765432 22346789999999999999999999999999999999
Q ss_pred EeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhh
Q 005427 140 FEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEIS 219 (697)
Q Consensus 140 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~ 219 (697)
+||+.+++|.+++.... .+++..+..++.|++.||+|||+.+|+|+||+|+||+++.++.+||+|||++.........
T Consensus 81 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~- 158 (265)
T cd06631 81 MEFVPGGSISSILNRFG-PLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLH- 158 (265)
T ss_pred EecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcccc-
Confidence 99999999999987654 6789999999999999999999999999999999999999999999999998754321100
Q ss_pred cccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHH
Q 005427 220 LKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQ 299 (697)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~ 299 (697)
...........|+..|+|||++.+..++.++|+|||||++|+|++|..||...+.......+..
T Consensus 159 ---------~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~------- 222 (265)
T cd06631 159 ---------GTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGA------- 222 (265)
T ss_pred ---------ccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhh-------
Confidence 0000112345689999999999998899999999999999999999999976543322211110
Q ss_pred HHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 005427 300 LTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350 (697)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~ 350 (697)
. ....+..+..++.++.++|++||+.+|.+||++.+++.|.|
T Consensus 223 ------~---~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~ 264 (265)
T cd06631 223 ------H---RGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDF 264 (265)
T ss_pred ------c---cCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCC
Confidence 0 01122344568999999999999999999999999998765
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=315.62 Aligned_cols=248 Identities=22% Similarity=0.353 Sum_probs=199.8
Q ss_pred ccccCCceEEEEEEE----CCeeEEEEeccCCCh-HHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEeecCCCC
Q 005427 73 PIARGAESVVYEATL----DGRKVAVKKPILSTS-EELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRN 147 (697)
Q Consensus 73 ~lg~G~~g~V~~~~~----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~ 147 (697)
.||+|+||.||+|.+ .+..||+|+...... ...+.+.+|+.++++++||||+++++++. ...+++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 489999999999975 245699998665433 33567899999999999999999999875 457899999999999
Q ss_pred HhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhcccccCCC
Q 005427 148 LAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227 (697)
Q Consensus 148 L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~ 227 (697)
|.+++......+++.+++.++.|++.||.|||++|++||||||+|||++.++.+||+|||++.........
T Consensus 81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~--------- 151 (257)
T cd05115 81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSY--------- 151 (257)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccc---------
Confidence 99999766667899999999999999999999999999999999999999999999999998654321100
Q ss_pred CCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCCchhHHHHHHHHhccccHHHHHHHHHh
Q 005427 228 KPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVS 306 (697)
Q Consensus 228 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (697)
........+++.|+|||++.+..++.++|||||||++|++++ |..||.+.........+.
T Consensus 152 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~--------------- 212 (257)
T cd05115 152 ----YKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIE--------------- 212 (257)
T ss_pred ----eeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHH---------------
Confidence 000112234678999999998889999999999999999996 999998765443322221
Q ss_pred CCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 307 GGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 307 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
.+.++ ..+..+++++.+++.+||..+|++||++.+|.+.+..+
T Consensus 213 ~~~~~---~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 213 QGKRL---DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 11121 12346789999999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=316.26 Aligned_cols=246 Identities=24% Similarity=0.379 Sum_probs=199.4
Q ss_pred ccccCCceEEEEEEE----CCeeEEEEeccCCC--hHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEeecCCC
Q 005427 73 PIARGAESVVYEATL----DGRKVAVKKPILST--SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESR 146 (697)
Q Consensus 73 ~lg~G~~g~V~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g 146 (697)
+||+|+||.||+|.+ ++..+|+|+..... ....+.+.+|+.+++.++||||+++++++. ...++++|||+.++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 689999999999964 46789999865443 234567899999999999999999999875 45778999999999
Q ss_pred CHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhcccccCC
Q 005427 147 NLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSS 226 (697)
Q Consensus 147 ~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~ 226 (697)
+|.+++.... .+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++.........
T Consensus 81 ~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~-------- 151 (257)
T cd05116 81 PLNKFLQKNK-HVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENY-------- 151 (257)
T ss_pred cHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCe--------
Confidence 9999987544 6899999999999999999999999999999999999999999999999998755321100
Q ss_pred CCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCCchhHHHHHHHHhccccHHHHHHHHH
Q 005427 227 GKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVV 305 (697)
Q Consensus 227 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (697)
........+++.|+|||++.+..++.++|+|||||++|||++ |..||.+.........+.
T Consensus 152 -----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~-------------- 212 (257)
T cd05116 152 -----YKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIE-------------- 212 (257)
T ss_pred -----eeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH--------------
Confidence 000122345679999999988889999999999999999998 999998765443322221
Q ss_pred hCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 005427 306 SGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL 351 (697)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~ 351 (697)
. +.++ ..+..+++++.++|.+||+.||++||++.+|...|..
T Consensus 213 ~-~~~~---~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 213 S-GERM---ECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred C-CCCC---CCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 1 1111 2345689999999999999999999999999887764
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=321.49 Aligned_cols=270 Identities=27% Similarity=0.409 Sum_probs=208.0
Q ss_pred CCCcccccccccCCceEEEEEEE------CCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeecccc--CCce
Q 005427 65 PSSYTLLSPIARGAESVVYEATL------DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAK--PPNY 136 (697)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~--~~~~ 136 (697)
..+|++.+.||+|+||.||++.. .+..||+|++..........+.+|+.+++.++||||+++++++.. ...+
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 82 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 82 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence 35799999999999999999974 467899999776666667889999999999999999999987644 3568
Q ss_pred EEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhh
Q 005427 137 MFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLK 216 (697)
Q Consensus 137 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~ 216 (697)
++||||+++++|.+++......+++..++.++.|++.||.|||+.|++||||||+||+++.++.+||+|||++.......
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 162 (284)
T cd05081 83 RLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDK 162 (284)
T ss_pred EEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccCCC
Confidence 99999999999999997665568999999999999999999999999999999999999999999999999987653211
Q ss_pred hhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccc-
Q 005427 217 EISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNY- 295 (697)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~- 295 (697)
.. ........++..|+|||++.+..++.++|||||||++|||++|..|+........ ........
T Consensus 163 ~~-------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~-~~~~~~~~~ 228 (284)
T cd05081 163 EY-------------YKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFM-RMMGNDKQG 228 (284)
T ss_pred cc-------------eeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhh-hhccccccc
Confidence 00 0001112345569999999988899999999999999999998877654332111 00000000
Q ss_pred --cHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 296 --TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 296 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
....+. .......++ ..+..++.++.+|+.+||..+|++|||+.+|++.|+.+
T Consensus 229 ~~~~~~~~-~~~~~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 229 QMIVYHLI-ELLKNNGRL---PAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred ccchHHHH-HHHhcCCcC---CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 001111 111121111 12356889999999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=325.81 Aligned_cols=267 Identities=24% Similarity=0.277 Sum_probs=204.2
Q ss_pred CcccccccccCCceEEEEEEE--CCeeEEEEeccCCChH--HHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEee
Q 005427 67 SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSE--ELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF 142 (697)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 142 (697)
+|++.++||+|+||.||+|++ +++.+|+|.+...... ....+.+|+.+++.++||||+++++++.+...+++++||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 589999999999999999987 5789999986543221 234677899999999999999999999999999999999
Q ss_pred cCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhccc
Q 005427 143 YESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKN 222 (697)
Q Consensus 143 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 222 (697)
+.+ +|.+++......+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~------ 153 (284)
T cd07839 81 CDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV------ 153 (284)
T ss_pred CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCC------
Confidence 975 8888876655578999999999999999999999999999999999999999999999999986543110
Q ss_pred ccCCCCCCCCccccccccCccccchhhhccc-CCCchhhHHHHHHHHHHHHhCCCCC-CCchhHHHHHHHHhccccHHHH
Q 005427 223 WRSSGKPTGGFHKKNMVGTLIYMAPEILKKE-IHSEKSDVYSFGISINELLTGVVPY-TDLRAEAQAHTVLEMNYTEQQL 300 (697)
Q Consensus 223 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~ell~g~~Pf-~~~~~~~~~~~~~~~~~~~~~~ 300 (697)
.......+++.|+|||++.+. .++.++|||||||++|+|++|..|| .+.+.......+..........
T Consensus 154 ----------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 223 (284)
T cd07839 154 ----------RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEE 223 (284)
T ss_pred ----------CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChH
Confidence 012234678899999998764 4689999999999999999988875 4444333333332211111111
Q ss_pred HHHHHhC--CC--CCcc------cccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 005427 301 TAAVVSG--GL--RPIL------ASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350 (697)
Q Consensus 301 ~~~~~~~--~~--~~~~------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~ 350 (697)
.+..... .. .+.. ......+++++.++|.+||+.||.+|||++++++|.|
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~ 283 (284)
T cd07839 224 SWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPY 283 (284)
T ss_pred HhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCC
Confidence 0000000 00 0000 1112357889999999999999999999999998876
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=316.45 Aligned_cols=256 Identities=29% Similarity=0.440 Sum_probs=210.7
Q ss_pred CCCCCCCcccccccccCCceEEEEEEE-CCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEE
Q 005427 61 LHLPPSSYTLLSPIARGAESVVYEATL-DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFF 139 (697)
Q Consensus 61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 139 (697)
|+++.++|++.++||+|+||.||++.. .++.+++|.+.... ...+.+.+|+.+++.++||||+++++++......+++
T Consensus 1 ~~~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 79 (261)
T cd05034 1 WEIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIV 79 (261)
T ss_pred CccchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEE
Confidence 456778999999999999999999987 45678999765432 3356789999999999999999999999988999999
Q ss_pred EeecCCCCHhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhh
Q 005427 140 FEFYESRNLAEKLHVEE-WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI 218 (697)
Q Consensus 140 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~ 218 (697)
|||+.+++|.+++.... ..+++.++..++.|++.||.|||+.|++|+||||+||+++.++.+||+|||++........
T Consensus 80 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~- 158 (261)
T cd05034 80 TEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY- 158 (261)
T ss_pred EeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchhh-
Confidence 99999999999987643 4689999999999999999999999999999999999999999999999999875542110
Q ss_pred hcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCCchhHHHHHHHHhccccH
Q 005427 219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTE 297 (697)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~ 297 (697)
.......++..|+|||.+.+..++.++|+||||+++|++++ |..||.+.........+..
T Consensus 159 --------------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~----- 219 (261)
T cd05034 159 --------------TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVER----- 219 (261)
T ss_pred --------------hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-----
Confidence 00112234678999999998889999999999999999998 9999987654443333221
Q ss_pred HHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 005427 298 QQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350 (697)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~ 350 (697)
..+. ..+...+.++.+++.+||+.+|.+||+++++++.++
T Consensus 220 ----------~~~~---~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~ 259 (261)
T cd05034 220 ----------GYRM---PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLE 259 (261)
T ss_pred ----------CCCC---CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHh
Confidence 1111 123456889999999999999999999999987664
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=319.52 Aligned_cols=253 Identities=25% Similarity=0.399 Sum_probs=203.7
Q ss_pred cccccccccCCceEEEEEEEC-----CeeEEEEeccCC--ChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCc-----
Q 005427 68 YTLLSPIARGAESVVYEATLD-----GRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPN----- 135 (697)
Q Consensus 68 y~~~~~lg~G~~g~V~~~~~~-----~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~----- 135 (697)
|.+.+.||+|+||.||+|... +..||+|.+... .......+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 678899999999999999762 367999986643 23446789999999999999999999998766554
Q ss_pred -eEEEEeecCCCCHhhhhhhc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccc
Q 005427 136 -YMFFFEFYESRNLAEKLHVE-----EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLA 209 (697)
Q Consensus 136 -~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a 209 (697)
.++++||+.+|+|..++... ...+++..++.++.|++.||.|||+.+++||||||+||+++.++.+||+|||++
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 160 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS 160 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccce
Confidence 79999999999999887432 235788999999999999999999999999999999999999999999999998
Q ss_pred hhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCCchhHHHHH
Q 005427 210 EYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAH 288 (697)
Q Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~~~~~~~~~ 288 (697)
+........ .......++..|+|||.+.+..++.++|||||||++|||++ |..||.+........
T Consensus 161 ~~~~~~~~~--------------~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~ 226 (273)
T cd05035 161 KKIYSGDYY--------------RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYD 226 (273)
T ss_pred eeccccccc--------------cccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 755321110 00112234678999999998889999999999999999999 999998765433322
Q ss_pred HHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 289 TVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
.+. .+. . ...+..++.++.+++.+||+.||++|||+.+++++|..+
T Consensus 227 ~~~--------------~~~-~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 227 YLR--------------HGN-R---LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred HHH--------------cCC-C---CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 221 111 1 123456889999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=332.69 Aligned_cols=255 Identities=22% Similarity=0.341 Sum_probs=220.3
Q ss_pred CCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCC--hHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEE
Q 005427 65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST--SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFF 140 (697)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 140 (697)
...|.+.+.||+|.|+.|.++++ ++..||+|.+.... ......+.+|+++|+.|+|||||+++.+...+..+|+||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 35699999999999999999987 78999999765443 233466899999999999999999999999999999999
Q ss_pred eecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhc
Q 005427 141 EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL 220 (697)
Q Consensus 141 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~ 220 (697)
||+.+|.+++++.+.+ +..+..+..++.|++.|++|||+++|+|||||++|||++.+.++||+|||++.++...
T Consensus 135 eya~~ge~~~yl~~~g-r~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~----- 208 (596)
T KOG0586|consen 135 EYASGGELFDYLVKHG-RMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYG----- 208 (596)
T ss_pred EeccCchhHHHHHhcc-cchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeeccc-----
Confidence 9999999999998777 5666999999999999999999999999999999999999999999999999877631
Q ss_pred ccccCCCCCCCCccccccccCccccchhhhcccCC-CchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHH
Q 005427 221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIH-SEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQ 299 (697)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~ 299 (697)
....+++|++.|.|||++.+..| ++.+|+||+|+++|-|++|.+||.+..-.......+...
T Consensus 209 ------------~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk----- 271 (596)
T KOG0586|consen 209 ------------LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGK----- 271 (596)
T ss_pred ------------ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeee-----
Confidence 23567899999999999998776 688999999999999999999999865444333333222
Q ss_pred HHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHh
Q 005427 300 LTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHR 356 (697)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~~ 356 (697)
++ ++..++.++.++|+++|-.+|.+|++.+++.++-|......
T Consensus 272 ---------~r-----Ip~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~ 314 (596)
T KOG0586|consen 272 ---------YR-----IPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLE 314 (596)
T ss_pred ---------ec-----ccceeechhHHHHHHhhccCccccCCHHHhhhhcccchhhh
Confidence 22 34457899999999999999999999999999999876543
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=317.42 Aligned_cols=252 Identities=24% Similarity=0.421 Sum_probs=210.4
Q ss_pred CCCcccccccccCCceEEEEEEEC--CeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEee
Q 005427 65 PSSYTLLSPIARGAESVVYEATLD--GRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF 142 (697)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 142 (697)
.++|++.+.||.|+||.||+|... ++.+++|...... ..+.+.+|+++++.++||||+++++.+.....+++++||
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~ 79 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE--DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY 79 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH--HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence 468999999999999999999873 6889999865432 267899999999999999999999999999999999999
Q ss_pred cCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhccc
Q 005427 143 YESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKN 222 (697)
Q Consensus 143 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 222 (697)
+.+++|.+++......+++..++.++.|++.||.|||+.+++|+||+|+||+++.++.+||+|||++........
T Consensus 80 ~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~----- 154 (256)
T cd06612 80 CGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA----- 154 (256)
T ss_pred CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc-----
Confidence 999999999977666789999999999999999999999999999999999999999999999999876542110
Q ss_pred ccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHHHH
Q 005427 223 WRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTA 302 (697)
Q Consensus 223 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 302 (697)
......|+..|+|||++.+..++.++||||||+++|+|++|..||...........+..
T Consensus 155 -----------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~---------- 213 (256)
T cd06612 155 -----------KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPN---------- 213 (256)
T ss_pred -----------ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhcc----------
Confidence 12334578899999999998999999999999999999999999986543322211110
Q ss_pred HHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 005427 303 AVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350 (697)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~ 350 (697)
...+. ...+..++.++.++|.+||+.||++|||+.+++.+.|
T Consensus 214 -----~~~~~-~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~ 255 (256)
T cd06612 214 -----KPPPT-LSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPF 255 (256)
T ss_pred -----CCCCC-CCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCC
Confidence 00011 1123357789999999999999999999999998765
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=345.73 Aligned_cols=269 Identities=20% Similarity=0.212 Sum_probs=201.0
Q ss_pred CCCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCChHHHHHHHHHHHHHHhcCC------CCceEEeeccccC-
Q 005427 63 LPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDH------PGLAKFVAAHAKP- 133 (697)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------pniv~l~~~~~~~- 133 (697)
+...+|+++++||+|+||+||+|.+ .++.||||++.... .....+..|+.+++.++| ++++.+++++..+
T Consensus 126 ~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~ 204 (467)
T PTZ00284 126 VSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNET 204 (467)
T ss_pred cCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCC
Confidence 3457899999999999999999987 57889999865322 223445677888777754 4588888888764
Q ss_pred CceEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCCCceeecCCC-------------
Q 005427 134 PNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHN-LGIVHRDVKPANVLLDRNL------------- 199 (697)
Q Consensus 134 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivHrDlkp~Nill~~~~------------- 199 (697)
.++|+|||++ +++|.+++...+ .+++..++.++.||+.||.|||+ .||+||||||+|||++.++
T Consensus 205 ~~~~iv~~~~-g~~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~ 282 (467)
T PTZ00284 205 GHMCIVMPKY-GPCLLDWIMKHG-PFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPP 282 (467)
T ss_pred ceEEEEEecc-CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCC
Confidence 5788899887 668888886554 78999999999999999999998 5999999999999998765
Q ss_pred ---CCeeeeeccchhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCC
Q 005427 200 ---CPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVV 276 (697)
Q Consensus 200 ---~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~ 276 (697)
.+||+|||++..... .....+||+.|+|||++.+..++.++|||||||++|||++|++
T Consensus 283 ~~~~vkl~DfG~~~~~~~-------------------~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~ 343 (467)
T PTZ00284 283 DPCRVRICDLGGCCDERH-------------------SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKL 343 (467)
T ss_pred CCceEEECCCCccccCcc-------------------ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 489999998743211 1345689999999999999999999999999999999999999
Q ss_pred CCCCchhHHHHHHHHhccccH-HHHHH--------HH--HhCCCCCcccc------------cccCChHHHHHHHHHhcc
Q 005427 277 PYTDLRAEAQAHTVLEMNYTE-QQLTA--------AV--VSGGLRPILAS------------LELGLPASILSLIQRCWD 333 (697)
Q Consensus 277 Pf~~~~~~~~~~~~~~~~~~~-~~~~~--------~~--~~~~~~~~~~~------------~~~~~~~~l~~li~~~l~ 333 (697)
||.+.........+....... ..+.. .. ..+..++.... .....++.+.+||.+||+
T Consensus 344 pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~ 423 (467)
T PTZ00284 344 LYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLH 423 (467)
T ss_pred CCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCC
Confidence 998876655444433221111 00000 00 00111111000 000124668899999999
Q ss_pred CCCCCCCCHHHHHHHHHHHH
Q 005427 334 GNPHNRPSFSDIALELDLVL 353 (697)
Q Consensus 334 ~dP~~Rpt~~ell~~l~~~~ 353 (697)
+||.+|||++|+++|.|+..
T Consensus 424 ~dP~~R~ta~e~L~Hp~~~~ 443 (467)
T PTZ00284 424 YDRQKRLNARQMTTHPYVLK 443 (467)
T ss_pred cChhhCCCHHHHhcCccccc
Confidence 99999999999999999853
|
|
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=323.31 Aligned_cols=263 Identities=25% Similarity=0.388 Sum_probs=206.1
Q ss_pred CCCCCcccccccccCCceEEEEEEEC------------------CeeEEEEeccCCC-hHHHHHHHHHHHHHHhcCCCCc
Q 005427 63 LPPSSYTLLSPIARGAESVVYEATLD------------------GRKVAVKKPILST-SEELDNFHKELQLLCKLDHPGL 123 (697)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~~------------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpni 123 (697)
++.++|++.++||+|+||.||++.+. +..+|+|...... ......+.+|+.+|+.++||||
T Consensus 2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (296)
T cd05095 2 FPRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNI 81 (296)
T ss_pred CChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCc
Confidence 56678999999999999999998542 3368999876543 3345688999999999999999
Q ss_pred eEEeeccccCCceEEEEeecCCCCHhhhhhhcC----------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCce
Q 005427 124 AKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEE----------WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANV 193 (697)
Q Consensus 124 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Ni 193 (697)
+++++++......+++|||+.+++|.+++.... ..+++.+++.++.|++.||+|||+.|++||||||+||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Ni 161 (296)
T cd05095 82 IRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNC 161 (296)
T ss_pred ceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheE
Confidence 999999999999999999999999999986532 1356778999999999999999999999999999999
Q ss_pred eecCCCCCeeeeeccchhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh
Q 005427 194 LLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT 273 (697)
Q Consensus 194 ll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~ 273 (697)
|++.++.++|+|||++..+..... ........+++.|++||+..+..++.++|+|||||++|||++
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~--------------~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~ 227 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDY--------------YRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcc--------------eeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHH
Confidence 999999999999999875432110 001122345678999999988889999999999999999998
Q ss_pred --CCCCCCCchhHHHHHHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 005427 274 --GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350 (697)
Q Consensus 274 --g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~ 350 (697)
|..||.............. .. .... .......+..+++.+.+|+.+||+.||++||++.+|++.|.
T Consensus 228 ~~~~~p~~~~~~~~~~~~~~~-------~~---~~~~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 228 LCKEQPYSQLSDEQVIENTGE-------FF---RDQG-RQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred hCCCCCccccChHHHHHHHHH-------HH---hhcc-ccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 7889976554433221111 00 0000 01111123457899999999999999999999999987764
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=307.09 Aligned_cols=275 Identities=18% Similarity=0.255 Sum_probs=215.2
Q ss_pred cccc-cccccCCceEEEEEEE--CCeeEEEEeccCCChHHHHHHHHHHHHHHhc-CCCCceEEeeccccCCceEEEEeec
Q 005427 68 YTLL-SPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKL-DHPGLAKFVAAHAKPPNYMFFFEFY 143 (697)
Q Consensus 68 y~~~-~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~ 143 (697)
|++. +.||+|+|+.|--+.. ++..+|||++.........++.+|++++.+. .|+||++|+++|+++..+|||||.+
T Consensus 79 YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm 158 (463)
T KOG0607|consen 79 YKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKM 158 (463)
T ss_pred HHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecc
Confidence 5554 5799999999988864 8999999998777677788999999999999 5999999999999999999999999
Q ss_pred CCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCC---CCeeeeeccchhhhhhhhhhc
Q 005427 144 ESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNL---CPHLADFGLAEYRENLKEISL 220 (697)
Q Consensus 144 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~---~~kL~Dfg~a~~~~~~~~~~~ 220 (697)
.||.|...+.+.. .|++.++.++..+|+.||.|||.+||.||||||+|||..... -||||||.+..-+....+.
T Consensus 159 ~GGplLshI~~~~-~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~-- 235 (463)
T KOG0607|consen 159 RGGPLLSHIQKRK-HFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDC-- 235 (463)
T ss_pred cCchHHHHHHHhh-hccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCC--
Confidence 9999999998766 799999999999999999999999999999999999996543 4899999998654322211
Q ss_pred ccccCCCCCCCCccccccccCccccchhhhc-----ccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHH-HHHHHHhcc
Q 005427 221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILK-----KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEA-QAHTVLEMN 294 (697)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~-~~~~~~~~~ 294 (697)
.+.......+.+|+..|||||+.. ...|+.+.|.|||||++|-||+|.+||.+.-... -+..-....
T Consensus 236 -------spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr 308 (463)
T KOG0607|consen 236 -------SPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCR 308 (463)
T ss_pred -------CCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccH
Confidence 122333456789999999999863 3568999999999999999999999997642211 000000000
Q ss_pred ccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 005427 295 YTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL 353 (697)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~ 353 (697)
.-...+...+- ++.-.+...-+..+|.+.++++..+|..|+.+|.++.++++|+|.-.
T Consensus 309 ~CQ~~LFesIQ-EGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~ 366 (463)
T KOG0607|consen 309 VCQNKLFESIQ-EGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQR 366 (463)
T ss_pred HHHHHHHHHHh-ccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccc
Confidence 00112222222 22223333345678999999999999999999999999999999854
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=328.98 Aligned_cols=264 Identities=20% Similarity=0.239 Sum_probs=190.8
Q ss_pred ccccccCCceEEEEEEE----CCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeecccc--CCceEEEEeecC
Q 005427 71 LSPIARGAESVVYEATL----DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAK--PPNYMFFFEFYE 144 (697)
Q Consensus 71 ~~~lg~G~~g~V~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~--~~~~~lv~e~~~ 144 (697)
.++||+|+||+||+|+. .++.+|+|.+.... ....+.+|+.+|+.++||||+++++++.. ...++++|||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 46899999999999985 35679999765432 23456789999999999999999998854 456889999986
Q ss_pred CCCHhhhhhhc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceee----cCCCCCeeeeeccchhh
Q 005427 145 SRNLAEKLHVE--------EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLL----DRNLCPHLADFGLAEYR 212 (697)
Q Consensus 145 ~g~L~~~l~~~--------~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill----~~~~~~kL~Dfg~a~~~ 212 (697)
+ +|.+++... ...+++..++.++.|++.||.|||+.||+||||||+|||+ +.++.+||+|||+++..
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~ 162 (317)
T cd07868 84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162 (317)
T ss_pred C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceecc
Confidence 5 888776432 2257889999999999999999999999999999999999 45678999999999755
Q ss_pred hhhhhhhcccccCCCCCCCCccccccccCccccchhhhcc-cCCCchhhHHHHHHHHHHHHhCCCCCCCchhH-------
Q 005427 213 ENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLTGVVPYTDLRAE------- 284 (697)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~------- 284 (697)
.... ..........||+.|+|||++.+ ..++.++||||+||++|+|++|.+||......
T Consensus 163 ~~~~-------------~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~ 229 (317)
T cd07868 163 NSPL-------------KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPY 229 (317)
T ss_pred CCCC-------------ccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccc
Confidence 3210 00111234678999999999977 45899999999999999999999999753321
Q ss_pred --HHHHHHHhccccHHHHHH--------------HHHhCCC-----CCcccccccCChHHHHHHHHHhccCCCCCCCCHH
Q 005427 285 --AQAHTVLEMNYTEQQLTA--------------AVVSGGL-----RPILASLELGLPASILSLIQRCWDGNPHNRPSFS 343 (697)
Q Consensus 285 --~~~~~~~~~~~~~~~~~~--------------~~~~~~~-----~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ 343 (697)
.....+...........+ ....... ...+.......+.++.+||.+||+.||.+|||++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~ 309 (317)
T cd07868 230 HHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSE 309 (317)
T ss_pred cHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHH
Confidence 111112111110000000 0000000 0000111123456789999999999999999999
Q ss_pred HHHHHHH
Q 005427 344 DIALELD 350 (697)
Q Consensus 344 ell~~l~ 350 (697)
|+++|.|
T Consensus 310 e~l~hp~ 316 (317)
T cd07868 310 QAMQDPY 316 (317)
T ss_pred HHhcCCC
Confidence 9998876
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=318.26 Aligned_cols=253 Identities=25% Similarity=0.404 Sum_probs=200.6
Q ss_pred cccccccccCCceEEEEEEEC--C--eeEEEEeccCC--ChHHHHHHHHHHHHHHhcCCCCceEEeeccccC------Cc
Q 005427 68 YTLLSPIARGAESVVYEATLD--G--RKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKP------PN 135 (697)
Q Consensus 68 y~~~~~lg~G~~g~V~~~~~~--~--~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~------~~ 135 (697)
|.+.++||+|+||.||+|... + ..+|+|..... .....+.+.+|+.+++.++||||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 457889999999999999863 2 26899976543 345567889999999999999999999876432 35
Q ss_pred eEEEEeecCCCCHhhhhhh-----cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccch
Q 005427 136 YMFFFEFYESRNLAEKLHV-----EEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAE 210 (697)
Q Consensus 136 ~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~ 210 (697)
.+++|||+.+|+|.+++.. ....+++..++.++.|++.||+|||+++|+||||||+|||++.++.+||+|||+++
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 160 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK 160 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCccc
Confidence 7899999999999988742 22347889999999999999999999999999999999999999999999999987
Q ss_pred hhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCCchhHHHHHH
Q 005427 211 YRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHT 289 (697)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~~~~~~~~~~ 289 (697)
.+...... .......+++.|++||++.+..++.++|||||||++|+|++ |..||.+.........
T Consensus 161 ~~~~~~~~--------------~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 226 (272)
T cd05075 161 KIYNGDYY--------------RQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDY 226 (272)
T ss_pred ccCcccce--------------ecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 65321100 01122346778999999999999999999999999999999 8999987544333222
Q ss_pred HHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 290 VLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
+. .+... ..+..++..+.+++.+||+.||.+|||+.+++++|..+
T Consensus 227 ~~--------------~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 227 LR--------------QGNRL----KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred HH--------------cCCCC----CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 21 11111 12346788999999999999999999999999888753
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=321.84 Aligned_cols=255 Identities=29% Similarity=0.383 Sum_probs=205.1
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccCCC-hHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEee
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST-SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF 142 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 142 (697)
++|++.++||+|+||.||+|.+ +++.||+|...... ......+.+|++++++++||||+++++.+......+++|||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 3688999999999999999986 67889999865442 33456789999999999999999999999999999999999
Q ss_pred cCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhccc
Q 005427 143 YESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKN 222 (697)
Q Consensus 143 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 222 (697)
+++++|..+. .+++..+..++.|++.||.|||+.||+|+||||+|||++.++.+||+|||++......
T Consensus 81 ~~~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~------- 148 (279)
T cd06619 81 MDGGSLDVYR-----KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS------- 148 (279)
T ss_pred CCCCChHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc-------
Confidence 9999986542 4678889999999999999999999999999999999999999999999998654310
Q ss_pred ccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHHHH
Q 005427 223 WRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTA 302 (697)
Q Consensus 223 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 302 (697)
......|+..|+|||++.+..++.++|+|||||++|+|++|..||.......... .......
T Consensus 149 -----------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~-------~~~~~~~ 210 (279)
T cd06619 149 -----------IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSL-------MPLQLLQ 210 (279)
T ss_pred -----------cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhccccccc-------chHHHHH
Confidence 1234578999999999999889999999999999999999999997532211000 0001111
Q ss_pred HHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 005427 303 AVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL 353 (697)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~ 353 (697)
...... .+.+ .....++++.+++.+||+.+|.+||+++++++|.|...
T Consensus 211 ~~~~~~-~~~~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~ 258 (279)
T cd06619 211 CIVDED-PPVL--PVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQ 258 (279)
T ss_pred HHhccC-CCCC--CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCccccc
Confidence 111111 1111 12347889999999999999999999999999988753
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=335.38 Aligned_cols=264 Identities=22% Similarity=0.305 Sum_probs=199.7
Q ss_pred CCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEee
Q 005427 65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF 142 (697)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 142 (697)
..+|++.+.||+|+||.||+|++ +++.||+|..... ....|+.+++.++||||+++++++......++|||+
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 138 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPH 138 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEc
Confidence 34799999999999999999987 4568999974322 235699999999999999999999999999999999
Q ss_pred cCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhccc
Q 005427 143 YESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKN 222 (697)
Q Consensus 143 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 222 (697)
+. ++|.+++......+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 139 ~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~------- 210 (357)
T PHA03209 139 YS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA------- 210 (357)
T ss_pred cC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccC-------
Confidence 96 5888888776667899999999999999999999999999999999999999999999999998643210
Q ss_pred ccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhC-CCCCCCchhH---------HHHHHHHh
Q 005427 223 WRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTG-VVPYTDLRAE---------AQAHTVLE 292 (697)
Q Consensus 223 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g-~~Pf~~~~~~---------~~~~~~~~ 292 (697)
.......||+.|+|||++.+..++.++|||||||++|||+++ ..+|...... .....+..
T Consensus 211 ----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~ 280 (357)
T PHA03209 211 ----------PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIIS 280 (357)
T ss_pred ----------cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHH
Confidence 012345689999999999999999999999999999999985 4444432111 01111111
Q ss_pred c-cccHHH--------HHHHHHh--CCCCCccc---c-cccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 293 M-NYTEQQ--------LTAAVVS--GGLRPILA---S-LELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 293 ~-~~~~~~--------~~~~~~~--~~~~~~~~---~-~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
. ...... ....... ...+.... . ....++.++.+||.+||+.||.+|||+.|+++|.|+.
T Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~ 355 (357)
T PHA03209 281 TLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFA 355 (357)
T ss_pred HhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhc
Confidence 0 000000 0000000 00000000 0 1125677888999999999999999999999998863
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=331.23 Aligned_cols=265 Identities=28% Similarity=0.404 Sum_probs=223.2
Q ss_pred CCCCccCCCCCCCcccccccccCCceEEEEEEEC---Ce--eEEEEeccCCChH-HHHHHHHHHHHHHhcCCCCceEEee
Q 005427 55 SSQSIPLHLPPSSYTLLSPIARGAESVVYEATLD---GR--KVAVKKPILSTSE-ELDNFHKELQLLCKLDHPGLAKFVA 128 (697)
Q Consensus 55 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~---~~--~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~ 128 (697)
......+-|+.++.++.++||+|.||.|++|.|+ |+ .||||.+...... ....|.+|+.+|.+|+|||+++||+
T Consensus 99 p~~~lkclIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyG 178 (1039)
T KOG0199|consen 99 PSIDLKCLIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYG 178 (1039)
T ss_pred cCCCcceeccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEee
Confidence 3455667788899999999999999999999884 33 5899987655443 6789999999999999999999999
Q ss_pred ccccCCceEEEEeecCCCCHhhhhhh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeec
Q 005427 129 AHAKPPNYMFFFEFYESRNLAEKLHV-EEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFG 207 (697)
Q Consensus 129 ~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg 207 (697)
+..+ ....||||.++.|+|.+.|++ ....|.......++.||+.|+.||.++++|||||..+|+|+-....|||+|||
T Consensus 179 vVl~-qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFG 257 (1039)
T KOG0199|consen 179 VVLD-QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFG 257 (1039)
T ss_pred eecc-chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeeccc
Confidence 9988 778999999999999999987 44567888999999999999999999999999999999999888999999999
Q ss_pred cchhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCCchhHHH
Q 005427 208 LAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQ 286 (697)
Q Consensus 208 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~~~~~~~ 286 (697)
|.+.+...++.-. ......-...|+|||.++...++.++|+|++||++|||++ |+-||.+.....+
T Consensus 258 LmRaLg~ned~Yv-------------m~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qI 324 (1039)
T KOG0199|consen 258 LMRALGENEDMYV-------------MAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQI 324 (1039)
T ss_pred ceeccCCCCcceE-------------ecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHH
Confidence 9987764332110 0112234678999999999999999999999999999999 9999999988777
Q ss_pred HHHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 005427 287 AHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL 351 (697)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~ 351 (697)
++++.... .++ -++.+|.++.++++.||..+|.+||||..|.+.+-.
T Consensus 325 L~~iD~~e-----------------rLp-RPk~csedIY~imk~cWah~paDRptFsair~~~~l 371 (1039)
T KOG0199|consen 325 LKNIDAGE-----------------RLP-RPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVL 371 (1039)
T ss_pred HHhccccc-----------------cCC-CCCCChHHHHHHHHHhccCCccccccHHHHHHhHHH
Confidence 76664211 111 256799999999999999999999999999765443
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=326.91 Aligned_cols=255 Identities=24% Similarity=0.386 Sum_probs=212.4
Q ss_pred CCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEee
Q 005427 65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF 142 (697)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 142 (697)
.++|++.+.||+|+||.||++.. .++.||+|..........+.+.+|+.+++.++||||+++++.+.....+++||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 46899999999999999999986 6889999987766555667789999999999999999999999999999999999
Q ss_pred cCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhccc
Q 005427 143 YESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKN 222 (697)
Q Consensus 143 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 222 (697)
+++++|.+++... .+++.++..++.|++.||.|||+.|++||||||+|||++.++.++|+|||++.......
T Consensus 98 ~~~~~L~~~~~~~--~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~------ 169 (297)
T cd06656 98 LAGGSLTDVVTET--CMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ------ 169 (297)
T ss_pred cCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCc------
Confidence 9999999998643 57889999999999999999999999999999999999999999999999986543211
Q ss_pred ccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHHHH
Q 005427 223 WRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTA 302 (697)
Q Consensus 223 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 302 (697)
.......+++.|+|||.+.+..++.++|+|||||++|++++|..||...........+..
T Consensus 170 ----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~---------- 229 (297)
T cd06656 170 ----------SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT---------- 229 (297)
T ss_pred ----------cCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeecc----------
Confidence 012345688999999999998899999999999999999999999976543222111100
Q ss_pred HHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 005427 303 AVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL 353 (697)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~ 353 (697)
.+ .+.. ..+..++..+.+++.+||+.+|++||++.++++|.|...
T Consensus 230 ----~~-~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~ 274 (297)
T cd06656 230 ----NG-TPEL-QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKL 274 (297)
T ss_pred ----CC-CCCC-CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhcc
Confidence 00 1111 123457889999999999999999999999999987753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=329.36 Aligned_cols=275 Identities=24% Similarity=0.299 Sum_probs=204.4
Q ss_pred ccccccccC--CceEEEEEEE--CCeeEEEEeccCCC--hHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEee
Q 005427 69 TLLSPIARG--AESVVYEATL--DGRKVAVKKPILST--SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF 142 (697)
Q Consensus 69 ~~~~~lg~G--~~g~V~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 142 (697)
+++++||+| +|++||++.. +++.||+|.+.... ......+.+|+.+++.++||||+++++++..++..++||||
T Consensus 1 ~~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 80 (327)
T cd08227 1 ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 80 (327)
T ss_pred ChhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence 367899999 6889999976 67899999876542 33456788899999999999999999999999999999999
Q ss_pred cCCCCHhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhcc
Q 005427 143 YESRNLAEKLHVE-EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLK 221 (697)
Q Consensus 143 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~ 221 (697)
+++|+|.+++... ...+++..++.++.|++.||.|||+.+|+||||||+|||++.++.++++||+.+.........
T Consensus 81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~--- 157 (327)
T cd08227 81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR--- 157 (327)
T ss_pred cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccccc---
Confidence 9999999998653 235889999999999999999999999999999999999999999999999875433211000
Q ss_pred cccCCCCCCCCccccccccCccccchhhhcc--cCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhcccc---
Q 005427 222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKK--EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYT--- 296 (697)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~--- 296 (697)
............++..|+|||++.+ ..++.++|||||||++|+|++|..||..................
T Consensus 158 ------~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 231 (327)
T cd08227 158 ------LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLL 231 (327)
T ss_pred ------ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccc
Confidence 0000001123457788999999976 45889999999999999999999999875543332222221110
Q ss_pred ------HHHHHHHHHhCC-------------CC-----CcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 297 ------EQQLTAAVVSGG-------------LR-----PILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 297 ------~~~~~~~~~~~~-------------~~-----~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
............ .+ .........+++++.+|+.+||+.||++|||++++++|+|+.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~ 311 (327)
T cd08227 232 DTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFK 311 (327)
T ss_pred cccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhh
Confidence 000000000000 00 000111234678999999999999999999999999999874
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=315.12 Aligned_cols=254 Identities=30% Similarity=0.449 Sum_probs=205.5
Q ss_pred CCCCCCcccccccccCCceEEEEEEEC-CeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEE
Q 005427 62 HLPPSSYTLLSPIARGAESVVYEATLD-GRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFF 140 (697)
Q Consensus 62 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 140 (697)
+++.++|++.++||+|+||.||++.+. +..+|+|...... ...+.+.+|+.+++.++|||++++++++.. ...+++|
T Consensus 2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~ 79 (260)
T cd05069 2 EIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVT 79 (260)
T ss_pred cCChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEE
Confidence 456678999999999999999999874 4578999765332 234678899999999999999999998754 5678999
Q ss_pred eecCCCCHhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhh
Q 005427 141 EFYESRNLAEKLHVEE-WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEIS 219 (697)
Q Consensus 141 e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~ 219 (697)
||+.+++|.+++.... ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++........
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~-- 157 (260)
T cd05069 80 EFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY-- 157 (260)
T ss_pred EcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCcc--
Confidence 9999999999986543 3478899999999999999999999999999999999999999999999999865532110
Q ss_pred cccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCCchhHHHHHHHHhccccHH
Q 005427 220 LKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQ 298 (697)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~ 298 (697)
.......++..|+|||.+.+..++.++||||||+++|+|++ |..||.+.........+.
T Consensus 158 -------------~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~------- 217 (260)
T cd05069 158 -------------TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVE------- 217 (260)
T ss_pred -------------cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-------
Confidence 01122346778999999998889999999999999999999 999998765443322221
Q ss_pred HHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 005427 299 QLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350 (697)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~ 350 (697)
....+ ..+...+..+.+++.+||..||.+||+++++++.|.
T Consensus 218 --------~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 258 (260)
T cd05069 218 --------RGYRM---PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLE 258 (260)
T ss_pred --------cCCCC---CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHh
Confidence 11111 123467899999999999999999999999987765
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=320.02 Aligned_cols=253 Identities=26% Similarity=0.420 Sum_probs=211.9
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccCCC-hHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEee
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST-SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF 142 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 142 (697)
++|++.+.||.|+||.||+|.+ +++.+|+|...... ......+.+|+.+++.++||||+++++.+.....+++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 4799999999999999999987 57899999876543 34456788999999999999999999999999999999999
Q ss_pred cCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhccc
Q 005427 143 YESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKN 222 (697)
Q Consensus 143 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 222 (697)
+.+++|.+++... .+++.+++.++.|++.||.|||+.+++||||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~------ 152 (274)
T cd06609 81 CGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM------ 152 (274)
T ss_pred eCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccc------
Confidence 9999999998754 68899999999999999999999999999999999999999999999999987654311
Q ss_pred ccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHHHH
Q 005427 223 WRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTA 302 (697)
Q Consensus 223 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 302 (697)
.......+++.|+|||.+.+..++.++||||||+++|+|++|..||...........+..
T Consensus 153 ----------~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~---------- 212 (274)
T cd06609 153 ----------SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPK---------- 212 (274)
T ss_pred ----------cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhh----------
Confidence 012345688899999999988899999999999999999999999976543322221111
Q ss_pred HHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 005427 303 AVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL 353 (697)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~ 353 (697)
...+.+.. ..++.++.+++.+||..+|++|||++++++|.|...
T Consensus 213 -----~~~~~~~~--~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~ 256 (274)
T cd06609 213 -----NNPPSLEG--NKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKK 256 (274)
T ss_pred -----cCCCCCcc--cccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcC
Confidence 11121111 127889999999999999999999999999988754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=316.33 Aligned_cols=250 Identities=27% Similarity=0.376 Sum_probs=206.5
Q ss_pred CcccccccccCCceEEEEEEE--CCeeEEEEeccCCC--hHHHHHHHHHHHHHHhcCCCCceEEeecccc-CCceEEEEe
Q 005427 67 SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST--SEELDNFHKELQLLCKLDHPGLAKFVAAHAK-PPNYMFFFE 141 (697)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~~lv~e 141 (697)
+|++.+.||+|++|.||++.. +++.+++|++.... ....+.+.+|+++++.++|||++++++.+.. ...++++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 489999999999999999986 56789999865432 3445678999999999999999999988764 446789999
Q ss_pred ecCCCCHhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhc
Q 005427 142 FYESRNLAEKLHVE-EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL 220 (697)
Q Consensus 142 ~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~ 220 (697)
|+++++|.+++... ...+++.+++.++.|++.||.|||+.|++||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~---- 156 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC---- 156 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccC----
Confidence 99999999998753 3357999999999999999999999999999999999999999999999999987553211
Q ss_pred ccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHH
Q 005427 221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQL 300 (697)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 300 (697)
.......+++.|+|||++.+..++.++|+||||+++++|++|..||...+.......+..
T Consensus 157 ------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~-------- 216 (257)
T cd08223 157 ------------DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIE-------- 216 (257)
T ss_pred ------------CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh--------
Confidence 012345689999999999999899999999999999999999999986544333222211
Q ss_pred HHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 005427 301 TAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350 (697)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~ 350 (697)
+. . +..+..+++++.+++.+||+.+|.+|||+.++++|.|
T Consensus 217 ------~~-~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~ 256 (257)
T cd08223 217 ------GK-L---PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPY 256 (257)
T ss_pred ------cC-C---CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCC
Confidence 11 1 1233468899999999999999999999999998765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=317.18 Aligned_cols=259 Identities=26% Similarity=0.415 Sum_probs=208.5
Q ss_pred CCCcccccccccCCceEEEEEEEC--C---eeEEEEeccCC-ChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEE
Q 005427 65 PSSYTLLSPIARGAESVVYEATLD--G---RKVAVKKPILS-TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMF 138 (697)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~--~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 138 (697)
...|++.+.||+|+||.||+|... + ..||+|..... .......+..|+.+++.++||||+++++++.....+++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 82 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMI 82 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEE
Confidence 356899999999999999999863 2 36999986544 34456789999999999999999999999999999999
Q ss_pred EEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhh
Q 005427 139 FFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI 218 (697)
Q Consensus 139 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~ 218 (697)
+|||+.+++|.+++......+++.+++.++.|++.||.|||+.|++|+||||+||+++.++.+||+|||++.........
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~ 162 (269)
T cd05065 83 ITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD 162 (269)
T ss_pred EEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCccc
Confidence 99999999999999876667899999999999999999999999999999999999999999999999998655321100
Q ss_pred hcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCCchhHHHHHHHHhccccH
Q 005427 219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTE 297 (697)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~ 297 (697)
+. .........+..|+|||.+.+..++.++|||||||++||+++ |..||.+.........+..
T Consensus 163 ----------~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~----- 226 (269)
T cd05065 163 ----------PT-YTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQ----- 226 (269)
T ss_pred ----------cc-cccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHc-----
Confidence 00 000111122467999999998899999999999999999887 9999987654433222211
Q ss_pred HHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 298 QQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
..+. ..+..+|..+.+++.+||+.+|++||++.+++..|+.+
T Consensus 227 ----------~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 227 ----------DYRL---PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ----------CCcC---CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1111 11346788999999999999999999999999877653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=316.46 Aligned_cols=238 Identities=24% Similarity=0.334 Sum_probs=192.7
Q ss_pred cccccCCceEEEEEEEC--------------CeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceE
Q 005427 72 SPIARGAESVVYEATLD--------------GRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYM 137 (697)
Q Consensus 72 ~~lg~G~~g~V~~~~~~--------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 137 (697)
+.||+|+||.||+|+.. ...|++|............+.+|+.+++.++||||+++++++..+...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 46899999999999742 2358888766555555668899999999999999999999999999999
Q ss_pred EEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCC-------Ceeeeeccch
Q 005427 138 FFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLC-------PHLADFGLAE 210 (697)
Q Consensus 138 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~-------~kL~Dfg~a~ 210 (697)
++|||+++|+|..++......+++..++.++.|++.||+|||+.+|+||||||+|||++.++. +|++|||++.
T Consensus 81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~ 160 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPI 160 (262)
T ss_pred EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCCCc
Confidence 999999999999988766667899999999999999999999999999999999999987654 8999999885
Q ss_pred hhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhc-ccCCCchhhHHHHHHHHHHHH-hCCCCCCCchhHHHHH
Q 005427 211 YRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILK-KEIHSEKSDVYSFGISINELL-TGVVPYTDLRAEAQAH 288 (697)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~~l~ell-~g~~Pf~~~~~~~~~~ 288 (697)
.... .....++..|+|||++. +..++.++|||||||++|+|+ .|..||.........
T Consensus 161 ~~~~--------------------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~- 219 (262)
T cd05077 161 TVLS--------------------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE- 219 (262)
T ss_pred cccC--------------------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-
Confidence 4321 22345788999999987 567899999999999999998 488998764322211
Q ss_pred HHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 005427 289 TVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALEL 349 (697)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l 349 (697)
.... .... .....++++.+||.+||+.||.+||++.+|++++
T Consensus 220 ~~~~--------------~~~~-----~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 220 RFYE--------------GQCM-----LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred HHHh--------------cCcc-----CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 1100 1111 1123467899999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=322.62 Aligned_cols=256 Identities=26% Similarity=0.371 Sum_probs=208.4
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccCC-ChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEee
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS-TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF 142 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 142 (697)
++|++++.||+|+||.||++.+ .++.||+|.+... .......+.+|+.++++++||||+++++.+..++.++++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 3699999999999999999987 5889999976544 334457889999999999999999999999999999999999
Q ss_pred cCCCCHhhhhhhc--CCCCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhh
Q 005427 143 YESRNLAEKLHVE--EWSPSVDQVLMIAAQLAKALQYLHN-LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEIS 219 (697)
Q Consensus 143 ~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~ 219 (697)
+++++|..++... ...+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++..+...
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---- 156 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS---- 156 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC----
Confidence 9999999888654 2368999999999999999999997 59999999999999999999999999998654210
Q ss_pred cccccCCCCCCCCccccccccCccccchhhhcccC------CCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhc
Q 005427 220 LKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEI------HSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEM 293 (697)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~ 293 (697)
......+++.|+|||++.+.. ++.++|+|||||++|+|++|..||...........+.
T Consensus 157 --------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~-- 220 (286)
T cd06622 157 --------------LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLS-- 220 (286)
T ss_pred --------------ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHH--
Confidence 123346888999999986543 4789999999999999999999997643322211110
Q ss_pred cccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 005427 294 NYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE 354 (697)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~ 354 (697)
..... . .+..+..++.++.++|.+||+.+|++||++.+++++.|....
T Consensus 221 ---------~~~~~-~---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~ 268 (286)
T cd06622 221 ---------AIVDG-D---PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKY 268 (286)
T ss_pred ---------HHhhc-C---CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhc
Confidence 11111 1 122344588999999999999999999999999999887643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=319.54 Aligned_cols=268 Identities=24% Similarity=0.367 Sum_probs=203.9
Q ss_pred CCc-ccccccccCCceEEEEEEE------CCeeEEEEeccCCCh-HHHHHHHHHHHHHHhcCCCCceEEeeccccC--Cc
Q 005427 66 SSY-TLLSPIARGAESVVYEATL------DGRKVAVKKPILSTS-EELDNFHKELQLLCKLDHPGLAKFVAAHAKP--PN 135 (697)
Q Consensus 66 ~~y-~~~~~lg~G~~g~V~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~ 135 (697)
++| ++.+.||+|+||+||++.+ .+..||+|....... .....+.+|+++|+.++||||+++++++... ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG 82 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence 345 9999999999999988753 466899998765432 3456788999999999999999999987653 45
Q ss_pred eEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhh
Q 005427 136 YMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL 215 (697)
Q Consensus 136 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~ 215 (697)
++++|||+.+++|.+++... .+++.+++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 83 ~~lv~e~~~~~~l~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 160 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLPKH--KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 160 (283)
T ss_pred EEEEecCCCCCCHHHHHHHc--CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCc
Confidence 88999999999999998654 5899999999999999999999999999999999999999999999999998755421
Q ss_pred hhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHH-HHHHhcc
Q 005427 216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQA-HTVLEMN 294 (697)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~-~~~~~~~ 294 (697)
.... .......++..|+|||++.+..++.++||||||+++|+|++|..||......... .......
T Consensus 161 ~~~~-------------~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~ 227 (283)
T cd05080 161 HEYY-------------RVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQ 227 (283)
T ss_pred chhh-------------ccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccc
Confidence 1100 0012234567799999999888999999999999999999999998754322110 0000000
Q ss_pred ccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 295 YTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
....... ........+ ..+..++.++.+++..||+.+|++|||+.++++.+..+
T Consensus 228 ~~~~~~~-~~~~~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 228 MTVVRLI-ELLERGMRL---PCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred cchhhhh-hhhhcCCCC---CCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 1111111 111111111 12456889999999999999999999999999887765
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=349.06 Aligned_cols=274 Identities=24% Similarity=0.327 Sum_probs=208.6
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccCCC---hHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEE
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST---SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFF 140 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 140 (697)
++|++.++||+|+||.||+|.+ +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..+++|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 5899999999999999999987 57899999865432 233567899999999999999999999999999999999
Q ss_pred eecCCCCHhhhhhhc----------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccch
Q 005427 141 EFYESRNLAEKLHVE----------EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAE 210 (697)
Q Consensus 141 e~~~~g~L~~~l~~~----------~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~ 210 (697)
||++||+|.+++... ....+...++.++.|++.||+|||+.||+||||||+|||++.++.+||+|||++.
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLAk 161 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAI 161 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcce
Confidence 999999999988632 1234567788999999999999999999999999999999999999999999997
Q ss_pred hhhhhhhhhc-ccccCCCC-CCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHH
Q 005427 211 YRENLKEISL-KNWRSSGK-PTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAH 288 (697)
Q Consensus 211 ~~~~~~~~~~-~~~~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~ 288 (697)
.......... ......+. ..........+||+.|+|||++.+..++.++|||||||++|||++|..||..........
T Consensus 162 ~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~~ 241 (932)
T PRK13184 162 FKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKISY 241 (932)
T ss_pred ecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhhh
Confidence 6622110000 00000000 000111234579999999999999999999999999999999999999997643322111
Q ss_pred HHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCC-CHHHHHHHHHHHHHH
Q 005427 289 TVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRP-SFSDIALELDLVLEH 355 (697)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-t~~ell~~l~~~~~~ 355 (697)
... ...|........+|+.+.+++.+||+.||++|| +++++++.+...++.
T Consensus 242 ~~~----------------i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 242 RDV----------------ILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred hhh----------------ccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 100 000100011236789999999999999999996 577777777776654
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=317.91 Aligned_cols=255 Identities=24% Similarity=0.396 Sum_probs=207.5
Q ss_pred CcccccccccCCceEEEEEEE--CCeeEEEEeccCCCh---------HHHHHHHHHHHHHHhcCCCCceEEeeccccCCc
Q 005427 67 SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTS---------EELDNFHKELQLLCKLDHPGLAKFVAAHAKPPN 135 (697)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 135 (697)
+|.+.+.||.|+||.||+|.+ .++.+|+|.+..... ...+.+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 578899999999999999986 578899997654321 123568899999999999999999999999999
Q ss_pred eEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhh
Q 005427 136 YMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL 215 (697)
Q Consensus 136 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~ 215 (697)
.+++|||+++++|.+++...+ .+++..+..++.|++.||+|||+.|++||||+|+||+++.++.+||+|||++......
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYG-AFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEAN 159 (267)
T ss_pred cEEEEEecCCCCHHHHHHhcc-CccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCcccccc
Confidence 999999999999999997653 6788999999999999999999999999999999999999999999999998765421
Q ss_pred hhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccc
Q 005427 216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNY 295 (697)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~ 295 (697)
... ...........|+..|+|||.+.+..++.++|+|||||++|+|++|..||.+.........+..
T Consensus 160 ~~~----------~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--- 226 (267)
T cd06628 160 SLS----------TKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGE--- 226 (267)
T ss_pred ccc----------CCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhc---
Confidence 100 0000112335688999999999988889999999999999999999999987544322221111
Q ss_pred cHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 005427 296 TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350 (697)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~ 350 (697)
... +..+..++..+.++|++||+.||.+||++.+++++.|
T Consensus 227 ------------~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 266 (267)
T cd06628 227 ------------NAS---PEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPF 266 (267)
T ss_pred ------------cCC---CcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCC
Confidence 111 2234568899999999999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=314.06 Aligned_cols=256 Identities=28% Similarity=0.440 Sum_probs=209.1
Q ss_pred CCCCCCCcccccccccCCceEEEEEEE-CCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEE
Q 005427 61 LHLPPSSYTLLSPIARGAESVVYEATL-DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFF 139 (697)
Q Consensus 61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 139 (697)
|++..++|++.++||+|+||.||++.. .+..+++|..... ....+.+.+|+.+++.++|+||+++++.+.. ..++++
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v 78 (260)
T cd05073 1 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYII 78 (260)
T ss_pred CcccccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEE
Confidence 467788999999999999999999986 5567999976533 3345788999999999999999999999887 788999
Q ss_pred EeecCCCCHhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhh
Q 005427 140 FEFYESRNLAEKLHVE-EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI 218 (697)
Q Consensus 140 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~ 218 (697)
|||+++++|.+++... ...+++.+++.++.|++.||.|||+.|++||||||+||+++.++.+||+|||++........
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 157 (260)
T cd05073 79 TEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY- 157 (260)
T ss_pred EEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCCc-
Confidence 9999999999998653 34578889999999999999999999999999999999999999999999999865432110
Q ss_pred hcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCCchhHHHHHHHHhccccH
Q 005427 219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTE 297 (697)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~ 297 (697)
.......++..|+|||++.+..++.++|+|||||++|++++ |..||.+.+.......+..
T Consensus 158 --------------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~----- 218 (260)
T cd05073 158 --------------TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER----- 218 (260)
T ss_pred --------------ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhC-----
Confidence 01122345678999999998889999999999999999998 9999987654433322211
Q ss_pred HHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 005427 298 QQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL 351 (697)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~ 351 (697)
.... ..+...+.++.+++.+||+.+|++||++.++++.|..
T Consensus 219 ----------~~~~---~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 219 ----------GYRM---PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred ----------CCCC---CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1111 1234678899999999999999999999999877653
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=314.86 Aligned_cols=250 Identities=22% Similarity=0.340 Sum_probs=209.9
Q ss_pred CcccccccccCCceEEEEEEE--CCeeEEEEeccCC--ChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEee
Q 005427 67 SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF 142 (697)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 142 (697)
+|++++.||.|+||.||.++. +++.+++|..... .......+.+|+.++++++||||+++++++.+....+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 589999999999999988876 6788999976544 234566788999999999999999999999999999999999
Q ss_pred cCCCCHhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhcc
Q 005427 143 YESRNLAEKLHVE-EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLK 221 (697)
Q Consensus 143 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~ 221 (697)
+++++|.+++... ...+++.++..++.|++.+|.|||+.|++|+||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~---- 156 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS---- 156 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc----
Confidence 9999999998765 44689999999999999999999999999999999999999999999999999865432110
Q ss_pred cccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHHH
Q 005427 222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLT 301 (697)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 301 (697)
......|++.|+|||++.+..++.++|+||||+++|+|++|..||...........+..
T Consensus 157 ------------~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~--------- 215 (256)
T cd08221 157 ------------MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQ--------- 215 (256)
T ss_pred ------------cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc---------
Confidence 12345689999999999888889999999999999999999999987554433333221
Q ss_pred HHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 005427 302 AAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350 (697)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~ 350 (697)
+...+ .+..++.++.+++.+||..+|.+||++.+++++++
T Consensus 216 -----~~~~~----~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~ 255 (256)
T cd08221 216 -----GNYTP----VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPL 255 (256)
T ss_pred -----CCCCC----CccccCHHHHHHHHHHcccCcccCCCHHHHhhCcC
Confidence 22222 22467899999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=314.84 Aligned_cols=246 Identities=31% Similarity=0.495 Sum_probs=206.5
Q ss_pred cccccCCceEEEEEEEC-----CeeEEEEeccCCChHH-HHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEeecCC
Q 005427 72 SPIARGAESVVYEATLD-----GRKVAVKKPILSTSEE-LDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYES 145 (697)
Q Consensus 72 ~~lg~G~~g~V~~~~~~-----~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 145 (697)
+.||+|+||.||+|... +..+++|......... ...+.+|+++++.++||||+++++++.....++++|||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 47999999999999874 7789999876554433 67899999999999999999999999999999999999999
Q ss_pred CCHhhhhhhc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhh
Q 005427 146 RNLAEKLHVE--------EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKE 217 (697)
Q Consensus 146 g~L~~~l~~~--------~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~ 217 (697)
++|.+++... ...+++.+++.++.|++.||.|||+.|++||||||+||+++.++.+||+|||.+........
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~ 160 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDY 160 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccccc
Confidence 9999999876 45789999999999999999999999999999999999999999999999999976543111
Q ss_pred hhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCCchhHHHHHHHHhcccc
Q 005427 218 ISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYT 296 (697)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~~~~~~~~~~~~~~~~~ 296 (697)
........+++.|+|||.+....++.++||||||+++|+|++ |..||.+.........+..
T Consensus 161 --------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~---- 222 (262)
T cd00192 161 --------------YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK---- 222 (262)
T ss_pred --------------cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc----
Confidence 011234467889999999988889999999999999999999 6999988754433332221
Q ss_pred HHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 005427 297 EQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALEL 349 (697)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l 349 (697)
..+ ...+..+|.++.+++.+||+.+|++|||+.+++++|
T Consensus 223 -----------~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l 261 (262)
T cd00192 223 -----------GYR---LPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERL 261 (262)
T ss_pred -----------CCC---CCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 111 123456789999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=322.73 Aligned_cols=247 Identities=25% Similarity=0.348 Sum_probs=209.5
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccCC---ChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEE
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFF 140 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 140 (697)
++|++.+.||+|+||.||++.+ .++.+|+|+.... .....+.+.+|++++++++||||+++++++.....++++|
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 3799999999999999999987 5789999976432 2234567899999999999999999999999999999999
Q ss_pred eecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhc
Q 005427 141 EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL 220 (697)
Q Consensus 141 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~ 220 (697)
||+.+++|.+++.... .+++..+..++.|++.||.|||+.|++|+||+|+|||++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~~-~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~----- 154 (290)
T cd05580 81 EYVPGGELFSHLRKSG-RFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR----- 154 (290)
T ss_pred ecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-----
Confidence 9999999999987654 7899999999999999999999999999999999999999999999999998654321
Q ss_pred ccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHH
Q 005427 221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQL 300 (697)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 300 (697)
.....|++.|+|||.+.+...+.++||||||+++|+|++|..||...........+..
T Consensus 155 --------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-------- 212 (290)
T cd05580 155 --------------TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILE-------- 212 (290)
T ss_pred --------------CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc--------
Confidence 2344688999999999888889999999999999999999999987654333332221
Q ss_pred HHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCC-----CHHHHHHHHHH
Q 005427 301 TAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRP-----SFSDIALELDL 351 (697)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~ell~~l~~ 351 (697)
+ .+ ..+..++..+.+++.+||..||.+|+ +++++++|.|+
T Consensus 213 ------~--~~---~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~ 257 (290)
T cd05580 213 ------G--KV---RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWF 257 (290)
T ss_pred ------C--Cc---cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCccc
Confidence 1 11 12345789999999999999999999 89999988764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=326.46 Aligned_cols=263 Identities=26% Similarity=0.407 Sum_probs=213.4
Q ss_pred cCCCCCCCcccccccccCCceEEEEEEEC---------CeeEEEEeccCCC-hHHHHHHHHHHHHHHhc-CCCCceEEee
Q 005427 60 PLHLPPSSYTLLSPIARGAESVVYEATLD---------GRKVAVKKPILST-SEELDNFHKELQLLCKL-DHPGLAKFVA 128 (697)
Q Consensus 60 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~---------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~l~~ 128 (697)
.+++...+|++++.||+|+||.||++++. ...||+|...... ....+.+.+|+.+++++ +||||+++++
T Consensus 6 ~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 85 (334)
T cd05100 6 KWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLG 85 (334)
T ss_pred ccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeE
Confidence 46777889999999999999999999752 2368999765432 34467899999999999 8999999999
Q ss_pred ccccCCceEEEEeecCCCCHhhhhhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCce
Q 005427 129 AHAKPPNYMFFFEFYESRNLAEKLHVEE---------------WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANV 193 (697)
Q Consensus 129 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Ni 193 (697)
++......++++||+.+|+|.+++.... ..+++.++..++.|++.||.|||+.|++||||||+||
T Consensus 86 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Ni 165 (334)
T cd05100 86 ACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNV 165 (334)
T ss_pred EEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceE
Confidence 9999999999999999999999986532 2467788999999999999999999999999999999
Q ss_pred eecCCCCCeeeeeccchhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh
Q 005427 194 LLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT 273 (697)
Q Consensus 194 ll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~ 273 (697)
|++.++.+||+|||+++........ .......++..|+|||++.+..++.++|||||||++|||++
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~--------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~ 231 (334)
T cd05100 166 LVTEDNVMKIADFGLARDVHNIDYY--------------KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231 (334)
T ss_pred EEcCCCcEEECCcccceeccccccc--------------ccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHh
Confidence 9999999999999998754321100 01122344578999999999999999999999999999998
Q ss_pred -CCCCCCCchhHHHHHHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 274 -GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 274 -g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
|..||.+.........+.. ...+ ..+..++.++.+++.+||+.+|.+|||+.+++++|..+
T Consensus 232 ~g~~p~~~~~~~~~~~~~~~---------------~~~~---~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~ 293 (334)
T cd05100 232 LGGSPYPGIPVEELFKLLKE---------------GHRM---DKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRV 293 (334)
T ss_pred cCCCCCCCCCHHHHHHHHHc---------------CCCC---CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 8999987654443332211 1111 12346788999999999999999999999999999888
Q ss_pred HH
Q 005427 353 LE 354 (697)
Q Consensus 353 ~~ 354 (697)
..
T Consensus 294 ~~ 295 (334)
T cd05100 294 LT 295 (334)
T ss_pred hh
Confidence 64
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=316.75 Aligned_cols=261 Identities=24% Similarity=0.338 Sum_probs=210.5
Q ss_pred CCCCCCcccccccccCCceEEEEEEEC------CeeEEEEeccCC-ChHHHHHHHHHHHHHHhcCCCCceEEeecccc-C
Q 005427 62 HLPPSSYTLLSPIARGAESVVYEATLD------GRKVAVKKPILS-TSEELDNFHKELQLLCKLDHPGLAKFVAAHAK-P 133 (697)
Q Consensus 62 ~~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~ 133 (697)
.+..++|++.+.||+|+||.||+|.+. +..|++|..... .......+.+|+.+++.++||||+++++++.. +
T Consensus 2 ~~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~ 81 (280)
T cd05043 2 AISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDG 81 (280)
T ss_pred ccchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 456789999999999999999999873 477899876543 34456778999999999999999999998665 5
Q ss_pred CceEEEEeecCCCCHhhhhhhcC-------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeee
Q 005427 134 PNYMFFFEFYESRNLAEKLHVEE-------WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADF 206 (697)
Q Consensus 134 ~~~~lv~e~~~~g~L~~~l~~~~-------~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Df 206 (697)
...+++++|+.+++|.+++.... ..+++.+++.++.|++.||+|||+.+++||||||+||+++.++.+||+||
T Consensus 82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCC
Confidence 77899999999999999986532 35789999999999999999999999999999999999999999999999
Q ss_pred ccchhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCCchhHH
Q 005427 207 GLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEA 285 (697)
Q Consensus 207 g~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~~~~~~ 285 (697)
|+++.+..... ........++..|+|||++.+..++.++|||||||++|++++ |..||...+...
T Consensus 162 g~~~~~~~~~~--------------~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~ 227 (280)
T cd05043 162 ALSRDLFPMDY--------------HCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE 227 (280)
T ss_pred CCcccccCCce--------------EEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH
Confidence 99875432110 000112345678999999998889999999999999999999 999998754433
Q ss_pred HHHHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 005427 286 QAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE 354 (697)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~ 354 (697)
....+. ...++. .+..+|+++.+++.+||..||++|||+.++++.|..+.+
T Consensus 228 ~~~~~~---------------~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 228 MAAYLK---------------DGYRLA---QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred HHHHHH---------------cCCCCC---CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 222111 111111 123578999999999999999999999999999887754
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=322.95 Aligned_cols=262 Identities=26% Similarity=0.434 Sum_probs=220.2
Q ss_pred ccCCCCCCCcccccccccCCceEEEEEEEC--CeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCce
Q 005427 59 IPLHLPPSSYTLLSPIARGAESVVYEATLD--GRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNY 136 (697)
Q Consensus 59 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 136 (697)
..|+....+.....+||-|.||.||.|.|+ .-.||||.+. .+..+.+.|..|+.+|+.++|||+|+|+++|..+..+
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLK-EDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF 338 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF 338 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhh-hcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence 567777788888999999999999999885 4568998753 4556789999999999999999999999999999999
Q ss_pred EEEEeecCCCCHhhhhhhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhh
Q 005427 137 MFFFEFYESRNLAEKLHVEEW-SPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL 215 (697)
Q Consensus 137 ~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~ 215 (697)
|+|+|||..|+|.++|++... ..+.--++.++.||..|++||..+++|||||..+|+|+.++..||++|||+++.+...
T Consensus 339 YIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgD 418 (1157)
T KOG4278|consen 339 YIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGD 418 (1157)
T ss_pred EEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCC
Confidence 999999999999999986553 3455677889999999999999999999999999999999999999999999988642
Q ss_pred hhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCCchhHHHHHHHHhcc
Q 005427 216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMN 294 (697)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~~~~~~~~~~~~~~~ 294 (697)
.... -....-++-|.|||-+....++.++|||+|||+|||+.| |..||.+.+.......+ +..
T Consensus 419 TYTA---------------HAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LL-Ekg 482 (1157)
T KOG4278|consen 419 TYTA---------------HAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLL-EKG 482 (1157)
T ss_pred ceec---------------ccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHH-hcc
Confidence 2110 011123678999999999999999999999999999999 99999997655443322 222
Q ss_pred ccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 005427 295 YTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE 354 (697)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~ 354 (697)
+| ..-|.+||+.+..||+.||+++|..||+|+|+-+.++.++.
T Consensus 483 --------------yR---M~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~ 525 (1157)
T KOG4278|consen 483 --------------YR---MDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS 525 (1157)
T ss_pred --------------cc---ccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence 11 12357899999999999999999999999999888877653
|
|
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=318.59 Aligned_cols=256 Identities=28% Similarity=0.431 Sum_probs=206.8
Q ss_pred CCCCCcccccccccCCceEEEEEEE-------CCeeEEEEeccCCCh-HHHHHHHHHHHHHHhcCCCCceEEeeccccCC
Q 005427 63 LPPSSYTLLSPIARGAESVVYEATL-------DGRKVAVKKPILSTS-EELDNFHKELQLLCKLDHPGLAKFVAAHAKPP 134 (697)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~-------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 134 (697)
++..+|++.+.||+|+||.||++.+ .+..+|+|....... .....+.+|+.+++.++||||+++++++....
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~ 81 (288)
T cd05050 2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGK 81 (288)
T ss_pred CChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC
Confidence 3457899999999999999999986 356899998765433 34567899999999999999999999999999
Q ss_pred ceEEEEeecCCCCHhhhhhhcC---------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCce
Q 005427 135 NYMFFFEFYESRNLAEKLHVEE---------------------WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANV 193 (697)
Q Consensus 135 ~~~lv~e~~~~g~L~~~l~~~~---------------------~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Ni 193 (697)
..+++|||+.+|+|.+++.... ..+++.+++.++.|++.||.|||+.+++||||||+||
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~ni 161 (288)
T cd05050 82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNC 161 (288)
T ss_pred ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhhe
Confidence 9999999999999999986432 2367788999999999999999999999999999999
Q ss_pred eecCCCCCeeeeeccchhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh
Q 005427 194 LLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT 273 (697)
Q Consensus 194 ll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~ 273 (697)
+++.++.+||+|||++......... .......+++.|+|||++.+..++.++|||||||++|+|++
T Consensus 162 l~~~~~~~~l~dfg~~~~~~~~~~~--------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~ 227 (288)
T cd05050 162 LVGENMVVKIADFGLSRNIYSADYY--------------KASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227 (288)
T ss_pred EecCCCceEECccccceecccCccc--------------cccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHh
Confidence 9999999999999998644321100 00122334678999999998899999999999999999998
Q ss_pred -CCCCCCCchhHHHHHHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 005427 274 -GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350 (697)
Q Consensus 274 -g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~ 350 (697)
|..||.+.........+. .+... ..+..++.++.+|+.+||+.+|.+|||+.|+++.|+
T Consensus 228 ~~~~p~~~~~~~~~~~~~~--------------~~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 228 YGMQPYYGMAHEEVIYYVR--------------DGNVL----SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred CCCCCCCCCCHHHHHHHHh--------------cCCCC----CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 888997654443322221 11111 123467899999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=309.98 Aligned_cols=245 Identities=27% Similarity=0.426 Sum_probs=200.8
Q ss_pred cccccCCceEEEEEEE-CCeeEEEEeccCCCh-HHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEeecCCCCHh
Q 005427 72 SPIARGAESVVYEATL-DGRKVAVKKPILSTS-EELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLA 149 (697)
Q Consensus 72 ~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~ 149 (697)
++||+|+||.||+|.. .++.+|+|....... .....+.+|+++++.++||||+++++++......++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 4799999999999986 567899998654432 33457889999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhcccccCCCCC
Q 005427 150 EKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKP 229 (697)
Q Consensus 150 ~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~ 229 (697)
+++......+++.+++.++.|++.+|.|||+.|++||||||+||+++.++.+||+|||++........
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~------------ 148 (250)
T cd05085 81 SFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY------------ 148 (250)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceecccccc------------
Confidence 99876665688999999999999999999999999999999999999999999999999864321000
Q ss_pred CCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCCchhHHHHHHHHhccccHHHHHHHHHhCC
Q 005427 230 TGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGG 308 (697)
Q Consensus 230 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (697)
.......+++.|+|||++.+..++.++||||||+++|++++ |..||.+.........+.. .
T Consensus 149 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~---------------~ 210 (250)
T cd05085 149 ---SSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEK---------------G 210 (250)
T ss_pred ---ccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHc---------------C
Confidence 00112234678999999998889999999999999999998 9999987654433222211 1
Q ss_pred CCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 005427 309 LRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALEL 349 (697)
Q Consensus 309 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l 349 (697)
.+. ..+..++..+.+++.+||..+|++||++.++++.+
T Consensus 211 ~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l 248 (250)
T cd05085 211 YRM---SCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKEL 248 (250)
T ss_pred CCC---CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHh
Confidence 111 22346789999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=315.13 Aligned_cols=256 Identities=25% Similarity=0.385 Sum_probs=207.3
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccCC---ChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEE
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFF 140 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 140 (697)
.+|++.+.||+|+||.||++.. +++.++||..... .......+.+|+.+++.++||||+++++++..+..++++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4799999999999999999985 6889999975432 2334567889999999999999999999999999999999
Q ss_pred eecCCCCHhhhhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhh
Q 005427 141 EFYESRNLAEKLHV---EEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKE 217 (697)
Q Consensus 141 e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~ 217 (697)
||+.+++|.+++.. ....+++.+++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~- 160 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT- 160 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCC-
Confidence 99999999998763 23457899999999999999999999999999999999999999999999999986543211
Q ss_pred hhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccH
Q 005427 218 ISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTE 297 (697)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~ 297 (697)
.......|++.|+|||++.+..++.++|+||||+++|+|++|..||.+......
T Consensus 161 ---------------~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~----------- 214 (267)
T cd08229 161 ---------------TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY----------- 214 (267)
T ss_pred ---------------cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHH-----------
Confidence 012234688999999999988899999999999999999999999975432110
Q ss_pred HHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 298 QQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
.....+......+. .+..++.++.+++.+||..||.+|||+.+|++.+..+
T Consensus 215 -~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 215 -SLCKKIEQCDYPPL---PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred -HHhhhhhcCCCCCC---CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 00111111111111 1235788999999999999999999999998876654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=317.34 Aligned_cols=237 Identities=26% Similarity=0.345 Sum_probs=190.9
Q ss_pred ccccCCceEEEEEEEC--------------------------CeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEE
Q 005427 73 PIARGAESVVYEATLD--------------------------GRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKF 126 (697)
Q Consensus 73 ~lg~G~~g~V~~~~~~--------------------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l 126 (697)
+||+|+||.||+|... ...|++|............+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 6999999999999631 13588887655544445678899999999999999999
Q ss_pred eeccccCCceEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCC-------
Q 005427 127 VAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNL------- 199 (697)
Q Consensus 127 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~------- 199 (697)
++++......++||||+++|+|..++......+++..+..++.|++.||+|||+++|+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~~~ 161 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSP 161 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCccc
Confidence 9999999999999999999999999876666789999999999999999999999999999999999997643
Q ss_pred CCeeeeeccchhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcc-cCCCchhhHHHHHHHHHHHH-hCCCC
Q 005427 200 CPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELL-TGVVP 277 (697)
Q Consensus 200 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~ell-~g~~P 277 (697)
.+||+|||++..... .....++..|+|||.+.+ ..++.++|||||||++||++ +|..|
T Consensus 162 ~~kl~d~g~~~~~~~--------------------~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p 221 (274)
T cd05076 162 FIKLSDPGVSFTALS--------------------REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVP 221 (274)
T ss_pred eeeecCCcccccccc--------------------ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 379999998753221 122357788999998875 56789999999999999995 69999
Q ss_pred CCCchhHHHHHHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 005427 278 YTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALEL 349 (697)
Q Consensus 278 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l 349 (697)
|.......... ... .. . ..+...++.+.++|.+||+.+|++|||+.+++++|
T Consensus 222 ~~~~~~~~~~~-~~~--------------~~--~---~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 222 LKERTPSEKER-FYE--------------KK--H---RLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred ccccChHHHHH-HHH--------------hc--c---CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 97654332211 100 00 0 11223567899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=312.44 Aligned_cols=252 Identities=27% Similarity=0.431 Sum_probs=199.0
Q ss_pred cccccCCceEEEEEEEC-----CeeEEEEeccC-CChHHHHHHHHHHHHHHhcCCCCceEEeeccc-cCCceEEEEeecC
Q 005427 72 SPIARGAESVVYEATLD-----GRKVAVKKPIL-STSEELDNFHKELQLLCKLDHPGLAKFVAAHA-KPPNYMFFFEFYE 144 (697)
Q Consensus 72 ~~lg~G~~g~V~~~~~~-----~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~~lv~e~~~ 144 (697)
+.||+|+||.||+|... ...+|+|.... ......+.+.+|+.+++.++||||+++++++. .+...+++|||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999752 35799998643 33455678899999999999999999999765 4556889999999
Q ss_pred CCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhccccc
Q 005427 145 SRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWR 224 (697)
Q Consensus 145 ~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~ 224 (697)
+|+|.+++......+++..+..++.|++.||.|||+.+++||||||+|||++.++.+||+|||+++.........
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~----- 155 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS----- 155 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCccee-----
Confidence 999999997665567788889999999999999999999999999999999999999999999986543211000
Q ss_pred CCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCCchhHHHHHHHHhccccHHHHHHH
Q 005427 225 SSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAA 303 (697)
Q Consensus 225 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (697)
........++..|+|||.+.+..++.++|||||||++|||++ |.+||...........+
T Consensus 156 -------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~------------- 215 (262)
T cd05058 156 -------VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYL------------- 215 (262)
T ss_pred -------ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-------------
Confidence 001123356778999999988889999999999999999999 56777654433222111
Q ss_pred HHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 005427 304 VVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL 353 (697)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~ 353 (697)
..+ ..+ ..+..+|..+.+++.+||..+|++||++.++++.+..+.
T Consensus 216 -~~~-~~~---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 216 -LQG-RRL---LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred -hcC-CCC---CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 111 111 123357889999999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=320.94 Aligned_cols=269 Identities=26% Similarity=0.324 Sum_probs=211.3
Q ss_pred CcccccccccCCceEEEEEEE--CCeeEEEEeccCCC--hHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEee
Q 005427 67 SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST--SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF 142 (697)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 142 (697)
+|++.+.||+|+||.||+|.+ .++.|++|+..... ......+.+|+.+++.++||||+++++++.....+++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 589999999999999999987 57899999866543 23356789999999999999999999999999999999999
Q ss_pred cCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhccc
Q 005427 143 YESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKN 222 (697)
Q Consensus 143 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 222 (697)
+ +++|.+++......+++.+++.++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++........
T Consensus 81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~----- 154 (286)
T cd07832 81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP----- 154 (286)
T ss_pred c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-----
Confidence 9 9999999876666789999999999999999999999999999999999999999999999999875532110
Q ss_pred ccCCCCCCCCccccccccCccccchhhhccc-CCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHHH
Q 005427 223 WRSSGKPTGGFHKKNMVGTLIYMAPEILKKE-IHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLT 301 (697)
Q Consensus 223 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 301 (697)
.......|+..|+|||++.+. .++.++||||+||++|+|++|.+||.+.........+...........
T Consensus 155 ----------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (286)
T cd07832 155 ----------RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEET 224 (286)
T ss_pred ----------CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHH
Confidence 012334689999999998654 468999999999999999999999987665544444332211110000
Q ss_pred HHHHh------C-CC----CCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 005427 302 AAVVS------G-GL----RPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL 351 (697)
Q Consensus 302 ~~~~~------~-~~----~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~ 351 (697)
+.... . .. ...+.......+.++.+++.+||+.+|.+|||+++++.|.|+
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~ 285 (286)
T cd07832 225 WPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285 (286)
T ss_pred HhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCc
Confidence 00000 0 00 000111223567899999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=351.56 Aligned_cols=260 Identities=23% Similarity=0.278 Sum_probs=221.2
Q ss_pred CCCCCCCcccccccccCCceEEEEEEE--CCeeEEEEeccC---CChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCc
Q 005427 61 LHLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPIL---STSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPN 135 (697)
Q Consensus 61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 135 (697)
+++..++|.+++.||+|+||.|.++++ +++.||+|++.. ....+..-|..|-++|..-+.+-|+.|+..|.++.+
T Consensus 70 lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~ 149 (1317)
T KOG0612|consen 70 LRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERY 149 (1317)
T ss_pred HhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccc
Confidence 556778999999999999999999987 678899997543 223345678999999999999999999999999999
Q ss_pred eEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhh
Q 005427 136 YMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL 215 (697)
Q Consensus 136 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~ 215 (697)
+|+||||++||+|..++.+.+ +++++.+++++..|+.||.-||+.|+|||||||+|||||..|++||+|||.|-.+..
T Consensus 150 LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~- 227 (1317)
T KOG0612|consen 150 LYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDA- 227 (1317)
T ss_pred eEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCC-
Confidence 999999999999999998877 899999999999999999999999999999999999999999999999999876652
Q ss_pred hhhhcccccCCCCCCCCccccccccCccccchhhhc----c-cCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHH
Q 005427 216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILK----K-EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTV 290 (697)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~ 290 (697)
.+.......+|||.|.+||++. + +.|++.+|+||+||++|||+.|..||...+...+..+|
T Consensus 228 --------------dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KI 293 (1317)
T KOG0612|consen 228 --------------DGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKI 293 (1317)
T ss_pred --------------CCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHH
Confidence 1222355679999999999995 3 56899999999999999999999999988777777777
Q ss_pred HhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCC---HHHHHHHHHHH
Q 005427 291 LEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPS---FSDIALELDLV 352 (697)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt---~~ell~~l~~~ 352 (697)
+.-.-. -.+| ....+|.++++||.+.+. +|+.|.. ++++..|+++.
T Consensus 294 m~hk~~--------------l~FP-~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~ 342 (1317)
T KOG0612|consen 294 MNHKES--------------LSFP-DETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFE 342 (1317)
T ss_pred hchhhh--------------cCCC-cccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCcccc
Confidence 643110 0111 124599999999998775 5889988 99999998764
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=312.65 Aligned_cols=252 Identities=27% Similarity=0.447 Sum_probs=206.8
Q ss_pred CCCCcccccccccCCceEEEEEEE-CCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEee
Q 005427 64 PPSSYTLLSPIARGAESVVYEATL-DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF 142 (697)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 142 (697)
.+.+|++.+.||+|+||.||++.+ .+..+|+|...... .....+.+|+++++.++||||+++++++......+++|||
T Consensus 2 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd05112 2 HPSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEF 80 (256)
T ss_pred ChhHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEc
Confidence 456899999999999999999987 47789999765332 2345688999999999999999999999999999999999
Q ss_pred cCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhccc
Q 005427 143 YESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKN 222 (697)
Q Consensus 143 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 222 (697)
+.+++|.+++......++++.++.++.|++.+|+|||+.+++||||||+||+++.++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~----- 155 (256)
T cd05112 81 MEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY----- 155 (256)
T ss_pred CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCcc-----
Confidence 999999999977665788999999999999999999999999999999999999999999999999864421100
Q ss_pred ccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCCchhHHHHHHHHhccccHHHHH
Q 005427 223 WRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLT 301 (697)
Q Consensus 223 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 301 (697)
.......++..|+|||++.+..++.++||||||+++|+|++ |..||...........+.
T Consensus 156 ----------~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~---------- 215 (256)
T cd05112 156 ----------TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETIN---------- 215 (256)
T ss_pred ----------cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHh----------
Confidence 00112335678999999998889999999999999999998 999998755443333221
Q ss_pred HHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 005427 302 AAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALEL 349 (697)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l 349 (697)
.+.++. .+...+..+.+|+.+||+.+|++|||+.++++++
T Consensus 216 -----~~~~~~---~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 216 -----AGFRLY---KPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred -----CCCCCC---CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 111221 1234688999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=320.26 Aligned_cols=268 Identities=25% Similarity=0.310 Sum_probs=206.3
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccCCCh--HHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEe
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTS--EELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFE 141 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 141 (697)
++|++.+.||+|+||.||+|++ +++.||+|+...... ...+.+.+|+.+++.++||||+++++++.....++++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 4799999999999999999987 578999997654321 223567899999999999999999999999999999999
Q ss_pred ecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhcc
Q 005427 142 FYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLK 221 (697)
Q Consensus 142 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~ 221 (697)
|++++.|..++... ..+++.+++.++.|++.||.|||+.|++||||||+||+++.++.+||+|||++........
T Consensus 81 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~---- 155 (286)
T cd07847 81 YCDHTVLNELEKNP-RGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD---- 155 (286)
T ss_pred ccCccHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcc----
Confidence 99998887776543 3689999999999999999999999999999999999999999999999999875532110
Q ss_pred cccCCCCCCCCccccccccCccccchhhhcc-cCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHH
Q 005427 222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQL 300 (697)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 300 (697)
......++..|+|||++.+ ..++.++|+||||+++|+|++|..||.+.........+..........
T Consensus 156 ------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 223 (286)
T cd07847 156 ------------DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPR 223 (286)
T ss_pred ------------cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChH
Confidence 1223457889999999876 557889999999999999999999998765544333322111100000
Q ss_pred HHHHHhC------CCCC------cccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 005427 301 TAAVVSG------GLRP------ILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350 (697)
Q Consensus 301 ~~~~~~~------~~~~------~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~ 350 (697)
....... ...+ ........++..+.+|+.+||+.+|++|||+.+++.|.|
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~ 285 (286)
T cd07847 224 HQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPY 285 (286)
T ss_pred HhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCC
Confidence 0000000 0000 001112356889999999999999999999999998765
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=316.07 Aligned_cols=256 Identities=27% Similarity=0.435 Sum_probs=208.4
Q ss_pred CCCCCcccccccccCCceEEEEEEEC-------CeeEEEEeccCCChH-HHHHHHHHHHHHHhcCCCCceEEeeccccCC
Q 005427 63 LPPSSYTLLSPIARGAESVVYEATLD-------GRKVAVKKPILSTSE-ELDNFHKELQLLCKLDHPGLAKFVAAHAKPP 134 (697)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 134 (697)
++.++|++.+.||+|+||.||+|+.. .+.+++|........ ..+.+.+|++++++++||||+++++++....
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 81 (275)
T cd05046 2 FPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAE 81 (275)
T ss_pred CChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCC
Confidence 34578999999999999999999852 357899976554443 4678999999999999999999999999989
Q ss_pred ceEEEEeecCCCCHhhhhhhcC--------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeee
Q 005427 135 NYMFFFEFYESRNLAEKLHVEE--------WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADF 206 (697)
Q Consensus 135 ~~~lv~e~~~~g~L~~~l~~~~--------~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Df 206 (697)
..++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+|+||||||+||+++.++.++|+||
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEccc
Confidence 9999999999999999986543 15789999999999999999999999999999999999999999999999
Q ss_pred ccchhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCCchhHH
Q 005427 207 GLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEA 285 (697)
Q Consensus 207 g~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~~~~~~ 285 (697)
|++....... ........+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+.....
T Consensus 162 ~~~~~~~~~~---------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~ 226 (275)
T cd05046 162 SLSKDVYNSE---------------YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE 226 (275)
T ss_pred ccccccCccc---------------ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH
Confidence 9986432110 011223456788999999988888999999999999999998 889997654433
Q ss_pred HHHHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 005427 286 QAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350 (697)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~ 350 (697)
....+.. +... ...+..++..+.+++.+||+.+|.+|||+.+++..++
T Consensus 227 ~~~~~~~--------------~~~~---~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 227 VLNRLQA--------------GKLE---LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred HHHHHHc--------------CCcC---CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 3222211 1111 1123467899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=317.27 Aligned_cols=268 Identities=25% Similarity=0.371 Sum_probs=206.4
Q ss_pred CCcccccccccCCceEEEEEEE------CCeeEEEEeccCCC-hHHHHHHHHHHHHHHhcCCCCceEEeeccccC--Cce
Q 005427 66 SSYTLLSPIARGAESVVYEATL------DGRKVAVKKPILST-SEELDNFHKELQLLCKLDHPGLAKFVAAHAKP--PNY 136 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~ 136 (697)
.-|+++++||+|+||.||++.+ .+..||+|...... ......+.+|+.+++.++||||+++++++... ..+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 4589999999999999999974 46789999865443 34456899999999999999999999988765 568
Q ss_pred EEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhh
Q 005427 137 MFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLK 216 (697)
Q Consensus 137 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~ 216 (697)
+++|||+++++|.+++......+++.+++.++.|++.||+|||+.|++||||||+||+++.++.+||+|||++.......
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~ 163 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK 163 (284)
T ss_pred EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccCc
Confidence 99999999999999987665568999999999999999999999999999999999999999999999999987553211
Q ss_pred hhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHH---hc
Q 005427 217 EISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVL---EM 293 (697)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~---~~ 293 (697)
.. ........++..|+|||++.+..++.++|||||||++|+|+++..|+....... .... ..
T Consensus 164 ~~-------------~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~--~~~~~~~~~ 228 (284)
T cd05079 164 EY-------------YTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLF--LKMIGPTHG 228 (284)
T ss_pred cc-------------eeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchh--hhhcccccc
Confidence 10 001223457778999999998889999999999999999999877654321110 0000 00
Q ss_pred cccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 294 NYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
......... ....+.+. ..+..++..+.+|+.+||+.+|++|||+.++++.+..+
T Consensus 229 ~~~~~~~~~-~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 229 QMTVTRLVR-VLEEGKRL---PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred cccHHHHHH-HHHcCccC---CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 011111111 11111111 12456889999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=314.56 Aligned_cols=250 Identities=23% Similarity=0.391 Sum_probs=209.1
Q ss_pred CcccccccccCCceEEEEEEE--CCeeEEEEeccCC--ChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEee
Q 005427 67 SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF 142 (697)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 142 (697)
+|++.+.||+|+||.||++.. .++.|++|.+... .......+.+|+.+++.++||||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 589999999999999999986 5788999986543 234456789999999999999999999999999999999999
Q ss_pred cCCCCHhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhcc
Q 005427 143 YESRNLAEKLHVEE-WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLK 221 (697)
Q Consensus 143 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~ 221 (697)
+.+++|.+.+.... ..+++.+++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~---- 156 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE---- 156 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh----
Confidence 99999999886543 3578899999999999999999999999999999999999999999999999865432111
Q ss_pred cccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHHH
Q 005427 222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLT 301 (697)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 301 (697)
......|++.|+|||++.+..++.++|+|||||++++|++|..||...........+..
T Consensus 157 ------------~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~--------- 215 (256)
T cd08218 157 ------------LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIR--------- 215 (256)
T ss_pred ------------hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhc---------
Confidence 12234688899999999988889999999999999999999999976544433332221
Q ss_pred HHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 005427 302 AAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350 (697)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~ 350 (697)
+.. +..+..++.++.++|.+||+.+|.+||++.++++|.|
T Consensus 216 -----~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~ 255 (256)
T cd08218 216 -----GSY----PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNF 255 (256)
T ss_pred -----CCC----CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcC
Confidence 111 1234467899999999999999999999999998865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=314.96 Aligned_cols=259 Identities=22% Similarity=0.368 Sum_probs=211.4
Q ss_pred CCCCCcccccccccCCceEEEEEEE--CCe----eEEEEeccCCC-hHHHHHHHHHHHHHHhcCCCCceEEeeccccCCc
Q 005427 63 LPPSSYTLLSPIARGAESVVYEATL--DGR----KVAVKKPILST-SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPN 135 (697)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 135 (697)
+...+|++.+.||+|+||.||+|.. ++. .+|+|...... ......+.+|+.+++.++||||+++++++.. ..
T Consensus 4 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~ 82 (279)
T cd05057 4 LKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQ 82 (279)
T ss_pred cCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cc
Confidence 4557899999999999999999975 232 58898765443 3345678999999999999999999999887 78
Q ss_pred eEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhh
Q 005427 136 YMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL 215 (697)
Q Consensus 136 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~ 215 (697)
.+++|||+.+|+|.+++......+++..++.++.|++.||+|||+.|++||||||+|||++.++.+||+|||++......
T Consensus 83 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~ 162 (279)
T cd05057 83 VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD 162 (279)
T ss_pred eEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccCc
Confidence 99999999999999999876667899999999999999999999999999999999999999999999999999765421
Q ss_pred hhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCCchhHHHHHHHHhcc
Q 005427 216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMN 294 (697)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~~~~~~~~~~~~~~~ 294 (697)
.. ........++..|+|||.+....++.++|+||||+++||+++ |..||.+.........+..
T Consensus 163 ~~--------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-- 226 (279)
T cd05057 163 EK--------------EYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEK-- 226 (279)
T ss_pred cc--------------ceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC--
Confidence 11 001112234678999999988889999999999999999998 9999987654433222211
Q ss_pred ccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 005427 295 YTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE 354 (697)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~ 354 (697)
+.. ...+..++.++.+++.+||..+|.+||++.++++.+..+.+
T Consensus 227 ------------~~~----~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 227 ------------GER----LPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred ------------CCC----CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 111 11234577899999999999999999999999998888754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=313.30 Aligned_cols=247 Identities=28% Similarity=0.477 Sum_probs=198.4
Q ss_pred cccccCCceEEEEEEEC--Ce--eEEEEeccCC-ChHHHHHHHHHHHHHHhc-CCCCceEEeeccccCCceEEEEeecCC
Q 005427 72 SPIARGAESVVYEATLD--GR--KVAVKKPILS-TSEELDNFHKELQLLCKL-DHPGLAKFVAAHAKPPNYMFFFEFYES 145 (697)
Q Consensus 72 ~~lg~G~~g~V~~~~~~--~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~ 145 (697)
+.||+|+||.||+|... +. .+++|..... .......+.+|+.++.++ +||||+++++++.....++++|||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 46899999999999863 33 4688876532 344566889999999999 899999999999999999999999999
Q ss_pred CCHhhhhhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccch
Q 005427 146 RNLAEKLHVEE---------------WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAE 210 (697)
Q Consensus 146 g~L~~~l~~~~---------------~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~ 210 (697)
|+|.+++.... ..+++.+++.++.|++.||+|||+.|++||||||+|||++.++.+||+|||++.
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~~ 160 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 160 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCcc
Confidence 99999986532 246889999999999999999999999999999999999999999999999975
Q ss_pred hhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCCchhHHHHHH
Q 005427 211 YRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHT 289 (697)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~~~~~~~~~~ 289 (697)
...... .......+..|+|||++.+..++.++|||||||++|||++ |..||.+.........
T Consensus 161 ~~~~~~-----------------~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~ 223 (270)
T cd05047 161 GQEVYV-----------------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK 223 (270)
T ss_pred ccchhh-----------------hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHH
Confidence 322100 0112234567999999998889999999999999999997 9999976544332222
Q ss_pred HHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 005427 290 VLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL 353 (697)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~ 353 (697)
+. ...+. ..+..++.++.+++.+||..+|.+|||+.+++..|..++
T Consensus 224 ~~---------------~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 224 LP---------------QGYRL---EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred Hh---------------CCCCC---CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 11 11111 123457889999999999999999999999999887764
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=301.98 Aligned_cols=252 Identities=21% Similarity=0.294 Sum_probs=205.8
Q ss_pred CCcccc-cccccCCceEEEEEEE--CCeeEEEEeccCCChHHHHHHHHHHHHHHhc-CCCCceEEeeccccC----CceE
Q 005427 66 SSYTLL-SPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKL-DHPGLAKFVAAHAKP----PNYM 137 (697)
Q Consensus 66 ~~y~~~-~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~----~~~~ 137 (697)
++|.+. ++||-|-.|.|-.+.+ +++++|+|++. +....++|+++.-+. .|||||.++++|++. ..+.
T Consensus 61 edY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~-----Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLL 135 (400)
T KOG0604|consen 61 EDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLL-----DSPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLL 135 (400)
T ss_pred hhheehhhhhccccCCceEEEEeccchhhhHHHHHh-----cCHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeE
Confidence 456554 5799999999999976 68899999864 334567899886655 699999999998763 4678
Q ss_pred EEEeecCCCCHhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecC---CCCCeeeeeccchhhh
Q 005427 138 FFFEFYESRNLAEKLHVEE-WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDR---NLCPHLADFGLAEYRE 213 (697)
Q Consensus 138 lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~---~~~~kL~Dfg~a~~~~ 213 (697)
+|||.++||.|+..+..++ ..|++.++..|++||..|+.|||+.+|.||||||+|+|... +..+||+|||+|+...
T Consensus 136 iVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~ 215 (400)
T KOG0604|consen 136 IVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQ 215 (400)
T ss_pred eeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccccC
Confidence 8999999999999997665 36899999999999999999999999999999999999954 4578999999997543
Q ss_pred hhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhH----HHHHH
Q 005427 214 NLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAE----AQAHT 289 (697)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~----~~~~~ 289 (697)
. .....+.+-||.|.|||++..+.|+...|+||+||++|-|++|.+||...... .+..+
T Consensus 216 ~-----------------~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~r 278 (400)
T KOG0604|consen 216 E-----------------PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRR 278 (400)
T ss_pred C-----------------CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhH
Confidence 2 12356778999999999999999999999999999999999999999764321 12223
Q ss_pred HHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 005427 290 VLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE 354 (697)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~ 354 (697)
|..+.+. +....+..+|...+++|+.+|+.+|++|.|++++++|.|....
T Consensus 279 I~~gqy~---------------FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~ 328 (400)
T KOG0604|consen 279 IRTGQYE---------------FPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQY 328 (400)
T ss_pred hhccCcc---------------CCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhccc
Confidence 3333222 2223345689999999999999999999999999999998653
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=322.01 Aligned_cols=255 Identities=23% Similarity=0.300 Sum_probs=223.2
Q ss_pred CCCCCcccccccccCCceEEEEEEECCee--EEEEe---ccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceE
Q 005427 63 LPPSSYTLLSPIARGAESVVYEATLDGRK--VAVKK---PILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYM 137 (697)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~--vavK~---~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 137 (697)
+.-++++++..||-|+||.|-++...++. +|+|. .++-.....+.+..|-++|...+.|+||+||-.|.+....|
T Consensus 417 v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvY 496 (732)
T KOG0614|consen 417 VKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVY 496 (732)
T ss_pred cchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhh
Confidence 34467888999999999999999876655 66664 44556677888999999999999999999999999999999
Q ss_pred EEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhh
Q 005427 138 FFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKE 217 (697)
Q Consensus 138 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~ 217 (697)
|+||-|-||.|+..|+.++ .|...++..++.-+++|++|||.+||++|||||+|+|++.+|-+||.|||+|+.+..
T Consensus 497 mLmEaClGGElWTiLrdRg-~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~--- 572 (732)
T KOG0614|consen 497 MLMEACLGGELWTILRDRG-SFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS--- 572 (732)
T ss_pred hhHHhhcCchhhhhhhhcC-CcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhcc---
Confidence 9999999999999998766 899999999999999999999999999999999999999999999999999987764
Q ss_pred hhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccH
Q 005427 218 ISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTE 297 (697)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~ 297 (697)
+..+.++||||.|.|||++.+...+.++|.||||+++|||++|.+||++.+.......|+.+.-..
T Consensus 573 --------------g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i 638 (732)
T KOG0614|consen 573 --------------GRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKI 638 (732)
T ss_pred --------------CCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhh
Confidence 224678999999999999999999999999999999999999999999999888887777643221
Q ss_pred HHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCC-----HHHHHHHHHHH
Q 005427 298 QQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPS-----FSDIALELDLV 352 (697)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt-----~~ell~~l~~~ 352 (697)
..|..++....+||+++.+.+|.+|.. +.+|.+|-|+.
T Consensus 639 -----------------~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~ 681 (732)
T KOG0614|consen 639 -----------------EFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFE 681 (732)
T ss_pred -----------------hcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhh
Confidence 235578899999999999999999976 67777776664
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=317.67 Aligned_cols=252 Identities=26% Similarity=0.411 Sum_probs=209.5
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccCCC-hHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEee
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST-SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF 142 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 142 (697)
+.|+..+.||+|+||.||+|.+ .++.||+|...... ....+.+.+|+.+++.++||||+++++.+.....+++||||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 4688999999999999999986 57889999866443 34456789999999999999999999999999999999999
Q ss_pred cCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhccc
Q 005427 143 YESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKN 222 (697)
Q Consensus 143 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 222 (697)
+++++|.+++.. ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~------ 155 (277)
T cd06642 84 LGGGSALDLLKP--GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ------ 155 (277)
T ss_pred cCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcc------
Confidence 999999998854 367889999999999999999999999999999999999999999999999986543211
Q ss_pred ccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHHHH
Q 005427 223 WRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTA 302 (697)
Q Consensus 223 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 302 (697)
.......|+..|+|||++.+..++.++|+|||||++|+|++|..||...........+
T Consensus 156 ----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~------------ 213 (277)
T cd06642 156 ----------IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLI------------ 213 (277)
T ss_pred ----------hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhh------------
Confidence 0122346888999999999988999999999999999999999999765433221111
Q ss_pred HHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 005427 303 AVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL 353 (697)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~ 353 (697)
.....+ ..+..++.++.+++.+||+.+|++||++.+++.|.|...
T Consensus 214 ---~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 258 (277)
T cd06642 214 ---PKNSPP---TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITR 258 (277)
T ss_pred ---hcCCCC---CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHH
Confidence 111111 223457889999999999999999999999999988653
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=315.06 Aligned_cols=252 Identities=25% Similarity=0.396 Sum_probs=203.4
Q ss_pred CcccccccccCCceEEEEEEE--CCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEeecC
Q 005427 67 SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYE 144 (697)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 144 (697)
.......||+|+||.||+|.+ ++..|++|..........+.+.+|+.+++.++||||+++++++..++.+++++||+.
T Consensus 9 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 88 (268)
T cd06624 9 ENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVP 88 (268)
T ss_pred cCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCC
Confidence 344456899999999999986 467899998777666677889999999999999999999999999999999999999
Q ss_pred CCCHhhhhhhcCCCC--CHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecC-CCCCeeeeeccchhhhhhhhhhcc
Q 005427 145 SRNLAEKLHVEEWSP--SVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDR-NLCPHLADFGLAEYRENLKEISLK 221 (697)
Q Consensus 145 ~g~L~~~l~~~~~~~--~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~-~~~~kL~Dfg~a~~~~~~~~~~~~ 221 (697)
+++|.+++......+ ++..+..++.|++.||+|||+.||+||||||+||+++. ++.+||+|||++.......
T Consensus 89 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~----- 163 (268)
T cd06624 89 GGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN----- 163 (268)
T ss_pred CCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCC-----
Confidence 999999997654445 78889999999999999999999999999999999976 6789999999986543110
Q ss_pred cccCCCCCCCCccccccccCccccchhhhcccC--CCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHH
Q 005427 222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEI--HSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQ 299 (697)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~ 299 (697)
.......|++.|+|||++.+.. ++.++|+||||+++|+|++|..||............
T Consensus 164 -----------~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~--------- 223 (268)
T cd06624 164 -----------PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFK--------- 223 (268)
T ss_pred -----------CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhh---------
Confidence 0122345789999999986543 788999999999999999999999754321111000
Q ss_pred HHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 005427 300 LTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350 (697)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~ 350 (697)
.. .....+..+..+++++.+++.+||+.+|.+|||+.+++.|.|
T Consensus 224 ----~~---~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~ 267 (268)
T cd06624 224 ----VG---MFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPF 267 (268)
T ss_pred ----hh---hhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCC
Confidence 00 001112234568899999999999999999999999998876
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=321.66 Aligned_cols=257 Identities=23% Similarity=0.363 Sum_probs=212.3
Q ss_pred CCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEe
Q 005427 64 PPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFE 141 (697)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 141 (697)
+.+.|.....||+|+||.||++.. ++..||||+.........+.+.+|+.+++.++||||+++++.+...+..+++||
T Consensus 20 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e 99 (292)
T cd06658 20 PREYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVME 99 (292)
T ss_pred hHHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEe
Confidence 345677788999999999999986 578899998766665667789999999999999999999999999999999999
Q ss_pred ecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhcc
Q 005427 142 FYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLK 221 (697)
Q Consensus 142 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~ 221 (697)
|+++++|.+++... .+++.+++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||++.......
T Consensus 100 ~~~~~~L~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~----- 172 (292)
T cd06658 100 FLEGGALTDIVTHT--RMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV----- 172 (292)
T ss_pred CCCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhccccc-----
Confidence 99999999987543 57899999999999999999999999999999999999999999999999986443110
Q ss_pred cccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHHH
Q 005427 222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLT 301 (697)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 301 (697)
.......|++.|+|||.+.+..++.++|+||||+++|||++|..||...........+.
T Consensus 173 -----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~---------- 231 (292)
T cd06658 173 -----------PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIR---------- 231 (292)
T ss_pred -----------ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH----------
Confidence 01234568999999999998889999999999999999999999998754433222111
Q ss_pred HHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 005427 302 AAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE 354 (697)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~ 354 (697)
....+.+. ....++..+.+++..||..||.+|||+++++++.|+...
T Consensus 232 -----~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~ 278 (292)
T cd06658 232 -----DNLPPRVK-DSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLA 278 (292)
T ss_pred -----hcCCCccc-cccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhcc
Confidence 11111111 123468899999999999999999999999998887653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=311.97 Aligned_cols=256 Identities=26% Similarity=0.414 Sum_probs=208.1
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccCC---ChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEE
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFF 140 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 140 (697)
++|++.+.||+|+||.||+|.. +++.||+|.+... .......+.+|++++++++|+||+++++.+...+..+++|
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 4799999999999999999987 5889999976432 2334678899999999999999999999999999999999
Q ss_pred eecCCCCHhhhhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhh
Q 005427 141 EFYESRNLAEKLHV---EEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKE 217 (697)
Q Consensus 141 e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~ 217 (697)
||+++++|.+++.. ....+++.+++.++.+++.||.|||+.|++||||||+||+++.++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~- 160 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT- 160 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCC-
Confidence 99999999998853 23457899999999999999999999999999999999999999999999999986543211
Q ss_pred hhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccH
Q 005427 218 ISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTE 297 (697)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~ 297 (697)
.......+++.|+|||.+.+..++.++|+|||||++|+|++|..||.......
T Consensus 161 ---------------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------------ 213 (267)
T cd08224 161 ---------------TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL------------ 213 (267)
T ss_pred ---------------cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccH------------
Confidence 01233468889999999998889999999999999999999999996543110
Q ss_pred HHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 298 QQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
.........+...+. ....++.++.++|.+||..+|++|||+.+|++.+..+
T Consensus 214 ~~~~~~~~~~~~~~~---~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 214 YSLCKKIEKCDYPPL---PADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred HHHHhhhhcCCCCCC---ChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 001111111111111 1125788999999999999999999999999887654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=315.79 Aligned_cols=253 Identities=25% Similarity=0.400 Sum_probs=211.4
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccCCC-hHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEee
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST-SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF 142 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 142 (697)
..|+..++||.|+||.||+|.+ .++.||+|...... ......+.+|+.+++.++||||+++++.+.+...+++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 4688999999999999999986 57899999865443 34567889999999999999999999999999999999999
Q ss_pred cCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhccc
Q 005427 143 YESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKN 222 (697)
Q Consensus 143 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 222 (697)
+.+++|.+++... .+++.++..++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~i~~~--~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~------ 155 (277)
T cd06640 84 LGGGSALDLLRAG--PFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ------ 155 (277)
T ss_pred CCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCc------
Confidence 9999999988643 57889999999999999999999999999999999999999999999999986543211
Q ss_pred ccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHHHH
Q 005427 223 WRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTA 302 (697)
Q Consensus 223 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 302 (697)
.......++..|+|||++.+..++.++|+|||||++|+|++|..||...........+.
T Consensus 156 ----------~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~----------- 214 (277)
T cd06640 156 ----------IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIP----------- 214 (277)
T ss_pred ----------cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhh-----------
Confidence 01233468889999999998889999999999999999999999998754432221110
Q ss_pred HHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 005427 303 AVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE 354 (697)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~ 354 (697)
.... +..+..++..+.+++.+||+.+|.+||++.+++.|.+....
T Consensus 215 ----~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06640 215 ----KNNP---PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKN 259 (277)
T ss_pred ----cCCC---CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhc
Confidence 1111 12334578899999999999999999999999999887654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=312.59 Aligned_cols=245 Identities=22% Similarity=0.336 Sum_probs=211.9
Q ss_pred CCCCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCC---ChHHHHHHHHHHHHHHhc-CCCCceEEeeccccCCc
Q 005427 62 HLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKL-DHPGLAKFVAAHAKPPN 135 (697)
Q Consensus 62 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~ 135 (697)
.+...+|.++.+||+|+||.|-++.. +.+.+|||++... ..++.+--+.|-++|... +-|.+++|+.+|.+.+.
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 45567899999999999999999976 4567999975432 234455566788888777 57899999999999999
Q ss_pred eEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhh
Q 005427 136 YMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL 215 (697)
Q Consensus 136 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~ 215 (697)
+|+||||+.||+|...++.-+ ++.+..+..++.+|+-||-+||++||+.||||.+|||++..|++||+|||+++.-
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~G-kFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEn--- 500 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQVG-KFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN--- 500 (683)
T ss_pred eeeEEEEecCchhhhHHHHhc-ccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeeccccccc---
Confidence 999999999999999987665 7888899999999999999999999999999999999999999999999998631
Q ss_pred hhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccc
Q 005427 216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNY 295 (697)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~ 295 (697)
...+..+.+++|||.|+|||++..++|+.++|.||+||+||||+.|++||.+.+..+....|.+.+.
T Consensus 501 -------------i~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnv 567 (683)
T KOG0696|consen 501 -------------IFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNV 567 (683)
T ss_pred -------------ccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccC
Confidence 1233457789999999999999999999999999999999999999999999998888877765443
Q ss_pred cHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCH
Q 005427 296 TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSF 342 (697)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~ 342 (697)
..|..+|.++.++.+..|...|.+|...
T Consensus 568 -------------------syPKslSkEAv~ickg~ltK~P~kRLGc 595 (683)
T KOG0696|consen 568 -------------------SYPKSLSKEAVAICKGLLTKHPGKRLGC 595 (683)
T ss_pred -------------------cCcccccHHHHHHHHHHhhcCCccccCC
Confidence 2466899999999999999999999753
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=311.62 Aligned_cols=248 Identities=24% Similarity=0.372 Sum_probs=200.0
Q ss_pred cccccCCceEEEEEEEC--C---eeEEEEeccCCCh-HHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEeecCC
Q 005427 72 SPIARGAESVVYEATLD--G---RKVAVKKPILSTS-EELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYES 145 (697)
Q Consensus 72 ~~lg~G~~g~V~~~~~~--~---~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 145 (697)
++||+|+||.||+|.+. + ..+|+|....... ...+.+.+|+.+++.+.||||+++++++. ...++++|||+.+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 47999999999999762 2 5799998665443 34567899999999999999999999876 4568999999999
Q ss_pred CCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhcccccC
Q 005427 146 RNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRS 225 (697)
Q Consensus 146 g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~ 225 (697)
++|.+++.... .+++..++.++.|++.||+|||+.+++||||||+|||++.++.+||+|||+++........
T Consensus 80 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~------- 151 (257)
T cd05060 80 GPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY------- 151 (257)
T ss_pred CcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcc-------
Confidence 99999997655 7899999999999999999999999999999999999999999999999998755321110
Q ss_pred CCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCCchhHHHHHHHHhccccHHHHHHHH
Q 005427 226 SGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAV 304 (697)
Q Consensus 226 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (697)
........++..|+|||.+.+..++.++|||||||++|+|++ |..||...+.......+..
T Consensus 152 ------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~------------ 213 (257)
T cd05060 152 ------YRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLES------------ 213 (257)
T ss_pred ------cccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHc------------
Confidence 000112234568999999998889999999999999999998 9999987654433222211
Q ss_pred HhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 305 VSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
. .+ ...+..++..+.+++.+||..+|++|||+.++++.+..+
T Consensus 214 --~-~~---~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 214 --G-ER---LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred --C-Cc---CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 1 11 113456889999999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=319.12 Aligned_cols=266 Identities=25% Similarity=0.362 Sum_probs=211.3
Q ss_pred CCCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCC-hHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEE
Q 005427 63 LPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST-SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFF 139 (697)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 139 (697)
+...+|++.+.||+|+||+||++.+ .++.||+|+..... ......+.+|+++++.++||||+++++.+.....+++|
T Consensus 2 l~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (284)
T cd06620 2 LRNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMC 81 (284)
T ss_pred ccHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEE
Confidence 3456899999999999999999987 47889999765443 33456789999999999999999999999999999999
Q ss_pred EeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhh
Q 005427 140 FEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHN-LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI 218 (697)
Q Consensus 140 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~ 218 (697)
|||+++++|.+++...+ .+++..+..++.+++.+|.|||+ .+++||||||+||+++.++.++|+|||++......
T Consensus 82 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~--- 157 (284)
T cd06620 82 MEFMDCGSLDRIYKKGG-PIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS--- 157 (284)
T ss_pred EecCCCCCHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh---
Confidence 99999999999887644 68899999999999999999997 69999999999999999999999999988643210
Q ss_pred hcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHH
Q 005427 219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQ 298 (697)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~ 298 (697)
......|+..|+|||++.+..++.++|+|||||++|+|++|..||............ .....
T Consensus 158 ---------------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~---~~~~~ 219 (284)
T cd06620 158 ---------------IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDD---PMGIL 219 (284)
T ss_pred ---------------ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhh---hhHHH
Confidence 112356899999999998888899999999999999999999999865432110000 00000
Q ss_pred HHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 005427 299 QLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL 353 (697)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~ 353 (697)
.......... .+.++ ...++.++.+|+.+||+.||.+|||+.|++++++.+.
T Consensus 220 ~~~~~~~~~~-~~~~~--~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~ 271 (284)
T cd06620 220 DLLQQIVQEP-PPRLP--SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ 271 (284)
T ss_pred HHHHHHhhcc-CCCCC--chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 1111111111 11111 1237789999999999999999999999999888764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=277.68 Aligned_cols=268 Identities=24% Similarity=0.297 Sum_probs=217.0
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccCCChHH--HHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEe
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEE--LDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFE 141 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 141 (697)
.+|...++||+|.||+||+|+. +.+.||+|.++....++ .....+|+-+|+.|+|.|||+++++...+..+.+|+|
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe 81 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence 3588889999999999999975 67899999988776544 5678899999999999999999999999999999999
Q ss_pred ecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhcc
Q 005427 142 FYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLK 221 (697)
Q Consensus 142 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~ 221 (697)
||.. +|..+...-...+..+.++.++.|+++||.++|++++.||||||+|+||+.+|.+||+|||+++.+.-.
T Consensus 82 ~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgip------ 154 (292)
T KOG0662|consen 82 FCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIP------ 154 (292)
T ss_pred HhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCc------
Confidence 9986 888888777778899999999999999999999999999999999999999999999999999866521
Q ss_pred cccCCCCCCCCccccccccCccccchhhhcccC-CCchhhHHHHHHHHHHHHh-CCCCCCCchhHHHHHHHHhccccHHH
Q 005427 222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEI-HSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQ 299 (697)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~~l~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~ 299 (697)
.. ....-+-|.+|++|.++.+.. |+...|+||-||++.|+.. |++.|.+.+...++.+|.....+..+
T Consensus 155 --------vr--cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~e 224 (292)
T KOG0662|consen 155 --------VR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTE 224 (292)
T ss_pred --------eE--eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCcc
Confidence 11 122336789999999998754 8999999999999999998 89999999999888888765444322
Q ss_pred HHHHHHh--CCCCC--cccc------cccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 005427 300 LTAAVVS--GGLRP--ILAS------LELGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350 (697)
Q Consensus 300 ~~~~~~~--~~~~~--~~~~------~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~ 350 (697)
..+--.. ..+.+ +.+. +.+.++..-+++++++|.-+|.+|.++++.++|.-
T Consensus 225 d~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpy 285 (292)
T KOG0662|consen 225 DQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPY 285 (292)
T ss_pred ccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcc
Confidence 2211111 11111 1110 11234445689999999999999999999887653
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=318.40 Aligned_cols=255 Identities=22% Similarity=0.355 Sum_probs=204.8
Q ss_pred CCCCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCChHHHHHHHHHHHHHHhc-CCCCceEEeecccc------
Q 005427 62 HLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKL-DHPGLAKFVAAHAK------ 132 (697)
Q Consensus 62 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~------ 132 (697)
..+.+.|++.+.||.|+||.||+|.+ .++.+|+|...... .....+..|+.+++.+ +||||+++++++..
T Consensus 12 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 90 (282)
T cd06636 12 RDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGH 90 (282)
T ss_pred cChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCC
Confidence 34567899999999999999999987 57889999865443 3446788999999998 79999999999853
Q ss_pred CCceEEEEeecCCCCHhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchh
Q 005427 133 PPNYMFFFEFYESRNLAEKLHVEE-WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEY 211 (697)
Q Consensus 133 ~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~ 211 (697)
...++++|||+.+|+|.+++.... ..+++..++.++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++..
T Consensus 91 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~ 170 (282)
T cd06636 91 DDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 170 (282)
T ss_pred CCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhh
Confidence 457899999999999999886533 3578888999999999999999999999999999999999999999999999865
Q ss_pred hhhhhhhhcccccCCCCCCCCccccccccCccccchhhhc-----ccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHH
Q 005427 212 RENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILK-----KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQ 286 (697)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~ 286 (697)
..... .......|++.|+|||++. +..++.++|+|||||++|+|++|..||.+......
T Consensus 171 ~~~~~----------------~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~ 234 (282)
T cd06636 171 LDRTV----------------GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA 234 (282)
T ss_pred hhccc----------------cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhh
Confidence 43210 0123457899999999986 34578899999999999999999999976543322
Q ss_pred HHHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 005427 287 AHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350 (697)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~ 350 (697)
...+.. ... .......++.++.+||.+||+.||.+|||+.||++|.|
T Consensus 235 ~~~~~~---------------~~~--~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~ 281 (282)
T cd06636 235 LFLIPR---------------NPP--PKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPF 281 (282)
T ss_pred hhhHhh---------------CCC--CCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCC
Confidence 211110 001 11122357899999999999999999999999998765
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=313.60 Aligned_cols=254 Identities=24% Similarity=0.354 Sum_probs=203.7
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccCC-----ChHHHHHHHHHHHHHHhcCCCCceEEeecccc--CCce
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS-----TSEELDNFHKELQLLCKLDHPGLAKFVAAHAK--PPNY 136 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~--~~~~ 136 (697)
..|++.+.||+|+||.||++.+ ++..|++|+.... .......+.+|+.+++.++||||+++++++.. ...+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 4689999999999999999986 5789999976533 12345678999999999999999999998865 3567
Q ss_pred EEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhh
Q 005427 137 MFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLK 216 (697)
Q Consensus 137 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~ 216 (697)
++++||+++++|.+++.... .+++...+.++.|++.||+|||+.+|+||||||+||+++.++.+||+|||++.......
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYG-ALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC 160 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccccccc
Confidence 89999999999999987654 57889999999999999999999999999999999999999999999999986543210
Q ss_pred hhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhcccc
Q 005427 217 EISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYT 296 (697)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~ 296 (697)
. .........++..|+|||++.+..++.++|+|||||++|+|++|..||.............
T Consensus 161 ~-------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~----- 222 (266)
T cd06651 161 M-------------SGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIA----- 222 (266)
T ss_pred c-------------cCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHh-----
Confidence 0 0001223458899999999998889999999999999999999999998654332222111
Q ss_pred HHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 005427 297 EQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL 351 (697)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~ 351 (697)
..... +..+..+++.+.+++ .||..+|++||+++|+++|.++
T Consensus 223 ---------~~~~~---~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~ 264 (266)
T cd06651 223 ---------TQPTN---PQLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFA 264 (266)
T ss_pred ---------cCCCC---CCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCccc
Confidence 11111 223345778889998 6888999999999999988764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=311.36 Aligned_cols=246 Identities=29% Similarity=0.454 Sum_probs=203.5
Q ss_pred CCCcccccccccCCceEEEEEEECCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEeecC
Q 005427 65 PSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYE 144 (697)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 144 (697)
.++|++.+.||+|+||.||++...++.+|+|...... ....+.+|+.+++.++||||+++++++... ..+++|||+.
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 5 LQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHHceeeeeeccCCCCceEecccCCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 4679999999999999999999899999999865432 346788999999999999999999998654 5789999999
Q ss_pred CCCHhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhcccc
Q 005427 145 SRNLAEKLHVEE-WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNW 223 (697)
Q Consensus 145 ~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~ 223 (697)
+++|.+++.... ..+++.+++.++.|++.||.|||+.|++||||||+||+++.++.+||+|||++......
T Consensus 82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-------- 153 (254)
T cd05083 82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-------- 153 (254)
T ss_pred CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc--------
Confidence 999999987543 35788999999999999999999999999999999999999999999999988643210
Q ss_pred cCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCCchhHHHHHHHHhccccHHHHHH
Q 005427 224 RSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTA 302 (697)
Q Consensus 224 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 302 (697)
......+..|+|||.+.+..++.++|+|||||++|+|++ |..||...........+.
T Consensus 154 -----------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~----------- 211 (254)
T cd05083 154 -----------VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVE----------- 211 (254)
T ss_pred -----------CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHh-----------
Confidence 112234568999999998889999999999999999998 999998765433222211
Q ss_pred HHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 005427 303 AVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350 (697)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~ 350 (697)
.+.++ ..+..++..+.+++.+||+.+|.+||++.++++.+.
T Consensus 212 ----~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 252 (254)
T cd05083 212 ----KGYRM---EPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLE 252 (254)
T ss_pred ----CCCCC---CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHc
Confidence 11222 123468899999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=321.06 Aligned_cols=270 Identities=24% Similarity=0.339 Sum_probs=213.7
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccCCCh---HHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEE
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTS---EELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFF 140 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 140 (697)
++|++.+.||+|+||.||+|.. .++.+|+|....... .....+..|+++++.++||||+++++.+......+++|
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 3799999999999999999987 478999998665432 24567899999999999999999999999999999999
Q ss_pred eecCCCCHhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhh
Q 005427 141 EFYESRNLAEKLHVE-EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEIS 219 (697)
Q Consensus 141 e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~ 219 (697)
||+.+++|.+++... ...+++..++.++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++..........
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence 999999999998654 3468999999999999999999999999999999999999999999999999987543211100
Q ss_pred ccccc-------------CCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHH
Q 005427 220 LKNWR-------------SSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQ 286 (697)
Q Consensus 220 ~~~~~-------------~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~ 286 (697)
..... ...............|+..|+|||++.+..++.++||||||+++|+|++|..||.+.+....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~ 240 (316)
T cd05574 161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDET 240 (316)
T ss_pred ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHH
Confidence 00000 00000111123345789999999999998899999999999999999999999987665444
Q ss_pred HHHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCC----HHHHHHHHHHH
Q 005427 287 AHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPS----FSDIALELDLV 352 (697)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt----~~ell~~l~~~ 352 (697)
...+.... +..+ ....++..+.+++.+||..||++||| +++++.|.|+.
T Consensus 241 ~~~~~~~~----------------~~~~-~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~ 293 (316)
T cd05574 241 FSNILKKE----------------VTFP-GSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFR 293 (316)
T ss_pred HHHHhcCC----------------ccCC-CccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhh
Confidence 33322111 1111 11237899999999999999999999 99999988774
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=313.05 Aligned_cols=253 Identities=26% Similarity=0.378 Sum_probs=203.8
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccCC-----ChHHHHHHHHHHHHHHhcCCCCceEEeeccccC--Cce
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS-----TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKP--PNY 136 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~ 136 (697)
.+|++.+.||+|+||.||++.+ ++..||+|.+... .......+.+|+.+++.++||||+++++++.++ ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 5799999999999999999986 5788999976432 123466889999999999999999999988764 467
Q ss_pred EEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhh
Q 005427 137 MFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLK 216 (697)
Q Consensus 137 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~ 216 (697)
+++|||+++++|.+++.... .+++..+..++.|++.||+|||+++++|+||||+||+++.++.+||+|||++.......
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~ 160 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYG-ALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTIC 160 (265)
T ss_pred EEEEEecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCcccccccccc
Confidence 89999999999999987553 57889999999999999999999999999999999999999999999999987543210
Q ss_pred hhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhcccc
Q 005427 217 EISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYT 296 (697)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~ 296 (697)
. .........|+..|+|||++.+..++.++|+|||||++|+|++|..||.............
T Consensus 161 ~-------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~----- 222 (265)
T cd06652 161 L-------------SGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIA----- 222 (265)
T ss_pred c-------------cccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHh-----
Confidence 0 0001223468899999999988888999999999999999999999998653332222111
Q ss_pred HHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 005427 297 EQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350 (697)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~ 350 (697)
.. +..+..+..++..+.+++.+||. +|.+||+++++++|.|
T Consensus 223 ---------~~---~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~ 263 (265)
T cd06652 223 ---------TQ---PTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTF 263 (265)
T ss_pred ---------cC---CCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcc
Confidence 01 11122344678889999999995 9999999999998765
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=315.24 Aligned_cols=238 Identities=24% Similarity=0.325 Sum_probs=193.0
Q ss_pred cccccCCceEEEEEEEC---------CeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEee
Q 005427 72 SPIARGAESVVYEATLD---------GRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF 142 (697)
Q Consensus 72 ~~lg~G~~g~V~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 142 (697)
+.||+|+||.||+|... ...+++|..........+.+.+|+.+++.++||||+++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 47999999999999762 234788876554445567889999999999999999999999999999999999
Q ss_pred cCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCC--------Ceeeeeccchhhhh
Q 005427 143 YESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLC--------PHLADFGLAEYREN 214 (697)
Q Consensus 143 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~--------~kL~Dfg~a~~~~~ 214 (697)
+.+|+|.+++...+..+++..++.++.|++.||+|||+.||+||||||+|||++.++. ++++|||++.....
T Consensus 81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~ 160 (258)
T cd05078 81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLP 160 (258)
T ss_pred CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccccCC
Confidence 9999999999876667899999999999999999999999999999999999987765 58999998754321
Q ss_pred hhhhhcccccCCCCCCCCccccccccCccccchhhhcc-cCCCchhhHHHHHHHHHHHHhC-CCCCCCchhHHHHHHHHh
Q 005427 215 LKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLTG-VVPYTDLRAEAQAHTVLE 292 (697)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~ell~g-~~Pf~~~~~~~~~~~~~~ 292 (697)
.....+++.|+|||++.+ ..++.++|||||||++|+|++| ..||.......... ...
T Consensus 161 --------------------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~-~~~ 219 (258)
T cd05078 161 --------------------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ-FYE 219 (258)
T ss_pred --------------------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH-HHH
Confidence 223467889999999986 4578999999999999999998 56666543322111 100
Q ss_pred ccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 005427 293 MNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALEL 349 (697)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l 349 (697)
. + ...+...+.++.+++.+||+.||++|||++++++.|
T Consensus 220 --------------~--~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 220 --------------D--R---HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred --------------c--c---ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 0 0 112345678899999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=315.97 Aligned_cols=255 Identities=24% Similarity=0.346 Sum_probs=202.4
Q ss_pred CCCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCChHHHHHHHHHHHHHHhc-CCCCceEEeeccc-----cCC
Q 005427 63 LPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKL-DHPGLAKFVAAHA-----KPP 134 (697)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~-----~~~ 134 (697)
...++|++.+.||+|+||.||++.+ .++.+|+|+..... .....+.+|+.+++.+ +||||+++++++. ...
T Consensus 15 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 93 (286)
T cd06638 15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGD 93 (286)
T ss_pred CcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCC
Confidence 3457899999999999999999987 57889999764322 2235678899999999 6999999999873 346
Q ss_pred ceEEEEeecCCCCHhhhhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchh
Q 005427 135 NYMFFFEFYESRNLAEKLHV---EEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEY 211 (697)
Q Consensus 135 ~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~ 211 (697)
.++++|||+++++|.+++.. ....+++..++.++.|++.||.|||+.+++||||||+||+++.++.+||+|||++..
T Consensus 94 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~ 173 (286)
T cd06638 94 QLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQ 173 (286)
T ss_pred eEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCceee
Confidence 78999999999999988752 234678899999999999999999999999999999999999999999999999865
Q ss_pred hhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcc-----cCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHH
Q 005427 212 RENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-----EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQ 286 (697)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~ 286 (697)
..... .......|++.|+|||++.. ..++.++|||||||++|+|++|..||........
T Consensus 174 ~~~~~----------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~ 237 (286)
T cd06638 174 LTSTR----------------LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA 237 (286)
T ss_pred cccCC----------------CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH
Confidence 43210 11234468999999999853 4478899999999999999999999986543322
Q ss_pred HHHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 005427 287 AHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350 (697)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~ 350 (697)
...... ...+.. ..+..++.++.++|.+||+.||++|||+.+++++++
T Consensus 238 ~~~~~~---------------~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~ 285 (286)
T cd06638 238 LFKIPR---------------NPPPTL-HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVF 285 (286)
T ss_pred Hhhccc---------------cCCCcc-cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhccc
Confidence 211110 111111 123346788999999999999999999999999876
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=319.18 Aligned_cols=253 Identities=21% Similarity=0.337 Sum_probs=209.6
Q ss_pred CcccccccccCCceEEEEEEE--CCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEeecC
Q 005427 67 SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYE 144 (697)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 144 (697)
-|.....||+|+||.||++.+ .++.||+|.+........+.+.+|+.+++.++||||+++++.+.....+++++||++
T Consensus 22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~ 101 (297)
T cd06659 22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQ 101 (297)
T ss_pred hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCC
Confidence 466677899999999999986 588999998765554556678899999999999999999999999999999999999
Q ss_pred CCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhccccc
Q 005427 145 SRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWR 224 (697)
Q Consensus 145 ~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~ 224 (697)
+++|..++.. ..+++.+++.++.|++.||.|||+.|++||||||+||+++.++.+||+|||++.......
T Consensus 102 ~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-------- 171 (297)
T cd06659 102 GGALTDIVSQ--TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-------- 171 (297)
T ss_pred CCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccccc--------
Confidence 9999997754 358899999999999999999999999999999999999999999999999986443210
Q ss_pred CCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHHHHHH
Q 005427 225 SSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAV 304 (697)
Q Consensus 225 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (697)
.......|++.|+|||++.+..++.++|||||||++|+|++|..||...........+...
T Consensus 172 --------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~----------- 232 (297)
T cd06659 172 --------PKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS----------- 232 (297)
T ss_pred --------ccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc-----------
Confidence 0123456899999999999888999999999999999999999999765443332222110
Q ss_pred HhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 005427 305 VSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL 353 (697)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~ 353 (697)
.+........++..+.++|.+||+.+|.+||++.+++++.+...
T Consensus 233 -----~~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~ 276 (297)
T cd06659 233 -----PPPKLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQ 276 (297)
T ss_pred -----CCCCccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhcc
Confidence 11111123457889999999999999999999999999887764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=310.84 Aligned_cols=250 Identities=24% Similarity=0.374 Sum_probs=193.8
Q ss_pred cccccCCceEEEEEEE----CCeeEEEEeccCCC-hHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEeecCCC
Q 005427 72 SPIARGAESVVYEATL----DGRKVAVKKPILST-SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESR 146 (697)
Q Consensus 72 ~~lg~G~~g~V~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g 146 (697)
++||+|+||.||+|.. ....+++|...... ......+.+|+.+++.++||||+++++.+.....+++||||+.+|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 4699999999999964 23568888755443 233567889999999999999999999999999999999999999
Q ss_pred CHhhhhhhcCC----CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhccc
Q 005427 147 NLAEKLHVEEW----SPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKN 222 (697)
Q Consensus 147 ~L~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 222 (697)
+|.+++..... ..++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+|||++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~---- 156 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYY---- 156 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchhe----
Confidence 99999865432 2467788999999999999999999999999999999999999999999998543211000
Q ss_pred ccCCCCCCCCccccccccCccccchhhhcc-------cCCCchhhHHHHHHHHHHHHh-CCCCCCCchhHHHHHHHHhcc
Q 005427 223 WRSSGKPTGGFHKKNMVGTLIYMAPEILKK-------EIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMN 294 (697)
Q Consensus 223 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~~l~ell~-g~~Pf~~~~~~~~~~~~~~~~ 294 (697)
.......+++.|+|||++.. ..++.++|||||||++|||++ |..||...............
T Consensus 157 ----------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~- 225 (269)
T cd05042 157 ----------ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVRE- 225 (269)
T ss_pred ----------eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhc-
Confidence 00123346778999999743 456789999999999999999 88999876544333222211
Q ss_pred ccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 005427 295 YTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALEL 349 (697)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l 349 (697)
...+...+..+..++..+.+++..|| .||++|||+++|++.+
T Consensus 226 ------------~~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 226 ------------QDIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred ------------cCccCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 11111222334568899999999999 5999999999998765
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=319.08 Aligned_cols=268 Identities=23% Similarity=0.313 Sum_probs=207.3
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccCCCh--HHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEe
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTS--EELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFE 141 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 141 (697)
++|++.++||+|+||.||+|.+ .++.||+|+...... ...+.+.+|+++++.++||||+++++++..+..+++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 4799999999999999999987 478899997543322 234568899999999999999999999999999999999
Q ss_pred ecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhcc
Q 005427 142 FYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLK 221 (697)
Q Consensus 142 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~ 221 (697)
|+.++.|..+..... .+++.+++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~----- 154 (286)
T cd07846 81 FVDHTVLDDLEKYPN-GLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG----- 154 (286)
T ss_pred cCCccHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-----
Confidence 999988887765443 58999999999999999999999999999999999999999999999999986543211
Q ss_pred cccCCCCCCCCccccccccCccccchhhhcc-cCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHH
Q 005427 222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQL 300 (697)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 300 (697)
.......++..|+|||++.+ ..++.++||||||+++|+|++|.+||...........+..........
T Consensus 155 -----------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (286)
T cd07846 155 -----------EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPR 223 (286)
T ss_pred -----------cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchh
Confidence 11233568899999999875 446889999999999999999999998765544433333211111000
Q ss_pred HHHH------HhCCCCCc------ccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 005427 301 TAAV------VSGGLRPI------LASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350 (697)
Q Consensus 301 ~~~~------~~~~~~~~------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~ 350 (697)
.... ......+. .......++..+.+++.+||+.+|.+||++.++++|.|
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~ 285 (286)
T cd07846 224 HQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEF 285 (286)
T ss_pred hHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCC
Confidence 0000 00000000 01113467899999999999999999999999998765
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=314.24 Aligned_cols=258 Identities=26% Similarity=0.409 Sum_probs=207.0
Q ss_pred CcccccccccCCceEEEEEEE--CCeeEEEEeccCCC------hHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEE
Q 005427 67 SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST------SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMF 138 (697)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 138 (697)
+|+..+.||+|+||.||++.. +++.+|+|++.... ....+.+.+|+.++++++||||+++++++.+.+.+++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 488899999999999999986 67899999865432 1235688999999999999999999999999999999
Q ss_pred EEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCC-CCeeeeeccchhhhhhhh
Q 005427 139 FFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNL-CPHLADFGLAEYRENLKE 217 (697)
Q Consensus 139 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~-~~kL~Dfg~a~~~~~~~~ 217 (697)
|+||+.+++|.+++.... .+++..++.++.|++.||.|||+.|++|+||+|+||+++.++ .+||+|||++........
T Consensus 81 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~ 159 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYG-AFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGT 159 (268)
T ss_pred EEeccCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccccccc
Confidence 999999999999987554 678999999999999999999999999999999999998776 599999999876542110
Q ss_pred hhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccH
Q 005427 218 ISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTE 297 (697)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~ 297 (697)
..........|+..|+|||++.+..++.++|+||||+++|+|++|..||...........+
T Consensus 160 ------------~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~------- 220 (268)
T cd06630 160 ------------GAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALI------- 220 (268)
T ss_pred ------------cCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHH-------
Confidence 0011123456899999999998888999999999999999999999999754321111111
Q ss_pred HHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 005427 298 QQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL 351 (697)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~ 351 (697)
........ .+..+..+++++.+++.+||..+|.+|||+.++++|.++
T Consensus 221 ----~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~ 267 (268)
T cd06630 221 ----FKIASATT---APSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVF 267 (268)
T ss_pred ----HHHhccCC---CCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCccc
Confidence 01111111 122344678999999999999999999999999987653
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=318.38 Aligned_cols=254 Identities=26% Similarity=0.358 Sum_probs=208.0
Q ss_pred CCCCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCC---ChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCce
Q 005427 62 HLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNY 136 (697)
Q Consensus 62 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 136 (697)
..+.++|++.+.||+|+||.||+|.. .++.||+|+.... .......+.+|+.+++.++||||+++++++.+....
T Consensus 11 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~ 90 (307)
T cd06607 11 DDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTA 90 (307)
T ss_pred CCcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeE
Confidence 34457899999999999999999986 5789999976532 233456788999999999999999999999999999
Q ss_pred EEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhh
Q 005427 137 MFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLK 216 (697)
Q Consensus 137 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~ 216 (697)
++|+||+. |++.+.+......+++.++..++.|++.||.|||+.|++||||+|+||+++.++.+||+|||++.....
T Consensus 91 ~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~-- 167 (307)
T cd06607 91 WLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSP-- 167 (307)
T ss_pred EEEHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCC--
Confidence 99999997 477777765555789999999999999999999999999999999999999999999999998864321
Q ss_pred hhhcccccCCCCCCCCccccccccCccccchhhhc---ccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhc
Q 005427 217 EISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILK---KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEM 293 (697)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~ 293 (697)
.....+++.|+|||++. ...++.++||||||+++|+|++|..||.+.........+..
T Consensus 168 ------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~- 228 (307)
T cd06607 168 ------------------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ- 228 (307)
T ss_pred ------------------CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhc-
Confidence 22346788999999874 35678899999999999999999999987654433222211
Q ss_pred cccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 005427 294 NYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL 353 (697)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~ 353 (697)
...+.. .+..++..+.++|.+||+.+|++||++.+++.|+|...
T Consensus 229 --------------~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 272 (307)
T cd06607 229 --------------NDSPTL--SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLR 272 (307)
T ss_pred --------------CCCCCC--CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcc
Confidence 001111 12346789999999999999999999999999988754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=318.38 Aligned_cols=267 Identities=26% Similarity=0.352 Sum_probs=207.6
Q ss_pred CcccccccccCCceEEEEEEE--CCeeEEEEeccCCC---hHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEe
Q 005427 67 SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST---SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFE 141 (697)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 141 (697)
+|++.+.||+|+||.||++.+ .++.|++|.+.... ......+.+|+++++.++||||+++++.+..+..++++||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVME 81 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEe
Confidence 689999999999999999987 56789999765443 2335678899999999999999999999999999999999
Q ss_pred ecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhcc
Q 005427 142 FYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLK 221 (697)
Q Consensus 142 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~ 221 (697)
|+.+++|.+++...+ .+++..+..++.|++.||+|||+.|++||||||+||+++.++.+||+|||+++...........
T Consensus 82 ~~~g~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (305)
T cd05609 82 YVEGGDCATLLKNIG-ALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLY 160 (305)
T ss_pred cCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccccc
Confidence 999999999997654 6889999999999999999999999999999999999999999999999988642110000000
Q ss_pred cccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHHH
Q 005427 222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLT 301 (697)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 301 (697)
. ................|+..|+|||.+.+..++.++|+|||||++|+|++|..||.+.........+..
T Consensus 161 ~-~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~--------- 230 (305)
T cd05609 161 E-GHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS--------- 230 (305)
T ss_pred c-cccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---------
Confidence 0 000000001112235688899999999888899999999999999999999999987554433332221
Q ss_pred HHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCC---HHHHHHHHHH
Q 005427 302 AAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPS---FSDIALELDL 351 (697)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt---~~ell~~l~~ 351 (697)
+.. ..+.....++.++.++|.+||+.+|++||+ +.+++++.|.
T Consensus 231 -----~~~--~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~ 276 (305)
T cd05609 231 -----DDI--EWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFF 276 (305)
T ss_pred -----ccc--CCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccc
Confidence 110 011122357899999999999999999998 6777777665
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=312.05 Aligned_cols=249 Identities=24% Similarity=0.363 Sum_probs=206.9
Q ss_pred CcccccccccCCceEEEEEEE--CCeeEEEEeccCC--ChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEee
Q 005427 67 SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF 142 (697)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 142 (697)
+|++.+.||+|+||.||++.. +++.+|+|.+... .......+.+|+.+|+.++||||+++++.+...+.+++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 589999999999999999976 6788999986543 234567899999999999999999999999999999999999
Q ss_pred cCCCCHhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCC-CCCeeeeeccchhhhhhhhhhc
Q 005427 143 YESRNLAEKLHVEE-WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRN-LCPHLADFGLAEYRENLKEISL 220 (697)
Q Consensus 143 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~-~~~kL~Dfg~a~~~~~~~~~~~ 220 (697)
+++++|.+++.... ..+++..++.++.+++.+|+|||++|++|+||||+||+++.+ +.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~---- 156 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS---- 156 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc----
Confidence 99999999997643 357899999999999999999999999999999999999865 457999999987543211
Q ss_pred ccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHH
Q 005427 221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQL 300 (697)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 300 (697)
......|++.|+|||.+.+..++.++|+||||+++|+|++|..||...+.......+.
T Consensus 157 -------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~--------- 214 (256)
T cd08220 157 -------------KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIM--------- 214 (256)
T ss_pred -------------cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHH---------
Confidence 1223568899999999998888999999999999999999999998755433322221
Q ss_pred HHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 005427 301 TAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350 (697)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~ 350 (697)
..... ..+..++.++.+++.+||+.+|.+|||+.+++.|.+
T Consensus 215 -----~~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~ 255 (256)
T cd08220 215 -----SGTFA----PISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPI 255 (256)
T ss_pred -----hcCCC----CCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCC
Confidence 11111 233467899999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=308.09 Aligned_cols=248 Identities=25% Similarity=0.398 Sum_probs=203.1
Q ss_pred cccccCCceEEEEEEEC---C--eeEEEEeccCCCh-HHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEeecCC
Q 005427 72 SPIARGAESVVYEATLD---G--RKVAVKKPILSTS-EELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYES 145 (697)
Q Consensus 72 ~~lg~G~~g~V~~~~~~---~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 145 (697)
++||+|+||.||+|.+. + ..||+|....... ...+.+.+|+.++++++||||+++++.+.. ..++++|||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 47899999999999862 2 3689998766655 567789999999999999999999999988 889999999999
Q ss_pred CCHhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhccccc
Q 005427 146 RNLAEKLHVEE-WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWR 224 (697)
Q Consensus 146 g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~ 224 (697)
++|.+.+.... ..+++..++.++.|++.||+|||+.|++|+||||+||+++.++.+||+|||++.........
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~------ 153 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH------ 153 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccc------
Confidence 99999987654 46789999999999999999999999999999999999999999999999998765421110
Q ss_pred CCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCCchhHHHHHHHHhccccHHHHHHH
Q 005427 225 SSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAA 303 (697)
Q Consensus 225 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (697)
........++..|+|||++.+..++.++|||||||++|+|++ |..||...+.......+...
T Consensus 154 -------~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~---------- 216 (257)
T cd05040 154 -------YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKE---------- 216 (257)
T ss_pred -------eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhc----------
Confidence 001123457788999999999899999999999999999998 99999776554433333210
Q ss_pred HHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 005427 304 VVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350 (697)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~ 350 (697)
... ...+..+|..+.+++.+||+.+|++|||+.++++.|.
T Consensus 217 ----~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 217 ----GER---LERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred ----CCc---CCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 001 1123457899999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=318.62 Aligned_cols=269 Identities=26% Similarity=0.278 Sum_probs=208.3
Q ss_pred CcccccccccCCceEEEEEEE--CCeeEEEEeccCCChH-----HHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEE
Q 005427 67 SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSE-----ELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFF 139 (697)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 139 (697)
+|++.+.||+|+||.||+|.+ +++.|++|.+...... ....+..|+++++.++||||+++++++.+....++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 588999999999999999987 5789999987654322 234677899999999999999999999999999999
Q ss_pred EeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhh
Q 005427 140 FEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEIS 219 (697)
Q Consensus 140 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~ 219 (697)
|||+ +++|.+++......+++..++.++.|++.||.|||+.|++|+||||+||+++.++.+||+|||++.......
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~--- 156 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN--- 156 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC---
Confidence 9999 889999997655578999999999999999999999999999999999999999999999999987553211
Q ss_pred cccccCCCCCCCCccccccccCccccchhhhcc-cCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHH
Q 005427 220 LKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQ 298 (697)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~ 298 (697)
.......+++.|+|||.+.+ ..++.++|+|||||++|+|++|.+||.+.........+........
T Consensus 157 -------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~ 223 (298)
T cd07841 157 -------------RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPT 223 (298)
T ss_pred -------------ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCc
Confidence 01223356888999999865 4578999999999999999999888877655444333322111110
Q ss_pred HHHHHHHhC--CC-------CCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 299 QLTAAVVSG--GL-------RPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 299 ~~~~~~~~~--~~-------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
...+..... .. ...........+..+.++|.+||+.+|++|||+.+++++.|+.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~ 286 (298)
T cd07841 224 EENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFS 286 (298)
T ss_pred hhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCcccc
Confidence 000000000 00 0001112234678999999999999999999999999987775
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=314.94 Aligned_cols=249 Identities=21% Similarity=0.285 Sum_probs=205.2
Q ss_pred CCCCCcccccccccCCceEEEEEE--ECCeeEEEEeccCC---ChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceE
Q 005427 63 LPPSSYTLLSPIARGAESVVYEAT--LDGRKVAVKKPILS---TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYM 137 (697)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~--~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 137 (697)
+....|+.-+.||+|+||.||-++ .+|+-+|+|++..+ ......-..+|-.+|.+++.++||.+-..|++++.+|
T Consensus 182 vt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LC 261 (591)
T KOG0986|consen 182 VTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALC 261 (591)
T ss_pred ccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceE
Confidence 445678899999999999999885 48899999864322 2223345678999999999999999999999999999
Q ss_pred EEEeecCCCCHhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhh
Q 005427 138 FFFEFYESRNLAEKLHVEE-WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLK 216 (697)
Q Consensus 138 lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~ 216 (697)
+|+..|+||+|.-++.+.+ ..|++..+..++.+|+.||++||..+||+|||||+|||+|+.|+++|+|+|+|..+....
T Consensus 262 lVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~ 341 (591)
T KOG0986|consen 262 LVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGK 341 (591)
T ss_pred EEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCCCC
Confidence 9999999999998886544 368999999999999999999999999999999999999999999999999998665321
Q ss_pred hhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhcccc
Q 005427 217 EISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYT 296 (697)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~ 296 (697)
.....+||.+|||||++.++.|+...|.|||||++|||+.|+.||.........
T Consensus 342 -----------------~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~--------- 395 (591)
T KOG0986|consen 342 -----------------PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKR--------- 395 (591)
T ss_pred -----------------ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhH---------
Confidence 234458999999999999999999999999999999999999999754322221
Q ss_pred HHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHH
Q 005427 297 EQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFS 343 (697)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ 343 (697)
+++...+... ...++..+|+++++|.+.+|+.||.+|....
T Consensus 396 -eEvdrr~~~~-----~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 396 -EEVDRRTLED-----PEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred -HHHHHHHhcc-----hhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence 1121111111 1234567999999999999999999998654
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=313.54 Aligned_cols=256 Identities=28% Similarity=0.397 Sum_probs=210.0
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccCCC-hHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEee
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST-SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF 142 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 142 (697)
++|++.+.||+|+||.||++.+ +++.+++|.+.... ......+.+|+++++.++||||+++++.+.....+++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 3688999999999999999987 47889999866543 34456789999999999999999999999999999999999
Q ss_pred cCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhcc
Q 005427 143 YESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHN-LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLK 221 (697)
Q Consensus 143 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~ 221 (697)
+.+++|.+++......+++..+..++.|++.||.|||+ .|++|+||||+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~----- 155 (265)
T cd06605 81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL----- 155 (265)
T ss_pred cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHH-----
Confidence 99999999997765578999999999999999999999 999999999999999999999999999986554211
Q ss_pred cccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHHH
Q 005427 222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLT 301 (697)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 301 (697)
.....++..|+|||.+.+..++.++||||||+++|+|++|..||........ ......
T Consensus 156 -------------~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~---------~~~~~~ 213 (265)
T cd06605 156 -------------AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPD---------GIFELL 213 (265)
T ss_pred -------------hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccc---------cHHHHH
Confidence 1125688899999999999999999999999999999999999976421000 000001
Q ss_pred HHHHhCCCCCcccccccC-ChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 302 AAVVSGGLRPILASLELG-LPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~-~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
.... ....+. .+.. ++.++.++|.+||..||.+|||+.+++.+.|+.
T Consensus 214 ~~~~-~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~ 261 (265)
T cd06605 214 QYIV-NEPPPR---LPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIK 261 (265)
T ss_pred HHHh-cCCCCC---CChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhh
Confidence 1111 111121 1222 788999999999999999999999999998874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=315.91 Aligned_cols=259 Identities=24% Similarity=0.390 Sum_probs=207.1
Q ss_pred CCCCCcccccccccCCceEEEEEEE--CCe----eEEEEeccCCCh-HHHHHHHHHHHHHHhcCCCCceEEeeccccCCc
Q 005427 63 LPPSSYTLLSPIARGAESVVYEATL--DGR----KVAVKKPILSTS-EELDNFHKELQLLCKLDHPGLAKFVAAHAKPPN 135 (697)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 135 (697)
+..++|+..+.||+|+||.||+|.+ ++. .+|+|....... .....+.+|+.+++.++||||+++++++..+ .
T Consensus 4 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~ 82 (303)
T cd05110 4 LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-T 82 (303)
T ss_pred cchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-C
Confidence 3456899999999999999999976 343 578887654432 3345688999999999999999999998754 5
Q ss_pred eEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhh
Q 005427 136 YMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL 215 (697)
Q Consensus 136 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~ 215 (697)
.++++||+++|+|.+++......+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.....
T Consensus 83 ~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~ 162 (303)
T cd05110 83 IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGD 162 (303)
T ss_pred ceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccCc
Confidence 67999999999999998776667889999999999999999999999999999999999999999999999999755321
Q ss_pred hhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCCchhHHHHHHHHhcc
Q 005427 216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMN 294 (697)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~~~~~~~~~~~~~~~ 294 (697)
.. ........++..|+|||++.+..++.++|||||||++|||++ |..||.+.........+
T Consensus 163 ~~--------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~---- 224 (303)
T cd05110 163 EK--------------EYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLL---- 224 (303)
T ss_pred cc--------------ccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH----
Confidence 10 001223346778999999999999999999999999999997 99999775432221111
Q ss_pred ccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 005427 295 YTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE 354 (697)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~ 354 (697)
....++ ..+..++..+.+++..||..+|++||++.++++.+..+..
T Consensus 225 -----------~~~~~~---~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~ 270 (303)
T cd05110 225 -----------EKGERL---PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMAR 270 (303)
T ss_pred -----------HCCCCC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 111111 1133577899999999999999999999999998887654
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=306.36 Aligned_cols=247 Identities=26% Similarity=0.414 Sum_probs=202.6
Q ss_pred cccccCCceEEEEEEEC-CeeEEEEeccCCChH-HHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEeecCCCCHh
Q 005427 72 SPIARGAESVVYEATLD-GRKVAVKKPILSTSE-ELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLA 149 (697)
Q Consensus 72 ~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~ 149 (697)
++||+|+||.||++.+. ++.|++|........ ....+.+|++++++++||||+++++++......+++|||+.+++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 47999999999999874 889999986654433 5678999999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhcccccCCCCC
Q 005427 150 EKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKP 229 (697)
Q Consensus 150 ~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~ 229 (697)
+++......+++..+..++.+++.+|.|||+.+++||||||+||+++.++.+||+|||++........
T Consensus 81 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~------------ 148 (251)
T cd05041 81 TFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIY------------ 148 (251)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcc------------
Confidence 99976655788999999999999999999999999999999999999999999999999865431100
Q ss_pred CCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCCchhHHHHHHHHhccccHHHHHHHHHhCC
Q 005427 230 TGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGG 308 (697)
Q Consensus 230 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (697)
........++..|+|||.+.+..++.++|+|||||++|+|++ |..||...........+. ..
T Consensus 149 --~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~---------------~~ 211 (251)
T cd05041 149 --TVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIE---------------SG 211 (251)
T ss_pred --eeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHh---------------cC
Confidence 000112234667999999998889999999999999999999 899998765433222221 11
Q ss_pred CCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 005427 309 LRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350 (697)
Q Consensus 309 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~ 350 (697)
.+. ..+..++.++.+++.+||+.+|.+|||+.++++.|.
T Consensus 212 ~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 212 YRM---PAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CCC---CCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 111 123467899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=313.41 Aligned_cols=256 Identities=25% Similarity=0.424 Sum_probs=205.8
Q ss_pred CcccccccccCCceEEEEEEE--CCeeEEEEeccCCCh----------HHHHHHHHHHHHHHhcCCCCceEEeeccccCC
Q 005427 67 SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTS----------EELDNFHKELQLLCKLDHPGLAKFVAAHAKPP 134 (697)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 134 (697)
+|.+.+.||.|+||.||+|.. +++.+|+|....... ...+.+.+|+.+++.++||||+++++++....
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 588999999999999999975 578899997643211 12356888999999999999999999999999
Q ss_pred ceEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhh
Q 005427 135 NYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYREN 214 (697)
Q Consensus 135 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~ 214 (697)
.+++||||+++++|.+++.... .+++..+..++.|++.||.|||+.+++||||+|+||+++.++.++|+|||++.....
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~ 160 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYG-RFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDD 160 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeeccccccccc
Confidence 9999999999999999987654 788999999999999999999999999999999999999999999999999865432
Q ss_pred hhhhhcccccCCCCCCCCccccccccCccccchhhhcccC--CCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHh
Q 005427 215 LKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEI--HSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLE 292 (697)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~ 292 (697)
.. .........|+..|+|||++.... ++.++|+||||+++|++++|..||...........+..
T Consensus 161 ~~--------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 226 (272)
T cd06629 161 IY--------------DNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGN 226 (272)
T ss_pred cc--------------cccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhc
Confidence 10 011123456889999999987654 78899999999999999999999976443322221110
Q ss_pred ccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 005427 293 MNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350 (697)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~ 350 (697)
.....+........++.++.+++.+||..+|++|||++++++|.|
T Consensus 227 -------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~ 271 (272)
T cd06629 227 -------------KRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPF 271 (272)
T ss_pred -------------cccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCC
Confidence 011111222233467899999999999999999999999998865
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=315.39 Aligned_cols=254 Identities=25% Similarity=0.378 Sum_probs=204.7
Q ss_pred CCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCChHHHHHHHHHHHHHHhc-CCCCceEEeeccccCC------
Q 005427 64 PPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKL-DHPGLAKFVAAHAKPP------ 134 (697)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~------ 134 (697)
+.++|++.+.||+|+||.||+|.. .++.+++|....... ..+.+.+|+.+++.+ .||||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 347899999999999999999987 567899998665443 446789999999999 7999999999986644
Q ss_pred ceEEEEeecCCCCHhhhhhhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchh
Q 005427 135 NYMFFFEFYESRNLAEKLHVE---EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEY 211 (697)
Q Consensus 135 ~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~ 211 (697)
.++++|||+.+++|.+++... ...+++..++.++.|++.||.|||+.+++|+||+|+||+++.++.+||+|||++..
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~ 162 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQ 162 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCcccee
Confidence 489999999999999987643 35789999999999999999999999999999999999999999999999999865
Q ss_pred hhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcc-----cCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHH
Q 005427 212 RENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-----EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQ 286 (697)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~ 286 (697)
..... .......|++.|+|||++.. ..++.++|||||||+||+|++|..||........
T Consensus 163 ~~~~~----------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~ 226 (275)
T cd06608 163 LDSTL----------------GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA 226 (275)
T ss_pred cccch----------------hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHH
Confidence 43211 01234568999999999853 3467889999999999999999999986544333
Q ss_pred HHHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 005427 287 AHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350 (697)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~ 350 (697)
...+... ..+.+. .+..++.++.+++.+||..||++|||+.++++|.|
T Consensus 227 ~~~~~~~---------------~~~~~~-~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~ 274 (275)
T cd06608 227 LFKIPRN---------------PPPTLK-SPENWSKKFNDFISECLIKNYEQRPFMEELLEHPF 274 (275)
T ss_pred HHHhhcc---------------CCCCCC-chhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCC
Confidence 2222111 111111 12347789999999999999999999999998765
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=309.37 Aligned_cols=250 Identities=26% Similarity=0.381 Sum_probs=193.0
Q ss_pred cccccCCceEEEEEEEC----CeeEEEEeccCCCh-HHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEeecCCC
Q 005427 72 SPIARGAESVVYEATLD----GRKVAVKKPILSTS-EELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESR 146 (697)
Q Consensus 72 ~~lg~G~~g~V~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g 146 (697)
+.||+|+||.||+|... +..+++|.+..... .....+.+|+.+++.++||||+++++.+.+...+++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 46999999999999752 35689998665432 33457889999999999999999999999999999999999999
Q ss_pred CHhhhhhhcC----CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhccc
Q 005427 147 NLAEKLHVEE----WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKN 222 (697)
Q Consensus 147 ~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 222 (697)
+|.+++.... ..+++..+..++.|++.||+|||+.+++||||||+||+++.++.+||+|||++........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~----- 155 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDY----- 155 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcce-----
Confidence 9999986432 2456678889999999999999999999999999999999999999999999854321100
Q ss_pred ccCCCCCCCCccccccccCccccchhhhccc-------CCCchhhHHHHHHHHHHHHh-CCCCCCCchhHHHHHHHHhcc
Q 005427 223 WRSSGKPTGGFHKKNMVGTLIYMAPEILKKE-------IHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMN 294 (697)
Q Consensus 223 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~DiwslG~~l~ell~-g~~Pf~~~~~~~~~~~~~~~~ 294 (697)
........+++.|+|||++.+. .++.++||||||+++|||++ |..||.............
T Consensus 156 ---------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~--- 223 (269)
T cd05087 156 ---------YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTV--- 223 (269)
T ss_pred ---------eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHh---
Confidence 0012234578899999998642 35789999999999999996 999997654433221111
Q ss_pred ccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 005427 295 YTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALEL 349 (697)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l 349 (697)
.....+...+......+..+.+++..|| .+|++|||+++|+..|
T Consensus 224 ----------~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l 267 (269)
T cd05087 224 ----------REQQLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLL 267 (269)
T ss_pred ----------hcccCCCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHh
Confidence 1111111222233457888999999999 6899999999998665
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=309.58 Aligned_cols=249 Identities=27% Similarity=0.433 Sum_probs=206.7
Q ss_pred CcccccccccCCceEEEEEEE--CCeeEEEEeccCCC-----hHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEE
Q 005427 67 SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST-----SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFF 139 (697)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 139 (697)
+|+..+.||+|+||.||+|.. +++.|++|...... .+..+.+.+|+.+++.++||||+++++++.....++++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 578889999999999999987 57899999765433 23456789999999999999999999999999999999
Q ss_pred EeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhh
Q 005427 140 FEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEIS 219 (697)
Q Consensus 140 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~ 219 (697)
+||+++++|.+++.... .+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~--- 156 (258)
T cd06632 81 LELVPGGSLAKLLKKYG-SFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS--- 156 (258)
T ss_pred EEecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc---
Confidence 99999999999987654 68899999999999999999999999999999999999999999999999986543211
Q ss_pred cccccCCCCCCCCccccccccCccccchhhhcccC-CCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHH
Q 005427 220 LKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEI-HSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQ 298 (697)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~ 298 (697)
......|++.|++||.+.... ++.++|+||||+++|+|++|..||...........+.
T Consensus 157 --------------~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~------- 215 (258)
T cd06632 157 --------------FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIG------- 215 (258)
T ss_pred --------------cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHH-------
Confidence 123456889999999987766 8999999999999999999999997654322221111
Q ss_pred HHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 005427 299 QLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350 (697)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~ 350 (697)
... ..+..+..+++.+.+++.+||+.+|.+||++.+++.+.+
T Consensus 216 -------~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~ 257 (258)
T cd06632 216 -------RSK---ELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPF 257 (258)
T ss_pred -------hcc---cCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCC
Confidence 101 112234568899999999999999999999999997754
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=320.95 Aligned_cols=264 Identities=20% Similarity=0.257 Sum_probs=189.7
Q ss_pred ccccccCCceEEEEEEE----CCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccc--cCCceEEEEeecC
Q 005427 71 LSPIARGAESVVYEATL----DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHA--KPPNYMFFFEFYE 144 (697)
Q Consensus 71 ~~~lg~G~~g~V~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~--~~~~~~lv~e~~~ 144 (697)
..+||+|+||.||+|+. .+..||+|.+.... ....+.+|+.+|+.++||||+++++++. ....++++|||+.
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 35899999999999985 34679999765332 2345778999999999999999999884 3567899999987
Q ss_pred CCCHhhhhhhc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceee----cCCCCCeeeeeccchhh
Q 005427 145 SRNLAEKLHVE--------EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLL----DRNLCPHLADFGLAEYR 212 (697)
Q Consensus 145 ~g~L~~~l~~~--------~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill----~~~~~~kL~Dfg~a~~~ 212 (697)
+ +|.+++... ...+++..++.++.|++.||.|||+.||+||||||+|||+ +.++.+||+|||+++..
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~ 162 (317)
T cd07867 84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162 (317)
T ss_pred C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceecc
Confidence 5 777776421 2247889999999999999999999999999999999999 56678999999999765
Q ss_pred hhhhhhhcccccCCCCCCCCccccccccCccccchhhhcc-cCCCchhhHHHHHHHHHHHHhCCCCCCCchhHH------
Q 005427 213 ENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLTGVVPYTDLRAEA------ 285 (697)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~------ 285 (697)
..... .........||+.|+|||++.+ ..++.++|||||||++|||++|.+||.......
T Consensus 163 ~~~~~-------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~ 229 (317)
T cd07867 163 NSPLK-------------PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPF 229 (317)
T ss_pred CCCcc-------------cccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccc
Confidence 42110 0011234578999999999976 457899999999999999999999997543211
Q ss_pred ---HHHHHHhccc-cH-HHHH------------HHHHhCC-----CCCcccccccCChHHHHHHHHHhccCCCCCCCCHH
Q 005427 286 ---QAHTVLEMNY-TE-QQLT------------AAVVSGG-----LRPILASLELGLPASILSLIQRCWDGNPHNRPSFS 343 (697)
Q Consensus 286 ---~~~~~~~~~~-~~-~~~~------------~~~~~~~-----~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ 343 (697)
....+..... .. ..+. ....... ............+..+.+|+.+||+.||.+|||+.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~ 309 (317)
T cd07867 230 HHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSE 309 (317)
T ss_pred cHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHH
Confidence 1111111000 00 0000 0000000 00000111123456789999999999999999999
Q ss_pred HHHHHHH
Q 005427 344 DIALELD 350 (697)
Q Consensus 344 ell~~l~ 350 (697)
|+++|+|
T Consensus 310 e~l~hp~ 316 (317)
T cd07867 310 QALQDPY 316 (317)
T ss_pred HHhcCCC
Confidence 9998876
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=324.66 Aligned_cols=267 Identities=22% Similarity=0.327 Sum_probs=206.6
Q ss_pred CCCcccccccccCCceEEEEEEE--CCeeEEEEeccCC--ChHHHHHHHHHHHHHHhcCCCCceEEeeccccC------C
Q 005427 65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKP------P 134 (697)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~------~ 134 (697)
.++|++.+.||+|+||.||+|.+ +++.||+|.+... .......+.+|+.+++.++||||+++++++... .
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 94 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ 94 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence 46899999999999999999987 6889999986432 333456778899999999999999999987643 3
Q ss_pred ceEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhh
Q 005427 135 NYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYREN 214 (697)
Q Consensus 135 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~ 214 (697)
..++||||+.+ +|.+.+... +++.++..++.|++.||+|||+.||+||||||+||+++.++.+||+|||++.....
T Consensus 95 ~~~lv~e~~~~-~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 170 (353)
T cd07850 95 DVYLVMELMDA-NLCQVIQMD---LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 170 (353)
T ss_pred cEEEEEeccCC-CHHHHHhhc---CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCC
Confidence 57999999975 888877543 78899999999999999999999999999999999999999999999999865432
Q ss_pred hhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhcc
Q 005427 215 LKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMN 294 (697)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~ 294 (697)
. .......+++.|+|||++.+..++.++|||||||++|+|++|..||...+.......+....
T Consensus 171 ~-----------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 233 (353)
T cd07850 171 S-----------------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQL 233 (353)
T ss_pred C-----------------CCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhc
Confidence 1 01233468899999999999999999999999999999999999998776555444443221
Q ss_pred ccH-HHHHHH-------HHhCCC----CC---cc---------cccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 005427 295 YTE-QQLTAA-------VVSGGL----RP---IL---------ASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350 (697)
Q Consensus 295 ~~~-~~~~~~-------~~~~~~----~~---~~---------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~ 350 (697)
... .++... ...... .+ .. ...+...+..+.++|.+||+.||++|||+.|+++|.|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~ 313 (353)
T cd07850 234 GTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPY 313 (353)
T ss_pred CCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChh
Confidence 111 111000 000000 00 00 0002235778999999999999999999999999988
Q ss_pred HH
Q 005427 351 LV 352 (697)
Q Consensus 351 ~~ 352 (697)
..
T Consensus 314 ~~ 315 (353)
T cd07850 314 IN 315 (353)
T ss_pred Hh
Confidence 75
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=311.50 Aligned_cols=258 Identities=27% Similarity=0.422 Sum_probs=210.7
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccCCC-hHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEee
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST-SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF 142 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 142 (697)
++|++.+.||.|+||+||+|.. ++..+++|+..... ......+.+|+++|+.++||||+++++.+.....+++++|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 4799999999999999999986 57789999865433 33567899999999999999999999999999999999999
Q ss_pred cCCCCHhhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhc
Q 005427 143 YESRNLAEKLHVEE--WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL 220 (697)
Q Consensus 143 ~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~ 220 (697)
+.+++|.+++.... ..+++..++.++.|++.||.|||+.|++||||||+||+++.++.++|+|||++..+......
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~-- 158 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR-- 158 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc--
Confidence 99999999987542 35789999999999999999999999999999999999999999999999998765432110
Q ss_pred ccccCCCCCCCCccccccccCccccchhhhccc-CCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHH
Q 005427 221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKE-IHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQ 299 (697)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~ 299 (697)
. ........|++.|+|||++... .++.++|+|||||++|+|++|..||...............
T Consensus 159 ---------~-~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~------ 222 (267)
T cd06610 159 ---------T-RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN------ 222 (267)
T ss_pred ---------c-ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcC------
Confidence 0 0112345689999999998876 7889999999999999999999999876443332222211
Q ss_pred HHHHHHhCCCCCccccc--ccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 005427 300 LTAAVVSGGLRPILASL--ELGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350 (697)
Q Consensus 300 ~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~ 350 (697)
..+.+... ...++..+.+++.+||..||++|||+.++++|.|
T Consensus 223 ---------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~ 266 (267)
T cd06610 223 ---------DPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKF 266 (267)
T ss_pred ---------CCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCC
Confidence 11111111 1367899999999999999999999999998865
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=319.82 Aligned_cols=271 Identities=25% Similarity=0.289 Sum_probs=209.0
Q ss_pred CCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCChHH--HHHHHHHHHHHHhcCCCCceEEeeccccC--CceEE
Q 005427 65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEE--LDNFHKELQLLCKLDHPGLAKFVAAHAKP--PNYMF 138 (697)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~~l 138 (697)
.++|++.+.||+|+||.||+|.+ +++.||+|+........ ...+.+|+.+++.++||||+++++++... ..+++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 46899999999999999999987 58899999865443221 23466899999999999999999998654 56899
Q ss_pred EEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhh
Q 005427 139 FFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI 218 (697)
Q Consensus 139 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~ 218 (697)
||||+.+ +|.+++......+++.+++.++.|++.||.|||+.|++||||||+||+++.++.+||+|||++........
T Consensus 86 v~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~- 163 (309)
T cd07845 86 VMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK- 163 (309)
T ss_pred EEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCccC-
Confidence 9999975 88888876556789999999999999999999999999999999999999999999999999875532110
Q ss_pred hcccccCCCCCCCCccccccccCccccchhhhcc-cCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccH
Q 005427 219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTE 297 (697)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~ 297 (697)
......+++.|+|||++.+ ..++.++|||||||++|+|++|.+||...+.......+.......
T Consensus 164 ---------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~ 228 (309)
T cd07845 164 ---------------PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTP 228 (309)
T ss_pred ---------------CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 1122345788999999875 557899999999999999999999998877666555554322211
Q ss_pred HHHHHH-HH----hCCCC------CcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 298 QQLTAA-VV----SGGLR------PILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 298 ~~~~~~-~~----~~~~~------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
....+. .. .+.+. ..+.......++++.++|.+||+.||++|||+.+++.|.|+.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~ 294 (309)
T cd07845 229 NESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFK 294 (309)
T ss_pred ChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhc
Confidence 110000 00 00000 000011123588899999999999999999999999998885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd00143 PP2Cc Serine/threonine phosphatases, family 2C, catalytic domain; The protein architecture and deduced catalytic mechanism of PP2C phosphatases are similar to the PP1, PP2A, PP2B family of protein Ser/Thr phosphatases, with which PP2C shares no sequence similarity | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=301.73 Aligned_cols=244 Identities=43% Similarity=0.650 Sum_probs=204.1
Q ss_pred ceEeeeccCCCCCCCceeEEcccccCCCceEEEEEecCCCChHHHHHHHHHhHHHHHhcCCC------CChHHHHHHHHH
Q 005427 430 SWGSFATCGRRETMEDTHFLMPHMYNQKEIHMFGIFDGHRGSAAAEFSARALPGFLQNLGST------TRPTDALLEAFI 503 (697)
Q Consensus 430 ~~~~~s~~G~R~~neD~~~~~~~~~~~~~~~~~~V~DG~GG~~~~~~as~~~~~~l~~~~~~------~~~~~~l~~~~~ 503 (697)
.++..+..|.|..|||++.+...... .+..+|+|||||||+..|++|++.+++.+.+.... ......+..++.
T Consensus 2 ~~~~~~~~g~r~~neD~~~~~~~~~~-~~~~~~~V~DG~Gg~~~~~~as~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~ 80 (254)
T cd00143 2 SAGVSDKGGDRKTNEDAVVIKPNLNN-EDGGLFGVFDGHGGHAAGEFASKLLVEELLEELEETLTLSEEDIEEALRKAFL 80 (254)
T ss_pred ceeeecCCCCCCCCcceEEEeccCCC-CCcEEEEEEcCCChHHHHHHHHHHHHHHHHHHHhhccccchHHHHHHHHHHHH
Confidence 46677788889999999998663211 25689999999999999999999999999876332 234456677777
Q ss_pred HHHHHHHHHHHHHHhhhhcccCCCCCCceEEEEEEecCeEEEEEcCCeEEEEEECCeeeecCCCCCCCCHHHHHHHHHcC
Q 005427 504 RTDVAFRNELDSLRKSKRVVQKDWHPGCTAIAALIVRNRLFVANAGDCRAILCRGGHPFALSRDHVASCLEERERVVSAG 583 (697)
Q Consensus 504 ~~~~~~~~~~~~~~~~~~~~~~~~~~GtT~~~~~i~~~~l~~anvGDSr~~l~~~~~~~~lt~dH~~~~~~e~~ri~~~g 583 (697)
.++..+....... .....+|||++++++.+++++++|+||||+|++++++++++|+||++.++.+..|+...+
T Consensus 81 ~~~~~l~~~~~~~-------~~~~~~gtT~~~~~~~~~~l~~~~vGDsr~~~~~~~~~~~lt~dh~~~~~~~~~~i~~~~ 153 (254)
T cd00143 81 RADEEILEEAQDE-------PDDARSGTTAVVALIRGNKLYVANVGDSRAVLCRNGEAVQLTKDHKPVNEEERERIEKAG 153 (254)
T ss_pred HHHHHHHHhhhhc-------cCCCCCCCcEEEEEEECCEEEEEEecCcEEEEEcCCceeEcCCCCCCcChHHHHHHHHcC
Confidence 7766665542211 223458999999999999999999999999999999999999999999999999999988
Q ss_pred CeeeeccCcceeCCCcceeccccCCCCCCCCcccCCceEEEEe-CCCCeEEEEEcCCcccCCChHHHHHHHHhhcC--Ch
Q 005427 584 GNVNWQVDTWRVGPPALQVTRSIGDDDLKPAVTAEPEITETIM-TPEDEYLVMASDGLWDVVSHVEAVGIIKDTVK--EP 660 (697)
Q Consensus 584 ~~~~~~~~~~~~~~~~~~ltralG~~~~k~~v~~~p~v~~~~l-~~~d~~lvl~SDGl~d~~~~~ei~~~~~~~~~--~~ 660 (697)
+.+. ....+.++.+||+||+..+|+++..+|++....+ +++| +||||||||||++++++|.+++..... ++
T Consensus 154 ~~~~-----~~~~~~~~~~t~~lG~~~~~~~~~~~~~~~~~~l~~~~d-~ill~SDG~~~~l~~~~i~~~~~~~~~~~~~ 227 (254)
T cd00143 154 GRVS-----NGRVPGVLAVTRALGDFDLKPGVSAEPDVTVVKLTEDDD-FLILASDGLWDVLSNQEAVDIVRSELAKEDL 227 (254)
T ss_pred CcEE-----eCEEcCceeeccccCCccccCCEEcCCeEEEEEeCCCCc-EEEEECCCCeeccChHHHHHHHHHHhcccCH
Confidence 7442 2445679999999999988888899999999999 7777 888999999999999999999988642 69
Q ss_pred hHHHHHHHHHHHhcCCCCCcEEEEEEe
Q 005427 661 GMCSKRLATEAAERGSKDNITVIVVFL 687 (697)
Q Consensus 661 ~~~a~~L~~~a~~~g~~DNiT~ivv~l 687 (697)
+++|+.|++.|..+++.||+|+|++++
T Consensus 228 ~~~a~~l~~~a~~~~~~Dn~t~i~~~~ 254 (254)
T cd00143 228 QEAAQELVDLALRRGSHDNITVVVVRL 254 (254)
T ss_pred HHHHHHHHHHHHhCCCCCCEEEEEEeC
Confidence 999999999999999999999999975
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=316.95 Aligned_cols=268 Identities=24% Similarity=0.293 Sum_probs=202.8
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccCCChH-HHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEee
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSE-ELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF 142 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 142 (697)
++|++.+.||+|+||.||+|.. .++.||+|........ ....+.+|+++++.++||||+++++++.+....++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 5899999999999999999986 5789999986543321 234567899999999999999999999999999999999
Q ss_pred cCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhccc
Q 005427 143 YESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKN 222 (697)
Q Consensus 143 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 222 (697)
+.+ +|.+++......+++..++.++.|++.||.|||+.+|+||||||+||+++.++.+||+|||++.......
T Consensus 85 ~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~------ 157 (291)
T cd07844 85 LDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPS------ 157 (291)
T ss_pred CCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCC------
Confidence 985 9999887665578999999999999999999999999999999999999999999999999986432100
Q ss_pred ccCCCCCCCCccccccccCccccchhhhcc-cCCCchhhHHHHHHHHHHHHhCCCCCCCch-hHHHHHHHHhcccc-HHH
Q 005427 223 WRSSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLTGVVPYTDLR-AEAQAHTVLEMNYT-EQQ 299 (697)
Q Consensus 223 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~ell~g~~Pf~~~~-~~~~~~~~~~~~~~-~~~ 299 (697)
.......++..|+|||++.+ ..++.++||||+|+++|+|++|..||.+.. .......+...... ...
T Consensus 158 ----------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (291)
T cd07844 158 ----------KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEE 227 (291)
T ss_pred ----------ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChh
Confidence 01122346889999999875 457899999999999999999999997654 22222222211110 000
Q ss_pred HHHHHHh-CCCC---------CcccccccCCh--HHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 005427 300 LTAAVVS-GGLR---------PILASLELGLP--ASILSLIQRCWDGNPHNRPSFSDIALELD 350 (697)
Q Consensus 300 ~~~~~~~-~~~~---------~~~~~~~~~~~--~~l~~li~~~l~~dP~~Rpt~~ell~~l~ 350 (697)
....... .... ..+......++ .++.+++.+||+.+|++|||+.+++.+.|
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~ 290 (291)
T cd07844 228 TWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPY 290 (291)
T ss_pred hhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCC
Confidence 0000000 0000 00000111233 78899999999999999999999998765
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=316.80 Aligned_cols=255 Identities=24% Similarity=0.377 Sum_probs=211.6
Q ss_pred CCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEee
Q 005427 65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF 142 (697)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 142 (697)
..+|.+.+.||+|+||.||++.. +++.|++|..........+.+.+|+.+++.++||||+++++.+......++|+||
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 46899999999999999999975 5788999987655555567889999999999999999999999999999999999
Q ss_pred cCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhccc
Q 005427 143 YESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKN 222 (697)
Q Consensus 143 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 222 (697)
+++++|.+++... .+++.++..++.|++.||.|||++|++|+||||+||+++.++.+||+|||++.......
T Consensus 98 ~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~------ 169 (293)
T cd06647 98 LAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ------ 169 (293)
T ss_pred CCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccccc------
Confidence 9999999998654 47889999999999999999999999999999999999999999999999886443211
Q ss_pred ccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHHHH
Q 005427 223 WRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTA 302 (697)
Q Consensus 223 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 302 (697)
.......|++.|++||.+.+..++.++|+||||+++|++++|..||...+.......+..
T Consensus 170 ----------~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~---------- 229 (293)
T cd06647 170 ----------SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT---------- 229 (293)
T ss_pred ----------cccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhc----------
Confidence 112345688999999999888889999999999999999999999986543322111100
Q ss_pred HHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 005427 303 AVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL 353 (697)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~ 353 (697)
. ..+... .+..++..+.+++++||..+|.+||++.+++.|.|+..
T Consensus 230 ----~-~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~ 274 (293)
T cd06647 230 ----N-GTPELQ-NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKI 274 (293)
T ss_pred ----C-CCCCCC-CccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhc
Confidence 0 011111 23357789999999999999999999999999987753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=309.58 Aligned_cols=250 Identities=27% Similarity=0.380 Sum_probs=206.2
Q ss_pred CcccccccccCCceEEEEEEE--CCeeEEEEeccCC--ChHHHHHHHHHHHHHHhcCCCCceEEeecccc--CCceEEEE
Q 005427 67 SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAK--PPNYMFFF 140 (697)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~--~~~~~lv~ 140 (697)
+|++.+.||.|+||.||++.+ +++.+|+|..... .....+.+..|+.+++.++||||+++++.+.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 588999999999999999986 5788999976543 33456778899999999999999999997754 45689999
Q ss_pred eecCCCCHhhhhhhc---CCCCCHHHHHHHHHHHHHHHHHHH-----hCCcccccCCCCceeecCCCCCeeeeeccchhh
Q 005427 141 EFYESRNLAEKLHVE---EWSPSVDQVLMIAAQLAKALQYLH-----NLGIVHRDVKPANVLLDRNLCPHLADFGLAEYR 212 (697)
Q Consensus 141 e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH-----~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~ 212 (697)
||+++++|.+++... ...+++.+++.++.|++.||.||| +.+++|+||||+||+++.++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999998653 446889999999999999999999 899999999999999999999999999998765
Q ss_pred hhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHh
Q 005427 213 ENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLE 292 (697)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~ 292 (697)
..... ......+++.|+|||++.+..++.++|+||||+++|+|++|..||...........+
T Consensus 161 ~~~~~----------------~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~-- 222 (265)
T cd08217 161 GHDSS----------------FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKI-- 222 (265)
T ss_pred cCCcc----------------cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHH--
Confidence 42110 123456899999999999888999999999999999999999999876533322221
Q ss_pred ccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 005427 293 MNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350 (697)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~ 350 (697)
..+. .+..+..++..+.+++.+||+.+|++|||+.+|++|.+
T Consensus 223 ------------~~~~----~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~ 264 (265)
T cd08217 223 ------------KEGK----FRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPL 264 (265)
T ss_pred ------------hcCC----CCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCC
Confidence 1111 12234568899999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=314.86 Aligned_cols=266 Identities=24% Similarity=0.284 Sum_probs=206.3
Q ss_pred CcccccccccCCceEEEEEEE--CCeeEEEEeccCCCh--HHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEee
Q 005427 67 SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTS--EELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF 142 (697)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 142 (697)
+|++.+.||.|+||.||+|.+ +++.||+|+...... .....+.+|++++++++||||+++++++.+....+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 488999999999999999987 578899998654432 2245788999999999999999999999999999999999
Q ss_pred cCCCCHhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhcc
Q 005427 143 YESRNLAEKLHVE-EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLK 221 (697)
Q Consensus 143 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~ 221 (697)
+. ++|.+++... ...+++.+++.++.|++.||+|||+.+++||||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~----- 154 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV----- 154 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCc-----
Confidence 96 5888887643 3467899999999999999999999999999999999999999999999999986543210
Q ss_pred cccCCCCCCCCccccccccCccccchhhhcccC-CCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHH
Q 005427 222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEI-HSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQL 300 (697)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 300 (697)
.......+++.|+|||++.+.. ++.++|||||||++|+|++|..||.+.........+.+........
T Consensus 155 -----------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 223 (284)
T cd07860 155 -----------RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEV 223 (284)
T ss_pred -----------cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 0122335788999999887644 5889999999999999999999998765544444433222111100
Q ss_pred H-----------HHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 005427 301 T-----------AAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350 (697)
Q Consensus 301 ~-----------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~ 350 (697)
. .... ...+..+......+++++.++|.+||+.||.+|||++++++|.|
T Consensus 224 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~ 283 (284)
T cd07860 224 VWPGVTSLPDYKPSFP-KWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPF 283 (284)
T ss_pred hhhhhhHHHHHHhhcc-cccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCC
Confidence 0 0000 00011111223457889999999999999999999999998866
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=295.58 Aligned_cols=278 Identities=24% Similarity=0.310 Sum_probs=216.8
Q ss_pred CCCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCChHH--HHHHHHHHHHHHhcCCCCceEEeeccccC-----
Q 005427 63 LPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEE--LDNFHKELQLLCKLDHPGLAKFVAAHAKP----- 133 (697)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~~----- 133 (697)
...+.|+.+.+||+|.||+||+|+. +++.||+|++...+..+ .....+|+++|..|+|+|++.++.+|...
T Consensus 14 ~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~ 93 (376)
T KOG0669|consen 14 DEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTN 93 (376)
T ss_pred ecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcc
Confidence 3456899999999999999999976 67889999866544332 34668999999999999999999888542
Q ss_pred ---CceEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccch
Q 005427 134 ---PNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAE 210 (697)
Q Consensus 134 ---~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~ 210 (697)
..+|+||.+|+. +|..+|.....+++..++.+++.++..||.|+|...|+|||+||.|+||+.+|.+||+|||+++
T Consensus 94 r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar 172 (376)
T KOG0669|consen 94 RDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLAR 172 (376)
T ss_pred cccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeecccccc
Confidence 348999999987 9999998887899999999999999999999999999999999999999999999999999997
Q ss_pred hhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhccc-CCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHH
Q 005427 211 YRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKE-IHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHT 289 (697)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~ 289 (697)
.+...+.. .+...++.+-|.+|++||.+.|. .|+++.|||+-||+|.||++|.+-+.+.+...++..
T Consensus 173 ~fs~~~n~------------~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~ 240 (376)
T KOG0669|consen 173 AFSTSKNV------------VKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHL 240 (376)
T ss_pred ceeccccc------------CCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHH
Confidence 66532221 11224566789999999998875 589999999999999999999999999877766655
Q ss_pred HHhc--cccHHH--------HHHHHHhC-----CCCCccccc-ccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 005427 290 VLEM--NYTEQQ--------LTAAVVSG-----GLRPILASL-ELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL 353 (697)
Q Consensus 290 ~~~~--~~~~~~--------~~~~~~~~-----~~~~~~~~~-~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~ 353 (697)
|-.. ..+.+. +..++..+ .++...... +-.-.++..+|+..+|..||.+|+++.++++|-++..
T Consensus 241 Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~k 320 (376)
T KOG0669|consen 241 ISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWK 320 (376)
T ss_pred HHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhc
Confidence 4332 222211 11111111 011000000 1122468899999999999999999999999988764
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=355.51 Aligned_cols=253 Identities=29% Similarity=0.419 Sum_probs=210.3
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccCCChH--HHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEe
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSE--ELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFE 141 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 141 (697)
-++.....||.|.||.||-|.. +|...|+|.+...... ......+|..+|..|+|||+|+++++-.+.+..++.||
T Consensus 1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFME 1314 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFME 1314 (1509)
T ss_pred eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHH
Confidence 3677889999999999999975 7889999976655433 34567899999999999999999999999999999999
Q ss_pred ecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhcc
Q 005427 142 FYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLK 221 (697)
Q Consensus 142 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~ 221 (697)
||.+|+|.+.+...+ ..++.....+..|++.|++|||++|||||||||.||+++.+|.+|++|||.|..+.....
T Consensus 1315 yC~~GsLa~ll~~gr-i~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~---- 1389 (1509)
T KOG4645|consen 1315 YCEGGSLASLLEHGR-IEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQ---- 1389 (1509)
T ss_pred HhccCcHHHHHHhcc-hhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchh----
Confidence 999999999987553 456666777999999999999999999999999999999999999999999987754210
Q ss_pred cccCCCCCCCCccccccccCccccchhhhccc---CCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHH
Q 005427 222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKKE---IHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQ 298 (697)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~ 298 (697)
.-+.....++||+.|||||++.+. ....++|||||||++.||+||+.||...+........+
T Consensus 1390 --------~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V------- 1454 (1509)
T KOG4645|consen 1390 --------TMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHV------- 1454 (1509)
T ss_pred --------cCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHH-------
Confidence 111234578999999999999754 35678999999999999999999999876655433222
Q ss_pred HHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005427 299 QLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALE 348 (697)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 348 (697)
..+..|.+ |..+|++..++|.+||..||++|.++.||++|
T Consensus 1455 -------~~gh~Pq~---P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1455 -------AAGHKPQI---PERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred -------hccCCCCC---chhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 22334433 34599999999999999999999999998865
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=290.96 Aligned_cols=253 Identities=25% Similarity=0.405 Sum_probs=205.8
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccCC-ChHHHHHHHHHHHHHHhc-CCCCceEEeeccccCCceEEEEe
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS-TSEELDNFHKELQLLCKL-DHPGLAKFVAAHAKPPNYMFFFE 141 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e 141 (697)
+..+++..||.|+-|.||++++ +|...|||..... +.++.+++...++++..- .+|+||+.+++|..+...++.||
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe 171 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME 171 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence 3456788999999999999987 5689999976544 556678888888887666 49999999999999999999999
Q ss_pred ecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhc
Q 005427 142 FYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHN-LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL 220 (697)
Q Consensus 142 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~ 220 (697)
.|.. .+..++..-..++++.-+-++...++.||.||.+ +||+|||+||+|||+|..|++||||||++..+.+...
T Consensus 172 lMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA--- 247 (391)
T KOG0983|consen 172 LMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA--- 247 (391)
T ss_pred HHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeecccc---
Confidence 8853 6667777666788988888999999999999975 5899999999999999999999999999977654221
Q ss_pred ccccCCCCCCCCccccccccCccccchhhhc---ccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccH
Q 005427 221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILK---KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTE 297 (697)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~ 297 (697)
.+...|.+.|||||.+. ...|+-++||||||++++||.||..||.+.+.+.....+
T Consensus 248 --------------htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltk------- 306 (391)
T KOG0983|consen 248 --------------HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTK------- 306 (391)
T ss_pred --------------cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHH-------
Confidence 23347899999999985 345888999999999999999999999986544332222
Q ss_pred HHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 005427 298 QQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL 351 (697)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~ 351 (697)
+.+ ...|.++. ..++|+.+.+|+..||+.|+.+||.+.++++|...
T Consensus 307 ------vln-~ePP~L~~-~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi 352 (391)
T KOG0983|consen 307 ------VLN-EEPPLLPG-HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFI 352 (391)
T ss_pred ------HHh-cCCCCCCc-ccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcce
Confidence 222 12244433 34599999999999999999999999999987543
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=313.06 Aligned_cols=271 Identities=26% Similarity=0.426 Sum_probs=209.2
Q ss_pred CCCcccccccccCCceEEEEEEEC------CeeEEEEeccCCChH-HHHHHHHHHHHHHhcCCCCceEEeecccc--CCc
Q 005427 65 PSSYTLLSPIARGAESVVYEATLD------GRKVAVKKPILSTSE-ELDNFHKELQLLCKLDHPGLAKFVAAHAK--PPN 135 (697)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~--~~~ 135 (697)
.+.|++.+.||+|+||.||++.+. ++.+|+|........ ....+.+|+++++.++||||+++++++.. ...
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~ 82 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS 82 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence 457899999999999999999853 578999987655443 56789999999999999999999998877 567
Q ss_pred eEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhh
Q 005427 136 YMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL 215 (697)
Q Consensus 136 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~ 215 (697)
.+++|||+++++|.+++......+++.+++.++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++......
T Consensus 83 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 162 (284)
T cd05038 83 LRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPED 162 (284)
T ss_pred eEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccccC
Confidence 89999999999999999776656899999999999999999999999999999999999999999999999998765421
Q ss_pred hhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHH-Hhcc
Q 005427 216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTV-LEMN 294 (697)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~-~~~~ 294 (697)
.... .......++..|++||.+.+..++.++||||||+++|+|++|..||............ ....
T Consensus 163 ~~~~-------------~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~ 229 (284)
T cd05038 163 KDYY-------------YVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQ 229 (284)
T ss_pred Ccce-------------eccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcccccccccc
Confidence 1100 0011234556799999998888999999999999999999999998764322110000 0000
Q ss_pred ccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 295 YTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
.......... ....+. ..+..++.++.+++.+||+.+|.+|||+.++++.|..+
T Consensus 230 ~~~~~~~~~~-~~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 230 MIVTRLLELL-KEGERL---PRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred ccHHHHHHHH-HcCCcC---CCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 0011111111 111111 12345778999999999999999999999999888754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=307.54 Aligned_cols=248 Identities=31% Similarity=0.518 Sum_probs=205.0
Q ss_pred cccccccccCCceEEEEEEECC------eeEEEEeccCCChH-HHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEE
Q 005427 68 YTLLSPIARGAESVVYEATLDG------RKVAVKKPILSTSE-ELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFF 140 (697)
Q Consensus 68 y~~~~~lg~G~~g~V~~~~~~~------~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 140 (697)
+++.+.||+|+||.||++.+.. ..||+|........ ....+..|+.+++.++||||+++++++.+....+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 4578899999999999998743 78999987655443 5678999999999999999999999999999999999
Q ss_pred eecCCCCHhhhhhhcCCC-CCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhh
Q 005427 141 EFYESRNLAEKLHVEEWS-PSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEIS 219 (697)
Q Consensus 141 e~~~~g~L~~~l~~~~~~-~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~ 219 (697)
||+++++|.+++...... +++.+++.++.|++.||+|||+.+++|+||||+||+++.++.++|+|||++.........
T Consensus 81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~- 159 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY- 159 (258)
T ss_pred eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceeccccccc-
Confidence 999999999998765433 899999999999999999999999999999999999999999999999998765432110
Q ss_pred cccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCCchhHHHHHHHHhccccHH
Q 005427 220 LKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQ 298 (697)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~ 298 (697)
......+++.|+|||.+.+..++.++|+||||+++|+|++ |..||...........+..
T Consensus 160 --------------~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~------ 219 (258)
T smart00219 160 --------------KKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKK------ 219 (258)
T ss_pred --------------ccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc------
Confidence 0111236789999999988889999999999999999998 8999987544433332221
Q ss_pred HHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005427 299 QLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALE 348 (697)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 348 (697)
.. .+ ..+..++.++.+++.+||+.+|++|||+.++++.
T Consensus 220 --------~~-~~---~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 257 (258)
T smart00219 220 --------GY-RL---PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEI 257 (258)
T ss_pred --------CC-CC---CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhh
Confidence 11 11 1233578999999999999999999999999864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=312.61 Aligned_cols=252 Identities=24% Similarity=0.373 Sum_probs=208.7
Q ss_pred CcccccccccCCceEEEEEEE--CCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEeecC
Q 005427 67 SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYE 144 (697)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 144 (697)
.|...+.||+|++|.||++.. .++.+++|+.........+.+.+|+.+++.++||||+++++++...+..++++||+.
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 566678999999999999986 578899998766655566778999999999999999999999999999999999999
Q ss_pred CCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhccccc
Q 005427 145 SRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWR 224 (697)
Q Consensus 145 ~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~ 224 (697)
+++|.+++.. ..+++++++.++.|++.||+|||+.|++||||+|+||+++.++.++|+|||++.......
T Consensus 100 ~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~-------- 169 (285)
T cd06648 100 GGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV-------- 169 (285)
T ss_pred CCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCC--------
Confidence 9999999876 368899999999999999999999999999999999999999999999999876433100
Q ss_pred CCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHHHHHH
Q 005427 225 SSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAV 304 (697)
Q Consensus 225 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (697)
.......|++.|+|||.+.+..++.++|+||||+++|+|++|..||...+.......+...
T Consensus 170 --------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~----------- 230 (285)
T cd06648 170 --------PRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN----------- 230 (285)
T ss_pred --------cccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhc-----------
Confidence 0123356899999999999888999999999999999999999999765443332222111
Q ss_pred HhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 305 VSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
..+... .+..++..+.+++.+||+.+|++|||+.++++|.+..
T Consensus 231 ----~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~ 273 (285)
T cd06648 231 ----LPPKLK-NLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLA 273 (285)
T ss_pred ----CCCCCc-ccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccc
Confidence 111111 1234788999999999999999999999999876654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=319.93 Aligned_cols=252 Identities=26% Similarity=0.405 Sum_probs=207.6
Q ss_pred CCc-ccccccccCCceEEEEEEECCeeEEEE--ec----cCCChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCc--e
Q 005427 66 SSY-TLLSPIARGAESVVYEATLDGRKVAVK--KP----ILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPN--Y 136 (697)
Q Consensus 66 ~~y-~~~~~lg~G~~g~V~~~~~~~~~vavK--~~----~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~--~ 136 (697)
.+| ++..+||+|+|-+||+|.++...+.|. .+ ........++|..|+.+|+.|+||||+++|+.+.+... +
T Consensus 39 gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~i 118 (632)
T KOG0584|consen 39 GRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTI 118 (632)
T ss_pred CceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCcee
Confidence 344 567889999999999998854444332 11 12345667899999999999999999999999987765 7
Q ss_pred EEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccccCCCCceeecC-CCCCeeeeeccchhhh
Q 005427 137 MFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLG--IVHRDVKPANVLLDR-NLCPHLADFGLAEYRE 213 (697)
Q Consensus 137 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~-~~~~kL~Dfg~a~~~~ 213 (697)
.+|+|.+..|+|..++++.+ +.....+..+++||+.||.|||++. |+|||||-+||+|+. .|.|||+|+|||..+.
T Consensus 119 n~iTEL~TSGtLr~Y~kk~~-~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r 197 (632)
T KOG0584|consen 119 NFITELFTSGTLREYRKKHR-RVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR 197 (632)
T ss_pred eeeeecccCCcHHHHHHHhc-cCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhh
Confidence 88999999999999987665 7888999999999999999999984 999999999999975 5899999999998765
Q ss_pred hhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhc
Q 005427 214 NLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEM 293 (697)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~ 293 (697)
.. .....+|||.|||||++. +.|+..+||||||+.|+||+|+..||+......+..+.+..
T Consensus 198 ~s------------------~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~S 258 (632)
T KOG0584|consen 198 KS------------------HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTS 258 (632)
T ss_pred cc------------------ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHc
Confidence 31 245689999999999998 78899999999999999999999999988776665554433
Q ss_pred cccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 005427 294 NYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE 354 (697)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~ 354 (697)
...+.. + ..--.+++++||.+||.. .++|||+.|||++..+...
T Consensus 259 GiKP~s-------------l---~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 259 GIKPAA-------------L---SKVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred CCCHHH-------------h---hccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 332221 1 122368999999999999 9999999999998766543
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=308.69 Aligned_cols=236 Identities=25% Similarity=0.369 Sum_probs=191.0
Q ss_pred cccccCCceEEEEEEECCe------------eEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEE
Q 005427 72 SPIARGAESVVYEATLDGR------------KVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFF 139 (697)
Q Consensus 72 ~~lg~G~~g~V~~~~~~~~------------~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 139 (697)
+.||+|+||.||+|.+... .+++|........ ...+.+|+.+++.++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 4799999999999987432 3777865444332 6788999999999999999999999888 778999
Q ss_pred EeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCC-------CCeeeeeccchhh
Q 005427 140 FEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNL-------CPHLADFGLAEYR 212 (697)
Q Consensus 140 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~-------~~kL~Dfg~a~~~ 212 (697)
|||+.+|+|.+++......+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||++...
T Consensus 79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~ 158 (259)
T cd05037 79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITV 158 (259)
T ss_pred EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCccccc
Confidence 999999999999987665789999999999999999999999999999999999999887 7999999998654
Q ss_pred hhhhhhhcccccCCCCCCCCccccccccCccccchhhhccc--CCCchhhHHHHHHHHHHHHh-CCCCCCCchhHHHHHH
Q 005427 213 ENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKE--IHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHT 289 (697)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~~l~ell~-g~~Pf~~~~~~~~~~~ 289 (697)
.. .....++..|+|||++.+. .++.++|||||||++|+|++ |..||...........
T Consensus 159 ~~--------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~ 218 (259)
T cd05037 159 LS--------------------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERF 218 (259)
T ss_pred cc--------------------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHH
Confidence 32 1233567789999999876 78999999999999999999 6888876542221111
Q ss_pred HHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 005427 290 VLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALEL 349 (697)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l 349 (697)
.. .... .+......+.+++.+||..+|.+|||+.++++.|
T Consensus 219 ~~--------------~~~~------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 219 YQ--------------DQHR------LPMPDCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred Hh--------------cCCC------CCCCCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 10 0110 1112237899999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=309.78 Aligned_cols=251 Identities=26% Similarity=0.427 Sum_probs=208.7
Q ss_pred CcccccccccCCceEEEEEEE--CCeeEEEEeccCCC-hHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEeec
Q 005427 67 SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST-SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFY 143 (697)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 143 (697)
-|++.++||.|+||.||+|.+ .++.+|+|...... ......+.+|+.+++.++||||+++++.+.....+++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 478899999999999999976 57889999865443 334567889999999999999999999999999999999999
Q ss_pred CCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhcccc
Q 005427 144 ESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNW 223 (697)
Q Consensus 144 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~ 223 (697)
.+++|.+++... .+++..+..++.|++.++.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 85 ~~~~l~~~i~~~--~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~------- 155 (277)
T cd06641 85 GGGSALDLLEPG--PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ------- 155 (277)
T ss_pred CCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccch-------
Confidence 999999988643 57899999999999999999999999999999999999999999999999986543211
Q ss_pred cCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHHHHH
Q 005427 224 RSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAA 303 (697)
Q Consensus 224 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (697)
.......++..|+|||.+.+...+.++|+|||||++|+|++|..||...........+.
T Consensus 156 ---------~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~------------ 214 (277)
T cd06641 156 ---------IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIP------------ 214 (277)
T ss_pred ---------hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHh------------
Confidence 01223467889999999988888999999999999999999999998654332222211
Q ss_pred HHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 005427 304 VVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL 353 (697)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~ 353 (697)
....+ ..+..++.++.+++.+||+.+|.+||++.+++.|.+...
T Consensus 215 ---~~~~~---~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~ 258 (277)
T cd06641 215 ---KNNPP---TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVR 258 (277)
T ss_pred ---cCCCC---CCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhh
Confidence 11111 233467899999999999999999999999999987764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=312.94 Aligned_cols=267 Identities=24% Similarity=0.310 Sum_probs=208.2
Q ss_pred CcccccccccCCceEEEEEEE--CCeeEEEEeccCCCh-HHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEeec
Q 005427 67 SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTS-EELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFY 143 (697)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 143 (697)
+|++.++||.|++|.||+|++ +++.||+|+...... .....+.+|+.+++.++||||+++++.+...+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 588999999999999999987 588999998765432 23456778999999999999999999999999999999999
Q ss_pred CCCCHhhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhcc
Q 005427 144 ESRNLAEKLHVEE--WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLK 221 (697)
Q Consensus 144 ~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~ 221 (697)
.+ +|.+++.... ..+++.++..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~----- 154 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV----- 154 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc-----
Confidence 85 8888876543 458999999999999999999999999999999999999999999999999986543210
Q ss_pred cccCCCCCCCCccccccccCccccchhhhccc-CCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHH
Q 005427 222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKKE-IHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQL 300 (697)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 300 (697)
.......+++.|++||++.+. .++.++|+|||||++|+|++|..||.+.+.......+.+........
T Consensus 155 -----------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (284)
T cd07836 155 -----------NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTES 223 (284)
T ss_pred -----------cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChh
Confidence 012234578899999998664 46889999999999999999999998876665555444332211111
Q ss_pred HHHHHhC--CCCCcc--------cccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 005427 301 TAAVVSG--GLRPIL--------ASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350 (697)
Q Consensus 301 ~~~~~~~--~~~~~~--------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~ 350 (697)
.+..... .+.... ....+.++..+.+++.+||+.||.+||++.+++++.|
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~ 283 (284)
T cd07836 224 TWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPW 283 (284)
T ss_pred hHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCC
Confidence 1111100 000000 1112346788999999999999999999999998765
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=315.02 Aligned_cols=268 Identities=24% Similarity=0.259 Sum_probs=206.6
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccCCChH--HHHHHHHHHHHHHhcCCCCceEEeeccccC--CceEEE
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSE--ELDNFHKELQLLCKLDHPGLAKFVAAHAKP--PNYMFF 139 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~~lv 139 (697)
++|++.+.||.|+||.||+|.+ +++.+++|........ ....+.+|+.+++.++||||+++++++..+ ...+++
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 5799999999999999999987 4788999986544322 233567899999999999999999998777 899999
Q ss_pred EeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhh
Q 005427 140 FEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEIS 219 (697)
Q Consensus 140 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~ 219 (697)
+||+.+ +|.+++......+++.+++.++.|++.||+|||+.|++|+||||+||+++.++.+||+|||++.......
T Consensus 85 ~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~--- 160 (293)
T cd07843 85 MEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL--- 160 (293)
T ss_pred ehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc---
Confidence 999985 9999887665568999999999999999999999999999999999999999999999999987544210
Q ss_pred cccccCCCCCCCCccccccccCccccchhhhccc-CCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHH
Q 005427 220 LKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKE-IHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQ 298 (697)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~ 298 (697)
.......+++.|+|||.+.+. .++.++|+||||+++|+|++|..||...........+........
T Consensus 161 -------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~ 227 (293)
T cd07843 161 -------------KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPT 227 (293)
T ss_pred -------------cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCc
Confidence 011234578899999998764 468899999999999999999999987765554444332211110
Q ss_pred HHHHHH-------HhC-----CCCCcccccccC-ChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 005427 299 QLTAAV-------VSG-----GLRPILASLELG-LPASILSLIQRCWDGNPHNRPSFSDIALELD 350 (697)
Q Consensus 299 ~~~~~~-------~~~-----~~~~~~~~~~~~-~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~ 350 (697)
...+.. ... .........+.. +++.+.++|++||+.+|++|||+.|++.|.|
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~ 292 (293)
T cd07843 228 EKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPY 292 (293)
T ss_pred hHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCC
Confidence 000000 000 000001111222 5888999999999999999999999998765
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=308.74 Aligned_cols=247 Identities=28% Similarity=0.421 Sum_probs=198.6
Q ss_pred cccccCCceEEEEEEECC--------eeEEEEeccCCC-hHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEee
Q 005427 72 SPIARGAESVVYEATLDG--------RKVAVKKPILST-SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF 142 (697)
Q Consensus 72 ~~lg~G~~g~V~~~~~~~--------~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 142 (697)
+.||+|+||.||+|+... ..+++|...... ......+.+|+.+++.++||||+++++++......+++|||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999998632 568999765432 23466788999999999999999999999999999999999
Q ss_pred cCCCCHhhhhhhc------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCC-----CCeeeeeccchh
Q 005427 143 YESRNLAEKLHVE------EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNL-----CPHLADFGLAEY 211 (697)
Q Consensus 143 ~~~g~L~~~l~~~------~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~-----~~kL~Dfg~a~~ 211 (697)
+++++|.+++... ...+++.+++.++.|++.||.|||+.+++|+||||+||+++.++ .+||+|||++..
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~ 160 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARD 160 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccccc
Confidence 9999999998642 23468899999999999999999999999999999999998877 899999999865
Q ss_pred hhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCCchhHHHHHHH
Q 005427 212 RENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTV 290 (697)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~~~~~~~~~~~ 290 (697)
....... .......++..|+|||++.+..++.++|||||||++|+|++ |..||...........+
T Consensus 161 ~~~~~~~--------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~ 226 (269)
T cd05044 161 IYKSDYY--------------RKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHV 226 (269)
T ss_pred ccccccc--------------ccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHH
Confidence 4321110 01122346788999999999899999999999999999998 99999866544332222
Q ss_pred HhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 005427 291 LEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350 (697)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~ 350 (697)
.. + .++ ..+..+|..+.++|.+||..+|.+||++.++++.|.
T Consensus 227 ~~--------------~-~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 227 TA--------------G-GRL---QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred hc--------------C-Ccc---CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 11 1 111 123467899999999999999999999999988764
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=312.58 Aligned_cols=255 Identities=26% Similarity=0.346 Sum_probs=203.2
Q ss_pred CCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCChHHHHHHHHHHHHHHhc-CCCCceEEeeccccC-----Cc
Q 005427 64 PPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKL-DHPGLAKFVAAHAKP-----PN 135 (697)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~-----~~ 135 (697)
..++|.+.+.||+|+||.||++.. .++.+|+|...... .....+.+|+.+++.+ +|||++++++++... ..
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~ 98 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQ 98 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCe
Confidence 356899999999999999999987 57889999865432 2345678899999999 899999999988653 35
Q ss_pred eEEEEeecCCCCHhhhhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhh
Q 005427 136 YMFFFEFYESRNLAEKLHV---EEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYR 212 (697)
Q Consensus 136 ~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~ 212 (697)
+++||||+++++|.++++. ....+++..++.++.|++.||+|||+.|++||||||+||+++.++.+||+|||++...
T Consensus 99 ~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~~ 178 (291)
T cd06639 99 LWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQL 178 (291)
T ss_pred eEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccchhc
Confidence 8999999999999998753 3346889999999999999999999999999999999999999999999999998754
Q ss_pred hhhhhhhcccccCCCCCCCCccccccccCccccchhhhccc-----CCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHH
Q 005427 213 ENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKE-----IHSEKSDVYSFGISINELLTGVVPYTDLRAEAQA 287 (697)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~ 287 (697)
.... .......|+..|+|||++... .++.++|||||||++|+|++|..||.........
T Consensus 179 ~~~~----------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~ 242 (291)
T cd06639 179 TSTR----------------LRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTL 242 (291)
T ss_pred cccc----------------ccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHH
Confidence 3211 012234688999999998643 3578999999999999999999999876443322
Q ss_pred HHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 005427 288 HTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL 351 (697)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~ 351 (697)
..+... ..+.+. .+..++..+.++|.+||+.+|++||++.++++|.|.
T Consensus 243 ~~~~~~---------------~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~ 290 (291)
T cd06639 243 FKIPRN---------------PPPTLL-HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFI 290 (291)
T ss_pred HHHhcC---------------CCCCCC-cccccCHHHHHHHHHHhhcChhhCcCHHHHhcCccc
Confidence 222111 011111 123467889999999999999999999999998764
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=310.52 Aligned_cols=264 Identities=24% Similarity=0.260 Sum_probs=201.5
Q ss_pred cccccccccCCceEEEEEEE--CCeeEEEEeccCCC-hHHHHHHHHHHHHHHhcC-CCCceEEeeccccC--CceEEEEe
Q 005427 68 YTLLSPIARGAESVVYEATL--DGRKVAVKKPILST-SEELDNFHKELQLLCKLD-HPGLAKFVAAHAKP--PNYMFFFE 141 (697)
Q Consensus 68 y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~--~~~~lv~e 141 (697)
|++.++||+|+||.||+|.. +++.+|+|+..... ........+|+.++.++. ||||+++++++.++ +.+++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 67899999999999999987 57889999765432 222233457888898885 99999999999887 88999999
Q ss_pred ecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhcc
Q 005427 142 FYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLK 221 (697)
Q Consensus 142 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~ 221 (697)
|+.+ +|.+.+......+++.+++.++.|++.||+|||+.|++||||||+||+++. +.+||+|||++.......
T Consensus 81 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~----- 153 (282)
T cd07831 81 LMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP----- 153 (282)
T ss_pred cCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCC-----
Confidence 9974 888888765557899999999999999999999999999999999999999 999999999987543211
Q ss_pred cccCCCCCCCCccccccccCccccchhhhc-ccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccH-HH
Q 005427 222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILK-KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTE-QQ 299 (697)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~-~~ 299 (697)
......+++.|+|||++. +..++.++|||||||++|||++|..||.+.+.......+....... ..
T Consensus 154 ------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 221 (282)
T cd07831 154 ------------PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAE 221 (282)
T ss_pred ------------CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHH
Confidence 112345789999999765 4557889999999999999999999998766544433332211111 11
Q ss_pred HHHHHHhCCCCC---------cccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 005427 300 LTAAVVSGGLRP---------ILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350 (697)
Q Consensus 300 ~~~~~~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~ 350 (697)
............ .+......++.++.++|.+||+.+|++|||+.++++|.|
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~ 281 (282)
T cd07831 222 VLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPY 281 (282)
T ss_pred HHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCC
Confidence 111110000000 001112357899999999999999999999999998865
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=312.92 Aligned_cols=266 Identities=26% Similarity=0.287 Sum_probs=207.1
Q ss_pred cccccccccCCceEEEEEEE--CCeeEEEEeccCCCh--HHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEeec
Q 005427 68 YTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTS--EELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFY 143 (697)
Q Consensus 68 y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 143 (697)
|++.++||.|++|.||+|.+ +++.|++|++..... .....+.+|+++++.++||||+++++++.+....+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 67899999999999999986 688999998765432 22356888999999999999999999999999999999999
Q ss_pred CCCCHhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhccc
Q 005427 144 ESRNLAEKLHVEE-WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKN 222 (697)
Q Consensus 144 ~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 222 (697)
. ++|.+++.... ..+++.+++.++.|++.||+|||+.+++||||+|+||+++.++.++|+|||++.......
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~------ 153 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV------ 153 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCc------
Confidence 5 58998886544 357899999999999999999999999999999999999999999999999986543110
Q ss_pred ccCCCCCCCCccccccccCccccchhhhccc-CCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHHH
Q 005427 223 WRSSGKPTGGFHKKNMVGTLIYMAPEILKKE-IHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLT 301 (697)
Q Consensus 223 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 301 (697)
.......+++.|+|||++.+. .++.++|+||||+++|+|++|..||...........+.+.........
T Consensus 154 ----------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 223 (283)
T cd07835 154 ----------RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDV 223 (283)
T ss_pred ----------cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHH
Confidence 011233568899999988764 568899999999999999999999987665544444433221111110
Q ss_pred H-------HH---HhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 005427 302 A-------AV---VSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350 (697)
Q Consensus 302 ~-------~~---~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~ 350 (697)
+ .. ......+........++..+.+++.+||+.||.+|||+.+++++.|
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~ 282 (283)
T cd07835 224 WPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPY 282 (283)
T ss_pred hhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCC
Confidence 0 00 0001111122234567899999999999999999999999998765
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=336.66 Aligned_cols=272 Identities=22% Similarity=0.285 Sum_probs=194.9
Q ss_pred CCcccccccccCCceEEEEEEEC---CeeEEEEe-----------------ccCCChHHHHHHHHHHHHHHhcCCCCceE
Q 005427 66 SSYTLLSPIARGAESVVYEATLD---GRKVAVKK-----------------PILSTSEELDNFHKELQLLCKLDHPGLAK 125 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~---~~~vavK~-----------------~~~~~~~~~~~~~~E~~~l~~l~hpniv~ 125 (697)
++|+++++||+|+||+||++... +...+.|. ...........+.+|+.+|++++||||++
T Consensus 148 ~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~ 227 (501)
T PHA03210 148 AHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILK 227 (501)
T ss_pred hccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCc
Confidence 57999999999999999998652 11111110 00112223456889999999999999999
Q ss_pred EeeccccCCceEEEEeecCCCCHhhhhhhcC----CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCC
Q 005427 126 FVAAHAKPPNYMFFFEFYESRNLAEKLHVEE----WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCP 201 (697)
Q Consensus 126 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~ 201 (697)
+++++......+++++++.+ +|.+++.... ......+++.++.|++.||+|||++||+||||||+|||++.++.+
T Consensus 228 l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~v 306 (501)
T PHA03210 228 IEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKI 306 (501)
T ss_pred EeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCE
Confidence 99999999999999999864 7777664322 123466788999999999999999999999999999999999999
Q ss_pred eeeeeccchhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCC-CCCC
Q 005427 202 HLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVV-PYTD 280 (697)
Q Consensus 202 kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~-Pf~~ 280 (697)
||+|||++..+..... .......||+.|+|||++.+..++.++|||||||++|||++|.. ||.+
T Consensus 307 kL~DFGla~~~~~~~~---------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~ 371 (501)
T PHA03210 307 VLGDFGTAMPFEKERE---------------AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGD 371 (501)
T ss_pred EEEeCCCceecCcccc---------------cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccC
Confidence 9999999976542110 11234679999999999999999999999999999999999775 4443
Q ss_pred ch--hHHHHHHHHhc-cccHH-------HHHHHHHhCCCC---Ccccc--cccCChHHHHHHHHHhccCCCCCCCCHHHH
Q 005427 281 LR--AEAQAHTVLEM-NYTEQ-------QLTAAVVSGGLR---PILAS--LELGLPASILSLIQRCWDGNPHNRPSFSDI 345 (697)
Q Consensus 281 ~~--~~~~~~~~~~~-~~~~~-------~~~~~~~~~~~~---~~~~~--~~~~~~~~l~~li~~~l~~dP~~Rpt~~el 345 (697)
.. .......++.. ..... .+...+....+. ..++. ....++.++.++|.+||++||.+|||+.|+
T Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~el 451 (501)
T PHA03210 372 GGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAEL 451 (501)
T ss_pred CCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHH
Confidence 21 11222222111 00000 011111110000 00000 012467788999999999999999999999
Q ss_pred HHHHHHHH
Q 005427 346 ALELDLVL 353 (697)
Q Consensus 346 l~~l~~~~ 353 (697)
+.|.|+..
T Consensus 452 L~hp~f~~ 459 (501)
T PHA03210 452 LALPLFSA 459 (501)
T ss_pred hhChhhhc
Confidence 99998843
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=313.97 Aligned_cols=253 Identities=24% Similarity=0.356 Sum_probs=208.1
Q ss_pred CCCcccccccccCCceEEEEEEE--CCeeEEEEeccCC---ChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEE
Q 005427 65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFF 139 (697)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 139 (697)
.+.|...+.||+|+||.||++.. .+..+|+|++... ..+....+.+|+.+++.++|||++++++++......++|
T Consensus 24 ~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 103 (317)
T cd06635 24 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLV 103 (317)
T ss_pred hhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEE
Confidence 35689999999999999999986 5788999986533 233456788999999999999999999999999999999
Q ss_pred EeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhh
Q 005427 140 FEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEIS 219 (697)
Q Consensus 140 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~ 219 (697)
|||+.+ +|.+.+......+++.++..++.|++.||.|||+.|++||||+|+||+++.++.+||+|||++.....
T Consensus 104 ~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~----- 177 (317)
T cd06635 104 MEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP----- 177 (317)
T ss_pred EeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC-----
Confidence 999975 78887766566789999999999999999999999999999999999999999999999998754321
Q ss_pred cccccCCCCCCCCccccccccCccccchhhhc---ccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhcccc
Q 005427 220 LKNWRSSGKPTGGFHKKNMVGTLIYMAPEILK---KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYT 296 (697)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~ 296 (697)
.....|++.|+|||++. ...++.++|+|||||++|+|++|..||...........+..
T Consensus 178 ---------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~---- 238 (317)
T cd06635 178 ---------------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ---- 238 (317)
T ss_pred ---------------cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHh----
Confidence 22346888999999974 45678899999999999999999999977544333332221
Q ss_pred HHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 005427 297 EQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH 355 (697)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~ 355 (697)
....+ .....+++.+.+++.+||+.+|.+||++.+++++++.....
T Consensus 239 ----------~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 284 (317)
T cd06635 239 ----------NESPT---LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRER 284 (317)
T ss_pred ----------ccCCC---CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccC
Confidence 11111 11235788999999999999999999999999999886543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=305.40 Aligned_cols=253 Identities=27% Similarity=0.413 Sum_probs=210.9
Q ss_pred CcccccccccCCceEEEEEEE--CCeeEEEEeccCCCh-HHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEeec
Q 005427 67 SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTS-EELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFY 143 (697)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 143 (697)
+|++.+.||+|++|.||++.+ +++.|++|+...... .....+.+|+..+..++||||+++++++..+..++++|||+
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYM 81 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEec
Confidence 688999999999999999987 488999998766544 45678999999999999999999999999999999999999
Q ss_pred CCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhccc
Q 005427 144 ESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHN-LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKN 222 (697)
Q Consensus 144 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 222 (697)
++++|.+++... ..+++..++.++.|++.||.|||+ .+++||||+|+||+++.++.++|+|||++........
T Consensus 82 ~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~----- 155 (264)
T cd06623 82 DGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD----- 155 (264)
T ss_pred CCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCC-----
Confidence 999999999765 478999999999999999999999 9999999999999999999999999999875532110
Q ss_pred ccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHHHH
Q 005427 223 WRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTA 302 (697)
Q Consensus 223 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 302 (697)
......++..|+|||.+.+..++.++|+||||+++|+|++|..||....... ......
T Consensus 156 -----------~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~-----------~~~~~~ 213 (264)
T cd06623 156 -----------QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPS-----------FFELMQ 213 (264)
T ss_pred -----------cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccC-----------HHHHHH
Confidence 1124568899999999999899999999999999999999999997764211 111111
Q ss_pred HHHhCCCCCcccccccC-ChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 005427 303 AVVSGGLRPILASLELG-LPASILSLIQRCWDGNPHNRPSFSDIALELDL 351 (697)
Q Consensus 303 ~~~~~~~~~~~~~~~~~-~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~ 351 (697)
.+.... .+..+.. ++..+.++|..||..+|++|||+.+++++.|.
T Consensus 214 ~~~~~~----~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~ 259 (264)
T cd06623 214 AICDGP----PPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFI 259 (264)
T ss_pred HHhcCC----CCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHH
Confidence 111111 1122334 88999999999999999999999999998776
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=312.06 Aligned_cols=270 Identities=22% Similarity=0.269 Sum_probs=205.2
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccCCCh--HHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEe
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTS--EELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFE 141 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 141 (697)
++|++.+.||+|++|+||+|.+ +++.||+|+...... .....+.+|+++++.++||||+++++++.....+++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 4799999999999999999986 578899998654432 234568899999999999999999999999999999999
Q ss_pred ecCCCCHhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecC-CCCCeeeeeccchhhhhhhhhh
Q 005427 142 FYESRNLAEKLHVEE-WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDR-NLCPHLADFGLAEYRENLKEIS 219 (697)
Q Consensus 142 ~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~-~~~~kL~Dfg~a~~~~~~~~~~ 219 (697)
|+.+ +|.+.+.... ..+++..++.++.||+.||+|||+++++||||+|+||+++. ++.+||+|||++.......
T Consensus 82 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~--- 157 (294)
T PLN00009 82 YLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV--- 157 (294)
T ss_pred cccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc---
Confidence 9964 7777765433 34678889999999999999999999999999999999985 5578999999986543210
Q ss_pred cccccCCCCCCCCccccccccCccccchhhhcc-cCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHH
Q 005427 220 LKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQ 298 (697)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~ 298 (697)
.......+++.|+|||++.+ ..++.++|||||||++|+|++|..||...........+........
T Consensus 158 -------------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~ 224 (294)
T PLN00009 158 -------------RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPN 224 (294)
T ss_pred -------------cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 01123467889999999876 4578899999999999999999999987655444333322111100
Q ss_pred HHHH---------HHHhCCC-CCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 299 QLTA---------AVVSGGL-RPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 299 ~~~~---------~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
...+ ....... ........+.+++++.+++.+||+.+|++||++.+++++.|+.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~ 288 (294)
T PLN00009 225 EETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFK 288 (294)
T ss_pred hhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHh
Confidence 0000 0000000 0111112346789999999999999999999999999988764
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=313.59 Aligned_cols=269 Identities=22% Similarity=0.273 Sum_probs=207.1
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccCCC--hHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEe
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST--SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFE 141 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 141 (697)
++|++.++||+|+||.||+|.+ +++.|++|+..... ......+.+|+++++.++||||+++++++...+.++++||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 3799999999999999999987 47889999765432 2335678999999999999999999999999999999999
Q ss_pred ecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhcc
Q 005427 142 FYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLK 221 (697)
Q Consensus 142 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~ 221 (697)
|+.++.+..+.. ....+++.+++.++.|++.||.|||+.+++|+||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~~~~l~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~---- 155 (288)
T cd07833 81 YVERTLLELLEA-SPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA---- 155 (288)
T ss_pred cCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc----
Confidence 999866665554 344689999999999999999999999999999999999999999999999999876542110
Q ss_pred cccCCCCCCCCccccccccCccccchhhhccc-CCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHH
Q 005427 222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKKE-IHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQL 300 (697)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 300 (697)
.......++..|+|||++.+. .++.++|+||||+++|+|++|.+||.+.........+..........
T Consensus 156 -----------~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (288)
T cd07833 156 -----------SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPS 224 (288)
T ss_pred -----------ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 012345688999999999887 78999999999999999999999998765444333322211110000
Q ss_pred HHH-H-HhCCCC-----Ccc------cccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 005427 301 TAA-V-VSGGLR-----PIL------ASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350 (697)
Q Consensus 301 ~~~-~-~~~~~~-----~~~------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~ 350 (697)
... . ...... +.. ...+..++.++.+||++||..+|++|||+++++++.|
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~ 287 (288)
T cd07833 225 HQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPY 287 (288)
T ss_pred HhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCC
Confidence 000 0 000000 000 0112335889999999999999999999999988755
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=310.63 Aligned_cols=257 Identities=26% Similarity=0.424 Sum_probs=213.7
Q ss_pred CCCCcccccccccCCceEEEEEEEC--CeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEe
Q 005427 64 PPSSYTLLSPIARGAESVVYEATLD--GRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFE 141 (697)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 141 (697)
..+.|++.+.||+|+||.||++.+. +..+++|+...... ....+.+|+++++.++||||+++++.+......++++|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 3457999999999999999999874 88999998765544 56678899999999999999999999999999999999
Q ss_pred ecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhcc
Q 005427 142 FYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLK 221 (697)
Q Consensus 142 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~ 221 (697)
|+.+++|.+++......+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus 96 ~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---- 171 (286)
T cd06614 96 YMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS---- 171 (286)
T ss_pred ccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh----
Confidence 9999999999987655789999999999999999999999999999999999999999999999998865432110
Q ss_pred cccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHHH
Q 005427 222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLT 301 (697)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 301 (697)
......+++.|++||++.+..++.++|+||||+++|+|++|..||...........+..
T Consensus 172 ------------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~--------- 230 (286)
T cd06614 172 ------------KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITT--------- 230 (286)
T ss_pred ------------hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---------
Confidence 12234578899999999988899999999999999999999999986544332222211
Q ss_pred HHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 005427 302 AAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL 353 (697)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~ 353 (697)
....+ .. .+..++.++.++|.+||+.+|.+|||+.+++++.+...
T Consensus 231 -----~~~~~-~~-~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 275 (286)
T cd06614 231 -----KGIPP-LK-NPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKK 275 (286)
T ss_pred -----cCCCC-Cc-chhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhc
Confidence 11111 11 12347889999999999999999999999999887764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=314.02 Aligned_cols=268 Identities=25% Similarity=0.273 Sum_probs=200.8
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccCCChHH-HHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEee
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEE-LDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF 142 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 142 (697)
++|++.+.||+|+||.||+|.. +++.|++|......... ...+.+|+.+++.++|+||+++++++......++||||
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEY 84 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEec
Confidence 5799999999999999999976 57899999865443222 34567899999999999999999999999999999999
Q ss_pred cCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhccc
Q 005427 143 YESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKN 222 (697)
Q Consensus 143 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 222 (697)
+. ++|.+.+......+++.++..++.|++.||.|||+.||+|+||||+|||++.++.+||+|||++.......
T Consensus 85 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~------ 157 (291)
T cd07870 85 MH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPS------ 157 (291)
T ss_pred cc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCC------
Confidence 96 67777765554567888999999999999999999999999999999999999999999999986432100
Q ss_pred ccCCCCCCCCccccccccCccccchhhhccc-CCCchhhHHHHHHHHHHHHhCCCCCCCchhHH-HHHHHHhccc-cHHH
Q 005427 223 WRSSGKPTGGFHKKNMVGTLIYMAPEILKKE-IHSEKSDVYSFGISINELLTGVVPYTDLRAEA-QAHTVLEMNY-TEQQ 299 (697)
Q Consensus 223 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~-~~~~~~~~~~-~~~~ 299 (697)
.......+++.|+|||++.+. .++.++|||||||++|+|++|..||.+..... ....+..... ....
T Consensus 158 ----------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~ 227 (291)
T cd07870 158 ----------QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTED 227 (291)
T ss_pred ----------CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChh
Confidence 012234578999999998754 57889999999999999999999998654321 1111111100 0000
Q ss_pred HHHHHHh-CCC---------CCcccccc--cCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 005427 300 LTAAVVS-GGL---------RPILASLE--LGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350 (697)
Q Consensus 300 ~~~~~~~-~~~---------~~~~~~~~--~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~ 350 (697)
....... ..+ .+...... ...+.++.+++.+||..||++|||+.|++.|.|
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~ 290 (291)
T cd07870 228 TWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPY 290 (291)
T ss_pred hhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCC
Confidence 0000000 000 00000000 123678999999999999999999999998765
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=310.12 Aligned_cols=250 Identities=25% Similarity=0.320 Sum_probs=206.7
Q ss_pred CcccccccccCCceEEEEEEE--CCeeEEEEeccCCC---hHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEe
Q 005427 67 SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST---SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFE 141 (697)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 141 (697)
+|++.+.||.|+||.||++.+ +++.||+|...... ....+.+.+|+.++++++||||+++++.+..+...++++|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 589999999999999999987 48899999765332 2456789999999999999999999999999999999999
Q ss_pred ecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhcc
Q 005427 142 FYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLK 221 (697)
Q Consensus 142 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~ 221 (697)
|+.+++|.+++... ..+++.++..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~----- 154 (258)
T cd05578 81 LLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT----- 154 (258)
T ss_pred CCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc-----
Confidence 99999999998765 478899999999999999999999999999999999999999999999999986543210
Q ss_pred cccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHHH
Q 005427 222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLT 301 (697)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 301 (697)
......|+..|+|||++.+..++.++|+||||+++|+|++|..||...+...... +.
T Consensus 155 ------------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~-~~---------- 211 (258)
T cd05578 155 ------------LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQ-IR---------- 211 (258)
T ss_pred ------------cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHH-HH----------
Confidence 1233568889999999998889999999999999999999999998765321100 00
Q ss_pred HHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCH--HHHHHHHH
Q 005427 302 AAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSF--SDIALELD 350 (697)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~--~ell~~l~ 350 (697)
. .... .....+..++..+.++|.+||+.||.+||++ .|+++|.|
T Consensus 212 ~-~~~~----~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~ 257 (258)
T cd05578 212 A-KQET----ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPY 257 (258)
T ss_pred H-Hhcc----ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCC
Confidence 0 0000 1112344678999999999999999999999 88876654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=308.80 Aligned_cols=250 Identities=28% Similarity=0.484 Sum_probs=205.5
Q ss_pred CcccccccccCCceEEEEEEE--CCeeEEEEeccCC-ChHHHHHHHHHHHHHHhcC---CCCceEEeeccccCCceEEEE
Q 005427 67 SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS-TSEELDNFHKELQLLCKLD---HPGLAKFVAAHAKPPNYMFFF 140 (697)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~---hpniv~l~~~~~~~~~~~lv~ 140 (697)
.|++.+.||+|+||.||+|.+ +++.+++|..... .......+.+|+.+++.++ |||++++++++.....++++|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 588999999999999999987 5788999986544 2344667889999999996 999999999999999999999
Q ss_pred eecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhc
Q 005427 141 EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL 220 (697)
Q Consensus 141 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~ 220 (697)
||+.+++|.+++... .+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~---- 155 (277)
T cd06917 82 EYAEGGSVRTLMKAG--PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS---- 155 (277)
T ss_pred ecCCCCcHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc----
Confidence 999999999988653 68899999999999999999999999999999999999999999999999987554211
Q ss_pred ccccCCCCCCCCccccccccCccccchhhhcc-cCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHH
Q 005427 221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQ 299 (697)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~ 299 (697)
.......|+..|+|||.+.+ ..++.++|+|||||++|+|++|..||.+.........+.
T Consensus 156 ------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~-------- 215 (277)
T cd06917 156 ------------SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIP-------- 215 (277)
T ss_pred ------------cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccc--------
Confidence 01233468899999999865 456889999999999999999999998654322211110
Q ss_pred HHHHHHhCCCCCccccccc-CChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 300 LTAAVVSGGLRPILASLEL-GLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~-~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
....+ .++. .++.++.+++.+||+.||++||++.+++.+.|..
T Consensus 216 -------~~~~~---~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~ 259 (277)
T cd06917 216 -------KSKPP---RLEDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIK 259 (277)
T ss_pred -------cCCCC---CCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhh
Confidence 01111 1222 3788999999999999999999999999987773
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=316.04 Aligned_cols=251 Identities=25% Similarity=0.345 Sum_probs=211.4
Q ss_pred cccc--cccccCCceEEEEEEE--CCeeEEEEeccCC--ChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEe
Q 005427 68 YTLL--SPIARGAESVVYEATL--DGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFE 141 (697)
Q Consensus 68 y~~~--~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 141 (697)
|++. +.||.|.||+||-|.+ +|+.||||++... ..+..+.+++|+.||+.+.||.||.|...|++++..+.|||
T Consensus 564 YQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVME 643 (888)
T KOG4236|consen 564 YQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVME 643 (888)
T ss_pred HHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEeh
Confidence 5543 7899999999999976 7999999975432 12334789999999999999999999999999999999999
Q ss_pred ecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecC---CCCCeeeeeccchhhhhhhhh
Q 005427 142 FYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDR---NLCPHLADFGLAEYRENLKEI 218 (697)
Q Consensus 142 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~---~~~~kL~Dfg~a~~~~~~~~~ 218 (697)
.+.|.-|.-.|.....++++.....++.||+.||.|||.++|+|+||||+|||+.. -..+||||||+|+++.+..
T Consensus 644 Kl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks-- 721 (888)
T KOG4236|consen 644 KLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS-- 721 (888)
T ss_pred hhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhh--
Confidence 99886677777777789999999999999999999999999999999999999954 3579999999999887522
Q ss_pred hcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHH
Q 005427 219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQ 298 (697)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~ 298 (697)
...+.+|||.|.|||++....|...-|+||+||++|--++|..||....+.. .+|.+..+.
T Consensus 722 ---------------FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIn--dQIQNAaFM-- 782 (888)
T KOG4236|consen 722 ---------------FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIN--DQIQNAAFM-- 782 (888)
T ss_pred ---------------hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchh--HHhhccccc--
Confidence 2567899999999999999999999999999999999999999998643322 222221111
Q ss_pred HHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 299 QLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
..+..+..+++++.+||..+|+..=.+|-|.++-+.|.|..
T Consensus 783 -------------yPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq 823 (888)
T KOG4236|consen 783 -------------YPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQ 823 (888)
T ss_pred -------------cCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhh
Confidence 11234567899999999999999999999999999999874
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=305.60 Aligned_cols=252 Identities=26% Similarity=0.392 Sum_probs=205.0
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccCC-----ChHHHHHHHHHHHHHHhcCCCCceEEeeccccC--Cce
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS-----TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKP--PNY 136 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~ 136 (697)
.+|.+.+.||+|+||.||+|.+ +++.+++|..... .......+.+|+.++++++||||+++++.+.+. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 5799999999999999999986 5789999976432 234456889999999999999999999988664 458
Q ss_pred EEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhh
Q 005427 137 MFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLK 216 (697)
Q Consensus 137 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~ 216 (697)
++++||+++++|.+++.... .+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.......
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 160 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYG-ALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTIC 160 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcccccccccccc
Confidence 89999999999999987654 57889999999999999999999999999999999999999999999999987543210
Q ss_pred hhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhcccc
Q 005427 217 EISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYT 296 (697)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~ 296 (697)
..........|+..|+|||++.+..++.++|+|||||++|+|++|..||.+.........+.
T Consensus 161 -------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~----- 222 (264)
T cd06653 161 -------------MSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIA----- 222 (264)
T ss_pred -------------ccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHH-----
Confidence 00111234568999999999998888999999999999999999999998654333222221
Q ss_pred HHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 005427 297 EQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALEL 349 (697)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l 349 (697)
. .+..+..+..+++.+.+++.+||+ +|..||++.+++.|+
T Consensus 223 ---------~---~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~ 262 (264)
T cd06653 223 ---------T---QPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHP 262 (264)
T ss_pred ---------c---CCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCC
Confidence 1 111223456788999999999999 579999999998765
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=304.39 Aligned_cols=250 Identities=21% Similarity=0.370 Sum_probs=191.7
Q ss_pred cccccCCceEEEEEEE-CC---eeEEEEeccCCC-hHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEeecCCC
Q 005427 72 SPIARGAESVVYEATL-DG---RKVAVKKPILST-SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESR 146 (697)
Q Consensus 72 ~~lg~G~~g~V~~~~~-~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g 146 (697)
++||+|+||.||++.. .+ ..+++|...... ....+.+.+|+.+++.++||||+++++.+......+++|||+.+|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3699999999999964 22 345677654433 345678999999999999999999999999999999999999999
Q ss_pred CHhhhhhhcC---CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhcccc
Q 005427 147 NLAEKLHVEE---WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNW 223 (697)
Q Consensus 147 ~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~ 223 (697)
+|.+++.... ...++..++.++.|++.||+|||+.+++||||||+|||++.++.+||+|||++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~----- 155 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYI----- 155 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhh-----
Confidence 9999987543 23566778899999999999999999999999999999999999999999987532210000
Q ss_pred cCCCCCCCCccccccccCccccchhhhcc-------cCCCchhhHHHHHHHHHHHHh-CCCCCCCchhHHHHHHHHhccc
Q 005427 224 RSSGKPTGGFHKKNMVGTLIYMAPEILKK-------EIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNY 295 (697)
Q Consensus 224 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~~l~ell~-g~~Pf~~~~~~~~~~~~~~~~~ 295 (697)
.......++..|+|||++.. ..++.++|||||||++|||++ |..||...........+...
T Consensus 156 ---------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~-- 224 (268)
T cd05086 156 ---------ETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKD-- 224 (268)
T ss_pred ---------hcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhh--
Confidence 01224567899999999753 245778999999999999997 67788765544333322211
Q ss_pred cHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 005427 296 TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALEL 349 (697)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l 349 (697)
.......+..+..+++.+.+++..|| .+|++||++.++++.|
T Consensus 225 -----------~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l 266 (268)
T cd05086 225 -----------QQVKLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLL 266 (268)
T ss_pred -----------cccccCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHh
Confidence 11111112233457889999999999 6799999999998765
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=306.12 Aligned_cols=250 Identities=26% Similarity=0.425 Sum_probs=205.8
Q ss_pred CcccccccccCCceEEEEEEE--CCeeEEEEeccCCC--hHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEee
Q 005427 67 SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST--SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF 142 (697)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 142 (697)
+|.+.+.||+|+||.||++.. .+..+|+|...... ....+.+.+|+.+++.++||||+++++.+.....+++++||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 588999999999999999987 57889999865432 23456788999999999999999999999999999999999
Q ss_pred cCCCCHhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCC-Ceeeeeccchhhhhhhhhhc
Q 005427 143 YESRNLAEKLHVEE-WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLC-PHLADFGLAEYRENLKEISL 220 (697)
Q Consensus 143 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~-~kL~Dfg~a~~~~~~~~~~~ 220 (697)
+.+++|.+++.... ..+++..+..++.|++.||.|||+.+++|+||||+||+++.++. +||+|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~--- 157 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME--- 157 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc---
Confidence 99999999986543 35789999999999999999999999999999999999988764 69999998865432110
Q ss_pred ccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHH
Q 005427 221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQL 300 (697)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 300 (697)
......|++.|+|||++.+..++.++|+||||+++|+|++|..||...........+.
T Consensus 158 -------------~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~--------- 215 (257)
T cd08225 158 -------------LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKIC--------- 215 (257)
T ss_pred -------------cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh---------
Confidence 1223468899999999988889999999999999999999999997654333222221
Q ss_pred HHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 005427 301 TAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350 (697)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~ 350 (697)
.+.. ......++.++.+++.+||..+|++|||+.+++++.|
T Consensus 216 -----~~~~----~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~ 256 (257)
T cd08225 216 -----QGYF----APISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPF 256 (257)
T ss_pred -----cccC----CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCC
Confidence 1111 1223457889999999999999999999999998865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=309.19 Aligned_cols=247 Identities=21% Similarity=0.247 Sum_probs=200.6
Q ss_pred cccCCceEEEEEEE--CCeeEEEEeccCCC---hHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEeecCCCCH
Q 005427 74 IARGAESVVYEATL--DGRKVAVKKPILST---SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNL 148 (697)
Q Consensus 74 lg~G~~g~V~~~~~--~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L 148 (697)
||+|+||+||++.. +++.+|+|...... ......+..|+++|+.++||||+++++.+...+.+|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 69999999999976 58899999765432 22345667899999999999999999999999999999999999999
Q ss_pred hhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhcccccCCC
Q 005427 149 AEKLHVEE-WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227 (697)
Q Consensus 149 ~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~ 227 (697)
.+++.... ..+++.+++.++.|++.||.|||+.|++||||+|+||+++.++.+||+|||++......
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~------------ 148 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG------------ 148 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccC------------
Confidence 99986544 35899999999999999999999999999999999999999999999999998654320
Q ss_pred CCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHHHHHHHhC
Q 005427 228 KPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSG 307 (697)
Q Consensus 228 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (697)
.......++..|+|||++.+..++.++|+|||||++|+|++|..||...........+...
T Consensus 149 -----~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-------------- 209 (277)
T cd05577 149 -----KKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRR-------------- 209 (277)
T ss_pred -----CccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhc--------------
Confidence 0123346788999999998888999999999999999999999999765432111111110
Q ss_pred CCCCcccccccCChHHHHHHHHHhccCCCCCCC-----CHHHHHHHHHHH
Q 005427 308 GLRPILASLELGLPASILSLIQRCWDGNPHNRP-----SFSDIALELDLV 352 (697)
Q Consensus 308 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~ell~~l~~~ 352 (697)
........+..+++++.++|.+||+.||.+|| ++.+++.|.|..
T Consensus 210 -~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~ 258 (277)
T cd05577 210 -TLEMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFK 258 (277)
T ss_pred -cccccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhh
Confidence 01111123456789999999999999999999 888899888774
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=306.57 Aligned_cols=256 Identities=30% Similarity=0.468 Sum_probs=207.9
Q ss_pred CcccccccccCCceEEEEEEE--CCeeEEEEeccCCCh--HHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEee
Q 005427 67 SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTS--EELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF 142 (697)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 142 (697)
+|++.+.||+|+||.||++.. +++.|++|.+..... .....+.+|+.+++.++||||+++++.+.....+++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 689999999999999999986 578999998765544 3677899999999999999999999999999999999999
Q ss_pred cCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhccc
Q 005427 143 YESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKN 222 (697)
Q Consensus 143 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 222 (697)
+.+++|.+++.... .+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.+||+|||++.........
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~---- 155 (264)
T cd06626 81 CSGGTLEELLEHGR-ILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT---- 155 (264)
T ss_pred CCCCcHHHHHhhcC-CCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCc----
Confidence 99999999987653 5788999999999999999999999999999999999999999999999998765431110
Q ss_pred ccCCCCCCCCccccccccCccccchhhhcccC---CCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHH
Q 005427 223 WRSSGKPTGGFHKKNMVGTLIYMAPEILKKEI---HSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQ 299 (697)
Q Consensus 223 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~ 299 (697)
.........+++.|+|||++.+.. ++.++||||||+++|++++|..||............
T Consensus 156 --------~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~--------- 218 (264)
T cd06626 156 --------MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFH--------- 218 (264)
T ss_pred --------ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHH---------
Confidence 000012356889999999998766 789999999999999999999999765322111111
Q ss_pred HHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 005427 300 LTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350 (697)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~ 350 (697)
... ...+.++. ...+++.+.+++.+||+.+|.+|||+.+++.+.|
T Consensus 219 ----~~~-~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~ 263 (264)
T cd06626 219 ----VGA-GHKPPIPD-SLQLSPEGKDFLDRCLESDPKKRPTASELLQHPF 263 (264)
T ss_pred ----Hhc-CCCCCCCc-ccccCHHHHHHHHHHccCCcccCCCHHHHhcCCC
Confidence 111 11222221 2245889999999999999999999999987754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=319.54 Aligned_cols=274 Identities=20% Similarity=0.278 Sum_probs=210.7
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccCCC--hHHHHHHHHHHHHHHhcCCCCceEEeecccc----CCceE
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST--SEELDNFHKELQLLCKLDHPGLAKFVAAHAK----PPNYM 137 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~----~~~~~ 137 (697)
.+|++.+.||+|+||.||+|.. +++.||+|++.... ......+.+|+.+|+.++||||+++++++.. ....+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 6899999999999999999986 58899999865432 2345677889999999999999999988753 35689
Q ss_pred EEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhh
Q 005427 138 FFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKE 217 (697)
Q Consensus 138 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~ 217 (697)
+||||+. ++|.+++.... .+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||++........
T Consensus 85 lv~e~~~-~~l~~~~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 162 (334)
T cd07855 85 VVMDLME-SDLHHIIHSDQ-PLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT 162 (334)
T ss_pred EEEehhh-hhHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCc
Confidence 9999996 58988886554 589999999999999999999999999999999999999999999999999865432110
Q ss_pred hhcccccCCCCCCCCccccccccCccccchhhhcc-cCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhcccc
Q 005427 218 ISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYT 296 (697)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~ 296 (697)
..........|+..|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+......
T Consensus 163 ------------~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~ 230 (334)
T cd07855 163 ------------EHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGS 230 (334)
T ss_pred ------------CCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCC
Confidence 01111234578999999999865 45789999999999999999999999877655444433322111
Q ss_pred H-HHHHHHHH---------hCCCCC--cccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 005427 297 E-QQLTAAVV---------SGGLRP--ILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL 353 (697)
Q Consensus 297 ~-~~~~~~~~---------~~~~~~--~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~ 353 (697)
. ........ .....+ .........+.++.++|++||+.+|.+|||+.+++.|+|...
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~ 299 (334)
T cd07855 231 PSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQ 299 (334)
T ss_pred ChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhh
Confidence 1 11111000 000011 111223457899999999999999999999999999998864
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=311.47 Aligned_cols=255 Identities=29% Similarity=0.384 Sum_probs=201.3
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccCCC-hHHHHHHHHHHHHHHhcC-CCCceEEeeccccCCceEEEEe
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST-SEELDNFHKELQLLCKLD-HPGLAKFVAAHAKPPNYMFFFE 141 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lv~e 141 (697)
++|...++||+|+||.||++.+ +++.+|+|.+.... ......+.+|+.++.++. ||||+++++++..+...+++||
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 4688899999999999999987 57899999865433 244567889999999996 9999999999999999999999
Q ss_pred ecCCCCHhhhh---h-hcCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccccCCCCceeecCCCCCeeeeeccchhhhhhh
Q 005427 142 FYESRNLAEKL---H-VEEWSPSVDQVLMIAAQLAKALQYLHNL-GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLK 216 (697)
Q Consensus 142 ~~~~g~L~~~l---~-~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~ 216 (697)
|+.. ++.++. . .....+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 84 ~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 162 (288)
T cd06616 84 LMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI 162 (288)
T ss_pred cccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhccCC
Confidence 9875 554432 2 2234689999999999999999999975 99999999999999999999999999987543210
Q ss_pred hhhcccccCCCCCCCCccccccccCccccchhhhccc---CCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhc
Q 005427 217 EISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKE---IHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEM 293 (697)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~ 293 (697)
......|++.|+|||++.+. .++.++|||||||++|+|++|..||....... ..+.
T Consensus 163 -----------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~~~-- 221 (288)
T cd06616 163 -----------------AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVF--DQLT-- 221 (288)
T ss_pred -----------------ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHH--HHHh--
Confidence 12234688899999999766 68899999999999999999999997643111 1110
Q ss_pred cccHHHHHHHHHhCCCCCcc-cccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 294 NYTEQQLTAAVVSGGLRPIL-ASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
.... ...+.+ ...+..++.++.+||.+||+.+|++|||+++++.+.|..
T Consensus 222 ---------~~~~-~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 271 (288)
T cd06616 222 ---------QVVK-GDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIK 271 (288)
T ss_pred ---------hhcC-CCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhh
Confidence 0111 111111 112245889999999999999999999999999998874
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=309.98 Aligned_cols=255 Identities=29% Similarity=0.423 Sum_probs=200.5
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccCCC-hHHHHHHHHHHHH-HHhcCCCCceEEeeccccCCceEEEEe
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST-SEELDNFHKELQL-LCKLDHPGLAKFVAAHAKPPNYMFFFE 141 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~-l~~l~hpniv~l~~~~~~~~~~~lv~e 141 (697)
++|++.+.||+|+||.||++.+ +++.||+|...... ......+..|+.+ ++.++||||+++++++..+...+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 3689999999999999999987 58899999865442 2233455566665 666799999999999999999999999
Q ss_pred ecCCCCHhhhhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccccCCCCceeecCCCCCeeeeeccchhhhhhhh
Q 005427 142 FYESRNLAEKLHV---EEWSPSVDQVLMIAAQLAKALQYLHNL-GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKE 217 (697)
Q Consensus 142 ~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~-~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~ 217 (697)
|++ |+|.+++.. ....+++.+++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~- 158 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV- 158 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccccccc-
Confidence 997 578777643 234689999999999999999999997 99999999999999999999999999986543210
Q ss_pred hhcccccCCCCCCCCccccccccCccccchhhhcc----cCCCchhhHHHHHHHHHHHHhCCCCCCCchhH-HHHHHHHh
Q 005427 218 ISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK----EIHSEKSDVYSFGISINELLTGVVPYTDLRAE-AQAHTVLE 292 (697)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~-~~~~~~~~ 292 (697)
......|+..|+|||++.+ ..++.++|+|||||++|+|++|..||...... ......
T Consensus 159 ----------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~-- 220 (283)
T cd06617 159 ----------------AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQV-- 220 (283)
T ss_pred ----------------ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHH--
Confidence 1123468889999999865 45688999999999999999999999753221 111111
Q ss_pred ccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 005427 293 MNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH 355 (697)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~ 355 (697)
.. ...+.+ ....+|.++.++|.+||..+|.+||++.++++|.|.....
T Consensus 221 ------------~~-~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 268 (283)
T cd06617 221 ------------VE-EPSPQL--PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL 268 (283)
T ss_pred ------------Hh-cCCCCC--CccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence 11 111111 1235789999999999999999999999999998887654
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=313.14 Aligned_cols=269 Identities=23% Similarity=0.259 Sum_probs=203.4
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccCCChH--HHHHHHHHHHHHHhcC-CCCceEEeeccccCCc-----
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSE--ELDNFHKELQLLCKLD-HPGLAKFVAAHAKPPN----- 135 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~----- 135 (697)
++|++.+.||+|+||.||+|.+ +++.||+|+....... ....+.+|+.+++.+. ||||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 3699999999999999999987 5789999986544322 2356788999999995 6999999999877665
Q ss_pred eEEEEeecCCCCHhhhhhhcC----CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecC-CCCCeeeeeccch
Q 005427 136 YMFFFEFYESRNLAEKLHVEE----WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDR-NLCPHLADFGLAE 210 (697)
Q Consensus 136 ~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~-~~~~kL~Dfg~a~ 210 (697)
.+++|||+.+ +|.+++.... ..+++.+++.++.||+.||.|||+.||+||||||+||+++. ++.+||+|||++.
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~ 159 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR 159 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccce
Confidence 8999999986 7888875432 35799999999999999999999999999999999999998 8899999999986
Q ss_pred hhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcc-cCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHH
Q 005427 211 YRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHT 289 (697)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~ 289 (697)
...... .......+++.|+|||++.+ ..++.++|+||||+++|+|++|..||.+.........
T Consensus 160 ~~~~~~----------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~ 223 (295)
T cd07837 160 AFSIPV----------------KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLH 223 (295)
T ss_pred ecCCCc----------------cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHH
Confidence 543110 01123357889999998865 4578999999999999999999999987665554443
Q ss_pred HHhccccHHH-HH-------HHHHhCCCCC-cccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 005427 290 VLEMNYTEQQ-LT-------AAVVSGGLRP-ILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL 351 (697)
Q Consensus 290 ~~~~~~~~~~-~~-------~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~ 351 (697)
+......... .. .........+ .+....+.++.++.++|.+||..||.+||++.+++.|.|.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~ 294 (295)
T cd07837 224 IFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYF 294 (295)
T ss_pred HHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCc
Confidence 3321110000 00 0000000000 1111224578999999999999999999999999988763
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=294.91 Aligned_cols=274 Identities=23% Similarity=0.260 Sum_probs=205.6
Q ss_pred CCcccccccccCCceEEEEEEEC------CeeEEEEeccCCChHH--HHHHHHHHHHHHhcCCCCceEEeecccc-CCce
Q 005427 66 SSYTLLSPIARGAESVVYEATLD------GRKVAVKKPILSTSEE--LDNFHKELQLLCKLDHPGLAKFVAAHAK-PPNY 136 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~------~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~ 136 (697)
..|++...||+|.||.||+|..+ .+.+|+|++...+... .....+|+.+++.|+||||+.|..+|.. +...
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 46999999999999999999531 2368999866543211 3456799999999999999999999987 7889
Q ss_pred EEEEeecCCCCHhhhhhhcC----CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCC----CCCeeeeecc
Q 005427 137 MFFFEFYESRNLAEKLHVEE----WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRN----LCPHLADFGL 208 (697)
Q Consensus 137 ~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~----~~~kL~Dfg~ 208 (697)
++++||.+. +|...++... ..++...+..|+.||+.|+.|||+.-|+||||||.|||+..+ |.|||+|||+
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGl 182 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLGL 182 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecccH
Confidence 999999987 8998886432 356788999999999999999999999999999999999776 9999999999
Q ss_pred chhhhhhhhhhcccccCCCCCCCCc-cccccccCccccchhhhcccC-CCchhhHHHHHHHHHHHHhCCCCCCCchhH--
Q 005427 209 AEYRENLKEISLKNWRSSGKPTGGF-HKKNMVGTLIYMAPEILKKEI-HSEKSDVYSFGISINELLTGVVPYTDLRAE-- 284 (697)
Q Consensus 209 a~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~~l~ell~g~~Pf~~~~~~-- 284 (697)
++.+.+. ..+. .....+-|.+|+|||.+.|.. |+++.|||++||++.||++-++-|.+....
T Consensus 183 aR~~~~p--------------lkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~ 248 (438)
T KOG0666|consen 183 ARLFNNP--------------LKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIK 248 (438)
T ss_pred HHHhhcc--------------ccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcc
Confidence 9987641 1111 233457899999999998865 899999999999999999999988764321
Q ss_pred -------HHHHHHHhccccHHHHHH--------------HHHhCCCCCc-ccc---cccCChHHHHHHHHHhccCCCCCC
Q 005427 285 -------AQAHTVLEMNYTEQQLTA--------------AVVSGGLRPI-LAS---LELGLPASILSLIQRCWDGNPHNR 339 (697)
Q Consensus 285 -------~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~-~~~---~~~~~~~~l~~li~~~l~~dP~~R 339 (697)
.+..+|++....+.+..| ......+.+. +.. ....-++...+|+.++|++||.+|
T Consensus 249 ~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kR 328 (438)
T KOG0666|consen 249 TKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKR 328 (438)
T ss_pred cCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhh
Confidence 233444443222211111 1110111110 000 012234558899999999999999
Q ss_pred CCHHHHHHHHHHHHH
Q 005427 340 PSFSDIALELDLVLE 354 (697)
Q Consensus 340 pt~~ell~~l~~~~~ 354 (697)
.|+++.++|.-+...
T Consensus 329 Ita~qAleh~yF~~d 343 (438)
T KOG0666|consen 329 ITAEQALEHPYFTED 343 (438)
T ss_pred ccHHHHhcccccccC
Confidence 999999988766543
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=304.78 Aligned_cols=244 Identities=25% Similarity=0.304 Sum_probs=202.8
Q ss_pred cccCCceEEEEEEEC--CeeEEEEeccCCC---hHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEeecCCCCH
Q 005427 74 IARGAESVVYEATLD--GRKVAVKKPILST---SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNL 148 (697)
Q Consensus 74 lg~G~~g~V~~~~~~--~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L 148 (697)
||.|+||.||++++. ++.+++|+..... ....+.+.+|+.+++.++||||+++++.+.++..+++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 799999999999985 8899999865432 23456799999999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhcccccCCCC
Q 005427 149 AEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK 228 (697)
Q Consensus 149 ~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~ 228 (697)
.+++.... .+++.++..++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~l~~~~-~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~------------ 147 (262)
T cd05572 81 WTILRDRG-LFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ------------ 147 (262)
T ss_pred HHHHhhcC-CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc------------
Confidence 99997654 58899999999999999999999999999999999999999999999999987554211
Q ss_pred CCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCch--hHHHHHHHHhccccHHHHHHHHHh
Q 005427 229 PTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLR--AEAQAHTVLEMNYTEQQLTAAVVS 306 (697)
Q Consensus 229 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 306 (697)
......|++.|++||.+.+..++.++|+||||+++|+|++|..||.... .......+ ..
T Consensus 148 -----~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--------------~~ 208 (262)
T cd05572 148 -----KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDI--------------LK 208 (262)
T ss_pred -----ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHH--------------hc
Confidence 1223468899999999988888999999999999999999999998754 22221111 11
Q ss_pred CCCCCcccccccCChHHHHHHHHHhccCCCCCCCC-----HHHHHHHHHHH
Q 005427 307 GGLRPILASLELGLPASILSLIQRCWDGNPHNRPS-----FSDIALELDLV 352 (697)
Q Consensus 307 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt-----~~ell~~l~~~ 352 (697)
+...+ ..+...++++.++|.+||..+|++||+ +.|+++|.|+-
T Consensus 209 ~~~~~---~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~ 256 (262)
T cd05572 209 GNGKL---EFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFN 256 (262)
T ss_pred cCCCC---CCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhh
Confidence 11111 123345889999999999999999999 99999988864
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=318.30 Aligned_cols=271 Identities=25% Similarity=0.330 Sum_probs=208.1
Q ss_pred CCCcccccccccCCceEEEEEEE--CCeeEEEEeccCC--ChHHHHHHHHHHHHHHhcCCCCceEEeeccccC-----Cc
Q 005427 65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKP-----PN 135 (697)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-----~~ 135 (697)
..+|.+.+.||+|+||+||++.+ +++.||+|.+... .......+.+|+.+++.++||||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 35799999999999999999987 5789999986532 233455678899999999999999999987654 35
Q ss_pred eEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhh
Q 005427 136 YMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL 215 (697)
Q Consensus 136 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~ 215 (697)
.++++||+. ++|.+++.... .+++..++.++.|++.||.|||+.+++||||||+||+++.++.+||+|||++......
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 161 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSSQ-TLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEK 161 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCC
Confidence 799999996 58888886544 7899999999999999999999999999999999999999999999999998654321
Q ss_pred hhhhcccccCCCCCCCCccccccccCccccchhhhcc-cCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhcc
Q 005427 216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMN 294 (697)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~ 294 (697)
. .......++..|+|||++.. ..++.++|||||||++|+|++|..||.+.+.......+....
T Consensus 162 ~----------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 225 (337)
T cd07858 162 G----------------DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELL 225 (337)
T ss_pred c----------------ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHh
Confidence 0 11234567889999998865 468899999999999999999999998765433333222111
Q ss_pred c--cHHHH--------HHHH--HhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 005427 295 Y--TEQQL--------TAAV--VSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL 353 (697)
Q Consensus 295 ~--~~~~~--------~~~~--~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~ 353 (697)
. ..... .... .....++......+.+++++.++|++||+.+|++|||++++++|.|...
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~ 296 (337)
T cd07858 226 GSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLAS 296 (337)
T ss_pred CCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhh
Confidence 1 00000 0000 0011111122233568899999999999999999999999999988753
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=317.83 Aligned_cols=272 Identities=25% Similarity=0.337 Sum_probs=204.9
Q ss_pred CCCcccccccccCCceEEEEEEE--CCeeEEEEeccCC-ChHHHHHHHHHHHHHHhcCCCCceEEeeccccC-----Cce
Q 005427 65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS-TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKP-----PNY 136 (697)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-----~~~ 136 (697)
.++|++.++||+|+||.||+|.+ +++.||+|+.... .......+.+|+.+++.++||||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 36899999999999999999986 6789999986532 233456788899999999999999999876543 357
Q ss_pred EEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhh
Q 005427 137 MFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLK 216 (697)
Q Consensus 137 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~ 216 (697)
++++||+.+ +|.+.+.. ..+++..++.++.|++.||+|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 84 ~lv~e~~~~-~l~~~~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~ 160 (336)
T cd07849 84 YIVQELMET-DLYKLIKT--QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEH 160 (336)
T ss_pred EEEehhccc-CHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeeccccc
Confidence 999999975 88877753 368999999999999999999999999999999999999999999999999986543211
Q ss_pred hhhcccccCCCCCCCCccccccccCccccchhhhcc-cCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccc
Q 005427 217 EISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNY 295 (697)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~ 295 (697)
. ..+ ......|++.|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+.......+.....
T Consensus 161 ~------------~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~ 227 (336)
T cd07849 161 D------------HTG-FLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLG 227 (336)
T ss_pred c------------ccC-CcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcC
Confidence 0 000 1234578999999998754 5688999999999999999999999987654443333222111
Q ss_pred cH-HHHHHHHHhCC---------CCCc--ccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 296 TE-QQLTAAVVSGG---------LRPI--LASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 296 ~~-~~~~~~~~~~~---------~~~~--~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
.. .+......... ..+. .......++.++.++|.+||+.+|.+|||+.++++|.|..
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~ 296 (336)
T cd07849 228 TPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLE 296 (336)
T ss_pred CCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccc
Confidence 10 00000000000 0000 0111235678899999999999999999999999998765
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=304.60 Aligned_cols=250 Identities=27% Similarity=0.418 Sum_probs=211.5
Q ss_pred CcccccccccCCceEEEEEEEC--CeeEEEEeccCCCh--HHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEee
Q 005427 67 SYTLLSPIARGAESVVYEATLD--GRKVAVKKPILSTS--EELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF 142 (697)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 142 (697)
+|.+.+.||+|+||.||++.+. ++.+++|+...... .....+.+|+++++.++|||++++++.+......++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 5889999999999999999884 88999998765433 5567889999999999999999999999999999999999
Q ss_pred cCCCCHhhhhhhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhh
Q 005427 143 YESRNLAEKLHVE---EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEIS 219 (697)
Q Consensus 143 ~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~ 219 (697)
+++++|.+++... ...+++.+++.++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--- 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV--- 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCc---
Confidence 9999999998764 3578999999999999999999999999999999999999999999999999986543211
Q ss_pred cccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHH
Q 005427 220 LKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQ 299 (697)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~ 299 (697)
.......|++.|+|||.+.+..++.++|+||+|+++++|++|..||.............
T Consensus 158 -------------~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~-------- 216 (258)
T cd08215 158 -------------DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKIL-------- 216 (258)
T ss_pred -------------ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHh--------
Confidence 11234578999999999998889999999999999999999999997665333222221
Q ss_pred HHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 005427 300 LTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350 (697)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~ 350 (697)
... ...++..++.++.+++.+||..+|++|||+.+++++.|
T Consensus 217 ------~~~----~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~ 257 (258)
T cd08215 217 ------KGQ----YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPF 257 (258)
T ss_pred ------cCC----CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCC
Confidence 111 12234478899999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=306.94 Aligned_cols=259 Identities=25% Similarity=0.336 Sum_probs=204.3
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccCCCh-HHHHHHHHHHHHHHhcCCCCceEEeecccc--CCceEEEE
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTS-EELDNFHKELQLLCKLDHPGLAKFVAAHAK--PPNYMFFF 140 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~--~~~~~lv~ 140 (697)
++|...+.||.|++|.||++.+ +++.+|+|....... .....+.+|+++++.++||||+++++++.. ...+++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 3688999999999999999987 578899998664433 345678999999999999999999998854 34789999
Q ss_pred eecCCCCHhhhhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhh
Q 005427 141 EFYESRNLAEKLHV---EEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKE 217 (697)
Q Consensus 141 e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~ 217 (697)
||+++++|.+++.. ....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~-- 158 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS-- 158 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccccc--
Confidence 99999999887643 3345788999999999999999999999999999999999999999999999998643210
Q ss_pred hhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccH
Q 005427 218 ISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTE 297 (697)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~ 297 (697)
......++..|+|||.+.+..++.++|||||||++|+|++|..||....... ...
T Consensus 159 ----------------~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---------~~~ 213 (287)
T cd06621 159 ----------------LAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPP---------LGP 213 (287)
T ss_pred ----------------ccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCC---------CCh
Confidence 0123457889999999999899999999999999999999999997652200 000
Q ss_pred HHHHHHHHhCCCCCccccc---ccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 298 QQLTAAVVSGGLRPILASL---ELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
.+....... ...+.+... ....++.+.+++.+||+.+|.+|||+.|+++|.|..
T Consensus 214 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~ 270 (287)
T cd06621 214 IELLSYIVN-MPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIK 270 (287)
T ss_pred HHHHHHHhc-CCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccc
Confidence 001111111 111111111 124578899999999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=315.42 Aligned_cols=267 Identities=22% Similarity=0.312 Sum_probs=208.3
Q ss_pred CCCcccccccccCCceEEEEEEE--CCeeEEEEeccCC--ChHHHHHHHHHHHHHHhcCCCCceEEeeccccCC------
Q 005427 65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPP------ 134 (697)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~------ 134 (697)
.++|++.+.||+|+||.||++.. ++..||||+.... .......+.+|+.+|+.++||||+++++++....
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFH 93 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccc
Confidence 56899999999999999999986 5789999986432 2223456889999999999999999999887653
Q ss_pred ceEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhh
Q 005427 135 NYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYREN 214 (697)
Q Consensus 135 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~ 214 (697)
.+++||||+ +++|.+++.. ..+++.+++.++.|++.||+|||+.||+||||||+||+++.++.+||+|||++.....
T Consensus 94 ~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~ 170 (343)
T cd07880 94 DFYLVMPFM-GTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDS 170 (343)
T ss_pred eEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccccccccc
Confidence 468999998 6789888754 3688999999999999999999999999999999999999999999999999864431
Q ss_pred hhhhhcccccCCCCCCCCccccccccCccccchhhhcc-cCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhc
Q 005427 215 LKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEM 293 (697)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~ 293 (697)
......+++.|+|||++.+ ..++.++|+|||||++|++++|..||.+.........+...
T Consensus 171 -------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~ 231 (343)
T cd07880 171 -------------------EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKV 231 (343)
T ss_pred -------------------CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 1223467889999999876 45788999999999999999999999877655444444332
Q ss_pred cccHH-HHHHHHHh-----------CCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 005427 294 NYTEQ-QLTAAVVS-----------GGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL 353 (697)
Q Consensus 294 ~~~~~-~~~~~~~~-----------~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~ 353 (697)
..... .+...... ...+..+......+++.+.++|.+||..||++|||+.+++.|.|+..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~ 303 (343)
T cd07880 232 TGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEE 303 (343)
T ss_pred cCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhh
Confidence 22111 11110000 00111122233567889999999999999999999999999888754
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=308.18 Aligned_cols=266 Identities=16% Similarity=0.205 Sum_probs=190.0
Q ss_pred CCCCCCcccccccccCCceEEEEEEEC-----CeeEEEEeccCCChHH-H----------HHHHHHHHHHHhcCCCCceE
Q 005427 62 HLPPSSYTLLSPIARGAESVVYEATLD-----GRKVAVKKPILSTSEE-L----------DNFHKELQLLCKLDHPGLAK 125 (697)
Q Consensus 62 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~vavK~~~~~~~~~-~----------~~~~~E~~~l~~l~hpniv~ 125 (697)
++..++|++.++||+|+||.||+|... +..+++|+........ . .....+...+..+.|+||++
T Consensus 8 ~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~ 87 (294)
T PHA02882 8 DITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPK 87 (294)
T ss_pred ccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCc
Confidence 456689999999999999999999863 3466777543332111 0 11223344556678999999
Q ss_pred EeeccccCC----ceEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCC
Q 005427 126 FVAAHAKPP----NYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCP 201 (697)
Q Consensus 126 l~~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~ 201 (697)
+++.+.... ..+++++++.. ++.+.+.... ..++..++.++.|++.||.|||+.+|+||||||+|||++.++.+
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~ 165 (294)
T PHA02882 88 YYGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRIK-CKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRG 165 (294)
T ss_pred EEEeeeEecCCceEEEEEEehhcc-CHHHHHHhhc-cCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcE
Confidence 998765443 33667777654 6666655432 45788899999999999999999999999999999999999999
Q ss_pred eeeeeccchhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCc
Q 005427 202 HLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDL 281 (697)
Q Consensus 202 kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~ 281 (697)
||+|||+++.+...... ............||+.|+|||++.+..++.++|||||||++|||++|..||.+.
T Consensus 166 ~l~DFGla~~~~~~~~~---------~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~ 236 (294)
T PHA02882 166 YIIDYGIASHFIIHGKH---------IEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGF 236 (294)
T ss_pred EEEEcCCceeeccCCcc---------cccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCcc
Confidence 99999999765321100 000001123357999999999999999999999999999999999999999876
Q ss_pred hhHHHHHHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 005427 282 RAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALEL 349 (697)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l 349 (697)
............ ++...+..+.. ....+++++.++++.||+.+|++||++++|++.+
T Consensus 237 ~~~~~~~~~~~~-----~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 237 GHNGNLIHAAKC-----DFIKRLHEGKI------KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred ccchHHHHHhHH-----HHHHHhhhhhh------ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 332221111111 11111111111 1235688999999999999999999999998754
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=313.56 Aligned_cols=275 Identities=23% Similarity=0.272 Sum_probs=203.6
Q ss_pred CCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCChH--HHHHHHHHHHHHHhcCCCCceEEeeccccCC-----
Q 005427 64 PPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSE--ELDNFHKELQLLCKLDHPGLAKFVAAHAKPP----- 134 (697)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~----- 134 (697)
..++|++.++||+|+||.||+|.. +++.||+|.+...... ....+.+|+.++++++||||+++++++....
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 346899999999999999999987 5789999976543221 2345678999999999999999999876654
Q ss_pred ---ceEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchh
Q 005427 135 ---NYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEY 211 (697)
Q Consensus 135 ---~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~ 211 (697)
..++||||+.+ +|.+.+......+++.+++.++.|++.||+|||+.|++|+||||+||+++.++.+||+|||++..
T Consensus 90 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 168 (310)
T cd07865 90 YKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARA 168 (310)
T ss_pred CCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCccc
Confidence 45999999975 88888876655789999999999999999999999999999999999999999999999999875
Q ss_pred hhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccC-CCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHH
Q 005427 212 RENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEI-HSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTV 290 (697)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~ 290 (697)
...... ..........++..|+|||++.+.. ++.++||||||+++|+|++|..||.+.........+
T Consensus 169 ~~~~~~------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~ 236 (310)
T cd07865 169 FSLSKN------------SKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLI 236 (310)
T ss_pred ccCCcc------------cCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 532110 0001123346788999999987653 688999999999999999999999876654433332
Q ss_pred Hhccc--cHHHH--------HHHHH-hCCCC-Cccccc-ccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 005427 291 LEMNY--TEQQL--------TAAVV-SGGLR-PILASL-ELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL 351 (697)
Q Consensus 291 ~~~~~--~~~~~--------~~~~~-~~~~~-~~~~~~-~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~ 351 (697)
..... ..... ..... ..... .....+ +...+..+.++|.+||..||.+|||++++++|.|+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 237 SQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred HHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 22111 00000 00000 00000 000000 11235678899999999999999999999988763
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG0700 consensus Protein phosphatase 2C/pyruvate dehydrogenase (lipoamide) phosphatase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=298.26 Aligned_cols=229 Identities=33% Similarity=0.482 Sum_probs=186.5
Q ss_pred CCCceeEEcccccCCCceEEEEEecCCCChHHHHHHHHHhHHHHHh------------c-CC------------------
Q 005427 442 TMEDTHFLMPHMYNQKEIHMFGIFDGHRGSAAAEFSARALPGFLQN------------L-GS------------------ 490 (697)
Q Consensus 442 ~neD~~~~~~~~~~~~~~~~~~V~DG~GG~~~~~~as~~~~~~l~~------------~-~~------------------ 490 (697)
--||++.+... ...++.|+||||||||++++++.++++..++.. . ..
T Consensus 84 ~~edrv~~~~s--~~~~~~fvGIyDGhgGp~as~~v~~~L~~~v~~~L~~~~~~~~~~f~~e~~~~~~~~~~~~~~~~~~ 161 (390)
T KOG0700|consen 84 AEEDRVSVAVS--EENGWLFVGIYDGHGGPDASRFLSDHLYPYVARELQGLLWQDEERFPSEYKSEELEHLLVYWKQLSS 161 (390)
T ss_pred cccCcceeeee--ccCCeEEEEEecCCCCccHHHHHHHHHHHHHHHHhhhhhhhhccccccccccchhhhhhhhhhcccc
Confidence 34566555332 245788999999999999999999999988761 1 00
Q ss_pred ----CCChHHHHHHHHHHHHHHHHHHHHHHHhhhhcccCCCCCCceEEEEEEecCeEEEEEcCCeEEEEEE---CC---e
Q 005427 491 ----TTRPTDALLEAFIRTDVAFRNELDSLRKSKRVVQKDWHPGCTAIAALIVRNRLFVANAGDCRAILCR---GG---H 560 (697)
Q Consensus 491 ----~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GtT~~~~~i~~~~l~~anvGDSr~~l~~---~~---~ 560 (697)
.....++|.+||.+++.++........ ...+...-||+|++++++.++.+||||+|||||+|.+ ++ .
T Consensus 162 ~~~~~~~v~~al~~Af~~tee~fl~~v~~~~---~~~p~lA~~GSC~Lv~~i~~~~LyVaN~GDSRAVLG~~~~~~~~~~ 238 (390)
T KOG0700|consen 162 ADQRHGDVLEALSKAFEATEEDFLEMVDKQL---QENPELALVGSCCLVGLIKGGDLYVANVGDSRAVLGVVENNGSWLV 238 (390)
T ss_pred cCccchhHHHHHHHHHHHHHHHHHHHHHHhh---ccchhhhhhcceEEEEEEeCCeEEEEecCcchhhhceecCCCCeEE
Confidence 245678999999999999986654433 2334456789999999999999999999999999975 23 5
Q ss_pred eeecCCCCCCCCHHHHHHHHHcCCeeee--ccCcceeCCCcceeccccCCCCCC---------------------CCccc
Q 005427 561 PFALSRDHVASCLEERERVVSAGGNVNW--QVDTWRVGPPALQVTRSIGDDDLK---------------------PAVTA 617 (697)
Q Consensus 561 ~~~lt~dH~~~~~~e~~ri~~~g~~~~~--~~~~~~~~~~~~~ltralG~~~~k---------------------~~v~~ 617 (697)
++|||+||+.+++.|++||+..++.-.. ....+|+- |.+.+||||||..+| |++++
T Consensus 239 A~qLS~dHn~~ne~Ev~Rir~eHPdd~~~vv~~~~Rvk-G~L~vsRAfGd~~lK~~~~n~e~l~~~fr~~~~~t~Pylta 317 (390)
T KOG0700|consen 239 AVQLSTDHNASNEDEVRRIRSEHPDDPHIVVNKHWRVK-GILQVSRAFGDGYLKWPEFNQEPLLEKFRIPYIGTPPYLTA 317 (390)
T ss_pred EEecChhhccccHHHHHHHHHhCCCCcceEeeccceee-EEEEeeeeccceeecchhhccchhHhhcCCCCCCCCCceec
Confidence 7999999999999999999999873211 11235776 799999999999998 47999
Q ss_pred CCceEEEEeCCCCeEEEEEcCCcccCCChHHHHHHHHhhcC---ChhHHHHHHHHHHHhcCC
Q 005427 618 EPEITETIMTPEDEYLVMASDGLWDVVSHVEAVGIIKDTVK---EPGMCSKRLATEAAERGS 676 (697)
Q Consensus 618 ~p~v~~~~l~~~d~~lvl~SDGl~d~~~~~ei~~~~~~~~~---~~~~~a~~L~~~a~~~g~ 676 (697)
+|.|+.++|.+.|+||||+|||||++++++|++.+|..... .-+.+|+.|++.|+.+..
T Consensus 318 eP~i~~HrL~p~DkFLIlASDGLwE~lsNeeaV~lV~~~i~~~~pd~~~A~hLIr~aL~~aa 379 (390)
T KOG0700|consen 318 EPSITHHKLTPNDKFLILASDGLWEYLSNEEAVSLVHEFISGKFPDGNPATHLIRHALGRAA 379 (390)
T ss_pred cceEEEEEcCCCCeEEEEeccchhhhcChHHHHHHHHHhhccCCCCCCHHHHHHHHHHhhhh
Confidence 99999999999999999999999999999999999988542 356799999999987654
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=315.90 Aligned_cols=272 Identities=26% Similarity=0.329 Sum_probs=214.0
Q ss_pred CcccccccccCCceEEEEEEE--CCeeEEEEeccCCC--hHHHHHHHHHHHHHHhcCCCCceEEeeccccCC-----ceE
Q 005427 67 SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST--SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPP-----NYM 137 (697)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-----~~~ 137 (697)
+|++.+.||+|+||.||+|.. .++.|++|++.... ....+.+.+|+.+++.++||||+++++++.... .++
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 589999999999999999987 47899999865433 344568899999999999999999999988775 789
Q ss_pred EEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhh
Q 005427 138 FFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKE 217 (697)
Q Consensus 138 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~ 217 (697)
++|||+.+ +|.+++.... .+++..++.++.|++.||+|||+.||+||||||+|||++.++.++|+|||++........
T Consensus 81 lv~e~~~~-~l~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~ 158 (330)
T cd07834 81 IVTELMET-DLHKVIKSPQ-PLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDED 158 (330)
T ss_pred EEecchhh-hHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccc
Confidence 99999984 8888886554 789999999999999999999999999999999999999999999999999876543110
Q ss_pred hhcccccCCCCCCCCccccccccCccccchhhhccc-CCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhcccc
Q 005427 218 ISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKE-IHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYT 296 (697)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~ 296 (697)
.........+++.|+|||++.+. .++.++|+||||+++|+|++|.+||.+.........+......
T Consensus 159 -------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~ 225 (330)
T cd07834 159 -------------EKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGT 225 (330)
T ss_pred -------------ccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCC
Confidence 00112345688999999999887 7899999999999999999999999887766555544432211
Q ss_pred HHHH----------HHHHHhCCC--CCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 005427 297 EQQL----------TAAVVSGGL--RPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL 353 (697)
Q Consensus 297 ~~~~----------~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~ 353 (697)
.... ...+..... ...+......++.++.++|.+||+.+|.+|||+++++.|.|+..
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~ 294 (330)
T cd07834 226 PSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQ 294 (330)
T ss_pred CChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHh
Confidence 1100 000000000 00111123457899999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=301.16 Aligned_cols=251 Identities=29% Similarity=0.474 Sum_probs=209.7
Q ss_pred CcccccccccCCceEEEEEEE--CCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEeecC
Q 005427 67 SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYE 144 (697)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 144 (697)
.|.+.+.||+|++|.||++.. +++.+++|+...........+.+|+.+++.++||||+++++.+......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 478899999999999999987 478899998776655567789999999999999999999999999999999999999
Q ss_pred CCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhccccc
Q 005427 145 SRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWR 224 (697)
Q Consensus 145 ~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~ 224 (697)
+++|.+++......+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~-------- 152 (253)
T cd05122 81 GGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTK-------- 152 (253)
T ss_pred CCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeeccccccccccc--------
Confidence 999999987765578999999999999999999999999999999999999999999999999986554211
Q ss_pred CCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHHHHHH
Q 005427 225 SSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAV 304 (697)
Q Consensus 225 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (697)
......++..|+|||.+.+..++.++|+||||+++|+|++|..||...+..........
T Consensus 153 ---------~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~------------ 211 (253)
T cd05122 153 ---------ARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT------------ 211 (253)
T ss_pred ---------cccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh------------
Confidence 02345688999999999888889999999999999999999999987643322221111
Q ss_pred HhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 005427 305 VSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350 (697)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~ 350 (697)
...+... .+..++..+.+++.+||+.||++|||+.++++|.|
T Consensus 212 ---~~~~~~~-~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 212 ---NGPPGLR-NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred ---cCCCCcC-cccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 0011111 11224889999999999999999999999998754
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >smart00332 PP2Cc Serine/threonine phosphatases, family 2C, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=295.98 Aligned_cols=243 Identities=44% Similarity=0.677 Sum_probs=203.2
Q ss_pred ccceEeeeccCCCCCCCceeEEcccccCCCceEEEEEecCCCChHHHHHHHHHhHHHHHhcCCCC-----ChHHHHHHHH
Q 005427 428 VLSWGSFATCGRRETMEDTHFLMPHMYNQKEIHMFGIFDGHRGSAAAEFSARALPGFLQNLGSTT-----RPTDALLEAF 502 (697)
Q Consensus 428 ~~~~~~~s~~G~R~~neD~~~~~~~~~~~~~~~~~~V~DG~GG~~~~~~as~~~~~~l~~~~~~~-----~~~~~l~~~~ 502 (697)
.+.++..+..|.|..|||++++.... ..+..+|+|||||||..+|+++++.+.+.+....... .+...+.+++
T Consensus 5 ~~~~~~~~~~~~r~~neD~~~~~~~~--~~~~~~~~v~DG~gg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 82 (255)
T smart00332 5 GLRYGLSSMQGVRKPMEDAHVITPDL--SDSGAFFGVFDGHGGSEAAKFLSKNLPEILAEELIKHKDELEDVEEALRKAF 82 (255)
T ss_pred ceeEEEecCCCCCCCCcceEEEeccC--CCCeEEEEEEeCCCcHHHHHHHHHHHHHHHHHhHhhcccchhHHHHHHHHHH
Confidence 35566677788899999999886532 1467899999999999999999999999888752211 3556677777
Q ss_pred HHHHHHHHHHHHHHHhhhhcccCCCCCCceEEEEEEecCeEEEEEcCCeEEEEEECCeeeecCCCCCCCCHHHHHHHHHc
Q 005427 503 IRTDVAFRNELDSLRKSKRVVQKDWHPGCTAIAALIVRNRLFVANAGDCRAILCRGGHPFALSRDHVASCLEERERVVSA 582 (697)
Q Consensus 503 ~~~~~~~~~~~~~~~~~~~~~~~~~~~GtT~~~~~i~~~~l~~anvGDSr~~l~~~~~~~~lt~dH~~~~~~e~~ri~~~ 582 (697)
..++..+........ ....||||++++++.+++++++|+||||+|++|++++.++|+||++.++.|..|+...
T Consensus 83 ~~~~~~~~~~~~~~~-------~~~~~gtT~~~~~~~~~~l~~~~vGDsr~y~~~~~~~~~lt~dh~~~~~~~~~~i~~~ 155 (255)
T smart00332 83 LKTDEEILEELESLE-------EDAGSGSTAVVALISGNKLYVANVGDSRAVLCRNGKAVQLTEDHKPSNEDERARIEAA 155 (255)
T ss_pred HHHHHHHHHhhhhcc-------CCCCCCccEEEEEEECCEEEEEeccCceEEEEeCCceeEcCCCCCCcCHHHHHHHHHc
Confidence 777776665422211 2345899999999999999999999999999999999999999999999999999999
Q ss_pred CCeeeeccCcceeCCCcceeccccCCCCCCCCcccCCceEEEEe-CCCCeEEEEEcCCcccCCChHHHHHHHHhhcC--C
Q 005427 583 GGNVNWQVDTWRVGPPALQVTRSIGDDDLKPAVTAEPEITETIM-TPEDEYLVMASDGLWDVVSHVEAVGIIKDTVK--E 659 (697)
Q Consensus 583 g~~~~~~~~~~~~~~~~~~ltralG~~~~k~~v~~~p~v~~~~l-~~~d~~lvl~SDGl~d~~~~~ei~~~~~~~~~--~ 659 (697)
++.+.. . .++..+.+||++|+..+|+.+..+|++....+ .++| +||||||||||+++++++.+++.+... +
T Consensus 156 ~~~~~~----~-~~~~~~~lt~~~g~~~~~~~i~~~p~~~~~~~~~~~d-~ill~SDGv~~~l~~~~i~~~~~~~~~~~~ 229 (255)
T smart00332 156 GGFVIN----G-RVNGVLALSRAIGDFFLKPYVSAEPDVTVVELTEKDD-FLILASDGLWDVLSNQEVVDIVRKHLSKSD 229 (255)
T ss_pred CCEEEC----C-eECCeEecccccCCHhhcCCeEeeeEEEEEEecCCCc-EEEEECCccccCCCHHHHHHHHHHHhhcCC
Confidence 885431 1 34468999999999999999999999999996 7767 888999999999999999999988653 5
Q ss_pred hhHHHHHHHHHHHhcCCCCCcEEEEE
Q 005427 660 PGMCSKRLATEAAERGSKDNITVIVV 685 (697)
Q Consensus 660 ~~~~a~~L~~~a~~~g~~DNiT~ivv 685 (697)
+.++|+.|++.|..+++.||+|+|||
T Consensus 230 ~~~~~~~l~~~a~~~~~~Dn~T~ivv 255 (255)
T smart00332 230 PEEAAKRLIDLALARGSKDNITVIVV 255 (255)
T ss_pred HHHHHHHHHHHHHHcCCCCCeEEEEC
Confidence 89999999999999999999999985
|
The protein architecture and deduced catalytic mechanism of PP2C phosphatases are similar to the PP1, PP2A, PP2B family of protein Ser/Thr phosphatases, with which PP2C shares no sequence similarity. |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=302.50 Aligned_cols=249 Identities=24% Similarity=0.435 Sum_probs=203.1
Q ss_pred CcccccccccCCceEEEEEEEC---CeeEEEEeccCC----------ChHHHHHHHHHHHHHHh-cCCCCceEEeecccc
Q 005427 67 SYTLLSPIARGAESVVYEATLD---GRKVAVKKPILS----------TSEELDNFHKELQLLCK-LDHPGLAKFVAAHAK 132 (697)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~~---~~~vavK~~~~~----------~~~~~~~~~~E~~~l~~-l~hpniv~l~~~~~~ 132 (697)
.|++.+.||+|+||.||+|.+. ++.+|+|.+... .......+.+|+.++.. ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 4889999999999999999873 578999975432 22345667889988865 799999999999999
Q ss_pred CCceEEEEeecCCCCHhhhhhh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCCCceeecCCCCCeeeeecc
Q 005427 133 PPNYMFFFEFYESRNLAEKLHV---EEWSPSVDQVLMIAAQLAKALQYLHN-LGIVHRDVKPANVLLDRNLCPHLADFGL 208 (697)
Q Consensus 133 ~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivHrDlkp~Nill~~~~~~kL~Dfg~ 208 (697)
....+++|||+.+++|.+++.. ....+++..++.++.|++.+|.|||+ .+++|+||+|+||+++.++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence 9999999999999999988743 34468899999999999999999996 7899999999999999999999999999
Q ss_pred chhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHH
Q 005427 209 AEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAH 288 (697)
Q Consensus 209 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~ 288 (697)
+....... ......|+..|++||++.+..++.++|+||||+++|+|++|..||..........
T Consensus 161 ~~~~~~~~-----------------~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~ 223 (269)
T cd08528 161 AKQKQPES-----------------KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLAT 223 (269)
T ss_pred eeeccccc-----------------ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHH
Confidence 86543211 1234568899999999998889999999999999999999999997654433322
Q ss_pred HHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 005427 289 TVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALEL 349 (697)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l 349 (697)
.+. .....+.. ...+++++.+++.+||+.||++||++.|+..++
T Consensus 224 ~~~--------------~~~~~~~~---~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~ 267 (269)
T cd08528 224 KIV--------------EAVYEPLP---EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMI 267 (269)
T ss_pred HHh--------------hccCCcCC---cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHh
Confidence 222 12222211 225789999999999999999999999998765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=303.51 Aligned_cols=253 Identities=25% Similarity=0.430 Sum_probs=200.3
Q ss_pred cccccccccCCceEEEEEEE-----CCeeEEEEeccCC--ChHHHHHHHHHHHHHHhcCCCCceEEeeccccCC------
Q 005427 68 YTLLSPIARGAESVVYEATL-----DGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPP------ 134 (697)
Q Consensus 68 y~~~~~lg~G~~g~V~~~~~-----~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~------ 134 (697)
|++.+.||+|+||.||+|.. ++..||+|..... .....+.+.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 67889999999999999975 3578999976543 3445677899999999999999999999876532
Q ss_pred ceEEEEeecCCCCHhhhhhhc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccc
Q 005427 135 NYMFFFEFYESRNLAEKLHVE-----EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLA 209 (697)
Q Consensus 135 ~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a 209 (697)
..+++++|+.+|+|.+++... ...+++..++.++.|++.||+|||+.||+||||||+||+++.++.+||+|||++
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~ 160 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS 160 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccccc
Confidence 247889999999998876432 224688899999999999999999999999999999999999999999999998
Q ss_pred hhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCCchhHHHHH
Q 005427 210 EYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAH 288 (697)
Q Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~~~~~~~~~ 288 (697)
+....... ........+++.|++||.+.+..++.++|||||||++|+|++ |.+||.+........
T Consensus 161 ~~~~~~~~--------------~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~ 226 (273)
T cd05074 161 KKIYSGDY--------------YRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYN 226 (273)
T ss_pred ccccCCcc--------------eecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHH
Confidence 75432110 001122345678999999999889999999999999999999 899998765433322
Q ss_pred HHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 289 TVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
.+.. .. .. ..+...+..+.+++.+||+.+|++|||+.+++..|..+
T Consensus 227 ~~~~--------------~~-~~---~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 227 YLIK--------------GN-RL---KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred HHHc--------------CC-cC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 2221 11 00 12245788999999999999999999999999888754
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=308.63 Aligned_cols=266 Identities=26% Similarity=0.313 Sum_probs=209.2
Q ss_pred cccccccccCCceEEEEEEE--CCeeEEEEeccCCCh--HHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEeec
Q 005427 68 YTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTS--EELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFY 143 (697)
Q Consensus 68 y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 143 (697)
|++.+.||.|++|.||++.. +++.+++|....... .....+.+|+.+|+.++||||+++++++..+...++++||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 67889999999999999986 578899998654432 24567889999999999999999999999999999999999
Q ss_pred CCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhcccc
Q 005427 144 ESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNW 223 (697)
Q Consensus 144 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~ 223 (697)
.+ +|.+.+......+++.+++.++.|++.||.|||+.+|+|+||||+||+++.++.+||+|||.+.......
T Consensus 81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~------- 152 (283)
T cd05118 81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV------- 152 (283)
T ss_pred CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-------
Confidence 75 8888887765678999999999999999999999999999999999999999999999999986553211
Q ss_pred cCCCCCCCCccccccccCccccchhhhccc-CCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccH-HHHH
Q 005427 224 RSSGKPTGGFHKKNMVGTLIYMAPEILKKE-IHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTE-QQLT 301 (697)
Q Consensus 224 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~-~~~~ 301 (697)
.......++..|+|||.+.+. .++.++|+||||+++|+|++|..||...+.......+....... ....
T Consensus 153 ---------~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (283)
T cd05118 153 ---------RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVW 223 (283)
T ss_pred ---------ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhc
Confidence 011234578899999998876 78899999999999999999999998776655444433221110 0000
Q ss_pred HHHH----------hCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 005427 302 AAVV----------SGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350 (697)
Q Consensus 302 ~~~~----------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~ 350 (697)
.... ..............++.++.++|.+||+.||.+||++.+++.|.|
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~ 282 (283)
T cd05118 224 PKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPY 282 (283)
T ss_pred ccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCC
Confidence 0000 000111112233457889999999999999999999999998865
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=316.83 Aligned_cols=272 Identities=25% Similarity=0.380 Sum_probs=207.3
Q ss_pred CCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccccC---------
Q 005427 65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKP--------- 133 (697)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--------- 133 (697)
..+|++.+.||.|+||.||+|.. +++.||+|++........+.+.+|+++++.++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 46899999999999999999987 5789999987766666677889999999999999999999876554
Q ss_pred -----CceEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecC-CCCCeeeeec
Q 005427 134 -----PNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDR-NLCPHLADFG 207 (697)
Q Consensus 134 -----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~-~~~~kL~Dfg 207 (697)
...+++|||+. ++|.+++.. ..+++..++.++.|++.||.|||+.||+||||||+||+++. ++.+||+|||
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~dfg 160 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQ--GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFG 160 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCcc
Confidence 35789999997 488887753 25889999999999999999999999999999999999974 5678999999
Q ss_pred cchhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcc-cCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHH
Q 005427 208 LAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQ 286 (697)
Q Consensus 208 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~ 286 (697)
++........ ..+ ......++..|+|||++.+ ..++.++|||||||++|+|++|..||.+......
T Consensus 161 ~~~~~~~~~~------------~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~ 227 (342)
T cd07854 161 LARIVDPHYS------------HKG-YLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQ 227 (342)
T ss_pred cceecCCccc------------ccc-ccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 9865432110 000 1123357889999998754 5678899999999999999999999987765554
Q ss_pred HHHHHhccc-cHHH--------HHHHHH--hCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 287 AHTVLEMNY-TEQQ--------LTAAVV--SGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 287 ~~~~~~~~~-~~~~--------~~~~~~--~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
...+..... .... ...... ....+.........++.++.+|+.+||+.||.+|||+.+++.|.|..
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~ 304 (342)
T cd07854 228 MQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMS 304 (342)
T ss_pred HHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccc
Confidence 444332211 0000 000000 00011111122346788999999999999999999999999998874
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=310.80 Aligned_cols=252 Identities=25% Similarity=0.353 Sum_probs=206.3
Q ss_pred CCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCC---ChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEE
Q 005427 64 PPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMF 138 (697)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 138 (697)
+...|...+.||+|+||.||+|+. .++.+++|..... .......+.+|+.+++.++|||++++++++......++
T Consensus 13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 92 (308)
T cd06634 13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL 92 (308)
T ss_pred cHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEE
Confidence 345699999999999999999987 5778999976532 23345678899999999999999999999999999999
Q ss_pred EEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhh
Q 005427 139 FFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI 218 (697)
Q Consensus 139 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~ 218 (697)
||||+. |++.+.+......+++.++..++.|++.||.|||+.+++||||||+||+++.++.+||+|||++.....
T Consensus 93 v~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~---- 167 (308)
T cd06634 93 VMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---- 167 (308)
T ss_pred EEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecC----
Confidence 999997 588887765555688999999999999999999999999999999999999999999999998864321
Q ss_pred hcccccCCCCCCCCccccccccCccccchhhhc---ccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccc
Q 005427 219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILK---KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNY 295 (697)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~ 295 (697)
.....|++.|+|||++. ...++.++|||||||++|+|++|..||...........+..
T Consensus 168 ----------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~--- 228 (308)
T cd06634 168 ----------------ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ--- 228 (308)
T ss_pred ----------------cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhh---
Confidence 22346888999999975 34578899999999999999999999976544332222211
Q ss_pred cHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 005427 296 TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL 353 (697)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~ 353 (697)
...+. .....++..+.++|++||..+|.+||++.+++.+.|...
T Consensus 229 ------------~~~~~--~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~ 272 (308)
T cd06634 229 ------------NESPA--LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (308)
T ss_pred ------------cCCCC--cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence 11111 112357889999999999999999999999999988765
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=307.76 Aligned_cols=254 Identities=23% Similarity=0.359 Sum_probs=208.8
Q ss_pred CcccccccccCCceEEEEEEE--CCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEeecC
Q 005427 67 SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYE 144 (697)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 144 (697)
.|....+||+|+||.||++.. +++.||+|++..........+.+|+.+++.++||||+++++.+...+..+++|||++
T Consensus 21 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 100 (292)
T cd06657 21 YLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE 100 (292)
T ss_pred HhhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCC
Confidence 355567899999999999977 678999998766555566779999999999999999999999999999999999999
Q ss_pred CCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhccccc
Q 005427 145 SRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWR 224 (697)
Q Consensus 145 ~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~ 224 (697)
+++|.+++... .+++..++.++.|++.+|+|||+.|++||||+|+||+++.++.++|+|||++.......
T Consensus 101 ~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~-------- 170 (292)
T cd06657 101 GGALTDIVTHT--RMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-------- 170 (292)
T ss_pred CCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccc--------
Confidence 99999987543 57889999999999999999999999999999999999999999999999875432100
Q ss_pred CCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHHHHHH
Q 005427 225 SSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAV 304 (697)
Q Consensus 225 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (697)
.......|++.|+|||.+.+..++.++|+||+|+++|+|++|..||.+.........+..
T Consensus 171 --------~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~------------ 230 (292)
T cd06657 171 --------PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD------------ 230 (292)
T ss_pred --------ccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh------------
Confidence 012234688999999999888889999999999999999999999987544332222111
Q ss_pred HhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 005427 305 VSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE 354 (697)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~ 354 (697)
...+.+.. ...++..+.+++.+||+.+|.+||++.+++.|.|+...
T Consensus 231 ---~~~~~~~~-~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~ 276 (292)
T cd06657 231 ---NLPPKLKN-LHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA 276 (292)
T ss_pred ---hCCcccCC-cccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhcc
Confidence 11111111 23578899999999999999999999999998877643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=306.76 Aligned_cols=245 Identities=23% Similarity=0.289 Sum_probs=191.9
Q ss_pred ccccCCceEEEEEEE--CCeeEEEEeccCCC---hHHHHHHHHHHHHHH---hcCCCCceEEeeccccCCceEEEEeecC
Q 005427 73 PIARGAESVVYEATL--DGRKVAVKKPILST---SEELDNFHKELQLLC---KLDHPGLAKFVAAHAKPPNYMFFFEFYE 144 (697)
Q Consensus 73 ~lg~G~~g~V~~~~~--~~~~vavK~~~~~~---~~~~~~~~~E~~~l~---~l~hpniv~l~~~~~~~~~~~lv~e~~~ 144 (697)
.||+|+||.||++.. +++.+|+|...... ......+.+|..+++ ..+||||+.+++.+..++.+++||||+.
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999987 57899999764322 112223344544443 3479999999999999999999999999
Q ss_pred CCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhccccc
Q 005427 145 SRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWR 224 (697)
Q Consensus 145 ~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~ 224 (697)
+++|.+++...+ .+++.++..++.|++.||+|||+.+|+||||||+|||++.++.++|+|||++......
T Consensus 81 ~~~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~--------- 150 (279)
T cd05633 81 GGDLHYHLSQHG-VFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--------- 150 (279)
T ss_pred CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc---------
Confidence 999999887554 6899999999999999999999999999999999999999999999999998643210
Q ss_pred CCCCCCCCccccccccCccccchhhhc-ccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHHHHH
Q 005427 225 SSGKPTGGFHKKNMVGTLIYMAPEILK-KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAA 303 (697)
Q Consensus 225 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (697)
......|++.|+|||.+. +..++.++|+||+||++|+|++|..||......... .+....
T Consensus 151 ---------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~~~~~--------- 211 (279)
T cd05633 151 ---------KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMT--------- 211 (279)
T ss_pred ---------CccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH-HHHHHh---------
Confidence 112346899999999986 456889999999999999999999999754321110 000000
Q ss_pred HHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCC-----CHHHHHHHHHHH
Q 005427 304 VVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRP-----SFSDIALELDLV 352 (697)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~ell~~l~~~ 352 (697)
.... ..++..++.++.++|.+||+.||.+|| |+.++++|+|+.
T Consensus 212 ---~~~~---~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~ 259 (279)
T cd05633 212 ---LTVN---VELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFK 259 (279)
T ss_pred ---hcCC---cCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCcccc
Confidence 0001 123456889999999999999999999 699999988773
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=302.04 Aligned_cols=245 Identities=26% Similarity=0.336 Sum_probs=196.3
Q ss_pred ccccccCCceEEEEEEE--CCeeEEEEeccCCCh---HHHHHHHHHHHHH-HhcCCCCceEEeeccccCCceEEEEeecC
Q 005427 71 LSPIARGAESVVYEATL--DGRKVAVKKPILSTS---EELDNFHKELQLL-CKLDHPGLAKFVAAHAKPPNYMFFFEFYE 144 (697)
Q Consensus 71 ~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~---~~~~~~~~E~~~l-~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 144 (697)
++.||.|+||.||+|.. .++.||+|....... .....+..|..++ ..++||||+++++++.....+++++||+.
T Consensus 1 ~~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (260)
T cd05611 1 LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLN 80 (260)
T ss_pred CccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccC
Confidence 36799999999999987 578999998654321 2223445555544 45589999999999999999999999999
Q ss_pred CCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhccccc
Q 005427 145 SRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWR 224 (697)
Q Consensus 145 ~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~ 224 (697)
+++|.+++.... .+++..+..++.|++.||.|||+.+++||||+|+||+++.++.+||+|||++.....
T Consensus 81 ~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---------- 149 (260)
T cd05611 81 GGDCASLIKTLG-GLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---------- 149 (260)
T ss_pred CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc----------
Confidence 999999987554 678999999999999999999999999999999999999999999999998854321
Q ss_pred CCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHHHHHH
Q 005427 225 SSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAV 304 (697)
Q Consensus 225 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (697)
.....|++.|+|||.+.+..++.++||||||+++|+|++|..||...........+....
T Consensus 150 ----------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---------- 209 (260)
T cd05611 150 ----------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRR---------- 209 (260)
T ss_pred ----------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcc----------
Confidence 223468889999999988888999999999999999999999998765443333222111
Q ss_pred HhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCH---HHHHHHHHH
Q 005427 305 VSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSF---SDIALELDL 351 (697)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~---~ell~~l~~ 351 (697)
. .........+++++.+++.+||+.+|++||++ .|++.|.|.
T Consensus 210 ----~-~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~ 254 (260)
T cd05611 210 ----I-NWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFF 254 (260)
T ss_pred ----c-CCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHh
Confidence 1 11112233678999999999999999999955 688888766
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=309.04 Aligned_cols=248 Identities=27% Similarity=0.363 Sum_probs=204.0
Q ss_pred CcccccccccCCceEEEEEEE--CCeeEEEEeccCC---ChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEe
Q 005427 67 SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFE 141 (697)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 141 (697)
.|...++||+|+||+||+|+. +++.|++|+.... .......+.+|+.+++.++|||++++++++.+....+++||
T Consensus 22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 101 (313)
T cd06633 22 IFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVME 101 (313)
T ss_pred HhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEe
Confidence 477788999999999999986 6789999986543 23345678899999999999999999999999999999999
Q ss_pred ecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhcc
Q 005427 142 FYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLK 221 (697)
Q Consensus 142 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~ 221 (697)
|+. |++.+.+......+++.+++.++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++....
T Consensus 102 ~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~-------- 172 (313)
T cd06633 102 YCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS-------- 172 (313)
T ss_pred cCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccC--------
Confidence 996 57888877666678999999999999999999999999999999999999999999999999874321
Q ss_pred cccCCCCCCCCccccccccCccccchhhhc---ccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHH
Q 005427 222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILK---KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQ 298 (697)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~ 298 (697)
......|+..|+|||++. ...++.++|||||||++|+|++|..||...........+....
T Consensus 173 ------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~---- 236 (313)
T cd06633 173 ------------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQND---- 236 (313)
T ss_pred ------------CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC----
Confidence 123456889999999984 4567889999999999999999999998765443333222111
Q ss_pred HHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 299 QLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
.+. .....++..+.+|+.+||+.+|.+||++.+++.|.|..
T Consensus 237 -----------~~~--~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~ 277 (313)
T cd06633 237 -----------SPT--LQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVR 277 (313)
T ss_pred -----------CCC--CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccC
Confidence 111 11235678899999999999999999999999887764
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=305.07 Aligned_cols=244 Identities=22% Similarity=0.247 Sum_probs=193.6
Q ss_pred Cccccccc--ccCCceEEEEEEE--CCeeEEEEeccCCChHHHHHHHHHHHHHHhc-CCCCceEEeeccccCCceEEEEe
Q 005427 67 SYTLLSPI--ARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKL-DHPGLAKFVAAHAKPPNYMFFFE 141 (697)
Q Consensus 67 ~y~~~~~l--g~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e 141 (697)
+|.+.+.+ |+|+||.||++.. ++..+|+|......... .|+.....+ +||||+++++.+..++.+++|||
T Consensus 15 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e 89 (267)
T PHA03390 15 NCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMD 89 (267)
T ss_pred hhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEecCCeeEEEEE
Confidence 56666666 9999999999986 57789999864432221 123333323 79999999999999999999999
Q ss_pred ecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCC-CCeeeeeccchhhhhhhhhhc
Q 005427 142 FYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNL-CPHLADFGLAEYRENLKEISL 220 (697)
Q Consensus 142 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~-~~kL~Dfg~a~~~~~~~~~~~ 220 (697)
|+++++|.+++.... .+++++++.++.|++.||.|||+.|++||||||+||+++.++ .++|+|||++.....
T Consensus 90 ~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~------ 162 (267)
T PHA03390 90 YIKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGT------ 162 (267)
T ss_pred cCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCC------
Confidence 999999999997665 789999999999999999999999999999999999999988 999999998865431
Q ss_pred ccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHH
Q 005427 221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQL 300 (697)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 300 (697)
.....|+..|+|||++.+..++.++|+||||+++|+|++|..||........... .+
T Consensus 163 --------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~---------~~ 219 (267)
T PHA03390 163 --------------PSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLE---------SL 219 (267)
T ss_pred --------------CccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHH---------HH
Confidence 1234588999999999998999999999999999999999999985433221100 11
Q ss_pred HHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCC-HHHHHHHHHH
Q 005427 301 TAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPS-FSDIALELDL 351 (697)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt-~~ell~~l~~ 351 (697)
.... .. ....+..+++.+.++|.+||+.+|.+||+ ++++++|.|.
T Consensus 220 ~~~~-----~~-~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~ 265 (267)
T PHA03390 220 LKRQ-----QK-KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFL 265 (267)
T ss_pred HHhh-----cc-cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCcc
Confidence 1000 00 01123368999999999999999999995 6999998875
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=308.39 Aligned_cols=267 Identities=26% Similarity=0.320 Sum_probs=206.4
Q ss_pred cccccccccCCceEEEEEEE--CCeeEEEEeccCCC--hHHHHHHHHHHHHHHhcCCCCceEEeeccccC--CceEEEEe
Q 005427 68 YTLLSPIARGAESVVYEATL--DGRKVAVKKPILST--SEELDNFHKELQLLCKLDHPGLAKFVAAHAKP--PNYMFFFE 141 (697)
Q Consensus 68 y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~~lv~e 141 (697)
|++.++||.|+||.||+|.. .++.+|+|...... ......+.+|+.+++.++|||++++++++... ...++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 67899999999999999987 46899999876553 33356788999999999999999999999888 89999999
Q ss_pred ecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhcc
Q 005427 142 FYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLK 221 (697)
Q Consensus 142 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~ 221 (697)
|+++ +|.+++......+++.+++.++.|++.||+|||+.|++|+||||+||+++.++.+||+|||++........
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~---- 155 (287)
T cd07840 81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS---- 155 (287)
T ss_pred cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc----
Confidence 9975 89888876655789999999999999999999999999999999999999999999999999875543110
Q ss_pred cccCCCCCCCCccccccccCccccchhhhcc-cCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHH
Q 005427 222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQL 300 (697)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 300 (697)
.......++..|+|||.+.+ ..++.++||||||+++|+|++|..||...........+..........
T Consensus 156 -----------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~ 224 (287)
T cd07840 156 -----------ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDE 224 (287)
T ss_pred -----------ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchh
Confidence 01123356889999998765 457899999999999999999999998876655444443321110000
Q ss_pred HHHH-----------HhCCCCCcccccccC-ChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 005427 301 TAAV-----------VSGGLRPILASLELG-LPASILSLIQRCWDGNPHNRPSFSDIALELD 350 (697)
Q Consensus 301 ~~~~-----------~~~~~~~~~~~~~~~-~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~ 350 (697)
.+.. ........+...... ++.++.+++++||+.+|.+||++.+++++.|
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~ 286 (287)
T cd07840 225 NWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEY 286 (287)
T ss_pred hccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcC
Confidence 0000 000000001111112 4889999999999999999999999998765
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=312.86 Aligned_cols=274 Identities=26% Similarity=0.361 Sum_probs=208.0
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccC--CChHHHHHHHHHHHHHHhc-CCCCceEEeeccccC--CceEE
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPIL--STSEELDNFHKELQLLCKL-DHPGLAKFVAAHAKP--PNYMF 138 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~--~~~~l 138 (697)
++|++.+.||+|+||.||+|.+ +++.+|+|++.. ........+.+|+.+++++ +||||+++++++... ..+++
T Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~l 86 (337)
T cd07852 7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYL 86 (337)
T ss_pred hHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEE
Confidence 5899999999999999999987 578899997643 2333456678899999999 999999999987643 46899
Q ss_pred EEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhh
Q 005427 139 FFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI 218 (697)
Q Consensus 139 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~ 218 (697)
||||+. ++|..++... .+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||++.........
T Consensus 87 v~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~ 163 (337)
T cd07852 87 VFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEEN 163 (337)
T ss_pred Eecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhcccccccc
Confidence 999997 4998888654 6788899999999999999999999999999999999999999999999998755421110
Q ss_pred hcccccCCCCCCCCccccccccCccccchhhhcc-cCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccH
Q 005427 219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTE 297 (697)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~ 297 (697)
..........|++.|+|||++.+ ..++.++|+||||+++|+|++|..||.+.........+.......
T Consensus 164 -----------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~ 232 (337)
T cd07852 164 -----------PENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPP 232 (337)
T ss_pred -----------ccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 00112334578999999998764 557889999999999999999999998765554443332221110
Q ss_pred -HH--------HHHHHH---hCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 005427 298 -QQ--------LTAAVV---SGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL 353 (697)
Q Consensus 298 -~~--------~~~~~~---~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~ 353 (697)
.. ...... .....+.+......++.++.++|.+||+.||++|||+.+++++.|...
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~ 300 (337)
T cd07852 233 SAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQ 300 (337)
T ss_pred CHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhh
Confidence 00 000000 011111112223347899999999999999999999999999876643
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=310.47 Aligned_cols=277 Identities=20% Similarity=0.232 Sum_probs=206.5
Q ss_pred cccccccccCCceEEEEEEECCeeEEEEeccCC--ChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEeecCC
Q 005427 68 YTLLSPIARGAESVVYEATLDGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYES 145 (697)
Q Consensus 68 y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 145 (697)
|.+.+.+|.|+++.||++..+++.||+|+.... .......+.+|+.+++.++||||+++++++......+++|||+.+
T Consensus 4 ~~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~ 83 (314)
T cd08216 4 TLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY 83 (314)
T ss_pred hhhhHhhcCCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence 556677777777777777778999999987654 345667899999999999999999999999999999999999999
Q ss_pred CCHhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhccccc
Q 005427 146 RNLAEKLHVE-EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWR 224 (697)
Q Consensus 146 g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~ 224 (697)
++|.+++... ...+++..+..++.|++.||+|||+++|+||||||+||+++.++.+||+|||.+..........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~----- 158 (314)
T cd08216 84 GSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQ----- 158 (314)
T ss_pred CCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccc-----
Confidence 9999998753 3357889999999999999999999999999999999999999999999999886543211100
Q ss_pred CCCCCCCCccccccccCccccchhhhccc--CCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccH----H
Q 005427 225 SSGKPTGGFHKKNMVGTLIYMAPEILKKE--IHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTE----Q 298 (697)
Q Consensus 225 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~----~ 298 (697)
...........++..|+|||++.+. .++.++|+|||||++|+|++|..||................... .
T Consensus 159 ----~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 234 (314)
T cd08216 159 ----RVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKS 234 (314)
T ss_pred ----cccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccC
Confidence 0011112345678899999998763 57889999999999999999999998765433222211111000 0
Q ss_pred HHHHHH--HhC----C-----CCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 005427 299 QLTAAV--VSG----G-----LRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL 353 (697)
Q Consensus 299 ~~~~~~--~~~----~-----~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~ 353 (697)
...... ... . ..+........++.++.+|+..||+.||++|||+.++++|++...
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~ 300 (314)
T cd08216 235 TYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQ 300 (314)
T ss_pred chhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhh
Confidence 000000 000 0 000001112245678999999999999999999999999998753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=311.24 Aligned_cols=270 Identities=22% Similarity=0.275 Sum_probs=200.4
Q ss_pred CcccccccccCCceEEEEEEE----CCeeEEEEeccCCC---hHHHHHHHHHHHHHHhcCCCCceEEeeccccC--CceE
Q 005427 67 SYTLLSPIARGAESVVYEATL----DGRKVAVKKPILST---SEELDNFHKELQLLCKLDHPGLAKFVAAHAKP--PNYM 137 (697)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~----~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~~ 137 (697)
+|.+.++||+|+||.||+|.. .++.||+|.+.... ......+.+|+.+++.++||||+++++++... ..++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 588999999999999999987 46899999866532 23346678899999999999999999999888 7899
Q ss_pred EEEeecCCCCHhhhhhhc----CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecC----CCCCeeeeeccc
Q 005427 138 FFFEFYESRNLAEKLHVE----EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDR----NLCPHLADFGLA 209 (697)
Q Consensus 138 lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~----~~~~kL~Dfg~a 209 (697)
+||||+.+ +|.+.+... ...+++..++.++.|++.||.|||+.+|+||||||+|||++. ++.+||+|||++
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 99999975 676665422 226789999999999999999999999999999999999999 899999999998
Q ss_pred hhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhccc-CCCchhhHHHHHHHHHHHHhCCCCCCCchhHH---
Q 005427 210 EYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKE-IHSEKSDVYSFGISINELLTGVVPYTDLRAEA--- 285 (697)
Q Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~--- 285 (697)
........ .........+++.|+|||++.+. .++.++|||||||++|+|++|.+||.+.....
T Consensus 160 ~~~~~~~~-------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~ 226 (316)
T cd07842 160 RLFNAPLK-------------PLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKS 226 (316)
T ss_pred cccCCCcc-------------cccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCccccccc
Confidence 76542111 01112345688999999988764 57899999999999999999999997654322
Q ss_pred ------HHHHHHhcccc-HH----------HHHHHHHhCCCCCcc-----cccc--cCChHHHHHHHHHhccCCCCCCCC
Q 005427 286 ------QAHTVLEMNYT-EQ----------QLTAAVVSGGLRPIL-----ASLE--LGLPASILSLIQRCWDGNPHNRPS 341 (697)
Q Consensus 286 ------~~~~~~~~~~~-~~----------~~~~~~~~~~~~~~~-----~~~~--~~~~~~l~~li~~~l~~dP~~Rpt 341 (697)
....++..... .. +...........+.. ...+ ...+.++.+++.+||+.||++|||
T Consensus 227 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps 306 (316)
T cd07842 227 NPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRIT 306 (316)
T ss_pred chhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcC
Confidence 11111110000 00 000000000000000 0011 156788999999999999999999
Q ss_pred HHHHHHHHH
Q 005427 342 FSDIALELD 350 (697)
Q Consensus 342 ~~ell~~l~ 350 (697)
+.|+++|.|
T Consensus 307 ~~eil~~~~ 315 (316)
T cd07842 307 AEEALEHPY 315 (316)
T ss_pred HHHHhcCCC
Confidence 999998865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=299.18 Aligned_cols=248 Identities=30% Similarity=0.497 Sum_probs=208.2
Q ss_pred CcccccccccCCceEEEEEEE--CCeeEEEEeccCCCh--HHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEee
Q 005427 67 SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTS--EELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF 142 (697)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 142 (697)
+|++.+.||+|++|.||++.. .++.+++|....... .....+.+|++++++++|||++++++++.+...++++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 588999999999999999986 577899998665543 4567899999999999999999999999999999999999
Q ss_pred cCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhccc
Q 005427 143 YESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKN 222 (697)
Q Consensus 143 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 222 (697)
+.+++|.+++... ..+++..++.++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~----- 154 (254)
T cd06627 81 AENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK----- 154 (254)
T ss_pred CCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcc-----
Confidence 9999999998765 4789999999999999999999999999999999999999999999999999876542111
Q ss_pred ccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHHHH
Q 005427 223 WRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTA 302 (697)
Q Consensus 223 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 302 (697)
......++..|+|||.+.+..++.++|+||||+++|+|++|..||.............
T Consensus 155 -----------~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~----------- 212 (254)
T cd06627 155 -----------DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV----------- 212 (254)
T ss_pred -----------cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh-----------
Confidence 1233468889999999988888999999999999999999999998654322222111
Q ss_pred HHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 005427 303 AVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALEL 349 (697)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l 349 (697)
.... +..+..++..+.+++.+||..+|++|||+.+++.+.
T Consensus 213 ---~~~~----~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~ 252 (254)
T cd06627 213 ---QDDH----PPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHP 252 (254)
T ss_pred ---ccCC----CCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCC
Confidence 1111 123456789999999999999999999999998764
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=310.97 Aligned_cols=266 Identities=23% Similarity=0.338 Sum_probs=204.0
Q ss_pred CCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCC--hHHHHHHHHHHHHHHhcCCCCceEEeeccccC------C
Q 005427 65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST--SEELDNFHKELQLLCKLDHPGLAKFVAAHAKP------P 134 (697)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~------~ 134 (697)
.++|.+.+.||+|+||.||++.+ +++.||+|+..... ....+.+.+|+.++++++||||+++++++... .
T Consensus 16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (345)
T cd07877 16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 95 (345)
T ss_pred cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccc
Confidence 47899999999999999999986 68899999865432 22346788899999999999999999987543 3
Q ss_pred ceEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhh
Q 005427 135 NYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYREN 214 (697)
Q Consensus 135 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~ 214 (697)
..+++++++ +++|.+++... .+++..++.++.|++.||+|||+.||+||||||+||+++.++.+||+|||++.....
T Consensus 96 ~~~lv~~~~-~~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~ 172 (345)
T cd07877 96 DVYLVTHLM-GADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 172 (345)
T ss_pred cEEEEehhc-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccccccc
Confidence 467788776 67998877543 588999999999999999999999999999999999999999999999999864321
Q ss_pred hhhhhcccccCCCCCCCCccccccccCccccchhhhcc-cCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhc
Q 005427 215 LKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEM 293 (697)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~ 293 (697)
......+++.|+|||++.+ ..++.++|||||||++|+|++|..||...........+...
T Consensus 173 -------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~ 233 (345)
T cd07877 173 -------------------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 233 (345)
T ss_pred -------------------cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 1233467899999999876 56788999999999999999999999876554444433322
Q ss_pred ccc-HHHHHHHH--------H---hCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 294 NYT-EQQLTAAV--------V---SGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 294 ~~~-~~~~~~~~--------~---~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
... .......+ . .......+.......++++.++|.+||+.||.+||++.+++.|.|+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~ 304 (345)
T cd07877 234 VGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 304 (345)
T ss_pred hCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhh
Confidence 111 11111000 0 00000111111224688899999999999999999999999998865
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=309.35 Aligned_cols=276 Identities=21% Similarity=0.254 Sum_probs=203.6
Q ss_pred ccccccC--CceEEEEEEE--CCeeEEEEeccCCC--hHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEeecC
Q 005427 71 LSPIARG--AESVVYEATL--DGRKVAVKKPILST--SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYE 144 (697)
Q Consensus 71 ~~~lg~G--~~g~V~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 144 (697)
...||+| +||+||++.+ .++.||+|...... ....+.+.+|+.+++.++||||++++++|......++++||+.
T Consensus 3 ~~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 3 QVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HHHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence 4567777 9999999987 68999999876432 3446788999999999999999999999999999999999999
Q ss_pred CCCHhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhcccc
Q 005427 145 SRNLAEKLHVEE-WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNW 223 (697)
Q Consensus 145 ~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~ 223 (697)
+++|.+++.... ..+++..+..++.|++.||+|||+.|++||||||+|||++.++.+|++||+.+..........
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~---- 158 (328)
T cd08226 83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA---- 158 (328)
T ss_pred CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc----
Confidence 999999887542 357889999999999999999999999999999999999999999999998664332110000
Q ss_pred cCCCCCCCCccccccccCccccchhhhccc--CCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhcccc-H---
Q 005427 224 RSSGKPTGGFHKKNMVGTLIYMAPEILKKE--IHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYT-E--- 297 (697)
Q Consensus 224 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~-~--- 297 (697)
...........++..|+|||++.+. .++.++|||||||++|+|++|..||.+................ +
T Consensus 159 -----~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 233 (328)
T cd08226 159 -----KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDI 233 (328)
T ss_pred -----cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccc
Confidence 0000001122356779999999764 4688999999999999999999999876544433322221100 0
Q ss_pred -----HHHH-------------HHHHhCCC------CCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 005427 298 -----QQLT-------------AAVVSGGL------RPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL 353 (697)
Q Consensus 298 -----~~~~-------------~~~~~~~~------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~ 353 (697)
.... ........ .......+..+++.+.+|+++||+.||.+|||+.++++|.|+..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~ 313 (328)
T cd08226 234 TTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQ 313 (328)
T ss_pred cccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHH
Confidence 0000 00000000 00001112346788999999999999999999999999999865
Q ss_pred HH
Q 005427 354 EH 355 (697)
Q Consensus 354 ~~ 355 (697)
..
T Consensus 314 ~~ 315 (328)
T cd08226 314 VK 315 (328)
T ss_pred HH
Confidence 43
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=306.32 Aligned_cols=265 Identities=24% Similarity=0.367 Sum_probs=211.7
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccCC---ChHHHHHHHHHHHHHHhcC-CCCceEEeeccccCCceEEE
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKLD-HPGLAKFVAAHAKPPNYMFF 139 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lv 139 (697)
++|.+.+.||+|+||.||++.. +++.|++|+.... .......+.+|+.++++++ ||||+++++++......+++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 4799999999999999999987 6889999986542 2334567889999999998 99999999999999999999
Q ss_pred EeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhh
Q 005427 140 FEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEIS 219 (697)
Q Consensus 140 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~ 219 (697)
||++.+++|.+++...+ .+++.+++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..........
T Consensus 81 ~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~ 159 (280)
T cd05581 81 LEYAPNGELLQYIRKYG-SLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPE 159 (280)
T ss_pred EcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCccccc
Confidence 99999999999997654 68999999999999999999999999999999999999999999999999987654321100
Q ss_pred cccc----cCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccc
Q 005427 220 LKNW----RSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNY 295 (697)
Q Consensus 220 ~~~~----~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~ 295 (697)
.... ................++..|+|||++.+..++.++|+||||++++++++|..||...........+....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~- 238 (280)
T cd05581 160 SNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLE- 238 (280)
T ss_pred cCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcC-
Confidence 0000 00000011122345578899999999988888999999999999999999999998765333322221110
Q ss_pred cHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCH----HHHHHHHH
Q 005427 296 TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSF----SDIALELD 350 (697)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~----~ell~~l~ 350 (697)
...+..+++.+.+++.+||+.+|.+|||+ .++++|.|
T Consensus 239 ------------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~ 279 (280)
T cd05581 239 ------------------YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPF 279 (280)
T ss_pred ------------------CCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCC
Confidence 11334678999999999999999999999 99988765
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=311.58 Aligned_cols=280 Identities=24% Similarity=0.296 Sum_probs=205.6
Q ss_pred CCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCChH--HHHHHHHHHHHHHhcCCCCceEEeeccccCC------
Q 005427 65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSE--ELDNFHKELQLLCKLDHPGLAKFVAAHAKPP------ 134 (697)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~------ 134 (697)
.++|++.++||+|+||.||+|.+ +++.+++|++...... ....+.+|+++++.++||||+++++++....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 36899999999999999999987 5788999976543322 2345678999999999999999998875433
Q ss_pred --ceEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhh
Q 005427 135 --NYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYR 212 (697)
Q Consensus 135 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~ 212 (697)
.+++++||+.+ +|...+......+++.+++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||++...
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 165 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPY 165 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchhc
Confidence 46999999875 777777665567999999999999999999999999999999999999999999999999999765
Q ss_pred hhhhhhhcccccCCCCCCCCccccccccCccccchhhhccc-CCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHH
Q 005427 213 ENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKE-IHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVL 291 (697)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~ 291 (697)
........ ..............+++.|+|||++.+. .++.++|||||||++|+|++|.+||.+.........+.
T Consensus 166 ~~~~~~~~-----~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~ 240 (311)
T cd07866 166 DGPPPNPK-----GGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF 240 (311)
T ss_pred cCCCcccc-----cCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 43211000 0000011112345788999999988654 57889999999999999999999998776655444433
Q ss_pred hccccHHHHHHH---HH--------hCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 005427 292 EMNYTEQQLTAA---VV--------SGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350 (697)
Q Consensus 292 ~~~~~~~~~~~~---~~--------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~ 350 (697)
..........+. .. .....+.+......+++.+.+++.+||+.||.+|||+.+++.|.|
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~ 310 (311)
T cd07866 241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPY 310 (311)
T ss_pred HHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCC
Confidence 221111000000 00 000011111111245578999999999999999999999998765
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=309.07 Aligned_cols=270 Identities=24% Similarity=0.283 Sum_probs=204.7
Q ss_pred CCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCCh--HHHHHHHHHHHHHHhcCCCCceEEeeccccCC------
Q 005427 65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTS--EELDNFHKELQLLCKLDHPGLAKFVAAHAKPP------ 134 (697)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~------ 134 (697)
.++|++.+.||+|+||.||+|.+ +++.||+|.+..... .....+.+|+.+++.++||||+++++++.+..
T Consensus 6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~ 85 (302)
T cd07864 6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFK 85 (302)
T ss_pred hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcc
Confidence 46899999999999999999987 578899998754432 22356778999999999999999999887654
Q ss_pred ----ceEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccch
Q 005427 135 ----NYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAE 210 (697)
Q Consensus 135 ----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~ 210 (697)
.+++++||+++ ++...+......+++.+++.++.|++.||+|||+.||+|+||||+||+++.++.+||+|||++.
T Consensus 86 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~ 164 (302)
T cd07864 86 KDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLAR 164 (302)
T ss_pred ccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcccccc
Confidence 79999999986 7777776555578999999999999999999999999999999999999999999999999987
Q ss_pred hhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcc-cCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHH
Q 005427 211 YRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHT 289 (697)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~ 289 (697)
....... .......++..|+|||++.+ ..++.++|||||||++|+|++|.+||...........
T Consensus 165 ~~~~~~~---------------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~ 229 (302)
T cd07864 165 LYNSEES---------------RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLEL 229 (302)
T ss_pred cccCCcc---------------cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 5542110 01122346788999998865 4568899999999999999999999987655444433
Q ss_pred HHhccccHHHHHH-HHHh----------CCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 005427 290 VLEMNYTEQQLTA-AVVS----------GGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350 (697)
Q Consensus 290 ~~~~~~~~~~~~~-~~~~----------~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~ 350 (697)
+...........+ .+.. .............+|..+.+++..||+.||.+|||+.+++.+.|
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~ 301 (302)
T cd07864 230 ISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPW 301 (302)
T ss_pred HHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 3322111100000 0000 00000011112347899999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=299.07 Aligned_cols=247 Identities=24% Similarity=0.360 Sum_probs=206.9
Q ss_pred CcccccccccCCceEEEEEEE--CCeeEEEEeccCC--ChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEee
Q 005427 67 SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF 142 (697)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 142 (697)
+|++.++||+|+||.||++.. +++.+++|..... .......+.+|+.+++.++||||+++++++.....+++|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 588999999999999999976 5778999986543 234456788999999999999999999999999999999999
Q ss_pred cCCCCHhhhhhhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhh
Q 005427 143 YESRNLAEKLHVE---EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEIS 219 (697)
Q Consensus 143 ~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~ 219 (697)
+++++|.+++... ...++++.++.++.|++.||+|||+.|++|+||+|.||+++.++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~---- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN---- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC----
Confidence 9999999988652 246788999999999999999999999999999999999999999999999998765421
Q ss_pred cccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHH
Q 005427 220 LKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQ 299 (697)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~ 299 (697)
......+++.|++||.+.+..++.++|+||||+++|+|++|..||...+.......+.
T Consensus 157 --------------~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~-------- 214 (256)
T cd08530 157 --------------MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQ-------- 214 (256)
T ss_pred --------------CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh--------
Confidence 1223457889999999999889999999999999999999999998765443322221
Q ss_pred HHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 005427 300 LTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALEL 349 (697)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l 349 (697)
... .+..+..++.++.+++.+||+.+|.+|||+.++++|+
T Consensus 215 ------~~~----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p 254 (256)
T cd08530 215 ------RGK----YPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASP 254 (256)
T ss_pred ------cCC----CCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCC
Confidence 111 1223346789999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=307.90 Aligned_cols=272 Identities=21% Similarity=0.264 Sum_probs=204.3
Q ss_pred CcccccccccCCceEEEEEEEC----CeeEEEEeccCC--ChHHHHHHHHHHHHHHhc-CCCCceEEeecccc----CCc
Q 005427 67 SYTLLSPIARGAESVVYEATLD----GRKVAVKKPILS--TSEELDNFHKELQLLCKL-DHPGLAKFVAAHAK----PPN 135 (697)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~~----~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~----~~~ 135 (697)
+|++.+.||+|+||.||++.+. +..||+|++... .......+.+|+.+++++ +||||+++++.+.. ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 5889999999999999999874 568999976532 222355678899999999 59999999986432 245
Q ss_pred eEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhh
Q 005427 136 YMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL 215 (697)
Q Consensus 136 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~ 215 (697)
.+++++|+. ++|.+.+.... .+++..++.++.|++.||+|||+.|++||||||+|||++.++.+||+|||++......
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~ 158 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQ-PLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSEN 158 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccc
Confidence 778888886 58988886443 6899999999999999999999999999999999999999999999999998754321
Q ss_pred hhhhcccccCCCCCCCCccccccccCccccchhhhcc-cCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhcc
Q 005427 216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMN 294 (697)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~ 294 (697)
.. ..........|++.|+|||++.+ ..++.++|||||||++|+|++|.+||...........+....
T Consensus 159 ~~------------~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 226 (332)
T cd07857 159 PG------------ENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVL 226 (332)
T ss_pred cc------------cccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHh
Confidence 10 00111234578999999998765 568899999999999999999999998766544444333221
Q ss_pred ccH-HHHHHHH-----------HhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 295 YTE-QQLTAAV-----------VSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 295 ~~~-~~~~~~~-----------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
... ....... ........+......++..+.+++.+||+.||.+|||+.+++.+.|..
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~ 296 (332)
T cd07857 227 GTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLA 296 (332)
T ss_pred CCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhh
Confidence 111 1110000 001111122223345688999999999999999999999999998863
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=288.17 Aligned_cols=252 Identities=23% Similarity=0.355 Sum_probs=206.9
Q ss_pred ccCCCCCCCcccccccccCCceEEEEEEE--CCeeEEEEecc---CCChHHHHHHHHHHHHHHhc-CCCCceEEeecccc
Q 005427 59 IPLHLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPI---LSTSEELDNFHKELQLLCKL-DHPGLAKFVAAHAK 132 (697)
Q Consensus 59 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~---~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~ 132 (697)
.++.+.-.+|.++.+||+|+|+.|.++++ +.+.+|+|++. ....++++-...|-.+..+. +||++|.|+.+|.+
T Consensus 243 ~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqt 322 (593)
T KOG0695|consen 243 ISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQT 322 (593)
T ss_pred cccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcc
Confidence 44556667999999999999999999986 67789998654 33455677788888888877 79999999999999
Q ss_pred CCceEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhh
Q 005427 133 PPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYR 212 (697)
Q Consensus 133 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~ 212 (697)
+..+++|.||++||+|.-.+.++. .++++.++.+..+|+.||.|||++||+.||||.+|+|+|..|++||+|+|+++.-
T Consensus 323 esrlffvieyv~ggdlmfhmqrqr-klpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~ 401 (593)
T KOG0695|consen 323 ESRLFFVIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG 401 (593)
T ss_pred cceEEEEEEEecCcceeeehhhhh-cCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcC
Confidence 999999999999999988876655 7899999999999999999999999999999999999999999999999998632
Q ss_pred hhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCc--hhHHHHHHH
Q 005427 213 ENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDL--RAEAQAHTV 290 (697)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~--~~~~~~~~~ 290 (697)
- ..+..+.+++|||.|.|||++++..|...+|.|+|||+|+||+.|+.||.-. ++..
T Consensus 402 l----------------~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d----- 460 (593)
T KOG0695|consen 402 L----------------GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPD----- 460 (593)
T ss_pred C----------------CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcc-----
Confidence 1 2234577899999999999999999999999999999999999999999521 1111
Q ss_pred HhccccHHHHHHHHHh-CCCCCcccccccCChHHHHHHHHHhccCCCCCCCC
Q 005427 291 LEMNYTEQQLTAAVVS-GGLRPILASLELGLPASILSLIQRCWDGNPHNRPS 341 (697)
Q Consensus 291 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt 341 (697)
.+.+++...+.- ...| +|..+|-....+++.-|++||.+|..
T Consensus 461 ----~ntedylfqvilekqir-----iprslsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 461 ----MNTEDYLFQVILEKQIR-----IPRSLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred ----cchhHHHHHHHhhhccc-----ccceeehhhHHHHHHhhcCCcHHhcC
Confidence 111222222222 2222 35567888889999999999999965
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=314.20 Aligned_cols=266 Identities=24% Similarity=0.370 Sum_probs=208.3
Q ss_pred CCCcccccccccCCceEEEEEEE--CCeeEEEEeccCC--ChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCc-----
Q 005427 65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPN----- 135 (697)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~----- 135 (697)
.++|++.+.||+|+||.||+|++ +++.||+|+.... .......+.+|+.+++.++||||+++++++.....
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ 93 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence 46899999999999999999987 5788999986543 23344667889999999999999999988876554
Q ss_pred -eEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhh
Q 005427 136 -YMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYREN 214 (697)
Q Consensus 136 -~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~ 214 (697)
.++|+||+ +++|.+++.. ..+++.+++.++.|++.||+|||+.||+||||||+||+++.++.+||+|||++.....
T Consensus 94 ~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~ 170 (343)
T cd07851 94 DVYLVTHLM-GADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDD 170 (343)
T ss_pred cEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccccccccccc
Confidence 89999998 5699998864 3689999999999999999999999999999999999999999999999999865431
Q ss_pred hhhhhcccccCCCCCCCCccccccccCccccchhhhcc-cCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhc
Q 005427 215 LKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEM 293 (697)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~ 293 (697)
......++..|+|||.+.+ ..++.++|||||||++|+|++|..||.+.........+...
T Consensus 171 -------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~ 231 (343)
T cd07851 171 -------------------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNL 231 (343)
T ss_pred -------------------cccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Confidence 1233467889999999865 36788999999999999999999999877655544444332
Q ss_pred ccc-HHHHHHHHH-----------hCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 294 NYT-EQQLTAAVV-----------SGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 294 ~~~-~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
... .+.+..... ....++.+......+++++.++|.+||+.+|.+|||+.+|+.|.|..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~ 302 (343)
T cd07851 232 VGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLA 302 (343)
T ss_pred cCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCcc
Confidence 111 111111110 00111122222345689999999999999999999999999988775
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=302.33 Aligned_cols=245 Identities=24% Similarity=0.283 Sum_probs=192.2
Q ss_pred ccccCCceEEEEEEE--CCeeEEEEeccCCCh---HHHHHHHHHH---HHHHhcCCCCceEEeeccccCCceEEEEeecC
Q 005427 73 PIARGAESVVYEATL--DGRKVAVKKPILSTS---EELDNFHKEL---QLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYE 144 (697)
Q Consensus 73 ~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~---~~~~~~~~E~---~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 144 (697)
.||+|+||.||++.+ +++.||+|.+..... .....+..|. .+++...||||+.+++.+...+.+++||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999986 578999997654321 1112233443 34455689999999999999999999999999
Q ss_pred CCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhccccc
Q 005427 145 SRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWR 224 (697)
Q Consensus 145 ~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~ 224 (697)
|++|.+++...+ .+++..++.++.|++.||.|||+.+++||||||+||+++.++.+||+|||++..+...
T Consensus 81 g~~L~~~l~~~~-~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~--------- 150 (278)
T cd05606 81 GGDLHYHLSQHG-VFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--------- 150 (278)
T ss_pred CCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc---------
Confidence 999999886544 6899999999999999999999999999999999999999999999999998643210
Q ss_pred CCCCCCCCccccccccCccccchhhhcc-cCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHHHHH
Q 005427 225 SSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAA 303 (697)
Q Consensus 225 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (697)
......|+..|+|||++.+ ..++.++||||+||++|+|++|..||.+........ ....
T Consensus 151 ---------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~-----------~~~~ 210 (278)
T cd05606 151 ---------KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-----------IDRM 210 (278)
T ss_pred ---------CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHH-----------HHHH
Confidence 1224468999999999875 468899999999999999999999998652211100 0000
Q ss_pred HHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCC-----CHHHHHHHHHHH
Q 005427 304 VVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRP-----SFSDIALELDLV 352 (697)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~ell~~l~~~ 352 (697)
. .... ...+..++.++.+++.+||..+|.+|| ++.++++|.|+.
T Consensus 211 ~--~~~~---~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~ 259 (278)
T cd05606 211 T--LTMA---VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFR 259 (278)
T ss_pred h--hccC---CCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCcccc
Confidence 0 0011 123445789999999999999999999 999999888773
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=296.43 Aligned_cols=253 Identities=27% Similarity=0.421 Sum_probs=210.3
Q ss_pred CcccccccccCCceEEEEEEEC--CeeEEEEeccCCCh--HHHHHHHHHHHHHHhcCCCCceEEeeccccC--CceEEEE
Q 005427 67 SYTLLSPIARGAESVVYEATLD--GRKVAVKKPILSTS--EELDNFHKELQLLCKLDHPGLAKFVAAHAKP--PNYMFFF 140 (697)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~~lv~ 140 (697)
+|.+.+.||+|++|.||+|... ++.|++|+...... ...+.+.+|+.++++++||||+++++.+... ..+++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4788999999999999999874 88999998665542 4577899999999999999999999999888 8899999
Q ss_pred eecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhc
Q 005427 141 EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL 220 (697)
Q Consensus 141 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~ 220 (697)
||+.+++|.+++.... .+++.+++.++.|++.+|+|||+.|++|+||+|+||+++.++.++|+|||.+.........
T Consensus 81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-- 157 (260)
T cd06606 81 EYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG-- 157 (260)
T ss_pred EecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccc--
Confidence 9999999999987665 7899999999999999999999999999999999999999999999999998765431110
Q ss_pred ccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHH
Q 005427 221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQL 300 (697)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 300 (697)
.......++..|+|||.+.+...+.++|+||||+++|+|++|..||..........
T Consensus 158 ------------~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~------------ 213 (260)
T cd06606 158 ------------EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAAL------------ 213 (260)
T ss_pred ------------ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHH------------
Confidence 01234568899999999988889999999999999999999999998765111100
Q ss_pred HHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 005427 301 TAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350 (697)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~ 350 (697)
...... ......+..++..+.+++.+||+.+|++||++.+++.|.|
T Consensus 214 -~~~~~~---~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~ 259 (260)
T cd06606 214 -YKIGSS---GEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPF 259 (260)
T ss_pred -Hhcccc---CCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCC
Confidence 011111 1122344567899999999999999999999999998875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=329.21 Aligned_cols=261 Identities=25% Similarity=0.410 Sum_probs=192.9
Q ss_pred CcccccccccCCceEEEEEEE--CCeeEEEEeccCCC-hHHHHHHHHHHHHHHhcCCCCceEEeecccc-----------
Q 005427 67 SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST-SEELDNFHKELQLLCKLDHPGLAKFVAAHAK----------- 132 (697)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~----------- 132 (697)
+|+.++.||+||||.||+++. +|+.||||++.... ......+.+|+.+|.+|+|||||+++..+..
T Consensus 480 DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~ 559 (1351)
T KOG1035|consen 480 DFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIV 559 (1351)
T ss_pred hhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccccc
Confidence 578899999999999999986 79999999987764 3446789999999999999999998642100
Q ss_pred --------------------------------------------------------------------------------
Q 005427 133 -------------------------------------------------------------------------------- 132 (697)
Q Consensus 133 -------------------------------------------------------------------------------- 132 (697)
T Consensus 560 ~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~ 639 (1351)
T KOG1035|consen 560 ASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGS 639 (1351)
T ss_pred ccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCc
Confidence
Q ss_pred --------------------C--------CceEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 005427 133 --------------------P--------PNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIV 184 (697)
Q Consensus 133 --------------------~--------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iv 184 (697)
+ -.+|+-||||+...+.++++.+...-..+..|+++++|++||.|+|++|||
T Consensus 640 ~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~giI 719 (1351)
T KOG1035|consen 640 VILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQGII 719 (1351)
T ss_pred cccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCcee
Confidence 0 125777899998778887776553224688999999999999999999999
Q ss_pred cccCCCCceeecCCCCCeeeeeccchhhhh----hhhhhcccccCCCCCCCCc-cccccccCccccchhhhcccC---CC
Q 005427 185 HRDVKPANVLLDRNLCPHLADFGLAEYREN----LKEISLKNWRSSGKPTGGF-HKKNMVGTLIYMAPEILKKEI---HS 256 (697)
Q Consensus 185 HrDlkp~Nill~~~~~~kL~Dfg~a~~~~~----~~~~~~~~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~---~~ 256 (697)
||||||.||+++.++.|||+|||+|+.... .... ...+ ......+. ..+..+||..|+|||++.+.. |+
T Consensus 720 HRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~-~~~~--~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn 796 (1351)
T KOG1035|consen 720 HRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQD-LSFS--TNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYN 796 (1351)
T ss_pred eccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhc-cCcc--ccccCCCCcccccccceeeeecHHHhccccccccc
Confidence 999999999999999999999999987331 1110 0111 11111111 356789999999999997655 99
Q ss_pred chhhHHHHHHHHHHHHhCCCCCCCc-hhHHHHHHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCC
Q 005427 257 EKSDVYSFGISINELLTGVVPYTDL-RAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGN 335 (697)
Q Consensus 257 ~~~DiwslG~~l~ell~g~~Pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 335 (697)
.|+||||||++|+||+. ||... .....+..+..... |..+.+...--+.-..+|++||+.|
T Consensus 797 ~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~i---------------P~~~~f~~~~~~~e~slI~~Ll~hd 858 (1351)
T KOG1035|consen 797 SKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSI---------------PEPADFFDPEHPEEASLIRWLLSHD 858 (1351)
T ss_pred chhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCC---------------CCCcccccccchHHHHHHHHHhcCC
Confidence 99999999999999986 46542 22222222211111 1111112233345678999999999
Q ss_pred CCCCCCHHHHHHH
Q 005427 336 PHNRPSFSDIALE 348 (697)
Q Consensus 336 P~~Rpt~~ell~~ 348 (697)
|++||||.|+|+.
T Consensus 859 P~kRPtA~eLL~s 871 (1351)
T KOG1035|consen 859 PSKRPTATELLNS 871 (1351)
T ss_pred CccCCCHHHHhhc
Confidence 9999999999854
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=311.22 Aligned_cols=266 Identities=23% Similarity=0.332 Sum_probs=203.2
Q ss_pred CCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCC--hHHHHHHHHHHHHHHhcCCCCceEEeeccccC------C
Q 005427 65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST--SEELDNFHKELQLLCKLDHPGLAKFVAAHAKP------P 134 (697)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~------~ 134 (697)
..+|.+.+.||+|+||.||+|.+ +++.||+|++.... ......+.+|+.+++.++||||+++++++... .
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 35899999999999999999986 58899999865332 22245678999999999999999999988654 3
Q ss_pred ceEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhh
Q 005427 135 NYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYREN 214 (697)
Q Consensus 135 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~ 214 (697)
.+++++||+.. +|...+ ...++++.+..++.|++.||+|||+.|++||||||+||+++.++.+||+|||++.....
T Consensus 94 ~~~lv~e~~~~-~l~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~ 169 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIM---GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA 169 (342)
T ss_pred eEEEEeccccc-CHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCC
Confidence 46999999864 676654 23588999999999999999999999999999999999999999999999999864321
Q ss_pred hhhhhcccccCCCCCCCCccccccccCccccchhhhcc-cCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhc
Q 005427 215 LKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEM 293 (697)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~ 293 (697)
......+++.|+|||++.+ ..++.++|+|||||++|||++|+.||.+.+.......+...
T Consensus 170 -------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~ 230 (342)
T cd07879 170 -------------------EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKV 230 (342)
T ss_pred -------------------CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 1223467889999999876 46889999999999999999999999886654444443332
Q ss_pred cc-cHHHHHHHHHhC-------CC----CCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 005427 294 NY-TEQQLTAAVVSG-------GL----RPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL 353 (697)
Q Consensus 294 ~~-~~~~~~~~~~~~-------~~----~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~ 353 (697)
.. ....+....... .. +..+....+..++++.+||.+||+.||.+||++.+++.|.|+..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~ 302 (342)
T cd07879 231 TGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDS 302 (342)
T ss_pred cCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhh
Confidence 11 111111111000 00 00111112356788999999999999999999999999977643
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=303.63 Aligned_cols=265 Identities=26% Similarity=0.308 Sum_probs=203.6
Q ss_pred cccccccccCCceEEEEEEE--CCeeEEEEeccCCCh--HHHHHHHHHHHHHHhc---CCCCceEEeeccccCCc-----
Q 005427 68 YTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTS--EELDNFHKELQLLCKL---DHPGLAKFVAAHAKPPN----- 135 (697)
Q Consensus 68 y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~hpniv~l~~~~~~~~~----- 135 (697)
|++.+.||+|+||.||+|.+ +++.+|+|....... .....+.+|+.+++++ +||||+++++++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 67899999999999999987 478999998764322 2234566788887766 59999999999988776
Q ss_pred eEEEEeecCCCCHhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhh
Q 005427 136 YMFFFEFYESRNLAEKLHVEE-WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYREN 214 (697)
Q Consensus 136 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~ 214 (697)
++++|||+.+ +|.+++.... ..+++.+++.++.|++.||.|||+.+++|+||+|+||+++.++.+||+|||++.....
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~ 159 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSF 159 (287)
T ss_pred eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccC
Confidence 9999999975 8888886543 3589999999999999999999999999999999999999999999999999865432
Q ss_pred hhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhcc
Q 005427 215 LKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMN 294 (697)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~ 294 (697)
.. ......+++.|+|||++.+..++.++|+|||||++|+|++|.+||.+.........+....
T Consensus 160 ~~-----------------~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 222 (287)
T cd07838 160 EM-----------------ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVI 222 (287)
T ss_pred Cc-----------------ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHc
Confidence 10 1122357889999999999889999999999999999999999998876665555443321
Q ss_pred ccHHHHHHH--------HHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 005427 295 YTEQQLTAA--------VVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350 (697)
Q Consensus 295 ~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~ 350 (697)
.......+. ................+++.+.+++.+||+.||.+||++.+++.|.|
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~ 286 (287)
T cd07838 223 GLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPY 286 (287)
T ss_pred CCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcC
Confidence 110000000 00000001111122346788899999999999999999999998765
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=285.80 Aligned_cols=261 Identities=26% Similarity=0.347 Sum_probs=206.4
Q ss_pred cCCCCCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCCh-HHHHHHHHHHHHHHh-cCCCCceEEeeccccCCc
Q 005427 60 PLHLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTS-EELDNFHKELQLLCK-LDHPGLAKFVAAHAKPPN 135 (697)
Q Consensus 60 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~-l~hpniv~l~~~~~~~~~ 135 (697)
-.++..++.+-+..||+|.||+|++-.+ .|+..|||+++.... .+..++..|.+...+ -++||||++||....++.
T Consensus 58 ~~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGd 137 (361)
T KOG1006|consen 58 LHTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGD 137 (361)
T ss_pred ccccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCc
Confidence 3556666778889999999999999987 688999999887655 567788889887554 479999999999999999
Q ss_pred eEEEEeecCCCCHhhhhh----hcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCCCceeecCCCCCeeeeeccch
Q 005427 136 YMFFFEFYESRNLAEKLH----VEEWSPSVDQVLMIAAQLAKALQYLHN-LGIVHRDVKPANVLLDRNLCPHLADFGLAE 210 (697)
Q Consensus 136 ~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~ 210 (697)
.|+.||.|+- +|..+.+ .....++++-+-.|..-.+.||.||.. ..|+|||+||+|||++..|.+||||||++.
T Consensus 138 cWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcG 216 (361)
T KOG1006|consen 138 CWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICG 216 (361)
T ss_pred eeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchH
Confidence 9999999974 5544432 234578888888899999999999975 589999999999999999999999999998
Q ss_pred hhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhc--ccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHH
Q 005427 211 YRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILK--KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAH 288 (697)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~ 288 (697)
.+.+.- ..+.-.|...|||||.+. +..|+-+||+||||++|||+.||..||.+.+... .
T Consensus 217 qLv~Si-----------------AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svf--e 277 (361)
T KOG1006|consen 217 QLVDSI-----------------AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVF--E 277 (361)
T ss_pred hHHHHH-----------------HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHH--H
Confidence 776422 234557889999999985 3458899999999999999999999998765422 1
Q ss_pred HHHhccccHHHHHHHHHhCCCCCccccc-ccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 005427 289 TVLEMNYTEQQLTAAVVSGGLRPILASL-ELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL 351 (697)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~ 351 (697)
++ ..+..+....+.... ...++..+..+|..||.+|-+.||.+.+++++...
T Consensus 278 ql-----------~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fy 330 (361)
T KOG1006|consen 278 QL-----------CQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFY 330 (361)
T ss_pred HH-----------HHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcCchh
Confidence 11 112222222222221 24589999999999999999999999999865443
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=311.20 Aligned_cols=283 Identities=21% Similarity=0.191 Sum_probs=207.3
Q ss_pred CCcc-cccccccCCceEEEEEEE--CCeeEEEEeccCCChHH--------------HHHHHHHHHHHHhcCCCCceEEee
Q 005427 66 SSYT-LLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEE--------------LDNFHKELQLLCKLDHPGLAKFVA 128 (697)
Q Consensus 66 ~~y~-~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~hpniv~l~~ 128 (697)
++|. +.+.||.|+||+||+|.+ .++.||+|+........ ...+.+|+++++.++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 4665 567799999999999986 57899999765432211 124778999999999999999999
Q ss_pred ccccCCceEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeecc
Q 005427 129 AHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGL 208 (697)
Q Consensus 129 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~ 208 (697)
++......+++|||+. |+|.+++.... .+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.+||+|||+
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~ 165 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRKI-RLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGL 165 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccc
Confidence 9999999999999997 58998886543 689999999999999999999999999999999999999999999999999
Q ss_pred chhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhccc-CCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHH
Q 005427 209 AEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKE-IHSEKSDVYSFGISINELLTGVVPYTDLRAEAQA 287 (697)
Q Consensus 209 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~ 287 (697)
+.............. ..............+++.|+|||++.+. .++.++|+|||||++|+|++|.+||.+.+.....
T Consensus 166 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~ 243 (335)
T PTZ00024 166 ARRYGYPPYSDTLSK--DETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQL 243 (335)
T ss_pred eeecccccccccccc--cccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 875542110000000 0000001112234578899999998764 4688999999999999999999999887655544
Q ss_pred HHHHhccccHHH--HHHHHHhCC-------CCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 288 HTVLEMNYTEQQ--LTAAVVSGG-------LRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 288 ~~~~~~~~~~~~--~~~~~~~~~-------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
..+......... +........ ..+.........+.++.+++.+||+.+|++|||+++++.|.|+.
T Consensus 244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~ 317 (335)
T PTZ00024 244 GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFK 317 (335)
T ss_pred HHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccC
Confidence 443321111100 000000000 00111112235678899999999999999999999999988884
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=300.45 Aligned_cols=252 Identities=27% Similarity=0.397 Sum_probs=202.9
Q ss_pred cccCCceEEEEEEE--CCeeEEEEeccCCCh---HHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEeecCCCCH
Q 005427 74 IARGAESVVYEATL--DGRKVAVKKPILSTS---EELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNL 148 (697)
Q Consensus 74 lg~G~~g~V~~~~~--~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L 148 (697)
||.|+||.||++.+ +++.+++|....... .....+.+|++++++++||||+++++.+.....+++++||+.+++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 68999999999987 488999998654433 3466789999999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhcccccCCCC
Q 005427 149 AEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK 228 (697)
Q Consensus 149 ~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~ 228 (697)
.+++.... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++......... ..
T Consensus 81 ~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~--------~~ 151 (265)
T cd05579 81 ASLLENVG-SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQI--------NL 151 (265)
T ss_pred HHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccc--------cc
Confidence 99997655 7899999999999999999999999999999999999999999999999998654321100 00
Q ss_pred CCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHHHHHHHhCC
Q 005427 229 PTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGG 308 (697)
Q Consensus 229 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (697)
+..........++..|++||.+.+...+.++|+||||+++|++++|..||...........+.. +.
T Consensus 152 ~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--------------~~ 217 (265)
T cd05579 152 NDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILN--------------GK 217 (265)
T ss_pred ccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc--------------CC
Confidence 0111123345688899999999888889999999999999999999999987654433333221 11
Q ss_pred CCCcccccccCChHHHHHHHHHhccCCCCCCCCH---HHHHHHHHH
Q 005427 309 LRPILASLELGLPASILSLIQRCWDGNPHNRPSF---SDIALELDL 351 (697)
Q Consensus 309 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~---~ell~~l~~ 351 (697)
.. . + ....++..+.+++.+||+.+|.+|||+ .+++++.|+
T Consensus 218 ~~-~-~-~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~ 260 (265)
T cd05579 218 IE-W-P-EDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFF 260 (265)
T ss_pred cC-C-C-ccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccc
Confidence 11 0 1 011248999999999999999999999 888877665
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=303.99 Aligned_cols=266 Identities=28% Similarity=0.337 Sum_probs=208.5
Q ss_pred cccccccccCCceEEEEEEE--CCeeEEEEeccCCC--hHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEeec
Q 005427 68 YTLLSPIARGAESVVYEATL--DGRKVAVKKPILST--SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFY 143 (697)
Q Consensus 68 y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 143 (697)
|++.+.||+|+||.||+|.. +++.+++|...... ......+..|+.+++.++||||+++++++.....+++|+||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 67788999999999999987 47899999866543 223467788999999999999999999999999999999999
Q ss_pred CCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhcccc
Q 005427 144 ESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNW 223 (697)
Q Consensus 144 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~ 223 (697)
.+ +|.+++......+++.+++.++.|++.||+|||+.||+||||+|+||+++.++.+||+|||++........
T Consensus 81 ~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~------ 153 (282)
T cd07829 81 DM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR------ 153 (282)
T ss_pred Cc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc------
Confidence 84 89999987645789999999999999999999999999999999999999999999999999865432110
Q ss_pred cCCCCCCCCccccccccCccccchhhhccc-CCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHHHH
Q 005427 224 RSSGKPTGGFHKKNMVGTLIYMAPEILKKE-IHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTA 302 (697)
Q Consensus 224 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 302 (697)
......++..|+|||.+.+. .++.++|+|||||++|||++|.+||...........+...........+
T Consensus 154 ----------~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (282)
T cd07829 154 ----------TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESW 223 (282)
T ss_pred ----------ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHH
Confidence 11233467889999998766 7889999999999999999999999887665555444332221111111
Q ss_pred HHHhCC--CC---C-----cccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 005427 303 AVVSGG--LR---P-----ILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350 (697)
Q Consensus 303 ~~~~~~--~~---~-----~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~ 350 (697)
...... .. + ......+.++..+.++|++||..||++||++.+++.|.|
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~ 281 (282)
T cd07829 224 PGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPY 281 (282)
T ss_pred HhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcC
Confidence 000000 00 0 001112245789999999999999999999999998876
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=296.08 Aligned_cols=271 Identities=28% Similarity=0.379 Sum_probs=219.4
Q ss_pred CCcccccccccCCceEEEEEEECCeeEEEEeccCCChHHHHHHHHHHHHHHhc--CCCCceEEeeccccCC----ceEEE
Q 005427 66 SSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKL--DHPGLAKFVAAHAKPP----NYMFF 139 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~hpniv~l~~~~~~~~----~~~lv 139 (697)
...+++++||+|.||.||+|..+++.||||++.. .+.+.+.+|-+|.+.. +|+||+++++.-.... .|+||
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLV 286 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLDNRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLV 286 (534)
T ss_pred CchhhHHHhhcCccceeehhhccCceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEE
Confidence 4577899999999999999999999999998754 4566788888887765 8999999999876655 89999
Q ss_pred EeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---------CcccccCCCCceeecCCCCCeeeeeccch
Q 005427 140 FEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL---------GIVHRDVKPANVLLDRNLCPHLADFGLAE 210 (697)
Q Consensus 140 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---------~ivHrDlkp~Nill~~~~~~kL~Dfg~a~ 210 (697)
++|.+.|+|.++|... .++|....+++..+++||+|||+. .|+|||||++||||..++++.|+|||+|.
T Consensus 287 t~fh~kGsL~dyL~~n--tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl 364 (534)
T KOG3653|consen 287 TEFHPKGSLCDYLKAN--TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLAL 364 (534)
T ss_pred eeeccCCcHHHHHHhc--cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeE
Confidence 9999999999999765 689999999999999999999964 59999999999999999999999999998
Q ss_pred hhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCC------CchhhHHHHHHHHHHHHhCCCCCC-Cchh
Q 005427 211 YRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIH------SEKSDVYSFGISINELLTGVVPYT-DLRA 283 (697)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~------~~~~DiwslG~~l~ell~g~~Pf~-~~~~ 283 (697)
.+.... +. ......+||.+|||||++.+... -.+.||||+|.+||||+++..-+. +.-.
T Consensus 365 ~~~p~~------------~~--~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp 430 (534)
T KOG3653|consen 365 RLEPGK------------PQ--GDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVP 430 (534)
T ss_pred EecCCC------------CC--cchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCC
Confidence 765211 11 12345799999999999986432 136899999999999998755442 2111
Q ss_pred HH--HHHHHHhccccHHHHHHHHHhCCCCCcccccccC--ChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 005427 284 EA--QAHTVLEMNYTEQQLTAAVVSGGLRPILASLELG--LPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH 355 (697)
Q Consensus 284 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~ 355 (697)
+. -...-+....+.+++...++..+.||.++..+.. -..-+++.+..||..||+.|.|+.-+.+.++.+...
T Consensus 431 ~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~ 506 (534)
T KOG3653|consen 431 EYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMML 506 (534)
T ss_pred cccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhcc
Confidence 11 1222344556678888888999999988775543 345688999999999999999999998888877643
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=298.70 Aligned_cols=249 Identities=27% Similarity=0.344 Sum_probs=198.8
Q ss_pred CcccccccccCCceEEEEEEEC--CeeEEEEeccC---C--ChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEE
Q 005427 67 SYTLLSPIARGAESVVYEATLD--GRKVAVKKPIL---S--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFF 139 (697)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~---~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 139 (697)
+|.+.++||+|+||.||++.+. +..+++|.... . .......+..|+.+++.++||||+++++.+.+...++++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 6899999999999999999873 33444544221 1 122344577899999999999999999999999999999
Q ss_pred EeecCCCCHhhhhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhh
Q 005427 140 FEFYESRNLAEKLHV---EEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLK 216 (697)
Q Consensus 140 ~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~ 216 (697)
+||+.+++|.+++.. ....+++.+++.++.|++.||.|||+.|++|+||||+||+++. +.+||+|||++.......
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~ 159 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC 159 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCCc
Confidence 999999999988753 3346899999999999999999999999999999999999975 569999999986543211
Q ss_pred hhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhcccc
Q 005427 217 EISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYT 296 (697)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~ 296 (697)
.......|++.|+|||.+.+..++.++|+||||+++|+|++|..||...........+..
T Consensus 160 ----------------~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~---- 219 (260)
T cd08222 160 ----------------DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVE---- 219 (260)
T ss_pred ----------------ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHc----
Confidence 012234578899999999888889999999999999999999999976543332222211
Q ss_pred HHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 005427 297 EQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350 (697)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~ 350 (697)
... +..+..++.++.++|.+||+.+|++||++.++++|.|
T Consensus 220 -----------~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 259 (260)
T cd08222 220 -----------GPT---PSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPF 259 (260)
T ss_pred -----------CCC---CCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCC
Confidence 111 1234567899999999999999999999999998865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=302.36 Aligned_cols=265 Identities=26% Similarity=0.299 Sum_probs=203.8
Q ss_pred cccccccccCCceEEEEEEE--CCeeEEEEeccCCCh-HHHHHHHHHHHHHHhcC-CCCceEEeeccccCCceEEEEeec
Q 005427 68 YTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTS-EELDNFHKELQLLCKLD-HPGLAKFVAAHAKPPNYMFFFEFY 143 (697)
Q Consensus 68 y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lv~e~~ 143 (697)
|.+.+.||+|+||+||+|.. .++.|++|+...... .+.....+|+..++.++ ||||+++++++..+...++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 67889999999999999987 577899997654322 22334567999999998 999999999999999999999999
Q ss_pred CCCCHhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhccc
Q 005427 144 ESRNLAEKLHVEE-WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKN 222 (697)
Q Consensus 144 ~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 222 (697)
+|+|.+.+.... ..+++.++..++.|++.+|.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~------ 153 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP------ 153 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCC------
Confidence 779998887654 467999999999999999999999999999999999999999999999999986543210
Q ss_pred ccCCCCCCCCccccccccCccccchhhhc-ccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccH--HH
Q 005427 223 WRSSGKPTGGFHKKNMVGTLIYMAPEILK-KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTE--QQ 299 (697)
Q Consensus 223 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~--~~ 299 (697)
......++..|+|||++. +..++.++|+||||+++++|++|.+||...........+....... ..
T Consensus 154 -----------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (283)
T cd07830 154 -----------PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQD 222 (283)
T ss_pred -----------CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhh
Confidence 112346788999999885 4457889999999999999999999998776555444433221111 00
Q ss_pred HHHHH-HhCCCC--------CcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 005427 300 LTAAV-VSGGLR--------PILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350 (697)
Q Consensus 300 ~~~~~-~~~~~~--------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~ 350 (697)
+.... ...... ..+.......+..+.+++++||+.+|.+|||+.|++.+.|
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~ 282 (283)
T cd07830 223 WPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPY 282 (283)
T ss_pred hhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCC
Confidence 00000 000000 1111112234788999999999999999999999998765
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=301.89 Aligned_cols=259 Identities=26% Similarity=0.388 Sum_probs=203.8
Q ss_pred CCCCCCCcccccccccCCceEEEEEEEC--CeeEEEEeccCCC-hHHHHHHHHHHHHHHhc-CCCCceEEeeccccCCce
Q 005427 61 LHLPPSSYTLLSPIARGAESVVYEATLD--GRKVAVKKPILST-SEELDNFHKELQLLCKL-DHPGLAKFVAAHAKPPNY 136 (697)
Q Consensus 61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~ 136 (697)
+.+..++|++.+.||+|+||.||+|.+. ++.||||...... ......+..|+.++..+ .||||+++++++......
T Consensus 10 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~ 89 (296)
T cd06618 10 YPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDV 89 (296)
T ss_pred ccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeE
Confidence 3455678999999999999999999985 8899999875433 23345566777777666 599999999999999999
Q ss_pred EEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCCCceeecCCCCCeeeeeccchhhhhh
Q 005427 137 MFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHN-LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL 215 (697)
Q Consensus 137 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~ 215 (697)
+++|||+.+ +|.+++......+++..+..++.|++.||+|||+ .||+||||+|+||+++.++.+||+|||++..+...
T Consensus 90 ~~v~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~ 168 (296)
T cd06618 90 FICMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDS 168 (296)
T ss_pred EEEeeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence 999999854 7777776545578999999999999999999997 59999999999999999999999999998654321
Q ss_pred hhhhcccccCCCCCCCCccccccccCccccchhhhcccC----CCchhhHHHHHHHHHHHHhCCCCCCCchhHH-HHHHH
Q 005427 216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEI----HSEKSDVYSFGISINELLTGVVPYTDLRAEA-QAHTV 290 (697)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~-~~~~~ 290 (697)
. ......+++.|+|||.+.+.. ++.++||||||+++|+|++|..||....... ....+
T Consensus 169 ~-----------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~ 231 (296)
T cd06618 169 K-----------------AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKI 231 (296)
T ss_pred C-----------------cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHH
Confidence 1 112235788999999987553 7889999999999999999999997532221 11111
Q ss_pred HhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 005427 291 LEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL 353 (697)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~ 353 (697)
.... .+..+ ....++.++.+|+.+||..||.+||++++++.+.|...
T Consensus 232 --------------~~~~-~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 278 (296)
T cd06618 232 --------------LQEE-PPSLP-PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRR 278 (296)
T ss_pred --------------hcCC-CCCCC-CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhc
Confidence 1111 11111 11247889999999999999999999999999988754
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=331.74 Aligned_cols=145 Identities=26% Similarity=0.391 Sum_probs=131.4
Q ss_pred CCcccccccccCCceEEEEEEEC--CeeEEEEeccCC---ChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEE
Q 005427 66 SSYTLLSPIARGAESVVYEATLD--GRKVAVKKPILS---TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFF 140 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 140 (697)
++|.+.++||+|+||.||+|.+. ++.||+|++... .......+..|+.+++.++||||+++++++.....+|+||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 58999999999999999999984 889999986533 2334567899999999999999999999999999999999
Q ss_pred eecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchh
Q 005427 141 EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEY 211 (697)
Q Consensus 141 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~ 211 (697)
||+.+++|.+++...+ .+++..++.++.||+.||.|||+.+|+||||||+|||++.++.+||+|||+++.
T Consensus 84 Ey~~g~~L~~li~~~~-~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~~ 153 (669)
T cd05610 84 EYLIGGDVKSLLHIYG-YFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153 (669)
T ss_pred eCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCcc
Confidence 9999999999987554 678899999999999999999999999999999999999999999999999863
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=294.39 Aligned_cols=264 Identities=27% Similarity=0.404 Sum_probs=212.3
Q ss_pred CCCcccccccccCCceEEEEEEECCeeEEEEeccCCChHHHHHHHHHHHHHHh--cCCCCceEEeeccccC----CceEE
Q 005427 65 PSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCK--LDHPGLAKFVAAHAKP----PNYMF 138 (697)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~hpniv~l~~~~~~~----~~~~l 138 (697)
..+.++.+.||+|.||+||+|++.|+.||||++... +...+.+|.+|.+. |+|+||+.+++.-... ..+||
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwL 286 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWL 286 (513)
T ss_pred hheeEEEEEecCccccceeeccccCCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEE
Confidence 357889999999999999999999999999987544 33456777777765 5999999999876544 36899
Q ss_pred EEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC--------CcccccCCCCceeecCCCCCeeeeeccch
Q 005427 139 FFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL--------GIVHRDVKPANVLLDRNLCPHLADFGLAE 210 (697)
Q Consensus 139 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~--------~ivHrDlkp~Nill~~~~~~kL~Dfg~a~ 210 (697)
|++|-+.|+|+|+|.. ..++.+..++++..++.||++||-. .|.|||||+.|||+..++.+-|+|+|||.
T Consensus 287 vTdYHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv 364 (513)
T KOG2052|consen 287 VTDYHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 364 (513)
T ss_pred eeecccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeE
Confidence 9999999999999976 3788999999999999999999953 59999999999999999999999999997
Q ss_pred hhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCC------CchhhHHHHHHHHHHHHhC----------
Q 005427 211 YRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIH------SEKSDVYSFGISINELLTG---------- 274 (697)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~------~~~~DiwslG~~l~ell~g---------- 274 (697)
......+ .-.......+||.+|||||++..... -..+||||||.++||++.+
T Consensus 365 ~h~~~t~------------~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey 432 (513)
T KOG2052|consen 365 RHDSDTD------------TIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEY 432 (513)
T ss_pred EecccCC------------cccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhh
Confidence 6543211 11122456699999999999964321 2368999999999999853
Q ss_pred CCCCCCchhHHHHHHHHhccccHHHHHHHHHhCCCCCcccccccCCh--HHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 275 VVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLP--ASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 275 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
.+||.+. .....+.+++...+....+||.++..+...+ ..+.++|+.||..||..|.|+--+.+.+..+
T Consensus 433 ~~Pyyd~---------Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l 503 (513)
T KOG2052|consen 433 QLPYYDV---------VPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKL 503 (513)
T ss_pred cCCcccC---------CCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHH
Confidence 4677653 2234456667777777888998887665544 3577999999999999999999998888877
Q ss_pred HH
Q 005427 353 LE 354 (697)
Q Consensus 353 ~~ 354 (697)
.+
T Consensus 504 ~~ 505 (513)
T KOG2052|consen 504 SN 505 (513)
T ss_pred hc
Confidence 64
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=305.33 Aligned_cols=266 Identities=24% Similarity=0.325 Sum_probs=203.6
Q ss_pred CCCcccccccccCCceEEEEEEE--CCeeEEEEeccCC--ChHHHHHHHHHHHHHHhcCCCCceEEeecccc-CCceEEE
Q 005427 65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAK-PPNYMFF 139 (697)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~~lv 139 (697)
..+|++.+.||+|+||.||++.+ +++.||+|++... .......+.+|+.+++.++||||+++++++.. ....+++
T Consensus 9 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv 88 (328)
T cd07856 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFV 88 (328)
T ss_pred ccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEE
Confidence 46799999999999999999986 5788999975432 22335678899999999999999999998865 4578899
Q ss_pred EeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhh
Q 005427 140 FEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEIS 219 (697)
Q Consensus 140 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~ 219 (697)
+||+. ++|..++... .+++..+..++.|++.||.|||+.+|+||||+|+||+++.++.+||+|||++.....
T Consensus 89 ~e~~~-~~L~~~~~~~--~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~----- 160 (328)
T cd07856 89 TELLG-TDLHRLLTSR--PLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP----- 160 (328)
T ss_pred eehhc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC-----
Confidence 99984 5888887543 578888999999999999999999999999999999999999999999999864321
Q ss_pred cccccCCCCCCCCccccccccCccccchhhhcc-cCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccc-cH
Q 005427 220 LKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNY-TE 297 (697)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~-~~ 297 (697)
......+++.|+|||++.+ ..++.++|+|||||++|+|++|..||...........+.+... ..
T Consensus 161 --------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~ 226 (328)
T cd07856 161 --------------QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPP 226 (328)
T ss_pred --------------CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 1223467889999998765 5689999999999999999999999987654333222221111 01
Q ss_pred HHHHHHHHhC-----------CCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 298 QQLTAAVVSG-----------GLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 298 ~~~~~~~~~~-----------~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
.+.......+ ..........+.++.++.++|.+||+.+|++|||+++++.+.|..
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~ 292 (328)
T cd07856 227 DDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLA 292 (328)
T ss_pred HHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccc
Confidence 1111000000 000011112245789999999999999999999999999888774
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=302.13 Aligned_cols=254 Identities=25% Similarity=0.359 Sum_probs=201.3
Q ss_pred CcccccccccCCceEEEEEEE-----CCeeEEEEeccCCC----hHHHHHHHHHHHHHHhc-CCCCceEEeeccccCCce
Q 005427 67 SYTLLSPIARGAESVVYEATL-----DGRKVAVKKPILST----SEELDNFHKELQLLCKL-DHPGLAKFVAAHAKPPNY 136 (697)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~-----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~ 136 (697)
.|++.+.||.|+||.||++.. +++.||+|.+.... ....+.+.+|+.+++.+ +||||+++++.+.....+
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 488999999999999999975 57889999865322 22346778999999999 599999999999999999
Q ss_pred EEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhh
Q 005427 137 MFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLK 216 (697)
Q Consensus 137 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~ 216 (697)
++||||+++++|.+++.... .+++..+..++.|++.||.|||+.|++||||+|+|||++.++.+||+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 159 (290)
T cd05613 81 HLILDYINGGELFTHLSQRE-RFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDE 159 (290)
T ss_pred EEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceeccccc
Confidence 99999999999999987654 67889999999999999999999999999999999999999999999999986543211
Q ss_pred hhhcccccCCCCCCCCccccccccCccccchhhhccc--CCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhcc
Q 005427 217 EISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKE--IHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMN 294 (697)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~ 294 (697)
. .......|+..|+|||.+.+. .++.++||||||+++|+|++|..||..........
T Consensus 160 ~---------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~------ 218 (290)
T cd05613 160 V---------------ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQA------ 218 (290)
T ss_pred c---------------cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHH------
Confidence 0 012235688999999998753 46789999999999999999999996432111111
Q ss_pred ccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCC-----CHHHHHHHHHH
Q 005427 295 YTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRP-----SFSDIALELDL 351 (697)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~ell~~l~~ 351 (697)
......... . +..+..+++.+.+++++||+.||.+|| ++++++.|.+.
T Consensus 219 ----~~~~~~~~~--~---~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~ 271 (290)
T cd05613 219 ----EISRRILKS--E---PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFF 271 (290)
T ss_pred ----HHHHHhhcc--C---CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCccc
Confidence 111111111 1 123456889999999999999999997 78888877665
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=311.06 Aligned_cols=241 Identities=24% Similarity=0.306 Sum_probs=201.1
Q ss_pred CCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCChHHHHHHHHHHHHHHhc-CCCCceEEeeccccCCceEEEEe
Q 005427 65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKL-DHPGLAKFVAAHAKPPNYMFFFE 141 (697)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e 141 (697)
...|.+...+|.|+|+.|-.+.+ +++..++|++... .....+|+.++... +||||+++.+.+.+..+.|+|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccc----ccccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 46799999999999999999976 6788999986544 12234677666555 79999999999999999999999
Q ss_pred ecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceee-cCCCCCeeeeeccchhhhhhhhhhc
Q 005427 142 FYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLL-DRNLCPHLADFGLAEYRENLKEISL 220 (697)
Q Consensus 142 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill-~~~~~~kL~Dfg~a~~~~~~~~~~~ 220 (697)
.+.|+.+.+.+.... .+. .++..|+.+|+.|+.|||++|++||||||+|||+ +..++++|+|||.++..+..
T Consensus 397 ~l~g~ell~ri~~~~-~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~----- 469 (612)
T KOG0603|consen 397 LLDGGELLRRIRSKP-EFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS----- 469 (612)
T ss_pred hccccHHHHHHHhcc-hhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh-----
Confidence 999999988876554 333 7788899999999999999999999999999999 68999999999999766531
Q ss_pred ccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhH-HHHHHHHhccccHHH
Q 005427 221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAE-AQAHTVLEMNYTEQQ 299 (697)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~-~~~~~~~~~~~~~~~ 299 (697)
..+.+-|..|.|||++....|+.++||||||++||+||+|..||...... +...++...
T Consensus 470 --------------~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~------ 529 (612)
T KOG0603|consen 470 --------------CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMP------ 529 (612)
T ss_pred --------------hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCC------
Confidence 22446788999999999999999999999999999999999999865544 222222111
Q ss_pred HHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 005427 300 LTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL 351 (697)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~ 351 (697)
.....+|.++++|+.+||+.||.+||++.++..|.|+
T Consensus 530 ---------------~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 530 ---------------KFSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred ---------------ccccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 1125689999999999999999999999999999998
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=298.10 Aligned_cols=266 Identities=26% Similarity=0.337 Sum_probs=206.6
Q ss_pred CCCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCChH-------HHHHHHHHHHHHHhcCCCCceEEeeccc-c
Q 005427 63 LPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSE-------ELDNFHKELQLLCKLDHPGLAKFVAAHA-K 132 (697)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~hpniv~l~~~~~-~ 132 (697)
...++|.++.+||+|||+.||+|.+ ..+.||||+..+...- -.+...+|.+|.+.|.||.||++|++|. +
T Consensus 460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD 539 (775)
T KOG1151|consen 460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD 539 (775)
T ss_pred chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence 4567899999999999999999976 6788999986554321 1345788999999999999999999986 4
Q ss_pred CCceEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC--CcccccCCCCceee---cCCCCCeeeeec
Q 005427 133 PPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL--GIVHRDVKPANVLL---DRNLCPHLADFG 207 (697)
Q Consensus 133 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~--~ivHrDlkp~Nill---~~~~~~kL~Dfg 207 (697)
...+|-|+|||+|.+|.-+|+... .+++.+++.|+-||+.||.||.+. .|+|-||||.|||+ +..|.+||+|||
T Consensus 540 tdsFCTVLEYceGNDLDFYLKQhk-lmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFG 618 (775)
T KOG1151|consen 540 TDSFCTVLEYCEGNDLDFYLKQHK-LMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFG 618 (775)
T ss_pred cccceeeeeecCCCchhHHHHhhh-hhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecc
Confidence 577999999999999988887655 789999999999999999999977 59999999999999 346889999999
Q ss_pred cchhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhccc----CCCchhhHHHHHHHHHHHHhCCCCCCCchh
Q 005427 208 LAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKE----IHSEKSDVYSFGISINELLTGVVPYTDLRA 283 (697)
Q Consensus 208 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwslG~~l~ell~g~~Pf~~~~~ 283 (697)
+++.+++....+ ..+-.-+....||.+|++||++.-. ..+.++||||+||+||..+.|+.||.....
T Consensus 619 LSKIMdddSy~~---------vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs 689 (775)
T KOG1151|consen 619 LSKIMDDDSYNS---------VDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS 689 (775)
T ss_pred hhhhccCCccCc---------ccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh
Confidence 999988643321 1111234567899999999987532 367899999999999999999999976432
Q ss_pred HHHHHHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 005427 284 EAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL 351 (697)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~ 351 (697)
. +.|++.+- +. .. ..-.++ ..+.++.+..+||++||.+.-+.|.+..++..+.-.
T Consensus 690 Q---QdILqeNT----Il----kA-tEVqFP-~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyl 744 (775)
T KOG1151|consen 690 Q---QDILQENT----IL----KA-TEVQFP-PKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYL 744 (775)
T ss_pred H---HHHHhhhc----hh----cc-eeccCC-CCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccc
Confidence 2 22221110 00 00 000011 124688999999999999999999999988765443
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=313.32 Aligned_cols=271 Identities=25% Similarity=0.396 Sum_probs=203.2
Q ss_pred cccccccccCCceEEEEEEE--CCeeEEEEeccCC-ChHHHHHHHHHHHHHHhcCCCCceEEeeccccCC------ceEE
Q 005427 68 YTLLSPIARGAESVVYEATL--DGRKVAVKKPILS-TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPP------NYMF 138 (697)
Q Consensus 68 y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~------~~~l 138 (697)
+...+.||+|+||.||++++ +|+.||||..... .....+...+|+++|++|+|||||+++++-++.. ...+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 55678999999999999986 7999999976543 3445778899999999999999999999876543 5789
Q ss_pred EEeecCCCCHhhhhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeec--CCC--CCeeeeeccchhh
Q 005427 139 FFEFYESRNLAEKLHVE--EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLD--RNL--CPHLADFGLAEYR 212 (697)
Q Consensus 139 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~--~~~--~~kL~Dfg~a~~~ 212 (697)
+||||.||+|...|... ...+++.+.+.++.++..||.|||++||+||||||.||++- .+| .-||+|||.|+.+
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel 174 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAREL 174 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccccC
Confidence 99999999999999754 34689999999999999999999999999999999999982 333 4699999999876
Q ss_pred hhhhhhhcccccCCCCCCCCccccccccCccccchhhhcc-cCCCchhhHHHHHHHHHHHHhCCCCCCCchhHH----HH
Q 005427 213 ENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLTGVVPYTDLRAEA----QA 287 (697)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~----~~ 287 (697)
.+.. ...+.+||+.|.+||++.. ..|+..+|.|||||++|+++||..||-...... ..
T Consensus 175 ~d~s-----------------~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~ 237 (732)
T KOG4250|consen 175 DDNS-----------------LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIM 237 (732)
T ss_pred CCCC-----------------eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhh
Confidence 6422 3567899999999999984 888999999999999999999999996543321 22
Q ss_pred HHHHhccccHHHHHHH-HHhC-----CCCCcccccccCChHHHHHHHHHhccCCCCCCC--CHHHHHHHHHHHHHH
Q 005427 288 HTVLEMNYTEQQLTAA-VVSG-----GLRPILASLELGLPASILSLIQRCWDGNPHNRP--SFSDIALELDLVLEH 355 (697)
Q Consensus 288 ~~~~~~~~~~~~~~~~-~~~~-----~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp--t~~ell~~l~~~~~~ 355 (697)
..+............. ..++ ..-|....+...+-..+-..+..+|..+|.+|. .+.+.-..+..++..
T Consensus 238 ~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~ 313 (732)
T KOG4250|consen 238 WHIITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNL 313 (732)
T ss_pred hhhhccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhh
Confidence 2222111110000000 0000 001111111122223345778889999999999 888888788877754
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=291.84 Aligned_cols=241 Identities=26% Similarity=0.358 Sum_probs=201.0
Q ss_pred cccCCceEEEEEEE--CCeeEEEEeccCCC---hHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEeecCCCCH
Q 005427 74 IARGAESVVYEATL--DGRKVAVKKPILST---SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNL 148 (697)
Q Consensus 74 lg~G~~g~V~~~~~--~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L 148 (697)
||+|+||.||++.. .++.+++|...... ......+..|+.+++.++||||+++++.+..+...+++|||+.+++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 79999999999987 47899999765432 23466889999999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhcccccCCCC
Q 005427 149 AEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK 228 (697)
Q Consensus 149 ~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~ 228 (697)
.+++.... .+++..++.++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~------------ 147 (250)
T cd05123 81 FSHLSKEG-RFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG------------ 147 (250)
T ss_pred HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCC------------
Confidence 99987654 68899999999999999999999999999999999999999999999999986543211
Q ss_pred CCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHHHHHHHhCC
Q 005427 229 PTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGG 308 (697)
Q Consensus 229 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (697)
.......++..|++||.+.+...+.++|+||||+++|++++|..||...........+.. .
T Consensus 148 ----~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--------------~- 208 (250)
T cd05123 148 ----SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK--------------D- 208 (250)
T ss_pred ----CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc--------------C-
Confidence 012345688899999999888889999999999999999999999976654332222221 1
Q ss_pred CCCcccccccCChHHHHHHHHHhccCCCCCCCCH---HHHHHHHH
Q 005427 309 LRPILASLELGLPASILSLIQRCWDGNPHNRPSF---SDIALELD 350 (697)
Q Consensus 309 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~---~ell~~l~ 350 (697)
. ...+...+..+.+++++||..||++||++ +++++|.|
T Consensus 209 -~---~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~ 249 (250)
T cd05123 209 -P---LRFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPF 249 (250)
T ss_pred -C---CCCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCC
Confidence 0 12344568999999999999999999999 78877654
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=298.95 Aligned_cols=248 Identities=25% Similarity=0.355 Sum_probs=196.1
Q ss_pred CcccccccccCCceEEEEEEE-----CCeeEEEEeccCCC----hHHHHHHHHHHHHHHhc-CCCCceEEeeccccCCce
Q 005427 67 SYTLLSPIARGAESVVYEATL-----DGRKVAVKKPILST----SEELDNFHKELQLLCKL-DHPGLAKFVAAHAKPPNY 136 (697)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~-----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~ 136 (697)
+|++.+.||+|+||.||++.. +++.||+|...... ......+.+|+.++.++ +||||+++++.+.....+
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 488999999999999999874 45789999765322 22345688999999999 599999999999999999
Q ss_pred EEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhh
Q 005427 137 MFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLK 216 (697)
Q Consensus 137 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~ 216 (697)
++||||+.+++|.+.+.... .+++..++.++.|++.+|.|||+.+++||||||+||+++.++.++|+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 159 (288)
T cd05583 81 HLILDYVNGGELFTHLYQRE-HFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEE 159 (288)
T ss_pred EEEEecCCCCcHHHHHhhcC-CcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccccccccc
Confidence 99999999999999987543 68899999999999999999999999999999999999999999999999986543211
Q ss_pred hhhcccccCCCCCCCCccccccccCccccchhhhcccC--CCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhcc
Q 005427 217 EISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEI--HSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMN 294 (697)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~ 294 (697)
........|++.|+|||.+.+.. .+.++|+||||+++|+|++|..||.........
T Consensus 160 ---------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~------- 217 (288)
T cd05583 160 ---------------EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQ------- 217 (288)
T ss_pred ---------------ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchH-------
Confidence 01122356889999999987655 688999999999999999999999643211111
Q ss_pred ccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHH
Q 005427 295 YTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345 (697)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~el 345 (697)
.......... . ...+..++..+.+++.+||+.||++|||+.++
T Consensus 218 ---~~~~~~~~~~-~----~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~ 260 (288)
T cd05583 218 ---SEISRRILKS-K----PPFPKTMSAEARDFIQKLLEKDPKKRLGANGA 260 (288)
T ss_pred ---HHHHHHHHcc-C----CCCCcccCHHHHHHHHHHhcCCHhhccCcchH
Confidence 1111111111 1 12344578899999999999999999996554
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=288.48 Aligned_cols=267 Identities=20% Similarity=0.281 Sum_probs=204.7
Q ss_pred CCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCChHHHHHHHHHHHHHHhcC--CC----CceEEeeccccCCc
Q 005427 64 PPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLD--HP----GLAKFVAAHAKPPN 135 (697)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--hp----niv~l~~~~~~~~~ 135 (697)
...+|.+++++|+|.||.|-.+.+ .+..||||++..- ..-.+..+-|+++|.++. -| -++.+.++|...++
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh 165 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH 165 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence 357899999999999999999976 4678999975432 233566778999999993 23 37888899999999
Q ss_pred eEEEEeecCCCCHhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecC-----------------
Q 005427 136 YMFFFEFYESRNLAEKLHVEE-WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDR----------------- 197 (697)
Q Consensus 136 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~----------------- 197 (697)
.|+|+|.+ |-++++++..++ .+++.+.+..|+.|++++++|||+.+++|.||||+|||+..
T Consensus 166 iCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r 244 (415)
T KOG0671|consen 166 ICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIR 244 (415)
T ss_pred eEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccceec
Confidence 99999988 459999998754 46789999999999999999999999999999999999831
Q ss_pred ---CCCCeeeeeccchhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhC
Q 005427 198 ---NLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTG 274 (697)
Q Consensus 198 ---~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g 274 (697)
+..+||+|||.|++... .-...+.|..|+|||++.+-+++.++||||+||+|+|+++|
T Consensus 245 ~~ks~~I~vIDFGsAtf~~e-------------------~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG 305 (415)
T KOG0671|consen 245 PLKSTAIKVIDFGSATFDHE-------------------HHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTG 305 (415)
T ss_pred cCCCcceEEEecCCcceecc-------------------CcceeeeccccCCchheeccCcCCccCceeeeeEEEEeecc
Confidence 34579999999976542 12456889999999999999999999999999999999999
Q ss_pred CCCCCCchhHH---HHHHHHhccccHHHHHHHH------HhCC------------------CCCccccc--ccCChHHHH
Q 005427 275 VVPYTDLRAEA---QAHTVLEMNYTEQQLTAAV------VSGG------------------LRPILASL--ELGLPASIL 325 (697)
Q Consensus 275 ~~Pf~~~~~~~---~~~~~~~~~~~~~~~~~~~------~~~~------------------~~~~~~~~--~~~~~~~l~ 325 (697)
..-|..-++.+ +...++. ..+. ....+. ..+. .+|.-... ....-.+|.
T Consensus 306 ~~LFqtHen~EHLaMMerIlG-p~P~-~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~Lf 383 (415)
T KOG0671|consen 306 ETLFQTHENLEHLAMMERILG-PIPS-RMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLF 383 (415)
T ss_pred ceecccCCcHHHHHHHHHhhC-CCcH-HHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHH
Confidence 99998765444 3333333 2111 111111 0000 11100000 011234688
Q ss_pred HHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 005427 326 SLIQRCWDGNPHNRPSFSDIALELDLVL 353 (697)
Q Consensus 326 ~li~~~l~~dP~~Rpt~~ell~~l~~~~ 353 (697)
+||++||.+||.+|+|+.|++.|+++..
T Consensus 384 DLl~~mL~fDP~~RiTl~EAL~HpFF~~ 411 (415)
T KOG0671|consen 384 DLLRRMLEFDPARRITLREALSHPFFAR 411 (415)
T ss_pred HHHHHHHccCccccccHHHHhcCHHhhc
Confidence 9999999999999999999999988753
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=319.27 Aligned_cols=262 Identities=30% Similarity=0.444 Sum_probs=216.7
Q ss_pred cCCCCCCCcccccccccCCceEEEEEEEC---------CeeEEEEeccCC-ChHHHHHHHHHHHHHHhc-CCCCceEEee
Q 005427 60 PLHLPPSSYTLLSPIARGAESVVYEATLD---------GRKVAVKKPILS-TSEELDNFHKELQLLCKL-DHPGLAKFVA 128 (697)
Q Consensus 60 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~---------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~l~~ 128 (697)
.++++.++..+.+.||+|.||.|++|... ...||||..... ...+.+.+..|+++|+.+ .||||+.+++
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 78888888899999999999999999642 346899976543 335678899999999999 6999999999
Q ss_pred ccccCCceEEEEeecCCCCHhhhhhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCce
Q 005427 129 AHAKPPNYMFFFEFYESRNLAEKLHVEE---------------WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANV 193 (697)
Q Consensus 129 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Ni 193 (697)
++......++|+||+..|+|.++++..+ ..++....+.++.||+.|++||++..++||||-.+||
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNV 449 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNV 449 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhE
Confidence 9999999999999999999999998766 3488899999999999999999999999999999999
Q ss_pred eecCCCCCeeeeeccchhhhhhhhhhcccccCCCCCCCCccccccc--cCccccchhhhcccCCCchhhHHHHHHHHHHH
Q 005427 194 LLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMV--GTLIYMAPEILKKEIHSEKSDVYSFGISINEL 271 (697)
Q Consensus 194 ll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el 271 (697)
|+..+..+||+|||+++....... +...... -+..|||||.+....|+.++||||+|++|||+
T Consensus 450 Li~~~~~~kIaDFGlar~~~~~~~---------------y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~Ei 514 (609)
T KOG0200|consen 450 LITKNKVIKIADFGLARDHYNKDY---------------YRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEI 514 (609)
T ss_pred EecCCCEEEEccccceeccCCCCc---------------eEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHH
Confidence 999999999999999975443211 1112222 24569999999999999999999999999999
Q ss_pred Hh-CCCCCCCch-hHHHHHHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 005427 272 LT-GVVPYTDLR-AEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALEL 349 (697)
Q Consensus 272 l~-g~~Pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l 349 (697)
++ |..||.+.. ...... . ...+.|. ..|..+++++.++|+.||+.+|++||+|.++.+.+
T Consensus 515 fsLG~~PYp~~~~~~~l~~-~--------------l~~G~r~---~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~ 576 (609)
T KOG0200|consen 515 FTLGGTPYPGIPPTEELLE-F--------------LKEGNRM---EQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFF 576 (609)
T ss_pred hhCCCCCCCCCCcHHHHHH-H--------------HhcCCCC---CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHH
Confidence 99 999998743 222211 1 1223332 23457899999999999999999999999999988
Q ss_pred HHHHH
Q 005427 350 DLVLE 354 (697)
Q Consensus 350 ~~~~~ 354 (697)
...+.
T Consensus 577 ~~~l~ 581 (609)
T KOG0200|consen 577 EKHLQ 581 (609)
T ss_pred HHHHH
Confidence 88553
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=286.96 Aligned_cols=226 Identities=22% Similarity=0.170 Sum_probs=183.4
Q ss_pred CCceEEEEEEE--CCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEeecCCCCHhhhhhh
Q 005427 77 GAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHV 154 (697)
Q Consensus 77 G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~ 154 (697)
|.||.||++++ +++.+|+|++.... .+.+|...+....||||+++++++.....++++|||+.+|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 89999999987 67889999865432 233455556667899999999999999999999999999999999875
Q ss_pred cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhcccccCCCCCCCCcc
Q 005427 155 EEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFH 234 (697)
Q Consensus 155 ~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (697)
.. .+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||.+......
T Consensus 79 ~~-~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~------------------- 138 (237)
T cd05576 79 FL-NIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS------------------- 138 (237)
T ss_pred hc-CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc-------------------
Confidence 54 5889999999999999999999999999999999999999999999999987544320
Q ss_pred ccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHHHHHHHhCCCCCccc
Q 005427 235 KKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILA 314 (697)
Q Consensus 235 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (697)
.....++..|+|||.+.+..++.++|+||+|+++|+|++|..||........ .... .
T Consensus 139 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~--------------------~~~~---~ 195 (237)
T cd05576 139 CDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN--------------------THTT---L 195 (237)
T ss_pred cccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc--------------------cccc---c
Confidence 1223456789999999888889999999999999999999988754211100 0000 1
Q ss_pred ccccCChHHHHHHHHHhccCCCCCCCCH-----HHHHHHHH
Q 005427 315 SLELGLPASILSLIQRCWDGNPHNRPSF-----SDIALELD 350 (697)
Q Consensus 315 ~~~~~~~~~l~~li~~~l~~dP~~Rpt~-----~ell~~l~ 350 (697)
..+..+++.+.++|.+||+.||++||++ +++++|.|
T Consensus 196 ~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~ 236 (237)
T cd05576 196 NIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPF 236 (237)
T ss_pred CCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCC
Confidence 1334678999999999999999999996 77776654
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=303.41 Aligned_cols=257 Identities=24% Similarity=0.353 Sum_probs=216.5
Q ss_pred CCcccccccccCCceEEEEEEE--CCe----eEEEEeccCCC-hHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEE
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGR----KVAVKKPILST-SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMF 138 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 138 (697)
...+..++||.|+||+||+|.+ +++ +||+|++.... .+....+..|+-+|.+|+|||+++|++++.... ..|
T Consensus 696 telkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~ql 774 (1177)
T KOG1025|consen 696 TELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQL 774 (1177)
T ss_pred hhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHH
Confidence 4567788999999999999987 333 58888765443 344678999999999999999999999998765 889
Q ss_pred EEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhh
Q 005427 139 FFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI 218 (697)
Q Consensus 139 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~ 218 (697)
|++|+++|+|.++++..+..+.....+.++.||+.||.|||++.++||||-.+|||+..-.++|+.|||+++......
T Consensus 775 vtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~-- 852 (1177)
T KOG1025|consen 775 VTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE-- 852 (1177)
T ss_pred HHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCccc--
Confidence 999999999999999988889999999999999999999999999999999999999999999999999998765311
Q ss_pred hcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCCchhHHHHHHHHhccccH
Q 005427 219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTE 297 (697)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~ 297 (697)
..+......-.+-|||-|.+....|+.++|||||||++||++| |..|+.+....++-..+....
T Consensus 853 ------------~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~ge--- 917 (1177)
T KOG1025|consen 853 ------------KEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGE--- 917 (1177)
T ss_pred ------------ccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccc---
Confidence 1222334445778999999999999999999999999999999 999999987666544332211
Q ss_pred HHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 005427 298 QQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH 355 (697)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~ 355 (697)
| -..|+.++-++..+|.+||..|+..||+|+++...+..+...
T Consensus 918 ------------R---LsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard 960 (1177)
T KOG1025|consen 918 ------------R---LSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD 960 (1177)
T ss_pred ------------c---CCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence 1 123567999999999999999999999999999888777643
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=297.57 Aligned_cols=271 Identities=22% Similarity=0.307 Sum_probs=211.7
Q ss_pred CCCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCC---hHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceE
Q 005427 63 LPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST---SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYM 137 (697)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 137 (697)
.+.+-|..++.||-|+||+|.+++. +...+|.|.+...+ ......++.|-+||.....+-||+||..|.+.+.+|
T Consensus 626 MdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLY 705 (1034)
T KOG0608|consen 626 MDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLY 705 (1034)
T ss_pred ccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceE
Confidence 3455688899999999999999975 56678998654332 234567889999999999999999999999999999
Q ss_pred EEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhh---h
Q 005427 138 FFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRE---N 214 (697)
Q Consensus 138 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~---~ 214 (697)
+||+|++||++..+|-+.+ -|.++.+++++.++..|+++.|..|+|||||||+|||||.+|++||+|||||+-+. +
T Consensus 706 FVMdYIPGGDmMSLLIrmg-IFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHd 784 (1034)
T KOG0608|consen 706 FVMDYIPGGDMMSLLIRMG-IFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 784 (1034)
T ss_pred EEEeccCCccHHHHHHHhc-cCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceeccc
Confidence 9999999999999998776 68899999999999999999999999999999999999999999999999996332 1
Q ss_pred hhhhh---------ccc---ccCCCCC-----------CCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHH
Q 005427 215 LKEIS---------LKN---WRSSGKP-----------TGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINEL 271 (697)
Q Consensus 215 ~~~~~---------~~~---~~~~~~~-----------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el 271 (697)
.+... ++. |...+.. .........+||+.|+|||++....|+..+|+||.||+||||
T Consensus 785 skYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em 864 (1034)
T KOG0608|consen 785 SKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEM 864 (1034)
T ss_pred cccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHH
Confidence 11110 110 1111111 011123457999999999999999999999999999999999
Q ss_pred HhCCCCCCCchhHHHHHHHHhccccHHHHHHHHHhCCCCCcccc-cccCChHHHHHHHHHhccCCCCCCC---CHHHHHH
Q 005427 272 LTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILAS-LELGLPASILSLIQRCWDGNPHNRP---SFSDIAL 347 (697)
Q Consensus 272 l~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dP~~Rp---t~~ell~ 347 (697)
+.|++||..........+++++... +.- ....+++++.++|.++. -+++.|. .++||..
T Consensus 865 ~~g~~pf~~~tp~~tq~kv~nw~~~----------------l~~~~~~~ls~e~~~li~kLc-~sad~RLGkng~d~vKa 927 (1034)
T KOG0608|consen 865 LVGQPPFLADTPGETQYKVINWRNF----------------LHIPYQGNLSKEALDLIQKLC-CSADSRLGKNGADQVKA 927 (1034)
T ss_pred hhCCCCccCCCCCcceeeeeehhhc----------------cccccccccCHHHHHHHHHHh-cChhhhhcccchhhhhc
Confidence 9999999988777766666543211 111 12468999999998754 4577775 3566777
Q ss_pred HHHH
Q 005427 348 ELDL 351 (697)
Q Consensus 348 ~l~~ 351 (697)
|.++
T Consensus 928 HpfF 931 (1034)
T KOG0608|consen 928 HPFF 931 (1034)
T ss_pred Cccc
Confidence 7665
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=258.70 Aligned_cols=265 Identities=21% Similarity=0.329 Sum_probs=203.8
Q ss_pred CCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCChHHHHHHHHHHHHHHhcC-CCCceEEeeccccCC--ceEEE
Q 005427 65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLD-HPGLAKFVAAHAKPP--NYMFF 139 (697)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~--~~~lv 139 (697)
.++|++.+++|+|.|++||.|.. ++++++||++..- ..+.+.+|+.||..|. ||||++|+++..++. .+.++
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 36899999999999999999984 7788999976433 3457889999999996 999999999998864 57899
Q ss_pred EeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCC-CCCeeeeeccchhhhhhhhh
Q 005427 140 FEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRN-LCPHLADFGLAEYRENLKEI 218 (697)
Q Consensus 140 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~-~~~kL~Dfg~a~~~~~~~~~ 218 (697)
+||+.+.+...+.. .++.-.+..++.+++.||.|||++||.|||+||.|++||.. -.++|+|+|+|.++.....
T Consensus 114 FE~v~n~Dfk~ly~----tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~e- 188 (338)
T KOG0668|consen 114 FEYVNNTDFKQLYP----TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE- 188 (338)
T ss_pred hhhhccccHHHHhh----hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCCce-
Confidence 99999877665543 46677899999999999999999999999999999999874 5689999999987753222
Q ss_pred hcccccCCCCCCCCccccccccCccccchhhhcc-cCCCchhhHHHHHHHHHHHHhCCCCC-CCchhHHHHHHHHhcccc
Q 005427 219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLTGVVPY-TDLRAEAQAHTVLEMNYT 296 (697)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~ell~g~~Pf-~~~~~~~~~~~~~~~~~~ 296 (697)
....+.+..|--||.+.. ..|+.+-|+|||||+|..|+..+-|| .+.++..++-+|.....+
T Consensus 189 ----------------YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt 252 (338)
T KOG0668|consen 189 ----------------YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGT 252 (338)
T ss_pred ----------------eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhCh
Confidence 334567788899999875 55889999999999999999987776 455555555555443322
Q ss_pred HHHH-------------HHHHHhCCCCC----ccccccc-CChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 005427 297 EQQL-------------TAAVVSGGLRP----ILASLEL-GLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL 353 (697)
Q Consensus 297 ~~~~-------------~~~~~~~~~~~----~~~~~~~-~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~ 353 (697)
.+-. ...+.....+. ++..-.. -.++++.+|+.++|.+|-.+|+|+.|.+.|+.+.-
T Consensus 253 ~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~ 327 (338)
T KOG0668|consen 253 DELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAP 327 (338)
T ss_pred HHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHH
Confidence 2111 11111111111 1111112 25699999999999999999999999999988754
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=301.43 Aligned_cols=256 Identities=23% Similarity=0.354 Sum_probs=210.9
Q ss_pred CCCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCChHHHHHHHHHHHHHHhc-CCCCceEEeecccc-----CC
Q 005427 63 LPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKL-DHPGLAKFVAAHAK-----PP 134 (697)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~-----~~ 134 (697)
.+...|++.+.||.|.+|.||+++. .++..|+|+....... .+.+..|.++|+.+ .|||++.++++|.. ++
T Consensus 16 dp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~-deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~D 94 (953)
T KOG0587|consen 16 DPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE-EEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGD 94 (953)
T ss_pred CCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc-cHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCC
Confidence 3446799999999999999999864 7889999987655433 35677899999998 69999999999853 56
Q ss_pred ceEEEEeecCCCCHhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhh
Q 005427 135 NYMFFFEFYESRNLAEKLHVE-EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRE 213 (697)
Q Consensus 135 ~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~ 213 (697)
.+|||||||.||+..|+++.. +.++.|+.+..|++.++.|+.+||...++|||||-.|||++.++.|||+|||++..+.
T Consensus 95 qLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQld 174 (953)
T KOG0587|consen 95 QLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 174 (953)
T ss_pred eEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeeee
Confidence 899999999999999998643 4578899999999999999999999999999999999999999999999999997665
Q ss_pred hhhhhhcccccCCCCCCCCccccccccCccccchhhhcc-----cCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHH
Q 005427 214 NLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-----EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAH 288 (697)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~ 288 (697)
... ....+.+|||.|||||++.. ..|+..+|+||||++..||.-|.+|+.+..+...+.
T Consensus 175 sT~----------------grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF 238 (953)
T KOG0587|consen 175 STV----------------GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALF 238 (953)
T ss_pred ccc----------------ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhc
Confidence 321 13578899999999999853 336778999999999999999999999876554444
Q ss_pred HHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 005427 289 TVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL 351 (697)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~ 351 (697)
.|.+.. +|.+. -|...++++.++|..||..|..+||+..++++|...
T Consensus 239 ~IpRNP---------------PPkLk-rp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi 285 (953)
T KOG0587|consen 239 LIPRNP---------------PPKLK-RPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFI 285 (953)
T ss_pred cCCCCC---------------Ccccc-chhhHHHHHHHHHHHHHhhccccCcchhhhccCCcc
Confidence 332111 11111 145688999999999999999999999999987643
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=270.35 Aligned_cols=268 Identities=24% Similarity=0.333 Sum_probs=209.4
Q ss_pred CcccccccccCCceEEEEEEE--CCeeEEEEeccC--CChHHHHHHHHHHHHHHhcCCCCceEEeeccccCC-----ceE
Q 005427 67 SYTLLSPIARGAESVVYEATL--DGRKVAVKKPIL--STSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPP-----NYM 137 (697)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-----~~~ 137 (697)
+.+--+.||.|+||.||.+++ +|+.||+|++.. .+-...+++.+|+++|..++|.|++..+++..-+. .+|
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 455667999999999999997 689999997542 23334678999999999999999999988765432 456
Q ss_pred EEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhh
Q 005427 138 FFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKE 217 (697)
Q Consensus 138 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~ 217 (697)
.++|.+.. +|...+-. ...++.+.+.-+++||++||+|||+.+|.||||||.|+|++.+..+||||||+++..+....
T Consensus 134 V~TELmQS-DLHKIIVS-PQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~ 211 (449)
T KOG0664|consen 134 VLTELMQS-DLHKIIVS-PQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDR 211 (449)
T ss_pred HHHHHHHh-hhhheecc-CCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhh
Confidence 77787754 77777654 34788899999999999999999999999999999999999999999999999987653222
Q ss_pred hhcccccCCCCCCCCccccccccCccccchhhhcccC-CCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhcccc
Q 005427 218 ISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEI-HSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYT 296 (697)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~ 296 (697)
. ..+.-+-|..|+|||++.|.. |+.+.||||+||++.|++.++..|.......++..|.+...+
T Consensus 212 ~---------------hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGT 276 (449)
T KOG0664|consen 212 L---------------NMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGT 276 (449)
T ss_pred h---------------hhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCC
Confidence 1 234456788999999999864 899999999999999999999999988888888888776666
Q ss_pred HHHHHHHHHhCCCC----------Cccccc-----ccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 005427 297 EQQLTAAVVSGGLR----------PILASL-----ELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL 351 (697)
Q Consensus 297 ~~~~~~~~~~~~~~----------~~~~~~-----~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~ 351 (697)
+.........++.+ |.++.+ +..-..+...++..+|..||++|.+.++.+.++..
T Consensus 277 Ps~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~ 346 (449)
T KOG0664|consen 277 PSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYL 346 (449)
T ss_pred CcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccc
Confidence 54444433333322 111111 11233467889999999999999999998776544
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-33 Score=305.67 Aligned_cols=269 Identities=21% Similarity=0.199 Sum_probs=177.8
Q ss_pred CCCCCCcccccccccCCceEEEEEEE--C----CeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeec------
Q 005427 62 HLPPSSYTLLSPIARGAESVVYEATL--D----GRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAA------ 129 (697)
Q Consensus 62 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~------ 129 (697)
.+..++|.+.++||+|+||.||+|++ + +..||+|+....... +....| .++...+.++..++..
T Consensus 128 ~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~ 203 (566)
T PLN03225 128 SFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVS 203 (566)
T ss_pred CCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccc
Confidence 44567899999999999999999987 3 678999975432211 111111 1222223333332222
Q ss_pred cccCCceEEEEeecCCCCHhhhhhhcCCCC-------------------CHHHHHHHHHHHHHHHHHHHhCCcccccCCC
Q 005427 130 HAKPPNYMFFFEFYESRNLAEKLHVEEWSP-------------------SVDQVLMIAAQLAKALQYLHNLGIVHRDVKP 190 (697)
Q Consensus 130 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~-------------------~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp 190 (697)
......+++|+||+.+++|.+++....... ....+..++.|++.||+|||+++|+||||||
T Consensus 204 ~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP 283 (566)
T PLN03225 204 SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKP 283 (566)
T ss_pred cccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCH
Confidence 245678999999999999999886543211 2344668999999999999999999999999
Q ss_pred CceeecC-CCCCeeeeeccchhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccC---------------
Q 005427 191 ANVLLDR-NLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEI--------------- 254 (697)
Q Consensus 191 ~Nill~~-~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--------------- 254 (697)
+|||++. ++.+||+|||+++.+.... .+......+++.|+|||.+....
T Consensus 284 ~NILl~~~~~~~KL~DFGlA~~l~~~~---------------~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~s 348 (566)
T PLN03225 284 QNIIFSEGSGSFKIIDLGAAADLRVGI---------------NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALS 348 (566)
T ss_pred HHEEEeCCCCcEEEEeCCCcccccccc---------------ccCCcccccCCCccChHHhhccCCCCCCcccccccccc
Confidence 9999986 5899999999997543211 11234568899999999764221
Q ss_pred -------CCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHH-HhccccHHHHHHHHHhCCCCCccc---ccccCChHH
Q 005427 255 -------HSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTV-LEMNYTEQQLTAAVVSGGLRPILA---SLELGLPAS 323 (697)
Q Consensus 255 -------~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ 323 (697)
++.++|||||||+||||+++..|+... ....... .........+..... ....+... ......+..
T Consensus 349 p~l~~~~~~~k~DVwSlGviL~el~~~~~~~~~~--~~~~~~~l~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~d~~~~~ 425 (566)
T PLN03225 349 PVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSDSN--LIQFNRQLKRNDYDLVAWRKLVE-PRASPDLRRGFEVLDLDGGA 425 (566)
T ss_pred chhccccCCCCcccHHHHHHHHHHHhCcCCCchH--HHHHHHHHHhcCCcHHHHHHhhc-cccchhhhhhhhhccccchH
Confidence 334569999999999999987775432 1122221 111222211111111 11111000 001122345
Q ss_pred HHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 324 ILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 324 l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
..+||.+||+.||++|||+.++++|+|+.
T Consensus 426 ~~dLi~~mL~~dP~kR~ta~e~L~Hpff~ 454 (566)
T PLN03225 426 GWELLKSMMRFKGRQRISAKAALAHPYFD 454 (566)
T ss_pred HHHHHHHHccCCcccCCCHHHHhCCcCcC
Confidence 67999999999999999999999998874
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=329.17 Aligned_cols=254 Identities=25% Similarity=0.359 Sum_probs=192.0
Q ss_pred CcccccccccCCceEEEEEEE--CCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEeecC
Q 005427 67 SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYE 144 (697)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 144 (697)
.|...+.||+|+||.||+|+. .+..||||++..... ....|++.+++++|||||++++++.++...++||||++
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~ 766 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIE 766 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCC
Confidence 355667899999999999986 678999998653322 12356889999999999999999999999999999999
Q ss_pred CCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhcc
Q 005427 145 SRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLH---NLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLK 221 (697)
Q Consensus 145 ~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~ 221 (697)
+|+|.++++ .+++.++..++.|++.||+||| +.+|+||||||+||+++.++..++. ||......
T Consensus 767 ~g~L~~~l~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~-------- 833 (968)
T PLN00113 767 GKNLSEVLR----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLC-------- 833 (968)
T ss_pred CCcHHHHHh----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccc--------
Confidence 999999985 3788999999999999999999 6699999999999999998887775 66543221
Q ss_pred cccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHH-HHHHHHhccccHHHH
Q 005427 222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEA-QAHTVLEMNYTEQQL 300 (697)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~-~~~~~~~~~~~~~~~ 300 (697)
......||+.|+|||++.+..++.++|||||||++|||++|+.||....... .........+....
T Consensus 834 ------------~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~- 900 (968)
T PLN00113 834 ------------TDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCH- 900 (968)
T ss_pred ------------cCCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccc-
Confidence 0123368899999999999999999999999999999999999995421110 00000000000000
Q ss_pred HHHHHhCCCCCcccc---cccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 005427 301 TAAVVSGGLRPILAS---LELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE 354 (697)
Q Consensus 301 ~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~ 354 (697)
.....+|.+.. .+.....++.+++.+||+.||++|||+.|+++.++.+.+
T Consensus 901 ----~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 901 ----LDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred ----hhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 00011121111 111233467899999999999999999999999988764
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-32 Score=290.39 Aligned_cols=270 Identities=17% Similarity=0.195 Sum_probs=188.7
Q ss_pred CCCCCCcccccccccCCceEEEEEEE------------------CCeeEEEEeccCCChHHHH--------------HHH
Q 005427 62 HLPPSSYTLLSPIARGAESVVYEATL------------------DGRKVAVKKPILSTSEELD--------------NFH 109 (697)
Q Consensus 62 ~~~~~~y~~~~~lg~G~~g~V~~~~~------------------~~~~vavK~~~~~~~~~~~--------------~~~ 109 (697)
.+..++|.+.++||+|+||+||+|.. .++.||||++........+ ...
T Consensus 141 r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~ 220 (507)
T PLN03224 141 RWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGM 220 (507)
T ss_pred CccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhH
Confidence 45577999999999999999999963 2457999987654332222 234
Q ss_pred HHHHHHHhcCCCCc-----eEEeecccc--------CCceEEEEeecCCCCHhhhhhhcC--------------------
Q 005427 110 KELQLLCKLDHPGL-----AKFVAAHAK--------PPNYMFFFEFYESRNLAEKLHVEE-------------------- 156 (697)
Q Consensus 110 ~E~~~l~~l~hpni-----v~l~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~-------------------- 156 (697)
.|+.++.+++|.++ ++++++|.. ....++|+||+.+++|.++++...
T Consensus 221 vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~ 300 (507)
T PLN03224 221 VEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDN 300 (507)
T ss_pred HHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhh
Confidence 47777777776654 566666543 356899999999999999886421
Q ss_pred ---CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhcccccCCCCCCCCc
Q 005427 157 ---WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGF 233 (697)
Q Consensus 157 ---~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~ 233 (697)
..+++..++.++.|++.+|.|||+.+|+||||||+|||++.++.+||+|||++....... ..
T Consensus 301 ~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~---------------~~ 365 (507)
T PLN03224 301 MPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGI---------------NF 365 (507)
T ss_pred cccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCC---------------cc
Confidence 123567788999999999999999999999999999999999999999999986432110 00
Q ss_pred cccccccCccccchhhhcccC--------------------C--CchhhHHHHHHHHHHHHhCCC-CCCCchhHHHHHHH
Q 005427 234 HKKNMVGTLIYMAPEILKKEI--------------------H--SEKSDVYSFGISINELLTGVV-PYTDLRAEAQAHTV 290 (697)
Q Consensus 234 ~~~~~~gt~~y~aPE~~~~~~--------------------~--~~~~DiwslG~~l~ell~g~~-Pf~~~~~~~~~~~~ 290 (697)
......+|+.|+|||++.... + ..+.||||+||++|+|++|.. ||.+..........
T Consensus 366 ~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~ 445 (507)
T PLN03224 366 NPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQ 445 (507)
T ss_pred CccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhh
Confidence 112234589999999885322 1 124699999999999999875 77653222111100
Q ss_pred HhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCC---CCCCCHHHHHHHHHHH
Q 005427 291 LEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNP---HNRPSFSDIALELDLV 352 (697)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP---~~Rpt~~ell~~l~~~ 352 (697)
+......+....+ ....++ .....++..++|+.+||..+| .+|+|+.|+++|.|+.
T Consensus 446 ----~~~~~~~~r~~~~-~~~~~~-~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~ 504 (507)
T PLN03224 446 ----YDNDLNRWRMYKG-QKYDFS-LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFL 504 (507)
T ss_pred ----ccchHHHHHhhcc-cCCCcc-cccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcC
Confidence 0000001111111 111111 234578999999999999876 6899999999999874
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-32 Score=246.18 Aligned_cols=204 Identities=27% Similarity=0.406 Sum_probs=173.0
Q ss_pred CCCCCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCC-ChHHHHHHHHHHHHHHhc-CCCCceEEeeccccCCce
Q 005427 61 LHLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS-TSEELDNFHKELQLLCKL-DHPGLAKFVAAHAKPPNY 136 (697)
Q Consensus 61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~ 136 (697)
++++.+....+..||+|+||.|-+-++ +|+..|+|.+... +..+..++.+|+++..+. .+|++|.+|+.+......
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv 120 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV 120 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence 778888899999999999999877765 7999999986654 345667888899886655 799999999999999999
Q ss_pred EEEEeecCCCCHhhhhh---hcCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccccCCCCceeecCCCCCeeeeeccchhh
Q 005427 137 MFFFEFYESRNLAEKLH---VEEWSPSVDQVLMIAAQLAKALQYLHNL-GIVHRDVKPANVLLDRNLCPHLADFGLAEYR 212 (697)
Q Consensus 137 ~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~ 212 (697)
++.||.|.- +|..+-+ ..+..+++.-+-+|+..++.||.|||++ .++|||+||+||||+.+|+||+||||.+.++
T Consensus 121 wIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L 199 (282)
T KOG0984|consen 121 WICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYL 199 (282)
T ss_pred EEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceee
Confidence 999999975 7665543 3566889999999999999999999987 8999999999999999999999999999877
Q ss_pred hhhhhhhcccccCCCCCCCCccccccccCccccchhhhcc----cCCCchhhHHHHHHHHHHHHhCCCCCCCch
Q 005427 213 ENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK----EIHSEKSDVYSFGISINELLTGVVPYTDLR 282 (697)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~~l~ell~g~~Pf~~~~ 282 (697)
.+.-. .+...|...|||||.+.. ..|+-++||||||+++.||.+++.||....
T Consensus 200 ~dSiA-----------------kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~ 256 (282)
T KOG0984|consen 200 VDSIA-----------------KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG 256 (282)
T ss_pred hhhhH-----------------HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence 65221 223568889999998853 468899999999999999999999998643
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.3e-33 Score=294.15 Aligned_cols=249 Identities=27% Similarity=0.396 Sum_probs=194.9
Q ss_pred cccccccccCCceE-EEEEEECCeeEEEEeccCCChHHHHHHHHHHHHHHhc-CCCCceEEeeccccCCceEEEEeecCC
Q 005427 68 YTLLSPIARGAESV-VYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKL-DHPGLAKFVAAHAKPPNYMFFFEFYES 145 (697)
Q Consensus 68 y~~~~~lg~G~~g~-V~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~~~ 145 (697)
|.-.+.+|.|..|+ ||+|.+.++.||||.+... ......+|+..|+.- +|||||++++.-.+....|+..|.|..
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~ 587 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYEGREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC 587 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeCCceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh
Confidence 44457799999995 7999999999999975432 334568999999888 699999999999999999999999986
Q ss_pred CCHhhhhhhc--CCCC-CHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecC---C--CCCeeeeeccchhhhhhhh
Q 005427 146 RNLAEKLHVE--EWSP-SVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDR---N--LCPHLADFGLAEYRENLKE 217 (697)
Q Consensus 146 g~L~~~l~~~--~~~~-~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~---~--~~~kL~Dfg~a~~~~~~~~ 217 (697)
+|.+++... .... .....+.++.|++.||++||+.+||||||||+||||+. + ..++|+|||+++.+...+.
T Consensus 588 -sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~s 666 (903)
T KOG1027|consen 588 -SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKS 666 (903)
T ss_pred -hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcc
Confidence 999999763 1111 11456789999999999999999999999999999965 3 4689999999987753221
Q ss_pred hhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCCchhHHHHHHHHhcccc
Q 005427 218 ISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYT 296 (697)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~~~~~~~~~~~~~~~~~ 296 (697)
.-....+..||-+|+|||++.....+.++|||||||++|+.++ |..||.+.... .-+|+...+.
T Consensus 667 -------------S~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R--~~NIl~~~~~ 731 (903)
T KOG1027|consen 667 -------------SFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER--QANILTGNYT 731 (903)
T ss_pred -------------hhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh--hhhhhcCccc
Confidence 1112456789999999999999888889999999999999999 69999875322 2233333322
Q ss_pred HHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 005427 297 EQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL 351 (697)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~ 351 (697)
.. .+......++.+||.+|+..+|..||++.+++.|+-+
T Consensus 732 L~----------------~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlF 770 (903)
T KOG1027|consen 732 LV----------------HLEPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLF 770 (903)
T ss_pred ee----------------eeccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCcc
Confidence 11 1111112288999999999999999999999988744
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.2e-31 Score=267.42 Aligned_cols=149 Identities=24% Similarity=0.313 Sum_probs=122.5
Q ss_pred CCcccCCCCCCCCccCCCCCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCChHHHHHHHHHHHHHHhcC----
Q 005427 46 PNTCIRGCCSSQSIPLHLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLD---- 119 (697)
Q Consensus 46 ~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---- 119 (697)
++.+..|......+.-.+...+|-+.++||.|.|++||++.+ ..+.||+|+.... ..-.+....||++|++++
T Consensus 58 ~~dY~kGGYHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp 136 (590)
T KOG1290|consen 58 PEDYRKGGYHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDP 136 (590)
T ss_pred hhhhhcCCCceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCC
Confidence 344556667777777888889999999999999999999988 4678999985422 223467789999999983
Q ss_pred -C---CCceEEeecccc----CCceEEEEeecCCCCHhhhhhhcCC-CCCHHHHHHHHHHHHHHHHHHHhC-CcccccCC
Q 005427 120 -H---PGLAKFVAAHAK----PPNYMFFFEFYESRNLAEKLHVEEW-SPSVDQVLMIAAQLAKALQYLHNL-GIVHRDVK 189 (697)
Q Consensus 120 -h---pniv~l~~~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~LH~~-~ivHrDlk 189 (697)
| ..||+|++.|.. ..+.|||+|++. .+|..++....+ .++...++.|++|++.||.|||.. ||+|.|||
T Consensus 137 ~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvLG-dnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlK 215 (590)
T KOG1290|consen 137 NDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVLG-DNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLK 215 (590)
T ss_pred CCCCCceeeeeeccceecCCCCcEEEEEehhhh-hHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCC
Confidence 3 369999999975 458999999984 588888866543 578899999999999999999965 99999999
Q ss_pred CCceeec
Q 005427 190 PANVLLD 196 (697)
Q Consensus 190 p~Nill~ 196 (697)
|+|||+.
T Consensus 216 PENvLl~ 222 (590)
T KOG1290|consen 216 PENVLLC 222 (590)
T ss_pred cceeeee
Confidence 9999983
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.9e-31 Score=265.55 Aligned_cols=240 Identities=28% Similarity=0.398 Sum_probs=196.3
Q ss_pred CceEEEEEEEC--CeeEEEEeccCCChHH-HHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEeecCCCCHhhhhhh
Q 005427 78 AESVVYEATLD--GRKVAVKKPILSTSEE-LDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHV 154 (697)
Q Consensus 78 ~~g~V~~~~~~--~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~ 154 (697)
+||.||+|... ++.+++|+........ .+.+.+|+..+++++|+||+++++.+......++++||+.+++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999874 6899999876655444 67899999999999999999999999999999999999999999999876
Q ss_pred cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhcccccCCCCCCCCcc
Q 005427 155 EEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFH 234 (697)
Q Consensus 155 ~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (697)
.. .+++.+++.++.+++.++.|||+.+++|+||+|+||+++.++.++|+|||.+....... .
T Consensus 81 ~~-~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-----------------~ 142 (244)
T smart00220 81 RG-RLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-----------------L 142 (244)
T ss_pred cc-CCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc-----------------c
Confidence 54 38899999999999999999999999999999999999999999999999987654211 1
Q ss_pred ccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHHHHHHHhCCCCCccc
Q 005427 235 KKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILA 314 (697)
Q Consensus 235 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (697)
.....++..|++||.+.+..++.++|+||||++++++++|..||.............. ....+ ..
T Consensus 143 ~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~--------------~~~~~-~~ 207 (244)
T smart00220 143 LTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIG--------------KPKPP-FP 207 (244)
T ss_pred cccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHh--------------ccCCC-Cc
Confidence 2345688899999999988889999999999999999999999976322222111111 01011 01
Q ss_pred ccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 005427 315 SLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350 (697)
Q Consensus 315 ~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~ 350 (697)
.....++.++.+++.+||..+|++||++.+++++.|
T Consensus 208 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~ 243 (244)
T smart00220 208 PPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPF 243 (244)
T ss_pred cccccCCHHHHHHHHHHccCCchhccCHHHHhhCCC
Confidence 111127889999999999999999999999997654
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-32 Score=263.24 Aligned_cols=264 Identities=24% Similarity=0.328 Sum_probs=207.0
Q ss_pred CCCcccccccccCCceEEEEEEE--CCeeEEEEeccCC--ChHHHHHHHHHHHHHHhcCCCCceEEeeccccC------C
Q 005427 65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKP------P 134 (697)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~------~ 134 (697)
+.+|.-++.+|.|.- .|--+-+ .+++||+|+.... ......+..+|..++..++|+||++++.+|.-. .
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 468999999999998 6666655 6889999974432 333466788999999999999999999988532 3
Q ss_pred ceEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhh
Q 005427 135 NYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYREN 214 (697)
Q Consensus 135 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~ 214 (697)
..|+|||++.. +|...+.. .+.-.++..++.|++.|++|||+.||+||||||+||++..+..+||.|||+++....
T Consensus 95 e~y~v~e~m~~-nl~~vi~~---elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~ 170 (369)
T KOG0665|consen 95 EVYLVMELMDA-NLCQVILM---ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDT 170 (369)
T ss_pred hHHHHHHhhhh-HHHHHHHH---hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccCc
Confidence 68999999976 88888763 355678999999999999999999999999999999999999999999999975432
Q ss_pred hhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhcc
Q 005427 215 LKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMN 294 (697)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~ 294 (697)
.+..+-++.|..|+|||++.+..+...+||||+||++.||++|..-|.+.+...++.++.+..
T Consensus 171 -----------------~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~l 233 (369)
T KOG0665|consen 171 -----------------DFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQL 233 (369)
T ss_pred -----------------ccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHh
Confidence 123456788999999999999889999999999999999999999999998888888777655
Q ss_pred ccHHHHHHHHHhCC------CCC---------cc--------cccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 005427 295 YTEQQLTAAVVSGG------LRP---------IL--------ASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350 (697)
Q Consensus 295 ~~~~~~~~~~~~~~------~~~---------~~--------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~ 350 (697)
.+...-........ .+| .+ ..-++--+.-+.+++.+||..||++|.|++++|.|+-
T Consensus 234 gtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY 312 (369)
T KOG0665|consen 234 GTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPY 312 (369)
T ss_pred cCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCe
Confidence 44322211111000 000 00 0001112345789999999999999999999998763
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-33 Score=278.65 Aligned_cols=269 Identities=23% Similarity=0.258 Sum_probs=209.7
Q ss_pred CCCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCChHHHHHHHHHHHHHHhcCC------CCceEEeeccccCC
Q 005427 63 LPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDH------PGLAKFVAAHAKPP 134 (697)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------pniv~l~~~~~~~~ 134 (697)
+.-.+|.+....|+|-|++|..|.+ .+..||||++...... ...=..|+++|++|+. -|+++|+..|...+
T Consensus 429 ~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hkn 507 (752)
T KOG0670|consen 429 LLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM-HKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKN 507 (752)
T ss_pred hhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH-hhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcc
Confidence 4456899999999999999999987 5779999987655333 2344689999999953 48999999999999
Q ss_pred ceEEEEeecCCCCHhhhhhhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCC-CCCeeeeeccchh
Q 005427 135 NYMFFFEFYESRNLAEKLHVEEW--SPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRN-LCPHLADFGLAEY 211 (697)
Q Consensus 135 ~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~-~~~kL~Dfg~a~~ 211 (697)
++|||||.+. .+|.++|.+-+. .+....+..++.|++.||..|-..||+|.||||+|||+++. ..+||||||.|..
T Consensus 508 HLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~ 586 (752)
T KOG0670|consen 508 HLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSASF 586 (752)
T ss_pred eeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCccccc
Confidence 9999999886 499999987554 46778999999999999999999999999999999999875 5689999999976
Q ss_pred hhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHH
Q 005427 212 RENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVL 291 (697)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~ 291 (697)
..+. ..+-+.-+..|.|||++.|.+|+...|+||+||+||||.||+..|++.++..++...+
T Consensus 587 ~~en------------------eitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~m 648 (752)
T KOG0670|consen 587 ASEN------------------EITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFM 648 (752)
T ss_pred cccc------------------cccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHH
Confidence 5431 1233455678999999999999999999999999999999999999998888777665
Q ss_pred hccccH--HHHHHHHH-hC--------------------------CCCCcc---------ccccc---CChHHHHHHHHH
Q 005427 292 EMNYTE--QQLTAAVV-SG--------------------------GLRPIL---------ASLEL---GLPASILSLIQR 330 (697)
Q Consensus 292 ~~~~~~--~~~~~~~~-~~--------------------------~~~~~~---------~~~~~---~~~~~l~~li~~ 330 (697)
...... ..+....- .. ..+|.- +.++. ..-..+.+|+.+
T Consensus 649 e~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdk 728 (752)
T KOG0670|consen 649 ELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDK 728 (752)
T ss_pred HhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHH
Confidence 443322 11111000 00 001100 00111 123468899999
Q ss_pred hccCCCCCCCCHHHHHHHHHH
Q 005427 331 CWDGNPHNRPSFSDIALELDL 351 (697)
Q Consensus 331 ~l~~dP~~Rpt~~ell~~l~~ 351 (697)
||..||.+|.|..+.|.|+.+
T Consensus 729 ml~LdP~KRit~nqAL~HpFi 749 (752)
T KOG0670|consen 729 MLILDPEKRITVNQALKHPFI 749 (752)
T ss_pred HhccChhhcCCHHHHhcCCcc
Confidence 999999999999999988754
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-32 Score=286.23 Aligned_cols=257 Identities=25% Similarity=0.391 Sum_probs=218.4
Q ss_pred CCCCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEE
Q 005427 62 HLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFF 139 (697)
Q Consensus 62 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 139 (697)
+-+..+|.++..+|.|+||.||++++ +++..|+|++.+...++...+..|+-+++..+|||||.+++.+......|+.
T Consensus 11 rnP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwic 90 (829)
T KOG0576|consen 11 RNPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWIC 90 (829)
T ss_pred cCCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEE
Confidence 35667899999999999999999987 6889999999988888889999999999999999999999999999999999
Q ss_pred EeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhh
Q 005427 140 FEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEIS 219 (697)
Q Consensus 140 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~ 219 (697)
||||.+|+|.+.-+-.+ .+++.++..++++.+.+++|||+.|=+|||||-.|||++..|.+||.|||.+..+...-.
T Consensus 91 MEycgggslQdiy~~Tg-plselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~-- 167 (829)
T KOG0576|consen 91 MEYCGGGSLQDIYHVTG-PLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIA-- 167 (829)
T ss_pred EEecCCCcccceeeecc-cchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhhh--
Confidence 99999999999877655 789999999999999999999999999999999999999999999999999866543111
Q ss_pred cccccCCCCCCCCccccccccCccccchhhh---cccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhcccc
Q 005427 220 LKNWRSSGKPTGGFHKKNMVGTLIYMAPEIL---KKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYT 296 (697)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~ 296 (697)
....+.||+.|||||+. +...|...+|||++|++..|+---++|..+........
T Consensus 168 --------------KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~-------- 225 (829)
T KOG0576|consen 168 --------------KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALF-------- 225 (829)
T ss_pred --------------hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHH--------
Confidence 35678999999999986 46678999999999999999988888866543322211
Q ss_pred HHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 005427 297 EQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALEL 349 (697)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l 349 (697)
-....++.|.--.-+...++.+.+|++.+|..+|++|||++.++.|.
T Consensus 226 ------LmTkS~~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~ 272 (829)
T KOG0576|consen 226 ------LMTKSGFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHP 272 (829)
T ss_pred ------HhhccCCCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhheece
Confidence 12223444433333456889999999999999999999999998754
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=273.75 Aligned_cols=196 Identities=29% Similarity=0.438 Sum_probs=168.8
Q ss_pred CCcccccccccCCceEEEEEEEC--CeeEEEEeccCCC--------hHHHHHHHHHHHHHHhcC---CCCceEEeecccc
Q 005427 66 SSYTLLSPIARGAESVVYEATLD--GRKVAVKKPILST--------SEELDNFHKELQLLCKLD---HPGLAKFVAAHAK 132 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---hpniv~l~~~~~~ 132 (697)
.+|..++.+|.|+||.|++|.++ ...|++|.+.... ....-.+-.|+.||..|+ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 36999999999999999999884 4568888654321 112334667999999997 9999999999999
Q ss_pred CCceEEEEeecC-CCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchh
Q 005427 133 PPNYMFFFEFYE-SRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEY 211 (697)
Q Consensus 133 ~~~~~lv~e~~~-~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~ 211 (697)
++.||++||.-. |-+|++++..+. ++++.++..|+.|++.|+++||+.||+|||||-+|+.++.+|.+||+|||.+.+
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~kp-~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa~ 719 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFKP-RMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAAY 719 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhccC-ccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchhh
Confidence 999999999754 458999998766 899999999999999999999999999999999999999999999999999876
Q ss_pred hhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCC-CchhhHHHHHHHHHHHHhCCCCCCC
Q 005427 212 RENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIH-SEKSDVYSFGISINELLTGVVPYTD 280 (697)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~~l~ell~g~~Pf~~ 280 (697)
... + +-..++||..|.|||++.|.+| +..-|||+||++||.++..+.||..
T Consensus 720 ~ks----------------g--pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 720 TKS----------------G--PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred hcC----------------C--CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 542 1 2356799999999999999887 5678999999999999999999863
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=252.34 Aligned_cols=262 Identities=25% Similarity=0.378 Sum_probs=207.8
Q ss_pred CCCCCCCcccccccccCCceEEEEEEEC-------CeeEEEEeccCC-ChHHHHHHHHHHHHHHhcCCCCceEEeecccc
Q 005427 61 LHLPPSSYTLLSPIARGAESVVYEATLD-------GRKVAVKKPILS-TSEELDNFHKELQLLCKLDHPGLAKFVAAHAK 132 (697)
Q Consensus 61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 132 (697)
+.+...|+++..++-+|.||.||.|.+. .+.|.+|.+... +.-+...+..|.-+|..+.|||+.++.+++..
T Consensus 279 l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie 358 (563)
T KOG1024|consen 279 LTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIE 358 (563)
T ss_pred hhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEee
Confidence 3445567889999999999999999653 234666643322 33456788999999999999999999988754
Q ss_pred -CCceEEEEeecCCCCHhhhhhhc-------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeee
Q 005427 133 -PPNYMFFFEFYESRNLAEKLHVE-------EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLA 204 (697)
Q Consensus 133 -~~~~~lv~e~~~~g~L~~~l~~~-------~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~ 204 (697)
....+.++.+..-|+|..++... ....+..+...++.|++.|++|||++|++|.||..+|++|++...|||+
T Consensus 359 ~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVklt 438 (563)
T KOG1024|consen 359 DYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLT 438 (563)
T ss_pred ccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEec
Confidence 45678888999899999999721 1245667888999999999999999999999999999999999999999
Q ss_pred eeccchhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCCchh
Q 005427 205 DFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRA 283 (697)
Q Consensus 205 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~~~~ 283 (697)
|=.+++.+-..+. . ..+ .+-..+..||+||.+.+..|+.++|+|||||+||||+| |+.||.+.++
T Consensus 439 DsaLSRDLFP~DY------h----cLG----DnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDP 504 (563)
T KOG1024|consen 439 DSALSRDLFPGDY------H----CLG----DNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDP 504 (563)
T ss_pred cchhccccCcccc------c----ccC----CCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCH
Confidence 9999875432111 0 000 11134678999999999999999999999999999999 9999998877
Q ss_pred HHHHHHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 005427 284 EAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE 354 (697)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~ 354 (697)
.++...+.. ++|- ..|-++|+++..+|.-||...|++||+++|++.-|..+-.
T Consensus 505 fEm~~ylkd---------------GyRl---aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~ 557 (563)
T KOG1024|consen 505 FEMEHYLKD---------------GYRL---AQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHT 557 (563)
T ss_pred HHHHHHHhc---------------ccee---cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHH
Confidence 766554432 2221 1356899999999999999999999999999988876644
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.8e-29 Score=238.30 Aligned_cols=274 Identities=20% Similarity=0.294 Sum_probs=225.1
Q ss_pred cCCCCCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCChHHHHHHHHHHHHHHhc-CCCCceEEeeccccCCce
Q 005427 60 PLHLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKL-DHPGLAKFVAAHAKPPNY 136 (697)
Q Consensus 60 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~ 136 (697)
...+.+-.|+++++||+|.||+.++|+. .+++||||.-.. ..+.-.++.|.+..+.| ..++|...|-+.....+-
T Consensus 22 ~~~~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr--kS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~N 99 (449)
T KOG1165|consen 22 GVLMVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR--KSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYN 99 (449)
T ss_pred CceEecccceeccccccCcceeeecccccccCceEEEEeccc--cCCcchHHHHHHHHHHHcCCCCCCceeeeccccchh
Confidence 4456677899999999999999999974 899999996332 23455788999999999 579999999888888899
Q ss_pred EEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCC-----CCeeeeeccchh
Q 005427 137 MFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNL-----CPHLADFGLAEY 211 (697)
Q Consensus 137 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~-----~~kL~Dfg~a~~ 211 (697)
.||+|.+ |.+|.|++.-.+.+|+..+++.++.|++.-++|+|++.+|.|||||+|+||...+ .+.++|||+|+.
T Consensus 100 iLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~ 178 (449)
T KOG1165|consen 100 ILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE 178 (449)
T ss_pred hhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence 9999988 5699999988888999999999999999999999999999999999999996543 478999999998
Q ss_pred hhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHH
Q 005427 212 RENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVL 291 (697)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~ 291 (697)
+.+.+....-.|+ ...+..||.+||+-.-+.|...+.+.|+-|||-+|+++|.|.+||.+........+..
T Consensus 179 YrDp~TkqHIPYr---------E~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYe 249 (449)
T KOG1165|consen 179 YRDPKTKQHIPYR---------EHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYE 249 (449)
T ss_pred hcCccccccCccc---------cccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHH
Confidence 8765544332222 2456789999999999999999999999999999999999999999987655444332
Q ss_pred hccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHh
Q 005427 292 EMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHR 356 (697)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~~ 356 (697)
+... ......+..+..++|.++..-|+-.-+.+-.+-|+++-+...+..++...
T Consensus 250 KIGe-----------~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~ 303 (449)
T KOG1165|consen 250 KIGE-----------TKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRL 303 (449)
T ss_pred Hhcc-----------ccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhc
Confidence 2221 12222333445679999999999999999999999999988888887653
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.6e-28 Score=235.43 Aligned_cols=210 Identities=37% Similarity=0.568 Sum_probs=182.6
Q ss_pred cccCCceEEEEEEEC--CeeEEEEeccCCChH-HHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEeecCCCCHhh
Q 005427 74 IARGAESVVYEATLD--GRKVAVKKPILSTSE-ELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAE 150 (697)
Q Consensus 74 lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~ 150 (697)
||.|.+|.||++... ++.+++|+....... ..+.+.+|+..++.++|++|+++++++......++++|++.+++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 689999999999985 889999987655432 35789999999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecC-CCCCeeeeeccchhhhhhhhhhcccccCCCCC
Q 005427 151 KLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDR-NLCPHLADFGLAEYRENLKEISLKNWRSSGKP 229 (697)
Q Consensus 151 ~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~-~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~ 229 (697)
++......+++..++.++.+++.++.+||+.|++|+||+|.||+++. ++.++|+|||.+........
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~------------ 148 (215)
T cd00180 81 LLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS------------ 148 (215)
T ss_pred HHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc------------
Confidence 98765446889999999999999999999999999999999999999 89999999999865432110
Q ss_pred CCCccccccccCccccchhhhccc-CCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHHHHHHHhCC
Q 005427 230 TGGFHKKNMVGTLIYMAPEILKKE-IHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGG 308 (697)
Q Consensus 230 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (697)
......+...|++||.+... .++.++|+|++|++++++
T Consensus 149 ----~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------- 187 (215)
T cd00180 149 ----LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------- 187 (215)
T ss_pred ----hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------
Confidence 12334578899999999877 788999999999999999
Q ss_pred CCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 005427 309 LRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALEL 349 (697)
Q Consensus 309 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l 349 (697)
..+.+++..||+.+|++||++.++++++
T Consensus 188 -------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 -------------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred -------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 3467999999999999999999998653
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.9e-29 Score=246.82 Aligned_cols=283 Identities=24% Similarity=0.360 Sum_probs=200.5
Q ss_pred CCCCcccccccccCCceEEEEEEE-----CCeeEEEEeccCCChHHHHHHHHHHHHHHhc-CCCCceEEeeccccCCceE
Q 005427 64 PPSSYTLLSPIARGAESVVYEATL-----DGRKVAVKKPILSTSEELDNFHKELQLLCKL-DHPGLAKFVAAHAKPPNYM 137 (697)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~ 137 (697)
....|.+.++||.|.|++||++.+ ..+.||+|.+...+ ...++.+|+++|..+ .+.||+++.+++..++...
T Consensus 34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ 111 (418)
T KOG1167|consen 34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVA 111 (418)
T ss_pred hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCCeeE
Confidence 345799999999999999999964 45789999866544 345689999999999 5899999999999999999
Q ss_pred EEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecC-CCCCeeeeeccchhhhhhh
Q 005427 138 FFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDR-NLCPHLADFGLAEYRENLK 216 (697)
Q Consensus 138 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~-~~~~kL~Dfg~a~~~~~~~ 216 (697)
+|+||++.....++.. .++..++..+++.++.||.++|..||+||||||.|+|.+. .+.-.|+|||+|...+...
T Consensus 112 ivlp~~~H~~f~~l~~----~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~ 187 (418)
T KOG1167|consen 112 IVLPYFEHDRFRDLYR----SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQ 187 (418)
T ss_pred EEecccCccCHHHHHh----cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhhh
Confidence 9999999988888775 3567899999999999999999999999999999999975 4667899999997432211
Q ss_pred hhhcc-c-------------c--c--CCCCCCCCc----------cccccccCccccchhhhcccC-CCchhhHHHHHHH
Q 005427 217 EISLK-N-------------W--R--SSGKPTGGF----------HKKNMVGTLIYMAPEILKKEI-HSEKSDVYSFGIS 267 (697)
Q Consensus 217 ~~~~~-~-------------~--~--~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~~ 267 (697)
..... . + . .......++ ......||++|+|||++.+.+ .++++||||.|++
T Consensus 188 ~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI 267 (418)
T KOG1167|consen 188 QTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVI 267 (418)
T ss_pred hhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccce
Confidence 00000 0 0 0 000001111 123458999999999987644 6889999999999
Q ss_pred HHHHHhCCCCCCCchhHH-HHHHHHhccccH-----------------------HHHH---HHHHhCCCCC-----cccc
Q 005427 268 INELLTGVVPYTDLRAEA-QAHTVLEMNYTE-----------------------QQLT---AAVVSGGLRP-----ILAS 315 (697)
Q Consensus 268 l~ell~g~~Pf~~~~~~~-~~~~~~~~~~~~-----------------------~~~~---~~~~~~~~~~-----~~~~ 315 (697)
+.-++++..||-...... ....+....... .+.. ..+..+.+.+ ....
T Consensus 268 ~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~ 347 (418)
T KOG1167|consen 268 LLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTERE 347 (418)
T ss_pred eehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeec
Confidence 999999999984322111 111110000000 0000 0000011111 0011
Q ss_pred -cccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 316 -LELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 316 -~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
.....+..+.+|+.+||..||.+|.|+++.|+|..+-
T Consensus 348 ~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~ 385 (418)
T KOG1167|consen 348 IGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFD 385 (418)
T ss_pred cccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCc
Confidence 1123566899999999999999999999999887654
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.9e-29 Score=231.41 Aligned_cols=254 Identities=20% Similarity=0.253 Sum_probs=190.4
Q ss_pred CCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCChHHHHHHHHHHHHHHhc-CCCCceEEeec-cccCCceEEEE
Q 005427 65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKL-DHPGLAKFVAA-HAKPPNYMFFF 140 (697)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~-~~~~~~~~lv~ 140 (697)
.+.|.+.+.||+|.||.+-++++ +++.+++|-+... ......|.+|...--.| .|.||+.-|++ |.+.+.|.+++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 46799999999999999999998 4678999975433 23467788998876666 58999997765 66778888999
Q ss_pred eecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceee-c-CCCCCeeeeeccchhhhhhhhh
Q 005427 141 EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLL-D-RNLCPHLADFGLAEYRENLKEI 218 (697)
Q Consensus 141 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill-~-~~~~~kL~Dfg~a~~~~~~~~~ 218 (697)
||++-|+|.+-+... .+.+.....++.|+++||.|+|+.++||||||.+|||| + +...|||||||+.+....
T Consensus 102 E~aP~gdL~snv~~~--GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~---- 175 (378)
T KOG1345|consen 102 EFAPRGDLRSNVEAA--GIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT---- 175 (378)
T ss_pred ccCccchhhhhcCcc--cccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCc----
Confidence 999999999988654 47888999999999999999999999999999999999 3 334799999999864432
Q ss_pred hcccccCCCCCCCCccccccccCccccchhhhccc-----CCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhc
Q 005427 219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKE-----IHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEM 293 (697)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~ 293 (697)
.....--+..|.+||+.... ...+.+|+|.||+++|.+++|.+||........
T Consensus 176 ---------------tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~------- 233 (378)
T KOG1345|consen 176 ---------------TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDK------- 233 (378)
T ss_pred ---------------eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCc-------
Confidence 12223346679999986422 246788999999999999999999974221110
Q ss_pred cccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCC---CCHHHHHHHHHH
Q 005427 294 NYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNR---PSFSDIALELDL 351 (697)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R---pt~~ell~~l~~ 351 (697)
....+..-.++..+.+|..-..+++.+..+.++-|..+|++| .++......+|.
T Consensus 234 ----~Y~~~~~w~~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~ 290 (378)
T KOG1345|consen 234 ----PYWEWEQWLKRKNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWK 290 (378)
T ss_pred ----hHHHHHHHhcccCccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHH
Confidence 001111111233344444445688999999999999999999 455554444444
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5e-28 Score=222.40 Aligned_cols=274 Identities=19% Similarity=0.286 Sum_probs=218.7
Q ss_pred CccCCCCCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCChHHHHHHHHHHHHHHhcCC-CCceEEeeccccCC
Q 005427 58 SIPLHLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDH-PGLAKFVAAHAKPP 134 (697)
Q Consensus 58 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~l~~~~~~~~ 134 (697)
+.+-.+...+|+++++||.|+||.+|+|.. .|..||+|+-... ..-..+.-|.++...|++ ..|..+..+..+..
T Consensus 7 s~~~~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~--a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ 84 (341)
T KOG1163|consen 7 SLEELIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK--AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKD 84 (341)
T ss_pred chhhheeccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc--CCCcchhHHHHHHHHhccCCCCchhhhhccccc
Confidence 344556778999999999999999999976 7999999973322 223457789999999964 67888888888888
Q ss_pred ceEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCC---CCCeeeeeccchh
Q 005427 135 NYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRN---LCPHLADFGLAEY 211 (697)
Q Consensus 135 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~---~~~kL~Dfg~a~~ 211 (697)
.-.+||+.+ |.+|.+++.....+++..+++.++-|++.-++|+|.++++||||||+|+|+.-+ ..+.|+|||+|+.
T Consensus 85 ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKk 163 (341)
T KOG1163|consen 85 YNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKK 163 (341)
T ss_pred cceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhh
Confidence 889999987 569999998888899999999999999999999999999999999999999543 4578999999987
Q ss_pred hhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHH
Q 005427 212 RENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVL 291 (697)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~ 291 (697)
+.+......- +-.......||.+|.+-..+.+...+...|+-|+|.+|.++..|..||.+.......++..
T Consensus 164 y~d~~t~~HI---------pyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyE 234 (341)
T KOG1163|consen 164 YRDIRTRQHI---------PYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYE 234 (341)
T ss_pred hccccccccC---------ccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHH
Confidence 7654332221 2223456789999999999999899999999999999999999999999987665544322
Q ss_pred hccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 005427 292 EMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE 354 (697)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~ 354 (697)
.+......-.+..+..++|.++.-.+.-|-..--.+-|+..-+.+.+..++.
T Consensus 235 -----------kI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr 286 (341)
T KOG1163|consen 235 -----------KISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFR 286 (341)
T ss_pred -----------HHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHh
Confidence 1111222233344556899999999999999999999999888766665554
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=6e-27 Score=231.54 Aligned_cols=198 Identities=35% Similarity=0.524 Sum_probs=172.7
Q ss_pred cccccccccCCceEEEEEEEC--CeeEEEEeccCCChH-HHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEeecC
Q 005427 68 YTLLSPIARGAESVVYEATLD--GRKVAVKKPILSTSE-ELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYE 144 (697)
Q Consensus 68 y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 144 (697)
|.+.+.||.|++|.||++... ++.+++|........ ..+.+.+|++.++.++|+|++++++.+......++++|++.
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 567889999999999999874 689999987766554 67789999999999999999999999999899999999999
Q ss_pred CCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhccccc
Q 005427 145 SRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWR 224 (697)
Q Consensus 145 ~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~ 224 (697)
+++|.+++......+++..++.++.+++.++.+||+.+++|+||+|.||+++.++.++|+|||++.......
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~-------- 152 (225)
T smart00221 81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDL-------- 152 (225)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc--------
Confidence 999999987654337889999999999999999999999999999999999999999999999987654211
Q ss_pred CCCCCCCCccccccccCccccchhhh-cccCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 005427 225 SSGKPTGGFHKKNMVGTLIYMAPEIL-KKEIHSEKSDVYSFGISINELLTGVVPYTD 280 (697)
Q Consensus 225 ~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~~l~ell~g~~Pf~~ 280 (697)
+.......++..|++||.+ ....++.++|+|+||+++++|++|+.||..
T Consensus 153 -------~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 153 -------AALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred -------cccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 0012345678899999998 667778899999999999999999999976
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.5e-28 Score=282.49 Aligned_cols=217 Identities=18% Similarity=0.166 Sum_probs=147.9
Q ss_pred HhcCC-CCceEEeecc-------ccCCceEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccc
Q 005427 116 CKLDH-PGLAKFVAAH-------AKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRD 187 (697)
Q Consensus 116 ~~l~h-pniv~l~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrD 187 (697)
+.++| +||+++++.| .....+++++|++ +++|.+++......+++.+++.++.||+.||.|||++||+|||
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrD 105 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHN 105 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeecc
Confidence 45556 5888888877 2334677788877 5599999976665789999999999999999999999999999
Q ss_pred CCCCceeecCCCC-------------------CeeeeeccchhhhhhhhhhcccccCCCCCCCCccccccccCccccchh
Q 005427 188 VKPANVLLDRNLC-------------------PHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPE 248 (697)
Q Consensus 188 lkp~Nill~~~~~-------------------~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 248 (697)
|||+||||+..+. +||+|||+++.....................+......+||+.|||||
T Consensus 106 lKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE 185 (793)
T PLN00181 106 VRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPE 185 (793)
T ss_pred CCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChh
Confidence 9999999965444 455555555432110000000000000000011122357899999999
Q ss_pred hhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHH
Q 005427 249 ILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLI 328 (697)
Q Consensus 249 ~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 328 (697)
++.+..++.++|||||||+||||++|.+|+...... ...+.. ....+ . .....+...+++
T Consensus 186 ~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~--~~~~~~--------------~~~~~---~-~~~~~~~~~~~~ 245 (793)
T PLN00181 186 EDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRT--MSSLRH--------------RVLPP---Q-ILLNWPKEASFC 245 (793)
T ss_pred hhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHH--HHHHHH--------------hhcCh---h-hhhcCHHHHHHH
Confidence 999999999999999999999999998887542111 111100 00001 0 011234567899
Q ss_pred HHhccCCCCCCCCHHHHHHHHHHHH
Q 005427 329 QRCWDGNPHNRPSFSDIALELDLVL 353 (697)
Q Consensus 329 ~~~l~~dP~~Rpt~~ell~~l~~~~ 353 (697)
.+||+.+|.+||++.|+++|.|...
T Consensus 246 ~~~L~~~P~~Rps~~eil~h~~~~~ 270 (793)
T PLN00181 246 LWLLHPEPSCRPSMSELLQSEFINE 270 (793)
T ss_pred HHhCCCChhhCcChHHHhhchhhhh
Confidence 9999999999999999999988743
|
|
| >KOG1323 consensus Serine/threonine phosphatase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6e-26 Score=215.94 Aligned_cols=223 Identities=32% Similarity=0.513 Sum_probs=167.7
Q ss_pred CCceEEEEEecCCCChHHHHHHHHHhHHHHHhcCC-----------------------------------------CCCh
Q 005427 456 QKEIHMFGIFDGHRGSAAAEFSARALPGFLQNLGS-----------------------------------------TTRP 494 (697)
Q Consensus 456 ~~~~~~~~V~DG~GG~~~~~~as~~~~~~l~~~~~-----------------------------------------~~~~ 494 (697)
..+..+|.+||||.|..++-.|++.++..+.+... ..-.
T Consensus 141 ~~~~~~~slfdghags~~avvAsrll~~hI~~ql~~vvd~i~~~~~~~~~~~g~~~~~s~~s~~~~~~~~ek~Ir~E~LV 220 (493)
T KOG1323|consen 141 RADGALFSLFDGHAGSAVAVVASRLLHRHIKEQLCEVVDTILHMDRHENLNFGKHRSESSYSMSEMSREDEKRIRHEHLV 220 (493)
T ss_pred CCcceeeeeecCCCcchHHHHHHHHHHHhhhHHHHHHHHHHhhhccccccccccccccCCcccccccchhhccCchHHhh
Confidence 34577999999999999999999988776644310 0012
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHHhhhhcccCCCCCCceEEEEEEecCeEEEEEcCCeEEEEEECCeeeecCCCCCCCCHH
Q 005427 495 TDALLEAFIRTDVAFRNELDSLRKSKRVVQKDWHPGCTAIAALIVRNRLFVANAGDCRAILCRGGHPFALSRDHVASCLE 574 (697)
Q Consensus 495 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GtT~~~~~i~~~~l~~anvGDSr~~l~~~~~~~~lt~dH~~~~~~ 574 (697)
..+|..||+.++..+.++..... ...|||+++++.--+++|+||.|||||+++|++++++|+.+.+|. .
T Consensus 221 iGAlEsAFqemDeqiarer~~~~---------~~GGCtalvvi~llGKlYvaNAGDsRAIlVrndeirplS~efTPe--t 289 (493)
T KOG1323|consen 221 IGALESAFQEMDEQIARERQVWR---------LPGGCTALVVIVLLGKLYVANAGDSRAILVRNDEIRPLSKEFTPE--T 289 (493)
T ss_pred HHHHHHHHHHHHHHHHHHHHhhc---------CCCCceEEEeeeeccceEEccCCCceEEEEecCCeeecccccCcH--H
Confidence 35778888888888776633322 136999999999999999999999999999999999999999665 8
Q ss_pred HHHHHHHcCCe--------------------------eeec-----------cCc--------------ceeCCCcceec
Q 005427 575 ERERVVSAGGN--------------------------VNWQ-----------VDT--------------WRVGPPALQVT 603 (697)
Q Consensus 575 e~~ri~~~g~~--------------------------~~~~-----------~~~--------------~~~~~~~~~lt 603 (697)
|++|+..-+-. +.+. .++ +|+. ..+.+|
T Consensus 290 ERqRlQ~Laf~~PeLlgneFtrLEfprRl~~~dLgqrvLyRD~~MtGWayKtve~~DLr~pLI~gegrkaRll-~TigVs 368 (493)
T KOG1323|consen 290 ERQRLQELAFRNPELLGNEFTRLEFPRRLTIKDLGQRVLYRDWNMTGWAYKTVEEEDLRFPLISGEGRKARLL-ATIGVS 368 (493)
T ss_pred HHHHHHHHhhcChHhhcccccceecccccChhhhcceeeeeccccccceeehhhhhcCCcceecccchhhhhh-hhheec
Confidence 88888764321 0000 000 0000 466799
Q ss_pred cccCCCCCC---------CCcccCCceEEEEeCC----CCeEEEEEcCCcccCCChHHHHHHHHhhcC-----Ch---hH
Q 005427 604 RSIGDDDLK---------PAVTAEPEITETIMTP----EDEYLVMASDGLWDVVSHVEAVGIIKDTVK-----EP---GM 662 (697)
Q Consensus 604 ralG~~~~k---------~~v~~~p~v~~~~l~~----~d~~lvl~SDGl~d~~~~~ei~~~~~~~~~-----~~---~~ 662 (697)
|.|||..+| |.+.+.|+|...++.. .|+++||+||||||+++++|++.+|+.... ++ ..
T Consensus 369 RGlGDH~Lkv~dsnl~iKPFLssvPeV~V~dl~q~e~~~DdVvilatDGLWDVlSneeva~~Vrs~L~~~dp~Dp~RYt~ 448 (493)
T KOG1323|consen 369 RGLGDHHLKVVDSNLSIKPFLSSVPEVRVYDLRQYEHLTDDVVILATDGLWDVLSNEEVALIVRSFLPSTDPADPSRYTQ 448 (493)
T ss_pred cccCcceeeeecCCcccchhhhcCCeeEEEehhhhccCCCcEEEEecCchhhhcccHHHHHHHHHhcCCCCCCChhHHHH
Confidence 999998876 5788999999888764 255999999999999999999999988663 22 25
Q ss_pred HHHHHHHHHHh-------------cCCCCCcEEEEEEeCCC
Q 005427 663 CSKRLATEAAE-------------RGSKDNITVIVVFLQPV 690 (697)
Q Consensus 663 ~a~~L~~~a~~-------------~g~~DNiT~ivv~l~~~ 690 (697)
+|+.|+..|.. .|+.|||||.||-|...
T Consensus 449 aaqdlva~arg~~k~rgWr~~n~~lgSgDDIsVfVIPL~~~ 489 (493)
T KOG1323|consen 449 AAQDLVAAARGQQKDRGWRMNNGGLGSGDDISVFVIPLKYC 489 (493)
T ss_pred HHHHHHHHhcCccCCCceeccCCCcCCCCceEEEEEeccCC
Confidence 78888887753 24679999999988643
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-26 Score=219.04 Aligned_cols=169 Identities=23% Similarity=0.303 Sum_probs=131.2
Q ss_pred CCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhcccccC
Q 005427 146 RNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRS 225 (697)
Q Consensus 146 g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~ 225 (697)
|+|.+++...+..+++.+++.++.|++.||.|||+.+ ||+|||++.++.+|+ ||++.....
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~----------- 61 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTP----------- 61 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecc-----------
Confidence 6899999876667999999999999999999999998 999999999999999 999865432
Q ss_pred CCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHH-HHHHHHhccccHHHHHHHH
Q 005427 226 SGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEA-QAHTVLEMNYTEQQLTAAV 304 (697)
Q Consensus 226 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~ 304 (697)
....||+.|+|||++.+..++.++|||||||++|||++|..||....... ....+.....
T Consensus 62 ----------~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~--------- 122 (176)
T smart00750 62 ----------EQSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMP--------- 122 (176)
T ss_pred ----------ccCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhc---------
Confidence 11258899999999999999999999999999999999999997643221 1111111000
Q ss_pred HhCCCCCcccccccCChH--HHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 005427 305 VSGGLRPILASLELGLPA--SILSLIQRCWDGNPHNRPSFSDIALELDLVLEH 355 (697)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~--~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~ 355 (697)
. ..+.....+..++. ++.+++.+||..+|.+||++.++++|++.....
T Consensus 123 --~-~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~ 172 (176)
T smart00750 123 --A-DDPRDRSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAE 172 (176)
T ss_pred --c-CCccccccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHH
Confidence 0 00000001122333 699999999999999999999999999988653
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.6e-25 Score=231.49 Aligned_cols=267 Identities=21% Similarity=0.241 Sum_probs=201.4
Q ss_pred CcccccccccCCceEEEEEEECC---eeEEEEeccCCChHHHHHHHHHHHHHHhcCC----CCceEEeecc-ccCCceEE
Q 005427 67 SYTLLSPIARGAESVVYEATLDG---RKVAVKKPILSTSEELDNFHKELQLLCKLDH----PGLAKFVAAH-AKPPNYMF 138 (697)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~~~---~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----pniv~l~~~~-~~~~~~~l 138 (697)
+|++.++||+|+||.||++.+.. ..+|+|............+..|..+|..+.. +++..+++.. ..+...++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 89999999999999999999743 4688887554433322368889999999973 6899999998 47777888
Q ss_pred EEeecCCCCHhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCC-----CCCeeeeeccchhh
Q 005427 139 FFEFYESRNLAEKLHVEE-WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRN-----LCPHLADFGLAEYR 212 (697)
Q Consensus 139 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~-----~~~kL~Dfg~a~~~ 212 (697)
||+.+ |.+|.++..... ..++..++..++.|++.+|++||+.|++||||||+|+++... ..+.|.|||+++..
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~ 177 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRF 177 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCccc
Confidence 98877 669999885554 689999999999999999999999999999999999999765 35899999999843
Q ss_pred hhhhhhhcccccCCCCCCCCcc-ccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHH
Q 005427 213 ENLKEISLKNWRSSGKPTGGFH-KKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVL 291 (697)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~ 291 (697)
....... ........ .....||..|+++.++.+...+++.|+||++.++.+++.|..||.............
T Consensus 178 ~~~~~~~-------~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~ 250 (322)
T KOG1164|consen 178 KYVGDSG-------GNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFE 250 (322)
T ss_pred cccCCCC-------cccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHH
Confidence 3111100 00011111 234679999999999999999999999999999999999999997755332222111
Q ss_pred hccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 005427 292 EMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH 355 (697)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~ 355 (697)
..... ..........+.++.+++..+-..+...+|....+...+......
T Consensus 251 ~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~ 300 (322)
T KOG1164|consen 251 KDPRK--------------LLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS 300 (322)
T ss_pred HHhhh--------------hccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence 11000 000002234567888999888889999999999999887776643
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2e-25 Score=208.57 Aligned_cols=250 Identities=22% Similarity=0.384 Sum_probs=200.6
Q ss_pred CCCCCcccccccccCCceEEEEEEECCeeEEEEeccCCCh--HHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEE
Q 005427 63 LPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTS--EELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFF 140 (697)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 140 (697)
+..++..+..+|.+...|+.|+|+++|..+++|++..... .....|..|.-.|+-+.||||+.+++.|..++++.++.
T Consensus 187 id~~~lnl~tkl~e~hsgelwrgrwqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~is 266 (448)
T KOG0195|consen 187 IDVSSLNLITKLAESHSGELWRGRWQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIIS 266 (448)
T ss_pred cchhhhhhhhhhccCCCcccccccccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEee
Confidence 3445677888999999999999999999998887655432 22457889999999999999999999999999999999
Q ss_pred eecCCCCHhhhhhhcCC-CCCHHHHHHHHHHHHHHHHHHHhCC--cccccCCCCceeecCCCCCeee--eeccchhhhhh
Q 005427 141 EFYESRNLAEKLHVEEW-SPSVDQVLMIAAQLAKALQYLHNLG--IVHRDVKPANVLLDRNLCPHLA--DFGLAEYRENL 215 (697)
Q Consensus 141 e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~~~~kL~--Dfg~a~~~~~~ 215 (697)
.|++.|+|+.+++.... -....++.+++.++++|++|||+.. |.---|.+..++||++.+.+|. |--++.
T Consensus 267 q~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsf----- 341 (448)
T KOG0195|consen 267 QYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSF----- 341 (448)
T ss_pred eeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeee-----
Confidence 99999999999987542 2356789999999999999999875 3444788899999998887764 322221
Q ss_pred hhhhcccccCCCCCCCCccccccccCccccchhhhcccCCC---chhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHh
Q 005427 216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHS---EKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLE 292 (697)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~ 292 (697)
......-.|.||+||.+...+-+ .++|+|||.+++|||-|++.||.+..+.+
T Consensus 342 ------------------qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspme------- 396 (448)
T KOG0195|consen 342 ------------------QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPME------- 396 (448)
T ss_pred ------------------eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchh-------
Confidence 11223457899999999876643 57899999999999999999999765443
Q ss_pred ccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 293 MNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
...++.-+++|+. +|++++..+..||.-|+..||.+||.|+.++-.|+.+
T Consensus 397 -------cgmkialeglrv~---ippgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 397 -------CGMKIALEGLRVH---IPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred -------hhhhhhhcccccc---CCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 3334444566654 4568999999999999999999999999998776654
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.6e-24 Score=220.77 Aligned_cols=174 Identities=18% Similarity=0.171 Sum_probs=131.5
Q ss_pred cCCCCCCCcccccccccCCceEEEEEEE---CCeeEEEEeccCC-----ChHHHHHHHHHHHHHHhcCCCCceE-Eeecc
Q 005427 60 PLHLPPSSYTLLSPIARGAESVVYEATL---DGRKVAVKKPILS-----TSEELDNFHKELQLLCKLDHPGLAK-FVAAH 130 (697)
Q Consensus 60 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~---~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~hpniv~-l~~~~ 130 (697)
+......+|.+.+.||+|+||+||+|++ +++.+|||+.... .......+.+|+++|+.++|+|+++ +++.
T Consensus 12 ~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~- 90 (365)
T PRK09188 12 QIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT- 90 (365)
T ss_pred ccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc-
Confidence 3445567899999999999999999976 4677899975422 2234567999999999999999985 5543
Q ss_pred ccCCceEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccC-CCCceeecCCCCCeeeeeccc
Q 005427 131 AKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDV-KPANVLLDRNLCPHLADFGLA 209 (697)
Q Consensus 131 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDl-kp~Nill~~~~~~kL~Dfg~a 209 (697)
...++||||++|++|... ... . ...++.+++.+|.|||++||+|||| ||+|||++.++.+||+|||+|
T Consensus 91 ---~~~~LVmE~~~G~~L~~~-~~~----~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA 159 (365)
T PRK09188 91 ---GKDGLVRGWTEGVPLHLA-RPH----G---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLA 159 (365)
T ss_pred ---CCcEEEEEccCCCCHHHh-Ccc----c---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccc
Confidence 457999999999999732 111 1 1467889999999999999999999 999999999999999999999
Q ss_pred hhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhccc
Q 005427 210 EYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKE 253 (697)
Q Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 253 (697)
+.+....... .-......++..+++.|+|||.+...
T Consensus 160 ~~~~~~~~~~--------~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 160 SVFRRRGALY--------RIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred eecccCcchh--------hhhhhhhhhhhhccCccCCcccCChh
Confidence 8664311100 00000112466889999999998643
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.7e-24 Score=238.82 Aligned_cols=261 Identities=21% Similarity=0.238 Sum_probs=193.2
Q ss_pred ccccccccCCceEEEEEEE--CCeeEEEEecc-----CCChHH-HHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEE
Q 005427 69 TLLSPIARGAESVVYEATL--DGRKVAVKKPI-----LSTSEE-LDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFF 140 (697)
Q Consensus 69 ~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~-----~~~~~~-~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 140 (697)
.....+|.|++|.|+.... ..+.++.|... ...... ...+..|+-+-..|.|||++..+..+.+.....-.|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 5677899999998877754 23334444322 111112 223677888888899999999888877776666669
Q ss_pred eecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhc
Q 005427 141 EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL 220 (697)
Q Consensus 141 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~ 220 (697)
|||++ +|+.++.... .++..++..++.|++.|++|+|+.||.|||+|++|++++.+|.+||+|||.+..+...-..
T Consensus 401 E~~~~-Dlf~~~~~~~-~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~-- 476 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSNG-KLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEK-- 476 (601)
T ss_pred hcccH-HHHHHHhccc-ccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcch--
Confidence 99999 9999987653 6788899999999999999999999999999999999999999999999998765421110
Q ss_pred ccccCCCCCCCCccccccccCccccchhhhcccCCCc-hhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHH
Q 005427 221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSE-KSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQ 299 (697)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~ 299 (697)
.-......+|+..|+|||++.+..|.+ ..||||.|++++.|.+|+.||.-........ ....+.
T Consensus 477 ----------~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~--~~~~~~--- 541 (601)
T KOG0590|consen 477 ----------NIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF--KTNNYS--- 541 (601)
T ss_pred ----------hhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch--hhhccc---
Confidence 012345678999999999999888764 6899999999999999999997643332211 000000
Q ss_pred HHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 005427 300 LTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL 353 (697)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~ 353 (697)
.+.....+.. .+...+|.+.+.+|.+||+.||.+|.|+++|++..|...
T Consensus 542 -~~~~~~~~~~----~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~ 590 (601)
T KOG0590|consen 542 -DQRNIFEGPN----RLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRS 590 (601)
T ss_pred -cccccccChH----HHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhh
Confidence 0000001111 122357888999999999999999999999999988753
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.7e-22 Score=206.48 Aligned_cols=256 Identities=31% Similarity=0.468 Sum_probs=198.6
Q ss_pred cccccccccCCceEEEEEEECCeeEEEEeccCCChH---HHHHHHHHHHHHHhcCCC-CceEEeeccccCCceEEEEeec
Q 005427 68 YTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSE---ELDNFHKELQLLCKLDHP-GLAKFVAAHAKPPNYMFFFEFY 143 (697)
Q Consensus 68 y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hp-niv~l~~~~~~~~~~~lv~e~~ 143 (697)
|.+.+.||.|+||.||++.+. ..+++|.+...... ....+.+|+.++..+.|+ +|+++.+.+......+++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 80 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYV 80 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec-cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecC
Confidence 788999999999999999887 77888875543322 467899999999999988 7999999997777789999999
Q ss_pred CCCCHhhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCC-CCeeeeeccchhhhhhhhhhc
Q 005427 144 ESRNLAEKLHVEE--WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNL-CPHLADFGLAEYRENLKEISL 220 (697)
Q Consensus 144 ~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~-~~kL~Dfg~a~~~~~~~~~~~ 220 (697)
.++++.+++.... ..++......++.|++.++.|+|+.+++|||+||+||+++..+ .++++|||++..........
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~- 159 (384)
T COG0515 81 DGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTS- 159 (384)
T ss_pred CCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCccc-
Confidence 9999997776554 2688899999999999999999999999999999999999988 69999999987443211100
Q ss_pred ccccCCCCCCCCccccccccCccccchhhhcc---cCCCchhhHHHHHHHHHHHHhCCCCCCCchh----HHHHHHHHhc
Q 005427 221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK---EIHSEKSDVYSFGISINELLTGVVPYTDLRA----EAQAHTVLEM 293 (697)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~----~~~~~~~~~~ 293 (697)
..........|+..|++||.+.+ ..+....|+||+|++++++++|..||..... ......+...
T Consensus 160 ---------~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~ 230 (384)
T COG0515 160 ---------SIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILEL 230 (384)
T ss_pred ---------cccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhc
Confidence 00012456789999999999987 5788999999999999999999999876543 1111111111
Q ss_pred cccHHHHHHHHHhCCCCCcccccccC----ChHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005427 294 NYTEQQLTAAVVSGGLRPILASLELG----LPASILSLIQRCWDGNPHNRPSFSDIALE 348 (697)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 348 (697)
... ......... ....+.+++..|+..+|..|.+..+...+
T Consensus 231 ~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 231 PTP--------------SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred CCc--------------ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 100 011111111 23678899999999999999999887765
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=8e-24 Score=221.53 Aligned_cols=224 Identities=30% Similarity=0.362 Sum_probs=183.8
Q ss_pred ccccCCceEEEEEE-----ECCeeEEEEeccCCChH--HHHHHHHHHHHHHhcC-CCCceEEeeccccCCceEEEEeecC
Q 005427 73 PIARGAESVVYEAT-----LDGRKVAVKKPILSTSE--ELDNFHKELQLLCKLD-HPGLAKFVAAHAKPPNYMFFFEFYE 144 (697)
Q Consensus 73 ~lg~G~~g~V~~~~-----~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lv~e~~~ 144 (697)
.+|+|.||.|++++ +.+..+|+|+....... .......|..++...+ ||.++++...+..+...++++++..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999999875 34667788764432211 1125567888888886 9999999999999999999999999
Q ss_pred CCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhccccc
Q 005427 145 SRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWR 224 (697)
Q Consensus 145 ~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~ 224 (697)
||.|...+.... .+.+.....+...++.+++++|+.+|+|||+|++||+++.+|++++.|||+++..-..+
T Consensus 81 gg~lft~l~~~~-~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~-------- 151 (612)
T KOG0603|consen 81 GGDLFTRLSKEV-MFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK-------- 151 (612)
T ss_pred cchhhhccccCC-chHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhh--------
Confidence 999999987655 67788889999999999999999999999999999999999999999999998765422
Q ss_pred CCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHHHHHH
Q 005427 225 SSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAV 304 (697)
Q Consensus 225 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (697)
..|||..|||||++. ....++|.||+|++++||++|..||.+ +....|.....
T Consensus 152 ------------~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~--------- 204 (612)
T KOG0603|consen 152 ------------IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAEL--------- 204 (612)
T ss_pred ------------hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhcc---------
Confidence 128999999999998 557789999999999999999999987 33333332111
Q ss_pred HhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCH
Q 005427 305 VSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSF 342 (697)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~ 342 (697)
..|..++..+.+++..++..+|.+|.-.
T Consensus 205 ----------~~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 205 ----------EMPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred ----------CCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 2345678899999999999999999754
|
|
| >KOG1379 consensus Serine/threonine protein phosphatase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.3e-21 Score=186.02 Aligned_cols=201 Identities=23% Similarity=0.301 Sum_probs=140.8
Q ss_pred CCCCceeEEcccccCCCceEEEEEecCCCChHH-----HHHHHHHhHHHHHhc-----CCCCChHHHHHHHHHHHHHHHH
Q 005427 441 ETMEDTHFLMPHMYNQKEIHMFGIFDGHRGSAA-----AEFSARALPGFLQNL-----GSTTRPTDALLEAFIRTDVAFR 510 (697)
Q Consensus 441 ~~neD~~~~~~~~~~~~~~~~~~V~DG~GG~~~-----~~~as~~~~~~l~~~-----~~~~~~~~~l~~~~~~~~~~~~ 510 (697)
..-||++++.. .....+.|||||+||+.- |.|+.+ ++....+. +...+|...|..++.++...-
T Consensus 89 ~~GEDa~Fvss----~~~~~v~GVADGVGGWa~~GiDpg~fS~e-LM~~ce~~v~~~~~~~~~P~~lL~~ay~~l~~~~- 162 (330)
T KOG1379|consen 89 KGGEDAWFVSS----NPHAIVMGVADGVGGWAEYGIDPGAFSRE-LMSNCERLVQNSDFNPSDPVNLLEKAYAELKSQK- 162 (330)
T ss_pred CCCCcceeecc----CcccceEEEccccchHhhcCcCHHHHHHH-HHHHHHHHhcccccCCCChHHHHHHHHHHHhhcC-
Confidence 56789999976 346779999999999854 444443 33333322 334466666666665432110
Q ss_pred HHHHHHHhhhhcccCCCCCCceEEEEEEe--cCeEEEEEcCCeEEEEEECCeeeecCCCCC--CCCHHHHHHHHHcCCee
Q 005427 511 NELDSLRKSKRVVQKDWHPGCTAIAALIV--RNRLFVANAGDCRAILCRGGHPFALSRDHV--ASCLEERERVVSAGGNV 586 (697)
Q Consensus 511 ~~~~~~~~~~~~~~~~~~~GtT~~~~~i~--~~~l~~anvGDSr~~l~~~~~~~~lt~dH~--~~~~~e~~ri~~~g~~~ 586 (697)
...-++|||+++++. +++||+||+|||-..++|+|++++-|..+. .+.|-+
T Consensus 163 --------------~~~vGSSTAcI~~l~~~~~~Lh~aNLGDSGF~VvR~G~vv~~S~~Q~H~FN~PyQ----------- 217 (330)
T KOG1379|consen 163 --------------VPIVGSSTACILALDRENGKLHTANLGDSGFLVVREGKVVFRSPEQQHYFNTPYQ----------- 217 (330)
T ss_pred --------------CCCCCcceeeeeeeecCCCeEEEeeccCcceEEEECCEEEEcCchheeccCCcee-----------
Confidence 011247899999888 889999999999999999999999988761 111111
Q ss_pred eeccCcceeCCCcceeccccCCCCCCCCcccCCceEEEEeCCCCeEEEEEcCCcccCCChHHHHHHHHhhc----CChhH
Q 005427 587 NWQVDTWRVGPPALQVTRSIGDDDLKPAVTAEPEITETIMTPEDEYLVMASDGLWDVVSHVEAVGIIKDTV----KEPGM 662 (697)
Q Consensus 587 ~~~~~~~~~~~~~~~ltralG~~~~k~~v~~~p~v~~~~l~~~d~~lvl~SDGl~d~~~~~ei~~~~~~~~----~~~~~ 662 (697)
....|... ..+++|.. -..+++.+.+++|| +||||||||||+|.+++|..++.... .+++.
T Consensus 218 ------Ls~~p~~~--~~~~~d~p------~~ad~~~~~v~~GD-vIilATDGlfDNl~e~~Il~il~~~~~~~~~~lq~ 282 (330)
T KOG1379|consen 218 ------LSSPPEGY--SSYISDVP------DSADVTSFDVQKGD-VIILATDGLFDNLPEKEILSILKGLDARGNLDLQV 282 (330)
T ss_pred ------eccCCccc--cccccCCc------cccceEEEeccCCC-EEEEecccccccccHHHHHHHHHHhhccccccHHH
Confidence 01111111 23344433 34678899999999 88899999999999999999997644 37899
Q ss_pred HHHHHHHHHHh-----------------------cCCCCCcEEEEEEe
Q 005427 663 CSKRLATEAAE-----------------------RGSKDNITVIVVFL 687 (697)
Q Consensus 663 ~a~~L~~~a~~-----------------------~g~~DNiT~ivv~l 687 (697)
.|+.|++.|.+ .|..|+||+||..+
T Consensus 283 ~A~~ia~~Ar~ls~d~~~~SPFA~~Ar~~g~~~~gGK~DdITvvls~v 330 (330)
T KOG1379|consen 283 TAQKIAEKARELSRDPKFQSPFAQAAREHGFKAYGGKPDDITVVLSSV 330 (330)
T ss_pred HHHHHHHHHHHhccCcCcCChHHHHHHHhCcccCCCCcccEEEEEecC
Confidence 99999999965 23469999999753
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=2e-22 Score=193.46 Aligned_cols=172 Identities=15% Similarity=0.155 Sum_probs=133.8
Q ss_pred CCCCCcccccccccCCceEEEEEEECCeeEEEEeccCCChHH---HHH------HHHHHHHHHhcCCCCceEEeeccccC
Q 005427 63 LPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEE---LDN------FHKELQLLCKLDHPGLAKFVAAHAKP 133 (697)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~---~~~------~~~E~~~l~~l~hpniv~l~~~~~~~ 133 (697)
+...+|++.++||.|+||.||++..++..+|+|.+....... ... +.+|+..+.++.||+|..+.+++...
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 445789999999999999999987778899999876443222 222 68999999999999999988876543
Q ss_pred --------CceEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeee
Q 005427 134 --------PNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLAD 205 (697)
Q Consensus 134 --------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~D 205 (697)
...+++|||++|.+|.+... +++ ....+++.+|..||+.|++|||+||+||+++.+| ++|+|
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liD 177 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIID 177 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEE
Confidence 35889999999999988632 232 2456999999999999999999999999999988 99999
Q ss_pred eccchhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHH
Q 005427 206 FGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELL 272 (697)
Q Consensus 206 fg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell 272 (697)
||.......... ....+....+..++|+||||+++..+.
T Consensus 178 fg~~~~~~e~~a----------------------------~d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 178 LSGKRCTAQRKA----------------------------KDRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCCcccccchhh----------------------------HHHHHHHhHhcccccccceeEeehHHH
Confidence 998754432111 011334444667899999999987654
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.7e-22 Score=218.80 Aligned_cols=250 Identities=22% Similarity=0.202 Sum_probs=183.6
Q ss_pred CcccccccccCCceEEEEEEECCeeEEEEeccCCCh-HHHHHH---HHHHHHHHhcCCCCceEEeeccccCCceEEEEee
Q 005427 67 SYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTS-EELDNF---HKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF 142 (697)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~-~~~~~~---~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 142 (697)
.|...+.||.+.|=.|.+|++....|+||++..... -..+.+ ..|++ ...++|||.+++.-+-....-.|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 677889999999999999998766699998655442 223333 34444 5666999999999888888888999999
Q ss_pred cCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhccc
Q 005427 143 YESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKN 222 (697)
Q Consensus 143 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 222 (697)
... +|+|.+..+. .+...+.+.|+.|++.||..+|..||+|||||.+||||+.=..+.|+||..-+..--
T Consensus 103 vkh-nLyDRlSTRP-FL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYL-------- 172 (1431)
T KOG1240|consen 103 VKH-NLYDRLSTRP-FLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYL-------- 172 (1431)
T ss_pred Hhh-hhhhhhccch-HHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccC--------
Confidence 987 9999997654 457778888999999999999999999999999999999999999999997642211
Q ss_pred ccCCCCCCC-CccccccccCccccchhhhccc----------C-CCchhhHHHHHHHHHHHHh-CCCCCCCchhHHHHHH
Q 005427 223 WRSSGKPTG-GFHKKNMVGTLIYMAPEILKKE----------I-HSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHT 289 (697)
Q Consensus 223 ~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~----------~-~~~~~DiwslG~~l~ell~-g~~Pf~~~~~~~~~~~ 289 (697)
....|.. .+.--+-..-.+|.|||.+... + .+++.||||+||+++||++ |++||.-. ++..
T Consensus 173 --PeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS----QL~a 246 (1431)
T KOG1240|consen 173 --PEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS----QLLA 246 (1431)
T ss_pred --CCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH----HHHh
Confidence 1111110 1111122233589999987531 2 4678999999999999999 89999621 2222
Q ss_pred HHhc-cccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005427 290 VLEM-NYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALE 348 (697)
Q Consensus 290 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 348 (697)
...+ ....+...+ .-.+..+++++..|++.||++|.++++.|+.
T Consensus 247 Yr~~~~~~~e~~Le---------------~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 247 YRSGNADDPEQLLE---------------KIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred HhccCccCHHHHHH---------------hCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 2222 122222221 1123478899999999999999999999876
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.5e-21 Score=190.61 Aligned_cols=204 Identities=27% Similarity=0.339 Sum_probs=146.1
Q ss_pred CCCCceEEeecccc---------------------------CCceEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHH
Q 005427 119 DHPGLAKFVAAHAK---------------------------PPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQL 171 (697)
Q Consensus 119 ~hpniv~l~~~~~~---------------------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi 171 (697)
+|||||++..+|.+ +...|+||.-++. +|..++..+ ..+......++.|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~--~~s~r~~~~~laQl 350 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR--HRSYRTGRVILAQL 350 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC--CCchHHHHHHHHHH
Confidence 69999999887643 3357889988876 899988655 35667888899999
Q ss_pred HHHHHHHHhCCcccccCCCCceee--cCCC--CCeeeeeccchhhhhhhhhhcccccCCCCCCCCccccccccCccccch
Q 005427 172 AKALQYLHNLGIVHRDVKPANVLL--DRNL--CPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAP 247 (697)
Q Consensus 172 ~~~l~~LH~~~ivHrDlkp~Nill--~~~~--~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 247 (697)
++|+.|||.+||.|||+|++|||+ +.++ .+.|+|||.+-.-+. ....-.|.+ .....-|...-|||
T Consensus 351 LEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~--hGlqlpy~S--------~~Vd~GGNa~lmAP 420 (598)
T KOG4158|consen 351 LEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDN--HGLQLPYES--------DEVDLGGNAKLMAP 420 (598)
T ss_pred HHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccc--ccccccccc--------ccccCCCcceecch
Confidence 999999999999999999999999 3333 467999998732211 000000111 11233577789999
Q ss_pred hhhcccCC------CchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHHHHHHHhCCCCCcccccccCCh
Q 005427 248 EILKKEIH------SEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLP 321 (697)
Q Consensus 248 E~~~~~~~------~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (697)
|+...-+- -.++|.|+.|.+.||+++...||.+...... . ...|.+ ..++.++..+|
T Consensus 421 Ei~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L-~---~r~Yqe-------------~qLPalp~~vp 483 (598)
T KOG4158|consen 421 EIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLL-D---TRTYQE-------------SQLPALPSRVP 483 (598)
T ss_pred hhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhee-c---hhhhhh-------------hhCCCCcccCC
Confidence 99864331 3589999999999999999999987321110 0 001222 12445677899
Q ss_pred HHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 322 ASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 322 ~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
+.+.+++..+|+.||++|++..=..+.+...
T Consensus 484 p~~rqlV~~lL~r~pskRvsp~iAANvl~Ls 514 (598)
T KOG4158|consen 484 PVARQLVFDLLKRDPSKRVSPNIAANVLNLS 514 (598)
T ss_pred hHHHHHHHHHhcCCccccCCccHHHhHHHHH
Confidence 9999999999999999999977665555443
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.85 E-value=8.9e-21 Score=187.67 Aligned_cols=230 Identities=21% Similarity=0.289 Sum_probs=147.8
Q ss_pred CcccccccccCCceEEEEEEE--CCeeEEEEeccCCCh---HHHHHHHHHHHHHHhcCC----------CCceEEeeccc
Q 005427 67 SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTS---EELDNFHKELQLLCKLDH----------PGLAKFVAAHA 131 (697)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h----------pniv~l~~~~~ 131 (697)
.+.....||.|+++.||.+++ +++.+|||+...... .+++.+++|.-....+.+ -.++--++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 466788999999999999999 579999998654432 346677777655544322 11222122111
Q ss_pred ------------cCC-----ceEEEEeecCCCCHhhhhhh---cCCC---CCHHHHHHHHHHHHHHHHHHHhCCcccccC
Q 005427 132 ------------KPP-----NYMFFFEFYESRNLAEKLHV---EEWS---PSVDQVLMIAAQLAKALQYLHNLGIVHRDV 188 (697)
Q Consensus 132 ------------~~~-----~~~lv~e~~~~g~L~~~l~~---~~~~---~~~~~~~~i~~qi~~~l~~LH~~~ivHrDl 188 (697)
+.. +++++|+-+. ++|.+++.. .... ......+.+..|++..+++||+.|++|+||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi 171 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI 171 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred EcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence 111 3466777774 588777542 2211 122344567799999999999999999999
Q ss_pred CCCceeecCCCCCeeeeeccchhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcc--------cCCCchhh
Q 005427 189 KPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK--------EIHSEKSD 260 (697)
Q Consensus 189 kp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~D 260 (697)
||+|++++.+|.++|+||+........ ......+..|.+||.... ..++.+.|
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~-------------------~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~D 232 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAGTR-------------------YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATD 232 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETTEE-------------------EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHH
T ss_pred ceeeEEEcCCCCEEEcChHHHeecCce-------------------eeccCCCcccCChhhhhhhcccCcccceeeeccC
Confidence 999999999999999999987654321 111334578999997743 34788999
Q ss_pred HHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCC
Q 005427 261 VYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNR 339 (697)
Q Consensus 261 iwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R 339 (697)
.|+||+++|.|+|+..||.......... ..+.... ++|..++.||..+|+.||.+|
T Consensus 233 aW~LG~~ly~lWC~~lPf~~~~~~~~~~----------------------~~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 233 AWQLGITLYSLWCGRLPFGLSSPEADPE----------------------WDFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHHHHHHHHHSS-STCCCGGGSTSG----------------------GGGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHHHHHHHHHHHHccCCCCCCCcccccc----------------------ccchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 9999999999999999998653322110 0122333 789999999999999999988
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.6e-21 Score=213.89 Aligned_cols=220 Identities=27% Similarity=0.362 Sum_probs=160.4
Q ss_pred CCCcccccccccCCceEEEEEEEC--CeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEee
Q 005427 65 PSSYTLLSPIARGAESVVYEATLD--GRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF 142 (697)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 142 (697)
..+|..++.|..|+||.||+++++ .+++|+|+ +.++. .+++ +|.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~l----ilRn---ilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNL----ILRN---ILTFAGNPFVV------------------ 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcc-cccch----hhhc---cccccCCccee------------------
Confidence 468999999999999999999875 77899954 21110 0011 33333444444
Q ss_pred cCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhh-cc
Q 005427 143 YESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEIS-LK 221 (697)
Q Consensus 143 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~-~~ 221 (697)
|+-...++..+ .++. +++.+++|||+.||+|||+||+|.||+.-|++|++|||+++......... ..
T Consensus 136 ---gDc~tllk~~g-~lPv--------dmvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~e 203 (1205)
T KOG0606|consen 136 ---GDCATLLKNIG-PLPV--------DMVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKE 203 (1205)
T ss_pred ---chhhhhcccCC-CCcc--------hhhHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhh
Confidence 44444554433 2332 23889999999999999999999999999999999999986443211110 00
Q ss_pred cccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHHH
Q 005427 222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLT 301 (697)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 301 (697)
.+. ......+.....+|||.|.|||++..+.|+..+|+|++|+++||++.|..||.+.+.++.+..++.....+.+
T Consensus 204 g~I--~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE-- 279 (1205)
T KOG0606|consen 204 GHI--EKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE-- 279 (1205)
T ss_pred cch--HHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccc--
Confidence 000 0123344566779999999999999999999999999999999999999999998888877776654433321
Q ss_pred HHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCC
Q 005427 302 AAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRP 340 (697)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp 340 (697)
-...+++++.+++.++|+.+|..|.
T Consensus 280 --------------~dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 280 --------------EDEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred --------------cCcCCCHHHHHHHHHHHHhChHhhc
Confidence 1345789999999999999999994
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.5e-21 Score=183.44 Aligned_cols=138 Identities=20% Similarity=0.170 Sum_probs=106.6
Q ss_pred ccccccCCceEEEEEEE-CCeeEEEEeccCCChH--H------------------------HHHHHHHHHHHHhcCCCCc
Q 005427 71 LSPIARGAESVVYEATL-DGRKVAVKKPILSTSE--E------------------------LDNFHKELQLLCKLDHPGL 123 (697)
Q Consensus 71 ~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~--~------------------------~~~~~~E~~~l~~l~hpni 123 (697)
...||+|+||.||+|.. +|+.||||+....... . ......|+.+|..+.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 56899999999999987 6899999986543210 0 1123459999999987776
Q ss_pred eEEeeccccCCceEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHH-HhCCcccccCCCCceeecCCCCCe
Q 005427 124 AKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYL-HNLGIVHRDVKPANVLLDRNLCPH 202 (697)
Q Consensus 124 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~L-H~~~ivHrDlkp~Nill~~~~~~k 202 (697)
.....+.. ...++||||++|+++...... ...+++.++..++.|++.+|.|+ |+.||+||||||+|||++ ++.++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~ 157 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLK-DAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLY 157 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhh-cCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEE
Confidence 43222211 223899999998777654332 34688899999999999999999 799999999999999998 47899
Q ss_pred eeeeccchhh
Q 005427 203 LADFGLAEYR 212 (697)
Q Consensus 203 L~Dfg~a~~~ 212 (697)
|+|||+|...
T Consensus 158 LiDFG~a~~~ 167 (190)
T cd05147 158 IIDVSQSVEH 167 (190)
T ss_pred EEEccccccC
Confidence 9999998644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=3e-20 Score=174.35 Aligned_cols=197 Identities=16% Similarity=0.100 Sum_probs=140.9
Q ss_pred ccccccccCCceEEEEEEECCeeEEEEeccCCChH----HHHHHHHHHHHHHhcC-CCCceEEeeccccCCceEEEEeec
Q 005427 69 TLLSPIARGAESVVYEATLDGRKVAVKKPILSTSE----ELDNFHKELQLLCKLD-HPGLAKFVAAHAKPPNYMFFFEFY 143 (697)
Q Consensus 69 ~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~----~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lv~e~~ 143 (697)
.+...|++|+||+||++...+.+++.+.+.....- ....+.+|+++|++|. |+++++++++ ...+++|||+
T Consensus 5 ~~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred ccceeecCCCcceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 46778999999999999888888887764433221 1235889999999995 5889999886 4569999999
Q ss_pred CCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccC-CCCceeecCCCCCeeeeeccchhhhhhhhhhccc
Q 005427 144 ESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDV-KPANVLLDRNLCPHLADFGLAEYRENLKEISLKN 222 (697)
Q Consensus 144 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDl-kp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 222 (697)
.|.+|...+.. ....++.|++.+|.++|+.||+|||| ||+|||++.++.++|+|||++.......... ..
T Consensus 81 ~G~~L~~~~~~--------~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~-r~ 151 (218)
T PRK12274 81 AGAAMYQRPPR--------GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWM-RL 151 (218)
T ss_pred cCccHHhhhhh--------hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHH-HH
Confidence 99888754321 12357789999999999999999999 7999999999999999999997443211000 00
Q ss_pred ccCCCCCCCCccccccccCccccchhhhccc-CCC-chhhHHHHHHHHHHHHhCCCCCCC
Q 005427 223 WRSSGKPTGGFHKKNMVGTLIYMAPEILKKE-IHS-EKSDVYSFGISINELLTGVVPYTD 280 (697)
Q Consensus 223 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~-~~~DiwslG~~l~ell~g~~Pf~~ 280 (697)
+.. .......+.-...++.|++|+...-. ..+ ...+.++.|+.+|.++|+..|+.+
T Consensus 152 L~~--rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 152 LAR--EDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred HHH--HHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 000 00000001112367888999865432 223 567889999999999998888654
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=9.3e-20 Score=174.55 Aligned_cols=140 Identities=23% Similarity=0.238 Sum_probs=109.0
Q ss_pred cccccccCCceEEEEEEE-CCeeEEEEeccCCChH--------------------------HHHHHHHHHHHHHhcCCCC
Q 005427 70 LLSPIARGAESVVYEATL-DGRKVAVKKPILSTSE--------------------------ELDNFHKELQLLCKLDHPG 122 (697)
Q Consensus 70 ~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~--------------------------~~~~~~~E~~~l~~l~hpn 122 (697)
+...||+|+||.||+|.+ +|+.||||+....... ....+..|...+.++.|++
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 1 INGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CCceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 357899999999999987 5999999986543210 0123468999999999998
Q ss_pred ceEEeeccccCCceEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCCCceeecCCCCC
Q 005427 123 LAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHN-LGIVHRDVKPANVLLDRNLCP 201 (697)
Q Consensus 123 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivHrDlkp~Nill~~~~~~ 201 (697)
+.....+... ..++||||++|+++...... ...++..++..++.|++.++.++|+ .||+||||||+|||++ ++.+
T Consensus 81 i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~-~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~ 156 (190)
T cd05145 81 VPVPEPILLK--KNVLVMEFIGDDGSPAPRLK-DVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKP 156 (190)
T ss_pred CCCceEEEec--CCEEEEEEecCCCchhhhhh-hccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCE
Confidence 7443332222 24899999998755443222 2357788999999999999999999 9999999999999998 7899
Q ss_pred eeeeeccchhhh
Q 005427 202 HLADFGLAEYRE 213 (697)
Q Consensus 202 kL~Dfg~a~~~~ 213 (697)
+|+|||++....
T Consensus 157 ~liDFG~a~~~~ 168 (190)
T cd05145 157 YIIDVSQAVELD 168 (190)
T ss_pred EEEEcccceecC
Confidence 999999997544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.1e-19 Score=201.90 Aligned_cols=253 Identities=20% Similarity=0.265 Sum_probs=183.5
Q ss_pred cCCCCCCCcccccccccCCceEEEEEEE-CCeeEEEEeccCCChHHHHHHHHHHHHHHhcC---CCCceEEeeccccCCc
Q 005427 60 PLHLPPSSYTLLSPIARGAESVVYEATL-DGRKVAVKKPILSTSEELDNFHKELQLLCKLD---HPGLAKFVAAHAKPPN 135 (697)
Q Consensus 60 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~l~~~~~~~~~ 135 (697)
.+++.++.|.|-+.||+|+||.||+|.. +++.||+|+-.....-+.-.. ..++.+|+ -+-|..+...+.-.+.
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI~---~q~~~RLk~~~~~~~~~~~~a~~~~~~ 768 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYIC---LQVMERLKPQMLPSIMHISSAHVFQNA 768 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeeeh---HHHHHhhchhhhcchHHHHHHHccCCc
Confidence 3556778899999999999999999986 689999998555443331111 12333443 2455556666667788
Q ss_pred eEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecC-------CCCCeeeeecc
Q 005427 136 YMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDR-------NLCPHLADFGL 208 (697)
Q Consensus 136 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~-------~~~~kL~Dfg~ 208 (697)
.++|+||.+.|+|.+++... ..+++.-++.+..|++..++.||..+|||+||||+|+||.. ..-++|+|||-
T Consensus 769 S~lv~ey~~~Gtlld~~N~~-~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~ 847 (974)
T KOG1166|consen 769 SVLVSEYSPYGTLLDLINTN-KVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGR 847 (974)
T ss_pred ceeeeeccccccHHHhhccC-CCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEeccc
Confidence 89999999999999999744 36888999999999999999999999999999999999942 34589999999
Q ss_pred chhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHH
Q 005427 209 AEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAH 288 (697)
Q Consensus 209 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~ 288 (697)
+.-+.-..+ +..-...++|-.+-.+|+..|.+++..+|.|.|+.+++-||.|+..=
T Consensus 848 siDm~lfp~--------------~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q---------- 903 (974)
T KOG1166|consen 848 SIDMKLFPD--------------GTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME---------- 903 (974)
T ss_pred ceeeeEcCC--------------CcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH----------
Confidence 865543222 22345668899999999999999999999999999999999986321
Q ss_pred HHHhccccHHHHHHHHHhCCCCCcccccccCChHH-HHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 005427 289 TVLEMNYTEQQLTAAVVSGGLRPILASLELGLPAS-ILSLIQRCWDGNPHNRPSFSDIALELDLVLEH 355 (697)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~ 355 (697)
+..+..+.....++...-.+ ..+++..+|+.|-..=|...+|...+...+..
T Consensus 904 ---------------~~~g~~~~~~~~~~Ry~~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~ 956 (974)
T KOG1166|consen 904 ---------------VKNGSSWMVKTNFPRYWKRDMWNKFFDLLLNPDCDTLPNLQELRTELEEVLAE 956 (974)
T ss_pred ---------------hcCCcceeccccchhhhhHHHHHHHHHHHhCcCcccchhHHHHHHHHHHHHHH
Confidence 01111111111111122233 33777778885544557777877777766654
|
|
| >PF13672 PP2C_2: Protein phosphatase 2C; PDB: 2JFT_A 2JFS_A 2V06_A 2JFR_A 2J86_A 2J82_A 2Y09_A 2XZV_A 2CM1_A 1TXO_B | Back alignment and domain information |
|---|
Probab=99.81 E-value=9.2e-20 Score=178.33 Aligned_cols=188 Identities=21% Similarity=0.277 Sum_probs=101.2
Q ss_pred eeccCCCCCCCceeEEcccccCCCceEEEEEecCCCChHHHHHHHHHhHHHHHhcCC--CCChHHH-HHHHHHHHHHHHH
Q 005427 434 FATCGRRETMEDTHFLMPHMYNQKEIHMFGIFDGHRGSAAAEFSARALPGFLQNLGS--TTRPTDA-LLEAFIRTDVAFR 510 (697)
Q Consensus 434 ~s~~G~R~~neD~~~~~~~~~~~~~~~~~~V~DG~GG~~~~~~as~~~~~~l~~~~~--~~~~~~~-l~~~~~~~~~~~~ 510 (697)
.+++|.|..|||++.+.. ..+..+++||||+||...|+.+|+.+++.+.+... ....... ....+..+...+.
T Consensus 3 ~sh~~~~~~nqD~~~~~~----~~~~~~~aVaDG~g~~~~~~~aa~~av~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 78 (212)
T PF13672_consen 3 RSHRGRGAPNQDAFGIRT----DDDGNLAAVADGVGGSPYGEEAAQLAVETFINYLKKLLSQESPSSIEALIRAIKKEIL 78 (212)
T ss_dssp ----TTSSS--EEEEEE-----TCCTCEEEEEEEESTTTHHHHHHHHHHHHHHHHHHHSCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccCCCCCCCCCEEeee----CCCCEEEEEEECCCCCchhHHHHHHHHHHHHHHHHhcccccchHHHHHHHHHHHHHHH
Confidence 578899999999999654 23445779999999999999988888887765521 1111111 2233333333333
Q ss_pred HHHHHHHhhhhcccCCCCCCceEEEEEEecCeEEEEEcCCeEEEE-EECCeeeecCCCCCCCCHHHHHHHHHcCCeeeec
Q 005427 511 NELDSLRKSKRVVQKDWHPGCTAIAALIVRNRLFVANAGDCRAIL-CRGGHPFALSRDHVASCLEERERVVSAGGNVNWQ 589 (697)
Q Consensus 511 ~~~~~~~~~~~~~~~~~~~GtT~~~~~i~~~~l~~anvGDSr~~l-~~~~~~~~lt~dH~~~~~~e~~ri~~~g~~~~~~ 589 (697)
..................++||++++++.+++++++|+||||+|+ .++|.+..+|.||+ .+.. .
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~tTl~~~v~~~~~~~~~~iGD~~i~~~~~~g~~~~l~~~~~----~~~~---~-------- 143 (212)
T PF13672_consen 79 SIVRAFQSAKQADLELRDYGTTLLALVIDPDKVYIFNIGDSRIYVIRRNGEIQQLTDDHS----GEYP---N-------- 143 (212)
T ss_dssp HHH----HHHHHSGGGTT-EE-EEEEEEETTEEEEEEESS-EEEEEEETTEEEE-S---B----HHHH---H--------
T ss_pred HHhhhhhhhhhccccccccCceEEEEEEECCEEEEEEECCCeEEEEECCCEEEEcCCCcc----chhh---h--------
Confidence 221000000001112335799999999999999999999999965 58999999999993 1110 0
Q ss_pred cCcceeCCCcceeccccCCCCCCCCcccCCceEEEEeCCCCeEEEEEcCCcccCCChHH-HHHHHHhhc
Q 005427 590 VDTWRVGPPALQVTRSIGDDDLKPAVTAEPEITETIMTPEDEYLVMASDGLWDVVSHVE-AVGIIKDTV 657 (697)
Q Consensus 590 ~~~~~~~~~~~~ltralG~~~~k~~v~~~p~v~~~~l~~~d~~lvl~SDGl~d~~~~~e-i~~~~~~~~ 657 (697)
. |+.+..... ....++..+.+.++| .|+|||||||+.+...+ +..++....
T Consensus 144 -----------~-~~~~~~~~~----~~~~~~~~~~~~~~d-~ilL~SDG~~~~l~~~~~~~~~l~~~~ 195 (212)
T PF13672_consen 144 -----------Q-TRSLTGDDP----EPDVQYGSIPLEEGD-VILLCSDGVWDNLRSYEDLEQFLKDLW 195 (212)
T ss_dssp -----------C-TTSCCHHCC----CTETEEEEEE--TT--EEEEE-HHHHTTS-HHHHHHHH-----
T ss_pred -----------h-hhccCcccc----ccCCeEEEEEcCCCC-EEEEECcCccccCCCHHHHHHHhhhcc
Confidence 0 222222110 123466677788888 67799999999998655 667776554
|
... |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=3e-19 Score=171.54 Aligned_cols=135 Identities=24% Similarity=0.304 Sum_probs=106.2
Q ss_pred cccccccCCceEEEEEEECCeeEEEEeccCCChHHHHHHHHHHHHHHhc-----CCCCceEEeeccccCC---c-eEEEE
Q 005427 70 LLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKL-----DHPGLAKFVAAHAKPP---N-YMFFF 140 (697)
Q Consensus 70 ~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~hpniv~l~~~~~~~~---~-~~lv~ 140 (697)
-.++||+|+||.||.-...+.. +||+.........+.+.+|+.+++.+ .||||+++++++.++. . +.+|+
T Consensus 6 ~~~~LG~G~~~~Vy~hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~ 84 (210)
T PRK10345 6 EQSPLGTGRHRKCYAHPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIA 84 (210)
T ss_pred CcceecCCCceEEEECCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEe
Confidence 4578999999999962223434 79987665444567899999999999 5799999999998874 3 34789
Q ss_pred ee--cCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHH-HHHHhCCcccccCCCCceeecC----CCCCeeeeeccc
Q 005427 141 EF--YESRNLAEKLHVEEWSPSVDQVLMIAAQLAKAL-QYLHNLGIVHRDVKPANVLLDR----NLCPHLADFGLA 209 (697)
Q Consensus 141 e~--~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l-~~LH~~~ivHrDlkp~Nill~~----~~~~kL~Dfg~a 209 (697)
|| +.+|+|.+++... .+++. ..++.+++.++ +|||+.+|+||||||+|||++. ++.++|+||+.+
T Consensus 85 e~~G~~~~tL~~~l~~~--~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 85 DFDGKPSITLTEFAEQC--RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred cCCCCcchhHHHHHHcc--cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 99 5579999999653 45555 35678888777 9999999999999999999974 347999995533
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.3e-19 Score=190.65 Aligned_cols=216 Identities=30% Similarity=0.518 Sum_probs=166.7
Q ss_pred HHhcCCCCceEEeeccccCCceEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCc-ccccCCCCce
Q 005427 115 LCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGI-VHRDVKPANV 193 (697)
Q Consensus 115 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i-vHrDlkp~Ni 193 (697)
|+.+.|.|+.++++.+.+++..+.|.+||..|+|.+.+......+++-....+.++++.||+|||+..| .|+.+++.|+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 467899999999999999999999999999999999998877778888889999999999999999877 9999999999
Q ss_pred eecCCCCCeeeeeccchhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccC-------CCchhhHHHHHH
Q 005427 194 LLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEI-------HSEKSDVYSFGI 266 (697)
Q Consensus 194 ll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~DiwslG~ 266 (697)
+++..+.+||+|||+......... .. ......-...|.|||.+.... .+.+.||||+|+
T Consensus 81 lvd~~w~lklt~~Gl~~~~~~~~~-------~~-------~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~i 146 (484)
T KOG1023|consen 81 LVDSRWVLKLTDFGLNSLLEETAE-------PE-------AHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGI 146 (484)
T ss_pred eeeeeEEEEechhhhccccccccc-------cc-------ccchhHHHHhccCHHHhcccccccccccccccCCeehHHH
Confidence 999999999999999876542000 00 011112456799999997642 356799999999
Q ss_pred HHHHHHhCCCCCCCchhHHHHHHHHhccccHHHHHHHHHh---CCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHH
Q 005427 267 SINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVS---GGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFS 343 (697)
Q Consensus 267 ~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ 343 (697)
+++|+++...||......... .+....+.. ..++|.+.... ..++++..+++.||..+|.+||+++
T Consensus 147 i~~ei~~r~~~~~~~~~~~~~----------~eii~~~~~~~~~~~rP~i~~~~-e~~~~l~~l~~~cw~e~P~~rPs~~ 215 (484)
T KOG1023|consen 147 IMYEILFRSGPFDLRNLVEDP----------DEIILRVKKGGSNPFRPSIELLN-ELPPELLLLVARCWEEIPEKRPSIE 215 (484)
T ss_pred HHHHHHhccCccccccccCCh----------HHHHHHHHhcCCCCcCcchhhhh-hcchHHHHHHHHhcccChhhCccHH
Confidence 999999999999763222111 111111222 22444444332 5667899999999999999999999
Q ss_pred HHHHHHHHHHHH
Q 005427 344 DIALELDLVLEH 355 (697)
Q Consensus 344 ell~~l~~~~~~ 355 (697)
++-..+..+...
T Consensus 216 ~i~~~~~~~~~~ 227 (484)
T KOG1023|consen 216 QIRSKLLTINKG 227 (484)
T ss_pred HHHhhhhhhccc
Confidence 998776666543
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.1e-17 Score=163.76 Aligned_cols=135 Identities=24% Similarity=0.432 Sum_probs=114.2
Q ss_pred ccccccCCceEEEEEEECCeeEEEEeccCCCh--------HHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEee
Q 005427 71 LSPIARGAESVVYEATLDGRKVAVKKPILSTS--------EELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF 142 (697)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 142 (697)
++.||+|++|.||+|.+.+..+++|+...... .....+.+|+.++..+.|++|+....++......+++|||
T Consensus 1 ~~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 1 MKLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred CcccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 36799999999999999999999997543221 1134678899999999999987766666677788999999
Q ss_pred cCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchh
Q 005427 143 YESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEY 211 (697)
Q Consensus 143 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~ 211 (697)
++|++|.+.+.... . ....++.+++.+|.++|+.|++|||++|.|||++ ++.++|+|||.+..
T Consensus 81 ~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG----M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999886432 2 7889999999999999999999999999999999 78899999998864
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.75 E-value=6.5e-18 Score=166.56 Aligned_cols=140 Identities=21% Similarity=0.209 Sum_probs=110.5
Q ss_pred CcccccccccCCceEEEEEE-E--CCeeEEEEeccCCChH------------------------HHHHHHHHHHHHHhcC
Q 005427 67 SYTLLSPIARGAESVVYEAT-L--DGRKVAVKKPILSTSE------------------------ELDNFHKELQLLCKLD 119 (697)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~-~--~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~ 119 (697)
-|.+.+.||+|+||.||+|. + +|+.||+|+....... ....+..|+.+++++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 48899999999999999998 3 6899999986543210 1124578999999997
Q ss_pred CC--CceEEeeccccCCceEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC-cccccCCCCceeec
Q 005427 120 HP--GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLG-IVHRDVKPANVLLD 196 (697)
Q Consensus 120 hp--niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-ivHrDlkp~Nill~ 196 (697)
+. .+++++.. ...++||||+.|++|....... ..+...++..++.|++.+|++||+.| ++||||||+||+++
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~ 183 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD-VEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH 183 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCccccccccc-CCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE
Confidence 53 34455543 2358999999998887654322 24566677899999999999999999 99999999999999
Q ss_pred CCCCCeeeeeccchhh
Q 005427 197 RNLCPHLADFGLAEYR 212 (697)
Q Consensus 197 ~~~~~kL~Dfg~a~~~ 212 (697)
++.++|+|||++...
T Consensus 184 -~~~i~LiDFg~a~~~ 198 (237)
T smart00090 184 -DGKVVIIDVSQSVEL 198 (237)
T ss_pred -CCCEEEEEChhhhcc
Confidence 889999999998643
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.1e-17 Score=179.30 Aligned_cols=249 Identities=26% Similarity=0.462 Sum_probs=199.6
Q ss_pred cCcccceEeeeccCCCCCCCceeEEcccccCCCceEEEEEecCCCChHHHHHHHHHhHHHHHhc-CCCCChHHHHHHHHH
Q 005427 425 YYPVLSWGSFATCGRRETMEDTHFLMPHMYNQKEIHMFGIFDGHRGSAAAEFSARALPGFLQNL-GSTTRPTDALLEAFI 503 (697)
Q Consensus 425 ~~~~~~~~~~s~~G~R~~neD~~~~~~~~~~~~~~~~~~V~DG~GG~~~~~~as~~~~~~l~~~-~~~~~~~~~l~~~~~ 503 (697)
......+|++...|.|..+-=+.....++...+ ...|+++||-+-.....+....+...+.+. ....+..+.++.+|.
T Consensus 518 n~~~~t~Gv~~~~gqrnk~c~~~~~v~nf~~~~-~a~~g~~dgs~n~~v~~~vq~~ma~~L~eev~~~~~et~~mr~~fl 596 (1081)
T KOG0618|consen 518 NAFLWTYGVAGVSGQRNKVCSRAVWVENFFLNP-QATFGCFDGSRNSRVLSLVQDTMASYLAEEVQLYGNETEQMRNTFL 596 (1081)
T ss_pred ceeheeeccchhcccccchhhhhhhhhhcccCC-cceEEEEcCCCchhHHHHHHHHHHHHHHHHHHhccChHHHHHHHHH
Confidence 334455999999999877766655444444343 348999999999999888888888777765 334455666889998
Q ss_pred HHHHHHHHHHHHHHhhhhcccCCCCCCceEEEEEEec--------CeEEEEEcCCeEEEEEECCeeeecCCCC-CCCCHH
Q 005427 504 RTDVAFRNELDSLRKSKRVVQKDWHPGCTAIAALIVR--------NRLFVANAGDCRAILCRGGHPFALSRDH-VASCLE 574 (697)
Q Consensus 504 ~~~~~~~~~~~~~~~~~~~~~~~~~~GtT~~~~~i~~--------~~l~~anvGDSr~~l~~~~~~~~lt~dH-~~~~~~ 574 (697)
..+.++-..-. .-|..++.+.|.. .++.+||+|+|.++++++|+..++|+-. -...+.
T Consensus 597 ~~~rklg~~g~-------------~lg~~~~~~~i~~d~~~~asS~~l~~Anvg~c~avls~ng~~~p~t~~~~~~v~~e 663 (1081)
T KOG0618|consen 597 RLNRKLGEEGQ-------------VLGGSVVLCQIVEDSLSPASSKTLFAANVGTCMAVLSRNGKPLPTTRSPMLEVDRE 663 (1081)
T ss_pred HHhhhhhhhhc-------------cccchhhheeecccccCcccchhhhHhhhccchhhhhhcCCcCcccccccccCCHH
Confidence 88877733211 1255555565553 3689999999999999999999988865 344899
Q ss_pred HHHHHHHcCCeeeeccCcceeCCCcceeccccCCCCCCCCcccCCceEEEEeCCCCeEEEEEcCCcccCCChHHHHHHHH
Q 005427 575 ERERVVSAGGNVNWQVDTWRVGPPALQVTRSIGDDDLKPAVTAEPEITETIMTPEDEYLVMASDGLWDVVSHVEAVGIIK 654 (697)
Q Consensus 575 e~~ri~~~g~~~~~~~~~~~~~~~~~~ltralG~~~~k~~v~~~p~v~~~~l~~~d~~lvl~SDGl~d~~~~~ei~~~~~ 654 (697)
|.+||+..+|.+. +..++. |....||++|-+..-|.|-+.|+|..+.+.+.|+|||+++-+||++|+-++++++++
T Consensus 664 E~~RI~~~~g~i~---ed~k~n-gvt~~tR~iG~~~l~P~v~p~Phv~~~~Lt~qdE~LIvgn~~lW~~Lsid~a~~~vR 739 (1081)
T KOG0618|consen 664 EYKRIVDSKGFIT---EDNKLN-GVTSSTRAIGPFSLFPHVLPDPHVSVVILTEQDEFLIVGNKQLWSVLSIDTAVDAVR 739 (1081)
T ss_pred HHHHHHHhcCeec---CCCeee-ceeeeeeecccccccccccCCCceeeEecccCceEEEEcchHHhhhccHHHHHHHHh
Confidence 9999999999653 234444 577899999999999999999999999999999999999999999999999999999
Q ss_pred hhcCChhHHHHHHHHHHHhcCCCCCcEEEEEEeCCCCc
Q 005427 655 DTVKEPGMCSKRLATEAAERGSKDNITVIVVFLQPVST 692 (697)
Q Consensus 655 ~~~~~~~~~a~~L~~~a~~~g~~DNiT~ivv~l~~~~~ 692 (697)
. ..+|=.||++|.+.|..-|..||++|+||++....+
T Consensus 740 n-~~dpL~AAkKL~d~AqSYgc~~nv~vlVv~l~~~~~ 776 (1081)
T KOG0618|consen 740 N-VEDPLLAAKKLCDLAQSYGCAENVSVLVVRLNHLEE 776 (1081)
T ss_pred c-CCchHHHHHHHHHHHHhcccccCeeEEEEEeecchh
Confidence 4 458999999999999999999999999999976544
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.74 E-value=1e-17 Score=162.24 Aligned_cols=131 Identities=25% Similarity=0.430 Sum_probs=107.3
Q ss_pred ccccCCceEEEEEEECCeeEEEEeccCCC---h-----HHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEeecC
Q 005427 73 PIARGAESVVYEATLDGRKVAVKKPILST---S-----EELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYE 144 (697)
Q Consensus 73 ~lg~G~~g~V~~~~~~~~~vavK~~~~~~---~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 144 (697)
.||+|+||.||+|.+.+..+++|...... . ....++.+|++++..+.|+++.....++......+++|||++
T Consensus 1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~ 80 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIE 80 (199)
T ss_pred CCCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEEC
Confidence 48999999999999999999999744321 1 123567899999999998876544444455667899999999
Q ss_pred CCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhh
Q 005427 145 SRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYR 212 (697)
Q Consensus 145 ~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~ 212 (697)
|++|.+.+..... .++.+++.+|.+||+.|++|||++|.||+++ ++.++++|||++...
T Consensus 81 g~~l~~~~~~~~~--------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 81 GKPLKDVIEEGND--------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CccHHHHHhhcHH--------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 9999988754321 7899999999999999999999999999999 789999999998653
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >smart00331 PP2C_SIG Sigma factor PP2C-like phosphatases | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.8e-16 Score=152.54 Aligned_cols=174 Identities=20% Similarity=0.180 Sum_probs=128.6
Q ss_pred CCCCceeEEcccccCCCceEEEEEecCCCChHHHHHHHHHhHHHHHhcCCCCChHHHHHHHHHHHHHHHHHHHHHHHhhh
Q 005427 441 ETMEDTHFLMPHMYNQKEIHMFGIFDGHRGSAAAEFSARALPGFLQNLGSTTRPTDALLEAFIRTDVAFRNELDSLRKSK 520 (697)
Q Consensus 441 ~~neD~~~~~~~~~~~~~~~~~~V~DG~GG~~~~~~as~~~~~~l~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 520 (697)
...-|.+.+.. ..++..+++|+||||+...|.+++..+...+........ .+.+.+..++..+...
T Consensus 15 ~~~GD~~~~~~---~~~~~~~~~v~Dg~G~G~~aa~~s~~~~~~~~~~~~~~~---~~~~~l~~~n~~l~~~-------- 80 (193)
T smart00331 15 QVGGDFYDVVK---LPEGRLLIAIADVMGKGLAAALAMSMARSALRTLLSEGI---SLSQILERLNRAIYEN-------- 80 (193)
T ss_pred hcCccEEEEEE---eCCCeEEEEEEecCCCChHHHHHHHHHHHHHHHHhhcCC---CHHHHHHHHHHHHHhc--------
Confidence 46667776654 234578999999999999999999999998887643321 2344444455444332
Q ss_pred hcccCCCCCCceEEEEEE--ecCeEEEEEcCCeEEEEEE-CCeeeecCCCCCCCCHHHHHHHHHcCCeeeeccCcceeCC
Q 005427 521 RVVQKDWHPGCTAIAALI--VRNRLFVANAGDCRAILCR-GGHPFALSRDHVASCLEERERVVSAGGNVNWQVDTWRVGP 597 (697)
Q Consensus 521 ~~~~~~~~~GtT~~~~~i--~~~~l~~anvGDSr~~l~~-~~~~~~lt~dH~~~~~~e~~ri~~~g~~~~~~~~~~~~~~ 597 (697)
....+|+|++++++ ..++++++|+||+|+|+++ ++...+++.+.
T Consensus 81 ----~~~~~~~T~~~~~id~~~~~l~~~~~Gd~~~~~~~~~~~~~~~~~~~----------------------------- 127 (193)
T smart00331 81 ----GEDGMFATLFLALYDFAGGTLSYANAGHSPPYLLRADGGLVEDLDDL----------------------------- 127 (193)
T ss_pred ----CCCCcEEEEEEEEEECCCCEEEEEeCCCCceEEEECCCCeEEEcCCC-----------------------------
Confidence 11246999999998 5789999999999999999 56566666542
Q ss_pred CcceeccccCCCCCCCCcccCCceEEEEeCCCCeEEEEEcCCcccCCChHHHHHHHHhhc-CChhHHHHHHHHHHH
Q 005427 598 PALQVTRSIGDDDLKPAVTAEPEITETIMTPEDEYLVMASDGLWDVVSHVEAVGIIKDTV-KEPGMCSKRLATEAA 672 (697)
Q Consensus 598 ~~~~ltralG~~~~k~~v~~~p~v~~~~l~~~d~~lvl~SDGl~d~~~~~ei~~~~~~~~-~~~~~~a~~L~~~a~ 672 (697)
++.+|... ..+++...+.+.++| .|+|+||||||.++.+++.+++.+.. .++++.++.|.+++.
T Consensus 128 -----~~~lG~~~-----~~~~~~~~~~l~~gd-~l~l~TDGl~e~~~~~~l~~~l~~~~~~~~~~~~~~i~~~~~ 192 (193)
T smart00331 128 -----GAPLGLEP-----DVEVDVRELTLEPGD-LLLLYTDGLTEARNPERLEELLEELLGSPPAEIAQRILEELL 192 (193)
T ss_pred -----CceeeeCC-----CCcceeEEEeeCCCC-EEEEECCCccccCChHHHHHHHHHhcCCCHHHHHHHHHHHHh
Confidence 23455544 345777888999999 77799999999999999999998865 358888888887654
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.72 E-value=6.3e-18 Score=174.19 Aligned_cols=247 Identities=23% Similarity=0.367 Sum_probs=160.0
Q ss_pred CCcccccccccCCceEEEEEEE-C----CeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEee-------cc---
Q 005427 66 SSYTLLSPIARGAESVVYEATL-D----GRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVA-------AH--- 130 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~-~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~-------~~--- 130 (697)
..+.+.+..+..+++.+..... . ...+..+.....+........+++-.+....|-+..-+.+ .+
T Consensus 244 ~s~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d~~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~~~~ 323 (516)
T KOG1033|consen 244 GSSSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVDSLCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFESSKRN 323 (516)
T ss_pred ccccccccccccccCCchhhhhcccchhhhhccchhhhccchhhhhhhhhhhhheeccccCCcccccCCCCchhhhcccc
Confidence 3455666677777776665432 1 1223333322333223333444444444444433333332 11
Q ss_pred --ccCCceEEEEeecCCCCHhhhhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeee
Q 005427 131 --AKPPNYMFFFEFYESRNLAEKLHVE--EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADF 206 (697)
Q Consensus 131 --~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Df 206 (697)
.....+++.|++|.-.+|.+++... ....++...+.++.|+..|+.| +|.+|||+||.||....+..+||.||
T Consensus 324 ~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDF 400 (516)
T KOG1033|consen 324 KVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDF 400 (516)
T ss_pred ccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhh
Confidence 1123578999999999999999533 3356778899999999999999 99999999999999999999999999
Q ss_pred ccchhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCCchhHH
Q 005427 207 GLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEA 285 (697)
Q Consensus 207 g~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~~~~~~ 285 (697)
|+......... ..+. .-..+...||.+||+||.+.+..|+.++||||||++|+|++. -..+|.......
T Consensus 401 gl~ts~~~~~~---------~~~~-~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~t~~ 470 (516)
T KOG1033|consen 401 GLVTSQDKDET---------VAPA-AASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIATLT 470 (516)
T ss_pred hheeecccCCc---------ccch-hhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHHhhh
Confidence 99876543220 0111 112456789999999999999999999999999999999998 444443221111
Q ss_pred HHHHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHH
Q 005427 286 QAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIA 346 (697)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell 346 (697)
.+.. +.+.|. ...++ ++-..|+.++|...|.+||++.+..
T Consensus 471 ---d~r~--------------g~ip~~---~~~d~-p~e~~ll~~lls~~p~~RP~~~~~~ 510 (516)
T KOG1033|consen 471 ---DIRD--------------GIIPPE---FLQDY-PEEYTLLQQLLSPSPEERPSAIEVA 510 (516)
T ss_pred ---hhhc--------------CCCChH---HhhcC-cHHHHHHHHhcCCCcccCchHHHHh
Confidence 1111 111110 01112 3345899999999999999655543
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.71 E-value=3.3e-17 Score=182.29 Aligned_cols=135 Identities=23% Similarity=0.356 Sum_probs=113.1
Q ss_pred CcccccccccCCceEEEEEEECCeeEEEEeccCCC--h------HHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEE
Q 005427 67 SYTLLSPIARGAESVVYEATLDGRKVAVKKPILST--S------EELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMF 138 (697)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~--~------~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 138 (697)
.|...++||+|+||+||++.+.+..+++|+..... . ...+.+.+|+++++.++|++++....++..+...++
T Consensus 334 ~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~l 413 (535)
T PRK09605 334 RKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTI 413 (535)
T ss_pred ccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEE
Confidence 45678999999999999999877766666432211 1 123568899999999999999887777777778899
Q ss_pred EEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchh
Q 005427 139 FFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEY 211 (697)
Q Consensus 139 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~ 211 (697)
||||++|++|.+++. ....++.+++.+|.|||+.|++||||||+|||+ .++.++|+|||+++.
T Consensus 414 v~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 414 VMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 999999999999875 356789999999999999999999999999999 677899999999864
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.70 E-value=8.7e-17 Score=155.35 Aligned_cols=136 Identities=21% Similarity=0.185 Sum_probs=108.3
Q ss_pred CcccccccccCCceEEEEEEE-CCeeEEEEeccCCCh----------------------HHHHHHHHHHHHHHhcCCC--
Q 005427 67 SYTLLSPIARGAESVVYEATL-DGRKVAVKKPILSTS----------------------EELDNFHKELQLLCKLDHP-- 121 (697)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~----------------------~~~~~~~~E~~~l~~l~hp-- 121 (697)
.|.+.+.||+|+||.||++.. +++.||||+...... .....+..|+.++..+.|+
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 388899999999999999987 689999997543220 0112367899999999877
Q ss_pred CceEEeeccccCCceEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCC
Q 005427 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCP 201 (697)
Q Consensus 122 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~ 201 (697)
.++..++. ...+++|||++|++|...... .....++.+++.++.++|+.||+||||||+||+++.++.+
T Consensus 96 ~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~ 164 (198)
T cd05144 96 PVPKPIDW----NRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKI 164 (198)
T ss_pred CCCceeec----CCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcE
Confidence 44555542 345899999999998765421 3456788999999999999999999999999999999999
Q ss_pred eeeeeccchhhh
Q 005427 202 HLADFGLAEYRE 213 (697)
Q Consensus 202 kL~Dfg~a~~~~ 213 (697)
+|+|||++....
T Consensus 165 ~liDfg~~~~~~ 176 (198)
T cd05144 165 YIIDWPQMVSTD 176 (198)
T ss_pred EEEECCccccCC
Confidence 999999985443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.67 E-value=4.4e-18 Score=188.13 Aligned_cols=263 Identities=26% Similarity=0.356 Sum_probs=202.6
Q ss_pred CCCCcccccccccCCceEEEEEEE---CCeeEEEEeccCCC--hHHHHHHHHHHHHHHhcC-CCCceEEeeccccCCceE
Q 005427 64 PPSSYTLLSPIARGAESVVYEATL---DGRKVAVKKPILST--SEELDNFHKELQLLCKLD-HPGLAKFVAAHAKPPNYM 137 (697)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~ 137 (697)
+...|.+.+.||+|.|+.|-+... ....+|+|.+.... .........|..+-+.+. |+|++.+++...++..++
T Consensus 18 ~~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~ 97 (601)
T KOG0590|consen 18 PNSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL 97 (601)
T ss_pred ccccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence 356799999999999999987754 34456666544432 333456667888888887 999999999999999999
Q ss_pred EEEeecCCCCHhhhh-hhcCCCCCHHHHHHHHHHHHHHHHHHH-hCCcccccCCCCceeecCCC-CCeeeeeccchhhhh
Q 005427 138 FFFEFYESRNLAEKL-HVEEWSPSVDQVLMIAAQLAKALQYLH-NLGIVHRDVKPANVLLDRNL-CPHLADFGLAEYREN 214 (697)
Q Consensus 138 lv~e~~~~g~L~~~l-~~~~~~~~~~~~~~i~~qi~~~l~~LH-~~~ivHrDlkp~Nill~~~~-~~kL~Dfg~a~~~~~ 214 (697)
+++++..|+++.+.+ +......+...+-.++.|+..++.|+| ..++.|||+||+|.+++..+ .+|+.|||+|..+..
T Consensus 98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 999999999999988 544335666788899999999999999 99999999999999999999 999999999976543
Q ss_pred hhhhhcccccCCCCCCCCcccccccc-Cccccchhhhcc-cCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHh
Q 005427 215 LKEISLKNWRSSGKPTGGFHKKNMVG-TLIYMAPEILKK-EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLE 292 (697)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~g-t~~y~aPE~~~~-~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~ 292 (697)
.+. ........+| ++.|+|||.+.+ ....+..|+||.|+++.-+++|..||............
T Consensus 178 ~~g-------------~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~-- 242 (601)
T KOG0590|consen 178 KNG-------------AERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSS-- 242 (601)
T ss_pred cCC-------------cceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccccee--
Confidence 111 1112344577 999999999988 45677899999999999999999999765332211000
Q ss_pred ccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 005427 293 MNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL 353 (697)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~ 353 (697)
..... ...-...+..++....+++.+++..+|..|.+.+++..+.|...
T Consensus 243 -----------~~~~~-~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 243 -----------WKSNK-GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred -----------ecccc-cccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 00000 01111234567889999999999999999999999988877765
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.2e-15 Score=140.46 Aligned_cols=133 Identities=24% Similarity=0.285 Sum_probs=114.1
Q ss_pred cccccccCCceEEEEEEECCeeEEEEeccCCChHHHHHHHHHHHHHHhcCC--CCceEEeeccccCCceEEEEeecCCCC
Q 005427 70 LLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDH--PGLAKFVAAHAKPPNYMFFFEFYESRN 147 (697)
Q Consensus 70 ~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--pniv~l~~~~~~~~~~~lv~e~~~~g~ 147 (697)
+.+.||.|.++.||++...+..+++|....... ...+.+|+.+++.++| +++++++.++...+..+++|||+.++.
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~ 79 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKDEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET 79 (155)
T ss_pred cceecccccccceEEEEecCCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence 467899999999999999888999998654433 4678899999999976 589999998888889999999999877
Q ss_pred HhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCCCCceeecCCCCCeeeeeccchhh
Q 005427 148 LAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL---GIVHRDVKPANVLLDRNLCPHLADFGLAEYR 212 (697)
Q Consensus 148 L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~ 212 (697)
+... +......++.+++.++.++|.. +++|+|++|.||+++..+.++++|||.+...
T Consensus 80 ~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 80 LDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred cccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 7654 4456677889999999999985 6999999999999999899999999998643
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.62 E-value=3.2e-15 Score=147.78 Aligned_cols=134 Identities=21% Similarity=0.250 Sum_probs=103.6
Q ss_pred cccc-cCCceEEEEEEECCeeEEEEeccCCC-------------hHHHHHHHHHHHHHHhcCCCCc--eEEeeccccCC-
Q 005427 72 SPIA-RGAESVVYEATLDGRKVAVKKPILST-------------SEELDNFHKELQLLCKLDHPGL--AKFVAAHAKPP- 134 (697)
Q Consensus 72 ~~lg-~G~~g~V~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~hpni--v~l~~~~~~~~- 134 (697)
..|| .|+.|+||.+...+..++||...... ......+.+|+.++..|.|++| +..+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~ 116 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHG 116 (239)
T ss_pred ceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecC
Confidence 4577 78889999998888899998653211 1234578899999999998875 66666543322
Q ss_pred ---ceEEEEeecCC-CCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccch
Q 005427 135 ---NYMFFFEFYES-RNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAE 210 (697)
Q Consensus 135 ---~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~ 210 (697)
..++|||+++| .+|.+++... .+++. .+.+++.+|.+||+.||+||||||.|||++.++.++|+|||.+.
T Consensus 117 ~~~~~~lV~e~l~G~~~L~~~l~~~--~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~~ 190 (239)
T PRK01723 117 LFYRADILIERIEGARDLVALLQEA--PLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRGE 190 (239)
T ss_pred cceeeeEEEEecCCCCCHHHHHhcC--CCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCcc
Confidence 22599999997 6888887543 34543 35789999999999999999999999999998899999999875
Q ss_pred h
Q 005427 211 Y 211 (697)
Q Consensus 211 ~ 211 (697)
.
T Consensus 191 ~ 191 (239)
T PRK01723 191 L 191 (239)
T ss_pred c
Confidence 3
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.60 E-value=3.8e-15 Score=142.67 Aligned_cols=135 Identities=23% Similarity=0.228 Sum_probs=97.7
Q ss_pred cccccccCCceEEEEEEEC-CeeEEEEeccCCChH--HHHH----------------------HHHHHHHHHhcCCC--C
Q 005427 70 LLSPIARGAESVVYEATLD-GRKVAVKKPILSTSE--ELDN----------------------FHKELQLLCKLDHP--G 122 (697)
Q Consensus 70 ~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~--~~~~----------------------~~~E~~~l~~l~hp--n 122 (697)
+.+.||+|+||.||+|.+. ++.||||+....... .... ...|...+..+.+. .
T Consensus 1 ~~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 1 VGGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CCcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 3578999999999999874 889999975543211 1111 13566666666443 3
Q ss_pred ceEEeeccccCCceEEEEeecCCCCHhhh-hhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCCCceeecCCCC
Q 005427 123 LAKFVAAHAKPPNYMFFFEFYESRNLAEK-LHVEEWSPSVDQVLMIAAQLAKALQYLHN-LGIVHRDVKPANVLLDRNLC 200 (697)
Q Consensus 123 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivHrDlkp~Nill~~~~~ 200 (697)
+.+.+++ ...+++|||++++.+... +.... .. .++..++.+++.++.++|. .||+||||||+||+++ ++.
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~ 152 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGK 152 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCc
Confidence 4445543 246899999998543321 11111 11 5788899999999999999 9999999999999999 889
Q ss_pred Ceeeeeccchhh
Q 005427 201 PHLADFGLAEYR 212 (697)
Q Consensus 201 ~kL~Dfg~a~~~ 212 (697)
++|+|||.+...
T Consensus 153 ~~liDfg~a~~~ 164 (187)
T cd05119 153 VYIIDVPQAVEI 164 (187)
T ss_pred EEEEECcccccc
Confidence 999999998644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >TIGR02865 spore_II_E stage II sporulation protein E | Back alignment and domain information |
|---|
Probab=99.58 E-value=6.7e-14 Score=159.33 Aligned_cols=192 Identities=20% Similarity=0.168 Sum_probs=138.4
Q ss_pred cCCCCCCCceeEEcccccCCCceEEEEEecCCCChHHHHHHHHHhHHHHHhcCCCCChHHHHHHHHHHHHHHHHHHHHHH
Q 005427 437 CGRRETMEDTHFLMPHMYNQKEIHMFGIFDGHRGSAAAEFSARALPGFLQNLGSTTRPTDALLEAFIRTDVAFRNELDSL 516 (697)
Q Consensus 437 ~G~R~~neD~~~~~~~~~~~~~~~~~~V~DG~GG~~~~~~as~~~~~~l~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 516 (697)
++.+..+.|.+.+.. ..++..+++|+||+|+...|..+|..+.+.+.+......+. ..++..++..+...
T Consensus 561 k~g~~vsGD~y~~~~---l~~g~~~~~laDGmGhG~~Aa~~S~~~~~ll~~~~~~g~~~---~~ai~~lN~~L~~~---- 630 (764)
T TIGR02865 561 KDGELVSGDSYSFGK---LSAGKYAVAISDGMGSGPEAAQESSACVRLLEKFLESGFDR---EVAIKTVNSILSLR---- 630 (764)
T ss_pred CCCCcccCceEEEEE---ECCCEEEEEEEcccCCCHHHHHHHHHHHHHHHHHHHcCCCH---HHHHHHHHHHHHhC----
Confidence 344789999988755 23456789999999987888888888888777653222222 33344444333211
Q ss_pred HhhhhcccCCCCCCceEEEEEEe--cCeEEEEEcCCeEEEEEECCeeeecCCCCCCCCHHHHHHHHHcCCeeeeccCcce
Q 005427 517 RKSKRVVQKDWHPGCTAIAALIV--RNRLFVANAGDCRAILCRGGHPFALSRDHVASCLEERERVVSAGGNVNWQVDTWR 594 (697)
Q Consensus 517 ~~~~~~~~~~~~~GtT~~~~~i~--~~~l~~anvGDSr~~l~~~~~~~~lt~dH~~~~~~e~~ri~~~g~~~~~~~~~~~ 594 (697)
....+.+|+..++++ .+++.++|+|+++.|+.|++.+..++..+-|
T Consensus 631 --------~~~~~faTl~l~~IDl~~g~~~~~~aG~~p~~i~r~~~v~~i~s~~lP------------------------ 678 (764)
T TIGR02865 631 --------STDEKFSTLDLSVIDLYTGQAEFVKVGAVPSFIKRGAKVEVIRSSNLP------------------------ 678 (764)
T ss_pred --------CCCCeEEEEEEEEEECCCCeEEEEecCCCceEEEECCEEEEecCCCce------------------------
Confidence 011368999999996 6889999999999999999988888654411
Q ss_pred eCCCcceeccccCCCCCCCCcccCCceEEEEeCCCCeEEEEEcCCcccCCChHH-----HHHHHHhh-cCChhHHHHHHH
Q 005427 595 VGPPALQVTRSIGDDDLKPAVTAEPEITETIMTPEDEYLVMASDGLWDVVSHVE-----AVGIIKDT-VKEPGMCSKRLA 668 (697)
Q Consensus 595 ~~~~~~~ltralG~~~~k~~v~~~p~v~~~~l~~~d~~lvl~SDGl~d~~~~~e-----i~~~~~~~-~~~~~~~a~~L~ 668 (697)
+|-.. ..+++....++.+|| +|||+|||++|..++.+ +.+++... ..++++.++.|+
T Consensus 679 -----------lGil~-----~~~~~~~~~~L~~GD-~Lll~SDGv~E~~~~~~~~~~~l~~~l~~~~~~~p~ela~~Il 741 (764)
T TIGR02865 679 -----------IGILD-----EVDVELVRKKLKNGD-LIVMVSDGVLEGEKEVEGKVLWLVRKLKETNTNDPEEIAEYLL 741 (764)
T ss_pred -----------eEecc-----CCccceEEEEeCCCC-EEEEECCCCCcCCcccccHHHHHHHHHHhcCCCCHHHHHHHHH
Confidence 23222 345777888999999 78899999999886533 67777653 247999999999
Q ss_pred HHHHhcC---CCCCcEEEEEEe
Q 005427 669 TEAAERG---SKDNITVIVVFL 687 (697)
Q Consensus 669 ~~a~~~g---~~DNiT~ivv~l 687 (697)
+.|.+.. ..||+|++++++
T Consensus 742 ~~a~~~~~~~~~DD~Tvlvirv 763 (764)
T TIGR02865 742 EKAKELRSGKIKDDMTVIVAKV 763 (764)
T ss_pred HHHHHhcCCCCCCCeEEEEEEe
Confidence 9998653 369999999986
|
Stage II sporulation protein E (SpoIIE) is a multiple membrane spanning protein with two separable functions. It plays a role in the switch to polar cell division during sporulation. By means of it protein phosphatase activity, located in the C-terminal region, it activates sigma-F. All proteins that score above the trusted cutoff to this model are found in endospore-forming Gram-positive bacteria. Surprisingly, a sequence from the Cyanobacterium-like (and presumably non-spore-forming) photosynthesizer Heliobacillus mobilis is homologous, and scores between the trusted and noise cutoffs. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.41 E-value=2.2e-13 Score=143.87 Aligned_cols=254 Identities=22% Similarity=0.202 Sum_probs=187.9
Q ss_pred CCCCCccccccccc--CCceEEEEEEE----CCeeEEEEeccCC--ChHHHHHHHHHHHHHHhc-CCCCceEEeeccccC
Q 005427 63 LPPSSYTLLSPIAR--GAESVVYEATL----DGRKVAVKKPILS--TSEELDNFHKELQLLCKL-DHPGLAKFVAAHAKP 133 (697)
Q Consensus 63 ~~~~~y~~~~~lg~--G~~g~V~~~~~----~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~ 133 (697)
+....+.+.+.+|. |.+|.||.+.. .+..+|+|+.... .......-.+|+...+.+ .|+|.++.+..+...
T Consensus 111 ~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~ 190 (524)
T KOG0601|consen 111 FFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGS 190 (524)
T ss_pred hhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccC
Confidence 33456788899999 99999998864 5778999973332 223333345666666666 599999999999999
Q ss_pred CceEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHH----HHHHHHhCCcccccCCCCceeecCC-CCCeeeeecc
Q 005427 134 PNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAK----ALQYLHNLGIVHRDVKPANVLLDRN-LCPHLADFGL 208 (697)
Q Consensus 134 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~----~l~~LH~~~ivHrDlkp~Nill~~~-~~~kL~Dfg~ 208 (697)
+..++-+|.|. .+|..+.+.....++...++..+.+... ||.++|+.+++|-|+||.||++..+ ...+++|||+
T Consensus 191 ~~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~ 269 (524)
T KOG0601|consen 191 GILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGL 269 (524)
T ss_pred Ccceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcce
Confidence 99999999996 6898888877767888999999999999 9999999999999999999999988 8899999999
Q ss_pred chhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCc-hhHHHH
Q 005427 209 AEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDL-RAEAQA 287 (697)
Q Consensus 209 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~-~~~~~~ 287 (697)
...+....-.... .......|...|++||...+. ++..+|++++|.++.+..++..+.... ....
T Consensus 270 v~~i~~~~~~~~~-----------~~~~r~~~~~~Y~~ke~~~~l-~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W-- 335 (524)
T KOG0601|consen 270 VSKISDGNFSSVF-----------KVSKRPEGDCIYAAKELLNGL-ATFASDIFSLGEVILEAILGSHLPSVGKNSSW-- 335 (524)
T ss_pred eEEccCCccccce-----------eeeecCCCCceEeChhhhccc-cchHhhhcchhhhhHhhHhhcccccCCCCCCc--
Confidence 8766542211000 011223678899999998665 478999999999999998876665432 1111
Q ss_pred HHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005427 288 HTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALE 348 (697)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 348 (697)
..+.. .+ +..+.-.+.+.++...+..|++.+|..|++++.+..+
T Consensus 336 ~~~r~---------------~~--ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l 379 (524)
T KOG0601|consen 336 SQLRQ---------------GY--IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL 379 (524)
T ss_pred ccccc---------------cc--CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence 00000 00 1111223456667779999999999999999887644
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.41 E-value=1.3e-12 Score=140.64 Aligned_cols=139 Identities=20% Similarity=0.253 Sum_probs=97.0
Q ss_pred cccccCCceEEEEEEE-CCeeEEEEeccCCChHHH----------------------------------------HHHHH
Q 005427 72 SPIARGAESVVYEATL-DGRKVAVKKPILSTSEEL----------------------------------------DNFHK 110 (697)
Q Consensus 72 ~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~----------------------------------------~~~~~ 110 (697)
+.||.|++|.||+|+. +|+.||||+......+.. -.+.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 5799999999999987 799999998654321110 02445
Q ss_pred HHHHHHhc----CCCCceEEeecc-ccCCceEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHH-HHHHHHhCCcc
Q 005427 111 ELQLLCKL----DHPGLAKFVAAH-AKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAK-ALQYLHNLGIV 184 (697)
Q Consensus 111 E~~~l~~l----~hpniv~l~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~-~l~~LH~~~iv 184 (697)
|+..+.++ +|.+-+.+-.++ ......++||||++|++|.+.......... ...++..++. .+..+|..|++
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g~~ 279 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDGFF 279 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCCce
Confidence 56555555 232222222222 223457899999999999887654322222 3345555555 46789999999
Q ss_pred cccCCCCceeecCCCCCeeeeeccchhhh
Q 005427 185 HRDVKPANVLLDRNLCPHLADFGLAEYRE 213 (697)
Q Consensus 185 HrDlkp~Nill~~~~~~kL~Dfg~a~~~~ 213 (697)
|+|+||.||+++.++.++|+|||++..+.
T Consensus 280 H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 280 HADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred eCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 99999999999999999999999987654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PF07228 SpoIIE: Stage II sporulation protein E (SpoIIE); InterPro: IPR001932 This domain is found in protein phosphatase 2C, as well as other proteins eg | Back alignment and domain information |
|---|
Probab=99.38 E-value=3.8e-11 Score=115.56 Aligned_cols=177 Identities=20% Similarity=0.191 Sum_probs=114.2
Q ss_pred CceEEEEEecCCCChHHHHHHHHHhHHHHHhcCCCCChHHHHHHHHHHHHHHHHHHHHHHHhhhhcccCCCCCCceEEEE
Q 005427 457 KEIHMFGIFDGHRGSAAAEFSARALPGFLQNLGSTTRPTDALLEAFIRTDVAFRNELDSLRKSKRVVQKDWHPGCTAIAA 536 (697)
Q Consensus 457 ~~~~~~~V~DG~GG~~~~~~as~~~~~~l~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GtT~~~~ 536 (697)
++..+++|+|++|....|.+.+..+...+......... ..+.+..++..+...... ..+++|++++
T Consensus 2 ~~~~~~~v~D~~GhG~~aa~~~~~~~~~~~~~~~~~~~---p~~~l~~ln~~l~~~~~~-----------~~~~~t~~~~ 67 (193)
T PF07228_consen 2 DGRYFIIVGDVSGHGVSAALLSAALASAIRELLDEGLD---PEELLEALNRRLYRDLKG-----------DNRYATACYA 67 (193)
T ss_dssp TTEEEEEEEEESSSSHHHHHHHHHHHHHHHHHHHTTTS---HHHHHHHHHHHHHHHTTT-----------TSTTEEEEEE
T ss_pred CCEEEEEEEEecCCCHHHHHHHHHHHHHHHHHHHcCCC---HHHHHHHHHHHHHHHhhh-----------ccccceEEEE
Confidence 35679999999996666666666666666654222211 233344444444332110 0257899988
Q ss_pred EEe--cCeEEEEEcCCeEEEEEECC--eeeecCCCCCCCCHHHHHHHHHcCCeeeeccCcceeCCCcceeccccCCCCCC
Q 005427 537 LIV--RNRLFVANAGDCRAILCRGG--HPFALSRDHVASCLEERERVVSAGGNVNWQVDTWRVGPPALQVTRSIGDDDLK 612 (697)
Q Consensus 537 ~i~--~~~l~~anvGDSr~~l~~~~--~~~~lt~dH~~~~~~e~~ri~~~g~~~~~~~~~~~~~~~~~~ltralG~~~~k 612 (697)
.++ .++++++|+|++++++++++ ....+.... -.+|-..
T Consensus 68 ~~d~~~~~l~~~~aG~~~~l~~~~~~~~~~~~~~~~-----------------------------------~~lG~~~-- 110 (193)
T PF07228_consen 68 IIDPETGTLTYANAGHPPPLLLRPGGREIEQLESEG-----------------------------------PPLGIFE-- 110 (193)
T ss_dssp EEETTTTEEEEEEESSSEEEEEETTCTEEEEETCSS-----------------------------------BBCSSSC--
T ss_pred EecccceEEEEeCCCCCCEEEEeccccceeecccCc-----------------------------------cceeeec--
Confidence 876 46899999999999999983 333333322 0144433
Q ss_pred CCcccCCceEEEEeCCCCeEEEEEcCCcccCCChH-------HHHHHHHhh-cCChhHHHHHHHHHHHhc---CCCCCcE
Q 005427 613 PAVTAEPEITETIMTPEDEYLVMASDGLWDVVSHV-------EAVGIIKDT-VKEPGMCSKRLATEAAER---GSKDNIT 681 (697)
Q Consensus 613 ~~v~~~p~v~~~~l~~~d~~lvl~SDGl~d~~~~~-------ei~~~~~~~-~~~~~~~a~~L~~~a~~~---g~~DNiT 681 (697)
...+....+.+.++| .|+|+||||+|....+ ++.+++.+. ..++++.++.|++.+... ...||+|
T Consensus 111 ---~~~~~~~~~~l~~gd-~l~l~TDGl~e~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~~~DD~t 186 (193)
T PF07228_consen 111 ---DIDYQEQEIQLEPGD-RLLLYTDGLFEALNEDGEFFGEERLLELLDENRGLSPQEIIDALLEAIDRFGKGPLRDDIT 186 (193)
T ss_dssp ---TTCEEEEEEE--TTE-EEEEECHHHCTTTCHHCHHCCCHHHHHHHHCHTTS-HHHHHHHHHHHHHHHTTSSTSS-EE
T ss_pred ---cccccceEEEecccc-EEEEeCCChhhccCCccchhHHHHHHHHHhhccCCCHHHHHHHHHHHHHHhcCCCCCCceE
Confidence 235566788999998 6779999999998433 345666643 246889999999988873 3569999
Q ss_pred EEEEEeC
Q 005427 682 VIVVFLQ 688 (697)
Q Consensus 682 ~ivv~l~ 688 (697)
+++++++
T Consensus 187 vl~~~~~ 193 (193)
T PF07228_consen 187 VLVIRRQ 193 (193)
T ss_dssp EEEEEE-
T ss_pred EEEEEEC
Confidence 9999875
|
pyruvate dehydrogenase (lipoamide)-phosphatase (3.1.3.43 from EC), adenylate cyclase (4.6.1.1 from EC) and some bacterial stage II sporulation E proteins (3.1.3.16 from EC). Protein phosphatase 2C (PP2C) is one of the four major classes of mammalian serine/threonine specific protein phosphatases (3.1.3.16 from EC). PP2C [] is a monomeric enzyme of about 42 Kd which shows broad substrate specificity and is dependent on divalent cations (mainly manganese and magnesium) for its activity. Its exact physiological role is still unclear. Three isozymes are currently known in mammals: PP2C-alpha, -beta and -gamma. In yeast, there are at least four PP2C homologs: phosphatase PTC1 [], which has weak tyrosine phosphatase activity in addition to its activity on serines, phosphatases PTC2 and PTC3, and hypothetical protein YBR125c. Isozymes of PP2C are also known from Arabidopsis thaliana (ABI1, PPH1), Caenorhabditis elegans (FEM-2, F42G9.1, T23F11.1), Leishmania chagasi and Paramecium tetraurelia. In A. thaliana, the kinase associated protein phosphatase (KAPP) [] is an enzyme that dephosphorylates the Ser/Thr receptor-like kinase RLK5 and which contains a C-terminal PP2C domain. PP2C does not seem to be evolutionary related to the main family of serine/ threonine phosphatases: PP1, PP2A and PP2B. However, it is significantly similar to the catalytic subunit of pyruvate dehydrogenase phosphatase 3.1.3.43 from EC (PDPC) [], which catalyzes dephosphorylation and concomitant reactivation of the alpha subunit of the E1 component of the pyruvate dehydrogenase complex. PDPC is a mitochondrial enzyme and, like PP2C, is magnesium-dependent.; GO: 0003824 catalytic activity; PDB: 3KE6_B 3ZT9_A 3RNR_A 3EQ2_A 3F7A_B 3F79_A 3ES2_B 3PU9_B 3T91_B 3T9Q_B .... |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.38 E-value=2.5e-13 Score=150.30 Aligned_cols=266 Identities=21% Similarity=0.303 Sum_probs=190.1
Q ss_pred CCCCCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCC---ChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCc
Q 005427 61 LHLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPN 135 (697)
Q Consensus 61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 135 (697)
.+...+.+.+.+-+-+|.++.++.++- .+...+.|+.... ...+.+....+-.++-.-.+|.++...-.+.-...
T Consensus 799 yrsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP 878 (1205)
T KOG0606|consen 799 YRSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSP 878 (1205)
T ss_pred ccCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCC
Confidence 345566788899999999999998864 3333333321111 11122333344444444456777766666666678
Q ss_pred eEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhh
Q 005427 136 YMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL 215 (697)
Q Consensus 136 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~ 215 (697)
.+++++|+.+++|...++..+ ..+.+.++.+...+..+++|||...+.|||++|.|+|+..+++.++.|||........
T Consensus 879 ~~L~~~~~~~~~~~Skl~~~~-~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~ 957 (1205)
T KOG0606|consen 879 LPLVGHYLNGGDLPSKLHNSG-CLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLI 957 (1205)
T ss_pred cchhhHHhccCCchhhhhcCC-CcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccc
Confidence 999999999999999998766 5666777888889999999999999999999999999999999999999854322211
Q ss_pred ---hhhh-------cccc-cCCCCCCCC----ccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 005427 216 ---KEIS-------LKNW-RSSGKPTGG----FHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTD 280 (697)
Q Consensus 216 ---~~~~-------~~~~-~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~ 280 (697)
...+ ...+ .....+.-. .......||+.|.+||.+.+......+|+|++|++++|.++|.+||..
T Consensus 958 ~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na 1037 (1205)
T KOG0606|consen 958 PPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNA 1037 (1205)
T ss_pred cCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCC
Confidence 0000 0000 000011100 124456899999999999999999999999999999999999999998
Q ss_pred chhHHHHHHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHH
Q 005427 281 LRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFS 343 (697)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ 343 (697)
.........+...... .+.-+...+++..+++...|..+|.+|..+.
T Consensus 1038 ~tpq~~f~ni~~~~~~----------------~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1038 ETPQQIFENILNRDIP----------------WPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred cchhhhhhccccCCCC----------------CCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 8777666655544332 2233456789999999999999999998776
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.34 E-value=3.3e-12 Score=120.21 Aligned_cols=127 Identities=25% Similarity=0.267 Sum_probs=96.9
Q ss_pred ccccccCCceEEEEEEECCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCc-eEEeeccccCCceEEEEeecCCCCHh
Q 005427 71 LSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGL-AKFVAAHAKPPNYMFFFEFYESRNLA 149 (697)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpni-v~l~~~~~~~~~~~lv~e~~~~g~L~ 149 (697)
.+.|+.|.++.||+++..+..+++|....... ....+..|+.+++.+.+.++ ++++.... ...++||||++|.++.
T Consensus 3 ~~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l~ 79 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVANKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSELL 79 (170)
T ss_pred eeecCCcccCceEEEEECCeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCccc
Confidence 46789999999999999999999998543321 22346789999999865554 34554432 3457999999998776
Q ss_pred hhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCc-----ccccCCCCceeecCCCCCeeeeeccch
Q 005427 150 EKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGI-----VHRDVKPANVLLDRNLCPHLADFGLAE 210 (697)
Q Consensus 150 ~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i-----vHrDlkp~Nill~~~~~~kL~Dfg~a~ 210 (697)
... .....++.+++.+|+.||+.++ +|+|++|.||+++ ++.++++|||.+.
T Consensus 80 ~~~---------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 80 TED---------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred ccc---------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 530 1123456789999999999985 9999999999999 6689999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.31 E-value=1.1e-11 Score=112.03 Aligned_cols=133 Identities=25% Similarity=0.412 Sum_probs=102.4
Q ss_pred cccccCCceEEEEEEECCeeEEEEeccCC---Ch-----HHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEeec
Q 005427 72 SPIARGAESVVYEATLDGRKVAVKKPILS---TS-----EELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFY 143 (697)
Q Consensus 72 ~~lg~G~~g~V~~~~~~~~~vavK~~~~~---~~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 143 (697)
..+++|+-+.+|.+.+.|..+.+|.-..+ .+ -..++..+|+.+|..+.--.|..-+=++.++....++|||+
T Consensus 2 ~~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred chhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 46889999999999888878888852221 11 12456788999999996554444444445677888999999
Q ss_pred CCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhh
Q 005427 144 ESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRE 213 (697)
Q Consensus 144 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~ 213 (697)
+|..|.+.+... ...++..+-.-+.-||..||+|+||.++||+++.++ +.++||||+.+..
T Consensus 82 ~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s~ 142 (204)
T COG3642 82 EGELLKDALEEA--------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEFSD 142 (204)
T ss_pred CChhHHHHHHhc--------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccccc
Confidence 999998888654 245677777888899999999999999999997765 9999999986543
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.31 E-value=2.1e-11 Score=114.98 Aligned_cols=136 Identities=18% Similarity=0.132 Sum_probs=99.6
Q ss_pred ccccccCCceEEEEEEEC--------CeeEEEEeccCCC----------------------hHHHHH----HHHHHHHHH
Q 005427 71 LSPIARGAESVVYEATLD--------GRKVAVKKPILST----------------------SEELDN----FHKELQLLC 116 (697)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~--------~~~vavK~~~~~~----------------------~~~~~~----~~~E~~~l~ 116 (697)
...||.|--+.||.|... +..+|||+..... ...... ..+|+..|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 457999999999999753 3689999633210 011222 348999999
Q ss_pred hcC--CCCceEEeeccccCCceEEEEeecCCCCHhh-hhhhcCCCCCHHHHHHHHHHHHHHHHHH-HhCCcccccCCCCc
Q 005427 117 KLD--HPGLAKFVAAHAKPPNYMFFFEFYESRNLAE-KLHVEEWSPSVDQVLMIAAQLAKALQYL-HNLGIVHRDVKPAN 192 (697)
Q Consensus 117 ~l~--hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~~~~~~~i~~qi~~~l~~L-H~~~ivHrDlkp~N 192 (697)
++. .-+++..+++ ...++||||+.++.+.. .+.. ..++.++...+..+++.+|..| |+.|++|+||++.|
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd--~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~N 155 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD--AKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYN 155 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc--cccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence 994 3566777764 46789999998754432 2221 2345567778889999999999 89999999999999
Q ss_pred eeecCCCCCeeeeeccchhhh
Q 005427 193 VLLDRNLCPHLADFGLAEYRE 213 (697)
Q Consensus 193 ill~~~~~~kL~Dfg~a~~~~ 213 (697)
||++ ++.++|+|||.+....
T Consensus 156 IL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 156 MLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred EEEE-CCcEEEEECCCceeCC
Confidence 9996 4679999999886443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.26 E-value=5.8e-12 Score=136.82 Aligned_cols=140 Identities=17% Similarity=0.175 Sum_probs=91.1
Q ss_pred CcccccccccCCceEEEEEEE-C-CeeEEEEeccCCChH----------------------------------HHHH---
Q 005427 67 SYTLLSPIARGAESVVYEATL-D-GRKVAVKKPILSTSE----------------------------------ELDN--- 107 (697)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~-~-~~~vavK~~~~~~~~----------------------------------~~~~--- 107 (697)
.|.. +.||.|++|.||+|+. + |+.||||+....-.+ -.+.
T Consensus 121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ 199 (537)
T PRK04750 121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD 199 (537)
T ss_pred hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence 4665 7899999999999987 3 899999987543111 0112
Q ss_pred ---HHHHHHHHHhc----CCCCceEEeecccc-CCceEEEEeecCCCCHhhhh--hhcCC---CCCHHHHHHHHHHHHHH
Q 005427 108 ---FHKELQLLCKL----DHPGLAKFVAAHAK-PPNYMFFFEFYESRNLAEKL--HVEEW---SPSVDQVLMIAAQLAKA 174 (697)
Q Consensus 108 ---~~~E~~~l~~l----~hpniv~l~~~~~~-~~~~~lv~e~~~~g~L~~~l--~~~~~---~~~~~~~~~i~~qi~~~ 174 (697)
+.+|+..+.++ .+.+.+.+-.++.+ ....++||||+.|+.+.+.. ...+. .+.+..+..++.|+
T Consensus 200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi--- 276 (537)
T PRK04750 200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV--- 276 (537)
T ss_pred hhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH---
Confidence 33344333333 13333332222222 34567999999999998753 22221 12333344444444
Q ss_pred HHHHHhCCcccccCCCCceeecCCC----CCeeeeeccchhhhh
Q 005427 175 LQYLHNLGIVHRDVKPANVLLDRNL----CPHLADFGLAEYREN 214 (697)
Q Consensus 175 l~~LH~~~ivHrDlkp~Nill~~~~----~~kL~Dfg~a~~~~~ 214 (697)
...|++|+|+||.||+++.++ .++++|||++..+..
T Consensus 277 ----f~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 277 ----FRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred ----HhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 458999999999999999887 899999999876643
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.26 E-value=1.1e-10 Score=124.47 Aligned_cols=163 Identities=20% Similarity=0.241 Sum_probs=124.4
Q ss_pred CCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEeecCCCCHhhhhhhcCCCCCHHHHHHH
Q 005427 88 DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMI 167 (697)
Q Consensus 88 ~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i 167 (697)
.+.+|.|...........+...+-++.|+.|+||||+++++.++..+..|+|+|-+. -|..++.+.+ ...+..-
T Consensus 36 ~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~----~~~v~~G 109 (690)
T KOG1243|consen 36 DGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG----KEEVCLG 109 (690)
T ss_pred cCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH----HHHHHHH
Confidence 577787776555555445677888999999999999999999999999999999985 4666665433 5677788
Q ss_pred HHHHHHHHHHHH-hCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhcccccCCCCCCCCccccccccCccccc
Q 005427 168 AAQLAKALQYLH-NLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMA 246 (697)
Q Consensus 168 ~~qi~~~l~~LH-~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 246 (697)
+.||+.||.||| +.+++|++|.-+.|+++..|..||++|.++........ ......--..|..
T Consensus 110 l~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~----------------~~~~~~~~~s~~~ 173 (690)
T KOG1243|consen 110 LFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA----------------PAKSLYLIESFDD 173 (690)
T ss_pred HHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc----------------ccccchhhhcccC
Confidence 899999999997 66899999999999999999999999998854332110 0111112223556
Q ss_pred hhhhcccCCCchhhHHHHHHHHHHHHhC
Q 005427 247 PEILKKEIHSEKSDVYSFGISINELLTG 274 (697)
Q Consensus 247 PE~~~~~~~~~~~DiwslG~~l~ell~g 274 (697)
|+.+.... -..|.|.|||+++|++.|
T Consensus 174 P~~~~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 174 PEEIDPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred hhhcCccc--cchhhhhHHHHHHHHhCc
Confidence 66543222 357999999999999999
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.26 E-value=3.3e-11 Score=108.32 Aligned_cols=142 Identities=23% Similarity=0.306 Sum_probs=108.0
Q ss_pred cccccccCCceEEEEEEECCeeEEEEeccCC--------ChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEe
Q 005427 70 LLSPIARGAESVVYEATLDGRKVAVKKPILS--------TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFE 141 (697)
Q Consensus 70 ~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~--------~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 141 (697)
.+..|-+|+-+.|+++.+.|+...||.-..+ ..-...+..+|+++|.++.--.|.--.-++.+...-.++||
T Consensus 11 ~l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME 90 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME 90 (229)
T ss_pred cceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence 5678899999999999999999999853222 11235678899999999864444333334556667789999
Q ss_pred ecCC-CCHhhhhhhcCCCCCHHHH-HHHHHHHHHHHHHHHhCCcccccCCCCceeecCCC---CCeeeeeccchh
Q 005427 142 FYES-RNLAEKLHVEEWSPSVDQV-LMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNL---CPHLADFGLAEY 211 (697)
Q Consensus 142 ~~~~-g~L~~~l~~~~~~~~~~~~-~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~---~~kL~Dfg~a~~ 211 (697)
|++| .++.+++........++.. ..++..|-+.+..||..+|+|+||..+||++..++ .+.|+|||++..
T Consensus 91 ~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 91 FIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred eccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 9987 4777777654434444444 78899999999999999999999999999996554 357999999853
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.25 E-value=6.3e-12 Score=122.05 Aligned_cols=206 Identities=20% Similarity=0.268 Sum_probs=141.9
Q ss_pred HHHHHhcCCCCceEEeecccc-----CCceEEEEeecCCCCHhhhhhhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC-
Q 005427 112 LQLLCKLDHPGLAKFVAAHAK-----PPNYMFFFEFYESRNLAEKLHVEE---WSPSVDQVLMIAAQLAKALQYLHNLG- 182 (697)
Q Consensus 112 ~~~l~~l~hpniv~l~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~- 182 (697)
..-|-++-|.|||+++.++.+ .....+++||+..|++..+|++.. ..+......+++.||+.||.|||+..
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~P 197 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDP 197 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCC
Confidence 455667789999999988754 356889999999999999987543 35677888999999999999999885
Q ss_pred -cccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhH
Q 005427 183 -IVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDV 261 (697)
Q Consensus 183 -ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 261 (697)
|+|+++..+.|++..+|.+|+.--.-...-..... .....+....+-++|.+||.=.....+.++||
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~------------~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dI 265 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNS------------TREAEKSVNTSLPGFSAPESGTTTNTTGASDI 265 (458)
T ss_pred ccccCCcchhheeecCCceEEecccCccccchhhhh------------hhHhhhhccccCCccccCCcCcccccccchhh
Confidence 99999999999999998888643221111000000 00111223456788999997655566778999
Q ss_pred HHHHHHHHHHHhCCCC-CCCchhHHHHHHHHhccccHHHHHHHHHhCCCCCcccccccCChH-HHHHHHHHhccCCCCCC
Q 005427 262 YSFGISINELLTGVVP-YTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPA-SILSLIQRCWDGNPHNR 339 (697)
Q Consensus 262 wslG~~l~ell~g~~P-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~l~~li~~~l~~dP~~R 339 (697)
|++|+...+|..+..- -.+.........+. .+.. .+.. -=..++.+||+-.|..|
T Consensus 266 y~fgmcAlemailEiq~tnseS~~~~ee~ia-----------~~i~------------~len~lqr~~i~kcl~~eP~~r 322 (458)
T KOG1266|consen 266 YKFGMCALEMAILEIQSTNSESKVEVEENIA-----------NVII------------GLENGLQRGSITKCLEGEPNGR 322 (458)
T ss_pred hhhhHHHHHHHHheeccCCCcceeehhhhhh-----------hhee------------eccCccccCcCcccccCCCCCC
Confidence 9999999999887643 22222111111110 0000 0111 12378899999999999
Q ss_pred CCHHHHHHHHHHH
Q 005427 340 PSFSDIALELDLV 352 (697)
Q Consensus 340 pt~~ell~~l~~~ 352 (697)
|++.+++.|+-.+
T Consensus 323 p~ar~llfHpllf 335 (458)
T KOG1266|consen 323 PDARLLLFHPLLF 335 (458)
T ss_pred cchhhhhcCceee
Confidence 9999998776554
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.14 E-value=2.8e-11 Score=128.10 Aligned_cols=245 Identities=22% Similarity=0.230 Sum_probs=176.2
Q ss_pred CCcccccccccCCceEEEEEEE---CCeeEEEEeccCCC--hHHHHHHHHHHHHHHhc-CCCCceEEeeccccCCceEEE
Q 005427 66 SSYTLLSPIARGAESVVYEATL---DGRKVAVKKPILST--SEELDNFHKELQLLCKL-DHPGLAKFVAAHAKPPNYMFF 139 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv 139 (697)
.+|..+..||.|.|+.|+.... .+..+++|...... ..+...-..|+-+...+ .|.+++.++..+....+.++-
T Consensus 265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip 344 (524)
T KOG0601|consen 265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIP 344 (524)
T ss_pred CCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCc
Confidence 4688899999999999998864 46678888543222 11222234566666666 599999988888887888899
Q ss_pred EeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCC-CCCeeeeeccchhhhhhhhh
Q 005427 140 FEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRN-LCPHLADFGLAEYRENLKEI 218 (697)
Q Consensus 140 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~-~~~kL~Dfg~a~~~~~~~~~ 218 (697)
.|||.++++...... ...+.+...+.+..|++.++.++|+..++|+|+||+||++..+ +..++.|||....+.-
T Consensus 345 ~e~~~~~s~~l~~~~-~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~---- 419 (524)
T KOG0601|consen 345 LEFCEGGSSSLRSVT-SQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAF---- 419 (524)
T ss_pred hhhhcCcchhhhhHH-HHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccce----
Confidence 999999988776632 2256778899999999999999999999999999999999876 7889999998753211
Q ss_pred hcccccCCCCCCCCccccccccCcccc--chhhhcccCCCchhhHHHHHHHHHHHHhCCC-CCCCchhHHHHHHHHhccc
Q 005427 219 SLKNWRSSGKPTGGFHKKNMVGTLIYM--APEILKKEIHSEKSDVYSFGISINELLTGVV-PYTDLRAEAQAHTVLEMNY 295 (697)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~DiwslG~~l~ell~g~~-Pf~~~~~~~~~~~~~~~~~ 295 (697)
......+.-+++ +|+......+..++|++|||..+.+.+++.. ++.+. ....+....
T Consensus 420 ---------------~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~----~~~~i~~~~- 479 (524)
T KOG0601|consen 420 ---------------SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV----QSLTIRSGD- 479 (524)
T ss_pred ---------------ecccccccccccccchhhccccccccccccccccccccccccCcccCcccc----cceeeeccc-
Confidence 112223333444 5555667788899999999999999999753 23221 111111100
Q ss_pred cHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 005427 296 TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL 353 (697)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~ 353 (697)
.+ ...+.+..+..+.+.++..++..||.+.++..+..+..
T Consensus 480 -----------------~p-~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~ 519 (524)
T KOG0601|consen 480 -----------------TP-NLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYR 519 (524)
T ss_pred -----------------cc-CCCchHHhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence 01 11234577889999999999999999999877665543
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.06 E-value=8.8e-10 Score=108.56 Aligned_cols=138 Identities=24% Similarity=0.349 Sum_probs=105.1
Q ss_pred cccccCCceEEEEEEECC-eeEEEEeccCCCh-HHHHHHHHHHHHHHhcCC--CCceEEeeccccC---CceEEEEeecC
Q 005427 72 SPIARGAESVVYEATLDG-RKVAVKKPILSTS-EELDNFHKELQLLCKLDH--PGLAKFVAAHAKP---PNYMFFFEFYE 144 (697)
Q Consensus 72 ~~lg~G~~g~V~~~~~~~-~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h--pniv~l~~~~~~~---~~~~lv~e~~~ 144 (697)
+.|+.|.++.||++...+ +.+++|....... .....+..|+.+++.+.+ .++.+++.+.... +..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 578999999999998765 8999998654322 134578899999999975 4456677766554 36789999999
Q ss_pred CCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------------
Q 005427 145 SRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHN-------------------------------------------- 180 (697)
Q Consensus 145 ~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~-------------------------------------------- 180 (697)
|.++.+.+.. ..+++++...++.+++..|.+||+
T Consensus 84 G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (223)
T cd05154 84 GRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLL 161 (223)
T ss_pred CEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHH
Confidence 9888776532 245666777777788888877773
Q ss_pred ------------CCcccccCCCCceeecC--CCCCeeeeeccchh
Q 005427 181 ------------LGIVHRDVKPANVLLDR--NLCPHLADFGLAEY 211 (697)
Q Consensus 181 ------------~~ivHrDlkp~Nill~~--~~~~kL~Dfg~a~~ 211 (697)
..++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 162 ~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 162 RWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 23689999999999988 56688999998754
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.02 E-value=9.3e-09 Score=106.53 Aligned_cols=212 Identities=15% Similarity=0.230 Sum_probs=152.3
Q ss_pred eEEEEEEE--CCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeecccc----CCceEEEEeecCC-CCHhhhh
Q 005427 80 SVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAK----PPNYMFFFEFYES-RNLAEKL 152 (697)
Q Consensus 80 g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~----~~~~~lv~e~~~~-g~L~~~l 152 (697)
.+.|++.. +|..|++|+++............-++.++++.|+|||+|.++|.. +..+++|++|+++ ++|.++-
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~ 369 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY 369 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence 46789975 788999998755444434344566789999999999999988863 4578999999987 5676653
Q ss_pred hh--------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhh
Q 005427 153 HV--------------EEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI 218 (697)
Q Consensus 153 ~~--------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~ 218 (697)
-. .+...+++.+|.++.|+..||.++|+.|+.-+-|.|.+||++.+..++|.-.|....+....
T Consensus 370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~-- 447 (655)
T KOG3741|consen 370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDP-- 447 (655)
T ss_pred ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecCCC--
Confidence 21 12245788999999999999999999999999999999999999888988888764433200
Q ss_pred hcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHH
Q 005427 219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQ 298 (697)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~ 298 (697)
. |-+.. ..+-|.=-||.+++.|.||..--...+.... ..
T Consensus 448 --------------------------~--~~le~---~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~--s~-------- 486 (655)
T KOG3741|consen 448 --------------------------T--EPLES---QQQNDLRDLGLLLLALATGTENSNRTDSTQS--SH-------- 486 (655)
T ss_pred --------------------------C--cchhH---HhhhhHHHHHHHHHHHhhcccccccccchHH--HH--------
Confidence 0 11111 2367899999999999998533111111000 00
Q ss_pred HHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 005427 299 QLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALEL 349 (697)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l 349 (697)
+..+...++.++++++.-....++++ -++.+++.+.
T Consensus 487 --------------~~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~ 522 (655)
T KOG3741|consen 487 --------------LTRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMI 522 (655)
T ss_pred --------------HHHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHH
Confidence 01122467899999999999999987 6788887654
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.96 E-value=1.3e-08 Score=101.83 Aligned_cols=133 Identities=19% Similarity=0.157 Sum_probs=95.8
Q ss_pred CceEEEEEEECCeeEEEEeccCCChHH-H----------HHHHHHHHHHHhcCCCCc--eEEeecccc-----CCceEEE
Q 005427 78 AESVVYEATLDGRKVAVKKPILSTSEE-L----------DNFHKELQLLCKLDHPGL--AKFVAAHAK-----PPNYMFF 139 (697)
Q Consensus 78 ~~g~V~~~~~~~~~vavK~~~~~~~~~-~----------~~~~~E~~~l~~l~hpni--v~l~~~~~~-----~~~~~lv 139 (697)
....|.+....|+.+.||......... . ..+.+|...+..|..-+| +..+.+... ....++|
T Consensus 34 ~~rrvvr~~~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LV 113 (268)
T PRK15123 34 EGRRTLRFELAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFII 113 (268)
T ss_pred CCceEEEEEECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEE
Confidence 334466777888999999754333211 1 137799999988843222 233333322 2357899
Q ss_pred EeecCCC-CHhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecC-------CCCCeeeeeccch
Q 005427 140 FEFYESR-NLAEKLHVE-EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDR-------NLCPHLADFGLAE 210 (697)
Q Consensus 140 ~e~~~~g-~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~-------~~~~kL~Dfg~a~ 210 (697)
||++++. +|.+++... ....+......++.+++..+..||+.||+|+|+++.|||++. ++.+.|+||+.+.
T Consensus 114 te~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 114 TEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred EeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 9999986 788887531 224566778899999999999999999999999999999975 4678999999774
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.94 E-value=2e-08 Score=101.46 Aligned_cols=264 Identities=19% Similarity=0.215 Sum_probs=162.6
Q ss_pred ccccccccCCceEEEEEEECCeeEEEEeccCCChHHHHHHHHHHHHHHhc-CCCCceE--------EeeccccCCceEEE
Q 005427 69 TLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKL-DHPGLAK--------FVAAHAKPPNYMFF 139 (697)
Q Consensus 69 ~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~--------l~~~~~~~~~~~lv 139 (697)
.....||+|+.+.+|-.-.-+.. +.|+........... .+..|... .||-+-. |++-- .....-++
T Consensus 14 ~~gr~LgqGgea~ly~l~e~~d~-VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~-~~~~iGfl 88 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEVRDQ-VAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGR-RGKVIGFL 88 (637)
T ss_pred CCCccccCCccceeeecchhhch-hheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCC-ccceeEEe
Confidence 35678999999999955322222 223323222221111 12222222 5654332 22211 11226677
Q ss_pred EeecCCCC-Hhhhhh---hc--CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhh
Q 005427 140 FEFYESRN-LAEKLH---VE--EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRE 213 (697)
Q Consensus 140 ~e~~~~g~-L~~~l~---~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~ 213 (697)
|..+.|.. +..++. ++ -....|+.+++.++.++.+.+.||+.|.+-+|+.++|+|+++++.|.|.|=..-..-
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~- 167 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQIN- 167 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccceeec-
Confidence 88777642 222221 11 113478899999999999999999999999999999999999999999885533211
Q ss_pred hhhhhhcccccCCCCCCCCccccccccCccccchhhhc-----ccCCCchhhHHHHHHHHHHHHh-CCCCCCCchhHHHH
Q 005427 214 NLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILK-----KEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQA 287 (697)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~~l~ell~-g~~Pf~~~~~~~~~ 287 (697)
..+......+|.+.|.+||.-. +..-+...|.|.||+++++++. |+.||++.......
T Consensus 168 ----------------~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~a 231 (637)
T COG4248 168 ----------------ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDA 231 (637)
T ss_pred ----------------cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCC
Confidence 1122234568999999999754 3445667899999999999998 59999875321110
Q ss_pred -----HHHHhccccHHHHHHHHHhCCCCCcccccc-cCChHHHHHHHHHhccC--CCCCCCCHHHHHHHHHHHHHHhcc
Q 005427 288 -----HTVLEMNYTEQQLTAAVVSGGLRPILASLE-LGLPASILSLIQRCWDG--NPHNRPSFSDIALELDLVLEHRKS 358 (697)
Q Consensus 288 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~~l~~--dP~~Rpt~~ell~~l~~~~~~~~~ 358 (697)
..|-.+.+... .....+++|.....| .-+++++..|..+|+.. ++.-|||++..+..|....+....
T Consensus 232 p~p~E~~Ia~g~f~ya----~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~ 306 (637)
T COG4248 232 PNPLETDIAHGRFAYA----SDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKK 306 (637)
T ss_pred CCcchhhhhcceeeec----hhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhh
Confidence 01111111110 011123333332222 34788999999999965 367899999999888887766443
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.86 E-value=1.3e-08 Score=95.91 Aligned_cols=123 Identities=26% Similarity=0.271 Sum_probs=81.8
Q ss_pred EEEEEEE-CCeeEEEEeccCCC---------------------h-----HHHHHHHHHHHHHHhcCCC--CceEEeeccc
Q 005427 81 VVYEATL-DGRKVAVKKPILST---------------------S-----EELDNFHKELQLLCKLDHP--GLAKFVAAHA 131 (697)
Q Consensus 81 ~V~~~~~-~~~~vavK~~~~~~---------------------~-----~~~~~~~~E~~~l~~l~hp--niv~l~~~~~ 131 (697)
.||.|.. ++..+|||...... . .......+|.+.|.++..- ++++.+++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 4899987 78899999643310 0 0134578899999999755 567777553
Q ss_pred cCCceEEEEeecC--CCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHH-HHhCCcccccCCCCceeecCCCCCeeeeecc
Q 005427 132 KPPNYMFFFEFYE--SRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQY-LHNLGIVHRDVKPANVLLDRNLCPHLADFGL 208 (697)
Q Consensus 132 ~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~-LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~ 208 (697)
..++||||++ |..+..+.... ++.+....++.+++..+.. +|..||+|+||.+.|||++.+ .+.|+|||.
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~---~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~q 152 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD---LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQ 152 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG---GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTT
T ss_pred ---CCEEEEEecCCCccchhhHHhcc---ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCc
Confidence 4579999998 54444433221 1134566778888885555 579999999999999999887 899999998
Q ss_pred chh
Q 005427 209 AEY 211 (697)
Q Consensus 209 a~~ 211 (697)
+..
T Consensus 153 av~ 155 (188)
T PF01163_consen 153 AVD 155 (188)
T ss_dssp EEE
T ss_pred cee
Confidence 854
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.84 E-value=1.7e-08 Score=97.21 Aligned_cols=134 Identities=25% Similarity=0.210 Sum_probs=102.8
Q ss_pred cccccccccCCceEEEEEEE-CCeeEEEEeccCCCh----------------------HHHHHHHHHHHHHHhcCCC--C
Q 005427 68 YTLLSPIARGAESVVYEATL-DGRKVAVKKPILSTS----------------------EELDNFHKELQLLCKLDHP--G 122 (697)
Q Consensus 68 y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~----------------------~~~~~~~~E~~~l~~l~hp--n 122 (697)
+.++.+||-|.-+.||.|.+ .|.++|||..+.... -......+|.++|.+|.-. .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 56788999999999999988 599999996433211 1134568899999999644 6
Q ss_pred ceEEeeccccCCceEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCe
Q 005427 123 LAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPH 202 (697)
Q Consensus 123 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~k 202 (697)
+++-+++ +.-.+|||+++|-.|...- +..+..-.++..|++-+..+-..||+|+|+++-||+++.+|.+.
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r------~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~ 242 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR------LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIV 242 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc------CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEE
Confidence 7776654 4568999999986655432 12344556677777777777799999999999999999999999
Q ss_pred eeeeccchh
Q 005427 203 LADFGLAEY 211 (697)
Q Consensus 203 L~Dfg~a~~ 211 (697)
++||-.+..
T Consensus 243 vIDwPQ~v~ 251 (304)
T COG0478 243 VIDWPQAVP 251 (304)
T ss_pred EEeCccccc
Confidence 999987753
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.72 E-value=2e-07 Score=88.03 Aligned_cols=137 Identities=14% Similarity=0.066 Sum_probs=102.5
Q ss_pred ccCCceEEEEEEECCeeEEEEeccCCC------hHHHHHHHHHHHHHHhcCCC--CceEEeec--cccC--CceEEEEee
Q 005427 75 ARGAESVVYEATLDGRKVAVKKPILST------SEELDNFHKELQLLCKLDHP--GLAKFVAA--HAKP--PNYMFFFEF 142 (697)
Q Consensus 75 g~G~~g~V~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~hp--niv~l~~~--~~~~--~~~~lv~e~ 142 (697)
|+||-+.|+.....|+.+-+|.....- ......|.+|+..|..|..- .+++.+.. ...+ -.-+||+|-
T Consensus 27 ~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe~ 106 (216)
T PRK09902 27 RRNGMSGVQCVERNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTED 106 (216)
T ss_pred CCCCcceEEEEEeCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEEe
Confidence 678999999998888889999743111 22356899999999999532 24444421 1122 246789998
Q ss_pred cCC-CCHhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCC--Ceeeeeccchh
Q 005427 143 YES-RNLAEKLHVEE-WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLC--PHLADFGLAEY 211 (697)
Q Consensus 143 ~~~-g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~--~kL~Dfg~a~~ 211 (697)
+.| -+|.+++.... .+.+..+...++.+++..+.-||+.|+.|+|+-+.|||++.++. ++++||.-++.
T Consensus 107 L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 107 MAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred CCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 765 48888875533 24567777899999999999999999999999999999986666 99999997653
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.67 E-value=7.1e-09 Score=111.44 Aligned_cols=160 Identities=19% Similarity=0.273 Sum_probs=109.4
Q ss_pred HHHHHHHHHHHHHHhC-CcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhcccccCCCCCCCCccccccccCccc
Q 005427 166 MIAAQLAKALQYLHNL-GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIY 244 (697)
Q Consensus 166 ~i~~qi~~~l~~LH~~-~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 244 (697)
.=+.++..|+.|+|.. ++||++|.|++|.++..+..||+.|+++.............|... ......-...|
T Consensus 103 ~nl~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~-------lp~~~~~~~~f 175 (700)
T KOG2137|consen 103 ANLGNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPP-------LPLLLQPHLNF 175 (700)
T ss_pred hhhhcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCC-------CChhhccCccc
Confidence 3344556999999965 899999999999999999999999999876654222211111111 11223456789
Q ss_pred cchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCCchhHHHHHHHHhccccHHHHHHHHHhCCCCCcccccccCChHH
Q 005427 245 MAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPAS 323 (697)
Q Consensus 245 ~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (697)
.|||++.+...+.++|++|+|+++|.+.. |..-+.......... +.... ..-........+|.+
T Consensus 176 ~apE~~~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~-~~~~~--------------~~~~~~~~s~~~p~e 240 (700)
T KOG2137|consen 176 LAPEYLLGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYS-FSRNL--------------LNAGAFGYSNNLPSE 240 (700)
T ss_pred ccchhhccccccccccceeeeeEEEEEecCCcchhhccCCcchhh-hhhcc--------------cccccccccccCcHH
Confidence 99999999888999999999999999995 554443321111100 00000 000011123578999
Q ss_pred HHHHHHHhccCCCCCCCCHHHHHH
Q 005427 324 ILSLIQRCWDGNPHNRPSFSDIAL 347 (697)
Q Consensus 324 l~~li~~~l~~dP~~Rpt~~ell~ 347 (697)
+.+-+.+++..++..||++.++..
T Consensus 241 l~~~l~k~l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 241 LRESLKKLLNGDSAVRPTLDLLLS 264 (700)
T ss_pred HHHHHHHHhcCCcccCcchhhhhc
Confidence 999999999999999998877753
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.67 E-value=1.3e-07 Score=91.59 Aligned_cols=106 Identities=23% Similarity=0.246 Sum_probs=81.3
Q ss_pred HHHHHHHHHHHHhcCCC--CceEEeeccccC----CceEEEEeecCCC-CHhhhhhhcCCCCCHHHHHHHHHHHHHHHHH
Q 005427 105 LDNFHKELQLLCKLDHP--GLAKFVAAHAKP----PNYMFFFEFYESR-NLAEKLHVEEWSPSVDQVLMIAAQLAKALQY 177 (697)
Q Consensus 105 ~~~~~~E~~~l~~l~hp--niv~l~~~~~~~----~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~ 177 (697)
..+..+|...+..|..- .++..+++.... ...++|+|++++. +|.+++.... .++......++.++...+.-
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~-~~~~~~~~~ll~~l~~~i~~ 133 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE-QLDPSQRRELLRALARLIAK 133 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc-ccchhhHHHHHHHHHHHHHH
Confidence 45678888888887432 233344443332 2458999999884 7888886533 25667788999999999999
Q ss_pred HHhCCcccccCCCCceeecCCC---CCeeeeeccchh
Q 005427 178 LHNLGIVHRDVKPANVLLDRNL---CPHLADFGLAEY 211 (697)
Q Consensus 178 LH~~~ivHrDlkp~Nill~~~~---~~kL~Dfg~a~~ 211 (697)
||+.||+|+|+++.|||++.++ .+.|+||+-+..
T Consensus 134 lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 134 LHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 9999999999999999998877 799999997753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.54 E-value=7.8e-07 Score=84.36 Aligned_cols=137 Identities=19% Similarity=0.266 Sum_probs=92.5
Q ss_pred CCCCcccccccccCCceEEEEEEECCeeEEEEeccCCChHHHHH---------HHHHHHHHHhcC---CCCceEEeec--
Q 005427 64 PPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDN---------FHKELQLLCKLD---HPGLAKFVAA-- 129 (697)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~---hpniv~l~~~-- 129 (697)
...+|.+.+.+-.....-|.+...+++.+.+|..........+. ..+++..+..+. ......++-+
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e 108 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE 108 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence 34578888888888888888888899999999866543322221 223334333332 2222222222
Q ss_pred ---cccCCceEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeee
Q 005427 130 ---HAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADF 206 (697)
Q Consensus 130 ---~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Df 206 (697)
+.-...++++|||++|..|.+... +++ .+...+.+++.-||+.|++|+|..|.|++++.++ ++++||
T Consensus 109 kk~~~~~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~-i~iID~ 178 (229)
T PF06176_consen 109 KKIFRYTSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG-IRIIDT 178 (229)
T ss_pred eeeccceeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-EEEEEC
Confidence 222356779999999988776542 222 2445677889999999999999999999998655 999999
Q ss_pred ccch
Q 005427 207 GLAE 210 (697)
Q Consensus 207 g~a~ 210 (697)
+..+
T Consensus 179 ~~k~ 182 (229)
T PF06176_consen 179 QGKR 182 (229)
T ss_pred cccc
Confidence 8653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.39 E-value=2.1e-06 Score=93.10 Aligned_cols=140 Identities=19% Similarity=0.246 Sum_probs=90.1
Q ss_pred cccccCCceEEEEEEE-CCeeEEEEeccCCChHH----------------------------------HH------HHHH
Q 005427 72 SPIARGAESVVYEATL-DGRKVAVKKPILSTSEE----------------------------------LD------NFHK 110 (697)
Q Consensus 72 ~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~----------------------------------~~------~~~~ 110 (697)
..|+.++-|.||+|+. +|+.||||+.+..-.+. .+ .+.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 5688999999999998 59999999855431110 01 1344
Q ss_pred HHHHHHhcC-----CCCceEEeeccccCCceEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 005427 111 ELQLLCKLD-----HPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVH 185 (697)
Q Consensus 111 E~~~l~~l~-----hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH 185 (697)
|+.-+.+++ .|+|.--.-+.+-...-.|+|||++|-.+.+.........+...+...+.++. +..+-..|++|
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f--~~q~~~dgffH 288 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAF--LRQLLRDGFFH 288 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHH--HHHHHhcCccc
Confidence 555444441 23322111122234567899999999888887533333455333333222222 23334479999
Q ss_pred ccCCCCceeecCCCCCeeeeeccchhhh
Q 005427 186 RDVKPANVLLDRNLCPHLADFGLAEYRE 213 (697)
Q Consensus 186 rDlkp~Nill~~~~~~kL~Dfg~a~~~~ 213 (697)
.|.+|.||+++.+|.+.+.|||+...+.
T Consensus 289 aDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 289 ADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred cCCCccceEEecCCcEEEEcCcceecCC
Confidence 9999999999999999999999986554
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.34 E-value=4.4e-06 Score=80.11 Aligned_cols=135 Identities=27% Similarity=0.287 Sum_probs=94.5
Q ss_pred cccccCCceEEEEEEE-CCeeEEEEeccCCChHH------------------------HHHHHHHHHHHHhcC--CCCce
Q 005427 72 SPIARGAESVVYEATL-DGRKVAVKKPILSTSEE------------------------LDNFHKELQLLCKLD--HPGLA 124 (697)
Q Consensus 72 ~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~------------------------~~~~~~E~~~l~~l~--hpniv 124 (697)
..|+.|.-+.||+|.. .+..+|+|+........ ..-..+|+.-|+++. +-.++
T Consensus 54 g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP 133 (268)
T COG1718 54 GCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP 133 (268)
T ss_pred eeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence 3677888889999975 68899999754332110 112456778888773 44455
Q ss_pred EEeeccccCCceEEEEeecCCCC-HhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCCCceeecCCCCCe
Q 005427 125 KFVAAHAKPPNYMFFFEFYESRN-LAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHN-LGIVHRDVKPANVLLDRNLCPH 202 (697)
Q Consensus 125 ~l~~~~~~~~~~~lv~e~~~~g~-L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivHrDlkp~Nill~~~~~~k 202 (697)
+-+.+. +-.|||||+.... -.-.|. ...+..+++..+..++++.+.-|-. .++||+||+.=|||+. ++.+.
T Consensus 134 ~Pi~~~----~nVLvMEfIg~~g~pAP~Lk--Dv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~ 206 (268)
T COG1718 134 EPIAFR----NNVLVMEFIGDDGLPAPRLK--DVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEPY 206 (268)
T ss_pred Cceeec----CCeEEEEeccCCCCCCCCcc--cCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeEE
Confidence 555543 4579999986531 111121 1233444778888999999998877 8999999999999998 88999
Q ss_pred eeeeccchhhh
Q 005427 203 LADFGLAEYRE 213 (697)
Q Consensus 203 L~Dfg~a~~~~ 213 (697)
++|||.|....
T Consensus 207 iID~~QaV~~~ 217 (268)
T COG1718 207 IIDVSQAVTID 217 (268)
T ss_pred EEECccccccC
Confidence 99999886543
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.33 E-value=1.2e-07 Score=100.87 Aligned_cols=192 Identities=17% Similarity=0.182 Sum_probs=143.6
Q ss_pred CCCCCCcccccccccCCceEEEEEEECCee-EEEEeccCCChHHHHHHHHHHHHHHhcCCCC-ceEEeeccccCCceEEE
Q 005427 62 HLPPSSYTLLSPIARGAESVVYEATLDGRK-VAVKKPILSTSEELDNFHKELQLLCKLDHPG-LAKFVAAHAKPPNYMFF 139 (697)
Q Consensus 62 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn-iv~l~~~~~~~~~~~lv 139 (697)
+-..+-|...+-+++|+++.+++.+...++ ...+.+... ....-++++|.+++||| .+..++-+.-+...++.
T Consensus 238 kDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~ 312 (829)
T KOG0576|consen 238 KDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIP 312 (829)
T ss_pred cCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchh
Confidence 334456888899999999999999875443 334443322 33456889999999999 77777777778889999
Q ss_pred EeecCCC-CHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhh
Q 005427 140 FEFYESR-NLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI 218 (697)
Q Consensus 140 ~e~~~~g-~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~ 218 (697)
++++.++ +...........+..-+...+++.-.++++++|+..=+|+| ||+..+ +..|+.||+....+...
T Consensus 313 ~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~--- 384 (829)
T KOG0576|consen 313 MRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRT--- 384 (829)
T ss_pred hhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCcc---
Confidence 9999887 33333222222344445666778888999999998778998 777655 67899999987655431
Q ss_pred hcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 005427 219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTD 280 (697)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~ 280 (697)
....+..+++.++|||+.....+....|.|++|+-..++.-|.+|-..
T Consensus 385 --------------~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~ 432 (829)
T KOG0576|consen 385 --------------MKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS 432 (829)
T ss_pred --------------cccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC
Confidence 135677899999999999999999999999999887788778777654
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.29 E-value=7e-06 Score=80.52 Aligned_cols=134 Identities=12% Similarity=0.120 Sum_probs=83.0
Q ss_pred cccccCCceEEEEEEECCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCC--CceEEeeccccCCceEEEEeecCCCC-H
Q 005427 72 SPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP--GLAKFVAAHAKPPNYMFFFEFYESRN-L 148 (697)
Q Consensus 72 ~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp--niv~l~~~~~~~~~~~lv~e~~~~g~-L 148 (697)
.+||.|..+.||+. .+..+++|...... ......+|.++++.+..- .+.+.+++....+.+.+|||+++|.. +
T Consensus 7 ~~i~~G~t~~~y~~--~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~ 82 (226)
T TIGR02172 7 TQTGEGGNGESYTH--KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSF 82 (226)
T ss_pred eeecCCCCcceeEe--cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccch
Confidence 57899999999984 35567888755432 234568999999998543 34667777777777889999999863 1
Q ss_pred hhh---------------------hhhcCC-CCCHHHH-HHHHH----------HHHH-HHHHHH----hCCcccccCCC
Q 005427 149 AEK---------------------LHVEEW-SPSVDQV-LMIAA----------QLAK-ALQYLH----NLGIVHRDVKP 190 (697)
Q Consensus 149 ~~~---------------------l~~~~~-~~~~~~~-~~i~~----------qi~~-~l~~LH----~~~ivHrDlkp 190 (697)
... ++.-.. ....... ..+.. .+.. ...+|. ...++|+|+.|
T Consensus 83 ~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~~ 162 (226)
T TIGR02172 83 SRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQI 162 (226)
T ss_pred hhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCCC
Confidence 111 111000 0111100 00100 0111 112222 12468999999
Q ss_pred CceeecCCCCCeeeeeccch
Q 005427 191 ANVLLDRNLCPHLADFGLAE 210 (697)
Q Consensus 191 ~Nill~~~~~~kL~Dfg~a~ 210 (697)
.||+++.++ +.|+||+.+.
T Consensus 163 ~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 163 GNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CcEEEcCCC-cEEEechhcC
Confidence 999999888 9999999874
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.27 E-value=6.5e-06 Score=74.51 Aligned_cols=133 Identities=22% Similarity=0.239 Sum_probs=96.6
Q ss_pred CCCcccccccccCCceEEEEEEECCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceE-EeeccccCCceEEEEeec
Q 005427 65 PSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAK-FVAAHAKPPNYMFFFEFY 143 (697)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~-l~~~~~~~~~~~lv~e~~ 143 (697)
....+..+.|++|.+|.||++.+.+..+|+|+....+ ....+..|+++|..++-.++-+ +|.+.. -++.|||.
T Consensus 21 ~~~~~v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i 94 (201)
T COG2112 21 KYELRVEKELAKGTTSVVYLGEWRGGEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYI 94 (201)
T ss_pred chhhhhhhhhhcccccEEEEeeccCceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhh
Confidence 3345678899999999999999999999999855433 4567899999999998776644 554432 23459999
Q ss_pred CCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCC-CCceeecCCCCCeeeeeccchh
Q 005427 144 ESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVK-PANVLLDRNLCPHLADFGLAEY 211 (697)
Q Consensus 144 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlk-p~Nill~~~~~~kL~Dfg~a~~ 211 (697)
.|..|.+..... + .+-+..+++.-.-|-..||-|+.|. |...++-.++.+.|+||..|+.
T Consensus 95 ~G~~L~~~~~~~----~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 95 DGRPLGKLEIGG----D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred cCcchhhhhhcc----c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 998887765321 1 2233456666666778899999987 4444444555899999998864
|
|
| >COG2208 RsbU Serine phosphatase RsbU, regulator of sigma subunit [Signal transduction mechanisms / Transcription] | Back alignment and domain information |
|---|
Probab=98.21 E-value=9.1e-05 Score=78.65 Aligned_cols=189 Identities=17% Similarity=0.143 Sum_probs=117.7
Q ss_pred CCCceeEEcccccCCCceEEEEEecCCC-ChHHHHHHHHHhHHHHHhcCC--CCChHHHHHHHHHHHHHHHHHHHHHHHh
Q 005427 442 TMEDTHFLMPHMYNQKEIHMFGIFDGHR-GSAAAEFSARALPGFLQNLGS--TTRPTDALLEAFIRTDVAFRNELDSLRK 518 (697)
Q Consensus 442 ~neD~~~~~~~~~~~~~~~~~~V~DG~G-G~~~~~~as~~~~~~l~~~~~--~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 518 (697)
-.=|.|-+.. .+.....++|.|.+| |-.++-. +......+..... ..++. +.+...+..+.....
T Consensus 161 vGGD~yd~~~---~~~~~~~i~I~DvsG~Gv~aal~-m~~~~~~~~~~~~~~~~~p~----~~l~~~n~~~~~~~~---- 228 (367)
T COG2208 161 VGGDYYDFIQ---LGEKRLRIGIGDVSGKGVPAALL-MLMPKLALRLLLESGPLDPA----DVLETLNRVLKQNLE---- 228 (367)
T ss_pred cCCceEEEEE---ECCcEEEEEEEeccCCCHHHHHH-HHHHHHHHHHhhhcccCCHH----HHHHHHHHHHHhccc----
Confidence 3345555433 122567899999999 5555544 4444444433311 22332 223333333332211
Q ss_pred hhhcccCCCCCCceEEEEEEe--cCeEEEEEcCCeEEEEEECCeeeecCCCCCCCCHHHHHHHHHcCCeeeeccCcceeC
Q 005427 519 SKRVVQKDWHPGCTAIAALIV--RNRLFVANAGDCRAILCRGGHPFALSRDHVASCLEERERVVSAGGNVNWQVDTWRVG 596 (697)
Q Consensus 519 ~~~~~~~~~~~GtT~~~~~i~--~~~l~~anvGDSr~~l~~~~~~~~lt~dH~~~~~~e~~ri~~~g~~~~~~~~~~~~~ 596 (697)
..+=+|+..++++ .+.+..+|+|=--+++++.+... +.-.
T Consensus 229 --------~~~f~T~~~~~~d~~~~~l~y~~aGH~p~~i~~~~~~~--~~~~---------------------------- 270 (367)
T COG2208 229 --------EDMFVTLFLGVYDLDSGELTYSNAGHEPALILSADGEI--EVED---------------------------- 270 (367)
T ss_pred --------CCcEEEEEEEEEeccCCEEEEeeCCCCCeeEEEcCCCc--eeEE----------------------------
Confidence 0146888888886 57899999999999888864321 0000
Q ss_pred CCcceeccccCCCCCCCCcccCCceEEEEeCCCCeEEEEEcCCccc-------CCChHHHHHHHHhhc-CChhHHHHHHH
Q 005427 597 PPALQVTRSIGDDDLKPAVTAEPEITETIMTPEDEYLVMASDGLWD-------VVSHVEAVGIIKDTV-KEPGMCSKRLA 668 (697)
Q Consensus 597 ~~~~~ltralG~~~~k~~v~~~p~v~~~~l~~~d~~lvl~SDGl~d-------~~~~~ei~~~~~~~~-~~~~~~a~~L~ 668 (697)
-......+|... ...+.+....+.+|| .+||.|||+.+ .+..+...+++.... .+++++++.+.
T Consensus 271 --l~~~g~piG~~~-----~~~~~~~~~~l~~gd-~lvl~tDGv~Ea~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~i~ 342 (367)
T COG2208 271 --LTALGLPIGLLP-----DYQYEVASLQLEPGD-LLVLYTDGVTEARNSDGEFFGLERLLKILGRLLGQPAEEILEAIL 342 (367)
T ss_pred --ccCCCceeeecC-----CccchheeEEecCCC-EEEEEcCCeeeeecCCccEecHHHHHHHHHHHhCCCHHHHHHHHH
Confidence 112234566555 556778888999988 88899999999 567777888887433 46788888777
Q ss_pred HHHHhcC----CCCCcEEEEEEeC
Q 005427 669 TEAAERG----SKDNITVIVVFLQ 688 (697)
Q Consensus 669 ~~a~~~g----~~DNiT~ivv~l~ 688 (697)
+...+-- ..||+|++++++.
T Consensus 343 ~~l~~~~~~~~~~DDiTll~lk~~ 366 (367)
T COG2208 343 ESLEELQGDQIQDDDITLLVLKVK 366 (367)
T ss_pred HHHHHhhCCccccCceEEEEEEec
Confidence 7665532 3488999999875
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.21 E-value=4.1e-05 Score=71.97 Aligned_cols=126 Identities=27% Similarity=0.360 Sum_probs=91.4
Q ss_pred CCCcccccccccCCc-eEEEEEEECCeeEEEEeccC---CCh------------------HHHHHHHHHHHHHHhcC---
Q 005427 65 PSSYTLLSPIARGAE-SVVYEATLDGRKVAVKKPIL---STS------------------EELDNFHKELQLLCKLD--- 119 (697)
Q Consensus 65 ~~~y~~~~~lg~G~~-g~V~~~~~~~~~vavK~~~~---~~~------------------~~~~~~~~E~~~l~~l~--- 119 (697)
..+++.++.||.|.- |.||+++..|+.+|+|.... ... ...+.|..|.+...+|+
T Consensus 36 ~~~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 36 GDDIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CCcEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 378999999999999 99999999999999998211 110 11346788888877774
Q ss_pred CCCc--eEEeecccc------------------CCceEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHH
Q 005427 120 HPGL--AKFVAAHAK------------------PPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLH 179 (697)
Q Consensus 120 hpni--v~l~~~~~~------------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH 179 (697)
+.++ |+++|+..- ...+.+|.||..... .++. .-+.++++-|..+|
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------~~~~----~~~~~~~~dl~~~~ 181 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------PLQI----RDIPQMLRDLKILH 181 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------ccch----hHHHHHHHHHHHHH
Confidence 5566 888887621 123556777766532 1222 23456777788899
Q ss_pred hCCcccccCCCCceeecCCCCCeeeeeccc
Q 005427 180 NLGIVHRDVKPANVLLDRNLCPHLADFGLA 209 (697)
Q Consensus 180 ~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a 209 (697)
..||+-+|+++.|.. .-||+|||.+
T Consensus 182 k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 182 KLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HCCeeeccCcccccc-----CCEEEecccC
Confidence 999999999999986 3489999964
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.18 E-value=1.2e-05 Score=80.29 Aligned_cols=135 Identities=15% Similarity=0.118 Sum_probs=84.9
Q ss_pred ccccCCc-eEEEEEEECCeeEEEEeccCCChHHHHHHHHHHHHHHhcC-CCCceEEeeccccCCceEEEEeecCCCCHhh
Q 005427 73 PIARGAE-SVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLD-HPGLAKFVAAHAKPPNYMFFFEFYESRNLAE 150 (697)
Q Consensus 73 ~lg~G~~-g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~ 150 (697)
.|-.|.. ..||+....+..+.+|...... ...+.+|+.+++.+. +--+.+++++....+..++||++++|.++..
T Consensus 5 ~~~~g~~~~~v~~~~~~~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~ 81 (244)
T cd05150 5 RVTEGQSGATVYRLDGKNPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA 81 (244)
T ss_pred ecCCCCCcCeEEEEcCCCCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence 4555665 6899998777788899754332 345678999998883 4456677877776677899999999876654
Q ss_pred hh-------------------hhcC---CCCCH--HHHHHHHH--------------------HHHHHHHHHH-------
Q 005427 151 KL-------------------HVEE---WSPSV--DQVLMIAA--------------------QLAKALQYLH------- 179 (697)
Q Consensus 151 ~l-------------------~~~~---~~~~~--~~~~~i~~--------------------qi~~~l~~LH------- 179 (697)
.. +... ..+.. ........ .+...+..|-
T Consensus 82 ~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 161 (244)
T cd05150 82 LWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEE 161 (244)
T ss_pred hhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcC
Confidence 31 1110 01110 00000000 0111122221
Q ss_pred hCCcccccCCCCceeecCCCCCeeeeeccch
Q 005427 180 NLGIVHRDVKPANVLLDRNLCPHLADFGLAE 210 (697)
Q Consensus 180 ~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~ 210 (697)
...++|+|+.|.|||++.++.+.|+||+.+.
T Consensus 162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred ceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 2248999999999999988778899999874
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.13 E-value=1.7e-05 Score=78.64 Aligned_cols=138 Identities=22% Similarity=0.264 Sum_probs=82.5
Q ss_pred ccccccCCceEEEEEEECCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCC--CceEEeecc---ccCCceEEEEeecCC
Q 005427 71 LSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP--GLAKFVAAH---AKPPNYMFFFEFYES 145 (697)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp--niv~l~~~~---~~~~~~~lv~e~~~~ 145 (697)
++.|+.|..+.||+....+..+++|..... .....+.+|..+++.|... .+.+++... ......+++|++++|
T Consensus 2 i~~l~~G~~n~~~~v~~~~~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g 79 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDDGRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG 79 (239)
T ss_dssp EEEEEESSSSEEEEEEETTSEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred CccCCCCCeeeEEEEEECCcEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence 467899999999999997789999985433 4566788999999888432 355566533 223457899999999
Q ss_pred CCHhh----------------h---hhhcC---CCCCHH---------HHHHH------------HHHHHH-HHHHHH--
Q 005427 146 RNLAE----------------K---LHVEE---WSPSVD---------QVLMI------------AAQLAK-ALQYLH-- 179 (697)
Q Consensus 146 g~L~~----------------~---l~~~~---~~~~~~---------~~~~i------------~~qi~~-~l~~LH-- 179 (697)
..+.. . ++... ..+... ..... ...+.. .+..++
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (239)
T PF01636_consen 80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL 159 (239)
T ss_dssp EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence 87766 1 11110 011100 00000 111222 233333
Q ss_pred -----hCCcccccCCCCceeec-CCCCCeeeeeccch
Q 005427 180 -----NLGIVHRDVKPANVLLD-RNLCPHLADFGLAE 210 (697)
Q Consensus 180 -----~~~ivHrDlkp~Nill~-~~~~~kL~Dfg~a~ 210 (697)
...++|+|+.|.|||++ .++.+.|+||+.+.
T Consensus 160 ~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 160 LPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred hccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 23599999999999999 55656799999764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.91 E-value=0.0001 Score=86.61 Aligned_cols=77 Identities=16% Similarity=0.296 Sum_probs=56.4
Q ss_pred ccccccCCceEEEEEEECC----eeEEEEeccCCC-hHHHHHHHHHHHHHHhcC-CCCc--eEEeeccccC---CceEEE
Q 005427 71 LSPIARGAESVVYEATLDG----RKVAVKKPILST-SEELDNFHKELQLLCKLD-HPGL--AKFVAAHAKP---PNYMFF 139 (697)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~~----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-hpni--v~l~~~~~~~---~~~~lv 139 (697)
+++|+.|.+..+|+....+ ..+++|+..... ......+.+|+++|+.|. |+++ ++++.++.++ +..|+|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 5778999999999987643 467777654322 123456889999999995 6654 7778777664 467899
Q ss_pred EeecCCCC
Q 005427 140 FEFYESRN 147 (697)
Q Consensus 140 ~e~~~~g~ 147 (697)
|||++|..
T Consensus 123 ME~v~G~~ 130 (822)
T PLN02876 123 MEYLEGRI 130 (822)
T ss_pred EEecCCcc
Confidence 99999854
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.86 E-value=0.0001 Score=79.82 Aligned_cols=138 Identities=21% Similarity=0.252 Sum_probs=88.1
Q ss_pred cccccCCceEEEEEEE-CCeeEEEEeccCCChH------------------------------H-HH------HHHHHHH
Q 005427 72 SPIARGAESVVYEATL-DGRKVAVKKPILSTSE------------------------------E-LD------NFHKELQ 113 (697)
Q Consensus 72 ~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~------------------------------~-~~------~~~~E~~ 113 (697)
+.||.-+.|.||+|+. .|+.||||+.+..-.. + .+ .|.+|++
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 5789999999999987 6889999985542111 0 11 1333443
Q ss_pred HHHh----cCCCC------ceEEeeccccCCceEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 005427 114 LLCK----LDHPG------LAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGI 183 (697)
Q Consensus 114 ~l~~----l~hpn------iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i 183 (697)
-..+ +.|-+ |+++|-.+ .....|+||||+|..+.|.-.-....++...+..-+.++.. +-+-..|+
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~--~qIf~~Gf 322 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYL--EQIFKTGF 322 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHH--HHHHhcCC
Confidence 3322 23444 33333222 34678999999998776654333334665544443333322 22345689
Q ss_pred ccccCCCCceeecC----CCCCeeeeeccchhhh
Q 005427 184 VHRDVKPANVLLDR----NLCPHLADFGLAEYRE 213 (697)
Q Consensus 184 vHrDlkp~Nill~~----~~~~kL~Dfg~a~~~~ 213 (697)
+|+|=+|.||+++. ++.+.+-|||+...+.
T Consensus 323 fHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 323 FHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred ccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 99999999999983 6789999999987554
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.82 E-value=7.2e-05 Score=85.66 Aligned_cols=204 Identities=18% Similarity=0.223 Sum_probs=139.7
Q ss_pred HHHHHHHHHHHHHhcCCCCceEEeeccccCCc----eEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHH
Q 005427 104 ELDNFHKELQLLCKLDHPGLAKFVAAHAKPPN----YMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLH 179 (697)
Q Consensus 104 ~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~----~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH 179 (697)
++....-|++.+..+.|+|++.++.+...... .....++|..-++...+..-. ..+.++.+.+..+++.||.|+|
T Consensus 225 ~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~-~i~~~~~r~~~~~~~~GL~~~h 303 (1351)
T KOG1035|consen 225 EIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG-SIPLETLRILHQKLLEGLAYLH 303 (1351)
T ss_pred HHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc-ccCHHHHHHHHHHHhhhHHHHH
Confidence 44555667778888899999999887654322 223457888888888776554 6788999999999999999999
Q ss_pred hCCcccccCCCC---ceeecCCCCCeee--eeccchhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccC
Q 005427 180 NLGIVHRDVKPA---NVLLDRNLCPHLA--DFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEI 254 (697)
Q Consensus 180 ~~~ivHrDlkp~---Nill~~~~~~kL~--Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 254 (697)
+....|.-+..+ +...+..+.+... ||+.+....+... .....-+..+.+||......
T Consensus 304 ~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~-----------------~~~~~~~~~~~~~e~~~~~~ 366 (1351)
T KOG1035|consen 304 SLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK-----------------SFSDLLAEIRNADEDLKENT 366 (1351)
T ss_pred HhccceeEEecccccccccCccceeecchhhhcccccCCCccc-----------------chhhcCcccccccccccccc
Confidence 996666655554 4444555666655 8887765443221 12234456677888876655
Q ss_pred CCc--hhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhc
Q 005427 255 HSE--KSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCW 332 (697)
Q Consensus 255 ~~~--~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 332 (697)
+.. ..|+|.+|..+..+..|..+-....... + .++........+...+|+
T Consensus 367 ~~~~r~~dL~~lgll~~~~~~~~~i~~~~~~~~-------------------------~---~l~~~~~~~~~d~~~~~~ 418 (1351)
T KOG1035|consen 367 AKKSRLTDLWCLGLLLLQLSQGEDISEKSAVPV-------------------------S---LLDVLSTSELLDALPKCL 418 (1351)
T ss_pred chhhhhhHHHHHHHHHhhhhhcCcccccccchh-------------------------h---hhccccchhhhhhhhhhc
Confidence 544 4799999999999988765432111000 0 011122226789999999
Q ss_pred cCCCCCCCCHHHHHHHHHHHH
Q 005427 333 DGNPHNRPSFSDIALELDLVL 353 (697)
Q Consensus 333 ~~dP~~Rpt~~ell~~l~~~~ 353 (697)
..++++|+++.+++.+...-.
T Consensus 419 ~~~~~~Rl~~~~ll~~~f~~~ 439 (1351)
T KOG1035|consen 419 DEDSEERLSALELLTHPFLRF 439 (1351)
T ss_pred chhhhhccchhhhhhchhccc
Confidence 999999999999998875543
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.69 E-value=0.00012 Score=69.23 Aligned_cols=102 Identities=20% Similarity=0.172 Sum_probs=81.4
Q ss_pred HHHHHHHHhcCC-CCceEEeeccccCCceEEEEeecCCCCHhhhhh--hcCCCCCHHHHHHHHHHHHHHHHHHHh---CC
Q 005427 109 HKELQLLCKLDH-PGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLH--VEEWSPSVDQVLMIAAQLAKALQYLHN---LG 182 (697)
Q Consensus 109 ~~E~~~l~~l~h-pniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~--~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ 182 (697)
..|.-+|+.+++ +++++++|+|.+ ++++||...+++...-. ..-...+|..+.+++.++++.+++++. ..
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 458888999976 699999999943 67999998776643210 011246899999999999999999987 34
Q ss_pred cccccCCCCceeecCCCCCeeeeeccchhhhh
Q 005427 183 IVHRDVKPANVLLDRNLCPHLADFGLAEYREN 214 (697)
Q Consensus 183 ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~ 214 (697)
+.-.|++|+|+-++.++.+|++|...+.....
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~~~ 114 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVEDK 114 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchhHH
Confidence 77789999999999999999999998865543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.68 E-value=0.00022 Score=70.73 Aligned_cols=73 Identities=15% Similarity=0.258 Sum_probs=46.3
Q ss_pred cccccCCce-EEEEEEECCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCC---CceEEeeccccC---CceEEEEeecC
Q 005427 72 SPIARGAES-VVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP---GLAKFVAAHAKP---PNYMFFFEFYE 144 (697)
Q Consensus 72 ~~lg~G~~g-~V~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp---niv~l~~~~~~~---~~~~lv~e~~~ 144 (697)
+.|+.|+.. .||+. +..+++|..... .....+.+|.++|..|... .+...++..... ...+++|++++
T Consensus 3 ~~~~~gG~~n~vy~~---~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~ 77 (235)
T cd05155 3 EPVDSGGTDNATFRL---GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLE 77 (235)
T ss_pred eeccCCCcccceEEc---CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeec
Confidence 467777766 58876 345777864432 2345788999999888532 344455544332 23588999999
Q ss_pred CCCHh
Q 005427 145 SRNLA 149 (697)
Q Consensus 145 ~g~L~ 149 (697)
|.++.
T Consensus 78 G~~l~ 82 (235)
T cd05155 78 GETAT 82 (235)
T ss_pred CCCCC
Confidence 86653
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.51 E-value=0.0011 Score=63.04 Aligned_cols=128 Identities=20% Similarity=0.245 Sum_probs=89.6
Q ss_pred ccccccCCceEEEEEEECCeeEEEEeccCCC----------------hHHHHHHHHHHHHHHhcC------CCCceEEee
Q 005427 71 LSPIARGAESVVYEATLDGRKVAVKKPILST----------------SEELDNFHKELQLLCKLD------HPGLAKFVA 128 (697)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~E~~~l~~l~------hpniv~l~~ 128 (697)
...||+|+.-.||.--. +....||+..... ........+|+.....+. +.+|.+++|
T Consensus 6 ~~~i~~G~~R~cy~HP~-dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G 84 (199)
T PF10707_consen 6 SDLIAQGGERDCYQHPD-DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYG 84 (199)
T ss_pred CcccccCCCceEEECCC-CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeE
Confidence 35789999999986432 3345677654443 122456677777776665 789999999
Q ss_pred ccccCCceEEEEeecCC------CCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCC--C-
Q 005427 129 AHAKPPNYMFFFEFYES------RNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRN--L- 199 (697)
Q Consensus 129 ~~~~~~~~~lv~e~~~~------g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~--~- 199 (697)
+.+++...-+|+|.+.. .+|.+++... .++. . +...+-+-..||-+.+|+.+|++|.||++... +
T Consensus 85 ~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~--~~~~-~---~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~ 158 (199)
T PF10707_consen 85 FVETNLGLGLVVELIRDADGNISPTLEDYLKEG--GLTE-E---LRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGE 158 (199)
T ss_pred EEecCCceEEEEEEEECCCCCcCccHHHHHHcC--CccH-H---HHHHHHHHHHHHHHcCCeecCCCcccEEEEecCCCc
Confidence 99999999999998643 3677877544 3443 3 33344455568889999999999999999542 2
Q ss_pred -CCeeee
Q 005427 200 -CPHLAD 205 (697)
Q Consensus 200 -~~kL~D 205 (697)
.+.|+|
T Consensus 159 ~~lvlID 165 (199)
T PF10707_consen 159 FRLVLID 165 (199)
T ss_pred eEEEEEe
Confidence 466776
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.46 E-value=0.00019 Score=71.34 Aligned_cols=132 Identities=20% Similarity=0.210 Sum_probs=97.2
Q ss_pred cccccccccCCceEEEEEEE-CCeeEEEEeccCCCh--------H--------------HHHHHHHHHHHHHhcC-C-CC
Q 005427 68 YTLLSPIARGAESVVYEATL-DGRKVAVKKPILSTS--------E--------------ELDNFHKELQLLCKLD-H-PG 122 (697)
Q Consensus 68 y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~--------~--------------~~~~~~~E~~~l~~l~-h-pn 122 (697)
+.++.+||-|.-+.||.+-+ .|++.++|..++... . ..-...+|...|+.|. | --
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp 173 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP 173 (465)
T ss_pred hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence 66788999999999999987 589999996443211 0 0123567888998884 3 34
Q ss_pred ceEEeeccccCCceEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCe
Q 005427 123 LAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPH 202 (697)
Q Consensus 123 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~k 202 (697)
+++.+++ +..++|||++.|-.|...-+-.. +-.+...+..-+.-|..+|+||+|..-=||+++.++.++
T Consensus 174 VPkpiD~----~RH~Vvmelv~g~Pl~~v~~v~d-------~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~ 242 (465)
T KOG2268|consen 174 VPKPIDH----NRHCVVMELVDGYPLRQVRHVED-------PPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIV 242 (465)
T ss_pred CCCcccc----cceeeHHHhhcccceeeeeecCC-------hHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCEE
Confidence 5555544 45689999999877766543222 233555666667788999999999999999999999999
Q ss_pred eeeeccch
Q 005427 203 LADFGLAE 210 (697)
Q Consensus 203 L~Dfg~a~ 210 (697)
++||-.+.
T Consensus 243 vIDFPQmv 250 (465)
T KOG2268|consen 243 VIDFPQMV 250 (465)
T ss_pred EeechHhh
Confidence 99998664
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.45 E-value=0.00058 Score=68.69 Aligned_cols=133 Identities=17% Similarity=0.224 Sum_probs=77.9
Q ss_pred ccccCCceEEEEEEECCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCc-eEEeeccccCCceEEEEeecCCCCHhhh
Q 005427 73 PIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGL-AKFVAAHAKPPNYMFFFEFYESRNLAEK 151 (697)
Q Consensus 73 ~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpni-v~l~~~~~~~~~~~lv~e~~~~g~L~~~ 151 (697)
.+..|-.+.+|+....++.+++|........-.-...+|..+++.+....+ .+++.... -++|+||++|..+...
T Consensus 3 ~~~~G~tn~~y~~~~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~ 78 (256)
T TIGR02721 3 TLSGGLTNRSWRIEHPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLD 78 (256)
T ss_pred cCCCcCcCCeEEEEeCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccccc
Confidence 355677889999988888899997433221110134789999999854333 33444332 3689999998654321
Q ss_pred -----------------hhhcC---CCCCHH-HHHHHHHHH---------HHHHHHHHh--------CCcccccCCCCce
Q 005427 152 -----------------LHVEE---WSPSVD-QVLMIAAQL---------AKALQYLHN--------LGIVHRDVKPANV 193 (697)
Q Consensus 152 -----------------l~~~~---~~~~~~-~~~~i~~qi---------~~~l~~LH~--------~~ivHrDlkp~Ni 193 (697)
++... ..++.. .+..+..++ ...+..+-. ..++|+|+.|.||
T Consensus 79 ~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni 158 (256)
T TIGR02721 79 QFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL 158 (256)
T ss_pred cccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence 11111 111211 111221111 111222211 2489999999999
Q ss_pred eecCCCCCeeeeeccch
Q 005427 194 LLDRNLCPHLADFGLAE 210 (697)
Q Consensus 194 ll~~~~~~kL~Dfg~a~ 210 (697)
+++.++ +.|+||+.+.
T Consensus 159 l~~~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 159 VVTPQG-LKLIDWEYAS 174 (256)
T ss_pred EEeCCC-CEEEeccccC
Confidence 999877 7999999875
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.34 E-value=0.0015 Score=64.80 Aligned_cols=73 Identities=18% Similarity=0.164 Sum_probs=46.9
Q ss_pred ccccccCCceEEEEEEEC---CeeEEEEeccCCChHHHHHHHHHHHHHHhcCC-CCceEEeeccccCCceEEEEeecCCC
Q 005427 71 LSPIARGAESVVYEATLD---GRKVAVKKPILSTSEELDNFHKELQLLCKLDH-PGLAKFVAAHAKPPNYMFFFEFYESR 146 (697)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~---~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~l~~~~~~~~~~~lv~e~~~~g 146 (697)
++.|..|-...+|+.... ++.+++|....... ..-...+|+.+++.+.. .-.++++..+. -.++|||++|.
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~-~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~ 77 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE-LIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGR 77 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc-ceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCC
Confidence 356777888899999864 57888997543221 11223478889988843 33444554432 24799999886
Q ss_pred CH
Q 005427 147 NL 148 (697)
Q Consensus 147 ~L 148 (697)
++
T Consensus 78 ~l 79 (235)
T cd05157 78 TL 79 (235)
T ss_pred cC
Confidence 54
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.28 E-value=0.0018 Score=66.74 Aligned_cols=137 Identities=22% Similarity=0.225 Sum_probs=84.3
Q ss_pred ccccccCCceEEEEEEECCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCC--CceEEeecc------ccCCceEEEEee
Q 005427 71 LSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP--GLAKFVAAH------AKPPNYMFFFEF 142 (697)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp--niv~l~~~~------~~~~~~~lv~e~ 142 (697)
.+.|..|....+|+....+..+++|+... .....+..|+.++..|.+. .+.+++... ...+..+++++|
T Consensus 19 i~~i~~G~~n~~y~v~~~~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~ 95 (296)
T cd05153 19 FEGISAGIENTNYFVTTDSGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEF 95 (296)
T ss_pred eecccCccccceEEEEeCCCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEe
Confidence 55777788889999887777899997543 2234567788888888432 244544321 224567899999
Q ss_pred cCCCCHhh--------------hhhhc--CCC--------CCHHHH----------HHHHHHHHHHHHHHHh-------C
Q 005427 143 YESRNLAE--------------KLHVE--EWS--------PSVDQV----------LMIAAQLAKALQYLHN-------L 181 (697)
Q Consensus 143 ~~~g~L~~--------------~l~~~--~~~--------~~~~~~----------~~i~~qi~~~l~~LH~-------~ 181 (697)
++|..+.. .++.. ... ..+... ......+..++.++.. .
T Consensus 96 i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~ 175 (296)
T cd05153 96 LAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPR 175 (296)
T ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCC
Confidence 99865421 01111 000 011000 0011112334444443 3
Q ss_pred CcccccCCCCceeecCCCCCeeeeeccch
Q 005427 182 GIVHRDVKPANVLLDRNLCPHLADFGLAE 210 (697)
Q Consensus 182 ~ivHrDlkp~Nill~~~~~~kL~Dfg~a~ 210 (697)
+++|+|+.|.|||++.++.+.|+||+.+.
T Consensus 176 ~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 176 GVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred cCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 79999999999999988777899999874
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.19 E-value=0.002 Score=66.64 Aligned_cols=140 Identities=24% Similarity=0.264 Sum_probs=82.6
Q ss_pred ccccccccCCceEEEEEEECCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCC--CceEEeecc------ccCCceEEEE
Q 005427 69 TLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP--GLAKFVAAH------AKPPNYMFFF 140 (697)
Q Consensus 69 ~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp--niv~l~~~~------~~~~~~~lv~ 140 (697)
...+.++.|....+|+....+..+++|+..... ..+.+..|+.++..|... .+++++... ...+..++++
T Consensus 25 ~~i~~~~~G~~n~~y~v~t~~~~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~ 102 (307)
T TIGR00938 25 LSLKGIAEGVENSNYLLTTDVGRYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLV 102 (307)
T ss_pred eeccccCCccccceEEEEeCCCcEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEE
Confidence 345677888888999987766678888754321 123455677777777422 234443321 1235678999
Q ss_pred eecCCCCHhh--------------hhhhcCCCC-----------CHHHHH------------HHHHHHHHHHHHHHh---
Q 005427 141 EFYESRNLAE--------------KLHVEEWSP-----------SVDQVL------------MIAAQLAKALQYLHN--- 180 (697)
Q Consensus 141 e~~~~g~L~~--------------~l~~~~~~~-----------~~~~~~------------~i~~qi~~~l~~LH~--- 180 (697)
+|++|..+.. .++.....+ .+.... .....+...++++..
T Consensus 103 e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~ 182 (307)
T TIGR00938 103 EFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWP 182 (307)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhh
Confidence 9998854310 112110000 000000 011123334555542
Q ss_pred ----CCcccccCCCCceeecCCCCCeeeeeccch
Q 005427 181 ----LGIVHRDVKPANVLLDRNLCPHLADFGLAE 210 (697)
Q Consensus 181 ----~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~ 210 (697)
.+++|+|+.+.||+++.++.+.|+||+.+.
T Consensus 183 ~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 183 RDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred hcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 579999999999999988777899999874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.12 E-value=0.0065 Score=63.33 Aligned_cols=137 Identities=21% Similarity=0.196 Sum_probs=76.3
Q ss_pred ccccccCCceEEEEEEECCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCC--CceEEeec------cccCCceEEEEee
Q 005427 71 LSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP--GLAKFVAA------HAKPPNYMFFFEF 142 (697)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp--niv~l~~~------~~~~~~~~lv~e~ 142 (697)
.+.|+.|....+|+....+..+++|+..... .+.+..|+.++..|... .+.+.+.. ....+..+++++|
T Consensus 27 ~~~l~~G~~n~~y~v~t~~g~~vLK~~~~~~---~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~ 103 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTTQGEYVLTLFERLT---AEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTF 103 (319)
T ss_pred cchhccccccceEEEEeCCCcEEEEEeccCC---hHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEe
Confidence 4567778888999998766688999764212 23344566666666311 13333321 1224567899999
Q ss_pred cCCCCHh-----------hh---hhhcCCCC--------C---HHHHH------------HHHHH-HHHHHHHHH-----
Q 005427 143 YESRNLA-----------EK---LHVEEWSP--------S---VDQVL------------MIAAQ-LAKALQYLH----- 179 (697)
Q Consensus 143 ~~~g~L~-----------~~---l~~~~~~~--------~---~~~~~------------~i~~q-i~~~l~~LH----- 179 (697)
++|..+. .. ++.....+ . +.... ..+.+ +...+..+.
T Consensus 104 l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 183 (319)
T PRK05231 104 LEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWP 183 (319)
T ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccccc
Confidence 9886431 11 11111000 0 11111 11111 111222332
Q ss_pred --hCCcccccCCCCceeecCCCCCeeeeeccch
Q 005427 180 --NLGIVHRDVKPANVLLDRNLCPHLADFGLAE 210 (697)
Q Consensus 180 --~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~ 210 (697)
..+++|+|+.|.|||++.+...-|+||+.+.
T Consensus 184 ~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 184 ALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 2379999999999999866556899999875
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.11 E-value=0.0082 Score=63.56 Aligned_cols=74 Identities=16% Similarity=0.093 Sum_probs=53.6
Q ss_pred ccccccCCceEEEEEEECC--eeEEEEeccCC-----C--hHHHHHHHHHHHHHHhcC---CCCceEEeeccccCCceEE
Q 005427 71 LSPIARGAESVVYEATLDG--RKVAVKKPILS-----T--SEELDNFHKELQLLCKLD---HPGLAKFVAAHAKPPNYMF 138 (697)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~-----~--~~~~~~~~~E~~~l~~l~---hpniv~l~~~~~~~~~~~l 138 (697)
.+.||.|.+..||++...+ +.++||..... . ....++...|.+.|+.+. ..++++++.+ ++...++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 4679999999999998854 48999973311 1 124567788888888873 3467777776 4466889
Q ss_pred EEeecCCC
Q 005427 139 FFEFYESR 146 (697)
Q Consensus 139 v~e~~~~g 146 (697)
|||++++.
T Consensus 109 VME~L~~~ 116 (401)
T PRK09550 109 VMEDLSDH 116 (401)
T ss_pred EEecCCCc
Confidence 99998864
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.95 E-value=0.00021 Score=83.74 Aligned_cols=158 Identities=13% Similarity=0.007 Sum_probs=116.1
Q ss_pred HHHHHHHHHHHhcCCCCceEEeecccc--CCceEEEEeecCCCCHhhhhhhcCCCC---CHHHHHHHHHHHHHHHHHHHh
Q 005427 106 DNFHKELQLLCKLDHPGLAKFVAAHAK--PPNYMFFFEFYESRNLAEKLHVEEWSP---SVDQVLMIAAQLAKALQYLHN 180 (697)
Q Consensus 106 ~~~~~E~~~l~~l~hpniv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~---~~~~~~~i~~qi~~~l~~LH~ 180 (697)
+-...|.+.++.+.|+++.....-... ....+..++++.+|.+++.+.+.-... ...-+.....+.+....-+|+
T Consensus 1274 emll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls 1353 (2724)
T KOG1826|consen 1274 EMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILS 1353 (2724)
T ss_pred HhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhh
Confidence 344556667777899998876654432 345678899999999999986543222 222232333333666666665
Q ss_pred C-----CcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCC
Q 005427 181 L-----GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIH 255 (697)
Q Consensus 181 ~-----~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 255 (697)
. -.+|++||+-|.+|..+..+|+.++|+.+....... ......+++.|+.|++...-.+
T Consensus 1354 ~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~s----------------f~Gl~l~sp~~v~qli~N~ik~ 1417 (2724)
T KOG1826|consen 1354 LTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLS----------------FFGLELCSPIYVLQLIKNEIKF 1417 (2724)
T ss_pred cccCCccchhhhhhhhccceecCCcccccccccccccCchHh----------------hhhhhhCCHHHHHHHHHHHHhh
Confidence 4 268999999999999999999999999984332221 2355678899999999988888
Q ss_pred CchhhHHHHHHHHHHHHhCCCCCC
Q 005427 256 SEKSDVYSFGISINELLTGVVPYT 279 (697)
Q Consensus 256 ~~~~DiwslG~~l~ell~g~~Pf~ 279 (697)
+.++|+|..|+.+|+...|..+|-
T Consensus 1418 t~rsdilr~s~~ly~rs~~n~~fi 1441 (2724)
T KOG1826|consen 1418 TKRSDILRRSLSLYLRSDGNAYFI 1441 (2724)
T ss_pred hhHHHHHHHHHHHHHHhcccHHHH
Confidence 888999999999999999988874
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.90 E-value=0.0086 Score=61.12 Aligned_cols=144 Identities=20% Similarity=0.261 Sum_probs=88.7
Q ss_pred cccccccccCCceEEEEEEECCeeEEEEecc-CCChHHHHHHHHHHHHHHhcCC--CCceEEeeccccCC--ceEEEEee
Q 005427 68 YTLLSPIARGAESVVYEATLDGRKVAVKKPI-LSTSEELDNFHKELQLLCKLDH--PGLAKFVAAHAKPP--NYMFFFEF 142 (697)
Q Consensus 68 y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~-~~~~~~~~~~~~E~~~l~~l~h--pniv~l~~~~~~~~--~~~lv~e~ 142 (697)
..+++.+..|..-.+|....+++++++.+.. ...........+|+.+|+.+.- .-+..-++.|.+.. ..+.||+|
T Consensus 27 ~~~v~~~~~G~sn~t~~~~~~~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~ 106 (321)
T COG3173 27 LLIVEEISGGWSNDTFRLGDTGQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEW 106 (321)
T ss_pred CceeeeccCCcccceEEEecCCceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEE
Confidence 3445555444444566666668888888432 2334456677889999988843 34444566666554 67999999
Q ss_pred cCCCCHhhhhhhcCCCCCHHHHHHHHH-HHHHHHHHHH------------------------------------------
Q 005427 143 YESRNLAEKLHVEEWSPSVDQVLMIAA-QLAKALQYLH------------------------------------------ 179 (697)
Q Consensus 143 ~~~g~L~~~l~~~~~~~~~~~~~~i~~-qi~~~l~~LH------------------------------------------ 179 (697)
+.|..+.+.+.... ....++. .+...|.-||
T Consensus 107 veGe~~~~~~~~~~------~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~ 180 (321)
T COG3173 107 VEGEVVWSALPPES------LGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLA 180 (321)
T ss_pred ecceeccCcCCccc------chHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchH
Confidence 99854333221110 0011111 3333333333
Q ss_pred --------hC--------CcccccCCCCceeecCCCCCeeeeeccchhhhhhhh
Q 005427 180 --------NL--------GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKE 217 (697)
Q Consensus 180 --------~~--------~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~ 217 (697)
.. .++|+|+.+.|++++..+.+=|.||+++..-....+
T Consensus 181 ~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP~~D 234 (321)
T COG3173 181 DRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDPLED 234 (321)
T ss_pred HHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCCcHHH
Confidence 22 489999999999999888899999999875544333
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.87 E-value=0.0049 Score=63.68 Aligned_cols=72 Identities=29% Similarity=0.307 Sum_probs=45.0
Q ss_pred cccccCCceEEEEEEEC--------CeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCC-ceEEeeccccCCceEEEEee
Q 005427 72 SPIARGAESVVYEATLD--------GRKVAVKKPILSTSEELDNFHKELQLLCKLDHPG-LAKFVAAHAKPPNYMFFFEF 142 (697)
Q Consensus 72 ~~lg~G~~g~V~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn-iv~l~~~~~~~~~~~lv~e~ 142 (697)
+.|..|-...||+.... ++.+++|+..... .......+|..+++.+.... ..+++..+.. .+|++|
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence 34555666688988754 4788899854332 22334578888888885322 3445555432 358899
Q ss_pred cCCCCH
Q 005427 143 YESRNL 148 (697)
Q Consensus 143 ~~~g~L 148 (697)
++|..+
T Consensus 79 i~G~~l 84 (302)
T cd05156 79 IPSRTL 84 (302)
T ss_pred eCCCcC
Confidence 887654
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.43 E-value=0.029 Score=58.16 Aligned_cols=72 Identities=17% Similarity=0.140 Sum_probs=48.6
Q ss_pred cccccCCceEEEEEEECC--eeEEEEec----cC---CChHHHHHHHHHHHHHHhcC--CC-CceEEeeccccCCceEEE
Q 005427 72 SPIARGAESVVYEATLDG--RKVAVKKP----IL---STSEELDNFHKELQLLCKLD--HP-GLAKFVAAHAKPPNYMFF 139 (697)
Q Consensus 72 ~~lg~G~~g~V~~~~~~~--~~vavK~~----~~---~~~~~~~~~~~E~~~l~~l~--hp-niv~l~~~~~~~~~~~lv 139 (697)
+.||-|....||++...+ +.|+||.- .. .-.-..++..-|...|+... .| .++++|.+ ++....++
T Consensus 1 ~EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~v 78 (370)
T TIGR01767 1 QEVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTV 78 (370)
T ss_pred CcCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceeh
Confidence 358999999999998754 57999952 11 11233556677888887763 34 45555543 56667789
Q ss_pred EeecCC
Q 005427 140 FEFYES 145 (697)
Q Consensus 140 ~e~~~~ 145 (697)
||+++.
T Consensus 79 MEdL~~ 84 (370)
T TIGR01767 79 MEDLSH 84 (370)
T ss_pred HhhCcc
Confidence 999854
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.41 E-value=0.029 Score=58.22 Aligned_cols=29 Identities=28% Similarity=0.352 Sum_probs=25.4
Q ss_pred CCcccccCCCCceeecCCCCCeeeeeccch
Q 005427 181 LGIVHRDVKPANVLLDRNLCPHLADFGLAE 210 (697)
Q Consensus 181 ~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~ 210 (697)
.+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 47899999999999987 678999999764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 697 | ||||
| 3nmv_B | 324 | Crystal Structure Of Pyrabactin-Bound Abscisic Acid | 5e-27 | ||
| 3kdj_B | 316 | Complex Structure Of (+)-Aba-Bound Pyl1 And Abi1 Le | 8e-27 | ||
| 3nmn_B | 319 | Crystal Structure Of Pyrabactin-Bound Abscisic Acid | 1e-26 | ||
| 3jrq_A | 326 | Crystal Structure Of (+)-aba-bound Pyl1 In Complex | 1e-26 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 6e-26 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-25 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-25 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-25 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-25 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-25 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-25 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-25 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-25 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-25 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-25 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 4e-25 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 4e-25 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 6e-25 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 6e-25 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-24 | ||
| 2i0o_A | 304 | Crystal Structure Of Anopheles Gambiae SerTHR PHOSP | 5e-24 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 5e-24 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-21 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-21 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 7e-21 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 8e-21 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 9e-21 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 9e-21 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 9e-21 | ||
| 4da1_A | 389 | Crystal Structure Of Branched-Chain Alpha-Ketoacid | 1e-20 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-20 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-20 | ||
| 2iq1_A | 274 | Crystal Structure Of Human Ppm1k Length = 274 | 2e-20 | ||
| 3rt0_A | 340 | Crystal Structure Of Pyl10-Hab1 Complex In The Abse | 3e-20 | ||
| 3ujg_B | 350 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 4e-20 | ||
| 4ds8_B | 343 | Complex Structure Of Abscisic Acid Receptor Pyl3-(+ | 4e-20 | ||
| 3nmt_B | 341 | Crystal Structure Of Pyrabactin Bound Abscisic Acid | 4e-20 | ||
| 3qn1_B | 337 | Crystal Structure Of The Pyr1 Abscisic Acid Recepto | 5e-20 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-20 | ||
| 3kb3_B | 321 | Crystal Structure Of Abscisic Acid-Bound Pyl2 In Co | 5e-20 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-20 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 6e-20 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 7e-20 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 7e-20 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 8e-20 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-19 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-19 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-19 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-19 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-19 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-19 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-19 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 5e-19 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-19 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 6e-19 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 6e-19 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 6e-19 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 7e-19 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 7e-19 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-19 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 8e-19 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-19 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-18 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-18 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-18 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-18 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-18 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-18 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-18 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-18 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-18 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-18 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-18 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-18 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-18 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-18 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-18 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-18 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-18 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-18 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-18 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-18 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-18 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-18 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-18 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-18 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-18 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-18 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-18 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-18 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-18 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-18 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-18 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 4e-18 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 5e-18 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-18 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 6e-18 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 6e-18 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-18 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 7e-18 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 7e-18 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-17 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-17 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-17 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-17 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-17 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-17 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-17 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-17 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-17 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-17 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-17 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-17 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-17 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-17 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-17 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-17 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-17 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-17 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-17 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-17 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-17 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-17 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-17 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-17 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-17 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-17 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-17 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-17 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-17 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-17 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-17 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-17 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-17 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-17 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 4e-17 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 4e-17 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 4e-17 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 4e-17 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 4e-17 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 4e-17 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-17 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 4e-17 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 4e-17 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 4e-17 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 4e-17 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 4e-17 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 4e-17 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 6e-17 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 7e-17 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 7e-17 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 8e-17 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 8e-17 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 9e-17 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-16 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-16 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-16 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-16 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-16 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-16 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-16 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-16 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-16 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-16 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-16 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-16 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-16 | ||
| 2p8e_A | 307 | Crystal Structure Of The SerineTHREONINE PHOSPHATAS | 2e-16 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-16 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-16 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-16 | ||
| 3fxj_A | 390 | Crystal Structure Of Human Protein Phosphatase 1a ( | 2e-16 | ||
| 1a6q_A | 382 | Crystal Structure Of The Protein SerineTHREONINE PH | 2e-16 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-16 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-16 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-16 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-16 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-16 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-16 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-16 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-16 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-16 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-16 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-16 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-16 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 3e-16 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-16 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-16 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-16 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-16 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-16 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-16 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 4e-16 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 4e-16 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-16 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 4e-16 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 4e-16 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 4e-16 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 5e-16 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 5e-16 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 5e-16 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-16 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 6e-16 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 6e-16 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 7e-16 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 7e-16 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 7e-16 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 7e-16 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 8e-16 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 8e-16 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 8e-16 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 8e-16 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 9e-16 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-15 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-15 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-15 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-15 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-15 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-15 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-15 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-15 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-15 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 3e-15 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-15 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 3e-15 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-15 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-15 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-15 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 4e-15 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 4e-15 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 4e-15 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 4e-15 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 4e-15 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 4e-15 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 5e-15 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 5e-15 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 5e-15 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 5e-15 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 5e-15 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-15 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-15 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 7e-15 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 7e-15 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 7e-15 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-14 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-14 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-14 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-14 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-14 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-14 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-14 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-14 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-14 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-14 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-14 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-14 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-14 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-14 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-14 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 3e-14 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 3e-14 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-14 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-14 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-14 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-14 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-14 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-14 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-14 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-14 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-14 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 4e-14 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-14 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 4e-14 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 4e-14 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 4e-14 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-14 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-14 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 5e-14 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-14 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-14 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-14 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-14 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 6e-14 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 6e-14 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 6e-14 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 7e-14 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 7e-14 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 7e-14 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 8e-14 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-14 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 8e-14 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 9e-14 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 9e-14 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-14 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-13 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-13 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-13 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-13 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-13 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-13 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-13 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-13 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-13 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-13 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-13 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-13 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-13 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-13 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-13 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-13 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-13 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-13 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-13 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-13 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-13 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-13 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-13 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-13 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-13 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-13 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-13 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 4e-13 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 4e-13 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-13 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-13 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 6e-13 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 7e-13 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 7e-13 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 7e-13 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 8e-13 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 8e-13 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 8e-13 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-13 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 8e-13 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 9e-13 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 9e-13 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 9e-13 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 9e-13 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 9e-13 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-12 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-12 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-12 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-12 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-12 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-12 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-12 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-12 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-12 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-12 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-12 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-12 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-12 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-12 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-12 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-12 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-12 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-12 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-12 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-12 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-12 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-12 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-12 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-12 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-12 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-12 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-12 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-12 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-12 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-12 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-12 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-12 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-12 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 3e-12 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 4e-12 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 4e-12 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 4e-12 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 4e-12 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 4e-12 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 4e-12 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-12 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 4e-12 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 4e-12 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 4e-12 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-12 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 4e-12 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-12 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-12 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 5e-12 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 5e-12 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 5e-12 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 5e-12 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 5e-12 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 5e-12 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 5e-12 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 5e-12 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 6e-12 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 6e-12 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 6e-12 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 6e-12 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 6e-12 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 6e-12 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 6e-12 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-12 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-12 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 6e-12 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 6e-12 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 6e-12 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-12 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-12 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 7e-12 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 7e-12 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-12 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 7e-12 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-12 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 7e-12 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 7e-12 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 7e-12 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 7e-12 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 8e-12 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 8e-12 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 8e-12 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 8e-12 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 8e-12 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 8e-12 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 8e-12 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 8e-12 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 8e-12 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 9e-12 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 9e-12 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 9e-12 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 9e-12 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-12 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 9e-12 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 9e-12 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 9e-12 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 9e-12 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 9e-12 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 9e-12 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 9e-12 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 9e-12 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 9e-12 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-11 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-11 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-11 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-11 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-11 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-11 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-11 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-11 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-11 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-11 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-11 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-11 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-11 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-11 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-11 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-11 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-11 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-11 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-11 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-11 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-11 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-11 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-11 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-11 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-11 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-11 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-11 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-11 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-11 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-11 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-11 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-11 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-11 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-11 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-11 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-11 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-11 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-11 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-11 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-11 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-11 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-11 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-11 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-11 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-11 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-11 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-11 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-11 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-11 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-11 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-11 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-11 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-11 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-11 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-11 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-11 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-11 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-11 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-11 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-11 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-11 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-11 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-11 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-11 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-11 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-11 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-11 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-11 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-11 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-11 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-11 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-11 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-11 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-11 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-11 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-11 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-11 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-11 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-11 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-11 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-11 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-11 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-11 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-11 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-11 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-11 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-11 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-11 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-11 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-11 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-11 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-11 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-11 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 3e-11 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 3e-11 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 3e-11 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-11 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-11 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-11 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-11 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-11 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-11 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-11 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-11 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-11 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-11 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-11 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-11 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-11 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-11 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-11 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-11 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-11 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-11 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-11 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-11 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-11 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-11 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-11 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-11 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 3e-11 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-11 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 3e-11 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-11 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-11 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 4e-11 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 4e-11 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 4e-11 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 5e-11 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 5e-11 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-11 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 5e-11 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 5e-11 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 5e-11 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 5e-11 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 6e-11 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 6e-11 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 6e-11 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 6e-11 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 6e-11 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-11 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 6e-11 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 6e-11 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 7e-11 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 8e-11 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 8e-11 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 8e-11 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 8e-11 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 8e-11 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 8e-11 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 8e-11 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 9e-11 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 9e-11 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 9e-11 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 9e-11 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 9e-11 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 9e-11 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-10 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-10 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-10 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-10 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-10 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-10 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-10 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-10 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-10 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-10 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-10 | ||
| 2i44_A | 324 | Crystal Structure Of Serine-Threonine Phosphatase 2 | 1e-10 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 1e-10 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-10 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-10 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-10 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-10 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-10 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-10 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-10 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-10 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-10 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-10 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-10 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-10 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-10 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-10 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-10 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-10 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-10 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-10 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-10 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-10 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-10 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-10 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-10 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-10 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-10 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-10 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-10 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-10 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-10 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-10 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-10 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-10 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-10 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-10 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-10 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-10 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-10 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-10 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-10 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-10 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-10 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-10 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-10 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-10 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-10 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-10 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-10 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-10 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-10 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-10 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-10 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-10 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-10 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-10 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-10 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-10 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-10 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-10 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-10 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-10 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-10 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-10 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-10 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-10 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-10 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 2e-10 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-10 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-10 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-10 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-10 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-10 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-10 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-10 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-10 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-10 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-10 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-10 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-10 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-10 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-10 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-10 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 2e-10 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-10 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-10 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-10 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-10 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-10 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-10 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-10 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-10 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-10 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-10 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-10 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-10 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-10 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 3e-10 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-10 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 3e-10 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 3e-10 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 3e-10 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 3e-10 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-10 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-10 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-10 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 3e-10 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 3e-10 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-10 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 3e-10 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-10 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 3e-10 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 3e-10 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 3e-10 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-10 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-10 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 3e-10 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 3e-10 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-10 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 4e-10 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 4e-10 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 4e-10 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-10 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-10 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 4e-10 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-10 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-10 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 4e-10 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 4e-10 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 5e-10 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 5e-10 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-10 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 5e-10 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 5e-10 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 5e-10 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 5e-10 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 5e-10 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 5e-10 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 5e-10 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 5e-10 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 5e-10 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 5e-10 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 5e-10 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 5e-10 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 5e-10 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 5e-10 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 5e-10 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 5e-10 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 5e-10 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 6e-10 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-10 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 6e-10 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 6e-10 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 6e-10 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 6e-10 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 6e-10 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 6e-10 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 6e-10 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 7e-10 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 7e-10 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 7e-10 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 7e-10 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 7e-10 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 7e-10 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 7e-10 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 7e-10 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 7e-10 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 7e-10 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 7e-10 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 7e-10 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 7e-10 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 7e-10 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 7e-10 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 7e-10 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 7e-10 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 7e-10 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-10 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 7e-10 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 7e-10 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 7e-10 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 7e-10 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 7e-10 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-10 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 7e-10 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 7e-10 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-10 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 7e-10 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 8e-10 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 8e-10 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 8e-10 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 8e-10 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 8e-10 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 8e-10 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 8e-10 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 8e-10 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 8e-10 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 8e-10 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 8e-10 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 8e-10 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 8e-10 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-10 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 8e-10 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 9e-10 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 9e-10 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 9e-10 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 9e-10 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 9e-10 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-09 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-09 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-09 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-09 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-09 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-09 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-09 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-09 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-09 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-09 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-09 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-09 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-09 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-09 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-09 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-09 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-09 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-09 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-09 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-09 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-09 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-09 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-09 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-09 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-09 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-09 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-09 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-09 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-09 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-09 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-09 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-09 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-09 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-09 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-09 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-09 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-09 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-09 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 3e-09 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-09 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 3e-09 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 3e-09 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-09 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-09 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-09 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-09 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-09 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 3e-09 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 4e-09 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-09 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 4e-09 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 4e-09 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 4e-09 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 4e-09 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 4e-09 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 5e-09 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 5e-09 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 5e-09 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 5e-09 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 5e-09 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 6e-09 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 6e-09 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 6e-09 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 6e-09 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 6e-09 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-09 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-09 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 6e-09 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-09 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 6e-09 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 6e-09 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-09 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-09 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 6e-09 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 6e-09 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 6e-09 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 6e-09 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-09 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 6e-09 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 7e-09 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 8e-09 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 8e-09 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-08 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-08 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-08 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-08 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-08 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 2e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-08 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-08 | ||
| 4hgl_A | 330 | Crystal Structure Of Ck1g3 With Compound 1 Length = | 3e-08 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-08 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-08 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 3e-08 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-08 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-08 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-08 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-08 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 3e-08 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 3e-08 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-08 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-08 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 3e-08 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 3e-08 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 3e-08 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 4e-08 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 4e-08 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-08 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 4e-08 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-08 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-08 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 4e-08 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 4e-08 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 4e-08 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 4e-08 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 4e-08 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 5e-08 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 5e-08 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 5e-08 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 5e-08 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 5e-08 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 5e-08 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 5e-08 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-08 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 6e-08 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 6e-08 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 6e-08 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 7e-08 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 7e-08 | ||
| 2cmw_A | 310 | Structure Of Human Casein Kinase 1 Gamma-1 In Compl | 8e-08 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 8e-08 | ||
| 2c47_A | 313 | Structure Of Casein Kinase 1 Gamma 2 Length = 313 | 9e-08 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 9e-08 | ||
| 2pop_A | 353 | The Crystal Structure Of Tab1 And Bir1 Complex Leng | 1e-07 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-07 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-07 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 1e-07 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-07 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 1e-07 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-07 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 1e-07 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-07 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-07 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-07 | ||
| 2izr_A | 330 | Structure Of Casein Kinase Gamma 3 In Complex With | 2e-07 | ||
| 2chl_A | 351 | Structure Of Casein Kinase 1 Gamma 3 Length = 351 | 2e-07 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-07 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-07 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-07 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-07 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-07 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-07 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-07 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-07 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-07 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-07 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-07 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-07 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-07 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-07 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-07 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-07 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-07 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-07 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-07 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-07 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 3e-07 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 3e-07 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-07 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-07 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-07 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-07 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-07 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 3e-07 | ||
| 2csn_A | 297 | Binary Complex Of Casein Kinase-1 With Cki7 Length | 3e-07 | ||
| 1eh4_A | 298 | Binary Complex Of Casein Kinase-1 From S. Pombe Wit | 4e-07 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 4e-07 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 5e-07 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 5e-07 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 5e-07 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-07 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 6e-07 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 6e-07 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 6e-07 |
| >pdb|3NMV|B Chain B, Crystal Structure Of Pyrabactin-Bound Abscisic Acid Receptor Pyl2 Mutant A93f In Complex With Type 2c Protein Phosphatase Abi2 Length = 324 | Back alignment and structure |
|
| >pdb|3KDJ|B Chain B, Complex Structure Of (+)-Aba-Bound Pyl1 And Abi1 Length = 316 | Back alignment and structure |
|
| >pdb|3NMN|B Chain B, Crystal Structure Of Pyrabactin-Bound Abscisic Acid Receptor Pyl1 In Complex With Type 2c Protein Phosphatase Abi1 Length = 319 | Back alignment and structure |
|
| >pdb|3JRQ|A Chain A, Crystal Structure Of (+)-aba-bound Pyl1 In Complex With Abi1 Length = 326 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2I0O|A Chain A, Crystal Structure Of Anopheles Gambiae SerTHR PHOSPHATASE COMPLEXED With Zn2+ Length = 304 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4DA1|A Chain A, Crystal Structure Of Branched-Chain Alpha-Ketoacid Dehydrogenase Phosphatase With Mg (Ii) Ions At The Active Site Length = 389 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2IQ1|A Chain A, Crystal Structure Of Human Ppm1k Length = 274 | Back alignment and structure |
|
| >pdb|3RT0|A Chain A, Crystal Structure Of Pyl10-Hab1 Complex In The Absence Of Abscisic Acid (Aba) Length = 340 | Back alignment and structure |
|
| >pdb|3UJG|B Chain B, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 350 | Back alignment and structure |
|
| >pdb|4DS8|B Chain B, Complex Structure Of Abscisic Acid Receptor Pyl3-(+)-Aba-Hab1 In The Presence Of Mn2+ Length = 343 | Back alignment and structure |
|
| >pdb|3NMT|B Chain B, Crystal Structure Of Pyrabactin Bound Abscisic Acid Receptor Pyl2 Mutant A93f In Complex With Type 2c Protein Phosphatase Hab1 Length = 341 | Back alignment and structure |
|
| >pdb|3QN1|B Chain B, Crystal Structure Of The Pyr1 Abscisic Acid Receptor In Complex With The Hab1 Type 2c Phosphatase Catalytic Domain Length = 337 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3KB3|B Chain B, Crystal Structure Of Abscisic Acid-Bound Pyl2 In Complex With Hab1 Length = 321 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2P8E|A Chain A, Crystal Structure Of The SerineTHREONINE PHOSPHATASE Domain Of Human Ppm1b Length = 307 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3FXJ|A Chain A, Crystal Structure Of Human Protein Phosphatase 1a (Ppm1a) Bound With Phosphate At 3 Mm Of Mn2+ Length = 390 | Back alignment and structure |
|
| >pdb|1A6Q|A Chain A, Crystal Structure Of The Protein SerineTHREONINE PHOSPHATASE 2C AT 2 A Resolution Length = 382 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2I44|A Chain A, Crystal Structure Of Serine-Threonine Phosphatase 2c From Toxoplasma Gondii Length = 324 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2C47|A Chain A, Structure Of Casein Kinase 1 Gamma 2 Length = 313 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2POP|A Chain A, The Crystal Structure Of Tab1 And Bir1 Complex Length = 353 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2IZR|A Chain A, Structure Of Casein Kinase Gamma 3 In Complex With Inhibitor Length = 330 | Back alignment and structure |
|
| >pdb|2CHL|A Chain A, Structure Of Casein Kinase 1 Gamma 3 Length = 351 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2CSN|A Chain A, Binary Complex Of Casein Kinase-1 With Cki7 Length = 297 | Back alignment and structure |
|
| >pdb|1EH4|A Chain A, Binary Complex Of Casein Kinase-1 From S. Pombe With An Atp Competitive Inhibitor, Ic261 Length = 298 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2iq1_A Protein phosphatase 2C kappa, PPM1K; structural genomics, PSI-2, protein structure initiative, NEW YORK SGX research center for structural genomics; 2.25A {Homo sapiens} Length = 274 | Back alignment and structure |
|---|
Score = 299 bits (767), Expect = 7e-97
Identities = 81/266 (30%), Positives = 121/266 (45%), Gaps = 15/266 (5%)
Query: 427 PVLSWGSFATCGRRETMEDTHFLMPHMYNQKEIHMFGIFDGHRGSAAAEFSARALPGFLQ 486
+ + G + G+R+ ED E+ F ++DGH G AAA+F + +
Sbjct: 6 SLENVGCASQIGKRKENEDRFDFAQ---LTDEVLYFAVYDGHGGPAAADFCHTHMEKCIM 62
Query: 487 N-LGSTTRPTDALLEAFIRTDVAFRNELDSLRKSKRVVQKDWHPGCTAIAALIVRNR-LF 544
+ L L AF+ D AF + + G TA AL+ L
Sbjct: 63 DLLPKEKNLETLLTLAFLEIDKAFSSHARLSADATL-----LTSGTTATVALLRDGIELV 117
Query: 545 VANAGDCRAILCRGGHPFALSRDHVASCLEERERVVSAGGNVNWQ-VDTWRVGPPALQVT 603
VA+ GD RAILCR G P L+ DH +E+ER+ GG V W + V L +T
Sbjct: 118 VASVGDSRAILCRKGKPMKLTIDHTPERKDEKERIKKCGGFVAWNSLGQPHVN-GRLAMT 176
Query: 604 RSIGDDDLKP-AVTAEPEITETIMTP-EDEYLVMASDGLWDVVSHVEAVGIIKDTVKEPG 661
RSIGD DLK V AEPE + +D +LV+ +DG+ +V+ E + +P
Sbjct: 177 RSIGDLDLKTSGVIAEPETKRIKLHHADDSFLVLTTDGINFMVNSQEICDFVNQ-CHDPN 235
Query: 662 MCSKRLATEAAERGSKDNITVIVVFL 687
+ + +A + G++DN T +VV
Sbjct: 236 EAAHAVTEQAIQYGTEDNSTAVVVPF 261
|
| >4da1_A Protein phosphatase 1K, mitochondrial; metal-ION-assisted catalysis, dehydrogenase phosphatase, hydrolase; 2.38A {Homo sapiens} PDB: 3qht_A 1l2n_A Length = 389 | Back alignment and structure |
|---|
Score = 297 bits (763), Expect = 7e-95
Identities = 83/290 (28%), Positives = 127/290 (43%), Gaps = 15/290 (5%)
Query: 405 SHAAESDVKLWLESANDALTYYPVLSWGSFATCGRRETMEDTHFLMPHMYNQKEIHMFGI 464
+H + + A + + + G + G+R+ ED E+ F +
Sbjct: 98 AHREQIGGENLYFQAGKPIPKISLENVGCASQIGKRKENEDRFDFAQL---TDEVLYFAV 154
Query: 465 FDGHRGSAAAEFSARALPGFLQN-LGSTTRPTDALLEAFIRTDVAFRNELDSLRKSKRVV 523
+DGH G AAA+F + + + L L AF+ D AF + +
Sbjct: 155 YDGHGGPAAADFCHTHMEKCIMDLLPKEKNLETLLTLAFLEIDKAFSSHARLSADATL-- 212
Query: 524 QKDWHPGCTAIAALIVRNR-LFVANAGDCRAILCRGGHPFALSRDHVASCLEERERVVSA 582
G TA AL+ L VA+ GD RAILCR G P L+ DH +E+ER+
Sbjct: 213 ---LTSGTTATVALLRDGIELVVASVGDSRAILCRKGKPMKLTIDHTPERKDEKERIKKC 269
Query: 583 GGNVNWQ-VDTWRVGPPALQVTRSIGDDDLKP-AVTAEPEITETIMTP-EDEYLVMASDG 639
GG V W + V L +TRSIGD DLK V AEPE + +D +LV+ +DG
Sbjct: 270 GGFVAWNSLGQPHVN-GRLAMTRSIGDLDLKTSGVIAEPETKRIKLHHADDSFLVLTTDG 328
Query: 640 LWDVVSHVEAVGIIKDTVKEPGMCSKRLATEAAERGSKDNITVIVVFLQP 689
+ +V+ E + +P + + +A + G++DN T +VV
Sbjct: 329 INFMVNSQEICDFVNQ-CHDPNEAAHAVTEQAIQYGTEDNSTAVVVPFGA 377
|
| >3kdj_B Protein phosphatase 2C 56; ABA, PYL1, abscisic acid signaling pathway, cell membr hydrolase, magnesium, manganese, metal-binding, nucleus; HET: A8S; 1.88A {Arabidopsis thaliana} PDB: 3nmn_B* 3jrq_A* 3ujk_A 3nmv_B 3ujl_B* Length = 316 | Back alignment and structure |
|---|
Score = 293 bits (751), Expect = 4e-94
Identities = 91/321 (28%), Positives = 137/321 (42%), Gaps = 65/321 (20%)
Query: 425 YYPVLSWGSFATCGRRETMEDTHFLMPHMYN-------------QKEIHMFGIFDGHRGS 471
+ V +G + CGRR MED +P Q H FG++DGH GS
Sbjct: 5 FKSVPLYGFTSICGRRPEMEDAVSTIPRFLQSSSGSMLDGRFDPQSAAHFFGVYDGHGGS 64
Query: 472 AAAEFSARALPGFL------------QNLGSTTRPTDALLEAFIRTDVAFRNELDSLRKS 519
A + + L + AL +F+R D +
Sbjct: 65 QVANYCRERMHLALAEEIAKEKPMLSDGDTWLEKWKKALFNSFLRVDSEIES-------- 116
Query: 520 KRVVQKDWHPGCTAIAALIVRNRLFVANAGDCRAILCRGGHPFALSRDHVASCLEERERV 579
G T++ A++ + +FVAN GD RA+LCRG LS DH +E R+
Sbjct: 117 ----VAPETVGSTSVVAVVFPSHIFVANCGDSRAVLCRGKTALPLSVDHKPDREDEAARI 172
Query: 580 VSAGGNVNWQVDTWRVGPPALQVTRSIGDDDLKPAVTAEPEITETIMTPEDEYLVMASDG 639
+AGG V + RV L ++RSIGD LKP++ +PE+T ED+ L++ASDG
Sbjct: 173 EAAGGKVIQ-WNGARVF-GVLAMSRSIGDRYLKPSIIPDPEVTAVKRVKEDDCLILASDG 230
Query: 640 LWDVVSHVEAVGIIKDTVKEPGM--------------------------CSKRLATEAAE 673
+WDV++ EA + + + ++ L+ A +
Sbjct: 231 VWDVMTDEEACEMARKRILLWHKKNAVAGGASLLADERRKEGKDPAAMSAAEYLSKLAIQ 290
Query: 674 RGSKDNITVIVVFLQPVSTAE 694
RGSKDNI+V+VV L+P +
Sbjct: 291 RGSKDNISVVVVDLKPRRKLK 311
|
| >3qn1_B Protein phosphatase 2C 16; start domain, BET V domain, PYR/PYL/RCAR, PP2C, abscisic ACI receptor, type 2C protein phosphatase; HET: A8S; 1.80A {Arabidopsis thaliana} PDB: 3ujg_B 3nmt_B* 3rt0_A 3kb3_B* Length = 337 | Back alignment and structure |
|---|
Score = 291 bits (747), Expect = 3e-93
Identities = 87/319 (27%), Positives = 128/319 (40%), Gaps = 59/319 (18%)
Query: 428 VLSWGSFATCGRRETMEDTHFLMPHMYNQ------------------KEIHMFGIFDGHR 469
+ WG+ + G R MED + PH H FG++DGH
Sbjct: 13 IPLWGTVSIQGNRSEMEDAFAVSPHFLKLPIKMLMGDHEGMSPSLTHLTGHFFGVYDGHG 72
Query: 470 GSAAAEFSARALPGFLQN---------------LGSTTRPTDALLEAFIRTDVAFRNELD 514
G A++ L L G + F+ D ++
Sbjct: 73 GHKVADYCRDRLHFALAEEIERIKDELCKRNTGEGRQVQWDKVFTSCFLTVDGEIEGKIG 132
Query: 515 SLRKSKRVVQKDWHP----GCTAIAALIVRNRLFVANAGDCRAILCRGGHPFALSRDHVA 570
+ G TA+ AL+ + + V+N GD RA+L RG LS DH
Sbjct: 133 RAVVGSSDKVLEAVASETVGSTAVVALVCSSHIVVSNCGDSRAVLFRGKEAMPLSVDHKP 192
Query: 571 SCLEERERVVSAGGNVNWQVDTWRVGPPALQVTRSIGDDDLKPAVTAEPEITETIMTPED 630
+E R+ +AGG V RV L ++RSIGD LKP V EPE+T + ED
Sbjct: 193 DREDEYARIENAGGKVIQ-WQGARVF-GVLAMSRSIGDRYLKPYVIPEPEVTFMPRSRED 250
Query: 631 EYLVMASDGLWDVVSHVEAVGIIKDTVKEPG--------------------MCSKRLATE 670
E L++ASDGLWDV+++ E I + + + L+
Sbjct: 251 ECLILASDGLWDVMNNQEVCEIARRRILMWHKKNGAPPLAERGKGIDPACQAAADYLSML 310
Query: 671 AAERGSKDNITVIVVFLQP 689
A ++GSKDNI++IV+ L+
Sbjct: 311 ALQKGSKDNISIIVIDLKA 329
|
| >2i0o_A Ser/Thr phosphatase; beta sandwich, structural genomics, PSI, protei structure initiative, NEW YORK SGX research center for STRU genomics; 1.70A {Anopheles gambiae} Length = 304 | Back alignment and structure |
|---|
Score = 288 bits (739), Expect = 2e-92
Identities = 84/288 (29%), Positives = 137/288 (47%), Gaps = 34/288 (11%)
Query: 429 LSWGSFATCGRRETMEDTHFLMPHMYNQKEIHMFGIFDGHRGSAAAEFSARALPGFLQNL 488
L+ GS + G R + ED H + + + + F ++DGH G+ A++ + LP FL+ +
Sbjct: 23 LASGSSSMQGWRISQEDAHNCILNFDD--QCSFFAVYDGHGGAEVAQYCSLHLPTFLKTV 80
Query: 489 GS--TTRPTDALLEAFIRTDVAFRNEL---DSLRKSKRVVQKDWHP----GCTAIAALIV 539
+ AL EAF+ D E + S D P GCTA+ AL+
Sbjct: 81 EAYGRKEFEKALKEAFLGFDATLLQEKVIEELKVLSGDSAGSDAEPGKDSGCTAVVALLH 140
Query: 540 RNRLFVANAGDCRAILCRGGHPFALSRDHVASCLEERERVVSAGGNVNWQVDTWRVGPPA 599
L+VANAGD R ++CR G +S DH E +R+ AGG V RV
Sbjct: 141 GKDLYVANAGDSRCVVCRNGKALEMSFDHKPEDTVEYQRIEKAGGRVTLD---GRVN-GG 196
Query: 600 LQVTRSIGDDDLK---------PAVTAEPEITETIMTPEDEYLVMASDGLWDVVSHVEAV 650
L ++R+IGD K ++A P+I + + PEDE++V+A DG+W+ ++ + V
Sbjct: 197 LNLSRAIGDHGYKMNKSLPAEEQMISALPDIEKITVGPEDEFMVLACDGIWNFMTSEQVV 256
Query: 651 GIIKDTVKEPGM----CSKRLATEAAERGSK------DNITVIVVFLQ 688
+++ + +PGM + L ++ DN+T I+V +
Sbjct: 257 QFVQERINKPGMKLSKICEELFDHCLAPHTRGDGTGCDNMTAIIVQFK 304
|
| >2i44_A Serine-threonine phosphatase 2C; PSI-2, 8817Z, structural genomics, protein structure initiative; 2.04A {Toxoplasma gondii} Length = 324 | Back alignment and structure |
|---|
Score = 286 bits (734), Expect = 2e-91
Identities = 70/315 (22%), Positives = 120/315 (38%), Gaps = 56/315 (17%)
Query: 423 LTYYPVLSWGSFATCGRRETMEDTHFLMPHMY-NQKEIHMFGIFDGHRGSAAAEFSARAL 481
T YP F G R+ ED L P + + + FG+FDG G A+E +
Sbjct: 16 PTSYPAFDAAIFTDIGGRKHQEDRFTLCPQLVPGRDDCAFFGVFDGTVGDFASENVKDLV 75
Query: 482 PGFLQN---------------------LGSTTRPTDALLEAFIRTDVAFRNELDSLRKSK 520
L + A+ + + D + L K
Sbjct: 76 VPQLISSPAWQEVTEMLRSDVPATEVDEKLPQLLDQAVDDMYKNADNELVKMCEQLNKD- 134
Query: 521 RVVQKDWHPGCTAIAALIVRNRLFVANAGDCRAILCR----GGHPFALSRDHVASCLEER 576
+ T++ A++ + + V + GD R + G + L+ DH E+
Sbjct: 135 -------YASSTSVTAVLAKGFVAVGHLGDSRIAMGVETPNGLNCEFLTVDHKPDMPHEK 187
Query: 577 ERVVSAGGNVNWQVDTWRVG----------------PPALQVTRSIGDDDLKP-AVTAEP 619
R++ GG+V + + P LQ +R+ G DLK ++ +P
Sbjct: 188 LRIMRNGGSVEYLHNHNNKPFIRGGDFSFRKSRGEQPMQLQYSRAFGGKDLKMYGLSNQP 247
Query: 620 EITETIMTPEDEYLVMASDGLWDVVSHVEAVGIIKDTVKEPG-----MCSKRLATEAAER 674
++ +TP+ +++A+DGLWDV+S +AV I +E + LA + +
Sbjct: 248 DVRVVRVTPQHRVMILATDGLWDVMSAAQAVEIAMQARQEGRNPAQALVEMTLAEQQSRN 307
Query: 675 GSKDNITVIVVFLQP 689
S DNIT + VF +
Sbjct: 308 QSADNITAMTVFFKK 322
|
| >2p8e_A PPM1B beta isoform variant 6; structural genomics, hydrolase, PSI-2, protein structure initiative; 1.82A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 283 bits (727), Expect = 1e-90
Identities = 74/288 (25%), Positives = 124/288 (43%), Gaps = 39/288 (13%)
Query: 429 LSWGSFATCGRRETMEDTHFLMPHM-YNQKEIHMFGIFDGHRGSAAAEFSARALPGFLQN 487
L +G + G R MED H + + + ++ F ++DGH GS A + + L +
Sbjct: 24 LRYGLSSMQGWRVEMEDAHTAVVGIPHGLEDWSFFAVYDGHAGSRVANYCSTHLLEHITT 83
Query: 488 --------------LGSTTRPTDALLEAFIRTDVAFRNELDSLRKSKRVVQKDWHPGCTA 533
S + + F++ D RN D G TA
Sbjct: 84 NEDFRAAGKSGSALELSVENVKNGIRTGFLKIDEYMRNFSDL-------RNGMDRSGSTA 136
Query: 534 IAALIVRNRLFVANAGDCRAILCRGGHPFALSRDHVASCLEERERVVSAGGNVNWQVDTW 593
+ +I ++ N GD RA+L R G ++DH E+ER+ +AGG V
Sbjct: 137 VGVMISPKHIYFINCGDSRAVLYRNGQVCFSTQDHKPCNPREKERIQNAGG----SVMIQ 192
Query: 594 RVGPPALQVTRSIGDDDLK---------PAVTAEPEITETIMTPEDEYLVMASDGLWDVV 644
RV +L V+R++GD D K V+ EPE+ E + EDE++++A DG+WDV+
Sbjct: 193 RVN-GSLAVSRALGDYDYKCVDGKGPTEQLVSPEPEVYEILRAEEDEFIILACDGIWDVM 251
Query: 645 SHVEAVGIIKD---TVKEPGMCSKRLATEAAERGSKDNITVIVVFLQP 689
S+ E +K + + +GS+DN+++++V
Sbjct: 252 SNEELCEYVKSRLEVSDDLENVCNWVVDTCLHKGSRDNMSIVLVCFSN 299
|
| >1a6q_A Phosphatase 2C; catalytic mechanism, metalloenzyme, transductuin, hydrolase; 2.00A {Homo sapiens} SCOP: a.159.1.1 d.219.1.1 PDB: 3fxk_A 3fxj_A 3fxl_A* 3fxm_A* 3fxo_A Length = 382 | Back alignment and structure |
|---|
Score = 281 bits (721), Expect = 9e-89
Identities = 73/292 (25%), Positives = 121/292 (41%), Gaps = 37/292 (12%)
Query: 427 PVLSWGSFATCGRRETMEDTHFLMPHMYNQKE-IHMFGIFDGHRGSAAAEFSARALPGFL 485
L +G + G R MED H + + + E F ++DGH GS A++ L +
Sbjct: 20 NGLRYGLSSMQGWRVEMEDAHTAVIGLPSGLESWSFFAVYDGHAGSQVAKYCCEHLLDHI 79
Query: 486 QN---------LGSTTRPTDALLEAFIRTDVAFRNELDSLRKSKRVVQKDWHPGCTAIAA 536
N S + + F+ D R + G TA+
Sbjct: 80 TNNQDFKGSAGAPSVENVKNGIRTGFLEIDEHMRVMSEK-------KHGADRSGSTAVGV 132
Query: 537 LIVRNRLFVANAGDCRAILCRGGHPFALSRDHVASCLEERERVVSAGGNVNWQVDTWRV- 595
LI + N GD R +LCR ++DH S E+ER+ +AGG V RV
Sbjct: 133 LISPQHTYFINCGDSRGLLCRNRKVHFFTQDHKPSNPLEKERIQNAGG----SVMIQRVN 188
Query: 596 GPPALQVTRSIGDDDLK---------PAVTAEPEITETIMTPE-DEYLVMASDGLWDVVS 645
G +L V+R++GD D K V+ EPE+ + + E D+++++A DG+WDV+
Sbjct: 189 G--SLAVSRALGDFDYKCVHGKGPTEQLVSPEPEVHDIERSEEDDQFIILACDGIWDVMG 246
Query: 646 HVEAVGIIKD---TVKEPGMCSKRLATEAAERGSKDNITVIVVFLQPVSTAE 694
+ E ++ + + +GS+DN++VI++
Sbjct: 247 NEELCDFVRSRLEVTDDLEKVCNEVVDTCLYKGSRDNMSVILICFPNAPKVS 298
|
| >3d8k_A PP2C, protein phosphatase 2C; nysgrc, PSI-II, STR genomics, protein structure initiative, NEW YORK structural research consortium, nysgxrc; 2.71A {Toxoplasma gondii} Length = 377 | Back alignment and structure |
|---|
Score = 254 bits (650), Expect = 2e-78
Identities = 64/323 (19%), Positives = 106/323 (32%), Gaps = 60/323 (18%)
Query: 429 LSWGSFATCGRRETMEDTHFLMPHMYN-----QKEIHMFGIFDGHRGSAAAEFSARALPG 483
S + RR T E H + + E + +FDG +G +A + A+ +
Sbjct: 13 TVCASATSRNRRPTSESPHSDDVVVVEGMLRGRPETRVHAMFDGFQGRHSAMWLAQNVMN 72
Query: 484 FLQNLGSTTRPTDALLEAFIRTDVAFRNE---------LDSLRKSKRVVQ---------- 524
+L +L + + F R D R + +R K+ +
Sbjct: 73 YLNDLRDVNE--EEITRQFERMDGDLRAANLPGGSSALIIFVRYEKKPTEARVVGRQIVP 130
Query: 525 ---------KDWHPGCTAIAALIVRNR----------LFVANAGDCRAILCRGGHPFALS 565
+ G + R + VA+ G+ R +L G LS
Sbjct: 131 EGAKEFTSVAEALGGPLMPVVAMNFRRDPRAAKGIYTIHVASLGNSRCVLKSGRTAIHLS 190
Query: 566 RDHVASCLEERERVVSAGGNVNWQVDTWRVGPPALQVTRSIGDDDLK---------PAVT 616
H AS +ER RV +AGG +G + +TR+ G D K V+
Sbjct: 191 TPHTASSHKERHRVQAAGGVFTTVNGELLLG-GVVPMTRAFGSFDFKKGGQGKLQQDLVS 249
Query: 617 AEPEITETIMTPEDEYLVMASDGLWDVVSHVEAVGIIKDTVKE----PGMCSKRLATEAA 672
A P++T P D+ +V + G + A+ +K + A
Sbjct: 250 AVPDVTTFFAYPGDD-IVAGTAGAFAHFRSHAAIAAAIALYPVSPETVLDAAKAMVVNAK 308
Query: 673 ERGSKDNITVIVVFLQPVSTAER 695
R NI+ V L T +
Sbjct: 309 RRKVTKNISTFVRHLPESRTRSQ 331
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 236 bits (605), Expect = 1e-72
Identities = 87/298 (29%), Positives = 135/298 (45%), Gaps = 39/298 (13%)
Query: 64 PPSSYTLLSPIARGAESVVYEATLDGRKVAVK--KPILSTSEELDNFHKELQLLCKLDHP 121
P + I G+ V+ A G VAVK +E ++ F +E+ ++ +L HP
Sbjct: 35 PWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHP 94
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVD--QVLMIAAQLAKALQYLH 179
+ F+ A +PPN E+ +L LH +D + L +A +AK + YLH
Sbjct: 95 NIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH 154
Query: 180 NLG--IVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKN 237
N IVHR++K N+L+D+ + DFGL+ R K + K+
Sbjct: 155 NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLS--RL--------------KASTFLSSKS 198
Query: 238 MVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTE 297
GT +MAPE+L+ E +EKSDVYSFG+ + EL T P+ +L
Sbjct: 199 AAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNL--------------NP 244
Query: 298 QQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH 355
Q+ AAV R + L + ++I+ CW P RPSF+ I L +++
Sbjct: 245 AQVVAAVGFKCKRLEIPR---NLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 231 bits (591), Expect = 1e-70
Identities = 79/298 (26%), Positives = 128/298 (42%), Gaps = 45/298 (15%)
Query: 64 PPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGL 123
+ + RGA VV +A + VA+K+ + + E F EL+ L +++HP +
Sbjct: 6 DYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQ--IESESERKAFIVELRQLSRVNHPNI 63
Query: 124 AKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVD--QVLMIAAQLAKALQYLHNL 181
K A P E+ E +L LH E P + Q ++ + YLH++
Sbjct: 64 VKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSM 121
Query: 182 ---GIVHRDVKPANVLLDRN-LCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKN 237
++HRD+KP N+LL + DFG A + ++ H N
Sbjct: 122 QPKALIHRDLKPPNLLLVAGGTVLKICDFGTA-----------CDIQT--------HMTN 162
Query: 238 MVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTE 297
G+ +MAPE+ + +SEK DV+S+GI + E++T P+ ++ A
Sbjct: 163 NKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR---------- 212
Query: 298 QQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH 355
V G RP L LP I SL+ RCW +P RPS +I + ++ +
Sbjct: 213 ---IMWAVHNGTRPPLIK---NLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRY 264
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 226 bits (577), Expect = 2e-68
Identities = 69/309 (22%), Positives = 122/309 (39%), Gaps = 41/309 (13%)
Query: 64 PPSSYTLLSPIARGAESVVYEATLDGRKVAVK--KPILSTSEELDNFHKELQLLCKLDHP 121
P + I +G VY G +VA++ ++L F +E+ + H
Sbjct: 31 PFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHE 89
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL 181
+ F+ A PP+ + R L + + V++ IA ++ K + YLH
Sbjct: 90 NVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAK 149
Query: 182 GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGT 241
GI+H+D+K NV D + DFGL S+ +G+ + G
Sbjct: 150 GILHKDLKSKNVFYDNGKV-VITDFGLF---------SISGVLQAGRREDKL--RIQNGW 197
Query: 242 LIYMAPEILK---------KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLE 292
L ++APEI++ K S+ SDV++ G EL P+ AEA
Sbjct: 198 LCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA------- 250
Query: 293 MNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352
+ G++P L+ ++G+ I ++ CW RP+F+ + L+ +
Sbjct: 251 --------IIWQMGTGMKPNLS--QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKL 300
Query: 353 LEHRKSLKE 361
+ + L
Sbjct: 301 PKRNRRLSH 309
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 223 bits (571), Expect = 6e-68
Identities = 81/292 (27%), Positives = 129/292 (44%), Gaps = 34/292 (11%)
Query: 64 PPSSYTLLSPIARGAESVVYEATLDGRKVAVK--KPILSTSEELDNFHKELQLLCKLDHP 121
P T+ I G+ VY+ G VAVK T ++L F E+ +L K H
Sbjct: 22 PDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 80
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL 181
+ F+ + P ++ E +L LH E + +++ IA Q A+ + YLH
Sbjct: 81 NILLFMGY-STAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAK 139
Query: 182 GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGT 241
I+HRD+K N+ L + + DFGLA E W S + G+
Sbjct: 140 SIIHRDLKSNNIFLHEDNTVKIGDFGLA--TE------KSRWSGSHQFEQL------SGS 185
Query: 242 LIYMAPEILKKEIH---SEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQ 298
+++MAPE+++ + S +SDVY+FGI + EL+TG +PY+++
Sbjct: 186 ILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN-------------RD 232
Query: 299 QLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350
Q+ V G L P L+ + P + L+ C RPSF I E++
Sbjct: 233 QIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIE 284
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 223 bits (571), Expect = 1e-67
Identities = 75/303 (24%), Positives = 118/303 (38%), Gaps = 20/303 (6%)
Query: 63 LPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDH 120
PS + +G + T G + +K+ I E F KE++++ L+H
Sbjct: 7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEH 66
Query: 121 PGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHN 180
P + KF+ K F E+ + L + + Q + A +A + YLH+
Sbjct: 67 PNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHS 126
Query: 181 LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
+ I+HRD+ N L+ N +ADFGLA R + E + S K + +VG
Sbjct: 127 MNIIHRDLNSHNCLVRENKNVVVADFGLA--RLMVDEKTQPEGLRSLKKPDRKKRYTVVG 184
Query: 241 TLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQL 300
+MAPE++ + EK DV+SFGI + E++ V D
Sbjct: 185 NPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLP-------------RTMD 231
Query: 301 TAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHRKSLK 360
V G L P S + RC D +P RPSF + L+ + H
Sbjct: 232 FGLNVRGFLDRYCPP---NCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHL 288
Query: 361 EED 363
Sbjct: 289 PLG 291
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 221 bits (565), Expect = 3e-67
Identities = 82/305 (26%), Positives = 129/305 (42%), Gaps = 52/305 (17%)
Query: 61 LHLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKK----PILSTSEELDNFHKELQLLC 116
L + + TL I G VY A G +VAVK P S+ ++N +E +L
Sbjct: 2 LEIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFA 61
Query: 117 KLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQ 176
L HP + K PN EF L L + P D ++ A Q+A+ +
Sbjct: 62 MLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPP--DILVNWAVQIARGMN 119
Query: 177 YLHNLG---IVHRDVKPANVLLDRNLCPH--------LADFGLAEYRENLKEISLKNWRS 225
YLH+ I+HRD+K +N+L+ + + + DFGLA
Sbjct: 120 YLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHR----------- 168
Query: 226 SGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEA 285
K + G +MAPE+++ + S+ SDV+S+G+ + ELLTG VP+ +
Sbjct: 169 -------TTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGI---- 217
Query: 286 QAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
+ V L + S P L++ CW+ +PH+RPSF++I
Sbjct: 218 ----------DGLAVAYGVAMNKLALPIPS---TCPEPFAKLMEDCWNPDPHSRPSFTNI 264
Query: 346 ALELD 350
+L
Sbjct: 265 LDQLT 269
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 217 bits (554), Expect = 1e-65
Identities = 56/297 (18%), Positives = 111/297 (37%), Gaps = 48/297 (16%)
Query: 64 PPSSYTLLSPIARGAESVVYEATLDGRKVAVK--KPILSTSEELDNFHKELQLLCKLDHP 121
L+ + +++ G + VK K ++ + +F++E L HP
Sbjct: 8 DFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHP 67
Query: 122 GLAKFVAAHAKPP--NYMFFFEFYESRNLAEKLHVEEWSP-SVDQVLMIAAQLAKALQYL 178
+ + A PP + + +L LH Q + A +A+ + +L
Sbjct: 68 NVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFL 127
Query: 179 HNLG--IVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
H L I + +V++D ++ ++ + S F
Sbjct: 128 HTLEPLIPRHALNSRSVMIDEDMTARISMADVK--------------FS-------FQSP 166
Query: 237 NMVGTLIYMAPEILKKE---IHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEM 293
+ ++APE L+K+ + +D++SF + + EL+T VP+ DL
Sbjct: 167 GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADL------------ 214
Query: 294 NYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350
+ ++ V GLRP + G+ + L++ C + +P RP F I L+
Sbjct: 215 --SNMEIGMKVALEGLRPTIPP---GISPHVSKLMKICMNEDPAKRPKFDMIVPILE 266
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 216 bits (552), Expect = 3e-65
Identities = 73/306 (23%), Positives = 129/306 (42%), Gaps = 54/306 (17%)
Query: 63 LPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKK-------PILSTSEELDNFHKELQ 113
L + I +G +V++ L D VA+K E+ F +E+
Sbjct: 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVF 75
Query: 114 LLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAK 173
++ L+HP + K PP + EF +L +L + L + +A
Sbjct: 76 IMSNLNHPNIVKLYGLMHNPPRMVM--EFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIAL 133
Query: 174 ALQYLHNLG--IVHRDVKPANVLLD-----RNLCPHLADFGLAEYRENLKEISLKNWRSS 226
++Y+ N IVHRD++ N+ L +C +ADFGL+ ++++
Sbjct: 134 GIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS--QQSVHS--------- 182
Query: 227 GKPTGGFHKKNMVGTLIYMAPEIL--KKEIHSEKSDVYSFGISINELLTGVVPYTDLRAE 284
++G +MAPE + ++E ++EK+D YSF + + +LTG P+ +
Sbjct: 183 --------VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDE---- 230
Query: 285 AQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSD 344
+Y + + + GLRP + P + ++I+ CW G+P RP FS
Sbjct: 231 --------YSYGKIKFINMIREEGLRPTIPE---DCPPRLRNVIELCWSGDPKKRPHFSY 279
Query: 345 IALELD 350
I EL
Sbjct: 280 IVKELS 285
|
| >2j4o_A Mitogen-activated protein kinase kinase kinase 7-interacting protein 1; TGF-beta, pseudo-phosphatase, TAK1 binding protein, protein binding; 2.25A {Homo sapiens} PDB: 2pom_A 2pop_A Length = 401 | Back alignment and structure |
|---|
Score = 219 bits (559), Expect = 7e-65
Identities = 68/327 (20%), Positives = 118/327 (36%), Gaps = 70/327 (21%)
Query: 418 SANDALTYYPVLSWGSFATCGRR--------ETMEDTHFLMPHMYNQKEIHMFGIFDGHR 469
S D L + GS + ED+ ++ ++G+F+G+
Sbjct: 16 SWTDDLPLCHLSGVGSASNRSYSADGKGTESHPPEDSWL---KFRSENNCFLYGVFNGYD 72
Query: 470 GSAAAEFSARALPGFL--QNLGSTTRPTD---ALLEAFIRTDVAFRNELDSLRKSK---- 520
G+ F A+ L L L + D LL+AF + +F +D K
Sbjct: 73 GNRVTNFVAQRLSAELLLGQLNAEHAEADVRRVLLQAFDVVERSFLESIDDALAEKASLQ 132
Query: 521 -----------------------RVVQKDWHPGCTAIAALIVRNRLFVANAGDCRAILCR 557
+ ++++ G A+ A+++ N+L+VAN G RA+LC+
Sbjct: 133 SQLPEGVPQHQLPPQYQKILERLKTLEREISGGAMAVVAVLLNNKLYVANVGTNRALLCK 192
Query: 558 ----GGHPFALSRDHVASCLEERERVVSAGGNVNWQVDTWRVGPPALQVTRSIGDDDLK- 612
G L+ DH +E R+ G + + + TR IGD +K
Sbjct: 193 STVDGLQVTQLNVDHTTENEDELFRLSQLGLDAGKIKQVGIIC--GQESTRRIGDYKVKY 250
Query: 613 -------------PAVTAEPEITE-TIMTPEDEYLVMASDGLWDVVSHVEAVGIIKDTVK 658
+ AEPEI + +LV+ S+GL+ + G +
Sbjct: 251 GYTDIDLLSAAKSKPIIAEPEIHGAQPLDGVTGFLVLMSEGLYKALEAAHGPGQANQEI- 309
Query: 659 EPGMCSKRLATEAAERGSKDNITVIVV 685
+ + TE A++ S D + VV
Sbjct: 310 -----AAMIDTEFAKQTSLDAVAQAVV 331
|
| >2irm_A Mitogen-activated protein kinase kinase kinase 7 interacting protein 1; TAK1-binding protein, TAB1; 3.00A {Anopheles gambiae} Length = 358 | Back alignment and structure |
|---|
Score = 209 bits (532), Expect = 1e-61
Identities = 59/332 (17%), Positives = 110/332 (33%), Gaps = 79/332 (23%)
Query: 434 FATCGRRETMEDTHFLMPHMYNQKEIHMFGIFDGHRGSAAAEFSARALPGFLQNLGSTTR 493
+ GRR ++ + ++ I GH G AE + + + L
Sbjct: 25 YKDDGRRCEGYESRDKKCLCISDNNTSLYAILSGHNGVTVAENALQEMAAELLLGQLNVC 84
Query: 494 PTD-----ALLEAFIRTDVAFRNELDSLRKSKRVVQKD---------------------- 526
TD + ++F+ + + + ++ +K +Q
Sbjct: 85 NTDEAVKELIRQSFMSVEKGYFDSINPHVATKTAIQLHLSADGMNQYEISQQFENVLQKL 144
Query: 527 ------WHPGCTAIAALIVRNRLFVANAGDCRAILCRGGHPF-----ALSRDHVASCLEE 575
G +A+ ALI R+ L++ N G+CRA+LC+ LS DH EE
Sbjct: 145 DSLNNALSVGSSAVLALIHRSHLYLGNIGNCRALLCKTDEHDTLTVTQLSVDHNLLNAEE 204
Query: 576 RERVVSAGGNV----NWQVDTWRVGPPALQVTRSIGDDDLKPA-----VTAEPEITETI- 625
R+ G + + R D + + V EPEI I
Sbjct: 205 AARLFRLGLMAQNFEGVPLYSTRCIGN-YLGKAGYKDCNFLSSATAEPVIFEPEIVGGIQ 263
Query: 626 MTPEDEYLVMASDGLWDVV----------SHVEAVGIIKDTVKE---PGMCSKRLATEAA 672
+TP +LV+ S GL + + E V +I + + G ++ +
Sbjct: 264 ITPACRFLVLMSSGLCRALHEIFPGDASTGNRELVRMISEEFQNQSTLGGVAQSVVHRIV 323
Query: 673 E-----------------RGSKDNITVIVVFL 687
+ S+D++T+++
Sbjct: 324 QAHHDTYMQLVEEHRSVTFNSRDDVTLLIRNF 355
|
| >2isn_A NYSGXRC-8828Z, phosphatase; pathogenic strain, praseodymium, sulfate structural genomics, PSI-2, protein structure initiative; 1.90A {Toxoplasma gondii} Length = 364 | Back alignment and structure |
|---|
Score = 202 bits (515), Expect = 5e-59
Identities = 66/336 (19%), Positives = 115/336 (34%), Gaps = 71/336 (21%)
Query: 429 LSWGSFATCGRRETMEDTHFLMPHMYNQKEIHMFGIFDGHRGSAAAEFSARALPGFL--- 485
+ + GRR T ED + ++ + + +FDGH G A +++ A+ L
Sbjct: 13 TTTVAATMLGRRPTDEDAILVSAPATSRPNVRIKAVFDGHAGEATSQYCAKHAAKHLGKL 72
Query: 486 -----QNLGSTTRPTD----------------ALLEAFIRTDVAFRNELDSLRKSKRVVQ 524
+ D ++ A R + R +
Sbjct: 73 SEFTFAEVKKACLSLDAEIIRKLGPKHVAGSTGIIVAIERLSAPVVENVVGREIVPRAHE 132
Query: 525 KDWHP-----------------GCTAIAALIV-------RNRLFVANAGDCRAILCR-GG 559
+ + P G + + N GD RA L G
Sbjct: 133 ETFVPLEKLIQEEEEAEHPELVGRYPRVPDVQQKTIPAGSFLVTAINIGDSRATLIHSDG 192
Query: 560 HPFALSRDHVASCLEERERVVSAGGNVNWQVDTWRV-GPPALQVTRSIGDDDLKP----- 613
LS+DH + E R+ AGG+V D RV G L ++R+ GD D K
Sbjct: 193 GLTRLSKDHKPNHPTEASRIEKAGGSVETF-DVPRVDG--VLALSRAFGDSDFKMNPNLP 249
Query: 614 ----AVTAEPEITETIMTPEDEYLVMASDGLWDVVSHVEAVGI------IKDTVKEPGMC 663
V A P++ + + L++A DG+++ A ++ + +
Sbjct: 250 PEEQKVIAVPDVRQFYAL-SSDLLLLACDGVYEPSGMDWAYVRDLTVAEMQRSKGDLEEV 308
Query: 664 SKRLATEAAERGSKDNITVIVVFL--QPVSTAERIY 697
+ R+ A + S+DNI+V++V Q V +Y
Sbjct: 309 AARVMDYAYDMNSQDNISVMLVAFHNQEVEHPTAVY 344
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 5e-58
Identities = 69/303 (22%), Positives = 113/303 (37%), Gaps = 36/303 (11%)
Query: 69 TLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVA 128
TLL + +G V+ + G VAVK S E+ EL L H + F+A
Sbjct: 11 TLLECVGKGRYGEVWRGSWQGENVAVKI-FSSRDEKSWFRETELYNTVMLRHENILGFIA 69
Query: 129 A----HAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL--- 181
+ ++E +L + L + + L I +A L +LH
Sbjct: 70 SDMTSRHSSTQLWLITHYHEMGSLYDYLQLT--TLDTVSCLRIVLSIASGLAHLHIEIFG 127
Query: 182 -----GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
I HRD+K N+L+ +N +AD GLA S
Sbjct: 128 TQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA--VM----------HSQSTNQLDVGNN 175
Query: 237 NMVGTLIYMAPEILKKEI------HSEKSDVYSFGISINELLTGVVPYTDLRAEAQA-HT 289
VGT YMAPE+L + I ++ D+++FG+ + E+ +V + +
Sbjct: 176 PRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD 235
Query: 290 VLEMNYTEQQLTAAVVSGGLRPIL--ASLELGLPASILSLIQRCWDGNPHNRPSFSDIAL 347
V+ + + + + V RP + S+ L++ CW NP R + I
Sbjct: 236 VVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295
Query: 348 ELD 350
L
Sbjct: 296 TLT 298
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 7e-57
Identities = 65/308 (21%), Positives = 111/308 (36%), Gaps = 36/308 (11%)
Query: 64 PPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGL 123
++ I +G V+ G KVAVK +T E E+ + H +
Sbjct: 35 IAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKV-FFTTEEASWFRETEIYQTVLMRHENI 93
Query: 124 AKFVAAHAKP----PNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLH 179
F+AA K +++E+ +L + L + +L +A L +LH
Sbjct: 94 LGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLH 151
Query: 180 NL--------GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTG 231
I HRD+K N+L+ +N +AD GLA S
Sbjct: 152 TEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVK------------FISDTNEV 199
Query: 232 GFHKKNMVGTLIYMAPEILKKEIH------SEKSDVYSFGISINELLTGVVPYTDLRAEA 285
VGT YM PE+L + ++ +D+YSFG+ + E+ V +
Sbjct: 200 DIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQ 259
Query: 286 QAH-TVLEMNYTEQQLTAAVVSGGLRPIL--ASLELGLPASILSLIQRCWDGNPHNRPSF 342
+ ++ + + + + V LRP + L+ CW NP +R +
Sbjct: 260 LPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTA 319
Query: 343 SDIALELD 350
+ L
Sbjct: 320 LRVKKTLA 327
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 2e-56
Identities = 68/313 (21%), Positives = 120/313 (38%), Gaps = 37/313 (11%)
Query: 69 TLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVA 128
L I +G V+ G +VAVK S E E+ L H + F+A
Sbjct: 45 VLQESIGKGRFGEVWRGKWRGEEVAVKI-FSSREERSWFREAEIYQTVMLRHENILGFIA 103
Query: 129 A----HAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLH----- 179
A + +++E +L + L+ + +V+ ++ +A A L +LH
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVG 161
Query: 180 ---NLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
I HRD+K N+L+ +N +AD GLA S T
Sbjct: 162 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR------------HDSATDTIDIAPN 209
Query: 237 NMVGTLIYMAPEILKKEI------HSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHT- 289
+ VGT YMAPE+L I +++D+Y+ G+ E+ +
Sbjct: 210 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 269
Query: 290 VLEMNYTEQQLTAAVVSGGLRPILASLELGLPA--SILSLIQRCWDGNPHNRPSFSDIAL 347
++ + + +++ V LRP + + A + +++ CW N R + I
Sbjct: 270 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 329
Query: 348 ELDLVLEHRKSLK 360
L L ++ +K
Sbjct: 330 TLS-QLSQQEGIK 341
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 191 bits (486), Expect = 2e-55
Identities = 79/313 (25%), Positives = 127/313 (40%), Gaps = 42/313 (13%)
Query: 61 LHLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELD-NFHKELQLLCKLD 119
L+ LL ARG V++A L VAVK I ++ E+ L +
Sbjct: 19 LYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVK--IFPIQDKQSWQNEYEVYSLPGMK 76
Query: 120 HPGLAKFVAAHAKPPN----YMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKAL 175
H + +F+ A + + F+E +L++ L S +++ IA +A+ L
Sbjct: 77 HENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN--VVSWNELCHIAETMARGL 134
Query: 176 QYLH----------NLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRS 225
YLH I HRD+K NVLL NL +ADFGLA + + +S
Sbjct: 135 AYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLA--------LKFEAGKS 186
Query: 226 SGKPTGGFHKKNMVGTLIYMAPEILKKEIH-----SEKSDVYSFGISINELLTGVVPYTD 280
+G G VGT YMAPE+L+ I+ + D+Y+ G+ + EL +
Sbjct: 187 AGDTHG------QVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADG 240
Query: 281 LRAEAQA--HTVLEMNYTEQQLTAAVVSGGLRPILAS--LELGLPASILSLIQRCWDGNP 336
E + + + + + VV RP+L + A + I+ CWD +
Sbjct: 241 PVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDA 300
Query: 337 HNRPSFSDIALEL 349
R S + +
Sbjct: 301 EARLSAGCVGERI 313
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 183 bits (465), Expect = 3e-52
Identities = 71/332 (21%), Positives = 125/332 (37%), Gaps = 43/332 (12%)
Query: 60 PLHLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQ--LLCK 117
L + LL I RG VY+ +LD R VAVK + S + NF E +
Sbjct: 7 EPSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVK--VFSFANR-QNFINEKNIYRVPL 63
Query: 118 LDHPGLAKFVAAHAKPP-----NYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLA 172
++H +A+F+ + Y+ E+Y + +L + L + + +A +
Sbjct: 64 MEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH--TSDWVSSCRLAHSVT 121
Query: 173 KALQYLH---------NLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNW 223
+ L YLH I HRD+ NVL+ + ++DFGL+ ++
Sbjct: 122 RGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLS--MRLTGNRLVRPG 179
Query: 224 RSSGKPTGGFHKKNMVGTLIYMAPEILKKEI-------HSEKSDVYSFGISINELL---T 273
VGT+ YMAPE+L+ + ++ D+Y+ G+ E+ T
Sbjct: 180 EEDNAAIS------EVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCT 233
Query: 274 GVVPYTDLRAEAQA-HTVLEMNYTEQQLTAAVVSGGLRPILA---SLELGLPASILSLIQ 329
+ P + A T + + T + + V RP S+ I+
Sbjct: 234 DLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIE 293
Query: 330 RCWDGNPHNRPSFSDIALELDLVLEHRKSLKE 361
CWD + R + + ++ + K
Sbjct: 294 DCWDQDAEARLTAQXAEERMAELMMIWERNKS 325
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 1e-43
Identities = 76/361 (21%), Positives = 153/361 (42%), Gaps = 45/361 (12%)
Query: 68 YTLLSPIARGAESVVYEA--TLDGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGL 123
Y L I G+ T DGR+ +K+ +S +S+E + +E+ +L + HP +
Sbjct: 26 YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNI 85
Query: 124 AKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSP-SVDQVLMIAAQLAKALQYLHNLG 182
++ + + + ++ E +L ++++ ++ DQ+L Q+ AL+++H+
Sbjct: 86 VQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK 145
Query: 183 IVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTL 242
I+HRD+K N+ L ++ L DFG+A + ++ + + +GT
Sbjct: 146 ILHRDIKSQNIFLTKDGTVQLGDFGIA------RVLN----------STVELARACIGTP 189
Query: 243 IYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTA 302
Y++PEI + + ++ KSD+++ G + EL T + + + L
Sbjct: 190 YYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAG--------------SMKNLVL 235
Query: 303 AVVSGGLRPILA--SLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHRKSLK 360
++SG P+ S +L SL+ + + NP +RPS + I LE + + +
Sbjct: 236 KIISGSFPPVSLHYSYDLR------SLVSQLFKRNPRDRPSVNSI-LEKGFIAKRIEKFL 288
Query: 361 EEDLCAGKSYVTYDDKLINSGNNMHTYHESINWTAQGEHSSKKASHAAESDVKLWLESAN 420
L A + + K S S + + K AA+ + L +
Sbjct: 289 SPQLIAEEFCLKTFSKF-GSQPIPAKRPASGQNSISVMPAQKITKPAAKYGIPLAYKKYG 347
Query: 421 D 421
D
Sbjct: 348 D 348
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 2e-43
Identities = 71/318 (22%), Positives = 126/318 (39%), Gaps = 46/318 (14%)
Query: 66 SSYTLLSPIARGAESVVYEAT--LDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP-- 121
S + ++ + +GA V +A LD R A+KK I T E+L E+ LL L+H
Sbjct: 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKK-IRHTEEKLSTILSEVMLLASLNHQYV 64
Query: 122 ----------GLAKFVAAHAKPPNYMFF-FEFYESRNLAEKLHVEEWSPSVDQVLMIAAQ 170
K + +F E+ E+ L + +H E + D+ + Q
Sbjct: 65 VRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQ 124
Query: 171 LAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPT 230
+ +AL Y+H+ GI+HRD+KP N+ +D + + DFGLA+ +I + ++ +
Sbjct: 125 ILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSS 184
Query: 231 GGFHKKNMVGTLIYMAPEILK-KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHT 289
+GT +Y+A E+L ++EK D+YS GI E++ T
Sbjct: 185 DNLTS--AIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP--FSTG--------- 231
Query: 290 VLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALEL 349
E+ + + +I+ D +P+ RP +
Sbjct: 232 ------MERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTL---- 281
Query: 350 DLVLEH---RKSLKEEDL 364
L ++E +
Sbjct: 282 ---LNSGWLPVKHQDEVI 296
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 3e-41
Identities = 64/302 (21%), Positives = 121/302 (40%), Gaps = 42/302 (13%)
Query: 68 YTLLSPIARGAESVVYEAT--LDGRKVAVKK-PILSTSEELDNFHKELQLLCKLDHPGLA 124
+ + + RG VV+EA +D A+K+ + + + +E++ L KL+HPG+
Sbjct: 7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 66
Query: 125 KFVAA---------HAKPPNYMFFF---EFYESRNLAEKLHVEEWS--PSVDQVLMIAAQ 170
++ A ++ + + NL + ++ L I Q
Sbjct: 67 RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQ 126
Query: 171 LAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPT 230
+A+A+++LH+ G++HRD+KP+N+ + + DFGL + +E
Sbjct: 127 IAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQ----TVLTPMP 182
Query: 231 GGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTV 290
VGT +YM+PE + +S K D++S G+ + ELL P T
Sbjct: 183 AYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---P---------FSTQ 230
Query: 291 LEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350
+E T + + P+ ++Q +P RP +I +E
Sbjct: 231 MERVRTLTDV----RNLKFPPLFTQ----KYPCEYVMVQDMLSPSPMERPEAINI-IENA 281
Query: 351 LV 352
+
Sbjct: 282 VF 283
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 1e-40
Identities = 57/290 (19%), Positives = 109/290 (37%), Gaps = 35/290 (12%)
Query: 68 YTLLSPIARGAESVVYEA--TLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAK 125
Y + + G S V DG A+K+ + ++ + +E + +HP + +
Sbjct: 31 YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILR 90
Query: 126 FVAAHAKPPN--YMFF--FEFYESRNLAEKL---HVEEWSPSVDQVLMIAAQLAKALQYL 178
VA + + + F++ L ++ + + DQ+L + + + L+ +
Sbjct: 91 LVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAI 150
Query: 179 HNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNM 238
H G HRD+KP N+LL P L D G + + S +
Sbjct: 151 HAKGYAHRDLKPTNILLGDEGQPVLMDLGSM-------NQACIHVEGSRQALTLQDWAAQ 203
Query: 239 VGTLIYMAPEILKKEIH---SEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNY 295
T+ Y APE+ + H E++DV+S G + ++ G PY +M +
Sbjct: 204 RCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPY-------------DMVF 250
Query: 296 TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
+ A V L + +++ L+ +PH RP +
Sbjct: 251 QKGDSVALAVQNQLSIPQSP---RHSSALWQLLNSMMTVDPHQRPHIPLL 297
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 2e-40
Identities = 81/312 (25%), Positives = 130/312 (41%), Gaps = 63/312 (20%)
Query: 68 YTLLSPIARGAESVVYEAT--LDGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGL 123
Y +L I G+ + DG+ + K+ T E E+ LL +L HP +
Sbjct: 8 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 67
Query: 124 AKFVAAHAKPPNYMFF--FEFYESRNLAEKL--------HVEEWSPSVDQVLMIAAQLAK 173
++ N + E+ E +LA + +++E + VL + QL
Sbjct: 68 VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDE-----EFVLRVMTQLTL 122
Query: 174 ALQYLHNLG-----IVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK 228
AL+ H ++HRD+KPANV LD L DFGLA + ++
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA------RILN--------- 167
Query: 229 PTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAH 288
K VGT YM+PE + + ++EKSD++S G + EL + P+T
Sbjct: 168 -HDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA-------- 218
Query: 289 TVLEMNYTEQQLTAAVVSGGLRPILA--SLELGLPASILSLIQRCWDGNPHNRPSFSDIA 346
+++++L + G R I S EL +I R + ++RPS +I
Sbjct: 219 ------FSQKELAGKIREGKFRRIPYRYSDEL------NEIITRMLNLKDYHRPSVEEI- 265
Query: 347 LELDLVLEHRKS 358
LE L+LEH
Sbjct: 266 LENPLILEHHHH 277
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 1e-39
Identities = 71/317 (22%), Positives = 126/317 (39%), Gaps = 60/317 (18%)
Query: 64 PPSSYTLLSPIARGAESVVYEA--TLDGRKVAVKK---PILSTSEELDNFHKELQLLCKL 118
+++ + I RG S VY A LDG VA+KK L ++ + KE+ LL +L
Sbjct: 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL 89
Query: 119 DHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKL--------HVEEWSPSVDQVLMIAAQ 170
+HP + K+ A+ + E ++ +L+ + + E V Q
Sbjct: 90 NHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPE-----RTVWKYFVQ 144
Query: 171 LAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPT 230
L AL+++H+ ++HRD+KPANV + L D GL + S K
Sbjct: 145 LCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLG------RFFSSKTT------- 191
Query: 231 GGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTV 290
++VGT YM+PE + + ++ KSD++S G + E+ P+ +
Sbjct: 192 ---AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF-----YGDKMNL 243
Query: 291 LEMNYTEQQLTAAVVSGGLRPILASLELGLPASILS-----LIQRCWDGNPHNRPSFSDI 345
L + P+ P+ S L+ C + +P RP + +
Sbjct: 244 Y-------SLCKKIEQCDYPPL--------PSDHYSEELRQLVNMCINPDPEKRPDVTYV 288
Query: 346 ALELDLVLEHRKSLKEE 362
++ + + E
Sbjct: 289 -YDVAKRMHACTASSLE 304
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 3e-39
Identities = 58/319 (18%), Positives = 114/319 (35%), Gaps = 74/319 (23%)
Query: 68 YTLLSPIARGAESVVYEAT--LDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP---- 121
+ + I G V++A +DG+ +K+ + +E++ L KLDH
Sbjct: 13 FKEIELIGSGGFGQVFKAKHRIDGKTYVIKR----VKYNNEKAEREVKALAKLDHVNIVH 68
Query: 122 -----------GLAKFVAAHAKPPNYMFFF-EFYESRNLAEKL------HVEEWSPSVDQ 163
+ +F EF + L + + +++
Sbjct: 69 YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDK-----VL 123
Query: 164 VLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNW 223
L + Q+ K + Y+H+ +++RD+KP+N+ L + DFGL +
Sbjct: 124 ALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLV------TSLKNDGK 177
Query: 224 RSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRA 283
R+ GTL YM+PE + + + ++ D+Y+ G+ + ELL +
Sbjct: 178 RTR-----------SKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE--- 223
Query: 284 EAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFS 343
T+ + I++ +L+Q+ P +RP+ S
Sbjct: 224 -----------------TSKFFTDLRDGIISD---IFDKKEKTLLQKLLSKKPEDRPNTS 263
Query: 344 DIALELDLVLEHRKSLKEE 362
+I L V + E
Sbjct: 264 EI-LRTLTVWKKSPEKNER 281
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 2e-38
Identities = 73/312 (23%), Positives = 115/312 (36%), Gaps = 62/312 (19%)
Query: 63 LPPSSYTLLSPIARGAESVVYEATLDGR--KVAVK--KPILSTSEELDNFHKELQLLCKL 118
L L I RG V+ L VAVK + + F +E ++L +
Sbjct: 111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET-LPPDLKAKFLQEARILKQY 169
Query: 119 DHPGLAKF--VAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQ 176
HP + + V +P E + + L E V +L + A ++
Sbjct: 170 SHPNIVRLIGVCTQKQP--IYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGME 227
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLA------EY--RENLKEISLKNWRSSGK 228
YL + +HRD+ N L+ ++DFG++ Y L+++ +K W
Sbjct: 228 YLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVK-W----- 281
Query: 229 PTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQA 287
APE L +S +SDV+SFGI + E + G PY +L
Sbjct: 282 ----------------TAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNL----SN 321
Query: 288 HTVLEMNYTEQQLTAAVVSGGLRPILASLEL--GLPASILSLIQRCWDGNPHNRPSFSDI 345
E V G R L P ++ L+++CW P RPSFS I
Sbjct: 322 QQTREF-----------VEKGGR-----LPCPELCPDAVFRLMEQCWAYEPGQRPSFSTI 365
Query: 346 ALELDLVLEHRK 357
EL + + +
Sbjct: 366 YQELQSIRKRHR 377
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 9e-38
Identities = 63/304 (20%), Positives = 106/304 (34%), Gaps = 56/304 (18%)
Query: 68 YTLLSPIARGAESVVYEAT-LDGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLA 124
Y++L I G S V++ + A+K L ++ LD++ E+ L KL
Sbjct: 30 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 89
Query: 125 --KFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLG 182
+ E + +L L ++ S + + +A+ +H G
Sbjct: 90 IIRLYDYEITDQYIYMVME-CGNIDLNSWL-KKKKSIDPWERKSYWKNMLEAVHTIHQHG 147
Query: 183 IVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTL 242
IVH D+KPAN L+ + L DFG+A T K + VGT+
Sbjct: 148 IVHSDLKPANFLIVDGML-KLIDFGIA--------------NQMQPDTTSVVKDSQVGTV 192
Query: 243 IYMAPEILK-----------KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVL 291
YM PE +K K S KSDV+S G + + G P+ + +
Sbjct: 193 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK---- 248
Query: 292 EMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL 351
A++ + +++ C +P R S ++
Sbjct: 249 ---------LHAIIDPNHEIEFPD---IPEKDLQDVLKCCLKRDPKQRISIPEL------ 290
Query: 352 VLEH 355
L H
Sbjct: 291 -LAH 293
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 9e-38
Identities = 63/304 (20%), Positives = 106/304 (34%), Gaps = 56/304 (18%)
Query: 68 YTLLSPIARGAESVVYEAT-LDGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLA 124
Y++L I G S V++ + A+K L ++ LD++ E+ L KL
Sbjct: 11 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 70
Query: 125 --KFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLG 182
+ E + +L L ++ S + + +A+ +H G
Sbjct: 71 IIRLYDYEITDQYIYMVME-CGNIDLNSWL-KKKKSIDPWERKSYWKNMLEAVHTIHQHG 128
Query: 183 IVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTL 242
IVH D+KPAN L+ + L DFG+A T K + VGT+
Sbjct: 129 IVHSDLKPANFLIVDGML-KLIDFGIA--------------NQMQPDTTSVVKDSQVGTV 173
Query: 243 IYMAPEILK-----------KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVL 291
YM PE +K K S KSDV+S G + + G P+ + +
Sbjct: 174 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK---- 229
Query: 292 EMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL 351
A++ + +++ C +P R S ++
Sbjct: 230 ---------LHAIIDPNHEIEFPD---IPEKDLQDVLKCCLKRDPKQRISIPEL------ 271
Query: 352 VLEH 355
L H
Sbjct: 272 -LAH 274
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 1e-37
Identities = 64/295 (21%), Positives = 104/295 (35%), Gaps = 44/295 (14%)
Query: 56 SQSIPLHLPPSSYTLLSPIARGAESVVYEAT--LDGRKVAVKKPILS--TSEELDNFHKE 111
S P S+ LS + G+ V++ DGR AVK+ + ++ E
Sbjct: 47 DPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAE 106
Query: 112 LQLLCKL-DHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQ 170
+ K+ HP + A + E +L + S QV
Sbjct: 107 VGSHEKVGQHPCCVRLEQAWEEGGILYLQTE-LCGPSLQQHCEAWGASLPEAQVWGYLRD 165
Query: 171 LAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPT 230
AL +LH+ G+VH DVKPAN+ L L DFGL E+
Sbjct: 166 TLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLL------VELGTAGAGEV---- 215
Query: 231 GGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTV 290
G YMAPE+L+ + +DV+S G++I E+ +
Sbjct: 216 -------QEGDPRYMAPELLQGS-YGTAADVFSLGLTILEVACNMELPH------GGEGW 261
Query: 291 LEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
++ G L P + GL + + S++ + +P R + +
Sbjct: 262 QQL-----------RQGYLPPEFTA---GLSSELRSVLVMMLEPDPKLRATAEAL 302
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 1e-37
Identities = 72/286 (25%), Positives = 116/286 (40%), Gaps = 46/286 (16%)
Query: 68 YTLLSPIARGAESVVYEA--TLDGRKVAVK--KPILSTSEE-LDNFHKELQLLCKLDHPG 122
Y L + G S V+ A D R VAVK + L+ F +E Q L+HP
Sbjct: 14 YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73
Query: 123 LAK-----FVAAHAKPPNY--MFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKAL 175
+ A P Y M E+ + L + +H E + + + + A +AL
Sbjct: 74 IVAVYDTGEAETPAGPLPYIVM---EYVDGVTLRDIVH-TEGPMTPKRAIEVIADACQAL 129
Query: 176 QYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHK 235
+ H GI+HRDVKPAN+++ + DFG+A R+ +
Sbjct: 130 NFSHQNGIIHRDVKPANIMISATNAVKVMDFGIA--------------RAIADSGNSVTQ 175
Query: 236 KNMV-GTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMN 294
V GT Y++PE + + +SDVYS G + E+LTG P+T ++
Sbjct: 176 TAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT---GDSPVSVAY--- 229
Query: 295 YTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRP 340
Q + + ++ GL A + +++ + NP NR
Sbjct: 230 ---QHVREDPIP------PSARHEGLSADLDAVVLKALAKNPENRY 266
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 2e-37
Identities = 64/317 (20%), Positives = 112/317 (35%), Gaps = 56/317 (17%)
Query: 55 SSQSIPLHLPPSSYTLLSPIARGAESVVYEAT-LDGRKVAVKKPILS--TSEELDNFHKE 111
SS + + + Y++L I G S V++ + A+K L ++ LD++ E
Sbjct: 45 SSANECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNE 104
Query: 112 LQLLCKLDHPGLA--KFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAA 169
+ L KL + E + +L L ++ S +
Sbjct: 105 IAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWL-KKKKSIDPWERKSYWK 162
Query: 170 QLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKP 229
+ +A+ +H GIVH D+KPAN L+ + L DFG+A ++
Sbjct: 163 NMLEAVHTIHQHGIVHSDLKPANFLIVDGML-KLIDFGIA------NQMQ--------PD 207
Query: 230 TGGFHKKNMVGTLIYMAPEILK-----------KEIHSEKSDVYSFGISINELLTGVVPY 278
T K + VG + YM PE +K K S KSDV+S G + + G P+
Sbjct: 208 TTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 267
Query: 279 TDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHN 338
+ + A++ + +++ C +P
Sbjct: 268 QQIINQISK-------------LHAIIDPNHEIEFPD---IPEKDLQDVLKCCLKRDPKQ 311
Query: 339 RPSFSDIALELDLVLEH 355
R S ++ L H
Sbjct: 312 RISIPEL-------LAH 321
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-37
Identities = 78/304 (25%), Positives = 118/304 (38%), Gaps = 62/304 (20%)
Query: 68 YTLLSPIARGAESVVYEA--TLDGRKVAVK--KPILSTSEE-LDNFHKELQLLCKLDHPG 122
Y L + RG VYEA T+ R VA+K LS+ +E + +L P
Sbjct: 36 YRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPH 95
Query: 123 LAKFVAAH----AKPPNY--MFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQ 176
+ V H Y M +LA L + + + + I Q+ AL
Sbjct: 96 V---VPIHDFGEIDGQLYVDM---RLINGVDLAAMLR-RQGPLAPPRAVAIVRQIGSALD 148
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKP----TGG 232
H G HRDVKP N+L+ + +L DFG+A ++ G
Sbjct: 149 AAHAAGATHRDVKPENILVSADDFAYLVDFGIA--------------SATTDEKLTQLG- 193
Query: 233 FHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYT-DLRAEAQAHTVL 291
N VGTL YMAPE + + ++D+Y+ + E LTG PY D + AH
Sbjct: 194 ----NTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAH--- 246
Query: 292 EMNYTEQQLTAAVVS-GGLRPILASLELGLPASILSLIQRCWDGNPHNR-PSFSDIALEL 349
+ A+ +RP G+P + ++I R NP +R + D++
Sbjct: 247 --------INQAIPRPSTVRP-------GIPVAFDAVIARGMAKNPEDRYVTCGDLSAAA 291
Query: 350 DLVL 353
L
Sbjct: 292 HAAL 295
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 2e-37
Identities = 75/299 (25%), Positives = 129/299 (43%), Gaps = 42/299 (14%)
Query: 68 YTLLSPIARGAESVVYEA--TLDGRKVAVK--KPILSTSEE-LDNFHKELQLLCKLDHPG 122
Y ++ + G S VY A T+ KVA+K EE L F +E+ +L H
Sbjct: 13 YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQN 72
Query: 123 LAK-FVAAHAKPPNY--MFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLH 179
+ Y M E+ E L+E + SVD + Q+ +++ H
Sbjct: 73 IVSMIDVDEEDDCYYLVM---EYIEGPTLSEYIE-SHGPLSVDTAINFTNQILDGIKHAH 128
Query: 180 NLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMV 239
++ IVHRD+KP N+L+D N + DFG+A K +S + + +++
Sbjct: 129 DMRIVHRDIKPQNILIDSNKTLKIFDFGIA------KALSETSLTQTN---------HVL 173
Query: 240 GTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQ 299
GT+ Y +PE K E E +D+YS GI + E+L G P+ A + A +
Sbjct: 174 GTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAI---------KH 224
Query: 300 LTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRP-SFSDIALELDLVLEHRK 357
+ +V + + +P S+ ++I R + + NR + ++ +L VL +
Sbjct: 225 IQDSVP-----NVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENR 278
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 4e-37
Identities = 75/317 (23%), Positives = 126/317 (39%), Gaps = 61/317 (19%)
Query: 63 LPPSSYTLLSPIARGAESVVYEATLDGR-----KVAVK--KPILSTSEELDNFHKELQLL 115
+ L + G VYE VAVK K T + + F E ++
Sbjct: 9 IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKD-CTLDNKEKFMSEAVIM 67
Query: 116 CKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKAL 175
LDHP + K + + P ++ E Y L L + S V +++ + Q+ KA+
Sbjct: 68 KNLDHPHIVKLIGIIEEEPTWIIM-ELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAM 126
Query: 176 QYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLA-------EYRENLKEISLKNWRSSGK 228
YL ++ VHRD+ N+L+ C L DFGL+ Y+ ++ + +K W
Sbjct: 127 AYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIK-W----- 180
Query: 229 PTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQA 287
M+PE + + SDV+ F + + E+L+ G P+ L
Sbjct: 181 ----------------MSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLE----N 220
Query: 288 HTVLEMNYTEQQLTAAVVSGGLRPILASLEL--GLPASILSLIQRCWDGNPHNRPSFSDI 345
V+ + + G R L P + +L+ RCWD +P +RP F+++
Sbjct: 221 KDVIGV-----------LEKGDR-----LPKPDLCPPVLYTLMTRCWDYDPSDRPRFTEL 264
Query: 346 ALELDLVLEHRKSLKEE 362
L V + K + E
Sbjct: 265 VCSLSDVYQMEKDIAME 281
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-36
Identities = 75/312 (24%), Positives = 128/312 (41%), Gaps = 46/312 (14%)
Query: 62 HLPPSSYTLLSPIARGAESVVYEATLDGR-----KVAVK--KPILSTSEELDNFHKELQL 114
+ S + I G V L VA+K K T + +F E +
Sbjct: 45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAG-YTERQRRDFLSEASI 103
Query: 115 LCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKA 174
+ + DHP + + + M E+ E+ +L L + ++ Q++ + +
Sbjct: 104 MGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAG 163
Query: 175 LQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK-PTGGF 233
++YL +LG VHRD+ NVL+D NL ++DFGL+ R + + GK P
Sbjct: 164 MRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLS--RVLEDDPDAAYTTTGGKIP---- 217
Query: 234 HKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLE 292
+ + APE + S SDV+SFG+ + E+L G PY ++
Sbjct: 218 --------IRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNM----------- 258
Query: 293 MNYTEQQLTAAVVSGGL--RPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350
T + + ++V G P+ P ++ L+ CW + RP FS I LD
Sbjct: 259 ---TNRDVISSVEEGYRLPAPMGC------PHALHQLMLDCWHKDRAQRPRFSQIVSVLD 309
Query: 351 LVLEHRKSLKEE 362
++ +SL+
Sbjct: 310 ALIRSPESLRAT 321
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-36
Identities = 71/304 (23%), Positives = 116/304 (38%), Gaps = 50/304 (16%)
Query: 63 LPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPG 122
L LL I +G V G KVAVK + F E ++ +L H
Sbjct: 18 LNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVK--CIKNDATAQAFLAEASVMTQLRHSN 75
Query: 123 LAKFVAAHAK-PPNYMFFFEFYESRNLAEKLHVEEWSP-SVDQVLMIAAQLAKALQYLHN 180
L + + + E+ +L + L S D +L + + +A++YL
Sbjct: 76 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 135
Query: 181 LGIVHRDVKPANVLLDRNLCPHLADFGLA--EYRENLKEISLKNWRSSGKPTGGFHKKNM 238
VHRD+ NVL+ + ++DFGL + +GK K
Sbjct: 136 NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----------QDTGK----LPVK-- 179
Query: 239 VGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTE 297
+ APE L+++ S KSDV+SFGI + E+ + G VPY +
Sbjct: 180 -----WTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI--------------PL 220
Query: 298 QQLTAAVVSGGL--RPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH 355
+ + V G P P ++ +++ CW + RPSF + +L+ + H
Sbjct: 221 KDVVPRVEKGYKMDAPDGC------PPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274
Query: 356 RKSL 359
L
Sbjct: 275 ELHL 278
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 3e-36
Identities = 78/334 (23%), Positives = 140/334 (41%), Gaps = 47/334 (14%)
Query: 40 GLKVL-EPNTCIRGCCSSQSIPLHLPPSSYTLLSPIARGAESVVYEATLDGR-----KVA 93
GL+ +P+T + L ++ ++ + G V L VA
Sbjct: 18 GLRTFVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVA 77
Query: 94 VK--KPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEK 151
+K K T ++ +F E ++ + DHP + + K M E+ E+ +L
Sbjct: 78 IKTLKVG-YTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSF 136
Query: 152 LHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEY 211
L + +V Q++ + +A ++YL ++G VHRD+ N+L++ NL ++DFGL
Sbjct: 137 LRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLG-- 194
Query: 212 RENLKEISLKNWRSSGK-PTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINE 270
R + GK P + + +PE + + SDV+S+GI + E
Sbjct: 195 RVLEDDPEAAYTTRGGKIP------------IRWTSPEAIAYRKFTSASDVWSYGIVLWE 242
Query: 271 LLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGL--RPILASLELGLPASILSL 327
+++ G PY ++ + Q + AV G P + PA++ L
Sbjct: 243 VMSYGERPYWEM--------------SNQDVIKAVDEGYRLPPP------MDCPAALYQL 282
Query: 328 IQRCWDGNPHNRPSFSDIALELDLVLEHRKSLKE 361
+ CW + +NRP F I LD ++ + SLK
Sbjct: 283 MLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKI 316
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 3e-36
Identities = 60/314 (19%), Positives = 121/314 (38%), Gaps = 63/314 (20%)
Query: 56 SQSIPLHLPPSSYTLLSPIARGAESVVYEATLDGR------KVAVK--KPILSTSEELDN 107
+Q++ L + + + + GA VY+ VA+K + ++ +
Sbjct: 5 NQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKE 63
Query: 108 FHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMI 167
E ++ +D+P + + + + + L + + + + +L
Sbjct: 64 ILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW 122
Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLA--------EYRENLKEIS 219
Q+AK + YL + +VHRD+ NVL+ + DFGLA EY ++
Sbjct: 123 CVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 182
Query: 220 LKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPY 278
+K W MA E + I++ +SDV+S+G+++ EL+T G PY
Sbjct: 183 IK-W---------------------MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 220
Query: 279 TDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLEL--GLPASILSLIQRCWDGNP 336
+ A + + + G R L + ++++CW +
Sbjct: 221 DGIP----ASEISSI-----------LEKGER-----LPQPPICTIDVYMIMRKCWMIDA 260
Query: 337 HNRPSFSDIALELD 350
+RP F ++ +E
Sbjct: 261 DSRPKFRELIIEFS 274
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 5e-36
Identities = 42/330 (12%), Positives = 84/330 (25%), Gaps = 74/330 (22%)
Query: 64 PPSSYTLLSPIARGAESVVYEAT--LDGRKVAVK---KPILSTSEELDNFHKELQLLCKL 118
L+ P+ G SVV+ A+K ++ EL+ H+ +L
Sbjct: 60 GERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARL 119
Query: 119 DHPGLAKFVAA--------------------------HAKPPNYMFFFEFYES-----RN 147
+ NY+ +
Sbjct: 120 LGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFS 179
Query: 148 LAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFG 207
+ ++V + + ++ AQL + L + G+VH P N+ + + L D
Sbjct: 180 TLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVS 239
Query: 208 LAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKE--IHSEKSDVYSFG 265
G + Y E L + + + G
Sbjct: 240 AL--------------WKVGTRG-----PASSVPVTYAPREFLNASTATFTHALNAWQLG 280
Query: 266 ISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASIL 325
+SI + +P+ + + G + LP +
Sbjct: 281 LSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVP----------GTDSLAFGSCTPLPDFVK 330
Query: 326 SLIQRCWDGNPHNRPSFSDIALELDLVLEH 355
+LI R + + R + +E
Sbjct: 331 TLIGRFLNFDRRRRLLPLEA-------MET 353
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 5e-36
Identities = 78/303 (25%), Positives = 131/303 (43%), Gaps = 38/303 (12%)
Query: 63 LPPSSYTLLSPIARGAESVVYEATLDGR-KVAVKKPILSTSEELDNFHKELQLLCKLDHP 121
+P S L + +G V+ T +G +VA+K + + + F +E Q++ KL H
Sbjct: 181 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKT-LKPGTMSPEAFLQEAQVMKKLRHE 239
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWS-PSVDQVLMIAAQLAKALQYLHN 180
L + A ++ P Y+ E+ +L + L E + Q++ +AAQ+A + Y+
Sbjct: 240 KLVQLYAVVSEEPIYIVT-EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 298
Query: 181 LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
+ VHRD++ AN+L+ NL +ADFGLA + I + + K +
Sbjct: 299 MNYVHRDLRAANILVGENLVCKVADFGLA------RLIEDNEYTARQ------GAKFPIK 346
Query: 241 TLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQ 299
+ APE + KSDV+SFGI + EL T G VPY + ++
Sbjct: 347 ---WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM--------------VNRE 389
Query: 300 LTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHRKSL 359
+ V G P P S+ L+ +CW P RP+F + L+ +
Sbjct: 390 VLDQVERGYRMPCPP----ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 445
Query: 360 KEE 362
+
Sbjct: 446 YQP 448
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 7e-36
Identities = 65/297 (21%), Positives = 124/297 (41%), Gaps = 50/297 (16%)
Query: 63 LPPSSYTLLSPIARGAESVVYEATLDGR-KVAVK--KPILSTSEELDNFHKELQLLCKLD 119
+ PS T + I G +V+ + KVA+K + + E+ F +E +++ KL
Sbjct: 5 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED---FIEEAEVMMKLS 61
Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLH 179
HP L + + EF E L++ L + + + +L + + + + YL
Sbjct: 62 HPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 121
Query: 180 NLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMV 239
++HRD+ N L+ N ++DFG+ + + + SS
Sbjct: 122 EACVIHRDLAARNCLVGENQVIKVSDFGMT------RFVLDDQYTSST------------ 163
Query: 240 GTLI---YMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNY 295
GT + +PE+ +S KSDV+SFG+ + E+ + G +PY +
Sbjct: 164 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR-------------- 209
Query: 296 TEQQLTAAVVSGGL--RPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350
+ ++ + +G +P LA + ++ CW P +RP+FS + +L
Sbjct: 210 SNSEVVEDISTGFRLYKPRLA------STHVYQIMNHCWRERPEDRPAFSRLLRQLA 260
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 7e-36
Identities = 71/301 (23%), Positives = 121/301 (40%), Gaps = 52/301 (17%)
Query: 69 TLLSPIARGAESVVYEATLDGR-----KVAVK--KPILSTSEELDNFHKELQLLCKLDHP 121
I RG VY TL AVK I + E+ F E ++ HP
Sbjct: 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHP 86
Query: 122 GLAKF--VAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLH 179
+ + ++ + + + +L + E +P+V ++ Q+AK ++YL
Sbjct: 87 NVLSLLGICLRSEGSPLVVL-PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA 145
Query: 180 NLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMV 239
+ VHRD+ N +LD +ADFGLA +++ K + S TG
Sbjct: 146 SKKFVHRDLAARNCMLDEKFTVKVADFGLA------RDMYDKEYYSVHNKTGA------- 192
Query: 240 GTLI---YMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNY 295
+ +MA E L+ + + KSDV+SFG+ + EL+T G PY D+
Sbjct: 193 --KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-------------- 236
Query: 296 TEQQLTAAVVSGGL--RPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL 353
+T ++ G +P P + ++ +CW RPSFS++ + +
Sbjct: 237 NTFDITVYLLQGRRLLQP------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 290
Query: 354 E 354
Sbjct: 291 S 291
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 8e-36
Identities = 71/324 (21%), Positives = 137/324 (42%), Gaps = 59/324 (18%)
Query: 63 LPPSSYTLLSPIARGAESVVYEATLDGR-----KVAVK--KPILSTSEELDNFHKELQLL 115
+P +TL + +G V EA L KVAVK K + S +++ F +E +
Sbjct: 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACM 79
Query: 116 CKLDHPGLAKFVAA------HAKPPNYMFFFEFYESRNL-----AEKLHVEEWSPSVDQV 164
+ DHP +AK V + P M F + +L A ++ ++ + +
Sbjct: 80 KEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTL 139
Query: 165 LMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWR 224
+ +A ++YL + +HRD+ N +L ++ +ADFGL+ +
Sbjct: 140 VRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYS---------- 189
Query: 225 SSGKPTGGFHKKNMVGTL-I-YMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDL 281
G ++++ L + ++A E L +++ SDV++FG+++ E++T G PY +
Sbjct: 190 ------GDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGI 243
Query: 282 RAEAQAHTVLEMNYTEQQLTAAVVSGGL--RPILASLELGLPASILSLIQRCWDGNPHNR 339
++ ++ G +P + L+ +CW +P R
Sbjct: 244 --------------ENAEIYNYLIGGNRLKQPP------ECMEEVYDLMYQCWSADPKQR 283
Query: 340 PSFSDIALELDLVLEHRKSLKEED 363
PSF+ + +EL+ +L H L
Sbjct: 284 PSFTCLRMELENILGHLSVLSTSQ 307
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 141 bits (356), Expect = 9e-36
Identities = 78/303 (25%), Positives = 131/303 (43%), Gaps = 38/303 (12%)
Query: 63 LPPSSYTLLSPIARGAESVVYEATLDG-RKVAVKKPILSTSEELDNFHKELQLLCKLDHP 121
+P S L + +G V+ T +G +VA+K + + + F +E Q++ KL H
Sbjct: 264 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKT-LKPGTMSPEAFLQEAQVMKKLRHE 322
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWS-PSVDQVLMIAAQLAKALQYLHN 180
L + A ++ P Y+ E+ +L + L E + Q++ +AAQ+A + Y+
Sbjct: 323 KLVQLYAVVSEEPIYIVT-EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 381
Query: 181 LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
+ VHRD++ AN+L+ NL +ADFGLA + I + + K +
Sbjct: 382 MNYVHRDLRAANILVGENLVCKVADFGLA------RLIEDNEYTARQ------GAKFPIK 429
Query: 241 TLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQ 299
+ APE + KSDV+SFGI + EL T G VPY + ++
Sbjct: 430 ---WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM--------------VNRE 472
Query: 300 LTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHRKSL 359
+ V G P P S+ L+ +CW P RP+F + L+ +
Sbjct: 473 VLDQVERGYRMPCPP----ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 528
Query: 360 KEE 362
+
Sbjct: 529 YQP 531
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 9e-36
Identities = 68/320 (21%), Positives = 124/320 (38%), Gaps = 70/320 (21%)
Query: 63 LPPSSYTLLSPIARGAESVVYEATLDGR-----KVAVK--KPILSTSEELDNFHKELQLL 115
+ + L + G V E L KVAVK K S+ E++ F E +
Sbjct: 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACM 90
Query: 116 CKLDHPGLAKFVAA-----HAKPPNYMFFFEFYESRNL-----AEKLHVEEWSPSVDQVL 165
HP + + + P M F + +L +L + +L
Sbjct: 91 KDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLL 150
Query: 166 MIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLA-------EYRENLK-E 217
+A ++YL N +HRD+ N +L ++ +ADFGL+ YR+ +
Sbjct: 151 KFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAK 210
Query: 218 ISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVV 276
+ +K W +A E L +++ KSDV++FG+++ E+ T G+
Sbjct: 211 MPVK-W---------------------IAIESLADRVYTSKSDVWAFGVTMWEIATRGMT 248
Query: 277 PYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGL--RPILASLELGLPASILSLIQRCWDG 334
PY + ++ ++ G +P + ++ CW
Sbjct: 249 PYPGV--------------QNHEMYDYLLHGHRLKQPE------DCLDELYEIMYSCWRT 288
Query: 335 NPHNRPSFSDIALELDLVLE 354
+P +RP+FS + L+L+ +LE
Sbjct: 289 DPLDRPTFSVLRLQLEKLLE 308
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 9e-36
Identities = 74/332 (22%), Positives = 129/332 (38%), Gaps = 54/332 (16%)
Query: 55 SSQSIPLHLPPSSYTLLSPIARGAESVVYEATLDGR-----KVAVK--KPILSTSEELDN 107
+ Q + + I RG VY TL AVK I E
Sbjct: 78 AVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ- 136
Query: 108 FHKELQLLCKLDHPGLAKF--VAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVL 165
F E ++ HP + + ++ + + + +L + E +P+V ++
Sbjct: 137 FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL-PYMKHGDLRNFIRNETHNPTVKDLI 195
Query: 166 MIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRS 225
Q+AK +++L + VHRD+ N +LD +ADFGLA +++ K + S
Sbjct: 196 GFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLA------RDMYDKEFDS 249
Query: 226 SGKPTGGFHKKNMVGTLI---YMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDL 281
TG + +MA E L+ + + KSDV+SFG+ + EL+T G PY D+
Sbjct: 250 VHNKTGA---------KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 300
Query: 282 RAEAQAHTVLEMNYTEQQLTAAVVSGGL--RPILASLELGLPASILSLIQRCWDGNPHNR 339
+T ++ G +P P + ++ +CW R
Sbjct: 301 --------------NTFDITVYLLQGRRLLQP------EYCPDPLYEVMLKCWHPKAEMR 340
Query: 340 PSFSDIALELDLVLEHRKSLKEEDLCAGKSYV 371
PSFS++ + + + E + +YV
Sbjct: 341 PSFSELVSRISAIF--STFIGEHYVHVNATYV 370
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-35
Identities = 80/312 (25%), Positives = 133/312 (42%), Gaps = 47/312 (15%)
Query: 62 HLPPSSYTLLSPIARGAESVVYEATLDGR------KVAVK--KPILSTSEELDNFHKELQ 113
+ PS T I G VY+ L VA+K K T ++ +F E
Sbjct: 40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG-YTEKQRVDFLGEAG 98
Query: 114 LLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAK 173
++ + H + + +K M E+ E+ L + L ++ SV Q++ + +A
Sbjct: 99 IMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAA 158
Query: 174 ALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK-PTGG 232
++YL N+ VHRD+ N+L++ NL ++DFGL+ R + S GK P
Sbjct: 159 GMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLS--RVLEDDPEATYTTSGGKIP--- 213
Query: 233 FHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVL 291
+ + APE + + SDV+SFGI + E++T G PY +L
Sbjct: 214 ---------IRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL---------- 254
Query: 292 EMNYTEQQLTAAVVSGGL--RPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALEL 349
+ ++ A+ G P + P++I L+ +CW RP F+DI L
Sbjct: 255 ----SNHEVMKAINDGFRLPTP------MDCPSAIYQLMMQCWQQERARRPKFADIVSIL 304
Query: 350 DLVLEHRKSLKE 361
D ++ SLK
Sbjct: 305 DKLIRAPDSLKT 316
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-35
Identities = 71/313 (22%), Positives = 126/313 (40%), Gaps = 34/313 (10%)
Query: 63 LPPSSYTLLSPIARGAESVVYEATLDGR------KVAVKKPILSTSEELDNFHKELQLLC 116
+S + +G V D VAVK+ S ++ +F +E+Q+L
Sbjct: 20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILK 79
Query: 117 KLDHPGLAKF---VAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAK 173
L + K+ + + E+ S L + L ++L+ ++Q+ K
Sbjct: 80 ALHSDFIVKYRGVSYGPGRQSLRLVM-EYLPSGCLRDFLQRHRARLDASRLLLYSSQICK 138
Query: 174 ALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK-PTGG 232
++YL + VHRD+ N+L++ +ADFGLA+ K+ + R G+ P
Sbjct: 139 GMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVV--REPGQSP--- 193
Query: 233 FHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVL 291
+ + APE L I S +SDV+SFG+ + EL T + +
Sbjct: 194 ---------IFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCE 244
Query: 292 EMNYTEQQLTAAVVSGGL--RPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALEL 349
+L + G P PA + L++ CW +P +RPSFS + +L
Sbjct: 245 RDVPALSRLLELLEEGQRLPAP------PACPAEVHELMKLCWAPSPQDRPSFSALGPQL 298
Query: 350 DLVLEHRKSLKEE 362
D++ + +
Sbjct: 299 DMLWSGSRGCETH 311
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-35
Identities = 70/305 (22%), Positives = 121/305 (39%), Gaps = 61/305 (20%)
Query: 63 LPPSSYTLLSPIARGAESVVYEATLDGR-----KVAVK--KPILSTSEELDNFHKELQLL 115
+ L I G V++ VA+K K ++ + F +E +
Sbjct: 12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKN-CTSDSVREKFLQEALTM 70
Query: 116 CKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKAL 175
+ DHP + K + + P ++ E L L V ++S + +++ A QL+ AL
Sbjct: 71 RQFDHPHIVKLIGVITENPVWIIM-ELCTLGELRSFLQVRKYSLDLASLILYAYQLSTAL 129
Query: 176 QYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLA-------EYRENLKEISLKNWRSSGK 228
YL + VHRD+ NVL+ N C L DFGL+ Y+ + ++ +K W
Sbjct: 130 AYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK-W----- 183
Query: 229 PTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQA 287
MAPE + + SDV+ FG+ + E+L GV P+ +
Sbjct: 184 ----------------MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV------ 221
Query: 288 HTVLEMNYTEQQLTAAVVSGGL--RPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
+ + +G P P ++ SL+ +CW +P RP F+++
Sbjct: 222 --------KNNDVIGRIENGERLPMPP------NCPPTLYSLMTKCWAYDPSRRPRFTEL 267
Query: 346 ALELD 350
+L
Sbjct: 268 KAQLS 272
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-35
Identities = 68/310 (21%), Positives = 127/310 (40%), Gaps = 50/310 (16%)
Query: 69 TLLSPIARGAESVVYEATLDGR-----KVAVK--KPILSTSEELDNFHKELQLLCKLDHP 121
I +G VVY + + A+K I + ++++ F +E L+ L+HP
Sbjct: 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI-TEMQQVEAFLREGLLMRGLNHP 82
Query: 122 GLAKF--VAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLH 179
+ + + ++ + +L + + + +P+V ++ Q+A+ ++YL
Sbjct: 83 NVLALIGIMLPPEGLPHVLL-PYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLA 141
Query: 180 NLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK-PTGGFHKKNM 238
VHRD+ N +LD + +ADFGLA + +E + P
Sbjct: 142 EQKFVHRDLAARNCMLDESFTVKVADFGLARDILD-REYYSVQQHRHARLP--------- 191
Query: 239 VGTLI-YMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYT 296
+ + A E L+ + KSDV+SFG+ + ELLT G PY +
Sbjct: 192 ----VKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHI--------------D 233
Query: 297 EQQLTAAVVSGGL--RPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE 354
LT + G +P P S+ ++Q+CW+ +P RP+F + E++ ++
Sbjct: 234 PFDLTHFLAQGRRLPQP------EYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVS 287
Query: 355 HRKSLKEEDL 364
L
Sbjct: 288 ALLGDHYVQL 297
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 3e-35
Identities = 74/305 (24%), Positives = 119/305 (39%), Gaps = 52/305 (17%)
Query: 63 LPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPG 122
L LL I +G V G KVAVK + F E ++ +L H
Sbjct: 190 LNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVK--CIKNDATAQAFLAEASVMTQLRHSN 247
Query: 123 LAKF--VAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSP-SVDQVLMIAAQLAKALQYLH 179
L + V K Y+ E+ +L + L S D +L + + +A++YL
Sbjct: 248 LVQLLGVIVEEKGGLYIVT-EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 306
Query: 180 NLGIVHRDVKPANVLLDRNLCPHLADFGLA--EYRENLKEISLKNWRSSGKPTGGFHKKN 237
VHRD+ NVL+ + ++DFGL + +GK K
Sbjct: 307 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----------QDTGK----LPVK- 351
Query: 238 MVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYT 296
+ APE L+++ S KSDV+SFGI + E+ + G VPY +
Sbjct: 352 ------WTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI--------------P 391
Query: 297 EQQLTAAVVSGGL--RPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE 354
+ + V G P G P ++ +++ CW + RP+F + +L+ +
Sbjct: 392 LKDVVPRVEKGYKMDAP------DGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT 445
Query: 355 HRKSL 359
H L
Sbjct: 446 HELHL 450
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 4e-35
Identities = 64/301 (21%), Positives = 113/301 (37%), Gaps = 50/301 (16%)
Query: 63 LPPSSYTLLSPIARGAESVVYEATLDG-RKVAVK--KPILSTSEELDNFHKELQLLCKLD 119
+ P T L + G VV G VA+K K S D F +E +++ L
Sbjct: 21 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKE---GSMSEDEFIEEAKVMMNLS 77
Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLH 179
H L + K E+ + L L Q+L + + +A++YL
Sbjct: 78 HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE 137
Query: 180 NLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMV 239
+ +HRD+ N L++ ++DFGL+ + + + SS
Sbjct: 138 SKQFLHRDLAARNCLVNDQGVVKVSDFGLS------RYVLDDEYTSSV------------ 179
Query: 240 GTLI---YMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNY 295
G+ + PE+L S KSD+++FG+ + E+ + G +PY
Sbjct: 180 GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF-------------- 225
Query: 296 TEQQLTAAVVSGGL--RPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL 353
T + + G RP LA + +++ CW RP+F + + V+
Sbjct: 226 TNSETAEHIAQGLRLYRPHLA------SEKVYTIMYSCWHEKADERPTFKILLSNILDVM 279
Query: 354 E 354
+
Sbjct: 280 D 280
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 6e-35
Identities = 69/294 (23%), Positives = 113/294 (38%), Gaps = 54/294 (18%)
Query: 74 IARGAESVVYEA--TLDGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKF--- 126
I RG+ VY+ T +VA + T E F +E ++L L HP + +F
Sbjct: 34 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 93
Query: 127 -VAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLH--NLGI 183
+ + E S L L + + Q+ K LQ+LH I
Sbjct: 94 WESTVKGKKCIVLVTELMTSGTLKTYLK-RFKVMKIKVLRSWCRQILKGLQFLHTRTPPI 152
Query: 184 VHRDVKPANVLLDRNL-CPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTL 242
+HRD+K N+ + + D GLA K ++GT
Sbjct: 153 IHRDLKCDNIFITGPTGSVKIGDLGLA------------------TLKRASFAKAVIGTP 194
Query: 243 IYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTA 302
+MAPE+ +++ + E DVY+FG+ + E+ T PY++ + AQ +
Sbjct: 195 EFMAPEMYEEK-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYR------------- 240
Query: 303 AVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHR 356
V+ G++P AS + + +I+ C N R S +L L H
Sbjct: 241 -RVTSGVKP--ASFDKVAIPEVKEIIEGCIRQNKDERYS----IKDL---LNHA 284
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 7e-35
Identities = 76/297 (25%), Positives = 120/297 (40%), Gaps = 50/297 (16%)
Query: 63 LPPSSYTLLSPIARGAESVVYEATLDGR-KVAVK--KPILSTSEELDNFHKELQLLCKLD 119
L TLL + G VV G+ VAVK K + +E F +E Q + KL
Sbjct: 5 LKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDE---FFQEAQTMMKLS 61
Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLH 179
HP L KF +K E+ + L L Q+L + + + + +L
Sbjct: 62 HPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE 121
Query: 180 NLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMV 239
+ +HRD+ N L+DR+LC ++DFG+ + + + SS
Sbjct: 122 SHQFIHRDLAARNCLVDRDLCVKVSDFGMT------RYVLDDQYVSSV------------ 163
Query: 240 GTLI---YMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNY 295
GT + APE+ +S KSDV++FGI + E+ + G +PY
Sbjct: 164 GTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLY-------------- 209
Query: 296 TEQQLTAAVVSGGL--RPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350
T ++ V G RP LA +I ++ CW P RP+F + ++
Sbjct: 210 TNSEVVLKVSQGHRLYRPHLA------SDTIYQIMYSCWHELPEKRPTFQQLLSSIE 260
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 8e-35
Identities = 75/364 (20%), Positives = 139/364 (38%), Gaps = 61/364 (16%)
Query: 4 YGLKPNEQRSFRFVRKTQVLLSSKYGLQFFTLNSKMGLKVLEPNTCIRGCCSSQSIPLHL 63
+ ++P ++ ++ + K G++ T++ E + +
Sbjct: 328 FIIRPQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTYTMPSTRDYEI 387
Query: 64 PPSSYTLLSPIARGAESVVYEATLDGR-----KVAVK--KPILSTSEELDNFHKELQLLC 116
L I G V++ VA+K K ++ + F +E +
Sbjct: 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKN-CTSDSVREKFLQEALTMR 446
Query: 117 KLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQ 176
+ DHP + K + + P ++ E L L V ++S + +++ A QL+ AL
Sbjct: 447 QFDHPHIVKLIGVITENPVWIIM-ELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALA 505
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLA-------EYRENLKEISLKNWRSSGKP 229
YL + VHRD+ NVL+ N C L DFGL+ Y+ + ++ +K W
Sbjct: 506 YLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK-W------ 558
Query: 230 TGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAH 288
MAPE + + SDV+ FG+ + E+L GV P+ +
Sbjct: 559 ---------------MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV------- 596
Query: 289 TVLEMNYTEQQLTAAVVSGGL--RPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIA 346
+ + +G P P ++ SL+ +CW +P RP F+++
Sbjct: 597 -------KNNDVIGRIENGERLPMP------PNCPPTLYSLMTKCWAYDPSRRPRFTELK 643
Query: 347 LELD 350
+L
Sbjct: 644 AQLS 647
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-34
Identities = 64/296 (21%), Positives = 98/296 (33%), Gaps = 45/296 (15%)
Query: 64 PPSSYTLLSPIARGAESVVYEA--TLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP 121
T + RG+ V+ G + AVKK L +EL L P
Sbjct: 56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRV-----EELVACAGLSSP 110
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSP-SVDQVLMIAAQLAKALQYLHN 180
+ A + P F E E +L + + ++ D+ L Q + L+YLH
Sbjct: 111 RIVPLYGAVREGPWVNIFMELLEGGSLGQLI--KQMGCLPEDRALYYLGQALEGLEYLHT 168
Query: 181 LGIVHRDVKPANVLLDRNLCP-HLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMV 239
I+H DVK NVLL + L DFG A + G +
Sbjct: 169 RRILHGDVKADNVLLSSDGSRAALCDFGHA-----------LCLQPDGLGKSLLTGDYIP 217
Query: 240 GTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQ 299
GT +MAPE++ + K D++S + +L G P+T +
Sbjct: 218 GTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQY----------------FR 261
Query: 300 LTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH 355
+ P + + IQ P +R S A+EL
Sbjct: 262 GPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRAS----AMEL---RRK 310
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 2e-34
Identities = 75/309 (24%), Positives = 117/309 (37%), Gaps = 64/309 (20%)
Query: 63 LPPSSYTLLSPIARGAESVVYEATLDGR-----KVAVK--KP-ILSTSEELDNFHKELQL 114
+ LL + G+ VV D VAVK KP +LS E +D+F +E+
Sbjct: 15 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 74
Query: 115 LCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKA 174
+ LDH L + PP M E +L ++L + + + A Q+A+
Sbjct: 75 MHSLDHRNLIRLYGVVLTPPMKMVT-ELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 133
Query: 175 LQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLA--------EY--RENLKEISLKNWR 224
+ YL + +HRD+ N+LL + DFGL Y +E+ K + W
Sbjct: 134 MGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK-VPFA-W- 190
Query: 225 SSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRA 283
APE LK S SD + FG+++ E+ T G P+ L
Sbjct: 191 --------------------CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN- 229
Query: 284 EAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLEL--GLPASILSLIQRCWDGNPHNRPS 341
+L + G R L P I +++ +CW P +RP+
Sbjct: 230 ---GSQILHK----------IDKEGER-----LPRPEDCPQDIYNVMVQCWAHKPEDRPT 271
Query: 342 FSDIALELD 350
F + L
Sbjct: 272 FVALRDFLL 280
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 2e-34
Identities = 78/314 (24%), Positives = 127/314 (40%), Gaps = 45/314 (14%)
Query: 60 PLHLPPSSYTLLSPIARGAESVVYEATLDGR------KVAVK--KPILSTSEELDNFHKE 111
P H + + G V D +VAVK KP S + + KE
Sbjct: 15 PTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE-SGGNHIADLKKE 73
Query: 112 LQLLCKLDHPGLAKFVAA--HAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAA 169
+++L L H + K+ EF S +L E L + ++ Q L A
Sbjct: 74 IEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAV 133
Query: 170 QLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK- 228
Q+ K + YL + VHRD+ NVL++ + DFGL + E KE +
Sbjct: 134 QICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTV--KDDRDS 191
Query: 229 PTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAH 288
P + + APE L + SDV+SFG++++ELLT Y D + A
Sbjct: 192 P------------VFWYAPECLMQSKFYIASDVWSFGVTLHELLT----YCDSDSSPMAL 235
Query: 289 TVLEMNYTEQQLTAAVVSGGLRPILASLELGL--------PASILSLIQRCWDGNPHNRP 340
+ + T Q+T + + +L+ G P + L+++CW+ P NR
Sbjct: 236 FLKMIGPTHGQMTVTRL-------VNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRT 288
Query: 341 SFSDIALELDLVLE 354
SF ++ + +L+
Sbjct: 289 SFQNLIEGFEALLK 302
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 3e-34
Identities = 73/315 (23%), Positives = 123/315 (39%), Gaps = 46/315 (14%)
Query: 63 LPPSSYTLLSPIARGAESVVYEATLDGR--KVAVKKPILSTSEELDNFHKELQLLCKLDH 120
+ + T+ + G VYE VAVK + + E++ F KE ++ ++ H
Sbjct: 217 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKT-LKEDTMEVEEFLKEAAVMKEIKH 275
Query: 121 PGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSP-SVDQVLMIAAQLAKALQYLH 179
P L + + + P + EF NL + L S +L +A Q++ A++YL
Sbjct: 276 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 335
Query: 180 NLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMV 239
+HR++ N L+ N +ADFGL+ G + +
Sbjct: 336 KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMT-----------------GDTYTAHAG 378
Query: 240 GTLIY--MAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYT 296
APE L S KSDV++FG+ + E+ T G+ PY +
Sbjct: 379 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI--------------D 424
Query: 297 EQQLTAAVVSGGL--RPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE 354
Q+ + RP P + L++ CW NP +RPSF++I + + +
Sbjct: 425 LSQVYELLEKDYRMERPEGC------PEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478
Query: 355 HRKSLKEEDLCAGKS 369
E + GK
Sbjct: 479 ESSISDEVEKELGKR 493
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 5e-34
Identities = 60/325 (18%), Positives = 122/325 (37%), Gaps = 63/325 (19%)
Query: 56 SQSIPLHLPPSSYTLLSPIARGAESVVYEATLDGR------KVAVK--KPILSTSEELDN 107
+Q++ L + + + + GA VY+ VA+K + ++ +
Sbjct: 5 NQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKE 63
Query: 108 FHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMI 167
E ++ +D+P + + + + + L + + + + +L
Sbjct: 64 ILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW 122
Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLA--------EYRENLKEIS 219
Q+AK + YL + +VHRD+ NVL+ + DFGLA EY ++
Sbjct: 123 CVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 182
Query: 220 LKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPY 278
+K W MA E + I++ +SDV+S+G+++ EL+T G PY
Sbjct: 183 IK-W---------------------MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 220
Query: 279 TDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLEL--GLPASILSLIQRCWDGNP 336
+ A + + + G R L + ++ +CW +
Sbjct: 221 DGIP----ASEISSI-----------LEKGER-----LPQPPICTIDVYMIMVKCWMIDA 260
Query: 337 HNRPSFSDIALELDLVLEHRKSLKE 361
+RP F ++ +E + +
Sbjct: 261 DSRPKFRELIIEFSKMARDPQRYLV 285
|
| >2pnq_A [pyruvate dehydrogenase [lipoamide]]-phosphatase 1; pyruvate dehydrogenase phosphatase 1, catalytic subunit, PDP1C, hydrolase; 1.81A {Rattus norvegicus} PDB: 3n3c_A 3mq3_A Length = 467 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 6e-34
Identities = 57/278 (20%), Positives = 91/278 (32%), Gaps = 51/278 (18%)
Query: 437 CGRRETMEDTHFLMPHMYNQKEIHMFGIFDGHRGSAAAEFSARALPGFLQNLGSTTRPT- 495
+E + + + + + A++ L + Q L
Sbjct: 97 LPHETLLEIENAVESGRALLPILQWHKHPNDYFSKEASKLYFNGLRTYWQELIDLNTGES 156
Query: 496 ------DALLEAFIRTDVAFRNELDSLRKSKRVVQKDWHP---GCTAIAALIVRNRLFVA 546
+AL+ AF R D E + + G TA A + L VA
Sbjct: 157 ADIDVKEALINAFKRLDNDISLEAQVGDPNSFLNYLVLRVAFSGATACVAHVDGVDLHVA 216
Query: 547 NAGDCRAILCRGGH-----PFALSRDHVASCLEERERVVSAGGNVNWQ--VDTWRVGPPA 599
N GD RA+L LS DH A E +R+ + V R+
Sbjct: 217 NTGDSRAMLGVQEEDGSWSAVTLSNDHNAQNERELQRLKLEHPKNEAKSVVKQDRL-LGL 275
Query: 600 LQVTRSIGDDDLK---------------------------------PAVTAEPEITETIM 626
L R+ GD K P +TAEPE+T +
Sbjct: 276 LMPFRAFGDVKFKWSIDLQKRVIESGPDQLNDNEYTKFIPPNYHTPPYLTAEPEVTYHRL 335
Query: 627 TPEDEYLVMASDGLWDVVSHVEAVGIIKDTVKEPGMCS 664
P+D++LV+A+DGLW+ + + V I+ + +
Sbjct: 336 RPQDKFLVLATDGLWETMHRQDVVRIVGEYLTGMHHQQ 373
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 7e-34
Identities = 81/308 (26%), Positives = 133/308 (43%), Gaps = 48/308 (15%)
Query: 63 LPPSSYTLLSPIARGAESVVYEATLDGR-KVAVKKPILSTSEELDNFHKELQLLCKLDHP 121
+P S L + G V+ AT + KVAVK + S ++ F E ++ L H
Sbjct: 185 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKT-MKPGSMSVEAFLAEANVMKTLQHD 243
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSP-SVDQVLMIAAQLAKALQYLHN 180
L K A K P Y+ EF +L + L +E S + +++ +AQ+A+ + ++
Sbjct: 244 KLVKLHAVVTKEPIYIIT-EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ 302
Query: 181 LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
+HRD++ AN+L+ +L +ADFGLA E+ + + G
Sbjct: 303 RNYIHRDLRAANILVSASLVCKIADFGLARVIED------NEYTARE------------G 344
Query: 241 TLI---YMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYT 296
+ APE + + KSDV+SFGI + E++T G +PY + +
Sbjct: 345 AKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM--------------S 390
Query: 297 EQQLTAAVVSGG--LRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE 354
++ A+ G RP P + +++ RCW P RP+F I LD
Sbjct: 391 NPEVIRALERGYRMPRPENC------PEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444
Query: 355 HRKSLKEE 362
+S EE
Sbjct: 445 ATESQYEE 452
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 7e-34
Identities = 67/291 (23%), Positives = 122/291 (41%), Gaps = 48/291 (16%)
Query: 74 IARGAESVVYEA--TLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHA 131
+ +G +VY + ++A+K+ S H+E+ L L H + +++ + +
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 132 KPPNYMFFFEFYESRNLAEKLHVEEWSPSVD---QVLMIAAQLAKALQYLHNLGIVHRDV 188
+ F E +L+ L +W P D + Q+ + L+YLH+ IVHRD+
Sbjct: 90 ENGFIKIFMEQVPGGSLSALLR-SKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDI 148
Query: 189 KPANVLLD-RNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAP 247
K NVL++ + ++DFG + K ++ + GTL YMAP
Sbjct: 149 KGDNVLINTYSGVLKISDFGTS------KRLA----------GINPCTETFTGTLQYMAP 192
Query: 248 EILKKEI--HSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVV 305
EI+ K + + +D++S G +I E+ TG P+ +L A M + V
Sbjct: 193 EIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAA-----M-F-------KVG 239
Query: 306 SGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHR 356
+ P + + A + I +C++ +P R A +L L
Sbjct: 240 MFKVHP---EIPESMSAEAKAFILKCFEPDPDKRAC----ANDL---LVDE 280
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 8e-34
Identities = 68/312 (21%), Positives = 111/312 (35%), Gaps = 42/312 (13%)
Query: 68 YTLLSPIARGAESVVYEAT--LDGRKVAVKKPILSTSEELDNFHKELQLLCKL-DHPGLA 124
+ +A G + VYEA GR+ A+K+ + + E+ +E+ + KL HP +
Sbjct: 30 LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIV 89
Query: 125 KFVAAHAKPPNYM-------FFFEFYESRNLAEKLHVEEWSP--SVDQVLMIAAQLAKAL 175
+F +A + L E L E S D VL I Q +A+
Sbjct: 90 QFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAV 149
Query: 176 QYLHNLG--IVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGF 233
Q++H I+HRD+K N+LL L DFG A S+ +
Sbjct: 150 QHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSA----TTISHYPDYSWSAQRRALVE 205
Query: 234 HKKNMVGTLIYMAPEIL---KKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTV 290
+ T +Y PEI+ EK D+++ G + L P+
Sbjct: 206 EEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF------------ 253
Query: 291 LEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350
E +V+G + SLI+ NP R S +++ +L
Sbjct: 254 ------EDGAKLRIVNGKYSIPPHDTQ---YTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304
Query: 351 LVLEHRKSLKEE 362
+ R +
Sbjct: 305 EIAAARNVNPKS 316
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 9e-34
Identities = 58/302 (19%), Positives = 108/302 (35%), Gaps = 60/302 (19%)
Query: 68 YTLLSPIARGAESVVYEAT---LDGRKVAVKKPILSTSEE-LDNFHKELQLLCKLDHPGL 123
Y + IA G +Y A ++GR V +K + S E E Q L ++ HP +
Sbjct: 82 YEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSI 141
Query: 124 AK---FVAAHAKPPNYMFFF--EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYL 178
+ FV + + + + E+ ++L + V + + ++ AL YL
Sbjct: 142 VQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK---LPVAEAIAYLLEILPALSYL 198
Query: 179 HNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNM 238
H++G+V+ D+KP N++L L D G G +
Sbjct: 199 HSIGLVYNDLKPENIMLTEEQ-LKLIDLGAV--------------SRINS-FG-----YL 237
Query: 239 VGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQ 298
GT + APEI++ + +D+Y+ G ++ L + +
Sbjct: 238 YGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRN---GRYVDGLPED------ 287
Query: 299 QLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRP-SFSDIALELDLVLEHRK 357
L S L++R D +P R + +++ +L VL
Sbjct: 288 ----------------DPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLREVV 331
Query: 358 SL 359
+
Sbjct: 332 AQ 333
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-33
Identities = 60/311 (19%), Positives = 114/311 (36%), Gaps = 49/311 (15%)
Query: 63 LPPSSYTLLSPIARGAESVVYEATLDGR------KVAVK--KPILSTSEELDNFHKELQL 114
+ L + G V++ V +K + S + +
Sbjct: 10 FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDK-SGRQSFQAVTDHMLA 68
Query: 115 LCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKA 174
+ LDH + + + + ++ +L + + + +L Q+AK
Sbjct: 69 IGSLDHAHIVRLLGLCPGSSLQLVT-QYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKG 127
Query: 175 LQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK-PTGGF 233
+ YL G+VHR++ NVLL +ADFG+A+ L + S K P
Sbjct: 128 MYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADL---LPPDDKQLLYSEAKTP---- 180
Query: 234 HKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLE 292
+ +MA E + ++ +SDV+S+G+++ EL+T G PY LR V +
Sbjct: 181 --------IKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLR----LAEVPD 228
Query: 293 MNYTEQQLTAAVVSGGLRPILASLEL--GLPASILSLIQRCWDGNPHNRPSFSDIALELD 350
+ + G R L + ++ +CW + + RP+F ++A E
Sbjct: 229 L-----------LEKGER-----LAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFT 272
Query: 351 LVLEHRKSLKE 361
+
Sbjct: 273 RMARDPPRYLV 283
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-33
Identities = 75/318 (23%), Positives = 124/318 (38%), Gaps = 52/318 (16%)
Query: 63 LPPSSYTLLSPIARGAESVVYEATLDGR--KVAVK--KPILSTSEELDNFHKELQLLCKL 118
+ + T+ + G VYE VAVK K + E++ F KE ++ ++
Sbjct: 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEI 66
Query: 119 DHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEE-WSPSVDQVLMIAAQLAKALQY 177
HP L + + + P + EF NL + L S +L +A Q++ A++Y
Sbjct: 67 KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEY 126
Query: 178 LHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKN 237
L +HRD+ N L+ N +ADFGL+ + +
Sbjct: 127 LEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG------DTYTAHA---------- 170
Query: 238 MVGTLI---YMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEM 293
G + APE L S KSDV++FG+ + E+ T G+ PY +
Sbjct: 171 --GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI------------ 216
Query: 294 NYTEQQLTAAVVSGGL--RPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL 351
Q+ + RP P + L++ CW NP +RPSF++I +
Sbjct: 217 --DLSQVYELLEKDYRMERPEGC------PEKVYELMRACWQWNPSDRPSFAEIHQAFET 268
Query: 352 VLEHRKSLKEEDLCAGKS 369
+ + E + GK
Sbjct: 269 MFQESSISDEVEKELGKR 286
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 75/313 (23%), Positives = 126/313 (40%), Gaps = 43/313 (13%)
Query: 60 PLHLPPSSYTLLSPIARGAESVVYEATLDGRK------VAVKKPILSTSEELDNFHKELQ 113
P L + +G V D + VAVKK ST E L +F +E++
Sbjct: 35 PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIE 94
Query: 114 LLCKLDHPGLAKFVA---AHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQ 170
+L L H + K+ + + + E+ +L + L + ++L +Q
Sbjct: 95 ILKSLQHDNIVKYKGVCYSAGRRNLKLIM-EYLPYGSLRDYLQKHKERIDHIKLLQYTSQ 153
Query: 171 LAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK-P 229
+ K ++YL +HRD+ N+L++ + DFGL + KE + G+ P
Sbjct: 154 ICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKV--KEPGESP 211
Query: 230 TGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHT 289
+ + APE L + S SDV+SFG+ + EL T Y + A
Sbjct: 212 ------------IFWYAPESLTESKFSVASDVWSFGVVLYELFT----YIEKSKSPPAEF 255
Query: 290 VLEM------NYTEQQLTAAVVSGGL--RPILASLELGLPASILSLIQRCWDGNPHNRPS 341
+ + L + + G RP G P I ++ CW+ N + RPS
Sbjct: 256 MRMIGNDKQGQMIVFHLIELLKNNGRLPRP------DGCPDEIYMIMTECWNNNVNQRPS 309
Query: 342 FSDIALELDLVLE 354
F D+AL +D + +
Sbjct: 310 FRDLALRVDQIRD 322
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 4e-33
Identities = 75/313 (23%), Positives = 126/313 (40%), Gaps = 43/313 (13%)
Query: 60 PLHLPPSSYTLLSPIARGAESVVYEATLDGRK------VAVKKPILSTSEELDNFHKELQ 113
P L + +G V D + VAVKK ST E L +F +E++
Sbjct: 4 PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIE 63
Query: 114 LLCKLDHPGLAKFVA---AHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQ 170
+L L H + K+ + + + E+ +L + L + ++L +Q
Sbjct: 64 ILKSLQHDNIVKYKGVCYSAGRRNLKLIM-EYLPYGSLRDYLQKHKERIDHIKLLQYTSQ 122
Query: 171 LAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK-P 229
+ K ++YL +HRD+ N+L++ + DFGL + KE + G+ P
Sbjct: 123 ICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKV--KEPGESP 180
Query: 230 TGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHT 289
+ + APE L + S SDV+SFG+ + EL T Y + A
Sbjct: 181 ------------IFWYAPESLTESKFSVASDVWSFGVVLYELFT----YIEKSKSPPAEF 224
Query: 290 VLEM------NYTEQQLTAAVVSGGL--RPILASLELGLPASILSLIQRCWDGNPHNRPS 341
+ + L + + G RP G P I ++ CW+ N + RPS
Sbjct: 225 MRMIGNDKQGQMIVFHLIELLKNNGRLPRP------DGCPDEIYMIMTECWNNNVNQRPS 278
Query: 342 FSDIALELDLVLE 354
F D+AL +D + +
Sbjct: 279 FRDLALRVDQIRD 291
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 4e-33
Identities = 73/311 (23%), Positives = 119/311 (38%), Gaps = 39/311 (12%)
Query: 63 LPPSSYTLLSPIARGAESVVYEATLDGRK------VAVK--KPILSTSEELDNFHKELQL 114
+ + G V D VAVK K + + + +E+ +
Sbjct: 28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD-AGPQHRSGWKQEIDI 86
Query: 115 LCKLDHPGLAKFVAA---HAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQL 171
L L H + K+ + E+ +L + L S + Q+L+ A Q+
Sbjct: 87 LRTLYHEHIIKYKGCCEDAGAASLQLVM-EYVPLGSLRDYLPRH--SIGLAQLLLFAQQI 143
Query: 172 AKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK-PT 230
+ + YLH +HRD+ NVLLD + + DFGLA+ E R G P
Sbjct: 144 CEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRV--REDGDSP- 200
Query: 231 GGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHT 289
+ + APE LK+ SDV+SFG+++ ELLT + +
Sbjct: 201 -----------VFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIG 249
Query: 290 VLEMNYTEQQLTAAVVSGGL--RPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIAL 347
+ + T +LT + G RP PA + L++ CW+ RP+F ++
Sbjct: 250 IAQGQMTVLRLTELLERGERLPRP------DKCPAEVYHLMKNCWETEASFRPTFENLIP 303
Query: 348 ELDLVLEHRKS 358
L V E +
Sbjct: 304 ILKTVHEKYQG 314
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 4e-33
Identities = 77/293 (26%), Positives = 133/293 (45%), Gaps = 42/293 (14%)
Query: 63 LPPSSYTLLSPIARGAESVVYEATLDGR-KVAVKKPILSTSEELDNFHKELQLLCKLDHP 121
+P + L+ + G V+ +G KVAVK + S D F E L+ +L H
Sbjct: 10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKS-LKQGSMSPDAFLAEANLMKQLQHQ 68
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEE-WSPSVDQVLMIAAQLAKALQYLHN 180
L + A + P Y+ E+ E+ +L + L +++++L +AAQ+A+ + ++
Sbjct: 69 RLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127
Query: 181 LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
+HRD++ AN+L+ L +ADFGLA E+ + + R K F K
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA----REGAK----FPIK---- 175
Query: 241 TLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQ 299
+ APE + + KSDV+SFGI + E++T G +PY + T +
Sbjct: 176 ---WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM--------------TNPE 218
Query: 300 LTAAVVSGG--LRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350
+ + G +RP P + L++ CW P +RP+F + L+
Sbjct: 219 VIQNLERGYRMVRPDNC------PEELYQLMRLCWKERPEDRPTFDYLRSVLE 265
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 5e-33
Identities = 68/299 (22%), Positives = 113/299 (37%), Gaps = 47/299 (15%)
Query: 63 LPPSSYTLLS-PIARGAESVVYEATLDGRK----VAVK--KPILSTSEELDNFHKELQLL 115
L TL + G V + +K VAVK K + D E ++
Sbjct: 13 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVM 72
Query: 116 CKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKAL 175
+LD+P + + + + E E L + L + + + Q++ +
Sbjct: 73 QQLDNPYIVRMIGICEAESWMLVM-EMAELGPLNKYLQQNRHVKDKNIIEL-VHQVSMGM 130
Query: 176 QYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK-PTGGFH 234
+YL VHRD+ NVLL ++DFGL+ + + + ++ GK P
Sbjct: 131 KYLEESNFVHRDLAARNVLLVTQHYAKISDFGLS--KALRADENYYKAQTHGKWP----- 183
Query: 235 KKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEM 293
+ + APE + S KSDV+SFG+ + E + G PY + + V M
Sbjct: 184 -------VKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM----KGSEVTAM 232
Query: 294 NYTEQQLTAAVVSGGLRPILASLEL--GLPASILSLIQRCWDGNPHNRPSFSDIALELD 350
+ G R + G P + L+ CW + NRP F+ + L L
Sbjct: 233 -----------LEKGER-----MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 275
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 1e-32
Identities = 55/302 (18%), Positives = 119/302 (39%), Gaps = 34/302 (11%)
Query: 66 SSYTLLSPIARGAESVVYEA--TLDGRKVAVKKPIL--STSEELDNFHKELQLLCKL-DH 120
+ + L I G V++ LDG A+K+ + S + N +E+ L H
Sbjct: 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQH 70
Query: 121 PGLAKFVAAHAKPPNYMFFF-EFYESRNLAEKLHVEEWSPSV---DQVLMIAAQLAKALQ 176
+ ++ +A A+ ++M E+ +LA+ + S ++ + Q+ + L+
Sbjct: 71 SHVVRYFSAWAED-DHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
Y+H++ +VH D+KP+N+ + R P+ A E ++ K G T +
Sbjct: 130 YIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKI-GDLGHVTRISSPQ 188
Query: 237 NMVGTLIYMAPEILKKEI-HSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNY 295
G ++A E+L++ H K+D+++ +++ + + +
Sbjct: 189 VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---------QWH- 238
Query: 296 TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH 355
+ G L I L L++ +P RPS + ++ ++L
Sbjct: 239 -------EIRQGRLPRI----PQVLSQEFTELLKVMIHPDPERRPSAMAL-VKHSVLLSA 286
Query: 356 RK 357
+
Sbjct: 287 SR 288
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-32
Identities = 77/344 (22%), Positives = 135/344 (39%), Gaps = 75/344 (21%)
Query: 62 HLPPSSYTLLSPIARGAESVVYEATLDG----RKVAVK--KPILSTSEELDNFHKELQLL 115
L + I G V +A + A+K K ++ ++ +F EL++L
Sbjct: 21 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVL 79
Query: 116 CKL-DHPGLAKFVAAHAKPPNYMFFFEF---------------YESRNLAEKLHVEEWSP 159
CKL HP + + A E+ E+ + +
Sbjct: 80 CKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 139
Query: 160 SVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLA----EYRENL 215
S Q+L AA +A+ + YL +HRD+ N+L+ N +ADFGL+ Y +
Sbjct: 140 SSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK-- 197
Query: 216 KEISLKNWRSSGK-PTGGFHKKNMVGTLI-YMAPEILKKEIHSEKSDVYSFGISINELLT 273
++ G+ P + +MA E L +++ SDV+S+G+ + E+++
Sbjct: 198 --------KTMGRLP-------------VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236
Query: 274 -GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGL--RPILASLELGLPASILSLIQR 330
G PY + T +L + G +P L + L+++
Sbjct: 237 LGGTPYCGM--------------TCAELYEKLPQGYRLEKP------LNCDDEVYDLMRQ 276
Query: 331 CWDGNPHNRPSFSDIALELDLVLEHRKSLKEEDLCAGKSYVTYD 374
CW P+ RPSF+ I + L+ +LE RK+ L +Y D
Sbjct: 277 CWREKPYERPSFAQILVSLNRMLEERKTYVNTTLYEKFTYAGID 320
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-32
Identities = 63/231 (27%), Positives = 107/231 (46%), Gaps = 41/231 (17%)
Query: 64 PPSSYTLLSPIARGAESVVYEA--TLDGRKVAVKK-PILSTSEELDNFHKELQLLCKLDH 120
P +T L I +G+ V++ + VA+K + +E+++ +E+ +L + D
Sbjct: 20 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS 79
Query: 121 PGLAKFVAAHAKPPNYMFFFEF---------YESRNLAEKLHVEEWSPSVDQVLMIAAQL 171
P + K+ ++ K E+ E L E Q+ I ++
Sbjct: 80 PYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDE-----------TQIATILREI 128
Query: 172 AKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTG 231
K L YLH+ +HRD+K ANVLL + LADFG+ +G+ T
Sbjct: 129 LKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGV-----------------AGQLTD 171
Query: 232 GFHKKN-MVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDL 281
K+N VGT +MAPE++K+ + K+D++S GI+ EL G P+++L
Sbjct: 172 TQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL 222
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 3e-32
Identities = 78/301 (25%), Positives = 127/301 (42%), Gaps = 41/301 (13%)
Query: 82 VYEATL-DGRKVAVKKPILSTSEELDN---FHKELQLLCKLDHPGLAKFVAAHAKPPNYM 137
VY+ L DG VAVK+ L F E++++ H L + P +
Sbjct: 46 VYKGRLADGTLVAVKR--LKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 103
Query: 138 FFFEFYESRNLAEKLHVEEWSPSV---DQVLMIAAQLAKALQYLH---NLGIVHRDVKPA 191
+ + + ++A L S + IA A+ L YLH + I+HRDVK A
Sbjct: 104 LVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAA 163
Query: 192 NVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMV-GTLIYMAPEIL 250
N+LLD + DFGLA K + H V GT+ ++APE L
Sbjct: 164 NILLDEEFEAVVGDFGLA------KLM----------DYKDTHVTTAVRGTIGHIAPEYL 207
Query: 251 KKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVL-----EMNYTEQQLTAAVV 305
SEK+DV+ +G+ + EL+TG + R +L + E++L A+V
Sbjct: 208 STGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL-LKEKKLE-ALV 265
Query: 306 SGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI--ALELDLVLEHRKSLKEED 363
L+ E+ ++ + C +P RP S++ LE D + E + ++E+
Sbjct: 266 DVDLQGNYKDEEV---EQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAERWEEWQKEE 322
Query: 364 L 364
+
Sbjct: 323 M 323
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 4e-32
Identities = 67/311 (21%), Positives = 118/311 (37%), Gaps = 47/311 (15%)
Query: 63 LPPSSYTLL-SPIARGAESVVYEATLDGR----KVAVK--KPILSTSEELDNFHKELQLL 115
L + + + G V + R VA+K K + + + +E Q++
Sbjct: 6 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIM 64
Query: 116 CKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKAL 175
+LD+P + + + + E L + L + V V + Q++ +
Sbjct: 65 HQLDNPYIVRLIGVCQAEALMLVM-EMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGM 123
Query: 176 QYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK-PTGGFH 234
+YL VHRD+ NVLL ++DFGL+ + + S RS+GK P
Sbjct: 124 KYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLS--KALGADDSYYTARSAGKWP----- 176
Query: 235 KKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEM 293
L + APE + S +SDV+S+G+++ E L+ G PY + + V+
Sbjct: 177 -------LKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM----KGPEVMAF 225
Query: 294 NYTEQQLTAAVVSGGLRPILASLEL--GLPASILSLIQRCWDGNPHNRPSFSDIALELDL 351
+ G R +E P + +L+ CW +RP F + +
Sbjct: 226 -----------IEQGKR-----MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 269
Query: 352 VLEHRKSLKEE 362
S E
Sbjct: 270 CYYSLASKVEG 280
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 6e-32
Identities = 56/318 (17%), Positives = 107/318 (33%), Gaps = 79/318 (24%)
Query: 62 HLPPSSYTLLSPIARGAESVVYEATLDGR---------KVAVK--KPILSTSEELDNFHK 110
+ + +G + +++ +V +K + ++F +
Sbjct: 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDK--AHRNYSESFFE 61
Query: 111 ELQLLCKLDHPGLAKFVAAHAK-PPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAA 169
++ KL H L N + EF + +L L + ++ L +A
Sbjct: 62 AASMMSKLSHKHLVLNYGVCVCGDENILVQ-EFVKFGSLDTYLKKNKNCINILWKLEVAK 120
Query: 170 QLAKALQYLHNLGIVHRDVKPANVLLDR--------NLCPHLADFGLA-------EYREN 214
QLA A+ +L ++H +V N+LL R L+D G++ +E
Sbjct: 121 QLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQER 180
Query: 215 LKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPE-ILKKEIHSEKSDVYSFGISINELLT 273
+ W + PE I + + +D +SFG ++ E+ +
Sbjct: 181 IP------W---------------------VPPECIENPKNLNLATDKWSFGTTLWEICS 213
Query: 274 -GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCW 332
G P + L + L+ + L A + +LI C
Sbjct: 214 GGDKPLSAL----DSQRKLQF-----------YEDRHQ-----LPAPKAAELANLINNCM 253
Query: 333 DGNPHNRPSFSDIALELD 350
D P +RPSF I +L+
Sbjct: 254 DYEPDHRPSFRAIIRDLN 271
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 7e-32
Identities = 71/297 (23%), Positives = 120/297 (40%), Gaps = 51/297 (17%)
Query: 68 YTLLSPIARGAESVVYEAT--LDGRKVAVK---KPILSTSEELDNFHKELQLLCKLDHPG 122
Y + +G+ V + G++ AVK K + + ++ +E+QLL +LDHP
Sbjct: 28 YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 87
Query: 123 LAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLG 182
+ K + E Y L +++ + S I Q+ + Y+H
Sbjct: 88 IMKLYEFFEDKGYFYLVGEVYTGGELFDEI-ISRKRFSEVDAARIIRQVLSGITYMHKNK 146
Query: 183 IVHRDVKPANVLL---DRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMV 239
IVHRD+KP N+LL ++ + DFGL+ + E K++ K+ +
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM-----------------KDKI 189
Query: 240 GTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQ 299
GT Y+APE+L + EK DV+S G+ + LL+G P+ E
Sbjct: 190 GTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSGCPPFNG--------------ANEYD 234
Query: 300 LTAAVVSGGLRPILASLE-LGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH 355
+ V G + + + S LI++ P R S A + L+H
Sbjct: 235 ILKKVEKG--KYTFELPQWKKVSESAKDLIRKMLTYVPSMRIS----ARD---ALDH 282
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 7e-32
Identities = 61/238 (25%), Positives = 104/238 (43%), Gaps = 22/238 (9%)
Query: 55 SSQSIPLHLPPSSYTLLSPIARGAESVVYEAT--LDGRKVAVKK-PILSTSEELDNFHKE 111
S ++P + Y L I GA +VV A KVA+K+ + +D KE
Sbjct: 4 DSSALPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKE 63
Query: 112 LQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLM----I 167
+Q + + HP + + + + ++ + + ++ I
Sbjct: 64 IQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTI 123
Query: 168 AA---QLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWR 224
A ++ + L+YLH G +HRDVK N+LL + +ADFG++ ++
Sbjct: 124 ATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVS------AFLA----- 172
Query: 225 SSGKPTGGFHKKNMVGTLIYMAPE-ILKKEIHSEKSDVYSFGISINELLTGVVPYTDL 281
+ G T +K VGT +MAPE + + + K+D++SFGI+ EL TG PY
Sbjct: 173 TGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKY 230
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 9e-32
Identities = 48/252 (19%), Positives = 93/252 (36%), Gaps = 26/252 (10%)
Query: 96 KPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLH-- 153
LS+ +D +++ + + + + NL + ++
Sbjct: 96 DWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRR 155
Query: 154 VEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRE 213
L I Q+A+A+++LH+ G++HRD+KP+N+ + + DFGL
Sbjct: 156 CSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLV---T 212
Query: 214 NLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT 273
+ + + + P H VGT +YM+PE + +S K D++S G+ + ELL
Sbjct: 213 AMDQDEEEQTVLTPMPAYATHTGQ-VGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLY 271
Query: 274 GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWD 333
T +E + + + ++Q
Sbjct: 272 S------------FSTQMERVRIITDV----RNLKFPLLFTQ----KYPQEHMMVQDMLS 311
Query: 334 GNPHNRPSFSDI 345
+P RP +DI
Sbjct: 312 PSPTERPEATDI 323
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 56/221 (25%), Positives = 111/221 (50%), Gaps = 22/221 (9%)
Query: 64 PPSSYTLLSPIARGAESVVYEAT--LDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP 121
P + +L + G+ VY+A G+ VA+K + +L KE+ ++ + D P
Sbjct: 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIK--QVPVESDLQEIIKEISIMQQCDSP 84
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL 181
+ K+ ++ K + E+ + ++++ + + + + D++ I K L+YLH +
Sbjct: 85 HVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFM 144
Query: 182 GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKN-MVG 240
+HRD+K N+LL+ LADFG+ +G+ T K+N ++G
Sbjct: 145 RKIHRDIKAGNILLNTEGHAKLADFGV-----------------AGQLTDTMAKRNTVIG 187
Query: 241 TLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDL 281
T +MAPE++++ ++ +D++S GI+ E+ G PY D+
Sbjct: 188 TPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADI 228
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 77/340 (22%), Positives = 133/340 (39%), Gaps = 90/340 (26%)
Query: 63 LPPSSYTLLSPIARGAESVVYEATLDG-------RKVAVK--KPILSTSEELDNFHKELQ 113
P + L + G V +AT VAVK K ++ EL + E
Sbjct: 20 FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN-ASPSELRDLLSEFN 78
Query: 114 LLCKLDHPGLAKFVAA--HAKP---------------------PNYMFFFEFYESRNLAE 150
+L +++HP + K A P + SRN +
Sbjct: 79 VLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSS 138
Query: 151 KLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLA- 209
H +E + ++ ++ A Q+++ +QYL + +VHRD+ N+L+ ++DFGL+
Sbjct: 139 LDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSR 198
Query: 210 ------EYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLI---YMAPEILKKEIHSEKSD 260
Y K + G I +MA E L I++ +SD
Sbjct: 199 DVYEEDSYV---------------KRSQG---------RIPVKWMAIESLFDHIYTTQSD 234
Query: 261 VYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGL--RPILASLE 317
V+SFG+ + E++T G PY + ++L + +G RP S E
Sbjct: 235 VWSFGVLLWEIVTLGGNPYPGI--------------PPERLFNLLKTGHRMERPDNCSEE 280
Query: 318 LGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHRK 357
+ L+ +CW P RP F+DI+ +L+ ++ R+
Sbjct: 281 MY------RLMLQCWKQEPDKRPVFADISKDLEKMMVKRR 314
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 76/281 (27%), Positives = 117/281 (41%), Gaps = 26/281 (9%)
Query: 82 VYEATL-DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFF 140
VY+ L DG KVA+K+ +S+ ++ F E++ L HP L + + + +
Sbjct: 55 VYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIY 114
Query: 141 EFYESRNLAEKLHVEEWSPSV---DQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDR 197
++ E+ NL L+ + +Q L I A+ L YLH I+HRDVK N+LLD
Sbjct: 115 KYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDE 174
Query: 198 NLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMV-GTLIYMAPEILKKEIHS 256
N P + DFG+++ G H +V GTL Y+ PE K +
Sbjct: 175 NFVPKITDFGISK---------------KGTELDQTHLSTVVKGTLGYIDPEYFIKGRLT 219
Query: 257 EKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLE-MNYTEQQLTAAVVSGGLRPILAS 315
EKSDVYSFG+ + E+L + + +V L +
Sbjct: 220 EKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRP 279
Query: 316 LELGLPASILSLIQRCWDGNPHNRPSFSDI--ALELDLVLE 354
L +C + +RPS D+ LE L L+
Sbjct: 280 ESL---RKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ 317
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-31
Identities = 68/322 (21%), Positives = 127/322 (39%), Gaps = 72/322 (22%)
Query: 62 HLPPSSYTLLSPIARGAESVVYEATLDG-------RKVAVK--KPILSTSEELDNFHKEL 112
+ T+ + +G+ +VYE G +VA+K S E ++ F E
Sbjct: 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE-FLNEA 79
Query: 113 QLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKL---------HVEEWSPSVDQ 163
++ + + + + + ++ + E +L L + PS+ +
Sbjct: 80 SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 139
Query: 164 VLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLA-------EYRENLK 216
++ +A ++A + YL+ VHRD+ N ++ + + DFG+ YR+ K
Sbjct: 140 MIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 199
Query: 217 E-ISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-G 274
+ ++ W M+PE LK + + SDV+SFG+ + E+ T
Sbjct: 200 GLLPVR-W---------------------MSPESLKDGVFTTYSDVWSFGVVLWEIATLA 237
Query: 275 VVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGL--RPILASLELGLPASILSLIQRCW 332
PY L + +Q+ V+ GGL +P P + L++ CW
Sbjct: 238 EQPYQGL--------------SNEQVLRFVMEGGLLDKP------DNCPDMLFELMRMCW 277
Query: 333 DGNPHNRPSFSDIALELDLVLE 354
NP RPSF +I + +E
Sbjct: 278 QYNPKMRPSFLEIISSIKEEME 299
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 2e-31
Identities = 54/307 (17%), Positives = 110/307 (35%), Gaps = 46/307 (14%)
Query: 68 YTLLSPIARGAESVVYEAT--LDGRKVAVKK-PILSTSEELDNFHKELQLLCKLDHPGLA 124
+ L + +GA + V+ G A+K +S +D +E ++L KL+H +
Sbjct: 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 125 KFVAAHAKPPNYMFFF--EFYESRNLAEKLHVEEWSPSV--DQVLMIAAQLAKALQYLHN 180
K A + EF +L L + + + L++ + + +L
Sbjct: 71 KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE 130
Query: 181 LGIVHRDVKPANVLLDRNLCPH----LADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
GIVHR++KP N++ L DFG A E+
Sbjct: 131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED-----------------DEQFV 173
Query: 237 NMVGTLIYMAPEILKKEI--------HSEKSDVYSFGISINELLTGVVPYTDLRAEAQAH 288
++ GT Y+ P++ ++ + + D++S G++ TG +P+ +
Sbjct: 174 SLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK 233
Query: 289 TVLE----------MNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHN 338
V+ ++ ++ + G P+ SL GL + ++ + +
Sbjct: 234 EVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEK 293
Query: 339 RPSFSDI 345
F
Sbjct: 294 CWGFDQF 300
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-31
Identities = 78/340 (22%), Positives = 134/340 (39%), Gaps = 64/340 (18%)
Query: 46 PNTCIRGCCSSQSIPLHLPPSSYTLLSPIARGAESVVYEATLDGR-------KVAVK--K 96
PN C G SS S +P + TL+ + GA VYE + G +VAVK
Sbjct: 10 PNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP 69
Query: 97 PILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKL---- 152
+ S +ELD F E ++ K +H + + + + E +L L
Sbjct: 70 EVCSEQDELD-FLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETR 128
Query: 153 --HVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDR---NLCPHLADFG 207
+ S ++ +L +A +A QYL +HRD+ N LL + DFG
Sbjct: 129 PRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFG 188
Query: 208 LAEYRENLKEISLKNW-RSSGKPTGGFHKKNMVGTLI---YMAPEILKKEIHSEKSDVYS 263
+A ++I ++ R G ++ +M PE + I + K+D +S
Sbjct: 189 MA------RDIYRASYYRKGGC------------AMLPVKWMPPEAFMEGIFTSKTDTWS 230
Query: 264 FGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGL--RPILASLELGL 320
FG+ + E+ + G +PY + Q++ V SGG P
Sbjct: 231 FGVLLWEIFSLGYMPYPSK--------------SNQEVLEFVTSGGRMDPP------KNC 270
Query: 321 PASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHRKSLK 360
P + ++ +CW P +RP+F+ I ++ + +
Sbjct: 271 PGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVIN 310
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 3e-31
Identities = 65/353 (18%), Positives = 128/353 (36%), Gaps = 51/353 (14%)
Query: 68 YTLLSPIARGAESVVYEAT--LDGRKVAVKK-PILSTSEELDNFHKELQLLCKLDHPGLA 124
+ L + +GA + V+ G A+K +S +D +E ++L KL+H +
Sbjct: 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 125 KFVAAHAKPPNYMFFF--EFYESRNLAEKLHVEEWSPSV--DQVLMIAAQLAKALQYLHN 180
K A + EF +L L + + + L++ + + +L
Sbjct: 71 KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE 130
Query: 181 LGIVHRDVKPANVLLDRNLCPH----LADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
GIVHR++KP N++ L DFG A E+
Sbjct: 131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED-----------------DEQFV 173
Query: 237 NMVGTLIYMAPEILKKEI--------HSEKSDVYSFGISINELLTGVVPYTDLRAEAQAH 288
++ GT Y+ P++ ++ + + D++S G++ TG +P+ +
Sbjct: 174 SLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK 233
Query: 289 TVLE----------MNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHN 338
V+ ++ ++ + G P+ SL GL + ++ + +
Sbjct: 234 EVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEK 293
Query: 339 RPSFSDIALELDLVLEHRKSLKEEDLCAGKSYVTYDDKLINSGNNMHTYHESI 391
F E +L HR + L ++ Y I+S N +HE +
Sbjct: 294 CWGFDQFFAETSDIL-HRMVIHVFSLQQMTAHKIY----IHSYNTATIFHELV 341
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-31
Identities = 50/224 (22%), Positives = 97/224 (43%), Gaps = 28/224 (12%)
Query: 64 PPSSYTLLSPIARGAESVVYEAT--LDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP 121
P I G+ +V A GR+VAVK L + + E+ ++ H
Sbjct: 43 PRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102
Query: 122 GLAKFVAAHAKPPNYMFFFEFYES---RNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYL 178
+ + ++ EF + ++ ++ + E +Q+ + + +AL YL
Sbjct: 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNE-----EQIATVCEAVLQALAYL 157
Query: 179 HNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKN- 237
H G++HRD+K ++LL + L+DFG + + K+
Sbjct: 158 HAQGVIHRDIKSDSILLTLDGRVKLSDFGF-----------------CAQISKDVPKRKS 200
Query: 238 MVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDL 281
+VGT +MAPE++ + +++ + D++S GI + E++ G PY
Sbjct: 201 LVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSD 244
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 3e-31
Identities = 58/226 (25%), Positives = 102/226 (45%), Gaps = 25/226 (11%)
Query: 64 PPSSYTLLSPIARGAESVVYEAT--LDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP 121
P + ++ + GA VY+A G A K + EEL+++ E+++L DHP
Sbjct: 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHP 76
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL 181
+ K + A+ EF + + + + Q+ ++ Q+ +AL +LH+
Sbjct: 77 YIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK 136
Query: 182 GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKN-MVG 240
I+HRD+K NVL+ LADFG S K K++ +G
Sbjct: 137 RIIHRDLKAGNVLMTLEGDIRLADFG-----------------VSAKNLKTLQKRDSFIG 179
Query: 241 TLIYMAPEILKKEIHSE-----KSDVYSFGISINELLTGVVPYTDL 281
T +MAPE++ E + K+D++S GI++ E+ P+ +L
Sbjct: 180 TPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL 225
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 3e-31
Identities = 69/311 (22%), Positives = 120/311 (38%), Gaps = 73/311 (23%)
Query: 67 SYTLLSPIARGAE-SVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAK 125
S+ + GAE ++VY D R VAVK+ IL E +E+QLL + D
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKR-ILP--ECFSFADREVQLLRESDE----- 76
Query: 126 FVAAHAKPPNYMFFFEFYESRN------------LAEKLHVEEWSPSVDQVLMIAAQLAK 173
H PN + +F + R L E + ++++ + + + Q
Sbjct: 77 ----H---PNVIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTS 129
Query: 174 ALQYLHNLGIVHRDVKPANVLL-----DRNLCPHLADFGLAEYRENLKEISLKNWRSSGK 228
L +LH+L IVHRD+KP N+L+ + ++DFGL + S
Sbjct: 130 GLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV-GRHSFSRR----- 183
Query: 229 PTGGFHKKNMVGTLIYMAPEILKKEIH---SEKSDVYSFGISINELLT-GVVPYTDLRAE 284
+ GT ++APE+L ++ + D++S G +++ G P+
Sbjct: 184 -------SGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKS--- 233
Query: 285 AQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSD 344
++Q + + L + + A LI++ +P RPS
Sbjct: 234 -----------LQRQANILLGACSLDCLHPEKHEDVIA--RELIEKMIAMDPQKRPSAKH 280
Query: 345 IALELDLVLEH 355
VL+H
Sbjct: 281 -------VLKH 284
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 4e-31
Identities = 40/330 (12%), Positives = 84/330 (25%), Gaps = 91/330 (27%)
Query: 64 PPSSYTLLSPIARGAESVVYEAT--LDGRKVAVK---KPILSTSEELDNFHKE---LQLL 115
P + + + + EAT G V S + +E L+LL
Sbjct: 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLL 130
Query: 116 CKLDHPGLAKFVAAHAKP---------PNYMFFFEFYESRNLAEKLHVEEW--------- 157
+ + AK P + + + +
Sbjct: 131 RGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFG 190
Query: 158 -----------SPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADF 206
S L + Q+ + L LH+ G+VH ++P +++LD+ L F
Sbjct: 191 EVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGF 250
Query: 207 GLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILK-----------KEIH 255
G + + + PE+ + +
Sbjct: 251 EHL------------------VRDG--ARVVSSVSRGFEPPELEARRATISYHRDRRTLM 290
Query: 256 SEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILAS 315
+ D ++ G+ I + +P T A + +
Sbjct: 291 TFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIFRSCK-------------------- 330
Query: 316 LELGLPASILSLIQRCWDGNPHNRPSFSDI 345
+P + +L++ +R
Sbjct: 331 ---NIPQPVRALLEGFLRYPKEDRLLPLQA 357
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 4e-31
Identities = 53/224 (23%), Positives = 103/224 (45%), Gaps = 28/224 (12%)
Query: 64 PPSSYTLLSPIARGAESVVYEAT--LDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP 121
P YT I +GA VY A G++VA+++ L + + E+ ++ + +P
Sbjct: 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNP 77
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLH---VEEWSPSVDQVLMIAAQLAKALQYL 178
+ ++ ++ E+ +L + + ++E Q+ + + +AL++L
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDE-----GQIAAVCRECLQALEFL 132
Query: 179 HNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKN- 237
H+ ++HRD+K N+LL + L DFG + T K++
Sbjct: 133 HSNQVIHRDIKSDNILLGMDGSVKLTDFGF-----------------CAQITPEQSKRST 175
Query: 238 MVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDL 281
MVGT +MAPE++ ++ + K D++S GI E++ G PY +
Sbjct: 176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE 219
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 4e-31
Identities = 71/331 (21%), Positives = 123/331 (37%), Gaps = 82/331 (24%)
Query: 63 LPPSSYTLLSPIARGAESVVYEATLDG-------RKVAVK--KPILSTSEELDNFHKELQ 113
P + + + GA V EAT G VAVK KP + E + EL+
Sbjct: 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKP-SAHLTEREALMSELK 78
Query: 114 LLCKL-DHPGLAKFVAAHAK-PPNYMFF----------------FEFYESRNLAEKLHVE 155
+L L +H + + A P + F S+ + +
Sbjct: 79 VLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 138
Query: 156 EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLA------ 209
E + ++ +L + Q+AK + +L + +HRD+ N+LL + DFGLA
Sbjct: 139 ELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKND 198
Query: 210 -EYRENLKEISLKNWRSSGKPTGGFH--KKNMVGTLIYMAPEILKKEIHSEKSDVYSFGI 266
Y K +MAPE + +++ +SDV+S+GI
Sbjct: 199 SNYV---------------VKGNARLPVK--------WMAPESIFNCVYTFESDVWSYGI 235
Query: 267 SINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGL--RPILASLELGLPAS 323
+ EL + G PY + +++ +M + G P A E+
Sbjct: 236 FLWELFSLGSSPYPGMPVDSK---FYKM----------IKEGFRMLSPEHAPAEMY---- 278
Query: 324 ILSLIQRCWDGNPHNRPSFSDIALELDLVLE 354
+++ CWD +P RP+F I ++ +
Sbjct: 279 --DIMKTCWDADPLKRPTFKQIVQLIEKQIS 307
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 6e-31
Identities = 69/332 (20%), Positives = 121/332 (36%), Gaps = 85/332 (25%)
Query: 63 LPPSSYTLLSPIARGAESVVYEATLDG-------RKVAVK--KPILSTSEELDNFHKELQ 113
P L P+ RGA V EA G R VAVK K +T E EL+
Sbjct: 24 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELK 82
Query: 114 LLCKLD-HPGLAKFVAA--HAKPPNYMFFFEF---------------YESRNLAEKLHVE 155
+L + H + + A P + EF +
Sbjct: 83 ILIHIGHHLNVVNLLGACTKPGGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKVAPEDLY 141
Query: 156 EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLA------ 209
+ +++ ++ + Q+AK +++L + +HRD+ N+LL + DFGLA
Sbjct: 142 KDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 201
Query: 210 -EYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLI---YMAPEILKKEIHSEKSDVYSFG 265
+Y + + +MAPE + +++ +SDV+SFG
Sbjct: 202 PDYV---------------RKGDA---------RLPLKWMAPETIFDRVYTIQSDVWSFG 237
Query: 266 ISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGL--RPILASLELGLPA 322
+ + E+ + G PY ++ + + + G P + E+
Sbjct: 238 VLLWEIFSLGASPYPGVKIDEE---FCRR----------LKEGTRMRAPDYTTPEMY--- 281
Query: 323 SILSLIQRCWDGNPHNRPSFSDIALELDLVLE 354
+ CW G P RP+FS++ L +L+
Sbjct: 282 ---QTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-30
Identities = 68/340 (20%), Positives = 119/340 (35%), Gaps = 74/340 (21%)
Query: 64 PPSSYTLLSPIARGAES--VVYEA--TLDGRKVAVKKPIL--STSEELDNFHKELQLLCK 117
Y LL+ I +G E V A G V V++ L ++E + EL +
Sbjct: 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKL 82
Query: 118 LDHPGLAKFVAAHAKPPN------YMFF------FEFYESRNLAEKLHVEEWSPSVDQVL 165
+HP + + A +M + + + E +
Sbjct: 83 FNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNE-----------LAIA 131
Query: 166 MIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRS 225
I + KAL Y+H++G VHR VK +++L+ + +L+ +S+ +
Sbjct: 132 YILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSN--------LSMIS-HG 182
Query: 226 SGKPTGGFHKKNMVGTLIYMAPEILKKEIH--SEKSDVYSFGISINELLTGVVPYTDL-- 281
+ K V L +++PE+L++ + KSD+YS GI+ EL G VP+ D+
Sbjct: 183 QRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPA 242
Query: 282 --------------------RAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLP 321
+ + L+ ++ + RP
Sbjct: 243 TQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPY 302
Query: 322 ASILS-----LIQRCWDGNPHNRPSFSDIALELDLVLEHR 356
S +++C NP RPS A L L H
Sbjct: 303 HRTFSPHFHHFVEQCLQRNPDARPS----ASTL---LNHS 335
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-30
Identities = 42/242 (17%), Positives = 78/242 (32%), Gaps = 36/242 (14%)
Query: 61 LHLPPSSYTLLSPIARGAESVVYEAT-------LDGRKVAVKKPILSTSEELDNFHKELQ 113
L + + GA + VYEAT + +K +K + E + ++
Sbjct: 60 FQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLME 119
Query: 114 LLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKL----HVEEWSPSVDQVLMIAA 169
L KF +AH + E Y L + + E V+ A
Sbjct: 120 RLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAM 179
Query: 170 QLAKALQYLHNLGIVHRDVKPANVLLDRNLCPH-----------LADFGLAEYRENLKEI 218
++ ++ +H+ I+H D+KP N +L L D G + I
Sbjct: 180 RMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQS--------I 231
Query: 219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
+K + T T + E+L + + + D + ++ +L G
Sbjct: 232 DMKLFPKGTIFTA------KCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMK 285
Query: 279 TD 280
Sbjct: 286 VK 287
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-30
Identities = 77/297 (25%), Positives = 124/297 (41%), Gaps = 52/297 (17%)
Query: 68 YTLLSPIARGAESVVYEAT--LDGRKVAVK---KPILSTSEELDNFHKELQLLCKLDHPG 122
Y + + GA V + + A+K K +STS +E+ +L LDHP
Sbjct: 39 YQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSN-SKLLEEVAVLKLLDHPN 97
Query: 123 LAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLG 182
+ K NY E Y+ L +++ + + +I Q+ + YLH
Sbjct: 98 IMKLYDFFEDKRNYYLVMECYKGGELFDEI-IHRMKFNEVDAAVIIKQVLSGVTYLHKHN 156
Query: 183 IVHRDVKPANVLL---DRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMV 239
IVHRD+KP N+LL +++ + DFGL+ EN K++ K +
Sbjct: 157 IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM-----------------KERL 199
Query: 240 GTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQ 299
GT Y+APE+L+K+ + EK DV+S G+ + LL G P+ T+Q+
Sbjct: 200 GTAYYIAPEVLRKK-YDEKCDVWSIGVILFILLAGYPPFGG--------------QTDQE 244
Query: 300 LTAAVVSGGLRPILASLEL-GLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH 355
+ V G + S E + LI++ + R S A + LEH
Sbjct: 245 ILRKVEKG--KYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRIS----AQQ---ALEH 292
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-30
Identities = 66/287 (22%), Positives = 107/287 (37%), Gaps = 49/287 (17%)
Query: 68 YTLLSPIARGAESVVYEAT--LDGRKVAVK---KPILSTSEELDNFHKELQLLCKLDHPG 122
Y + +G + +E + A K K +L + + E+ + L H
Sbjct: 17 YVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQH 76
Query: 123 LAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLG 182
+ F E R+L E + + + Q+ QYLH
Sbjct: 77 VVGFHGFFEDNDFVFVVLELCRRRSLLELH-KRRKALTEPEARYYLRQIVLGCQYLHRNR 135
Query: 183 IVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTL 242
++HRD+K N+ L+ +L + DFGLA E G KK + GT
Sbjct: 136 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVE----------------YDGERKKVLCGTP 179
Query: 243 IYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTA 302
Y+APE+L K+ HS + DV+S G + LL G P+ + + E
Sbjct: 180 NYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPF-------ETSCLKET--------- 223
Query: 303 AVVSGGLRPILASLELGLPASI----LSLIQRCWDGNPHNRPSFSDI 345
I + E +P I SLIQ+ +P RP+ +++
Sbjct: 224 ------YLRIKKN-EYSIPKHINPVAASLIQKMLQTDPTARPTINEL 263
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 3e-30
Identities = 68/314 (21%), Positives = 120/314 (38%), Gaps = 47/314 (14%)
Query: 61 LHLPPSSYTLLSP-IARGAESVVYEATLDGRK----VAVK--KPILSTSEELDNFHKELQ 113
L L + + + G V + RK VA+K K + + + +E Q
Sbjct: 330 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQ 388
Query: 114 LLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAK 173
++ +LD+P + + + + E L + L + V V + Q++
Sbjct: 389 IMHQLDNPYIVRLIGVCQAEALMLVM-EMAGGGPLHKFLVGKREEIPVSNVAELLHQVSM 447
Query: 174 ALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK-PTGG 232
++YL VHR++ NVLL ++DFGL+ + + S RS+GK P
Sbjct: 448 GMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLS--KALGADDSYYTARSAGKWP--- 502
Query: 233 FHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVL 291
L + APE + S +SDV+S+G+++ E L+ G PY + + V+
Sbjct: 503 ---------LKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM----KGPEVM 549
Query: 292 EMNYTEQQLTAAVVSGGLRPILASLEL--GLPASILSLIQRCWDGNPHNRPSFSDIALEL 349
+ G R +E P + +L+ CW +RP F + +
Sbjct: 550 AF-----------IEQGKR-----MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM 593
Query: 350 DLVLEHRKSLKEED 363
S E
Sbjct: 594 RACYYSLASKVEGG 607
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 3e-30
Identities = 79/356 (22%), Positives = 137/356 (38%), Gaps = 64/356 (17%)
Query: 30 LQFFTLNSKMGLKVLEPNTCIRGCCSSQSIPLHLPPSSYTLLSPIARGAESVVYEATLDG 89
+ L + + PN C G SS S +P + TL+ + GA VYE + G
Sbjct: 35 YKLSKLRTSTIMTDYNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSG 94
Query: 90 R-------KVAVK--KPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFF 140
+VAVK + S +ELD F E ++ K +H + + + +
Sbjct: 95 MPNDPSPLQVAVKTLPEVCSEQDELD-FLMEALIISKFNHQNIVRCIGVSLQSLPRFILL 153
Query: 141 EFYESRNLAEKL------HVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVL 194
E +L L + S ++ +L +A +A QYL +HRD+ N L
Sbjct: 154 ELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCL 213
Query: 195 LDR---NLCPHLADFGLAEYRENLKEISLKNW-RSSGKPTGGFHKKNMVGTLI---YMAP 247
L + DFG+A ++I + R G ++ +M P
Sbjct: 214 LTCPGPGRVAKIGDFGMA------RDIYRAGYYRKGGC------------AMLPVKWMPP 255
Query: 248 EILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVS 306
E + I + K+D +SFG+ + E+ + G +PY + Q++ V S
Sbjct: 256 EAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK--------------SNQEVLEFVTS 301
Query: 307 GGL--RPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHRKSLK 360
GG P P + ++ +CW P +RP+F+ I ++ + +
Sbjct: 302 GGRMDPP------KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVIN 351
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 3e-30
Identities = 72/336 (21%), Positives = 124/336 (36%), Gaps = 80/336 (23%)
Query: 63 LPPSSYTLLSPIARGAESVVYEATLDG-------RKVAVK--KPILSTSEELDNFHKELQ 113
P ++ + GA V EAT G KVAVK K + ++E + EL+
Sbjct: 43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKS-TAHADEKEALMSELK 101
Query: 114 LLCKLD-HPGLAKFVAAHAKPPNYMFFFEFYESRNL-------------AEKLHVEEWSP 159
++ L H + + A + E+ +L + +
Sbjct: 102 IMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTA 161
Query: 160 SVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLA-------EYR 212
S +L ++Q+A+ + +L + +HRDV NVLL + DFGLA Y
Sbjct: 162 STRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI 221
Query: 213 ENLKEISLKNWRSSGKPTGGFH--KKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINE 270
K +MAPE + +++ +SDV+S+GI + E
Sbjct: 222 ---------------VKGNARLPVK--------WMAPESIFDCVYTVQSDVWSYGILLWE 258
Query: 271 LLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGL--RPILASLELGLPASILSL 327
+ + G+ PY + ++ ++ V G +P A + S+
Sbjct: 259 IFSLGLNPYPGILVNSK---FYKL----------VKDGYQMAQPAFAPKNIY------SI 299
Query: 328 IQRCWDGNPHNRPSFSDIALELDLVLEHRKSLKEED 363
+Q CW P +RP+F I L + +E D
Sbjct: 300 MQACWALEPTHRPTFQQICSFLQEQAQE--DRRERD 333
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 7e-30
Identities = 66/287 (22%), Positives = 107/287 (37%), Gaps = 49/287 (17%)
Query: 68 YTLLSPIARGAESVVYEAT--LDGRKVAVK---KPILSTSEELDNFHKELQLLCKLDHPG 122
Y + +G + +E + A K K +L + + E+ + L H
Sbjct: 43 YVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQH 102
Query: 123 LAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLG 182
+ F E R+L E + + + Q+ QYLH
Sbjct: 103 VVGFHGFFEDNDFVFVVLELCRRRSLLELH-KRRKALTEPEARYYLRQIVLGCQYLHRNR 161
Query: 183 IVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTL 242
++HRD+K N+ L+ +L + DFGLA E G KK + GT
Sbjct: 162 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVE----------------YDGERKKVLCGTP 205
Query: 243 IYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTA 302
Y+APE+L K+ HS + DV+S G + LL G P+ + + E
Sbjct: 206 NYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPF-------ETSCLKET--------- 249
Query: 303 AVVSGGLRPILASLELGLPASI----LSLIQRCWDGNPHNRPSFSDI 345
I + E +P I SLIQ+ +P RP+ +++
Sbjct: 250 ------YLRIKKN-EYSIPKHINPVAASLIQKMLQTDPTARPTINEL 289
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 8e-30
Identities = 72/329 (21%), Positives = 124/329 (37%), Gaps = 82/329 (24%)
Query: 62 HLPPSSYTLLSPIARGAESVVYEATLDGR-------KVAVK--KPILSTSEELDNFHKEL 112
H+ L + GA V+ A VAVK K ++ +F +E
Sbjct: 37 HIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE--ASESARQDFQREA 94
Query: 113 QLLCKLDHPGLAKFVAAHAK-PPNYMFFFEF--------------YESRNLAEKLHVEEW 157
+LL L H + +F + P M F E+ +++ LA V
Sbjct: 95 ELLTMLQHQHIVRFFGVCTEGRPLLMVF-EYMRHGDLNRFLRSHGPDAKLLAGGEDVAPG 153
Query: 158 SPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLA------EY 211
+ Q+L +A+Q+A + YL L VHRD+ N L+ + L + DFG++ +Y
Sbjct: 154 PLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDY 213
Query: 212 RENLKEISLKNWRSSGKPTGGFHKKNMVGTLI---YMAPEILKKEIHSEKSDVYSFGISI 268
+R G+ T++ +M PE + + +SDV+SFG+ +
Sbjct: 214 -----------YRVGGR------------TMLPIRWMPPESILYRKFTTESDVWSFGVVL 250
Query: 269 NELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGL--RPILASLELGLPASIL 325
E+ T G P+ L + + + G RP P +
Sbjct: 251 WEIFTYGKQPWYQL--------------SNTEAIDCITQGRELERPR------ACPPEVY 290
Query: 326 SLIQRCWDGNPHNRPSFSDIALELDLVLE 354
++++ CW P R S D+ L + +
Sbjct: 291 AIMRGCWQREPQQRHSIKDVHARLQALAQ 319
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-29
Identities = 74/346 (21%), Positives = 125/346 (36%), Gaps = 87/346 (25%)
Query: 63 LPPSSYTLLSPIARGAESVVYEATLDG-------RKVAVK--KPILSTSEELDNFHKELQ 113
P + + GA V AT G +VAVK K + S E + EL+
Sbjct: 42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKE-KADSSEREALMSELK 100
Query: 114 LLCKL-DHPGLAKFVAA--HAKPP----NYM----------------FFFEFYESRNLAE 150
++ +L H + + A + P Y E
Sbjct: 101 MMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRL 160
Query: 151 KLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLA- 209
+ + + + +L A Q+AK +++L VHRD+ NVL+ + DFGLA
Sbjct: 161 EEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLAR 220
Query: 210 ------EYRENLKEISLKNWRSSGKPTGGFH--KKNMVGTLIYMAPEILKKEIHSEKSDV 261
Y K +MAPE L + I++ KSDV
Sbjct: 221 DIMSDSNYV---------------VRGNARLPVK--------WMAPESLFEGIYTIKSDV 257
Query: 262 YSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGG--LRPILASLEL 318
+S+GI + E+ + GV PY + +A ++ + +G +P A+ E+
Sbjct: 258 WSYGILLWEIFSLGVNPYPGIPVDAN---FYKL----------IQNGFKMDQPFYATEEI 304
Query: 319 GLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHRKSLKEEDL 364
++Q CW + RPSF ++ L L + +++
Sbjct: 305 Y------IIMQSCWAFDSRKRPSFPNLTSFLGCQLADAEEAMYQNV 344
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 1e-29
Identities = 74/332 (22%), Positives = 124/332 (37%), Gaps = 85/332 (25%)
Query: 63 LPPSSYTLLSPIARGAESVVYEATLDG---------RKVAVK--KPILSTSEELDNFHKE 111
P TL P+ GA V A G VAVK K +T ++L + E
Sbjct: 32 FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSE 90
Query: 112 LQLLCKL-DHPGLAKFVAAHAKPPNYMFFFEF---------------YESRNLAEKLHVE 155
++++ + H + + A + E+ + V
Sbjct: 91 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 150
Query: 156 EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLA------ 209
E + ++ QLA+ ++YL + +HRD+ NVL+ N +ADFGLA
Sbjct: 151 EEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNI 210
Query: 210 -EYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLI---YMAPEILKKEIHSEKSDVYSFG 265
Y+ K T G + +MAPE L +++ +SDV+SFG
Sbjct: 211 DYYK---------------KTTNG---------RLPVKWMAPEALFDRVYTHQSDVWSFG 246
Query: 266 ISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGL--RPILASLELGLPA 322
+ + E+ T G PY + ++L + G +P + EL
Sbjct: 247 VLMWEIFTLGGSPYPGI--------------PVEELFKLLKEGHRMDKPANCTNELY--- 289
Query: 323 SILSLIQRCWDGNPHNRPSFSDIALELDLVLE 354
+++ CW P RP+F + +LD +L
Sbjct: 290 ---MMMRDCWHAVPSQRPTFKQLVEDLDRILT 318
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-29
Identities = 44/330 (13%), Positives = 86/330 (26%), Gaps = 92/330 (27%)
Query: 64 PPSSYTLLSPIARGAESVVYEAT--LDGRKVAVK---KPILSTSEELDNFHKE---LQLL 115
P + + + + EAT G V S + +E L+LL
Sbjct: 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLL 135
Query: 116 CKLDHPGLAKFVAAHAKP------------------------PNYMFFFEFYES------ 145
+ + AK P + F + +S
Sbjct: 136 RGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFG 195
Query: 146 RNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLAD 205
L + S L + Q+ + L LH+ G+VH ++P +++LD+ L
Sbjct: 196 EVLLSHSSTHK-SLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTG 254
Query: 206 FGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEI----------H 255
F G + PE + +
Sbjct: 255 FEHL--------------VRDGASA------VSPIGRGFAPPETTAERMLPFGQHHPTLM 294
Query: 256 SEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILAS 315
+ D ++ G++I + +P TD A + +
Sbjct: 295 TFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIFRSCK-------------------- 334
Query: 316 LELGLPASILSLIQRCWDGNPHNRPSFSDI 345
+P + +L++ +R
Sbjct: 335 ---NIPQPVRALLEGFLRYPKEDRLLPLQA 361
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 56/203 (27%), Positives = 97/203 (47%), Gaps = 29/203 (14%)
Query: 82 VYEATLDGRKVAVKKPILSTSEELDN------FHKELQLLCKLDHPGLAKFVAAHAKPPN 135
VY+ ++ VAVKK L+ ++ F +E++++ K H L + + + +
Sbjct: 47 VYKGYVNNTTVAVKK--LAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDD 104
Query: 136 YMFFFEFYESRNLAEKLHVEEWSPSVD--QVLMIAAQLAKALQYLHNLGIVHRDVKPANV 193
+ + + +L ++L + +P + IA A + +LH +HRD+K AN+
Sbjct: 105 LCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANI 164
Query: 194 LLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGF-HKKNMV-GTLIYMAPEILK 251
LLD ++DFGLA R + + + GT YMAPE L+
Sbjct: 165 LLDEAFTAKISDFGLA--RAS--------------EKFAQTVMTSRIVGTTAYMAPEALR 208
Query: 252 KEIHSEKSDVYSFGISINELLTG 274
EI + KSD+YSFG+ + E++TG
Sbjct: 209 GEI-TPKSDIYSFGVVLLEIITG 230
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 64/327 (19%), Positives = 114/327 (34%), Gaps = 84/327 (25%)
Query: 62 HLPPSSYTLLSPIARGAESVVYEATLDGR-------KVAVK--KPILSTSEELDNFHKEL 112
+ S+ + + VY+ L G VA+K K + + F E
Sbjct: 5 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKD-KAEGPLREEFRHEA 63
Query: 113 QLLCKLDHPGLAKFVAAHAK-PPNYMFFFEF---------------YESRNLAEKLHVEE 156
L +L HP + + K P M F + + + +
Sbjct: 64 MLRARLQHPNVVCLLGVVTKDQPLSMIF-SYCSHGDLHEFLVMRSPHSDVGSTDDDRTVK 122
Query: 157 WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLA------- 209
+ + + AQ+A ++YL + +VH+D+ NVL+ L ++D GL
Sbjct: 123 SALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAAD 182
Query: 210 EYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLI---YMAPEILKKEIHSEKSDVYSFGI 266
Y+ G +L+ +MAPE + S SD++S+G+
Sbjct: 183 YYK-----------------LLG-------NSLLPIRWMAPEAIMYGKFSIDSDIWSYGV 218
Query: 267 SINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGL--RPILASLELGLPAS 323
+ E+ + G+ PY + Q + + + + P PA
Sbjct: 219 VLWEVFSYGLQPYCGY--------------SNQDVVEMIRNRQVLPCP------DDCPAW 258
Query: 324 ILSLIQRCWDGNPHNRPSFSDIALELD 350
+ +L+ CW+ P RP F DI L
Sbjct: 259 VYALMIECWNEFPSRRPRFKDIHSRLR 285
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 3e-29
Identities = 68/307 (22%), Positives = 113/307 (36%), Gaps = 61/307 (19%)
Query: 68 YTLLSPIARGAESVVYEAT--LDGRKVAVK-------------KPILSTSEELDNFHKEL 112
Y + + GA V + A+K + + + + E+
Sbjct: 38 YFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEI 97
Query: 113 QLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLA 172
LL LDHP + K + EFYE L E++ + I Q+
Sbjct: 98 SLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQI-INRHKFDECDAANIMKQIL 156
Query: 173 KALQYLHNLGIVHRDVKPANVLL---DRNLCPHLADFGLAEYRENLKEISLKNWRSSGKP 229
+ YLH IVHRD+KP N+LL + L + DFGL+ + ++
Sbjct: 157 SGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKL----------- 205
Query: 230 TGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHT 289
++ +GT Y+APE+LKK+ ++EK DV+S G+ + LL G P+
Sbjct: 206 ------RDRLGTAYYIAPEVLKKK-YNEKCDVWSCGVIMYILLCGYPPFGG--------- 249
Query: 290 VLEMNYTEQQLTAAVVSGGLRPILASLEL-GLPASILSLIQRCWDGNPHNRPSFSDIALE 348
+Q + V G + + + LI+ + + R + A E
Sbjct: 250 -----QNDQDIIKKVEKG--KYYFDFNDWKNISDEAKELIKLMLTYDYNKRCT----AEE 298
Query: 349 LDLVLEH 355
L
Sbjct: 299 ---ALNS 302
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-29
Identities = 71/326 (21%), Positives = 116/326 (35%), Gaps = 83/326 (25%)
Query: 62 HLPPSSYTLLSPIARGAESVVYEATLDG-------RKVAVK--KPILSTSEELDNFHKEL 112
H+ L + GA V+ A VAVK K T +F +E
Sbjct: 11 HIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKD--PTLAARKDFQREA 68
Query: 113 QLLCKLDHPGLAKFVAAHAK-PPNYMFFFEF---------------YESRNLAEKLHVEE 156
+LL L H + KF P M F E+ + + +
Sbjct: 69 ELLTNLQHEHIVKFYGVCGDGDPLIMVF-EYMKHGDLNKFLRAHGPDAMILVDGQPRQAK 127
Query: 157 WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLA------E 210
+ Q+L IA+Q+A + YL + VHRD+ N L+ NL + DFG++ +
Sbjct: 128 GELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTD 187
Query: 211 YRENLKEISLKNWRSSGKPTGGFHKKNMVGTLI---YMAPEILKKEIHSEKSDVYSFGIS 267
Y +R G T++ +M PE + + +SDV+SFG+
Sbjct: 188 Y-----------YRVGGH------------TMLPIRWMPPESIMYRKFTTESDVWSFGVI 224
Query: 268 INELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGL--RPILASLELGLPASI 324
+ E+ T G P+ L + ++ + G + RP P +
Sbjct: 225 LWEIFTYGKQPWFQL--------------SNTEVIECITQGRVLERP------RVCPKEV 264
Query: 325 LSLIQRCWDGNPHNRPSFSDIALELD 350
++ CW P R + +I L
Sbjct: 265 YDVMLGCWQREPQQRLNIKEIYKILH 290
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 3e-29
Identities = 82/390 (21%), Positives = 143/390 (36%), Gaps = 92/390 (23%)
Query: 11 QRSFRFVRKTQVLLSSKYGLQFFTLNSKMGLKVLE-PNTCIRGCCSSQSIPLH----LPP 65
+ R+ V S + T ++ ++ +T + S +P P
Sbjct: 21 TKRIPLRRQVTVSAESSSSMNSNTPLVRITTRLSSTADTPMLAGVSEYELPEDPKWEFPR 80
Query: 66 SSYTLLSPIARGAESVVYEATLDG---------RKVAVK--KPILSTSEELDNFHKELQL 114
TL P+ G V A G VAVK K +T ++L + E+++
Sbjct: 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEM 139
Query: 115 LCKL-DHPGLAKFVAAHAK-PPNYMFFFEF---------------YESRNLAEKLHVEEW 157
+ + H + + A + P Y+ E+ + V E
Sbjct: 140 MKMIGKHKNIINLLGACTQDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDINRVPEE 198
Query: 158 SPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLA-------E 210
+ ++ QLA+ ++YL + +HRD+ NVL+ N +ADFGLA
Sbjct: 199 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDY 258
Query: 211 YRENLKEISLKNWRSSGKPTGGFHKKNMVGTLI---YMAPEILKKEIHSEKSDVYSFGIS 267
Y+ K T G + +MAPE L +++ +SDV+SFG+
Sbjct: 259 YK---------------KTTNG---------RLPVKWMAPEALFDRVYTHQSDVWSFGVL 294
Query: 268 INELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGL--RPILASLELGLPASI 324
+ E+ T G PY + ++L + G +P + EL
Sbjct: 295 MWEIFTLGGSPYPGI--------------PVEELFKLLKEGHRMDKPANCTNELY----- 335
Query: 325 LSLIQRCWDGNPHNRPSFSDIALELDLVLE 354
+++ CW P RP+F + +LD +L
Sbjct: 336 -MMMRDCWHAVPSQRPTFKQLVEDLDRILT 364
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 3e-29
Identities = 67/289 (23%), Positives = 114/289 (39%), Gaps = 26/289 (8%)
Query: 63 LPPSSYTLLSPIARGAESVVYEA--TLDGRKVAVKK-PILSTSEELDNFHKELQLLCKLD 119
L + +S + G VV++ G +A K + + +ELQ+L + +
Sbjct: 30 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECN 89
Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLH 179
P + F A E + +L + L P + ++ + K L YL
Sbjct: 90 SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIP-EQILGKVSIAVIKGLTYLR 148
Query: 180 -NLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNM 238
I+HRDVKP+N+L++ L DFG++ + S+ N +
Sbjct: 149 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMAN--------------SF 190
Query: 239 VGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQ 298
VGT YM+PE L+ +S +SD++S G+S+ E+ G P A+ +
Sbjct: 191 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDA 250
Query: 299 QLTAAVVSGGLRPI-LASLELGLPASILSLIQRCWDGNPHNRPS--FSD 344
T RP+ ++ P +I L+ + P PS FS
Sbjct: 251 AETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSL 299
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 4e-29
Identities = 67/297 (22%), Positives = 124/297 (41%), Gaps = 52/297 (17%)
Query: 68 YTLLSPIARGAESVVYEAT--LDGRKVAVK---KPILSTSEELDNFHKELQLLCKLDHPG 122
Y ++ + +G+ V + + ++ AVK K +++ +E++LL KLDHP
Sbjct: 24 YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA-KNKDTSTILREVELLKKLDHPN 82
Query: 123 LAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLG 182
+ K ++ E Y L +++ ++ S I Q+ + Y+H
Sbjct: 83 IMKLFEILEDSSSFYIVGELYTGGELFDEI-IKRKRFSEHDAARIIKQVFSGITYMHKHN 141
Query: 183 IVHRDVKPANVLL---DRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMV 239
IVHRD+KP N+LL +++ + DFGL+ + ++ K+ +
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM-----------------KDRI 184
Query: 240 GTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQ 299
GT Y+APE+L+ + EK DV+S G+ + LL+G P+ E
Sbjct: 185 GTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYG--------------KNEYD 229
Query: 300 LTAAVVSGGLRPILASLE-LGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH 355
+ V +G + + + LI++ +P R + A + LEH
Sbjct: 230 ILKRVETG--KYAFDLPQWRTISDDAKDLIRKMLTFHPSLRIT----ATQ---CLEH 277
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 4e-29
Identities = 62/299 (20%), Positives = 115/299 (38%), Gaps = 40/299 (13%)
Query: 68 YTLLSPIARGAESVVYEAT--LDGRKVAVKK-PILSTSEELDNFHKELQLLCKLDHPGLA 124
+ + + G V G +VA+K+ + + + + E+Q++ KL+HP +
Sbjct: 16 WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 75
Query: 125 K----FVAAHAKPPNYMFFF--EFYESRNLAEKLHVEEWSPSV--DQVLMIAAQLAKALQ 176
PN + E+ E +L + L+ E + + + + ++ AL+
Sbjct: 76 SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALR 135
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPH----LADFGLA-EYRENLKEISLKNWRSSGKPTG 231
YLH I+HRD+KP N++L + D G A E +
Sbjct: 136 YLHENRIIHRDLKPENIVLQPG-PQRLIHKIIDLGYAKELDQGELCTEF----------- 183
Query: 232 GFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVL 291
VGTL Y+APE+L+++ ++ D +SFG E +TG P+ Q H +
Sbjct: 184 -------VGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKV 236
Query: 292 EMNYTEQQLTAAVVSGGLR-----PILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
E + ++G ++ P L L + +Q + R +
Sbjct: 237 REKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN 295
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 6e-29
Identities = 76/334 (22%), Positives = 125/334 (37%), Gaps = 87/334 (26%)
Query: 63 LPPSSYTLLSPIARGAESVVYEATLDG---------RKVAVK--KPILSTSEELDNFHKE 111
LP L P+ GA V A G KVAVK K + + D E
Sbjct: 66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSD-LISE 124
Query: 112 LQLLCKL-DHPGLAKFVAAHAK-PPNYMFFFEF---------------YESRNLAEKLHV 154
++++ + H + + A + P Y+ E+ H
Sbjct: 125 MEMMKMIGKHKNIINLLGACTQDGPLYVIV-EYASKGNLREYLQARRPPGLEYSYNPSHN 183
Query: 155 EEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLA----- 209
E S ++ A Q+A+ ++YL + +HRD+ NVL+ + +ADFGLA
Sbjct: 184 PEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH 243
Query: 210 --EYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLI---YMAPEILKKEIHSEKSDVYSF 264
Y+ K T G + +MAPE L I++ +SDV+SF
Sbjct: 244 IDYYK---------------KTTNG---------RLPVKWMAPEALFDRIYTHQSDVWSF 279
Query: 265 GISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGL--RPILASLELGLP 321
G+ + E+ T G PY + ++L + G +P + EL
Sbjct: 280 GVLLWEIFTLGGSPYPGV--------------PVEELFKLLKEGHRMDKPSNCTNELY-- 323
Query: 322 ASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH 355
+++ CW P RP+F + +LD ++
Sbjct: 324 ----MMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 353
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 8e-29
Identities = 81/375 (21%), Positives = 139/375 (37%), Gaps = 89/375 (23%)
Query: 30 LQFFTLNSKMGLKVLEPN---TCIRGCCSSQSIPLHLPPSSYTLLSPIARGAESVVYEAT 86
+ TL S++ L L PN + + + + L P ++ + I GA V++A
Sbjct: 8 VTLTTLPSELLLDRLHPNPMYQRMPLLLNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQAR 67
Query: 87 LDG-------RKVAVK--KPILSTSEELDNFHKELQLLCKLDHPGLAKFVAA--HAKP-- 133
G VAVK K S + D F +E L+ + D+P + K + KP
Sbjct: 68 APGLLPYEPFTMVAVKMLKEEASADMQAD-FQREAALMAEFDNPNIVKLLGVCAVGKPMC 126
Query: 134 -------------------PNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKA 174
P+ + + A S + L IA Q+A
Sbjct: 127 LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAG 186
Query: 175 LQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLA-------EYRENLK-EISLKNWRSS 226
+ YL VHRD+ N L+ N+ +ADFGL+ Y+ + I ++ W
Sbjct: 187 MAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIR-W--- 242
Query: 227 GKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEA 285
M PE + ++ +SDV+++G+ + E+ + G+ PY +
Sbjct: 243 ------------------MPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM---- 280
Query: 286 QAHTVLEMNYTEQQLTAAVVSGGL--RPILASLELGLPASILSLIQRCWDGNPHNRPSFS 343
+++ V G + P P + +L++ CW P +RPSF
Sbjct: 281 ----------AHEEVIYYVRDGNILACP------ENCPLELYNLMRLCWSKLPADRPSFC 324
Query: 344 DIALELDLVLEHRKS 358
I L + E +
Sbjct: 325 SIHRILQRMCERAEG 339
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 64/287 (22%), Positives = 113/287 (39%), Gaps = 48/287 (16%)
Query: 68 YTLLSPIARGAESVVYEAT--LDGRKVAVK---KPILSTSEELDNFHKELQLLCKLDHPG 122
+ + + + +G+ + VY A G +VA+K K + + + E+++ C+L HP
Sbjct: 13 FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPS 72
Query: 123 LAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLG 182
+ + E + + L S ++ Q+ + YLH+ G
Sbjct: 73 ILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG 132
Query: 183 IVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTL 242
I+HRD+ +N+LL RN+ +ADFGLA + + GT
Sbjct: 133 ILHRDLTLSNLLLTRNMNIKIADFGLATQLK----------------MPHEKHYTLCGTP 176
Query: 243 IYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTA 302
Y++PEI + H +SDV+S G LL G P+ TV
Sbjct: 177 NYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPF-------DTDTVKNT--------- 220
Query: 303 AVVSGGLRPILASLELGLPASILS----LIQRCWDGNPHNRPSFSDI 345
L ++ + + +P+ + LI + NP +R S S +
Sbjct: 221 ------LNKVVLA-DYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSV 260
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-28
Identities = 70/319 (21%), Positives = 127/319 (39%), Gaps = 70/319 (21%)
Query: 68 YTLLSPIARGAES-VVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLD-HPGLAK 125
+ G+ VV++ + GR VAVK+ +L + D E++LL + D HP + +
Sbjct: 17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKR-MLI--DFCDIALMEIKLLTESDDHPNVIR 73
Query: 126 FVAAHAKPPN-YMF-------FFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQY 177
+ + Y+ + ES+N++++ + + +L Q+A + +
Sbjct: 74 YYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLR---QIASGVAH 130
Query: 178 LHNLGIVHRDVKPANVLLDRNLCPH-------------LADFGLAEYRENLKEISLKNWR 224
LH+L I+HRD+KP N+L+ + ++DFGL K++
Sbjct: 131 LHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLC------KKL------ 178
Query: 225 SSGKPTGGFHKKNMVGTLIYMAPEILKKEIH-------SEKSDVYSFGISINELLT-GVV 276
SG+ + + N GT + APE+L++ + + D++S G +L+ G
Sbjct: 179 DSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238
Query: 277 PYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNP 336
P+ D E + + S L L A LI + D +P
Sbjct: 239 PFGD------------KYSRESNIIRGIFSLDEMKCLHDRSLIAEA--TDLISQMIDHDP 284
Query: 337 HNRPSFSDIALELDLVLEH 355
RP+ VL H
Sbjct: 285 LKRPTAMK-------VLRH 296
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 7e-28
Identities = 82/311 (26%), Positives = 123/311 (39%), Gaps = 61/311 (19%)
Query: 63 LPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKK-PILSTSEELDNFHKELQLLCKL- 118
L I RGA V + G+ +AVK+ +E +L ++ +
Sbjct: 19 FTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSS 78
Query: 119 DHPGLAKFVAAHAKPPN------YMF--FFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQ 170
D P + +F A + + M F +FY+ + E + + I
Sbjct: 79 DCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPE-----EILGKITLA 133
Query: 171 LAKALQYLH-NLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKP 229
KAL +L NL I+HRD+KP+N+LLDR+ L DFG+ SG+
Sbjct: 134 TVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGI-----------------SGQL 176
Query: 230 TGGFHKKNMVGTLIYMAPEILKKEIH----SEKSDVYSFGISINELLTGVVPYTDLRAEA 285
K G YMAPE + +SDV+S GI++ EL TG PY
Sbjct: 177 VDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKW---- 232
Query: 286 QAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGL-PASILSLIQRCWDGNPHNRPSFSD 344
++V + QLT VV G P L++ E S ++ + C + RP
Sbjct: 233 --NSVFD------QLT-QVVKGDP-PQLSNSEEREFSPSFINFVNLCLTKDESKRPK--- 279
Query: 345 IALELDLVLEH 355
EL L+H
Sbjct: 280 -YKEL---LKH 286
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 54/234 (23%), Positives = 100/234 (42%), Gaps = 34/234 (14%)
Query: 64 PPSSYTLLSPIARGAESVVYEA--TLDGRKVAVKKPILSTSEELDNFHKELQLLCKL-DH 120
P + L+ + G VY+ G+ A+K + T +E + +E+ +L K H
Sbjct: 22 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKV-MDVTGDEEEEIKQEINMLKKYSHH 80
Query: 121 PGLAKFVAAHAKPPNYMFFF------EFYESRNLAEKLHVEEWSP-SVDQVLMIAAQLAK 173
+A + A K EF + ++ + + + + + + I ++ +
Sbjct: 81 RNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILR 140
Query: 174 ALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGF 233
L +LH ++HRD+K NVLL N L DFG+ S +
Sbjct: 141 GLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGV-----------------SAQLDRTV 183
Query: 234 HKKN-MVGTLIYMAPEILKKEIHSE-----KSDVYSFGISINELLTGVVPYTDL 281
++N +GT +MAPE++ + + + KSD++S GI+ E+ G P D+
Sbjct: 184 GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM 237
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 3e-27
Identities = 56/312 (17%), Positives = 107/312 (34%), Gaps = 58/312 (18%)
Query: 68 YTLLSPIARGAESVVYEATLDGRKVAVK-----------------KPILSTSEELDNFHK 110
Y ++ + +G + + D + A+K +S + D+F
Sbjct: 33 YRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKN 92
Query: 111 ELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLH-------VEEWSPSVDQ 163
ELQ++ + + +E+ E+ ++ + +
Sbjct: 93 ELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQV 152
Query: 164 VLMIAAQLAKALQYLHN-LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKN 222
+ I + + Y+HN I HRDVKP+N+L+D+N L+DFG +EY + K
Sbjct: 153 IKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKK------ 206
Query: 223 WRSSGKPTGGFHKKNMVGTLIYMAPEIL--KKEIHSEKSDVYSFGISINELLTGVVPYTD 280
K GT +M PE + + K D++S GI + + VVP++
Sbjct: 207 ------------IKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSL 254
Query: 281 LRAEAQAHTVLEM-------NYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWD 333
+++E+ N + L + ++
Sbjct: 255 ------KISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLR 308
Query: 334 GNPHNRPSFSDI 345
NP R + D
Sbjct: 309 KNPAERITSEDA 320
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-27
Identities = 68/341 (19%), Positives = 109/341 (31%), Gaps = 90/341 (26%)
Query: 68 YTLLSPIARGAESVVYEAT--LDGRKVAVK-----KPILSTSEELDNFHKELQLLCKLDH 120
Y L I +G+ VV A A+K K ++++ E++L+ KL H
Sbjct: 28 YHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHH 87
Query: 121 PGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAA----------- 169
P +A+ + E +L +KL+V + + +
Sbjct: 88 PNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNE 147
Query: 170 ----------------------------QLAKALQYLHNLGIVHRDVKPANVLL--DRNL 199
Q+ AL YLHN GI HRD+KP N L +++
Sbjct: 148 EAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSF 207
Query: 200 CPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHS--E 257
L DFGL+ + GT ++APE+L S
Sbjct: 208 EIKLVDFGLS------------KEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGP 255
Query: 258 KSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLR---PILA 314
K D +S G+ ++ LL G VP+ + + V++ L P
Sbjct: 256 KCDAWSAGVLLHLLLMGAVPFPG--------------VNDADTISQVLNKKLCFENPNYN 301
Query: 315 SLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH 355
L L+ + N R L+H
Sbjct: 302 V----LSPLARDLLSNLLNRNVDERFDAMR-------ALQH 331
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 109 bits (276), Expect = 6e-27
Identities = 61/287 (21%), Positives = 108/287 (37%), Gaps = 51/287 (17%)
Query: 68 YTLLSPIARGAESVVYEA--TLDGRKVAVK---KPILSTSEELDNFHKELQLLCKLDHPG 122
+ + P+ +G VY A +A+K K L + +E+++ L HP
Sbjct: 11 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 70
Query: 123 LAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLG 182
+ + E+ + +L + + +LA AL Y H+
Sbjct: 71 ILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCHSKR 129
Query: 183 IVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTL 242
++HRD+KP N+LL +ADFG + + + + + ++ GTL
Sbjct: 130 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR------------------RTDLCGTL 171
Query: 243 IYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTA 302
Y+ PE+++ +H EK D++S G+ E L G P+ +T E
Sbjct: 172 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA-------NTYQET--------- 215
Query: 303 AVVSGGLRPILASLELGLPASI----LSLIQRCWDGNPHNRPSFSDI 345
+ I +E P + LI R NP RP ++
Sbjct: 216 ------YKRIS-RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREV 255
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 72/303 (23%), Positives = 111/303 (36%), Gaps = 50/303 (16%)
Query: 63 LPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKK-PILSTSEELDNFHKELQLLCKL- 118
+ L + G V++ G +AVK+ EE +L ++ K
Sbjct: 22 AEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSH 81
Query: 119 DHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYL 178
D P + + + E + K ++ P + + + KAL YL
Sbjct: 82 DCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIP-ERILGKMTVAIVKALYYL 140
Query: 179 H-NLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKN 237
G++HRDVKP+N+LLD L DFG+ SG+ K
Sbjct: 141 KEKHGVIHRDVKPSNILLDERGQIKLCDFGI-----------------SGRLVDDKAKDR 183
Query: 238 MVGTLIYMAPEILKKEIHSE-----KSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLE 292
G YMAPE + ++ ++DV+S GIS+ EL TG PY + T E
Sbjct: 184 SAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNC------KTDFE 237
Query: 293 MNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352
LT + P+L +G S ++ C + RP +L
Sbjct: 238 ------VLTKVL--QEEPPLLPG-HMGFSGDFQSFVKDCLTKDHRKRPK----YNKL--- 281
Query: 353 LEH 355
LEH
Sbjct: 282 LEH 284
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 56/221 (25%), Positives = 103/221 (46%), Gaps = 28/221 (12%)
Query: 68 YTLLSPIARGAESVVYEAT--LDGRKVAVK---KPILSTSEELDNFHKELQLLCKLDHPG 122
Y ++ + +G+ V + + ++ AVK K +++ +E++LL KLDHP
Sbjct: 24 YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA-KNKDTSTILREVELLKKLDHPN 82
Query: 123 LAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLG 182
+ K ++ E Y L +++ ++ S I Q+ + Y+H
Sbjct: 83 IMKLFEILEDSSSFYIVGELYTGGELFDEI-IKRKRFSEHDAARIIKQVFSGITYMHKHN 141
Query: 183 IVHRDVKPANVLL---DRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMV 239
IVHRD+KP N+LL +++ + DFGL+ + ++ K+ +
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM-----------------KDRI 184
Query: 240 GTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTD 280
GT Y+APE+L+ + EK DV+S G+ + LL+G P+
Sbjct: 185 GTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYG 224
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 59/238 (24%), Positives = 95/238 (39%), Gaps = 64/238 (26%)
Query: 68 YTLLSPIARGAESVVYEAT--LDGRKVAVK---KPILSTSEELDNFHKELQLLCKLDHPG 122
+ + + GA S V+ L G+ A+K K L+N E+ +L K+ H
Sbjct: 11 FIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLEN---EIAVLKKIKHE- 66
Query: 123 LAKFVAAHAKPPNYMFFFEFYESRN-----------------LAEKLHVEEWSPSVDQVL 165
N + + YES + E+ E S+
Sbjct: 67 ------------NIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASL---- 110
Query: 166 MIAAQLAKALQYLHNLGIVHRDVKPANVLL---DRNLCPHLADFGLAEYRENLKEISLKN 222
+ Q+ A++YLH GIVHRD+KP N+L + N + DFGL++ +N
Sbjct: 111 -VIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN-------- 161
Query: 223 WRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTD 280
G GT Y+APE+L ++ +S+ D +S G+ LL G P+ +
Sbjct: 162 --------GIM--STACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYE 209
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 4e-26
Identities = 56/227 (24%), Positives = 93/227 (40%), Gaps = 31/227 (13%)
Query: 64 PPSSYTLLSPIARGAESVVYEA--TLDGRKVAVKKPIL---STSEELDNFHKELQLLCKL 118
P ++ L I G+ VY A + VA+KK ++E+ + KE++ L KL
Sbjct: 52 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL 111
Query: 119 DHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYL 178
HP ++ + + E+ + ++ L V + ++ + + L YL
Sbjct: 112 RHPNTIQYRGCYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYL 170
Query: 179 HNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKN- 237
H+ ++HRDVK N+LL L DFG A N
Sbjct: 171 HSHNMIHRDVKAGNILLSEPGLVKLGDFGSA---------------------SIMAPANS 209
Query: 238 MVGTLIYMAPEI---LKKEIHSEKSDVYSFGISINELLTGVVPYTDL 281
VGT +MAPE+ + + + K DV+S GI+ EL P ++
Sbjct: 210 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 256
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 5e-26
Identities = 59/228 (25%), Positives = 96/228 (42%), Gaps = 33/228 (14%)
Query: 68 YTLLSPIARGAESVVYEAT--LDGRKVAVK---KPILSTSEELD--NFHKELQLLCKLDH 120
Y L I +G SVV G++ AVK ++S L + +E + L H
Sbjct: 26 YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 121 PGLAKFVAAHAKPPNYMFFFEFYE-----SRNLAEKLHVEEWSPSVDQVLMIAAQLAKAL 175
P + + + ++ FEF + + +S +V M Q+ +AL
Sbjct: 86 PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMR--QILEAL 143
Query: 176 QYLHNLGIVHRDVKPANVLL---DRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGG 232
+Y H+ I+HRDVKP VLL + + L FG+A G
Sbjct: 144 RYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGE----------------SG 187
Query: 233 FHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTD 280
VGT +MAPE++K+E + + DV+ G+ + LL+G +P+
Sbjct: 188 LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYG 235
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 8e-26
Identities = 54/220 (24%), Positives = 91/220 (41%), Gaps = 28/220 (12%)
Query: 68 YTLLSPIARGAESVVYEAT--LDGRKVAVKKPILSTS--EELDNFHKELQLLCKLDHPGL 123
YTL + I RG+ V A + A K + E++D F +E++++ LDHP +
Sbjct: 11 YTLENTIGRGSWGEVKIAVQKGTRIRRAAK--KIPKYFVEDVDRFKQEIEIMKSLDHPNI 68
Query: 124 AKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGI 183
+ + E L E++ V + I + A+ Y H L +
Sbjct: 69 IRLYETFEDNTDIYLVMELCTGGELFERV-VHKRVFRESDAARIMKDVLSAVAYCHKLNV 127
Query: 184 VHRDVKPANVLL---DRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
HRD+KP N L + L DFGLA + K + + VG
Sbjct: 128 AHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM-----------------RTKVG 170
Query: 241 TLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTD 280
T Y++P++L+ + + D +S G+ + LL G P++
Sbjct: 171 TPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSA 209
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 8e-26
Identities = 56/222 (25%), Positives = 94/222 (42%), Gaps = 27/222 (12%)
Query: 68 YTLLSPIARGAESVVYEAT--LDGRKVAVKK-PILSTSEELDNFHKELQLLCKLDHPGLA 124
+ + GA V+ G + +K + ++ E+++L LDHP +
Sbjct: 24 FIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNII 83
Query: 125 KFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSP---SVDQVLMIAAQLAKALQYLHNL 181
K N E E L E++ + S V + Q+ AL Y H+
Sbjct: 84 KIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ 143
Query: 182 GIVHRDVKPANVLL---DRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNM 238
+VH+D+KP N+L + + DFGLAE ++ + N
Sbjct: 144 HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS-----------------TNA 186
Query: 239 VGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTD 280
GT +YMAPE+ K++ + K D++S G+ + LLTG +P+T
Sbjct: 187 AGTALYMAPEVFKRD-VTFKCDIWSAGVVMYFLLTGCLPFTG 227
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 58/221 (26%), Positives = 98/221 (44%), Gaps = 27/221 (12%)
Query: 68 YTLLSPIARGAESVVYEAT--LDGRKVAVK---KPILSTSEELDNFHKELQLLCKLDHPG 122
Y + + +GA SVV G + A K LS + + +E ++ KL HP
Sbjct: 8 YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPN 66
Query: 123 LAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLG 182
+ + + + + F+ L E + V S Q+ +++ Y H+ G
Sbjct: 67 IVRLHDSIQEESFHYLVFDLVTGGELFEDI-VAREFYSEADASHCIQQILESIAYCHSNG 125
Query: 183 IVHRDVKPANVLL---DRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMV 239
IVHR++KP N+LL + LADFGLA E+ + +
Sbjct: 126 IVHRNLKPENLLLASKAKGAAVKLADFGLA------IEV---------NDSEAW--HGFA 168
Query: 240 GTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTD 280
GT Y++PE+LKK+ +S+ D+++ G+ + LL G P+ D
Sbjct: 169 GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD 209
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 44/296 (14%), Positives = 78/296 (26%), Gaps = 72/296 (24%)
Query: 68 YTLLSPIARGAESVVYEA--TLDGRKVAVK---KPILSTSEELDNFHKELQLLCKLDHPG 122
Y LL ++A T R+VA+ + + L L ++D PG
Sbjct: 33 YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPG 92
Query: 123 LAK---FVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLH 179
+A+ V A E+ +L E + SPS + LA A H
Sbjct: 93 VARVLDVVHTRAGGLVVA---EWIRGGSLQEVA---DTSPSPVGAIRAMQSLAAAADAAH 146
Query: 180 NLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMV 239
G+ P+ V + + LA
Sbjct: 147 RAGVALSIDHPSRVRVSIDGDVVLAYPA-------------------------------- 174
Query: 240 GTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQ 299
M + + D+ G S+ LL P + + +
Sbjct: 175 ----TMPDA-------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE------RD 217
Query: 300 LTAAVVS-GGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE 354
+ + +P I ++ R G+ R + S + +
Sbjct: 218 TAGQPIEPADIDR-------DIPFQISAVAARSVQGDGGIRSA-STLLNLMQQATA 265
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-25
Identities = 64/321 (19%), Positives = 116/321 (36%), Gaps = 90/321 (28%)
Query: 68 YTLLSPIARGAESVVYEAT--LDGRKVAVK-----KPILSTSEELDNFHK---ELQLLCK 117
Y + + GA V A +KVA++ K + ++ E D E+++L K
Sbjct: 137 YIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKK 196
Query: 118 LDHPGLAKFVAAHAKPPNYMFFFEFYESRNL----------------AEKLHVEEWSPSV 161
L+HP + F+++ + ++E
Sbjct: 197 LNHP-------------CIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKE----- 238
Query: 162 DQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLL---DRNLCPHLADFGLAEYRENLKEI 218
+ Q+ A+QYLH GI+HRD+KP NVLL + + + DFG ++ +
Sbjct: 239 ATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM 298
Query: 219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIH---SEKSDVYSFGISINELLTGV 275
+ + GT Y+APE+L + D +S G+ + L+G
Sbjct: 299 -----------------RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGY 341
Query: 276 VPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLR-PILASLELGLPASILSLIQRCWDG 334
P+++ + T+ L + SG E+ A L L+++
Sbjct: 342 PPFSE-------------HRTQVSLKDQITSGKYNFIPEVWAEVSEKA--LDLVKKLLVV 386
Query: 335 NPHNRPSFSDIALELDLVLEH 355
+P R + + L H
Sbjct: 387 DPKARFTTEE-------ALRH 400
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 39/214 (18%), Positives = 84/214 (39%), Gaps = 22/214 (10%)
Query: 68 YTLLSPIARGAESVVYEAT--LDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAK 125
Y + + RG +V+ + K + + KE+ +L H +
Sbjct: 7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKF-VKVKGTDQVLVKKEISILNIARHRNILH 65
Query: 126 FVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVH 185
+ + FEF ++ E+++ + + +++ Q+ +ALQ+LH+ I H
Sbjct: 66 LHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGH 125
Query: 186 RDVKPANVLLDRNLCPHL--ADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLI 243
D++P N++ + +FG A + + +
Sbjct: 126 FDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF-----------------RLLFTAPE 168
Query: 244 YMAPEILKKEIHSEKSDVYSFGISINELLTGVVP 277
Y APE+ + ++ S +D++S G + LL+G+ P
Sbjct: 169 YYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINP 202
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 55/222 (24%), Positives = 94/222 (42%), Gaps = 30/222 (13%)
Query: 68 YTLLSPIARGAESVVYEAT--LDGRKVAVK---KPILSTSE---ELDNFHKELQLLCKLD 119
Y + + G ++V + G++ A K K LS+S + +E+ +L ++
Sbjct: 7 YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR 66
Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLH 179
HP + + + E L + L E+ S + D+ Q+ + YLH
Sbjct: 67 HPNIITLHDIFENKTDVVLILELVSGGELFDFL-AEKESLTEDEATQFLKQILDGVHYLH 125
Query: 180 NLGIVHRDVKPANVLLDRNLCPH----LADFGLAEYRENLKEISLKNWRSSGKPTGGFHK 235
+ I H D+KP N++L P+ L DFG+A E E
Sbjct: 126 SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF----------------- 168
Query: 236 KNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVP 277
KN+ GT ++APEI+ E ++D++S G+ LL+G P
Sbjct: 169 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 210
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 3e-25
Identities = 54/218 (24%), Positives = 94/218 (43%), Gaps = 26/218 (11%)
Query: 68 YTLLSPIARGAESVVYEAT--LDGRKVAVK---KPILSTSEELDNFHKELQLLCKLDHPG 122
Y L + +GA SVV L G++ A LS + +E ++ L HP
Sbjct: 13 YQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDH-QKLEREARICRLLKHPN 71
Query: 123 LAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLG 182
+ + + ++ ++ F+ L E + V S Q+ +A+ + H +G
Sbjct: 72 IVRLHDSISEEGHHYLIFDLVTGGELFEDI-VAREYYSEADASHCIQQILEAVLHCHQMG 130
Query: 183 IVHRDVKPANVLL---DRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMV 239
+VHR++KP N+LL + LADFGLA E +
Sbjct: 131 VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG--------------EQQAWFG--FA 174
Query: 240 GTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVP 277
GT Y++PE+L+K+ + + D+++ G+ + LL G P
Sbjct: 175 GTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPP 212
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 5e-25
Identities = 53/216 (24%), Positives = 86/216 (39%), Gaps = 21/216 (9%)
Query: 66 SSYTLLSPIARGAESVVYEAT--LDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGL 123
Y + + GA VV+ T G A K + + + KE+Q + L HP L
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 216
Query: 124 AKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGI 183
A + +EF L EK+ E S D+ + Q+ K L ++H
Sbjct: 217 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNY 276
Query: 184 VHRDVKPANVLLDRNLCPHL--ADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGT 241
VH D+KP N++ L DFGL + + + + K GT
Sbjct: 277 VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV-----------------KVTTGT 319
Query: 242 LIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVP 277
+ APE+ + + +D++S G+ LL+G+ P
Sbjct: 320 AEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP 355
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 5e-25
Identities = 49/214 (22%), Positives = 86/214 (40%), Gaps = 21/214 (9%)
Query: 68 YTLLSPIARGAESVVYEAT--LDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAK 125
Y +L + GA VV+ GR K + E+ ++ +L HP L
Sbjct: 53 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLIN 112
Query: 126 FVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVH 185
A + EF L +++ E++ S +V+ Q + L+++H IVH
Sbjct: 113 LHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVH 172
Query: 186 RDVKPANVLLDRNLCPHL--ADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLI 243
D+KP N++ + + DFGLA + + K T
Sbjct: 173 LDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV-----------------KVTTATAE 215
Query: 244 YMAPEILKKEIHSEKSDVYSFGISINELLTGVVP 277
+ APEI+ +E +D+++ G+ LL+G+ P
Sbjct: 216 FAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP 249
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 6e-25
Identities = 57/221 (25%), Positives = 96/221 (43%), Gaps = 27/221 (12%)
Query: 68 YTLLSPIARGAESVVYEAT--LDGRKVAVK---KPILSTSEELDNFHKELQLLCKLDHPG 122
Y + + +GA SVV G + A K LS + + +E ++ KL HP
Sbjct: 31 YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPN 89
Query: 123 LAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLG 182
+ + + + + F+ L E + V S Q+ +++ Y H+ G
Sbjct: 90 IVRLHDSIQEESFHYLVFDLVTGGELFEDI-VAREFYSEADASHCIQQILESIAYCHSNG 148
Query: 183 IVHRDVKPANVLL---DRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMV 239
IVHR++KP N+LL + LADFGLA + +
Sbjct: 149 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND------------SEAW-----HGFA 191
Query: 240 GTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTD 280
GT Y++PE+LKK+ +S+ D+++ G+ + LL G P+ D
Sbjct: 192 GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD 232
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 7e-25
Identities = 52/222 (23%), Positives = 89/222 (40%), Gaps = 30/222 (13%)
Query: 68 YTLLSPIARGAESVVYEAT--LDGRKVAVK---KPILSTSE---ELDNFHKELQLLCKLD 119
Y + + G ++V + G + A K K S + +E+ +L ++
Sbjct: 14 YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLH 179
H + + + + E L + L ++ S S ++ Q+ + YLH
Sbjct: 74 HHNVITLHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEATSFIKQILDGVNYLH 132
Query: 180 NLGIVHRDVKPANVLLDRNLCPH----LADFGLAEYRENLKEISLKNWRSSGKPTGGFHK 235
I H D+KP N++L P L DFGLA E+ E
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF----------------- 175
Query: 236 KNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVP 277
KN+ GT ++APEI+ E ++D++S G+ LL+G P
Sbjct: 176 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 7e-25
Identities = 62/238 (26%), Positives = 99/238 (41%), Gaps = 40/238 (16%)
Query: 61 LHLPPSSYTLLSPIARGAESVVYEA--TLDGRKVAVKK-PILSTSEELDNFHKELQLLCK 117
+ + + + RGA VV + G+ +AVK+ S+E +L + +
Sbjct: 2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMR 61
Query: 118 L-DHPGLAKFVAAHAKPPN------YM--FFFEFYESRNLAEKLHVEEWSPSVDQVLMIA 168
D P F A + + M +FY+ + + + + E D + IA
Sbjct: 62 TVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYK-QVIDKGQTIPE-----DILGKIA 115
Query: 169 AQLAKALQYLH-NLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
+ KAL++LH L ++HRDVKP+NVL++ + DFG IS
Sbjct: 116 VSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFG----------ISGYLVDDVA 165
Query: 228 KPTGGFHKKNMVGTLIYMAPEILKKEIH----SEKSDVYSFGISINELLTGVVPYTDL 281
K G YMAPE + E++ S KSD++S GI++ EL PY
Sbjct: 166 KDI-------DAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSW 216
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-24
Identities = 53/222 (23%), Positives = 90/222 (40%), Gaps = 30/222 (13%)
Query: 68 YTLLSPIARGAESVVYEAT--LDGRKVAVK---KPILSTSEEL---DNFHKELQLLCKLD 119
Y + + G ++V + G + A K K S + +E+ +L ++
Sbjct: 14 YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL 73
Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLH 179
HP + + + + E L + L ++ S S ++ Q+ + YLH
Sbjct: 74 HPNIITLHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEATSFIKQILDGVNYLH 132
Query: 180 NLGIVHRDVKPANVLLDRNLCPH----LADFGLAEYRENLKEISLKNWRSSGKPTGGFHK 235
I H D+KP N++L P L DFGLA E+ E
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF----------------- 175
Query: 236 KNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVP 277
KN+ GT ++APEI+ E ++D++S G+ LL+G P
Sbjct: 176 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 51/218 (23%), Positives = 91/218 (41%), Gaps = 24/218 (11%)
Query: 68 YTLLSPIARGAESVVYEA--TLDGRKVAVK---KPILSTSEELDNFHKELQLLCKLDHPG 122
+ + P+ +G VY A + +A+K K L +E+++ L HP
Sbjct: 16 FDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPN 75
Query: 123 LAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLG 182
+ + EF L ++L + + +LA AL Y H
Sbjct: 76 ILRMYNYFHDRKRIYLMLEFAPRGELYKEL-QKHGRFDEQRSATFMEELADALHYCHERK 134
Query: 183 IVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTL 242
++HRD+KP N+L+ +ADFG + + +L+ ++ M GTL
Sbjct: 135 VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR------------------RRTMCGTL 176
Query: 243 IYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTD 280
Y+ PE+++ + H EK D++ G+ E L G+ P+
Sbjct: 177 DYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDS 214
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 53/222 (23%), Positives = 92/222 (41%), Gaps = 30/222 (13%)
Query: 68 YTLLSPIARGAESVVYEAT--LDGRKVAVK---KPILSTSE---ELDNFHKELQLLCKLD 119
Y + G +VV + G + A K K +S ++ +E+ +L ++
Sbjct: 13 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLH 179
HP + + + + E L + L E+ S + ++ Q+ + YLH
Sbjct: 73 HPNVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQILNGVYYLH 131
Query: 180 NLGIVHRDVKPANVLLDRNLCPH----LADFGLAEYRENLKEISLKNWRSSGKPTGGFHK 235
+L I H D+KP N++L P + DFGLA + E
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF----------------- 174
Query: 236 KNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVP 277
KN+ GT ++APEI+ E ++D++S G+ LL+G P
Sbjct: 175 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
|
| >2pk0_A Serine/threonine protein phosphatase STP1; SI motif, signaling protein; 2.65A {Streptococcus agalactiae} Length = 250 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 7e-24
Identities = 55/253 (21%), Positives = 98/253 (38%), Gaps = 32/253 (12%)
Query: 439 RRETMEDTHFLMPHMYNQKEIHMFGIFDGHRGSAAAEF-SARALPGFLQNLGSTTRPTDA 497
RR +D N+ + + + DG G A S + + T +
Sbjct: 17 RRSNNQDFINQFE---NKAGVPLIILADGMGGHRAGNIASEMTVTDLGSDWAETDFSELS 73
Query: 498 LLEAFIRTDVAFRNELDSLRKSKRVVQKDWHP-----GCTAIAALIVRNRLFVANAGDCR 552
+ ++ + N ++ + G T A IV + + A+ GD R
Sbjct: 74 EIRDWMLVSIETENR--------KIYELGQSDDYKGMGTTIEAVAIVGDNIIFAHVGDSR 125
Query: 553 AILCRGGHPFALSRDHVASCLEERERVVSAGGNVNWQVDTWRVGPPALQVTRSIGDDDLK 612
+ R G L+ DH S + E +V AG + + P +T+SIG +
Sbjct: 126 IGIVRQGEYHLLTSDH--SLVNE---LVKAGQLTEEEAASH---PQKNIITQSIGQAN-- 175
Query: 613 PAVTAEPEITETIMTPEDEYLVMASDGLWDVVSHVEAVGIIKDTVKEPGMCSKRLATEAA 672
EP++ ++ D + + SDGL +++S+ + ++ K ++ L T A
Sbjct: 176 ---PVEPDLGVHLLEEGDYLV-VNSDGLTNMLSNADIATVLTQE-KTLDDKNQDLITLAN 230
Query: 673 ERGSKDNITVIVV 685
RG DNITV +V
Sbjct: 231 HRGGLDNITVALV 243
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 7e-24
Identities = 61/235 (25%), Positives = 97/235 (41%), Gaps = 59/235 (25%)
Query: 68 YTLLSPIARGAESVVYEAT--LDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAK 125
+ + S + RGA S+VY + A+K +L + + E+ +L +L HP
Sbjct: 55 FEVESELGRGATSIVYRCKQKGTQKPYALK--VLKKTVDKKIVRTEIGVLLRLSHP---- 108
Query: 126 FVAAHAKPPNYMFFFEFYESRN-----------------LAEKLHVEEWSPSVDQVLMIA 168
N + E +E+ + EK + E D +
Sbjct: 109 ---------NIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSE----RDAADAVK 155
Query: 169 AQLAKALQYLHNLGIVHRDVKPANVLL---DRNLCPHLADFGLAEYRENLKEISLKNWRS 225
Q+ +A+ YLH GIVHRD+KP N+L + +ADFGL++ E+ +
Sbjct: 156 -QILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLM------- 207
Query: 226 SGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTD 280
K + GT Y APEIL+ + + D++S GI LL G P+ D
Sbjct: 208 ----------KTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYD 252
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 2e-23
Identities = 49/192 (25%), Positives = 79/192 (41%), Gaps = 48/192 (25%)
Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
+L AL YL N I+HRD+KP N+LLD + H+ DF +A + + ++
Sbjct: 121 ICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIA------AMLPRETQITT- 173
Query: 228 KPTGGFHKKNMVGTLIYMAPEILKKEI---HSEKSDVYSFGISINELLTGVVPYTDLRAE 284
M GT YMAPE+ +S D +S G++ ELL G PY +
Sbjct: 174 ----------MAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSST 223
Query: 285 AQAHTVLEMNYTEQQLTAAVVSGGLR-PILASLELGLPASILSLIQRCWDGNPHNR---- 339
+ +++ + + P S E ++SL+++ + NP R
Sbjct: 224 -----------SSKEIVHTFETTVVTYPSAWSQE------MVSLLKKLLEPNPDQRFSQL 266
Query: 340 ------PSFSDI 345
P +DI
Sbjct: 267 SDVQNFPYMNDI 278
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 59/247 (23%), Positives = 98/247 (39%), Gaps = 68/247 (27%)
Query: 68 YTLLSPIARGAESVVYEAT--LDGRKVAVK-----KPILSTSEEL----DNFHKELQLLC 116
Y + RG SVV ++ AVK ++EE+ + KE+ +L
Sbjct: 19 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 78
Query: 117 KLDHPGLAKFVAAHAKPPNYMFFFEFYESRN-----------------LAEKLHVEEWSP 159
K+ H PN + + YE+ L EK+ + E
Sbjct: 79 KVSG---------H---PNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSE--- 123
Query: 160 SVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEIS 219
+ I L + + LH L IVHRD+KP N+LLD ++ L DFG + ++
Sbjct: 124 --KETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFS------CQL- 174
Query: 220 LKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEI------HSEKSDVYSFGISINELLT 273
P + + GT Y+APEI++ + + ++ D++S G+ + LL
Sbjct: 175 --------DPGEKL--REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLA 224
Query: 274 GVVPYTD 280
G P+
Sbjct: 225 GSPPFWH 231
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-23
Identities = 49/244 (20%), Positives = 93/244 (38%), Gaps = 62/244 (25%)
Query: 68 YTLLSPIARGAESVVYEAT--LDGRKVAVKKPILSTSEELDNFHKELQLLCKL-DHPGLA 124
Y + I G+ SV + AVK I+ S+ + +E+++L + HP
Sbjct: 24 YEVKEDIGVGSYSVCKRCIHKATNMEFAVK--IIDKSKR--DPTEEIEILLRYGQHP--- 76
Query: 125 KFVAAHAKPPNYMFFFEFYESRN-----------------LAEKLHVEEWSPSVDQVLMI 167
N + + Y+ + + E + +
Sbjct: 77 ----------NIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSE-----REASAV 121
Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLL---DRNLCP-HLADFGLAEYRENLKEISLKNW 223
+ K ++YLH G+VHRD+KP+N+L N + DFG A K++
Sbjct: 122 LFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFA------KQL----- 170
Query: 224 RSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRA 283
+ G T ++APE+L+++ + D++S G+ + +LTG P+ +
Sbjct: 171 ----RAENGLLMT-PCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPD 225
Query: 284 EAQA 287
+
Sbjct: 226 DTPE 229
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 3e-23
Identities = 55/243 (22%), Positives = 95/243 (39%), Gaps = 44/243 (18%)
Query: 55 SSQSIPLHLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVK---KPILSTSEELDNFH 109
P P + + G+ S V A R+ A+K K + ++
Sbjct: 19 QPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVT 78
Query: 110 KELQLLCKLDHPGLAKFVAAHAKPPN-YM---------FFFEFYESRNLAEKLHVEEWSP 159
+E ++ +LDHP K Y + + E
Sbjct: 79 RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE--------- 129
Query: 160 SVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPH--LADFGLAEYRENLKE 217
A++ AL+YLH GI+HRD+KP N+LL+ ++ H + DFG A K
Sbjct: 130 --TCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDM--HIQITDFGTA------KV 179
Query: 218 ISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVP 277
+S + + VGT Y++PE+L ++ + SD+++ G I +L+ G+ P
Sbjct: 180 LS--------PESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231
Query: 278 YTD 280
+
Sbjct: 232 FRA 234
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 5e-23
Identities = 57/248 (22%), Positives = 95/248 (38%), Gaps = 58/248 (23%)
Query: 68 YTLLSPIARGAESVVYEAT--LDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAK 125
P+ G+ S+ + + AVK I+S N KE+ L +
Sbjct: 13 DLKDKPLGEGSFSICRKCVHKKSNQAFAVK--IISKRM-EANTQKEITALKLCEG----- 64
Query: 126 FVAAHAKPPNYMFFFEFYESRN-----------------LAEKLHVEEWSPSVDQVLMIA 168
H PN + E + + + +K H E S I
Sbjct: 65 ----H---PNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASY-----IM 112
Query: 169 AQLAKALQYLHNLGIVHRDVKPANVLL---DRNLCPHLADFGLAEYRENLKEISLKNWRS 225
+L A+ ++H++G+VHRD+KP N+L + NL + DFG A +
Sbjct: 113 RKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLK------------- 159
Query: 226 SGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEA 285
P K TL Y APE+L + + E D++S G+ + +L+G VP+
Sbjct: 160 --PPDNQPLKT-PCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSL 216
Query: 286 QAHTVLEM 293
+ +E+
Sbjct: 217 TCTSAVEI 224
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 6e-23
Identities = 62/307 (20%), Positives = 110/307 (35%), Gaps = 89/307 (28%)
Query: 68 YTLLSPIARGAESVVYEAT--LDGRKVAVK---KPILSTSEELDNFHK---ELQLLCKLD 119
Y + + G VY D VA+K K +S EL N + E+ LL K+
Sbjct: 45 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 104
Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRN------------------LAEKLHVEEWSPSV 161
+ +++E + + E+ ++E
Sbjct: 105 SG-----------FSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQE----- 148
Query: 162 DQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCP-HLADFGLAEYRENLKEISL 220
+ Q+ +A+++ HN G++HRD+K N+L+D N L DFG LK+
Sbjct: 149 ELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL---LKDTVY 205
Query: 221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILK-KEIHSEKSDVYSFGISINELLTGVVPYT 279
++ GT +Y PE ++ H + V+S GI + +++ G +P+
Sbjct: 206 TDF---------------DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 250
Query: 280 DLRAEAQAHTVLEMNYTEQQLTAAVVSGGLR-PILASLELGLPASILSLIQRCWDGNPHN 338
++ G + S E LI+ C P +
Sbjct: 251 HDE--------------------EIIRGQVFFRQRVSSEC------QHLIRWCLALRPSD 284
Query: 339 RPSFSDI 345
RP+F +I
Sbjct: 285 RPTFEEI 291
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 7e-23
Identities = 53/245 (21%), Positives = 94/245 (38%), Gaps = 67/245 (27%)
Query: 68 YTLLSPIARGAESVVYEAT--LDGRKVAVK-----KPILSTSEELDNFHK---ELQLLCK 117
Y + + GA V A +KVA+K K + ++ E D E+++L K
Sbjct: 12 YIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKK 71
Query: 118 LDHPGLAKFVAAHAKPPNYMFFFEFYESRNL----------------AEKLHVEEWSPSV 161
L+HP + F+++ + ++E
Sbjct: 72 LNHP-------------CIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKE----- 113
Query: 162 DQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLL---DRNLCPHLADFGLAEYRENLKEI 218
+ Q+ A+QYLH GI+HRD+KP NVLL + + + DFG ++
Sbjct: 114 ATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE---- 169
Query: 219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEI---HSEKSDVYSFGISINELLTGV 275
+ + GT Y+APE+L ++ D +S G+ + L+G
Sbjct: 170 ------------TSLMRT-LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGY 216
Query: 276 VPYTD 280
P+++
Sbjct: 217 PPFSE 221
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 1e-22
Identities = 46/218 (21%), Positives = 97/218 (44%), Gaps = 23/218 (10%)
Query: 66 SSYTLLSP--IARGAESVVYEAT--LDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP 121
S YT+ + G V++ G K+A K ++ + E+ ++ +LDH
Sbjct: 87 SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHA 146
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL 181
L + A + + E+ + L +++ E ++ + ++ Q+ + ++++H +
Sbjct: 147 NLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQM 206
Query: 182 GIVHRDVKPANVLLDRNLCPHL--ADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMV 239
I+H D+KP N+L + DFGLA + +++ K
Sbjct: 207 YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL-----------------KVNF 249
Query: 240 GTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVP 277
GT ++APE++ + S +D++S G+ LL+G+ P
Sbjct: 250 GTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSP 287
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 98.8 bits (246), Expect = 2e-22
Identities = 45/228 (19%), Positives = 93/228 (40%), Gaps = 36/228 (15%)
Query: 130 HAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVK 189
+ ++ + + + +++ ++ + Q+AK +++L + +HRD+
Sbjct: 161 SSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLA 220
Query: 190 PANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEI 249
N+LL + DFGLA R+ K+ ++ G K +MAPE
Sbjct: 221 ARNILLSEKNVVKICDFGLA--RDIYKD---PDYVRKGD--ARLPLK-------WMAPET 266
Query: 250 LKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGG 308
+ +++ +SDV+SFG+ + E+ + G PY ++ + + + G
Sbjct: 267 IFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---FCRR----------LKEGT 313
Query: 309 --LRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE 354
P + + CW G P RP+FS++ L +L+
Sbjct: 314 RMRAPDYT------TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 355
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 2e-22
Identities = 57/295 (19%), Positives = 102/295 (34%), Gaps = 65/295 (22%)
Query: 68 YTLLSPIARGAESVVYEAT--LDGRKVAVK--------KPILSTSEELDNFHKELQLLCK 117
Y+ +SP+ GA V+ A ++V VK + +L E+ +L +
Sbjct: 26 YSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSR 85
Query: 118 LDHPGLAKFVAAHAKPPNYMFFFEFYESRN-----LAEKLHVEEWSPSVDQVLMIAAQLA 172
++H + K + + E + S + ++E I QL
Sbjct: 86 VEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDE-----PLASYIFRQLV 140
Query: 173 KALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGG 232
A+ YL I+HRD+K N+++ + L DFG + G
Sbjct: 141 SAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGS-----------------AAYLERG 183
Query: 233 FHKKNMVGTLIYMAPEILK-KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVL 291
GT+ Y APE+L + +++S G+++ L+ P+ +L
Sbjct: 184 KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELE--------- 234
Query: 292 EMNYTEQQLTAAVVSGGLR-PILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
V + P L S EL +SL+ P R + +
Sbjct: 235 -----------ETVEAAIHPPYLVSKEL------MSLVSGLLQPVPERRTTLEKL 272
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 3e-22
Identities = 68/289 (23%), Positives = 114/289 (39%), Gaps = 54/289 (18%)
Query: 68 YTLLSPIARGAESVVYEAT--LDGRKVAVKKPILS----TSEELDNFHKELQLLCKLDHP 121
Y LL I +G + V A L GR+VA+K I+ L +E++++ L+HP
Sbjct: 17 YRLLKTIGKGNFAKVKLARHILTGREVAIK--IIDKTQLNPTSLQKLFREVRIMKILNHP 74
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKL----HVEEWSPSVDQVLMIAAQLAKALQY 177
+ K E+ + + L ++E + Q+ A+QY
Sbjct: 75 NIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKE-----KEARSKFRQIVSAVQY 129
Query: 178 LHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKN 237
H IVHRD+K N+LLD ++ +ADFG S + T G
Sbjct: 130 CHQKRIVHRDLKAENLLLDADMNIKIADFGF-----------------SNEFTVGGKLDA 172
Query: 238 MVGTLIYMAPEILK-KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYT 296
G Y APE+ + K+ + DV+S G+ + L++G +P+
Sbjct: 173 FCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG--------------QN 218
Query: 297 EQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
++L V+ G R + + +L++R NP R + I
Sbjct: 219 LKELRERVLRGKYR-----IPFYMSTDCENLLKRFLVLNPIKRGTLEQI 262
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 3e-22
Identities = 53/260 (20%), Positives = 95/260 (36%), Gaps = 37/260 (14%)
Query: 68 YTLLS-PIARGAESVVYEAT--LDGRKVAVKKPILSTS--EELDNFHKELQLLCKL-DHP 121
Y L + GA + V + ++ AVK I+ +E+++L + H
Sbjct: 14 YQLQEDVLGEGAHARVQTCINLITSQEYAVK--IIEKQPGHIRSRVFREVEMLYQCQGHR 71
Query: 122 GLAKFVAAHAKPPNYMFFFEFYE-----SRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQ 176
+ + + + + FE S + ++ H E SV + +A AL
Sbjct: 72 NVLELIEFFEEEDRFYLVFEKMRGGSILSH-IHKRRHFNELEASV-----VVQDVASALD 125
Query: 177 YLHNLGIVHRDVKPANVLL---DRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGF 233
+LHN GI HRD+KP N+L ++ + DF L + P
Sbjct: 126 FLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL---------NGDCSPISTP 176
Query: 234 HKKNMVGTLIYMAPEILKKEIHSEKS-----DVYSFGISINELLTGVVP-YTDLRAEAQA 287
G+ YMAPE+++ D++S G+ + LL+G P ++
Sbjct: 177 ELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGW 236
Query: 288 HTVLEMNYTEQQLTAAVVSG 307
+ L ++ G
Sbjct: 237 DRGEACPACQNMLFESIQEG 256
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 4e-22
Identities = 50/243 (20%), Positives = 83/243 (34%), Gaps = 77/243 (31%)
Query: 68 YTLLS-PIARGAESVVYEAT--LDGRKVAVKKPILSTSEELDNFHKELQLLCKL-DHPGL 123
Y L + G V E G+K A+K +L S + +E+ + P
Sbjct: 30 YQLSKQVLGLGVNGKVLECFHRRTGQKCALK--LLYDSPKA---RQEVDHHWQASGGP-- 82
Query: 124 AKFVAAHAKPPNYMFFFEFYESRNLAEKLH--VEEWSPSVDQVLM--------------- 166
+ + + YE+ + ++ + E M
Sbjct: 83 -----------HIVCILDVYENMHHGKRCLLIIME--------CMEGGELFSRIQERGDQ 123
Query: 167 ---------IAAQLAKALQYLHNLGIVHRDVKPANVLL---DRNLCPHLADFGLAEYREN 214
I + A+Q+LH+ I HRDVKP N+L +++ L DFG A+
Sbjct: 124 AFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ 183
Query: 215 LKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTG 274
T Y+APE+L E + + D++S G+ + LL G
Sbjct: 184 ----------------NALQT--PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 225
Query: 275 VVP 277
P
Sbjct: 226 FPP 228
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 99.9 bits (249), Expect = 4e-22
Identities = 37/115 (32%), Positives = 59/115 (51%), Gaps = 21/115 (18%)
Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPH--LADFGLAEYRENLKEISLKNWRS 225
AA++ L+ LH IV+RD+KP N+LLD + H ++D GLA +
Sbjct: 292 AAEICCGLEDLHRERIVYRDLKPENILLDDH--GHIRISDLGLA------VHV------P 337
Query: 226 SGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTD 280
G+ G VGT+ YMAPE++K E ++ D ++ G + E++ G P+
Sbjct: 338 EGQTIKGR-----VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQ 387
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 5e-22
Identities = 64/298 (21%), Positives = 110/298 (36%), Gaps = 69/298 (23%)
Query: 68 YTLLSPIARGAESVVYEAT--LDGRKVAVK---KPILSTSEELDNFHK---ELQLLCKLD 119
Y L + +G V+ D +VA+K + + L + E+ LL K+
Sbjct: 33 YRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVG 92
Query: 120 ----HPGLAKFVAAHAKPPNYMFFFEFYESRN-----LAEKLHVEEWSPSVDQVLMIAAQ 170
HPG+ + + +M E + EK + E Q
Sbjct: 93 AGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGE-----GPSRCFFGQ 147
Query: 171 LAKALQYLHNLGIVHRDVKPANVLLD-RNLCPHLADFGLAEYRENLKEISLKNWRSSGKP 229
+ A+Q+ H+ G+VHRD+K N+L+D R C L DFG +
Sbjct: 148 VVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHD--------------- 192
Query: 230 TGGFHKKNMVGTLIYMAPEILK-KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAH 288
+ GT +Y PE + + H+ + V+S GI + +++ G +P+ +
Sbjct: 193 -EPYTD--FDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------ 243
Query: 289 TVLEMNYTEQQLTAAVVSGGLR-PILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
++ L P S + +LI+RC P +RPS +I
Sbjct: 244 --------------EILEAELHFPAHVSPDC------CALIRRCLAPKPSSRPSLEEI 281
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 5e-22
Identities = 63/271 (23%), Positives = 100/271 (36%), Gaps = 73/271 (26%)
Query: 45 EPNTCIRGCCSSQSIPLHLPPSS----YTLLSPIARGAESVVYEAT--LDGRKVAVK--- 95
N + +P Y I RG SVV G + AVK
Sbjct: 69 TENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIME 128
Query: 96 KPILSTSEEL-----DNFHKELQLLCKL-DHPGLAKFVAAHAKPPNYMFFFEFYESRN-- 147
S E + +E +L ++ HP + + + YES +
Sbjct: 129 VTAERLSPEQLEEVREATRRETHILRQVAGHP-------------HIITLIDSYESSSFM 175
Query: 148 ---------------LAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPAN 192
L EK+ + E + I L +A+ +LH IVHRD+KP N
Sbjct: 176 FLVFDLMRKGELFDYLTEKVALSE-----KETRSIMRSLLEAVSFLHANNIVHRDLKPEN 230
Query: 193 VLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK 252
+LLD N+ L+DFG + + +P + + GT Y+APEILK
Sbjct: 231 ILLDDNMQIRLSDFGFS------CHL---------EPGEKL--RELCGTPGYLAPEILKC 273
Query: 253 EI------HSEKSDVYSFGISINELLTGVVP 277
+ + ++ D+++ G+ + LL G P
Sbjct: 274 SMDETHPGYGKEVDLWACGVILFTLLAGSPP 304
|
| >1txo_A Putative bacterial enzyme; serine/threonine protein phosphatases, PSTP/PPP, structural genomics, PSI, protein structure initiative; 1.95A {Mycobacterium tuberculosis} SCOP: d.219.1.1 PDB: 2cm1_A Length = 237 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 5e-22
Identities = 40/163 (24%), Positives = 63/163 (38%), Gaps = 31/163 (19%)
Query: 530 GCTAIAALIVRNRLFVANAGDCRAILCRGGHPFALSRDH--VASCLE-----ERERVVSA 582
G T A L NRL + + GD R L R G +++D V + ++ E
Sbjct: 95 GTTLTAILFAGNRLGLVHIGDSRGYLLRDGELTQITKDDTFVQTLVDEGRITPEEAHSHP 154
Query: 583 GGNVNWQVDTWRVGPPALQVTRSIGDDDLKPAVTAEPEITETIMTPEDEYLVMASDGLWD 642
++ + R++ ++ EP +T D YL + SDGL D
Sbjct: 155 QRSL---------------IMRALTGHEV------EPTLTMREARAGDRYL-LCSDGLSD 192
Query: 643 VVSHVEAVGIIKDTVKEPGMCSKRLATEAAERGSKDNITVIVV 685
VS + ++ E + RL A G DN+TV+V
Sbjct: 193 PVSDETILEALQI--PEVAESAHRLIELALRGGGPDNVTVVVA 233
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 1e-21
Identities = 58/234 (24%), Positives = 89/234 (38%), Gaps = 31/234 (13%)
Query: 61 LHLPPSSYTLLSPIARGAESVVY--EATLDGRKVAVK---KPILSTSEELDNFHKELQLL 115
+ L + +L I RGA S V + G+ A+K K + E+ F +E +L
Sbjct: 56 VRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVL 115
Query: 116 CKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKAL 175
D + + A E+Y +L L + A++ A+
Sbjct: 116 VNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAI 175
Query: 176 QYLHNLGIVHRDVKPANVLLDRNLCPH--LADFGLAEYRENLKEISLKNWRSSGKPTGGF 233
+H LG VHRD+KP N+LLDR H LADFG + + G
Sbjct: 176 DSVHRLGYVHRDIKPDNILLDRC--GHIRLADFGSC------LK---------LRADGTV 218
Query: 234 HKKNMVGTLIYMAPEILKKEIHSEKSDVY-------SFGISINELLTGVVPYTD 280
VGT Y++PEIL+ + Y + G+ E+ G P+
Sbjct: 219 RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYA 272
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 94.9 bits (237), Expect = 2e-21
Identities = 44/115 (38%), Positives = 68/115 (59%), Gaps = 20/115 (17%)
Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPH--LADFGLAEYRENLKEISLKNWRS 225
A+LA AL +LH+LGI++RD+KP N+LLD H L DFGL+ +E++
Sbjct: 132 LAELALALDHLHSLGIIYRDLKPENILLDEE--GHIKLTDFGLS--KESIDH-------- 179
Query: 226 SGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTD 280
K F GT+ YMAPE++ + H++ +D +SFG+ + E+LTG +P+
Sbjct: 180 -EKKAYSF-----CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQG 228
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 2e-21
Identities = 52/234 (22%), Positives = 88/234 (37%), Gaps = 55/234 (23%)
Query: 68 YTLLS-PIARGAESVVYEAT--LDGRKVAVK---KPILSTSEELDNFHKELQLLCKLDHP 121
Y L S + RG +VV + G++ A K K E+ +L
Sbjct: 30 YILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCR-AEILHEIAVLELAKSC 88
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRN-------------LAEKLHVEEWSPSV--DQVLM 166
P + E YE+ + + + E + V + V+
Sbjct: 89 ------------PRVINLHEVYENTSEIILILEYAAGGEIFSLC-LPELAEMVSENDVIR 135
Query: 167 IAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPH---LADFGLAEYRENLKEISLKNW 223
+ Q+ + + YLH IVH D+KP N+LL + DFG++ + E+
Sbjct: 136 LIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACEL----- 190
Query: 224 RSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVP 277
+ ++GT Y+APEIL + + +D+++ GI LLT P
Sbjct: 191 ------------REIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSP 232
|
| >2j82_A TPPHA, protein serine-threonine phosphatase; PP2C family phosphatase, hydrolase; 1.28A {Synechococcus elongatus} PDB: 2j86_A 2y09_A 2xzv_A Length = 240 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 2e-21
Identities = 49/250 (19%), Positives = 94/250 (37%), Gaps = 26/250 (10%)
Query: 439 RRETMEDTHFLMPHMYNQKEIHMFGIFDGHRGSAAAEF-SARALPGFLQNLGSTTRPTDA 497
R++ +D + ++K F + DG G A E S A+ Q L +
Sbjct: 12 IRKSNQDAFY-----IDEKHQRFFIVADGMGGHAGGEEASRLAVDHIRQYLETHLEDLQH 66
Query: 498 LLEAFIRTDVAFRNELDSLRKSKRVVQKDWHPGCTAIAALIVR--NRLFVANAGDCRAIL 555
+R N + + ++ + G TA+ L+ +R + A+ GD R
Sbjct: 67 DPVTLLRQAFLAANH-AIVEQQRQNSARA-DMGTTAVVILLDEKGDRAWCAHVGDSRIYR 124
Query: 556 CRGGHPFALSRDHVASCLEERERVVSAGGNVNWQVDTWRVGPPALQVTRSIGDDDLKPAV 615
R ++ DH + + + V G Q P +++ +G +D
Sbjct: 125 WRKDQLQQITSDH--TWIAQA---VQLGSLTIEQARQH---PWRHVLSQCLGRED----- 171
Query: 616 TAEPEITETIMTPEDEYLVMASDGLWDVVSHVEAVGIIKDTVKEPGMCSKRLATEAAERG 675
++ +I + P D L + SDGL + ++ + + + L A G
Sbjct: 172 LSQIDIQPIDLEPGDRLL-LCSDGLTEELTDDVISIYLSE--PNVQKAAAALVDAAKTHG 228
Query: 676 SKDNITVIVV 685
+DN+TV+V+
Sbjct: 229 GRDNVTVVVI 238
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 96.4 bits (240), Expect = 5e-21
Identities = 34/115 (29%), Positives = 58/115 (50%), Gaps = 20/115 (17%)
Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPH--LADFGLAEYRENLKEISLKNWRS 225
AQ+ L++LH I++RD+KP NVLLD + + ++D GLA E+ +
Sbjct: 295 TAQIVSGLEHLHQRNIIYRDLKPENVLLDDD--GNVRISDLGLA------VELK-----A 341
Query: 226 SGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTD 280
T G+ GT +MAPE+L E + D ++ G+++ E++ P+
Sbjct: 342 GQTKTKGY-----AGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRA 391
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 6e-21
Identities = 56/231 (24%), Positives = 96/231 (41%), Gaps = 52/231 (22%)
Query: 65 PSSYTLLSPIARGAESVVYEATL-DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP-- 121
+YT I G+ VV++A L + +VA+KK + + +ELQ++ + HP
Sbjct: 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKN----RELQIMRIVKHPNV 94
Query: 122 -GLAKFVAAHAKPPNYMFF---FEFYESRNLAEKLH-VEEWSPSVDQVLMIAA------Q 170
L F ++ + +F E+ E ++ + Q + + Q
Sbjct: 95 VDLKAFFYSNGDKKDEVFLNLVLEYVP-----ETVYRASRHYAKLKQTMPMLLIKLYMYQ 149
Query: 171 LAKALQYLHNLGIVHRDVKPANVLLDRNLCPHL--ADFGLA----EYRENLKEISLKNWR 224
L ++L Y+H++GI HRD+KP N+LLD L DFG A N+ I
Sbjct: 150 LLRSLAYIHSIGICHRDIKPQNLLLDPP-SGVLKLIDFGSAKILIAGEPNVSYIC----- 203
Query: 225 SSGKPTGGFHKKNMVGTLIYMAPEILKKEIH-SEKSDVYSFGISINELLTG 274
+ Y APE++ + + D++S G + EL+ G
Sbjct: 204 ----------------SRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQG 238
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 8e-21
Identities = 50/257 (19%), Positives = 82/257 (31%), Gaps = 75/257 (29%)
Query: 68 YTLLSPIARGAESVVYEAT--LDGRKVAVKKPILSTSEELDNFHKELQLLCKL-DHPGLA 124
+ G V + K A+K +L + +E++L + P
Sbjct: 64 KVTSQVLGLGINGKVLQIFNKRTQEKFALK--MLQDCPKA---RREVELHWRASQCP--- 115
Query: 125 KFVAAHAKPPNYMFFFEFYESRNLAEKLH--VEEWSPSVDQVLM---------------- 166
+ + + YE+ K V E +
Sbjct: 116 ----------HIVRIVDVYENLYAGRKCLLIVME--------CLDGGELFSRIQDRGDQA 157
Query: 167 --------IAAQLAKALQYLHNLGIVHRDVKPANVLL---DRNLCPHLADFGLAEYRENL 215
I + +A+QYLH++ I HRDVKP N+L N L DFG A+
Sbjct: 158 FTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET--- 214
Query: 216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGV 275
T Y+APE+L E + + D++S G+ + LL G
Sbjct: 215 ------------TSHNSLTTP--CYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGY 260
Query: 276 VPYTDLRAEAQAHTVLE 292
P+ A + +
Sbjct: 261 PPFYSNHGLAISPGMKT 277
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 9e-21
Identities = 65/229 (28%), Positives = 99/229 (43%), Gaps = 51/229 (22%)
Query: 67 SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP--- 121
SYT I G+ VVY+A L G VA+KK + + +ELQ++ KLDH
Sbjct: 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN----RELQIMRKLDHCNIV 110
Query: 122 GLAKFVAAHAKPPNYMFF---FEFYESRNLAEKLH-VEEWSPSVDQVLMIAA------QL 171
L F + + + ++ ++ E ++ V Q L + QL
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVP-----ETVYRVARHYSRAKQTLPVIYVKLYMYQL 165
Query: 172 AKALQYLHNLGIVHRDVKPANVLLDRNLCPHL--ADFGLAEYRENLKEISLKNWRSSGKP 229
++L Y+H+ GI HRD+KP N+LLD + L DFG A K++ G+P
Sbjct: 166 FRSLAYIHSFGICHRDIKPQNLLLDPD-TAVLKLCDFGSA------KQL------VRGEP 212
Query: 230 TGGFHKKNMVG---TLIYMAPEILKKEIH-SEKSDVYSFGISINELLTG 274
V + Y APE++ + DV+S G + ELL G
Sbjct: 213 --------NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 253
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 94.9 bits (236), Expect = 1e-20
Identities = 64/314 (20%), Positives = 115/314 (36%), Gaps = 49/314 (15%)
Query: 65 PSSYTLLSPIARGAESVVYEA--TLDGRKVAVKK--PILSTSEELDNFHKELQLLCKLDH 120
Y L PI GA+ +V A + R VA+KK ++EL L+ ++H
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 120
Query: 121 PGLAKFVAAHAKPPNYMFFFEFYESRNLAE-KLHVEEWSP-SVDQVLMIAAQLAKALQYL 178
+ + F + Y L + L +++ + Q+ +++L
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 180
Query: 179 HNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNM 238
H+ GI+HRD+KP+N+++ + + DFGLA R++G F
Sbjct: 181 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLA--------------RTAGT---SFMMTPY 223
Query: 239 VGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVV--PYTD---------------- 280
V T Y APE++ + E D++S G + E++ + P D
Sbjct: 224 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC 283
Query: 281 ------LRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDG 334
L+ + + V + L P + + L+ +
Sbjct: 284 PEFMKKLQPTVRNY-VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVI 342
Query: 335 NPHNRPSFSDIALE 348
+P R S D AL+
Sbjct: 343 DPAKRISVDD-ALQ 355
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 1e-20
Identities = 41/115 (35%), Positives = 63/115 (54%), Gaps = 20/115 (17%)
Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPH--LADFGLAEYRENLKEISLKNWRS 225
A+++ AL +LH GI++RD+KP N++L+ H L DFGL +E++ +
Sbjct: 127 LAEISMALGHLHQKGIIYRDLKPENIMLNHQ--GHVKLTDFGLC--KESIHD-------- 174
Query: 226 SGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTD 280
G T F GT+ YMAPEIL + H+ D +S G + ++LTG P+T
Sbjct: 175 -GTVTHTF-----CGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTG 223
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 1e-20
Identities = 69/284 (24%), Positives = 112/284 (39%), Gaps = 39/284 (13%)
Query: 68 YTLLSPIARGAESVVYEAT--LDGRKVAVKKPILSTSEELDNFHK---ELQLLCKLDHPG 122
+ L+ + GA V A + VAVK I+ +D E+ + L+H
Sbjct: 9 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVK--IVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 123 LAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLG 182
+ KF + F E+ L +++ + QL + YLH +G
Sbjct: 67 VVKFYGHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 183 IVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTL 242
I HRD+KP N+LLD ++DFGLA +K M GTL
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLA------------TVFRYNNRERLLNK--MCGTL 171
Query: 243 IYMAPEIL-KKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLT 301
Y+APE+L ++E H+E DV+S GI + +L G +P+ + Y++
Sbjct: 172 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ-------PSDSCQEYSD---- 220
Query: 302 AAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
+ ++ L+L+ + NP R + DI
Sbjct: 221 --WKEKKTYLNPWK---KIDSAPLALLHKILVENPSARITIPDI 259
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 92.2 bits (230), Expect = 1e-20
Identities = 53/212 (25%), Positives = 91/212 (42%), Gaps = 22/212 (10%)
Query: 68 YTLLSPIARGAESVVYEA--TLDGRKVAVKKPILSTSEELDNF--HKELQLLCKLDHPGL 123
Y + I G+ VV++ G+ VA+KK + S + + +E+++L +L HP L
Sbjct: 5 YEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNL 64
Query: 124 AKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGI 183
+ + FE+ + + +L + V I Q +A+ + H
Sbjct: 65 VNLLEVFRRKRRLHLVFEYCD-HTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNC 123
Query: 184 VHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLI 243
+HRDVKP N+L+ ++ L DFG A R P+ + + V T
Sbjct: 124 IHRDVKPENILITKHSVIKLCDFGFA--------------RLLTGPSDYY--DDEVATRW 167
Query: 244 YMAPEILKKEIH-SEKSDVYSFGISINELLTG 274
Y +PE+L + DV++ G ELL+G
Sbjct: 168 YRSPELLVGDTQYGPPVDVWAIGCVFAELLSG 199
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 1e-20
Identities = 55/228 (24%), Positives = 91/228 (39%), Gaps = 36/228 (15%)
Query: 65 PSSYTLLSPIARGAESVVYEA--TLDGRKVAVKKPILSTSEELDNFHK---------ELQ 113
S + L S + GA VV A G VA+KK ++ F K E++
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKK--------IEPFDKPLFALRTLREIK 61
Query: 114 LLCKLDHPGLAKFVAAHAKPPNYMFF------FEFYESRNLAEKLHVEEWSPSVDQVLMI 167
+L H + +P ++ F E ++ +L + + S Q +
Sbjct: 62 ILKHFKHENIITIFNIQ-RPDSFENFNEVYIIQELMQT-DLHRVISTQMLSDDHIQYFIY 119
Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
Q +A++ LH ++HRD+KP+N+L++ N + DFGLA + + +
Sbjct: 120 --QTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQS 177
Query: 228 KPTGGFHKKNMVGTLIYMAPEI-LKKEIHSEKSDVYSFGISINELLTG 274
V T Y APE+ L +S DV+S G + EL
Sbjct: 178 GMVE------FVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLR 219
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 2e-20
Identities = 60/247 (24%), Positives = 95/247 (38%), Gaps = 53/247 (21%)
Query: 68 YTLLSPIARGAESVVYEAT--LDGRKVAVK--------------------------KPIL 99
YTL I +G+ VV A D A+K +
Sbjct: 15 YTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCI 74
Query: 100 STSEELDNFHKELQLLCKLDHPGLAKF--VAAHAKPPNYMFFFEFYESRNLAEKLHVEEW 157
++ ++E+ +L KLDHP + K V + FE + V
Sbjct: 75 QPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQ---GPVMEVPTL 131
Query: 158 SP-SVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLK 216
P S DQ L K ++YLH I+HRD+KP+N+L+ + +ADFG++ +
Sbjct: 132 KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFK--- 188
Query: 217 EISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEIL---KKEIHSEKSDVYSFGISINELLT 273
N VGT +MAPE L +K + DV++ G+++ +
Sbjct: 189 -------------GSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVF 235
Query: 274 GVVPYTD 280
G P+ D
Sbjct: 236 GQCPFMD 242
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 94.6 bits (235), Expect = 3e-20
Identities = 39/116 (33%), Positives = 61/116 (52%), Gaps = 23/116 (19%)
Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPH--LADFGLAEYRENLKEISLKNWRS 225
AA++ L+++HN +V+RD+KPAN+LLD + H ++D GLA +
Sbjct: 298 AAEIILGLEHMHNRFVVYRDLKPANILLDEH--GHVRISDLGLA------CDF------- 342
Query: 226 SGKPTGGFHKKNMVGTLIYMAPEILKKEI-HSEKSDVYSFGISINELLTGVVPYTD 280
S K VGT YMAPE+L+K + + +D +S G + +LL G P+
Sbjct: 343 SKKKPHAS-----VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQ 393
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 3e-20
Identities = 37/119 (31%), Positives = 59/119 (49%), Gaps = 23/119 (19%)
Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPH--LADFGLAEYRENLKEISLKNWRS 225
A++ AL +H++G +HRDVKP N+LLD++ H LADFG ++
Sbjct: 174 TAEVVLALDAIHSMGFIHRDVKPDNMLLDKS--GHLKLADFGTC------MKM------- 218
Query: 226 SGKPTGGFHKKNMVGTLIYMAPEILKKE----IHSEKSDVYSFGISINELLTGVVPYTD 280
G VGT Y++PE+LK + + + D +S G+ + E+L G P+
Sbjct: 219 --NKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA 275
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 3e-20
Identities = 55/231 (23%), Positives = 95/231 (41%), Gaps = 49/231 (21%)
Query: 65 PSSYTLLSPIARGAESVVYEA--TLDGRKVAVKKPILSTSEELDNFHK---------ELQ 113
YT LS I GA +V A L+ +VA+KK + F E++
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKK--------ISPFEHQTYCQRTLREIK 77
Query: 114 LLCKLDHPGLAKFVAAHAKPPNYMFF------FEFYESRNLAEKLHVEEWSPSVDQVLMI 167
+L + H + + P + E+ +L + L + S +
Sbjct: 78 ILLRFRHENIIGINDII-RAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLY 135
Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSG 227
Q+ + L+Y+H+ ++HRD+KP+N+LL+ + DFGLA R +
Sbjct: 136 --QILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLA--------------RVAD 179
Query: 228 KPTGGFHKKNM---VGTLIYMAPEI-LKKEIHSEKSDVYSFGISINELLTG 274
H + V T Y APEI L + +++ D++S G + E+L+
Sbjct: 180 PDHD--HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 228
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 3e-20
Identities = 59/237 (24%), Positives = 100/237 (42%), Gaps = 30/237 (12%)
Query: 65 PSSYTLLSPIARGAESVVYEA--TLDGRKVAVKKPILSTSEELDNFHK---------ELQ 113
P +Y + I RG+ VY A + VA+KK + F E+
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKK-VN------RMFEDLIDCKRILREIT 77
Query: 114 LLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEK-LHVEEWSP---SVDQVLMIAA 169
+L +L + + P + + F E Y +A+ L +P + + + I
Sbjct: 78 ILNRLKSDYIIRLYDLI-IPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILY 136
Query: 170 QLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLA---EYRENLKEISLKNWRSS 226
L ++H GI+HRD+KPAN LL+++ + DFGLA ++ ++
Sbjct: 137 NLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEE 196
Query: 227 GKPTGGFHKKNM---VGTLIYMAPEI-LKKEIHSEKSDVYSFGISINELLTGVVPYT 279
P KK + V T Y APE+ L +E +++ D++S G ELL + +
Sbjct: 197 PGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 3e-20
Identities = 59/229 (25%), Positives = 93/229 (40%), Gaps = 49/229 (21%)
Query: 65 PSSYTLLSPIARGAESVVYEA--TLDGRKVAVKKPILSTSEELDNFHK-----ELQLLCK 117
Y L+ + RG S V+EA + KV VK L K E+++L
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKI--------LKPVKKKKIKREIKILEN 86
Query: 118 L-DHP---GLAKFVAAHAKPP---NYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQ 170
L P LA V K P FE + + K + + + M +
Sbjct: 87 LRGGPNIITLADIV----KDPVSRTPALVFEHVNNTDF--KQLYQTLTDYDIRFYMY--E 138
Query: 171 LAKALQYLHNLGIVHRDVKPANVLLDRNLCP-HLADFGLAEYRENLKEISLKNWRSSGKP 229
+ KAL Y H++GI+HRDVKP NV++D L D+GLAE+ +E +++
Sbjct: 139 ILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR-------- 190
Query: 230 TGGFHKKNMVGTLIYMAPEILKKEIHSEKS-DVYSFGISINELLTGVVP 277
V + + PE+L + S D++S G + ++ P
Sbjct: 191 ---------VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 230
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 4e-20
Identities = 36/120 (30%), Positives = 53/120 (44%), Gaps = 24/120 (20%)
Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPH--LADFGLAEYRENLKEISLKNWRS 225
A++ A+ +H L VHRD+KP N+L+D N H LADFG +
Sbjct: 181 LAEMVIAIDSVHQLHYVHRDIKPDNILMDMN--GHIRLADFGSC------LK-------- 224
Query: 226 SGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKS-----DVYSFGISINELLTGVVPYTD 280
G VGT Y++PEIL+ + D +S G+ + E+L G P+
Sbjct: 225 -LMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYA 283
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 4e-20
Identities = 56/217 (25%), Positives = 95/217 (43%), Gaps = 26/217 (11%)
Query: 65 PSSYTLLSPIARGAESVVYEA--TLDGRKVAVKK--PILSTSEELDNFHKELQLLCKLDH 120
P +Y + + GA V A G KVA+KK + ++EL LL + H
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQH 82
Query: 121 PGLAKFVAAHAKPPNYMFFFEFYESRNLAEK-LHVEEWSP-SVDQVLMIAAQLAKALQYL 178
+ + + F++FY + L S +++ + Q+ K L+Y+
Sbjct: 83 ENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYI 142
Query: 179 HNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNM 238
H+ G+VHRD+KP N+ ++ + + DFGLA R + G+
Sbjct: 143 HSAGVVHRDLKPGNLAVNEDCELKILDFGLA--------------RHADAEMTGY----- 183
Query: 239 VGTLIYMAPEI-LKKEIHSEKSDVYSFGISINELLTG 274
V T Y APE+ L +++ D++S G + E+LTG
Sbjct: 184 VVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTG 220
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 4e-20
Identities = 49/229 (21%), Positives = 87/229 (37%), Gaps = 38/229 (16%)
Query: 65 PSSYTLLSPIARGAESVVYEAT-LDGRKVAVKK--PILSTSEELDNFHK---------EL 112
S YT+ I+ G+ V +G VA+K+ +S ++ E+
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 113 QLLCKLDHPGLAKFVAAHAKPPNYMFF------FEFYESRNLAEKLHVEEWSPSVDQVLM 166
+LL HP + E + +LA+ +H + S +
Sbjct: 81 RLLNHFHHPNILGLRDIF-VHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQY 138
Query: 167 IAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSS 226
+ L LH G+VHRD+ P N+LL N + DF LA RE+ + + ++
Sbjct: 139 FMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLA--REDTADANKTHY--- 193
Query: 227 GKPTGGFHKKNMVGTLIYMAPEI-LKKEIHSEKSDVYSFGISINELLTG 274
V Y APE+ ++ + ++ D++S G + E+
Sbjct: 194 ------------VTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNR 230
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 4e-20
Identities = 43/115 (37%), Positives = 61/115 (53%), Gaps = 20/115 (17%)
Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPH--LADFGLAEYRENLKEISLKNWRS 225
AA++A AL YLH+L IV+RD+KP N+LLD H L DFGL +EN++
Sbjct: 145 AAEIASALGYLHSLNIVYRDLKPENILLDSQ--GHIVLTDFGLC--KENIEH-------- 192
Query: 226 SGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTD 280
T F GT Y+APE+L K+ + D + G + E+L G+ P+
Sbjct: 193 -NSTTSTF-----CGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS 241
|
| >3rnr_A Stage II sporulation E family protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG; HET: MSE; 2.00A {Thermanaerovibrio acidaminovorans} Length = 211 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 5e-20
Identities = 50/224 (22%), Positives = 78/224 (34%), Gaps = 40/224 (17%)
Query: 467 GHRGSAAAEFSARALPGFLQNLGSTTRPTDALLEAF--IRTDVAFRNELDSLRKSKRVVQ 524
G A + RAL + L + P DA+L A + + L
Sbjct: 21 GMIRGDEA--AQRALSASVGVLDAGGSPLDAVLAAQAAVHRWASQGGILG---------- 68
Query: 525 KDWHPGCTAIAALIVR--NRLFVANAGDCRAILCRGGHPFALSRDHVASCLEERERVVSA 582
G T A + L A+ GDCR L +GG LS DH + E V
Sbjct: 69 ---RTGATMAVAAVNLRDGTLEWASVGDCRVYLFKGGRLSRLSLDH--NVSSEM---VLL 120
Query: 583 GGNVNWQVDTWRVGPPALQVTRSIGDDDLKPAVTAEPEITETIMTPED-EYLVMASDGLW 641
G GP +T IG ++ E +E + E E +++ SDG++
Sbjct: 121 GRGP-------VPGPAGEMITSFIGIEN-----LTEISTSEAPLPLEAGEGVLVVSDGVY 168
Query: 642 DVVSHVEAVGIIKDTVKEPGMCSKRLATEAAERGSKDNITVIVV 685
+ + + + + EA R +DN T+ +V
Sbjct: 169 RSLHEDRIAMALS-RGSDARGILQEV--EAQGRPYQDNATLALV 209
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 6e-20
Identities = 71/285 (24%), Positives = 114/285 (40%), Gaps = 41/285 (14%)
Query: 68 YTLLSPIARGAESVVYEAT--LDGRKVAVKKPILSTSEELDNFHK---ELQLLCKLDHPG 122
+ L+ + GA V A + VAVK I+ +D E+ + L+H
Sbjct: 9 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVK--IVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 123 LAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLG 182
+ KF + F E+ L +++ + QL + YLH +G
Sbjct: 67 VVKFYGHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 183 IVHRDVKPANVLLDRNLCPHLADFGL-AEYRENLKEISLKNWRSSGKPTGGFHKKNMVGT 241
I HRD+KP N+LLD ++DFGL +R N +E L GT
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM---------------CGT 170
Query: 242 LIYMAPEIL-KKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQL 300
L Y+APE+L ++E H+E DV+S GI + +L G +P+ Q Y++
Sbjct: 171 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-------EYSD--- 220
Query: 301 TAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
+ ++ L+L+ + NP R + DI
Sbjct: 221 ---WKEKKTYLNPWK---KIDSAPLALLHKILVENPSARITIPDI 259
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 6e-20
Identities = 44/202 (21%), Positives = 84/202 (41%), Gaps = 45/202 (22%)
Query: 91 KVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPN-YM---------FFF 140
K+ K+ ++ + +++ E ++L ++ P L K + N YM F
Sbjct: 72 KILDKQKVVKLKQ-IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS 130
Query: 141 EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLC 200
+E AAQ+ +YLH+L +++RD+KP N+L+D+
Sbjct: 131 HLRRIGRFSE-----------PHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-- 177
Query: 201 PH--LADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEK 258
+ + DFG A K + + W + GT +APEI+ + +++
Sbjct: 178 GYIQVTDFGFA------KRVKGRTW-------------TLCGTPEALAPEIILSKGYNKA 218
Query: 259 SDVYSFGISINELLTGVVPYTD 280
D ++ G+ I E+ G P+
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFA 240
|
| >2jfr_A Ser-Thr phosphatase MSPP; hydrolase, PPM phosphatase, manganese, phosphate; 0.83A {Mycobacterium smegmatis} PDB: 2jfs_A 2jft_A 2v06_A Length = 234 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 7e-20
Identities = 36/164 (21%), Positives = 56/164 (34%), Gaps = 31/164 (18%)
Query: 530 GCTAIAALIV-RNRLFVANAGDCRAILCRGGHPFALSRDH--VASCLE-----ERERVVS 581
TA+A + V N GD R GH L+ DH + E
Sbjct: 91 TLTAVAVFEPGQGGPLVVNIGDSPLYRIRDGHMEQLTDDHSVAGELVRMGEITRHEARWH 150
Query: 582 AGGNVNWQVDTWRVGPPALQVTRSIGDDDLKPAVTAEPEITETIMTPEDEYLVMASDGLW 641
++ +TR++G P++ P D L ++SDGL+
Sbjct: 151 PQRHL---------------LTRALGIGP-----HIGPDVFGIDCGPGDRLL-ISSDGLF 189
Query: 642 DVVSHVEAVGIIKDTVKEPGMCSKRLATEAAERGSKDNITVIVV 685
V +P + +RL A + G DN TV+V+
Sbjct: 190 AAADEALIVDAATS--PDPQVAVRRLVEVANDAGGSDNTTVVVI 231
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 8e-20
Identities = 55/218 (25%), Positives = 95/218 (43%), Gaps = 27/218 (12%)
Query: 65 PSSYTLLSPIARGAESVVYEA--TLDGRKVAVKKPILSTSEELDNFHK----ELQLLCKL 118
Y L PI GA+ +V A + R VA+KK LS + K EL L+ +
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKK--LSRPFQNQTHAKRAYRELVLMKCV 81
Query: 119 DHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEK-LHVEEWSP-SVDQVLMIAAQLAKALQ 176
+H + + + F + Y L + L +++ + Q+ ++
Sbjct: 82 NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK 141
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
+LH+ GI+HRD+KP+N+++ + + DFGLA R++G F
Sbjct: 142 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA--------------RTAGT---SFMMT 184
Query: 237 NMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTG 274
V T Y APE++ + E D++S G + E++ G
Sbjct: 185 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 222
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 9e-20
Identities = 58/229 (25%), Positives = 81/229 (35%), Gaps = 42/229 (18%)
Query: 66 SSYTLLSPIARGAESVVYEA--TLDGRKVAVKKPILSTSEE-LDNFH-------KELQLL 115
S Y ++ I GA VY+A G VA+K + L+ L
Sbjct: 9 SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRL 68
Query: 116 CKLDHP---GLAKFVAAHAKPPNYMFF--FEFYES--RNLAEKLHVEEWSPSVDQVLMIA 168
+HP L A FE + R +K + LM
Sbjct: 69 EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMR- 127
Query: 169 AQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK 228
Q + L +LH IVHRD+KP N+L+ LADFGLA R
Sbjct: 128 -QFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLA--------------RIYSY 172
Query: 229 P---TGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTG 274
T +V TL Y APE+L + ++ D++S G E+
Sbjct: 173 QMALT------PVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRR 215
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 1e-19
Identities = 64/225 (28%), Positives = 98/225 (43%), Gaps = 32/225 (14%)
Query: 66 SSYTLLSPIARGAESVVYEA--TLDGRKVAVKKPILSTSEELDNF--HKELQLLCKLDHP 121
S Y L+ I +G V++A G+KVA+KK ++ +E +E+++L L H
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 76
Query: 122 ---GLAKFVAAHAKPPN------YMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLA 172
L + A P N Y+ F +F E +LA L ++ ++ + L
Sbjct: 77 NVVNLIEICRTKASPYNRCKGSIYLVF-DFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLL 134
Query: 173 KALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGG 232
L Y+H I+HRD+K ANVL+ R+ LADFGLA R+
Sbjct: 135 NGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLA--------------RAFSLAKNS 180
Query: 233 FHKK--NMVGTLIYMAPEILKKEIH-SEKSDVYSFGISINELLTG 274
+ N V TL Y PE+L E D++ G + E+ T
Sbjct: 181 QPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR 225
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 1e-19
Identities = 57/224 (25%), Positives = 86/224 (38%), Gaps = 26/224 (11%)
Query: 68 YTLLSPIARGAESVVYEAT--LDGRKVAVK----KPILSTSEELDNFHKELQLLCKLDHP 121
Y + + G+ V E + AVK K + N KE+QLL +L H
Sbjct: 7 YLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHK 66
Query: 122 GLAKF--VAAHAKPPNYMFFFEFYESRNLAEKL-HVEEWSPSVDQVLMIAAQLAKALQYL 178
+ + V + + E Y + E L V E V Q QL L+YL
Sbjct: 67 NVIQLVDVLYNEEKQKMYMVME-YCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYL 125
Query: 179 HNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNM 238
H+ GIVH+D+KP N+LL ++ G+AE S G P
Sbjct: 126 HSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCR-TSQGSPA-------- 176
Query: 239 VGTLIYMAPEIL--KKEIHSEKSDVYSFGISINELLTGVVPYTD 280
+ PEI K D++S G+++ + TG+ P+
Sbjct: 177 -----FQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEG 215
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 1e-19
Identities = 33/115 (28%), Positives = 60/115 (52%), Gaps = 20/115 (17%)
Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPH--LADFGLAEYRENLKEISLKNWRS 225
A++ AL+YLH+ +V+RD+K N++LD++ H + DFGL +E + +
Sbjct: 111 GAEIVSALEYLHSRDVVYRDIKLENLMLDKD--GHIKITDFGLC--KEGISD-------- 158
Query: 226 SGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTD 280
G F GT Y+APE+L+ + D + G+ + E++ G +P+ +
Sbjct: 159 -GATMKTF-----CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 207
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 1e-19
Identities = 48/175 (27%), Positives = 79/175 (45%), Gaps = 32/175 (18%)
Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPH--LADFGLAEYRENLKEISLKNWRS 225
+A+++ AL YLH GI++RD+K NVLLD H L D+G+ +E L+
Sbjct: 116 SAEISLALNYLHERGIIYRDLKLDNVLLDSE--GHIKLTDYGMC--KEGLRP-------- 163
Query: 226 SGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEA 285
G T F GT Y+APEIL+ E + D ++ G+ + E++ G P+ + +
Sbjct: 164 -GDTTSTF-----CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD 217
Query: 286 QAHTVLEMNYTEQQLTAAVVSGGLR-PILASLELGLPASILSLIQRCWDGNPHNR 339
TE L ++ +R P L S+++ + +P R
Sbjct: 218 NPD-----QNTEDYLFQVILEKQIRIPR------SLSVKAASVLKSFLNKDPKER 261
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 89.1 bits (222), Expect = 1e-19
Identities = 41/115 (35%), Positives = 64/115 (55%), Gaps = 23/115 (20%)
Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPH--LADFGLAEYRENLKEISLKNWRS 225
AA++ AL+YLH+ I++RD+KP N+LLD+N H + DFG A K + +
Sbjct: 112 AAEVCLALEYLHSKDIIYRDLKPENILLDKN--GHIKITDFGFA------KYVPDVTY-- 161
Query: 226 SGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTD 280
T + GT Y+APE++ + +++ D +SFGI I E+L G P+ D
Sbjct: 162 ----T-------LCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD 205
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 1e-19
Identities = 40/115 (34%), Positives = 61/115 (53%), Gaps = 20/115 (17%)
Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPH--LADFGLAEYRENLKEISLKNWRS 225
AA++ AL +LH+ GI++RD+K NVLLD H LADFG+ +E +
Sbjct: 130 AAEIISALMFLHDKGIIYRDLKLDNVLLDHE--GHCKLADFGMC--KEGICN-------- 177
Query: 226 SGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTD 280
G T F GT Y+APEIL++ ++ D ++ G+ + E+L G P+
Sbjct: 178 -GVTTATF-----CGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEA 226
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 2e-19
Identities = 48/175 (27%), Positives = 79/175 (45%), Gaps = 32/175 (18%)
Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPH--LADFGLAEYRENLKEISLKNWRS 225
+A+++ AL YLH GI++RD+K NVLLD H L D+G+ +E L+
Sbjct: 159 SAEISLALNYLHERGIIYRDLKLDNVLLDSE--GHIKLTDYGMC--KEGLRP-------- 206
Query: 226 SGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEA 285
G T F GT Y+APEIL+ E + D ++ G+ + E++ G P+ + +
Sbjct: 207 -GDTTSTF-----CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD 260
Query: 286 QAHTVLEMNYTEQQLTAAVVSGGLR-PILASLELGLPASILSLIQRCWDGNPHNR 339
TE L ++ +R P L S+++ + +P R
Sbjct: 261 NPD-----QNTEDYLFQVILEKQIRIPR------SLSVKAASVLKSFLNKDPKER 304
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 2e-19
Identities = 41/115 (35%), Positives = 63/115 (54%), Gaps = 20/115 (17%)
Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPH--LADFGLAEYRENLKEISLKNWRS 225
AA++ LQ+LH+ GIV+RD+K N+LLD++ H +ADFG+ +EN+
Sbjct: 124 AAEIILGLQFLHSKGIVYRDLKLDNILLDKD--GHIKIADFGMC--KENMLG-------- 171
Query: 226 SGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTD 280
T F GT Y+APEIL + ++ D +SFG+ + E+L G P+
Sbjct: 172 -DAKTNTF-----CGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG 220
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 2e-19
Identities = 38/115 (33%), Positives = 62/115 (53%), Gaps = 20/115 (17%)
Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPH--LADFGLAEYRENLKEISLKNWRS 225
AA++A L +L + GI++RD+K NV+LD H +ADFG+ +EN+ +
Sbjct: 127 AAEIAIGLFFLQSKGIIYRDLKLDNVMLDSE--GHIKIADFGMC--KENIWD-------- 174
Query: 226 SGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTD 280
G T F GT Y+APEI+ + + + D ++FG+ + E+L G P+
Sbjct: 175 -GVTTKTF-----CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG 223
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 3e-19
Identities = 57/221 (25%), Positives = 94/221 (42%), Gaps = 33/221 (14%)
Query: 65 PSSYTLLSPIARGAESVVYEA--TLDGRKVAVKK--PILSTSEELDNFHKELQLLCKLDH 120
+ Y L P+ GA V A G KVA+KK + ++EL+LL + H
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRH 83
Query: 121 PGLAKFVAAHAKPPNYMFF------FEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKA 174
+ + F F + +L + + E+ Q L+ Q+ K
Sbjct: 84 ENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHEKLGEDRIQFLVY--QMLKG 140
Query: 175 LQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFH 234
L+Y+H GI+HRD+KP N+ ++ + + DFGLA R + G+
Sbjct: 141 LRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA--------------RQADSEMTGY- 185
Query: 235 KKNMVGTLIYMAPEI-LKKEIHSEKSDVYSFGISINELLTG 274
V T Y APE+ L +++ D++S G + E++TG
Sbjct: 186 ----VVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITG 222
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 90.3 bits (224), Expect = 3e-19
Identities = 62/240 (25%), Positives = 105/240 (43%), Gaps = 21/240 (8%)
Query: 65 PSSYTLLSPIARGAESVVYEA--TLDGRKVAVKKPILSTSEELDNFH--KELQLLCKLDH 120
P Y + I G+ V EA L+ R VA+KK + + +D +E+ +L +L+H
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNH 111
Query: 121 PGLAKFVAAHAKPPNYMFFFEFYESRNLAEK-LHVEEWSP---SVDQVLMIAAQLAKALQ 176
+ K + P + F E Y +A+ +P + + + L ++
Sbjct: 112 DHVVKVLDI-VIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVK 170
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLA--------EYRENLKEISLKNWRSSGK 228
Y+H+ GI+HRD+KPAN L++++ + DFGLA + +
Sbjct: 171 YVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTF 230
Query: 229 PTGGFHKKNM---VGTLIYMAPEI-LKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAE 284
P K+ + V T Y APE+ L +E ++E DV+S G ELL + A+
Sbjct: 231 PHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHAD 290
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 4e-19
Identities = 52/231 (22%), Positives = 99/231 (42%), Gaps = 40/231 (17%)
Query: 65 PSSYTLLSPIARGAESVVYEA--TLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP- 121
S Y L P+ G +V+ A ++VA+KK +L+ + + + +E++++ +LDH
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDN 69
Query: 122 --GL-----AKFVAAHAKPPNYMFF------FEFYESRNLAEKLHVEEWSPSVDQVLMIA 168
+ + E+ E+ +LA L ++ M
Sbjct: 70 IVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLEQGPLLEEHARLFMY- 127
Query: 169 AQLAKALQYLHNLGIVHRDVKPANVLLDRNLCP-HLADFGLAEYRENLKEISLKNWRSSG 227
QL + L+Y+H+ ++HRD+KPAN+ ++ + DFGLA R
Sbjct: 128 -QLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLA--------------RIMD 172
Query: 228 KPTGGFHKKNM---VGTLIYMAPEI-LKKEIHSEKSDVYSFGISINELLTG 274
HK ++ + T Y +P + L +++ D+++ G E+LTG
Sbjct: 173 PHYS--HKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG 221
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 5e-19
Identities = 53/212 (25%), Positives = 93/212 (43%), Gaps = 22/212 (10%)
Query: 68 YTLLSPIARGAESVVYEA--TLDGRKVAVKKPILSTSEELDNF--HKELQLLCKLDHPGL 123
Y L + G+ +V + GR VA+KK + S +++ +E++LL +L H L
Sbjct: 27 YENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENL 86
Query: 124 AKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGI 183
+ K + FEF + + + L + V Q+ + + H+ I
Sbjct: 87 VNLLEVCKKKKRWYLVFEFVD-HTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNI 145
Query: 184 VHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLI 243
+HRD+KP N+L+ ++ L DFG A R+ P + + V T
Sbjct: 146 IHRDIKPENILVSQSGVVKLCDFGFA--------------RTLAAPGEVY--DDEVATRW 189
Query: 244 YMAPEILKKEIHSEKS-DVYSFGISINELLTG 274
Y APE+L ++ K+ DV++ G + E+ G
Sbjct: 190 YRAPELLVGDVKYGKAVDVWAIGCLVTEMFMG 221
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 5e-19
Identities = 43/130 (33%), Positives = 67/130 (51%), Gaps = 24/130 (18%)
Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPH--LADFGLAEYRENLKEISLKNWRS 225
++ AL++LH LGI++RD+K N+LLD N H L DFGL+ KE
Sbjct: 165 VGEIVLALEHLHKLGIIYRDIKLENILLDSN--GHVVLTDFGLS------KE----FVAD 212
Query: 226 SGKPTGGFHKKNMVGTLIYMAPEILKKEI--HSEKSDVYSFGISINELLTGVVPYTDLRA 283
+ F GT+ YMAP+I++ H + D +S G+ + ELLTG P+T
Sbjct: 213 ETERAYDF-----CGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFT---V 264
Query: 284 EAQAHTVLEM 293
+ + ++ E+
Sbjct: 265 DGEKNSQAEI 274
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 1e-18
Identities = 55/219 (25%), Positives = 93/219 (42%), Gaps = 24/219 (10%)
Query: 68 YTLLSPIARGAESVVYEAT--LDGRKVAVK---KPILSTSEELDNFHKELQLLCKLDHPG 122
Y L + G V L G KVAVK + + + + + +E+Q L HP
Sbjct: 13 YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPH 72
Query: 123 LAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLG 182
+ K + P ++ E+ L + + + + + Q+ A+ Y H
Sbjct: 73 IIKLYQVISTPTDFFMVMEYVSGGELFDYI-CKHGRVEEMEARRLFQQILSAVDYCHRHM 131
Query: 183 IVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTL 242
+VHRD+KP NVLLD ++ +ADFGL S + G + G+
Sbjct: 132 VVHRDLKPENVLLDAHMNAKIADFGL-----------------SNMMSDGEFLRTSCGSP 174
Query: 243 IYMAPEIL-KKEIHSEKSDVYSFGISINELLTGVVPYTD 280
Y APE++ + + D++S G+ + LL G +P+ D
Sbjct: 175 NYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDD 213
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 2e-18
Identities = 64/231 (27%), Positives = 105/231 (45%), Gaps = 35/231 (15%)
Query: 55 SSQSIPLHLPPSSYTLLSPIARGAESVVYEAT-LDGRKVAVKKPILSTSEE------LDN 107
+++ Y L + G VVY+A GR VA+K+ L +E +
Sbjct: 10 GRENLYFQGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAI-- 67
Query: 108 FHKELQLLCKLDHP---GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQV 164
+E+ LL +L HP L + H++ + F EF E +L + L + Q+
Sbjct: 68 --REISLLKELHHPNIVSLIDVI--HSERCLTLVF-EFMEK-DLKKVLDENKTGLQDSQI 121
Query: 165 LMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWR 224
+ QL + + + H I+HRD+KP N+L++ + LADFGLA R
Sbjct: 122 KIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLA--------------R 167
Query: 225 SSGKPTGGFHKKNMVGTLIYMAPEIL-KKEIHSEKSDVYSFGISINELLTG 274
+ G P + + V TL Y AP++L + +S D++S G E++TG
Sbjct: 168 AFGIPVRSY--THEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITG 216
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 88.9 bits (220), Expect = 2e-18
Identities = 38/115 (33%), Positives = 62/115 (53%), Gaps = 20/115 (17%)
Query: 168 AAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPH--LADFGLAEYRENLKEISLKNWRS 225
AA++A L +L + GI++RD+K NV+LD H +ADFG+ +EN+ +
Sbjct: 448 AAEIAIGLFFLQSKGIIYRDLKLDNVMLDSE--GHIKIADFGMC--KENIWD-------- 495
Query: 226 SGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTD 280
G T F GT Y+APEI+ + + + D ++FG+ + E+L G P+
Sbjct: 496 -GVTTKTF-----CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG 544
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 2e-18
Identities = 60/223 (26%), Positives = 93/223 (41%), Gaps = 36/223 (16%)
Query: 68 YTLLSPIARGAESVVYEA--TLDGRKVAVKKPILSTSEE------LDNFHKELQLLCKLD 119
Y L I G V++A VA+K+ L +E L +E+ LL +L
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSAL----REICLLKELK 59
Query: 120 HP---GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQ 176
H L + H+ + F EF + +L + + V QL K L
Sbjct: 60 HKNIVRLHDVL--HSDKKLTLVF-EFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLG 115
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
+ H+ ++HRD+KP N+L++RN LA+FGLA R+ G P +
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGELKLANFGLA--------------RAFGIPVRCY--S 159
Query: 237 NMVGTLIYMAPEIL-KKEIHSEKSDVYSFGISINELLTGVVPY 278
V TL Y P++L +++S D++S G EL P
Sbjct: 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 3e-18
Identities = 60/219 (27%), Positives = 93/219 (42%), Gaps = 26/219 (11%)
Query: 68 YTLLSPIARGAESVVYEAT--LDGRKVAVKKPILSTSEELD-NFHKELQLLCKLDHPGLA 124
Y + I G V L VAVK + +D N +E+ L HP +
Sbjct: 22 YDFVKDIGSGNFGVARLMRDKLTKELVAVK--YIERGAAIDENVQREIINHRSLRHPNIV 79
Query: 125 KFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIV 184
+F P + E+ L E++ S D+ QL + Y H++ I
Sbjct: 80 RFKEVILTPTHLAIIMEYASGGELYERI-CNAGRFSEDEARFFFQQLLSGVSYCHSMQIC 138
Query: 185 HRDVKPANVLLDRNLCPHL--ADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTL 242
HRD+K N LLD + P L DFG + K+ +P K+ VGT
Sbjct: 139 HRDLKLENTLLDGSPAPRLKICDFGYS-----------KSSVLHSQP------KSTVGTP 181
Query: 243 IYMAPEIL-KKEIHSEKSDVYSFGISINELLTGVVPYTD 280
Y+APE+L ++E + +DV+S G+++ +L G P+ D
Sbjct: 182 AYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFED 220
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 4e-18
Identities = 57/227 (25%), Positives = 94/227 (41%), Gaps = 44/227 (19%)
Query: 66 SSYTLLSPIARGAESVVYEA--TLDGRKVAVKKPILSTSEE------LDNFHKELQLLCK 117
Y ++ + G VY+A T+ VA+K+ L EE + +E+ LL +
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAI----REVSLLKE 89
Query: 118 LDHP---GLAKFVAAHAKPPNYMFFFEFYESRNLAEKL-HVEEWSPSVDQVLMIAAQLAK 173
L H L + H ++ F E+ E+ +L + + + S V + + QL
Sbjct: 90 LQHRNIIELKSVI--HHNHRLHLIF-EYAEN-DLKKYMDKNPDVSMRVIKSFLY--QLIN 143
Query: 174 ALQYLHNLGIVHRDVKPANVLLDRNLCPH-----LADFGLAEYRENLKEISLKNWRSSGK 228
+ + H+ +HRD+KP N+LL + + DFGLA R+ G
Sbjct: 144 GVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA--------------RAFGI 189
Query: 229 PTGGFHKKNMVGTLIYMAPEIL-KKEIHSEKSDVYSFGISINELLTG 274
P F + + TL Y PEIL +S D++S E+L
Sbjct: 190 PIRQF--THEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMK 234
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 4e-18
Identities = 59/221 (26%), Positives = 96/221 (43%), Gaps = 33/221 (14%)
Query: 65 PSSYTLLSPIARGAESVVYEA--TLDGRKVAVKKPILSTSEELDNFH--KELQLLCKLDH 120
P Y LSP+ GA V A T G +VAVKK + +EL+LL + H
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 87
Query: 121 PGLAKFVAAHAKPPNYMFF------FEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKA 174
+ + + F + +L + ++ + Q L+ Q+ +
Sbjct: 88 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLIY--QILRG 144
Query: 175 LQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFH 234
L+Y+H+ I+HRD+KP+N+ ++ + + DFGLA R E++
Sbjct: 145 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA--RHTADEMT--------------- 187
Query: 235 KKNMVGTLIYMAPEI-LKKEIHSEKSDVYSFGISINELLTG 274
V T Y APEI L +++ D++S G + ELLTG
Sbjct: 188 --GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 226
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 84.9 bits (211), Expect = 5e-18
Identities = 64/221 (28%), Positives = 97/221 (43%), Gaps = 31/221 (14%)
Query: 66 SSYTLLSPIARGAESVVYEA--TLDGRKVAVKK-PILSTSEELDNFH----KELQLLCKL 118
Y L + G + VY+A + VA+KK + SE D + +E++LL +L
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 69
Query: 119 DHP---GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKAL 175
HP GL K + F +F E+ +L + + + + L
Sbjct: 70 SHPNIIGLLDAF--GHKSNISLVF-DFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGL 125
Query: 176 QYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHK 235
+YLH I+HRD+KP N+LLD N LADFGLA +S G P +
Sbjct: 126 EYLHQHWILHRDLKPNNLLLDENGVLKLADFGLA--------------KSFGSPNRAY-- 169
Query: 236 KNMVGTLIYMAPEIL-KKEIHSEKSDVYSFGISINELLTGV 275
+ V T Y APE+L ++ D+++ G + ELL V
Sbjct: 170 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRV 210
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 9e-18
Identities = 60/220 (27%), Positives = 94/220 (42%), Gaps = 37/220 (16%)
Query: 67 SYTLLSPIARGAESVVYEAT--LDGRKVAVKKPILSTSEE------LDNFHKELQLLCKL 118
+Y L + G + VY+ L VA+K+ I EE + +E+ LL L
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKE-IRLEHEEGAPCTAI----REVSLLKDL 57
Query: 119 DHP---GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKAL 175
H L + H + + F E+ + +L + L ++ V + QL + L
Sbjct: 58 KHANIVTLHDII--HTEKSLTLVF-EYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGL 113
Query: 176 QYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHK 235
Y H ++HRD+KP N+L++ LADFGLA R+ PT +
Sbjct: 114 AYCHRQKVLHRDLKPQNLLINERGELKLADFGLA--------------RAKSIPTKTY-- 157
Query: 236 KNMVGTLIYMAPEIL-KKEIHSEKSDVYSFGISINELLTG 274
N V TL Y P+IL +S + D++ G E+ TG
Sbjct: 158 DNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATG 197
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 9e-18
Identities = 62/231 (26%), Positives = 105/231 (45%), Gaps = 32/231 (13%)
Query: 65 PSSYTLLSPIARGAESVVYEA--TLDGRKVAVKKPILSTSEELDNFHK---------ELQ 113
Y L+ + +GA +V+++ G VAVKK I D F E+
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKK-IF------DAFQNSTDAQRTFREIM 60
Query: 114 LLCKL-DHPGLAKFVAAHAKPPNYM---FFFEFYESRNLAEKLHVEEWSPSVDQVLMIAA 169
+L +L H + + + N F++ E+ +L + P Q ++
Sbjct: 61 ILTELSGHENIVNLLNVL-RADNDRDVYLVFDYMET-DLHAVIRANILEPVHKQYVVY-- 116
Query: 170 QLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKP 229
QL K ++YLH+ G++HRD+KP+N+LL+ +ADFGL+ N++ ++ S +
Sbjct: 117 QLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINEN 176
Query: 230 TGGFHKKNM-----VGTLIYMAPEI-LKKEIHSEKSDVYSFGISINELLTG 274
T F V T Y APEI L +++ D++S G + E+L G
Sbjct: 177 TENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCG 227
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 1e-17
Identities = 56/222 (25%), Positives = 91/222 (40%), Gaps = 39/222 (17%)
Query: 74 IARGAESVVYEA----TLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP---GLAKF 126
+ RG VY+A D + A+K+ I T + +E+ LL +L HP L K
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQ-IEGTGISMSAC-REIALLRELKHPNVISLQKV 86
Query: 127 VAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAA--------QLAKALQYL 178
+HA ++ F ++ E +L + S + + + + Q+ + YL
Sbjct: 87 FLSHADRKVWLLF-DYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 144
Query: 179 HNLGIVHRDVKPANVLLDRNLCPH----LADFGLAEYRENLKEISLKNWRSSGKPTGGF- 233
H ++HRD+KPAN+L+ +AD G A R P
Sbjct: 145 HANWVLHRDLKPANILVMGEGPERGRVKIADMGFA--------------RLFNSPLKPLA 190
Query: 234 HKKNMVGTLIYMAPEILKKEIH-SEKSDVYSFGISINELLTG 274
+V T Y APE+L H ++ D+++ G ELLT
Sbjct: 191 DLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS 232
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 1e-17
Identities = 61/235 (25%), Positives = 94/235 (40%), Gaps = 57/235 (24%)
Query: 68 YTLLSPIARGAESVVYEAT--LDGRKVAVK---KPILSTSEELDNFHKELQLLCKLDHPG 122
Y + + G+ V AT +KVA+K + +L S+ +E+ L L HP
Sbjct: 11 YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHP- 69
Query: 123 LAKFVAAHAKPPNYMFFFEFYESRN----------------LAEKLHVEEWSPSVDQVLM 166
+ + ++ + + EK + E D+
Sbjct: 70 ------------HIIKLYDVITTPTDIVMVIEYAGGELFDYIVEKKRMTE-----DEGRR 112
Query: 167 IAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSS 226
Q+ A++Y H IVHRD+KP N+LLD NL +ADFGL S
Sbjct: 113 FFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGL-----------------S 155
Query: 227 GKPTGGFHKKNMVGTLIYMAPEILK-KEIHSEKSDVYSFGISINELLTGVVPYTD 280
T G K G+ Y APE++ K + DV+S GI + +L G +P+ D
Sbjct: 156 NIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDD 210
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 2e-17
Identities = 33/114 (28%), Positives = 59/114 (51%), Gaps = 17/114 (14%)
Query: 168 AAQLAKALQYLHN-LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSS 226
A++ AL YLH+ +V+RD+K N++LD++ + DFGL +E +K+
Sbjct: 254 GAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLC--KEGIKD--------- 302
Query: 227 GKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTD 280
G F GT Y+APE+L+ + D + G+ + E++ G +P+ +
Sbjct: 303 GATMKTF-----CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 351
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 2e-17
Identities = 57/233 (24%), Positives = 89/233 (38%), Gaps = 52/233 (22%)
Query: 66 SSYTLLSPIARGAESVVYEAT---LDGRKVAVKKPILSTSEE-----------LDNFHKE 111
Y ++ I GA V++A GR VA+K+ + T EE +
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAV------ 64
Query: 112 LQLLCKLDHP---GLAKFVAAHAKPPNYMFF--FEFYES--RNLAEKLHVEEWSPSVDQV 164
L+ L +HP L FE + +K+ +
Sbjct: 65 LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKD 124
Query: 165 LMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWR 224
+M QL + L +LH+ +VHRD+KP N+L+ + LADFGLA R
Sbjct: 125 MMF--QLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA--------------R 168
Query: 225 SSGKP---TGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTG 274
T ++V TL Y APE+L + ++ D++S G E+
Sbjct: 169 IYSFQMALT------SVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRR 215
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 81.8 bits (203), Expect = 3e-17
Identities = 58/217 (26%), Positives = 92/217 (42%), Gaps = 33/217 (15%)
Query: 68 YTLLSPIARGAESVVYEA---TLDGRKVAVKKPILSTSEE------LDNFHKELQLLCKL 118
Y L I G VVY+A G A+KK L +E + +E+ +L +L
Sbjct: 4 YHGLEKIGEGTYGVVYKAQNNY--GETFALKKIRLEKEDEGIPSTTI----REISILKEL 57
Query: 119 DHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYL 178
H + K + FE + +L + L V E QL + Y
Sbjct: 58 KHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYC 116
Query: 179 HNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNM 238
H+ ++HRD+KP N+L++R +ADFGLA R+ G P + +
Sbjct: 117 HDRRVLHRDLKPQNLLINREGELKIADFGLA--------------RAFGIPVRKY--THE 160
Query: 239 VGTLIYMAPEIL-KKEIHSEKSDVYSFGISINELLTG 274
+ TL Y AP++L + +S D++S G E++ G
Sbjct: 161 IVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 3e-17
Identities = 47/237 (19%), Positives = 79/237 (33%), Gaps = 59/237 (24%)
Query: 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSE----ELDNFHKELQLLCKLD 119
+ + +G V G VA+KK ++ EL + +Q L L
Sbjct: 23 DRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKK-VIQDPRFRNREL----QIMQDLAVLH 77
Query: 120 HPGLAK----FVAAHAKPPNYMFF---FEFYESRNLAEKLH-VEEWSPSVDQVLMIAA-- 169
HP + + F + ++ E+ + LH
Sbjct: 78 HPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP-----DTLHRCCRNYYRRQVAPPPILIK 132
Query: 170 ----QLAKALQYLHN--LGIVHRDVKPANVLLDRNLCP-HLADFGLA----EYRENLKEI 218
QL +++ LH + + HRD+KP NVL++ L DFG A N+ I
Sbjct: 133 VFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYI 192
Query: 219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIH-SEKSDVYSFGISINELLTG 274
+ Y APE++ H + D++S G E++ G
Sbjct: 193 C---------------------SRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLG 228
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 3e-17
Identities = 57/227 (25%), Positives = 96/227 (42%), Gaps = 44/227 (19%)
Query: 66 SSYTLLSPIARGAESVVYEA--TLDGRKVAVKKPILSTSEE------LDNFHKELQLLCK 117
S + L + G + VY+ G VA+K+ + SEE + +E+ L+ +
Sbjct: 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKE-VKLDSEEGTPSTAI----REISLMKE 59
Query: 118 LDHP---GLAKFVAAHAKPPNYMFFFEFYES------RNLAEKLHVEEWSPSVDQVLMIA 168
L H L + H + + F EF ++ + ++ +
Sbjct: 60 LKHENIVRLYDVI--HTENKLTLVF-EFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQW- 115
Query: 169 AQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGK 228
QL + L + H I+HRD+KP N+L+++ L DFGLA R+ G
Sbjct: 116 -QLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLA--------------RAFGI 160
Query: 229 PTGGFHKKNMVGTLIYMAPEIL-KKEIHSEKSDVYSFGISINELLTG 274
P F + V TL Y AP++L +S D++S G + E++TG
Sbjct: 161 PVNTF--SSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITG 205
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 6e-17
Identities = 46/253 (18%), Positives = 89/253 (35%), Gaps = 58/253 (22%)
Query: 68 YTLLSPIARGAESVVYEAT----------LDGRKVAVK-----KPILSTSEELDNFHKEL 112
+ L S R + ++YEA +K ++K + + K L
Sbjct: 44 WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPL 103
Query: 113 QL-----LCKLDHPGLAKFVA--AHAKPPNYMFF----------FEFYESRNLAEKLHVE 155
Q+ L + + H ++ + L+E+
Sbjct: 104 QVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERS--- 160
Query: 156 EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLL---DRNLCPHLADFGLA-EY 211
VL +A +L AL++LH VH +V N+ + D++ LA +G A Y
Sbjct: 161 --------VLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQV-TLAGYGFAFRY 211
Query: 212 RENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINEL 271
+ K ++ + G L +++ ++ K S +SD+ S G + +
Sbjct: 212 CPSGKHVAYVEGS----------RSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKW 261
Query: 272 LTGVVPYTDLRAE 284
L G +P+T+
Sbjct: 262 LYGFLPWTNCLPN 274
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 7e-17
Identities = 50/259 (19%), Positives = 91/259 (35%), Gaps = 75/259 (28%)
Query: 65 PSSYTLLSPIARGAESVVYEA--TLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP- 121
Y+L + G+ +V E G++ A+KK + + +EL ++ LDH
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKN----RELDIMKVLDHVN 61
Query: 122 -------------------------------GLAKFVAAHAKPPNYMFF------FEFYE 144
+ N E+
Sbjct: 62 IIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP 121
Query: 145 SRNLAEKLH-VEEWSPSVDQVL------MIAAQLAKALQYLHNLGIVHRDVKPANVLLDR 197
+ LH V + + + + QL +A+ ++H+LGI HRD+KP N+L++
Sbjct: 122 -----DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNS 176
Query: 198 NLCP-HLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIH- 255
L DFG A K++ +P+ + + + Y APE++
Sbjct: 177 KDNTLKLCDFGSA------KKL------IPSEPSVAY-----ICSRFYRAPELMLGATEY 219
Query: 256 SEKSDVYSFGISINELLTG 274
+ D++S G EL+ G
Sbjct: 220 TPSIDLWSIGCVFGELILG 238
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 7e-17
Identities = 50/230 (21%), Positives = 86/230 (37%), Gaps = 30/230 (13%)
Query: 68 YTLLSPIARGAESVVYEAT--LDGRKVAVKKPILSTSEELDNFHKELQLLCKLDH-PGLA 124
+ + I G + VA+K + H E + +L G+
Sbjct: 11 FRVGKKIGCGNFGELRLGKNLYTNEYVAIK--LEPMKSRAPQLHLEYRFYKQLGSGDGIP 68
Query: 125 KFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIV 184
+ Y +L + + + + S+ VLMIA QL ++Y+H+ ++
Sbjct: 69 QVYY-FGPCGKYNAMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLI 127
Query: 185 HRDVKPANVLLDRNLCP-----HLADFGLAEYRENLKEISLKNWRSSGKPTGGFH----- 234
+RDVKP N L+ R H+ DF LA K + P H
Sbjct: 128 YRDVKPENFLIGRPGNKTQQVIHIIDFALA-----------KEYID---PETKKHIPYRE 173
Query: 235 KKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAE 284
K++ GT YM+ + S + D+ + G L G +P+ L+A+
Sbjct: 174 HKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKAD 223
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 81.4 bits (201), Expect = 2e-16
Identities = 54/219 (24%), Positives = 91/219 (41%), Gaps = 24/219 (10%)
Query: 68 YTLLSPIARGAESVVYEAT--LDGRKVAVK---KPILSTSEELDNFHKELQLLCKLDHPG 122
Y L + G V L G KVAVK + + + + + +E+Q L HP
Sbjct: 18 YILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPH 77
Query: 123 LAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLG 182
+ K + P + E+ L + + + + + Q+ + Y H
Sbjct: 78 IIKLYQVISTPSDIFMVMEYVSGGELFDYI-CKNGRLDEKESRRLFQQILSGVDYCHRHM 136
Query: 183 IVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTL 242
+VHRD+KP NVLLD ++ +ADFGL S + G + G+
Sbjct: 137 VVHRDLKPENVLLDAHMNAKIADFGL-----------------SNMMSDGEFLRTSCGSP 179
Query: 243 IYMAPEIL-KKEIHSEKSDVYSFGISINELLTGVVPYTD 280
Y APE++ + + D++S G+ + LL G +P+ D
Sbjct: 180 NYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDD 218
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 4e-15
Identities = 53/230 (23%), Positives = 88/230 (38%), Gaps = 30/230 (13%)
Query: 68 YTLLSPIARGAESVVYEAT--LDGRKVAVKKPILSTSEELDNFHKELQLLCKLDH-PGLA 124
Y + I G+ V++E T L+ ++VA+K + E + L G+
Sbjct: 12 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFE--PRRSDAPQLRDEYRTYKLLAGCTGIP 69
Query: 125 KFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIV 184
+ + +L + L + SV V M A Q+ +Q +H +V
Sbjct: 70 NVYY-FGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLV 128
Query: 185 HRDVKPANVLLDRNLCP-----HLADFGLAEYRENLKEISLKNWRSSGKPTGGFH----- 234
+RD+KP N L+ R ++ DFG+ K +R P H
Sbjct: 129 YRDIKPDNFLIGRPNSKNANMIYVVDFGMV-----------KFYRD---PVTKQHIPYRE 174
Query: 235 KKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAE 284
KKN+ GT YM+ S + D+ + G L G +P+ L+A
Sbjct: 175 KKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAA 224
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 5e-15
Identities = 51/228 (22%), Positives = 85/228 (37%), Gaps = 28/228 (12%)
Query: 68 YTLLSPIARGAESVVYEAT--LDGRKVAVKKPILSTSEELDNFHKELQLLCKLDH-PGLA 124
Y L I G+ +Y T G +VA+K + H E ++ + G+
Sbjct: 11 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLE--CVKTKHPQLHIESKIYKMMQGGVGIP 68
Query: 125 KFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIV 184
+Y +L + + S+ VL++A Q+ ++Y+H+ +
Sbjct: 69 TIRW-CGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFI 127
Query: 185 HRDVKPANVLLDRNLCPH---LADFGLAEYRENLKEISLKNWRSSGKPTGGFH-----KK 236
HRDVKP N L+ + + DFGLA K +R H K
Sbjct: 128 HRDVKPDNFLMGLGKKGNLVYIIDFGLA-----------KKYRD---ARTHQHIPYRENK 173
Query: 237 NMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAE 284
N+ GT Y + S + D+ S G + G +P+ L+A
Sbjct: 174 NLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAA 221
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 5e-15
Identities = 30/126 (23%), Positives = 55/126 (43%), Gaps = 17/126 (13%)
Query: 164 VLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCP--HLADFGLA-EYREN--LKEI 218
VL ++ ++ L+Y+H VH D+K +N+LL+ +L D+GLA Y K
Sbjct: 154 VLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAY 213
Query: 219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278
+ K+ GT+ + + + S + D+ G + + LTG +P+
Sbjct: 214 AADP------------KRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPW 261
Query: 279 TDLRAE 284
D +
Sbjct: 262 EDNLKD 267
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 74.5 bits (182), Expect = 2e-14
Identities = 43/281 (15%), Positives = 81/281 (28%), Gaps = 57/281 (20%)
Query: 53 CCSSQSIPLH--LPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDN--- 107
C +P LP I G V++ D VA+K + + ++
Sbjct: 5 CSQKGPVPFSHCLPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQ 64
Query: 108 -----FHKELQLLCKL---------DHPGLAKFVAAH----AKPPNYMFFFEFYESRNLA 149
E+ + +L G + H + PP + ++ Y S +
Sbjct: 65 KTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGS 124
Query: 150 EK------------------------LHVEEWSPSVDQVLMIAAQLAKALQYLHN-LGIV 184
+ S+ I QL +L L
Sbjct: 125 ANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFE 184
Query: 185 HRDVKPANVLLDRNLCPHLADFGLAEYRE---NLKEISLKNWRSSGKPTGGFHKKNMVGT 241
HRD+ NVLL + L + ++S+ ++ S G +V
Sbjct: 185 HRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFC 240
Query: 242 LIYMAPEILKKEIHSEKSDVYSF-GISINELLTGVVPYTDL 281
+ M ++ + + D+Y N PY+++
Sbjct: 241 DVSMDEDLFTGD-GDYQFDIYRLMKKENNNRWGEYHPYSNV 280
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 2e-14
Identities = 50/239 (20%), Positives = 83/239 (34%), Gaps = 33/239 (13%)
Query: 68 YTLLSPIARGAESVVYEAT--LDGRKVAVK--KPILSTSEELDNFHKELQLLCKLDHPGL 123
+ L I G ++Y A K A K + L + K Q + K D
Sbjct: 39 WVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKK 98
Query: 124 AKFVAAHAKP--PNYMFF--FEFYES-----------RNLAEKLHVEEWSPSVDQVLMIA 168
P + EF +L +K+ + + VL +
Sbjct: 99 WIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDL-QKISGQNGTFKKSTVLQLG 157
Query: 169 AQLAKALQYLHNLGIVHRDVKPANVLLDRNLCP--HLADFGLA-EYRENLKEISLKNWRS 225
++ L+Y+H VH D+K AN+LL +LAD+GL+ Y N +
Sbjct: 158 IRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQ-ENP 216
Query: 226 SGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAE 284
+K GT+ + + + K S +SDV G + L G +P+ +
Sbjct: 217 ---------RKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKD 266
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 5e-14
Identities = 45/257 (17%), Positives = 76/257 (29%), Gaps = 96/257 (37%)
Query: 68 YTLLSPIARGAESVVYEAT--LDGRKVAVKKPILSTSEELDNFHKELQLLCKL-DHPGLA 124
+ G V + K A+K +L + +E++L + P
Sbjct: 20 KVTSQVLGLGINGKVLQIFNKRTQEKFALK--MLQDCPKAR---REVELHWRASQCP--- 71
Query: 125 KFVAAHAKPPNYMFFFEFYESRNLAEK-LH-VEEWSPSVDQVLM---------------- 166
+ + + YE+ K L V E +
Sbjct: 72 ----------HIVRIVDVYENLYAGRKCLLIVME--------CLDGGELFSRIQDRGDQA 113
Query: 167 --------IAAQLAKALQYLHNLGIVHRDVKPANVLL---DRNLCPHLADFGLAEYRENL 215
I + +A+QYLH++ I HRDVKP N+L N L DFG
Sbjct: 114 FTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF------- 166
Query: 216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGV 275
A E ++ + + D++S G+ + LL G
Sbjct: 167 ------------------------------AKETTGEK-YDKSCDMWSLGVIMYILLCGY 195
Query: 276 VPYTDLRAEAQAHTVLE 292
P+ A + +
Sbjct: 196 PPFYSNHGLAISPGMKT 212
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 72.3 bits (177), Expect = 2e-13
Identities = 49/228 (21%), Positives = 86/228 (37%), Gaps = 28/228 (12%)
Query: 68 YTLLSPIARGAESVVYEAT--LDGRKVAVKKPILSTSEELDNFHKELQLLCKL-DHPGLA 124
+ L I G+ +Y T +VA+K + + E ++ L G+
Sbjct: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLE--NVKTKHPQLLYESKIYRILQGGTGIP 66
Query: 125 KFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIV 184
+Y +L + + S+ VLM+A Q+ ++++H+ +
Sbjct: 67 NVRW-FGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFL 125
Query: 185 HRDVKPANVLLDRNLCPH---LADFGLAEYRENLKEISLKNWRSSGKPTGGFH-----KK 236
HRD+KP N L+ + + DFGLA K +R + H K
Sbjct: 126 HRDIKPDNFLMGLGRRANQVYIIDFGLA-----------KKYRD---TSTHQHIPYRENK 171
Query: 237 NMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAE 284
N+ GT Y + S + D+ S G + L G +P+ L+A
Sbjct: 172 NLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 219
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 53/234 (22%), Positives = 88/234 (37%), Gaps = 60/234 (25%)
Query: 68 YTLLSPIARGAESVVYEAT--LDGRKVAVKKPILSTSEELDNFHKE-------LQLLCKL 118
Y +L I +G+ V +A + VA+K ++ + FH++ L+ L K
Sbjct: 99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALK--MVRNEK---RFHRQAAEEIRILEHLRKQ 153
Query: 119 DHPGLAKFVAAHAKPPNYMFFFEFYE---------SRNLAEKLHVEEWSP-SVDQVLMIA 168
D + + + F F S NL E + ++ S+ V A
Sbjct: 154 DKDNTMNVI-------HMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFA 206
Query: 169 AQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPH--LADFGLAEYRENLKEISLKNWRSS 226
+ + L LH I+H D+KP N+LL + + DFG +
Sbjct: 207 HSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS----------------- 249
Query: 227 GKPTGGFHKKNMVGTLI----YMAPEILKKEIHSEKSDVYSFGISINELLTGVV 276
++ V T I Y APE++ + D++S G + ELLTG
Sbjct: 250 ------CYEHQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYP 297
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 55/241 (22%), Positives = 88/241 (36%), Gaps = 60/241 (24%)
Query: 68 YTLLSPIARGAESVVYEA--TLDGRKVAVKKPIL-STSEELDNFHKELQLLCKL------ 118
Y L+ + G S V+ A ++ VA+K I+ + E++LL ++
Sbjct: 21 YILVRKLGWGHFSTVWLAKDMVNNTHVAMK--IVRGDKVYTEAAEDEIKLLQRVNDADNT 78
Query: 119 --DHPGLAKFVAAHAKPPNYMFFFEF-----------YE--SRNLAEKLHVEEWSP-SVD 162
D G + + F +E NL + E +
Sbjct: 79 KEDSMGANHIL-------KLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLI 131
Query: 163 QVLMIAAQLAKALQYLH-NLGIVHRDVKPANVLLDRNLCPH------LADFGLAEYRENL 215
V I+ QL L Y+H GI+H D+KP NVL++ P +AD G A + +
Sbjct: 132 YVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE- 190
Query: 216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGV 275
H N + T Y +PE+L +D++S I EL+TG
Sbjct: 191 ------------------HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
Query: 276 V 276
Sbjct: 233 F 233
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 62.6 bits (151), Expect = 3e-10
Identities = 76/514 (14%), Positives = 145/514 (28%), Gaps = 169/514 (32%)
Query: 110 KELQLLC-KLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIA 168
+ LQ L ++D ++ + H+ KL + + + L+ +
Sbjct: 200 EMLQKLLYQIDPNWTSR--SDHSSNI----------------KLRIHSIQAELRR-LLKS 240
Query: 169 AQLAKALQYLHNLGIVHRDVKPANVLLDRNL-CPHL--------ADFGLAEYRENLKEIS 219
L +V +V+ A NL C L DF A IS
Sbjct: 241 KPYENCL-------LVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATT---THIS 290
Query: 220 LKNWRSSGKPTGGFHKKNMVGTL---IYMAPEILKKEIHSEKSDVYSFGISINELLTGVV 276
L + + L + P+ L +E+ + N ++
Sbjct: 291 LD------HHSMTLTPDEVKSLLLKYLDCRPQDLPREVLT-----------TNPRRLSII 333
Query: 277 P------------YTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLEL-----G 319
+ + + T++E + L A R + L +
Sbjct: 334 AESIRDGLATWDNWKHVNCDKL-TTIIESSL--NVLEPAE----YRKMFDRLSVFPPSAH 386
Query: 320 LPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHRKSLKEEDLCAGKSYVTYD--DKL 377
+P +LSLI W + + +L H+ SL E+ + +L
Sbjct: 387 IPTILLSLI---WFDVIKSDVM--VVVNKL-----HKYSLVEKQPKESTISI-PSIYLEL 435
Query: 378 INSGNNMHTYHESINWTAQGEHSSKKASHAAESDVKLWLESANDALTYYPVLSWGSFATC 437
N + H SI +H + + ++ + +L+ Y+ +
Sbjct: 436 KVKLENEYALHRSIV-----DHYNIPKTFDSDDLIPPYLDQ------YF-------Y--- 474
Query: 438 GRRETMEDTHFLMPHMYNQKEIHMFGIFDGHRGSAAAEFSARALPGFLQNLGSTTRPTDA 497
+ H+ N + +F R + FL +
Sbjct: 475 ---------SHIGHHLKNIEHPERMTLF-------------RMV--FL-DFR-------- 501
Query: 498 LLEAFIRTD-------VAFRNELDSLRKSKRVVQKDWHPGCTAIAALIVRNRLFVANAGD 550
LE IR D + N L L+ K + + P + I+ F+
Sbjct: 502 FLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDN-DPKYERLVNAILD---FLPKIE- 556
Query: 551 CRAILCRGGHP----FALSRDHVASCLEERERVV 580
L + AL + + EE + V
Sbjct: 557 --ENLICSKYTDLLRIALMAED-EAIFEEAHKQV 587
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 61.4 bits (148), Expect = 9e-10
Identities = 79/503 (15%), Positives = 150/503 (29%), Gaps = 136/503 (27%)
Query: 87 LDGRKVA-VKKPILSTSEELDNFHKE----------LQLLCKLDHPGLAKFVAAHAKPPN 135
D + V + K IL + EE+D+ L + KFV + N
Sbjct: 33 FDCKDVQDMPKSIL-SKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRI-N 90
Query: 136 YMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLL 195
Y F L + E+ PS+ + Y+ ++ D +
Sbjct: 91 YKF---------LMSPIKTEQRQPSMMTRM-----------YIEQRDRLYNDNQV---FA 127
Query: 196 DRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGG--FHKKNMVG----TLIYMAPEI 249
N+ R L+ +P ++G + A ++
Sbjct: 128 KYNVS-----------RLQPYL-KLRQALLELRPAKNVLID--GVLGSGKTWV---ALDV 170
Query: 250 LKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGL 309
+ F I + +L+ TVLEM Q+L +
Sbjct: 171 CLSY---KVQCKMDFKIF----------WLNLKNCNSPETVLEM---LQKLLYQIDPNWT 214
Query: 310 RPILASLELGLPA-SILSLIQRCWDGNPHNRPSFSDIALELDLVLEH---RKSLKEEDL- 364
S + L SI + ++R P+ L LVL + K+ +L
Sbjct: 215 SRSDHSSNIKLRIHSIQAELRRLLKSKPYEN------CL---LVLLNVQNAKAWNAFNLS 265
Query: 365 CAGKSYVTYDDK-LINSGNNMHTYHESINWTAQGEHSSKKASHAAESDVKLWLESANDAL 423
C K +T K + + + T H S++ + + +S + +L+ L
Sbjct: 266 C--KILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDE-----VKSLLLKYLDCRPQDL 318
Query: 424 TYYPVLSWGSFATCGRRETMEDTHFLMPHMYNQKEIHMFGIFDGHRGSAAAEFSARALPG 483
RE + T+ + + +D + + + +
Sbjct: 319 ---------------PRE-VLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLT-TIIES 361
Query: 484 FLQNLGST-TR---------PTDA-----LLEAF----IRTDVAFRNELDSLRKSKRVVQ 524
L L R P A LL I++DV ++ L K +V+
Sbjct: 362 SLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDV--MVVVNKLHK-YSLVE 418
Query: 525 KDWHPGCTAIAALIVRNRLFVAN 547
K +I ++ + ++ + N
Sbjct: 419 KQPKESTISIPSIYLELKVKLEN 441
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 60.3 bits (145), Expect = 2e-09
Identities = 65/448 (14%), Positives = 129/448 (28%), Gaps = 126/448 (28%)
Query: 305 VSGGLRPILASLE----LGLPASILSLIQRCW---DGNPHNRPSFSDIALELD---LVLE 354
V + IL+ E + ++ ++ W F + L ++ L+
Sbjct: 38 VQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSP 97
Query: 355 HRKSLKEEDLCAGKSYVTYDDKLINSGNNMHTYHESINWTAQGEHSSKKA--SHAAESDV 412
+ ++ + + Y+ D+L N Y+ S Q ++A +V
Sbjct: 98 IKTEQRQPSMMT-RMYIEQRDRLYNDNQVFAKYNVSR---LQPYLKLRQALLELRPAKNV 153
Query: 413 ---------KLWLESANDALTYYPVLS-------WGSFATCGRRET----MEDTHFLMPH 452
K W+ A D Y V W + C ET ++ + +
Sbjct: 154 LIDGVLGSGKTWV--ALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDP 211
Query: 453 MYNQKEIHMFGIFDGHRGSAAAEFSARALPGFLQNLGSTTRPTDALL-----------EA 501
+ + H I + ++ L+ L + + LL A
Sbjct: 212 NWTSRSDHSSNI----------KLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNA 261
Query: 502 F---IRTDVAFRNE--LDSL--RKSKRVVQKDWHPGCTAIAALIVRNRLFVANAGDCRA- 553
F + + R + D L + + T L DCR
Sbjct: 262 FNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVK----SLL-LKYLDCRPQ 316
Query: 554 ---ILCRGGHPFALS------RDHVASCLEERERVVSAGGNVNWQVDTWR-VGPPALQVT 603
+P LS RD +A+ W D W+ V L
Sbjct: 317 DLPREVLTTNPRRLSIIAESIRDGLAT----------------W--DNWKHVNCDKLTTI 358
Query: 604 RSIGDDDLKPAVTAEPEITE-----TIMTPEDEYL---VMASDGLWDVVSHVEAVGIIKD 655
+ L+PA E + ++ P ++ +++ +W V + + ++
Sbjct: 359 IESSLNVLEPA-----EYRKMFDRLSVF-PPSAHIPTILLSL--IWFDVIKSDVMVVVNK 410
Query: 656 TVKEPGMCSKRLATEAAERGSKDNITVI 683
+ L E+ K++ I
Sbjct: 411 ------LHKYSL----VEKQPKESTISI 428
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 8e-10
Identities = 51/236 (21%), Positives = 83/236 (35%), Gaps = 62/236 (26%)
Query: 68 YTLLSPIARGAESVVYEA--TLDGRKVAVKKPILSTSEELDNFHKE-------LQLLCKL 118
Y + S I +G+ V +A ++ VA+K I+ + F + L+L+ K
Sbjct: 56 YEIDSLIGKGSFGQVVKAYDRVEQEWVAIK--IIKNKK---AFLNQAQIEVRLLELMNKH 110
Query: 119 DHPGLAKFVAAHAKPPNYMFFFEFYE---------SRNLAEKLHVEEWSP-SVDQVLMIA 168
D V + F F S NL + L + S++ A
Sbjct: 111 DTEMKYYIV-------HLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFA 163
Query: 169 AQLAKALQYLHN--LGIVHRDVKPANVLLDRNLCPH--LADFGLAEYRENLKEISLKNWR 224
Q+ AL +L L I+H D+KP N+LL + DFG +
Sbjct: 164 QQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS--------------- 208
Query: 225 SSGKPTGGFHKKNMVGTLI----YMAPEILKKEIHSEKSDVYSFGISINELLTGVV 276
+ I Y +PE+L + D++S G + E+ TG
Sbjct: 209 --------CQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEP 256
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 1e-09
Identities = 31/140 (22%), Positives = 59/140 (42%), Gaps = 19/140 (13%)
Query: 160 SVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEIS 219
+ V +A QL AL++LH + H D+KP N+L + L + + +++K S
Sbjct: 121 PLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTS 180
Query: 220 LK--NWRSSGKPTGGFHKKNMVGTLI----YMAPEILKKEIHSEKSDVYSFGISINELLT 273
++ ++ S+ T++ Y PE++ + ++ DV+S G + E
Sbjct: 181 IRVADFGSA------TFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYR 234
Query: 274 GVVPYTDLRAEAQAHTVLEM 293
G + Q H E
Sbjct: 235 GFTLF-------QTHENREH 247
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 57.6 bits (139), Expect = 6e-09
Identities = 44/264 (16%), Positives = 78/264 (29%), Gaps = 70/264 (26%)
Query: 68 YTLLSPIARGAESVVYEA--TLDGRKVAVKKPIL-STSEELDNFHKELQLLCKL-----D 119
Y ++ + G S V+ + + VA+K ++ S + E++LL + +
Sbjct: 39 YHVIRKLGWGHFSTVWLSWDIQGKKFVAMK--VVKSAEHYTETALDEIRLLKSVRNSDPN 96
Query: 120 HPGLAKFVAA-----HAKP-------------PNYMFFFEFYESRNLAEKLHVEEWSPSV 161
P V + + + + + L +
Sbjct: 97 DPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGL-----------PL 145
Query: 162 DQVLMIAAQLAKALQYLHN-LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL 220
V I Q+ + L YLH I+H D+KP N+LL N A +
Sbjct: 146 PCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPP 205
Query: 221 KNWRSSGKPT------------------------------GGFHKKNMVGTLIYMAPEIL 250
S P H + T Y + E+L
Sbjct: 206 SGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVL 265
Query: 251 KKEIHSEKSDVYSFGISINELLTG 274
++ +D++S EL TG
Sbjct: 266 IGSGYNTPADIWSTACMAFELATG 289
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 6e-09
Identities = 30/140 (21%), Positives = 57/140 (40%), Gaps = 19/140 (13%)
Query: 160 SVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEIS 219
+D + +A Q+ K++ +LH+ + H D+KP N+L ++ + + L
Sbjct: 116 RLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPD 175
Query: 220 LK--NWRSSGKPTGGFHKKNMVGTLI----YMAPEILKKEIHSEKSDVYSFGISINELLT 273
+K ++ S+ + TL+ Y APE++ S+ DV+S G + E
Sbjct: 176 IKVVDFGSA------TYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYL 229
Query: 274 GVVPYTDLRAEAQAHTVLEM 293
G + H E
Sbjct: 230 GFTVF-------PTHDSKEH 242
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 29/126 (23%), Positives = 48/126 (38%), Gaps = 16/126 (12%)
Query: 160 SVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEIS 219
++ + + ++ KAL YL + + H D+KP N+LLD + +
Sbjct: 135 HIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLI-----TVRRVTDGK 189
Query: 220 LKNWRSSGKPT------GG--FHKKNM---VGTLIYMAPEILKKEIHSEKSDVYSFGISI 268
+ G F + T Y APE++ SD++SFG +
Sbjct: 190 KIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVL 249
Query: 269 NELLTG 274
EL TG
Sbjct: 250 AELYTG 255
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 2e-08
Identities = 27/150 (18%), Positives = 54/150 (36%), Gaps = 19/150 (12%)
Query: 74 IARGAESVVYEATLDGRKVAVKKPILST--SEELDNF------HKELQLLCKLDHPGLAK 125
I +GAE+ + + V +K+ + E LD +E + L + G+
Sbjct: 344 IGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPA 403
Query: 126 FVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVH 185
N + + + + ++D I + K LH ++H
Sbjct: 404 PYIFDVDLDNKRIMMSYINGKLAKDVI-----EDNLDIAYKIGEIVGK----LHKNDVIH 454
Query: 186 RDVKPANVLLDRNLCPHLADFGLAEYRENL 215
D+ +N + D++L + DFGL +
Sbjct: 455 NDLTTSNFIFDKDLY--IIDFGLGKISNLD 482
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282 | Back alignment and structure |
|---|
Score = 43.0 bits (101), Expect = 2e-04
Identities = 26/161 (16%), Positives = 51/161 (31%), Gaps = 32/161 (19%)
Query: 68 YTLLSPIARGAESVVYEA-TLDGRKVAVKKPILSTSE--------ELDNFH--------- 109
+ + G ES V+ + + VK + + + + H
Sbjct: 92 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSA 151
Query: 110 -KELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIA 168
E + L KL + K A E +++ L V+ +
Sbjct: 152 RNEFRALQKLQGLAVPKVYAWE----GNAVLMELIDAKELYR--------VRVENPDEVL 199
Query: 169 AQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLA 209
+ + + ++ GIVH D+ NVL+ + DF +
Sbjct: 200 DMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQS 239
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 697 | |||
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2iq1_A | 274 | Protein phosphatase 2C kappa, PPM1K; structural ge | 100.0 | |
| 2p8e_A | 307 | PPM1B beta isoform variant 6; structural genomics, | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3qn1_B | 337 | Protein phosphatase 2C 16; start domain, BET V dom | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3kdj_B | 316 | Protein phosphatase 2C 56; ABA, PYL1, abscisic aci | 100.0 | |
| 2i0o_A | 304 | Ser/Thr phosphatase; beta sandwich, structural gen | 100.0 | |
| 4da1_A | 389 | Protein phosphatase 1K, mitochondrial; metal-ION-a | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 1a6q_A | 382 | Phosphatase 2C; catalytic mechanism, metalloenzyme | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3d8k_A | 377 | PP2C, protein phosphatase 2C; nysgrc, PSI-II, STR | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2isn_A | 364 | NYSGXRC-8828Z, phosphatase; pathogenic strain, pra | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2i44_A | 324 | Serine-threonine phosphatase 2C; PSI-2, 8817Z, str | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2j4o_A | 401 | Mitogen-activated protein kinase kinase kinase 7-i | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2irm_A | 358 | Mitogen-activated protein kinase kinase kinase 7 i | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2pnq_A | 467 | [pyruvate dehydrogenase [lipoamide]]-phosphatase 1 | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2pk0_A | 250 | Serine/threonine protein phosphatase STP1; SI moti | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1txo_A | 237 | Putative bacterial enzyme; serine/threonine protei | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2j82_A | 240 | TPPHA, protein serine-threonine phosphatase; PP2C | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2jfr_A | 234 | Ser-Thr phosphatase MSPP; hydrolase, PPM phosphata | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3rnr_A | 211 | Stage II sporulation E family protein; structural | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.89 | |
| 3pu9_A | 242 | Protein serine/threonine phosphatase; PSI-biology, | 99.85 | |
| 3t91_A | 242 | Stage II sporulation protein E; SPOIIE, phosphatas | 99.84 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.8 | |
| 3f79_A | 255 | Probable two-component response regulator; adaptor | 99.73 | |
| 3zt9_A | 193 | Serine phosphatase; hydrolase, signal transduction | 99.72 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.69 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.3 | |
| 3ke6_A | 399 | Protein RV1364C/MT1410; anti-sigma factor, anti-si | 99.2 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.07 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.06 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.92 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.67 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.38 | |
| 3eq2_A | 394 | Probable two-component response regulator; adaptor | 98.38 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.24 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.2 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.15 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.08 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 98.04 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.95 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.92 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.61 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.54 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.14 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.05 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.88 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.87 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.8 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.68 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.54 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.36 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.18 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.05 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.66 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.02 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 90.07 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 82.94 |
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-57 Score=467.26 Aligned_cols=255 Identities=23% Similarity=0.384 Sum_probs=217.7
Q ss_pred CCCcccccccccCCceEEEEEEE--CCeeEEEEeccCC--ChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEE
Q 005427 65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFF 140 (697)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 140 (697)
.++|+++++||+|+||+||+|++ +++.||||++... .....+.+.+|+.+|++|+|||||++++++.+++.+|+||
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 36899999999999999999998 5889999987544 3455778999999999999999999999999999999999
Q ss_pred eecCCCCHhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhh
Q 005427 141 EFYESRNLAEKLHVEE-WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEIS 219 (697)
Q Consensus 141 e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~ 219 (697)
|||+||+|.+++...+ ..+++.+++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||+|+.......
T Consensus 103 Ey~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~-- 180 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE-- 180 (350)
T ss_dssp ECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHH--
T ss_pred eCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCcc--
Confidence 9999999999997543 4579999999999999999999999999999999999999999999999999987654221
Q ss_pred cccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHH
Q 005427 220 LKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQ 299 (697)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~ 299 (697)
...+.+||+.|||||++.+..|+.++|||||||+||||++|..||.+.+.......+....
T Consensus 181 --------------~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~----- 241 (350)
T 4b9d_A 181 --------------LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGS----- 241 (350)
T ss_dssp --------------HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC-----
T ss_pred --------------cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC-----
Confidence 1345689999999999999999999999999999999999999999877666555554322
Q ss_pred HHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 005427 300 LTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL 353 (697)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~ 353 (697)
+. ..+..+|+++.+||.+||+.||++|||++|+++|.|...
T Consensus 242 ---------~~----~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~ 282 (350)
T 4b9d_A 242 ---------FP----PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAK 282 (350)
T ss_dssp ---------CC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHT
T ss_pred ---------CC----CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhc
Confidence 21 234578999999999999999999999999999998753
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-56 Score=453.76 Aligned_cols=266 Identities=30% Similarity=0.479 Sum_probs=222.4
Q ss_pred ccCCCCCCCcccccccccCCceEEEEEEECCeeEEEEeccCC--ChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCce
Q 005427 59 IPLHLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNY 136 (697)
Q Consensus 59 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 136 (697)
..|+++.+++++.++||+|+||+||+|++.+ .||||++... .....+.|.+|+.+|++++|||||++++++.+ +.+
T Consensus 29 ~~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~ 106 (307)
T 3omv_A 29 YYWEIEASEVMLSTRIGSGSFGTVYKGKWHG-DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNL 106 (307)
T ss_dssp CCCBCCTTSCCEEEECCCCSSSEEEEEESSS-EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSC
T ss_pred cCcEEcHHHeEEeeEEeeCCCcEEEEEEECC-cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeE
Confidence 4588999999999999999999999998765 5899986543 34557889999999999999999999998754 578
Q ss_pred EEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhh
Q 005427 137 MFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLK 216 (697)
Q Consensus 137 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~ 216 (697)
++|||||++|+|.++++.....+++.++..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+|+......
T Consensus 107 ~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~ 186 (307)
T 3omv_A 107 AIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWS 186 (307)
T ss_dssp EEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC-----
T ss_pred EEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCC
Confidence 99999999999999998777789999999999999999999999999999999999999999999999999997654311
Q ss_pred hhhcccccCCCCCCCCccccccccCccccchhhhcc---cCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhc
Q 005427 217 EISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK---EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEM 293 (697)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~ 293 (697)
. .....+.+||+.|||||++.+ .+|+.++|||||||+||||+||+.||.+.+.......+
T Consensus 187 ~--------------~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~--- 249 (307)
T 3omv_A 187 G--------------SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFM--- 249 (307)
T ss_dssp ---------------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHH---
T ss_pred c--------------ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHH---
Confidence 1 112345689999999999964 46899999999999999999999999876544333222
Q ss_pred cccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 005427 294 NYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL 353 (697)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~ 353 (697)
+..+...|.++..+.++|+++.+||.+||+.||++|||+.||+++|+.+.
T Consensus 250 ----------~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~ 299 (307)
T 3omv_A 250 ----------VGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQ 299 (307)
T ss_dssp ----------HHTTCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHH
T ss_pred ----------HhcCCCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 22233445556667789999999999999999999999999999998764
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-57 Score=459.37 Aligned_cols=255 Identities=22% Similarity=0.341 Sum_probs=221.0
Q ss_pred CCCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCC---hHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceE
Q 005427 63 LPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST---SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYM 137 (697)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 137 (697)
...++|+++++||+|+||+||+|++ +++.||||++.... ....+.+.+|+++|+.|+|||||+++++|.++..+|
T Consensus 29 ~~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~y 108 (311)
T 4aw0_A 29 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLY 108 (311)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred CCccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 3446899999999999999999997 68899999865321 233578999999999999999999999999999999
Q ss_pred EEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhh
Q 005427 138 FFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKE 217 (697)
Q Consensus 138 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~ 217 (697)
+|||||+||+|.+++...+ .+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.+....
T Consensus 109 ivmEy~~gG~L~~~i~~~~-~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~- 186 (311)
T 4aw0_A 109 FGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES- 186 (311)
T ss_dssp EEECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTT-
T ss_pred EEEecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC-
Confidence 9999999999999997665 79999999999999999999999999999999999999999999999999998654211
Q ss_pred hhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccH
Q 005427 218 ISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTE 297 (697)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~ 297 (697)
......+.+||+.|||||++.+..|+.++|||||||++|+|++|.+||.+.+.......+....+
T Consensus 187 -------------~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-- 251 (311)
T 4aw0_A 187 -------------KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEY-- 251 (311)
T ss_dssp -------------TCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC--
T ss_pred -------------CcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC--
Confidence 11134567999999999999999999999999999999999999999998776666655544322
Q ss_pred HHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 005427 298 QQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL 351 (697)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~ 351 (697)
..+..+|+++.+||.+||+.||++|||++|++.+.|.
T Consensus 252 -----------------~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i 288 (311)
T 4aw0_A 252 -----------------DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPL 288 (311)
T ss_dssp -----------------CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHH
T ss_pred -----------------CCCcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHH
Confidence 1345789999999999999999999999998766554
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-57 Score=464.76 Aligned_cols=254 Identities=23% Similarity=0.351 Sum_probs=220.6
Q ss_pred CCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEee
Q 005427 65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF 142 (697)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 142 (697)
.+.|+++++||+|+||+||+|++ +++.||||++........+.+.+|+.+|+.++|||||+++++|.+++.+|+||||
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 152 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 152 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 35799999999999999999998 5889999987665545566789999999999999999999999999999999999
Q ss_pred cCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhccc
Q 005427 143 YESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKN 222 (697)
Q Consensus 143 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 222 (697)
|+||+|.+++... .+++.+++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||+|+.+...
T Consensus 153 ~~gg~L~~~l~~~--~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~------- 223 (346)
T 4fih_A 153 LEGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE------- 223 (346)
T ss_dssp CTTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSS-------
T ss_pred CCCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCC-------
Confidence 9999999998753 6899999999999999999999999999999999999999999999999999765421
Q ss_pred ccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHHHH
Q 005427 223 WRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTA 302 (697)
Q Consensus 223 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 302 (697)
.....+.+||+.|||||++.+..|+.++|||||||++|||++|.+||.+.+.......+...
T Consensus 224 ---------~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~--------- 285 (346)
T 4fih_A 224 ---------VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN--------- 285 (346)
T ss_dssp ---------SCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS---------
T ss_pred ---------CCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcC---------
Confidence 11245679999999999999999999999999999999999999999887665554444321
Q ss_pred HHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 303 AVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
..+.+ ..+..+|+++.+||.+||+.||++|||++|+++|.|+.
T Consensus 286 ------~~~~~-~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~ 328 (346)
T 4fih_A 286 ------LPPRL-KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLA 328 (346)
T ss_dssp ------SCCCC-SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGG
T ss_pred ------CCCCC-CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhc
Confidence 11111 12346899999999999999999999999999998874
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-55 Score=450.88 Aligned_cols=262 Identities=25% Similarity=0.390 Sum_probs=223.3
Q ss_pred CCCCCCCcccccccccCCceEEEEEEE-------CCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccccC
Q 005427 61 LHLPPSSYTLLSPIARGAESVVYEATL-------DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKP 133 (697)
Q Consensus 61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~-------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~ 133 (697)
.+++.++|.+.++||+|+||+||+|++ ++..||||++........+.|.+|+++|++|+|||||++++++.++
T Consensus 8 ~~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~ 87 (299)
T 4asz_A 8 QHIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEG 87 (299)
T ss_dssp CBCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred cccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC
Confidence 356678899999999999999999986 3678999998777777788999999999999999999999999999
Q ss_pred CceEEEEeecCCCCHhhhhhhcC------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCC
Q 005427 134 PNYMFFFEFYESRNLAEKLHVEE------------WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCP 201 (697)
Q Consensus 134 ~~~~lv~e~~~~g~L~~~l~~~~------------~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~ 201 (697)
+.+++|||||++|+|.++++..+ ..+++.+++.++.||+.||+|||+++|+||||||+|||++.++.+
T Consensus 88 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~ 167 (299)
T 4asz_A 88 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLV 167 (299)
T ss_dssp SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCE
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcE
Confidence 99999999999999999997532 468999999999999999999999999999999999999999999
Q ss_pred eeeeeccchhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 005427 202 HLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTD 280 (697)
Q Consensus 202 kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~ 280 (697)
||+|||+|+........ .......||+.|||||++.+..|+.++|||||||+||||+| |+.||.+
T Consensus 168 Ki~DFGla~~~~~~~~~--------------~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~ 233 (299)
T 4asz_A 168 KIGDFGMSRDVYSTDYY--------------RVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQ 233 (299)
T ss_dssp EECCCSCHHHHTGGGCE--------------EETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred EECCcccceecCCCCce--------------eecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Confidence 99999999866432211 01234579999999999999999999999999999999998 9999998
Q ss_pred chhHHHHHHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 005427 281 LRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE 354 (697)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~ 354 (697)
.+.......+.. +.. + ..|..+|+++.+||.+||+.||++|||+.+|+..|+.+.+
T Consensus 234 ~~~~~~~~~i~~--------------~~~-~---~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~ 289 (299)
T 4asz_A 234 LSNNEVIECITQ--------------GRV-L---QRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK 289 (299)
T ss_dssp SCHHHHHHHHHH--------------TCC-C---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHc--------------CCC-C---CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 765554443322 221 1 2355799999999999999999999999999988877654
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-55 Score=442.23 Aligned_cols=249 Identities=26% Similarity=0.363 Sum_probs=203.7
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccCCC---hHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEE
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST---SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFF 140 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 140 (697)
++|++++.||+|+||+||+|++ +++.||+|++.... ......+.+|+.+|+.++|||||++++++.++..+|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 5899999999999999999987 58999999865432 233567999999999999999999999999999999999
Q ss_pred eecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhc
Q 005427 141 EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL 220 (697)
Q Consensus 141 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~ 220 (697)
||| +|+|.+++...+ .+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 93 Ey~-~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~---- 166 (275)
T 3hyh_A 93 EYA-GNELFDYIVQRD-KMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN---- 166 (275)
T ss_dssp ECC-CEEHHHHHHHSC-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC-----------
T ss_pred eCC-CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCC----
Confidence 999 679999987654 79999999999999999999999999999999999999999999999999997654211
Q ss_pred ccccCCCCCCCCccccccccCccccchhhhcccCC-CchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHH
Q 005427 221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIH-SEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQ 299 (697)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~ 299 (697)
...+.+||+.|||||++.+..+ +.++|||||||++|+|++|..||.+.+.......+....+
T Consensus 167 -------------~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~---- 229 (275)
T 3hyh_A 167 -------------FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVY---- 229 (275)
T ss_dssp ---------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC----
T ss_pred -------------ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCC----
Confidence 2345789999999999998876 5899999999999999999999988765555444432211
Q ss_pred HHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 300 LTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
..+..+|+++.+||.+||+.||++|||++|+++|.|+-
T Consensus 230 ---------------~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k 267 (275)
T 3hyh_A 230 ---------------TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFK 267 (275)
T ss_dssp ---------------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHH
T ss_pred ---------------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCcccc
Confidence 13457899999999999999999999999999999984
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-55 Score=451.53 Aligned_cols=262 Identities=24% Similarity=0.401 Sum_probs=218.7
Q ss_pred CCCCCCCcccccccccCCceEEEEEEE-------CCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccccC
Q 005427 61 LHLPPSSYTLLSPIARGAESVVYEATL-------DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKP 133 (697)
Q Consensus 61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~-------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~ 133 (697)
..+..++|.+.++||+|+||+||+|++ +++.||||++........+.|.+|+++|++|+|||||+++++|.++
T Consensus 36 ~~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~ 115 (329)
T 4aoj_A 36 HHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEG 115 (329)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred cccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence 456667899999999999999999986 3678999998777777788999999999999999999999999999
Q ss_pred CceEEEEeecCCCCHhhhhhhcC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCC
Q 005427 134 PNYMFFFEFYESRNLAEKLHVEE--------------WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNL 199 (697)
Q Consensus 134 ~~~~lv~e~~~~g~L~~~l~~~~--------------~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~ 199 (697)
..+++|||||++|+|.++++... ..+++.+++.++.|++.||+|||+++|+||||||+||||+.++
T Consensus 116 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~ 195 (329)
T 4aoj_A 116 RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGL 195 (329)
T ss_dssp SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTT
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCC
Confidence 99999999999999999987532 3589999999999999999999999999999999999999999
Q ss_pred CCeeeeeccchhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCC
Q 005427 200 CPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPY 278 (697)
Q Consensus 200 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf 278 (697)
.+||+|||+++........ ......+||+.|||||++.+..++.++|||||||+||||+| |+.||
T Consensus 196 ~~Ki~DFGla~~~~~~~~~--------------~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf 261 (329)
T 4aoj_A 196 VVKIGDFGMSRDIYSTDYY--------------RVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPW 261 (329)
T ss_dssp EEEECCCC------------------------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred cEEEcccccceeccCCCcc--------------eecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCC
Confidence 9999999999865432111 11235679999999999999999999999999999999999 99999
Q ss_pred CCchhHHHHHHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 005427 279 TDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE 354 (697)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~ 354 (697)
.+.........+.. + .++ ..|..+|+++.+||.+||+.||++|||+.||+++|+.+.+
T Consensus 262 ~~~~~~~~~~~i~~--------------g-~~~---~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~ 319 (329)
T 4aoj_A 262 YQLSNTEAIDCITQ--------------G-REL---ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 319 (329)
T ss_dssp CSSCHHHHHHHHHH--------------T-CCC---CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHc--------------C-CCC---CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence 98765544433322 2 122 2345789999999999999999999999999999988865
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-55 Score=452.73 Aligned_cols=262 Identities=23% Similarity=0.239 Sum_probs=219.3
Q ss_pred CCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEe
Q 005427 64 PPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFE 141 (697)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 141 (697)
..+.|++.++||+|+||+||+|++ +++.||||++..... ..+|+.+|+.|+|||||++++++.+++.+|+|||
T Consensus 56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmE 130 (336)
T 4g3f_A 56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFME 130 (336)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 345799999999999999999998 588999998765432 2479999999999999999999999999999999
Q ss_pred ecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCC-CCeeeeeccchhhhhhhhhhc
Q 005427 142 FYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNL-CPHLADFGLAEYRENLKEISL 220 (697)
Q Consensus 142 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~-~~kL~Dfg~a~~~~~~~~~~~ 220 (697)
||+||+|.+++...+ .+++.+++.++.||+.||+|||++||+||||||+||||+.+| .+||+|||+|+.+......
T Consensus 131 y~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~-- 207 (336)
T 4g3f_A 131 LLEGGSLGQLIKQMG-CLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG-- 207 (336)
T ss_dssp CCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC--------
T ss_pred ccCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc--
Confidence 999999999997665 799999999999999999999999999999999999999987 6999999999876431110
Q ss_pred ccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHH
Q 005427 221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQL 300 (697)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 300 (697)
.........+||+.|||||++.+..|+.++|||||||+||||++|.+||.+.........+....
T Consensus 208 ---------~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~------ 272 (336)
T 4g3f_A 208 ---------KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEP------ 272 (336)
T ss_dssp ---------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSC------
T ss_pred ---------cceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCC------
Confidence 01112345689999999999999999999999999999999999999998765544444443221
Q ss_pred HHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhcc
Q 005427 301 TAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHRKS 358 (697)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~~~~ 358 (697)
+.+...+..+|+++.+||.+||+.||.+|||+.||+++++..++....
T Consensus 273 ----------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~ 320 (336)
T 4g3f_A 273 ----------PPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGG 320 (336)
T ss_dssp ----------CGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTS
T ss_pred ----------CCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhh
Confidence 222345678999999999999999999999999999999998876443
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-55 Score=466.39 Aligned_cols=253 Identities=23% Similarity=0.354 Sum_probs=221.2
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEeec
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFY 143 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 143 (697)
+.|+++++||+|+||.||+|++ +|+.||||++........+.+.+|+.+|+.|+|||||+++++|.+++.+|+|||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 5699999999999999999998 58999999987666556677899999999999999999999999999999999999
Q ss_pred CCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhcccc
Q 005427 144 ESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNW 223 (697)
Q Consensus 144 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~ 223 (697)
+||+|.+++... .+++.+++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||+|+.+...
T Consensus 231 ~gG~L~~~i~~~--~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~-------- 300 (423)
T 4fie_A 231 EGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE-------- 300 (423)
T ss_dssp TTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSS--------
T ss_pred CCCcHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCC--------
Confidence 999999998654 5899999999999999999999999999999999999999999999999999765421
Q ss_pred cCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHHHHH
Q 005427 224 RSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAA 303 (697)
Q Consensus 224 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (697)
.....+.+||+.|||||++.+..|+.++|||||||++|||++|.+||.+.+.......+...
T Consensus 301 --------~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~---------- 362 (423)
T 4fie_A 301 --------VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN---------- 362 (423)
T ss_dssp --------CCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS----------
T ss_pred --------CccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcC----------
Confidence 11245679999999999999999999999999999999999999999887665554444321
Q ss_pred HHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 304 VVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
..+.+ ..+..+|+++.+||.+||+.||++|||+.|+++|.|+.
T Consensus 363 -----~~~~~-~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~ 405 (423)
T 4fie_A 363 -----LPPRL-KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLA 405 (423)
T ss_dssp -----CCCCC-SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGG
T ss_pred -----CCCCC-cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhc
Confidence 11111 12356899999999999999999999999999998874
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-56 Score=451.95 Aligned_cols=253 Identities=27% Similarity=0.405 Sum_probs=211.2
Q ss_pred CCCCCcccccccccCCceEEEEEEE-----CCeeEEEEeccCCC--hHHHHHHHHHHHHHHhcCCCCceEEeeccccCCc
Q 005427 63 LPPSSYTLLSPIARGAESVVYEATL-----DGRKVAVKKPILST--SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPN 135 (697)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 135 (697)
..+++|+++++||+|+||+||+|++ +++.||+|++.... ......+.+|+.+|++++|||||++++++.+++.
T Consensus 21 ~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~ 100 (304)
T 3ubd_A 21 ADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGK 100 (304)
T ss_dssp CCGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTE
T ss_pred CCccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCE
Confidence 4457899999999999999999986 36789999865432 1223467899999999999999999999999999
Q ss_pred eEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhh
Q 005427 136 YMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL 215 (697)
Q Consensus 136 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~ 215 (697)
+|+|||||+||+|.+++...+ .+++.+++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.....
T Consensus 101 ~~ivmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 179 (304)
T 3ubd_A 101 LYLILDFLRGGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH 179 (304)
T ss_dssp EEEEECCCTTCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC----
T ss_pred EEEEEEcCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCC
Confidence 999999999999999997665 7999999999999999999999999999999999999999999999999999754321
Q ss_pred hhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccc
Q 005427 216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNY 295 (697)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~ 295 (697)
. ....+.+||+.|||||++.+..|+.++|||||||++|||++|..||.+.+.......+.+...
T Consensus 180 ~----------------~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~ 243 (304)
T 3ubd_A 180 E----------------KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKL 243 (304)
T ss_dssp -----------------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC
T ss_pred C----------------ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCC
Confidence 1 124567899999999999999999999999999999999999999998776666555543221
Q ss_pred cHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCH-----HHHHHHHHH
Q 005427 296 TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSF-----SDIALELDL 351 (697)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~-----~ell~~l~~ 351 (697)
..|..+|+++.+||.+||+.||++|||+ +|+++|.|+
T Consensus 244 -------------------~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f 285 (304)
T 3ubd_A 244 -------------------GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFF 285 (304)
T ss_dssp -------------------CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGG
T ss_pred -------------------CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccc
Confidence 1345789999999999999999999984 788877765
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-54 Score=444.51 Aligned_cols=258 Identities=23% Similarity=0.378 Sum_probs=217.9
Q ss_pred CCCCCCcccccccccCCceEEEEEEE-------CCeeEEEEeccCCC-hHHHHHHHHHHHHHHhcCCCCceEEeeccccC
Q 005427 62 HLPPSSYTLLSPIARGAESVVYEATL-------DGRKVAVKKPILST-SEELDNFHKELQLLCKLDHPGLAKFVAAHAKP 133 (697)
Q Consensus 62 ~~~~~~y~~~~~lg~G~~g~V~~~~~-------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~ 133 (697)
+++.+++++.++||+|+||+||+|++ +++.||||++.... ....+.|.+|+.+|++|+|||||+++++|.++
T Consensus 22 ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~ 101 (308)
T 4gt4_A 22 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKD 101 (308)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEEC
Confidence 45667899999999999999999986 35789999875443 23467899999999999999999999999999
Q ss_pred CceEEEEeecCCCCHhhhhhhc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCC
Q 005427 134 PNYMFFFEFYESRNLAEKLHVE---------------EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRN 198 (697)
Q Consensus 134 ~~~~lv~e~~~~g~L~~~l~~~---------------~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~ 198 (697)
..+++|||||++|+|.++|... ...+++.+++.++.||+.||+|||+++|+||||||+||||+.+
T Consensus 102 ~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~ 181 (308)
T 4gt4_A 102 QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDK 181 (308)
T ss_dssp SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG
T ss_pred CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCC
Confidence 9999999999999999999643 2358899999999999999999999999999999999999999
Q ss_pred CCCeeeeeccchhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCC
Q 005427 199 LCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVP 277 (697)
Q Consensus 199 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~P 277 (697)
+.+||+|||+++........ ......+||+.|||||++.+..|+.++|||||||+||||+| |..|
T Consensus 182 ~~~Ki~DFGlar~~~~~~~~--------------~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~P 247 (308)
T 4gt4_A 182 LNVKISDLGLFREVYAADYY--------------KLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 247 (308)
T ss_dssp GCEEECCSCCBCGGGGGGCB--------------CSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred CCEEECCcccceeccCCCce--------------eEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCC
Confidence 99999999999866432210 12345689999999999999999999999999999999998 8999
Q ss_pred CCCchhHHHHHHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 005427 278 YTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL 351 (697)
Q Consensus 278 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~ 351 (697)
|.+.+.......+ ..+...| .|..+|+++.+||.+||+.||++|||+.||+++|+.
T Consensus 248 f~~~~~~~~~~~i--------------~~~~~~~----~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a 303 (308)
T 4gt4_A 248 YCGYSNQDVVEMI--------------RNRQVLP----CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRA 303 (308)
T ss_dssp TTTCCHHHHHHHH--------------HTTCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred CCCCCHHHHHHHH--------------HcCCCCC----CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 9987655443333 2222222 356799999999999999999999999999988764
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-54 Score=439.39 Aligned_cols=248 Identities=26% Similarity=0.382 Sum_probs=207.8
Q ss_pred cccccccccCCceEEEEEEE--CCeeEEEEeccCC--ChHHHHHHHHHHHHHHhcCCCCceEEeecccc----CCceEEE
Q 005427 68 YTLLSPIARGAESVVYEATL--DGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAK----PPNYMFF 139 (697)
Q Consensus 68 y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~----~~~~~lv 139 (697)
|++.++||+|+||+||+|++ ++..||+|++... .....+.+.+|+++|++|+|||||+++++|.+ +..+|+|
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 47888999999999999998 5788999986533 34556789999999999999999999999865 3568999
Q ss_pred EeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccccCCCCceeecC-CCCCeeeeeccchhhhhhh
Q 005427 140 FEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLG--IVHRDVKPANVLLDR-NLCPHLADFGLAEYRENLK 216 (697)
Q Consensus 140 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~-~~~~kL~Dfg~a~~~~~~~ 216 (697)
||||+||+|.+++...+ .+++..++.++.||+.||+|||++| |+||||||+||||+. ++.+||+|||+|+....
T Consensus 108 mEy~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~-- 184 (290)
T 3fpq_A 108 TELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA-- 184 (290)
T ss_dssp EECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT--
T ss_pred EeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC--
Confidence 99999999999997654 7899999999999999999999998 999999999999975 79999999999975321
Q ss_pred hhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhcccc
Q 005427 217 EISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYT 296 (697)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~ 296 (697)
....+.+||+.|||||++.+ .|+.++|||||||+||||+||..||.+..........+
T Consensus 185 ----------------~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i----- 242 (290)
T 3fpq_A 185 ----------------SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRV----- 242 (290)
T ss_dssp ----------------TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHH-----
T ss_pred ----------------CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHH-----
Confidence 12346789999999999875 58999999999999999999999998754433322221
Q ss_pred HHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 005427 297 EQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL 351 (697)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~ 351 (697)
. .+..| ...+..+++++.+||.+||+.||++|||++|+++|+|+
T Consensus 243 --------~-~~~~~--~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~ 286 (290)
T 3fpq_A 243 --------T-SGVKP--ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 286 (290)
T ss_dssp --------T-TTCCC--GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred --------H-cCCCC--CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence 1 11122 22345688999999999999999999999999999886
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-53 Score=443.42 Aligned_cols=267 Identities=27% Similarity=0.428 Sum_probs=222.6
Q ss_pred CccCCCCCCCcccccccccCCceEEEEEEECC-------eeEEEEeccCCC-hHHHHHHHHHHHHHHhcCC-CCceEEee
Q 005427 58 SIPLHLPPSSYTLLSPIARGAESVVYEATLDG-------RKVAVKKPILST-SEELDNFHKELQLLCKLDH-PGLAKFVA 128 (697)
Q Consensus 58 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h-pniv~l~~ 128 (697)
...|+++.++|++.++||+|+||+||+|++.+ +.||||++.... ..+.+.+.+|+.+|++++| ||||++++
T Consensus 56 ~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g 135 (353)
T 4ase_A 56 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 135 (353)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEE
Confidence 34578999999999999999999999998632 579999876543 3456789999999999965 89999999
Q ss_pred ccccC-CceEEEEeecCCCCHhhhhhhc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCc
Q 005427 129 AHAKP-PNYMFFFEFYESRNLAEKLHVE---------------EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPAN 192 (697)
Q Consensus 129 ~~~~~-~~~~lv~e~~~~g~L~~~l~~~---------------~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~N 192 (697)
+|.++ ..+++|||||++|+|.++|+.. ...+++.+++.++.||+.||+|||+++|+||||||+|
T Consensus 136 ~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~N 215 (353)
T 4ase_A 136 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN 215 (353)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred EEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccc
Confidence 98765 5689999999999999999753 2347899999999999999999999999999999999
Q ss_pred eeecCCCCCeeeeeccchhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHH
Q 005427 193 VLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELL 272 (697)
Q Consensus 193 ill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell 272 (697)
||++.++.+||+|||+|+.+..... .....+.+||+.|||||++.+..|+.++|||||||+||||+
T Consensus 216 ILl~~~~~vKi~DFGlar~~~~~~~--------------~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~ 281 (353)
T 4ase_A 216 ILLSEKNVVKICDFGLARDIYKDPD--------------YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 281 (353)
T ss_dssp EEECGGGCEEECCCGGGSCTTTCTT--------------SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHT
T ss_pred eeeCCCCCEEECcchhhhhcccCCC--------------ceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHH
Confidence 9999999999999999986542111 11234568999999999999999999999999999999999
Q ss_pred h-CCCCCCCchhHHHHHHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 005427 273 T-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL 351 (697)
Q Consensus 273 ~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~ 351 (697)
| |..||.+..........+ . .+.++ ..|..+|+++.+||.+||+.||++|||+.||+++|..
T Consensus 282 t~G~~Pf~~~~~~~~~~~~i-------------~-~g~~~---~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~ 344 (353)
T 4ase_A 282 SLGASPYPGVKIDEEFCRRL-------------K-EGTRM---RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 344 (353)
T ss_dssp TTSCCSSTTCCCSHHHHHHH-------------H-HTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred hCCCCCCCCCCHHHHHHHHH-------------H-cCCCC---CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHH
Confidence 8 999998765433322221 1 12232 2345789999999999999999999999999999998
Q ss_pred HHHH
Q 005427 352 VLEH 355 (697)
Q Consensus 352 ~~~~ 355 (697)
+++.
T Consensus 345 llq~ 348 (353)
T 4ase_A 345 LLQA 348 (353)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 8764
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-51 Score=435.25 Aligned_cols=274 Identities=22% Similarity=0.283 Sum_probs=219.9
Q ss_pred CCCcccccccccCCceEEEEEEE--CCeeEEEEeccCC--ChHHHHHHHHHHHHHHhcCCCCceEEeecccc------CC
Q 005427 65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAK------PP 134 (697)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~------~~ 134 (697)
.++|+++++||+|+||+||+|++ +|+.||||++... .....+.+.+|+.+|+.|+|||||++++++.. ..
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 36899999999999999999998 5899999987543 23446778999999999999999999998654 46
Q ss_pred ceEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhh
Q 005427 135 NYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYREN 214 (697)
Q Consensus 135 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~ 214 (697)
.+|+|||||. |+|.+++...+ .+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.+..
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~~~-~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~ 210 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHSSQ-PLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCT 210 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTSSS-CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC--
T ss_pred EEEEEEeCCC-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeeccc
Confidence 7899999996 68999987654 799999999999999999999999999999999999999999999999999976542
Q ss_pred hhhhhcccccCCCCCCCCccccccccCccccchhhhccc-CCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhc
Q 005427 215 LKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKE-IHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEM 293 (697)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~ 293 (697)
... .......+.+||+.|||||++.+. .++.++||||+||++|||++|.+||.+.+...+...+...
T Consensus 211 ~~~------------~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~ 278 (398)
T 4b99_A 211 SPA------------EHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMV 278 (398)
T ss_dssp -----------------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHH
T ss_pred Ccc------------ccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHh
Confidence 111 111234567999999999998875 5699999999999999999999999998888777777654
Q ss_pred cccHHHH----------HHHHHh--CCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 294 NYTEQQL----------TAAVVS--GGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 294 ~~~~~~~----------~~~~~~--~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
....... ...... ......+....+.+++++.+||.+||+.||++|||++|+++|+|+.
T Consensus 279 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~ 349 (398)
T 4b99_A 279 LGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLA 349 (398)
T ss_dssp HCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGT
T ss_pred cCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhC
Confidence 3322110 000000 0001111223356889999999999999999999999999999874
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-52 Score=422.69 Aligned_cols=260 Identities=24% Similarity=0.355 Sum_probs=193.5
Q ss_pred CcccccccccCCceEEEEEEE--CCeeEEEEeccCCCh-HHHHHHHHHHHHHHhcCCCCceEEeeccccCC---------
Q 005427 67 SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTS-EELDNFHKELQLLCKLDHPGLAKFVAAHAKPP--------- 134 (697)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~--------- 134 (697)
+|++++.||+|+||+||+|++ +++.||||++..... ...+.+.+|+.+|++|+|||||++++++.+.+
T Consensus 6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~ 85 (299)
T 4g31_A 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSS 85 (299)
T ss_dssp HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---------
T ss_pred hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccC
Confidence 589999999999999999997 588999998765443 44678999999999999999999999986544
Q ss_pred ---ceEEEEeecCCCCHhhhhhhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccc
Q 005427 135 ---NYMFFFEFYESRNLAEKLHVEEW--SPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLA 209 (697)
Q Consensus 135 ---~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a 209 (697)
.+|+|||||.+|+|.+++..... ..++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|
T Consensus 86 ~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGla 165 (299)
T 4g31_A 86 PKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLV 165 (299)
T ss_dssp -CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCCCC
T ss_pred CCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCccc
Confidence 37899999999999999976542 2355678999999999999999999999999999999999999999999999
Q ss_pred hhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHH-HHH
Q 005427 210 EYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEA-QAH 288 (697)
Q Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~-~~~ 288 (697)
+.+......... ...........+.+||+.|||||++.+..|+.++|||||||+||||++ ||.+..... ...
T Consensus 166 ~~~~~~~~~~~~----~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~ 238 (299)
T 4g31_A 166 TAMDQDEEEQTV----LTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLT 238 (299)
T ss_dssp ------------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHH
T ss_pred eecCCCcccccc----ccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHH
Confidence 876542211100 000011112345689999999999999999999999999999999996 886543221 111
Q ss_pred HHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 005427 289 TVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL 351 (697)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~ 351 (697)
.+ ....+. ......++.+.+||.+||+.||.+|||+.|+++|.|+
T Consensus 239 ~~--------------~~~~~p----~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~ 283 (299)
T 4g31_A 239 DV--------------RNLKFP----PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVF 283 (299)
T ss_dssp HH--------------HTTCCC----HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred HH--------------hcCCCC----CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhh
Confidence 11 111111 1122345678899999999999999999999987664
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-51 Score=424.73 Aligned_cols=274 Identities=23% Similarity=0.287 Sum_probs=210.8
Q ss_pred CCcccccccccCCceEEEEEEECCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccccCC----ceEEEEe
Q 005427 66 SSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPP----NYMFFFE 141 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~----~~~lv~e 141 (697)
++|.+.++||+|+||+||+|+++|+.||||++..... ....+..|+..+.+++|||||++++++.++. .+++|||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~E 81 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEec
Confidence 4689999999999999999999999999998754322 2223345666667889999999999997654 5799999
Q ss_pred ecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC--------CcccccCCCCceeecCCCCCeeeeeccchhhh
Q 005427 142 FYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL--------GIVHRDVKPANVLLDRNLCPHLADFGLAEYRE 213 (697)
Q Consensus 142 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~--------~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~ 213 (697)
||++|+|.++++.. .++++++..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+|+...
T Consensus 82 y~~~gsL~~~l~~~--~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~ 159 (303)
T 3hmm_A 82 YHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD 159 (303)
T ss_dssp CCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEE
T ss_pred CCCCCcHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcccc
Confidence 99999999999764 588999999999999999999987 99999999999999999999999999997654
Q ss_pred hhhhhhcccccCCCCCCCCccccccccCccccchhhhccc------CCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHH
Q 005427 214 NLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKE------IHSEKSDVYSFGISINELLTGVVPYTDLRAEAQA 287 (697)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~ 287 (697)
.... .........+||+.|||||++.+. .++.++|||||||+||||+||.+||.........
T Consensus 160 ~~~~------------~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p 227 (303)
T 3hmm_A 160 SATD------------TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 227 (303)
T ss_dssp TTTT------------EESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCT
T ss_pred CCCC------------ceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCcccccccc
Confidence 3211 001123456899999999999764 3678999999999999999998887543221110
Q ss_pred -HHHHhccccHHHHHHHHHhCCCCCccccccc--CChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 005427 288 -HTVLEMNYTEQQLTAAVVSGGLRPILASLEL--GLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE 354 (697)
Q Consensus 288 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~ 354 (697)
................+.....+|.++.... ..+..+.+|+.+||+.||++|||+.||++.|..+.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~ 297 (303)
T 3hmm_A 228 YYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp TTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred chhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 0011112233444455566677776655333 345688999999999999999999999999988764
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-50 Score=448.16 Aligned_cols=254 Identities=24% Similarity=0.325 Sum_probs=225.0
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEeec
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFY 143 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 143 (697)
++|++++.||+|+||+||+|++ +|+.||+|++......+.+.+.+|+.+|+.|+|||||+++++|.++..+|+|||||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~ 236 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 236 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence 5799999999999999999998 68899999987777777788999999999999999999999999999999999999
Q ss_pred CCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCC--CCCeeeeeccchhhhhhhhhhcc
Q 005427 144 ESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRN--LCPHLADFGLAEYRENLKEISLK 221 (697)
Q Consensus 144 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~--~~~kL~Dfg~a~~~~~~~~~~~~ 221 (697)
.||+|.+++......+++.++..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+|+.+....
T Consensus 237 ~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~----- 311 (573)
T 3uto_A 237 SGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ----- 311 (573)
T ss_dssp CCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS-----
T ss_pred CCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCC-----
Confidence 9999999997666689999999999999999999999999999999999999754 899999999998664311
Q ss_pred cccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHHH
Q 005427 222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLT 301 (697)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 301 (697)
...+.+||+.|||||++.+..|+.++|||||||+||||++|.+||.+.+.......+....+.
T Consensus 312 ------------~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~----- 374 (573)
T 3uto_A 312 ------------SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWN----- 374 (573)
T ss_dssp ------------EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCC-----
T ss_pred ------------ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCC-----
Confidence 234568999999999999999999999999999999999999999988776666655443321
Q ss_pred HHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 005427 302 AAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL 351 (697)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~ 351 (697)
+....+..+|+++.+||++||+.||.+|||+.|+++|.|+
T Consensus 375 ----------~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~ 414 (573)
T 3uto_A 375 ----------MDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWL 414 (573)
T ss_dssp ----------CCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTT
T ss_pred ----------CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCc
Confidence 1123345789999999999999999999999999999886
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-50 Score=419.22 Aligned_cols=280 Identities=26% Similarity=0.305 Sum_probs=208.5
Q ss_pred CCcccccccccCCceEEEEEEE-----CCeeEEEEeccCCChHHHHHHHHHHHHHHhc-CCCCceEEeeccccCCceEEE
Q 005427 66 SSYTLLSPIARGAESVVYEATL-----DGRKVAVKKPILSTSEELDNFHKELQLLCKL-DHPGLAKFVAAHAKPPNYMFF 139 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~-----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv 139 (697)
++|++.++||+|+||+||+|++ +++.||+|++.... ....+.+|+++|+.+ +||||++++++|.+++++|+|
T Consensus 21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lv 98 (361)
T 4f9c_A 21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIA 98 (361)
T ss_dssp GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEE
T ss_pred CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEE
Confidence 5799999999999999999976 36789999865433 345678999999998 699999999999999999999
Q ss_pred EeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCC-CCCeeeeeccchhhhhhhhh
Q 005427 140 FEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRN-LCPHLADFGLAEYRENLKEI 218 (697)
Q Consensus 140 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~-~~~kL~Dfg~a~~~~~~~~~ 218 (697)
||||++|+|.+++. .+++.+++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+........
T Consensus 99 mE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~ 174 (361)
T 4f9c_A 99 MPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIE 174 (361)
T ss_dssp EECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCG
T ss_pred EeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcccc
Confidence 99999999999984 58999999999999999999999999999999999999876 79999999999765432111
Q ss_pred hcccccCCC------------CCCCCccccccccCccccchhhhccc-CCCchhhHHHHHHHHHHHHhCCCCCCCc-hhH
Q 005427 219 SLKNWRSSG------------KPTGGFHKKNMVGTLIYMAPEILKKE-IHSEKSDVYSFGISINELLTGVVPYTDL-RAE 284 (697)
Q Consensus 219 ~~~~~~~~~------------~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~ell~g~~Pf~~~-~~~ 284 (697)
......... .........+.+||+.|||||++.+. .|+.++||||+||++|||++|+.||... +..
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~ 254 (361)
T 4f9c_A 175 LLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDL 254 (361)
T ss_dssp GGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHH
T ss_pred ccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHH
Confidence 000000000 00011123456899999999999876 4899999999999999999999999554 344
Q ss_pred HHHHHHHhccccHHHHHHHHHh----------------------CCCC---C----------cccccccCChHHHHHHHH
Q 005427 285 AQAHTVLEMNYTEQQLTAAVVS----------------------GGLR---P----------ILASLELGLPASILSLIQ 329 (697)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~----------------------~~~~---~----------~~~~~~~~~~~~l~~li~ 329 (697)
.+...+.....+.......... .... | ........+|+++.+||+
T Consensus 255 ~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~ 334 (361)
T 4f9c_A 255 TALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLD 334 (361)
T ss_dssp HHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHHHH
T ss_pred HHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHHHH
Confidence 4444444322221111110000 0000 0 001123468899999999
Q ss_pred HhccCCCCCCCCHHHHHHHHHH
Q 005427 330 RCWDGNPHNRPSFSDIALELDL 351 (697)
Q Consensus 330 ~~l~~dP~~Rpt~~ell~~l~~ 351 (697)
+||+.||++|||++|+++|+|+
T Consensus 335 ~lL~~dP~~R~ta~eaL~Hp~f 356 (361)
T 4f9c_A 335 KLLDLNPASRITAEEALLHPFF 356 (361)
T ss_dssp HHTCSCTTTSCCHHHHHTSGGG
T ss_pred HHCcCChhHCcCHHHHhcCccc
Confidence 9999999999999999999886
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-49 Score=434.66 Aligned_cols=254 Identities=23% Similarity=0.285 Sum_probs=207.1
Q ss_pred CCCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCC------hHHHHHHHHHHHHHHhcCCCCceEEeeccccCC
Q 005427 63 LPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST------SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPP 134 (697)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 134 (697)
+..++|+++++||+|+||.||+|++ +++.||||++.... .........++.+++.++|||||+++++|.++.
T Consensus 186 ~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~ 265 (689)
T 3v5w_A 186 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD 265 (689)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS
T ss_pred CchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECC
Confidence 3446899999999999999999998 68899999864321 111222334466777889999999999999999
Q ss_pred ceEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhh
Q 005427 135 NYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYREN 214 (697)
Q Consensus 135 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~ 214 (697)
.+|+|||||.||+|.+++...+ .+++..++.++.||+.||+|||++||+||||||+||||+.+|++||+|||+|+.+..
T Consensus 266 ~lylVmEy~~GGdL~~~l~~~~-~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~ 344 (689)
T 3v5w_A 266 KLSFILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 344 (689)
T ss_dssp EEEEEECCCCSCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EEEEEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCC
Confidence 9999999999999999998665 799999999999999999999999999999999999999999999999999975432
Q ss_pred hhhhhcccccCCCCCCCCccccccccCccccchhhhc-ccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhc
Q 005427 215 LKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILK-KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEM 293 (697)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~ 293 (697)
....+.+||+.|||||++. +..|+.++|||||||++|||++|.+||.+........
T Consensus 345 ------------------~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~----- 401 (689)
T 3v5w_A 345 ------------------KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE----- 401 (689)
T ss_dssp ------------------CCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHH-----
T ss_pred ------------------CCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH-----
Confidence 1235679999999999996 4679999999999999999999999997643221111
Q ss_pred cccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCC-----HHHHHHHHHH
Q 005427 294 NYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPS-----FSDIALELDL 351 (697)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt-----~~ell~~l~~ 351 (697)
+...+.... ...+..+|+++.+||.+||+.||.+|++ ++||++|.|+
T Consensus 402 ------i~~~i~~~~-----~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF 453 (689)
T 3v5w_A 402 ------IDRMTLTMA-----VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF 453 (689)
T ss_dssp ------HHHHHHHCC-----CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGG
T ss_pred ------HHHhhcCCC-----CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccc
Confidence 111111111 1235578999999999999999999998 6888766654
|
| >2iq1_A Protein phosphatase 2C kappa, PPM1K; structural genomics, PSI-2, protein structure initiative, NEW YORK SGX research center for structural genomics; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=377.48 Aligned_cols=259 Identities=31% Similarity=0.450 Sum_probs=216.6
Q ss_pred cccceEeeeccCCCCCCCceeEEcccccCCCceEEEEEecCCCChHHHHHHHHHhHHHHHhcCC-CCChHHHHHHHHHHH
Q 005427 427 PVLSWGSFATCGRRETMEDTHFLMPHMYNQKEIHMFGIFDGHRGSAAAEFSARALPGFLQNLGS-TTRPTDALLEAFIRT 505 (697)
Q Consensus 427 ~~~~~~~~s~~G~R~~neD~~~~~~~~~~~~~~~~~~V~DG~GG~~~~~~as~~~~~~l~~~~~-~~~~~~~l~~~~~~~ 505 (697)
....+|..|++|.|..|||++++.. ..++..+|+|||||||+.+|++|++.+++.|.+... ..+....+.++|..+
T Consensus 6 ~~~~~g~~s~~G~R~~nED~~~~~~---~~~~~~l~~V~DG~GG~~~a~~as~~~~~~l~~~~~~~~~~~~~l~~a~~~~ 82 (274)
T 2iq1_A 6 SLENVGCASQIGKRKENEDRFDFAQ---LTDEVLYFAVYDGHGGPAAADFCHTHMEKCIMDLLPKEKNLETLLTLAFLEI 82 (274)
T ss_dssp CGGGCEEEEECCSSSSCCEEEEEEE---CSSSEEEEEEEEEESSTHHHHHHHHHHHHHHHHHTTTCCCHHHHHHHHHHHH
T ss_pred cCCeEEEEecccCCCCccceEEEee---CCCCeEEEEEECCCCCHHHHHHHHHHHHHHHHHHhcccccHHHHHHHHHHHH
Confidence 3457899999999999999998854 134678999999999999999999999999887643 456778899999999
Q ss_pred HHHHHHHHHHHHhhhhcccCCCCCCceEEEEEEec-CeEEEEEcCCeEEEEEECCeeeecCCCCCCCCHHHHHHHHHcCC
Q 005427 506 DVAFRNELDSLRKSKRVVQKDWHPGCTAIAALIVR-NRLFVANAGDCRAILCRGGHPFALSRDHVASCLEERERVVSAGG 584 (697)
Q Consensus 506 ~~~~~~~~~~~~~~~~~~~~~~~~GtT~~~~~i~~-~~l~~anvGDSr~~l~~~~~~~~lt~dH~~~~~~e~~ri~~~g~ 584 (697)
+..+........ ......||||++++++.+ +++|++||||||+|++|+|++.+||+||++..+.|++||.+.||
T Consensus 83 ~~~i~~~~~~~~-----~~~~~~~GtT~~~~~i~~~~~l~~anvGDSR~~l~r~g~~~~lT~DH~~~~~~E~~Ri~~~gG 157 (274)
T 2iq1_A 83 DKAFSSHARLSA-----DATLLTSGTTATVALLRDGIELVVASVGDSRAILCRKGKPMKLTIDHTPERKDEKERIKKCGG 157 (274)
T ss_dssp HHHHHHHHHC--------CCGGGCEECEEEEEEETTTEEEEEEESSCEEEEEETTEEEECCCCCCTTSHHHHHHHHHTTC
T ss_pred HHHHHHHhhhcc-----ccCCCCCCCcEEEEEEECCCEEEEEEecCceEEEEeCCEeeECCCCCCCcCHHHHHHHHHcCC
Confidence 888876532110 112235899999999985 58999999999999999999999999999999999999999999
Q ss_pred eeeeccCcceeCCCcceeccccCCCCCCC-CcccCCceEEEEeCCC-CeEEEEEcCCcccCCChHHHHHHHHhhcCChhH
Q 005427 585 NVNWQVDTWRVGPPALQVTRSIGDDDLKP-AVTAEPEITETIMTPE-DEYLVMASDGLWDVVSHVEAVGIIKDTVKEPGM 662 (697)
Q Consensus 585 ~~~~~~~~~~~~~~~~~ltralG~~~~k~-~v~~~p~v~~~~l~~~-d~~lvl~SDGl~d~~~~~ei~~~~~~~~~~~~~ 662 (697)
.+..........++++++|||||+..+|+ +++++|++..+++.++ |+|||||||||||++++++|.+++... .++++
T Consensus 158 ~v~~~~~~~~~~~~~~~ltralGd~~~k~~~v~~~pdi~~~~l~~g~d~~lll~SDGl~d~l~~~ei~~~~~~~-~~~~~ 236 (274)
T 2iq1_A 158 FVAWNSLGQPHVNGRLAMTRSIGDLDLKTSGVIAEPETKRIKLHHADDSFLVLTTDGINFMVNSQEICDFVNQC-HDPNE 236 (274)
T ss_dssp CEEECTTSCEEETTTBSCSBCEECGGGTTTTCBCCCEEEEEECCTTTEEEEEEECHHHHTTCCHHHHHHHHHTS-SSHHH
T ss_pred EEEcCCCCceeECCeEeeccccCChhhccCCEEeCCEEEEEEeCCCCCcEEEEEccCcccCCCHHHHHHHHHHc-CCHHH
Confidence 87643222112247899999999999887 5899999999999986 669999999999999999999999875 38999
Q ss_pred HHHHHHHHHHhcCCCCCcEEEEEEeCCCCccc
Q 005427 663 CSKRLATEAAERGSKDNITVIVVFLQPVSTAE 694 (697)
Q Consensus 663 ~a~~L~~~a~~~g~~DNiT~ivv~l~~~~~~~ 694 (697)
+|+.|++.|+++|+.||+|||||++.+....+
T Consensus 237 ~a~~L~~~A~~~g~~DNiTvivv~~~~~~~~~ 268 (274)
T 2iq1_A 237 AAHAVTEQAIQYGTEDNSTAVVVPFGAWGKEG 268 (274)
T ss_dssp HHHHHHHHHHHTTCCSCEEEEEEECTTC----
T ss_pred HHHHHHHHHHHcCCCCCeEEEEEEccCCCCCC
Confidence 99999999999999999999999998776553
|
| >2p8e_A PPM1B beta isoform variant 6; structural genomics, hydrolase, PSI-2, protein structure initiative; 1.82A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=385.70 Aligned_cols=253 Identities=29% Similarity=0.483 Sum_probs=207.9
Q ss_pred cccceEeeeccCCCCCCCceeEEcccccC-CCceEEEEEecCCCChHHHHHHHHHhHHHHHhc--CCCC-----------
Q 005427 427 PVLSWGSFATCGRRETMEDTHFLMPHMYN-QKEIHMFGIFDGHRGSAAAEFSARALPGFLQNL--GSTT----------- 492 (697)
Q Consensus 427 ~~~~~~~~s~~G~R~~neD~~~~~~~~~~-~~~~~~~~V~DG~GG~~~~~~as~~~~~~l~~~--~~~~----------- 492 (697)
..+.|+.++++|.|..|||++++...+.. ..+..+|+|||||||+.+|++|++.+++.|.+. +...
T Consensus 22 ~~~~~~~~s~~G~R~~nED~~~~~~~~~~~~~~~~l~~V~DGhGG~~~a~~as~~~~~~l~~~~~~~~~~~~~~~~~~~~ 101 (307)
T 2p8e_A 22 NGLRYGLSSMQGWRVEMEDAHTAVVGIPHGLEDWSFFAVYDGHAGSRVANYCSTHLLEHITTNEDFRAAGKSGSALELSV 101 (307)
T ss_dssp TTEEEEEEEEEETSSSCCEEEEEEEEETTTEEEEEEEEEEEEESCSHHHHHHHHHHHHHHHTSTTTC-----------CH
T ss_pred CCeeEEEEecCCCCCcccceEEEEecCCCCCCCeEEEEEECCCCCHHHHHHHHHHHHHHHHhhHhhhhcccccccccccH
Confidence 47899999999999999999988654321 135679999999999999999999999999762 2211
Q ss_pred -ChHHHHHHHHHHHHHHHHHHHHHHHhhhhcccCCCCCCceEEEEEEecCeEEEEEcCCeEEEEEECCeeeecCCCCCCC
Q 005427 493 -RPTDALLEAFIRTDVAFRNELDSLRKSKRVVQKDWHPGCTAIAALIVRNRLFVANAGDCRAILCRGGHPFALSRDHVAS 571 (697)
Q Consensus 493 -~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GtT~~~~~i~~~~l~~anvGDSr~~l~~~~~~~~lt~dH~~~ 571 (697)
.....|.++|.+++..+..... .......||||++++++.++++|+|||||||+|++|+|++.+||+||++.
T Consensus 102 ~~~~~~l~~a~~~~~~~i~~~~~-------~~~~~~~~GtT~~~~~i~~~~l~vanvGDSRa~l~r~g~~~~lT~DH~~~ 174 (307)
T 2p8e_A 102 ENVKNGIRTGFLKIDEYMRNFSD-------LRNGMDRSGSTAVGVMISPKHIYFINCGDSRAVLYRNGQVCFSTQDHKPC 174 (307)
T ss_dssp HHHHHHHHHHHHHHHHHHHTSTT-------TC---CCCEECEEEEEECSSEEEEEEESSCEEEEEETTEEEEECCCCCTT
T ss_pred HHHHHHHHHHHHHHHHHHHhhhh-------hccCCCCCCCeEEEEEEECCcEEEEEccCcEEEEEECCccccCCCCCCCC
Confidence 1245666677777666654311 11123458999999999999999999999999999999999999999999
Q ss_pred CHHHHHHHHHcCCeeeeccCcceeCCCcceeccccCCCCCCC---------CcccCCceEEEEeCCCCeEEEEEcCCccc
Q 005427 572 CLEERERVVSAGGNVNWQVDTWRVGPPALQVTRSIGDDDLKP---------AVTAEPEITETIMTPEDEYLVMASDGLWD 642 (697)
Q Consensus 572 ~~~e~~ri~~~g~~~~~~~~~~~~~~~~~~ltralG~~~~k~---------~v~~~p~v~~~~l~~~d~~lvl~SDGl~d 642 (697)
++.|++||...|+.+.. .|+. +.+.+|||||+..+|. .|+++|++..+.+.++|+|||||||||||
T Consensus 175 ~~~E~~rI~~~gg~v~~----~rv~-g~l~ltRalGd~~~k~~~~~~~~~~~v~~~pdv~~~~l~~~d~~llL~SDGl~d 249 (307)
T 2p8e_A 175 NPREKERIQNAGGSVMI----QRVN-GSLAVSRALGDYDYKCVDGKGPTEQLVSPEPEVYEILRAEEDEFIILACDGIWD 249 (307)
T ss_dssp SHHHHHHHHHTTCCEET----TEET-TTBSCSBCEECGGGSCCTTCCGGGSSSBCCCEEEEEECCTTEEEEEEECHHHHT
T ss_pred CHHHHHHHHHcCCEEEe----Cccc-CeEeccccccCHHHhcCcccCCCCCeEeccCeEEEEEcCCCCeEEEEECCCccc
Confidence 99999999999986642 3444 5789999999998773 47899999999999998899999999999
Q ss_pred CCChHHHHHHHHhh---cCChhHHHHHHHHHHHhcCCCCCcEEEEEEeCCCC
Q 005427 643 VVSHVEAVGIIKDT---VKEPGMCSKRLATEAAERGSKDNITVIVVFLQPVS 691 (697)
Q Consensus 643 ~~~~~ei~~~~~~~---~~~~~~~a~~L~~~a~~~g~~DNiT~ivv~l~~~~ 691 (697)
++++++|++++... ..+++++|+.|++.|+.+|+.||||||||++.+.+
T Consensus 250 ~ls~~ei~~~v~~~~~~~~~~~~~a~~Lv~~A~~~g~~DNiTvivv~~~~~~ 301 (307)
T 2p8e_A 250 VMSNEELCEYVKSRLEVSDDLENVCNWVVDTCLHKGSRDNMSIVLVCFSNEG 301 (307)
T ss_dssp TSCHHHHHHHHHHHHTTCCCHHHHHHHHHHHHHHTTCCSCEEEEEEEC----
T ss_pred CCCHHHHHHHHHHHHhcCCCHHHHHHHHHHHHHHcCCCCCeEEEEEECCCCC
Confidence 99999999999874 24899999999999999999999999999997654
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=389.92 Aligned_cols=251 Identities=24% Similarity=0.364 Sum_probs=217.9
Q ss_pred CCCcccccccccCCceEEEEEEE--CCeeEEEEeccCC--ChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEE
Q 005427 65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFF 140 (697)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 140 (697)
.++|++.+.||+|+||.||+|++ +++.||||++... .....+.+.+|+.+|+.++||||+++++++.+...+++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 36899999999999999999997 6889999986543 4455778999999999999999999999999999999999
Q ss_pred eecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhc
Q 005427 141 EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL 220 (697)
Q Consensus 141 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~ 220 (697)
||+++|+|.+++...+ .+++.+++.++.|++.||+|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 94 e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~----- 167 (328)
T 3fe3_A 94 EYASGGEVFDYLVAHG-RMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG----- 167 (328)
T ss_dssp CCCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS-----
T ss_pred ECCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCC-----
Confidence 9999999999997654 6899999999999999999999999999999999999999999999999999754321
Q ss_pred ccccCCCCCCCCccccccccCccccchhhhcccCCC-chhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHH
Q 005427 221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHS-EKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQ 299 (697)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~ 299 (697)
......+||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+.......+....+
T Consensus 168 ------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~---- 231 (328)
T 3fe3_A 168 ------------GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY---- 231 (328)
T ss_dssp ------------CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC----
T ss_pred ------------CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC----
Confidence 123456899999999999888765 899999999999999999999998766555444433221
Q ss_pred HHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 300 LTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
..+..+++++.+||++||+.||.+|||++|+++|.|..
T Consensus 232 ---------------~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~ 269 (328)
T 3fe3_A 232 ---------------RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWIN 269 (328)
T ss_dssp ---------------CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTT
T ss_pred ---------------CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhc
Confidence 12346889999999999999999999999999998874
|
| >3qn1_B Protein phosphatase 2C 16; start domain, BET V domain, PYR/PYL/RCAR, PP2C, abscisic ACI receptor, type 2C protein phosphatase; HET: A8S; 1.80A {Arabidopsis thaliana} PDB: 3zvu_B* 3ujg_B 3nmt_B* 4ds8_B* 3rt0_A 3kb3_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=389.65 Aligned_cols=262 Identities=33% Similarity=0.473 Sum_probs=212.5
Q ss_pred ceEeeeccCCCCCCCceeEEcccccC------------------CCceEEEEEecCCCChHHHHHHHHHhHHHHHhcCC-
Q 005427 430 SWGSFATCGRRETMEDTHFLMPHMYN------------------QKEIHMFGIFDGHRGSAAAEFSARALPGFLQNLGS- 490 (697)
Q Consensus 430 ~~~~~s~~G~R~~neD~~~~~~~~~~------------------~~~~~~~~V~DG~GG~~~~~~as~~~~~~l~~~~~- 490 (697)
.||..|++|+|.+|||++++.+++.. ..+..+|||||||||+.+|++|++.++..|.+...
T Consensus 15 ~~G~~s~~G~R~~nEDa~~~~~~~~~~p~~~~~~~~~g~~~~~~~~~~~l~~V~DGhGG~~~~~~as~~~~~~l~~~~~~ 94 (337)
T 3qn1_B 15 LWGTVSIQGNRSEMEDAFAVSPHFLKLPIKMLMGDHEGMSPSLTHLTGHFFGVYDGHGGHKVADYCRDRLHFALAEEIER 94 (337)
T ss_dssp CEEEEEECTTSSSCCEEEEEEEEEEEEEGGGTC----------CEEEEEEEEEEEEESSSHHHHHHHHHHHHHHHHHHHH
T ss_pred ceEEEEeeeCCchhhhHHHHHhhhhcccchhcccccccccccccCCCeEEEEEEeCCCChhHHHHHHHHHHHHHHHHHHh
Confidence 58999999999999999998765321 11567999999999999999999999998876411
Q ss_pred --------------CCChHHHHHHHHHHHHHHHHHHHHHHHh----hhhcccCCCCCCceEEEEEEecCeEEEEEcCCeE
Q 005427 491 --------------TTRPTDALLEAFIRTDVAFRNELDSLRK----SKRVVQKDWHPGCTAIAALIVRNRLFVANAGDCR 552 (697)
Q Consensus 491 --------------~~~~~~~l~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~GtT~~~~~i~~~~l~~anvGDSr 552 (697)
.......+.++|..++..+......... ..........||||++++++.++++|+|||||||
T Consensus 95 ~~~~~~~~~~~~~~~~~~~~~l~~a~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~GtT~~~~~i~~~~l~~anvGDSR 174 (337)
T 3qn1_B 95 IKDELCKRNTGEGRQVQWDKVFTSCFLTVDGEIEGKIGRAVVGSSDKVLEAVASETVGSTAVVALVCSSHIVVSNCGDSR 174 (337)
T ss_dssp TC------------CHHHHHHHHHHHHHHHHHHHTSSCBCCTTCSSCBCCCSSCTTCEECEEEEEECSSEEEEEEESSCE
T ss_pred hhhhhhccccccchHHHHHHHHHHHHHHhhHHHHhhhhccccccccccccccccCCCCceEEEEEEECCEEEEEeccCcE
Confidence 1123466777777777666543100000 0001122346899999999999999999999999
Q ss_pred EEEEECCeeeecCCCCCCCCHHHHHHHHHcCCeeeeccCcceeCCCcceeccccCCCCCCCCcccCCceEEEEeCCCCeE
Q 005427 553 AILCRGGHPFALSRDHVASCLEERERVVSAGGNVNWQVDTWRVGPPALQVTRSIGDDDLKPAVTAEPEITETIMTPEDEY 632 (697)
Q Consensus 553 ~~l~~~~~~~~lt~dH~~~~~~e~~ri~~~g~~~~~~~~~~~~~~~~~~ltralG~~~~k~~v~~~p~v~~~~l~~~d~~ 632 (697)
+|++|+|++++||+||++..+.|..||...|+.+... ...++. +.+++||+||+..+|+.++++|++..+.+.+.++|
T Consensus 175 ~~l~r~g~~~~lT~DH~~~~~~e~~ri~~~gg~v~~~-~~~r~~-g~l~~sRalGd~~~~~~v~~~pdv~~~~~~~~~d~ 252 (337)
T 3qn1_B 175 AVLFRGKEAMPLSVDHKPDREDEYARIENAGGKVIQW-QGARVF-GVLAMSRSIGDRYLKPYVIPEPEVTFMPRSREDEC 252 (337)
T ss_dssp EEEEETTEEEESCCCCCTTSHHHHHHHHHTTCCEEES-SSEEET-TTBSCSBCEECGGGTTTSBCCCEEEEEECCTTEEE
T ss_pred EEEEeCCEeeeecCCCCCCCHHHHHHHHHcCCeEEec-CCceec-CccccccccccccccCCCCCcceEEEEEeCCCCCE
Confidence 9999999999999999999999999999999977542 233444 78999999999999999999999999998776779
Q ss_pred EEEEcCCcccCCChHHHHHHHHhh--------------------cCChhHHHHHHHHHHHhcCCCCCcEEEEEEeCCCCc
Q 005427 633 LVMASDGLWDVVSHVEAVGIIKDT--------------------VKEPGMCSKRLATEAAERGSKDNITVIVVFLQPVST 692 (697)
Q Consensus 633 lvl~SDGl~d~~~~~ei~~~~~~~--------------------~~~~~~~a~~L~~~a~~~g~~DNiT~ivv~l~~~~~ 692 (697)
||||||||||+++++||+++++.. ..+++.+|+.|++.|+.+|+.||||||||+|.+++.
T Consensus 253 llL~SDGl~d~l~~~ei~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~~Lv~~A~~~g~~DNiTvivv~l~~~~~ 332 (337)
T 3qn1_B 253 LILASDGLWDVMNNQEVCEIARRRILMWHKKNGAPPLAERGKGIDPACQAAADYLSMLALQKGSKDNISIIVIDLKAQRK 332 (337)
T ss_dssp EEEECHHHHTTSCHHHHHHHHHHHHHHHHHHHCCC----CCSSCCHHHHHHHHHHHHHHHHTTCCSCEEEEEEECCSCC-
T ss_pred EEEEecCcccCCCHHHHHHHHHHHhhhhccccccccccccccccChhHHHHHHHHHHHHHHcCCCCCEEEEEEEecCCcc
Confidence 999999999999999999999762 225789999999999999999999999999987655
Q ss_pred c
Q 005427 693 A 693 (697)
Q Consensus 693 ~ 693 (697)
.
T Consensus 333 ~ 333 (337)
T 3qn1_B 333 F 333 (337)
T ss_dssp -
T ss_pred c
Confidence 3
|
| >3kdj_B Protein phosphatase 2C 56; ABA, PYL1, abscisic acid signaling pathway, cell membr hydrolase, magnesium, manganese, metal-binding, nucleus; HET: A8S; 1.88A {Arabidopsis thaliana} PDB: 3nmn_B* 3jrq_A* 3ujk_A 3nmv_B 3ujl_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-46 Score=383.94 Aligned_cols=254 Identities=36% Similarity=0.570 Sum_probs=203.7
Q ss_pred cccceEeeeccCCCCCCCceeEEcccccC-------------CCceEEEEEecCCCChHHHHHHHHHhHHHHHhcCC---
Q 005427 427 PVLSWGSFATCGRRETMEDTHFLMPHMYN-------------QKEIHMFGIFDGHRGSAAAEFSARALPGFLQNLGS--- 490 (697)
Q Consensus 427 ~~~~~~~~s~~G~R~~neD~~~~~~~~~~-------------~~~~~~~~V~DG~GG~~~~~~as~~~~~~l~~~~~--- 490 (697)
....||..|++|+|.+|||++++.+++.. ..+..+|+|||||||+.+|++|++.+++.|.+...
T Consensus 7 ~~~~~g~~s~~G~R~~nEDa~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~V~DG~GG~~~~~~as~~~~~~l~~~~~~~~ 86 (316)
T 3kdj_B 7 SVPLYGFTSICGRRPEMEDAVSTIPRFLQSSSGSMLDGRFDPQSAAHFFGVYDGHGGSQVANYCRERMHLALAEEIAKEK 86 (316)
T ss_dssp ---CEEEEEECTTSSSCCEEEEEETTCC-----------CCGGGGCEEEEEEEEESSSHHHHHHHHHHHHHHHHHHHHHC
T ss_pred CCCeEEEEEeEeCCCCCccceeeecccccccccccccccccCCCCeEEEEEEeCCCcHHHHHHHHHHHHHHHHHHHHhhh
Confidence 35679999999999999999998664321 23578999999999999999999999998876411
Q ss_pred CC---------ChHHHHHHHHHHHHHHHHHHHHHHHhhhhcccCCCCCCceEEEEEEecCeEEEEEcCCeEEEEEECCee
Q 005427 491 TT---------RPTDALLEAFIRTDVAFRNELDSLRKSKRVVQKDWHPGCTAIAALIVRNRLFVANAGDCRAILCRGGHP 561 (697)
Q Consensus 491 ~~---------~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GtT~~~~~i~~~~l~~anvGDSr~~l~~~~~~ 561 (697)
.. .....+.+++..++..+.. .....||||++++++.++++|+|||||||+|++|+|++
T Consensus 87 ~~~~~~~~~~~~~~~~l~~a~~~~~~~~~~------------~~~~~~GtT~~~~~i~~~~l~vanvGDSR~yl~r~g~~ 154 (316)
T 3kdj_B 87 PMLSDGDTWLEKWKKALFNSFLRVDSEIES------------VAPETVGSTSVVAVVFPSHIFVANCGDSRAVLCRGKTA 154 (316)
T ss_dssp CCGGGTHHHHHHHHHHHHHHHHHHHHHGGG------------TSCTTCEECEEEEEECSSEEEEEEESSCEEEEEETTEE
T ss_pred cccccccchHHHHHHHHHHHHHHHHHHHhc------------ccCCCCCCcEEEEEEECCEEEEEEccCCEEEEEECCEe
Confidence 10 1233344444444333311 11235899999999999999999999999999999999
Q ss_pred eecCCCCCCCCHHHHHHHHHcCCeeeeccCcceeCCCcceeccccCCCCCCCCcccCCceEEEEeCCCCeEEEEEcCCcc
Q 005427 562 FALSRDHVASCLEERERVVSAGGNVNWQVDTWRVGPPALQVTRSIGDDDLKPAVTAEPEITETIMTPEDEYLVMASDGLW 641 (697)
Q Consensus 562 ~~lt~dH~~~~~~e~~ri~~~g~~~~~~~~~~~~~~~~~~ltralG~~~~k~~v~~~p~v~~~~l~~~d~~lvl~SDGl~ 641 (697)
++||+||++..+.|..|+...|+.+... ...++. +.+++||+||+..+|+.++++|++..+.+.+.++||||||||||
T Consensus 155 ~~lT~DH~~~~~~e~~ri~~~~g~v~~~-~~~r~~-g~l~~sRalGd~~~~~~~~~~pdv~~~~~~~~~d~llL~SDGl~ 232 (316)
T 3kdj_B 155 LPLSVDHKPDREDEAARIEAAGGKVIQW-NGARVF-GVLAMSRSIGDRYLKPSIIPDPEVTAVKRVKEDDCLILASDGVW 232 (316)
T ss_dssp EESCCCCCTTSHHHHHHHHHTTCCEEES-SSEEET-TTBSCSBCEECGGGTTTSBCCCEEEEEECCTTEEEEEEECHHHH
T ss_pred cccCCCCCCCCHHHHHHHHHcCCeEEec-CCceEc-ceeccccccCccccCCCcCCCCceEEEEecCCCCEEEEEccCcc
Confidence 9999999999999999999999977532 234554 68999999999999999999999999985555569999999999
Q ss_pred cCCChHHHHHHHHhh--------------------------cCChhHHHHHHHHHHHhcCCCCCcEEEEEEeCCCCccc
Q 005427 642 DVVSHVEAVGIIKDT--------------------------VKEPGMCSKRLATEAAERGSKDNITVIVVFLQPVSTAE 694 (697)
Q Consensus 642 d~~~~~ei~~~~~~~--------------------------~~~~~~~a~~L~~~a~~~g~~DNiT~ivv~l~~~~~~~ 694 (697)
|+++++||+++++.. ..+++.+|+.|++.|+.+|+.||||||||++.+++...
T Consensus 233 d~l~~~ei~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~aa~~Lv~~A~~~g~~DNiTvivv~l~~~~~~~ 311 (316)
T 3kdj_B 233 DVMTDEEACEMARKRILLWHKKNAVAGGASLLADERRKEGKDPAAMSAAEYLSKLAIQRGSKDNISVVVVDLKPRRKLK 311 (316)
T ss_dssp TSSCHHHHHHHHHHHHHHHTTC-----------------CCCHHHHHHHHHHHHHHHHTTCCSCEEEEEEECSCC----
T ss_pred cCCCHHHHHHHHHHHhhhhccccccccccccccccccccccCchHHHHHHHHHHHHHHcCCCCCeEEEEEEccCCCccc
Confidence 999999999999762 12478899999999999999999999999998776543
|
| >2i0o_A Ser/Thr phosphatase; beta sandwich, structural genomics, PSI, protei structure initiative, NEW YORK SGX research center for STRU genomics; 1.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=378.66 Aligned_cols=256 Identities=31% Similarity=0.516 Sum_probs=208.1
Q ss_pred cccceEeeeccCCCCCCCceeEEcccccCCCceEEEEEecCCCChHHHHHHHHHhHHHHHhc--CCCCChHHHHHHHHHH
Q 005427 427 PVLSWGSFATCGRRETMEDTHFLMPHMYNQKEIHMFGIFDGHRGSAAAEFSARALPGFLQNL--GSTTRPTDALLEAFIR 504 (697)
Q Consensus 427 ~~~~~~~~s~~G~R~~neD~~~~~~~~~~~~~~~~~~V~DG~GG~~~~~~as~~~~~~l~~~--~~~~~~~~~l~~~~~~ 504 (697)
..+.+|..+++|.|..|||++++...+ ..+..+|+|||||||+.+|++|++.+++.|.+. +........+.++|..
T Consensus 21 ~~~~~~~~s~~G~R~~nED~~~~~~~~--~~~~~l~~V~DGhGG~~~a~~as~~~~~~l~~~~~~~~~~~~~~l~~a~~~ 98 (304)
T 2i0o_A 21 EFLASGSSSMQGWRISQEDAHNCILNF--DDQCSFFAVYDGHGGAEVAQYCSLHLPTFLKTVEAYGRKEFEKALKEAFLG 98 (304)
T ss_dssp SSEEEEEEEEEESSSCCCEEEEEEEEE--ETTEEEEEEEECSSCSHHHHHHHHHHHHHHHHSHHHHTTCHHHHHHHHHHH
T ss_pred CceEEEEeecCCCCCCccCEEEEEecc--CCCeEEEEEEcCCCCHHHHHHHHHHHHHHHHhhhhcccccHHHHHHHHHHH
Confidence 468899999999999999999875432 236789999999999999999999999998764 2234567888999998
Q ss_pred HHHHHHHHHHH--HHhhhh-----cccCCCCCCceEEEEEEecCeEEEEEcCCeEEEEEECCeeeecCCCCCCCCHHHHH
Q 005427 505 TDVAFRNELDS--LRKSKR-----VVQKDWHPGCTAIAALIVRNRLFVANAGDCRAILCRGGHPFALSRDHVASCLEERE 577 (697)
Q Consensus 505 ~~~~~~~~~~~--~~~~~~-----~~~~~~~~GtT~~~~~i~~~~l~~anvGDSr~~l~~~~~~~~lt~dH~~~~~~e~~ 577 (697)
++..+...... ...... .......||||++++++.++++|+|||||||+|++|+|++++||+||++.++.|++
T Consensus 99 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~GtT~~~~~i~~~~l~vanvGDSRa~l~r~g~~~~LT~DH~~~~~~e~~ 178 (304)
T 2i0o_A 99 FDATLLQEKVIEELKVLSGDSAGSDAEPGKDSGCTAVVALLHGKDLYVANAGDSRCVVCRNGKALEMSFDHKPEDTVEYQ 178 (304)
T ss_dssp HHHHTTSHHHHHHHHHHHCC-----CCTTTSCEEEEEEEEEETTEEEEEEESSCEEEEEETTEEEECCCCCCTTSHHHHH
T ss_pred HHHHHHhhhhHHHHhhhccccccccccCCCCCCccEEEEEEECCEEEEEEccCcEEEEEECCEEEEcCCCcCCcCHHHHH
Confidence 88877543210 000000 01113468999999999999999999999999999999999999999999999999
Q ss_pred HHHHcCCeeeeccCcceeCCCcceeccccCCCCCCC---------CcccCCceEEEEeCCCCeEEEEEcCCcccCCChHH
Q 005427 578 RVVSAGGNVNWQVDTWRVGPPALQVTRSIGDDDLKP---------AVTAEPEITETIMTPEDEYLVMASDGLWDVVSHVE 648 (697)
Q Consensus 578 ri~~~g~~~~~~~~~~~~~~~~~~ltralG~~~~k~---------~v~~~p~v~~~~l~~~d~~lvl~SDGl~d~~~~~e 648 (697)
||...||.+.. ..|+. +.+.+|||||+..+|. +|+++|++..+.+.++|.|||||||||||++++++
T Consensus 179 rI~~~gg~v~~---~~rv~-g~l~ltRalGd~~~k~~~~l~~~~~~v~~~pdi~~~~l~~~D~fllL~SDGl~d~l~~~e 254 (304)
T 2i0o_A 179 RIEKAGGRVTL---DGRVN-GGLNLSRAIGDHGYKMNKSLPAEEQMISALPDIEKITVGPEDEFMVLACDGIWNFMTSEQ 254 (304)
T ss_dssp HHHHTTCCBCT---TSCBT-TSCSCSBCEECGGGCCCTTSCGGGSSSBCCCEEEEEECCTTEEEEEEECHHHHTTCCHHH
T ss_pred HHHhCCCEEEe---CCeEc-CceeccccccCHHHccCccCCccCCeEEeeCeEEEEEcCCCCeEEEEECcCccccCCHHH
Confidence 99999996642 23443 6889999999998773 57899999999999999999999999999999999
Q ss_pred HHHHHHhh----cCChhHHHHHHHHHHHh------cCCCCCcEEEEEEeC
Q 005427 649 AVGIIKDT----VKEPGMCSKRLATEAAE------RGSKDNITVIVVFLQ 688 (697)
Q Consensus 649 i~~~~~~~----~~~~~~~a~~L~~~a~~------~g~~DNiT~ivv~l~ 688 (697)
+++++... ..+++++|+.|++.|+. +++.||||||||+|+
T Consensus 255 i~~~v~~~~~~~~~~~~~~a~~L~~~a~~~~~~g~~g~~DNiTvivv~~~ 304 (304)
T 2i0o_A 255 VVQFVQERINKPGMKLSKICEELFDHCLAPHTRGDGTGCDNMTAIIVQFK 304 (304)
T ss_dssp HHHHHHHHHTSTTCCHHHHHHHHHHHHC------------CEEEEEEEEC
T ss_pred HHHHHHHHHhhcCCCHHHHHHHHHHHHHHhhhccCCCCCCCeEEEEEEeC
Confidence 99999863 24789999999999986 457899999999984
|
| >4da1_A Protein phosphatase 1K, mitochondrial; metal-ION-assisted catalysis, dehydrogenase phosphatase, hydrolase; 2.38A {Homo sapiens} PDB: 3qht_A 1l2n_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=388.08 Aligned_cols=259 Identities=31% Similarity=0.454 Sum_probs=218.4
Q ss_pred cccceEeeeccCCCCCCCceeEEcccccCCCceEEEEEecCCCChHHHHHHHHHhHHHHHhcCC-CCChHHHHHHHHHHH
Q 005427 427 PVLSWGSFATCGRRETMEDTHFLMPHMYNQKEIHMFGIFDGHRGSAAAEFSARALPGFLQNLGS-TTRPTDALLEAFIRT 505 (697)
Q Consensus 427 ~~~~~~~~s~~G~R~~neD~~~~~~~~~~~~~~~~~~V~DG~GG~~~~~~as~~~~~~l~~~~~-~~~~~~~l~~~~~~~ 505 (697)
..+.+|..|++|.|..|||++++.. ...+..+|+|||||||+.+|++|++.+++.+.+... .......+..++..+
T Consensus 120 ~~~~~g~~s~~G~R~~NED~~~~~~---~~~~~~l~~VaDG~GG~~~g~~as~~~~~~l~~~~~~~~~~~~~l~~a~~~~ 196 (389)
T 4da1_A 120 SLENVGCASQIGKRKENEDRFDFAQ---LTDEVLYFAVYDGHGGPAAADFCHTHMEKCIMDLLPKEKNLETLLTLAFLEI 196 (389)
T ss_dssp CGGGCEEEEECTTSSSCCEEEEEEE---CSSSEEEEEEEEEESSTHHHHHHHHHHHHHHHHHTTTCCCHHHHHHHHHHHH
T ss_pred cceeEEEecCCCCCCCCcceeeeee---cCCCEEEEEEEECCCCHHHHHHHHHHHHHHHHHHhccccCHHHHHHHHHHHH
Confidence 3578999999999999999998854 234678999999999999999999999999987633 456778899999999
Q ss_pred HHHHHHHHHHHHhhhhcccCCCCCCceEEEEEEecC-eEEEEEcCCeEEEEEECCeeeecCCCCCCCCHHHHHHHHHcCC
Q 005427 506 DVAFRNELDSLRKSKRVVQKDWHPGCTAIAALIVRN-RLFVANAGDCRAILCRGGHPFALSRDHVASCLEERERVVSAGG 584 (697)
Q Consensus 506 ~~~~~~~~~~~~~~~~~~~~~~~~GtT~~~~~i~~~-~l~~anvGDSr~~l~~~~~~~~lt~dH~~~~~~e~~ri~~~g~ 584 (697)
+..+........ ......||||++++++.++ ++|+|||||||+|++|+|++++||+||++.++.|++||.+.||
T Consensus 197 n~~i~~~~~~~~-----~~~~~~~GtT~~~~li~~~~~l~vanvGDSRayl~r~g~~~~LT~DHs~~~~~E~~Ri~~~gG 271 (389)
T 4da1_A 197 DKAFSSHARLSA-----DATLLTSGTTATVALLRDGIELVVASVGDSRAILCRKGKPMKLTIDHTPERKDEKERIKKCGG 271 (389)
T ss_dssp HHHHHHHHHHSS-----CGGGGGCEECEEEEEEETTTEEEEEEESSCEEEEEETTEEEECCCCCCTTSHHHHHHHHHHTC
T ss_pred HHHHHHHhhhcc-----ccccCCCCCeEEEEEEEcCCeEEEEEeeccEEEEEECCEeEEeCCCCCCCCHHHHHHHHHcCC
Confidence 988876533211 1112348999999999876 9999999999999999999999999999999999999999999
Q ss_pred eeeeccCcceeCCCcceeccccCCCCCCC-CcccCCceEEEEeCCC-CeEEEEEcCCcccCCChHHHHHHHHhhcCChhH
Q 005427 585 NVNWQVDTWRVGPPALQVTRSIGDDDLKP-AVTAEPEITETIMTPE-DEYLVMASDGLWDVVSHVEAVGIIKDTVKEPGM 662 (697)
Q Consensus 585 ~~~~~~~~~~~~~~~~~ltralG~~~~k~-~v~~~p~v~~~~l~~~-d~~lvl~SDGl~d~~~~~ei~~~~~~~~~~~~~ 662 (697)
.+..........++++++|||||+..+|+ +++++|++..+.+.++ |+|||||||||||++++++|++++... .++++
T Consensus 272 ~v~~~~~~~~~~~g~l~ltRalGd~~~k~~~v~~~pdi~~~~l~~~~dd~llL~SDGL~d~l~~~ei~~il~~~-~~~~~ 350 (389)
T 4da1_A 272 FVAWNSLGQPHVNGRLAMTRSIGDLDLKTSGVIAEPETKRIKLHHADDSFLVLTTDGINFMVNSQEICDFVNQC-HDPNE 350 (389)
T ss_dssp CEECC---CCEETTTBSCSBCEECGGGGGGTCBCCCEEEEEECCSSSCEEEEEECHHHHTTCCHHHHHHHHHHS-SSHHH
T ss_pred eEecccCCCccCCCeEeeEeeeCChhhccCCCCCCCceEEEEEcCCCCcEEEEEeCCcccCCCHHHHHHHHHhc-CCHHH
Confidence 87654333333457999999999999887 5899999999999875 679999999999999999999999875 48999
Q ss_pred HHHHHHHHHHhcCCCCCcEEEEEEeCCCCccc
Q 005427 663 CSKRLATEAAERGSKDNITVIVVFLQPVSTAE 694 (697)
Q Consensus 663 ~a~~L~~~a~~~g~~DNiT~ivv~l~~~~~~~ 694 (697)
+|+.|++.|+.+|+.||||||||++..+...+
T Consensus 351 ~a~~Lv~~A~~~g~~DNiTvivv~~~~~~~~~ 382 (389)
T 4da1_A 351 AAHAVTEQAIQYGTEDNSTAVVVPFGAWGKYK 382 (389)
T ss_dssp HHHHHHHHHHHHTCCSCEEEEEEEECCC----
T ss_pred HHHHHHHHHHHcCCCCCeEEEEEEecCCCCCC
Confidence 99999999999999999999999998776543
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=379.91 Aligned_cols=264 Identities=31% Similarity=0.497 Sum_probs=215.5
Q ss_pred ccCCCCCCCcccccccccCCceEEEEEEECCeeEEEEeccCCC--hHHHHHHHHHHHHHHhcCCCCceEEeeccccCCce
Q 005427 59 IPLHLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILST--SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNY 136 (697)
Q Consensus 59 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 136 (697)
..++++..+|++.++||+|+||.||+|+++++.||||++.... ....+.+.+|+.+|++++||||+++++++.+...+
T Consensus 30 ~~~~i~~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 109 (309)
T 3p86_A 30 DDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNL 109 (309)
T ss_dssp --CBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCC
T ss_pred ccccCChhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCce
Confidence 3456778899999999999999999999999999999865543 44567899999999999999999999999999999
Q ss_pred EEEEeecCCCCHhhhhhhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC--cccccCCCCceeecCCCCCeeeeeccchhh
Q 005427 137 MFFFEFYESRNLAEKLHVEEW--SPSVDQVLMIAAQLAKALQYLHNLG--IVHRDVKPANVLLDRNLCPHLADFGLAEYR 212 (697)
Q Consensus 137 ~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~ 212 (697)
++||||+.+|+|.+++..... .+++..++.++.|++.||+|||+.| |+||||||+|||++.++.+||+|||+++..
T Consensus 110 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 189 (309)
T 3p86_A 110 SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK 189 (309)
T ss_dssp EEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC-----
T ss_pred EEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCccc
Confidence 999999999999999976432 3889999999999999999999999 999999999999999999999999999754
Q ss_pred hhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHh
Q 005427 213 ENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLE 292 (697)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~ 292 (697)
.... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.........+..
T Consensus 190 ~~~~----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~ 253 (309)
T 3p86_A 190 ASTF----------------LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGF 253 (309)
T ss_dssp ----------------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHH
T ss_pred cccc----------------cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 3211 113456799999999999999999999999999999999999999987655443332211
Q ss_pred ccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 005427 293 MNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH 355 (697)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~ 355 (697)
...+ ...+..+++++.+||.+||+.||.+|||+.++++.|..+++.
T Consensus 254 --------------~~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 254 --------------KCKR---LEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp --------------SCCC---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred --------------cCCC---CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 1111 123457899999999999999999999999999999888764
|
| >1a6q_A Phosphatase 2C; catalytic mechanism, metalloenzyme, transductuin, hydrolase; 2.00A {Homo sapiens} SCOP: a.159.1.1 d.219.1.1 PDB: 3fxk_A 3fxj_A 3fxl_A* 3fxm_A* 3fxo_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=385.70 Aligned_cols=254 Identities=27% Similarity=0.474 Sum_probs=213.7
Q ss_pred cccceEeeeccCCCCCCCceeEEcccccC-CCceEEEEEecCCCChHHHHHHHHHhHHHHHhc--CCC-------CChHH
Q 005427 427 PVLSWGSFATCGRRETMEDTHFLMPHMYN-QKEIHMFGIFDGHRGSAAAEFSARALPGFLQNL--GST-------TRPTD 496 (697)
Q Consensus 427 ~~~~~~~~s~~G~R~~neD~~~~~~~~~~-~~~~~~~~V~DG~GG~~~~~~as~~~~~~l~~~--~~~-------~~~~~ 496 (697)
..+.||.++++|.|..|||++++...+.. ..+..+|+|||||||+.+|++|++.+++.|... +.. .....
T Consensus 20 ~~l~~g~~s~~G~R~~nEDa~~~~~~~~~~~~~~~lf~V~DGhGG~~aa~~as~~l~~~l~~~~~~~~~~~~~~~~~~~~ 99 (382)
T 1a6q_A 20 NGLRYGLSSMQGWRVEMEDAHTAVIGLPSGLESWSFFAVYDGHAGSQVAKYCCEHLLDHITNNQDFKGSAGAPSVENVKN 99 (382)
T ss_dssp TTEEEEEEEEEETSSSCCEEEEEEEEETTTEEEEEEEEEEEEESCSHHHHHHHHHHHHHHHTSHHHHCSSSSCCHHHHHH
T ss_pred CceEEEEEecCCCCCCCCceeEEecCCCCCCCCeEEEEEEcCCCcHHHHHHHHHHHHHHHHhhhhhhccCCCCCHHHHHH
Confidence 46899999999999999999998654322 135679999999999999999999999988742 111 12356
Q ss_pred HHHHHHHHHHHHHHHHHHHHHhhhhcccCCCCCCceEEEEEEecCeEEEEEcCCeEEEEEECCeeeecCCCCCCCCHHHH
Q 005427 497 ALLEAFIRTDVAFRNELDSLRKSKRVVQKDWHPGCTAIAALIVRNRLFVANAGDCRAILCRGGHPFALSRDHVASCLEER 576 (697)
Q Consensus 497 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GtT~~~~~i~~~~l~~anvGDSr~~l~~~~~~~~lt~dH~~~~~~e~ 576 (697)
.|.++|..++..+...... ......||||++++++.++++|+|||||||+|++|+|++.+||+||++.++.|+
T Consensus 100 ~l~~af~~~n~~i~~~~~~-------~~~~~~~GtT~~~~li~~~~l~vanvGDSRayl~r~g~~~~LT~DHs~~~~~E~ 172 (382)
T 1a6q_A 100 GIRTGFLEIDEHMRVMSEK-------KHGADRSGSTAVGVLISPQHTYFINCGDSRGLLCRNRKVHFFTQDHKPSNPLEK 172 (382)
T ss_dssp HHHHHHHHHHHHHHHHHHH-------TTCCCCCEECEEEEEECSSEEEEEEESSCEEEEEETTEEEEECCCCCTTSHHHH
T ss_pred HHHHHHHHHHHHHHhhhhh-------ccCCCCCcceEEEEEEECCeEEEEEcCCCeEEEEECCceEEeCCCCCCCCHHHH
Confidence 7778888888777654221 122345899999999999999999999999999999999999999999999999
Q ss_pred HHHHHcCCeeeeccCcceeCCCcceeccccCCCCCC---------CCcccCCceEEEEeC-CCCeEEEEEcCCcccCCCh
Q 005427 577 ERVVSAGGNVNWQVDTWRVGPPALQVTRSIGDDDLK---------PAVTAEPEITETIMT-PEDEYLVMASDGLWDVVSH 646 (697)
Q Consensus 577 ~ri~~~g~~~~~~~~~~~~~~~~~~ltralG~~~~k---------~~v~~~p~v~~~~l~-~~d~~lvl~SDGl~d~~~~ 646 (697)
+||..+|+.+.. .|+. +.+++|||||+..+| +.|+++|++..+.+. ++|+|||||||||||++++
T Consensus 173 ~RI~~~gg~v~~----~Rv~-g~l~ltRalGd~~~K~~~~~~~~~~~v~~~Pdv~~~~l~~~~dd~llLaSDGlwd~ls~ 247 (382)
T 1a6q_A 173 ERIQNAGGSVMI----QRVN-GSLAVSRALGDFDYKCVHGKGPTEQLVSPEPEVHDIERSEEDDQFIILACDGIWDVMGN 247 (382)
T ss_dssp HHHHHTTCCEET----TEET-TTBSCSBCEECGGGSCCTTCCGGGSSSBCCCEEEEEECCTTTEEEEEEECHHHHTTSCH
T ss_pred HHHHhcCcEEec----cccc-CceeeeeecCcHhhcccccCCCccCeeeeeeeEEEEEccCCCCeEEEEeccCccCCCCh
Confidence 999999987642 3444 578999999998877 357899999999999 7778999999999999999
Q ss_pred HHHHHHHHhh---cCChhHHHHHHHHHHHhcCCCCCcEEEEEEeCCCCc
Q 005427 647 VEAVGIIKDT---VKEPGMCSKRLATEAAERGSKDNITVIVVFLQPVST 692 (697)
Q Consensus 647 ~ei~~~~~~~---~~~~~~~a~~L~~~a~~~g~~DNiT~ivv~l~~~~~ 692 (697)
++|++++... ..+++.+|+.|++.|+.+|+.||||||||++...+.
T Consensus 248 ~ei~~~v~~~~~~~~~~~~~a~~Lv~~A~~~g~~DNiTvivv~~~~~~~ 296 (382)
T 1a6q_A 248 EELCDFVRSRLEVTDDLEKVCNEVVDTCLYKGSRDNMSVILICFPNAPK 296 (382)
T ss_dssp HHHHHHHHHHHTTCCCHHHHHHHHHHHHHHTTCCSCEEEEEEECTTSCC
T ss_pred HHHHHHHHHHHhcCCCHHHHHHHHHHHHHhcCCcCCEEEEEEEecCCCC
Confidence 9999999874 248999999999999999999999999999986554
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=383.11 Aligned_cols=255 Identities=18% Similarity=0.285 Sum_probs=221.3
Q ss_pred CCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEee
Q 005427 65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF 142 (697)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 142 (697)
.++|++.+.||+|+||.||+|.+ +++.+|+|.+.... .....+.+|+.+|+.++||||+++++++.+...+++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 46899999999999999999998 57899999876543 4556789999999999999999999999999999999999
Q ss_pred cCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecC--CCCCeeeeeccchhhhhhhhhhc
Q 005427 143 YESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDR--NLCPHLADFGLAEYRENLKEISL 220 (697)
Q Consensus 143 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~--~~~~kL~Dfg~a~~~~~~~~~~~ 220 (697)
+.+|+|.+++......+++.+++.++.|++.||.|||+.||+||||||+|||++. ++.+||+|||++.......
T Consensus 83 ~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~---- 158 (321)
T 1tki_A 83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---- 158 (321)
T ss_dssp CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC----
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC----
Confidence 9999999999877667999999999999999999999999999999999999987 7899999999997654211
Q ss_pred ccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHH
Q 005427 221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQL 300 (697)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 300 (697)
......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.........+....+..
T Consensus 159 -------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~--- 222 (321)
T 1tki_A 159 -------------NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTF--- 222 (321)
T ss_dssp -------------EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCC---
T ss_pred -------------ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCC---
Confidence 1345679999999999999989999999999999999999999998876665555554433221
Q ss_pred HHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 301 TAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
.......+|.++.+||.+||..||.+|||+.|+++|+|..
T Consensus 223 ------------~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~ 262 (321)
T 1tki_A 223 ------------DEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLK 262 (321)
T ss_dssp ------------CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHH
T ss_pred ------------ChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhc
Confidence 1222357899999999999999999999999999999975
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-46 Score=382.86 Aligned_cols=254 Identities=23% Similarity=0.373 Sum_probs=217.2
Q ss_pred CCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEee
Q 005427 65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF 142 (697)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 142 (697)
.++|++.++||+|+||+||+|.+ +++.||+|++........+.+.+|+.+++.++||||+++++++.....+++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 46899999999999999999986 6889999987665555567889999999999999999999999999999999999
Q ss_pred cCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhccc
Q 005427 143 YESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKN 222 (697)
Q Consensus 143 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 222 (697)
+.+|+|.+++... .+++.+++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 99 ~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~------ 170 (297)
T 3fxz_A 99 LAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ------ 170 (297)
T ss_dssp CTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT------
T ss_pred CCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc------
Confidence 9999999999764 58999999999999999999999999999999999999999999999999986543211
Q ss_pred ccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHHHH
Q 005427 223 WRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTA 302 (697)
Q Consensus 223 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 302 (697)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.........+....
T Consensus 171 ----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~-------- 232 (297)
T 3fxz_A 171 ----------SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG-------- 232 (297)
T ss_dssp ----------CCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHC--------
T ss_pred ----------cccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--------
Confidence 12345689999999999999999999999999999999999999998765544333322111
Q ss_pred HHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 303 AVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
.+.. ..+..+++.+.+||.+||+.||.+|||+.|+++|.|+-
T Consensus 233 -------~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~ 274 (297)
T 3fxz_A 233 -------TPEL-QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLK 274 (297)
T ss_dssp -------SCCC-SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGG
T ss_pred -------CCCC-CCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhc
Confidence 1111 12346889999999999999999999999999988764
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=384.96 Aligned_cols=253 Identities=23% Similarity=0.327 Sum_probs=217.0
Q ss_pred CCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCC---ChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEE
Q 005427 64 PPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMF 138 (697)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 138 (697)
..++|++++.||+|+||.||+|++ +++.||+|++... .......+.+|+.+|+.++||||+++++++.+...+++
T Consensus 3 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 82 (337)
T 1o6l_A 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF 82 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred ChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEE
Confidence 456899999999999999999998 5889999986532 12235678899999999999999999999999999999
Q ss_pred EEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhh
Q 005427 139 FFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI 218 (697)
Q Consensus 139 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~ 218 (697)
||||+++|+|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 83 v~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~---- 157 (337)
T 1o6l_A 83 VMEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS---- 157 (337)
T ss_dssp EEECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC----
T ss_pred EEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhccc----
Confidence 999999999999987654 789999999999999999999999999999999999999999999999999864321
Q ss_pred hcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHH
Q 005427 219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQ 298 (697)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~ 298 (697)
.+......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+.......+...
T Consensus 158 ------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~----- 220 (337)
T 1o6l_A 158 ------------DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME----- 220 (337)
T ss_dssp ------------TTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-----
T ss_pred ------------CCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcC-----
Confidence 111245678999999999999999999999999999999999999999877655544443321
Q ss_pred HHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCC-----CHHHHHHHHHHH
Q 005427 299 QLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRP-----SFSDIALELDLV 352 (697)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~ell~~l~~~ 352 (697)
.. ..+..+++++.+||.+||+.||.+|| ++.|+++|.|+.
T Consensus 221 ---------~~-----~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~ 265 (337)
T 1o6l_A 221 ---------EI-----RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL 265 (337)
T ss_dssp ---------CC-----CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGT
T ss_pred ---------CC-----CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcC
Confidence 11 13456899999999999999999999 999999998763
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=387.87 Aligned_cols=255 Identities=21% Similarity=0.285 Sum_probs=218.8
Q ss_pred CCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCChH------HHHHHHHHHHHHHhcCCCCceEEeeccccCCce
Q 005427 65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSE------ELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNY 136 (697)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 136 (697)
.++|++.+.||+|+||.||+|++ +++.||+|++...... ..+.+.+|+.+|+.++||||+++++++.+...+
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 35799999999999999999998 5889999986543321 356789999999999999999999999999999
Q ss_pred EEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCC----CCeeeeeccchhh
Q 005427 137 MFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNL----CPHLADFGLAEYR 212 (697)
Q Consensus 137 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~----~~kL~Dfg~a~~~ 212 (697)
++||||+.+|+|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++.++ .+||+|||++...
T Consensus 91 ~lv~e~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~ 169 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169 (361)
T ss_dssp EEEEECCCSCBHHHHHTTCS-CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEEC
T ss_pred EEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEc
Confidence 99999999999999997654 789999999999999999999999999999999999998776 7999999999765
Q ss_pred hhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHh
Q 005427 213 ENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLE 292 (697)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~ 292 (697)
... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.........+..
T Consensus 170 ~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~ 232 (361)
T 2yab_A 170 EDG-----------------VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITA 232 (361)
T ss_dssp CTT-----------------CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHT
T ss_pred CCC-----------------CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 421 123456799999999999999999999999999999999999999998766665555544
Q ss_pred ccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 293 MNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
..+. +.+..+..+++++.+||.+||..||.+|||+.|+++|+|..
T Consensus 233 ~~~~---------------~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~ 277 (361)
T 2yab_A 233 VSYD---------------FDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWIT 277 (361)
T ss_dssp TCCC---------------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTS
T ss_pred cCCC---------------CCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcC
Confidence 3322 11223457899999999999999999999999999998863
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-46 Score=389.74 Aligned_cols=255 Identities=24% Similarity=0.346 Sum_probs=213.2
Q ss_pred CCCCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCC---ChHHHHHHHHHHHHHHhc-CCCCceEEeeccccCCc
Q 005427 62 HLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKL-DHPGLAKFVAAHAKPPN 135 (697)
Q Consensus 62 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~ 135 (697)
.+..++|+++++||+|+||.||+|++ +++.||+|++... .......+.+|..+|+.+ +||||+++++++.+...
T Consensus 19 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~ 98 (353)
T 3txo_A 19 RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDR 98 (353)
T ss_dssp ----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred CCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCE
Confidence 35567999999999999999999997 5789999986532 223356788999999988 79999999999999999
Q ss_pred eEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhh
Q 005427 136 YMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL 215 (697)
Q Consensus 136 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~ 215 (697)
+|+||||+.+|+|.+++.... .+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 99 ~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~- 176 (353)
T 3txo_A 99 LFFVMEFVNGGDLMFHIQKSR-RFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC- 176 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-
T ss_pred EEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeeccc-
Confidence 999999999999999997654 799999999999999999999999999999999999999999999999999864321
Q ss_pred hhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccc
Q 005427 216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNY 295 (697)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~ 295 (697)
.+......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+.......+.....
T Consensus 177 ---------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~ 241 (353)
T 3txo_A 177 ---------------NGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV 241 (353)
T ss_dssp ------------------------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC
T ss_pred ---------------CCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC
Confidence 11124567899999999999999999999999999999999999999998776666555543221
Q ss_pred cHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCH------HHHHHHHHHH
Q 005427 296 TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSF------SDIALELDLV 352 (697)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~------~ell~~l~~~ 352 (697)
..+..+++++.+||++||+.||.+||++ .++++|.|+-
T Consensus 242 -------------------~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~ 285 (353)
T 3txo_A 242 -------------------VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFK 285 (353)
T ss_dssp -------------------CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGT
T ss_pred -------------------CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCccc
Confidence 1234688999999999999999999998 8999988763
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-45 Score=380.93 Aligned_cols=269 Identities=26% Similarity=0.430 Sum_probs=223.5
Q ss_pred ccCCCCCCCcccccccccCCceEEEEEEEC-----CeeEEEEeccCC-ChHHHHHHHHHHHHHHhcCCCCceEEeecccc
Q 005427 59 IPLHLPPSSYTLLSPIARGAESVVYEATLD-----GRKVAVKKPILS-TSEELDNFHKELQLLCKLDHPGLAKFVAAHAK 132 (697)
Q Consensus 59 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 132 (697)
...++..++|++.+.||+|+||.||+|.+. +..||||++... .....+.+.+|+.+|+.++||||+++++++.+
T Consensus 42 ~~~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 121 (325)
T 3kul_A 42 FTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTR 121 (325)
T ss_dssp -CCBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECG
T ss_pred hccccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence 445677889999999999999999999872 446999987654 34456789999999999999999999999999
Q ss_pred CCceEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhh
Q 005427 133 PPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYR 212 (697)
Q Consensus 133 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~ 212 (697)
...+++||||+.+|+|.+++......+++.+++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||++...
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 122 GRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201 (325)
T ss_dssp GGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred CCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCccccc
Confidence 99999999999999999999877668999999999999999999999999999999999999999999999999999765
Q ss_pred hhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCCchhHHHHHHHH
Q 005427 213 ENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVL 291 (697)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~~~~~~~~~~~~ 291 (697)
..... .........+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.........+.
T Consensus 202 ~~~~~-------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~ 268 (325)
T 3kul_A 202 EDDPD-------------AAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVE 268 (325)
T ss_dssp C-----------------CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHH
T ss_pred ccCcc-------------ceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH
Confidence 43211 1111233456889999999999999999999999999999999 999998766554443332
Q ss_pred hccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhcc
Q 005427 292 EMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHRKS 358 (697)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~~~~ 358 (697)
. + .++ ..+..+++++.+||..||..||.+|||+.++++.|..+++....
T Consensus 269 ~--------------~-~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~ 317 (325)
T 3kul_A 269 E--------------G-YRL---PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPES 317 (325)
T ss_dssp T--------------T-CCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC-
T ss_pred c--------------C-CCC---CCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCccc
Confidence 2 1 111 13457899999999999999999999999999999998865443
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=366.61 Aligned_cols=261 Identities=23% Similarity=0.408 Sum_probs=223.3
Q ss_pred cCCCCCCCcccccccccCCceEEEEEEE-CCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEE
Q 005427 60 PLHLPPSSYTLLSPIARGAESVVYEATL-DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMF 138 (697)
Q Consensus 60 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 138 (697)
.+.+..++|++.+.||+|+||.||+|.+ .++.||+|++..... ..+.+.+|+.++++++||||+++++++.+....++
T Consensus 4 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (269)
T 4hcu_A 4 KWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICL 82 (269)
T ss_dssp -CBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred cEEeChhhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEE
Confidence 4667788999999999999999999998 678899998764432 34678999999999999999999999999999999
Q ss_pred EEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhh
Q 005427 139 FFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI 218 (697)
Q Consensus 139 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~ 218 (697)
||||+++++|.+++......+++..++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||++.........
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 162 (269)
T 4hcu_A 83 VFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 162 (269)
T ss_dssp EEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred EEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccccccc
Confidence 99999999999999877767999999999999999999999999999999999999999999999999999765432211
Q ss_pred hcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCCchhHHHHHHHHhccccH
Q 005427 219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTE 297 (697)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~ 297 (697)
......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+.........+..
T Consensus 163 ---------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~----- 222 (269)
T 4hcu_A 163 ---------------SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST----- 222 (269)
T ss_dssp ---------------STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT-----
T ss_pred ---------------cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc-----
Confidence 1233457889999999999999999999999999999999 9999988665544433322
Q ss_pred HHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 005427 298 QQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE 354 (697)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~ 354 (697)
..++ ..+..+++++.+++.+||+.||.+|||+.+++++|..+.+
T Consensus 223 ----------~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 223 ----------GFRL---YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp ----------TCCC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----------CccC---CCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 1111 2234678999999999999999999999999999998875
|
| >3d8k_A PP2C, protein phosphatase 2C; nysgrc, PSI-II, STR genomics, protein structure initiative, NEW YORK structural research consortium, nysgxrc; 2.71A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-45 Score=381.57 Aligned_cols=250 Identities=25% Similarity=0.326 Sum_probs=210.9
Q ss_pred ccceEeeeccCCCCCCC-----ceeEEcccccCCCceEEEEEecCCCChHHHHHHHHHhHHHHHhcCCCCChHHHHHHHH
Q 005427 428 VLSWGSFATCGRRETME-----DTHFLMPHMYNQKEIHMFGIFDGHRGSAAAEFSARALPGFLQNLGSTTRPTDALLEAF 502 (697)
Q Consensus 428 ~~~~~~~s~~G~R~~ne-----D~~~~~~~~~~~~~~~~~~V~DG~GG~~~~~~as~~~~~~l~~~~~~~~~~~~l~~~~ 502 (697)
.+.++.+|++|+|.+|| |++++...+....+..+|||||||||+.+|++|++.+++.|.+.. ..+.+++.++|
T Consensus 12 ~~~~~~~s~~G~R~~~ED~~neD~~~~~~~~~~~~~~~lf~V~DGhGG~~aa~~as~~l~~~l~~~~--~~~~~al~~af 89 (377)
T 3d8k_A 12 RTVCASATSRNRRPTSESPHSDDVVVVEGMLRGRPETRVHAMFDGFQGRHSAMWLAQNVMNYLNDLR--DVNEEEITRQF 89 (377)
T ss_dssp HHHHHHTTTCEEEEEECC---CEEEEEEEECSSCTTEEEEEEEEBSSSSHHHHHHHHHHHHHHTTCS--SSSHHHHHHHH
T ss_pred cEEEEEEEccCCCCccccchhcceEEEecccCCCCCeEEEEEEcCCCcHHHHHHHHHHHHHHHHHhc--ccHHHHHHHHH
Confidence 56788999999998775 555554434345678899999999999999999999999997642 34578899999
Q ss_pred HHHHHHHHHHHHHHHhhhhcccCCCCCCceEEEEEEe-------------------------------------------
Q 005427 503 IRTDVAFRNELDSLRKSKRVVQKDWHPGCTAIAALIV------------------------------------------- 539 (697)
Q Consensus 503 ~~~~~~~~~~~~~~~~~~~~~~~~~~~GtT~~~~~i~------------------------------------------- 539 (697)
.+++..+.... ..+|||++++++.
T Consensus 90 ~~~d~~l~~~~-------------~~~GtTa~~~~i~~~~~~~~~~~~g~~~~p~~~~~~~~~~~~~g~ta~a~vali~~ 156 (377)
T 3d8k_A 90 ERMDGDLRAAN-------------LPGGSSALIIFVRYEKKPTEARVVGRQIVPEGAKEFTSVAEALGGPLMPVVAMNFR 156 (377)
T ss_dssp HHHHHHHHHHT-------------CCCCBCEEEEEEEEESSCCCEEEETTEEECCC---CCCHHHHSSCCCCCCEEECGG
T ss_pred HHHHHHHHhcc-------------cCCCCceEEEEEeccccccccccccccccccccccccccccccccccccceeeecc
Confidence 99988887541 1379999998885
Q ss_pred --------cCeEEEEEcCCeEEEEEECCeeeecCCCCCCCCHHHHHHHHHcCCeeeeccCcceeCCCcceeccccCCCCC
Q 005427 540 --------RNRLFVANAGDCRAILCRGGHPFALSRDHVASCLEERERVVSAGGNVNWQVDTWRVGPPALQVTRSIGDDDL 611 (697)
Q Consensus 540 --------~~~l~~anvGDSr~~l~~~~~~~~lt~dH~~~~~~e~~ri~~~g~~~~~~~~~~~~~~~~~~ltralG~~~~ 611 (697)
++++|+|||||||+|++|+|++++||+||+|.++.|+.||.++|+.+.......|+. +.+++||||||..+
T Consensus 157 ~~p~~~~~~~~l~vanvGDSRa~l~r~g~~~~LT~DH~~~~~~E~~RI~~~gg~v~~~~g~~rv~-G~l~vtRalGd~~~ 235 (377)
T 3d8k_A 157 RDPRAAKGIYTIHVASLGNSRCVLKSGRTAIHLSTPHTASSHKERHRVQAAGGVFTTVNGELLLG-GVVPMTRAFGSFDF 235 (377)
T ss_dssp GCGGGTTCEEEEEEEEESSCEEEEEETTEEEESSCCCSSSSHHHHHHHHTTTCCEEECSSSEEET-TTBSCSBCSSCGGG
T ss_pred cccccccCCCeEEEEEcccceEEEEECCEEEECCcCCCCCCHHHHHHHHHcCCEEEecCCcEEEc-CceecceeecChhh
Confidence 148999999999999999999999999999999999999999999775333344665 68899999999988
Q ss_pred C---------CCcccCCceEEEEeCCCCeEEEEEcCCcccCCChHHHHHHHHhh----cCChhHHHHHHHHHHHhcCCCC
Q 005427 612 K---------PAVTAEPEITETIMTPEDEYLVMASDGLWDVVSHVEAVGIIKDT----VKEPGMCSKRLATEAAERGSKD 678 (697)
Q Consensus 612 k---------~~v~~~p~v~~~~l~~~d~~lvl~SDGl~d~~~~~ei~~~~~~~----~~~~~~~a~~L~~~a~~~g~~D 678 (697)
| ++|+++|++..+.+.++| +||||||||||+++++|+++.+... ..+++.+|+.|++.|+++|+.|
T Consensus 236 k~~~~~~~~~~~v~~~Pdv~~~~l~~~D-~llL~SDGl~d~ls~~e~v~~v~~~~~~~~~~~~~~a~~Lv~~A~~~g~~D 314 (377)
T 3d8k_A 236 KKGGQGKLQQDLVSAVPDVTTFFAYPGD-DIVAGTAGAFAHFRSHAAIAAAIALYPVSPETVLDAAKAMVVNAKRRKVTK 314 (377)
T ss_dssp SCC---CCSSCSSBCCCEEEEEEECTTC-EEEEECGGGGCSCSSHHHHHHHHTTSCCCGGGHHHHHHHHHHTTTTSSCCS
T ss_pred hcccccccccCccccCCcEEEEEcCCCC-EEEEEECCcccCCCcHHHHHHHHHHhhccCCCHHHHHHHHHHHHHhcCCCC
Confidence 7 478999999999999998 8999999999999999988755542 2478999999999999999999
Q ss_pred CcEEEEEEeCCCCccc
Q 005427 679 NITVIVVFLQPVSTAE 694 (697)
Q Consensus 679 NiT~ivv~l~~~~~~~ 694 (697)
|||||||++.+..+.+
T Consensus 315 NiTvivv~~~~~~~~~ 330 (377)
T 3d8k_A 315 NISTFVRHLPESRTRS 330 (377)
T ss_dssp CCCEEEEECCSSCCCC
T ss_pred CEEEEEEEecCCcchh
Confidence 9999999998776644
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=382.23 Aligned_cols=264 Identities=26% Similarity=0.403 Sum_probs=221.0
Q ss_pred cCCCCCCCcccccccccCCceEEEEEEEC---------CeeEEEEeccCCC-hHHHHHHHHHHHHHHhc-CCCCceEEee
Q 005427 60 PLHLPPSSYTLLSPIARGAESVVYEATLD---------GRKVAVKKPILST-SEELDNFHKELQLLCKL-DHPGLAKFVA 128 (697)
Q Consensus 60 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~---------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~l~~ 128 (697)
.+.+..++|++.+.||+|+||.||+|++. +..||||++.... ....+.+.+|+.+|+.+ +||||+++++
T Consensus 75 ~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~ 154 (370)
T 2psq_A 75 KWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLG 154 (370)
T ss_dssp TTBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEE
T ss_pred cccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence 35667789999999999999999999862 3569999876543 34567899999999999 8999999999
Q ss_pred ccccCCceEEEEeecCCCCHhhhhhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCce
Q 005427 129 AHAKPPNYMFFFEFYESRNLAEKLHVEE---------------WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANV 193 (697)
Q Consensus 129 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Ni 193 (697)
++.+...+++||||+.+|+|.+++.... ..+++.+++.++.||+.||+|||++||+||||||+||
T Consensus 155 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NI 234 (370)
T 2psq_A 155 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV 234 (370)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGE
T ss_pred EEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhE
Confidence 9999999999999999999999997643 2478899999999999999999999999999999999
Q ss_pred eecCCCCCeeeeeccchhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh
Q 005427 194 LLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT 273 (697)
Q Consensus 194 ll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~ 273 (697)
|++.++.+||+|||+++....... ........+|+.|+|||++.+..++.++|||||||++|||++
T Consensus 235 ll~~~~~~kl~DFG~a~~~~~~~~--------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt 300 (370)
T 2psq_A 235 LVTENNVMKIADFGLARDINNIDY--------------YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300 (370)
T ss_dssp EECTTCCEEECCCSSCEETTCCCT--------------TCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHT
T ss_pred EECCCCCEEEccccCCcccCcccc--------------eecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHc
Confidence 999999999999999975542111 011234567899999999999999999999999999999999
Q ss_pred -CCCCCCCchhHHHHHHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 274 -GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 274 -g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
|..||.+.........+. .+.++ ..+..++.++.++|.+||+.||.+|||+.|++++|+.+
T Consensus 301 ~g~~p~~~~~~~~~~~~~~---------------~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~i 362 (370)
T 2psq_A 301 LGGSPYPGIPVEELFKLLK---------------EGHRM---DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 362 (370)
T ss_dssp TSCCSSTTCCGGGHHHHHH---------------TTCCC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHh---------------cCCCC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 999998765443332221 11121 23457899999999999999999999999999999998
Q ss_pred HHH
Q 005427 353 LEH 355 (697)
Q Consensus 353 ~~~ 355 (697)
+..
T Consensus 363 l~~ 365 (370)
T 2psq_A 363 LTL 365 (370)
T ss_dssp HHH
T ss_pred HHH
Confidence 764
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=383.47 Aligned_cols=265 Identities=23% Similarity=0.389 Sum_probs=221.6
Q ss_pred cCCCCCCCcccccccccCCceEEEEEEE-------CCeeEEEEeccCC-ChHHHHHHHHHHHHHHhcCCCCceEEeeccc
Q 005427 60 PLHLPPSSYTLLSPIARGAESVVYEATL-------DGRKVAVKKPILS-TSEELDNFHKELQLLCKLDHPGLAKFVAAHA 131 (697)
Q Consensus 60 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~-------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~ 131 (697)
..++..++|++.++||+|+||.||+|++ .++.||||++... .......+.+|+.+++.++||||+++++++.
T Consensus 65 ~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 144 (367)
T 3l9p_A 65 LKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL 144 (367)
T ss_dssp SCBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hhhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 3466778999999999999999999984 3568999987544 3445667899999999999999999999999
Q ss_pred cCCceEEEEeecCCCCHhhhhhhcC------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCC---CCe
Q 005427 132 KPPNYMFFFEFYESRNLAEKLHVEE------WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNL---CPH 202 (697)
Q Consensus 132 ~~~~~~lv~e~~~~g~L~~~l~~~~------~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~---~~k 202 (697)
+....++||||+.+|+|.+++.... ..+++.+++.++.|++.||+|||++||+||||||+|||++.++ .+|
T Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~k 224 (367)
T 3l9p_A 145 QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK 224 (367)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred cCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEE
Confidence 9999999999999999999997653 3588999999999999999999999999999999999998554 599
Q ss_pred eeeeccchhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCCc
Q 005427 203 LADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDL 281 (697)
Q Consensus 203 L~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~~ 281 (697)
|+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||++ |..||.+.
T Consensus 225 L~DFG~a~~~~~~~~~--------------~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~ 290 (367)
T 3l9p_A 225 IGDFGMARDIYRAGYY--------------RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK 290 (367)
T ss_dssp ECCCHHHHHHHHHSSC--------------TTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ECCCcccccccccccc--------------ccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999865432110 11334578999999999999999999999999999999998 99999887
Q ss_pred hhHHHHHHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHh
Q 005427 282 RAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHR 356 (697)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~~ 356 (697)
........+.. +. ++ ..+..++..+.+||.+||+.||.+|||+.+++++|+.+.+..
T Consensus 291 ~~~~~~~~i~~--------------~~-~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~ 347 (367)
T 3l9p_A 291 SNQEVLEFVTS--------------GG-RM---DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 347 (367)
T ss_dssp CHHHHHHHHHT--------------TC-CC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred CHHHHHHHHHc--------------CC-CC---CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence 65544333322 11 11 124568999999999999999999999999999999987653
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-45 Score=377.98 Aligned_cols=249 Identities=23% Similarity=0.355 Sum_probs=216.1
Q ss_pred CCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCC---hHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEE
Q 005427 64 PPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST---SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMF 138 (697)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 138 (697)
..++|++.+.||+|+||.||+|++ +++.||+|++.... ....+.+.+|+.+|+.++||||+++++++.+...+++
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 83 (318)
T 1fot_A 4 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM 83 (318)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred ChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEE
Confidence 346899999999999999999997 58899999865321 1235678899999999999999999999999999999
Q ss_pred EEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhh
Q 005427 139 FFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI 218 (697)
Q Consensus 139 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~ 218 (697)
||||+.+|+|.+++.... .+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 84 v~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~---- 158 (318)
T 1fot_A 84 IMDYIEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD---- 158 (318)
T ss_dssp EECCCCSCBHHHHHHHTS-SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS----
T ss_pred EEeCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCC----
Confidence 999999999999997654 789999999999999999999999999999999999999999999999999975432
Q ss_pred hcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHH
Q 005427 219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQ 298 (697)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~ 298 (697)
.....+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+.......+.....
T Consensus 159 ---------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~--- 220 (318)
T 1fot_A 159 ---------------VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL--- 220 (318)
T ss_dssp ---------------CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCC---
T ss_pred ---------------ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC---
Confidence 13456899999999999999999999999999999999999999988766555444433211
Q ss_pred HHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCC-----CHHHHHHHHHH
Q 005427 299 QLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRP-----SFSDIALELDL 351 (697)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~ell~~l~~ 351 (697)
..+..+++++.++|.+||+.||.+|| +++++++|.|+
T Consensus 221 ----------------~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f 262 (318)
T 1fot_A 221 ----------------RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWF 262 (318)
T ss_dssp ----------------CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGG
T ss_pred ----------------CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccc
Confidence 12356889999999999999999999 99999999876
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=391.13 Aligned_cols=256 Identities=23% Similarity=0.314 Sum_probs=217.0
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccCCC--hHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEe
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST--SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFE 141 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 141 (697)
++|++.++||+|+||.||+|.+ +++.+|+|++.... ....+.+.+|+.+|+.++||||+++++++.+....++|||
T Consensus 11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E 90 (444)
T 3soa_A 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFD 90 (444)
T ss_dssp HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEE
Confidence 5799999999999999999987 68899999876543 3346678999999999999999999999999999999999
Q ss_pred ecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeec---CCCCCeeeeeccchhhhhhhhh
Q 005427 142 FYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLD---RNLCPHLADFGLAEYRENLKEI 218 (697)
Q Consensus 142 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~---~~~~~kL~Dfg~a~~~~~~~~~ 218 (697)
|+.+|+|.+.+.... .+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++.......
T Consensus 91 ~~~gg~L~~~i~~~~-~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~-- 167 (444)
T 3soa_A 91 LVTGGELFEDIVARE-YYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ-- 167 (444)
T ss_dssp CCBCCBHHHHHHHCS-CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTC--
T ss_pred eCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCC--
Confidence 999999999987665 689999999999999999999999999999999999998 46789999999996554211
Q ss_pred hcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHH
Q 005427 219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQ 298 (697)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~ 298 (697)
.......||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+.......+....+
T Consensus 168 --------------~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~--- 230 (444)
T 3soa_A 168 --------------QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAY--- 230 (444)
T ss_dssp --------------CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC---
T ss_pred --------------ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCC---
Confidence 123456899999999999999999999999999999999999999988766555554443222
Q ss_pred HHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 005427 299 QLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL 353 (697)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~ 353 (697)
. ........+++++.+||.+||+.||.+|||+.|+++|+|...
T Consensus 231 -----------~-~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~ 273 (444)
T 3soa_A 231 -----------D-FPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISH 273 (444)
T ss_dssp -----------C-CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHH
T ss_pred -----------C-CCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccC
Confidence 1 111223468999999999999999999999999999998754
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-45 Score=377.37 Aligned_cols=271 Identities=25% Similarity=0.310 Sum_probs=214.9
Q ss_pred CCCCcccccccccCCceEEEEEEE-CCeeEEEEeccCCChH--HHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEE
Q 005427 64 PPSSYTLLSPIARGAESVVYEATL-DGRKVAVKKPILSTSE--ELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFF 140 (697)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 140 (697)
..++|+++++||+|+||+||+|++ +++.||+|++...... ....+.+|+.+|+.++||||+++++++.++..+++||
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 347899999999999999999998 6889999987644322 3567889999999999999999999999999999999
Q ss_pred eecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhc
Q 005427 141 EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL 220 (697)
Q Consensus 141 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~ 220 (697)
||+.+ +|.+.+......+++.+++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 99 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~---- 173 (311)
T 3niz_A 99 EFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPV---- 173 (311)
T ss_dssp ECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC----
T ss_pred cCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCc----
Confidence 99985 8888887777679999999999999999999999999999999999999999999999999997553210
Q ss_pred ccccCCCCCCCCccccccccCccccchhhhcc-cCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHH
Q 005427 221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQ 299 (697)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~ 299 (697)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+.........
T Consensus 174 ------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 241 (311)
T 3niz_A 174 ------------RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNP 241 (311)
T ss_dssp ------------C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCT
T ss_pred ------------ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCCh
Confidence 11334578999999999976 56899999999999999999999999887665555444332111000
Q ss_pred -------HHHHHHhCCC----CCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 005427 300 -------LTAAVVSGGL----RPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL 351 (697)
Q Consensus 300 -------~~~~~~~~~~----~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~ 351 (697)
.......... ..........+++++.+||.+||+.||.+|||+.|+++|.|+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f 304 (311)
T 3niz_A 242 REWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYF 304 (311)
T ss_dssp TTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGG
T ss_pred HHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCccc
Confidence 0000000000 111122345688999999999999999999999999998876
|
| >2isn_A NYSGXRC-8828Z, phosphatase; pathogenic strain, praseodymium, sulfate structural genomics, PSI-2, protein structure initiative; 1.90A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-44 Score=372.74 Aligned_cols=249 Identities=26% Similarity=0.358 Sum_probs=206.7
Q ss_pred cceEeeeccCCCCCCCceeEEcccccCCCceEEEEEecCCCChHHHHHHHHHhHHHHHhcCCCCChHHHHHHHHHHHHHH
Q 005427 429 LSWGSFATCGRRETMEDTHFLMPHMYNQKEIHMFGIFDGHRGSAAAEFSARALPGFLQNLGSTTRPTDALLEAFIRTDVA 508 (697)
Q Consensus 429 ~~~~~~s~~G~R~~neD~~~~~~~~~~~~~~~~~~V~DG~GG~~~~~~as~~~~~~l~~~~~~~~~~~~l~~~~~~~~~~ 508 (697)
+.++..+++|+|..|||++++...+...++..+|+|||||||+.+|++|++.++..|.+. .......+.++|..++..
T Consensus 13 ~~~~~~s~~G~R~~nED~~~v~~~~~~~~~~~lf~VfDGHGG~~as~~a~~~l~~~l~~~--~~~~~~~l~~a~~~~d~~ 90 (364)
T 2isn_A 13 TTTVAATMLGRRPTDEDAILVSAPATSRPNVRIKAVFDGHAGEATSQYCAKHAAKHLGKL--SEFTFAEVKKACLSLDAE 90 (364)
T ss_dssp EEEEEEEECTTSSSCCEEEEEECC----CCEEEEEEEEEESCSHHHHHHHHHHHHHHTTC--SSCCHHHHHHHHHHHHHH
T ss_pred eEEEEEEcCCCCCcCCCeeEEeccCCCCCCeEEEEEEECCCCHHHHHHHHHHHHHHHHHh--hcccHHHHHHHHHHHHHH
Confidence 678999999999999999998765555567889999999999999999999999998763 223467889999988888
Q ss_pred HHHHHHHHHhhhhcccCCCCCCceEEEEEEec------------------------------------------------
Q 005427 509 FRNELDSLRKSKRVVQKDWHPGCTAIAALIVR------------------------------------------------ 540 (697)
Q Consensus 509 ~~~~~~~~~~~~~~~~~~~~~GtT~~~~~i~~------------------------------------------------ 540 (697)
+.+... ....||||++++++.+
T Consensus 91 i~~~~~----------~~~~~GtT~v~~~i~~~~~p~~~~~~g~~~~~~~~~~~f~~l~~~~~~~~~~~~~~~~~~~~~~ 160 (364)
T 2isn_A 91 IIRKLG----------PKHVAGSTGIIVAIERLSAPVVENVVGREIVPRAHEETFVPLEKLIQEEEEAEHPELVGRYPRV 160 (364)
T ss_dssp HHHHHC----------SSSCCEECEEEEEEEECSSCEEEEEETTEECCC-----CCCHHHHHHHHHHC-----CCSSCCC
T ss_pred HHHhcc----------cCCCCCcceehhhhhccccccccccccccccccccccchhhhhhhhhhhhhccccccccccccc
Confidence 865421 0135899999999853
Q ss_pred ------------CeEEEEEcCCeEEEEE-ECCeeeecCCCCCCCCHHHHHHHHHcCCeeeeccCcceeCCCcceeccccC
Q 005427 541 ------------NRLFVANAGDCRAILC-RGGHPFALSRDHVASCLEERERVVSAGGNVNWQVDTWRVGPPALQVTRSIG 607 (697)
Q Consensus 541 ------------~~l~~anvGDSr~~l~-~~~~~~~lt~dH~~~~~~e~~ri~~~g~~~~~~~~~~~~~~~~~~ltralG 607 (697)
.++|+|||||||+|++ |+|++++||+||++.++.|+.||.++||.+... ..+|+. +.+++|||||
T Consensus 161 ~~~~~~~~~~g~~~l~vanvGDSRayl~~r~g~~~~LT~DH~~~~~~e~~rI~~~gG~v~~~-~~~rv~-g~l~ltRalG 238 (364)
T 2isn_A 161 PDVQQKTIPAGSFLVTAINIGDSRATLIHSDGGLTRLSKDHKPNHPTEASRIEKAGGSVETF-DVPRVD-GVLALSRAFG 238 (364)
T ss_dssp CCCEEEEECTTCEEEEEEEESSCEEEEECTTSCEEECCCCCCTTSHHHHHHHHHTTCCEEES-SSEEET-TTBSCSBCEE
T ss_pred ccccccccccCccEEEEEECccCEEEEEeeCCEEEEcCcCCCCCCHHHHHHHHHcCCeEecC-CCcccC-CceeeEEEec
Confidence 3899999999999999 689999999999999999999999999877532 233433 5678999999
Q ss_pred CCCCC---------CCcccCCceEEEEeCCCCeEEEEEcCCcccCCC--hHHHHHHHHh----hcCChhHHHHHHHHHHH
Q 005427 608 DDDLK---------PAVTAEPEITETIMTPEDEYLVMASDGLWDVVS--HVEAVGIIKD----TVKEPGMCSKRLATEAA 672 (697)
Q Consensus 608 ~~~~k---------~~v~~~p~v~~~~l~~~d~~lvl~SDGl~d~~~--~~ei~~~~~~----~~~~~~~~a~~L~~~a~ 672 (697)
+..+| ++|+++||+..+.+.++| |||||||||||+++ ++++.+++.. ...+++++|+.|++.|+
T Consensus 239 d~~~k~~~~l~~~~~~v~~~Pdv~~~~l~~~D-~llL~SDGl~d~l~~~~~~v~~~~~~~~~~~~~~~~~~a~~Lv~~A~ 317 (364)
T 2isn_A 239 DSDFKMNPNLPPEEQKVIAVPDVRQFYALSSD-LLLLACDGVYEPSGMDWAYVRDLTVAEMQRSKGDLEEVAARVMDYAY 317 (364)
T ss_dssp CGGGSCCCSSCGGGSSSBCCCEEEEEEECTTC-EEEEECHHHHCSSSCCHHHHHHHHHHHHHHTTSCHHHHHHHHHHHHH
T ss_pred chhhccccccCcccCceEEEeEEEEEECCCCC-EEEEEcCCCCCCCCCCHHHHHHHHHHHHhhcCCCHHHHHHHHHHHHH
Confidence 99877 367899999999999988 99999999999976 8888876532 22479999999999999
Q ss_pred hcCCCCCcEEEEEEeCCCCc
Q 005427 673 ERGSKDNITVIVVFLQPVST 692 (697)
Q Consensus 673 ~~g~~DNiT~ivv~l~~~~~ 692 (697)
.+|+.||||||||++.+...
T Consensus 318 ~~g~~DNiTvivv~~~~~~~ 337 (364)
T 2isn_A 318 DMNSQDNISVMLVAFHNQEV 337 (364)
T ss_dssp HTTCCSCEEEEEEEECSSCC
T ss_pred hcCCCCCEEEEEEEcCCCCC
Confidence 99999999999999975543
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=371.17 Aligned_cols=278 Identities=27% Similarity=0.398 Sum_probs=220.0
Q ss_pred cCCCCCCCcccccccccCCceEEEEEEE------CCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeecccc-
Q 005427 60 PLHLPPSSYTLLSPIARGAESVVYEATL------DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAK- 132 (697)
Q Consensus 60 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~- 132 (697)
+..+..++|+++++||+|+||.||+|++ +++.||||++........+.+.+|+.+|+.++||||+++++++..
T Consensus 4 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 83 (295)
T 3ugc_A 4 PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 83 (295)
T ss_dssp --CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHH
T ss_pred cCcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 3456778999999999999999999984 578999999887777778899999999999999999999998854
Q ss_pred -CCceEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchh
Q 005427 133 -PPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEY 211 (697)
Q Consensus 133 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~ 211 (697)
...+++||||+++|+|.+++......+++.+++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||++..
T Consensus 84 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~ 163 (295)
T 3ugc_A 84 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV 163 (295)
T ss_dssp HHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred CCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCccccc
Confidence 4568999999999999999987766799999999999999999999999999999999999999999999999999976
Q ss_pred hhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHH
Q 005427 212 RENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVL 291 (697)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~ 291 (697)
....... ........+++.|+|||++.+..++.++||||||+++|+|++|..||......... ...
T Consensus 164 ~~~~~~~-------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~-~~~ 229 (295)
T 3ugc_A 164 LPQDKEF-------------FKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMR-MIG 229 (295)
T ss_dssp -------------------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHH-HHC
T ss_pred ccCCcce-------------eeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHh-hhc
Confidence 5432110 01123345788899999999999999999999999999999999999765332211 111
Q ss_pred hccc---cHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 005427 292 EMNY---TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH 355 (697)
Q Consensus 292 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~ 355 (697)
.... ............. ++ ..+..+|+++.+||.+||+.||.+|||+.|+++.|..+.+.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~-~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~ 292 (295)
T 3ugc_A 230 NDKQGQMIVFHLIELLKNNG-RL---PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292 (295)
T ss_dssp TTCCTHHHHHHHHHHHHTTC-CC---CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CccccchhHHHHHHHHhccC-cC---CCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 1000 0111222222222 21 23457899999999999999999999999999999988753
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=381.03 Aligned_cols=255 Identities=24% Similarity=0.324 Sum_probs=216.8
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccCC--ChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEe
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFE 141 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 141 (697)
++|++.+.||+|+||.||+|.+ +++.||+|++... .....+.+.+|+.+|+.++||||+++++++.+....++|||
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e 108 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 108 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 4799999999999999999998 5889999987544 34456789999999999999999999999999999999999
Q ss_pred ecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCC---CCCeeeeeccchhhhhhhhh
Q 005427 142 FYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRN---LCPHLADFGLAEYRENLKEI 218 (697)
Q Consensus 142 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~---~~~kL~Dfg~a~~~~~~~~~ 218 (697)
|+.+|+|.+.+.... .+++.+++.++.||+.||.|||+.||+||||||+|||++.+ +.+||+|||++.......
T Consensus 109 ~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~-- 185 (362)
T 2bdw_A 109 LVTGGELFEDIVARE-FYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE-- 185 (362)
T ss_dssp CCCSCBHHHHHTTCS-CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCC--
T ss_pred cCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCc--
Confidence 999999999987654 68999999999999999999999999999999999999764 459999999997554211
Q ss_pred hcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHH
Q 005427 219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQ 298 (697)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~ 298 (697)
......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+....+
T Consensus 186 ---------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~--- 247 (362)
T 2bdw_A 186 ---------------AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY--- 247 (362)
T ss_dssp ---------------SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC---
T ss_pred ---------------ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC---
Confidence 12346799999999999999999999999999999999999999988765554444433221
Q ss_pred HHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 005427 299 QLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL 353 (697)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~ 353 (697)
.. .......+++++.+||.+||+.||.+|||+.++++|.|...
T Consensus 248 -----------~~-~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 290 (362)
T 2bdw_A 248 -----------DY-PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICN 290 (362)
T ss_dssp -----------CC-CTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred -----------CC-CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence 11 11223468899999999999999999999999999999753
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-44 Score=365.71 Aligned_cols=263 Identities=21% Similarity=0.345 Sum_probs=220.9
Q ss_pred ccCCCCCCCcccccccccCCceEEEEEEE-CCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceE
Q 005427 59 IPLHLPPSSYTLLSPIARGAESVVYEATL-DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYM 137 (697)
Q Consensus 59 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 137 (697)
..+++..++|++.+.||+|+||.||++.+ .+..||+|++..... ..+.+.+|+++++.++||||+++++++.+...++
T Consensus 17 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 95 (283)
T 3gen_A 17 GSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIF 95 (283)
T ss_dssp CTTBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred CCccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeE
Confidence 35678889999999999999999999988 456899998764432 3467889999999999999999999999999999
Q ss_pred EEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhh
Q 005427 138 FFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKE 217 (697)
Q Consensus 138 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~ 217 (697)
+||||+.+++|.+++......+++.+++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 175 (283)
T 3gen_A 96 IITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 175 (283)
T ss_dssp EEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH
T ss_pred EEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEcccccccccccccc
Confidence 99999999999999987566799999999999999999999999999999999999999999999999999976643221
Q ss_pred hhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCCchhHHHHHHHHhcccc
Q 005427 218 ISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYT 296 (697)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~~~~~~~~~~~~~~~~~ 296 (697)
. ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||...........+...
T Consensus 176 ~---------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~--- 237 (283)
T 3gen_A 176 T---------------SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG--- 237 (283)
T ss_dssp H---------------STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTT---
T ss_pred c---------------cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcc---
Confidence 1 1223457889999999999999999999999999999998 99999886655444433221
Q ss_pred HHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 005427 297 EQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH 355 (697)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~ 355 (697)
.++ ..+..+++.+.+++.+||+.||.+|||+.+++++|..+.+.
T Consensus 238 ------------~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 238 ------------LRL---YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp ------------CCC---CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ------------cCC---CCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 111 12346789999999999999999999999999999988753
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=374.96 Aligned_cols=276 Identities=26% Similarity=0.374 Sum_probs=221.9
Q ss_pred CCCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEE
Q 005427 63 LPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFF 140 (697)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 140 (697)
+..++|++.++||+|+||+||+|.+ +++.||+|++........+.+.+|+.+|+.++||||+++++++.+....++||
T Consensus 7 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 86 (310)
T 3s95_A 7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFIT 86 (310)
T ss_dssp ECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred eChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEE
Confidence 4467899999999999999999998 48899999877667777889999999999999999999999999999999999
Q ss_pred eecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhc
Q 005427 141 EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL 220 (697)
Q Consensus 141 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~ 220 (697)
||+.+|+|.+++......+++.+++.++.|++.||+|||+.||+||||||+|||++.++.+||+|||++...........
T Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 166 (310)
T 3s95_A 87 EYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPE 166 (310)
T ss_dssp ECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC-------
T ss_pred EecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceeccccccccc
Confidence 99999999999988677899999999999999999999999999999999999999999999999999976643221100
Q ss_pred ccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHH
Q 005427 221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQL 300 (697)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 300 (697)
. .. ..............||+.|+|||++.+..++.++|||||||++|+|++|..||.......... .......
T Consensus 167 ~-~~-~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~-----~~~~~~~ 239 (310)
T 3s95_A 167 G-LR-SLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF-----GLNVRGF 239 (310)
T ss_dssp ---------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTS-----SBCHHHH
T ss_pred c-cc-cccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHH-----hhhhhcc
Confidence 0 00 000001112235689999999999999999999999999999999999999987643211100 0000000
Q ss_pred HHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHh
Q 005427 301 TAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHR 356 (697)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~~ 356 (697)
.. ...+..+|+++.+++.+||+.||.+|||+.++++.|..+....
T Consensus 240 ~~-----------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~ 284 (310)
T 3s95_A 240 LD-----------RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL 284 (310)
T ss_dssp HH-----------HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred cc-----------ccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 00 1124568899999999999999999999999999999887654
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-45 Score=382.40 Aligned_cols=254 Identities=25% Similarity=0.371 Sum_probs=214.8
Q ss_pred CCCCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCC---hHHHHHHHHHHHHHHhc-CCCCceEEeeccccCCc
Q 005427 62 HLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST---SEELDNFHKELQLLCKL-DHPGLAKFVAAHAKPPN 135 (697)
Q Consensus 62 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~ 135 (697)
.+..++|++.+.||+|+||.||+|++ +++.||+|++.... ......+..|..+|+.+ +||||+++++++.+...
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 45567999999999999999999998 58899999865321 12356678899999887 99999999999999999
Q ss_pred eEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhh
Q 005427 136 YMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL 215 (697)
Q Consensus 136 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~ 215 (697)
+++||||+.+|+|.+++.... .+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~- 170 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML- 170 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC-
T ss_pred EEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhccc-
Confidence 999999999999999997654 689999999999999999999999999999999999999999999999999864321
Q ss_pred hhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccc
Q 005427 216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNY 295 (697)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~ 295 (697)
........+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+.......+....
T Consensus 171 ---------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~- 234 (345)
T 1xjd_A 171 ---------------GDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN- 234 (345)
T ss_dssp ---------------TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-
T ss_pred ---------------CCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCC-
Confidence 1112456789999999999999999999999999999999999999998876655544443211
Q ss_pred cHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHH-HHHHHHHH
Q 005427 296 TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFS-DIALELDL 351 (697)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~-ell~~l~~ 351 (697)
+ ..+..+++++.+||.+||+.||.+||++. ++++|.|+
T Consensus 235 ---------------~---~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f 273 (345)
T 1xjd_A 235 ---------------P---FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLF 273 (345)
T ss_dssp ---------------C---CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGG
T ss_pred ---------------C---CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccc
Confidence 1 12446899999999999999999999998 88877765
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=385.37 Aligned_cols=255 Identities=22% Similarity=0.305 Sum_probs=219.7
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEeec
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFY 143 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 143 (697)
++|++.++||+|+||.||+|.+ +++.||+|++......+...+.+|+.+|+.++||||+++++++.+...+++||||+
T Consensus 51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~ 130 (387)
T 1kob_A 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 130 (387)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcC
Confidence 5799999999999999999988 57899999887666666778999999999999999999999999999999999999
Q ss_pred CCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecC--CCCCeeeeeccchhhhhhhhhhcc
Q 005427 144 ESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDR--NLCPHLADFGLAEYRENLKEISLK 221 (697)
Q Consensus 144 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~--~~~~kL~Dfg~a~~~~~~~~~~~~ 221 (697)
.+|+|.+++......+++.+++.++.||+.||+|||+.||+||||||+|||++. .+.+||+|||++.......
T Consensus 131 ~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~----- 205 (387)
T 1kob_A 131 SGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE----- 205 (387)
T ss_dssp CCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS-----
T ss_pred CCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCc-----
Confidence 999999999877667999999999999999999999999999999999999974 5779999999997653211
Q ss_pred cccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHHH
Q 005427 222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLT 301 (697)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 301 (697)
......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.........+....+.
T Consensus 206 ------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~----- 268 (387)
T 1kob_A 206 ------------IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWE----- 268 (387)
T ss_dssp ------------CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCC-----
T ss_pred ------------ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-----
Confidence 123457999999999999999999999999999999999999999987665554444332211
Q ss_pred HHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 302 AAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
........+++++.+||.+||+.||.+|||+.|+++|.|..
T Consensus 269 ----------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~ 309 (387)
T 1kob_A 269 ----------FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLK 309 (387)
T ss_dssp ----------CCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTS
T ss_pred ----------CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCcccc
Confidence 11222346899999999999999999999999999988763
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=376.09 Aligned_cols=256 Identities=24% Similarity=0.370 Sum_probs=209.3
Q ss_pred cCCCCCCCcccccccccCCceEEEEEEE-----CCeeEEEEeccCCC----hHHHHHHHHHHHHHHhcCCCCceEEeecc
Q 005427 60 PLHLPPSSYTLLSPIARGAESVVYEATL-----DGRKVAVKKPILST----SEELDNFHKELQLLCKLDHPGLAKFVAAH 130 (697)
Q Consensus 60 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~hpniv~l~~~~ 130 (697)
+..+..++|++.+.||+|+||.||+++. +++.||+|++.... ......+.+|+.+|+.++||||+++++++
T Consensus 11 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 90 (327)
T 3a62_A 11 PEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAF 90 (327)
T ss_dssp --CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEE
T ss_pred CCCCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEE
Confidence 3456678999999999999999999986 57899999865432 23456688999999999999999999999
Q ss_pred ccCCceEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccch
Q 005427 131 AKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAE 210 (697)
Q Consensus 131 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~ 210 (697)
.+...+++||||+.+++|.+++.... .+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 91 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 91 QTGGKLYLILEYLSGGELFMQLEREG-IFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp ECSSCEEEEEECCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred EcCCEEEEEEeCCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 99999999999999999999997654 68999999999999999999999999999999999999999999999999986
Q ss_pred hhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHH
Q 005427 211 YRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTV 290 (697)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~ 290 (697)
...... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.........+
T Consensus 170 ~~~~~~----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i 233 (327)
T 3a62_A 170 ESIHDG----------------TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKI 233 (327)
T ss_dssp -------------------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred ccccCC----------------ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 533211 1234567999999999999999999999999999999999999999887665554444
Q ss_pred HhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCC-----CHHHHHHHHHH
Q 005427 291 LEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRP-----SFSDIALELDL 351 (697)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~ell~~l~~ 351 (697)
..... ..+..+++++.+||.+||+.||.+|| ++.++++|.|+
T Consensus 234 ~~~~~-------------------~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f 280 (327)
T 3a62_A 234 LKCKL-------------------NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFF 280 (327)
T ss_dssp HHTCC-------------------CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGG
T ss_pred HhCCC-------------------CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcc
Confidence 33211 13456889999999999999999999 88899998886
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=384.85 Aligned_cols=263 Identities=24% Similarity=0.359 Sum_probs=212.0
Q ss_pred CCCCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCC---ChHHHHHHHHHHHHHHhc-CCCCceEEeeccccCCc
Q 005427 62 HLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKL-DHPGLAKFVAAHAKPPN 135 (697)
Q Consensus 62 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~ 135 (697)
.+..++|+++++||+|+||.||+|++ +++.||+|++... .....+.+.+|..+|.++ +||||+++++++.+...
T Consensus 48 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~ 127 (396)
T 4dc2_A 48 SLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR 127 (396)
T ss_dssp -CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCE
Confidence 34557899999999999999999987 5789999986533 233445688999999887 89999999999999999
Q ss_pred eEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhh
Q 005427 136 YMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL 215 (697)
Q Consensus 136 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~ 215 (697)
+++||||+.+|+|..++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 128 ~~lV~E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~- 205 (396)
T 4dc2_A 128 LFFVIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR- 205 (396)
T ss_dssp EEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC-
T ss_pred EEEEEEcCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeeccc-
Confidence 999999999999999997654 789999999999999999999999999999999999999999999999999864221
Q ss_pred hhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccc
Q 005427 216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNY 295 (697)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~ 295 (697)
.+....+.+||+.|+|||++.+..++.++|||||||++|||++|..||.......... ..
T Consensus 206 ---------------~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~-----~~ 265 (396)
T 4dc2_A 206 ---------------PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD-----QN 265 (396)
T ss_dssp ---------------TTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC-----------C
T ss_pred ---------------CCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccc-----hh
Confidence 1113456789999999999999999999999999999999999999996532111100 00
Q ss_pred cHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCH------HHHHHHHHH
Q 005427 296 TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSF------SDIALELDL 351 (697)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~------~ell~~l~~ 351 (697)
........+..... ..+..+++++.+||++||+.||.+||++ +|+++|.|+
T Consensus 266 ~~~~~~~~i~~~~~-----~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff 322 (396)
T 4dc2_A 266 TEDYLFQVILEKQI-----RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF 322 (396)
T ss_dssp CHHHHHHHHHHCCC-----CCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTT
T ss_pred hHHHHHHHHhcccc-----CCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccc
Confidence 11112222222221 2345789999999999999999999985 799988876
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-44 Score=380.82 Aligned_cols=269 Identities=25% Similarity=0.436 Sum_probs=213.6
Q ss_pred CccCCCCCCCcccccccccCCceEEEEEEEC-----CeeEEEEeccCC-ChHHHHHHHHHHHHHHhcCCCCceEEeeccc
Q 005427 58 SIPLHLPPSSYTLLSPIARGAESVVYEATLD-----GRKVAVKKPILS-TSEELDNFHKELQLLCKLDHPGLAKFVAAHA 131 (697)
Q Consensus 58 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~ 131 (697)
....++..++|++.+.||+|+||.||+|++. +..||||++... .....+.+.+|+.+|++++||||+++++++.
T Consensus 37 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 116 (373)
T 2qol_A 37 EFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVT 116 (373)
T ss_dssp TTSCBCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred HHHhhcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 3445677789999999999999999999863 567999987654 3445678999999999999999999999999
Q ss_pred cCCceEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchh
Q 005427 132 KPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEY 211 (697)
Q Consensus 132 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~ 211 (697)
+...+++||||+++|+|.+++......+++.+++.++.|++.||+|||+.||+||||||+|||++.++.+||+|||+++.
T Consensus 117 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 196 (373)
T 2qol_A 117 KSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRV 196 (373)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred eCCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccc
Confidence 99999999999999999999987776899999999999999999999999999999999999999999999999999976
Q ss_pred hhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCCchhHHHHHHH
Q 005427 212 RENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTV 290 (697)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~~~~~~~~~~~ 290 (697)
....... ........+++.|+|||++.+..++.++|||||||++|||++ |..||.+.........+
T Consensus 197 ~~~~~~~-------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i 263 (373)
T 2qol_A 197 LEDDPEA-------------AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 263 (373)
T ss_dssp ------------------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHH
T ss_pred cccCCcc-------------ceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 6432110 011223346789999999999999999999999999999998 99999876554433322
Q ss_pred HhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhc
Q 005427 291 LEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHRK 357 (697)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~~~ 357 (697)
.. +.++ ..+..++.++.+++.+||+.||.+||++.++++.|..+.....
T Consensus 264 ~~---------------~~~~---~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~~ 312 (373)
T 2qol_A 264 DE---------------GYRL---PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPG 312 (373)
T ss_dssp HT---------------TEEC---CCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCGG
T ss_pred Hc---------------CCCC---CCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCcc
Confidence 21 1111 1234689999999999999999999999999999999886543
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-44 Score=365.75 Aligned_cols=262 Identities=26% Similarity=0.444 Sum_probs=210.7
Q ss_pred cCCCCCCCcccccccccCCceEEEEEEEC-----CeeEEEEeccCC-ChHHHHHHHHHHHHHHhcCCCCceEEeeccccC
Q 005427 60 PLHLPPSSYTLLSPIARGAESVVYEATLD-----GRKVAVKKPILS-TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKP 133 (697)
Q Consensus 60 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~ 133 (697)
.+++..++|++.+.||+|+||.||+|.+. +..||+|..... .....+.+.+|+.+++.++||||+++++++. .
T Consensus 9 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~ 87 (281)
T 1mp8_A 9 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E 87 (281)
T ss_dssp CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-S
T ss_pred ceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-c
Confidence 45677889999999999999999999873 356999986543 3345678999999999999999999999984 5
Q ss_pred CceEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhh
Q 005427 134 PNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRE 213 (697)
Q Consensus 134 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~ 213 (697)
+..++||||+.+++|.+++......+++.+++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||++....
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (281)
T 1mp8_A 88 NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 167 (281)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred CccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccC
Confidence 67899999999999999998777679999999999999999999999999999999999999999999999999997654
Q ss_pred hhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCCchhHHHHHHHHh
Q 005427 214 NLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLE 292 (697)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~~~~~~~~~~~~~ 292 (697)
.... .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.........+..
T Consensus 168 ~~~~---------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~ 232 (281)
T 1mp8_A 168 DSTY---------------YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN 232 (281)
T ss_dssp --------------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT
T ss_pred cccc---------------cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHc
Confidence 3111 11233457889999999999999999999999999999997 9999987655443333221
Q ss_pred ccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 005427 293 MNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH 355 (697)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~ 355 (697)
+... ..+..+|+++.++|.+||+.||.+|||+.+++++|..+.+.
T Consensus 233 --------------~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 277 (281)
T 1mp8_A 233 --------------GERL----PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277 (281)
T ss_dssp --------------TCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --------------CCCC----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 1111 23457899999999999999999999999999999998765
|
| >2i44_A Serine-threonine phosphatase 2C; PSI-2, 8817Z, structural genomics, protein structure initiative; 2.04A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-44 Score=371.97 Aligned_cols=255 Identities=24% Similarity=0.394 Sum_probs=203.1
Q ss_pred cccceEeeeccCCCCCCCceeEEccccc-CCCceEEEEEecCCCChHHHHHHHHHhHHHHHhc--CC-------------
Q 005427 427 PVLSWGSFATCGRRETMEDTHFLMPHMY-NQKEIHMFGIFDGHRGSAAAEFSARALPGFLQNL--GS------------- 490 (697)
Q Consensus 427 ~~~~~~~~s~~G~R~~neD~~~~~~~~~-~~~~~~~~~V~DG~GG~~~~~~as~~~~~~l~~~--~~------------- 490 (697)
..+.+++.|++|.|..|||++++..... ...+..+|+|||||||+.+|++||+.+++.|.+. +.
T Consensus 20 ~~~~~~~~s~~G~R~~nED~~~~~~~~~~~~~~~~l~~V~DGhGG~~~~~~as~~~~~~l~~~~~~~~~~~~l~~~~~~~ 99 (324)
T 2i44_A 20 PAFDAAIFTDIGGRKHQEDRFTLCPQLVPGRDDCAFFGVFDGTVGDFASENVKDLVVPQLISSPAWQEVTEMLRSDVPAT 99 (324)
T ss_dssp TTEEEEEEEECTTSSSCCEEEEEESCCSTTCSSEEEEEEEEEESSSHHHHHHHHHHHHHHHTCHHHHHHHHHHTSCCCHH
T ss_pred cceEEEEEECCCCCCccCCeEEEEecCCCCCCCeEEEEEeCCCCchHHHHHHHHHHHHHHHhhhHHHHHHHHhhccCCcc
Confidence 4688999999999999999999875332 2356789999999999999999999999988763 11
Q ss_pred ------CCChHHHHHHHHHHHHHHHHHHHHHHHhhhhcccCCCCCCceEEEEEEecCeEEEEEcCCeEEEEEEC---C-e
Q 005427 491 ------TTRPTDALLEAFIRTDVAFRNELDSLRKSKRVVQKDWHPGCTAIAALIVRNRLFVANAGDCRAILCRG---G-H 560 (697)
Q Consensus 491 ------~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GtT~~~~~i~~~~l~~anvGDSr~~l~~~---~-~ 560 (697)
.......+.++|..++..+....... .... .|+|++++++.++++|+|||||||+|++|+ | +
T Consensus 100 ~~~~~~~~~~~~~l~~a~~~~~~~i~~~~~~~------~~~~--~g~gtt~~~i~~~~l~vanvGDSRa~l~r~~~~g~~ 171 (324)
T 2i44_A 100 EVDEKLPQLLDQAVDDMYKNADNELVKMCEQL------NKDY--ASSTSVTAVLAKGFVAVGHLGDSRIAMGVETPNGLN 171 (324)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHT------TCSS--CEECEEEEEEETTEEEEEEESSCEEEEEEEETTEEE
T ss_pred ccccccchhHHHHHHHHHHHHHHHHHHHHhhc------CCCC--CCCCeEEEEEECCeEEEEEccCceEEEEeccCCCce
Confidence 11224567777777777776553221 0112 244444445899999999999999999996 7 8
Q ss_pred eeecCCCCCCCCHHHHHHHHHcCCeeeeccC----cceeCCCcceeccccCC----CCCC----------CCcccCCceE
Q 005427 561 PFALSRDHVASCLEERERVVSAGGNVNWQVD----TWRVGPPALQVTRSIGD----DDLK----------PAVTAEPEIT 622 (697)
Q Consensus 561 ~~~lt~dH~~~~~~e~~ri~~~g~~~~~~~~----~~~~~~~~~~ltralG~----~~~k----------~~v~~~p~v~ 622 (697)
+++||+||++.++.|++||.++||.+..... ..+. .+.+.+||++|+ ..+| ++|+++|++.
T Consensus 172 ~~~LT~DH~~~~~~E~~Ri~~~Gg~v~~~~~~~~~~~~~-~g~l~~sra~Gd~p~~~~~~~~~g~~~~~~~~v~~~pdv~ 250 (324)
T 2i44_A 172 CEFLTVDHKPDMPHEKLRIMRNGGSVEYLHNHNNKPFIR-GGDFSFRKSRGEQPMQLQYSRAFGGKDLKMYGLSNQPDVR 250 (324)
T ss_dssp EEESCCCCCTTSHHHHHHHHHTTCEEECCTTCTTSCEEE-CTTHHHHHHTTCCCCCBSSSBCEECGGGTTTTCBCCCEEE
T ss_pred EEECCCCCCCcCHHHHHHHHHcCCEEEecccccCCCccc-cCcccchhhcCCccccceeccccCCccccCCeEeecCEEE
Confidence 9999999999999999999999997732111 1112 357889999999 4443 3578999999
Q ss_pred EEEeCCCCeEEEEEcCCcccCCChHHHHHHHHhhc---CChhH--HHHHHHHHHHhcCCCCCcEEEEEEeCCC
Q 005427 623 ETIMTPEDEYLVMASDGLWDVVSHVEAVGIIKDTV---KEPGM--CSKRLATEAAERGSKDNITVIVVFLQPV 690 (697)
Q Consensus 623 ~~~l~~~d~~lvl~SDGl~d~~~~~ei~~~~~~~~---~~~~~--~a~~L~~~a~~~g~~DNiT~ivv~l~~~ 690 (697)
.+.+.++|+|||||||||||+++++++++++.... .++++ +|+.|++.|+++|+.||||||||++.+.
T Consensus 251 ~~~l~~~d~~llLaSDGl~d~ls~~ei~~~v~~~~~~~~~~~~~~~a~~L~~~A~~~g~~DNiTvivv~~~~~ 323 (324)
T 2i44_A 251 VVRVTPQHRVMILATDGLWDVMSAAQAVEIAMQARQEGRNPAQALVEMTLAEQQSRNQSADNITAMTVFFKKT 323 (324)
T ss_dssp EEECCTTEEEEEEECHHHHTTCCHHHHHHHHHHHHHTTCCHHHHHHHHHHHHHHHTTCCCCCEEEEEEEEC--
T ss_pred EEEcCCCCeEEEEEcCchhccCCHHHHHHHHHHHHhcCCCHHHHHHHHHHHHHHHhcCCCCCCEEEEEEeeCC
Confidence 99999998899999999999999999999998753 47888 9999999999999999999999999753
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=379.07 Aligned_cols=249 Identities=19% Similarity=0.276 Sum_probs=216.4
Q ss_pred CCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCC---hHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEE
Q 005427 64 PPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST---SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMF 138 (697)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 138 (697)
..++|++++.||+|+||.||+|++ +++.||+|++.... ....+.+.+|+.+|+.++||||+++++++.+...+++
T Consensus 39 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 118 (350)
T 1rdq_E 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred CHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEE
Confidence 346899999999999999999998 58899999864332 1235678899999999999999999999999999999
Q ss_pred EEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhh
Q 005427 139 FFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI 218 (697)
Q Consensus 139 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~ 218 (697)
||||+.+|+|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 119 v~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~---- 193 (350)
T 1rdq_E 119 VMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG---- 193 (350)
T ss_dssp EEECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS----
T ss_pred EEcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccC----
Confidence 999999999999997654 689999999999999999999999999999999999999999999999999975432
Q ss_pred hcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHH
Q 005427 219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQ 298 (697)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~ 298 (697)
.....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+.....
T Consensus 194 ---------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~--- 255 (350)
T 1rdq_E 194 ---------------RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV--- 255 (350)
T ss_dssp ---------------CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC---
T ss_pred ---------------CcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCC---
Confidence 13456899999999999999999999999999999999999999988765555444433211
Q ss_pred HHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCC-----HHHHHHHHHH
Q 005427 299 QLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPS-----FSDIALELDL 351 (697)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt-----~~ell~~l~~ 351 (697)
..+..+++++.+||.+||+.||.+||+ ++++++|.|+
T Consensus 256 ----------------~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f 297 (350)
T 1rdq_E 256 ----------------RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297 (350)
T ss_dssp ----------------CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGG
T ss_pred ----------------CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCc
Confidence 124568999999999999999999998 9999998876
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=375.33 Aligned_cols=253 Identities=23% Similarity=0.314 Sum_probs=215.8
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccCCChH------HHHHHHHHHHHHHhcCCCCceEEeeccccCCceE
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSE------ELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYM 137 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 137 (697)
++|++.+.||+|+||.||+|++ +++.||+|++...... ..+.+.+|+.+|+.++||||+++++++.+...++
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 5799999999999999999998 5889999986543221 3577899999999999999999999999999999
Q ss_pred EEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCC----CCeeeeeccchhhh
Q 005427 138 FFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNL----CPHLADFGLAEYRE 213 (697)
Q Consensus 138 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~----~~kL~Dfg~a~~~~ 213 (697)
+||||+.+++|.+++.... .+++.+++.++.|++.||.|||+.||+||||||+|||++.++ .+||+|||++....
T Consensus 91 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~ 169 (326)
T 2y0a_A 91 LILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 169 (326)
T ss_dssp EEEECCCSCBHHHHHTTSS-CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred EEEEcCCCCCHHHHHHhcC-CcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECC
Confidence 9999999999999997544 789999999999999999999999999999999999998877 79999999997553
Q ss_pred hhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhc
Q 005427 214 NLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEM 293 (697)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~ 293 (697)
... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.........+...
T Consensus 170 ~~~-----------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~ 232 (326)
T 2y0a_A 170 FGN-----------------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232 (326)
T ss_dssp TTS-----------------CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHT
T ss_pred CCC-----------------ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhc
Confidence 211 123457999999999999999999999999999999999999999887655544444332
Q ss_pred cccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 005427 294 NYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL 351 (697)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~ 351 (697)
... ........+++.+.+||.+||+.||.+|||+.++++|+|+
T Consensus 233 ~~~---------------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~ 275 (326)
T 2y0a_A 233 NYE---------------FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275 (326)
T ss_dssp CCC---------------CCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTT
T ss_pred CCC---------------cCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCc
Confidence 221 1122335688999999999999999999999999999876
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-45 Score=381.16 Aligned_cols=250 Identities=26% Similarity=0.345 Sum_probs=211.3
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccCCCh---HHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEE
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTS---EELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFF 140 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 140 (697)
++|++.+.||+|+||.||+|.+ +++.||+|++..... .....+.+|+.+|+.++||||+++++++.++...++||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 5899999999999999999998 688999998643211 12357889999999999999999999999999999999
Q ss_pred eecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhc
Q 005427 141 EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL 220 (697)
Q Consensus 141 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~ 220 (697)
||+ +|+|.+++...+ .+++.+++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 89 E~~-~g~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~----- 161 (336)
T 3h4j_B 89 EYA-GGELFDYIVEKK-RMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG----- 161 (336)
T ss_dssp CCC-CEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS-----
T ss_pred ECC-CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCC-----
Confidence 999 679999887654 7899999999999999999999999999999999999999999999999998755421
Q ss_pred ccccCCCCCCCCccccccccCccccchhhhcccCC-CchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHH
Q 005427 221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIH-SEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQ 299 (697)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~ 299 (697)
......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.........+
T Consensus 162 ------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i--------- 220 (336)
T 3h4j_B 162 ------------NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV--------- 220 (336)
T ss_dssp ------------BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCC---------
T ss_pred ------------cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHH---------
Confidence 12345679999999999988776 78999999999999999999999875432221111
Q ss_pred HHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 005427 300 LTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL 353 (697)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~ 353 (697)
.......+..+|+++.+||++||+.||.+|||++|+++|+|+..
T Consensus 221 ----------~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~ 264 (336)
T 3h4j_B 221 ----------NSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNV 264 (336)
T ss_dssp ----------CSSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHT
T ss_pred ----------HcCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhcc
Confidence 11112234568999999999999999999999999999999853
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=376.15 Aligned_cols=262 Identities=24% Similarity=0.362 Sum_probs=213.7
Q ss_pred CCCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCC---ChHHHHHHHHHHHHHHhc-CCCCceEEeeccccCCce
Q 005427 63 LPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKL-DHPGLAKFVAAHAKPPNY 136 (697)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~ 136 (697)
+..++|++++.||+|+||.||+|++ +++.||+|++... .....+.+.+|..+|+.+ +||||+++++++.+...+
T Consensus 6 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 85 (345)
T 3a8x_A 6 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL 85 (345)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEE
Confidence 3446899999999999999999998 5889999986533 345567889999999988 899999999999999999
Q ss_pred EEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhh
Q 005427 137 MFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLK 216 (697)
Q Consensus 137 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~ 216 (697)
++||||+.+|+|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 86 ~lv~e~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~-- 162 (345)
T 3a8x_A 86 FFVIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR-- 162 (345)
T ss_dssp EEEECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC--
T ss_pred EEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccC--
Confidence 99999999999999997654 789999999999999999999999999999999999999999999999999864321
Q ss_pred hhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhcccc
Q 005427 217 EISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYT 296 (697)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~ 296 (697)
.+......+||+.|+|||++.+..++.++|||||||++|||++|..||.......... ...
T Consensus 163 --------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~-----~~~ 223 (345)
T 3a8x_A 163 --------------PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD-----QNT 223 (345)
T ss_dssp --------------TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC------------C
T ss_pred --------------CCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccc-----ccc
Confidence 1112456789999999999999999999999999999999999999997532111000 001
Q ss_pred HHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCH------HHHHHHHHH
Q 005427 297 EQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSF------SDIALELDL 351 (697)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~------~ell~~l~~ 351 (697)
.......+..... ..+..++.++.+||.+||+.||.+||++ .++++|.|+
T Consensus 224 ~~~~~~~i~~~~~-----~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f 279 (345)
T 3a8x_A 224 EDYLFQVILEKQI-----RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF 279 (345)
T ss_dssp HHHHHHHHHHCCC-----CCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGG
T ss_pred HHHHHHHHHcCCC-----CCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCcc
Confidence 1111122222221 1345789999999999999999999995 789988876
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-44 Score=367.30 Aligned_cols=261 Identities=26% Similarity=0.448 Sum_probs=214.0
Q ss_pred CCCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCC---ChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceE
Q 005427 63 LPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYM 137 (697)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 137 (697)
+..++|++.+.||+|+||.||+|++ .++.||+|.+... .....+.+.+|+.+++.++||||+++++++.+...++
T Consensus 8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 87 (294)
T 4eqm_A 8 IINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYY 87 (294)
T ss_dssp CEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEE
T ss_pred HhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEE
Confidence 3457899999999999999999987 5789999986432 3445678999999999999999999999999999999
Q ss_pred EEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhh
Q 005427 138 FFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKE 217 (697)
Q Consensus 138 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~ 217 (697)
+||||+++++|.+++...+ .+++.+++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus 88 lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 166 (294)
T 4eqm_A 88 LVMEYIEGPTLSEYIESHG-PLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL 166 (294)
T ss_dssp EEEECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-----
T ss_pred EEEeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccccc
Confidence 9999999999999997654 789999999999999999999999999999999999999999999999999976542111
Q ss_pred hhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccH
Q 005427 218 ISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTE 297 (697)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~ 297 (697)
.......||+.|+|||++.+..++.++||||||+++|+|++|..||.+............
T Consensus 167 ---------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~----- 226 (294)
T 4eqm_A 167 ---------------TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQ----- 226 (294)
T ss_dssp -----------------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHS-----
T ss_pred ---------------cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhh-----
Confidence 113345799999999999999999999999999999999999999988765444333222
Q ss_pred HHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCC-CHHHHHHHHHHHH
Q 005427 298 QQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRP-SFSDIALELDLVL 353 (697)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-t~~ell~~l~~~~ 353 (697)
....+.....+..+|+.+.++|.+||+.||.+|| +++++.+.|..++
T Consensus 227 ---------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~ 274 (294)
T 4eqm_A 227 ---------DSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVL 274 (294)
T ss_dssp ---------SCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred ---------ccCCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence 1222222334567899999999999999999998 7888877665543
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=384.72 Aligned_cols=265 Identities=25% Similarity=0.364 Sum_probs=222.3
Q ss_pred ccCCCCCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCC-hHHHHHHHHHHHHHHhcCCCCceEEeeccccCCc
Q 005427 59 IPLHLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST-SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPN 135 (697)
Q Consensus 59 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 135 (697)
..+.+..++|++.++||+|+||.||+|++ +++.||||...... ....+.+.+|+.+|+.++||||+++++++.....
T Consensus 107 ~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 186 (377)
T 3cbl_A 107 DKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQP 186 (377)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred cccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCC
Confidence 35678888999999999999999999998 58899999866443 3345678999999999999999999999999999
Q ss_pred eEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhh
Q 005427 136 YMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL 215 (697)
Q Consensus 136 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~ 215 (697)
+++||||+++|+|.+++...+..+++.+++.++.|++.||+|||+.||+||||||+|||++.++.+||+|||+++.....
T Consensus 187 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~ 266 (377)
T 3cbl_A 187 IYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADG 266 (377)
T ss_dssp CEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence 99999999999999999877667899999999999999999999999999999999999999999999999998754321
Q ss_pred hhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCCchhHHHHHHHHhcc
Q 005427 216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMN 294 (697)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~~~~~~~~~~~~~~~ 294 (697)
.. ........+++.|+|||++.+..++.++|||||||++|||++ |..||.+.........+.
T Consensus 267 ~~--------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~--- 329 (377)
T 3cbl_A 267 VY--------------AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE--- 329 (377)
T ss_dssp EE--------------ECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHH---
T ss_pred ce--------------eecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH---
Confidence 10 000122346788999999998889999999999999999998 999998765543322221
Q ss_pred ccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 005427 295 YTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH 355 (697)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~ 355 (697)
.+.+. ..+..+|+++.+||.+||+.||.+|||+.++++.|..+.+.
T Consensus 330 ------------~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 330 ------------KGGRL---PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp ------------TTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ------------cCCCC---CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 11121 12456899999999999999999999999999999988654
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=379.17 Aligned_cols=254 Identities=21% Similarity=0.314 Sum_probs=215.2
Q ss_pred CCCCCCcccccccccCCceEEEEEEEC--CeeEEEEeccCCC---hHHHHHHHHHHHHHHhc-CCCCceEEeeccccCCc
Q 005427 62 HLPPSSYTLLSPIARGAESVVYEATLD--GRKVAVKKPILST---SEELDNFHKELQLLCKL-DHPGLAKFVAAHAKPPN 135 (697)
Q Consensus 62 ~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~ 135 (697)
.+..++|++++.||+|+||.||+|++. ++.||+|++.... ....+.+..|..+|..+ +||||+++++++.+...
T Consensus 16 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~ 95 (353)
T 2i0e_A 16 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 95 (353)
T ss_dssp ---CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSE
T ss_pred CCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCE
Confidence 345579999999999999999999984 6789999865331 12356788999999988 89999999999999999
Q ss_pred eEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhh
Q 005427 136 YMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL 215 (697)
Q Consensus 136 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~ 215 (697)
+|+||||+.||+|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 96 ~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~- 173 (353)
T 2i0e_A 96 LYFVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW- 173 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC-
T ss_pred EEEEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCccccccc-
Confidence 999999999999999997654 689999999999999999999999999999999999999999999999999864321
Q ss_pred hhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccc
Q 005427 216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNY 295 (697)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~ 295 (697)
.+......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+.......+.....
T Consensus 174 ---------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~ 238 (353)
T 2i0e_A 174 ---------------DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV 238 (353)
T ss_dssp ---------------TTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC
T ss_pred ---------------CCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCC
Confidence 11124567899999999999999999999999999999999999999998766655555443221
Q ss_pred cHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCC-----HHHHHHHHHH
Q 005427 296 TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPS-----FSDIALELDL 351 (697)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt-----~~ell~~l~~ 351 (697)
..+..+++++.+||.+||+.||.+||+ ++++++|.|+
T Consensus 239 -------------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f 280 (353)
T 2i0e_A 239 -------------------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFF 280 (353)
T ss_dssp -------------------CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGG
T ss_pred -------------------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccc
Confidence 134578999999999999999999995 6899988775
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-44 Score=366.04 Aligned_cols=270 Identities=29% Similarity=0.505 Sum_probs=211.4
Q ss_pred CCCCccCCCCCCCcccccccccCCceEEEEEEECCeeEEEEeccCC--ChHHHHHHHHHHHHHHhcCCCCceEEeecccc
Q 005427 55 SSQSIPLHLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAK 132 (697)
Q Consensus 55 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 132 (697)
.....+.++..++|++.++||+|+||.||+|++.+ .||+|++... .....+.+.+|+.+|+.++||||+++++++ .
T Consensus 13 ~~~~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~-~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~ 90 (289)
T 3og7_A 13 RDAADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-T 90 (289)
T ss_dssp -----CCBCCTTSCEEEEEEEECSSEEEEEEESSS-EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-C
T ss_pred CCCCCCCccCccceeeeeEecCCCCeEEEEEEEcC-ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-c
Confidence 34455778999999999999999999999998765 4999986544 345567899999999999999999999965 5
Q ss_pred CCceEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhh
Q 005427 133 PPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYR 212 (697)
Q Consensus 133 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~ 212 (697)
....++||||+.+++|.+++......+++.+++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||++...
T Consensus 91 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 170 (289)
T 3og7_A 91 APQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEK 170 (289)
T ss_dssp SSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC-----
T ss_pred CCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceecccc
Confidence 56789999999999999999877778999999999999999999999999999999999999999999999999998754
Q ss_pred hhhhhhhcccccCCCCCCCCccccccccCccccchhhhc---ccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHH
Q 005427 213 ENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILK---KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHT 289 (697)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~ 289 (697)
..... ........||+.|+|||++. +..++.++||||||+++|+|++|..||.+.........
T Consensus 171 ~~~~~--------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~ 236 (289)
T 3og7_A 171 SRWSG--------------SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIE 236 (289)
T ss_dssp ---------------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHH
T ss_pred ccccc--------------cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHH
Confidence 42111 11233457999999999997 66788999999999999999999999987544332222
Q ss_pred HHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 005427 290 VLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL 353 (697)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~ 353 (697)
. +..+...+.+......+|+++.+||.+||+.||.+|||+.++++.|..+.
T Consensus 237 ~-------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 237 M-------------VGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp H-------------HHHTSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred H-------------hcccccCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 2 22233344444455678999999999999999999999999999887754
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-44 Score=378.29 Aligned_cols=263 Identities=24% Similarity=0.360 Sum_probs=206.0
Q ss_pred ccCCCCCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCce
Q 005427 59 IPLHLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNY 136 (697)
Q Consensus 59 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 136 (697)
.+.....++|+++++||+|+||+||++++ +++.||||++..... ..+.+.+|+.+++.++||||+++++++.++..+
T Consensus 13 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 91 (361)
T 3uc3_A 13 MPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHL 91 (361)
T ss_dssp CCCCCCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCCCCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEE
Confidence 44556678999999999999999999998 588999998754332 235688999999999999999999999999999
Q ss_pred EEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCC--Ceeeeeccchhhhh
Q 005427 137 MFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLC--PHLADFGLAEYREN 214 (697)
Q Consensus 137 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~--~kL~Dfg~a~~~~~ 214 (697)
++||||+.+|+|.+++...+ .+++..++.++.|++.||+|||++||+||||||+|||++.++. +||+|||+++....
T Consensus 92 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~ 170 (361)
T 3uc3_A 92 AIIMEYASGGELYERICNAG-RFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 170 (361)
T ss_dssp EEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-----
T ss_pred EEEEEeCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccc
Confidence 99999999999999987655 6899999999999999999999999999999999999987665 99999999864321
Q ss_pred hhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCch-hhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhc
Q 005427 215 LKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEK-SDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEM 293 (697)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~ 293 (697)
.. ......||+.|+|||++.+..++.+ +|||||||++|+|++|..||.+...........
T Consensus 171 ~~-----------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~-- 231 (361)
T 3uc3_A 171 HS-----------------QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTI-- 231 (361)
T ss_dssp ---------------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHH--
T ss_pred cC-----------------CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHH--
Confidence 11 1344579999999999988887655 899999999999999999998754322222111
Q ss_pred cccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 005427 294 NYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL 353 (697)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~ 353 (697)
..+...... + .....+++++.+||.+||+.||.+|||+.|+++|.|+..
T Consensus 232 --------~~~~~~~~~--~-~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~ 280 (361)
T 3uc3_A 232 --------QRILSVKYS--I-PDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLK 280 (361)
T ss_dssp --------HHHHTTCCC--C-CTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHT
T ss_pred --------HHHhcCCCC--C-CCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhc
Confidence 111111111 1 112357899999999999999999999999999999853
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-44 Score=380.25 Aligned_cols=255 Identities=20% Similarity=0.286 Sum_probs=214.2
Q ss_pred Cccc--ccccccCCceEEEEEEE--CCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEee
Q 005427 67 SYTL--LSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF 142 (697)
Q Consensus 67 ~y~~--~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 142 (697)
.|.+ .+.||+|+||.||+|.+ +++.||+|++........+.+.+|+.+|+.++||||+++++++.+...+++||||
T Consensus 88 ~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 167 (373)
T 2x4f_A 88 FYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEY 167 (373)
T ss_dssp TEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeC
Confidence 3544 67899999999999987 5889999998777667778899999999999999999999999999999999999
Q ss_pred cCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceee--cCCCCCeeeeeccchhhhhhhhhhc
Q 005427 143 YESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLL--DRNLCPHLADFGLAEYRENLKEISL 220 (697)
Q Consensus 143 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill--~~~~~~kL~Dfg~a~~~~~~~~~~~ 220 (697)
+++++|.+++......+++.+++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++.......
T Consensus 168 ~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~---- 243 (373)
T 2x4f_A 168 VDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE---- 243 (373)
T ss_dssp CTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC----
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc----
Confidence 99999999987766678999999999999999999999999999999999999 567789999999997654211
Q ss_pred ccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHH
Q 005427 221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQL 300 (697)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 300 (697)
......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.........+....+.
T Consensus 244 -------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~---- 306 (373)
T 2x4f_A 244 -------------KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWD---- 306 (373)
T ss_dssp -------------BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC----
T ss_pred -------------ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC----
Confidence 123457999999999999999999999999999999999999999987766555555433221
Q ss_pred HHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 005427 301 TAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL 353 (697)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~ 353 (697)
........+++++.+||.+||+.||.+|||+.|+++|.|+..
T Consensus 307 -----------~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~ 348 (373)
T 2x4f_A 307 -----------LEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSD 348 (373)
T ss_dssp -----------SCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHC
T ss_pred -----------CChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCC
Confidence 112233568999999999999999999999999999998753
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=368.16 Aligned_cols=269 Identities=24% Similarity=0.310 Sum_probs=212.9
Q ss_pred CCcccccccccCCceEEEEEEE-CCeeEEEEeccCCChH--HHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEee
Q 005427 66 SSYTLLSPIARGAESVVYEATL-DGRKVAVKKPILSTSE--ELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF 142 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 142 (697)
++|+++++||+|+||.||+|++ .++.||+|++...... ....+.+|+.+++.++||||+++++++.+...+++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 5899999999999999999998 5889999987655432 246788999999999999999999999999999999999
Q ss_pred cCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhccc
Q 005427 143 YESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKN 222 (697)
Q Consensus 143 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 222 (697)
+.+ +|.+++......+++.+++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~----- 155 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR----- 155 (288)
T ss_dssp CSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--------
T ss_pred cCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccc-----
Confidence 986 99999887666899999999999999999999999999999999999999999999999999976542110
Q ss_pred ccCCCCCCCCccccccccCccccchhhhccc-CCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHH--
Q 005427 223 WRSSGKPTGGFHKKNMVGTLIYMAPEILKKE-IHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQ-- 299 (697)
Q Consensus 223 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~-- 299 (697)
......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.........+.........
T Consensus 156 -----------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 224 (288)
T 1ob3_A 156 -----------KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKN 224 (288)
T ss_dssp -----------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred -----------ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhh
Confidence 12345789999999999764 5899999999999999999999999987666555544332111000
Q ss_pred HHHHHHhCCCCC--------cccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 005427 300 LTAAVVSGGLRP--------ILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL 351 (697)
Q Consensus 300 ~~~~~~~~~~~~--------~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~ 351 (697)
+........+.+ ........+++++.+||.+||+.||++|||+.|+++|.|+
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f 284 (288)
T 1ob3_A 225 WPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284 (288)
T ss_dssp STTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGG
T ss_pred chhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcch
Confidence 000000000010 0112234689999999999999999999999999998875
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=390.08 Aligned_cols=263 Identities=24% Similarity=0.279 Sum_probs=219.8
Q ss_pred CCCCCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCCh---HHHHHHHHHHHHHHhcCCCCceEEeeccccCCc
Q 005427 61 LHLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTS---EELDNFHKELQLLCKLDHPGLAKFVAAHAKPPN 135 (697)
Q Consensus 61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 135 (697)
..+..++|+++++||+|+||+||+|++ +++.||+|++..... .....+.+|..+|..++||||++++++|.+...
T Consensus 69 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~ 148 (437)
T 4aw2_A 69 MRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNN 148 (437)
T ss_dssp HSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSE
T ss_pred ccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCE
Confidence 345567999999999999999999998 478999998643211 112348899999999999999999999999999
Q ss_pred eEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhh
Q 005427 136 YMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL 215 (697)
Q Consensus 136 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~ 215 (697)
+++||||+.+|+|.+++......+++..++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++.....
T Consensus 149 ~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 228 (437)
T 4aw2_A 149 LYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 228 (437)
T ss_dssp EEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccC
Confidence 99999999999999999876668999999999999999999999999999999999999999999999999999654321
Q ss_pred hhhhcccccCCCCCCCCccccccccCccccchhhhc-----ccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHH
Q 005427 216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILK-----KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTV 290 (697)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~ 290 (697)
. .......+||+.|+|||++. ...++.++|||||||++|||++|..||.+.+.......+
T Consensus 229 ~---------------~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i 293 (437)
T 4aw2_A 229 G---------------TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 293 (437)
T ss_dssp S---------------CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH
T ss_pred C---------------CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhh
Confidence 1 11234568999999999997 456899999999999999999999999987766666555
Q ss_pred HhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCC--CCCHHHHHHHHHHH
Q 005427 291 LEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHN--RPSFSDIALELDLV 352 (697)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~--Rpt~~ell~~l~~~ 352 (697)
..... +..++.....+++++.+||++||..+|++ ||+++|+++|+|+-
T Consensus 294 ~~~~~--------------~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~ 343 (437)
T 4aw2_A 294 MNHKE--------------RFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFS 343 (437)
T ss_dssp HTHHH--------------HCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGT
T ss_pred hhccc--------------cccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccC
Confidence 43211 11122223468999999999999998888 99999999999884
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=374.65 Aligned_cols=279 Identities=27% Similarity=0.335 Sum_probs=222.6
Q ss_pred cCCCCCCCcccccccccCCceEEEEEEECCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccccCC----c
Q 005427 60 PLHLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPP----N 135 (697)
Q Consensus 60 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~----~ 135 (697)
.+.+..++|++.++||+|+||.||+|++.++.||||++.... ........|+.+|+.++||||+++++++.... .
T Consensus 18 n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (322)
T 3soc_A 18 NLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVD 96 (322)
T ss_dssp CEEETTEEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred ccccchhhchhhheecccCceEEEEEEECCCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCce
Confidence 345667899999999999999999999999999999875443 33445667999999999999999999998754 3
Q ss_pred eEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC----------CcccccCCCCceeecCCCCCeeee
Q 005427 136 YMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL----------GIVHRDVKPANVLLDRNLCPHLAD 205 (697)
Q Consensus 136 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~----------~ivHrDlkp~Nill~~~~~~kL~D 205 (697)
+++||||+++|+|.+++... .+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|
T Consensus 97 ~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~D 174 (322)
T 3soc_A 97 LWLITAFHEKGSLSDFLKAN--VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIAD 174 (322)
T ss_dssp EEEEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECC
T ss_pred EEEEEecCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEcc
Confidence 79999999999999999764 489999999999999999999999 999999999999999999999999
Q ss_pred eccchhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcc-----cCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 005427 206 FGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-----EIHSEKSDVYSFGISINELLTGVVPYTD 280 (697)
Q Consensus 206 fg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~~l~ell~g~~Pf~~ 280 (697)
||+++....... ........||+.|+|||++.+ ..++.++|||||||++|||++|..||.+
T Consensus 175 Fg~a~~~~~~~~--------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~ 240 (322)
T 3soc_A 175 FGLALKFEAGKS--------------AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADG 240 (322)
T ss_dssp CTTCEEECTTSC--------------CCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSS
T ss_pred CCcccccccccC--------------ccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCC
Confidence 999976542111 111334679999999999986 3456789999999999999999999986
Q ss_pred chhHHHH--HHHHhccccHHHHHHHHHhCCCCCcccccc--cCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 005427 281 LRAEAQA--HTVLEMNYTEQQLTAAVVSGGLRPILASLE--LGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH 355 (697)
Q Consensus 281 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~ 355 (697)
....... ......................+|.++... ...++++.+||.+||+.||.+|||+.++++.|+.+.+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 241 PVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp CCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CcchhccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 5332211 111122223444444555555565554432 23466799999999999999999999999999988754
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=364.40 Aligned_cols=260 Identities=26% Similarity=0.384 Sum_probs=219.2
Q ss_pred CCCCCCCcccccccccCCceEEEEEEEC-CeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEE
Q 005427 61 LHLPPSSYTLLSPIARGAESVVYEATLD-GRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFF 139 (697)
Q Consensus 61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 139 (697)
+++..++|++.+.||+|+||.||+|.+. +..||+|++..... ..+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 3 ~~l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (268)
T 3sxs_A 3 MELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIV 81 (268)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEE
T ss_pred eEechhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEE
Confidence 4567789999999999999999999884 56899998764432 346689999999999999999999999999999999
Q ss_pred EeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhh
Q 005427 140 FEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEIS 219 (697)
Q Consensus 140 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~ 219 (697)
|||+++++|.+++......+++.+++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||++........
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-- 159 (268)
T 3sxs_A 82 TEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY-- 159 (268)
T ss_dssp EECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE--
T ss_pred EEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhhh--
Confidence 999999999999987766799999999999999999999999999999999999999999999999999975542111
Q ss_pred cccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCCchhHHHHHHHHhccccHH
Q 005427 220 LKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQ 298 (697)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~ 298 (697)
.......+|+.|+|||++.+..++.++||||||+++|+|++ |..||...........+...
T Consensus 160 -------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~----- 221 (268)
T 3sxs_A 160 -------------VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQG----- 221 (268)
T ss_dssp -------------EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTT-----
T ss_pred -------------hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcC-----
Confidence 11233456788999999999889999999999999999999 99999876655443333211
Q ss_pred HHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 005427 299 QLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE 354 (697)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~ 354 (697)
..+ ..+..+++.+.+++..||+.||.+|||+.+++++|+.+.+
T Consensus 222 ----------~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 222 ----------HRL---YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp ----------CCC---CCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred ----------CCC---CCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 111 1234578999999999999999999999999999877654
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-44 Score=369.02 Aligned_cols=254 Identities=27% Similarity=0.379 Sum_probs=206.3
Q ss_pred CCCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCCh--------------------------HHHHHHHHHHHH
Q 005427 63 LPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTS--------------------------EELDNFHKELQL 114 (697)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~--------------------------~~~~~~~~E~~~ 114 (697)
+..++|++.+.||+|+||.||+|++ +++.||||++..... ...+.+.+|+.+
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 89 (298)
T 2zv2_A 10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI 89 (298)
T ss_dssp CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence 3446899999999999999999987 588999998654321 123568899999
Q ss_pred HHhcCCCCceEEeecccc--CCceEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCc
Q 005427 115 LCKLDHPGLAKFVAAHAK--PPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPAN 192 (697)
Q Consensus 115 l~~l~hpniv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~N 192 (697)
|+.++||||+++++++.+ ...+++||||+++++|.+++.. ..+++.+++.++.|++.||+|||+.||+||||||+|
T Consensus 90 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~N 167 (298)
T 2zv2_A 90 LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL--KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSN 167 (298)
T ss_dssp HHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred HHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHH
Confidence 999999999999999886 5679999999999999987643 368999999999999999999999999999999999
Q ss_pred eeecCCCCCeeeeeccchhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccC---CCchhhHHHHHHHHH
Q 005427 193 VLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEI---HSEKSDVYSFGISIN 269 (697)
Q Consensus 193 ill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~~l~ 269 (697)
||++.++.+||+|||++....... .......||+.|+|||++.+.. ++.++|||||||++|
T Consensus 168 il~~~~~~~kl~Dfg~~~~~~~~~----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~ 231 (298)
T 2zv2_A 168 LLVGEDGHIKIADFGVSNEFKGSD----------------ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLY 231 (298)
T ss_dssp EEECTTSCEEECCCTTCEECSSSS----------------CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHH
T ss_pred EEECCCCCEEEecCCCcccccccc----------------ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHH
Confidence 999999999999999987543211 1123457999999999998765 478899999999999
Q ss_pred HHHhCCCCCCCchhHHHHHHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 005427 270 ELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALEL 349 (697)
Q Consensus 270 ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l 349 (697)
+|++|..||.+.........+.. ..... .....+++++.+||.+||+.||++|||+.|+++|.
T Consensus 232 ~l~~g~~pf~~~~~~~~~~~~~~--------------~~~~~---~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp 294 (298)
T 2zv2_A 232 CFVFGQCPFMDERIMCLHSKIKS--------------QALEF---PDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHP 294 (298)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHH--------------CCCCC---CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCH
T ss_pred HHHHCCCCCCCccHHHHHHHHhc--------------ccCCC---CCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCc
Confidence 99999999987654433322221 11111 11246899999999999999999999999999998
Q ss_pred HH
Q 005427 350 DL 351 (697)
Q Consensus 350 ~~ 351 (697)
|+
T Consensus 295 ~~ 296 (298)
T 2zv2_A 295 WV 296 (298)
T ss_dssp HH
T ss_pred cc
Confidence 86
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=376.49 Aligned_cols=266 Identities=26% Similarity=0.394 Sum_probs=224.0
Q ss_pred ccCCCCCCCcccccccccCCceEEEEEEEC---------CeeEEEEeccCCC-hHHHHHHHHHHHHHHhc-CCCCceEEe
Q 005427 59 IPLHLPPSSYTLLSPIARGAESVVYEATLD---------GRKVAVKKPILST-SEELDNFHKELQLLCKL-DHPGLAKFV 127 (697)
Q Consensus 59 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~---------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~l~ 127 (697)
..+++..++|++.++||+|+||.||+|++. +..||||++.... ......+.+|+++++.+ +||||++++
T Consensus 62 ~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~ 141 (382)
T 3tt0_A 62 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLL 141 (382)
T ss_dssp TTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhhe
Confidence 456788899999999999999999999862 2579999876543 44567899999999999 999999999
Q ss_pred eccccCCceEEEEeecCCCCHhhhhhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCc
Q 005427 128 AAHAKPPNYMFFFEFYESRNLAEKLHVEE---------------WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPAN 192 (697)
Q Consensus 128 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~N 192 (697)
+++......++||||+.+|+|.+++.... ..+++.+++.++.|++.||.|||+.||+||||||+|
T Consensus 142 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N 221 (382)
T 3tt0_A 142 GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARN 221 (382)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred eeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcce
Confidence 99999999999999999999999997653 358999999999999999999999999999999999
Q ss_pred eeecCCCCCeeeeeccchhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHH
Q 005427 193 VLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELL 272 (697)
Q Consensus 193 ill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell 272 (697)
||++.++.+||+|||+++....... ........+|+.|+|||++.+..++.++|||||||++|+|+
T Consensus 222 Ill~~~~~~kL~DFG~a~~~~~~~~--------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ell 287 (382)
T 3tt0_A 222 VLVTEDNVMKIADFGLARDIHHIDY--------------YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 287 (382)
T ss_dssp EEECTTCCEEECSCSCCCCSSCCCT--------------TCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHH
T ss_pred EEEcCCCcEEEcccCcccccccccc--------------cccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHH
Confidence 9999999999999999975542111 01123456789999999999999999999999999999999
Q ss_pred h-CCCCCCCchhHHHHHHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 005427 273 T-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL 351 (697)
Q Consensus 273 ~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~ 351 (697)
+ |..||.+.........+.. ..++ ..+..+++++.+||.+||+.||.+|||+.+++++|+.
T Consensus 288 t~g~~p~~~~~~~~~~~~~~~---------------~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 349 (382)
T 3tt0_A 288 TLGGSPYPGVPVEELFKLLKE---------------GHRM---DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 349 (382)
T ss_dssp TTSCCSSTTCCHHHHHHHHHT---------------TCCC---CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred hCCCCCCCCCCHHHHHHHHHc---------------CCCC---CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 9 9999987655443333221 1111 2245789999999999999999999999999999999
Q ss_pred HHHHh
Q 005427 352 VLEHR 356 (697)
Q Consensus 352 ~~~~~ 356 (697)
+....
T Consensus 350 ~~~~~ 354 (382)
T 3tt0_A 350 IVALT 354 (382)
T ss_dssp HHHHS
T ss_pred HHHHH
Confidence 98654
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-44 Score=377.32 Aligned_cols=257 Identities=25% Similarity=0.339 Sum_probs=212.4
Q ss_pred CCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCC-----hHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceE
Q 005427 65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST-----SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYM 137 (697)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 137 (697)
.++|++.+.||+|+||.||+|.+ +++.||||++.... ....+.+.+|+.+|+.++||||+++++++.+...++
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 35799999999999999999987 58899999864321 113567899999999999999999999999999999
Q ss_pred EEEeecCCCCHhhhhhhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCC---Ceeeeeccchh
Q 005427 138 FFFEFYESRNLAEKLHVE---EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLC---PHLADFGLAEY 211 (697)
Q Consensus 138 lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~---~kL~Dfg~a~~ 211 (697)
+||||+.+++|.+.+... +..+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++..
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 182 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ 182 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEE
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeE
Confidence 999999999998877543 335899999999999999999999999999999999999976554 99999999976
Q ss_pred hhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHH
Q 005427 212 RENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVL 291 (697)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~ 291 (697)
.... .......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+... .....+.
T Consensus 183 ~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~i~ 245 (351)
T 3c0i_A 183 LGES----------------GLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE-RLFEGII 245 (351)
T ss_dssp CCTT----------------SCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH-HHHHHHH
T ss_pred ecCC----------------CeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH-HHHHHHH
Confidence 5421 1123456799999999999999999999999999999999999999987532 2222222
Q ss_pred hccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 005427 292 EMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL 353 (697)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~ 353 (697)
. +... ..+.....+++++.+||.+||+.||.+|||+.++++|.|...
T Consensus 246 ~--------------~~~~-~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~ 292 (351)
T 3c0i_A 246 K--------------GKYK-MNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKE 292 (351)
T ss_dssp H--------------TCCC-CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred c--------------CCCC-CCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcC
Confidence 2 1111 112223568999999999999999999999999999998853
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=372.82 Aligned_cols=264 Identities=27% Similarity=0.426 Sum_probs=221.4
Q ss_pred cCCCCCCCcccccccccCCceEEEEEEECC-------eeEEEEeccCCC-hHHHHHHHHHHHHHHhcCCCCceEEeeccc
Q 005427 60 PLHLPPSSYTLLSPIARGAESVVYEATLDG-------RKVAVKKPILST-SEELDNFHKELQLLCKLDHPGLAKFVAAHA 131 (697)
Q Consensus 60 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~ 131 (697)
.+.+..++|++.+.||+|+||.||+|++.+ +.||+|++.... ....+.+.+|+.+++.++||||+++++++.
T Consensus 41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 120 (343)
T 1luf_A 41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 120 (343)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred eeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 456778899999999999999999998753 789999876543 344678999999999999999999999999
Q ss_pred cCCceEEEEeecCCCCHhhhhhhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccC
Q 005427 132 KPPNYMFFFEFYESRNLAEKLHVEE-----------------------WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDV 188 (697)
Q Consensus 132 ~~~~~~lv~e~~~~g~L~~~l~~~~-----------------------~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDl 188 (697)
+...+++||||+.+|+|.+++.... ..+++.+++.++.|++.||.|||++||+||||
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dl 200 (343)
T 1luf_A 121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDL 200 (343)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence 9999999999999999999997632 46899999999999999999999999999999
Q ss_pred CCCceeecCCCCCeeeeeccchhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHH
Q 005427 189 KPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISI 268 (697)
Q Consensus 189 kp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l 268 (697)
||+|||++.++.+||+|||++......... .......||+.|+|||++.+..++.++|||||||++
T Consensus 201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~--------------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il 266 (343)
T 1luf_A 201 ATRNCLVGENMVVKIADFGLSRNIYSADYY--------------KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVL 266 (343)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGCB--------------C----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred CcceEEECCCCeEEEeecCCCcccccCccc--------------cccCCCcccceecChhhhccCCcCcccccHHHHHHH
Confidence 999999999999999999999766432110 012345689999999999999999999999999999
Q ss_pred HHHHh-CCCCCCCchhHHHHHHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005427 269 NELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIAL 347 (697)
Q Consensus 269 ~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 347 (697)
|+|++ |..||.+.........+.. +.. ...+..+++++.+||.+||+.||.+|||+.++++
T Consensus 267 ~el~t~g~~p~~~~~~~~~~~~~~~--------------~~~----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~ 328 (343)
T 1luf_A 267 WEIFSYGLQPYYGMAHEEVIYYVRD--------------GNI----LACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 328 (343)
T ss_dssp HHHHTTTCCTTTTSCHHHHHHHHHT--------------TCC----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHhcCCCcCCCCChHHHHHHHhC--------------CCc----CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 99999 9999987655444333222 111 1234578999999999999999999999999999
Q ss_pred HHHHHHHH
Q 005427 348 ELDLVLEH 355 (697)
Q Consensus 348 ~l~~~~~~ 355 (697)
+|..+.+.
T Consensus 329 ~L~~~~~~ 336 (343)
T 1luf_A 329 ILQRMCER 336 (343)
T ss_dssp HHHHTTC-
T ss_pred HHHHHHhh
Confidence 99887643
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=356.51 Aligned_cols=260 Identities=23% Similarity=0.398 Sum_probs=221.9
Q ss_pred CCCCCCCcccccccccCCceEEEEEEE-CCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEE
Q 005427 61 LHLPPSSYTLLSPIARGAESVVYEATL-DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFF 139 (697)
Q Consensus 61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 139 (697)
+.+..++|++.+.||+|+||.||+|.+ .++.||+|++..... ..+.+.+|+.+++.++||||+++++++.+...++++
T Consensus 3 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (267)
T 3t9t_A 3 WVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV 81 (267)
T ss_dssp CBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEE
T ss_pred eEEchhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEE
Confidence 567788999999999999999999998 677899998765432 346789999999999999999999999999999999
Q ss_pred EeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhh
Q 005427 140 FEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEIS 219 (697)
Q Consensus 140 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~ 219 (697)
|||+++++|.+++......+++.+++.++.|++.||.|||+.|++||||||+||+++.++.+||+|||++.........
T Consensus 82 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~- 160 (267)
T 3t9t_A 82 TEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT- 160 (267)
T ss_dssp ECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHH-
T ss_pred EeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccccccc-
Confidence 9999999999999877667899999999999999999999999999999999999999999999999999765432111
Q ss_pred cccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCCchhHHHHHHHHhccccHH
Q 005427 220 LKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQ 298 (697)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~ 298 (697)
......+++.|+|||++.+..++.++||||||+++|+|++ |..||.+.........+..
T Consensus 161 --------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~------ 220 (267)
T 3t9t_A 161 --------------SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST------ 220 (267)
T ss_dssp --------------STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT------
T ss_pred --------------ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhc------
Confidence 1233457889999999999999999999999999999999 9999987655443333221
Q ss_pred HHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 005427 299 QLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE 354 (697)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~ 354 (697)
+.++ ..+..++..+.+++.+||+.||.+|||+.+++++|..+.+
T Consensus 221 ---------~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 221 ---------GFRL---YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp ---------TCCC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---------CCcC---CCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 1111 1234678999999999999999999999999999998875
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=386.10 Aligned_cols=257 Identities=25% Similarity=0.413 Sum_probs=218.3
Q ss_pred cCCCCCCCcccccccccCCceEEEEEEECCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccccCC-ceEE
Q 005427 60 PLHLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPP-NYMF 138 (697)
Q Consensus 60 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-~~~l 138 (697)
.+++..++|++.++||+|+||.||+|.+.++.||||++.... ..+.+.+|+.+|++++||||+++++++.... .+++
T Consensus 187 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~i 264 (450)
T 1k9a_A 187 GWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 264 (450)
T ss_dssp TCBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEE
T ss_pred ccccChHHeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEE
Confidence 467888999999999999999999999999999999876443 4567999999999999999999999976655 7999
Q ss_pred EEeecCCCCHhhhhhhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhh
Q 005427 139 FFEFYESRNLAEKLHVEEW-SPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKE 217 (697)
Q Consensus 139 v~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~ 217 (697)
||||+.+|+|.+++...+. .+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 265 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~--- 341 (450)
T 1k9a_A 265 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS--- 341 (450)
T ss_dssp EEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC----
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccc---
Confidence 9999999999999987654 368999999999999999999999999999999999999999999999999864321
Q ss_pred hhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCCchhHHHHHHHHhcccc
Q 005427 218 ISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYT 296 (697)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~~~~~~~~~~~~~~~~~ 296 (697)
......+++.|+|||++.+..++.++|||||||++|||++ |..||.+.........+.
T Consensus 342 ----------------~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~----- 400 (450)
T 1k9a_A 342 ----------------TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE----- 400 (450)
T ss_dssp ---------------------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHH-----
T ss_pred ----------------cccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-----
Confidence 1122357889999999999999999999999999999998 999998765443332221
Q ss_pred HHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 005427 297 EQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH 355 (697)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~ 355 (697)
.+.++ ..+..+|+++.+||.+||+.||.+|||+.++++.|..+..+
T Consensus 401 ----------~~~~~---~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 401 ----------KGYKM---DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp ----------TTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ----------cCCCC---CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 12222 23457899999999999999999999999999999888654
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-44 Score=378.45 Aligned_cols=254 Identities=26% Similarity=0.346 Sum_probs=206.2
Q ss_pred CCCCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCC---hHHHHHHHHHHHH-HHhcCCCCceEEeeccccCCc
Q 005427 62 HLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST---SEELDNFHKELQL-LCKLDHPGLAKFVAAHAKPPN 135 (697)
Q Consensus 62 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~---~~~~~~~~~E~~~-l~~l~hpniv~l~~~~~~~~~ 135 (697)
.+..++|++++.||+|+||.||+|++ +++.||+|++.... ......+.+|..+ ++.++||||+++++++.+...
T Consensus 34 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~ 113 (373)
T 2r5t_A 34 HAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADK 113 (373)
T ss_dssp TCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSE
T ss_pred CCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCE
Confidence 44567899999999999999999998 57789999865432 2334566777776 577899999999999999999
Q ss_pred eEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhh
Q 005427 136 YMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL 215 (697)
Q Consensus 136 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~ 215 (697)
+|+||||+.||+|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 114 ~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~ 192 (373)
T 2r5t_A 114 LYFVLDYINGGELFYHLQRER-CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH 192 (373)
T ss_dssp EEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred EEEEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence 999999999999999997654 6899999999999999999999999999999999999999999999999998753210
Q ss_pred hhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccc
Q 005427 216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNY 295 (697)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~ 295 (697)
.......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+.......+.....
T Consensus 193 ----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~ 256 (373)
T 2r5t_A 193 ----------------NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL 256 (373)
T ss_dssp ----------------CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCC
T ss_pred ----------------CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccc
Confidence 1124567899999999999999999999999999999999999999988766655555443211
Q ss_pred cHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCH----HHHHHHHHH
Q 005427 296 TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSF----SDIALELDL 351 (697)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~----~ell~~l~~ 351 (697)
..+..++.++.+||.+||+.||.+||++ .++++|.|+
T Consensus 257 -------------------~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f 297 (373)
T 2r5t_A 257 -------------------QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFF 297 (373)
T ss_dssp -------------------CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGG
T ss_pred -------------------CCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccc
Confidence 1245689999999999999999999997 466666554
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=358.63 Aligned_cols=253 Identities=32% Similarity=0.506 Sum_probs=205.3
Q ss_pred CCCCCCcccccccccCCceEEEEEEECCeeEEEEeccCCChH----HHHHHHHHHHHHHhcCCCCceEEeeccccCCceE
Q 005427 62 HLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSE----ELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYM 137 (697)
Q Consensus 62 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 137 (697)
++..++|++.++||+|+||.||+|.+.++.||||+....... ..+.+.+|+++++.++||||+++++++.+....+
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (271)
T 3dtc_A 3 EIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLC 82 (271)
T ss_dssp BCCTTSEEEEEEEEEETTEEEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CE
T ss_pred ccchhheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceE
Confidence 456689999999999999999999999999999986554322 2567899999999999999999999999999999
Q ss_pred EEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCCCCceeecC--------CCCCeeeee
Q 005427 138 FFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLG---IVHRDVKPANVLLDR--------NLCPHLADF 206 (697)
Q Consensus 138 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~--------~~~~kL~Df 206 (697)
+||||+.+++|.+++.. ..+++..++.++.|++.||.|||+.| |+||||||+|||++. ++.+||+||
T Consensus 83 lv~e~~~~~~L~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 83 LVMEFARGGPLNRVLSG--KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp EEEECCTTEEHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EEEEcCCCCCHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 99999999999999853 36899999999999999999999999 899999999999986 678999999
Q ss_pred ccchhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHH
Q 005427 207 GLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQ 286 (697)
Q Consensus 207 g~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~ 286 (697)
|++....... .....||+.|+|||++.+..++.++||||||+++|+|++|..||.+......
T Consensus 161 g~~~~~~~~~------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~ 222 (271)
T 3dtc_A 161 GLAREWHRTT------------------KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAV 222 (271)
T ss_dssp CC-------------------------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHH
T ss_pred Cccccccccc------------------ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 9997554211 2245789999999999999999999999999999999999999987655443
Q ss_pred HHHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 005427 287 AHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL 351 (697)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~ 351 (697)
...... ....+ ..+..+++++.+++.+||+.||.+|||+.|++++|..
T Consensus 223 ~~~~~~--------------~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 223 AYGVAM--------------NKLAL---PIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp HHHHHT--------------SCCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred HHhhhc--------------CCCCC---CCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 332221 11111 2345789999999999999999999999999998864
|
| >2j4o_A Mitogen-activated protein kinase kinase kinase 7-interacting protein 1; TGF-beta, pseudo-phosphatase, TAK1 binding protein, protein binding; 2.25A {Homo sapiens} PDB: 2pom_A 2pop_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=380.88 Aligned_cols=262 Identities=23% Similarity=0.339 Sum_probs=210.6
Q ss_pred CcccceEeeeccCCCC--------CCCceeEEcccccCCCceEEEEEecCCCChHHHHHHHHHhHHHHHhc-CCC----C
Q 005427 426 YPVLSWGSFATCGRRE--------TMEDTHFLMPHMYNQKEIHMFGIFDGHRGSAAAEFSARALPGFLQNL-GST----T 492 (697)
Q Consensus 426 ~~~~~~~~~s~~G~R~--------~neD~~~~~~~~~~~~~~~~~~V~DG~GG~~~~~~as~~~~~~l~~~-~~~----~ 492 (697)
-+.+.+|+++.+|.|. .|||++++.. ...+..||||||||||+.+|++|++.++..|... ... .
T Consensus 24 ~~~~~~G~~~~~G~r~~g~~~~r~~nED~~~~~~---~~~~~~lf~V~DGhGG~~aa~~as~~l~~~l~~~~~~~~~~~~ 100 (401)
T 2j4o_A 24 CHLSGVGSASNRSYSADGKGTESHPPEDSWLKFR---SENNCFLYGVFNGYDGNRVTNFVAQRLSAELLLGQLNAEHAEA 100 (401)
T ss_dssp CTTEEEEEECCEEECSSSSCEECCCCCEEEEEEE---ETTTEEEEEEEEEESSSHHHHHHHHHHHHTTSSSSCCTTSCHH
T ss_pred cccCceeEEecccccccccccCCCCCCceEEEec---CCCCeEEEEEEcCCCCHHHHHHHHHHHHHHHHHhhhhcccchh
Confidence 3567899999999887 5999998754 2446789999999999999999999999988642 211 2
Q ss_pred ChHHHHHHHHHHHHHHHHHHHHHHHhhhh-----------------cc----------cCCCCCCceEEEEEEecCeEEE
Q 005427 493 RPTDALLEAFIRTDVAFRNELDSLRKSKR-----------------VV----------QKDWHPGCTAIAALIVRNRLFV 545 (697)
Q Consensus 493 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~-----------------~~----------~~~~~~GtT~~~~~i~~~~l~~ 545 (697)
....+|.++|..++..+............ .. .....||||+++++|.++++||
T Consensus 101 ~~~~~l~~af~~~~~~i~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~GtTa~~~li~~~~l~v 180 (401)
T 2j4o_A 101 DVRRVLLQAFDVVERSFLESIDDALAEKASLQSQLPEGVPQHQLPPQYQKILERLKTLEREISGGAMAVVAVLLNNKLYV 180 (401)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHTSCTTCCSSCSCGGGHHHHHHHHHHHHHHCCEEEEEEEEEETTEEEE
T ss_pred hHHHHHHHHHHHHHHHHHHHHHHHHhhhhcccccccccccccccccccchhhhhhhcccccCCCccCEEEEEEECCEEEE
Confidence 34667888888888877654321110000 00 0123589999999999999999
Q ss_pred EEcCCeEEEEEECC----eeeecCCCCCCCCHHHHHHHHHcCCeeeeccCcceeCCCcceeccccCCCCCC---------
Q 005427 546 ANAGDCRAILCRGG----HPFALSRDHVASCLEERERVVSAGGNVNWQVDTWRVGPPALQVTRSIGDDDLK--------- 612 (697)
Q Consensus 546 anvGDSr~~l~~~~----~~~~lt~dH~~~~~~e~~ri~~~g~~~~~~~~~~~~~~~~~~ltralG~~~~k--------- 612 (697)
|||||||+|++|++ ++++||+||+|.++.|++||.+.|+.+... ...+.+ +.+++||||||..+|
T Consensus 181 anvGDSRa~l~r~~~~g~~~~~LT~DH~~~~~~E~~Ri~~~Gg~v~~~-~~~r~~-g~l~vtRalGd~~~k~~~~~~~~~ 258 (401)
T 2j4o_A 181 ANVGTNRALLCKSTVDGLQVTQLNVDHTTENEDELFRLSQLGLDAGKI-KQVGII-CGQESTRRIGDYKVKYGYTDIDLL 258 (401)
T ss_dssp EEESSCEEEEEEECSSSEEEEECSCCCSTTSHHHHHHHHTTTCCHHHH-HHHCCB-TTBCCSBCEECHHHHHSGGGSTTT
T ss_pred EEccCceEEEEEcCCCCceEEECCCCCCCCCHHHHHHHHHcCCCeeec-cCcccc-CCcccccccCCHhhcccccccccc
Confidence 99999999999988 999999999999999999999999864211 123444 467999999997665
Q ss_pred -----CCcccCCceEE-EEeCCCCeEEEEEcCCcccCC--------ChHHHHHHHHhh---cCChhHHHHHHHHHHHh--
Q 005427 613 -----PAVTAEPEITE-TIMTPEDEYLVMASDGLWDVV--------SHVEAVGIIKDT---VKEPGMCSKRLATEAAE-- 673 (697)
Q Consensus 613 -----~~v~~~p~v~~-~~l~~~d~~lvl~SDGl~d~~--------~~~ei~~~~~~~---~~~~~~~a~~L~~~a~~-- 673 (697)
++++++||+.. +.+.++|+|||||||||||+| +++||++++... ..+++.+|+.|++.|++
T Consensus 259 ~~~~~~~v~~~Pdv~~~~~l~~~d~flvLaSDGlwd~l~~~~~~~~s~~ei~~~v~~~l~~~~~~~~~a~~Lv~~A~~~~ 338 (401)
T 2j4o_A 259 SAAKSKPIIAEPEIHGAQPLDGVTGFLVLMSEGLYKALEAAHGPGQANQEIAAMIDTEFAKQTSLDAVAQAVVDRVKRIH 338 (401)
T ss_dssp TTCSSCSSBCCCEEEEEEECTTCCEEEEEECHHHHHHHHHHHCTTCHHHHHHHHHHHHHHHCSSHHHHHHHHHHHHHHHH
T ss_pred cccCCCCeeccceEEEeEEeCCCCcEEEEEccchhhcccccccCCCCHHHHHHHHHHHHhcCCCHHHHHHHHHHHHHHhh
Confidence 47899999996 999999999999999999999 899999999874 34899999999999986
Q ss_pred -----cCC--------CCCcEEEEEEeCCCCc
Q 005427 674 -----RGS--------KDNITVIVVFLQPVST 692 (697)
Q Consensus 674 -----~g~--------~DNiT~ivv~l~~~~~ 692 (697)
+|+ .||||||||+|..+..
T Consensus 339 ~~a~~~G~~~~~~~~~~DNiTvivv~~~~~~~ 370 (401)
T 2j4o_A 339 SDTFASGGERARFCPRHEDMTLLVRNFGYPLG 370 (401)
T ss_dssp HHHHHSCSSGGGGCSEECCEEEEEEEEBCCCC
T ss_pred hhhhhcCCcccccCCCCCCeEEEEEEcCCCCc
Confidence 666 7999999999976543
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=385.58 Aligned_cols=261 Identities=25% Similarity=0.308 Sum_probs=216.7
Q ss_pred CCCCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCC---hHHHHHHHHHHHHHHhcCCCCceEEeeccccCCce
Q 005427 62 HLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST---SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNY 136 (697)
Q Consensus 62 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 136 (697)
.+..++|+++++||+|+||.||++++ +++.||+|++.... ....+.+.+|..+|..++||||+++++++.+...+
T Consensus 57 ~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~ 136 (412)
T 2vd5_A 57 RLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYL 136 (412)
T ss_dssp SCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEE
T ss_pred cCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEE
Confidence 45567899999999999999999998 58899999864321 12234588999999999999999999999999999
Q ss_pred EEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhh
Q 005427 137 MFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLK 216 (697)
Q Consensus 137 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~ 216 (697)
|+||||+.+|+|.+++...+..+++..++.++.||+.||+|||+.||+||||||+|||++.++++||+|||+++......
T Consensus 137 ~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~ 216 (412)
T 2vd5_A 137 YLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADG 216 (412)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred EEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCCC
Confidence 99999999999999998766679999999999999999999999999999999999999999999999999997543211
Q ss_pred hhhcccccCCCCCCCCccccccccCccccchhhhc-------ccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHH
Q 005427 217 EISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILK-------KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHT 289 (697)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~ 289 (697)
.......+||+.|+|||++. +..++.++|||||||++|||++|..||.+.+.......
T Consensus 217 ---------------~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~ 281 (412)
T 2vd5_A 217 ---------------TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGK 281 (412)
T ss_dssp ---------------CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH
T ss_pred ---------------ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 11233568999999999997 35689999999999999999999999998776666555
Q ss_pred HHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCC---CCHHHHHHHHHHH
Q 005427 290 VLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNR---PSFSDIALELDLV 352 (697)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R---pt~~ell~~l~~~ 352 (697)
+..... ...++..+..+|+++.+||++||. +|.+| |+++|+++|.|+.
T Consensus 282 i~~~~~--------------~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~ 332 (412)
T 2vd5_A 282 IVHYKE--------------HLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFF 332 (412)
T ss_dssp HHTHHH--------------HCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGT
T ss_pred HHhccc--------------CcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcC
Confidence 543210 011122235789999999999999 99998 5999999998873
|
| >2irm_A Mitogen-activated protein kinase kinase kinase 7 interacting protein 1; TAK1-binding protein, TAB1; 3.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-44 Score=375.65 Aligned_cols=247 Identities=25% Similarity=0.382 Sum_probs=201.9
Q ss_pred eeccCCCC---CCCceeEEcccccCCCceEEEEEecCCCChHHHHHHHHHhHHHHHh-cCCC----CChHHHHHHHHHHH
Q 005427 434 FATCGRRE---TMEDTHFLMPHMYNQKEIHMFGIFDGHRGSAAAEFSARALPGFLQN-LGST----TRPTDALLEAFIRT 505 (697)
Q Consensus 434 ~s~~G~R~---~neD~~~~~~~~~~~~~~~~~~V~DG~GG~~~~~~as~~~~~~l~~-~~~~----~~~~~~l~~~~~~~ 505 (697)
++.+|+|. .|||++++.. ...+..+|||||||||+.+|++|++.++..|.. .... ......|.++|..+
T Consensus 25 ~~~~G~r~~~~~nED~~~~~~---~~~~~~lf~V~DGhGG~~aa~~as~~l~~~l~~~~l~~~~~~~~~~~~l~~a~~~~ 101 (358)
T 2irm_A 25 YKDDGRRCEGYESRDKKCLCI---SDNNTSLYAILSGHNGVTVAENALQEMAAELLLGQLNVCNTDEAVKELIRQSFMSV 101 (358)
T ss_dssp ECSSSCEEECSSCCEEEEEEE---CSSSEEEEEEEEEESCSHHHHHHHHHHHHHSSSSTTTTCCSHHHHHHHHHHHHHHH
T ss_pred eecCCCCCCCCCCCceEEEEE---CCCCEEEEEEEcCCCCHHHHHHHHHHHHHHHHHhhhccccchhhHHHHHHHHHHHH
Confidence 67799976 5999998864 245678999999999999999999999999875 2111 23467888888888
Q ss_pred HHHHHHHHHHHHhhh-----h-----------------------cccCCCCCCceEEEEEEecCeEEEEEcCCeEEEEEE
Q 005427 506 DVAFRNELDSLRKSK-----R-----------------------VVQKDWHPGCTAIAALIVRNRLFVANAGDCRAILCR 557 (697)
Q Consensus 506 ~~~~~~~~~~~~~~~-----~-----------------------~~~~~~~~GtT~~~~~i~~~~l~~anvGDSr~~l~~ 557 (697)
+..+........... . .......||||+++++|.++++|||||||||+|++|
T Consensus 102 d~~i~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~GtTav~~li~~~~l~vAnvGDSRa~l~r 181 (358)
T 2irm_A 102 EKGYFDSINPHVATKTAIQLHLSADGMNQYEISQQFENVLQKLDSLNNALSVGSSAVLALIHRSHLYLGNIGNCRALLCK 181 (358)
T ss_dssp HHHHHHHSHHHHHHHHHHHHTTC---------------CCCTHHHHHTTTTCEEEEEEEEEESSEEEEEEESSCEEEEEE
T ss_pred HHHHHHHHHhhhhccccccccccccccccccchhhccchhhhcccccCCCCCCCcEEEEEEECCEEEEEEcccCeEEEEE
Confidence 888865432111000 0 001233589999999999999999999999999999
Q ss_pred C---C--eeeecCCCCCCCCHHHHHHHHHcCCeeeeccCcceeCCCcceeccccCCCCCC--------------CCcccC
Q 005427 558 G---G--HPFALSRDHVASCLEERERVVSAGGNVNWQVDTWRVGPPALQVTRSIGDDDLK--------------PAVTAE 618 (697)
Q Consensus 558 ~---~--~~~~lt~dH~~~~~~e~~ri~~~g~~~~~~~~~~~~~~~~~~ltralG~~~~k--------------~~v~~~ 618 (697)
+ | ++++||+||+|.++.|++||.++|+.+. ..+++ ++.+||||||..+| ++++++
T Consensus 182 ~~~~g~~~~~~LT~DH~~~~~~E~~Ri~~~Gg~v~----~~r~~--g~llTRalGd~~~K~~~~~~~~~~~~~~~~v~~~ 255 (358)
T 2irm_A 182 TDEHDTLTVTQLSVDHNLLNAEEAARLFRLGLMAQ----NFEGV--PLYSTRCIGNYLGKAGYKDCNFLSSATAEPVIFE 255 (358)
T ss_dssp CCTTCSCEEEECSCCCBTTSHHHHHHHHTTTCCGG----GGTTC--TTCBSBCEECHHHHTTGGGSSSSTTCSSCSSBCC
T ss_pred ecCCCceeeEeCCCCCCCCCHHHHHHHHHcCCeEe----ccCcC--CEEcccCCcCHHHhccccccccccccCCCCEecc
Confidence 8 8 9999999999999999999999998653 24444 34499999997765 378999
Q ss_pred CceEE-EEeCCCCeEEEEEcCCcccCCC----------hHHHHHHHHhhc---CChhHHHHHHHHHHHh-----------
Q 005427 619 PEITE-TIMTPEDEYLVMASDGLWDVVS----------HVEAVGIIKDTV---KEPGMCSKRLATEAAE----------- 673 (697)
Q Consensus 619 p~v~~-~~l~~~d~~lvl~SDGl~d~~~----------~~ei~~~~~~~~---~~~~~~a~~L~~~a~~----------- 673 (697)
||+.. +.+.++|.|||||||||||+++ +++|++++.... .+++.+|+.|++.|++
T Consensus 256 Pdi~~~~~l~~~d~fllL~SDGl~d~l~~~~~~~~~~~~~ei~~~v~~~~~~~~~~~~~a~~Lv~~A~~~~~~~~~~~~~ 335 (358)
T 2irm_A 256 PEIVGGIQITPACRFLVLMSSGLCRALHEIFPGDASTGNRELVRMISEEFQNQSTLGGVAQSVVHRIVQAHHDTYMQLVE 335 (358)
T ss_dssp CEEEEEEECCTTEEEEEEECHHHHHHHHHHSCSSSSHHHHHHHHHHHHHTTTCCSHHHHHHHHHHHHHHHHHHHHHHHHS
T ss_pred CeEEEEEEeCCCCcEEEEECCCcccCccccccccccccHHHHHHHHHHHHhcCCCHHHHHHHHHHHHHHhhhhhhccccc
Confidence 99994 9999999999999999999999 999999998752 4899999999999977
Q ss_pred ----cC--CCCCcEEEEEEeCC
Q 005427 674 ----RG--SKDNITVIVVFLQP 689 (697)
Q Consensus 674 ----~g--~~DNiT~ivv~l~~ 689 (697)
+| +.||||||||+|..
T Consensus 336 ~~~~~Gg~~~DNiTvivv~~~~ 357 (358)
T 2irm_A 336 EHRSVTFNSRDDVTLLIRNFNY 357 (358)
T ss_dssp SSCCCCCCEECCEEEEEEESCC
T ss_pred cccccCCCCCCCeEEEEEeCCC
Confidence 46 88999999999975
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=376.08 Aligned_cols=266 Identities=27% Similarity=0.430 Sum_probs=219.3
Q ss_pred ccCCCCCCCcccccccccCCceEEEEEEE-------CCeeEEEEeccCCC-hHHHHHHHHHHHHHHhc-CCCCceEEeec
Q 005427 59 IPLHLPPSSYTLLSPIARGAESVVYEATL-------DGRKVAVKKPILST-SEELDNFHKELQLLCKL-DHPGLAKFVAA 129 (697)
Q Consensus 59 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~l~~~ 129 (697)
..++++.++|++.++||+|+||.||+|++ +++.||||++.... ....+.+.+|+.+|+++ +||||++++++
T Consensus 15 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~ 94 (359)
T 3vhe_A 15 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 94 (359)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeee
Confidence 35678889999999999999999999984 34789999876543 34467899999999999 79999999999
Q ss_pred cccCCc-eEEEEeecCCCCHhhhhhhcCC---------------------------------------------------
Q 005427 130 HAKPPN-YMFFFEFYESRNLAEKLHVEEW--------------------------------------------------- 157 (697)
Q Consensus 130 ~~~~~~-~~lv~e~~~~g~L~~~l~~~~~--------------------------------------------------- 157 (697)
+..+.. +++||||+.+|+|.+++.....
T Consensus 95 ~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (359)
T 3vhe_A 95 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLS 174 (359)
T ss_dssp ECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------------
T ss_pred eecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccc
Confidence 887654 8999999999999999976432
Q ss_pred --------------CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhcccc
Q 005427 158 --------------SPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNW 223 (697)
Q Consensus 158 --------------~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~ 223 (697)
.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 175 ~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~------- 247 (359)
T 3vhe_A 175 DVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP------- 247 (359)
T ss_dssp ---------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT-------
T ss_pred hhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccc-------
Confidence 18899999999999999999999999999999999999999999999999997553211
Q ss_pred cCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCCchhHHHHHHHHhccccHHHHHH
Q 005427 224 RSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTA 302 (697)
Q Consensus 224 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 302 (697)
.........||+.|+|||++.+..++.++|||||||++|+|++ |..||.+............
T Consensus 248 -------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~---------- 310 (359)
T 3vhe_A 248 -------DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK---------- 310 (359)
T ss_dssp -------TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHH----------
T ss_pred -------cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHH----------
Confidence 1112345678999999999999999999999999999999998 9999987653332222211
Q ss_pred HHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 005427 303 AVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH 355 (697)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~ 355 (697)
.+. . ...+..+++++.+++.+||+.||.+|||+.|++++|..+++.
T Consensus 311 ---~~~-~---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 311 ---EGT-R---MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp ---HTC-C---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---cCC-C---CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence 111 1 123456889999999999999999999999999999998764
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-44 Score=373.54 Aligned_cols=256 Identities=26% Similarity=0.359 Sum_probs=209.9
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccCCChH-HHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEee
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSE-ELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF 142 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 142 (697)
++|++.++||+|+||.||+|++ +++.||+|++...... ..+.+.+|+.+++.++||||+++++++.+....++||||
T Consensus 7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 86 (323)
T 3tki_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (323)
T ss_dssp TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEc
Confidence 6899999999999999999987 5889999987554332 346788999999999999999999999999999999999
Q ss_pred cCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhccc
Q 005427 143 YESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKN 222 (697)
Q Consensus 143 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 222 (697)
+.+|+|.+++.... .+++.+++.++.|++.||+|||+.||+||||||+|||++.++.+||+|||++..+.....
T Consensus 87 ~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~----- 160 (323)
T 3tki_A 87 CSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR----- 160 (323)
T ss_dssp CTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE-----
T ss_pred CCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCc-----
Confidence 99999999987554 689999999999999999999999999999999999999999999999999976542111
Q ss_pred ccCCCCCCCCccccccccCccccchhhhcccCC-CchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHHH
Q 005427 223 WRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIH-SEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLT 301 (697)
Q Consensus 223 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 301 (697)
........||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+............
T Consensus 161 ---------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~--------- 222 (323)
T 3tki_A 161 ---------ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK--------- 222 (323)
T ss_dssp ---------ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHH---------
T ss_pred ---------ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh---------
Confidence 112345689999999999987765 7789999999999999999999987543322111110
Q ss_pred HHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 302 AAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
.... .......+++++.+||.+||+.||.+|||+.|+++|.|+.
T Consensus 223 ----~~~~---~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~ 266 (323)
T 3tki_A 223 ----EKKT---YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN 266 (323)
T ss_dssp ----TTCT---TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTT
T ss_pred ----cccc---cCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhc
Confidence 0100 0111245889999999999999999999999999998874
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=358.52 Aligned_cols=255 Identities=21% Similarity=0.368 Sum_probs=216.4
Q ss_pred CCCCCCCcccccccccCCceEEEEEEECCeeEEEEeccCCC--hHHHHHHHHHHHHHHhcCCCCceEEeeccccC--Cce
Q 005427 61 LHLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILST--SEELDNFHKELQLLCKLDHPGLAKFVAAHAKP--PNY 136 (697)
Q Consensus 61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~ 136 (697)
..+..++|++.+.||+|+||.||+|+++++.||||++.... ....+.+.+|+.+++.++||||+++++++.++ ..+
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 84 (271)
T 3kmu_A 5 SGIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHP 84 (271)
T ss_dssp CCCCGGGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSC
T ss_pred CCCCHHHhHHHHHhcCCCcceEEEEEECCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCe
Confidence 34566799999999999999999999999999999876543 44567899999999999999999999999887 788
Q ss_pred EEEEeecCCCCHhhhhhhcCC-CCCHHHHHHHHHHHHHHHHHHHhCC--cccccCCCCceeecCCCCCeeeeeccchhhh
Q 005427 137 MFFFEFYESRNLAEKLHVEEW-SPSVDQVLMIAAQLAKALQYLHNLG--IVHRDVKPANVLLDRNLCPHLADFGLAEYRE 213 (697)
Q Consensus 137 ~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~ 213 (697)
++||||+++|+|.+++..... .+++.+++.++.|++.||.|||+.| |+||||||+|||++.++.++|+|||++....
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~ 164 (271)
T 3kmu_A 85 TLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ 164 (271)
T ss_dssp EEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred EeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeec
Confidence 999999999999999976543 4899999999999999999999999 9999999999999999999999999864322
Q ss_pred hhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCC---chhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHH
Q 005427 214 NLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHS---EKSDVYSFGISINELLTGVVPYTDLRAEAQAHTV 290 (697)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~ 290 (697)
.....||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.........+
T Consensus 165 ---------------------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~ 223 (271)
T 3kmu_A 165 ---------------------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKV 223 (271)
T ss_dssp ---------------------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHH
T ss_pred ---------------------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHH
Confidence 2345789999999999876544 4899999999999999999999876554443332
Q ss_pred HhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 005427 291 LEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL 353 (697)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~ 353 (697)
. ....++ ..+..+++++.+++.+||+.||.+|||+.++++.|..+.
T Consensus 224 ~--------------~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 224 A--------------LEGLRP---TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp H--------------HSCCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred H--------------hcCCCC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 2 222232 234578999999999999999999999999999888764
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-44 Score=377.59 Aligned_cols=256 Identities=25% Similarity=0.354 Sum_probs=211.5
Q ss_pred CCCCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCC---hHHHHHHHHHHHHHHhcCCCCceEEeeccccCCce
Q 005427 62 HLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST---SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNY 136 (697)
Q Consensus 62 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 136 (697)
.+..++|++++.||+|+||.||++++ +++.||+|++.... ......+.+|+.+|+.++||||+++++++.+...+
T Consensus 11 ~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 90 (384)
T 4fr4_A 11 DVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDM 90 (384)
T ss_dssp CCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 45567899999999999999999987 57889999864322 22356788999999999999999999999999999
Q ss_pred EEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhh
Q 005427 137 MFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLK 216 (697)
Q Consensus 137 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~ 216 (697)
++||||+.+|+|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 91 ~lv~e~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~- 168 (384)
T 4fr4_A 91 FMVVDLLLGGDLRYHLQQNV-HFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE- 168 (384)
T ss_dssp EEEECCCTTEEHHHHHHTTC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT-
T ss_pred EEEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCC-
Confidence 99999999999999997644 7899999999999999999999999999999999999999999999999999754321
Q ss_pred hhhcccccCCCCCCCCccccccccCccccchhhhcc---cCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhc
Q 005427 217 EISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK---EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEM 293 (697)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~ 293 (697)
......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||..........
T Consensus 169 ----------------~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~----- 227 (384)
T 4fr4_A 169 ----------------TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKE----- 227 (384)
T ss_dssp ----------------CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHH-----
T ss_pred ----------------CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHH-----
Confidence 12456789999999999974 458899999999999999999999997543221111
Q ss_pred cccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCC-HHHHHHHHHH
Q 005427 294 NYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPS-FSDIALELDL 351 (697)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt-~~ell~~l~~ 351 (697)
......... ...+..+++++.+||.+||+.||.+||+ ++++++|.|+
T Consensus 228 ------~~~~~~~~~-----~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f 275 (384)
T 4fr4_A 228 ------IVHTFETTV-----VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYM 275 (384)
T ss_dssp ------HHHHHHHCC-----CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGG
T ss_pred ------HHHHHhhcc-----cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhh
Confidence 111111111 1234578999999999999999999998 8888877765
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=387.05 Aligned_cols=254 Identities=23% Similarity=0.346 Sum_probs=217.1
Q ss_pred CCCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCCh---HHHHHHHHHHHHHHhcCCCCceEEeeccccCCceE
Q 005427 63 LPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTS---EELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYM 137 (697)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 137 (697)
+..++|.+.+.||+|+||.||+|++ +++.||||++..... .....+.+|+.+|+.++||||+++++++.++..++
T Consensus 13 ~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~ 92 (476)
T 2y94_A 13 VKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIF 92 (476)
T ss_dssp CEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred ceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 3456899999999999999999998 588999998653321 23567899999999999999999999999999999
Q ss_pred EEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhh
Q 005427 138 FFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKE 217 (697)
Q Consensus 138 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~ 217 (697)
+||||+.+|+|.+++...+ .+++.+++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 93 lv~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~-- 169 (476)
T 2y94_A 93 MVMEYVSGGELFDYICKNG-RLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-- 169 (476)
T ss_dssp EEEECCSSEEHHHHTTSSS-SCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTT--
T ss_pred EEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcccc--
Confidence 9999999999999997544 7899999999999999999999999999999999999999999999999999754321
Q ss_pred hhcccccCCCCCCCCccccccccCccccchhhhcccCC-CchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhcccc
Q 005427 218 ISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIH-SEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYT 296 (697)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~ 296 (697)
......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.........+....
T Consensus 170 ---------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-- 232 (476)
T 2y94_A 170 ---------------EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGI-- 232 (476)
T ss_dssp ---------------CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTC--
T ss_pred ---------------ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC--
Confidence 12345689999999999988765 789999999999999999999998866554444433221
Q ss_pred HHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 005427 297 EQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL 353 (697)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~ 353 (697)
. ..+..+++++.+||++||+.||.+|||+.++++|.|+..
T Consensus 233 ------------~-----~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~ 272 (476)
T 2y94_A 233 ------------F-----YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQ 272 (476)
T ss_dssp ------------C-----CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHT
T ss_pred ------------c-----CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhh
Confidence 1 123468899999999999999999999999999999853
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-44 Score=366.79 Aligned_cols=269 Identities=24% Similarity=0.261 Sum_probs=211.2
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccCCC--hHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEe
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST--SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFE 141 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 141 (697)
++|++.++||+|+||+||+|++ +++.||+|++.... ......+.+|+.+++.++||||+++++++.+...+++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 5899999999999999999998 57899999876443 3345778899999999999999999999999999999999
Q ss_pred ecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhcc
Q 005427 142 FYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLK 221 (697)
Q Consensus 142 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~ 221 (697)
|+.+ +|.+.+......+++.+++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 82 ~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~------ 154 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP------ 154 (292)
T ss_dssp CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSC------
T ss_pred cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCc------
Confidence 9986 677766665668999999999999999999999999999999999999999999999999999754321
Q ss_pred cccCCCCCCCCccccccccCccccchhhhcccC-CCchhhHHHHHHHHHHHHhCCCC-CCCchhHHHHHHHHhccccHHH
Q 005427 222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEI-HSEKSDVYSFGISINELLTGVVP-YTDLRAEAQAHTVLEMNYTEQQ 299 (697)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~~l~ell~g~~P-f~~~~~~~~~~~~~~~~~~~~~ 299 (697)
........||+.|+|||++.+.. ++.++|||||||++|+|++|..| |.+.........+.........
T Consensus 155 ----------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~ 224 (292)
T 3o0g_A 155 ----------VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTE 224 (292)
T ss_dssp ----------CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred ----------cccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCCh
Confidence 11234457899999999998765 79999999999999999987777 5555444444444332111100
Q ss_pred HHHHH--HhCCCC--------CcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 005427 300 LTAAV--VSGGLR--------PILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL 351 (697)
Q Consensus 300 ~~~~~--~~~~~~--------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~ 351 (697)
..+.. ...... .........+++++.+||.+||+.||.+|||++|+++|.|+
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f 286 (292)
T 3o0g_A 225 EQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF 286 (292)
T ss_dssp TTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred hhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCccc
Confidence 00000 000000 01111234588999999999999999999999999999876
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=372.26 Aligned_cols=266 Identities=26% Similarity=0.390 Sum_probs=219.0
Q ss_pred ccCCCCCCCcccccccccCCceEEEEEEE-------CCeeEEEEeccCCC-hHHHHHHHHHHHHHHhc-CCCCceEEeec
Q 005427 59 IPLHLPPSSYTLLSPIARGAESVVYEATL-------DGRKVAVKKPILST-SEELDNFHKELQLLCKL-DHPGLAKFVAA 129 (697)
Q Consensus 59 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~l~~~ 129 (697)
..++++.++|++.+.||+|+||.||+|++ .+..||+|++.... ....+.+.+|+.+|+++ +||||++++++
T Consensus 38 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 117 (344)
T 1rjb_A 38 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGA 117 (344)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cCcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 45778889999999999999999999986 34579999876442 23457899999999999 89999999999
Q ss_pred cccCCceEEEEeecCCCCHhhhhhhcCC----------------------CCCHHHHHHHHHHHHHHHHHHHhCCccccc
Q 005427 130 HAKPPNYMFFFEFYESRNLAEKLHVEEW----------------------SPSVDQVLMIAAQLAKALQYLHNLGIVHRD 187 (697)
Q Consensus 130 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~----------------------~~~~~~~~~i~~qi~~~l~~LH~~~ivHrD 187 (697)
+.....+++||||+++|+|.+++..... .+++.+++.++.|++.||.|||+.||+|||
T Consensus 118 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~D 197 (344)
T 1rjb_A 118 CTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRD 197 (344)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred EeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence 9999999999999999999999976542 378899999999999999999999999999
Q ss_pred CCCCceeecCCCCCeeeeeccchhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHH
Q 005427 188 VKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGIS 267 (697)
Q Consensus 188 lkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~ 267 (697)
|||+|||++.++.+||+|||++........ ........||+.|+|||++.+..++.++|||||||+
T Consensus 198 ikp~NIll~~~~~~kL~Dfg~~~~~~~~~~--------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i 263 (344)
T 1rjb_A 198 LAARNVLVTHGKVVKICDFGLARDIMSDSN--------------YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGIL 263 (344)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTT--------------SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHH
T ss_pred CChhhEEEcCCCcEEeCCCccCcccccCcc--------------ceeccCccCccCccCHHHhccCCCChhHhHHHHHHH
Confidence 999999999999999999999976543111 112334568899999999999999999999999999
Q ss_pred HHHHHh-CCCCCCCchhHHHHHHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHH
Q 005427 268 INELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIA 346 (697)
Q Consensus 268 l~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell 346 (697)
+|+|++ |..||.+............ ...++ ..+..+++++.+||.+||+.||.+|||+.+++
T Consensus 264 l~el~t~g~~p~~~~~~~~~~~~~~~--------------~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~ 326 (344)
T 1rjb_A 264 LWEIFSLGVNPYPGIPVDANFYKLIQ--------------NGFKM---DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLT 326 (344)
T ss_dssp HHHHTTTSCCSSTTCCCSHHHHHHHH--------------TTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HHHHHcCCCCCcccCCcHHHHHHHHh--------------cCCCC---CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHH
Confidence 999998 9999987654333222221 12222 22446899999999999999999999999999
Q ss_pred HHHHHHHHH
Q 005427 347 LELDLVLEH 355 (697)
Q Consensus 347 ~~l~~~~~~ 355 (697)
++|+.++..
T Consensus 327 ~~l~~~~~~ 335 (344)
T 1rjb_A 327 SFLGCQLAD 335 (344)
T ss_dssp HHHHHHC--
T ss_pred HHHHHHHHH
Confidence 999988654
|
| >2pnq_A [pyruvate dehydrogenase [lipoamide]]-phosphatase 1; pyruvate dehydrogenase phosphatase 1, catalytic subunit, PDP1C, hydrolase; 1.81A {Rattus norvegicus} PDB: 3n3c_A 3mq3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=377.84 Aligned_cols=259 Identities=29% Similarity=0.366 Sum_probs=200.3
Q ss_pred ccceEeeeccCC-CCCCCceeEEcccccCCCceEEEEEecCCCChHHHHHHHHHhHHHHHhcC-----------------
Q 005427 428 VLSWGSFATCGR-RETMEDTHFLMPHMYNQKEIHMFGIFDGHRGSAAAEFSARALPGFLQNLG----------------- 489 (697)
Q Consensus 428 ~~~~~~~s~~G~-R~~neD~~~~~~~~~~~~~~~~~~V~DG~GG~~~~~~as~~~~~~l~~~~----------------- 489 (697)
....++.|++|. |..|||++.+...+ ..+..+|||||||||+.+|++|++.++..|....
T Consensus 36 ~~v~~~~s~~g~~R~~nED~~~v~~~~--~~~~~lfgVfDGHGG~~aa~~as~~L~~~i~~~l~~~~~l~~~~~~~~~~~ 113 (467)
T 2pnq_A 36 SSILGFDSNRLPANAPIEDRRSATTCL--QTRGMLLGVFDGHAGCACSQAVSERLFYYIAVSLLPHETLLEIENAVESGR 113 (467)
T ss_dssp CSEEEEEEEEECCSSSCCEEEEEEEES--SSSCEEEEEEEEESSSHHHHHHHHHHHHHHHHHHCCHHHHHHHHTTTC---
T ss_pred cceEEEEeeccCCCCCCCCceeeeecc--CCCcEEEEEECCCCCHHHHHHHHHHHHHHHHHhhcchhhhhhhhhhhhccc
Confidence 344555667765 99999999875432 2356799999999999999999999998775310
Q ss_pred -------------------------------------------CCCChHHHHHHHHHHHHHHHHHHHHHHH---hhhhcc
Q 005427 490 -------------------------------------------STTRPTDALLEAFIRTDVAFRNELDSLR---KSKRVV 523 (697)
Q Consensus 490 -------------------------------------------~~~~~~~~l~~~~~~~~~~~~~~~~~~~---~~~~~~ 523 (697)
.......+|.++|.+++..+........ ......
T Consensus 114 ~~~~~l~~~~~~~~~~~~~~~~~y~~~~~~~~~~~~~~~~~~~~~~~~~~aL~~af~~~d~~i~~~~~~~~~~~~~~~~~ 193 (467)
T 2pnq_A 114 ALLPILQWHKHPNDYFSKEASKLYFNGLRTYWQELIDLNTGESADIDVKEALINAFKRLDNDISLEAQVGDPNSFLNYLV 193 (467)
T ss_dssp -CCCCEEECCCTTCCCCSTTHHHHHHHHHHHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHHHCCSSHHHHHHH
T ss_pred cccccccccccccccchhhhhhhhhcchhhhhhhhccccccccchhhHHHHHHHHHHHHHHHHHHhhhhccccccccccc
Confidence 0114667889999999988876532100 000000
Q ss_pred cCCCCCCceEEEEEEecCeEEEEEcCCeEEEEEE---CC--eeeecCCCCCCCCHHHHHHHHHcCCeeee--ccCcceeC
Q 005427 524 QKDWHPGCTAIAALIVRNRLFVANAGDCRAILCR---GG--HPFALSRDHVASCLEERERVVSAGGNVNW--QVDTWRVG 596 (697)
Q Consensus 524 ~~~~~~GtT~~~~~i~~~~l~~anvGDSr~~l~~---~~--~~~~lt~dH~~~~~~e~~ri~~~g~~~~~--~~~~~~~~ 596 (697)
.....||||+++++|.++++|||||||||||++| +| .+++||+||++.++.|++||.++|+.... .....|+.
T Consensus 194 ~~~~~~GtTa~v~li~~~~l~vAnvGDSRa~l~r~~~~g~~~~~~LT~DH~~~~~~E~~Ri~~~g~~~~~~~~~~~~Rv~ 273 (467)
T 2pnq_A 194 LRVAFSGATACVAHVDGVDLHVANTGDSRAMLGVQEEDGSWSAVTLSNDHNAQNERELQRLKLEHPKNEAKSVVKQDRLL 273 (467)
T ss_dssp HHHHHSEECEEEEEEETTEEEEEEESSCEEEEEEECTTSCEEEEECCCCCSTTCHHHHHHHHHTSCGGGHHHHBSSSSBT
T ss_pred ccCCCCcceEEEEEEECCEEEEEECCCceEEEEEecCCCcEEEEECCCCCCCCCHHHHHHHHHcCCCcccceeEecCccc
Confidence 1112489999999999999999999999999999 47 89999999999999999999999973211 00122443
Q ss_pred CCcceeccccCCCCCC---------------------------------CCcccCCceEEEEeCCCCeEEEEEcCCcccC
Q 005427 597 PPALQVTRSIGDDDLK---------------------------------PAVTAEPEITETIMTPEDEYLVMASDGLWDV 643 (697)
Q Consensus 597 ~~~~~ltralG~~~~k---------------------------------~~v~~~p~v~~~~l~~~d~~lvl~SDGl~d~ 643 (697)
+.+++||||||..+| ++++++|+|..+.+.++|.|||||||||||+
T Consensus 274 -G~l~vtRAlGd~~~K~~~~~~~~~~~~~~G~~~~~~~~~~~~~~~~~~p~v~~~Pdv~~~~l~~~D~fLVLaSDGLwd~ 352 (467)
T 2pnq_A 274 -GLLMPFRAFGDVKFKWSIDLQKRVIESGPDQLNDNEYTKFIPPNYHTPPYLTAEPEVTYHRLRPQDKFLVLATDGLWET 352 (467)
T ss_dssp -TTBSSSBCEECGGGTSCHHHHHHHHSSSCC-----------CTTCSSSCCCBCCCEEEEEECCTTEEEEEEECHHHHTT
T ss_pred -cccccchhcCchhhcccchhhhhhhcccccccccccccccccccccCCCcccccceEEEEEcCCCCeEEEEEecCcccc
Confidence 579999999999766 3489999999999999999999999999999
Q ss_pred CChHHHHHHHHhhcC-----Ch------------------------------hHHHHHHHHHHHhcC-------------
Q 005427 644 VSHVEAVGIIKDTVK-----EP------------------------------GMCSKRLATEAAERG------------- 675 (697)
Q Consensus 644 ~~~~ei~~~~~~~~~-----~~------------------------------~~~a~~L~~~a~~~g------------- 675 (697)
|+++|+++++..... +| +.+|..|++.|+.+|
T Consensus 353 ls~~eiv~iv~~~~~~~~~~~p~~~~~~~~~~~~~~~~l~~r~~~~~~~~~~~naA~~Lir~Al~~~~~Ge~~~~~~~~l 432 (467)
T 2pnq_A 353 MHRQDVVRIVGEYLTGMHHQQPIAVGGYKVTLGQMHGLLTERRAKMSSVFEDQNAATHLIRHAVGNNEFGAVDHERLSKM 432 (467)
T ss_dssp SCHHHHHHHHHHHHTTCSSCC-------------------------------CCHHHHHHHHHHC---------------
T ss_pred CChHHHHHHHHHHHhhccccCcccccccCccHHHHHHHHHHhhhcccCCchhhHHHHHHHHHHhcCCCcCcchHHHHHhh
Confidence 999999999987642 22 678999999999875
Q ss_pred ----------CCCCcEEEEEEeCC
Q 005427 676 ----------SKDNITVIVVFLQP 689 (697)
Q Consensus 676 ----------~~DNiT~ivv~l~~ 689 (697)
.+||||||||++.+
T Consensus 433 l~~~~~~~R~~~DdITViVv~~~~ 456 (467)
T 2pnq_A 433 LSLPEELARMYRDDITIIVVQFNS 456 (467)
T ss_dssp ----------CCSCEEEEEEEECH
T ss_pred hcCCccccccCCCCcEEEEEEeCc
Confidence 38999999999963
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=366.66 Aligned_cols=261 Identities=25% Similarity=0.342 Sum_probs=209.7
Q ss_pred CCCcccccccccCCceEEEEEEE--CCeeEEEEeccCC---ChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCc----
Q 005427 65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPN---- 135 (697)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~---- 135 (697)
.++|++.++||+|+||.||+|++ +++.||||++... .......+.+|+.+++.++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 46899999999999999999997 6889999987654 23445688999999999999999999999876554
Q ss_pred eEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhh
Q 005427 136 YMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL 215 (697)
Q Consensus 136 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~ 215 (697)
.++||||+++++|.+++...+ .+++.+++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 169 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS 169 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC------
T ss_pred cEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccccccc
Confidence 399999999999999997654 6899999999999999999999999999999999999999999999999999765431
Q ss_pred hhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccc
Q 005427 216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNY 295 (697)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~ 295 (697)
.. .........||+.|+|||++.+..++.++|||||||++|+|++|..||.+...............
T Consensus 170 ~~-------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~ 236 (311)
T 3ork_A 170 GN-------------SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDP 236 (311)
T ss_dssp -------------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCC
T ss_pred cc-------------ccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCC
Confidence 11 00123345799999999999999999999999999999999999999988765554443332211
Q ss_pred cHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 005427 296 TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE 354 (697)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~ 354 (697)
.+ .......+++++.++|.+||+.||.+||+..+++.+.+....
T Consensus 237 --------------~~-~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 237 --------------IP-PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp --------------CC-HHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred --------------CC-cccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence 11 112245689999999999999999999999888887776553
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=366.05 Aligned_cols=264 Identities=25% Similarity=0.391 Sum_probs=221.6
Q ss_pred cCCCCCCCcccccccccCCceEEEEEEE-------CCeeEEEEeccCC-ChHHHHHHHHHHHHHHhcCCCCceEEeeccc
Q 005427 60 PLHLPPSSYTLLSPIARGAESVVYEATL-------DGRKVAVKKPILS-TSEELDNFHKELQLLCKLDHPGLAKFVAAHA 131 (697)
Q Consensus 60 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~-------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~ 131 (697)
.+++..++|++.+.||+|+||.||+|.+ .++.||+|+.... .....+.+.+|+.+|+.++||||+++++++.
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 96 (314)
T 2ivs_A 17 KWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACS 96 (314)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred ccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEe
Confidence 4677788999999999999999999986 2378999987654 3455678999999999999999999999999
Q ss_pred cCCceEEEEeecCCCCHhhhhhhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccC
Q 005427 132 KPPNYMFFFEFYESRNLAEKLHVEE-----------------------WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDV 188 (697)
Q Consensus 132 ~~~~~~lv~e~~~~g~L~~~l~~~~-----------------------~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDl 188 (697)
+...+++||||+.+++|.+++.... ..+++.+++.++.|++.||.|||++||+||||
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~di 176 (314)
T 2ivs_A 97 QDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDL 176 (314)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred cCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCccccc
Confidence 9999999999999999999997643 23789999999999999999999999999999
Q ss_pred CCCceeecCCCCCeeeeeccchhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHH
Q 005427 189 KPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISI 268 (697)
Q Consensus 189 kp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l 268 (697)
||+|||++.++.+||+|||++........ ........+|+.|+|||++.+..++.++|||||||++
T Consensus 177 kp~NIli~~~~~~kl~Dfg~~~~~~~~~~--------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 242 (314)
T 2ivs_A 177 AARNILVAEGRKMKISDFGLSRDVYEEDS--------------YVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLL 242 (314)
T ss_dssp SGGGEEEETTTEEEECCCTTCEECTTTSC--------------EECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHH
T ss_pred chheEEEcCCCCEEEcccccccccccccc--------------ceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHH
Confidence 99999999999999999999875542111 0112344678899999999999999999999999999
Q ss_pred HHHHh-CCCCCCCchhHHHHHHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005427 269 NELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIAL 347 (697)
Q Consensus 269 ~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 347 (697)
|+|++ |..||.+.........+.. + .. ...+..+++++.+++.+||+.||.+|||+.++++
T Consensus 243 ~el~t~g~~p~~~~~~~~~~~~~~~--------------~-~~---~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~ 304 (314)
T 2ivs_A 243 WEIVTLGGNPYPGIPPERLFNLLKT--------------G-HR---MERPDNCSEEMYRLMLQCWKQEPDKRPVFADISK 304 (314)
T ss_dssp HHHHTTSCCSSTTCCGGGHHHHHHT--------------T-CC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHhCCCCCCCCCCHHHHHHHhhc--------------C-Cc---CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 99999 9999987654433322211 1 11 1234578999999999999999999999999999
Q ss_pred HHHHHHHH
Q 005427 348 ELDLVLEH 355 (697)
Q Consensus 348 ~l~~~~~~ 355 (697)
+|..++..
T Consensus 305 ~l~~~~~~ 312 (314)
T 2ivs_A 305 DLEKMMVK 312 (314)
T ss_dssp HHHHHHHT
T ss_pred HHHHHHhh
Confidence 99998764
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=368.21 Aligned_cols=268 Identities=19% Similarity=0.264 Sum_probs=216.1
Q ss_pred CCCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCChHHHHHHHHHHHHHHhc-CCCCceEEeeccccCCceEEE
Q 005427 63 LPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKL-DHPGLAKFVAAHAKPPNYMFF 139 (697)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv 139 (697)
+..++|++.+.||+|+||.||+|++ +++.||||+...... .+.+.+|+.+++.+ +||||+++++++......++|
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv 83 (330)
T 2izr_A 6 MVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMV 83 (330)
T ss_dssp EETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEE
T ss_pred EEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEE
Confidence 3457899999999999999999996 689999998654432 34578999999999 999999999999999999999
Q ss_pred EeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCC-----Ceeeeeccchhhhh
Q 005427 140 FEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLC-----PHLADFGLAEYREN 214 (697)
Q Consensus 140 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~-----~kL~Dfg~a~~~~~ 214 (697)
|||+ +++|.+++......+++.+++.++.|++.||+|||+.||+||||||+|||++.++. +||+|||++..+..
T Consensus 84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~ 162 (330)
T 2izr_A 84 LELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYID 162 (330)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBC
T ss_pred EEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeec
Confidence 9999 89999999876668999999999999999999999999999999999999998876 99999999976543
Q ss_pred hhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHH---HHHHH
Q 005427 215 LKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQ---AHTVL 291 (697)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~---~~~~~ 291 (697)
..... ...........||+.|+|||++.+..++.++|||||||++|||++|..||.+...... ...+.
T Consensus 163 ~~~~~---------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~ 233 (330)
T 2izr_A 163 PETKK---------HIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIG 233 (330)
T ss_dssp TTTCC---------BCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHH
T ss_pred CCCCc---------cccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHH
Confidence 21110 0001123456899999999999999999999999999999999999999987533222 12211
Q ss_pred hccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhc
Q 005427 292 EMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHRK 357 (697)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~~~ 357 (697)
.... ..........+| ++.+++..||+.||.+||++.+|++.+..+.+...
T Consensus 234 ~~~~--------------~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~ 284 (330)
T 2izr_A 234 DTKR--------------ATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKG 284 (330)
T ss_dssp HHHH--------------HSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred hhhc--------------cCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcC
Confidence 1110 001111223466 99999999999999999999999999988876543
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-44 Score=383.61 Aligned_cols=260 Identities=21% Similarity=0.276 Sum_probs=216.9
Q ss_pred CCCCCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCCh---HHHHHHHHHHHHHHhcCCCCceEEeeccccCCc
Q 005427 61 LHLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTS---EELDNFHKELQLLCKLDHPGLAKFVAAHAKPPN 135 (697)
Q Consensus 61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 135 (697)
+.+..++|+++++||+|+||.||+|++ +++.||+|++..... .....+.+|+.+|+.++||||+++++++.+...
T Consensus 64 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 143 (410)
T 3v8s_A 64 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 143 (410)
T ss_dssp HSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE
Confidence 345567899999999999999999998 578899998643211 112357899999999999999999999999999
Q ss_pred eEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhh
Q 005427 136 YMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL 215 (697)
Q Consensus 136 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~ 215 (697)
+|+||||++||+|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 144 ~~lV~E~~~gg~L~~~l~~~--~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~ 221 (410)
T 3v8s_A 144 LYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE 221 (410)
T ss_dssp EEEEECCCTTEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEEeCCCCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccC
Confidence 99999999999999998654 5899999999999999999999999999999999999999999999999999755321
Q ss_pred hhhhcccccCCCCCCCCccccccccCccccchhhhcccC----CCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHH
Q 005427 216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEI----HSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVL 291 (697)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~ 291 (697)
. .....+.+||+.|+|||++.+.. ++.++|||||||++|||++|..||.+.+.......+.
T Consensus 222 ~---------------~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~ 286 (410)
T 3v8s_A 222 G---------------MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 286 (410)
T ss_dssp S---------------EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred C---------------cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHH
Confidence 1 11234678999999999998765 7889999999999999999999999877666665554
Q ss_pred hccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCC--CCCHHHHHHHHHHH
Q 005427 292 EMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHN--RPSFSDIALELDLV 352 (697)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~--Rpt~~ell~~l~~~ 352 (697)
..... ...+ ....+|+++.+||++||+.+|.+ ||+++||++|.|+-
T Consensus 287 ~~~~~--------------~~~p-~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~ 334 (410)
T 3v8s_A 287 NHKNS--------------LTFP-DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFK 334 (410)
T ss_dssp THHHH--------------CCCC-TTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGC
T ss_pred hcccc--------------ccCC-CcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCcccc
Confidence 32110 0011 12368999999999999999988 99999999998873
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=379.58 Aligned_cols=283 Identities=22% Similarity=0.272 Sum_probs=215.9
Q ss_pred CCCCCCCcccccccccC--CceEEEEEEE--CCeeEEEEeccCC--ChHHHHHHHHHHHHHHhcCCCCceEEeeccccCC
Q 005427 61 LHLPPSSYTLLSPIARG--AESVVYEATL--DGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPP 134 (697)
Q Consensus 61 ~~~~~~~y~~~~~lg~G--~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 134 (697)
+....++|+++++||+| +||.||+|++ +++.||||++... .....+.+.+|+.+|+.++||||+++++++.+..
T Consensus 20 ~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 99 (389)
T 3gni_B 20 FLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN 99 (389)
T ss_dssp CCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred ccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECC
Confidence 34456789999999999 9999999998 4889999986543 3445678899999999999999999999999999
Q ss_pred ceEEEEeecCCCCHhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhh
Q 005427 135 NYMFFFEFYESRNLAEKLHVE-EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRE 213 (697)
Q Consensus 135 ~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~ 213 (697)
.+++||||+.+|+|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~ 179 (389)
T 3gni_B 100 ELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMI 179 (389)
T ss_dssp EEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred EEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence 999999999999999998764 2468999999999999999999999999999999999999999999999999886543
Q ss_pred hhhhhhcccccCCCCCCCCccccccccCccccchhhhcc--cCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHH
Q 005427 214 NLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK--EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVL 291 (697)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~ 291 (697)
...... ...........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+.
T Consensus 180 ~~~~~~---------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~ 250 (389)
T 3gni_B 180 SHGQRQ---------RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKL 250 (389)
T ss_dssp ETTEEC---------SCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-
T ss_pred cccccc---------cccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHh
Confidence 211100 001112334579999999999987 678999999999999999999999998765544443332
Q ss_pred hccccHHH---------HH-------------HHHHhCC-----CCCcccccccCChHHHHHHHHHhccCCCCCCCCHHH
Q 005427 292 EMNYTEQQ---------LT-------------AAVVSGG-----LRPILASLELGLPASILSLIQRCWDGNPHNRPSFSD 344 (697)
Q Consensus 292 ~~~~~~~~---------~~-------------~~~~~~~-----~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~e 344 (697)
........ .. ....... ........+..+++++.+||.+||+.||.+|||+.|
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e 330 (389)
T 3gni_B 251 NGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSAST 330 (389)
T ss_dssp -------------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHH
T ss_pred cCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHH
Confidence 22111000 00 0000000 000011234568899999999999999999999999
Q ss_pred HHHHHHHH
Q 005427 345 IALELDLV 352 (697)
Q Consensus 345 ll~~l~~~ 352 (697)
+++|.|+-
T Consensus 331 ll~hp~f~ 338 (389)
T 3gni_B 331 LLNHSFFK 338 (389)
T ss_dssp HTTSGGGG
T ss_pred HhcCHHHH
Confidence 99998874
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=368.97 Aligned_cols=273 Identities=28% Similarity=0.426 Sum_probs=220.0
Q ss_pred CCCCCCcccccccccCCceEEEEEEE-CCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEE
Q 005427 62 HLPPSSYTLLSPIARGAESVVYEATL-DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFF 140 (697)
Q Consensus 62 ~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 140 (697)
....++|++.+.||+|+||.||+|++ +++.||||+.........+.+.+|+.+|+.++||||+++++++.+....++||
T Consensus 35 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 114 (321)
T 2qkw_B 35 EEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIY 114 (321)
T ss_dssp CCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEE
T ss_pred HHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEE
Confidence 34557899999999999999999997 57899999877666667788999999999999999999999999999999999
Q ss_pred eecCCCCHhhhhhhcC---CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhh
Q 005427 141 EFYESRNLAEKLHVEE---WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKE 217 (697)
Q Consensus 141 e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~ 217 (697)
||+.+|+|.+++.... ..+++.+++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 115 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 193 (321)
T 2qkw_B 115 KYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELD- 193 (321)
T ss_dssp ECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSS-
T ss_pred EcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccccccccc-
Confidence 9999999999986543 358999999999999999999999999999999999999999999999999986543211
Q ss_pred hhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccH
Q 005427 218 ISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTE 297 (697)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~ 297 (697)
.........||+.|+|||++.+..++.++|||||||++|+|++|..||.+........... .
T Consensus 194 -------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~-~---- 255 (321)
T 2qkw_B 194 -------------QTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAE-W---- 255 (321)
T ss_dssp -------------CCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHH-H----
T ss_pred -------------ccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHH-H----
Confidence 1112234569999999999999999999999999999999999999997643322111000 0
Q ss_pred HHHHHHHHhCCCC----Cc-ccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 005427 298 QQLTAAVVSGGLR----PI-LASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH 355 (697)
Q Consensus 298 ~~~~~~~~~~~~~----~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~ 355 (697)
.......+... +. ....+..++..+.+++.+||+.||++|||+.|++++|+.+++.
T Consensus 256 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 256 --AVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp --THHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred --hhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 00001111111 11 1122334678899999999999999999999999999988754
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=368.97 Aligned_cols=261 Identities=22% Similarity=0.382 Sum_probs=210.8
Q ss_pred CCCCCCcccccccccCCceEEEEEEE--CCe----eEEEEeccCCC-hHHHHHHHHHHHHHHhcCCCCceEEeeccccCC
Q 005427 62 HLPPSSYTLLSPIARGAESVVYEATL--DGR----KVAVKKPILST-SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPP 134 (697)
Q Consensus 62 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 134 (697)
.+..++|++.++||+|+||.||+|++ +++ +||+|.+.... ......+.+|+.++++++||||+++++++...
T Consensus 11 ~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~- 89 (327)
T 3poz_A 11 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS- 89 (327)
T ss_dssp ECCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-
T ss_pred hcCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-
Confidence 45567899999999999999999987 333 36888754332 23457899999999999999999999999875
Q ss_pred ceEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhh
Q 005427 135 NYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYREN 214 (697)
Q Consensus 135 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~ 214 (697)
..++++||+.+|+|.+++......+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 90 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 169 (327)
T 3poz_A 90 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp SEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred CeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence 47899999999999999988777899999999999999999999999999999999999999999999999999986643
Q ss_pred hhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCCchhHHHHHHHHhc
Q 005427 215 LKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEM 293 (697)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~~~~~~~~~~~~~~ 293 (697)
... ........||+.|+|||++.+..++.++|||||||++|||++ |..||.+.........+..
T Consensus 170 ~~~--------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~- 234 (327)
T 3poz_A 170 EEK--------------EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK- 234 (327)
T ss_dssp TCC---------------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT-
T ss_pred Ccc--------------cccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHc-
Confidence 111 112234467889999999999999999999999999999999 9999987654433222211
Q ss_pred cccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 005427 294 NYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH 355 (697)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~ 355 (697)
+. ++ ..+..++.++.+++.+||+.||.+|||+.+++++|..+...
T Consensus 235 -------------~~-~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 235 -------------GE-RL---PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp -------------TC-CC---CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred -------------CC-CC---CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 11 11 12346889999999999999999999999999999888653
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=358.64 Aligned_cols=255 Identities=25% Similarity=0.325 Sum_probs=216.6
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEeec
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFY 143 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 143 (697)
++|++.++||+|+||.||+|.+ ++..+|+|++........+.+.+|+.+++.++||||+++++++.+....++||||+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELC 88 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEecc
Confidence 5799999999999999999998 46689999876554455678999999999999999999999999999999999999
Q ss_pred CCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceee---cCCCCCeeeeeccchhhhhhhhhhc
Q 005427 144 ESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLL---DRNLCPHLADFGLAEYRENLKEISL 220 (697)
Q Consensus 144 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill---~~~~~~kL~Dfg~a~~~~~~~~~~~ 220 (697)
.+++|.+++.... .+++.+++.++.|++.||.|||++||+||||||+|||+ +.++.+||+|||++.......
T Consensus 89 ~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~---- 163 (277)
T 3f3z_A 89 TGGELFERVVHKR-VFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK---- 163 (277)
T ss_dssp CSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS----
T ss_pred CCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc----
Confidence 9999999987654 68999999999999999999999999999999999999 788999999999986543211
Q ss_pred ccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHH
Q 005427 221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQL 300 (697)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 300 (697)
......||+.|+|||++.+. ++.++||||||+++|+|++|..||.+.........+......
T Consensus 164 -------------~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~---- 225 (277)
T 3f3z_A 164 -------------MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFT---- 225 (277)
T ss_dssp -------------CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC----
T ss_pred -------------chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCC----
Confidence 23445799999999998765 789999999999999999999999887665554444332221
Q ss_pred HHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 005427 301 TAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE 354 (697)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~ 354 (697)
........+++++.+||.+||+.||.+|||+.++++|.|+...
T Consensus 226 -----------~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~ 268 (277)
T 3f3z_A 226 -----------FPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQ 268 (277)
T ss_dssp -----------CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHH
T ss_pred -----------CCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcc
Confidence 1112234688999999999999999999999999999998654
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-44 Score=371.46 Aligned_cols=271 Identities=23% Similarity=0.297 Sum_probs=200.9
Q ss_pred CCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCCh-HHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEe
Q 005427 65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTS-EELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFE 141 (697)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 141 (697)
.++|+++++||+|+||.||+|.+ +++.||+|++..... ...+.+.+|+.+|+.++||||+++++++.+++.+++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 35899999999999999999987 588999998765432 234678899999999999999999999999999999999
Q ss_pred ecCCCCHhhhhhhcC-----CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhh
Q 005427 142 FYESRNLAEKLHVEE-----WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLK 216 (697)
Q Consensus 142 ~~~~g~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~ 216 (697)
|+. |+|.+++.... ..+++..++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 162 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPV 162 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTSCC
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCCCc
Confidence 998 59999886532 358899999999999999999999999999999999999999999999999997543210
Q ss_pred hhhcccccCCCCCCCCccccccccCccccchhhhcc-cCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccc
Q 005427 217 EISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNY 295 (697)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~ 295 (697)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+.....
T Consensus 163 ----------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~ 226 (317)
T 2pmi_A 163 ----------------NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMG 226 (317)
T ss_dssp ----------------CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred ----------------ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence 01234578999999999986 4689999999999999999999999998776665555543211
Q ss_pred cHHHHHHH-H-HhCCCCCc-------------ccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 296 TEQQLTAA-V-VSGGLRPI-------------LASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 296 ~~~~~~~~-~-~~~~~~~~-------------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
......+. . ....+.+. .+..+..++.++.+||.+||+.||++|||+.|+++|.|+.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~ 298 (317)
T 2pmi_A 227 TPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFA 298 (317)
T ss_dssp SCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGG
T ss_pred CCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhh
Confidence 10000000 0 00000000 0112336789999999999999999999999999988864
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=364.12 Aligned_cols=268 Identities=26% Similarity=0.420 Sum_probs=217.3
Q ss_pred ccCCCCCCCcccccccccCCceEEEEEEEC------CeeEEEEeccCCC-hHHHHHHHHHHHHHHhcCCCCceEEeeccc
Q 005427 59 IPLHLPPSSYTLLSPIARGAESVVYEATLD------GRKVAVKKPILST-SEELDNFHKELQLLCKLDHPGLAKFVAAHA 131 (697)
Q Consensus 59 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~ 131 (697)
...++..++|++.+.||+|+||.||+|.+. +..||+|.+.... ......+.+|+.+++.++||||+++++++.
T Consensus 37 ~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 116 (333)
T 1mqb_A 37 FTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS 116 (333)
T ss_dssp -CCBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred ccccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEe
Confidence 345678899999999999999999999763 2359999876543 344667999999999999999999999999
Q ss_pred cCCceEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchh
Q 005427 132 KPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEY 211 (697)
Q Consensus 132 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~ 211 (697)
+....++||||+.+|+|.+++......+++.+++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||++..
T Consensus 117 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 196 (333)
T 1mqb_A 117 KYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRV 196 (333)
T ss_dssp SSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred cCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchh
Confidence 99999999999999999999987766899999999999999999999999999999999999999999999999999976
Q ss_pred hhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCCchhHHHHHHH
Q 005427 212 RENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTV 290 (697)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~~~~~~~~~~~ 290 (697)
....... ........+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.........+
T Consensus 197 ~~~~~~~-------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~ 263 (333)
T 1mqb_A 197 LEDDPEA-------------TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI 263 (333)
T ss_dssp ---------------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH
T ss_pred hcccccc-------------ccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHH
Confidence 5432110 011223456889999999999999999999999999999999 99999876554433322
Q ss_pred HhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhc
Q 005427 291 LEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHRK 357 (697)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~~~ 357 (697)
.. + .++ ..+..++..+.+++.+||+.||.+||++.+++++|+.+.....
T Consensus 264 ~~--------------~-~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~ 312 (333)
T 1mqb_A 264 ND--------------G-FRL---PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 312 (333)
T ss_dssp HT--------------T-CCC---CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred HC--------------C-CcC---CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcch
Confidence 21 1 111 1234689999999999999999999999999999999886543
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-43 Score=363.03 Aligned_cols=266 Identities=26% Similarity=0.391 Sum_probs=222.5
Q ss_pred ccCCCCCCCcccccccccCCceEEEEEEE-------CCeeEEEEeccCCC-hHHHHHHHHHHHHHHhc-CCCCceEEeec
Q 005427 59 IPLHLPPSSYTLLSPIARGAESVVYEATL-------DGRKVAVKKPILST-SEELDNFHKELQLLCKL-DHPGLAKFVAA 129 (697)
Q Consensus 59 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~l~~~ 129 (697)
..++++.++|++.+.||+|+||.||+|++ .++.||+|+..... ....+.+.+|+.+|+++ +||||++++++
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 95 (313)
T 1t46_A 16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGA 95 (313)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEE
Confidence 34678888999999999999999999985 35789999876543 34567899999999999 99999999999
Q ss_pred cccCCceEEEEeecCCCCHhhhhhhcCC-----------------CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCc
Q 005427 130 HAKPPNYMFFFEFYESRNLAEKLHVEEW-----------------SPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPAN 192 (697)
Q Consensus 130 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~-----------------~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~N 192 (697)
+..+...++||||+++|+|.+++..... .+++.+++.++.|++.||.|||+.||+||||||+|
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~N 175 (313)
T 1t46_A 96 CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN 175 (313)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred EecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccce
Confidence 9999999999999999999999976542 48999999999999999999999999999999999
Q ss_pred eeecCCCCCeeeeeccchhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHH
Q 005427 193 VLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELL 272 (697)
Q Consensus 193 ill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell 272 (697)
||++.++.+||+|||++........ ........||+.|+|||++.+..++.++||||||+++|+|+
T Consensus 176 il~~~~~~~kl~Dfg~~~~~~~~~~--------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell 241 (313)
T 1t46_A 176 ILLTHGRITKICDFGLARDIKNDSN--------------YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF 241 (313)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTT--------------SEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred EEEcCCCCEEEcccccccccccccc--------------ceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHH
Confidence 9999999999999999976543111 11123456788999999999999999999999999999999
Q ss_pred h-CCCCCCCchhHHHHHHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 005427 273 T-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL 351 (697)
Q Consensus 273 ~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~ 351 (697)
+ |..||.+............ ...++ ..+..+++++.+++.+||+.||.+|||+.+++++|..
T Consensus 242 t~g~~p~~~~~~~~~~~~~~~--------------~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 304 (313)
T 1t46_A 242 SLGSSPYPGMPVDSKFYKMIK--------------EGFRM---LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304 (313)
T ss_dssp TTTCCSSTTCCSSHHHHHHHH--------------HTCCC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred hCCCCCCCcccchhHHHHHhc--------------cCCCC---CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHH
Confidence 9 9999987654333222221 11111 1234688999999999999999999999999999998
Q ss_pred HHHH
Q 005427 352 VLEH 355 (697)
Q Consensus 352 ~~~~ 355 (697)
++..
T Consensus 305 ~~~~ 308 (313)
T 1t46_A 305 QISE 308 (313)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 8764
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=367.42 Aligned_cols=252 Identities=22% Similarity=0.352 Sum_probs=214.8
Q ss_pred CcccccccccCCceEEEEEEE--CCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEeecC
Q 005427 67 SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYE 144 (697)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~ 144 (697)
.|...++||+|+||.||+|++ +++.||||++........+.+.+|+.+++.++||||+++++++......++||||+.
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 125 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQ 125 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCC
Confidence 478888999999999999987 588999998776665567789999999999999999999999999999999999999
Q ss_pred CCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhccccc
Q 005427 145 SRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWR 224 (697)
Q Consensus 145 ~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~ 224 (697)
+++|.+++... .+++.+++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 126 ~~~L~~~l~~~--~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-------- 195 (321)
T 2c30_A 126 GGALTDIVSQV--RLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-------- 195 (321)
T ss_dssp SCBHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS--------
T ss_pred CCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCc--------
Confidence 99999998643 68999999999999999999999999999999999999999999999999986543210
Q ss_pred CCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHHHHHH
Q 005427 225 SSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAV 304 (697)
Q Consensus 225 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (697)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.........+...
T Consensus 196 --------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~----------- 256 (321)
T 2c30_A 196 --------PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS----------- 256 (321)
T ss_dssp --------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS-----------
T ss_pred --------cccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-----------
Confidence 1134567999999999999999999999999999999999999999876554433332211
Q ss_pred HhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 305 VSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
..+.+. .+..+++++.++|.+||+.||++|||+.++++|+|..
T Consensus 257 ----~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~ 299 (321)
T 2c30_A 257 ----PPPKLK-NSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLL 299 (321)
T ss_dssp ----SCCCCT-TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGG
T ss_pred ----CCCCcC-ccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhc
Confidence 111111 1335789999999999999999999999999998875
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-44 Score=389.10 Aligned_cols=267 Identities=22% Similarity=0.291 Sum_probs=208.3
Q ss_pred CCCcccccccccCCceEEEEEEE--CCeeEEEEeccCC--ChHHHHHHHHHHHHHHhcCCCCceEEeeccccC------C
Q 005427 65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKP------P 134 (697)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~------~ 134 (697)
.++|+++++||+|+||+||+|.+ +++.||||++... .......+.+|+.+|+.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 36899999999999999999987 5889999987543 445567889999999999999999999998655 3
Q ss_pred ceEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhh
Q 005427 135 NYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYREN 214 (697)
Q Consensus 135 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~ 214 (697)
.+|+||||+.+ +|.+.+.. .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 141 ~~~lv~E~~~~-~l~~~~~~---~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 216 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 216 (464)
T ss_dssp EEEEEEECCSE-EHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----
T ss_pred eEEEEEeCCCC-CHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCC
Confidence 56999999986 56666643 488999999999999999999999999999999999999999999999999975432
Q ss_pred hhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhcc
Q 005427 215 LKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMN 294 (697)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~ 294 (697)
. ......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+...+...+.+..
T Consensus 217 ~-----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~l 279 (464)
T 3ttj_A 217 S-----------------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQL 279 (464)
T ss_dssp C-----------------CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred C-----------------cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 1 12345689999999999999999999999999999999999999999988777776665532
Q ss_pred ccHHHH--------HHHHHhCCCC-C--ccccc-c-----------cCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 005427 295 YTEQQL--------TAAVVSGGLR-P--ILASL-E-----------LGLPASILSLIQRCWDGNPHNRPSFSDIALELDL 351 (697)
Q Consensus 295 ~~~~~~--------~~~~~~~~~~-~--~~~~~-~-----------~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~ 351 (697)
...... .......... . .++.. + ...++++.+||.+||+.||++|||++|+++|+|+
T Consensus 280 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~ 359 (464)
T 3ttj_A 280 GTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 359 (464)
T ss_dssp CSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTT
T ss_pred CCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhh
Confidence 221110 0011111000 0 00000 0 0126789999999999999999999999999987
Q ss_pred H
Q 005427 352 V 352 (697)
Q Consensus 352 ~ 352 (697)
.
T Consensus 360 ~ 360 (464)
T 3ttj_A 360 N 360 (464)
T ss_dssp G
T ss_pred h
Confidence 4
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=361.94 Aligned_cols=270 Identities=21% Similarity=0.282 Sum_probs=219.9
Q ss_pred CCCCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCChHHHHHHHHHHHHHHhc-CCCCceEEeeccccCCceEE
Q 005427 62 HLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKL-DHPGLAKFVAAHAKPPNYMF 138 (697)
Q Consensus 62 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~l 138 (697)
.+..++|++.+.||+|+||.||+|.+ +++.||||++.... ..+.+.+|+.+++.+ +|||++++++++......++
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~l 83 (298)
T 1csn_A 6 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL 83 (298)
T ss_dssp CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred cccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEE
Confidence 34567899999999999999999996 68999999865332 334578999999999 79999999999999999999
Q ss_pred EEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCC-----Ceeeeeccchhhh
Q 005427 139 FFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLC-----PHLADFGLAEYRE 213 (697)
Q Consensus 139 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~-----~kL~Dfg~a~~~~ 213 (697)
||||+ +++|.+++...+..+++.+++.++.|++.||+|||++||+||||||+|||++.++. +||+|||++....
T Consensus 84 v~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~ 162 (298)
T 1csn_A 84 VIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 162 (298)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred EEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccc
Confidence 99999 89999999877667999999999999999999999999999999999999987765 9999999997654
Q ss_pred hhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhH---HHHHHH
Q 005427 214 NLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAE---AQAHTV 290 (697)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~---~~~~~~ 290 (697)
...... ...........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.... .....+
T Consensus 163 ~~~~~~---------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 233 (298)
T 1csn_A 163 DPVTKQ---------HIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI 233 (298)
T ss_dssp CTTTCC---------BCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHH
T ss_pred cccccc---------cccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHH
Confidence 321100 00111234568999999999999999999999999999999999999999874322 111111
Q ss_pred HhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhc
Q 005427 291 LEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHRK 357 (697)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~~~ 357 (697)
... ...+..+.....+|+++.+++.+||+.||++|||+.+|++.|..+.+...
T Consensus 234 ~~~--------------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~ 286 (298)
T 1csn_A 234 GEK--------------KQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN 286 (298)
T ss_dssp HHH--------------HHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred Hhh--------------ccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcC
Confidence 111 01122223345789999999999999999999999999999999887543
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=367.21 Aligned_cols=266 Identities=25% Similarity=0.436 Sum_probs=206.1
Q ss_pred cCCCCCCCcccccccccCCceEEEEEEEC--Ce---eEEEEeccCC--ChHHHHHHHHHHHHHHhcCCCCceEEeecccc
Q 005427 60 PLHLPPSSYTLLSPIARGAESVVYEATLD--GR---KVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAK 132 (697)
Q Consensus 60 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~---~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 132 (697)
...+..++|++.+.||+|+||.||+|++. +. .||||++... .....+.+.+|+.+++.++||||+++++++..
T Consensus 17 ~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 96 (323)
T 3qup_A 17 DVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLR 96 (323)
T ss_dssp TTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEEC
T ss_pred hcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeec
Confidence 34567789999999999999999999863 22 7999986544 34557789999999999999999999999987
Q ss_pred CCce------EEEEeecCCCCHhhhhhhcC-----CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCC
Q 005427 133 PPNY------MFFFEFYESRNLAEKLHVEE-----WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCP 201 (697)
Q Consensus 133 ~~~~------~lv~e~~~~g~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~ 201 (697)
.... ++||||+.+|+|.+++.... ..+++.+++.++.|++.||.|||++||+||||||+|||++.++.+
T Consensus 97 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~ 176 (323)
T 3qup_A 97 SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTV 176 (323)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCE
T ss_pred cccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCE
Confidence 7655 99999999999999986432 258999999999999999999999999999999999999999999
Q ss_pred eeeeeccchhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 005427 202 HLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTD 280 (697)
Q Consensus 202 kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~ 280 (697)
||+|||++......... .......+++.|+|||++.+..++.++|||||||++|+|++ |..||.+
T Consensus 177 kl~Dfg~a~~~~~~~~~--------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~ 242 (323)
T 3qup_A 177 CVADFGLSRKIYSGDYY--------------RQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAG 242 (323)
T ss_dssp EECCCCC-------------------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred EEeeccccccccccccc--------------cccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccc
Confidence 99999999765432110 01223457889999999999999999999999999999999 9999988
Q ss_pred chhHHHHHHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhc
Q 005427 281 LRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHRK 357 (697)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~~~ 357 (697)
.........+.. +. . ...+..+++++.+|+.+||+.||.+|||+.++++.+..++.+..
T Consensus 243 ~~~~~~~~~~~~--------------~~-~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~ 301 (323)
T 3qup_A 243 IENAEIYNYLIG--------------GN-R---LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLS 301 (323)
T ss_dssp CCGGGHHHHHHT--------------TC-C---CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred cChHHHHHHHhc--------------CC-C---CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhh
Confidence 665544333322 11 1 12245688999999999999999999999999999999987644
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=368.91 Aligned_cols=279 Identities=25% Similarity=0.367 Sum_probs=222.7
Q ss_pred CCCCCCcccccccccCCceEEEEEEE------CCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccc--cC
Q 005427 62 HLPPSSYTLLSPIARGAESVVYEATL------DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHA--KP 133 (697)
Q Consensus 62 ~~~~~~y~~~~~lg~G~~g~V~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~--~~ 133 (697)
-+..++|++.++||+|+||.||+|++ .++.||||++........+.+.+|+.+++.++||||+++++++. +.
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 98 (327)
T 3lxl_A 19 IFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGR 98 (327)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSS
T ss_pred hhchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCC
Confidence 35567999999999999999999984 57889999988777777888999999999999999999999876 45
Q ss_pred CceEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhh
Q 005427 134 PNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRE 213 (697)
Q Consensus 134 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~ 213 (697)
...++||||+++++|.+++......+++.+++.++.|++.||+|||+.||+||||||+|||++.++.+||+|||++....
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 178 (327)
T 3lxl_A 99 QSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLP 178 (327)
T ss_dssp CEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEECC
T ss_pred ceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceecc
Confidence 66899999999999999998765579999999999999999999999999999999999999999999999999997654
Q ss_pred hhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhc
Q 005427 214 NLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEM 293 (697)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~ 293 (697)
..... ........||+.|+|||++.+..++.++|||||||++|+|++|..||...............
T Consensus 179 ~~~~~-------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~ 245 (327)
T 3lxl_A 179 LDKDY-------------YVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCER 245 (327)
T ss_dssp TTCSE-------------EECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC---
T ss_pred cCCcc-------------ceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhccccc
Confidence 21110 01123456888999999999999999999999999999999999999875443322211111
Q ss_pred cccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHh
Q 005427 294 NYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHR 356 (697)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~~ 356 (697)
................++ ..+..+++++.+||.+||+.||.+|||+.+++++|+.+....
T Consensus 246 ~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 305 (327)
T 3lxl_A 246 DVPALSRLLELLEEGQRL---PAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305 (327)
T ss_dssp -CCHHHHHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred ccccHHHHHHHhhcccCC---CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 122212222222222222 224578999999999999999999999999999998876543
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-43 Score=357.52 Aligned_cols=256 Identities=24% Similarity=0.319 Sum_probs=216.5
Q ss_pred CCCcccccccccCCceEEEEEEE--CCeeEEEEeccCC--ChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEE
Q 005427 65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFF 140 (697)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 140 (697)
.++|++.+.||+|+||.||+|.+ +++.||+|++... .....+.+.+|+.+++.++||||+++++++......++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 47899999999999999999987 4789999986543 3455678899999999999999999999999999999999
Q ss_pred eecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCC---Ceeeeeccchhhhhhhh
Q 005427 141 EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLC---PHLADFGLAEYRENLKE 217 (697)
Q Consensus 141 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~---~kL~Dfg~a~~~~~~~~ 217 (697)
||+.+++|.+.+.... .+++..++.++.|++.||.|||+.||+||||||+|||++.++. +||+|||++.......
T Consensus 85 e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~- 162 (284)
T 3kk8_A 85 DLVTGGELFEDIVARE-FYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE- 162 (284)
T ss_dssp CCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSC-
T ss_pred ecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCc-
Confidence 9999999999887654 6899999999999999999999999999999999999976655 9999999986543211
Q ss_pred hhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccH
Q 005427 218 ISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTE 297 (697)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~ 297 (697)
......||+.|+|||++.+..++.++||||||+++|+|++|..||.+.........+.....
T Consensus 163 ----------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~-- 224 (284)
T 3kk8_A 163 ----------------AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY-- 224 (284)
T ss_dssp ----------------BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC--
T ss_pred ----------------cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccc--
Confidence 12345799999999999999999999999999999999999999988765554444332221
Q ss_pred HHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 005427 298 QQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL 353 (697)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~ 353 (697)
.. .......+++++.+||.+||+.||.+|||+.|+++|.|...
T Consensus 225 ------------~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 267 (284)
T 3kk8_A 225 ------------DY-PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICN 267 (284)
T ss_dssp ------------CC-CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHS
T ss_pred ------------cC-CchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccC
Confidence 11 11123468899999999999999999999999999998753
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=371.24 Aligned_cols=254 Identities=25% Similarity=0.338 Sum_probs=199.1
Q ss_pred CCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEe
Q 005427 64 PPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFE 141 (697)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 141 (697)
..++|++.+.||+|+||.||+|++ +++.||||++... ...+.+.+|+.+|+.++||||+++++++.++..+++|||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKT--VDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccc--hhHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 346799999999999999999998 4678999986543 244678899999999999999999999999999999999
Q ss_pred ecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecC---CCCCeeeeeccchhhhhhhhh
Q 005427 142 FYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDR---NLCPHLADFGLAEYRENLKEI 218 (697)
Q Consensus 142 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~---~~~~kL~Dfg~a~~~~~~~~~ 218 (697)
|+.+|+|.+++.... .+++.+++.++.|++.||.|||+.||+||||||+|||++. ++.+||+|||++.......
T Consensus 129 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~-- 205 (349)
T 2w4o_A 129 LVTGGELFDRIVEKG-YYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV-- 205 (349)
T ss_dssp CCCSCBHHHHHTTCS-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC-----------
T ss_pred eCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCccc--
Confidence 999999999987654 6899999999999999999999999999999999999975 8899999999997654211
Q ss_pred hcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHH-HHHHHHhccccH
Q 005427 219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEA-QAHTVLEMNYTE 297 (697)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~-~~~~~~~~~~~~ 297 (697)
......||+.|+|||++.+..++.++|||||||++|+|++|..||.+..... ....+..
T Consensus 206 ---------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~----- 265 (349)
T 2w4o_A 206 ---------------LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILN----- 265 (349)
T ss_dssp ----------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHT-----
T ss_pred ---------------ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHh-----
Confidence 1234679999999999999999999999999999999999999997754332 2222221
Q ss_pred HHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 298 QQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
... .........++.++.+||.+||+.||++|||+.|+++|.|..
T Consensus 266 ---------~~~-~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~ 310 (349)
T 2w4o_A 266 ---------CEY-YFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVT 310 (349)
T ss_dssp ---------TCC-CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTT
T ss_pred ---------CCC-ccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccC
Confidence 111 122223456899999999999999999999999999988764
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-44 Score=388.18 Aligned_cols=255 Identities=23% Similarity=0.321 Sum_probs=208.4
Q ss_pred CCCCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCC---ChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCce
Q 005427 62 HLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNY 136 (697)
Q Consensus 62 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 136 (697)
.+..++|+++++||+|+||.||+|.+ +++.||||++... .......+.+|+.+|+.++||||+++++++.+...+
T Consensus 144 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~ 223 (446)
T 4ejn_A 144 RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRL 223 (446)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEE
T ss_pred CCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEE
Confidence 34557899999999999999999987 5789999986532 233456788999999999999999999999999999
Q ss_pred EEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCCCceeecCCCCCeeeeeccchhhhhh
Q 005427 137 MFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHN-LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL 215 (697)
Q Consensus 137 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~ 215 (697)
++||||+.+|+|.+++.... .+++..++.++.||+.||+|||+ .||+||||||+|||++.++.+||+|||+++.....
T Consensus 224 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 302 (446)
T 4ejn_A 224 CFVMEYANGGELFFHLSRER-VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD 302 (446)
T ss_dssp EEEECCCSSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-
T ss_pred EEEEeeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCC
Confidence 99999999999999987655 78999999999999999999998 99999999999999999999999999998643211
Q ss_pred hhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccc
Q 005427 216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNY 295 (697)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~ 295 (697)
+......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.........+....
T Consensus 303 ----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~- 365 (446)
T 4ejn_A 303 ----------------GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE- 365 (446)
T ss_dssp --------------------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-
T ss_pred ----------------CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCC-
Confidence 112345789999999999999999999999999999999999999998876655444443221
Q ss_pred cHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCC-----CHHHHHHHHHHH
Q 005427 296 TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRP-----SFSDIALELDLV 352 (697)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~ell~~l~~~ 352 (697)
. ..+..+++++.+||.+||+.||.+|| |++|+++|.|+.
T Consensus 366 -------------~-----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~ 409 (446)
T 4ejn_A 366 -------------I-----RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFA 409 (446)
T ss_dssp -------------C-----CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGT
T ss_pred -------------C-----CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCcccc
Confidence 1 13456899999999999999999999 999999988774
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-44 Score=372.49 Aligned_cols=271 Identities=24% Similarity=0.269 Sum_probs=210.5
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccCCChHH-HHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEee
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEE-LDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF 142 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 142 (697)
++|+++++||+|+||.||+|++ +++.||+|++....... ...+.+|+.+|+.++||||+++++++.+...+++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 5899999999999999999998 57899999876543222 22456799999999999999999999999999999999
Q ss_pred cCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhccc
Q 005427 143 YESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKN 222 (697)
Q Consensus 143 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 222 (697)
+.+ +|.+++......+++.+++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~------ 154 (324)
T 3mtl_A 82 LDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT------ 154 (324)
T ss_dssp CSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC----------
T ss_pred ccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCc------
Confidence 985 9999988777679999999999999999999999999999999999999999999999999987543211
Q ss_pred ccCCCCCCCCccccccccCccccchhhhcc-cCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHH---
Q 005427 223 WRSSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQ--- 298 (697)
Q Consensus 223 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~--- 298 (697)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+........
T Consensus 155 ----------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 224 (324)
T 3mtl_A 155 ----------KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEET 224 (324)
T ss_dssp ------------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred ----------cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHh
Confidence 11234578999999999986 5689999999999999999999999998876666555543211110
Q ss_pred --------HHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 005427 299 --------QLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL 353 (697)
Q Consensus 299 --------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~ 353 (697)
.....................+++++.+||.+||+.||.+|||++|+++|+|+..
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 287 (324)
T 3mtl_A 225 WPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLS 287 (324)
T ss_dssp STTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGG
T ss_pred chhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhh
Confidence 0000000000001111223468899999999999999999999999999998853
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-43 Score=357.86 Aligned_cols=266 Identities=22% Similarity=0.332 Sum_probs=221.7
Q ss_pred CCCCCCCccccc-ccccCCceEEEEEEE----CCeeEEEEeccCC-ChHHHHHHHHHHHHHHhcCCCCceEEeeccccCC
Q 005427 61 LHLPPSSYTLLS-PIARGAESVVYEATL----DGRKVAVKKPILS-TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPP 134 (697)
Q Consensus 61 ~~~~~~~y~~~~-~lg~G~~g~V~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 134 (697)
+.+..++|.+.+ .||+|+||.||+|.+ .+..||+|++... .....+.+.+|+.+++.++||||+++++++ ...
T Consensus 4 ~~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~ 82 (287)
T 1u59_A 4 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAE 82 (287)
T ss_dssp CBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESS
T ss_pred ccccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCC
Confidence 456677898887 999999999999975 5778999987654 344577899999999999999999999999 556
Q ss_pred ceEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhh
Q 005427 135 NYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYREN 214 (697)
Q Consensus 135 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~ 214 (697)
.+++||||+.+++|.+++......+++.+++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 162 (287)
T 1u59_A 83 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA 162 (287)
T ss_dssp SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred CcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence 79999999999999999977666799999999999999999999999999999999999999999999999999976542
Q ss_pred hhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCCchhHHHHHHHHhc
Q 005427 215 LKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEM 293 (697)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~~~~~~~~~~~~~~ 293 (697)
.... ........||+.|+|||++.+..++.++||||||+++|+|++ |..||.+.........+..
T Consensus 163 ~~~~-------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~- 228 (287)
T 1u59_A 163 DDSY-------------YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ- 228 (287)
T ss_dssp CSCE-------------ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHT-
T ss_pred Ccce-------------eeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhc-
Confidence 1110 001233457899999999998889999999999999999998 9999987655443332221
Q ss_pred cccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhcc
Q 005427 294 NYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHRKS 358 (697)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~~~~ 358 (697)
+.++ ..+..+|+++.++|.+||+.||.+|||+.+++++|+.+......
T Consensus 229 --------------~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 276 (287)
T 1u59_A 229 --------------GKRM---ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 276 (287)
T ss_dssp --------------TCCC---CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHT
T ss_pred --------------CCcC---CCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCC
Confidence 1111 23457899999999999999999999999999999999876443
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=371.66 Aligned_cols=266 Identities=22% Similarity=0.321 Sum_probs=211.9
Q ss_pred CCCcccccccccCCceEEEEEEE--CCeeEEEEeccCC--ChHHHHHHHHHHHHHHhcCCCCceEEeeccccC------C
Q 005427 65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKP------P 134 (697)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~------~ 134 (697)
.++|++.+.||+|+||.||+|.+ +++.||||++... .....+.+.+|+.+|+.++||||+++++++... .
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 46899999999999999999997 5889999986433 334467889999999999999999999998765 3
Q ss_pred ceEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhh
Q 005427 135 NYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYREN 214 (697)
Q Consensus 135 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~ 214 (697)
.+++||||+ +++|.+++... .+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++....
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 180 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS 180 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred eEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeeccccccc
Confidence 469999999 77999998763 689999999999999999999999999999999999999999999999999975431
Q ss_pred hhhhhcccccCCCCCCCCccccccccCccccchhhhcc-cCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhc
Q 005427 215 LKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEM 293 (697)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~ 293 (697)
.....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+...+...+...
T Consensus 181 -------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~ 241 (367)
T 1cm8_A 181 -------------------EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKV 241 (367)
T ss_dssp -------------------SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred -------------------ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 1334678999999999987 67899999999999999999999999988777766666543
Q ss_pred cccHHHHHH------------HHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 294 NYTEQQLTA------------AVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 294 ~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
......... .......+..+.......++++.+||.+||+.||.+|||+.|+++|.|+.
T Consensus 242 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~ 312 (367)
T 1cm8_A 242 TGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFE 312 (367)
T ss_dssp HCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGT
T ss_pred cCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHH
Confidence 322211100 00111112223334457899999999999999999999999999998863
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=369.19 Aligned_cols=250 Identities=24% Similarity=0.347 Sum_probs=212.4
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccCCC---hHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEE
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST---SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFF 140 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 140 (697)
++|++++.||+|+||.||+|++ +++.||||++.... ....+.+.+|+.+|+.++||||+++++++..+...++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4699999999999999999997 68899999875432 234567899999999999999999999999999999999
Q ss_pred eecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhc
Q 005427 141 EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL 220 (697)
Q Consensus 141 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~ 220 (697)
||+. |+|.+.+......+++.+++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~------ 206 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ 206 (348)
T ss_dssp ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS------
T ss_pred ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC------
Confidence 9998 588888876666899999999999999999999999999999999999999999999999999865431
Q ss_pred ccccCCCCCCCCccccccccCccccchhhhc---ccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccH
Q 005427 221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILK---KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTE 297 (697)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~ 297 (697)
.....||+.|+|||++. +..++.++|||||||++|||++|..||.+.........+..
T Consensus 207 --------------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~----- 267 (348)
T 1u5q_A 207 --------------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ----- 267 (348)
T ss_dssp --------------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH-----
T ss_pred --------------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh-----
Confidence 23457999999999985 56789999999999999999999999987655443333222
Q ss_pred HHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 005427 298 QQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL 353 (697)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~ 353 (697)
.. .+. ..+..+++.+.+||.+||+.||++|||+.++++|+|...
T Consensus 268 ---------~~-~~~--~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~ 311 (348)
T 1u5q_A 268 ---------NE-SPA--LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 311 (348)
T ss_dssp ---------SC-CCC--CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred ---------cC-CCC--CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhc
Confidence 11 111 123468899999999999999999999999999999854
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=358.12 Aligned_cols=253 Identities=22% Similarity=0.367 Sum_probs=213.4
Q ss_pred CCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCChH---HHHHHHHHHHHHHhcCCCCceEEeeccccCCceEE
Q 005427 64 PPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSE---ELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMF 138 (697)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 138 (697)
..++|++.+.||+|+||.||+|.+ +++.||+|++...... ....+.+|+.+++.++||||+++++++.+....++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 346899999999999999999988 4678999986433211 24578899999999999999999999999999999
Q ss_pred EEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhh
Q 005427 139 FFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI 218 (697)
Q Consensus 139 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~ 218 (697)
||||+++++|.+.+.... .+++..++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 87 v~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~--- 162 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--- 162 (279)
T ss_dssp EECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC------
T ss_pred EEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCcc---
Confidence 999999999999987654 6899999999999999999999999999999999999999999999999998543321
Q ss_pred hcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHH
Q 005427 219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQ 298 (697)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~ 298 (697)
......||+.|+|||++.+..++.++||||||+++|+|++|..||...........+.....
T Consensus 163 ---------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--- 224 (279)
T 3fdn_A 163 ---------------RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF--- 224 (279)
T ss_dssp --------------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC---
T ss_pred ---------------cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCC---
Confidence 12345789999999999999999999999999999999999999987665544443322111
Q ss_pred HHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 005427 299 QLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE 354 (697)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~ 354 (697)
..+..+++++.+||.+||+.||.+|||+.|+++|.|....
T Consensus 225 ----------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~ 264 (279)
T 3fdn_A 225 ----------------TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITAN 264 (279)
T ss_dssp ----------------CCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHH
T ss_pred ----------------CCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCC
Confidence 1244688999999999999999999999999999998653
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-43 Score=382.14 Aligned_cols=261 Identities=27% Similarity=0.429 Sum_probs=219.0
Q ss_pred ccCCCCCCCcccccccccCCceEEEEEEE-CCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceE
Q 005427 59 IPLHLPPSSYTLLSPIARGAESVVYEATL-DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYM 137 (697)
Q Consensus 59 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 137 (697)
..++++.++|++.++||+|+||.||+|.+ .+..||||++.... ...+.+.+|+.+|+.++||||+++++++. ....+
T Consensus 181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~ 258 (454)
T 1qcf_A 181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIY 258 (454)
T ss_dssp TCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCE
T ss_pred cceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccE
Confidence 45778889999999999999999999998 47889999876443 34678999999999999999999999986 56789
Q ss_pred EEEeecCCCCHhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhh
Q 005427 138 FFFEFYESRNLAEKLHVEE-WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLK 216 (697)
Q Consensus 138 lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~ 216 (697)
+||||+.+|+|.+++.... ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 259 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~ 338 (454)
T 1qcf_A 259 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 338 (454)
T ss_dssp EEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH
T ss_pred EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc
Confidence 9999999999999997542 367889999999999999999999999999999999999999999999999998664322
Q ss_pred hhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCCchhHHHHHHHHhccc
Q 005427 217 EISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNY 295 (697)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~~~~~~~~~~~~~~~~ 295 (697)
.. ......+|+.|+|||++.+..++.++|||||||++|||++ |..||.+.........+..
T Consensus 339 ~~---------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~--- 400 (454)
T 1qcf_A 339 YT---------------AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER--- 400 (454)
T ss_dssp HH---------------TTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHH---
T ss_pred ee---------------ccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc---
Confidence 11 1123456889999999999999999999999999999999 9999988765544333221
Q ss_pred cHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 005427 296 TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE 354 (697)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~ 354 (697)
+ .+. ..+..+|+++.+||.+||+.||.+|||+.+|++.|+.+..
T Consensus 401 -----------~-~~~---~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~ 444 (454)
T 1qcf_A 401 -----------G-YRM---PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444 (454)
T ss_dssp -----------T-CCC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred -----------C-CCC---CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence 1 111 1245789999999999999999999999999988876643
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=362.91 Aligned_cols=253 Identities=22% Similarity=0.315 Sum_probs=211.8
Q ss_pred CCCCCCcccccccccCCceEEEEEEEC--C-------eeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeecccc
Q 005427 62 HLPPSSYTLLSPIARGAESVVYEATLD--G-------RKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAK 132 (697)
Q Consensus 62 ~~~~~~y~~~~~lg~G~~g~V~~~~~~--~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 132 (697)
++..++|++.+.||+|+||.||+|++. + ..||+|+.........+.+.+|+.+++.++||||+++++++.+
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 83 (289)
T 4fvq_A 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVC 83 (289)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECC
T ss_pred EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEe
Confidence 456679999999999999999999763 2 5699998766655667889999999999999999999999999
Q ss_pred CCceEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCC--------Ceee
Q 005427 133 PPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLC--------PHLA 204 (697)
Q Consensus 133 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~--------~kL~ 204 (697)
+...++||||+.+|+|.+++......+++.+++.++.|++.||.|||++||+||||||+|||++.++. +||+
T Consensus 84 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~ 163 (289)
T 4fvq_A 84 GDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLS 163 (289)
T ss_dssp TTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEEC
T ss_pred CCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeeec
Confidence 99999999999999999999877666999999999999999999999999999999999999988877 9999
Q ss_pred eeccchhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcc-cCCCchhhHHHHHHHHHHHHh-CCCCCCCch
Q 005427 205 DFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLT-GVVPYTDLR 282 (697)
Q Consensus 205 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~ell~-g~~Pf~~~~ 282 (697)
|||++..... .....||+.|+|||++.+ ..++.++|||||||++|+|++ +.+||....
T Consensus 164 Dfg~~~~~~~--------------------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~ 223 (289)
T 4fvq_A 164 DPGISITVLP--------------------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD 223 (289)
T ss_dssp CCCSCTTTSC--------------------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred cCcccccccC--------------------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccc
Confidence 9999865432 123458899999999987 778999999999999999999 555665543
Q ss_pred hHHHHHHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 005427 283 AEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE 354 (697)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~ 354 (697)
........ . . . ...+...++++.+||.+||+.||.+|||+.+++++|..++.
T Consensus 224 ~~~~~~~~-~--------------~--~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 224 SQRKLQFY-E--------------D--R---HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp HHHHHHHH-H--------------T--T---CCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred hHHHHHHh-h--------------c--c---CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 32221111 1 0 0 11234567889999999999999999999999999887653
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-43 Score=363.17 Aligned_cols=270 Identities=23% Similarity=0.305 Sum_probs=210.9
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccCCCh--HHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEe
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTS--EELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFE 141 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 141 (697)
++|+++++||+|+||.||+|.+ +++.||+|++..... ...+.+.+|+.+++.++||||+++++++......++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 5899999999999999999998 488999998654432 335678899999999999999999999999999999999
Q ss_pred ecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhcc
Q 005427 142 FYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLK 221 (697)
Q Consensus 142 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~ 221 (697)
|+.+++|.+++.... .+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 83 ~~~~~~l~~~~~~~~-~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---- 157 (311)
T 4agu_A 83 YCDHTVLHELDRYQR-GVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD---- 157 (311)
T ss_dssp CCSEEHHHHHHHTSS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC--------
T ss_pred eCCCchHHHHHhhhc-CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc----
Confidence 999999988876544 689999999999999999999999999999999999999999999999999976542111
Q ss_pred cccCCCCCCCCccccccccCccccchhhhcc-cCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHH
Q 005427 222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQL 300 (697)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 300 (697)
......||+.|+|||++.+ ..++.++||||||+++|+|++|..||.+.........+..........
T Consensus 158 ------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 225 (311)
T 4agu_A 158 ------------YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPR 225 (311)
T ss_dssp --------------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHH
T ss_pred ------------ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccc
Confidence 1234578999999999976 668999999999999999999999999877665554443221111000
Q ss_pred HHHH-HhC-----CCCC------cccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 301 TAAV-VSG-----GLRP------ILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 301 ~~~~-~~~-----~~~~------~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
.... ... ...+ ........+++++.+||.+||+.||.+|||++|+++|.|+.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~ 289 (311)
T 4agu_A 226 HQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFE 289 (311)
T ss_dssp HHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGT
T ss_pred cccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHH
Confidence 0000 000 0000 00111246889999999999999999999999999998764
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-43 Score=360.15 Aligned_cols=277 Identities=26% Similarity=0.367 Sum_probs=217.7
Q ss_pred cCCCCCCCcccccccccCCceEEEEEEE------CCeeEEEEeccCCCh-HHHHHHHHHHHHHHhcCCCCceEEeecccc
Q 005427 60 PLHLPPSSYTLLSPIARGAESVVYEATL------DGRKVAVKKPILSTS-EELDNFHKELQLLCKLDHPGLAKFVAAHAK 132 (697)
Q Consensus 60 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 132 (697)
+..+...+|++.++||+|+||.||+|++ +++.||+|++..... ...+.+.+|+.+|+.++||||+++++++..
T Consensus 15 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 94 (302)
T 4e5w_A 15 PTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTE 94 (302)
T ss_dssp TTBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred hhhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEec
Confidence 3445567899999999999999999984 578999998764432 335788999999999999999999999987
Q ss_pred C--CceEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccch
Q 005427 133 P--PNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAE 210 (697)
Q Consensus 133 ~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~ 210 (697)
. ..+++||||+.+++|.+++......+++.+++.++.|++.||+|||+.||+||||||+|||++.++.+||+|||++.
T Consensus 95 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 95 DGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp ---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred CCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccc
Confidence 6 67899999999999999997776689999999999999999999999999999999999999999999999999997
Q ss_pred hhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHH
Q 005427 211 YRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTV 290 (697)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~ 290 (697)
........ ........||+.|+|||++.+..++.++||||||+++|+|++|..|+............
T Consensus 175 ~~~~~~~~-------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~ 241 (302)
T 4e5w_A 175 AIETDKEY-------------YTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIG 241 (302)
T ss_dssp ECCTTCCE-------------EECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHC
T ss_pred cccCCCcc-------------eeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccC
Confidence 65431110 01233456888999999999999999999999999999999999997654322111100
Q ss_pred -HhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 005427 291 -LEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL 353 (697)
Q Consensus 291 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~ 353 (697)
................+. +. ..+..+++++.+||.+||+.||.+|||+.++++.|..++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~-~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 242 PTHGQMTVTRLVNTLKEGK-RL---PCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp SCCGGGHHHHHHHHHHTTC-CC---CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CcccccCHHHHHHHHhccC-CC---CCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 001111122222222222 21 234578999999999999999999999999999998765
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=366.81 Aligned_cols=277 Identities=20% Similarity=0.278 Sum_probs=208.6
Q ss_pred CCCcccc-cccccCCceEEEEEEE--CCeeEEEEeccCCChHHHHHHHHHHHHHHhc-CCCCceEEeeccccCCceEEEE
Q 005427 65 PSSYTLL-SPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKL-DHPGLAKFVAAHAKPPNYMFFF 140 (697)
Q Consensus 65 ~~~y~~~-~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv~ 140 (697)
.++|++. +.||+|+||.||+|.+ +++.||||++..........+.+|+.+|+++ +||||+++++++.+...+++||
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 3679985 7899999999999986 6889999987665555567899999999985 7999999999999999999999
Q ss_pred eecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCC---Ceeeeeccchhhhhhhh
Q 005427 141 EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLC---PHLADFGLAEYRENLKE 217 (697)
Q Consensus 141 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~---~kL~Dfg~a~~~~~~~~ 217 (697)
||+.+|+|.+++.... .+++.+++.++.|++.||+|||+.||+||||||+|||++.++. +||+|||++........
T Consensus 91 e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~ 169 (316)
T 2ac3_A 91 EKMRGGSILSHIHKRR-HFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGD 169 (316)
T ss_dssp ECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------
T ss_pred EcCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCc
Confidence 9999999999997654 6899999999999999999999999999999999999988765 89999999876542111
Q ss_pred hhcccccCCCCCCCCccccccccCccccchhhhcc-----cCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHh
Q 005427 218 ISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-----EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLE 292 (697)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~ 292 (697)
.. ..........+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+............
T Consensus 170 ~~---------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~ 240 (316)
T 2ac3_A 170 CS---------PISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGE 240 (316)
T ss_dssp ---------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----
T ss_pred cc---------cccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccc
Confidence 00 001112234579999999999975 5678999999999999999999999976532110000000
Q ss_pred c-cccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 293 M-NYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 293 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
. ..........+..+... ........+++++.+||.+||+.||.+|||+.|+++|.|..
T Consensus 241 ~~~~~~~~~~~~i~~~~~~-~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~ 300 (316)
T 2ac3_A 241 ACPACQNMLFESIQEGKYE-FPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQ 300 (316)
T ss_dssp CCHHHHHHHHHHHHHCCCC-CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC
T ss_pred cchhHHHHHHHHHhccCcc-cCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhc
Confidence 0 00011112222222221 11222346889999999999999999999999999998864
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-43 Score=365.09 Aligned_cols=253 Identities=21% Similarity=0.279 Sum_probs=215.6
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccCCChH------HHHHHHHHHHHHHhcCCCCceEEeeccccCCceE
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSE------ELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYM 137 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 137 (697)
++|++.+.||+|+||.||+|++ +++.||+|++...... ..+.+.+|+.+|+.++||||+++++++.+...++
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV 91 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 5799999999999999999998 5789999986543221 3577899999999999999999999999999999
Q ss_pred EEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCC----CCeeeeeccchhhh
Q 005427 138 FFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNL----CPHLADFGLAEYRE 213 (697)
Q Consensus 138 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~----~~kL~Dfg~a~~~~ 213 (697)
+||||+.+++|.+++.... .+++..++.++.|++.||.|||+.||+||||||+|||++.++ .+||+|||++....
T Consensus 92 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~ 170 (321)
T 2a2a_A 92 LILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170 (321)
T ss_dssp EEECCCCSCBHHHHHHTCS-CEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECC
T ss_pred EEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceecC
Confidence 9999999999999997644 689999999999999999999999999999999999999887 79999999987543
Q ss_pred hhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhc
Q 005427 214 NLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEM 293 (697)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~ 293 (697)
.. .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.........+...
T Consensus 171 ~~-----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~ 233 (321)
T 2a2a_A 171 DG-----------------VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSV 233 (321)
T ss_dssp TT-----------------CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTT
T ss_pred cc-----------------ccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhc
Confidence 21 1123457999999999999999999999999999999999999999887655554444332
Q ss_pred cccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 005427 294 NYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL 351 (697)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~ 351 (697)
.. ...+..+..++..+.+||.+||+.||.+|||+.|+++|.|.
T Consensus 234 ~~---------------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~ 276 (321)
T 2a2a_A 234 SY---------------DFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276 (321)
T ss_dssp CC---------------CCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTT
T ss_pred cc---------------ccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccc
Confidence 21 11122345688999999999999999999999999998876
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=363.30 Aligned_cols=267 Identities=23% Similarity=0.389 Sum_probs=217.7
Q ss_pred CccCCCCCCCcccccccccCCceEEEEEEE-------CCeeEEEEeccCC-ChHHHHHHHHHHHHHHhcCCCCceEEeec
Q 005427 58 SIPLHLPPSSYTLLSPIARGAESVVYEATL-------DGRKVAVKKPILS-TSEELDNFHKELQLLCKLDHPGLAKFVAA 129 (697)
Q Consensus 58 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~ 129 (697)
..-.++..++|++.+.||+|+||.||+|++ ++..||||.+... .......+.+|+.+++.++||||++++++
T Consensus 22 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 101 (327)
T 2yfx_A 22 SDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGV 101 (327)
T ss_dssp GGSCBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred hhcccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEE
Confidence 334467788999999999999999999983 4568999987544 34456789999999999999999999999
Q ss_pred cccCCceEEEEeecCCCCHhhhhhhcC------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecC---CCC
Q 005427 130 HAKPPNYMFFFEFYESRNLAEKLHVEE------WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDR---NLC 200 (697)
Q Consensus 130 ~~~~~~~~lv~e~~~~g~L~~~l~~~~------~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~---~~~ 200 (697)
+......++||||+++++|.+++.... ..+++.+++.++.|++.||.|||+.||+||||||+|||++. +..
T Consensus 102 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~ 181 (327)
T 2yfx_A 102 SLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRV 181 (327)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCC
T ss_pred EcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcce
Confidence 999999999999999999999997654 34789999999999999999999999999999999999984 446
Q ss_pred CeeeeeccchhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCC
Q 005427 201 PHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYT 279 (697)
Q Consensus 201 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~ 279 (697)
+||+|||++......... .......||+.|+|||++.+..++.++|||||||++|+|++ |..||.
T Consensus 182 ~kl~Dfg~~~~~~~~~~~--------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~ 247 (327)
T 2yfx_A 182 AKIGDFGMARDIYRASYY--------------RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYP 247 (327)
T ss_dssp EEECCCHHHHHHHC--------------------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred EEECcccccccccccccc--------------ccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Confidence 999999999765431110 11234568999999999999999999999999999999998 999998
Q ss_pred CchhHHHHHHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHh
Q 005427 280 DLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHR 356 (697)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~~ 356 (697)
+.........+.. +. ++ ..+..++..+.++|.+||+.||.+|||+.+++++++.+....
T Consensus 248 ~~~~~~~~~~~~~--------------~~-~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 306 (327)
T 2yfx_A 248 SKSNQEVLEFVTS--------------GG-RM---DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 306 (327)
T ss_dssp TCCHHHHHHHHHT--------------TC-CC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred CcCHHHHHHHHhc--------------CC-CC---CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCH
Confidence 7654443332221 11 11 224568999999999999999999999999999999987643
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=364.07 Aligned_cols=266 Identities=26% Similarity=0.408 Sum_probs=222.0
Q ss_pred cCCCCCCCcccccccccCCceEEEEEEEC---------CeeEEEEeccCCC-hHHHHHHHHHHHHHHhc-CCCCceEEee
Q 005427 60 PLHLPPSSYTLLSPIARGAESVVYEATLD---------GRKVAVKKPILST-SEELDNFHKELQLLCKL-DHPGLAKFVA 128 (697)
Q Consensus 60 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~---------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~l~~ 128 (697)
.++++.++|++.+.||+|+||.||+|++. +..||+|+..... ......+.+|+.+++.+ +||||+++++
T Consensus 29 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 108 (334)
T 2pvf_A 29 KWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLG 108 (334)
T ss_dssp TTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEE
Confidence 46778899999999999999999999863 4679999876543 34567899999999999 8999999999
Q ss_pred ccccCCceEEEEeecCCCCHhhhhhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCce
Q 005427 129 AHAKPPNYMFFFEFYESRNLAEKLHVEE---------------WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANV 193 (697)
Q Consensus 129 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Ni 193 (697)
++.+...+++||||+.+|+|.+++.... ..+++.+++.++.|++.||.|||+.||+||||||+||
T Consensus 109 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI 188 (334)
T 2pvf_A 109 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV 188 (334)
T ss_dssp EECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred EEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceE
Confidence 9999999999999999999999997643 2478999999999999999999999999999999999
Q ss_pred eecCCCCCeeeeeccchhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh
Q 005427 194 LLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT 273 (697)
Q Consensus 194 ll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~ 273 (697)
|++.++.+||+|||++........ ........+|+.|+|||++.+..++.++|||||||++|+|++
T Consensus 189 ll~~~~~~kL~Dfg~~~~~~~~~~--------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt 254 (334)
T 2pvf_A 189 LVTENNVMKIADFGLARDINNIDY--------------YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254 (334)
T ss_dssp EECTTCCEEECCCTTCEECTTTSS--------------EECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHT
T ss_pred EEcCCCCEEEcccccccccccccc--------------ccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHh
Confidence 999999999999999975542111 001233467889999999999889999999999999999999
Q ss_pred -CCCCCCCchhHHHHHHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 274 -GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 274 -g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
|..||.+.........+.. +. ++ ..+..++.++.++|.+||+.||.+|||+.+++++|..+
T Consensus 255 ~g~~p~~~~~~~~~~~~~~~--------------~~-~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l 316 (334)
T 2pvf_A 255 LGGSPYPGIPVEELFKLLKE--------------GH-RM---DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316 (334)
T ss_dssp TSCCSSTTCCHHHHHHHHHH--------------TC-CC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCcCcCCHHHHHHHHhc--------------CC-CC---CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 9999987655443332221 11 11 23456899999999999999999999999999999999
Q ss_pred HHHhc
Q 005427 353 LEHRK 357 (697)
Q Consensus 353 ~~~~~ 357 (697)
+....
T Consensus 317 ~~~~~ 321 (334)
T 2pvf_A 317 LTLTT 321 (334)
T ss_dssp HHHHC
T ss_pred Hhccc
Confidence 87533
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=355.77 Aligned_cols=261 Identities=26% Similarity=0.418 Sum_probs=215.4
Q ss_pred CCCCCCCcccccccccCCceEEEEEEEC-----CeeEEEEeccCC-ChHHHHHHHHHHHHHHhcCCCCceEEeeccccCC
Q 005427 61 LHLPPSSYTLLSPIARGAESVVYEATLD-----GRKVAVKKPILS-TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPP 134 (697)
Q Consensus 61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 134 (697)
+.+..++|++.+.||+|+||.||+|.+. +..||+|..... .....+.+.+|+.+++.++||||+++++++.+ .
T Consensus 7 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~ 85 (281)
T 3cc6_A 7 YGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-E 85 (281)
T ss_dssp CSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-S
T ss_pred ceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-C
Confidence 4566789999999999999999999862 235999986654 34456789999999999999999999999865 4
Q ss_pred ceEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhh
Q 005427 135 NYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYREN 214 (697)
Q Consensus 135 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~ 214 (697)
..++||||+.+++|.+++......+++..++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 86 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 165 (281)
T 3cc6_A 86 PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIED 165 (281)
T ss_dssp SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC--
T ss_pred CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCccccc
Confidence 56899999999999999987776799999999999999999999999999999999999999999999999999976543
Q ss_pred hhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCCchhHHHHHHHHhc
Q 005427 215 LKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEM 293 (697)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~~~~~~~~~~~~~~ 293 (697)
... .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||...........+..
T Consensus 166 ~~~---------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~- 229 (281)
T 3cc6_A 166 EDY---------------YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEK- 229 (281)
T ss_dssp ----------------------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHH-
T ss_pred ccc---------------cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhc-
Confidence 111 11233457889999999999999999999999999999998 9999986544433222211
Q ss_pred cccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 005427 294 NYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH 355 (697)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~ 355 (697)
+... ..+..+++.+.+++.+||+.||.+|||+.+++++|..+.+.
T Consensus 230 -------------~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 274 (281)
T 3cc6_A 230 -------------GDRL----PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274 (281)
T ss_dssp -------------TCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -------------CCCC----CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence 1111 12346889999999999999999999999999999988764
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-43 Score=370.31 Aligned_cols=269 Identities=20% Similarity=0.264 Sum_probs=215.2
Q ss_pred CCCCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCChHHHHHHHHHHHHHHhcC-----CCCceEEeeccccCC
Q 005427 62 HLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLD-----HPGLAKFVAAHAKPP 134 (697)
Q Consensus 62 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----hpniv~l~~~~~~~~ 134 (697)
.+..++|++.++||+|+||.||+|++ +++.||||++.. .......+..|+.+++.+. ||||+++++++....
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~ 109 (360)
T 3llt_A 31 MLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN-IKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYD 109 (360)
T ss_dssp CEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETT
T ss_pred eEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc-chhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECC
Confidence 34457899999999999999999998 688999998653 3445567888999999996 999999999999999
Q ss_pred ceEEEEeecCCCCHhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecC----------------
Q 005427 135 NYMFFFEFYESRNLAEKLHVEE-WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDR---------------- 197 (697)
Q Consensus 135 ~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~---------------- 197 (697)
..++||||+ +++|.+++.... ..+++.+++.++.||+.||+|||+.||+||||||+|||++.
T Consensus 110 ~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~ 188 (360)
T 3llt_A 110 HMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDG 188 (360)
T ss_dssp EEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTC
T ss_pred eeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhccccc
Confidence 999999999 889999997654 35899999999999999999999999999999999999975
Q ss_pred ---------CCCCeeeeeccchhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHH
Q 005427 198 ---------NLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISI 268 (697)
Q Consensus 198 ---------~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l 268 (697)
++.+||+|||++..... ......||+.|+|||++.+..++.++|||||||++
T Consensus 189 ~~~~~~~~~~~~~kl~DFG~a~~~~~-------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il 249 (360)
T 3llt_A 189 KKIQIYRTKSTGIKLIDFGCATFKSD-------------------YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVL 249 (360)
T ss_dssp CEEEEEEESCCCEEECCCTTCEETTS-------------------CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHH
T ss_pred ccccccccCCCCEEEEeccCceecCC-------------------CCcCccCcccccCcHHHcCCCCCCccchHHHHHHH
Confidence 78899999999975332 12356789999999999999999999999999999
Q ss_pred HHHHhCCCCCCCchhHHHHHHHHhccccHHHHHHHHHhC-C---------CC-----------------CcccccccCCh
Q 005427 269 NELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSG-G---------LR-----------------PILASLELGLP 321 (697)
Q Consensus 269 ~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~---------~~-----------------~~~~~~~~~~~ 321 (697)
|+|++|..||.+.........+................. . .+ ...+..+...+
T Consensus 250 ~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 329 (360)
T 3llt_A 250 AELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKH 329 (360)
T ss_dssp HHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCC
T ss_pred HHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchH
Confidence 999999999988766655554443322211111100000 0 00 00011122345
Q ss_pred HHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 005427 322 ASILSLIQRCWDGNPHNRPSFSDIALELDL 351 (697)
Q Consensus 322 ~~l~~li~~~l~~dP~~Rpt~~ell~~l~~ 351 (697)
+.+.+||.+||+.||.+|||+.|+++|.|+
T Consensus 330 ~~l~~li~~~L~~dP~~Rpta~elL~hp~f 359 (360)
T 3llt_A 330 ELFCDFLYSILQIDPTLRPSPAELLKHKFL 359 (360)
T ss_dssp HHHHHHHHHHCCSSGGGSCCHHHHTTSGGG
T ss_pred HHHHHHHHHHhcCChhhCCCHHHHhcCccc
Confidence 788999999999999999999999998774
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=355.42 Aligned_cols=254 Identities=30% Similarity=0.531 Sum_probs=209.5
Q ss_pred CCCCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCChH---H----HHHHHHHHHHHHhcCCCCceEEeecccc
Q 005427 62 HLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSE---E----LDNFHKELQLLCKLDHPGLAKFVAAHAK 132 (697)
Q Consensus 62 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~---~----~~~~~~E~~~l~~l~hpniv~l~~~~~~ 132 (697)
.+..++|++.+.||+|+||.||+|++ +++.||+|++...... . .+.+.+|+.+++.++||||+++++++.+
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 94 (287)
T 4f0f_A 15 TLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN 94 (287)
T ss_dssp BCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETT
T ss_pred hhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecC
Confidence 45668999999999999999999998 6889999987543321 1 1678999999999999999999999876
Q ss_pred CCceEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccccCCCCceeecCCCC-----Ceeee
Q 005427 133 PPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLG--IVHRDVKPANVLLDRNLC-----PHLAD 205 (697)
Q Consensus 133 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~~~-----~kL~D 205 (697)
+. ++||||+.+|+|.+.+......+++..++.++.|++.||+|||+.| |+||||||+|||++.++. +||+|
T Consensus 95 ~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 95 PP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp TT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred CC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 55 6999999999999998777778999999999999999999999999 999999999999987776 99999
Q ss_pred eccchhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhc--ccCCCchhhHHHHHHHHHHHHhCCCCCCCchh
Q 005427 206 FGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILK--KEIHSEKSDVYSFGISINELLTGVVPYTDLRA 283 (697)
Q Consensus 206 fg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~ 283 (697)
||++..... ......||+.|+|||++. ...++.++|||||||++|+|++|..||.....
T Consensus 173 fg~~~~~~~-------------------~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 233 (287)
T 4f0f_A 173 FGLSQQSVH-------------------SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSY 233 (287)
T ss_dssp CTTCBCCSS-------------------CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCC
T ss_pred CCccccccc-------------------cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccc
Confidence 999864321 133467999999999984 45678999999999999999999999986543
Q ss_pred HHHHHHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 005427 284 EAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL 351 (697)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~ 351 (697)
.... ..........++ ..+..+++++.++|.+||+.||.+|||+.++++.|..
T Consensus 234 ~~~~------------~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 234 GKIK------------FINMIREEGLRP---TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp CHHH------------HHHHHHHSCCCC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred cHHH------------HHHHHhccCCCC---CCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 2211 111112222232 2345789999999999999999999999999988753
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=367.58 Aligned_cols=274 Identities=22% Similarity=0.249 Sum_probs=205.9
Q ss_pred cCCCCCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCChH--HHHHHHHHHHHHHhcCCCCceEEeeccccCCc
Q 005427 60 PLHLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSE--ELDNFHKELQLLCKLDHPGLAKFVAAHAKPPN 135 (697)
Q Consensus 60 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 135 (697)
+.....++|++.++||+|+||+||+|++ +++.||||++...... ....+.+|+.+|+.++||||+++++++.+...
T Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (329)
T 3gbz_A 28 PSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHR 107 (329)
T ss_dssp ----CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTE
T ss_pred CcccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCE
Confidence 3444557899999999999999999987 6889999987654432 24567899999999999999999999999999
Q ss_pred eEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeec-----CCCCCeeeeeccch
Q 005427 136 YMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLD-----RNLCPHLADFGLAE 210 (697)
Q Consensus 136 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~-----~~~~~kL~Dfg~a~ 210 (697)
+++||||+.+ +|.+++.... .+++.+++.++.||+.||.|||++||+||||||+|||++ ..+.+||+|||++.
T Consensus 108 ~~lv~e~~~~-~L~~~~~~~~-~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~ 185 (329)
T 3gbz_A 108 LHLIFEYAEN-DLKKYMDKNP-DVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185 (329)
T ss_dssp EEEEEECCSE-EHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHH
T ss_pred EEEEEecCCC-CHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCcc
Confidence 9999999985 9999987655 689999999999999999999999999999999999994 44559999999997
Q ss_pred hhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhccc-CCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHH
Q 005427 211 YRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKE-IHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHT 289 (697)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~ 289 (697)
....... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.........
T Consensus 186 ~~~~~~~----------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~ 249 (329)
T 3gbz_A 186 AFGIPIR----------------QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFK 249 (329)
T ss_dssp HHC---------------------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred ccCCccc----------------ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHH
Confidence 6542111 13345789999999999874 489999999999999999999999998776665555
Q ss_pred HHhccccHHHHHHHHH--hCCCCC---------cccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 005427 290 VLEMNYTEQQLTAAVV--SGGLRP---------ILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL 351 (697)
Q Consensus 290 ~~~~~~~~~~~~~~~~--~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~ 351 (697)
+...........+... ...... .....+..+++++.+||.+||+.||.+|||+.|+++|.|+
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f 322 (329)
T 3gbz_A 250 IFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYF 322 (329)
T ss_dssp HHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred HHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCccc
Confidence 4432111000000000 000000 0001122378999999999999999999999999998876
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=359.45 Aligned_cols=253 Identities=22% Similarity=0.326 Sum_probs=213.3
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEeec
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFY 143 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 143 (697)
++|++.+.||+|+||.||++++ +++.||+|++........+.+.+|+.+++.++||||+++++++.+...+++||||+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLV 88 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcC
Confidence 5799999999999999999998 58899999877655445567899999999999999999999999999999999999
Q ss_pred CCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceee---cCCCCCeeeeeccchhhhhhhhhhc
Q 005427 144 ESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLL---DRNLCPHLADFGLAEYRENLKEISL 220 (697)
Q Consensus 144 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill---~~~~~~kL~Dfg~a~~~~~~~~~~~ 220 (697)
.+++|.+++...+ .+++.+++.++.|++.||.|||+.||+||||||+|||+ +.++.+||+|||++......
T Consensus 89 ~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~----- 162 (304)
T 2jam_A 89 SGGELFDRILERG-VYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG----- 162 (304)
T ss_dssp CSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB-----
T ss_pred CCccHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC-----
Confidence 9999999987654 68999999999999999999999999999999999999 77889999999998643210
Q ss_pred ccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHH
Q 005427 221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQL 300 (697)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 300 (697)
......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.........+.....
T Consensus 163 -------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~----- 224 (304)
T 2jam_A 163 -------------IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYY----- 224 (304)
T ss_dssp -------------TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCC-----
T ss_pred -------------ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCC-----
Confidence 12345789999999999999999999999999999999999999987665544433332211
Q ss_pred HHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 301 TAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
+.....+..+++++.+||.+||+.||.+|||+.++++|.|..
T Consensus 225 ----------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~ 266 (304)
T 2jam_A 225 ----------EFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWID 266 (304)
T ss_dssp ----------CCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHH
T ss_pred ----------CCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccc
Confidence 111223457899999999999999999999999999998874
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=360.62 Aligned_cols=278 Identities=24% Similarity=0.336 Sum_probs=217.8
Q ss_pred CCCCCcccccccccCCceEEEEEEE------CCeeEEEEeccCCC-hHHHHHHHHHHHHHHhcCCCCceEEeeccccC--
Q 005427 63 LPPSSYTLLSPIARGAESVVYEATL------DGRKVAVKKPILST-SEELDNFHKELQLLCKLDHPGLAKFVAAHAKP-- 133 (697)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-- 133 (697)
+..+.|+++++||+|+||.||++.+ +++.||||++.... ....+.+.+|+++|+.++||||+++++++.+.
T Consensus 28 ~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (318)
T 3lxp_A 28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGA 107 (318)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTT
T ss_pred ecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCC
Confidence 3333459999999999999999864 57889999876543 34567899999999999999999999999874
Q ss_pred CceEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhh
Q 005427 134 PNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRE 213 (697)
Q Consensus 134 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~ 213 (697)
..+++||||+++|+|.+++... .+++.+++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||++....
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 185 (318)
T 3lxp_A 108 ASLQLVMEYVPLGSLRDYLPRH--SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185 (318)
T ss_dssp TEEEEEECCCTTCBHHHHGGGS--CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred ceEEEEEecccCCcHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcccccccc
Confidence 6789999999999999999755 48999999999999999999999999999999999999999999999999997654
Q ss_pred hhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHh-
Q 005427 214 NLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLE- 292 (697)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~- 292 (697)
..... ........||+.|+|||++.+..++.++|||||||++|+|++|..||..............
T Consensus 186 ~~~~~-------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~ 252 (318)
T 3lxp_A 186 EGHEY-------------YRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQ 252 (318)
T ss_dssp TTCSE-------------EEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCC
T ss_pred ccccc-------------cccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccc
Confidence 31110 0112345688899999999998899999999999999999999999976543221111000
Q ss_pred ccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhccc
Q 005427 293 MNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHRKSL 359 (697)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~~~~~ 359 (697)
...........+. ...++ ..+..+++++.+||++||+.||.+|||+.++++.|..+.+.....
T Consensus 253 ~~~~~~~~~~~~~-~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~ 315 (318)
T 3lxp_A 253 GQMTVLRLTELLE-RGERL---PRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQ 315 (318)
T ss_dssp HHHHHHHHHHHHH-TTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC-
T ss_pred cchhHHHHHHHHh-cccCC---CCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccC
Confidence 0111111222222 22222 234578999999999999999999999999999999988776543
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-43 Score=375.20 Aligned_cols=284 Identities=23% Similarity=0.329 Sum_probs=206.7
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccC--CChHHHHHHHHHHHHHHhcC-CCCceEEeeccccCC--ceEE
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPIL--STSEELDNFHKELQLLCKLD-HPGLAKFVAAHAKPP--NYMF 138 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~--~~~l 138 (697)
++|+++++||+|+||.||+|.+ +++.||||++.. ........+.+|+.+|+.+. ||||+++++++..++ .+|+
T Consensus 9 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l 88 (388)
T 3oz6_A 9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYL 88 (388)
T ss_dssp TTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEE
T ss_pred CceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEE
Confidence 5899999999999999999987 588999998643 34556778899999999997 999999999987544 7899
Q ss_pred EEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhh
Q 005427 139 FFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI 218 (697)
Q Consensus 139 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~ 218 (697)
||||+. ++|..++... .+++..+..++.|++.||+|||+.||+||||||+|||++.++.+||+|||+++.+......
T Consensus 89 v~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 165 (388)
T 3oz6_A 89 VFDYME-TDLHAVIRAN--ILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRV 165 (388)
T ss_dssp EEECCS-EEHHHHHHHT--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCC
T ss_pred EecccC-cCHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccccccccc
Confidence 999998 5899988753 6889999999999999999999999999999999999999999999999999765321110
Q ss_pred hccc-----ccCCCCCCCCccccccccCccccchhhhcc-cCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHh
Q 005427 219 SLKN-----WRSSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLE 292 (697)
Q Consensus 219 ~~~~-----~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~ 292 (697)
.... ................+||+.|+|||++.+ ..++.++|||||||++|||++|.+||.+.+...+...+..
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~ 245 (388)
T 3oz6_A 166 TNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIG 245 (388)
T ss_dssp CCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred cccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 0000 000000011122445689999999999986 6789999999999999999999999999887776666653
Q ss_pred ccccHHHHH-------------HHHH------hCCCCCccc---------ccccCChHHHHHHHHHhccCCCCCCCCHHH
Q 005427 293 MNYTEQQLT-------------AAVV------SGGLRPILA---------SLELGLPASILSLIQRCWDGNPHNRPSFSD 344 (697)
Q Consensus 293 ~~~~~~~~~-------------~~~~------~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dP~~Rpt~~e 344 (697)
....+.... .... ....+..++ ..+..+++++.+||.+||+.||.+|||++|
T Consensus 246 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e 325 (388)
T 3oz6_A 246 VIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISAND 325 (388)
T ss_dssp HHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred hcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHH
Confidence 222111100 0000 000001110 012367899999999999999999999999
Q ss_pred HHHHHHHH
Q 005427 345 IALELDLV 352 (697)
Q Consensus 345 ll~~l~~~ 352 (697)
+++|+|.-
T Consensus 326 ~l~Hp~~~ 333 (388)
T 3oz6_A 326 ALKHPFVS 333 (388)
T ss_dssp HTTSTTTT
T ss_pred HhCCHHHH
Confidence 99998864
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=355.10 Aligned_cols=263 Identities=26% Similarity=0.436 Sum_probs=223.0
Q ss_pred cCCCCCCCcccccccccCCceEEEEEEEC--CeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceE
Q 005427 60 PLHLPPSSYTLLSPIARGAESVVYEATLD--GRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYM 137 (697)
Q Consensus 60 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 137 (697)
.+++..++|++.++||+|+||.||+|.+. +..||+|.+... ....+.+.+|+.+++.++||||+++++++.+...++
T Consensus 7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 85 (288)
T 3kfa_A 7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 85 (288)
T ss_dssp TTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEE
T ss_pred cccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEE
Confidence 56778889999999999999999999984 789999987543 345678999999999999999999999999999999
Q ss_pred EEEeecCCCCHhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhh
Q 005427 138 FFFEFYESRNLAEKLHVEE-WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLK 216 (697)
Q Consensus 138 lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~ 216 (697)
+||||+.+++|.+++.... ..+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||++.......
T Consensus 86 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 165 (288)
T 3kfa_A 86 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165 (288)
T ss_dssp EEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred EEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence 9999999999999997643 458999999999999999999999999999999999999999999999999997654211
Q ss_pred hhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCCchhHHHHHHHHhccc
Q 005427 217 EISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNY 295 (697)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~~~~~~~~~~~~~~~~ 295 (697)
........+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+.........+..
T Consensus 166 ---------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~--- 227 (288)
T 3kfa_A 166 ---------------YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK--- 227 (288)
T ss_dssp ---------------SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHT---
T ss_pred ---------------cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc---
Confidence 112234567889999999999999999999999999999999 9999987654433322211
Q ss_pred cHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHh
Q 005427 296 TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHR 356 (697)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~~ 356 (697)
..+ ...+..+|+.+.+|+.+||+.||.+|||+.++++.|..+.+..
T Consensus 228 ------------~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~ 273 (288)
T 3kfa_A 228 ------------DYR---MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 273 (288)
T ss_dssp ------------TCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ------------cCC---CCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhc
Confidence 111 1234578999999999999999999999999999999887653
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=367.87 Aligned_cols=254 Identities=22% Similarity=0.315 Sum_probs=207.8
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccCCChHHHHHHHHHHHHHHhc-CCCCceEEeeccccCCceEEEEee
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKL-DHPGLAKFVAAHAKPPNYMFFFEF 142 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~ 142 (697)
++|++.+.||+|+||.||+|.+ +++.||+|++..... ...+|+++|.++ +||||+++++++.+...+++||||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~ 97 (342)
T 2qr7_A 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTEL 97 (342)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred ccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeC
Confidence 5799999999999999999998 588999998754332 235788888888 799999999999999999999999
Q ss_pred cCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCC----CCCeeeeeccchhhhhhhhh
Q 005427 143 YESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRN----LCPHLADFGLAEYRENLKEI 218 (697)
Q Consensus 143 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~----~~~kL~Dfg~a~~~~~~~~~ 218 (697)
+.+|+|.+++...+ .+++.+++.++.||+.||+|||+.||+||||||+|||+... +.+||+|||++.......
T Consensus 98 ~~gg~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~-- 174 (342)
T 2qr7_A 98 MKGGELLDKILRQK-FFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN-- 174 (342)
T ss_dssp CCSCBHHHHHHTCT-TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTT--
T ss_pred CCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCC--
Confidence 99999999987654 68999999999999999999999999999999999998433 349999999997543211
Q ss_pred hcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHH
Q 005427 219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQ 298 (697)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~ 298 (697)
......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.... ...
T Consensus 175 --------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-----------~~~ 229 (342)
T 2qr7_A 175 --------------GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDD-----------TPE 229 (342)
T ss_dssp --------------CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTS-----------CHH
T ss_pred --------------CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcC-----------CHH
Confidence 1234568999999999999888999999999999999999999999863211 111
Q ss_pred HHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 299 QLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
.+...+..+.+. .....+..+|+++.+||++||+.||.+|||+.++++|.|..
T Consensus 230 ~~~~~i~~~~~~-~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~ 282 (342)
T 2qr7_A 230 EILARIGSGKFS-LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIV 282 (342)
T ss_dssp HHHHHHHHCCCC-CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHH
T ss_pred HHHHHHccCCcc-cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeec
Confidence 122222222221 22223457899999999999999999999999999999984
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=366.36 Aligned_cols=261 Identities=21% Similarity=0.340 Sum_probs=211.2
Q ss_pred CCCCCCcccccccccCCceEEEEEEE--CCee----EEEEeccCCC-hHHHHHHHHHHHHHHhcCCCCceEEeeccccCC
Q 005427 62 HLPPSSYTLLSPIARGAESVVYEATL--DGRK----VAVKKPILST-SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPP 134 (697)
Q Consensus 62 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 134 (697)
.+..++|++.++||+|+||.||+|++ +++. ||+|...... ......+.+|+.+++.++||||+++++++. ..
T Consensus 9 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~ 87 (325)
T 3kex_A 9 IFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GS 87 (325)
T ss_dssp BCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BS
T ss_pred hcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CC
Confidence 45668999999999999999999987 3443 7778654332 222456778999999999999999999886 46
Q ss_pred ceEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhh
Q 005427 135 NYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYREN 214 (697)
Q Consensus 135 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~ 214 (697)
..++||||+.+|+|.+++......+++..++.++.|++.||+|||+.||+||||||+|||++.++.+||+|||+++....
T Consensus 88 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 167 (325)
T 3kex_A 88 SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPP 167 (325)
T ss_dssp SEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred ccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccCc
Confidence 78999999999999999987656789999999999999999999999999999999999999999999999999976542
Q ss_pred hhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCCchhHHHHHHHHhc
Q 005427 215 LKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEM 293 (697)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~~~~~~~~~~~~~~ 293 (697)
... ........||+.|+|||++.+..++.++|||||||++|+|++ |..||.+.........+..
T Consensus 168 ~~~--------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~- 232 (325)
T 3kex_A 168 DDK--------------QLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEK- 232 (325)
T ss_dssp CTT--------------CCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHT-
T ss_pred ccc--------------cccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHc-
Confidence 111 112344568889999999999999999999999999999999 9999987654443332221
Q ss_pred cccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 005427 294 NYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH 355 (697)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~ 355 (697)
..++ ..+..++.++.++|.+||+.||.+|||+.+++++|..+...
T Consensus 233 --------------~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 233 --------------GERL---AQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp --------------TCBC---CCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred --------------CCCC---CCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 1111 12345778899999999999999999999999999887643
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=354.91 Aligned_cols=257 Identities=26% Similarity=0.410 Sum_probs=210.6
Q ss_pred cCCCCCCCcccccccccCCceEEEEEEECCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccccC-CceEE
Q 005427 60 PLHLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKP-PNYMF 138 (697)
Q Consensus 60 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-~~~~l 138 (697)
.+.+..++|++.+.||+|+||.||++.++++.||||...... ..+.+.+|+.+++.++||||+++++++... ..+++
T Consensus 15 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~l 92 (278)
T 1byg_A 15 GWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 92 (278)
T ss_dssp CCBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEE
T ss_pred cccCChhhceEEeEEecCCCceEEEEEEcCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEE
Confidence 356677899999999999999999999999999999875433 457789999999999999999999986554 57999
Q ss_pred EEeecCCCCHhhhhhhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhh
Q 005427 139 FFEFYESRNLAEKLHVEEW-SPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKE 217 (697)
Q Consensus 139 v~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~ 217 (697)
||||+.+++|.+++..... .+++.+++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||++......
T Consensus 93 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-- 170 (278)
T 1byg_A 93 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 170 (278)
T ss_dssp EECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred EEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccccccccc--
Confidence 9999999999999976532 3788999999999999999999999999999999999999999999999998654321
Q ss_pred hhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCCchhHHHHHHHHhcccc
Q 005427 218 ISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYT 296 (697)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~~~~~~~~~~~~~~~~~ 296 (697)
.....+++.|+|||++.+..++.++||||||+++|+|++ |..||...........+.
T Consensus 171 -----------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~----- 228 (278)
T 1byg_A 171 -----------------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE----- 228 (278)
T ss_dssp ----------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHT-----
T ss_pred -----------------ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-----
Confidence 123457889999999999999999999999999999998 999998765433322221
Q ss_pred HHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 005427 297 EQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH 355 (697)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~ 355 (697)
.+.+ ...+..+++.+.++|.+||+.||.+|||+.++++.|..+..+
T Consensus 229 ----------~~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 229 ----------KGYK---MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp ----------TTCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----------cCCC---CCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 1111 123457899999999999999999999999999999988754
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=365.90 Aligned_cols=272 Identities=24% Similarity=0.275 Sum_probs=210.3
Q ss_pred CCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCCh-----HHHHHHHHHHHHHHhc---CCCCceEEeeccccC
Q 005427 64 PPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTS-----EELDNFHKELQLLCKL---DHPGLAKFVAAHAKP 133 (697)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l---~hpniv~l~~~~~~~ 133 (697)
..++|++.++||+|+||+||+|++ +++.||+|++..... .....+.+|+.+++.+ +||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 457999999999999999999996 688999998653321 1124566777777766 499999999998776
Q ss_pred C-----ceEEEEeecCCCCHhhhhhhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeec
Q 005427 134 P-----NYMFFFEFYESRNLAEKLHVEEW-SPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFG 207 (697)
Q Consensus 134 ~-----~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg 207 (697)
. .++++|||+. ++|.+++..... .+++.+++.++.|++.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg 165 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFG 165 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCS
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCc
Confidence 5 4899999997 599999876543 38999999999999999999999999999999999999999999999999
Q ss_pred cchhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHH
Q 005427 208 LAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQA 287 (697)
Q Consensus 208 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~ 287 (697)
++...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.......
T Consensus 166 ~a~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~ 228 (308)
T 3g33_A 166 LARIYSYQ-----------------MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQL 228 (308)
T ss_dssp CTTTSTTC-----------------CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHH
T ss_pred cccccCCC-----------------cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 99754321 1234567999999999999999999999999999999999999999987766665
Q ss_pred HHHHhccccHHHHHH--------HHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 005427 288 HTVLEMNYTEQQLTA--------AVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL 353 (697)
Q Consensus 288 ~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~ 353 (697)
..+...........+ .................+++++.+||.+||+.||.+|||+.|+++|.|+..
T Consensus 229 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~ 302 (308)
T 3g33_A 229 GKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHK 302 (308)
T ss_dssp HHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC--
T ss_pred HHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccC
Confidence 555432111000000 000000011112233568899999999999999999999999999988754
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-43 Score=364.65 Aligned_cols=263 Identities=22% Similarity=0.381 Sum_probs=211.1
Q ss_pred cCCCCCCCcccccccccCCceEEEEEEE--CCee----EEEEeccCC-ChHHHHHHHHHHHHHHhcCCCCceEEeecccc
Q 005427 60 PLHLPPSSYTLLSPIARGAESVVYEATL--DGRK----VAVKKPILS-TSEELDNFHKELQLLCKLDHPGLAKFVAAHAK 132 (697)
Q Consensus 60 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~----vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 132 (697)
.-.+..++|++.++||+|+||.||+|++ +++. |++|..... .......+.+|+.+++.++||||+++++++..
T Consensus 9 ~~~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 88 (327)
T 3lzb_A 9 LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT 88 (327)
T ss_dssp CEECCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEES
T ss_pred hcccCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEec
Confidence 3346678999999999999999999987 4443 577765432 23346788999999999999999999999987
Q ss_pred CCceEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhh
Q 005427 133 PPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYR 212 (697)
Q Consensus 133 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~ 212 (697)
. ..++++||+.+|+|.+++......+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 89 ~-~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 89 S-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp S-SEEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred C-CceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 5 488999999999999999887778999999999999999999999999999999999999999999999999999765
Q ss_pred hhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCCchhHHHHHHHH
Q 005427 213 ENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVL 291 (697)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~~~~~~~~~~~~ 291 (697)
..... ........+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.........+.
T Consensus 168 ~~~~~--------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~ 233 (327)
T 3lzb_A 168 GAEEK--------------EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233 (327)
T ss_dssp --------------------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH
T ss_pred cCccc--------------cccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH
Confidence 43111 112234467889999999999999999999999999999999 999998765544332221
Q ss_pred hccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 005427 292 EMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH 355 (697)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~ 355 (697)
. +. ++ ..+..++.++.++|.+||+.||.+|||+.|+++.|..+...
T Consensus 234 ~--------------~~-~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 234 K--------------GE-RL---PQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp T--------------TC-CC---CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred c--------------CC-CC---CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 1 11 11 12446889999999999999999999999999999988754
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-43 Score=384.94 Aligned_cols=254 Identities=24% Similarity=0.342 Sum_probs=213.5
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccCC--ChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEe
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFE 141 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 141 (697)
++|+++++||+|+||+||+|++ +++.||||++... .......+.+|+.+|++++||||+++++++.+...+++|||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 101 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEE
Confidence 5799999999999999999998 5889999986432 12235678999999999999999999999999999999999
Q ss_pred ecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeec---CCCCCeeeeeccchhhhhhhhh
Q 005427 142 FYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLD---RNLCPHLADFGLAEYRENLKEI 218 (697)
Q Consensus 142 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~---~~~~~kL~Dfg~a~~~~~~~~~ 218 (697)
||.+|+|.+.+.... .+++.+++.++.|++.||.|||++||+||||||+|||++ .++.+||+|||++.......
T Consensus 102 ~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~-- 178 (486)
T 3mwu_A 102 LYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT-- 178 (486)
T ss_dssp CCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC---
T ss_pred cCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCC--
Confidence 999999999987654 789999999999999999999999999999999999995 45679999999997553211
Q ss_pred hcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHH
Q 005427 219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQ 298 (697)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~ 298 (697)
.....+||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.........+....
T Consensus 179 ---------------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~---- 238 (486)
T 3mwu_A 179 ---------------KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGK---- 238 (486)
T ss_dssp ------------------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC----
T ss_pred ---------------ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC----
Confidence 1345579999999999976 48999999999999999999999998876655544443322
Q ss_pred HHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 005427 299 QLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL 353 (697)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~ 353 (697)
.....+ .+..+|+++.+||.+||+.||.+|||+.++++|+|...
T Consensus 239 ----------~~~~~~-~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~ 282 (486)
T 3mwu_A 239 ----------YAFDLP-QWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK 282 (486)
T ss_dssp ----------CCSCSG-GGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHH
T ss_pred ----------CCCCCc-ccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhcc
Confidence 221111 23468999999999999999999999999999999854
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-43 Score=363.13 Aligned_cols=273 Identities=21% Similarity=0.323 Sum_probs=209.9
Q ss_pred CCCCcccccccccCCceEEEEEEEC--CeeEEEEeccCCC-hHHHHHHHHHHHHHHhcCCCCceEEeeccccCC--ceEE
Q 005427 64 PPSSYTLLSPIARGAESVVYEATLD--GRKVAVKKPILST-SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPP--NYMF 138 (697)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~--~~~l 138 (697)
..++|++.++||+|+||.||+|++. ++.||||++.... ....+.+.+|+.+|+.++||||+++++++.... ..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (319)
T 4euu_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (319)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEE
Confidence 3568999999999999999999984 8899999865432 233567889999999999999999999987655 7899
Q ss_pred EEeecCCCCHhhhhhhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceee----cCCCCCeeeeeccchhh
Q 005427 139 FFEFYESRNLAEKLHVEEW--SPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLL----DRNLCPHLADFGLAEYR 212 (697)
Q Consensus 139 v~e~~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill----~~~~~~kL~Dfg~a~~~ 212 (697)
||||+.+++|.+++..... .+++.+++.++.|++.||+|||+.||+||||||+|||+ +.++.+||+|||+++..
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~ 166 (319)
T 4euu_A 87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166 (319)
T ss_dssp EEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEEC
T ss_pred EEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCceec
Confidence 9999999999999976432 38999999999999999999999999999999999999 77888999999999765
Q ss_pred hhhhhhhcccccCCCCCCCCccccccccCccccchhhhc--------ccCCCchhhHHHHHHHHHHHHhCCCCCCCchhH
Q 005427 213 ENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILK--------KEIHSEKSDVYSFGISINELLTGVVPYTDLRAE 284 (697)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~ 284 (697)
.... ......||+.|+|||++. +..++.++|||||||++|||++|..||......
T Consensus 167 ~~~~-----------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~ 229 (319)
T 4euu_A 167 EDDE-----------------QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP 229 (319)
T ss_dssp CTTC-----------------CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCG
T ss_pred CCCC-----------------ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcc
Confidence 4211 123457999999999986 567889999999999999999999999754322
Q ss_pred H----HHHHHHhccccHHHH-HHHHHhC-----CCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 005427 285 A----QAHTVLEMNYTEQQL-TAAVVSG-----GLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL 353 (697)
Q Consensus 285 ~----~~~~~~~~~~~~~~~-~~~~~~~-----~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~ 353 (697)
. ....+.......... ....... ...+....++..++..+.++|++||+.||++|||++|+++|+....
T Consensus 230 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 230 RRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp GGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred chhHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 2 222222111000000 0000000 0001111223346778999999999999999999999999987653
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=365.93 Aligned_cols=258 Identities=23% Similarity=0.341 Sum_probs=206.9
Q ss_pred CCCCCCcccccccccCCceEEEEEEE-CCeeEEEEeccCC--ChHHHHHHHHHHHHHHhcCC--CCceEEeeccccCCce
Q 005427 62 HLPPSSYTLLSPIARGAESVVYEATL-DGRKVAVKKPILS--TSEELDNFHKELQLLCKLDH--PGLAKFVAAHAKPPNY 136 (697)
Q Consensus 62 ~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h--pniv~l~~~~~~~~~~ 136 (697)
.+..++|++.++||+|+||.||++.+ +++.||||++... .....+.+.+|+.+|+.++| |||+++++++.+...+
T Consensus 5 ~~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~ 84 (343)
T 3dbq_A 5 SVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 84 (343)
T ss_dssp ESSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred eeecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEE
Confidence 45678899999999999999999987 6788999986544 34456789999999999986 9999999999999999
Q ss_pred EEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhh
Q 005427 137 MFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLK 216 (697)
Q Consensus 137 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~ 216 (697)
++||| +.+++|.+++.... .+++.+++.++.|++.||.|||+.||+||||||+|||++ ++.+||+|||++.......
T Consensus 85 ~lv~e-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~ 161 (343)
T 3dbq_A 85 YMVME-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 161 (343)
T ss_dssp EEEEC-CCSEEHHHHHHHSC-CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC----
T ss_pred EEEEe-CCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCccc
Confidence 99999 56789999997654 789999999999999999999999999999999999997 5789999999997654211
Q ss_pred hhhcccccCCCCCCCCccccccccCccccchhhhcc-----------cCCCchhhHHHHHHHHHHHHhCCCCCCCchhHH
Q 005427 217 EISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-----------EIHSEKSDVYSFGISINELLTGVVPYTDLRAEA 285 (697)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~ 285 (697)
. .......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.....
T Consensus 162 ~--------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~ 227 (343)
T 3dbq_A 162 T--------------SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI 227 (343)
T ss_dssp ----------------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH
T ss_pred c--------------cccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHH
Confidence 1 112335679999999999865 678999999999999999999999997643221
Q ss_pred -HHHHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 005427 286 -QAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL 353 (697)
Q Consensus 286 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~ 353 (697)
....+ ...... ...+...+.++.+||.+||+.||.+|||+.|+++|+|...
T Consensus 228 ~~~~~~--------------~~~~~~---~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~ 279 (343)
T 3dbq_A 228 SKLHAI--------------IDPNHE---IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 279 (343)
T ss_dssp HHHHHH--------------HCTTSC---CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHS
T ss_pred HHHHHH--------------hcCCcc---cCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccc
Confidence 11111 111111 1233456789999999999999999999999999999864
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=362.24 Aligned_cols=265 Identities=26% Similarity=0.398 Sum_probs=220.3
Q ss_pred cCCCCCCCcccccccccCCceEEEEEEECC-------eeEEEEeccCCC-hHHHHHHHHHHHHHHhc-CCCCceEEeecc
Q 005427 60 PLHLPPSSYTLLSPIARGAESVVYEATLDG-------RKVAVKKPILST-SEELDNFHKELQLLCKL-DHPGLAKFVAAH 130 (697)
Q Consensus 60 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~l~~~~ 130 (697)
.+++..++|++.+.||+|+||.||+|.+.+ ..||+|...... ....+.+.+|+.+|+.+ +||||+++++++
T Consensus 40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 119 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC 119 (333)
T ss_dssp GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 467888999999999999999999998732 379999876543 34567899999999999 899999999999
Q ss_pred ccCCceEEEEeecCCCCHhhhhhhc-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecC
Q 005427 131 AKPPNYMFFFEFYESRNLAEKLHVE-------------EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDR 197 (697)
Q Consensus 131 ~~~~~~~lv~e~~~~g~L~~~l~~~-------------~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~ 197 (697)
.+...+++||||+++|+|.+++... ...+++..++.++.|++.||.|||+.||+||||||+|||++.
T Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~ 199 (333)
T 2i1m_A 120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTN 199 (333)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEG
T ss_pred ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECC
Confidence 9999999999999999999998653 235789999999999999999999999999999999999999
Q ss_pred CCCCeeeeeccchhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCC
Q 005427 198 NLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVV 276 (697)
Q Consensus 198 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~ 276 (697)
++.+||+|||++........ ........||+.|+|||++.+..++.++|||||||++|+|++ |..
T Consensus 200 ~~~~kl~Dfg~~~~~~~~~~--------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~ 265 (333)
T 2i1m_A 200 GHVAKIGDFGLARDIMNDSN--------------YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLN 265 (333)
T ss_dssp GGEEEBCCCGGGCCGGGCTT--------------SEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCC
T ss_pred CCeEEECccccccccccccc--------------eeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCC
Confidence 99999999999976543111 112334567889999999999999999999999999999998 999
Q ss_pred CCCCchhHHHHHHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 005427 277 PYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH 355 (697)
Q Consensus 277 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~ 355 (697)
||.+............. ...+ ..+..+++.+.++|.+||+.||.+|||+.+++++|..+.+.
T Consensus 266 p~~~~~~~~~~~~~~~~--------------~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 327 (333)
T 2i1m_A 266 PYPGILVNSKFYKLVKD--------------GYQM---AQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE 327 (333)
T ss_dssp SSTTCCSSHHHHHHHHH--------------TCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCcccchhHHHHHHHhc--------------CCCC---CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence 99875443332222211 1111 12345789999999999999999999999999999888764
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=365.11 Aligned_cols=275 Identities=18% Similarity=0.211 Sum_probs=212.8
Q ss_pred CCCCCcccccccccCCceEEEEEEEC-------CeeEEEEeccCCChHH-----------HHHHHHHHHHHHhcCCCCce
Q 005427 63 LPPSSYTLLSPIARGAESVVYEATLD-------GRKVAVKKPILSTSEE-----------LDNFHKELQLLCKLDHPGLA 124 (697)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~hpniv 124 (697)
+..++|++.++||+|+||.||+|.+. ++.||||+........ ...+..|+..++.++||||+
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv 111 (364)
T 3op5_A 32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP 111 (364)
T ss_dssp TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence 44568999999999999999999873 4689999866554221 11234566677788999999
Q ss_pred EEeeccccC----CceEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeec--CC
Q 005427 125 KFVAAHAKP----PNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLD--RN 198 (697)
Q Consensus 125 ~l~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~--~~ 198 (697)
++++++... ...++||||+ +++|.+++......+++.+++.++.||+.||+|||+.||+||||||+|||++ .+
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~ 190 (364)
T 3op5_A 112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNP 190 (364)
T ss_dssp CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCT
T ss_pred eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCC
Confidence 999998765 4589999999 8999999987766899999999999999999999999999999999999998 88
Q ss_pred CCCeeeeeccchhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCC
Q 005427 199 LCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278 (697)
Q Consensus 199 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf 278 (697)
+.+||+|||+++.+...... ............||+.|+|||++.+..++.++|||||||++|||++|..||
T Consensus 191 ~~~kl~DFG~a~~~~~~~~~---------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf 261 (364)
T 3op5_A 191 DQVYLVDYGLAYRYCPEGVH---------KAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPW 261 (364)
T ss_dssp TCEEECCCTTCEESSGGGCC---------CCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTT
T ss_pred CeEEEEECCcceecccCCcc---------cccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence 99999999999766532210 011111234567999999999999999999999999999999999999999
Q ss_pred CCchhHHHHHHHHhccc--cHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHh
Q 005427 279 TDLRAEAQAHTVLEMNY--TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHR 356 (697)
Q Consensus 279 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~~ 356 (697)
.+..............+ ....+.... + ....+|+++.+++..||+.||.+||++.+|++.|..+++..
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~--~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~ 331 (364)
T 3op5_A 262 EDNLKDPKYVRDSKIRYRENIASLMDKC--------F--PAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAI 331 (364)
T ss_dssp GGGTTCHHHHHHHHHHHHHCHHHHHHHH--------S--CTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred cccccCHHHHHHHHHHhhhhHHHHHHHh--------c--ccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Confidence 86433322222111111 111111000 0 12468999999999999999999999999999999988754
Q ss_pred c
Q 005427 357 K 357 (697)
Q Consensus 357 ~ 357 (697)
.
T Consensus 332 ~ 332 (364)
T 3op5_A 332 G 332 (364)
T ss_dssp T
T ss_pred C
Confidence 3
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=354.89 Aligned_cols=255 Identities=31% Similarity=0.473 Sum_probs=207.0
Q ss_pred CCCCCcccccccccCCceEEEEEEECCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEee
Q 005427 63 LPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF 142 (697)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 142 (697)
+..++|++.+.||+|+||.||++++.++.||+|++.. ....+.+.+|+.+|++++||||+++++++.+ ..++||||
T Consensus 5 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~ 80 (307)
T 2eva_A 5 IDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIES--ESERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEY 80 (307)
T ss_dssp CCGGGEEEEEEEECCSSSEEEEEEETTEEEEEEECSS--TTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEEC
T ss_pred CCHhHeeeeeEeecCCCceEEEEEECCeeEEEEEecC--hhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEc
Confidence 4557899999999999999999999999999998653 3456789999999999999999999999874 48999999
Q ss_pred cCCCCHhhhhhhcCC--CCCHHHHHHHHHHHHHHHHHHHh---CCcccccCCCCceeecCCCC-Ceeeeeccchhhhhhh
Q 005427 143 YESRNLAEKLHVEEW--SPSVDQVLMIAAQLAKALQYLHN---LGIVHRDVKPANVLLDRNLC-PHLADFGLAEYRENLK 216 (697)
Q Consensus 143 ~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~-~kL~Dfg~a~~~~~~~ 216 (697)
+++|+|.+++..... .+++..++.++.|++.||.|||+ +||+||||||+|||++.++. +||+|||++.....
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~-- 158 (307)
T 2eva_A 81 AEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT-- 158 (307)
T ss_dssp CTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--------
T ss_pred CCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccc--
Confidence 999999999976542 46889999999999999999999 89999999999999998887 79999999865432
Q ss_pred hhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhcccc
Q 005427 217 EISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYT 296 (697)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~ 296 (697)
......||+.|+|||++.+..++.++||||||+++|+|++|..||........
T Consensus 159 -----------------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~---------- 211 (307)
T 2eva_A 159 -----------------HMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF---------- 211 (307)
T ss_dssp -----------------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH----------
T ss_pred -----------------ccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH----------
Confidence 12234689999999999999999999999999999999999999975432211
Q ss_pred HHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHh
Q 005427 297 EQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHR 356 (697)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~~ 356 (697)
........+. ++ ..+..+|..+.+++.+||+.||.+|||+.+++++|..+.+..
T Consensus 212 --~~~~~~~~~~-~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 265 (307)
T 2eva_A 212 --RIMWAVHNGT-RP---PLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF 265 (307)
T ss_dssp --HHHHHHHTTC-CC---CCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGC
T ss_pred --HHHHHHhcCC-CC---CcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhc
Confidence 1111111111 11 234578999999999999999999999999999998886543
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-43 Score=371.00 Aligned_cols=265 Identities=23% Similarity=0.311 Sum_probs=199.1
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccCC--ChHHHHHHHHHHHHHHhcCCCCceEEeeccccC------Cc
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKP------PN 135 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~------~~ 135 (697)
++|++++.||+|+||.||+|.+ +++.||||++... .......+.+|+.+|+.++||||+++++++... ..
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 108 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 108 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence 6899999999999999999987 6889999986543 344567889999999999999999999998654 56
Q ss_pred eEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhh
Q 005427 136 YMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL 215 (697)
Q Consensus 136 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~ 215 (697)
+++++|++ +++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....
T Consensus 109 ~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~- 184 (367)
T 2fst_X 109 VYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD- 184 (367)
T ss_dssp CEEEEECC-CEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC----------
T ss_pred EEEEeccc-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccccccccc-
Confidence 89999998 6799998865 3689999999999999999999999999999999999999999999999999975432
Q ss_pred hhhhcccccCCCCCCCCccccccccCccccchhhhcc-cCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhcc
Q 005427 216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMN 294 (697)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~ 294 (697)
......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+....
T Consensus 185 ------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~ 246 (367)
T 2fst_X 185 ------------------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 246 (367)
T ss_dssp ------------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred ------------------cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 1234679999999999987 678999999999999999999999999887776666655432
Q ss_pred ccHHHH---------HHHHHhC---CCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 295 YTEQQL---------TAAVVSG---GLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 295 ~~~~~~---------~~~~~~~---~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
...... ....... .....+.......++++.+||.+||+.||.+|||+.|+++|.|+.
T Consensus 247 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~ 316 (367)
T 2fst_X 247 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 316 (367)
T ss_dssp CSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGT
T ss_pred CCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhh
Confidence 221110 0001100 011112223346789999999999999999999999999998864
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=364.64 Aligned_cols=272 Identities=22% Similarity=0.301 Sum_probs=219.7
Q ss_pred CCCCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCC-ChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEE
Q 005427 62 HLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS-TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMF 138 (697)
Q Consensus 62 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 138 (697)
++..++|++.++||+|+||.||+|.+ +++.||+|++... .....+.+.+|+.+|+.++||||+++++++.+...+++
T Consensus 29 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 108 (360)
T 3eqc_A 29 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 108 (360)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred ccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEE
Confidence 45567899999999999999999998 4889999987655 34446789999999999999999999999999999999
Q ss_pred EEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccccCCCCceeecCCCCCeeeeeccchhhhhhhh
Q 005427 139 FFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL-GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKE 217 (697)
Q Consensus 139 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~ 217 (697)
||||+++++|.+++.... .+++..+..++.|++.||.|||+. ||+||||||+|||++.++.+||+|||++......
T Consensus 109 v~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 185 (360)
T 3eqc_A 109 CMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 185 (360)
T ss_dssp EECCCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred EEECCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc--
Confidence 999999999999997655 689999999999999999999996 9999999999999999999999999999765421
Q ss_pred hhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhc----
Q 005427 218 ISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEM---- 293 (697)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~---- 293 (697)
......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+...
T Consensus 186 ----------------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 249 (360)
T 3eqc_A 186 ----------------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGD 249 (360)
T ss_dssp ----------------C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------
T ss_pred ----------------cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccccccc
Confidence 123457999999999999999999999999999999999999999876544432211000
Q ss_pred ------------------------cccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 005427 294 ------------------------NYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALEL 349 (697)
Q Consensus 294 ------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l 349 (697)
................ +. ..+..++.++.+||.+||+.||.+|||+.|+++|.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 326 (360)
T 3eqc_A 250 AAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPP-PK--LPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA 326 (360)
T ss_dssp ------------------------CCCHHHHHHHHHHSCC-CC--CCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSH
T ss_pred CCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCC-CC--CCcccccHHHHHHHHHHhhcChhhCCCHHHHhhCh
Confidence 0000111111222211 11 11235789999999999999999999999999999
Q ss_pred HHHHHH
Q 005427 350 DLVLEH 355 (697)
Q Consensus 350 ~~~~~~ 355 (697)
|+....
T Consensus 327 ~~~~~~ 332 (360)
T 3eqc_A 327 FIKRSD 332 (360)
T ss_dssp HHHHHH
T ss_pred Hhhcch
Confidence 987543
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=383.78 Aligned_cols=254 Identities=26% Similarity=0.334 Sum_probs=210.8
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccCCC--hHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEe
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST--SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFE 141 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 141 (697)
++|+++++||+|+||+||+|++ ++..||+|++.... ......+.+|+.+|+.++||||+++++++.+...+++|||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 116 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME 116 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 4699999999999999999998 57889999865432 2235678999999999999999999999999999999999
Q ss_pred ecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecC---CCCCeeeeeccchhhhhhhhh
Q 005427 142 FYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDR---NLCPHLADFGLAEYRENLKEI 218 (697)
Q Consensus 142 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~---~~~~kL~Dfg~a~~~~~~~~~ 218 (697)
||.+|+|.+.+.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++.......
T Consensus 117 ~~~~g~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~-- 193 (494)
T 3lij_A 117 CYKGGELFDEIIHRM-KFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK-- 193 (494)
T ss_dssp CCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB--
T ss_pred cCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc--
Confidence 999999999887654 6899999999999999999999999999999999999976 4559999999997654211
Q ss_pred hcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHH
Q 005427 219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQ 298 (697)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~ 298 (697)
.....+||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.........+....+
T Consensus 194 ---------------~~~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~--- 254 (494)
T 3lij_A 194 ---------------KMKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKY--- 254 (494)
T ss_dssp ---------------CBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC---
T ss_pred ---------------cccccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC---
Confidence 2345679999999999864 589999999999999999999999998766555544433222
Q ss_pred HHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 005427 299 QLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL 353 (697)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~ 353 (697)
.. .......+|+++.+||++||+.||.+|||+.++++|+|...
T Consensus 255 -----------~~-~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 297 (494)
T 3lij_A 255 -----------TF-DSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKE 297 (494)
T ss_dssp -----------CC-CSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHH
T ss_pred -----------CC-CchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCccccc
Confidence 11 12223578999999999999999999999999999999864
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-43 Score=369.45 Aligned_cols=261 Identities=26% Similarity=0.337 Sum_probs=210.0
Q ss_pred CCCcccccccccCCceEEEEEEE--CCeeEEEEeccCC-----ChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceE
Q 005427 65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS-----TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYM 137 (697)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 137 (697)
.++|++.+.||+|+||.||+|.+ +++.||+|++... .....+.+.+|+.+|+.++||||+++++++.+....+
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 104 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC 104 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEE
Confidence 46799999999999999999987 5778999976432 2345678999999999999999999999999999999
Q ss_pred EEEeecCCCCHhhhhhhc---------------------------------------CCCCCHHHHHHHHHHHHHHHHHH
Q 005427 138 FFFEFYESRNLAEKLHVE---------------------------------------EWSPSVDQVLMIAAQLAKALQYL 178 (697)
Q Consensus 138 lv~e~~~~g~L~~~l~~~---------------------------------------~~~~~~~~~~~i~~qi~~~l~~L 178 (697)
+||||+++|+|.+++... ...+++..++.++.|++.||+||
T Consensus 105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L 184 (345)
T 3hko_A 105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL 184 (345)
T ss_dssp EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence 999999999999988521 11235678899999999999999
Q ss_pred HhCCcccccCCCCceeecCCC--CCeeeeeccchhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcc--cC
Q 005427 179 HNLGIVHRDVKPANVLLDRNL--CPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK--EI 254 (697)
Q Consensus 179 H~~~ivHrDlkp~Nill~~~~--~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~ 254 (697)
|+.||+||||||+|||++.++ .+||+|||++..+..... ..........||+.|+|||++.+ ..
T Consensus 185 H~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~------------~~~~~~~~~~gt~~y~aPE~~~~~~~~ 252 (345)
T 3hko_A 185 HNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNN------------GEYYGMTTKAGTPYFVAPEVLNTTNES 252 (345)
T ss_dssp HHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTC------------C--------CCCGGGCCHHHHTCSSSC
T ss_pred HHCCccccCCChhhEEEecCCCceEEEeeccccccccccCc------------cccccccccCCCccccCchhhccCCCC
Confidence 999999999999999998766 899999999976543111 01112345679999999999975 67
Q ss_pred CCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccC
Q 005427 255 HSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDG 334 (697)
Q Consensus 255 ~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 334 (697)
++.++|||||||++|+|++|..||.+.........+..... .. .......+++++.+||.+||+.
T Consensus 253 ~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~--------------~~-~~~~~~~~~~~~~~li~~~l~~ 317 (345)
T 3hko_A 253 YGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKL--------------CF-ENPNYNVLSPLARDLLSNLLNR 317 (345)
T ss_dssp CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--------------CT-TSGGGGGSCHHHHHHHHHHSCS
T ss_pred CCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhccc--------------cc-CCcccccCCHHHHHHHHHHcCC
Confidence 89999999999999999999999988766555544433221 11 1112235789999999999999
Q ss_pred CCCCCCCHHHHHHHHHHH
Q 005427 335 NPHNRPSFSDIALELDLV 352 (697)
Q Consensus 335 dP~~Rpt~~ell~~l~~~ 352 (697)
||.+|||+.++++|.|+-
T Consensus 318 ~p~~Rps~~~~l~hp~~~ 335 (345)
T 3hko_A 318 NVDERFDAMRALQHPWIS 335 (345)
T ss_dssp CTTTSCCHHHHHHSHHHH
T ss_pred ChhHCCCHHHHhcChhhc
Confidence 999999999999999874
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=355.10 Aligned_cols=254 Identities=21% Similarity=0.354 Sum_probs=216.3
Q ss_pred CCCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCCh---HHHHHHHHHHHHHHhcCCCCceEEeeccccCCceE
Q 005427 63 LPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTS---EELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYM 137 (697)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 137 (697)
+..++|++.+.||+|+||.||+|++ +++.||+|++..... .....+.+|+.+++.++||||+++++++.+...++
T Consensus 11 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 90 (284)
T 2vgo_A 11 FTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIY 90 (284)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEE
Confidence 4456899999999999999999998 478899998643321 12467899999999999999999999999999999
Q ss_pred EEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhh
Q 005427 138 FFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKE 217 (697)
Q Consensus 138 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~ 217 (697)
+||||+.+++|.+++.... .+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||++.....
T Consensus 91 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~--- 166 (284)
T 2vgo_A 91 LMLEFAPRGELYKELQKHG-RFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS--- 166 (284)
T ss_dssp EEECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSS---
T ss_pred EEEEeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCcc---
Confidence 9999999999999997654 689999999999999999999999999999999999999999999999999854331
Q ss_pred hhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccH
Q 005427 218 ISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTE 297 (697)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~ 297 (697)
.......|++.|+|||++.+..++.++||||||+++|+|++|..||...........+.....
T Consensus 167 ---------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-- 229 (284)
T 2vgo_A 167 ---------------LRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDL-- 229 (284)
T ss_dssp ---------------SCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC--
T ss_pred ---------------cccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhcccc--
Confidence 112345799999999999999999999999999999999999999987655444333322111
Q ss_pred HHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 005427 298 QQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE 354 (697)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~ 354 (697)
..+..++.++.++|.+||+.||.+|||+.++++|.|....
T Consensus 230 -----------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~ 269 (284)
T 2vgo_A 230 -----------------KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKAN 269 (284)
T ss_dssp -----------------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHH
T ss_pred -----------------CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhh
Confidence 1235688999999999999999999999999999988654
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=378.57 Aligned_cols=286 Identities=22% Similarity=0.253 Sum_probs=196.9
Q ss_pred CCCcccccccccCCceEEEEEEE--CCeeEEEEeccC--CChHHHHHHHHHHHHHHhcCCCCceEEeecccc-----CCc
Q 005427 65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPIL--STSEELDNFHKELQLLCKLDHPGLAKFVAAHAK-----PPN 135 (697)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-----~~~ 135 (697)
.++|+++++||+|+||.||+|++ +++.||||++.. ......+.+.+|+.+|+.++||||+++++++.. ...
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 47899999999999999999987 578999998654 234556789999999999999999999999843 357
Q ss_pred eEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhh
Q 005427 136 YMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL 215 (697)
Q Consensus 136 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~ 215 (697)
+|+||||+. ++|.+++... ..+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++.....
T Consensus 132 ~~lv~e~~~-~~L~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 209 (458)
T 3rp9_A 132 LYVVLEIAD-SDFKKLFRTP-VYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYP 209 (458)
T ss_dssp EEEEECCCS-EEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSC
T ss_pred EEEEEeccc-cchhhhcccC-CCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccCc
Confidence 999999985 6999988654 37899999999999999999999999999999999999999999999999999866432
Q ss_pred hhhhcccccC-----------CCCCCCCccccccccCccccchhhh-cccCCCchhhHHHHHHHHHHHHh----------
Q 005427 216 KEISLKNWRS-----------SGKPTGGFHKKNMVGTLIYMAPEIL-KKEIHSEKSDVYSFGISINELLT---------- 273 (697)
Q Consensus 216 ~~~~~~~~~~-----------~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~~l~ell~---------- 273 (697)
.......... .............+||+.|+|||++ .+..++.++|||||||+||||++
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~ 289 (458)
T 3rp9_A 210 ENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHA 289 (458)
T ss_dssp TTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGG
T ss_pred cccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccc
Confidence 1100000000 0000001123556899999999986 56679999999999999999998
Q ss_pred -CCCCCCCchh--------------------HHHHHHHHhccccH--HHH-------HHHHHh---CCCCCcccccccCC
Q 005427 274 -GVVPYTDLRA--------------------EAQAHTVLEMNYTE--QQL-------TAAVVS---GGLRPILASLELGL 320 (697)
Q Consensus 274 -g~~Pf~~~~~--------------------~~~~~~~~~~~~~~--~~~-------~~~~~~---~~~~~~~~~~~~~~ 320 (697)
|.++|.+... ..+...+....... ..+ ...... ......+......+
T Consensus 290 ~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 369 (458)
T 3rp9_A 290 DRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPAS 369 (458)
T ss_dssp GCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTS
T ss_pred cccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCC
Confidence 6777765431 11222221111110 000 000000 01111122233467
Q ss_pred hHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 321 PASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 321 ~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
++++.+||++||..||.+|||++|+++|.|+.
T Consensus 370 s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~ 401 (458)
T 3rp9_A 370 SADAIHLLKRMLVFNPNKRITINECLAHPFFK 401 (458)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGT
T ss_pred CHHHHHHHHHHhccCccccCCHHHHhcCHhhh
Confidence 89999999999999999999999999998875
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=361.08 Aligned_cols=262 Identities=23% Similarity=0.401 Sum_probs=219.1
Q ss_pred cCCCCCCCcccccccccCCceEEEEEEEC-------CeeEEEEeccCCC-hHHHHHHHHHHHHHHhcCCCCceEEeeccc
Q 005427 60 PLHLPPSSYTLLSPIARGAESVVYEATLD-------GRKVAVKKPILST-SEELDNFHKELQLLCKLDHPGLAKFVAAHA 131 (697)
Q Consensus 60 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~ 131 (697)
.+++..++|++.+.||+|+||.||+|.+. ++.||+|.+.... ......+.+|+.+++.++||||+++++++.
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 98 (322)
T 1p4o_A 19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 98 (322)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEc
Confidence 46677789999999999999999999754 5789999876443 345667899999999999999999999999
Q ss_pred cCCceEEEEeecCCCCHhhhhhhcC---------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCe
Q 005427 132 KPPNYMFFFEFYESRNLAEKLHVEE---------WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPH 202 (697)
Q Consensus 132 ~~~~~~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~k 202 (697)
+....++||||+.+|+|.+++.... ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+|
T Consensus 99 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~k 178 (322)
T 1p4o_A 99 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVK 178 (322)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEE
T ss_pred cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEE
Confidence 9999999999999999999986532 3568999999999999999999999999999999999999999999
Q ss_pred eeeeccchhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCCc
Q 005427 203 LADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDL 281 (697)
Q Consensus 203 L~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~~ 281 (697)
|+|||++......... .......||+.|+|||++.+..++.++|||||||++|+|++ |..||.+.
T Consensus 179 l~Dfg~~~~~~~~~~~--------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 244 (322)
T 1p4o_A 179 IGDFGMTRDIYETDYY--------------RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL 244 (322)
T ss_dssp ECCTTCCCGGGGGGCE--------------EGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS
T ss_pred ECcCcccccccccccc--------------ccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccC
Confidence 9999999765432110 01234567899999999999999999999999999999999 89999876
Q ss_pred hhHHHHHHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 005427 282 RAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL 353 (697)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~ 353 (697)
........+.. +.. ...+..+++.+.++|.+||+.||.+|||+.+++++|....
T Consensus 245 ~~~~~~~~~~~--------------~~~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~ 298 (322)
T 1p4o_A 245 SNEQVLRFVME--------------GGL----LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 298 (322)
T ss_dssp CHHHHHHHHHT--------------TCC----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred CHHHHHHHHHc--------------CCc----CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhh
Confidence 55444333322 111 1234578999999999999999999999999999887654
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=355.95 Aligned_cols=252 Identities=26% Similarity=0.372 Sum_probs=205.5
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccCCC-hHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEee
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST-SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF 142 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 142 (697)
++|.+.++||+|+||.||++.+ ++..+|+|++.... ....+.+.+|+++|+.++||||+++++++.+....++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 5799999999999999999987 57889999865432 23467889999999999999999999999999999999999
Q ss_pred cCCCCHhhhhhhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceee---cCCCCCeeeeeccchhhhhhh
Q 005427 143 YESRNLAEKLHVE---EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLL---DRNLCPHLADFGLAEYRENLK 216 (697)
Q Consensus 143 ~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill---~~~~~~kL~Dfg~a~~~~~~~ 216 (697)
+.+|+|.+.+... ...+++..++.++.|++.||+|||+.||+||||||+|||+ +.++.+||+|||++.......
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~ 181 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE 181 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-----
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCcc
Confidence 9999999988542 3578999999999999999999999999999999999999 456789999999997554211
Q ss_pred hhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhcccc
Q 005427 217 EISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYT 296 (697)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~ 296 (697)
......||+.|+|||++. ..++.++|||||||++|+|++|..||.+..............
T Consensus 182 -----------------~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~-- 241 (285)
T 3is5_A 182 -----------------HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKE-- 241 (285)
T ss_dssp ----------------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--
T ss_pred -----------------cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCC--
Confidence 123457999999999986 457899999999999999999999998865544333222111
Q ss_pred HHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 005427 297 EQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL 351 (697)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~ 351 (697)
+........+++++.+||.+||+.||.+|||+.|+++|.|+
T Consensus 242 --------------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f 282 (285)
T 3is5_A 242 --------------PNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWF 282 (285)
T ss_dssp --------------CCCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGG
T ss_pred --------------cccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHh
Confidence 11111223478999999999999999999999999988775
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=382.73 Aligned_cols=255 Identities=25% Similarity=0.323 Sum_probs=213.6
Q ss_pred CCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCCh-------------HHHHHHHHHHHHHHhcCCCCceEEeec
Q 005427 65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTS-------------EELDNFHKELQLLCKLDHPGLAKFVAA 129 (697)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~hpniv~l~~~ 129 (697)
.++|+++++||+|+||+||+|.+ +++.||+|++..... ...+.+.+|+.+|+.++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 46899999999999999999998 578899998654321 225678999999999999999999999
Q ss_pred cccCCceEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCC---CCeeeee
Q 005427 130 HAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNL---CPHLADF 206 (697)
Q Consensus 130 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~---~~kL~Df 206 (697)
+.+...+++|||||.+|+|.+.+.... .+++..++.++.||+.||.|||+.||+||||||+|||++.++ .+||+||
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Df 193 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIINRH-KFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDF 193 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCC
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEEC
Confidence 999999999999999999999987654 689999999999999999999999999999999999998776 6899999
Q ss_pred ccchhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHH
Q 005427 207 GLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQ 286 (697)
Q Consensus 207 g~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~ 286 (697)
|++...... ......+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+......
T Consensus 194 g~a~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 255 (504)
T 3q5i_A 194 GLSSFFSKD-----------------YKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDI 255 (504)
T ss_dssp TTCEECCTT-----------------SCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred CCCEEcCCC-----------------CccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 999765421 12345679999999999875 589999999999999999999999998776665
Q ss_pred HHHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 005427 287 AHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL 353 (697)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~ 353 (697)
...+....+. . ....+..+|+++.+||++||+.||.+|||+.|+++|.|...
T Consensus 256 ~~~i~~~~~~--------------~-~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 307 (504)
T 3q5i_A 256 IKKVEKGKYY--------------F-DFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKK 307 (504)
T ss_dssp HHHHHHCCCC--------------C-CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred HHHHHcCCCC--------------C-CccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhh
Confidence 5555433221 1 11123578999999999999999999999999999999854
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-43 Score=384.98 Aligned_cols=255 Identities=26% Similarity=0.327 Sum_probs=217.1
Q ss_pred CCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCC---hHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEE
Q 005427 65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST---SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFF 139 (697)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 139 (697)
.++|++.++||+|+||.||+|++ +++.||||++.... ....+.+.+|+.+|++++||||+++++++.+...+++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 46899999999999999999998 58899999864332 33467899999999999999999999999999999999
Q ss_pred EeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceee---cCCCCCeeeeeccchhhhhhh
Q 005427 140 FEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLL---DRNLCPHLADFGLAEYRENLK 216 (697)
Q Consensus 140 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill---~~~~~~kL~Dfg~a~~~~~~~ 216 (697)
|||+.+|+|.+.+.... .+++.+++.++.|++.||.|||++||+||||||+|||+ +.++.+||+|||++.......
T Consensus 105 ~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~ 183 (484)
T 3nyv_A 105 GEVYTGGELFDEIISRK-RFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK 183 (484)
T ss_dssp ECCCCSCBHHHHHHTCS-CCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCC
T ss_pred EecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccccc
Confidence 99999999999987654 78999999999999999999999999999999999999 567899999999997654211
Q ss_pred hhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhcccc
Q 005427 217 EISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYT 296 (697)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~ 296 (697)
.....+||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.........+....
T Consensus 184 -----------------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~-- 243 (484)
T 3nyv_A 184 -----------------KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGK-- 243 (484)
T ss_dssp -----------------SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--
T ss_pred -----------------ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC--
Confidence 1334579999999999976 58999999999999999999999999876655554443322
Q ss_pred HHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 005427 297 EQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL 353 (697)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~ 353 (697)
.....+ .+..+|+++.+||.+||+.||.+|||+.|+++|+|...
T Consensus 244 ------------~~~~~~-~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~ 287 (484)
T 3nyv_A 244 ------------YTFELP-QWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQT 287 (484)
T ss_dssp ------------CCCCSG-GGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHH
T ss_pred ------------CCCCCc-ccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhcc
Confidence 221111 23468999999999999999999999999999999864
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=360.47 Aligned_cols=248 Identities=24% Similarity=0.267 Sum_probs=202.1
Q ss_pred CCCcccccccccCCceEEEEEEE--CCeeEEEEeccCC--ChHHHHHHHHHHHHHHhc-CCCCceEEeeccccCCceEEE
Q 005427 65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS--TSEELDNFHKELQLLCKL-DHPGLAKFVAAHAKPPNYMFF 139 (697)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv 139 (697)
.++|++.++||+|+||+||+|++ +++.||||+.... ..........|+..+..+ +||||+++++++.+...+++|
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 36799999999999999999998 5889999986543 233444555666666555 999999999999999999999
Q ss_pred EeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhh
Q 005427 140 FEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEIS 219 (697)
Q Consensus 140 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~ 219 (697)
|||+ +++|.+++...+..+++.+++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 136 ~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~--- 211 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG--- 211 (311)
T ss_dssp EECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC------
T ss_pred Eecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCC---
Confidence 9999 569999988777789999999999999999999999999999999999999999999999999986543211
Q ss_pred cccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHH
Q 005427 220 LKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQ 299 (697)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~ 299 (697)
......||+.|+|||++.+ .++.++|||||||++|||++|..|+.+..... .+..
T Consensus 212 --------------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~~---~~~~------- 266 (311)
T 3p1a_A 212 --------------AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQ---QLRQ------- 266 (311)
T ss_dssp -----------------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHH---HHTT-------
T ss_pred --------------CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHH---HHhc-------
Confidence 1234569999999999886 68999999999999999999976665432211 1111
Q ss_pred HHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 005427 300 LTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL 351 (697)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~ 351 (697)
+. ..+..+..+++++.+||.+||+.||.+|||+.|+++|+|.
T Consensus 267 -------~~---~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~ 308 (311)
T 3p1a_A 267 -------GY---LPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVL 308 (311)
T ss_dssp -------TC---CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGG
T ss_pred -------cC---CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccc
Confidence 11 1122345789999999999999999999999999998875
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=358.05 Aligned_cols=264 Identities=25% Similarity=0.370 Sum_probs=206.3
Q ss_pred CCCCCcccccccccCCceEEEEEEECCeeEEEEeccCCChHHHHHHHHHHHHHHh--cCCCCceEEeecccc----CCce
Q 005427 63 LPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCK--LDHPGLAKFVAAHAK----PPNY 136 (697)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~hpniv~l~~~~~~----~~~~ 136 (697)
+..++|++.++||+|+||.||+|+++++.||||++... ....+..|.+++.. ++||||+++++++.. ...+
T Consensus 5 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 5 TVARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp CCGGGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred cccCcEEEEEeeccCCCcEEEEEEECCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 34578999999999999999999999999999986533 34556677777776 799999999998644 3568
Q ss_pred EEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHH--------hCCcccccCCCCceeecCCCCCeeeeecc
Q 005427 137 MFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLH--------NLGIVHRDVKPANVLLDRNLCPHLADFGL 208 (697)
Q Consensus 137 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH--------~~~ivHrDlkp~Nill~~~~~~kL~Dfg~ 208 (697)
++||||+.+|+|.+++... .+++..++.++.|++.||+||| +.||+||||||+|||++.++.+||+|||+
T Consensus 82 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 159 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQLT--TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGL 159 (301)
T ss_dssp EEEECCCTTCBHHHHHTTC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEehhhccCCCHHHHHhhc--ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCC
Confidence 9999999999999999543 6899999999999999999999 99999999999999999999999999999
Q ss_pred chhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhccc------CCCchhhHHHHHHHHHHHHhC--------
Q 005427 209 AEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKE------IHSEKSDVYSFGISINELLTG-------- 274 (697)
Q Consensus 209 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~~l~ell~g-------- 274 (697)
+......... .........||+.|+|||++.+. .++.++|||||||++|||++|
T Consensus 160 a~~~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~ 227 (301)
T 3q4u_A 160 AVMHSQSTNQ------------LDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVE 227 (301)
T ss_dssp CEEEETTTTE------------EECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCC
T ss_pred eeeccccccc------------ccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccc
Confidence 9755431110 00112345799999999999876 455799999999999999999
Q ss_pred --CCCCCCchhHHHHHHHHhccccHHHHHHHHHhCCCCCcccc--cccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 005427 275 --VVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILAS--LELGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350 (697)
Q Consensus 275 --~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~ 350 (697)
..||.+..... ...............++.++. .+..+++++.+|+.+||+.||.+|||+.++++.|.
T Consensus 228 ~~~~pf~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~ 298 (301)
T 3q4u_A 228 DYKPPFYDVVPND---------PSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT 298 (301)
T ss_dssp CCCCTTTTTSCSS---------CCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHH
T ss_pred cccccccccCCCC---------cchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHh
Confidence 88886532211 011111122222333333322 23346789999999999999999999999999887
Q ss_pred HH
Q 005427 351 LV 352 (697)
Q Consensus 351 ~~ 352 (697)
.+
T Consensus 299 ~i 300 (301)
T 3q4u_A 299 KI 300 (301)
T ss_dssp HH
T ss_pred cc
Confidence 64
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=359.06 Aligned_cols=255 Identities=24% Similarity=0.353 Sum_probs=210.2
Q ss_pred CCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEee
Q 005427 65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF 142 (697)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 142 (697)
.++|++.+.||+|+||.||+|.+ +++.||+|++........+.+.+|+.+++.++||||+++++++.....+++||||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 97 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence 46899999999999999999998 4789999987766556678899999999999999999999999999999999999
Q ss_pred cCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhccc
Q 005427 143 YESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKN 222 (697)
Q Consensus 143 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 222 (697)
+++++|.+++......+++.+++.++.|++.||.|||+.|++||||||+|||++.++.+||+|||++........
T Consensus 98 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~----- 172 (302)
T 2j7t_A 98 CPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQ----- 172 (302)
T ss_dssp CTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHH-----
T ss_pred CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCcccccccc-----
Confidence 999999999877666799999999999999999999999999999999999999999999999999864432111
Q ss_pred ccCCCCCCCCccccccccCccccchhhhc-----ccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccH
Q 005427 223 WRSSGKPTGGFHKKNMVGTLIYMAPEILK-----KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTE 297 (697)
Q Consensus 223 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~ 297 (697)
......||+.|+|||++. +..++.++||||||+++|+|++|..||...........+...
T Consensus 173 -----------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---- 237 (302)
T 2j7t_A 173 -----------KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS---- 237 (302)
T ss_dssp -----------C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS----
T ss_pred -----------ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhcc----
Confidence 123457899999999983 667889999999999999999999999876554433322211
Q ss_pred HHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 005427 298 QQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL 351 (697)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~ 351 (697)
.. +. ...+..++.++.++|.+||+.||.+|||+.++++|.|.
T Consensus 238 ----------~~-~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~ 279 (302)
T 2j7t_A 238 ----------DP-PT-LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFV 279 (302)
T ss_dssp ----------CC-CC-CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTT
T ss_pred ----------CC-cc-cCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHH
Confidence 11 11 11234678999999999999999999999999988765
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=363.27 Aligned_cols=272 Identities=22% Similarity=0.299 Sum_probs=213.7
Q ss_pred CCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCC--hHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEE
Q 005427 65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST--SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFF 140 (697)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 140 (697)
.++|++.+.||+|+||.||+|++ +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+...+++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 46899999999999999999998 48899999865433 334567889999999999999999999999999999999
Q ss_pred eecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhc
Q 005427 141 EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL 220 (697)
Q Consensus 141 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~ 220 (697)
||+.+++|.+++.... .+++..++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||++........
T Consensus 104 e~~~~~~l~~~~~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--- 179 (331)
T 4aaa_A 104 EFVDHTILDDLELFPN-GLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE--- 179 (331)
T ss_dssp ECCSEEHHHHHHHSTT-CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC-----------
T ss_pred ecCCcchHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc---
Confidence 9999988888765443 689999999999999999999999999999999999999999999999999976542111
Q ss_pred ccccCCCCCCCCccccccccCccccchhhhccc-CCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHH
Q 005427 221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKE-IHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQ 299 (697)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~ 299 (697)
......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.........+.........
T Consensus 180 -------------~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 246 (331)
T 4aaa_A 180 -------------VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIP 246 (331)
T ss_dssp -----------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCH
T ss_pred -------------ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCh
Confidence 12345789999999999875 6899999999999999999999999987766655544332211100
Q ss_pred HHHH-HHh-----CCCCC------cccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 005427 300 LTAA-VVS-----GGLRP------ILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL 353 (697)
Q Consensus 300 ~~~~-~~~-----~~~~~------~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~ 353 (697)
.... ... +...+ ........+++++.+||.+||+.||.+|||+.|+++|.|+-.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 312 (331)
T 4aaa_A 247 RHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM 312 (331)
T ss_dssp HHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHG
T ss_pred hhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhcc
Confidence 0000 000 00001 111123468899999999999999999999999999999854
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=373.68 Aligned_cols=297 Identities=21% Similarity=0.236 Sum_probs=211.8
Q ss_pred CCCCCccCCCCCCCcccccccccCCceEEEEEEE--CCeeEEEEeccC--CChHHHHHHHHHHHHHHhcCCCCceEEeec
Q 005427 54 CSSQSIPLHLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPIL--STSEELDNFHKELQLLCKLDHPGLAKFVAA 129 (697)
Q Consensus 54 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~l~~~ 129 (697)
...+.+......++|++.+.||+|+||.||+|++ +++.||||++.. ......+.+.+|+.+|+.++||||++++++
T Consensus 14 ~~~Q~~~~~~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~ 93 (432)
T 3n9x_A 14 LYFQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDL 93 (432)
T ss_dssp CCTTCGGGCCCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred hhhcCCCcceecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEE
Confidence 3444444444568999999999999999999987 578999998754 234456789999999999999999999999
Q ss_pred cccC-----CceEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeee
Q 005427 130 HAKP-----PNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLA 204 (697)
Q Consensus 130 ~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~ 204 (697)
+... ..+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+
T Consensus 94 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~-~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~ 171 (432)
T 3n9x_A 94 IIPDDLLKFDELYIVLEIAD-SDLKKLFKTP-IFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVC 171 (432)
T ss_dssp CCCSCTTTCCCEEEEEECCS-EEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEEC
T ss_pred EecCCCCcCCeEEEEEecCC-cCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEc
Confidence 8776 57999999987 5999998754 368999999999999999999999999999999999999999999999
Q ss_pred eeccchhhhhhhhhhcccc-cCCC-----CCCCCccccccccCccccchhhh-cccCCCchhhHHHHHHHHHHHHhCCC-
Q 005427 205 DFGLAEYRENLKEISLKNW-RSSG-----KPTGGFHKKNMVGTLIYMAPEIL-KKEIHSEKSDVYSFGISINELLTGVV- 276 (697)
Q Consensus 205 Dfg~a~~~~~~~~~~~~~~-~~~~-----~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~~l~ell~g~~- 276 (697)
|||+++............. .... ...........+||+.|+|||++ .+..++.++|||||||++|||++|..
T Consensus 172 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p 251 (432)
T 3n9x_A 172 DFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQS 251 (432)
T ss_dssp CCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTT
T ss_pred cCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccc
Confidence 9999987653221100000 0000 00000123567899999999986 56679999999999999999998544
Q ss_pred ----------CCCCch-----------------hHHHHHHHHhccccH----------HHHHHHHHhCCCC--Ccccccc
Q 005427 277 ----------PYTDLR-----------------AEAQAHTVLEMNYTE----------QQLTAAVVSGGLR--PILASLE 317 (697)
Q Consensus 277 ----------Pf~~~~-----------------~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~--~~~~~~~ 317 (697)
+|.+.. ...+...+......+ ......+..-..+ ..+....
T Consensus 252 ~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (432)
T 3n9x_A 252 HINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKY 331 (432)
T ss_dssp TCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHS
T ss_pred cccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHC
Confidence 443322 112222222111110 1111111111111 1111223
Q ss_pred cCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 318 LGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 318 ~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
..+++++.+||.+||+.||.+|||++|+++|+|+.
T Consensus 332 ~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~ 366 (432)
T 3n9x_A 332 PSISDDGINLLESMLKFNPNKRITIDQALDHPYLK 366 (432)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGT
T ss_pred CCCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhh
Confidence 56899999999999999999999999999998874
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=379.25 Aligned_cols=261 Identities=29% Similarity=0.412 Sum_probs=213.9
Q ss_pred ccCCCCCCCcccccccccCCceEEEEEEEC-CeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceE
Q 005427 59 IPLHLPPSSYTLLSPIARGAESVVYEATLD-GRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYM 137 (697)
Q Consensus 59 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 137 (697)
..++++.++|++.++||+|+||.||+|.+. +..||||++.... ...+.+.+|+.+|++++||||+++++++.+ ...+
T Consensus 177 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~ 254 (452)
T 1fmk_A 177 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 254 (452)
T ss_dssp TCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred cccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceE
Confidence 357788899999999999999999999985 4679999876443 235678999999999999999999999876 6789
Q ss_pred EEEeecCCCCHhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhh
Q 005427 138 FFFEFYESRNLAEKLHVE-EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLK 216 (697)
Q Consensus 138 lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~ 216 (697)
+||||+.+|+|.+++... ...+++.+++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 255 iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 334 (452)
T 1fmk_A 255 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 334 (452)
T ss_dssp EEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred EEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCc
Confidence 999999999999999753 3468999999999999999999999999999999999999999999999999997654211
Q ss_pred hhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCCchhHHHHHHHHhccc
Q 005427 217 EISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNY 295 (697)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~~~~~~~~~~~~~~~~ 295 (697)
. .......+|+.|+|||++.+..++.++|||||||++|||++ |..||.+.........+.
T Consensus 335 ~---------------~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~---- 395 (452)
T 1fmk_A 335 Y---------------TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE---- 395 (452)
T ss_dssp -----------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH----
T ss_pred e---------------ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH----
Confidence 0 01223457889999999999999999999999999999999 999998865544333322
Q ss_pred cHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 005427 296 TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE 354 (697)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~ 354 (697)
.+.++ ..+..+|+.+.+||.+||+.||++|||+++|++.|..+..
T Consensus 396 -----------~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~ 440 (452)
T 1fmk_A 396 -----------RGYRM---PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 440 (452)
T ss_dssp -----------TTCCC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred -----------cCCCC---CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence 11221 1245789999999999999999999999999988877653
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=351.52 Aligned_cols=262 Identities=26% Similarity=0.440 Sum_probs=218.4
Q ss_pred cCCCCCCCcccccccccCCceEEEEEEEC-CeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEE
Q 005427 60 PLHLPPSSYTLLSPIARGAESVVYEATLD-GRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMF 138 (697)
Q Consensus 60 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 138 (697)
.++++.++|++.+.||+|+||.||+|.+. +..||+|.+.... ...+.+.+|+++|+.++||||+++++++.. +..++
T Consensus 7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~ 84 (279)
T 1qpc_A 7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYI 84 (279)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred hcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEE
Confidence 46788899999999999999999999984 5689999865433 235678999999999999999999999864 56899
Q ss_pred EEeecCCCCHhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhh
Q 005427 139 FFEFYESRNLAEKLHVEE-WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKE 217 (697)
Q Consensus 139 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~ 217 (697)
||||+.+++|.+++.... ..+++.+++.++.|++.||+|||+.||+||||||+|||++.++.+||+|||++........
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 164 (279)
T 1qpc_A 85 ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164 (279)
T ss_dssp EEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred EEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCccc
Confidence 999999999999986542 2689999999999999999999999999999999999999999999999999976542110
Q ss_pred hhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCCchhHHHHHHHHhcccc
Q 005427 218 ISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYT 296 (697)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~~~~~~~~~~~~~~~~~ 296 (697)
.......+++.|+|||++.+..++.++||||||+++|+|++ |..||.+.........+..
T Consensus 165 ---------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~---- 225 (279)
T 1qpc_A 165 ---------------TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER---- 225 (279)
T ss_dssp ---------------ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT----
T ss_pred ---------------ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhc----
Confidence 01233457889999999998889999999999999999999 9999987655443333221
Q ss_pred HHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHh
Q 005427 297 EQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHR 356 (697)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~~ 356 (697)
..++ ..+..++.++.+++.+||+.||++|||+.++++.|..+....
T Consensus 226 -----------~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 271 (279)
T 1qpc_A 226 -----------GYRM---VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271 (279)
T ss_dssp -----------TCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred -----------ccCC---CCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhc
Confidence 1111 123578999999999999999999999999999999887653
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-43 Score=365.27 Aligned_cols=258 Identities=23% Similarity=0.335 Sum_probs=190.1
Q ss_pred Ccccc---cccccCCceEEEEEEE--CCeeEEEEeccCCChHHHHHHHHHHHHHHhcC-CCCceEEeeccccCCceEEEE
Q 005427 67 SYTLL---SPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLD-HPGLAKFVAAHAKPPNYMFFF 140 (697)
Q Consensus 67 ~y~~~---~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lv~ 140 (697)
+|.+. ++||+|+||.||+|.+ +++.||||++.. .....+.+|+.+++.+. ||||+++++++.+....++||
T Consensus 9 ~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~ 85 (325)
T 3kn6_A 9 HYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVM 85 (325)
T ss_dssp HEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEG---GGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred ccccccCCCccccCCCeEEEEEEECCCCCEEEEEEECh---hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEE
Confidence 45554 7899999999999998 478999998643 23456789999999997 999999999999999999999
Q ss_pred eecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCC---CCeeeeeccchhhhhhhh
Q 005427 141 EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNL---CPHLADFGLAEYRENLKE 217 (697)
Q Consensus 141 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~---~~kL~Dfg~a~~~~~~~~ 217 (697)
||+.+|+|.+++.... .+++.+++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||++.......
T Consensus 86 e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~- 163 (325)
T 3kn6_A 86 ELLNGGELFERIKKKK-HFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN- 163 (325)
T ss_dssp CCCCSCBHHHHHHHCS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC---
T ss_pred EccCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC-
Confidence 9999999999997654 789999999999999999999999999999999999997665 79999999997543211
Q ss_pred hhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccH
Q 005427 218 ISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTE 297 (697)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~ 297 (697)
......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+...... ....
T Consensus 164 ---------------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-------~~~~ 221 (325)
T 3kn6_A 164 ---------------QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLT-------CTSA 221 (325)
T ss_dssp -----------------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC--------------CCCH
T ss_pred ---------------CcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccc-------cccH
Confidence 123456789999999999999999999999999999999999999986543211 0111
Q ss_pred HHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 298 QQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
......+..+.. +........+++++.+||.+||+.||.+|||+.++++|.|..
T Consensus 222 ~~~~~~i~~~~~-~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~ 275 (325)
T 3kn6_A 222 VEIMKKIKKGDF-SFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQ 275 (325)
T ss_dssp HHHHHHHTTTCC-CCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGC
T ss_pred HHHHHHHHcCCC-CCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhc
Confidence 122222222222 122223356899999999999999999999999999888764
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=351.90 Aligned_cols=257 Identities=21% Similarity=0.304 Sum_probs=214.4
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccCCCh------HHHHHHHHHHHHHHhcCCCCceEEeeccccCCceE
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTS------EELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYM 137 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 137 (697)
++|++.+.||+|+||.||+|++ +++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+...++
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 5799999999999999999998 488999997654321 13578899999999999999999999999999999
Q ss_pred EEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCC----CCeeeeeccchhhh
Q 005427 138 FFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNL----CPHLADFGLAEYRE 213 (697)
Q Consensus 138 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~----~~kL~Dfg~a~~~~ 213 (697)
+||||+.+++|.+++.... .+++.+++.++.|++.||.|||+.||+||||||+||+++.++ .+||+|||++....
T Consensus 85 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~ 163 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEKE-SLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE 163 (283)
T ss_dssp EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred EEEeecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceecc
Confidence 9999999999999997654 689999999999999999999999999999999999998876 79999999987543
Q ss_pred hhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhc
Q 005427 214 NLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEM 293 (697)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~ 293 (697)
... ......||+.|+|||++.+..++.++||||||+++|+|++|..||.+.........+...
T Consensus 164 ~~~-----------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 226 (283)
T 3bhy_A 164 AGN-----------------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAV 226 (283)
T ss_dssp -------------------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT
T ss_pred CCC-----------------cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhc
Confidence 211 123456899999999999999999999999999999999999999887655444433322
Q ss_pred cccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 005427 294 NYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH 355 (697)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~ 355 (697)
.. .........++..+.+|+.+||+.||++|||+.++++|.|...-.
T Consensus 227 ~~---------------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 273 (283)
T 3bhy_A 227 NY---------------DFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR 273 (283)
T ss_dssp CC---------------CCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred cc---------------CCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence 11 111223456889999999999999999999999999998876543
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=353.66 Aligned_cols=260 Identities=26% Similarity=0.397 Sum_probs=212.5
Q ss_pred CCcccccccccCCceEEEEEEEC-----CeeEEEEeccCC-ChHHHHHHHHHHHHHHhcCCCCceEEeecc-ccCCceEE
Q 005427 66 SSYTLLSPIARGAESVVYEATLD-----GRKVAVKKPILS-TSEELDNFHKELQLLCKLDHPGLAKFVAAH-AKPPNYMF 138 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~-~~~~~~~l 138 (697)
.+|++.++||+|+||.||+|.+. ...+|+|..... .....+.+.+|+.++++++||||+++++++ ......++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 46999999999999999999862 235888876543 345567899999999999999999999985 45668899
Q ss_pred EEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhh
Q 005427 139 FFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI 218 (697)
Q Consensus 139 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~ 218 (697)
||||+.+|+|.+++......+++.+++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~ 184 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYY 184 (298)
T ss_dssp EEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGGC
T ss_pred EEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccccchh
Confidence 99999999999999877777899999999999999999999999999999999999999999999999999765432211
Q ss_pred hcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCCchhHHHHHHHHhccccH
Q 005427 219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTE 297 (697)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~ 297 (697)
. ........||+.|+|||++.+..++.++||||||+++|+|++ |.+||.+.........+..
T Consensus 185 ~------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~----- 247 (298)
T 3f66_A 185 S------------VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ----- 247 (298)
T ss_dssp B------------C-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHT-----
T ss_pred c------------cccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhc-----
Confidence 0 111334568899999999999999999999999999999999 6777776544333322221
Q ss_pred HHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 005427 298 QQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH 355 (697)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~ 355 (697)
+ .++ ..+..+++.+.+++.+||+.||.+|||+.++++.|..+...
T Consensus 248 ---------~-~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 292 (298)
T 3f66_A 248 ---------G-RRL---LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 292 (298)
T ss_dssp ---------T-CCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ---------C-CCC---CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 1 111 12346889999999999999999999999999999998764
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=362.38 Aligned_cols=254 Identities=24% Similarity=0.312 Sum_probs=216.6
Q ss_pred CCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCC---ChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEE
Q 005427 64 PPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMF 138 (697)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 138 (697)
..++|++.+.||+|+||.||++.+ +++.||+|++... .....+.+.+|+.+++.++||||+++++++.+...+++
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 118 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 118 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 346899999999999999999998 4778999976433 34556789999999999999999999999999999999
Q ss_pred EEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhh
Q 005427 139 FFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI 218 (697)
Q Consensus 139 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~ 218 (697)
||||+.+++|.+++.... .+++.+++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 119 v~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~--- 194 (335)
T 2owb_A 119 VLELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD--- 194 (335)
T ss_dssp EECCCTTCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCST---
T ss_pred EEecCCCCCHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccC---
Confidence 999999999999887654 7899999999999999999999999999999999999999999999999998754321
Q ss_pred hcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHH
Q 005427 219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQ 298 (697)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~ 298 (697)
+.......||+.|+|||++.+..++.++||||||+++|+|++|..||...........+..
T Consensus 195 -------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~------ 255 (335)
T 2owb_A 195 -------------GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKK------ 255 (335)
T ss_dssp -------------TCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH------
T ss_pred -------------cccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhc------
Confidence 1123446799999999999999999999999999999999999999987654443332221
Q ss_pred HHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 005427 299 QLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL 353 (697)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~ 353 (697)
... ..+..+++++.+||.+||+.||++|||+.|+++|.|+..
T Consensus 256 --------~~~-----~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~ 297 (335)
T 2owb_A 256 --------NEY-----SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTS 297 (335)
T ss_dssp --------TCC-----CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHT
T ss_pred --------CCC-----CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 111 124468899999999999999999999999999988753
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=354.81 Aligned_cols=253 Identities=24% Similarity=0.313 Sum_probs=216.0
Q ss_pred CCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCC---ChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEE
Q 005427 64 PPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMF 138 (697)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 138 (697)
..++|++.+.||+|+||.||++.+ +++.+|+|++... .....+.+.+|+.+++.++||||+++++++.+....++
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 92 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 92 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence 346899999999999999999998 4788999976433 34556789999999999999999999999999999999
Q ss_pred EEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhh
Q 005427 139 FFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI 218 (697)
Q Consensus 139 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~ 218 (697)
||||+.+++|.+++.... .+++.+++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 93 v~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~--- 168 (294)
T 2rku_A 93 VLELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD--- 168 (294)
T ss_dssp EEECCTTCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCST---
T ss_pred EEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccC---
Confidence 999999999999887654 7899999999999999999999999999999999999999999999999998754321
Q ss_pred hcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHH
Q 005427 219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQ 298 (697)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~ 298 (697)
+.......||+.|+|||++.+..++.++||||||+++|+|++|..||.+.........+..
T Consensus 169 -------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~------ 229 (294)
T 2rku_A 169 -------------GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKK------ 229 (294)
T ss_dssp -------------TCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT------
T ss_pred -------------ccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhh------
Confidence 1113346799999999999999899999999999999999999999987654443332221
Q ss_pred HHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 299 QLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
.. ...+..+++.+.+++.+||+.||++|||+.++++|.|+.
T Consensus 230 --------~~-----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~ 270 (294)
T 2rku_A 230 --------NE-----YSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFT 270 (294)
T ss_dssp --------TC-----CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHH
T ss_pred --------cc-----CCCccccCHHHHHHHHHHcccChhhCcCHHHHhhChhee
Confidence 11 113456889999999999999999999999999998875
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=359.31 Aligned_cols=266 Identities=27% Similarity=0.427 Sum_probs=218.8
Q ss_pred ccCCCCCCCcccccccccCCceEEEEEEE-------CCeeEEEEeccCCC-hHHHHHHHHHHHHHHhc-CCCCceEEeec
Q 005427 59 IPLHLPPSSYTLLSPIARGAESVVYEATL-------DGRKVAVKKPILST-SEELDNFHKELQLLCKL-DHPGLAKFVAA 129 (697)
Q Consensus 59 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~l~~~ 129 (697)
..+.+..++|++.+.||+|+||.||+|.+ +++.||||++.... ......+.+|+.+++.+ +||||++++++
T Consensus 20 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 99 (316)
T 2xir_A 20 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 99 (316)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEE
Confidence 34667788999999999999999999985 34789999876543 34467899999999999 79999999999
Q ss_pred cccCC-ceEEEEeecCCCCHhhhhhhcCCC---------------CCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCce
Q 005427 130 HAKPP-NYMFFFEFYESRNLAEKLHVEEWS---------------PSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANV 193 (697)
Q Consensus 130 ~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~---------------~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Ni 193 (697)
+..+. .+++||||+.+++|.+++...... +++..++.++.|++.||.|||+.||+||||||+||
T Consensus 100 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Ni 179 (316)
T 2xir_A 100 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 179 (316)
T ss_dssp ECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred EecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceE
Confidence 87755 589999999999999999765432 78999999999999999999999999999999999
Q ss_pred eecCCCCCeeeeeccchhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh
Q 005427 194 LLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT 273 (697)
Q Consensus 194 ll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~ 273 (697)
|++.++.+||+|||++....... .........||+.|+|||++.+..++.++|||||||++|+|++
T Consensus 180 l~~~~~~~kl~Dfg~~~~~~~~~--------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t 245 (316)
T 2xir_A 180 LLSEKNVVKICDFGLARDIYKDP--------------DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245 (316)
T ss_dssp EECGGGCEEECCCGGGSCTTTCT--------------TSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred EECCCCCEEECCCccccccccCc--------------cceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHh
Confidence 99999999999999997553211 1112344578999999999999999999999999999999998
Q ss_pred -CCCCCCCchhHHHHHHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 274 -GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 274 -g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
|..||.+........... ..+. ++ ..+..+++++.+++.+||+.||.+|||+.+++++|..+
T Consensus 246 ~g~~p~~~~~~~~~~~~~~-------------~~~~-~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 308 (316)
T 2xir_A 246 LGASPYPGVKIDEEFCRRL-------------KEGT-RM---RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308 (316)
T ss_dssp TSCCSSTTCCCSHHHHHHH-------------HHTC-CC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCcccchhHHHHHHh-------------ccCc-cC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 999998754332222111 1111 11 12346889999999999999999999999999999998
Q ss_pred HHH
Q 005427 353 LEH 355 (697)
Q Consensus 353 ~~~ 355 (697)
++.
T Consensus 309 ~~~ 311 (316)
T 2xir_A 309 LQA 311 (316)
T ss_dssp HHH
T ss_pred Hhh
Confidence 864
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=360.88 Aligned_cols=261 Identities=28% Similarity=0.483 Sum_probs=213.7
Q ss_pred CCCCCcccccccccCCceEEEEEEE--CCeeE--EEEeccCC-ChHHHHHHHHHHHHHHhc-CCCCceEEeeccccCCce
Q 005427 63 LPPSSYTLLSPIARGAESVVYEATL--DGRKV--AVKKPILS-TSEELDNFHKELQLLCKL-DHPGLAKFVAAHAKPPNY 136 (697)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~v--avK~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~ 136 (697)
+..++|++.+.||+|+||.||+|++ ++..+ |+|.+... .....+.+.+|+.+|+++ +||||+++++++.+...+
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 101 (327)
T 1fvr_A 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL 101 (327)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEE
T ss_pred ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCce
Confidence 4457899999999999999999986 56654 88876533 233456789999999999 899999999999999999
Q ss_pred EEEEeecCCCCHhhhhhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCC
Q 005427 137 MFFFEFYESRNLAEKLHVEE---------------WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCP 201 (697)
Q Consensus 137 ~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~ 201 (697)
++||||+++++|.+++.... ..+++.+++.++.|++.||.|||++||+||||||+|||++.++.+
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 102 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVA 181 (327)
T ss_dssp EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCE
T ss_pred EEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCeE
Confidence 99999999999999987543 368999999999999999999999999999999999999999999
Q ss_pred eeeeeccchhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 005427 202 HLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTD 280 (697)
Q Consensus 202 kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~ 280 (697)
||+|||++...... .......+++.|+|||++.+..++.++|||||||++|+|++ |..||.+
T Consensus 182 kL~Dfg~~~~~~~~-----------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~ 244 (327)
T 1fvr_A 182 KIADFGLSRGQEVY-----------------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG 244 (327)
T ss_dssp EECCTTCEESSCEE-----------------CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred EEcccCcCcccccc-----------------ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCC
Confidence 99999998643210 01233457889999999999889999999999999999998 9999987
Q ss_pred chhHHHHHHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhcc
Q 005427 281 LRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHRKS 358 (697)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~~~~ 358 (697)
.........+.. +.++ ..+..+++++.+||.+||+.||.+|||+.+++++|..+++..+.
T Consensus 245 ~~~~~~~~~~~~---------------~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 304 (327)
T 1fvr_A 245 MTCAELYEKLPQ---------------GYRL---EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 304 (327)
T ss_dssp CCHHHHHHHGGG---------------TCCC---CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSC
T ss_pred CcHHHHHHHhhc---------------CCCC---CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcC
Confidence 655443333221 1111 22346889999999999999999999999999999999876543
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=384.21 Aligned_cols=258 Identities=21% Similarity=0.243 Sum_probs=213.6
Q ss_pred CCCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCC---hHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceE
Q 005427 63 LPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST---SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYM 137 (697)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 137 (697)
+..++|++.+.||+|+||.||+|++ +++.||+|++.... ......+.+|+.+|+.++||||+++++++.+...++
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 260 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC 260 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence 5567899999999999999999998 58899999864321 123456889999999999999999999999999999
Q ss_pred EEEeecCCCCHhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhh
Q 005427 138 FFFEFYESRNLAEKLHVEE-WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLK 216 (697)
Q Consensus 138 lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~ 216 (697)
+||||+.||+|.+++...+ ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 261 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~ 340 (576)
T 2acx_A 261 LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 340 (576)
T ss_dssp EEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred EEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccCc
Confidence 9999999999999987644 348999999999999999999999999999999999999999999999999997543211
Q ss_pred hhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhcccc
Q 005427 217 EISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYT 296 (697)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~ 296 (697)
.....+||+.|+|||++.+..++.++|||||||++|||++|..||.+........
T Consensus 341 -----------------~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~-------- 395 (576)
T 2acx_A 341 -----------------TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE-------- 395 (576)
T ss_dssp -----------------CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHH--------
T ss_pred -----------------cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHH--------
Confidence 1334589999999999999999999999999999999999999998753211111
Q ss_pred HHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCC-----CHHHHHHHHHHH
Q 005427 297 EQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRP-----SFSDIALELDLV 352 (697)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~ell~~l~~~ 352 (697)
.+...+.... ...+..+|+++.+||.+||+.||.+|| +++|+++|.|+.
T Consensus 396 --~i~~~i~~~~-----~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~ 449 (576)
T 2acx_A 396 --EVERLVKEVP-----EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFK 449 (576)
T ss_dssp --HHHHHHHHCC-----CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGT
T ss_pred --HHHHHhhccc-----ccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhc
Confidence 1111111110 123456899999999999999999999 789999887763
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=381.72 Aligned_cols=258 Identities=19% Similarity=0.271 Sum_probs=212.6
Q ss_pred CCCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCCh---HHHHHHHHHHHHHHhcCCCCceEEeeccccCCceE
Q 005427 63 LPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTS---EELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYM 137 (697)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 137 (697)
+..++|++.+.||+|+||.||+|++ +++.||+|++..... .....+.+|+.+|+.++||||+++++++.+...+|
T Consensus 182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 261 (543)
T 3c4z_A 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLC 261 (543)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEE
Confidence 4557899999999999999999998 588999998653321 23467889999999999999999999999999999
Q ss_pred EEEeecCCCCHhhhhhhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhh
Q 005427 138 FFFEFYESRNLAEKLHVE---EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYREN 214 (697)
Q Consensus 138 lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~ 214 (697)
+||||+.||+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.+..
T Consensus 262 lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 262 LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp EEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 999999999999998654 33689999999999999999999999999999999999999999999999999976432
Q ss_pred hhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhcc
Q 005427 215 LKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMN 294 (697)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~ 294 (697)
.. ......+||+.|+|||++.+..++.++|||||||++|||++|..||.+......
T Consensus 342 ~~----------------~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~-------- 397 (543)
T 3c4z_A 342 GQ----------------TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE-------- 397 (543)
T ss_dssp TC----------------CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC--------
T ss_pred CC----------------cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchh--------
Confidence 11 113446899999999999999999999999999999999999999987532110
Q ss_pred ccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCH-----HHHHHHHHH
Q 005427 295 YTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSF-----SDIALELDL 351 (697)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~-----~ell~~l~~ 351 (697)
...+...+..... ..+..+|+++.+||++||+.||.+||++ +++++|.|+
T Consensus 398 --~~~~~~~i~~~~~-----~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff 452 (543)
T 3c4z_A 398 --NKELKQRVLEQAV-----TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLF 452 (543)
T ss_dssp --HHHHHHHHHHCCC-----CCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGG
T ss_pred --HHHHHHHHhhccc-----CCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccc
Confidence 1111111121111 2345789999999999999999999964 788887765
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=394.92 Aligned_cols=253 Identities=21% Similarity=0.318 Sum_probs=216.9
Q ss_pred CCCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCC---ChHHHHHHHHHHHHHHhc-CCCCceEEeeccccCCce
Q 005427 63 LPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKL-DHPGLAKFVAAHAKPPNY 136 (697)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~ 136 (697)
+..++|+++++||+|+||.||+|++ +++.||||++... .....+.+..|..+|..+ +||||+++++++.+...+
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~ 417 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 417 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence 4457899999999999999999998 5778999986532 122356788899999988 799999999999999999
Q ss_pred EEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhh
Q 005427 137 MFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLK 216 (697)
Q Consensus 137 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~ 216 (697)
|+||||+.+|+|.+++...+ .+++..++.++.||+.||+|||+.||+||||||+||||+.++.+||+|||+++....
T Consensus 418 ~lV~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~-- 494 (674)
T 3pfq_A 418 YFVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW-- 494 (674)
T ss_dssp EEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCC--
T ss_pred EEEEeCcCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeecccc--
Confidence 99999999999999998665 799999999999999999999999999999999999999999999999999874321
Q ss_pred hhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhcccc
Q 005427 217 EISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYT 296 (697)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~ 296 (697)
.+....+.+||+.|+|||++.+..++.++|||||||+||||++|..||.+.+.......+.....
T Consensus 495 --------------~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~- 559 (674)
T 3pfq_A 495 --------------DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV- 559 (674)
T ss_dssp --------------TTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCC-
T ss_pred --------------CCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCC-
Confidence 11124567899999999999999999999999999999999999999998776666555543221
Q ss_pred HHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCH-----HHHHHHHHH
Q 005427 297 EQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSF-----SDIALELDL 351 (697)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~-----~ell~~l~~ 351 (697)
..+..+++++.+||++||+.||.+||++ +||++|.|+
T Consensus 560 ------------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff 601 (674)
T 3pfq_A 560 ------------------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFF 601 (674)
T ss_dssp ------------------CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGG
T ss_pred ------------------CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccc
Confidence 1345789999999999999999999998 889888766
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=376.00 Aligned_cols=255 Identities=24% Similarity=0.348 Sum_probs=200.4
Q ss_pred CCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCC--------hHHHHHHHHHHHHHHhcCCCCceEEeeccccCC
Q 005427 65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST--------SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPP 134 (697)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 134 (697)
.++|.+.++||+|+||.||+|.+ +++.||||++.... ......+.+|+.+|++++||||+++++++.. .
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~ 212 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-E 212 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-S
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-C
Confidence 36799999999999999999987 57899999865321 1123357899999999999999999999754 5
Q ss_pred ceEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCC---CCCeeeeeccchh
Q 005427 135 NYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRN---LCPHLADFGLAEY 211 (697)
Q Consensus 135 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~---~~~kL~Dfg~a~~ 211 (697)
.+++||||+.+|+|.+++.... .+++.+++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++.
T Consensus 213 ~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~ 291 (419)
T 3i6u_A 213 DYYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 291 (419)
T ss_dssp EEEEEEECCTTCBGGGGTSSSC-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTS
T ss_pred ceEEEEEcCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeeccccee
Confidence 6899999999999999987554 78999999999999999999999999999999999999654 4599999999976
Q ss_pred hhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcc---cCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHH
Q 005427 212 RENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK---EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAH 288 (697)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~ 288 (697)
..... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+........
T Consensus 292 ~~~~~-----------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~ 354 (419)
T 3i6u_A 292 LGETS-----------------LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK 354 (419)
T ss_dssp CC----------------------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHH
T ss_pred cCCCc-----------------cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHH
Confidence 54211 1345689999999999863 567889999999999999999999998653322111
Q ss_pred HHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 289 TVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
.. +. .+..+..+.....+++.+.+||.+||+.||.+|||+.|+++|.|+.
T Consensus 355 ~~-------------i~-~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~ 404 (419)
T 3i6u_A 355 DQ-------------IT-SGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ 404 (419)
T ss_dssp HH-------------HH-TTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred HH-------------Hh-cCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccC
Confidence 11 11 1222233344567899999999999999999999999999998874
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=380.32 Aligned_cols=261 Identities=26% Similarity=0.426 Sum_probs=219.5
Q ss_pred ccCCCCCCCcccccccccCCceEEEEEEEC--CeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCce
Q 005427 59 IPLHLPPSSYTLLSPIARGAESVVYEATLD--GRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNY 136 (697)
Q Consensus 59 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 136 (697)
..+++..++|++.++||+|+||.||+|.+. +..||||.+.... ...+.+.+|+.+|++++||||+++++++.....+
T Consensus 213 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 291 (495)
T 1opk_A 213 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 291 (495)
T ss_dssp SCCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred cccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcE
Confidence 356778889999999999999999999984 7899999876443 3467899999999999999999999999999999
Q ss_pred EEEEeecCCCCHhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhh
Q 005427 137 MFFFEFYESRNLAEKLHVE-EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL 215 (697)
Q Consensus 137 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~ 215 (697)
++||||+.+|+|.+++... ...+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 292 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 371 (495)
T 1opk_A 292 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGD 371 (495)
T ss_dssp EEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTC
T ss_pred EEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCC
Confidence 9999999999999999764 346899999999999999999999999999999999999999999999999999765421
Q ss_pred hhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCCchhHHHHHHHHhcc
Q 005427 216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMN 294 (697)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~~~~~~~~~~~~~~~ 294 (697)
.. .......+++.|+|||++.+..++.++|||||||++|||++ |..||.+.........+.
T Consensus 372 ~~---------------~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~--- 433 (495)
T 1opk_A 372 TY---------------TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE--- 433 (495)
T ss_dssp CE---------------ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH---
T ss_pred ce---------------eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH---
Confidence 10 01223456789999999999999999999999999999999 999998765443322221
Q ss_pred ccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 005427 295 YTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL 353 (697)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~ 353 (697)
...+. ..+..+|+++.+||.+||+.||.+|||+.+|++.|..++
T Consensus 434 ------------~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 434 ------------KDYRM---ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp ------------TTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred ------------cCCCC---CCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 12222 234578999999999999999999999999998877654
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=364.81 Aligned_cols=271 Identities=26% Similarity=0.284 Sum_probs=210.8
Q ss_pred CCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCChHH-----HHHHHHHHHHHHhcCCCCceEEeeccccCCceE
Q 005427 65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEE-----LDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYM 137 (697)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~-----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 137 (697)
.++|++.+.||+|+||.||+|++ +++.||||++....... ...+.+|+.+++.++||||+++++++.+....+
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 88 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNIS 88 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCE
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceE
Confidence 46899999999999999999987 47899999876432221 246789999999999999999999999999999
Q ss_pred EEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhh
Q 005427 138 FFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKE 217 (697)
Q Consensus 138 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~ 217 (697)
+||||+.+ +|.+++......+++.+++.++.|++.||+|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 89 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~- 166 (346)
T 1ua2_A 89 LVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN- 166 (346)
T ss_dssp EEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC-
T ss_pred EEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCCc-
Confidence 99999986 8999887776678999999999999999999999999999999999999999999999999997653211
Q ss_pred hhcccccCCCCCCCCccccccccCccccchhhhccc-CCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhcccc
Q 005427 218 ISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKE-IHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYT 296 (697)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~ 296 (697)
.......||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.........+......
T Consensus 167 ---------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~ 231 (346)
T 1ua2_A 167 ---------------RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGT 231 (346)
T ss_dssp ---------------CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred ---------------ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCC
Confidence 123456789999999999764 5899999999999999999999999987766665555432111
Q ss_pred HHHHHHHHHh--------CCCC-CcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 297 EQQLTAAVVS--------GGLR-PILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 297 ~~~~~~~~~~--------~~~~-~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
.....+.... .... .........+++++.+||.+||+.||.+|||+.|+++|.|+.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~ 296 (346)
T 1ua2_A 232 PTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFS 296 (346)
T ss_dssp CCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGT
T ss_pred CChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhh
Confidence 1000000000 0000 000112256789999999999999999999999999998874
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=358.17 Aligned_cols=252 Identities=25% Similarity=0.364 Sum_probs=191.8
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccCCCh---HHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEE
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTS---EELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFF 140 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 140 (697)
++|++.+.||+|+||.||+|++ +++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+....++||
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL 90 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence 5799999999999999999997 688999998643321 12467899999999999999999999999999999999
Q ss_pred eecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhc
Q 005427 141 EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL 220 (697)
Q Consensus 141 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~ 220 (697)
||+++++|.+++......+++.+++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||++........
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~--- 167 (278)
T 3cok_A 91 EMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE--- 167 (278)
T ss_dssp ECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-------
T ss_pred ecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC---
Confidence 99999999999987766899999999999999999999999999999999999999999999999999875432110
Q ss_pred ccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHH
Q 005427 221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQL 300 (697)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 300 (697)
......||+.|+|||++.+..++.++||||||+++|+|++|..||...........+..
T Consensus 168 -------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-------- 226 (278)
T 3cok_A 168 -------------KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVL-------- 226 (278)
T ss_dssp -------------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCS--------
T ss_pred -------------cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhh--------
Confidence 12345789999999999999999999999999999999999999986543322211110
Q ss_pred HHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 301 TAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
.. ...+..++.++.+||.+||+.||.+|||+.++++|.|..
T Consensus 227 ------~~-----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~ 267 (278)
T 3cok_A 227 ------AD-----YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMS 267 (278)
T ss_dssp ------SC-----CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC
T ss_pred ------cc-----cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCcccc
Confidence 00 113446889999999999999999999999999988764
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-42 Score=354.64 Aligned_cols=265 Identities=24% Similarity=0.388 Sum_probs=209.7
Q ss_pred cCCCCCCCcccccccccCCceEEEEEEE-----CCeeEEEEeccCC--ChHHHHHHHHHHHHHHhcCCCCceEEeecccc
Q 005427 60 PLHLPPSSYTLLSPIARGAESVVYEATL-----DGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAK 132 (697)
Q Consensus 60 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 132 (697)
.+.+..++|++.+.||+|+||.||+|.. .+..||+|.+... .....+.+.+|+.+++.++||||+++++++..
T Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 107 (313)
T 3brb_A 28 DVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIE 107 (313)
T ss_dssp TTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC
T ss_pred hcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEee
Confidence 3556778999999999999999999976 2347999986644 34456789999999999999999999999877
Q ss_pred CC-----ceEEEEeecCCCCHhhhhhh-----cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCe
Q 005427 133 PP-----NYMFFFEFYESRNLAEKLHV-----EEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPH 202 (697)
Q Consensus 133 ~~-----~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~k 202 (697)
.. ..++||||+.+++|.+++.. ....+++.+++.++.|++.||.|||+.||+||||||+|||++.++.+|
T Consensus 108 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~k 187 (313)
T 3brb_A 108 MSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVC 187 (313)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEE
T ss_pred ccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEE
Confidence 54 45999999999999999843 334689999999999999999999999999999999999999999999
Q ss_pred eeeeccchhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCCc
Q 005427 203 LADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDL 281 (697)
Q Consensus 203 L~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~~ 281 (697)
|+|||++......... .......+++.|+|||++.+..++.++||||||+++|+|++ |..||.+.
T Consensus 188 l~Dfg~~~~~~~~~~~--------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 253 (313)
T 3brb_A 188 VADFGLSKKIYSGDYY--------------RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGV 253 (313)
T ss_dssp ECSCSCC------------------------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred EeecCcceeccccccc--------------CcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccC
Confidence 9999999765431110 01233467889999999999999999999999999999999 99999876
Q ss_pred hhHHHHHHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHh
Q 005427 282 RAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHR 356 (697)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~~ 356 (697)
........+.. +. ++ ..+..+++++.++|.+||+.||.+|||+.+++++|..+++..
T Consensus 254 ~~~~~~~~~~~--------------~~-~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l 310 (313)
T 3brb_A 254 QNHEMYDYLLH--------------GH-RL---KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL 310 (313)
T ss_dssp CGGGHHHHHHT--------------TC-CC---CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred CHHHHHHHHHc--------------CC-CC---CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 55443332221 11 11 234578999999999999999999999999999999988653
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=366.47 Aligned_cols=258 Identities=22% Similarity=0.337 Sum_probs=207.5
Q ss_pred CCCCCCcccccccccCCceEEEEEEE-CCeeEEEEeccCC--ChHHHHHHHHHHHHHHhcC--CCCceEEeeccccCCce
Q 005427 62 HLPPSSYTLLSPIARGAESVVYEATL-DGRKVAVKKPILS--TSEELDNFHKELQLLCKLD--HPGLAKFVAAHAKPPNY 136 (697)
Q Consensus 62 ~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--hpniv~l~~~~~~~~~~ 136 (697)
.+...+|++.++||+|+||.||++.+ .++.||||++... .....+.+.+|+.+|+.++ ||||+++++++.....+
T Consensus 52 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~ 131 (390)
T 2zmd_A 52 SVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 131 (390)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred cccCCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEE
Confidence 34556799999999999999999987 5788999987544 3445678999999999996 59999999999999999
Q ss_pred EEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhh
Q 005427 137 MFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLK 216 (697)
Q Consensus 137 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~ 216 (697)
++||| +.+++|.+++.... .+++.+++.++.||+.||.|||+.||+||||||+|||++ ++.+||+|||+++.+....
T Consensus 132 ~lv~E-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~ 208 (390)
T 2zmd_A 132 YMVME-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 208 (390)
T ss_dssp EEEEE-CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred EEEEe-cCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence 99999 66789999997655 788999999999999999999999999999999999995 5889999999997654211
Q ss_pred hhhcccccCCCCCCCCccccccccCccccchhhhcc-----------cCCCchhhHHHHHHHHHHHHhCCCCCCCchhH-
Q 005427 217 EISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-----------EIHSEKSDVYSFGISINELLTGVVPYTDLRAE- 284 (697)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~- 284 (697)
. .......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+....
T Consensus 209 ~--------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~ 274 (390)
T 2zmd_A 209 T--------------SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI 274 (390)
T ss_dssp -------------------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH
T ss_pred c--------------cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHH
Confidence 1 011345679999999999875 46899999999999999999999999764322
Q ss_pred HHHHHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 005427 285 AQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL 353 (697)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~ 353 (697)
.....+ ....... ..+...+.++.+||.+||+.||.+|||+.|+++|+|...
T Consensus 275 ~~~~~~--------------~~~~~~~---~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~ 326 (390)
T 2zmd_A 275 SKLHAI--------------IDPNHEI---EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 326 (390)
T ss_dssp HHHHHH--------------HCTTSCC---CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHS
T ss_pred HHHHHH--------------hCccccC---CCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccc
Confidence 111111 1111111 123446789999999999999999999999999998853
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-42 Score=350.93 Aligned_cols=260 Identities=25% Similarity=0.340 Sum_probs=200.5
Q ss_pred CCCCCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCC-hH-HHHHHHHHHHHHHhcCCCCceEEeeccccCCce
Q 005427 61 LHLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST-SE-ELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNY 136 (697)
Q Consensus 61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 136 (697)
+++..++|++.++||+|+||.||+|++ +++.||+|++.... .. ..+.+.++...++.++||||+++++++.++...
T Consensus 2 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~ 81 (290)
T 3fme_A 2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDV 81 (290)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSE
T ss_pred CcccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCE
Confidence 456778999999999999999999998 78999999876542 22 234455566668888999999999999999999
Q ss_pred EEEEeecCCCCHhhhhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccccCCCCceeecCCCCCeeeeeccchhh
Q 005427 137 MFFFEFYESRNLAEKLHV---EEWSPSVDQVLMIAAQLAKALQYLHNL-GIVHRDVKPANVLLDRNLCPHLADFGLAEYR 212 (697)
Q Consensus 137 ~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~-~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~ 212 (697)
++||||+.+ +|.+++.. ....+++..++.++.|++.||.|||++ ||+||||||+|||++.++.+||+|||++...
T Consensus 82 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 82 WICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred EEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 999999985 88777653 455789999999999999999999998 9999999999999999999999999999765
Q ss_pred hhhhhhhcccccCCCCCCCCccccccccCccccchhhh----cccCCCchhhHHHHHHHHHHHHhCCCCCCCchhH-HHH
Q 005427 213 ENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEIL----KKEIHSEKSDVYSFGISINELLTGVVPYTDLRAE-AQA 287 (697)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~-~~~ 287 (697)
.... ......||+.|+|||++ .+..++.++|||||||++|+|++|..||...... ...
T Consensus 161 ~~~~-----------------~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~ 223 (290)
T 3fme_A 161 VDDV-----------------AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQL 223 (290)
T ss_dssp --------------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHH
T ss_pred cccc-----------------cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHH
Confidence 4311 12334699999999996 5667899999999999999999999999863222 111
Q ss_pred HHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 005427 288 HTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH 355 (697)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~ 355 (697)
..... ... + ...+..+++++.+++.+||+.||.+|||+.|+++|+|+....
T Consensus 224 ~~~~~--------------~~~-~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~~ 274 (290)
T 3fme_A 224 KQVVE--------------EPS-P--QLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHE 274 (290)
T ss_dssp HHHHH--------------SCC-C--CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred HHHhc--------------cCC-C--CcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccCc
Confidence 11111 111 1 112346889999999999999999999999999999987643
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=350.11 Aligned_cols=254 Identities=24% Similarity=0.359 Sum_probs=207.2
Q ss_pred CCCCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCCh---HHHHHHHHHHHHHHhcCCCCceEEeeccccCCce
Q 005427 62 HLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTS---EELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNY 136 (697)
Q Consensus 62 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 136 (697)
.+..++|++.+.||+|+||.||+|.+ +++.||+|++..... ...+.+.+|+.+++.++||||+++++++.++..+
T Consensus 7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 86 (276)
T 2h6d_A 7 RVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDF 86 (276)
T ss_dssp CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred cceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeE
Confidence 34457899999999999999999998 588999998654321 2256789999999999999999999999999999
Q ss_pred EEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhh
Q 005427 137 MFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLK 216 (697)
Q Consensus 137 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~ 216 (697)
++||||+.+++|.+++.... .+++.+++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||++.......
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 165 (276)
T 2h6d_A 87 FMVMEYVSGGELFDYICKHG-RVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 165 (276)
T ss_dssp EEEEECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred EEEEeccCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCCc
Confidence 99999999999999997654 68999999999999999999999999999999999999999999999999987543211
Q ss_pred hhhcccccCCCCCCCCccccccccCccccchhhhcccCC-CchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccc
Q 005427 217 EISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIH-SEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNY 295 (697)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~ 295 (697)
......||+.|+|||++.+..+ +.++||||||+++|+|++|..||.+.........+..
T Consensus 166 -----------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~--- 225 (276)
T 2h6d_A 166 -----------------FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRG--- 225 (276)
T ss_dssp ----------------------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH---
T ss_pred -----------------ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhc---
Confidence 1234578999999999988765 6899999999999999999999987655443333221
Q ss_pred cHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 296 TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
+. ...+..++.++.++|.+||+.||.+|||+.++++|.|+.
T Consensus 226 -----------~~-----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~ 266 (276)
T 2h6d_A 226 -----------GV-----FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFK 266 (276)
T ss_dssp -----------CC-----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHH
T ss_pred -----------Cc-----ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhc
Confidence 11 112446789999999999999999999999999998874
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=364.96 Aligned_cols=261 Identities=26% Similarity=0.395 Sum_probs=204.9
Q ss_pred CCcccccccccCCceEEEEEEE--C-C--eeEEEEeccCC-ChHHHHHHHHHHHHHHhcCCCCceEEeeccc-cCCceEE
Q 005427 66 SSYTLLSPIARGAESVVYEATL--D-G--RKVAVKKPILS-TSEELDNFHKELQLLCKLDHPGLAKFVAAHA-KPPNYMF 138 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~-~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~~l 138 (697)
..|++.++||+|+||.||+|++ . + ..||+|..... .....+.+.+|+.+|+.++||||+++++++. .....++
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 3588899999999999999986 2 2 35889976533 3456788999999999999999999999865 4568899
Q ss_pred EEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhh
Q 005427 139 FFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI 218 (697)
Q Consensus 139 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~ 218 (697)
||||+.+|+|.+++......+++.+++.++.|++.||+|||+.||+||||||+|||++.++.+||+|||+++........
T Consensus 169 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~ 248 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 248 (373)
T ss_dssp EEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------------
T ss_pred EEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccccccc
Confidence 99999999999999877777899999999999999999999999999999999999999999999999999765431110
Q ss_pred hcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCCchhHHHHHHHHhccccH
Q 005427 219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTE 297 (697)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~ 297 (697)
.........+|+.|+|||++.+..++.++|||||||++|||++ |.+||.+.........+.
T Consensus 249 ------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~------ 310 (373)
T 3c1x_A 249 ------------SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL------ 310 (373)
T ss_dssp ---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHH------
T ss_pred ------------cccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHH------
Confidence 0011234467889999999999999999999999999999999 788887654333222221
Q ss_pred HHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHh
Q 005427 298 QQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHR 356 (697)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~~ 356 (697)
.+ .++ ..+..+|..+.++|.+||+.||.+|||+.+++++|..+....
T Consensus 311 --------~~-~~~---~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~ 357 (373)
T 3c1x_A 311 --------QG-RRL---LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 357 (373)
T ss_dssp --------TT-CCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred --------cC-CCC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 11 111 123568999999999999999999999999999999988653
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=371.07 Aligned_cols=273 Identities=22% Similarity=0.232 Sum_probs=216.9
Q ss_pred cCCCCCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCChHHHHHHHHHHHHHHhc------CCCCceEEeeccc
Q 005427 60 PLHLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKL------DHPGLAKFVAAHA 131 (697)
Q Consensus 60 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~hpniv~l~~~~~ 131 (697)
+......+|+++++||+|+||.||+|.+ +++.||||++.. .......+.+|+.+++.+ +|+||+++++++.
T Consensus 91 ~~~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~-~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~ 169 (429)
T 3kvw_A 91 PHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRN-EKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFT 169 (429)
T ss_dssp TTCEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECS-CHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEE
T ss_pred CCCcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECC-ccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecc
Confidence 3344557899999999999999999987 578999998754 334456778899988887 5779999999999
Q ss_pred cCCceEEEEeecCCCCHhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCC--Ceeeeecc
Q 005427 132 KPPNYMFFFEFYESRNLAEKLHVEE-WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLC--PHLADFGL 208 (697)
Q Consensus 132 ~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~--~kL~Dfg~ 208 (697)
....+++||||+. ++|.+++.... ..+++..++.++.||+.||+|||+.||+||||||+|||++.++. +||+|||+
T Consensus 170 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~ 248 (429)
T 3kvw_A 170 FRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGS 248 (429)
T ss_dssp ETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred cCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeeccc
Confidence 9999999999997 59999887654 35899999999999999999999999999999999999999887 99999999
Q ss_pred chhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHH
Q 005427 209 AEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAH 288 (697)
Q Consensus 209 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~ 288 (697)
++.... .....+||+.|+|||++.+..++.++|||||||++|||++|.+||.+.+......
T Consensus 249 a~~~~~-------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~ 309 (429)
T 3kvw_A 249 SCYEHQ-------------------RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLA 309 (429)
T ss_dssp CEETTC-------------------CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred ceecCC-------------------cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 864331 1345689999999999999999999999999999999999999999887766665
Q ss_pred HHHhccccHHHHHHH-------HHh-CCCC--------------------------------CcccccccCChHHHHHHH
Q 005427 289 TVLEMNYTEQQLTAA-------VVS-GGLR--------------------------------PILASLELGLPASILSLI 328 (697)
Q Consensus 289 ~~~~~~~~~~~~~~~-------~~~-~~~~--------------------------------~~~~~~~~~~~~~l~~li 328 (697)
.+............. ... .+.. .....++...++++.+||
T Consensus 310 ~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli 389 (429)
T 3kvw_A 310 CMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFL 389 (429)
T ss_dssp HHHHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHH
T ss_pred HHHHHcCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHH
Confidence 554432211111100 000 0000 000011223578899999
Q ss_pred HHhccCCCCCCCCHHHHHHHHHHHH
Q 005427 329 QRCWDGNPHNRPSFSDIALELDLVL 353 (697)
Q Consensus 329 ~~~l~~dP~~Rpt~~ell~~l~~~~ 353 (697)
++||+.||++|||+.|+++|.|+..
T Consensus 390 ~~~L~~dP~~Rpta~e~L~Hpw~~~ 414 (429)
T 3kvw_A 390 KQCLEWDPAVRMTPGQALRHPWLRR 414 (429)
T ss_dssp HHHTCSSTTTSCCHHHHHTSTTTC-
T ss_pred HHHCCCChhhCCCHHHHhCChhhcc
Confidence 9999999999999999999998754
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-42 Score=351.90 Aligned_cols=255 Identities=25% Similarity=0.364 Sum_probs=209.8
Q ss_pred CCCCCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCC--ChHHHHHHHHHHHHHHhcCCCCceEEeecccc----
Q 005427 61 LHLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAK---- 132 (697)
Q Consensus 61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~---- 132 (697)
.......|++.+.||+|+||.||+|.+ ++..||+|++... .....+.+.+|+.+|+.++||||+++++++..
T Consensus 21 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (290)
T 1t4h_A 21 MSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKG 100 (290)
T ss_dssp ECTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSS
T ss_pred cccCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCC
Confidence 344556799999999999999999988 5678999976533 34567789999999999999999999998765
Q ss_pred CCceEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccccCCCCceeec-CCCCCeeeeeccc
Q 005427 133 PPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLG--IVHRDVKPANVLLD-RNLCPHLADFGLA 209 (697)
Q Consensus 133 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~Nill~-~~~~~kL~Dfg~a 209 (697)
...+++||||+.+++|.+++.... .+++..++.++.|++.||.|||+.| |+||||||+|||++ .++.+||+|||++
T Consensus 101 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~ 179 (290)
T 1t4h_A 101 KKCIVLVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 179 (290)
T ss_dssp CEEEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred CceEEEEEEecCCCCHHHHHHHcc-CCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCc
Confidence 456899999999999999997654 6899999999999999999999999 99999999999997 7899999999998
Q ss_pred hhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHH
Q 005427 210 EYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHT 289 (697)
Q Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~ 289 (697)
..... .......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.........
T Consensus 180 ~~~~~------------------~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~ 240 (290)
T 1t4h_A 180 TLKRA------------------SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYR 240 (290)
T ss_dssp GGCCT------------------TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHH
T ss_pred ccccc------------------cccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHH
Confidence 64331 11234579999999998875 489999999999999999999999987544332222
Q ss_pred HHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 005427 290 VLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL 351 (697)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~ 351 (697)
... ....+ ...+...++++.+||.+||+.||.+|||+.++++|.|+
T Consensus 241 ~~~--------------~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f 286 (290)
T 1t4h_A 241 RVT--------------SGVKP--ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 286 (290)
T ss_dssp HHT--------------TTCCC--GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred HHh--------------ccCCc--cccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCccc
Confidence 111 11111 22345678999999999999999999999999998875
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=370.98 Aligned_cols=255 Identities=21% Similarity=0.285 Sum_probs=199.3
Q ss_pred CCcccc-cccccCCceEEEEEEE--CCeeEEEEeccCCChHHHHHHHHHHHHHH-hcCCCCceEEeecccc----CCceE
Q 005427 66 SSYTLL-SPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLC-KLDHPGLAKFVAAHAK----PPNYM 137 (697)
Q Consensus 66 ~~y~~~-~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~-~l~hpniv~l~~~~~~----~~~~~ 137 (697)
++|.+. +.||+|+||.||++.+ +++.||||++... ..+.+|+.++. .++||||+++++++.. ...+|
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 467776 7899999999999998 5789999986422 35678888874 4589999999998865 56789
Q ss_pred EEEeecCCCCHhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecC---CCCCeeeeeccchhhh
Q 005427 138 FFFEFYESRNLAEKLHVEE-WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDR---NLCPHLADFGLAEYRE 213 (697)
Q Consensus 138 lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~---~~~~kL~Dfg~a~~~~ 213 (697)
+||||+.+|+|.+++.... ..+++.+++.++.||+.||.|||+.||+||||||+|||++. ++.+||+|||+++...
T Consensus 136 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~ 215 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 215 (400)
T ss_dssp EEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred EEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccccC
Confidence 9999999999999997653 35899999999999999999999999999999999999987 7889999999997543
Q ss_pred hhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhc
Q 005427 214 NLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEM 293 (697)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~ 293 (697)
... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+........
T Consensus 216 ~~~-----------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~----- 273 (400)
T 1nxk_A 216 SHN-----------------SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP----- 273 (400)
T ss_dssp ----------------------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCC-----
T ss_pred CCC-----------------ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccH-----
Confidence 211 1345689999999999999999999999999999999999999997654321100
Q ss_pred cccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 005427 294 NYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL 353 (697)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~ 353 (697)
.....+..+.+.. .......++.++.+||++||+.||.+|||+.|+++|.|+..
T Consensus 274 -----~~~~~i~~~~~~~-~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~ 327 (400)
T 1nxk_A 274 -----GMKTRIRMGQYEF-PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 327 (400)
T ss_dssp -----SHHHHHHHTCCCC-CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHT
T ss_pred -----HHHHHHHcCcccC-CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccC
Confidence 0011111122111 11123468999999999999999999999999999999864
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-43 Score=365.60 Aligned_cols=243 Identities=23% Similarity=0.347 Sum_probs=207.1
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccCCCh--------HHHHHHHHHHHHHHhcCCCCceEEeeccccCCc
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTS--------EELDNFHKELQLLCKLDHPGLAKFVAAHAKPPN 135 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 135 (697)
++|++.++||+|+||.||+|++ +++.||||++..... .....+.+|+.+|+.++||||+++++++.+...
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 103 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF 103 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCE
Confidence 5799999999999999999987 688999998654421 123467789999999999999999999999999
Q ss_pred eEEEEeecCCC-CHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhh
Q 005427 136 YMFFFEFYESR-NLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYREN 214 (697)
Q Consensus 136 ~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~ 214 (697)
+++||||+.+| +|.+++.... .+++..++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 104 ~~lv~e~~~~g~~l~~~~~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 182 (335)
T 3dls_A 104 FQLVMEKHGSGLDLFAFIDRHP-RLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLER 182 (335)
T ss_dssp EEEEEECCTTSCBHHHHHHTCC-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEEEeCCCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECCC
Confidence 99999999776 9999987654 689999999999999999999999999999999999999999999999999976542
Q ss_pred hhhhhcccccCCCCCCCCccccccccCccccchhhhcccCC-CchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhc
Q 005427 215 LKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIH-SEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEM 293 (697)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~ 293 (697)
.. ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||....... .
T Consensus 183 ~~-----------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~------~- 238 (335)
T 3dls_A 183 GK-----------------LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV------E- 238 (335)
T ss_dssp TC-----------------CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT------T-
T ss_pred CC-----------------ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH------h-
Confidence 11 1334679999999999988776 889999999999999999999997632210 0
Q ss_pred cccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 005427 294 NYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL 351 (697)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~ 351 (697)
.. ...+..+++++.+||.+||+.||.+|||+.++++|.|.
T Consensus 239 -------------~~-----~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~ 278 (335)
T 3dls_A 239 -------------AA-----IHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWV 278 (335)
T ss_dssp -------------TC-----CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTT
T ss_pred -------------hc-----cCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccc
Confidence 00 11234589999999999999999999999999998886
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=357.97 Aligned_cols=277 Identities=27% Similarity=0.409 Sum_probs=221.0
Q ss_pred cCCCCCCCcccccccccCCceEEEEEEE------CCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccccC
Q 005427 60 PLHLPPSSYTLLSPIARGAESVVYEATL------DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKP 133 (697)
Q Consensus 60 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~ 133 (697)
+..+..++|++++.||+|+||.||++++ +++.||+|++........+.+.+|+.+|+.++||||+++++++...
T Consensus 35 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 114 (326)
T 2w1i_A 35 PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 114 (326)
T ss_dssp --CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC-
T ss_pred ccccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEec
Confidence 4456678899999999999999999984 5789999998777777788899999999999999999999988765
Q ss_pred C--ceEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchh
Q 005427 134 P--NYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEY 211 (697)
Q Consensus 134 ~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~ 211 (697)
. .+++||||+++++|.+++......+++.+++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||++..
T Consensus 115 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 115 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp ---CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred CCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 4 78999999999999999987766799999999999999999999999999999999999999999999999999976
Q ss_pred hhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHH
Q 005427 212 RENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVL 291 (697)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~ 291 (697)
....... ........+++.|+|||++.+..++.++||||||+++|+|++|..||........ ...
T Consensus 195 ~~~~~~~-------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~--~~~ 259 (326)
T 2w1i_A 195 LPQDKEY-------------YKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFM--RMI 259 (326)
T ss_dssp CCSSCSE-------------EECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHH--HHH
T ss_pred ccccccc-------------cccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHH--Hhh
Confidence 5421110 0012234578889999999998899999999999999999999999875432211 111
Q ss_pred hcccc----HHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 005427 292 EMNYT----EQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH 355 (697)
Q Consensus 292 ~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~ 355 (697)
..... ...+...+..+. ++ ..+..+|+++.+||.+||+.||.+|||+.++++.|..+.+.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~-~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 260 GNDKQGQMIVFHLIELLKNNG-RL---PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp CTTCCTHHHHHHHHHHHHTTC-CC---CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ccccchhhhHHHHHHHhhcCC-CC---CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 10000 111122222222 21 12457899999999999999999999999999999988764
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=366.46 Aligned_cols=266 Identities=22% Similarity=0.278 Sum_probs=203.9
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccCC--ChHHHHHHHHHHHHHHhcCCCCceEEeeccccCC------c
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPP------N 135 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~------~ 135 (697)
++|++.+.||+|+||.||+|.+ +++.||||++... .......+.+|+.+++.++||||+++++++.... .
T Consensus 25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 104 (371)
T 2xrw_A 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD 104 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCE
T ss_pred hheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccc
Confidence 6899999999999999999987 5889999986543 3445678899999999999999999999987665 6
Q ss_pred eEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhh
Q 005427 136 YMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL 215 (697)
Q Consensus 136 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~ 215 (697)
+++||||+.+ +|.+.+.. .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 105 ~~lv~e~~~~-~l~~~~~~---~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~ 180 (371)
T 2xrw_A 105 VYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 180 (371)
T ss_dssp EEEEEECCSE-EHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC-------
T ss_pred eEEEEEcCCC-CHHHHHhh---ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccccccc
Confidence 8999999985 78887752 5889999999999999999999999999999999999999999999999999754321
Q ss_pred hhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccc
Q 005427 216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNY 295 (697)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~ 295 (697)
. ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+.....
T Consensus 181 ~-----------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~ 243 (371)
T 2xrw_A 181 F-----------------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLG 243 (371)
T ss_dssp --------------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CC
T ss_pred c-----------------ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 1 12346799999999999999999999999999999999999999998877666665544322
Q ss_pred cHHH---------HHHHHHhC-CCC-------------CcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 296 TEQQ---------LTAAVVSG-GLR-------------PILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 296 ~~~~---------~~~~~~~~-~~~-------------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
.... ........ .+. |.....+...+.++.+||.+||+.||.+|||++|+++|.|+.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~ 323 (371)
T 2xrw_A 244 TPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN 323 (371)
T ss_dssp CCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHH
T ss_pred CCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchh
Confidence 1100 00000000 000 000000111367899999999999999999999999999985
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=363.58 Aligned_cols=253 Identities=25% Similarity=0.349 Sum_probs=212.0
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccCCCh--------HHHHHHHHHHHHHHhc-CCCCceEEeeccccCC
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTS--------EELDNFHKELQLLCKL-DHPGLAKFVAAHAKPP 134 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~ 134 (697)
++|++.+.||+|+||.||+|++ +|+.||||++..... ...+.+.+|+.+++.+ +||||+++++++....
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 4699999999999999999998 488999998654321 1245788999999999 8999999999999999
Q ss_pred ceEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhh
Q 005427 135 NYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYREN 214 (697)
Q Consensus 135 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~ 214 (697)
..++||||+.+++|.+++.... .+++..++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||++..+..
T Consensus 174 ~~~lv~e~~~g~~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~ 252 (365)
T 2y7j_A 174 FMFLVFDLMRKGELFDYLTEKV-ALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP 252 (365)
T ss_dssp EEEEEECCCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred EEEEEEEeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCC
Confidence 9999999999999999997654 689999999999999999999999999999999999999999999999999875542
Q ss_pred hhhhhcccccCCCCCCCCccccccccCccccchhhhcc------cCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHH
Q 005427 215 LKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK------EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAH 288 (697)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~ 288 (697)
.. ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+........
T Consensus 253 ~~-----------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~ 315 (365)
T 2y7j_A 253 GE-----------------KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLR 315 (365)
T ss_dssp TC-----------------CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred Cc-----------------ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence 11 1345679999999999864 357889999999999999999999998765544444
Q ss_pred HHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 005427 289 TVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL 351 (697)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~ 351 (697)
.+.... .... ...+..++.++.+||.+||+.||.+|||+.++++|.|+
T Consensus 316 ~i~~~~--------------~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f 363 (365)
T 2y7j_A 316 MIMEGQ--------------YQFS-SPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFF 363 (365)
T ss_dssp HHHHTC--------------CCCC-HHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred HHHhCC--------------CCCC-CcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccc
Confidence 333222 1111 11234688999999999999999999999999998875
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=359.02 Aligned_cols=276 Identities=24% Similarity=0.386 Sum_probs=197.3
Q ss_pred CccCCCCCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCC-hHHHHHHHHHHHHHHhcCCCCceEEeeccccCC
Q 005427 58 SIPLHLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST-SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPP 134 (697)
Q Consensus 58 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 134 (697)
..++.+..++|++.+.||+|+||.||+|++ +++.||||.+.... ....+.+.+|+.+++.++||||+++++++....
T Consensus 7 ~~p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 86 (303)
T 2vwi_A 7 ALPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKD 86 (303)
T ss_dssp ------CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSS
T ss_pred ccccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecC
Confidence 457788889999999999999999999986 68899999865543 234567889999999999999999999999999
Q ss_pred ceEEEEeecCCCCHhhhhhh-------cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeec
Q 005427 135 NYMFFFEFYESRNLAEKLHV-------EEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFG 207 (697)
Q Consensus 135 ~~~lv~e~~~~g~L~~~l~~-------~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg 207 (697)
..++||||+.+++|.+++.. ....+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg 166 (303)
T 2vwi_A 87 ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFG 166 (303)
T ss_dssp CEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCH
T ss_pred CcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEecc
Confidence 99999999999999999864 23468999999999999999999999999999999999999999999999999
Q ss_pred cchhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcc-cCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHH
Q 005427 208 LAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQ 286 (697)
Q Consensus 208 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~ 286 (697)
++......... ..........||+.|+|||++.+ ..++.++|||||||++|+|++|..||........
T Consensus 167 ~~~~~~~~~~~-----------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 235 (303)
T 2vwi_A 167 VSAFLATGGDI-----------TRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV 235 (303)
T ss_dssp HHHHCC--------------------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH
T ss_pred chheeccCCCc-----------cchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH
Confidence 98765432110 00112334579999999999976 5689999999999999999999999987654433
Q ss_pred HHHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 005427 287 AHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL 353 (697)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~ 353 (697)
............. ...........++.++.++|.+||+.||.+|||+.++++|.|+..
T Consensus 236 ~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 293 (303)
T 2vwi_A 236 LMLTLQNDPPSLE---------TGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQK 293 (303)
T ss_dssp HHHHHTSSCCCTT---------C-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC--
T ss_pred HHHHhccCCCccc---------cccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhc
Confidence 3222211110000 000011223468899999999999999999999999999887643
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=349.09 Aligned_cols=261 Identities=25% Similarity=0.406 Sum_probs=213.1
Q ss_pred CcccccccccCCceEEEEEEE--CC---eeEEEEeccCC-ChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCce-EEE
Q 005427 67 SYTLLSPIARGAESVVYEATL--DG---RKVAVKKPILS-TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNY-MFF 139 (697)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~--~~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~-~lv 139 (697)
.|.+.++||+|+||.||+|.+ ++ ..+|+|..... .....+.+.+|+.+++.++||||+++++++.+.... +++
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 467789999999999999986 22 36999986543 334567899999999999999999999999876665 999
Q ss_pred EeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhh
Q 005427 140 FEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEIS 219 (697)
Q Consensus 140 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~ 219 (697)
|||+.+|+|.+++......+++.+++.++.|++.||+|||+.||+||||||+|||++.++.+||+|||++.........
T Consensus 102 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~- 180 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYY- 180 (298)
T ss_dssp ECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGG-
T ss_pred EecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCccc-
Confidence 9999999999999876778899999999999999999999999999999999999999999999999999765432211
Q ss_pred cccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCCchhHHHHHHHHhccccHH
Q 005427 220 LKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQ 298 (697)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~ 298 (697)
.........+|+.|+|||++.+..++.++|||||||++|+|++ |.+||...........+..
T Consensus 181 -----------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~------ 243 (298)
T 3pls_A 181 -----------SVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQ------ 243 (298)
T ss_dssp -----------CSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHT------
T ss_pred -----------ccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhc------
Confidence 0112344578999999999999999999999999999999999 5555555443332222211
Q ss_pred HHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhc
Q 005427 299 QLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHRK 357 (697)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~~~ 357 (697)
.. . ...+..+++++.+++.+||+.||.+|||+.++++.+..+.+...
T Consensus 244 --------~~-~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~ 290 (298)
T 3pls_A 244 --------GR-R---LPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALL 290 (298)
T ss_dssp --------TC-C---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred --------CC-C---CCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHh
Confidence 11 1 11245688999999999999999999999999999999987643
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=367.40 Aligned_cols=270 Identities=24% Similarity=0.374 Sum_probs=210.3
Q ss_pred CCCCCCCcccccccccCCceEEEEEEE-CCeeEEEEeccCCChH-HHHHHHHHHHHHHhcCCCCceEEeeccccCCceEE
Q 005427 61 LHLPPSSYTLLSPIARGAESVVYEATL-DGRKVAVKKPILSTSE-ELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMF 138 (697)
Q Consensus 61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 138 (697)
+.+..++|++.+.||+|+||.||+|+. +++.||||++...... ....+.+|+.+++.++||||+++++++.++...++
T Consensus 25 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 104 (326)
T 3uim_A 25 LQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL 104 (326)
T ss_dssp HHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEE
T ss_pred HHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCCceEE
Confidence 445668999999999999999999986 5889999987654322 22368999999999999999999999999999999
Q ss_pred EEeecCCCCHhhhhhhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCCCCceeecCCCCCeeeeeccchhh
Q 005427 139 FFEFYESRNLAEKLHVEE---WSPSVDQVLMIAAQLAKALQYLHNL---GIVHRDVKPANVLLDRNLCPHLADFGLAEYR 212 (697)
Q Consensus 139 v~e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~ 212 (697)
||||+.+|+|.+++.... ..+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||++...
T Consensus 105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 184 (326)
T 3uim_A 105 VYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 184 (326)
T ss_dssp EEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred EEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCcccccc
Confidence 999999999999997643 2489999999999999999999999 9999999999999999999999999999755
Q ss_pred hhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHh
Q 005427 213 ENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLE 292 (697)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~ 292 (697)
... .........||+.|+|||++.+..++.++|||||||++|+|++|..||.........
T Consensus 185 ~~~---------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~----- 244 (326)
T 3uim_A 185 DYK---------------DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDD----- 244 (326)
T ss_dssp CSS---------------SSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTS-----
T ss_pred Ccc---------------cccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccccccccccc-----
Confidence 321 111234456999999999999888999999999999999999999999632111000
Q ss_pred ccccHHHHHHHHHhC-CCCCc-----ccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 005427 293 MNYTEQQLTAAVVSG-GLRPI-----LASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL 351 (697)
Q Consensus 293 ~~~~~~~~~~~~~~~-~~~~~-----~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~ 351 (697)
.............. ..... ....+...+..+.+++..||+.||.+|||+.+++++|+.
T Consensus 245 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 245 -DVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp -CSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred -chhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 00000000000000 00000 011223356789999999999999999999999999875
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=368.08 Aligned_cols=270 Identities=21% Similarity=0.288 Sum_probs=210.5
Q ss_pred CCCCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeecccc-------
Q 005427 62 HLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAK------- 132 (697)
Q Consensus 62 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~------- 132 (697)
+...++|++.+.||+|+||.||+|++ +++.||+|++..... ...+|+.+|+.++||||+++++++..
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 34567999999999999999999987 688999998654321 23479999999999999999999843
Q ss_pred -------------------------------CCceEEEEeecCCCCHhhhhhh---cCCCCCHHHHHHHHHHHHHHHHHH
Q 005427 133 -------------------------------PPNYMFFFEFYESRNLAEKLHV---EEWSPSVDQVLMIAAQLAKALQYL 178 (697)
Q Consensus 133 -------------------------------~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~L 178 (697)
...+++||||+++ +|.+.+.. ....+++..++.++.|++.||.||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 3348899999985 87776642 345789999999999999999999
Q ss_pred HhCCcccccCCCCceeec-CCCCCeeeeeccchhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhccc-CCC
Q 005427 179 HNLGIVHRDVKPANVLLD-RNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKE-IHS 256 (697)
Q Consensus 179 H~~~ivHrDlkp~Nill~-~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~ 256 (697)
|+.||+||||||+|||++ .++.+||+|||++....... ......||+.|+|||++.+. .++
T Consensus 158 H~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~-----------------~~~~~~~t~~y~aPE~~~~~~~~~ 220 (383)
T 3eb0_A 158 HSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE-----------------PSVAYICSRFYRAPELMLGATEYT 220 (383)
T ss_dssp HTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS-----------------CCCCCCCCSSCCCHHHHTTCSSCC
T ss_pred HHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC-----------------CCcCcccCCCccCHHHhcCCCCCC
Confidence 999999999999999997 68899999999997543211 13455789999999998875 489
Q ss_pred chhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHHHHHHHhCCCC----------CcccccccCChHHHHH
Q 005427 257 EKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLR----------PILASLELGLPASILS 326 (697)
Q Consensus 257 ~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~l~~ 326 (697)
.++|||||||++|+|++|..||.+.........+..................+. ......+..+|+++.+
T Consensus 221 ~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (383)
T 3eb0_A 221 PSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAID 300 (383)
T ss_dssp THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHH
T ss_pred cchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHH
Confidence 999999999999999999999999877776666654333221111111111110 0111134568899999
Q ss_pred HHHHhccCCCCCCCCHHHHHHHHHHHH
Q 005427 327 LIQRCWDGNPHNRPSFSDIALELDLVL 353 (697)
Q Consensus 327 li~~~l~~dP~~Rpt~~ell~~l~~~~ 353 (697)
||.+||+.||.+|||+.|+++|.|+-.
T Consensus 301 li~~~L~~dP~~R~t~~e~l~hp~f~~ 327 (383)
T 3eb0_A 301 LLEQILRYEPDLRINPYEAMAHPFFDH 327 (383)
T ss_dssp HHHHHCCSSGGGSCCHHHHHTSGGGHH
T ss_pred HHHHHccCChhhCCCHHHHhcCHHHHH
Confidence 999999999999999999999998753
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=350.21 Aligned_cols=262 Identities=24% Similarity=0.374 Sum_probs=205.7
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccC---CChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEE
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPIL---STSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFF 140 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 140 (697)
++|++.+.||+|+||.||+|.+ +++.||+|++.. ........+.+|+.+++.++||||+++++++.....+++||
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 111 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 111 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence 5799999999999999999987 688999998754 23455778999999999999999999999999999999999
Q ss_pred eecCCCCHhhhhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhh
Q 005427 141 EFYESRNLAEKLHV---EEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKE 217 (697)
Q Consensus 141 e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~ 217 (697)
||+.+++|.+++.. ....+++..++.++.|++.||.|||+.|++||||||+|||++.++.+||+|||++........
T Consensus 112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 191 (310)
T 2wqm_A 112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 191 (310)
T ss_dssp ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC-----------
T ss_pred ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCCc
Confidence 99999999998864 345689999999999999999999999999999999999999999999999999876542111
Q ss_pred hhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccH
Q 005427 218 ISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTE 297 (697)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~ 297 (697)
......|++.|+|||++.+..++.++||||||+++|+|++|..||.+.....
T Consensus 192 ----------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------------ 243 (310)
T 2wqm_A 192 ----------------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL------------ 243 (310)
T ss_dssp -----------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCH------------
T ss_pred ----------------cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhH------------
Confidence 1234578999999999999999999999999999999999999997642111
Q ss_pred HHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhcc
Q 005427 298 QQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHRKS 358 (697)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~~~~ 358 (697)
......+......+. ....+++++.+||.+||+.||.+|||+.++++.+..+......
T Consensus 244 ~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~ 301 (310)
T 2wqm_A 244 YSLCKKIEQCDYPPL---PSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTAS 301 (310)
T ss_dssp HHHHHHHHTTCSCCC---CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred HHHHHHhhcccCCCC---cccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhh
Confidence 111112222222221 1246889999999999999999999999999999998775443
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=375.57 Aligned_cols=248 Identities=19% Similarity=0.211 Sum_probs=198.6
Q ss_pred CCCCCCCcccccccccCCceEEEEEEE--CCeeEEEEeccC---CChHHHHHHHHHHH---HHHhcCCCCceEEe-----
Q 005427 61 LHLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPIL---STSEELDNFHKELQ---LLCKLDHPGLAKFV----- 127 (697)
Q Consensus 61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~---~~~~~~~~~~~E~~---~l~~l~hpniv~l~----- 127 (697)
+....++|++.+.||+|+||.||+|++ +++.||||++.. ......+.+.+|+. +|+.++||||++++
T Consensus 68 ~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~ 147 (377)
T 3byv_A 68 LGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIF 147 (377)
T ss_dssp SSCCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCC
T ss_pred cCCCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhh
Confidence 334567899999999999999999985 588999998753 34456678999995 55555899999998
Q ss_pred --eccccCC-----------------ceEEEEeecCCCCHhhhhhhcCCCCC-------HHHHHHHHHHHHHHHHHHHhC
Q 005427 128 --AAHAKPP-----------------NYMFFFEFYESRNLAEKLHVEEWSPS-------VDQVLMIAAQLAKALQYLHNL 181 (697)
Q Consensus 128 --~~~~~~~-----------------~~~lv~e~~~~g~L~~~l~~~~~~~~-------~~~~~~i~~qi~~~l~~LH~~ 181 (697)
+++.+++ ..+++|||+ +|+|.+++.... .++ +..++.++.||+.||+|||++
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~-~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~ 225 (377)
T 3byv_A 148 PFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLL-SHSSTHKSLVHHARLQLTLQVIRLLASLHHY 225 (377)
T ss_dssp CSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHH-HTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred hhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhcc-ccccccccccHHHHHHHHHHHHHHHHHHHhC
Confidence 5544443 388999999 579999997643 233 478888999999999999999
Q ss_pred CcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhccc--------
Q 005427 182 GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKE-------- 253 (697)
Q Consensus 182 ~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------- 253 (697)
||+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+.
T Consensus 226 ~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-------------------~~~~~~g-~~y~aPE~~~~~~~~~~~~~ 285 (377)
T 3byv_A 226 GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-------------------RVVSSVS-RGFEPPELEARRATISYHRD 285 (377)
T ss_dssp TEECSCCCGGGEEECTTCCEEECCGGGCEETTC-------------------EEECCCC-TTCCCHHHHHHHTSTHHHHC
T ss_pred CeecCCCCHHHEEEcCCCCEEEEechhheecCC-------------------cccCCCC-cCccChhhhccccccccccc
Confidence 999999999999999999999999999874321 1344567 999999999887
Q ss_pred ---CCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHH
Q 005427 254 ---IHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQR 330 (697)
Q Consensus 254 ---~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 330 (697)
.++.++|||||||++|||++|..||.+.........+. .....+++++.+||.+
T Consensus 286 ~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~li~~ 342 (377)
T 3byv_A 286 RRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIF-----------------------RSCKNIPQPVRALLEG 342 (377)
T ss_dssp CEEECCHHHHHHHHHHHHHHHHHSSCCC------CCSGGGG-----------------------SSCCCCCHHHHHHHHH
T ss_pred ccccCChhhhHHHHHHHHHHHHHCCCCCcccccccchhhhh-----------------------hhccCCCHHHHHHHHH
Confidence 89999999999999999999999997654322211111 1124689999999999
Q ss_pred hccCCCCCCCCHHHHHHHHHHHH
Q 005427 331 CWDGNPHNRPSFSDIALELDLVL 353 (697)
Q Consensus 331 ~l~~dP~~Rpt~~ell~~l~~~~ 353 (697)
||+.||.+|||+.++++|.|+..
T Consensus 343 ~L~~dp~~Rpt~~e~l~hp~f~~ 365 (377)
T 3byv_A 343 FLRYPKEDRLLPLQAMETPEYEQ 365 (377)
T ss_dssp HTCSSGGGCCCHHHHHTSHHHHH
T ss_pred HcCCCchhCCCHHHHhhChHHHH
Confidence 99999999999999999988753
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=352.84 Aligned_cols=254 Identities=28% Similarity=0.401 Sum_probs=210.5
Q ss_pred CCCcccccccccCCceEEEEEEE--CCeeEEEEeccCC--ChHHHHHHHHHHHHHHhcCCCCceEEeecc--ccCCceEE
Q 005427 65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAH--AKPPNYMF 138 (697)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~--~~~~~~~l 138 (697)
.++|++.+.||+|+||.||++++ +++.||+|.+... .....+.+.+|+.+++.++||||+++++++ .....+++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 35899999999999999999998 5789999987644 344567899999999999999999999987 44678999
Q ss_pred EEeecCCCCHhhhhhhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC-----cccccCCCCceeecCCCCCeeeeeccch
Q 005427 139 FFEFYESRNLAEKLHVE---EWSPSVDQVLMIAAQLAKALQYLHNLG-----IVHRDVKPANVLLDRNLCPHLADFGLAE 210 (697)
Q Consensus 139 v~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~-----ivHrDlkp~Nill~~~~~~kL~Dfg~a~ 210 (697)
||||+++++|.+++... ...+++.+++.++.|++.||+|||+.| |+||||||+|||++.++.+||+|||++.
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 99999999999998653 234899999999999999999999999 9999999999999999999999999997
Q ss_pred hhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHH
Q 005427 211 YRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTV 290 (697)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~ 290 (697)
....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||...........+
T Consensus 165 ~~~~~~~----------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i 228 (279)
T 2w5a_A 165 ILNHDTS----------------FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI 228 (279)
T ss_dssp HC---CH----------------HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred eeccccc----------------cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHH
Confidence 6543111 123457899999999999999999999999999999999999999876544433332
Q ss_pred HhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 291 LEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
.. +... ..+..++.++.++|.+||+.||.+|||+.|+++++|..
T Consensus 229 ~~--------------~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~ 272 (279)
T 2w5a_A 229 RE--------------GKFR----RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLIL 272 (279)
T ss_dssp HH--------------TCCC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCC
T ss_pred hh--------------cccc----cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhh
Confidence 22 2211 23456899999999999999999999999999877653
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-42 Score=351.45 Aligned_cols=263 Identities=24% Similarity=0.353 Sum_probs=214.8
Q ss_pred CCCCCCCccccc-ccccCCceEEEEEEE----CCeeEEEEeccCCC--hHHHHHHHHHHHHHHhcCCCCceEEeeccccC
Q 005427 61 LHLPPSSYTLLS-PIARGAESVVYEATL----DGRKVAVKKPILST--SEELDNFHKELQLLCKLDHPGLAKFVAAHAKP 133 (697)
Q Consensus 61 ~~~~~~~y~~~~-~lg~G~~g~V~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~ 133 (697)
..+..++|++.+ .||+|+||.||+|.+ .++.||||+..... ....+.+.+|+.+++.++||||+++++++ ..
T Consensus 11 ~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~ 89 (291)
T 1xbb_A 11 VYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EA 89 (291)
T ss_dssp CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ES
T ss_pred eeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CC
Confidence 345667899998 999999999999965 35789999875442 23367899999999999999999999998 56
Q ss_pred CceEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhh
Q 005427 134 PNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRE 213 (697)
Q Consensus 134 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~ 213 (697)
..+++||||+.+++|.+++.... .+++.+++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||++....
T Consensus 90 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 168 (291)
T 1xbb_A 90 ESWMLVMEMAELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALR 168 (291)
T ss_dssp SSEEEEEECCTTEEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred CCcEEEEEeCCCCCHHHHHHhCc-CCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeec
Confidence 78899999999999999997654 68999999999999999999999999999999999999999999999999987654
Q ss_pred hhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCCchhHHHHHHHHh
Q 005427 214 NLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLE 292 (697)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~~~~~~~~~~~~~ 292 (697)
..... ........+++.|+|||++.+..++.++||||||+++|+|++ |..||.+.........+..
T Consensus 169 ~~~~~-------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~ 235 (291)
T 1xbb_A 169 ADENY-------------YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK 235 (291)
T ss_dssp TTCSE-------------EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT
T ss_pred cCCCc-------------ccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc
Confidence 21110 001223456789999999998889999999999999999999 9999987655443332221
Q ss_pred ccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHh
Q 005427 293 MNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHR 356 (697)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~~ 356 (697)
+ .++ ..+..+++++.++|.+||+.||.+|||+.++++.|..++...
T Consensus 236 --------------~-~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 281 (291)
T 1xbb_A 236 --------------G-ERM---GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 281 (291)
T ss_dssp --------------T-CCC---CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred --------------C-CCC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence 1 111 234578999999999999999999999999999999887653
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=361.14 Aligned_cols=264 Identities=21% Similarity=0.290 Sum_probs=211.5
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccCC--ChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCce-----
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNY----- 136 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~----- 136 (697)
++|.+.+.||+|+||.||+|.+ +++.||||++... .......+.+|+.+++.++||||+++++++......
T Consensus 42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 121 (371)
T 4exu_A 42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 121 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCC
T ss_pred ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccccee
Confidence 6899999999999999999987 5899999987643 333467889999999999999999999999877654
Q ss_pred -EEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhh
Q 005427 137 -MFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL 215 (697)
Q Consensus 137 -~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~ 215 (697)
++||||+. ++|.+.+.. .+++.+++.++.|++.||+|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 122 ~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~- 196 (371)
T 4exu_A 122 FYLVMPFMQ-TDLQKIMGM---EFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA- 196 (371)
T ss_dssp CEEEEECCC-EEHHHHTTS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC------
T ss_pred EEEEEcccc-ccHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCccccccc-
Confidence 99999998 588887742 589999999999999999999999999999999999999999999999999975432
Q ss_pred hhhhcccccCCCCCCCCccccccccCccccchhhhcc-cCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhcc
Q 005427 216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMN 294 (697)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~ 294 (697)
......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+....
T Consensus 197 ------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~ 258 (371)
T 4exu_A 197 ------------------EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVT 258 (371)
T ss_dssp ---------------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred ------------------CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence 1234578999999999987 678999999999999999999999999877666655554322
Q ss_pred ccHHHH------------HHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 295 YTEQQL------------TAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 295 ~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
...... .........+..+......+++++.+||.+||+.||.+|||+.|+++|.|+-
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~ 328 (371)
T 4exu_A 259 GVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFE 328 (371)
T ss_dssp CCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGT
T ss_pred CCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccc
Confidence 111000 0001111112222333456899999999999999999999999999998874
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-42 Score=353.62 Aligned_cols=254 Identities=25% Similarity=0.414 Sum_probs=216.6
Q ss_pred CCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCC-hHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEe
Q 005427 65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST-SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFE 141 (697)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 141 (697)
.++|++.+.||+|+||.||+|.+ +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+...+++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 45799999999999999999987 57899999876543 3446789999999999999999999999999999999999
Q ss_pred ecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhcc
Q 005427 142 FYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLK 221 (697)
Q Consensus 142 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~ 221 (697)
|+.+++|.+++.. ..+++.+++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||++.......
T Consensus 101 ~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~----- 173 (303)
T 3a7i_A 101 YLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ----- 173 (303)
T ss_dssp CCTTEEHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB-----
T ss_pred eCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccc-----
Confidence 9999999999864 368999999999999999999999999999999999999999999999999986554211
Q ss_pred cccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHHH
Q 005427 222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLT 301 (697)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 301 (697)
.......||+.|+|||++.+..++.++||||||+++|+|++|..||...........+..
T Consensus 174 -----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--------- 233 (303)
T 3a7i_A 174 -----------IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPK--------- 233 (303)
T ss_dssp -----------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH---------
T ss_pred -----------cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhc---------
Confidence 113455799999999999999999999999999999999999999987654433322211
Q ss_pred HHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 005427 302 AAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE 354 (697)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~ 354 (697)
.. . +..+..++..+.+||.+||+.||.+|||+.++++|+|....
T Consensus 234 -----~~-~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 277 (303)
T 3a7i_A 234 -----NN-P---PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRN 277 (303)
T ss_dssp -----SC-C---CCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred -----CC-C---CCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcC
Confidence 11 1 12345789999999999999999999999999999998654
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=361.94 Aligned_cols=272 Identities=23% Similarity=0.282 Sum_probs=215.6
Q ss_pred CCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCC-hHHHHHHHHHHHHHHhcCCCCceEEeeccccC-----Cce
Q 005427 65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST-SEELDNFHKELQLLCKLDHPGLAKFVAAHAKP-----PNY 136 (697)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-----~~~ 136 (697)
..+|++++.||+|+||.||+|++ +++.||+|++.... ......+.+|+.+|+.++||||+++++++..+ ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 46899999999999999999987 58899999876433 34457899999999999999999999998655 468
Q ss_pred EEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhh
Q 005427 137 MFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLK 216 (697)
Q Consensus 137 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~ 216 (697)
++||||+.+ +|.+++... .+++.+++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 106 ~iv~e~~~~-~L~~~l~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 182 (364)
T 3qyz_A 106 YIVQDLMET-DLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 182 (364)
T ss_dssp EEEEECCSE-EHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred EEEEcccCc-CHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCC
Confidence 999999985 999988654 58999999999999999999999999999999999999999999999999997654321
Q ss_pred hhhcccccCCCCCCCCccccccccCccccchhhhcc-cCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccc
Q 005427 217 EISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNY 295 (697)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~ 295 (697)
.. .......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+.....
T Consensus 183 ~~-------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~ 249 (364)
T 3qyz_A 183 DH-------------TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG 249 (364)
T ss_dssp CB-------------CCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHC
T ss_pred Cc-------------cccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhC
Confidence 10 011244689999999998764 5589999999999999999999999998776666555543222
Q ss_pred cHHHHH----------HHHHhC--CCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 296 TEQQLT----------AAVVSG--GLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 296 ~~~~~~----------~~~~~~--~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
...... .....- ............+++++.+||.+||+.||.+|||+.|+++|.|+.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~ 318 (364)
T 3qyz_A 250 SPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 318 (364)
T ss_dssp SCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGT
T ss_pred CCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchh
Confidence 111100 000000 001111223456889999999999999999999999999998874
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=362.35 Aligned_cols=274 Identities=24% Similarity=0.250 Sum_probs=211.0
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccCCChH--HHHHHHHHHHHHHhcCCCCceEEeecccc--------C
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSE--ELDNFHKELQLLCKLDHPGLAKFVAAHAK--------P 133 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~--------~ 133 (697)
++|+++++||+|+||.||+|++ +++.||+|++...... ....+.+|+.+|+.++||||+++++++.. .
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 6899999999999999999998 5889999986544322 24567899999999999999999999876 3
Q ss_pred CceEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhh
Q 005427 134 PNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRE 213 (697)
Q Consensus 134 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~ 213 (697)
..+++||||+.+ +|.+.+......+++.+++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++..+.
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 175 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFS 175 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred ceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhccccc
Confidence 468999999986 8888877666679999999999999999999999999999999999999999999999999997654
Q ss_pred hhhhhhcccccCCCCCCCCccccccccCccccchhhhcc-cCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHh
Q 005427 214 NLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLE 292 (697)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~ 292 (697)
.... ..........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+..
T Consensus 176 ~~~~------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~ 243 (351)
T 3mi9_A 176 LAKN------------SQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ 243 (351)
T ss_dssp CCSS------------SSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred cccc------------ccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 2111 11112345678999999999976 4579999999999999999999999998776655554433
Q ss_pred ccccHHHHHHHHH-----hCCCC------Ccc-cc-cccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 293 MNYTEQQLTAAVV-----SGGLR------PIL-AS-LELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 293 ~~~~~~~~~~~~~-----~~~~~------~~~-~~-~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
.........+... ..... ..+ .. .....++++.+||.+||+.||.+|||+.|+++|.|+.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~ 316 (351)
T 3mi9_A 244 LCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFW 316 (351)
T ss_dssp HHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGG
T ss_pred HhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcC
Confidence 2111100000000 00000 000 00 0001367899999999999999999999999998874
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-42 Score=353.71 Aligned_cols=268 Identities=25% Similarity=0.384 Sum_probs=211.2
Q ss_pred CcccccccccCCceEEEEEEECCeeEEEEeccCC----ChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEee
Q 005427 67 SYTLLSPIARGAESVVYEATLDGRKVAVKKPILS----TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF 142 (697)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 142 (697)
.|...++||+|+||.||+|..+++.||+|++... .....+.+.+|+.+++.++||||+++++++.+....++||||
T Consensus 32 ~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 111 (307)
T 2nru_A 32 ISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVY 111 (307)
T ss_dssp TTTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred ccccCCccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEe
Confidence 4667799999999999999999999999986532 234467899999999999999999999999999999999999
Q ss_pred cCCCCHhhhhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhc
Q 005427 143 YESRNLAEKLHVE--EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL 220 (697)
Q Consensus 143 ~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~ 220 (697)
+++++|.+++... ...+++..++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 112 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~---- 187 (307)
T 2nru_A 112 MPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFA---- 187 (307)
T ss_dssp CTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCS----
T ss_pred cCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeeccccccccccc----
Confidence 9999999998643 3358999999999999999999999999999999999999999999999999987543211
Q ss_pred ccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHH
Q 005427 221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQL 300 (697)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 300 (697)
.........||+.|+|||++.+. ++.++||||||+++|+|++|..||.+.........+..........
T Consensus 188 ----------~~~~~~~~~g~~~y~aPE~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 256 (307)
T 2nru_A 188 ----------QTVMTSRIVGTTAYMAPEALRGE-ITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKT 256 (307)
T ss_dssp ----------SCEECSSCCSCGGGCCHHHHTTE-ECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCC
T ss_pred ----------ccccccccCCCcCcCChHHhcCC-CCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhh
Confidence 11123345799999999998764 6889999999999999999999998754433222221110000000
Q ss_pred HHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 005427 301 TAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL 353 (697)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~ 353 (697)
..... .+.+...+..++..+.+++.+||+.||.+|||+.+++++|..+.
T Consensus 257 ~~~~~----~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 257 IEDYI----DKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp HHHHS----CSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred hhhhc----cccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 00111 11112223346788999999999999999999999999998764
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-42 Score=353.58 Aligned_cols=259 Identities=25% Similarity=0.340 Sum_probs=206.7
Q ss_pred CCCcccccccccCCceEEEEEEE--CCeeEEEEeccCC---ChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEE
Q 005427 65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFF 139 (697)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 139 (697)
.++|++.+.||+|+||.||+|.+ +++.||+|++... .....+.+.+|+.+++.++||||+++++++.....++++
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 46899999999999999999997 5889999986543 233357899999999999999999999999999999999
Q ss_pred EeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhh
Q 005427 140 FEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEIS 219 (697)
Q Consensus 140 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~ 219 (697)
|||+++++|.+++.... .+++.+++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||++........
T Consensus 113 ~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~-- 189 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQG-PLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKL-- 189 (309)
T ss_dssp EECCCCEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC-----------
T ss_pred EEecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccccccc--
Confidence 99999999999997654 689999999999999999999999999999999999999999999999999876543111
Q ss_pred cccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHH
Q 005427 220 LKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQ 299 (697)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~ 299 (697)
.......||+.|+|||++.+..++.++||||||+++|+|++|..||.+.........+.
T Consensus 190 -------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~-------- 248 (309)
T 2h34_A 190 -------------TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHIN-------- 248 (309)
T ss_dssp --------------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHH--------
T ss_pred -------------ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhc--------
Confidence 11234579999999999999999999999999999999999999998765432221111
Q ss_pred HHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCC-CHHHHHHHHHHHHHH
Q 005427 300 LTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRP-SFSDIALELDLVLEH 355 (697)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-t~~ell~~l~~~~~~ 355 (697)
.. .+.....+..+|+++.++|.+||+.||.+|| |++++++.+...+..
T Consensus 249 -------~~-~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~ 297 (309)
T 2h34_A 249 -------QA-IPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALAT 297 (309)
T ss_dssp -------SC-CCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-
T ss_pred -------cC-CCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHh
Confidence 11 1222234567899999999999999999999 999999888876543
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=350.11 Aligned_cols=266 Identities=21% Similarity=0.303 Sum_probs=212.7
Q ss_pred CCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeecc-ccCCceEEEEe
Q 005427 65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAH-AKPPNYMFFFE 141 (697)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~-~~~~~~~lv~e 141 (697)
.++|++.+.||+|+||.||+|++ +++.||||+...... .+.+.+|+.+++.++|++++..+..+ ......++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 46899999999999999999996 689999998654432 24588999999999998876665554 55677899999
Q ss_pred ecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceee---cCCCCCeeeeeccchhhhhhhhh
Q 005427 142 FYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLL---DRNLCPHLADFGLAEYRENLKEI 218 (697)
Q Consensus 142 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill---~~~~~~kL~Dfg~a~~~~~~~~~ 218 (697)
|+ +++|.+++......+++.+++.++.|++.||+|||++||+||||||+|||+ +.++.+||+|||++.........
T Consensus 86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (296)
T 3uzp_A 86 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 164 (296)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTC
T ss_pred ec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccccc
Confidence 99 889999998666689999999999999999999999999999999999999 48889999999999765432110
Q ss_pred hcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHH---HHHHHHhccc
Q 005427 219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEA---QAHTVLEMNY 295 (697)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~---~~~~~~~~~~ 295 (697)
. ...........||+.|+|||++.+..++.++|||||||++|+|++|..||.+..... ....+....
T Consensus 165 ~---------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~- 234 (296)
T 3uzp_A 165 Q---------HIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK- 234 (296)
T ss_dssp C---------BCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHH-
T ss_pred c---------ccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccc-
Confidence 0 001112345689999999999999999999999999999999999999998743221 111111110
Q ss_pred cHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHh
Q 005427 296 TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHR 356 (697)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~~ 356 (697)
.....+.....+|+++.+++.+||+.||.+|||+.++++.|..+....
T Consensus 235 -------------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 282 (296)
T 3uzp_A 235 -------------MSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 282 (296)
T ss_dssp -------------HHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHT
T ss_pred -------------cCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhc
Confidence 011112234578999999999999999999999999999999987653
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=354.11 Aligned_cols=256 Identities=22% Similarity=0.409 Sum_probs=210.0
Q ss_pred CCCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEE
Q 005427 63 LPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFF 140 (697)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 140 (697)
...++|++.+.||+|+||.||+|.+ +++.||+|.+.... ..+.+.+|+.+++.++||||+++++++.....+++||
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM 103 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence 3457899999999999999999998 48899999875433 3467889999999999999999999999999999999
Q ss_pred eecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhc
Q 005427 141 EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL 220 (697)
Q Consensus 141 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~ 220 (697)
||+.+++|.+++......+++.+++.++.|++.||.|||+.|++||||||+||+++.++.+||+|||++.......
T Consensus 104 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~---- 179 (314)
T 3com_A 104 EYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM---- 179 (314)
T ss_dssp ECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB----
T ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc----
Confidence 9999999999997666689999999999999999999999999999999999999999999999999986543211
Q ss_pred ccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHH
Q 005427 221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQL 300 (697)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 300 (697)
.......||+.|+|||++.+..++.++||||||+++|+|++|..||.+.........+..
T Consensus 180 ------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-------- 239 (314)
T 3com_A 180 ------------AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPT-------- 239 (314)
T ss_dssp ------------SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH--------
T ss_pred ------------cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhc--------
Confidence 012345789999999999999999999999999999999999999987654333222111
Q ss_pred HHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 301 TAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
. ..+.. ..+..++..+.+||.+||+.||.+|||+.++++|.|..
T Consensus 240 ------~-~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~ 283 (314)
T 3com_A 240 ------N-PPPTF-RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVR 283 (314)
T ss_dssp ------S-CCCCC-SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHH
T ss_pred ------C-CCccc-CCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHh
Confidence 1 11111 12345789999999999999999999999999998875
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=354.04 Aligned_cols=272 Identities=22% Similarity=0.336 Sum_probs=210.7
Q ss_pred CCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccc-----------
Q 005427 65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHA----------- 131 (697)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~----------- 131 (697)
.++|++++.||+|+||.||+|.+ +++.||+|++........+.+.+|+.+++.++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 47899999999999999999998 48999999887777777888999999999999999999998873
Q ss_pred ---cCCceEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeec-CCCCCeeeeec
Q 005427 132 ---KPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLD-RNLCPHLADFG 207 (697)
Q Consensus 132 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~-~~~~~kL~Dfg 207 (697)
....+++||||+. |+|.+++.. ..+++..++.++.|++.||+|||++||+||||||+|||++ .++.+||+|||
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg 166 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQ--GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFG 166 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCCT
T ss_pred cccccCceeEEeeccC-CCHHHHhhc--CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccCc
Confidence 4467899999998 599999864 3689999999999999999999999999999999999997 56789999999
Q ss_pred cchhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcc-cCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHH
Q 005427 208 LAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQ 286 (697)
Q Consensus 208 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~ 286 (697)
++........ .........+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+......
T Consensus 167 ~~~~~~~~~~-------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 233 (320)
T 2i6l_A 167 LARIMDPHYS-------------HKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQ 233 (320)
T ss_dssp TCBCC---------------------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred cccccCCCcc-------------cccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHH
Confidence 9976542110 0011234568999999998865 6789999999999999999999999998776665
Q ss_pred HHHHHhccccHHHHH-HHHH----------hCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 287 AHTVLEMNYTEQQLT-AAVV----------SGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 287 ~~~~~~~~~~~~~~~-~~~~----------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
...+........... .... .......+......++.++.+||.+||+.||.+|||+.++++|.|+-
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~ 310 (320)
T 2i6l_A 234 MQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMS 310 (320)
T ss_dssp HHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHH
T ss_pred HHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccc
Confidence 555543321111000 0000 00111122233457899999999999999999999999999998875
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=359.97 Aligned_cols=281 Identities=24% Similarity=0.348 Sum_probs=208.4
Q ss_pred CCCCCCcccccccccCCceEEEEEEECCeeEEEEeccCCChHHHHHHHHHHHH--HHhcCCCCceEEeecc-----ccCC
Q 005427 62 HLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQL--LCKLDHPGLAKFVAAH-----AKPP 134 (697)
Q Consensus 62 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~hpniv~l~~~~-----~~~~ 134 (697)
.+..++|++.++||+|+||.||+|+.+++.||||++.... ...+..|.++ +..++||||+++++.+ ....
T Consensus 9 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 85 (336)
T 3g2f_A 9 SLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRM 85 (336)
T ss_dssp CCCTTSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCE
T ss_pred CcChHHhheeeecccCCCeEEEEEEECCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCc
Confidence 4566899999999999999999999999999999875432 2334444444 4558999999998743 3344
Q ss_pred ceEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---------CcccccCCCCceeecCCCCCeeee
Q 005427 135 NYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL---------GIVHRDVKPANVLLDRNLCPHLAD 205 (697)
Q Consensus 135 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---------~ivHrDlkp~Nill~~~~~~kL~D 205 (697)
.+++||||+++|+|.+++.... .++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|
T Consensus 86 ~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~D 163 (336)
T 3g2f_A 86 EYLLVMEYYPNGSLXKYLSLHT--SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISD 163 (336)
T ss_dssp EEEEEECCCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECC
T ss_pred eEEEEEecCCCCcHHHHHhhcc--cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEee
Confidence 6799999999999999996553 58899999999999999999999 999999999999999999999999
Q ss_pred eccchhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcc-------cCCCchhhHHHHHHHHHHHHhCCCCC
Q 005427 206 FGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-------EIHSEKSDVYSFGISINELLTGVVPY 278 (697)
Q Consensus 206 fg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~~l~ell~g~~Pf 278 (697)
||++..+....... ............||+.|+|||++.+ ..++.++|||||||++|||++|..||
T Consensus 164 FG~a~~~~~~~~~~--------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~ 235 (336)
T 3g2f_A 164 FGLSMRLTGNRLVR--------PGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL 235 (336)
T ss_dssp CTTCEECSSSSCC-----------------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGG
T ss_pred ccceeecccccccC--------ccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcC
Confidence 99997654311100 0001112335679999999999987 45677999999999999999997766
Q ss_pred CCchhHHH----HHHHHhccccHHHHHHHHHhCCCCCccccccc---CChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 005427 279 TDLRAEAQ----AHTVLEMNYTEQQLTAAVVSGGLRPILASLEL---GLPASILSLIQRCWDGNPHNRPSFSDIALELDL 351 (697)
Q Consensus 279 ~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~ 351 (697)
........ .................+.....++.++.... .+++++.+||.+||+.||++|||+.|+++.|..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ 315 (336)
T 3g2f_A 236 FPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAE 315 (336)
T ss_dssp STTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred CCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHH
Confidence 43221110 01111111222333333344444554443222 256789999999999999999999999999999
Q ss_pred HHHH
Q 005427 352 VLEH 355 (697)
Q Consensus 352 ~~~~ 355 (697)
++..
T Consensus 316 ll~~ 319 (336)
T 3g2f_A 316 LMMI 319 (336)
T ss_dssp HHHC
T ss_pred HHHH
Confidence 8864
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=382.55 Aligned_cols=265 Identities=22% Similarity=0.328 Sum_probs=214.7
Q ss_pred CCCCCCCccccc-ccccCCceEEEEEEE----CCeeEEEEeccCCC-hHHHHHHHHHHHHHHhcCCCCceEEeeccccCC
Q 005427 61 LHLPPSSYTLLS-PIARGAESVVYEATL----DGRKVAVKKPILST-SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPP 134 (697)
Q Consensus 61 ~~~~~~~y~~~~-~lg~G~~g~V~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 134 (697)
+.+..+++.+.+ +||+|+||.||+|.+ .+..||||++.... ....+.+.+|+.+|+.++||||+++++++.. +
T Consensus 330 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~ 408 (613)
T 2ozo_A 330 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-E 408 (613)
T ss_dssp SBCCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-S
T ss_pred eeccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-C
Confidence 344556666666 899999999999976 34579999876543 3356789999999999999999999999876 5
Q ss_pred ceEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhh
Q 005427 135 NYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYREN 214 (697)
Q Consensus 135 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~ 214 (697)
.+++||||+.+|+|.+++......+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 409 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~ 488 (613)
T 2ozo_A 409 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGA 488 (613)
T ss_dssp SEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-
T ss_pred CeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccC
Confidence 69999999999999999987766799999999999999999999999999999999999999999999999999976542
Q ss_pred hhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCCchhHHHHHHHHhc
Q 005427 215 LKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEM 293 (697)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~~~~~~~~~~~~~~ 293 (697)
.... ........+|+.|+|||++.+..++.++|||||||++|||++ |..||.+.........+..
T Consensus 489 ~~~~-------------~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~- 554 (613)
T 2ozo_A 489 DDSY-------------YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ- 554 (613)
T ss_dssp --------------------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHT-
T ss_pred CCce-------------eeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc-
Confidence 1110 001123346789999999999999999999999999999998 9999988665544333321
Q ss_pred cccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhc
Q 005427 294 NYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHRK 357 (697)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~~~ 357 (697)
+.++ ..+..+|+++.+||.+||+.||.+|||+.+|++.|..+.....
T Consensus 555 --------------~~~~---~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~ 601 (613)
T 2ozo_A 555 --------------GKRM---ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 601 (613)
T ss_dssp --------------TCCC---CCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHS
T ss_pred --------------CCCC---CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhc
Confidence 1121 2345789999999999999999999999999999988876543
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=382.09 Aligned_cols=261 Identities=29% Similarity=0.415 Sum_probs=218.3
Q ss_pred ccCCCCCCCcccccccccCCceEEEEEEEC-CeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceE
Q 005427 59 IPLHLPPSSYTLLSPIARGAESVVYEATLD-GRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYM 137 (697)
Q Consensus 59 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 137 (697)
..+++..++|++.++||+|+||.||+|.+. +..||||++.... ...+.+.+|+.+|+.++||||+++++++.+ ..++
T Consensus 260 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~ 337 (535)
T 2h8h_A 260 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 337 (535)
T ss_dssp TCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred cceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccce
Confidence 357788899999999999999999999985 4679999876543 235679999999999999999999999876 6789
Q ss_pred EEEeecCCCCHhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhh
Q 005427 138 FFFEFYESRNLAEKLHVE-EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLK 216 (697)
Q Consensus 138 lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~ 216 (697)
+||||+.+|+|.+++... ...+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 338 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 417 (535)
T 2h8h_A 338 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 417 (535)
T ss_dssp EEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH
T ss_pred EeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCc
Confidence 999999999999999753 3468999999999999999999999999999999999999999999999999997654321
Q ss_pred hhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCCchhHHHHHHHHhccc
Q 005427 217 EISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNY 295 (697)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~~~~~~~~~~~~~~~~ 295 (697)
.. ......+++.|+|||++.+..++.++|||||||+||||++ |..||.+.........+..
T Consensus 418 ~~---------------~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~--- 479 (535)
T 2h8h_A 418 YT---------------ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER--- 479 (535)
T ss_dssp HH---------------TTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHT---
T ss_pred ee---------------cccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc---
Confidence 10 1123457889999999999999999999999999999999 9999988655444333221
Q ss_pred cHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 005427 296 TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE 354 (697)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~ 354 (697)
+.+. ..+..++.++.+||.+||+.||++|||+.+|++.|..+..
T Consensus 480 ------------~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 480 ------------GYRM---PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp ------------TCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred ------------CCCC---CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence 1221 1245789999999999999999999999999988876643
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=350.71 Aligned_cols=270 Identities=20% Similarity=0.294 Sum_probs=210.3
Q ss_pred CCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeecc-ccCCceEEEEe
Q 005427 65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAH-AKPPNYMFFFE 141 (697)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~-~~~~~~~lv~e 141 (697)
.++|++.+.||+|+||.||+|++ +++.||||+..... ....+.+|+.+++.++|++++..+..+ ......++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEE
Confidence 46899999999999999999996 68899999754332 234578999999999988877766555 56778899999
Q ss_pred ecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceee---cCCCCCeeeeeccchhhhhhhhh
Q 005427 142 FYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLL---DRNLCPHLADFGLAEYRENLKEI 218 (697)
Q Consensus 142 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill---~~~~~~kL~Dfg~a~~~~~~~~~ 218 (697)
|+ +++|.+++......+++.+++.++.|++.||.|||++||+||||||+|||+ +.++.+||+|||++.........
T Consensus 86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~ 164 (296)
T 4hgt_A 86 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 164 (296)
T ss_dssp CC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTC
T ss_pred cc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccC
Confidence 99 889999998766689999999999999999999999999999999999999 78899999999999765432110
Q ss_pred hcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHH
Q 005427 219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQ 298 (697)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~ 298 (697)
. ...........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.........+....
T Consensus 165 ~---------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~---- 231 (296)
T 4hgt_A 165 Q---------HIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS---- 231 (296)
T ss_dssp C---------BCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHH----
T ss_pred c---------cCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhh----
Confidence 0 001112345689999999999999999999999999999999999999998753322111111000
Q ss_pred HHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhc
Q 005427 299 QLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHRK 357 (697)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~~~ 357 (697)
..............+|+++.+|+..||+.||++|||+.++++.+..+.+...
T Consensus 232 -------~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~ 283 (296)
T 4hgt_A 232 -------EKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 283 (296)
T ss_dssp -------HHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred -------cccccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhC
Confidence 0000111122335689999999999999999999999999999999887543
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=363.22 Aligned_cols=271 Identities=22% Similarity=0.269 Sum_probs=209.4
Q ss_pred CCCCcccccccccCCceEEEEEEE-CCeeEEEEeccCC-----------ChHHHHHHHHHHHHHHhcCCCCceEEeeccc
Q 005427 64 PPSSYTLLSPIARGAESVVYEATL-DGRKVAVKKPILS-----------TSEELDNFHKELQLLCKLDHPGLAKFVAAHA 131 (697)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~-----------~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~ 131 (697)
..++|++.+.||+|+||.||+|.+ .++.||||++... .....+.+.+|+.+|+.++||||+++++++.
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 99 (362)
T 3pg1_A 20 MQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFV 99 (362)
T ss_dssp TTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEE
T ss_pred hccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEE
Confidence 357899999999999999999987 6889999976432 2223578999999999999999999999984
Q ss_pred -----cCCceEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeee
Q 005427 132 -----KPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADF 206 (697)
Q Consensus 132 -----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Df 206 (697)
....+++||||+. |+|.+.+......+++..++.++.|++.||.|||+.||+||||||+|||++.++.+||+||
T Consensus 100 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Df 178 (362)
T 3pg1_A 100 HFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDF 178 (362)
T ss_dssp ECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCT
T ss_pred eccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEec
Confidence 3446899999998 5888888777668999999999999999999999999999999999999999999999999
Q ss_pred ccchhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcc-cCCCchhhHHHHHHHHHHHHhCCCCCCCchhHH
Q 005427 207 GLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLTGVVPYTDLRAEA 285 (697)
Q Consensus 207 g~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~ 285 (697)
|++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.....
T Consensus 179 g~~~~~~~~~-----------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~ 241 (362)
T 3pg1_A 179 NLAREDTADA-----------------NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYN 241 (362)
T ss_dssp TC--------------------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred Cccccccccc-----------------ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHH
Confidence 9996433211 1334578999999999987 678999999999999999999999999877666
Q ss_pred HHHHHHhccccHHHH---------HHHHHhCCCC----CcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 286 QAHTVLEMNYTEQQL---------TAAVVSGGLR----PILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 286 ~~~~~~~~~~~~~~~---------~~~~~~~~~~----~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
....+.......... .......... .........+++.+.+||.+||+.||.+|||+.|+++|+|+-
T Consensus 242 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~ 321 (362)
T 3pg1_A 242 QLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFE 321 (362)
T ss_dssp HHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGT
T ss_pred HHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhh
Confidence 655554322211110 0001111111 111223456789999999999999999999999999998874
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-42 Score=352.03 Aligned_cols=265 Identities=25% Similarity=0.381 Sum_probs=208.9
Q ss_pred CccCCCCCCCcccccccccCCceEEEEEEE---CC--eeEEEEeccCC---ChHHHHHHHHHHHHHHhcCCCCceEEeec
Q 005427 58 SIPLHLPPSSYTLLSPIARGAESVVYEATL---DG--RKVAVKKPILS---TSEELDNFHKELQLLCKLDHPGLAKFVAA 129 (697)
Q Consensus 58 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~---~~--~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~ 129 (697)
.....+..++|++.+.||+|+||.||+|++ .+ ..||+|++... .....+.+.+|+.+++.++||||++++++
T Consensus 10 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 89 (291)
T 1u46_A 10 SLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGV 89 (291)
T ss_dssp -CCEECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEE
Confidence 344556678999999999999999999985 22 25899976543 33456789999999999999999999999
Q ss_pred cccCCceEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccc
Q 005427 130 HAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLA 209 (697)
Q Consensus 130 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a 209 (697)
+..+. .++||||+.+++|.+++......+++.+++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||++
T Consensus 90 ~~~~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~ 168 (291)
T 1u46_A 90 VLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLM 168 (291)
T ss_dssp ECSSS-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred EccCC-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEcccccc
Confidence 98765 88999999999999999876667899999999999999999999999999999999999999999999999998
Q ss_pred hhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCCchhHHHHH
Q 005427 210 EYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAH 288 (697)
Q Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~~~~~~~~~ 288 (697)
........ .........+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+........
T Consensus 169 ~~~~~~~~-------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~ 235 (291)
T 1u46_A 169 RALPQNDD-------------HYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILH 235 (291)
T ss_dssp EECCC-CC-------------EEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH
T ss_pred cccccccc-------------chhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHH
Confidence 76542111 0011234467889999999998889999999999999999999 999998776544433
Q ss_pred HHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 005427 289 TVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL 353 (697)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~ 353 (697)
.+.. ...++ ..+..++.++.++|.+||+.||.+|||+.+++++|....
T Consensus 236 ~~~~--------------~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 283 (291)
T 1u46_A 236 KIDK--------------EGERL---PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283 (291)
T ss_dssp HHHT--------------SCCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred HHHc--------------cCCCC---CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence 3322 11111 123578999999999999999999999999999887764
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-42 Score=350.14 Aligned_cols=247 Identities=19% Similarity=0.297 Sum_probs=205.4
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccCC--ChHHHHHHHHHHHHHHhc-CCCCceEEeeccccCCceEEEE
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS--TSEELDNFHKELQLLCKL-DHPGLAKFVAAHAKPPNYMFFF 140 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv~ 140 (697)
++|++.+.||+|+||.||+|.+ +++.||+|++... .......+.+|+..+..+ +||||+++++++.++..+++||
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~ 90 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQN 90 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEE
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 5799999999999999999998 5889999986643 334567788999999999 9999999999999999999999
Q ss_pred eecCCCCHhhhhhhcC---CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCC-------------------
Q 005427 141 EFYESRNLAEKLHVEE---WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRN------------------- 198 (697)
Q Consensus 141 e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~------------------- 198 (697)
||+++++|.+++.... ..+++.+++.++.|++.||.|||++||+||||||+|||++.+
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~ 170 (289)
T 1x8b_A 91 EYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNK 170 (289)
T ss_dssp ECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------C
T ss_pred EecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCCc
Confidence 9999999999987542 468999999999999999999999999999999999999844
Q ss_pred CCCeeeeeccchhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhccc-CCCchhhHHHHHHHHHHHHhCCCC
Q 005427 199 LCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKE-IHSEKSDVYSFGISINELLTGVVP 277 (697)
Q Consensus 199 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~ell~g~~P 277 (697)
..+||+|||++..... .....||+.|+|||++.+. .++.++|||||||++|+|++|.+|
T Consensus 171 ~~~kl~Dfg~~~~~~~--------------------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~ 230 (289)
T 1x8b_A 171 VMFKIGDLGHVTRISS--------------------PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL 230 (289)
T ss_dssp CCEEECCCTTCEETTC--------------------SCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCC
T ss_pred eEEEEcccccccccCC--------------------ccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCC
Confidence 4789999999875432 1234589999999999876 566899999999999999999988
Q ss_pred CCCchhHHHHHHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 005427 278 YTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL 353 (697)
Q Consensus 278 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~ 353 (697)
+....... .+ ..+. .+..+..+++++.+||.+||+.||.+|||+.++++|.|...
T Consensus 231 ~~~~~~~~---~~--------------~~~~----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 285 (289)
T 1x8b_A 231 PRNGDQWH---EI--------------RQGR----LPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLS 285 (289)
T ss_dssp CSSSHHHH---HH--------------HTTC----CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC--
T ss_pred CcchhHHH---HH--------------HcCC----CCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhh
Confidence 76543211 11 1111 12345578999999999999999999999999999988754
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-42 Score=352.11 Aligned_cols=263 Identities=23% Similarity=0.355 Sum_probs=210.8
Q ss_pred ccCCCCCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCce
Q 005427 59 IPLHLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNY 136 (697)
Q Consensus 59 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 136 (697)
........+|.....||+|+||.||+|.+ +++.||+|.+........+.+.+|+.+++.++||||+++++++......
T Consensus 15 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 94 (295)
T 2clq_A 15 LEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFI 94 (295)
T ss_dssp CCEEECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred ccccccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcE
Confidence 33344445666677999999999999997 5788999987766666678899999999999999999999999999999
Q ss_pred EEEEeecCCCCHhhhhhhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecC-CCCCeeeeeccchhhh
Q 005427 137 MFFFEFYESRNLAEKLHVEEW--SPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDR-NLCPHLADFGLAEYRE 213 (697)
Q Consensus 137 ~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~-~~~~kL~Dfg~a~~~~ 213 (697)
++||||+++++|.+++..... .+++..++.++.|++.||.|||+.||+||||||+|||++. ++.+||+|||++....
T Consensus 95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~ 174 (295)
T 2clq_A 95 KIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLA 174 (295)
T ss_dssp EEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESC
T ss_pred EEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccC
Confidence 999999999999999976532 4568899999999999999999999999999999999987 8999999999987543
Q ss_pred hhhhhhcccccCCCCCCCCccccccccCccccchhhhcccC--CCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHH
Q 005427 214 NLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEI--HSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVL 291 (697)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~ 291 (697)
... .......||+.|+|||++.+.. ++.++||||||+++|+|++|..||............
T Consensus 175 ~~~----------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~- 237 (295)
T 2clq_A 175 GIN----------------PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFK- 237 (295)
T ss_dssp C---------------------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHH-
T ss_pred CCC----------------CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHh-
Confidence 211 0123457899999999997654 789999999999999999999999754322111000
Q ss_pred hccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 005427 292 EMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL 353 (697)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~ 353 (697)
....... +..+..+++++.+||.+||+.||++|||+.++++|.|...
T Consensus 238 ------------~~~~~~~---~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 284 (295)
T 2clq_A 238 ------------VGMFKVH---PEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKV 284 (295)
T ss_dssp ------------HHHHCCC---CCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC
T ss_pred ------------hcccccc---ccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhh
Confidence 0000111 2234578999999999999999999999999998877643
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=359.92 Aligned_cols=262 Identities=24% Similarity=0.345 Sum_probs=201.0
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccCCC-hHHHHHHHHHHHHHHhcCCCCceEEeeccccCC--------
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST-SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPP-------- 134 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-------- 134 (697)
++|++.++||+|+||.||+|++ +++.||||++.... ....+.+.+|+.+|+.++||||+++++++.+..
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 85 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM 85 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence 4799999999999999999998 58899999876543 335678999999999999999999999875543
Q ss_pred -------------------------------------------------ceEEEEeecCCCCHhhhhhhcCC--CCCHHH
Q 005427 135 -------------------------------------------------NYMFFFEFYESRNLAEKLHVEEW--SPSVDQ 163 (697)
Q Consensus 135 -------------------------------------------------~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~ 163 (697)
..++|||||.+++|.+++..... ..++..
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~ 165 (332)
T 3qd2_B 86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGV 165 (332)
T ss_dssp HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHH
T ss_pred hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHH
Confidence 27999999999999999976442 245667
Q ss_pred HHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhcccccCCCCCCCCccccccccCcc
Q 005427 164 VLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLI 243 (697)
Q Consensus 164 ~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 243 (697)
++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++............ ..............||+.
T Consensus 166 ~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~----~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 166 CLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV----LTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC------------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccc----cccccccccccccCCCcC
Confidence 8999999999999999999999999999999999999999999999766432110000 000000112345679999
Q ss_pred ccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHHHHHHHhCCCCCcccccccCChHH
Q 005427 244 YMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPAS 323 (697)
Q Consensus 244 y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (697)
|+|||++.+..++.++|||||||++|+|++|..|+.... ........ . ..+......+++
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~--~~~~~~~~--------------~----~~~~~~~~~~~~ 301 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERV--RIITDVRN--------------L----KFPLLFTQKYPQ 301 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHH--HHHHHHHT--------------T----CCCHHHHHHCHH
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHH--HHHHHhhc--------------c----CCCcccccCChh
Confidence 999999999999999999999999999999877753211 11111111 1 111112245678
Q ss_pred HHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 005427 324 ILSLIQRCWDGNPHNRPSFSDIALELDL 351 (697)
Q Consensus 324 l~~li~~~l~~dP~~Rpt~~ell~~l~~ 351 (697)
+.+||.+||+.||.+|||+.|+++|.|+
T Consensus 302 ~~~li~~~l~~~p~~Rps~~~~l~~~~f 329 (332)
T 3qd2_B 302 EHMMVQDMLSPSPTERPEATDIIENAIF 329 (332)
T ss_dssp HHHHHHHHHCSSGGGSCCHHHHHHSTTC
T ss_pred HHHHHHHHccCCCCcCCCHHHHhhchhh
Confidence 8999999999999999999999988764
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=349.44 Aligned_cols=254 Identities=23% Similarity=0.318 Sum_probs=212.7
Q ss_pred CCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCC---------hHHHHHHHHHHHHHHhcC-CCCceEEeecccc
Q 005427 65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST---------SEELDNFHKELQLLCKLD-HPGLAKFVAAHAK 132 (697)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~ 132 (697)
.++|++.+.||+|+||.||+|.+ +++.||||++.... ....+.+.+|+.+|+++. ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 47899999999999999999998 57899999875543 123567889999999995 9999999999999
Q ss_pred CCceEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhh
Q 005427 133 PPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYR 212 (697)
Q Consensus 133 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~ 212 (697)
....++||||+.+++|.+++.... .+++.+++.++.|++.||.|||+.|++||||||+||+++.++.+||+|||++...
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 174 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL 174 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred CCeEEEEEeccCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhhc
Confidence 999999999999999999997654 7899999999999999999999999999999999999999999999999998754
Q ss_pred hhhhhhhcccccCCCCCCCCccccccccCccccchhhhc------ccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHH
Q 005427 213 ENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILK------KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQ 286 (697)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~ 286 (697)
.... ......|++.|+|||++. ...++.++||||||+++|+|++|..||.+......
T Consensus 175 ~~~~-----------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~ 237 (298)
T 1phk_A 175 DPGE-----------------KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM 237 (298)
T ss_dssp CTTC-----------------CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred CCCc-----------------ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHH
Confidence 3211 133457899999999985 45678899999999999999999999987655444
Q ss_pred HHHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 005427 287 AHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL 351 (697)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~ 351 (697)
...+... .... .......++..+.+||.+||+.||.+|||+.++++|.|+
T Consensus 238 ~~~~~~~--------------~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~ 287 (298)
T 1phk_A 238 LRMIMSG--------------NYQF-GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFF 287 (298)
T ss_dssp HHHHHHT--------------CCCC-CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGG
T ss_pred HHHHhcC--------------Cccc-CcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHh
Confidence 4333322 1111 111224688999999999999999999999999988775
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=366.04 Aligned_cols=260 Identities=25% Similarity=0.351 Sum_probs=210.0
Q ss_pred CCCCCCcccccccccCCceEEEEEEE-----CCeeEEEEeccCCC----hHHHHHHHHHHHHHHhc-CCCCceEEeeccc
Q 005427 62 HLPPSSYTLLSPIARGAESVVYEATL-----DGRKVAVKKPILST----SEELDNFHKELQLLCKL-DHPGLAKFVAAHA 131 (697)
Q Consensus 62 ~~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~ 131 (697)
.+..++|++.++||+|+||.||++++ +++.||||++.... ....+.+.+|+.+|+.+ +||||+++++++.
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 129 (355)
T 1vzo_A 50 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ 129 (355)
T ss_dssp CCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE
T ss_pred cccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEe
Confidence 34457899999999999999999987 67899999865321 12345677899999999 6999999999999
Q ss_pred cCCceEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchh
Q 005427 132 KPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEY 211 (697)
Q Consensus 132 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~ 211 (697)
....+++||||+.+|+|.+++.... .+++.+++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++.
T Consensus 130 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 208 (355)
T 1vzo_A 130 TETKLHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 208 (355)
T ss_dssp ETTEEEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred eCceEEEEeecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence 9999999999999999999997655 689999999999999999999999999999999999999999999999999975
Q ss_pred hhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcc--cCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHH
Q 005427 212 RENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK--EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHT 289 (697)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~ 289 (697)
...... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........
T Consensus 209 ~~~~~~---------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~ 273 (355)
T 1vzo_A 209 FVADET---------------ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAE 273 (355)
T ss_dssp CCGGGG---------------GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHH
T ss_pred cccCCC---------------CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHH
Confidence 532111 11334679999999999986 3478999999999999999999999975432211111
Q ss_pred HHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCC-----CHHHHHHHHHHH
Q 005427 290 VLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRP-----SFSDIALELDLV 352 (697)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~ell~~l~~~ 352 (697)
+ ...+... .+..+..++..+.+||.+||..||.+|| |+.++++|+|+.
T Consensus 274 ~----------~~~~~~~-----~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~ 326 (355)
T 1vzo_A 274 I----------SRRILKS-----EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQ 326 (355)
T ss_dssp H----------HHHHHHC-----CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGT
T ss_pred H----------HHHHhcc-----CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchh
Confidence 1 1111111 1123457889999999999999999999 999999988764
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-42 Score=357.21 Aligned_cols=254 Identities=22% Similarity=0.272 Sum_probs=210.1
Q ss_pred CCcccc-cccccCCceEEEEEEE--CCeeEEEEeccCCC--hHHHHHHHHHHHHHHhc-CCCCceEEeeccccCCceEEE
Q 005427 66 SSYTLL-SPIARGAESVVYEATL--DGRKVAVKKPILST--SEELDNFHKELQLLCKL-DHPGLAKFVAAHAKPPNYMFF 139 (697)
Q Consensus 66 ~~y~~~-~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv 139 (697)
++|.+. ++||+|+||.||+|.+ +++.||+|++.... ......+.+|+.+++.+ .||||+++++++.+...+++|
T Consensus 28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv 107 (327)
T 3lm5_A 28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILI 107 (327)
T ss_dssp HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEE
Confidence 468887 8999999999999988 48899999865432 23357789999999999 569999999999999999999
Q ss_pred EeecCCCCHhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecC---CCCCeeeeeccchhhhhh
Q 005427 140 FEFYESRNLAEKLHVE-EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDR---NLCPHLADFGLAEYRENL 215 (697)
Q Consensus 140 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~---~~~~kL~Dfg~a~~~~~~ 215 (697)
|||+.+|+|.+++... ...+++.+++.++.|++.||+|||++||+||||||+|||++. ++.+||+|||++......
T Consensus 108 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~ 187 (327)
T 3lm5_A 108 LEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA 187 (327)
T ss_dssp EECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC---
T ss_pred EEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCCc
Confidence 9999999999998543 346899999999999999999999999999999999999987 789999999999765421
Q ss_pred hhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccc
Q 005427 216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNY 295 (697)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~ 295 (697)
. ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.........+.....
T Consensus 188 ~-----------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~ 250 (327)
T 3lm5_A 188 C-----------------ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNV 250 (327)
T ss_dssp -----------------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred c-----------------ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccc
Confidence 1 12345799999999999999999999999999999999999999988766554444332211
Q ss_pred cHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 005427 296 TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL 351 (697)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~ 351 (697)
.........+++.+.+||.+||+.||.+|||++++++|.|.
T Consensus 251 ---------------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~ 291 (327)
T 3lm5_A 251 ---------------DYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWL 291 (327)
T ss_dssp ---------------CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGG
T ss_pred ---------------ccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhh
Confidence 11122234688999999999999999999999999988776
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=353.96 Aligned_cols=263 Identities=20% Similarity=0.293 Sum_probs=207.1
Q ss_pred CCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCChHHHHHHHHHHHHHHhcC-CCCceEEeecccc--CCceEEE
Q 005427 65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLD-HPGLAKFVAAHAK--PPNYMFF 139 (697)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~--~~~~~lv 139 (697)
.++|++.++||+|+||.||+|++ +++.||+|++.... .+.+.+|+.+|+.++ ||||+++++++.+ ....++|
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 36899999999999999999987 68899999875433 456889999999997 9999999999987 5678999
Q ss_pred EeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCC-CCeeeeeccchhhhhhhhh
Q 005427 140 FEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNL-CPHLADFGLAEYRENLKEI 218 (697)
Q Consensus 140 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~-~~kL~Dfg~a~~~~~~~~~ 218 (697)
|||+.+++|.+++. .+++.+++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||++.......
T Consensus 112 ~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~-- 185 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ-- 185 (330)
T ss_dssp EECCCCCCHHHHGG----GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC--
T ss_pred EeccCchhHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC--
Confidence 99999999999885 378899999999999999999999999999999999999776 89999999997543211
Q ss_pred hcccccCCCCCCCCccccccccCccccchhhhcc-cCCCchhhHHHHHHHHHHHHhCCCCCCCch-hHHHHHHHHhcccc
Q 005427 219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLTGVVPYTDLR-AEAQAHTVLEMNYT 296 (697)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~ell~g~~Pf~~~~-~~~~~~~~~~~~~~ 296 (697)
......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.... .......+.... .
T Consensus 186 ---------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~-~ 249 (330)
T 3nsz_A 186 ---------------EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVL-G 249 (330)
T ss_dssp ---------------CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHH-C
T ss_pred ---------------ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhc-C
Confidence 1334578999999999987 678999999999999999999999995432 222222222211 1
Q ss_pred HHHHHHHHHhCC--------------CCCcc-----cccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 297 EQQLTAAVVSGG--------------LRPIL-----ASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 297 ~~~~~~~~~~~~--------------~~~~~-----~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
............ ..... ...+..+++++.+||.+||+.||.+|||++|+++|.|+.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~ 324 (330)
T 3nsz_A 250 TEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY 324 (330)
T ss_dssp HHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGT
T ss_pred CchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHh
Confidence 111111111111 00000 111233789999999999999999999999999998864
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=353.15 Aligned_cols=259 Identities=23% Similarity=0.377 Sum_probs=207.9
Q ss_pred cCCCCCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCChHHHHHHHHHHHHHHhc-CCCCceEEeecccc----
Q 005427 60 PLHLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKL-DHPGLAKFVAAHAK---- 132 (697)
Q Consensus 60 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~---- 132 (697)
.+....++|++.+.||+|+||.||+|++ +++.||+|++.... .....+.+|+.+++.+ +||||+++++++..
T Consensus 18 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 96 (326)
T 2x7f_A 18 ALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 96 (326)
T ss_dssp CCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--
T ss_pred hccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCc
Confidence 3445668999999999999999999998 68899999875443 2346788999999999 89999999999876
Q ss_pred --CCceEEEEeecCCCCHhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccc
Q 005427 133 --PPNYMFFFEFYESRNLAEKLHVEE-WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLA 209 (697)
Q Consensus 133 --~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a 209 (697)
...+++||||+.+++|.+++.... ..+++..++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||++
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 176 (326)
T 2x7f_A 97 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVS 176 (326)
T ss_dssp CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTT
T ss_pred cccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCc
Confidence 467899999999999999997642 46899999999999999999999999999999999999999999999999998
Q ss_pred hhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhc-----ccCCCchhhHHHHHHHHHHHHhCCCCCCCchhH
Q 005427 210 EYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILK-----KEIHSEKSDVYSFGISINELLTGVVPYTDLRAE 284 (697)
Q Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~ 284 (697)
........ ......||+.|+|||++. +..++.++|||||||++|+|++|..||.+....
T Consensus 177 ~~~~~~~~----------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~ 240 (326)
T 2x7f_A 177 AQLDRTVG----------------RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM 240 (326)
T ss_dssp C-----------------------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH
T ss_pred eecCcCcc----------------ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH
Confidence 76542110 123457999999999997 566889999999999999999999999876544
Q ss_pred HHHHHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 285 AQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
.....+.. ... + ...+..++..+.+||.+||..||.+|||+.++++|.|+.
T Consensus 241 ~~~~~~~~--------------~~~-~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~ 291 (326)
T 2x7f_A 241 RALFLIPR--------------NPA-P--RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIR 291 (326)
T ss_dssp HHHHHHHH--------------SCC-C--CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHH
T ss_pred HHHHHhhc--------------Ccc-c--cCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHh
Confidence 33322211 111 1 112346889999999999999999999999999998874
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=357.40 Aligned_cols=270 Identities=19% Similarity=0.187 Sum_probs=203.3
Q ss_pred CCCCCCcccccccccCCceEEEEEEE-----CCeeEEEEeccCCChHH-----------HHHHHHHHHHHHhcCCCCceE
Q 005427 62 HLPPSSYTLLSPIARGAESVVYEATL-----DGRKVAVKKPILSTSEE-----------LDNFHKELQLLCKLDHPGLAK 125 (697)
Q Consensus 62 ~~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~hpniv~ 125 (697)
.+..++|++.++||+|+||.||+|++ .+..+|+|+........ ...+.+|+.+++.++||||++
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~ 112 (345)
T 2v62_A 33 DMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPL 112 (345)
T ss_dssp CTTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCC
T ss_pred cccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcce
Confidence 34567899999999999999999998 45789999866543211 124667889999999999999
Q ss_pred Eeecccc----CCceEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCC--
Q 005427 126 FVAAHAK----PPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNL-- 199 (697)
Q Consensus 126 l~~~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~-- 199 (697)
+++++.. ....++||||+ +++|.+++...+ .+++.+++.++.|++.||+|||+.||+||||||+|||++.++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~ 190 (345)
T 2v62_A 113 FYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPD 190 (345)
T ss_dssp EEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTT
T ss_pred eecccccccCCCcEEEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCC
Confidence 9999877 77899999999 899999997665 789999999999999999999999999999999999998877
Q ss_pred CCeeeeeccchhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCC
Q 005427 200 CPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYT 279 (697)
Q Consensus 200 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~ 279 (697)
.+||+|||+++.+...... ............||+.|+|||++.+..++.++|||||||++|||++|..||.
T Consensus 191 ~~kL~Dfg~a~~~~~~~~~---------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~ 261 (345)
T 2v62_A 191 QVYLADYGLSYRYCPNGNH---------KQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWE 261 (345)
T ss_dssp SEEECCCTTCEESSGGGCC---------CCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTG
T ss_pred cEEEEeCCCceeccccccc---------ccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 9999999999766432110 0111112345689999999999999999999999999999999999999996
Q ss_pred CchhHHHHHHHHhccccHHHHHHHHHhCCCCCccccc--ccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 280 DLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASL--ELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
+................ ....+.+... ...+|+++.++|..||+.||++|||+.+|++.|+..
T Consensus 262 ~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 326 (345)
T 2v62_A 262 QNLKDPVAVQTAKTNLL----------DELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH 326 (345)
T ss_dssp GGTTCHHHHHHHHHHHH----------HTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred ccccccHHHHHHHHhhc----------ccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence 53221111111100000 0000000001 126889999999999999999999999998776553
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-42 Score=349.07 Aligned_cols=255 Identities=27% Similarity=0.371 Sum_probs=209.8
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccCCC-hHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEee
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST-SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF 142 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 142 (697)
++|++.+.||+|+||.||+|.+ +++.||+|+..... ....+.+.+|+.+++.++||||+++++++.+....++||||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence 4799999999999999999988 58899999865432 33467889999999999999999999999999999999999
Q ss_pred cCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhccc
Q 005427 143 YESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKN 222 (697)
Q Consensus 143 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 222 (697)
+.+++|.+++.... .+++.+++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||++........
T Consensus 87 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~----- 160 (276)
T 2yex_A 87 CSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR----- 160 (276)
T ss_dssp CTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE-----
T ss_pred cCCCcHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcc-----
Confidence 99999999986543 689999999999999999999999999999999999999999999999999875532110
Q ss_pred ccCCCCCCCCccccccccCccccchhhhcccCC-CchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHHH
Q 005427 223 WRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIH-SEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLT 301 (697)
Q Consensus 223 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 301 (697)
........||+.|+|||++.+..+ +.++||||||+++|+|++|..||.............
T Consensus 161 ---------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~---------- 221 (276)
T 2yex_A 161 ---------ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW---------- 221 (276)
T ss_dssp ---------ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHH----------
T ss_pred ---------hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHh----------
Confidence 011334679999999999987665 789999999999999999999998754322111111
Q ss_pred HHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 005427 302 AAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL 351 (697)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~ 351 (697)
.... ... .....+++.+.+||.+||+.||.+|||+.|+++|.|+
T Consensus 222 ---~~~~--~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 265 (276)
T 2yex_A 222 ---KEKK--TYL-NPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWY 265 (276)
T ss_dssp ---HTTC--TTS-TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTT
T ss_pred ---hhcc--ccc-CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccc
Confidence 0010 001 1124578999999999999999999999999988775
|
| >2pk0_A Serine/threonine protein phosphatase STP1; SI motif, signaling protein; 2.65A {Streptococcus agalactiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=334.07 Aligned_cols=237 Identities=24% Similarity=0.312 Sum_probs=200.2
Q ss_pred cccceEeeeccCC-CCCCCceeEEcccccCCCceEEEEEecCCCChHHHHHHHHHhHHHHH-hcCCCC-----ChHHHHH
Q 005427 427 PVLSWGSFATCGR-RETMEDTHFLMPHMYNQKEIHMFGIFDGHRGSAAAEFSARALPGFLQ-NLGSTT-----RPTDALL 499 (697)
Q Consensus 427 ~~~~~~~~s~~G~-R~~neD~~~~~~~~~~~~~~~~~~V~DG~GG~~~~~~as~~~~~~l~-~~~~~~-----~~~~~l~ 499 (697)
+.+.++..|++|. |..|||++.+... ..+..+|+|||||||+.+|++||+.+++.+. +..... .....+.
T Consensus 4 ~~~~~~~~s~~G~~r~~neD~~~~~~~---~~~~~~~~V~DG~Gg~~~~~~as~~~~~~l~~~~~~~~~~~~~~~~~~l~ 80 (250)
T 2pk0_A 4 KYMEISLLTDIGQRRSNNQDFINQFEN---KAGVPLIILADGMGGHRAGNIASEMTVTDLGSDWAETDFSELSEIRDWML 80 (250)
T ss_dssp CCEEEEEEEECCTTCSCCCEEEEEEEC---TTCCEEEEEEEEECTTTHHHHHHHHHHHHHHHHHTTCCCCSHHHHHHHHH
T ss_pred ceEEEEEecCCCCCCCcCCCceEeccC---CCCcEEEEEEeCCCCcHHHHHHHHHHHHHHHHHHhhcccCChhhHHHHHH
Confidence 4578999999999 9999999998653 2357899999999999999999999999998 443222 2345677
Q ss_pred HHHHHHHHHHHHHHHHHHhhhhcccCCCCCCceEEEEEEecCeEEEEEcCCeEEEEEECCeeeecCCCCCCCCHHHHHHH
Q 005427 500 EAFIRTDVAFRNELDSLRKSKRVVQKDWHPGCTAIAALIVRNRLFVANAGDCRAILCRGGHPFALSRDHVASCLEERERV 579 (697)
Q Consensus 500 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GtT~~~~~i~~~~l~~anvGDSr~~l~~~~~~~~lt~dH~~~~~~e~~ri 579 (697)
+++..++..+...... .. ...+|||++++++.+++++++|+||||+|++|+|++.+||.||++ .+++
T Consensus 81 ~~~~~~~~~l~~~~~~-------~~-~~~~gtT~~~~~i~~~~l~~anvGDsr~~l~r~g~~~~lt~dh~~-----~~~~ 147 (250)
T 2pk0_A 81 VSIETENRKIYELGQS-------DD-YKGMGTTIEAVAIVGDNIIFAHVGDSRIGIVRQGEYHLLTSDHSL-----VNEL 147 (250)
T ss_dssp HHHHHHHHHHHHHHHH-------TT-CTTCEECEEEEEEETTEEEEEEESSCEEEEEETTEEEECCCCCBH-----HHHH
T ss_pred HHHHHHHHHHHHHHhh-------CC-CCCCcceEEEEEEECCeEEEEEeCCCeEEEEcCCcEEEeCCCCCH-----HHHH
Confidence 7777777777654321 11 335899999999999999999999999999999999999999955 3446
Q ss_pred HHcCCeeeeccCcceeCCCcceeccccCCCCCCCCcccCCceEEEEeCCCCeEEEEEcCCcccCCChHHHHHHHHhhcCC
Q 005427 580 VSAGGNVNWQVDTWRVGPPALQVTRSIGDDDLKPAVTAEPEITETIMTPEDEYLVMASDGLWDVVSHVEAVGIIKDTVKE 659 (697)
Q Consensus 580 ~~~g~~~~~~~~~~~~~~~~~~ltralG~~~~k~~v~~~p~v~~~~l~~~d~~lvl~SDGl~d~~~~~ei~~~~~~~~~~ 659 (697)
.+.|. +...+.+.+|+++.+||+||+.. .++|++..+.+.++| +||||||||||+++++++.+++... .+
T Consensus 148 ~~~g~---i~~~~~~~~~~~~~ltralG~~~-----~~~p~~~~~~l~~gd-~lll~SDGl~d~l~~~~i~~~~~~~-~~ 217 (250)
T 2pk0_A 148 VKAGQ---LTEEEAASHPQKNIITQSIGQAN-----PVEPDLGVHLLEEGD-YLVVNSDGLTNMLSNADIATVLTQE-KT 217 (250)
T ss_dssp HHTTS---SCHHHHHTCCSCCCBSCCBSCSS-----CCCCEEEEEECCTTC-EEEEECHHHHTTSCHHHHHHHHTSS-SC
T ss_pred HHcCC---CCHHHHHhCCCcceEEeecCCCC-----CccceEEEEEcCCCC-EEEEECCCCCCCcCHHHHHHHHhcC-CC
Confidence 67776 45566778889999999999988 789999999999998 7899999999999999999999874 38
Q ss_pred hhHHHHHHHHHHHhcCCCCCcEEEEEEeCC
Q 005427 660 PGMCSKRLATEAAERGSKDNITVIVVFLQP 689 (697)
Q Consensus 660 ~~~~a~~L~~~a~~~g~~DNiT~ivv~l~~ 689 (697)
++++|+.|++.|+++|+.||+|||||++.+
T Consensus 218 ~~~~a~~L~~~a~~~g~~DniTvivv~~~~ 247 (250)
T 2pk0_A 218 LDDKNQDLITLANHRGGLDNITVALVYVES 247 (250)
T ss_dssp HHHHHHHHHHHHHHTTCCSCEEEEEEEECC
T ss_pred HHHHHHHHHHHHHHcCCCCCeEEEEEEeeC
Confidence 999999999999999999999999999975
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=365.91 Aligned_cols=275 Identities=20% Similarity=0.325 Sum_probs=211.5
Q ss_pred CCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCC-hHHHHHHHHHHHHHHhcCCCCceEEeeccccCC--ceEE
Q 005427 64 PPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST-SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPP--NYMF 138 (697)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~--~~~l 138 (697)
..++|++.++||+|+||.||+|++ +++.||||++.... ....+.+.+|+++|+.++||||+++++++.... ..++
T Consensus 7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 86 (396)
T 4eut_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (396)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEE
Confidence 356899999999999999999998 48899999865432 223567889999999999999999999987655 7899
Q ss_pred EEeecCCCCHhhhhhhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceee----cCCCCCeeeeeccchhh
Q 005427 139 FFEFYESRNLAEKLHVEEW--SPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLL----DRNLCPHLADFGLAEYR 212 (697)
Q Consensus 139 v~e~~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill----~~~~~~kL~Dfg~a~~~ 212 (697)
||||+.+|+|.+++..... .+++.+++.++.|++.||+|||+.||+||||||+|||+ +.++.+||+|||+++..
T Consensus 87 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~ 166 (396)
T 4eut_A 87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166 (396)
T ss_dssp EECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEEC
T ss_pred EEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEc
Confidence 9999999999999976432 38999999999999999999999999999999999999 77788999999999765
Q ss_pred hhhhhhhcccccCCCCCCCCccccccccCccccchhhhcc--------cCCCchhhHHHHHHHHHHHHhCCCCCCCchh-
Q 005427 213 ENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK--------EIHSEKSDVYSFGISINELLTGVVPYTDLRA- 283 (697)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~- 283 (697)
.... ......||+.|+|||++.+ ..++.++|||||||++|||++|..||.....
T Consensus 167 ~~~~-----------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~ 229 (396)
T 4eut_A 167 EDDE-----------------QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP 229 (396)
T ss_dssp CCGG-----------------GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCT
T ss_pred cCCC-----------------ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcc
Confidence 4311 1234579999999999875 5678899999999999999999999975322
Q ss_pred ---HHHHHHHHhccccHHHH-HHHHHhC-----CCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 005427 284 ---EAQAHTVLEMNYTEQQL-TAAVVSG-----GLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE 354 (697)
Q Consensus 284 ---~~~~~~~~~~~~~~~~~-~~~~~~~-----~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~ 354 (697)
......+.......... ......+ ...+....++..++..+.++|.+||+.||++|||+.++++++..+++
T Consensus 230 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~ 309 (396)
T 4eut_A 230 RRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (396)
T ss_dssp TTCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred cchHHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence 12222222111000000 0000000 00011112223467789999999999999999999999999988875
Q ss_pred H
Q 005427 355 H 355 (697)
Q Consensus 355 ~ 355 (697)
.
T Consensus 310 ~ 310 (396)
T 4eut_A 310 R 310 (396)
T ss_dssp C
T ss_pred c
Confidence 4
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=366.64 Aligned_cols=259 Identities=17% Similarity=0.186 Sum_probs=190.8
Q ss_pred CCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCCh---HHHHHHHHHHHHHHhc--CCCCceEEee-------cc
Q 005427 65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTS---EELDNFHKELQLLCKL--DHPGLAKFVA-------AH 130 (697)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l--~hpniv~l~~-------~~ 130 (697)
..+|++.++||+|+||.||+|++ +++.||||++..... ...+.+.+|+.+++.| +||||++++. ++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 45699999999999999999997 588999998766442 3466788886555555 6999888653 33
Q ss_pred ccC-----------------CceEEEEeecCCCCHhhhhhhcCCCCCHHHH------HHHHHHHHHHHHHHHhCCccccc
Q 005427 131 AKP-----------------PNYMFFFEFYESRNLAEKLHVEEWSPSVDQV------LMIAAQLAKALQYLHNLGIVHRD 187 (697)
Q Consensus 131 ~~~-----------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~------~~i~~qi~~~l~~LH~~~ivHrD 187 (697)
..+ ..+++||||+. |+|.+++...+..+++..+ +.++.||+.||+|||++||+|||
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrD 219 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGH 219 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCc
Confidence 222 33899999999 7999999865444555555 67889999999999999999999
Q ss_pred CCCCceeecCCCCCeeeeeccchhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcc--cCCCchhhHHHHH
Q 005427 188 VKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK--EIHSEKSDVYSFG 265 (697)
Q Consensus 188 lkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG 265 (697)
|||+|||++.++.+||+|||+++.... ......+|+.|+|||++.+ ..++.++||||||
T Consensus 220 ikp~NIll~~~~~~kL~DFG~a~~~~~-------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG 280 (371)
T 3q60_A 220 FTPDNLFIMPDGRLMLGDVSALWKVGT-------------------RGPASSVPVTYAPREFLNASTATFTHALNAWQLG 280 (371)
T ss_dssp CSGGGEEECTTSCEEECCGGGEEETTC-------------------EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHH
T ss_pred CCHHHEEECCCCCEEEEecceeeecCC-------------------CccCccCCcCCcChhhccCCCCCcCccccHHHHH
Confidence 999999999999999999999975432 1124467799999999987 7899999999999
Q ss_pred HHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHH
Q 005427 266 ISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345 (697)
Q Consensus 266 ~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~el 345 (697)
|++|+|++|..||.+........ ...... ......... ......+++++.+||.+||+.||++|||+.++
T Consensus 281 ~il~elltg~~Pf~~~~~~~~~~-~~~~~~--------~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~ 350 (371)
T 3q60_A 281 LSIYRVWCLFLPFGLVTPGIKGS-WKRPSL--------RVPGTDSLA-FGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEA 350 (371)
T ss_dssp HHHHHHHHSSCSTTBCCTTCTTC-CCBCCT--------TSCCCCSCC-CTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHH
T ss_pred HHHHHHHhCCCCCCCcCcccccc-hhhhhh--------hhccccccc-hhhccCCCHHHHHHHHHHcCCChhhCCCHHHH
Confidence 99999999999998763321100 000000 000000111 11234789999999999999999999999999
Q ss_pred HHHHHHHH
Q 005427 346 ALELDLVL 353 (697)
Q Consensus 346 l~~l~~~~ 353 (697)
++|.|+..
T Consensus 351 l~hp~f~~ 358 (371)
T 3q60_A 351 METPEFLQ 358 (371)
T ss_dssp TTSHHHHH
T ss_pred hcCHHHHH
Confidence 99998754
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=381.03 Aligned_cols=262 Identities=26% Similarity=0.444 Sum_probs=217.6
Q ss_pred cCCCCCCCcccccccccCCceEEEEEEEC-----CeeEEEEeccCC-ChHHHHHHHHHHHHHHhcCCCCceEEeeccccC
Q 005427 60 PLHLPPSSYTLLSPIARGAESVVYEATLD-----GRKVAVKKPILS-TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKP 133 (697)
Q Consensus 60 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~ 133 (697)
.+++..++|++.+.||+|+||.||+|.+. +..||+|..... .....+.+.+|+.+|+.++||||+++++++. .
T Consensus 384 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~ 462 (656)
T 2j0j_A 384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E 462 (656)
T ss_dssp GTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred ccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-c
Confidence 45677789999999999999999999873 356999986543 3344678999999999999999999999985 4
Q ss_pred CceEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhh
Q 005427 134 PNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRE 213 (697)
Q Consensus 134 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~ 213 (697)
+..++||||+.+|+|.+++......+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 463 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~ 542 (656)
T 2j0j_A 463 NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 542 (656)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCC
T ss_pred CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecC
Confidence 67899999999999999998777678999999999999999999999999999999999999999999999999997654
Q ss_pred hhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCCchhHHHHHHHHh
Q 005427 214 NLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLE 292 (697)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~~~~~~~~~~~~~ 292 (697)
.... .......+|+.|+|||++.+..++.++|||||||++|||++ |..||.+.........+..
T Consensus 543 ~~~~---------------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~ 607 (656)
T 2j0j_A 543 DSTY---------------YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN 607 (656)
T ss_dssp C-------------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHH
T ss_pred CCcc---------------eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc
Confidence 2111 11233467889999999999999999999999999999997 9999988765544333321
Q ss_pred ccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 005427 293 MNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH 355 (697)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~ 355 (697)
+... ..+..+|+.+.+||.+||+.||.+|||+.++++.|..+++.
T Consensus 608 --------------~~~~----~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 608 --------------GERL----PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp --------------TCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --------------CCCC----CCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 2111 13457899999999999999999999999999999988754
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=354.25 Aligned_cols=265 Identities=25% Similarity=0.380 Sum_probs=207.1
Q ss_pred CCCcccccccccCCceEEEEEEECCeeEEEEeccCCChHHHHHHHHHHHHHHhc--CCCCceEEeeccccC----CceEE
Q 005427 65 PSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKL--DHPGLAKFVAAHAKP----PNYMF 138 (697)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~hpniv~l~~~~~~~----~~~~l 138 (697)
.++|++.++||+|+||.||+|+++++.||||++... ....+..|.+++..+ +||||+++++++... ..+++
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~l 112 (337)
T 3mdy_A 36 AKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYL 112 (337)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEE
T ss_pred ccceEEEeEeecCCCeEEEEEEECCceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEE
Confidence 368999999999999999999999999999986433 233455566666555 999999999998877 68999
Q ss_pred EEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC--------CcccccCCCCceeecCCCCCeeeeeccch
Q 005427 139 FFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL--------GIVHRDVKPANVLLDRNLCPHLADFGLAE 210 (697)
Q Consensus 139 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~--------~ivHrDlkp~Nill~~~~~~kL~Dfg~a~ 210 (697)
||||+.+|+|.+++... .+++.+++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||++.
T Consensus 113 v~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~ 190 (337)
T 3mdy_A 113 ITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 190 (337)
T ss_dssp EECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred EEeccCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCce
Confidence 99999999999999654 589999999999999999999999 99999999999999999999999999997
Q ss_pred hhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCch------hhHHHHHHHHHHHHhC----------
Q 005427 211 YRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEK------SDVYSFGISINELLTG---------- 274 (697)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~------~DiwslG~~l~ell~g---------- 274 (697)
....... ..........||+.|+|||++.+...... +|||||||++|||++|
T Consensus 191 ~~~~~~~------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~ 258 (337)
T 3mdy_A 191 KFISDTN------------EVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEY 258 (337)
T ss_dssp ECC---------------------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred eeccccc------------cccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccc
Confidence 5542111 00111235689999999999987766554 9999999999999999
Q ss_pred CCCCCCchhHHHHHHHHhccccHHHHHHHHHhCCCCCccccc--ccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 275 VVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASL--ELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 275 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
..||....... ...............++.++.. +..+++++.+||.+||+.||.+|||+.+++++|..+
T Consensus 259 ~~p~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 329 (337)
T 3mdy_A 259 QLPYHDLVPSD---------PSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKM 329 (337)
T ss_dssp CCTTTTTSCSS---------CCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred cccHhhhcCCC---------CchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHH
Confidence 66665432111 1112222222333334433321 235788899999999999999999999999999998
Q ss_pred HHH
Q 005427 353 LEH 355 (697)
Q Consensus 353 ~~~ 355 (697)
.+.
T Consensus 330 ~~~ 332 (337)
T 3mdy_A 330 SES 332 (337)
T ss_dssp HHT
T ss_pred Hhh
Confidence 764
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=368.26 Aligned_cols=266 Identities=24% Similarity=0.292 Sum_probs=206.6
Q ss_pred CCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccccC------Cce
Q 005427 65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKP------PNY 136 (697)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~------~~~ 136 (697)
..+|++.+.||+|+||.||+|++ +++.||||++.... ....+|+++|+.++||||+++++++... ..+
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~ 128 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 128 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence 34799999999999999999998 58899999865432 1234799999999999999999987432 236
Q ss_pred EEEEeecCCCCHhhhhh---hcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCC-CCCeeeeeccchhh
Q 005427 137 MFFFEFYESRNLAEKLH---VEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRN-LCPHLADFGLAEYR 212 (697)
Q Consensus 137 ~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~-~~~kL~Dfg~a~~~ 212 (697)
++||||+.+ +|.+.+. .....+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++..
T Consensus 129 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~ 207 (420)
T 1j1b_A 129 NLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207 (420)
T ss_dssp EEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred Eeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhc
Confidence 789999986 6666553 234578999999999999999999999999999999999999965 56899999999754
Q ss_pred hhhhhhhcccccCCCCCCCCccccccccCccccchhhhccc-CCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHH
Q 005427 213 ENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKE-IHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVL 291 (697)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~ 291 (697)
... .......||+.|+|||++.+. .++.++|||||||++|||++|..||.+.........++
T Consensus 208 ~~~-----------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~ 270 (420)
T 1j1b_A 208 VRG-----------------EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEII 270 (420)
T ss_dssp CTT-----------------CCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred ccC-----------------CCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 321 112346789999999999765 78999999999999999999999999887766666655
Q ss_pred hccccHHHHHHHHHhCCCCC-ccc---------ccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 292 EMNYTEQQLTAAVVSGGLRP-ILA---------SLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~-~~~---------~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
.................+.. .++ ..+..+++++.+||.+||+.||.+|||+.|+++|.|+.
T Consensus 271 ~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~ 341 (420)
T 1j1b_A 271 KVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFD 341 (420)
T ss_dssp HHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGG
T ss_pred HHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhc
Confidence 43222111111111111111 011 12346789999999999999999999999999998873
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-42 Score=355.97 Aligned_cols=253 Identities=25% Similarity=0.346 Sum_probs=203.7
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccCCCh--------HHHHHHHHHHHHHHhcCCCCceEEeeccccCCc
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTS--------EELDNFHKELQLLCKLDHPGLAKFVAAHAKPPN 135 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 135 (697)
++|++.+.||+|+||.||+|.+ +++.||||++..... .....+.+|+.+|+.++||||+++++++....
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 88 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED- 88 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence 5799999999999999999987 578999998654321 22345889999999999999999999987654
Q ss_pred eEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCC---Ceeeeeccchhh
Q 005427 136 YMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLC---PHLADFGLAEYR 212 (697)
Q Consensus 136 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~---~kL~Dfg~a~~~ 212 (697)
+++||||+.+++|.+++.... .+++.+++.++.|++.||.|||++||+||||||+|||++.++. +||+|||++...
T Consensus 89 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 167 (322)
T 2ycf_A 89 YYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 167 (322)
T ss_dssp EEEEEECCTTEETHHHHSTTC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEEC
T ss_pred eEEEEecCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceec
Confidence 899999999999999887544 7899999999999999999999999999999999999987654 999999998765
Q ss_pred hhhhhhhcccccCCCCCCCCccccccccCccccchhhhc---ccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHH
Q 005427 213 ENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILK---KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHT 289 (697)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~ 289 (697)
.... ......||+.|+|||++. ...++.++|||||||++|+|++|..||...........
T Consensus 168 ~~~~-----------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~ 230 (322)
T 2ycf_A 168 GETS-----------------LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKD 230 (322)
T ss_dssp CCCH-----------------HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHH
T ss_pred cccc-----------------ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHH
Confidence 3211 123457899999999974 46688999999999999999999999976543211111
Q ss_pred HHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 005427 290 VLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL 351 (697)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~ 351 (697)
. +..+. .+..+..+..++.++.+||.+||+.||.+|||+.++++|.|.
T Consensus 231 ~-------------~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~ 278 (322)
T 2ycf_A 231 Q-------------ITSGK-YNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 278 (322)
T ss_dssp H-------------HHHTC-CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGG
T ss_pred H-------------HHhCc-cccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCc
Confidence 1 11111 122333445789999999999999999999999999998876
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=357.30 Aligned_cols=270 Identities=25% Similarity=0.394 Sum_probs=213.5
Q ss_pred ccCCCCCCCcccccccccCCceEEEEEEECCeeEEEEeccCCC--hHHHHHHHHHHHHHHhcCCCCceEEeeccccCCce
Q 005427 59 IPLHLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILST--SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNY 136 (697)
Q Consensus 59 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 136 (697)
..+++..++|++.+.||+|+||.||+|.+.+ .+|+|++.... ....+.+.+|+.+++.++||||+++++++.++..+
T Consensus 26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~-~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 104 (319)
T 2y4i_B 26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHL 104 (319)
T ss_dssp GGSSSCCSCEECCCBCCCSSSSEEEEEEESS-SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCE
T ss_pred ccccCCHHHeEEeeEeccCCceEEEEEEEcC-eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCce
Confidence 4678888999999999999999999999866 58999865432 22345678899999999999999999999999999
Q ss_pred EEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhh
Q 005427 137 MFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLK 216 (697)
Q Consensus 137 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~ 216 (697)
+++|||+.+++|.+++......+++.+++.++.|++.||+|||+.||+||||||+|||++ ++.+||+|||++.......
T Consensus 105 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~ 183 (319)
T 2y4i_B 105 AIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQ 183 (319)
T ss_dssp EEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC------
T ss_pred EEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCcccccccc
Confidence 999999999999999987766789999999999999999999999999999999999998 6799999999987543211
Q ss_pred hhhcccccCCCCCCCCccccccccCccccchhhhcc---------cCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHH
Q 005427 217 EISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK---------EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQA 287 (697)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~ 287 (697)
.. ..........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.......
T Consensus 184 ~~-----------~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~ 252 (319)
T 2y4i_B 184 AG-----------RREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAII 252 (319)
T ss_dssp ---------------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHH
T ss_pred cc-----------ccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 10 01112334569999999999974 45789999999999999999999999876554443
Q ss_pred HHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhcc
Q 005427 288 HTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHRKS 358 (697)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~~~~ 358 (697)
..+.. ..++.. .+..++.++.+++.+||..||.+|||+.++++.|..+.+....
T Consensus 253 ~~~~~---------------~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~ 306 (319)
T 2y4i_B 253 WQMGT---------------GMKPNL--SQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRR 306 (319)
T ss_dssp HHHHT---------------TCCCCC--CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC------
T ss_pred HHhcc---------------CCCCCC--CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 33221 112221 1235788999999999999999999999999998887765433
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=356.01 Aligned_cols=271 Identities=25% Similarity=0.314 Sum_probs=198.3
Q ss_pred cCCCCCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCChHHHHHHHHHHHHHHhcC-CCCceEEeecc------
Q 005427 60 PLHLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLD-HPGLAKFVAAH------ 130 (697)
Q Consensus 60 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~------ 130 (697)
.+++...+|++.++||+|+||.||+|++ +++.||+|++..........+.+|+.+++.+. ||||+++++++
T Consensus 22 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 101 (337)
T 3ll6_A 22 TVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEE 101 (337)
T ss_dssp EEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTT
T ss_pred eeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccc
Confidence 3456677999999999999999999998 68899999877666677788999999999996 99999999988
Q ss_pred --ccCCceEEEEeecCCCCHhhhhhh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccccCCCCceeecCCCCCeee
Q 005427 131 --AKPPNYMFFFEFYESRNLAEKLHV--EEWSPSVDQVLMIAAQLAKALQYLHNLG--IVHRDVKPANVLLDRNLCPHLA 204 (697)
Q Consensus 131 --~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~~~~kL~ 204 (697)
.....++++|||+. |+|.+++.. ....+++.+++.++.|++.||.|||+.| |+||||||+|||++.++.+||+
T Consensus 102 ~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~ 180 (337)
T 3ll6_A 102 SDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLC 180 (337)
T ss_dssp STTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBC
T ss_pred cccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEe
Confidence 34455899999996 699888864 3446899999999999999999999999 9999999999999999999999
Q ss_pred eeccchhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhh---cccCCCchhhHHHHHHHHHHHHhCCCCCCCc
Q 005427 205 DFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEIL---KKEIHSEKSDVYSFGISINELLTGVVPYTDL 281 (697)
Q Consensus 205 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~ 281 (697)
|||++............. .............||+.|+|||++ .+..++.++|||||||++|+|++|..||.+.
T Consensus 181 Dfg~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 256 (337)
T 3ll6_A 181 DFGSATTISHYPDYSWSA----QRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDG 256 (337)
T ss_dssp CCTTCBCCSSCC-----------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---
T ss_pred cCccceeccccCcccccc----cccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcch
Confidence 999997654322111000 000000112245799999999998 5677899999999999999999999999764
Q ss_pred hhHHHHHHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHh
Q 005427 282 RAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHR 356 (697)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~~ 356 (697)
....... .... ...+...+..+.+||.+||+.||.+|||+.|++++|+.+....
T Consensus 257 ~~~~~~~------------------~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~ 310 (337)
T 3ll6_A 257 AKLRIVN------------------GKYS---IPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR 310 (337)
T ss_dssp ---------------------------CC---CCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred hHHHhhc------------------Cccc---CCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 3321111 1111 1123456778999999999999999999999999999988653
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=347.58 Aligned_cols=254 Identities=23% Similarity=0.277 Sum_probs=206.8
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccCCC----hHHHHHHHHHHHHHHhcCCCCceEEeecc--ccCCceE
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST----SEELDNFHKELQLLCKLDHPGLAKFVAAH--AKPPNYM 137 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~hpniv~l~~~~--~~~~~~~ 137 (697)
++|++.+.||+|+||.||++.+ +++.||+|++.... ......+.+|+.+++.++||||+++++++ .+....+
T Consensus 5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (305)
T 2wtk_C 5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMY 84 (305)
T ss_dssp CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEE
T ss_pred cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEE
Confidence 6899999999999999999987 57899999865432 23457799999999999999999999998 4556899
Q ss_pred EEEeecCCCCHhhhhhh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhh
Q 005427 138 FFFEFYESRNLAEKLHV-EEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLK 216 (697)
Q Consensus 138 lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~ 216 (697)
+||||+.++ |.+++.. ....+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 85 lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~ 163 (305)
T 2wtk_C 85 MVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFA 163 (305)
T ss_dssp EEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTC
T ss_pred EEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCccc
Confidence 999999976 6666654 34468999999999999999999999999999999999999999999999999987543211
Q ss_pred hhhcccccCCCCCCCCccccccccCccccchhhhcccC--CCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhcc
Q 005427 217 EISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEI--HSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMN 294 (697)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~ 294 (697)
.........||+.|+|||++.+.. ++.++||||||+++|+|++|..||.+.........+..
T Consensus 164 --------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~-- 227 (305)
T 2wtk_C 164 --------------ADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGK-- 227 (305)
T ss_dssp --------------SSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH--
T ss_pred --------------cccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhc--
Confidence 011233557999999999998654 37899999999999999999999987654443333322
Q ss_pred ccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 005427 295 YTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL 353 (697)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~ 353 (697)
+.. ..+..+++.+.+||.+||+.||.+|||+.++++|.|+..
T Consensus 228 ------------~~~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 269 (305)
T 2wtk_C 228 ------------GSY-----AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRK 269 (305)
T ss_dssp ------------CCC-----CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHS
T ss_pred ------------CCC-----CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCccccc
Confidence 111 134568899999999999999999999999999988753
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-42 Score=365.90 Aligned_cols=267 Identities=22% Similarity=0.295 Sum_probs=206.4
Q ss_pred CCCcccccccccCCceEEEEEEE-CCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccccCC------ceE
Q 005427 65 PSSYTLLSPIARGAESVVYEATL-DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPP------NYM 137 (697)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~------~~~ 137 (697)
..+|++.++||+|+||.||+|++ .+..+|+|++..... ...+|+.+|+.++||||+++++++.... .++
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 35799999999999999999998 556689987643321 2237999999999999999999985443 388
Q ss_pred EEEeecCCCCHhhhhh--hcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeec-CCCCCeeeeeccchhhhh
Q 005427 138 FFFEFYESRNLAEKLH--VEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLD-RNLCPHLADFGLAEYREN 214 (697)
Q Consensus 138 lv~e~~~~g~L~~~l~--~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~-~~~~~kL~Dfg~a~~~~~ 214 (697)
+||||+.++.+..... .....+++..++.++.|++.||+|||++||+||||||+|||++ .++.+||+|||+++....
T Consensus 115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~ 194 (394)
T 4e7w_A 115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIA 194 (394)
T ss_dssp EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccC
Confidence 9999998754333322 2344789999999999999999999999999999999999998 789999999999976432
Q ss_pred hhhhhcccccCCCCCCCCccccccccCccccchhhhccc-CCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhc
Q 005427 215 LKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKE-IHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEM 293 (697)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~ 293 (697)
. .......||+.|+|||++.+. .++.++|||||||++|||++|..||.+.+.......+...
T Consensus 195 ~-----------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~ 257 (394)
T 4e7w_A 195 G-----------------EPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKV 257 (394)
T ss_dssp T-----------------CCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred C-----------------CCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 1 113456789999999999765 5899999999999999999999999998777766666543
Q ss_pred cccHHHHHHHHHhCCC----------CCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 294 NYTEQQLTAAVVSGGL----------RPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 294 ~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
...............+ .+.....+..+++++.+||.+||+.||.+|||+.|+++|.|+-
T Consensus 258 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~ 326 (394)
T 4e7w_A 258 LGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFD 326 (394)
T ss_dssp HCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGS
T ss_pred hCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhh
Confidence 2222111111111100 0111122345889999999999999999999999999998863
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-41 Score=353.79 Aligned_cols=264 Identities=21% Similarity=0.312 Sum_probs=210.1
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccCC--ChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCc------
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPN------ 135 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~------ 135 (697)
++|.+.+.||+|+||.||+|.+ +++.||||++... .......+.+|+.+++.++||||+++++++.....
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 6899999999999999999987 5899999987543 33446788999999999999999999999987654
Q ss_pred eEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhh
Q 005427 136 YMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL 215 (697)
Q Consensus 136 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~ 215 (697)
+++||||+. ++|.+++.. .+++.+++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 104 ~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~- 178 (353)
T 3coi_A 104 FYLVMPFMQ-TDLQKIMGL---KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA- 178 (353)
T ss_dssp CEEEEECCS-EEGGGTTTS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC----
T ss_pred EEEEecccc-CCHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCC-
Confidence 499999998 588887743 589999999999999999999999999999999999999999999999999875432
Q ss_pred hhhhcccccCCCCCCCCccccccccCccccchhhhcc-cCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhcc
Q 005427 216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMN 294 (697)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~ 294 (697)
......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+....
T Consensus 179 ------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~ 240 (353)
T 3coi_A 179 ------------------EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVT 240 (353)
T ss_dssp -----------------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHH
T ss_pred ------------------CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 1234578999999999987 678999999999999999999999999877665555444321
Q ss_pred ccH-HHH--------HHHHHh---CCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 295 YTE-QQL--------TAAVVS---GGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 295 ~~~-~~~--------~~~~~~---~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
... ... ...... ...++.+......+++++.+||.+||+.||++|||+.++++|.|+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~ 310 (353)
T 3coi_A 241 GVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFE 310 (353)
T ss_dssp CBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGT
T ss_pred CCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchh
Confidence 111 000 000110 1112222334457899999999999999999999999999998863
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-41 Score=365.18 Aligned_cols=268 Identities=20% Similarity=0.294 Sum_probs=213.5
Q ss_pred CCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCChHHHHHHHHHHHHHHhcCC-CCceEEeeccccCCceEEEEe
Q 005427 65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDH-PGLAKFVAAHAKPPNYMFFFE 141 (697)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~l~~~~~~~~~~~lv~e 141 (697)
.++|++.++||+|+||.||+|++ +++.||||+...... ...+.+|+++++.|+| ++|..+..++......++|||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 47899999999999999999997 588999997554332 2357899999999987 555566666677788899999
Q ss_pred ecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceee---cCCCCCeeeeeccchhhhhhhhh
Q 005427 142 FYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLL---DRNLCPHLADFGLAEYRENLKEI 218 (697)
Q Consensus 142 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill---~~~~~~kL~Dfg~a~~~~~~~~~ 218 (697)
|+ +++|.+++......+++.+++.++.||+.||+|||++||+||||||+|||| +.++.+||+|||+++.+......
T Consensus 84 ~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (483)
T 3sv0_A 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (483)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTC
T ss_pred CC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCccc
Confidence 99 889999998766689999999999999999999999999999999999999 68899999999999765532211
Q ss_pred hcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHH
Q 005427 219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQ 298 (697)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~ 298 (697)
. ...........||+.|+|||++.+..++.++|||||||+||||++|..||.+.........+....
T Consensus 163 ~---------~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~---- 229 (483)
T 3sv0_A 163 Q---------HIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS---- 229 (483)
T ss_dssp C---------BCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHH----
T ss_pred c---------ccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHh----
Confidence 0 000112336789999999999999999999999999999999999999998754322222111100
Q ss_pred HHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 005427 299 QLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH 355 (697)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~ 355 (697)
.......+..+...++.++.+||..||+.||.+||++.+|++.|..++..
T Consensus 230 -------~~~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~ 279 (483)
T 3sv0_A 230 -------EKKVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIR 279 (483)
T ss_dssp -------HHHHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred -------hccccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHH
Confidence 00011222233457899999999999999999999999999999988865
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=354.80 Aligned_cols=279 Identities=22% Similarity=0.220 Sum_probs=213.0
Q ss_pred CCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCC-hHHHHHHHHHHHHHHhcCCCCceEEeeccccC-----Cce
Q 005427 65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST-SEELDNFHKELQLLCKLDHPGLAKFVAAHAKP-----PNY 136 (697)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-----~~~ 136 (697)
.++|++.+.||+|+||.||+|++ +++.||||++.... ......+.+|+.+|+.++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 47899999999999999999998 48899999875433 34466788999999999999999999987654 678
Q ss_pred EEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhh
Q 005427 137 MFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLK 216 (697)
Q Consensus 137 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~ 216 (697)
++||||+. ++|.+++... .+++..++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 90 ~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 166 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVISTQ--MLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESA 166 (353)
T ss_dssp EEEECCCS-EEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred EEEEeccC-ccHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEeccccccccccc
Confidence 99999998 5899988753 68999999999999999999999999999999999999999999999999997654321
Q ss_pred hhhcccccCCCCCCCCccccccccCccccchhhhcc-cCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccc
Q 005427 217 EISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNY 295 (697)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~ 295 (697)
..... ............||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+.....
T Consensus 167 ~~~~~------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 240 (353)
T 2b9h_A 167 ADNSE------PTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIG 240 (353)
T ss_dssp -------------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred ccccC------ccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Confidence 10000 0000011234679999999998764 7789999999999999999999999998765554443332111
Q ss_pred cH-----------HHHHHHHHhC--CCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 296 TE-----------QQLTAAVVSG--GLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 296 ~~-----------~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
.. .........- .....+......+++++.+||.+||+.||.+|||+.++++|.|..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~ 310 (353)
T 2b9h_A 241 TPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQ 310 (353)
T ss_dssp CCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGT
T ss_pred CCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCcccc
Confidence 00 0000011100 001112223457899999999999999999999999999998874
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-42 Score=356.42 Aligned_cols=271 Identities=21% Similarity=0.303 Sum_probs=211.4
Q ss_pred cCCCCCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccc----cC
Q 005427 60 PLHLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHA----KP 133 (697)
Q Consensus 60 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~----~~ 133 (697)
.+.+..++|++.+.||+|+||.||++.+ +++.||||++........+.+.+|+.+++.++||||+++++++. ..
T Consensus 23 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 102 (317)
T 2buj_A 23 MVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAK 102 (317)
T ss_dssp EEEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTE
T ss_pred EEEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCC
Confidence 3456778999999999999999999997 68899999877777777888999999999999999999999986 34
Q ss_pred CceEEEEeecCCCCHhhhhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccch
Q 005427 134 PNYMFFFEFYESRNLAEKLHV---EEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAE 210 (697)
Q Consensus 134 ~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~ 210 (697)
...++||||+.+|+|.+++.. ....+++.+++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||++.
T Consensus 103 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~ 182 (317)
T 2buj_A 103 HEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMN 182 (317)
T ss_dssp EEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred ceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcch
Confidence 578999999999999999875 34578999999999999999999999999999999999999999999999999886
Q ss_pred hhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccC---CCchhhHHHHHHHHHHHHhCCCCCCCchhHHHH
Q 005427 211 YRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEI---HSEKSDVYSFGISINELLTGVVPYTDLRAEAQA 287 (697)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~ 287 (697)
............ ..........||+.|+|||++.+.. ++.++|||||||++|+|++|..||........
T Consensus 183 ~~~~~~~~~~~~-------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~- 254 (317)
T 2buj_A 183 QACIHVEGSRQA-------LTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD- 254 (317)
T ss_dssp ESCEEEESHHHH-------HHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS-
T ss_pred hccccccccccc-------ccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc-
Confidence 543110000000 0000012346799999999997554 68899999999999999999999964211100
Q ss_pred HHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 005427 288 HTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL 353 (697)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~ 353 (697)
....... ..... ..+..++.++.++|.+||+.||.+|||+.+++++|+.+.
T Consensus 255 -----------~~~~~~~-~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 305 (317)
T 2buj_A 255 -----------SVALAVQ-NQLSI---PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305 (317)
T ss_dssp -----------CHHHHHH-CC--C---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred -----------hhhHHhh-ccCCC---CccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence 0000111 11111 123468899999999999999999999999999887753
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=356.04 Aligned_cols=268 Identities=18% Similarity=0.235 Sum_probs=209.8
Q ss_pred CCCCcccccccccCCceEEEEEEEC----------CeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceE--------
Q 005427 64 PPSSYTLLSPIARGAESVVYEATLD----------GRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAK-------- 125 (697)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~----------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~-------- 125 (697)
..++|++.+.||+|+||.||+|++. ++.||+|..... +.+.+|+++++.++||||++
T Consensus 40 ~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~ 114 (352)
T 2jii_A 40 SGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYST 114 (352)
T ss_dssp TSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTC
T ss_pred cCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccC
Confidence 3578999999999999999999873 678999986543 35789999999999999988
Q ss_pred -------Eeecccc-CCceEEEEeecCCCCHhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeec
Q 005427 126 -------FVAAHAK-PPNYMFFFEFYESRNLAEKLHVE-EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLD 196 (697)
Q Consensus 126 -------l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~ 196 (697)
+++++.. ...+++||||+ +++|.+++... ...+++.+++.++.|++.||.|||++||+||||||+|||++
T Consensus 115 ~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~ 193 (352)
T 2jii_A 115 PLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVD 193 (352)
T ss_dssp TTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEE
T ss_pred CccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEc
Confidence 4555544 67889999999 89999999765 34789999999999999999999999999999999999999
Q ss_pred CCC--CCeeeeeccchhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhC
Q 005427 197 RNL--CPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTG 274 (697)
Q Consensus 197 ~~~--~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g 274 (697)
.++ .+||+|||+++.+...... ............||+.|+|||++.+..++.++|||||||++|+|++|
T Consensus 194 ~~~~~~~kl~Dfg~a~~~~~~~~~---------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g 264 (352)
T 2jii_A 194 PEDQSQVTLAGYGFAFRYCPSGKH---------VAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYG 264 (352)
T ss_dssp TTEEEEEEECCGGGCBCSSGGGCC---------CCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHS
T ss_pred CCCCceEEEecCcceeeccCCCcc---------ccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhC
Confidence 988 8999999999766532210 00011122445899999999999999999999999999999999999
Q ss_pred CCCCCCch-hHHHHHHHHhccccHHHHHHHHHhCCCCCcccc--cccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 005427 275 VVPYTDLR-AEAQAHTVLEMNYTEQQLTAAVVSGGLRPILAS--LELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL 351 (697)
Q Consensus 275 ~~Pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~ 351 (697)
..||.+.. .......... ... ....+.... ....+++++.+||.+||+.||.+|||+.++++.|..
T Consensus 265 ~~pf~~~~~~~~~~~~~~~----------~~~-~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~ 333 (352)
T 2jii_A 265 FLPWTNCLPNTEDIMKQKQ----------KFV-DKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEA 333 (352)
T ss_dssp CCTTGGGTTCHHHHHHHHH----------HHH-HSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHH
T ss_pred CCCcccCCcCHHHHHHHHH----------hcc-CChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHH
Confidence 99998753 1111111110 000 011111110 123578999999999999999999999999999999
Q ss_pred HHHHhc
Q 005427 352 VLEHRK 357 (697)
Q Consensus 352 ~~~~~~ 357 (697)
+++...
T Consensus 334 ~~~~~~ 339 (352)
T 2jii_A 334 LLQDLR 339 (352)
T ss_dssp HHHHTT
T ss_pred HHHhcC
Confidence 887644
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=379.36 Aligned_cols=257 Identities=24% Similarity=0.358 Sum_probs=207.7
Q ss_pred CCcccc-cccccCCceEEEEEEE----CCeeEEEEeccCC--ChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEE
Q 005427 66 SSYTLL-SPIARGAESVVYEATL----DGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMF 138 (697)
Q Consensus 66 ~~y~~~-~~lg~G~~g~V~~~~~----~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 138 (697)
+.+.+. ++||+|+||.||+|.+ .++.||||++... .....+.+.+|+.+|+.++||||+++++++.. ..+++
T Consensus 368 ~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~l 446 (635)
T 4fl3_A 368 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWML 446 (635)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred hhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEE
Confidence 334443 4799999999999965 3578999986543 22346789999999999999999999999864 56889
Q ss_pred EEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhh
Q 005427 139 FFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI 218 (697)
Q Consensus 139 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~ 218 (697)
||||+.+|+|.+++.... .+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+......
T Consensus 447 v~E~~~~g~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 525 (635)
T 4fl3_A 447 VMEMAELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 525 (635)
T ss_dssp EEECCTTEEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC----
T ss_pred EEEccCCCCHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccc
Confidence 999999999999997554 7899999999999999999999999999999999999999999999999999876432110
Q ss_pred hcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCCchhHHHHHHHHhccccH
Q 005427 219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTE 297 (697)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~ 297 (697)
........+|+.|+|||++.+..++.++|||||||++|||++ |..||.+.........+..
T Consensus 526 -------------~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~----- 587 (635)
T 4fl3_A 526 -------------YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK----- 587 (635)
T ss_dssp ----------------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT-----
T ss_pred -------------cccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-----
Confidence 001233457889999999999999999999999999999998 9999988765544333322
Q ss_pred HHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 005427 298 QQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH 355 (697)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~ 355 (697)
+ .++ ..+..+|+++.+||..||+.||.+|||+.+|++.|..+...
T Consensus 588 ---------~-~~~---~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 632 (635)
T 4fl3_A 588 ---------G-ERM---GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 632 (635)
T ss_dssp ---------T-CCC---CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred ---------C-CCC---CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 1 111 23457899999999999999999999999999999887653
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=344.52 Aligned_cols=253 Identities=25% Similarity=0.352 Sum_probs=211.4
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccCC--ChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEe
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFE 141 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 141 (697)
++|++.++||+|+||.||+|++ +++.||+|++... .....+.+.+|+.++++++||||+++++++.+...+++|||
T Consensus 22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 101 (287)
T 2wei_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (287)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEE
Confidence 5799999999999999999998 5889999986433 22346788999999999999999999999999999999999
Q ss_pred ecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCC---CCCeeeeeccchhhhhhhhh
Q 005427 142 FYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRN---LCPHLADFGLAEYRENLKEI 218 (697)
Q Consensus 142 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~---~~~kL~Dfg~a~~~~~~~~~ 218 (697)
|+.+++|.+.+.... .+++.+++.++.|++.||.|||+.||+||||||+||+++.+ +.+||+|||++.......
T Consensus 102 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~-- 178 (287)
T 2wei_A 102 LYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT-- 178 (287)
T ss_dssp CCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCS--
T ss_pred ccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCC--
Confidence 999999999887654 68999999999999999999999999999999999999654 469999999987543211
Q ss_pred hcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHH
Q 005427 219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQ 298 (697)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~ 298 (697)
......||+.|+|||++.+. ++.++||||||+++|+|++|..||.+.........+..
T Consensus 179 ---------------~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~------ 236 (287)
T 2wei_A 179 ---------------KMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVET------ 236 (287)
T ss_dssp ---------------SCSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH------
T ss_pred ---------------ccccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHc------
Confidence 12344689999999998765 78999999999999999999999988665444333322
Q ss_pred HHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 299 QLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
+...... .....+++++.++|.+||+.||.+|||+.++++|.|..
T Consensus 237 --------~~~~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~ 281 (287)
T 2wei_A 237 --------GKYAFDL-PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQ 281 (287)
T ss_dssp --------CCCCCCS-GGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHH
T ss_pred --------CCCCCCc-hhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHh
Confidence 2221111 12346899999999999999999999999999998875
|
| >1txo_A Putative bacterial enzyme; serine/threonine protein phosphatases, PSTP/PPP, structural genomics, PSI, protein structure initiative; 1.95A {Mycobacterium tuberculosis} SCOP: d.219.1.1 PDB: 2cm1_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=326.81 Aligned_cols=229 Identities=25% Similarity=0.296 Sum_probs=196.3
Q ss_pred ccceEeeeccCC-CCCCCceeEEcccccCCCceEEEEEecCCCChHHHHHHHHHhHHHHHhcCC---CCChHHHHHHHHH
Q 005427 428 VLSWGSFATCGR-RETMEDTHFLMPHMYNQKEIHMFGIFDGHRGSAAAEFSARALPGFLQNLGS---TTRPTDALLEAFI 503 (697)
Q Consensus 428 ~~~~~~~s~~G~-R~~neD~~~~~~~~~~~~~~~~~~V~DG~GG~~~~~~as~~~~~~l~~~~~---~~~~~~~l~~~~~ 503 (697)
.+.++..|++|. |..|||++++. ..+|+|||||||+.+|++||+.+++.+.+... .....+.+.+++.
T Consensus 4 ~~~~~~~s~~G~~r~~nED~~~~~--------~~~~~V~DG~Gg~~~~~~as~~~~~~l~~~~~~~~~~~~~~~l~~a~~ 75 (237)
T 1txo_A 4 VLRYAARSDRGLVRANNEDSVYAG--------ARLLALADGMGGHAAGEVASQLVIAALAHLDDDEPGGDLLAKLDAAVR 75 (237)
T ss_dssp EEEEEEEEECCSSCSSCCEEEEEC--------SSEEEEEEEECTTTHHHHHHHHHHHHHGGGGSSCCCSCHHHHHHHHHH
T ss_pred EEEEEEecCCCCCCCcCCCccccC--------CCEEEEEeCCCCcHHHHHHHHHHHHHHHHHhhhCCchhHHHHHHHHHH
Confidence 478999999997 99999999862 35999999999999999999999999987532 3456778889998
Q ss_pred HHHHHHHHHHHHHHhhhhcccCCCCCCceEEEEEEecCeEEEEEcCCeEEEEEECCeeeecCCCCCCCCHHHHHHHHHcC
Q 005427 504 RTDVAFRNELDSLRKSKRVVQKDWHPGCTAIAALIVRNRLFVANAGDCRAILCRGGHPFALSRDHVASCLEERERVVSAG 583 (697)
Q Consensus 504 ~~~~~~~~~~~~~~~~~~~~~~~~~~GtT~~~~~i~~~~l~~anvGDSr~~l~~~~~~~~lt~dH~~~~~~e~~ri~~~g 583 (697)
.++..+....... .....+|||++++++.+++++++|+||||+|++|+|++.+||+||++ .+++.+.|
T Consensus 76 ~~~~~i~~~~~~~-------~~~~~~gtT~~~~~i~~~~l~~a~vGDsr~~l~r~g~~~~lt~dh~~-----~~~~~~~G 143 (237)
T 1txo_A 76 AGNSAIAAQVEME-------PDLEGMGTTLTAILFAGNRLGLVHIGDSRGYLLRDGELTQITKDDTF-----VQTLVDEG 143 (237)
T ss_dssp HHHHHHHHHHHHC-------GGGTTCEECEEEEEEETTEEEEEEESSCEEEEEETTEEEECSCCCBH-----HHHHHHTT
T ss_pred HHHHHHHHHHhhC-------CCCCCCcceEEEEEEECCEEEEEEEccCcEEEEeCCEeEEeCCCCCH-----HHHHHHcC
Confidence 8888887653321 11235799999999999999999999999999999999999999954 45677777
Q ss_pred CeeeeccCcceeCCCcceeccccCCCCCCCCcccCCceEEEEeCCCCeEEEEEcCCcccCCChHHHHHHHHhhcCChhHH
Q 005427 584 GNVNWQVDTWRVGPPALQVTRSIGDDDLKPAVTAEPEITETIMTPEDEYLVMASDGLWDVVSHVEAVGIIKDTVKEPGMC 663 (697)
Q Consensus 584 ~~~~~~~~~~~~~~~~~~ltralG~~~~k~~v~~~p~v~~~~l~~~d~~lvl~SDGl~d~~~~~ei~~~~~~~~~~~~~~ 663 (697)
. +...+.+.+|.++.+||++|+. .++|++..+.+.++| +||||||||||+++++++.+++.. .+++++
T Consensus 144 ~---i~~~~~~~~~~~~~~tr~lg~~------~~~p~~~~~~l~~~d-~lvl~SDGl~d~l~~~~i~~~~~~--~~~~~~ 211 (237)
T 1txo_A 144 R---ITPEEAHSHPQRSLIMRALTGH------EVEPTLTMREARAGD-RYLLCSDGLSDPVSDETILEALQI--PEVAES 211 (237)
T ss_dssp S---SCTTGGGGCTTTTCBCCCBSSS------CCCCEEEEEECCTTC-EEEEECHHHHTTSCHHHHHHHHTS--SSHHHH
T ss_pred C---CCHHHHhhCccccceeeccCCC------CccceEEEEecCCCC-EEEEECCCCCCCCCHHHHHHHHhc--CCHHHH
Confidence 5 4566777888899999999964 468999999999998 568999999999999999999975 389999
Q ss_pred HHHHHHHHHhcCCCCCcEEEEEEeC
Q 005427 664 SKRLATEAAERGSKDNITVIVVFLQ 688 (697)
Q Consensus 664 a~~L~~~a~~~g~~DNiT~ivv~l~ 688 (697)
|+.|++.|+.+|+.||+||||+++.
T Consensus 212 a~~L~~~a~~~g~~DniTvivv~~~ 236 (237)
T 1txo_A 212 AHRLIELALRGGGPDNVTVVVADLE 236 (237)
T ss_dssp HHHHHHHHHHTTCCSCEEEEEEEEE
T ss_pred HHHHHHHHHHcCCCCCeEEEEEEee
Confidence 9999999999999999999999985
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=362.32 Aligned_cols=270 Identities=22% Similarity=0.287 Sum_probs=211.4
Q ss_pred CCCcccccccccCCceEEEEEEECCeeEEEEeccCCChH-----------------HHHHHHHHHHHHHhcCCCCceEEe
Q 005427 65 PSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSE-----------------ELDNFHKELQLLCKLDHPGLAKFV 127 (697)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~-----------------~~~~~~~E~~~l~~l~hpniv~l~ 127 (697)
.++|++.+.||+|+||.||+|.++++.||+|++...... ..+.+.+|+.+++.++||||++++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 109 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCE 109 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCS
T ss_pred cCceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEE
Confidence 468999999999999999999999999999986532111 127899999999999999999999
Q ss_pred eccccCCceEEEEeecCCCCHhhh------hhhc-CCCCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCCCceeecCCC
Q 005427 128 AAHAKPPNYMFFFEFYESRNLAEK------LHVE-EWSPSVDQVLMIAAQLAKALQYLHN-LGIVHRDVKPANVLLDRNL 199 (697)
Q Consensus 128 ~~~~~~~~~~lv~e~~~~g~L~~~------l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivHrDlkp~Nill~~~~ 199 (697)
+++.+...+++||||+++++|.++ +... ...+++..++.++.|++.||.|||+ .||+||||||+|||++.++
T Consensus 110 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~~~ 189 (348)
T 2pml_X 110 GIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNG 189 (348)
T ss_dssp EEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEECTTS
T ss_pred EEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEcCCC
Confidence 999999999999999999999998 5542 4578999999999999999999999 9999999999999999999
Q ss_pred CCeeeeeccchhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhccc-CCCc-hhhHHHHHHHHHHHHhCCCC
Q 005427 200 CPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKE-IHSE-KSDVYSFGISINELLTGVVP 277 (697)
Q Consensus 200 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DiwslG~~l~ell~g~~P 277 (697)
.+||+|||++...... ......||+.|+|||++.+. .++. ++|||||||++|+|++|..|
T Consensus 190 ~~kl~dfg~~~~~~~~------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p 251 (348)
T 2pml_X 190 RVKLSDFGESEYMVDK------------------KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251 (348)
T ss_dssp CEEECCCTTCEECBTT------------------EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCS
T ss_pred cEEEeccccccccccc------------------cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCC
Confidence 9999999998754321 13456799999999999877 5665 99999999999999999999
Q ss_pred CCCchh-HHHHHHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 278 YTDLRA-EAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 278 f~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
|..... ......+.............................+++++.+||.+||+.||.+|||+.|+++|.|+.
T Consensus 252 f~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~ 327 (348)
T 2pml_X 252 FSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLA 327 (348)
T ss_dssp SCCSSCSHHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGT
T ss_pred CCCCCcHHHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCcccc
Confidence 987654 333333322211100000000000000000011256899999999999999999999999999988763
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-41 Score=351.27 Aligned_cols=269 Identities=21% Similarity=0.290 Sum_probs=211.6
Q ss_pred CCCCCcccccccccCCceEEEEEEE---CCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCC------CceEEeeccccC
Q 005427 63 LPPSSYTLLSPIARGAESVVYEATL---DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP------GLAKFVAAHAKP 133 (697)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp------niv~l~~~~~~~ 133 (697)
+..++|++.+.||+|+||.||+|.+ .++.||||++.. .....+.+.+|+.+++.++|+ +++++++++...
T Consensus 11 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~ 89 (339)
T 1z57_A 11 VLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKN-VDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHH 89 (339)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS-SHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEET
T ss_pred CccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEec-CCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccC
Confidence 3457999999999999999999987 578999998653 334567889999999999665 499999999999
Q ss_pred CceEEEEeecCCCCHhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecC---------------
Q 005427 134 PNYMFFFEFYESRNLAEKLHVEE-WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDR--------------- 197 (697)
Q Consensus 134 ~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~--------------- 197 (697)
..+++||||+ +++|.+++.... ..+++.+++.++.|++.||+|||++||+||||||+|||++.
T Consensus 90 ~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~ 168 (339)
T 1z57_A 90 GHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDE 168 (339)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEE
T ss_pred CcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCcccccc
Confidence 9999999999 789999987654 35789999999999999999999999999999999999987
Q ss_pred ----CCCCeeeeeccchhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh
Q 005427 198 ----NLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT 273 (697)
Q Consensus 198 ----~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~ 273 (697)
++.+||+|||++..... ......||+.|+|||++.+..++.++|||||||++|||++
T Consensus 169 ~~~~~~~~kl~Dfg~~~~~~~-------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~ 229 (339)
T 1z57_A 169 RTLINPDIKVVDFGSATYDDE-------------------HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYL 229 (339)
T ss_dssp EEESCCCEEECCCSSCEETTS-------------------CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHH
T ss_pred ccccCCCceEeeCcccccCcc-------------------ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHh
Confidence 66899999999865331 1234578999999999999999999999999999999999
Q ss_pred CCCCCCCchhHHHHHHHHhccccHHH-HHHH----------------------HHhCCCCCcc--cccccCChHHHHHHH
Q 005427 274 GVVPYTDLRAEAQAHTVLEMNYTEQQ-LTAA----------------------VVSGGLRPIL--ASLELGLPASILSLI 328 (697)
Q Consensus 274 g~~Pf~~~~~~~~~~~~~~~~~~~~~-~~~~----------------------~~~~~~~~~~--~~~~~~~~~~l~~li 328 (697)
|..||...+.......+......... .... ......++.. .......++++.+||
T Consensus 230 g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 309 (339)
T 1z57_A 230 GFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLI 309 (339)
T ss_dssp SSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHH
T ss_pred CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHH
Confidence 99999887655544333221111100 0000 0000001100 011223568899999
Q ss_pred HHhccCCCCCCCCHHHHHHHHHHH
Q 005427 329 QRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 329 ~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
.+||+.||.+|||+.|+++|.|+.
T Consensus 310 ~~~L~~dP~~Rpt~~ell~hp~f~ 333 (339)
T 1z57_A 310 QKMLEYDPAKRITLREALKHPFFD 333 (339)
T ss_dssp HHHTCSSTTTSCCHHHHTTSGGGG
T ss_pred HHHhCcCcccccCHHHHhcCHHHH
Confidence 999999999999999999988763
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=362.57 Aligned_cols=264 Identities=20% Similarity=0.215 Sum_probs=203.6
Q ss_pred CCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCChHHHHHHHHHHHHHHhcC--------CCCceEEeeccc---
Q 005427 65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLD--------HPGLAKFVAAHA--- 131 (697)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------hpniv~l~~~~~--- 131 (697)
.++|++.++||+|+||+||+|++ +++.||||++.. .....+.+.+|+.+|+.++ ||||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKS-AEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS-CHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEec-CCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 47899999999999999999987 588999998753 3445678899999999995 788999999987
Q ss_pred -cCCceEEEEeecCCCCHhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhC-CcccccCCCCceeecCCC---------
Q 005427 132 -KPPNYMFFFEFYESRNLAEKLHVE-EWSPSVDQVLMIAAQLAKALQYLHNL-GIVHRDVKPANVLLDRNL--------- 199 (697)
Q Consensus 132 -~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~-~ivHrDlkp~Nill~~~~--------- 199 (697)
....+++||||+. ++|.+.+... ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++
T Consensus 115 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~ 193 (397)
T 1wak_A 115 VNGTHICMVFEVLG-HHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAE 193 (397)
T ss_dssp TTEEEEEEEECCCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHH
T ss_pred CCCceEEEEEeccC-ccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhh
Confidence 5678999999995 5666665443 35689999999999999999999998 999999999999998775
Q ss_pred ----------------------------------------CCeeeeeccchhhhhhhhhhcccccCCCCCCCCccccccc
Q 005427 200 ----------------------------------------CPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMV 239 (697)
Q Consensus 200 ----------------------------------------~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (697)
.+||+|||++..... ......
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~-------------------~~~~~~ 254 (397)
T 1wak_A 194 ATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK-------------------HFTEDI 254 (397)
T ss_dssp HC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB-------------------CSCSCC
T ss_pred hHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc-------------------cCccCC
Confidence 799999999975432 123457
Q ss_pred cCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchh------HHHHHHHHhccccHHHHHHHHHhCCCC---
Q 005427 240 GTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRA------EAQAHTVLEMNYTEQQLTAAVVSGGLR--- 310 (697)
Q Consensus 240 gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 310 (697)
||+.|+|||++.+..++.++|||||||++|+|++|..||.+... ......+........... +..+...
T Consensus 255 gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~--~~~~~~~~~~ 332 (397)
T 1wak_A 255 QTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKL--IVAGKYSKEF 332 (397)
T ss_dssp SCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHH--HHHCTTGGGT
T ss_pred CCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHH--hhcccccccc
Confidence 89999999999999999999999999999999999999976432 122222211111100000 0000000
Q ss_pred --------Cccc--------------ccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 005427 311 --------PILA--------------SLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL 351 (697)
Q Consensus 311 --------~~~~--------------~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~ 351 (697)
.... ..+...++.+.+||.+||+.||++|||+.|+++|.|+
T Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~ 395 (397)
T 1wak_A 333 FTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWL 395 (397)
T ss_dssp BCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGG
T ss_pred cCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccc
Confidence 0000 0122346789999999999999999999999998875
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=350.74 Aligned_cols=264 Identities=25% Similarity=0.393 Sum_probs=211.4
Q ss_pred CCcccccccccCCceEEEEEEECCeeEEEEeccCCChHHHHHHHHHHHHHHh--cCCCCceEEeeccccCC----ceEEE
Q 005427 66 SSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCK--LDHPGLAKFVAAHAKPP----NYMFF 139 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~hpniv~l~~~~~~~~----~~~lv 139 (697)
++|++.+.||+|+||.||+|+++++.||||++.. .....+.+|+++++. ++||||+++++++.... ..++|
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~---~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv 118 (342)
T 1b6c_B 42 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 118 (342)
T ss_dssp HHCEEEEEEEEETTEEEEEEEETTEEEEEEEECG---GGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEE
T ss_pred ccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCc---hhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEE
Confidence 5899999999999999999999999999998643 234567889999988 79999999999998876 79999
Q ss_pred EeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHH--------hCCcccccCCCCceeecCCCCCeeeeeccchh
Q 005427 140 FEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLH--------NLGIVHRDVKPANVLLDRNLCPHLADFGLAEY 211 (697)
Q Consensus 140 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH--------~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~ 211 (697)
|||+.+|+|.+++... .+++.+++.++.|++.||.||| +.||+||||||+|||++.++.+||+|||++..
T Consensus 119 ~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~ 196 (342)
T 1b6c_B 119 SDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 196 (342)
T ss_dssp ECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EeecCCCcHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCCcee
Confidence 9999999999999754 5899999999999999999999 89999999999999999999999999999976
Q ss_pred hhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccC------CCchhhHHHHHHHHHHHHhC----------C
Q 005427 212 RENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEI------HSEKSDVYSFGISINELLTG----------V 275 (697)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~DiwslG~~l~ell~g----------~ 275 (697)
....... .........||+.|+|||++.+.. ++.++|||||||++|+|++| .
T Consensus 197 ~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~ 264 (342)
T 1b6c_B 197 HDSATDT------------IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ 264 (342)
T ss_dssp EETTTTE------------EEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred ccccccc------------cccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccc
Confidence 5431110 000134557999999999998763 33789999999999999999 7
Q ss_pred CCCCCchhHHHHHHHHhccccHHHHHHHHHhCCCCCccccc--ccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 005427 276 VPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASL--ELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL 353 (697)
Q Consensus 276 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~ 353 (697)
.||....... .........+.....++.++.. ...++..+.+||.+||+.||++|||+.+++++|..+.
T Consensus 265 ~p~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~ 335 (342)
T 1b6c_B 265 LPYYDLVPSD---------PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 335 (342)
T ss_dssp CTTTTTSCSS---------CCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCccccCcCc---------ccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence 7886542110 1112222223333444433321 2345678999999999999999999999999999987
Q ss_pred HH
Q 005427 354 EH 355 (697)
Q Consensus 354 ~~ 355 (697)
+.
T Consensus 336 ~~ 337 (342)
T 1b6c_B 336 QQ 337 (342)
T ss_dssp HT
T ss_pred HH
Confidence 64
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=344.75 Aligned_cols=246 Identities=22% Similarity=0.350 Sum_probs=205.7
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeecccc-----------
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAK----------- 132 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~----------- 132 (697)
.+|++.+.||+|+||.||+|.+ +++.||+|++.... +.+.+|+.+++.++||||+++++++..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 86 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKN 86 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-------
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccc
Confidence 4799999999999999999998 48899999876543 346789999999999999999998754
Q ss_pred -----CCceEEEEeecCCCCHhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeee
Q 005427 133 -----PPNYMFFFEFYESRNLAEKLHVE-EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADF 206 (697)
Q Consensus 133 -----~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Df 206 (697)
...+++||||+++++|.+++... ...+++..++.++.|++.||.|||+.||+||||||+|||++.++.+||+||
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Df 166 (284)
T 2a19_B 87 SSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDF 166 (284)
T ss_dssp --CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCC
T ss_pred ccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEECcc
Confidence 44589999999999999999754 347899999999999999999999999999999999999999999999999
Q ss_pred ccchhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHH
Q 005427 207 GLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQ 286 (697)
Q Consensus 207 g~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~ 286 (697)
|++....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||..... .
T Consensus 167 g~~~~~~~~~-----------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~--~ 227 (284)
T 2a19_B 167 GLVTSLKNDG-----------------KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK--F 227 (284)
T ss_dssp TTCEESSCCS-----------------CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHH--H
T ss_pred hhheeccccc-----------------cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHH--H
Confidence 9986543210 12345699999999999999999999999999999999999988753211 1
Q ss_pred HHHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 005427 287 AHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH 355 (697)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~ 355 (697)
.. ....+ ..+..++..+.++|.+||+.||.+|||+.+++++|+.+.+.
T Consensus 228 ~~--------------~~~~~-------~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~ 275 (284)
T 2a19_B 228 FT--------------DLRDG-------IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275 (284)
T ss_dssp HH--------------HHHTT-------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred HH--------------Hhhcc-------cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence 00 11111 12345789999999999999999999999999999988643
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=356.25 Aligned_cols=266 Identities=21% Similarity=0.223 Sum_probs=208.7
Q ss_pred CCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCChHHHHHHHHHHHHHHhcC-CC-----CceEEeeccccCCce
Q 005427 65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLD-HP-----GLAKFVAAHAKPPNY 136 (697)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hp-----niv~l~~~~~~~~~~ 136 (697)
.++|++.++||+|+||+||+|++ +++.||||++.. .......+..|+.+++.++ |+ +|+++++++......
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 131 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN-KKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHL 131 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECS-SHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEE
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEec-cHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCce
Confidence 46899999999999999999987 578999998753 3344567888999999885 55 499999999999999
Q ss_pred EEEEeecCCCCHhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHH--hCCcccccCCCCceeec--CCCCCeeeeeccchh
Q 005427 137 MFFFEFYESRNLAEKLHVEE-WSPSVDQVLMIAAQLAKALQYLH--NLGIVHRDVKPANVLLD--RNLCPHLADFGLAEY 211 (697)
Q Consensus 137 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH--~~~ivHrDlkp~Nill~--~~~~~kL~Dfg~a~~ 211 (697)
++||||+.+ +|.+++.... ..+++..++.++.|++.||.||| +.||+||||||+|||++ .++.+||+|||+++.
T Consensus 132 ~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~ 210 (382)
T 2vx3_A 132 CLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 210 (382)
T ss_dssp EEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCEE
T ss_pred EEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCcee
Confidence 999999965 9999987654 45899999999999999999999 57999999999999994 478899999999975
Q ss_pred hhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHH
Q 005427 212 RENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVL 291 (697)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~ 291 (697)
... ......||+.|+|||++.+..++.++|||||||++|||++|..||.+.........+.
T Consensus 211 ~~~-------------------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~ 271 (382)
T 2vx3_A 211 LGQ-------------------RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIV 271 (382)
T ss_dssp TTC-------------------CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred ccc-------------------ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 432 1235679999999999999999999999999999999999999999887766666555
Q ss_pred hccccHHHHHHH-------HHhC----C------------CCC-ccccc---------------------ccCChHHHHH
Q 005427 292 EMNYTEQQLTAA-------VVSG----G------------LRP-ILASL---------------------ELGLPASILS 326 (697)
Q Consensus 292 ~~~~~~~~~~~~-------~~~~----~------------~~~-~~~~~---------------------~~~~~~~l~~ 326 (697)
............ .... . +.+ ....+ ....++++.+
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 351 (382)
T 2vx3_A 272 EVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKD 351 (382)
T ss_dssp HHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHH
T ss_pred HHhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHH
Confidence 432211111000 0000 0 000 00000 0001247899
Q ss_pred HHHHhccCCCCCCCCHHHHHHHHHH
Q 005427 327 LIQRCWDGNPHNRPSFSDIALELDL 351 (697)
Q Consensus 327 li~~~l~~dP~~Rpt~~ell~~l~~ 351 (697)
||.+||+.||++|||+.|+++|.|+
T Consensus 352 li~~mL~~dP~~Rpta~e~L~hp~f 376 (382)
T 2vx3_A 352 LILRMLDYDPKTRIQPYYALQHSFF 376 (382)
T ss_dssp HHHHHTCSCTTTSCCHHHHTTSGGG
T ss_pred HHHHhcCCChhhCCCHHHHhcCccc
Confidence 9999999999999999999999886
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=353.03 Aligned_cols=256 Identities=18% Similarity=0.189 Sum_probs=209.9
Q ss_pred cCCCCCCCcccccccccCCceEEEEEE-------ECCeeEEEEeccCCChHHHHHHHHHHHHHHhcC---CCCceEEeec
Q 005427 60 PLHLPPSSYTLLSPIARGAESVVYEAT-------LDGRKVAVKKPILSTSEELDNFHKELQLLCKLD---HPGLAKFVAA 129 (697)
Q Consensus 60 ~~~~~~~~y~~~~~lg~G~~g~V~~~~-------~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~l~~~ 129 (697)
.+++..++|.+.++||+|+||.||+|. ..++.||+|+..... ...+..|+.+++.++ |+||+.++++
T Consensus 59 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~ 135 (365)
T 3e7e_A 59 EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSA 135 (365)
T ss_dssp EEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEE
T ss_pred eEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhhee
Confidence 355677899999999999999999993 267899999876544 345677888888886 9999999999
Q ss_pred cccCCceEEEEeecCCCCHhhhhhh----cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecC--------
Q 005427 130 HAKPPNYMFFFEFYESRNLAEKLHV----EEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDR-------- 197 (697)
Q Consensus 130 ~~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~-------- 197 (697)
+...+..++||||+++|+|.+++.. ....+++.+++.++.|++.||+|||++||+||||||+|||++.
T Consensus 136 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~ 215 (365)
T 3e7e_A 136 HLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDE 215 (365)
T ss_dssp EECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC---
T ss_pred eecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcccc
Confidence 9999999999999999999999975 3456899999999999999999999999999999999999988
Q ss_pred ---CCCCeeeeeccchhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhC
Q 005427 198 ---NLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTG 274 (697)
Q Consensus 198 ---~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g 274 (697)
++.+||+|||+++.+.... ........+||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 216 ~~~~~~~kl~DFG~a~~~~~~~--------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg 281 (365)
T 3e7e_A 216 DDLSAGLALIDLGQSIDMKLFP--------------KGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFG 281 (365)
T ss_dssp ---CTTEEECCCTTCEEGGGSC--------------TTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHS
T ss_pred ccccCCEEEeeCchhhhhhccC--------------CCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhC
Confidence 8999999999997554211 11123456899999999999999999999999999999999999
Q ss_pred CCCCCCchhHHHHHHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCC-CCHHHHHHHHHHHH
Q 005427 275 VVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNR-PSFSDIALELDLVL 353 (697)
Q Consensus 275 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-pt~~ell~~l~~~~ 353 (697)
..||........ . ....+.. ...++.+.+++..||+.+|.+| |++.++.+.+..++
T Consensus 282 ~~pf~~~~~~~~---------~------------~~~~~~~--~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l 338 (365)
T 3e7e_A 282 TYMKVKNEGGEC---------K------------PEGLFRR--LPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVF 338 (365)
T ss_dssp SCCCEEEETTEE---------E------------ECSCCTT--CSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHH
T ss_pred CCccccCCCCce---------e------------echhccc--cCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHH
Confidence 999965432110 0 0011111 1247788999999999999999 67888888888777
Q ss_pred HH
Q 005427 354 EH 355 (697)
Q Consensus 354 ~~ 355 (697)
+.
T Consensus 339 ~~ 340 (365)
T 3e7e_A 339 QQ 340 (365)
T ss_dssp HH
T ss_pred HH
Confidence 65
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=344.37 Aligned_cols=260 Identities=23% Similarity=0.326 Sum_probs=206.4
Q ss_pred CCCCCCCcccccccccCCceEEEEEEE-CCeeEEEEeccCC--ChHHHHHHHHHHHHHHhcC--CCCceEEeeccccCCc
Q 005427 61 LHLPPSSYTLLSPIARGAESVVYEATL-DGRKVAVKKPILS--TSEELDNFHKELQLLCKLD--HPGLAKFVAAHAKPPN 135 (697)
Q Consensus 61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--hpniv~l~~~~~~~~~ 135 (697)
+.+..++|++.+.||+|+||.||++.+ +++.||+|++... .....+.+.+|+.+++.++ ||||+++++++.....
T Consensus 23 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~ 102 (313)
T 3cek_A 23 MSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 102 (313)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSE
T ss_pred eeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCE
Confidence 455677899999999999999999987 5788999987543 3455678999999999997 5999999999999999
Q ss_pred eEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhh
Q 005427 136 YMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL 215 (697)
Q Consensus 136 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~ 215 (697)
++++|| +.+++|.+++.... .+++.+++.++.|++.||.|||+.||+||||||+|||++. +.+||+|||++......
T Consensus 103 ~~lv~e-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~ 179 (313)
T 3cek_A 103 IYMVME-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPD 179 (313)
T ss_dssp EEEEEC-CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-TEEEECCCSSSCC----
T ss_pred EEEEEe-cCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-CeEEEeeccccccccCc
Confidence 999999 66789999997654 7899999999999999999999999999999999999964 88999999999765421
Q ss_pred hhhhcccccCCCCCCCCccccccccCccccchhhhcc-----------cCCCchhhHHHHHHHHHHHHhCCCCCCCchhH
Q 005427 216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-----------EIHSEKSDVYSFGISINELLTGVVPYTDLRAE 284 (697)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~ 284 (697)
.. ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||......
T Consensus 180 ~~--------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 245 (313)
T 3cek_A 180 TT--------------SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ 245 (313)
T ss_dssp ------------------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH
T ss_pred cc--------------cccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH
Confidence 11 011234579999999999875 46889999999999999999999999764322
Q ss_pred HHHHHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 005427 285 AQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL 353 (697)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~ 353 (697)
... ........... ..+...+.++.++|.+||+.||.+|||+.|+++|+|...
T Consensus 246 ~~~-------------~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~ 298 (313)
T 3cek_A 246 ISK-------------LHAIIDPNHEI---EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 298 (313)
T ss_dssp HHH-------------HHHHHCTTSCC---CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHC
T ss_pred HHH-------------HHHHHhccccc---CCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccC
Confidence 111 01111111111 223456889999999999999999999999999998753
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=349.98 Aligned_cols=269 Identities=23% Similarity=0.296 Sum_probs=211.2
Q ss_pred CCCcccccccccCCceEEEEEEE---CCeeEEEEeccCCCh--HHHHHHHHHHHHHHhc---CCCCceEEeeccc-----
Q 005427 65 PSSYTLLSPIARGAESVVYEATL---DGRKVAVKKPILSTS--EELDNFHKELQLLCKL---DHPGLAKFVAAHA----- 131 (697)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~---~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~hpniv~l~~~~~----- 131 (697)
.++|++.+.||+|+||.||+|++ .++.||+|++..... .....+.+|+.+++.+ +||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~ 89 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 89 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccC
Confidence 36899999999999999999987 478899997653321 1123456777777766 8999999999987
Q ss_pred cCCceEEEEeecCCCCHhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccch
Q 005427 132 KPPNYMFFFEFYESRNLAEKLHVEE-WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAE 210 (697)
Q Consensus 132 ~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~ 210 (697)
....+++||||+. |+|.+++.... ..+++.+++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||++.
T Consensus 90 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~ 168 (326)
T 1blx_A 90 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 168 (326)
T ss_dssp SEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred CCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCcccc
Confidence 5678999999998 59999987643 348999999999999999999999999999999999999999999999999987
Q ss_pred hhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHH
Q 005427 211 YRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTV 290 (697)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~ 290 (697)
...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.........+
T Consensus 169 ~~~~~~-----------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i 231 (326)
T 1blx_A 169 IYSFQM-----------------ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKI 231 (326)
T ss_dssp CCCGGG-----------------GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred cccCCC-----------------CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence 554211 133457899999999999999999999999999999999999999987766555554
Q ss_pred HhccccH--HHHHH------HHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 005427 291 LEMNYTE--QQLTA------AVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL 351 (697)
Q Consensus 291 ~~~~~~~--~~~~~------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~ 351 (697)
....... ..+.. ..........+......++..+.+||.+||+.||.+|||+.++++|.|+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~ 300 (326)
T 1blx_A 232 LDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 300 (326)
T ss_dssp HHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGG
T ss_pred HHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccc
Confidence 4321100 00000 0000001112233446789999999999999999999999999988876
|
| >2j82_A TPPHA, protein serine-threonine phosphatase; PP2C family phosphatase, hydrolase; 1.28A {Synechococcus elongatus} PDB: 2j86_A 2y09_A 2xzv_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=326.65 Aligned_cols=231 Identities=22% Similarity=0.332 Sum_probs=180.9
Q ss_pred cceEeeeccCC-CCCCCceeEEcccccCCCceEEEEEecCCCChHHHHHHHHHhHHHHHhcCC------CCChHHHHHHH
Q 005427 429 LSWGSFATCGR-RETMEDTHFLMPHMYNQKEIHMFGIFDGHRGSAAAEFSARALPGFLQNLGS------TTRPTDALLEA 501 (697)
Q Consensus 429 ~~~~~~s~~G~-R~~neD~~~~~~~~~~~~~~~~~~V~DG~GG~~~~~~as~~~~~~l~~~~~------~~~~~~~l~~~ 501 (697)
|+++..|++|. |..|||++ +... ..+. +|+|||||||+.+|++||+.+++.+.+... ...+...+.++
T Consensus 1 ~~~~~~s~~G~~r~~neD~~-~~~~---~~~~-~~~V~DG~Gg~~~~~~as~~~~~~l~~~~~~~~~~~~~~~~~~l~~~ 75 (240)
T 2j82_A 1 MDVAGLTDCGLIRKSNQDAF-YIDE---KHQR-FFIVADGMGGHAGGEEASRLAVDHIRQYLETHLEDLQHDPVTLLRQA 75 (240)
T ss_dssp CEEEEEEECCSSCSSCCEEE-EECT---TTCC-EEEEEEBC---CHHHHHHHHHHHHHHHHHHHHHHHHTTSHHHHHHHH
T ss_pred CeEEEeCCCCCCCCcCCCcc-EecC---CCCe-EEEEEcCCCCchHHHHHHHHHHHHHHHHHHhcccccchhHHHHHHHH
Confidence 57899999999 99999999 6542 2345 999999999999999999999888865421 34566778888
Q ss_pred HHHHHHHHHHHHHHHHhhhhcccCCCCCCceEEEEEEe--cCeEEEEEcCCeEEEEEECCeeeecCCCCCCCCHHHHHHH
Q 005427 502 FIRTDVAFRNELDSLRKSKRVVQKDWHPGCTAIAALIV--RNRLFVANAGDCRAILCRGGHPFALSRDHVASCLEERERV 579 (697)
Q Consensus 502 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~GtT~~~~~i~--~~~l~~anvGDSr~~l~~~~~~~~lt~dH~~~~~~e~~ri 579 (697)
+..++..+..... .......||||++++++. +++++++|+||||+|++|+|++.+||+||++ .+++
T Consensus 76 ~~~~~~~l~~~~~-------~~~~~~~~gtT~~~~~i~~~~~~l~~anvGDsr~~l~r~~~~~~lt~dh~~-----~~~~ 143 (240)
T 2j82_A 76 FLAANHAIVEQQR-------QNSARADMGTTAVVILLDEKGDRAWCAHVGDSRIYRWRKDQLQQITSDHTW-----IAQA 143 (240)
T ss_dssp HHHHHHHHHHHHT-------TSCSCTTCCBCEEEEEECTTSSEEEEEEESSCEEEEEETTEEEECSCCCBH-----HHHC
T ss_pred HHHHHHHHHHHhh-------cccCCCCCCceEEEEEEEecCCEEEEEEEccCceEEEeCCEEEEECCCCcH-----HHHH
Confidence 8888887765421 112334589999999999 9999999999999999999999999999955 3446
Q ss_pred HHcCCeeeeccCcceeCCCcceeccccCCCCCCCCcccCCceEEEEeCCCCeEEEEEcCCcccCCChHHHHHHHHhhcCC
Q 005427 580 VSAGGNVNWQVDTWRVGPPALQVTRSIGDDDLKPAVTAEPEITETIMTPEDEYLVMASDGLWDVVSHVEAVGIIKDTVKE 659 (697)
Q Consensus 580 ~~~g~~~~~~~~~~~~~~~~~~ltralG~~~~k~~v~~~p~v~~~~l~~~d~~lvl~SDGl~d~~~~~ei~~~~~~~~~~ 659 (697)
.+.|+ +...+.+.+|+++.+||+||+.. .++|++..+.+.++| +||||||||||+++++++.+++. ..+
T Consensus 144 ~~~g~---i~~~~~~~~~~~~~ltralG~~~-----~~~p~~~~~~l~~gd-~lll~SDGl~d~l~~~~i~~~l~--~~~ 212 (240)
T 2j82_A 144 VQLGS---LTIEQARQHPWRHVLSQCLGRED-----LSQIDIQPIDLEPGD-RLLLCSDGLTEELTDDVISIYLS--EPN 212 (240)
T ss_dssp -------------------CCCBSCCBSCTT-----CCCCEEEEEECCTTC-EEEEECHHHHTTSCHHHHHHHHT--CSS
T ss_pred HHcCC---CCHHHHhcCCCcCeEeecCCCCC-----ceeEEEEEEeeCCCC-EEEEECCCCCCCCCHHHHHHHHc--cCC
Confidence 66675 45566778889999999999987 789999999999998 68899999999999999999998 458
Q ss_pred hhHHHHHHHHHHHhcCCCCCcEEEEEEe
Q 005427 660 PGMCSKRLATEAAERGSKDNITVIVVFL 687 (697)
Q Consensus 660 ~~~~a~~L~~~a~~~g~~DNiT~ivv~l 687 (697)
++++|+.|++.|+.+|+.||+|+||+++
T Consensus 213 ~~~~a~~l~~~a~~~g~~DniTvivv~~ 240 (240)
T 2j82_A 213 VQKAAAALVDAAKTHGGRDNVTVVVISV 240 (240)
T ss_dssp HHHHHHHHHHHHHHTTCCSCEEEEEEEC
T ss_pred HHHHHHHHHHHHHHcCCCCCeEEEEEeC
Confidence 9999999999999999999999999975
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-41 Score=354.35 Aligned_cols=270 Identities=18% Similarity=0.215 Sum_probs=198.5
Q ss_pred CCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCc-------
Q 005427 65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPN------- 135 (697)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~------- 135 (697)
.++|++.++||+|+||.||+|++ +++.||||++... ........+|+..++.++||||+++++++.....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 100 (360)
T 3e3p_A 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD-PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIY 100 (360)
T ss_dssp HTTEEEC----------CEEEEETTTCCEEEEEEEECC-TTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecC-ccccHHHHHHHHHHHhcCCCCcccHHHhhhcccccccccee
Confidence 36899999999999999999998 4889999976433 2223456778888999999999999999865433
Q ss_pred eEEEEeecCCCCHhhhhh---hcCCCCCHHHHHHHHHHHHHHHHHHH--hCCcccccCCCCceeecC-CCCCeeeeeccc
Q 005427 136 YMFFFEFYESRNLAEKLH---VEEWSPSVDQVLMIAAQLAKALQYLH--NLGIVHRDVKPANVLLDR-NLCPHLADFGLA 209 (697)
Q Consensus 136 ~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~~i~~qi~~~l~~LH--~~~ivHrDlkp~Nill~~-~~~~kL~Dfg~a 209 (697)
+++||||+.+ +|...+. .....+++..++.++.|++.||.||| +.||+||||||+|||++. ++.+||+|||++
T Consensus 101 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a 179 (360)
T 3e3p_A 101 LNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSA 179 (360)
T ss_dssp EEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTTC
T ss_pred EEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCCc
Confidence 7899999987 5544433 24447889999999999999999999 999999999999999996 899999999999
Q ss_pred hhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccC-CCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHH
Q 005427 210 EYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEI-HSEKSDVYSFGISINELLTGVVPYTDLRAEAQAH 288 (697)
Q Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~ 288 (697)
....... ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+........
T Consensus 180 ~~~~~~~-----------------~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~ 242 (360)
T 3e3p_A 180 KKLSPSE-----------------PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLH 242 (360)
T ss_dssp BCCCTTS-----------------CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred eecCCCC-----------------CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHH
Confidence 7554211 123457899999999987654 8999999999999999999999999887776666
Q ss_pred HHHhccccHHH-HHHHHHhCCCC------------CcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 005427 289 TVLEMNYTEQQ-LTAAVVSGGLR------------PILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL 353 (697)
Q Consensus 289 ~~~~~~~~~~~-~~~~~~~~~~~------------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~ 353 (697)
.+......... ........... ..++......++++.+||.+||+.||.+|||+.|+++|.|+..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 320 (360)
T 3e3p_A 243 EIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDE 320 (360)
T ss_dssp HHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGG
T ss_pred HHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccc
Confidence 65543222211 11111110000 0011122347889999999999999999999999999988753
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=342.39 Aligned_cols=266 Identities=26% Similarity=0.367 Sum_probs=201.4
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeecccc-----------
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAK----------- 132 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~----------- 132 (697)
++|++.+.||+|+||.||+|++ +++.||+|++.. .....+.+.+|+.+++.++||||+++++++.+
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAV 84 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE-EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-----
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec-cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccc
Confidence 4799999999999999999997 588999998643 34456789999999999999999999998754
Q ss_pred --CCceEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccch
Q 005427 133 --PPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAE 210 (697)
Q Consensus 133 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~ 210 (697)
....++||||+.+|+|.+++......+++.+++.++.|++.||+|||+.||+||||||+|||++.++.+||+|||++.
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~ 164 (303)
T 1zy4_A 85 KKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAK 164 (303)
T ss_dssp -CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCCCS
T ss_pred ccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCcchh
Confidence 456899999999999999998766678889999999999999999999999999999999999999999999999997
Q ss_pred hhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhccc-CCCchhhHHHHHHHHHHHHhCCCCCCCchhHH-HHH
Q 005427 211 YRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKE-IHSEKSDVYSFGISINELLTGVVPYTDLRAEA-QAH 288 (697)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~-~~~ 288 (697)
.......... ......+..........||+.|+|||++.+. .++.++|||||||++|+|++ ||....... ...
T Consensus 165 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~ 239 (303)
T 1zy4_A 165 NVHRSLDILK--LDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILK 239 (303)
T ss_dssp CTTC---------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHH
T ss_pred hcccccchhc--cccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHH
Confidence 6542211000 0000001111123456799999999999865 68999999999999999998 665432211 111
Q ss_pred HHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 289 TVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
.+ .. ......+..+...++.+.++|.+||+.||.+|||+.++++|.|..
T Consensus 240 ~~--------------~~-~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~ 288 (303)
T 1zy4_A 240 KL--------------RS-VSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLP 288 (303)
T ss_dssp HH--------------HS-TTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSC
T ss_pred hc--------------cc-cccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcC
Confidence 11 11 111222334456788999999999999999999999999988763
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=346.89 Aligned_cols=263 Identities=25% Similarity=0.361 Sum_probs=192.7
Q ss_pred cCCCCCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCC-hHHHHHHHHHHH-HHHhcCCCCceEEeeccccCCc
Q 005427 60 PLHLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST-SEELDNFHKELQ-LLCKLDHPGLAKFVAAHAKPPN 135 (697)
Q Consensus 60 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~-~l~~l~hpniv~l~~~~~~~~~ 135 (697)
.+.+..++|++.+.||+|+||.||+|.+ +++.||||++.... ......+..|+. +++.++||||+++++++..++.
T Consensus 16 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~ 95 (327)
T 3aln_A 16 HWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGD 95 (327)
T ss_dssp EECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSE
T ss_pred hcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCc
Confidence 4567788999999999999999999998 48999999876543 334455666666 7777899999999999999999
Q ss_pred eEEEEeecCCCCHhhhhhh----cCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccccCCCCceeecCCCCCeeeeeccch
Q 005427 136 YMFFFEFYESRNLAEKLHV----EEWSPSVDQVLMIAAQLAKALQYLHNL-GIVHRDVKPANVLLDRNLCPHLADFGLAE 210 (697)
Q Consensus 136 ~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~i~~qi~~~l~~LH~~-~ivHrDlkp~Nill~~~~~~kL~Dfg~a~ 210 (697)
.++||||+.+ +|.+++.. ....+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||++.
T Consensus 96 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~ 174 (327)
T 3aln_A 96 CWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISG 174 (327)
T ss_dssp EEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSC
T ss_pred eEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCce
Confidence 9999999986 88777653 244789999999999999999999999 99999999999999999999999999987
Q ss_pred hhhhhhhhhcccccCCCCCCCCccccccccCccccchhhh----cccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHH-
Q 005427 211 YRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEIL----KKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEA- 285 (697)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~- 285 (697)
...... ......||+.|+|||++ .+..++.++|||||||++|+|++|..||.+.....
T Consensus 175 ~~~~~~-----------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 237 (327)
T 3aln_A 175 QLVDSI-----------------AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD 237 (327)
T ss_dssp C-----------------------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-----
T ss_pred eccccc-----------------ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH
Confidence 554211 12234699999999998 46678999999999999999999999998643211
Q ss_pred HHHHHHhccccHHHHHHHHHhCCCCCcc-cccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 005427 286 QAHTVLEMNYTEQQLTAAVVSGGLRPIL-ASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH 355 (697)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~ 355 (697)
....+. .+..+.+ ......+++++.+||.+||+.||.+|||+.++++|+|.....
T Consensus 238 ~~~~~~---------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 293 (327)
T 3aln_A 238 QLTQVV---------------KGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYE 293 (327)
T ss_dssp --CCCC---------------CSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred HHHHHh---------------cCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhH
Confidence 111000 1111111 222346899999999999999999999999999999986543
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=348.54 Aligned_cols=267 Identities=21% Similarity=0.279 Sum_probs=208.0
Q ss_pred CCCcccccccccCCceEEEEEEE--CC-eeEEEEeccCCChHHHHHHHHHHHHHHhcCCCC------ceEEeeccccCCc
Q 005427 65 PSSYTLLSPIARGAESVVYEATL--DG-RKVAVKKPILSTSEELDNFHKELQLLCKLDHPG------LAKFVAAHAKPPN 135 (697)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~--~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn------iv~l~~~~~~~~~ 135 (697)
.++|++.+.||+|+||.||+|.+ ++ +.||+|++.. .....+.+.+|+.+++.++|++ ++.+++++.....
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~-~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRN-VGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS-CHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcc-cccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 57999999999999999999987 33 7899998753 3445677889999999997665 8999999999999
Q ss_pred eEEEEeecCCCCHhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceee-------------------
Q 005427 136 YMFFFEFYESRNLAEKLHVEE-WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLL------------------- 195 (697)
Q Consensus 136 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill------------------- 195 (697)
+++||||+ +++|.+.+.... ..+++.+++.++.||+.||.|||++||+||||||+|||+
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~ 175 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKS 175 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEE
T ss_pred EEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccccccc
Confidence 99999999 557777765543 468999999999999999999999999999999999999
Q ss_pred cCCCCCeeeeeccchhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCC
Q 005427 196 DRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGV 275 (697)
Q Consensus 196 ~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~ 275 (697)
+.++.+||+|||++..... ......||+.|+|||++.+..++.++|||||||++|+|++|.
T Consensus 176 ~~~~~~kl~Dfg~~~~~~~-------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~ 236 (355)
T 2eu9_A 176 VKNTSIRVADFGSATFDHE-------------------HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGF 236 (355)
T ss_dssp ESCCCEEECCCTTCEETTS-------------------CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred cCCCcEEEeecCccccccc-------------------cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCC
Confidence 5678999999999865321 123457999999999999999999999999999999999999
Q ss_pred CCCCCchhHHHHHHHHhccccHHH-HHHH----------------------HHhCCCCCccc--ccccCChHHHHHHHHH
Q 005427 276 VPYTDLRAEAQAHTVLEMNYTEQQ-LTAA----------------------VVSGGLRPILA--SLELGLPASILSLIQR 330 (697)
Q Consensus 276 ~Pf~~~~~~~~~~~~~~~~~~~~~-~~~~----------------------~~~~~~~~~~~--~~~~~~~~~l~~li~~ 330 (697)
.||.+.........+......... .... .......+... ......+.++.+||.+
T Consensus 237 ~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 316 (355)
T 2eu9_A 237 TLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRR 316 (355)
T ss_dssp CSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHH
Confidence 999887655544333222111100 0000 00000001000 0112246789999999
Q ss_pred hccCCCCCCCCHHHHHHHHHHH
Q 005427 331 CWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 331 ~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
||+.||.+|||+.|+++|.|+.
T Consensus 317 ~L~~dP~~Rpt~~e~l~hp~f~ 338 (355)
T 2eu9_A 317 MLEFDPAQRITLAEALLHPFFA 338 (355)
T ss_dssp HTCSSTTTSCCHHHHTTSGGGG
T ss_pred HhcCChhhCcCHHHHhcChhhc
Confidence 9999999999999999988764
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=357.76 Aligned_cols=271 Identities=19% Similarity=0.248 Sum_probs=189.1
Q ss_pred CCccc-ccccccCCceEEEEEEEC----CeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeecc--ccCCceEE
Q 005427 66 SSYTL-LSPIARGAESVVYEATLD----GRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAH--AKPPNYMF 138 (697)
Q Consensus 66 ~~y~~-~~~lg~G~~g~V~~~~~~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~--~~~~~~~l 138 (697)
+.|.+ .++||+|+||.||+|++. ++.||+|++.... ....+.+|+.+|+.++||||+++++++ .....+++
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l 97 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWL 97 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence 35776 458999999999999863 6789999875432 234678999999999999999999999 45778999
Q ss_pred EEeecCCCCHhhhhhhc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceee----cCCCCCeeeee
Q 005427 139 FFEFYESRNLAEKLHVE--------EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLL----DRNLCPHLADF 206 (697)
Q Consensus 139 v~e~~~~g~L~~~l~~~--------~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill----~~~~~~kL~Df 206 (697)
||||+.+ +|.+++... ...+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+||
T Consensus 98 v~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Df 176 (405)
T 3rgf_A 98 LFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADM 176 (405)
T ss_dssp EEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCT
T ss_pred EEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEEC
Confidence 9999975 888777532 1248999999999999999999999999999999999999 67789999999
Q ss_pred ccchhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcc-cCCCchhhHHHHHHHHHHHHhCCCCCCCchhH-
Q 005427 207 GLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLTGVVPYTDLRAE- 284 (697)
Q Consensus 207 g~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~- 284 (697)
|+++....... ........+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+....
T Consensus 177 g~a~~~~~~~~-------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~ 243 (405)
T 3rgf_A 177 GFARLFNSPLK-------------PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI 243 (405)
T ss_dssp TCCC-----------------------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC---
T ss_pred CCceecCCCCc-------------ccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccc
Confidence 99976543110 0012345689999999999987 45899999999999999999999999765432
Q ss_pred --------HHHHHHHhccccH--------------HHHHHHHHhCCCCC-----cccccccCChHHHHHHHHHhccCCCC
Q 005427 285 --------AQAHTVLEMNYTE--------------QQLTAAVVSGGLRP-----ILASLELGLPASILSLIQRCWDGNPH 337 (697)
Q Consensus 285 --------~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~-----~~~~~~~~~~~~l~~li~~~l~~dP~ 337 (697)
.....+....... ...........+.. .+.......++.+.+||.+||+.||.
T Consensus 244 ~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~ 323 (405)
T 3rgf_A 244 KTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPI 323 (405)
T ss_dssp ---CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGG
T ss_pred cccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcc
Confidence 1222221110000 00000000000000 00001123477899999999999999
Q ss_pred CCCCHHHHHHHHHHH
Q 005427 338 NRPSFSDIALELDLV 352 (697)
Q Consensus 338 ~Rpt~~ell~~l~~~ 352 (697)
+|||++|+++|.|+.
T Consensus 324 ~R~ta~e~L~hp~f~ 338 (405)
T 3rgf_A 324 KRITSEQAMQDPYFL 338 (405)
T ss_dssp GSCCHHHHHTSGGGT
T ss_pred cCCCHHHHhcChhhc
Confidence 999999999999985
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=339.90 Aligned_cols=258 Identities=25% Similarity=0.358 Sum_probs=192.6
Q ss_pred CCCCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCCh-HH-HHHHHHHHHHHHhcCCCCceEEeeccccCCceE
Q 005427 62 HLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTS-EE-LDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYM 137 (697)
Q Consensus 62 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~-~~-~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 137 (697)
.+..++|++.+.||+|+||.||+|.+ +++.||||++..... .. .+.+..+..+++.++||||+++++++.++..++
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 100 (318)
T 2dyl_A 21 QAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVF 100 (318)
T ss_dssp ECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred hhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEE
Confidence 34456899999999999999999998 588999998765432 22 334555556788889999999999999999999
Q ss_pred EEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccccCCCCceeecCCCCCeeeeeccchhhhhhh
Q 005427 138 FFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL-GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLK 216 (697)
Q Consensus 138 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~ 216 (697)
+||||+ ++.+..+.......+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||++.......
T Consensus 101 lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (318)
T 2dyl_A 101 IAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK 179 (318)
T ss_dssp EEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred EEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc
Confidence 999999 5566666655556789999999999999999999995 99999999999999999999999999986554211
Q ss_pred hhhcccccCCCCCCCCccccccccCccccchhhhc-----ccCCCchhhHHHHHHHHHHHHhCCCCCCCchhH-HHHHHH
Q 005427 217 EISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILK-----KEIHSEKSDVYSFGISINELLTGVVPYTDLRAE-AQAHTV 290 (697)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~-~~~~~~ 290 (697)
......||+.|+|||++. +..++.++|||||||++|+|++|..||...... .....+
T Consensus 180 -----------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~ 242 (318)
T 2dyl_A 180 -----------------AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKV 242 (318)
T ss_dssp ------------------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHH
T ss_pred -----------------cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHH
Confidence 123456899999999994 556889999999999999999999999864322 222222
Q ss_pred HhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 005427 291 LEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL 353 (697)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~ 353 (697)
.. + ..+.++ ....+++++.+||.+||+.||.+|||+.++++|.|...
T Consensus 243 ~~--------------~-~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (318)
T 2dyl_A 243 LQ--------------E-EPPLLP-GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKR 289 (318)
T ss_dssp HH--------------S-CCCCCC-SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHH
T ss_pred hc--------------c-CCCCCC-ccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHh
Confidence 11 1 111111 12368999999999999999999999999999988753
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=352.64 Aligned_cols=271 Identities=22% Similarity=0.270 Sum_probs=205.2
Q ss_pred CCCCCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCChHHHHHHHHHHHHHHhcC-----------CCCceEEe
Q 005427 61 LHLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLD-----------HPGLAKFV 127 (697)
Q Consensus 61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------hpniv~l~ 127 (697)
..+..++|++.+.||+|+||.||+|++ +++.||||++.. .....+.+.+|+.+++.++ ||||++++
T Consensus 14 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~ 92 (373)
T 1q8y_A 14 EPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL 92 (373)
T ss_dssp CEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS-CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCC
T ss_pred CcccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC-CccchhhhhHHHHHHHHhhcccccchhccccchHHHHH
Confidence 344567999999999999999999997 688999998753 3345677889999999886 89999999
Q ss_pred eccccCC----ceEEEEeecCCCCHhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhC-CcccccCCCCceeec-----
Q 005427 128 AAHAKPP----NYMFFFEFYESRNLAEKLHVE-EWSPSVDQVLMIAAQLAKALQYLHNL-GIVHRDVKPANVLLD----- 196 (697)
Q Consensus 128 ~~~~~~~----~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~-~ivHrDlkp~Nill~----- 196 (697)
+++.... .++++||++ +++|.+++... ...+++..++.++.||+.||+|||++ ||+||||||+|||++
T Consensus 93 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 93 DHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETT
T ss_pred HHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCC
Confidence 9987654 789999999 88999998763 34589999999999999999999998 999999999999994
Q ss_pred -CCCCCeeeeeccchhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCC
Q 005427 197 -RNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGV 275 (697)
Q Consensus 197 -~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~ 275 (697)
..+.+||+|||++..... ......||+.|+|||++.+..++.++|||||||++|+|++|.
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~-------------------~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~ 232 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDE-------------------HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232 (373)
T ss_dssp TTEEEEEECCCTTCEETTB-------------------CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred cCcceEEEcccccccccCC-------------------CCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCC
Confidence 344799999999975432 123457899999999999999999999999999999999999
Q ss_pred CCCCCchh------HHHHHHHHhccccHHHHHHH-------HHh--CCCCCc--------------ccccccCChHHHHH
Q 005427 276 VPYTDLRA------EAQAHTVLEMNYTEQQLTAA-------VVS--GGLRPI--------------LASLELGLPASILS 326 (697)
Q Consensus 276 ~Pf~~~~~------~~~~~~~~~~~~~~~~~~~~-------~~~--~~~~~~--------------~~~~~~~~~~~l~~ 326 (697)
.||.+... ......+............. ... +..+.. ....+..++.++.+
T Consensus 233 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (373)
T 1q8y_A 233 FLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISD 312 (373)
T ss_dssp CCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHH
T ss_pred CCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHH
Confidence 99986532 11122221111100000000 000 000000 00112346788999
Q ss_pred HHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 327 LIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 327 li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
||.+||+.||.+|||+.|+++|.|+.
T Consensus 313 li~~~L~~dP~~Rpt~~ell~hp~f~ 338 (373)
T 1q8y_A 313 FLSPMLQLDPRKRADAGGLVNHPWLK 338 (373)
T ss_dssp HHGGGGCSSTTTCBCHHHHHTCGGGT
T ss_pred HHHHHhccCccccCCHHHHhhChhhh
Confidence 99999999999999999999998874
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=346.01 Aligned_cols=256 Identities=21% Similarity=0.256 Sum_probs=179.8
Q ss_pred CCCccccc-ccccCCceEEEEEEE--CCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeecccc----CCceE
Q 005427 65 PSSYTLLS-PIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAK----PPNYM 137 (697)
Q Consensus 65 ~~~y~~~~-~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~----~~~~~ 137 (697)
.++|.+.+ .||+|+||.||+|.+ +++.||||++... .. ........++.++||||+++++++.. ...++
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~---~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 102 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-PK---ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL 102 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-HH---HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-HH---HHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence 46899965 699999999999998 4889999986542 11 12223344677799999999999876 44589
Q ss_pred EEEeecCCCCHhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecC---CCCCeeeeeccchhhh
Q 005427 138 FFFEFYESRNLAEKLHVEE-WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDR---NLCPHLADFGLAEYRE 213 (697)
Q Consensus 138 lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~---~~~~kL~Dfg~a~~~~ 213 (697)
+||||+.+|+|.+++.... ..+++.+++.++.|++.||.|||+.||+||||||+|||++. ++.+||+|||++....
T Consensus 103 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~ 182 (336)
T 3fhr_A 103 IIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT 182 (336)
T ss_dssp EEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC-
T ss_pred EEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceecc
Confidence 9999999999999997654 36899999999999999999999999999999999999976 4559999999986543
Q ss_pred hhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhc
Q 005427 214 NLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEM 293 (697)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~ 293 (697)
.. ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+............
T Consensus 183 ~~------------------~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~- 243 (336)
T 3fhr_A 183 QN------------------ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKR- 243 (336)
T ss_dssp ---------------------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------
T ss_pred cc------------------ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHH-
Confidence 21 12345789999999999888899999999999999999999999976543322111100
Q ss_pred cccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 005427 294 NYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL 353 (697)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~ 353 (697)
...... ..........+++++.+||.+||+.||.+|||+.|+++|+|+..
T Consensus 244 ---------~~~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 293 (336)
T 3fhr_A 244 ---------RIRLGQ-YGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQ 293 (336)
T ss_dssp -----------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred ---------hhhccc-cccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccc
Confidence 000000 01111123468999999999999999999999999999999864
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-41 Score=348.03 Aligned_cols=247 Identities=22% Similarity=0.340 Sum_probs=205.7
Q ss_pred CCCCCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCCh------HHHHHHHHHHHHHHhcC--CCCceEEeecc
Q 005427 61 LHLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTS------EELDNFHKELQLLCKLD--HPGLAKFVAAH 130 (697)
Q Consensus 61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--hpniv~l~~~~ 130 (697)
.....++|++.+.||+|+||.||+|.+ +++.||||++..... .....+.+|+.+++.++ ||||+++++++
T Consensus 38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~ 117 (320)
T 3a99_A 38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF 117 (320)
T ss_dssp --CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred cCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE
Confidence 344567899999999999999999987 688999998654321 12245678999999996 59999999999
Q ss_pred ccCCceEEEEeecCC-CCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeec-CCCCCeeeeecc
Q 005427 131 AKPPNYMFFFEFYES-RNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLD-RNLCPHLADFGL 208 (697)
Q Consensus 131 ~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~-~~~~~kL~Dfg~ 208 (697)
..+..+++|||++.+ ++|.+++.... .+++..++.++.|++.||+|||+.||+||||||+|||++ .++.+||+|||+
T Consensus 118 ~~~~~~~lv~e~~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~ 196 (320)
T 3a99_A 118 ERPDSFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGS 196 (320)
T ss_dssp ECSSEEEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTT
T ss_pred ecCCcEEEEEEcCCCCccHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCcc
Confidence 999999999999986 89999987654 789999999999999999999999999999999999998 788999999999
Q ss_pred chhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCC-CchhhHHHHHHHHHHHHhCCCCCCCchhHHHH
Q 005427 209 AEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIH-SEKSDVYSFGISINELLTGVVPYTDLRAEAQA 287 (697)
Q Consensus 209 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~ 287 (697)
+...... ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||......
T Consensus 197 ~~~~~~~------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~--- 255 (320)
T 3a99_A 197 GALLKDT------------------VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI--- 255 (320)
T ss_dssp CEECCSS------------------CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH---
T ss_pred ccccccc------------------cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhh---
Confidence 8754321 1234579999999999987665 68899999999999999999999764211
Q ss_pred HHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 005427 288 HTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL 351 (697)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~ 351 (697)
.. .. ...+..+++++.+||.+||+.||.+|||+.++++|.|+
T Consensus 256 ---~~--------------~~-----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~ 297 (320)
T 3a99_A 256 ---IR--------------GQ-----VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 297 (320)
T ss_dssp ---HH--------------CC-----CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred ---hc--------------cc-----ccccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhh
Confidence 00 10 01234689999999999999999999999999988775
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=343.54 Aligned_cols=248 Identities=24% Similarity=0.396 Sum_probs=198.1
Q ss_pred CCCCCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCCh------HHHHHHHHHHHHHHhc----CCCCceEEee
Q 005427 61 LHLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTS------EELDNFHKELQLLCKL----DHPGLAKFVA 128 (697)
Q Consensus 61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l----~hpniv~l~~ 128 (697)
.+...++|++.+.||+|+||.||+|.+ +++.||||++..... .....+.+|+.+++++ +||||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 344567899999999999999999987 678999998755432 1234566799999999 8999999999
Q ss_pred ccccCCceEEEEee-cCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeec-CCCCCeeeee
Q 005427 129 AHAKPPNYMFFFEF-YESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLD-RNLCPHLADF 206 (697)
Q Consensus 129 ~~~~~~~~~lv~e~-~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~-~~~~~kL~Df 206 (697)
++......++|||+ +.+++|.+++.... .+++..++.++.|++.||.|||+.||+||||||+||+++ .++.+||+||
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~df 184 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITEKG-PLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDF 184 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCC
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEc
Confidence 99999999999999 78899999997654 689999999999999999999999999999999999998 7899999999
Q ss_pred ccchhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCC-CchhhHHHHHHHHHHHHhCCCCCCCchhHH
Q 005427 207 GLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIH-SEKSDVYSFGISINELLTGVVPYTDLRAEA 285 (697)
Q Consensus 207 g~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~~l~ell~g~~Pf~~~~~~~ 285 (697)
|++...... ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||......
T Consensus 185 g~~~~~~~~------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~- 245 (312)
T 2iwi_A 185 GSGALLHDE------------------PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEI- 245 (312)
T ss_dssp SSCEECCSS------------------CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH-
T ss_pred chhhhcccC------------------cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHH-
Confidence 998754321 1234569999999999987665 45899999999999999999999763211
Q ss_pred HHHHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 286 QAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
.. .. ...+..++.++.++|.+||+.||++|||+.|+++|.|..
T Consensus 246 -----~~--------------~~-----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~ 288 (312)
T 2iwi_A 246 -----LE--------------AE-----LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQ 288 (312)
T ss_dssp -----HH--------------TC-----CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTC
T ss_pred -----hh--------------hc-----cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhc
Confidence 10 00 112356889999999999999999999999999987764
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=354.91 Aligned_cols=258 Identities=23% Similarity=0.321 Sum_probs=196.6
Q ss_pred CCCCCCCcccccccccCCceEE-EEEEECCeeEEEEeccCCChHHHHHHHHHHHHHHhc-CCCCceEEeeccccCCceEE
Q 005427 61 LHLPPSSYTLLSPIARGAESVV-YEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKL-DHPGLAKFVAAHAKPPNYMF 138 (697)
Q Consensus 61 ~~~~~~~y~~~~~lg~G~~g~V-~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~l 138 (697)
+.+...+|.+.+.||+|+||+| |++..+++.||||++..... ..+.+|+.+|+.+ +||||+++++++.+....++
T Consensus 19 ~~i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~l 95 (432)
T 3p23_A 19 VIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYI 95 (432)
T ss_dssp EEETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEE
T ss_pred EEEccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEE
Confidence 3455567999999999999985 55566899999998754322 2356899999999 79999999999999999999
Q ss_pred EEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecC---C--CCCeeeeeccchhhh
Q 005427 139 FFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDR---N--LCPHLADFGLAEYRE 213 (697)
Q Consensus 139 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~---~--~~~kL~Dfg~a~~~~ 213 (697)
|||||. |+|.+++......+++.+++.++.||+.||.|||+.||+||||||+|||++. + ..+||+|||+++...
T Consensus 96 v~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~ 174 (432)
T 3p23_A 96 AIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA 174 (432)
T ss_dssp EEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-
T ss_pred EEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeecc
Confidence 999997 5999999877666666678899999999999999999999999999999943 2 357799999997654
Q ss_pred hhhhhhcccccCCCCCCCCccccccccCccccchhhhc---ccCCCchhhHHHHHHHHHHHHh-CCCCCCCchhHHHHHH
Q 005427 214 NLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILK---KEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHT 289 (697)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~~l~ell~-g~~Pf~~~~~~~~~~~ 289 (697)
.... ........+||+.|+|||++. ...++.++|||||||++|||++ |..||...........
T Consensus 175 ~~~~-------------~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~ 241 (432)
T 3p23_A 175 VGRH-------------SFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANIL 241 (432)
T ss_dssp ------------------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHH
T ss_pred CCCc-------------ceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHH
Confidence 3111 001234567999999999997 4567889999999999999999 9999975433221111
Q ss_pred HHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 005427 290 VLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL 351 (697)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~ 351 (697)
. ..........+...+..+.+||.+||+.||.+|||+.++++|+|+
T Consensus 242 ~----------------~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f 287 (432)
T 3p23_A 242 L----------------GACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFF 287 (432)
T ss_dssp T----------------TCCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTT
T ss_pred h----------------ccCCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccc
Confidence 0 110110011122346678999999999999999999999998876
|
| >2jfr_A Ser-Thr phosphatase MSPP; hydrolase, PPM phosphatase, manganese, phosphate; 0.83A {Mycobacterium smegmatis} PDB: 2jfs_A 2jft_A 2v06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-39 Score=316.91 Aligned_cols=225 Identities=25% Similarity=0.315 Sum_probs=184.8
Q ss_pred cccceEeeeccCC-CCCCCceeEEcccccCCCceEEEEEecCCCChHHHHHHHHHhHHHHHhcCC-CCChHHHHHHHHHH
Q 005427 427 PVLSWGSFATCGR-RETMEDTHFLMPHMYNQKEIHMFGIFDGHRGSAAAEFSARALPGFLQNLGS-TTRPTDALLEAFIR 504 (697)
Q Consensus 427 ~~~~~~~~s~~G~-R~~neD~~~~~~~~~~~~~~~~~~V~DG~GG~~~~~~as~~~~~~l~~~~~-~~~~~~~l~~~~~~ 504 (697)
..+.++..|++|. |..|||++++ +..+|+|||||||+ |+.||+.+.+.+.+... ..+ ...+.+++..
T Consensus 4 ~~~~~~~~s~~G~~r~~neD~~~~--------~~~~~~V~DG~Gg~--G~~as~~~~~~l~~~~~~~~~-~~~l~~~~~~ 72 (234)
T 2jfr_A 4 SVLSAATATDQGPVRENNQDACLA--------DGILYAVADGFGAR--GHHASATALKTLSAGFAAAPD-RDGLLEAVQQ 72 (234)
T ss_dssp SEEEEEEEEECCSSCSSCCEEEEE--------ETTEEEEEEEESTT--HHHHHHHHHHHHHHHHHHSCS-HHHHHHHHHH
T ss_pred eeEEEEEecCCCCCCCcCCCccee--------CCcEEEEEeCCCcc--HHHHHHHHHHHHHHHHhcCCc-HHHHHHHHHH
Confidence 3578999999999 9999999966 24599999999988 55555555444433211 112 6778888888
Q ss_pred HHHHHHHHHHHHHhhhhcccCCCCCCceEEEEEEecCe---EEEEEcCCeEEEEEECCeeeecCCCCCCCCHHHHHHHHH
Q 005427 505 TDVAFRNELDSLRKSKRVVQKDWHPGCTAIAALIVRNR---LFVANAGDCRAILCRGGHPFALSRDHVASCLEERERVVS 581 (697)
Q Consensus 505 ~~~~~~~~~~~~~~~~~~~~~~~~~GtT~~~~~i~~~~---l~~anvGDSr~~l~~~~~~~~lt~dH~~~~~~e~~ri~~ 581 (697)
++..+...... ... .+|||++++++.+++ ++++|+||||+|++|++++.+||+||++ .+++.+
T Consensus 73 ~~~~l~~~~~~-------~~~--~~gtT~~~~~i~~~~~~~l~~anvGDsr~~l~r~g~~~~lt~dh~~-----~~~~~~ 138 (234)
T 2jfr_A 73 ANLRVFELLGD-------EPT--VSGTTLTAVAVFEPGQGGPLVVNIGDSPLYRIRDGHMEQLTDDHSV-----AGELVR 138 (234)
T ss_dssp HHHHHHHHHTT-------SSS--CCEECEEEEECCCGGGTSCEEEEESSCCEEEEETTEEEECSCCCBH-----HHHHHH
T ss_pred HHHHHHHhhcc-------CCC--CCCccEEEEEEECCCccEEEEEEEccCceEEEECCEEEEeCCCCCH-----HHHHHH
Confidence 88777654211 111 179999999999998 9999999999999999999999999954 446777
Q ss_pred cCCeeeeccCcceeCCCcceeccccCCCCCCCCcccCCceEEEEeCCCCeEEEEEcCCcccCCChHHHHHHHHhhcCChh
Q 005427 582 AGGNVNWQVDTWRVGPPALQVTRSIGDDDLKPAVTAEPEITETIMTPEDEYLVMASDGLWDVVSHVEAVGIIKDTVKEPG 661 (697)
Q Consensus 582 ~g~~~~~~~~~~~~~~~~~~ltralG~~~~k~~v~~~p~v~~~~l~~~d~~lvl~SDGl~d~~~~~ei~~~~~~~~~~~~ 661 (697)
.|. ++..+.+.+|+++.+||+||+.. .++|++..+++.++| +||||||||||+++++++.+++ . ..+++
T Consensus 139 ~g~---i~~~~~~~~~~~~~~tralG~~~-----~~~~~~~~~~l~~gd-~lll~SDGl~d~~~~~~i~~~~-~-~~~~~ 207 (234)
T 2jfr_A 139 MGE---ITRHEARWHPQRHLLTRALGIGP-----HIGPDVFGIDCGPGD-RLLISSDGLFAAADEALIVDAA-T-SPDPQ 207 (234)
T ss_dssp TTS---SCHHHHTTCTTTTCBSCCBSSSS-----CCCCEEEECCCCTTC-EEEEECGGGGTTSCHHHHHHHH-T-CSSHH
T ss_pred cCC---CCHHHHhcCcccceeeecCcCCC-----CceeEEEEEecCCCC-EEEEECCCCccccCHHHHHHHH-c-cCCHH
Confidence 776 45566778889999999999987 789999999999998 6789999999999999999999 4 34899
Q ss_pred HHHHHHHHHHHhcCCCCCcEEEEEEe
Q 005427 662 MCSKRLATEAAERGSKDNITVIVVFL 687 (697)
Q Consensus 662 ~~a~~L~~~a~~~g~~DNiT~ivv~l 687 (697)
++|+.|++.|+.+++.||+|+|+|++
T Consensus 208 ~~a~~l~~~a~~~g~~DniTvivv~~ 233 (234)
T 2jfr_A 208 VAVRRLVEVANDAGGSDNTTVVVIDL 233 (234)
T ss_dssp HHHHHHHHHHHHTTCCSCEEEEEEEE
T ss_pred HHHHHHHHHHHHcCCCCCeEEEEEEe
Confidence 99999999999999999999999987
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=367.47 Aligned_cols=270 Identities=21% Similarity=0.271 Sum_probs=205.2
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccCC-ChHHHHHHHHHHHHHHhcCCCCceEEeecccc------CCce
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS-TSEELDNFHKELQLLCKLDHPGLAKFVAAHAK------PPNY 136 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~------~~~~ 136 (697)
++|++.++||+|+||.||+|.+ +++.||||++... .....+.+.+|+.+|+.++||||+++++++.. ....
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 6899999999999999999987 5889999986654 34556789999999999999999999998766 6778
Q ss_pred EEEEeecCCCCHhhhhhhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCC---Ceeeeeccchh
Q 005427 137 MFFFEFYESRNLAEKLHVEEW--SPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLC---PHLADFGLAEY 211 (697)
Q Consensus 137 ~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~---~kL~Dfg~a~~ 211 (697)
++||||+.+|+|.+++..... .+++..++.++.|++.||.|||+.||+||||||+|||++.++. +||+|||++..
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~ 173 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE 173 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCCB
T ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccccccc
Confidence 999999999999999976432 5788999999999999999999999999999999999987665 89999999975
Q ss_pred hhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHH
Q 005427 212 RENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVL 291 (697)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~ 291 (697)
.... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+...........
T Consensus 174 ~~~~-----------------~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i 236 (676)
T 3qa8_A 174 LDQG-----------------ELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKV 236 (676)
T ss_dssp TTSC-----------------CCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTC
T ss_pred cccc-----------------cccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhh
Confidence 5321 11244679999999999999999999999999999999999999997653332211111
Q ss_pred hccccHHHHHHHHHh-----CCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 292 EMNYTEQQLTAAVVS-----GGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 292 ~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
............... ....+.....+..+++.+.++|..||..||.+|||+.++++|.|+.
T Consensus 237 ~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~ 302 (676)
T 3qa8_A 237 REKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQ 302 (676)
T ss_dssp C------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHH
T ss_pred hcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHH
Confidence 000000000000000 0011112223445789999999999999999999999988777653
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=348.86 Aligned_cols=256 Identities=23% Similarity=0.338 Sum_probs=190.6
Q ss_pred CCcccccccccCCceEEEEE-EECCeeEEEEeccCCChHHHHHHHHHHHHHHhc-CCCCceEEeeccccCCceEEEEeec
Q 005427 66 SSYTLLSPIARGAESVVYEA-TLDGRKVAVKKPILSTSEELDNFHKELQLLCKL-DHPGLAKFVAAHAKPPNYMFFFEFY 143 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv~e~~ 143 (697)
+.|.+.+.||+|+||+||.+ ..+++.||||++... ..+.+.+|+.+|+.+ +||||+++++++.+...+++|||||
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 45777889999999999755 447899999986543 235678999999876 8999999999999999999999999
Q ss_pred CCCCHhhhhhhcCCCC------CHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCC-------------CCCeee
Q 005427 144 ESRNLAEKLHVEEWSP------SVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRN-------------LCPHLA 204 (697)
Q Consensus 144 ~~g~L~~~l~~~~~~~------~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~-------------~~~kL~ 204 (697)
. |+|.+++....... ++..++.++.||+.||+|||+.||+||||||+|||++.+ +.+||+
T Consensus 92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~ 170 (434)
T 2rio_A 92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILIS 170 (434)
T ss_dssp S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEEC
T ss_pred C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEEEc
Confidence 6 59999997654211 223457899999999999999999999999999999754 479999
Q ss_pred eeccchhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcc-------cCCCchhhHHHHHHHHHHHHh-CCC
Q 005427 205 DFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-------EIHSEKSDVYSFGISINELLT-GVV 276 (697)
Q Consensus 205 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~~l~ell~-g~~ 276 (697)
|||++......... .........||+.|+|||++.+ ..++.++|||||||++|||++ |..
T Consensus 171 DFG~a~~~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~ 238 (434)
T 2rio_A 171 DFGLCKKLDSGQSS------------FRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238 (434)
T ss_dssp CCTTCEECCC--------------------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCC
T ss_pred ccccceecCCCCcc------------ceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCC
Confidence 99999765431110 0011234579999999999976 668999999999999999999 999
Q ss_pred CCCCchhHHHHHHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 005427 277 PYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL 351 (697)
Q Consensus 277 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~ 351 (697)
||.+..... ..+...... ........+..+++++.+||.+||+.||.+|||+.++++|+|+
T Consensus 239 Pf~~~~~~~--~~i~~~~~~------------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f 299 (434)
T 2rio_A 239 PFGDKYSRE--SNIIRGIFS------------LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF 299 (434)
T ss_dssp TTCSTTTHH--HHHHHTCCC------------CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred CCCCchhhH--HHHhcCCCC------------cccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCcc
Confidence 997653322 111111110 0000001122467899999999999999999999999998876
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=321.08 Aligned_cols=234 Identities=18% Similarity=0.162 Sum_probs=191.3
Q ss_pred CCCCCcccccccccCCceEEEEEEEC--CeeEEEEeccCCC---hHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceE
Q 005427 63 LPPSSYTLLSPIARGAESVVYEATLD--GRKVAVKKPILST---SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYM 137 (697)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 137 (697)
+..++|++.+.||+|+||.||+|++. ++.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 107 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL 107 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence 44578999999999999999999984 8999999876542 344678999999999999999999999999999999
Q ss_pred EEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhh
Q 005427 138 FFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKE 217 (697)
Q Consensus 138 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~ 217 (697)
+||||+.|++|.+++... ....++..++.|++.||+|||++||+||||||+|||++.++.+||+++|
T Consensus 108 lv~e~~~g~~L~~~l~~~---~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~---------- 174 (286)
T 3uqc_A 108 VVAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA---------- 174 (286)
T ss_dssp EEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC----------
T ss_pred EEEEecCCCCHHHHHhcC---CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc----------
Confidence 999999999999998542 4667889999999999999999999999999999999999999998554
Q ss_pred hhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccH
Q 005427 218 ISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTE 297 (697)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~ 297 (697)
|++ +++.++|||||||++|+|++|..||.+..............
T Consensus 175 --------------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~--- 218 (286)
T 3uqc_A 175 --------------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDT--- 218 (286)
T ss_dssp --------------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCT---
T ss_pred --------------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHh---
Confidence 222 36889999999999999999999998754322110000000
Q ss_pred HHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 005427 298 QQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH 355 (697)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~ 355 (697)
....+........+|+++.+||.+||+.||.+| |+.++++.|..+...
T Consensus 219 ---------~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~ 266 (286)
T 3uqc_A 219 ---------AGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAV 266 (286)
T ss_dssp ---------TSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred ---------ccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence 000111223346789999999999999999999 999999999887643
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=342.62 Aligned_cols=248 Identities=17% Similarity=0.160 Sum_probs=192.2
Q ss_pred CCCCCcccccccccCCceEEEEEEECCeeEEEEeccCCC--------hHHHHHHHHHHHHHHhcC---------CCCceE
Q 005427 63 LPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILST--------SEELDNFHKELQLLCKLD---------HPGLAK 125 (697)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---------hpniv~ 125 (697)
+..++|++.++||+|+||+||+|+++++.||||++.... ....+.+.+|+.+|+.++ ||||++
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 455789999999999999999999999999999876542 223477889999999886 555555
Q ss_pred E-----------------eecccc-------------CCceEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHH
Q 005427 126 F-----------------VAAHAK-------------PPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKAL 175 (697)
Q Consensus 126 l-----------------~~~~~~-------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l 175 (697)
+ ++++.+ ...+++||||+.+|++.+.+.. ..+++.+++.++.||+.||
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHH
Confidence 4 444443 7889999999999987777644 3689999999999999999
Q ss_pred HHHH-hCCcccccCCCCceeecCCC--------------------CCeeeeeccchhhhhhhhhhcccccCCCCCCCCcc
Q 005427 176 QYLH-NLGIVHRDVKPANVLLDRNL--------------------CPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFH 234 (697)
Q Consensus 176 ~~LH-~~~ivHrDlkp~Nill~~~~--------------------~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (697)
+||| +.||+||||||+|||++.++ .+||+|||+++....
T Consensus 175 ~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------------------- 234 (336)
T 2vuw_A 175 AVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------------------- 234 (336)
T ss_dssp HHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET--------------------
T ss_pred HHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC--------------------
Confidence 9999 99999999999999999887 899999999976542
Q ss_pred ccccccCccccchhhhcccCCCchhhHHHHHHH-HHHHHhCCCCCCCchh-HHHHHHHHhccccHHHHHHHHHhCCCCCc
Q 005427 235 KKNMVGTLIYMAPEILKKEIHSEKSDVYSFGIS-INELLTGVVPYTDLRA-EAQAHTVLEMNYTEQQLTAAVVSGGLRPI 312 (697)
Q Consensus 235 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~-l~ell~g~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (697)
...+||+.|+|||++.+.. +.++||||||++ .+++++|..||.+... ......+.... ......
T Consensus 235 -~~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~------------~~~~~~ 300 (336)
T 2vuw_A 235 -GIVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQM------------TFKTKC 300 (336)
T ss_dssp -TEEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTC------------CCSSCC
T ss_pred -CcEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhh------------ccCccc
Confidence 2347999999999999877 899999998777 7778889999964211 00111111000 000111
Q ss_pred ccccccCChHHHHHHHHHhccCCCCCCCCHHHHH-HHHHH
Q 005427 313 LASLELGLPASILSLIQRCWDGNPHNRPSFSDIA-LELDL 351 (697)
Q Consensus 313 ~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell-~~l~~ 351 (697)
....+..+++++.+||++||+.| |++|++ +|+|+
T Consensus 301 ~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f 335 (336)
T 2vuw_A 301 NTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSLF 335 (336)
T ss_dssp CSHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGG
T ss_pred chhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcCCCc
Confidence 12233457899999999999976 999999 88764
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=342.18 Aligned_cols=246 Identities=16% Similarity=0.190 Sum_probs=189.5
Q ss_pred CCCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCCh---HHHHHHHHHHHHHHhcCC-CCceE-----------
Q 005427 63 LPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTS---EELDNFHKELQLLCKLDH-PGLAK----------- 125 (697)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h-pniv~----------- 125 (697)
.....|++.+.||+|+||+||+|++ +++.||||++..... ...+.+.+|+.+++.++| +|...
T Consensus 75 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~ 154 (413)
T 3dzo_A 75 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF 154 (413)
T ss_dssp SCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCC
T ss_pred CCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccch
Confidence 3445688999999999999999998 489999998764332 236789999999999987 32211
Q ss_pred ----------Eeecccc-----CCceEEEEeecCCCCHhhhhh------hcCCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 005427 126 ----------FVAAHAK-----PPNYMFFFEFYESRNLAEKLH------VEEWSPSVDQVLMIAAQLAKALQYLHNLGIV 184 (697)
Q Consensus 126 ----------l~~~~~~-----~~~~~lv~e~~~~g~L~~~l~------~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iv 184 (697)
+..++.. ...++++|+++ +++|.+++. .....+++..++.++.|++.||+|||++||+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ii 233 (413)
T 3dzo_A 155 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLV 233 (413)
T ss_dssp EEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred hhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 1111111 22456667665 579998884 2233467788999999999999999999999
Q ss_pred cccCCCCceeecCCCCCeeeeeccchhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhh----------cccC
Q 005427 185 HRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEIL----------KKEI 254 (697)
Q Consensus 185 HrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~ 254 (697)
||||||+|||++.++.+||+|||+++.... .....+| +.|+|||++ .+..
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~-------------------~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~ 293 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-------------------SAVSPIG-RGFAPPETTAERMLPFGQHHPTL 293 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTE-------------------EECCCCC-TTTCCHHHHHHHTSTTGGGCCEE
T ss_pred cCCcccceEEEecCCeEEEEeccceeecCC-------------------ccccCCC-CceeCchhhhccccccccccCcC
Confidence 999999999999999999999999875432 1344567 999999999 5566
Q ss_pred CCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccC
Q 005427 255 HSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDG 334 (697)
Q Consensus 255 ~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 334 (697)
++.++|||||||++|||++|..||.+.........+ +. ....+|+++.+||.+||+.
T Consensus 294 ~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~----------------------~~-~~~~~~~~~~~li~~~l~~ 350 (413)
T 3dzo_A 294 MTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWI----------------------FR-SCKNIPQPVRALLEGFLRY 350 (413)
T ss_dssp ECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSGGG----------------------GS-SCCCCCHHHHHHHHHHTCS
T ss_pred CCchhhHHHHHHHHHHHHHCCCCCCCcchhhhHHHH----------------------Hh-hcccCCHHHHHHHHHHccC
Confidence 889999999999999999999999875433221111 11 1236789999999999999
Q ss_pred CCCCCCCHHHHHHHHHHH
Q 005427 335 NPHNRPSFSDIALELDLV 352 (697)
Q Consensus 335 dP~~Rpt~~ell~~l~~~ 352 (697)
||.+|||+.+++++.|+.
T Consensus 351 dP~~Rpt~~~~l~~~~~~ 368 (413)
T 3dzo_A 351 PKEDRLLPLQAMETPEYE 368 (413)
T ss_dssp SGGGSCCHHHHTTSHHHH
T ss_pred ChhhCcCHHHHHhCHHHH
Confidence 999999999999987764
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=321.64 Aligned_cols=235 Identities=20% Similarity=0.260 Sum_probs=186.1
Q ss_pred CCcccc-cccccCCceEEEEEEE--CCeeEEEEeccCCChHHHHHHHHHHHHH-HhcCCCCceEEeecccc----CCceE
Q 005427 66 SSYTLL-SPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLL-CKLDHPGLAKFVAAHAK----PPNYM 137 (697)
Q Consensus 66 ~~y~~~-~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~hpniv~l~~~~~~----~~~~~ 137 (697)
++|.+. +.||+|+||.||++.+ +++.||+|++.. ...+.+|+.++ +.++||||+++++++.. ...++
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 568777 7899999999999988 678999998643 23567888888 66699999999999876 67799
Q ss_pred EEEeecCCCCHhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecC---CCCCeeeeeccchhhh
Q 005427 138 FFFEFYESRNLAEKLHVEE-WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDR---NLCPHLADFGLAEYRE 213 (697)
Q Consensus 138 lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~---~~~~kL~Dfg~a~~~~ 213 (697)
+||||+.+|+|.+++.... ..+++.+++.++.|++.||.|||+.||+||||||+|||++. ++.+||+|||++....
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 171 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 171 (299)
T ss_dssp EEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT
T ss_pred EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccccccc
Confidence 9999999999999997654 36899999999999999999999999999999999999988 7889999999885322
Q ss_pred hhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhc
Q 005427 214 NLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEM 293 (697)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~ 293 (697)
+..++.++|||||||++|+|++|..||.+.............
T Consensus 172 --------------------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~ 213 (299)
T 3m2w_A 172 --------------------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR 213 (299)
T ss_dssp --------------------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCS
T ss_pred --------------------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHH
Confidence 134577999999999999999999999765433221111000
Q ss_pred cccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 005427 294 NYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE 354 (697)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~ 354 (697)
.. ....+........+++++.+||.+||+.||.+|||+.|+++|+|....
T Consensus 214 ~~-----------~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~ 263 (299)
T 3m2w_A 214 IR-----------MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 263 (299)
T ss_dssp SC-----------TTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTG
T ss_pred Hh-----------hccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhccc
Confidence 00 000111111225689999999999999999999999999999998643
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=352.14 Aligned_cols=241 Identities=23% Similarity=0.306 Sum_probs=194.2
Q ss_pred CCCCCcccccccccCCceEEEEEEE---CCeeEEEEeccCC-ChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCc---
Q 005427 63 LPPSSYTLLSPIARGAESVVYEATL---DGRKVAVKKPILS-TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPN--- 135 (697)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~--- 135 (697)
+..++|++.++||+|+||.||+|.+ +++.||||++... .......+.+|+.+|+.++||||+++++++.....
T Consensus 77 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 156 (681)
T 2pzi_A 77 IVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGD 156 (681)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSC
T ss_pred EeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCC
Confidence 3457899999999999999999987 4789999986544 33456788999999999999999999999987665
Q ss_pred --eEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhh
Q 005427 136 --YMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRE 213 (697)
Q Consensus 136 --~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~ 213 (697)
.|+||||++|++|.+++.. .+++.+++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||++....
T Consensus 157 ~~~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~ 232 (681)
T 2pzi_A 157 PVGYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRIN 232 (681)
T ss_dssp EEEEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETT
T ss_pred ceeEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhcc
Confidence 7999999999999987654 68999999999999999999999999999999999999885 89999999987543
Q ss_pred hhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhc
Q 005427 214 NLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEM 293 (697)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~ 293 (697)
. .....||+.|+|||++.+.. +.++|||||||++|+|++|..||.+......
T Consensus 233 ~--------------------~~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~------- 284 (681)
T 2pzi_A 233 S--------------------FGYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL------- 284 (681)
T ss_dssp C--------------------CSCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSC-------
T ss_pred c--------------------CCccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccccc-------
Confidence 2 13457999999999998765 8999999999999999999999875321100
Q ss_pred cccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHH-HHHHHHHH
Q 005427 294 NYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI-ALELDLVL 353 (697)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~el-l~~l~~~~ 353 (697)
.... .....++.+.+||.+||+.||.+||+..+. ...+..++
T Consensus 285 ----------------~~~~--~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 285 ----------------PEDD--PVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp ----------------CTTC--HHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ----------------cccc--cccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 0000 011245789999999999999999965554 44444443
|
| >3rnr_A Stage II sporulation E family protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG; HET: MSE; 2.00A {Thermanaerovibrio acidaminovorans} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=295.04 Aligned_cols=198 Identities=21% Similarity=0.244 Sum_probs=159.5
Q ss_pred CceEEEEEecCCCChHHHHHHHHHhHHHHHhcCCCCChHHHHHHHHHHHHHHHHHHHHHHHhhhhcccCCCCCCceEEEE
Q 005427 457 KEIHMFGIFDGHRGSAAAEFSARALPGFLQNLGSTTRPTDALLEAFIRTDVAFRNELDSLRKSKRVVQKDWHPGCTAIAA 536 (697)
Q Consensus 457 ~~~~~~~V~DG~GG~~~~~~as~~~~~~l~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GtT~~~~ 536 (697)
++..+|+|||||||+.+|++||+.+++.+.+....... +.+++..++..+...... ......||||++++
T Consensus 8 ~~~~l~~VaDG~GG~~~g~~AS~~~~~~l~~~~~~~~~---~~~~~~~an~~l~~~~~~-------~~~~~~~GtT~~~~ 77 (211)
T 3rnr_A 8 GDKAYCVVVDGMGGMIRGDEAAQRALSASVGVLDAGGS---PLDAVLAAQAAVHRWASQ-------GGILGRTGATMAVA 77 (211)
T ss_dssp TTEEEEEEEEECTTSTTHHHHHHHHHHHHHHHHHTTCC---HHHHHHHHHHHHHHHHHH-------TTCTTSCCEEEEEE
T ss_pred CCccEEEEEeCCcCcHHHHHHHHHHHHHHHHHHhccCC---HHHHHHHHHHHHHHHHhh-------ccCCCCcchhheee
Confidence 46789999999999999999999999998765222211 256777777777655221 22334689999999
Q ss_pred EEe--cCeEEEEEcCCeEEEEEECCeeeecCCCCCCCCHHHHHHHHHcCCeeeeccCcceeCCCcceeccccCCCCCCCC
Q 005427 537 LIV--RNRLFVANAGDCRAILCRGGHPFALSRDHVASCLEERERVVSAGGNVNWQVDTWRVGPPALQVTRSIGDDDLKPA 614 (697)
Q Consensus 537 ~i~--~~~l~~anvGDSr~~l~~~~~~~~lt~dH~~~~~~e~~ri~~~g~~~~~~~~~~~~~~~~~~ltralG~~~~k~~ 614 (697)
++. +++++++|+||||+|++|+|++.+||+|| +..+++.+.|. .. +.+|.++.+||++|...
T Consensus 78 ~i~~~~~~~~~anvGDSr~yl~r~g~~~~lt~dh-----~~~~~~~~~g~-~~------~~~~~~~~ltralG~~~---- 141 (211)
T 3rnr_A 78 AVNLRDGTLEWASVGDCRVYLFKGGRLSRLSLDH-----NVSSEMVLLGR-GP------VPGPAGEMITSFIGIEN---- 141 (211)
T ss_dssp EEETTTTEEEEEEESSCEEEEEETTEEEECCCCC-----BHHHHHHHTTS-CC------CCSHHHHCBSCCBTCSS----
T ss_pred eeeeCCCEEEEEEEccCeEEEEeCCEEEEECCCc-----HHHHHHHHcCC-Ch------hhCCCccEEecccCCCC----
Confidence 999 99999999999999999999999999999 45666788875 21 77778999999999988
Q ss_pred cccCCce--EEEEeCCCCeEEEEEcCCcccCCChHHHHHHHHhhcCChhHHHHHHHHHHHhcC--CCCCcEEEEEEe
Q 005427 615 VTAEPEI--TETIMTPEDEYLVMASDGLWDVVSHVEAVGIIKDTVKEPGMCSKRLATEAAERG--SKDNITVIVVFL 687 (697)
Q Consensus 615 v~~~p~v--~~~~l~~~d~~lvl~SDGl~d~~~~~ei~~~~~~~~~~~~~~a~~L~~~a~~~g--~~DNiT~ivv~l 687 (697)
..+|++ ..+.+.++| +||||||||||+++++++.+++.... + |+.|++.|+++| +.||+|||||+|
T Consensus 142 -~~~~~~~~~~~~l~~gd-~llL~SDGl~d~~~~~~i~~~l~~~~-~----a~~L~~~a~~~g~~~~DNiTvivv~L 211 (211)
T 3rnr_A 142 -LTEISTSEAPLPLEAGE-GVLVVSDGVYRSLHEDRIAMALSRGS-D----ARGILQEVEAQGRPYQDNATLALVIL 211 (211)
T ss_dssp -CCCCEECSSCEECCTTC-EEEEEEC-----CCTTEEEEEECTTS-C----HHHHHHHHHHSCTTSCSSCEEEEEEC
T ss_pred -CcceeEecceecCCCCC-EEEEEcCCCCCCcCHHHHHHHHhcCC-h----HHHHHHHHHHcCCCCCCceEEEEEeC
Confidence 678999 789999999 66799999999999999998886543 2 999999999999 999999999986
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=9.4e-31 Score=291.46 Aligned_cols=186 Identities=19% Similarity=0.171 Sum_probs=132.0
Q ss_pred cccccCCceEEEEEE--ECCeeEEEEeccCCC----------hHHHHHHHHHHHHHHhc-CCCCceEEeeccccCCceEE
Q 005427 72 SPIARGAESVVYEAT--LDGRKVAVKKPILST----------SEELDNFHKELQLLCKL-DHPGLAKFVAAHAKPPNYMF 138 (697)
Q Consensus 72 ~~lg~G~~g~V~~~~--~~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~l 138 (697)
...+.|++|.+..++ +.|+.++||.+.... ....+.+.+|+++|+++ .|+||++++++++++..+||
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL 319 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL 319 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence 356677777777664 378899999865331 12356799999999999 79999999999999999999
Q ss_pred EEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhh
Q 005427 139 FFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI 218 (697)
Q Consensus 139 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~ 218 (697)
||||++|++|.+++...+ .+++. .|+.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.....
T Consensus 320 VMEyv~G~~L~d~i~~~~-~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~--- 392 (569)
T 4azs_A 320 VMEKLPGRLLSDMLAAGE-EIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD--- 392 (569)
T ss_dssp EEECCCSEEHHHHHHTTC-CCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC-----
T ss_pred EEecCCCCcHHHHHHhCC-CCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCC---
Confidence 999999999999997654 56654 47899999999999999999999999999999999999999999765421
Q ss_pred hcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCC
Q 005427 219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278 (697)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf 278 (697)
.....+.+||+.|||||++.+. +..++|+||+|++++++.++..|+
T Consensus 393 -------------~~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 393 -------------CSWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp --------------CCSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred -------------CccccCceechhhccHHHhCCC-CCCcccccccccchhhhccccchh
Confidence 1124567899999999999875 467899999999998887665443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=4.6e-27 Score=260.29 Aligned_cols=191 Identities=16% Similarity=0.175 Sum_probs=146.9
Q ss_pred ccccccccCCceEEEEEEECCeeEEEEeccCCCh--------HHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEE
Q 005427 69 TLLSPIARGAESVVYEATLDGRKVAVKKPILSTS--------EELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFF 140 (697)
Q Consensus 69 ~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 140 (697)
...++||+|+||.||+|...++.+++|+...... ...+.+.+|+++|++++||||+++..++......++||
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm 418 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM 418 (540)
T ss_dssp ---------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred CCCCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence 3467899999999999988899999997543221 12456899999999999999995555555677789999
Q ss_pred eecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhc
Q 005427 141 EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL 220 (697)
Q Consensus 141 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~ 220 (697)
||+++++|.+++.. +..++.|++.||+|||++||+||||||+|||++. .+||+|||+++..........
T Consensus 419 E~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~ 487 (540)
T 3en9_A 419 SYINGKLAKDVIED---------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAV 487 (540)
T ss_dssp ECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHH
T ss_pred ECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCcccccc
Confidence 99999999999865 5689999999999999999999999999999998 999999999987654322110
Q ss_pred ccccCCCCCCCCccccccccCccccchhhhcc--cCCCchhhHHHHHHHHHHHHhCCCCCC
Q 005427 221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK--EIHSEKSDVYSFGISINELLTGVVPYT 279 (697)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~~l~ell~g~~Pf~ 279 (697)
.. .......+||+.|||||++.. ..|+..+|+||..+-..+-..++.+|.
T Consensus 488 ~~---------~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 488 DL---------IVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HH---------HHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred ch---------hhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 00 001235689999999999987 667888999999998888887777664
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.9e-23 Score=211.98 Aligned_cols=131 Identities=18% Similarity=0.202 Sum_probs=107.5
Q ss_pred CcccccccccCCceEEEEEEE-CCeeEEEEeccCCCh------------------HHHHHHHHHHHHHHhcCCCCceEEe
Q 005427 67 SYTLLSPIARGAESVVYEATL-DGRKVAVKKPILSTS------------------EELDNFHKELQLLCKLDHPGLAKFV 127 (697)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~hpniv~l~ 127 (697)
.|.+.+.||+|+||.||+|.+ +++.||+|....... .....+.+|+.+|+.++| +++.
T Consensus 91 ~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~---~~v~ 167 (282)
T 1zar_A 91 VDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG---LAVP 167 (282)
T ss_dssp CSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT---SSSC
T ss_pred EEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC---CCcC
Confidence 355669999999999999998 588999998754321 235678999999999994 5555
Q ss_pred eccccCCceEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeec
Q 005427 128 AAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFG 207 (697)
Q Consensus 128 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg 207 (697)
+++.. +..++||||++|++|.+ +.. .....++.|++.||.|||+.||+||||||+|||++ ++.+||+|||
T Consensus 168 ~~~~~-~~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG 237 (282)
T 1zar_A 168 KVYAW-EGNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFP 237 (282)
T ss_dssp CEEEE-ETTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCT
T ss_pred eEEec-cceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECC
Confidence 54433 56799999999999998 422 23557999999999999999999999999999999 9999999999
Q ss_pred cch
Q 005427 208 LAE 210 (697)
Q Consensus 208 ~a~ 210 (697)
+++
T Consensus 238 ~a~ 240 (282)
T 1zar_A 238 QSV 240 (282)
T ss_dssp TCE
T ss_pred CCe
Confidence 985
|
| >3pu9_A Protein serine/threonine phosphatase; PSI-biology, MCSG, structural genomics; HET: MSE; 1.55A {Sphaerobacter thermophilus} | Back alignment and structure |
|---|
Probab=99.85 E-value=6.1e-20 Score=181.52 Aligned_cols=208 Identities=17% Similarity=0.103 Sum_probs=152.5
Q ss_pred ccceEeeeccCC-CCCCCceeEEcccccCCCceEEEEEecCCCChHHHHHHHHHhHHHHHhcCCCCChHHHHHHHHHHHH
Q 005427 428 VLSWGSFATCGR-RETMEDTHFLMPHMYNQKEIHMFGIFDGHRGSAAAEFSARALPGFLQNLGSTTRPTDALLEAFIRTD 506 (697)
Q Consensus 428 ~~~~~~~s~~G~-R~~neD~~~~~~~~~~~~~~~~~~V~DG~GG~~~~~~as~~~~~~l~~~~~~~~~~~~l~~~~~~~~ 506 (697)
.++++..+.... +..+.|.+.+.. ...+..+++|+||+|+...|..++..+...+......... ..+.+..++
T Consensus 10 ~~~~~~~~~~~~~~~vgGD~y~~~~---~~~~~~~~~vaD~~G~G~~aa~~s~~~~~~l~~~~~~~~~---~~~~l~~~n 83 (242)
T 3pu9_A 10 TIELAVAKTHKFGTRESGDTVELVE---RPGGGFSAVLVDGQGSGAGAKRLSLLVAGAAVRLLNEGVR---DGAAARAAH 83 (242)
T ss_dssp EEEEEEEEECCTTCSSCSEEEEEEE---CTTSEEEEEEEEESSSHHHHHHHHHHHHHHHHHHHHTTCC---HHHHHHHHH
T ss_pred EEEEEEEecccCccccCCceEEEEE---eCCCEEEEEEEecCCCCHHHHHHHHHHHHHHHHHHHcCCC---HHHHHHHHH
Confidence 455666665554 788999988754 1335667999999999999999999887777654222111 234444455
Q ss_pred HHHHHHHHHHHhhhhcccCCCCCCceEEEEEEe--cCeEEEEEcCCeEEEEEECCeeeecCCCCCCCCHHHHHHHHHcCC
Q 005427 507 VAFRNELDSLRKSKRVVQKDWHPGCTAIAALIV--RNRLFVANAGDCRAILCRGGHPFALSRDHVASCLEERERVVSAGG 584 (697)
Q Consensus 507 ~~~~~~~~~~~~~~~~~~~~~~~GtT~~~~~i~--~~~l~~anvGDSr~~l~~~~~~~~lt~dH~~~~~~e~~ri~~~g~ 584 (697)
..+.... ...+++|+++++++ .++++++|+||+|+|++|+|++.+|+.+|.
T Consensus 84 ~~l~~~~------------~~~~~~T~~~~~id~~~~~l~~~~aG~~~~~l~r~g~~~~l~~~~~--------------- 136 (242)
T 3pu9_A 84 DFLYAMR------------DGKVSAALDILSVDLASRSVLVTRNSEVPMLLGRNGEFEQISESGG--------------- 136 (242)
T ss_dssp HHHHHHT------------TTCCCEEEEEEEEETTTTEEEEEEESCCCEEEEETTEEEEECCCCC---------------
T ss_pred HHHHhcc------------CCCcEEEEEEEEEECCCCEEEEEeCCCCcEEEEECCEEEEeCCCCc---------------
Confidence 4443220 01368999999996 578999999999999999999999998872
Q ss_pred eeeeccCcceeCCCcceeccccCCCCCCCCcccCCceEEEEeCCCCeEEEEEcCCcccCCC-------hHHHHHHHHhhc
Q 005427 585 NVNWQVDTWRVGPPALQVTRSIGDDDLKPAVTAEPEITETIMTPEDEYLVMASDGLWDVVS-------HVEAVGIIKDTV 657 (697)
Q Consensus 585 ~~~~~~~~~~~~~~~~~ltralG~~~~k~~v~~~p~v~~~~l~~~d~~lvl~SDGl~d~~~-------~~ei~~~~~~~~ 657 (697)
.+|... ..+++...+.+.++| .|+||||||++..+ .+++..++....
T Consensus 137 --------------------~lG~~~-----~~~~~~~~~~l~~Gd-~lll~TDGl~e~~~~~~~~~g~~~l~~l~~~~~ 190 (242)
T 3pu9_A 137 --------------------RIGIYR-----HTRPRVLEFPAEPGL-TVILVSDGIIGAGGRRGQPLEFLATGGRVAGPE 190 (242)
T ss_dssp --------------------CBSSCT-----TCCCEEEEEECCTTC-EEEEECHHHHTTTTTTTCCCCHHHHHHHHCCTT
T ss_pred --------------------cccccC-----CCCceEEEEEeCCCC-EEEEECcCcccCCCCccccccHHHHHHHHhccC
Confidence 244333 346778889999999 77799999998764 478866554333
Q ss_pred CChhHHHHHHHHHHHhcC---CCCCcEEEEEEeCCCCccc
Q 005427 658 KEPGMCSKRLATEAAERG---SKDNITVIVVFLQPVSTAE 694 (697)
Q Consensus 658 ~~~~~~a~~L~~~a~~~g---~~DNiT~ivv~l~~~~~~~ 694 (697)
.+++++++.|++.+...+ ..||+|++++++.+....+
T Consensus 191 ~~~~~~~~~l~~~~~~~~~~~~~DDiTvlvv~~~~~~~~~ 230 (242)
T 3pu9_A 191 TPAQAIADELLEAALVADDGRAGDDMTVVVLRLRNVEEVE 230 (242)
T ss_dssp CCHHHHHHHHHHHHHHHTTTSCSSCEEEEEEEEEECCCSS
T ss_pred CCHHHHHHHHHHHHHHhcCCCCCCCeEEEEEEEecCCCCC
Confidence 479999999999998765 5699999999997655443
|
| >3t91_A Stage II sporulation protein E; SPOIIE, phosphatase, manganese binding, PP2C PH domain; HET: GL0 MAN; 2.64A {Bacillus subtilis} PDB: 3t9q_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=7e-21 Score=188.93 Aligned_cols=205 Identities=18% Similarity=0.167 Sum_probs=142.0
Q ss_pred ccceEeeeccCC-CCCCCceeEEcccccCCCceEEEEEecCCCChHHHHHHHHHhHHHHHhcCC-CCChHHHHHHHHHHH
Q 005427 428 VLSWGSFATCGR-RETMEDTHFLMPHMYNQKEIHMFGIFDGHRGSAAAEFSARALPGFLQNLGS-TTRPTDALLEAFIRT 505 (697)
Q Consensus 428 ~~~~~~~s~~G~-R~~neD~~~~~~~~~~~~~~~~~~V~DG~GG~~~~~~as~~~~~~l~~~~~-~~~~~~~l~~~~~~~ 505 (697)
.+.+++++..-. +..+.|.+.+.. ...+..+++|+||+|+...|.+++..+...+..... ...+ .+++..+
T Consensus 7 ~i~~~~~~~~~p~~~v~GD~y~~~~---~~~~~~~~~vaDg~G~G~~aa~~s~~~~~~l~~~~~~~~~~----~~~l~~~ 79 (242)
T 3t91_A 7 RVSTGAAHAAKGGGLVSGDSYSMME---LGARKYAAAISDGMGNGARAHFESNETIKLLEKILESGIDE----KIAIKTI 79 (242)
T ss_dssp EEEEEEEEECTTSCSCCSCEEEEEE---ETTTEEEEEEECC-----CCSEEECHHHHHHHHHHHHTCCH----HHHHHHH
T ss_pred EEEEEeehhcCCccccCCcEEEEEE---eCCCeEEEEEEeeCCCCHHHHHHHHHHHHHHHHHHHhCCCH----HHHHHHH
Confidence 466777776554 789999988754 133566899999999888888877777766655311 1122 2333333
Q ss_pred HHHHHHHHHHHHhhhhcccCCCCCCceEEEEEEe--cCeEEEEEcCCeEEEEEECCeeeecCCCCCCCCHHHHHHHHHcC
Q 005427 506 DVAFRNELDSLRKSKRVVQKDWHPGCTAIAALIV--RNRLFVANAGDCRAILCRGGHPFALSRDHVASCLEERERVVSAG 583 (697)
Q Consensus 506 ~~~~~~~~~~~~~~~~~~~~~~~~GtT~~~~~i~--~~~l~~anvGDSr~~l~~~~~~~~lt~dH~~~~~~e~~ri~~~g 583 (697)
+..+... ....+++|+++++++ +++++++|+||||+|++|+|++.+++.++.
T Consensus 80 n~~l~~~------------~~~~~~~T~~~~~id~~~~~l~~~~aG~~~~~l~r~g~~~~l~~~~~-------------- 133 (242)
T 3t91_A 80 NSILSLR------------TTDEIYSTLDLSIIDLQDASCKFLKVGSTPSFIKRGDQVMKVQASNL-------------- 133 (242)
T ss_dssp HHHHTTC----------------CCCCEEEEEEETTTCEEEEEEESCCCEEEEETTEEEECCCC----------------
T ss_pred HHHHHhc------------CCCCeEeEEEEEEEECCCCEEEEEcCCCCceEEEECCEEEEecCCCc--------------
Confidence 3333221 012478999999997 689999999999999999999999876551
Q ss_pred CeeeeccCcceeCCCcceeccccCCCCCCCCcccCCceEEEEeCCCCeEEEEEcCCcccCCC-----hHHHHHHHHhh-c
Q 005427 584 GNVNWQVDTWRVGPPALQVTRSIGDDDLKPAVTAEPEITETIMTPEDEYLVMASDGLWDVVS-----HVEAVGIIKDT-V 657 (697)
Q Consensus 584 ~~~~~~~~~~~~~~~~~~ltralG~~~~k~~v~~~p~v~~~~l~~~d~~lvl~SDGl~d~~~-----~~ei~~~~~~~-~ 657 (697)
.+|... ..+++...+.+.++| .|+||||||||.++ ...+.+++... .
T Consensus 134 ---------------------~lG~~~-----~~~~~~~~~~l~~GD-~lll~SDGl~e~~~~~~~~~~~~~~ll~~~~~ 186 (242)
T 3t91_A 134 ---------------------PIGIIN-----EFDVEVVSEQLKAGD-LLIMMSDGIFEGPKHVENHDLWMKRKMKGLKT 186 (242)
T ss_dssp ------------------------CCC-----TTCEEEEEEECCTTC-EEEEECHHHHTCSTTCSCHHHHHHHHHHTCCC
T ss_pred ---------------------eeEecC-----CCcceEEEEEeCCCC-EEEEECCCcccCCCcccchHHHHHHHHHHhcC
Confidence 233322 345677788999999 67799999999998 66777777643 2
Q ss_pred CChhHHHHHHHHHHHhcCC---CCCcEEEEEEeCCCCc
Q 005427 658 KEPGMCSKRLATEAAERGS---KDNITVIVVFLQPVST 692 (697)
Q Consensus 658 ~~~~~~a~~L~~~a~~~g~---~DNiT~ivv~l~~~~~ 692 (697)
.+++++++.|++.+...++ .||+|++++++.+..+
T Consensus 187 ~~~~~~~~~l~~~~~~~~~~~~~DDiTvv~i~~~~~~~ 224 (242)
T 3t91_A 187 NDPQEIADLLMEEVIRTRSGQIEDDMTVVVVRIDHNTP 224 (242)
T ss_dssp CCHHHHHHHHHHHHHHHTTSCCCSCEEEEEEEEEECCC
T ss_pred CCHHHHHHHHHHHHHHHcCCCCCCceEEEEEEEecCCC
Confidence 4789999999999988763 5999999999975443
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=3.1e-20 Score=186.08 Aligned_cols=136 Identities=23% Similarity=0.196 Sum_probs=106.7
Q ss_pred CcccccccccCCceEEEEEEE--CCee--EEEEeccCCChH------------------------HHHHHHHHHHHHHhc
Q 005427 67 SYTLLSPIARGAESVVYEATL--DGRK--VAVKKPILSTSE------------------------ELDNFHKELQLLCKL 118 (697)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~--~~~~--vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l 118 (697)
-|.+.+.||+|+||.||+|.+ +|+. ||||+....... ....+.+|+.+|+.+
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 378899999999999999987 7888 999975432111 123688999999999
Q ss_pred CCCCc--eEEeeccccCCceEEEEeecCC-C----CHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHH-hCCcccccCCC
Q 005427 119 DHPGL--AKFVAAHAKPPNYMFFFEFYES-R----NLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLH-NLGIVHRDVKP 190 (697)
Q Consensus 119 ~hpni--v~l~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH-~~~ivHrDlkp 190 (697)
.|+++ +.+++. ...++||||+.+ | +|.+.... .++..+..++.|++.+|.||| +.||+||||||
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp 199 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQEAELVHADLSE 199 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCST
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCH
Confidence 88754 344432 367899999942 3 66665432 234567889999999999999 99999999999
Q ss_pred CceeecCCCCCeeeeeccchhh
Q 005427 191 ANVLLDRNLCPHLADFGLAEYR 212 (697)
Q Consensus 191 ~Nill~~~~~~kL~Dfg~a~~~ 212 (697)
+|||++. .++|+|||+|...
T Consensus 200 ~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 200 YNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp TSEEESS--SEEECCCTTCEET
T ss_pred HHEEEcC--cEEEEECcccccC
Confidence 9999988 8999999998643
|
| >3f79_A Probable two-component response regulator; adaptor, signaling protein; 2.80A {Pseudomonas aeruginosa} PDB: 3es2_A | Back alignment and structure |
|---|
Probab=99.73 E-value=4.3e-17 Score=162.89 Aligned_cols=204 Identities=17% Similarity=0.079 Sum_probs=132.0
Q ss_pred CcccceEeeeccCCCCCCCceeEEcccccCCCceEEEEEecCCCChHHHHHHHHHhHHHHHhc----CC-CCChHHHHHH
Q 005427 426 YPVLSWGSFATCGRRETMEDTHFLMPHMYNQKEIHMFGIFDGHRGSAAAEFSARALPGFLQNL----GS-TTRPTDALLE 500 (697)
Q Consensus 426 ~~~~~~~~~s~~G~R~~neD~~~~~~~~~~~~~~~~~~V~DG~GG~~~~~~as~~~~~~l~~~----~~-~~~~~~~l~~ 500 (697)
.+.+++++..... +...-|.+-+.. ..++..+++|+||+|+...|.+++..+...+... .. .......+.+
T Consensus 35 ~~~~~~~~~~~p~-~~vgGD~yd~~~---~~~~~~~~~vaD~~GhG~~aa~~s~~~~~~~~~~~~~~~~~~~~~~~~p~~ 110 (255)
T 3f79_A 35 IEGLEFSHRIIPS-LYLSGDFVDYFR---VDERRVAFYLADVSGHGASSAFVTVLLKFMTTRLLYESRRNGTLPEFKPSE 110 (255)
T ss_dssp ETTEEEEEEEECS-SSSCSEEEEEEE---ETTTEEEEEEEEESSCSHHHHHHHHHHHHHHHHHHHHHTTCCC----CHHH
T ss_pred CCCEEEEEEEeEh-hhcCceEEeEEE---eCCCEEEEEEEEecCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCHHH
Confidence 3455666665554 567788875543 1335678999999998888888877776666542 10 0111122334
Q ss_pred HHHHHHHHHHHHHHHHHhhhhcccCCCCCCceEEEEEEe--cCeEEEEEcCC-eEEEEEECCeeeecCCCCCCCCHHHHH
Q 005427 501 AFIRTDVAFRNELDSLRKSKRVVQKDWHPGCTAIAALIV--RNRLFVANAGD-CRAILCRGGHPFALSRDHVASCLEERE 577 (697)
Q Consensus 501 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GtT~~~~~i~--~~~l~~anvGD-Sr~~l~~~~~~~~lt~dH~~~~~~e~~ 577 (697)
.+..++..+... ..++++|+++++++ .++++++|+|+ ++.|++++|++.+++.+|.|
T Consensus 111 ~l~~ln~~l~~~-------------~~~~~~T~~~~~id~~~~~l~~~~aGh~p~~~l~~~g~~~~l~~~~~~------- 170 (255)
T 3f79_A 111 VLAHINRGLINT-------------KLGKHVTMLGGVIDLEKNSLTYSIGGHLPLPVLFVEGQAGYLEGRGLP------- 170 (255)
T ss_dssp HHHHHHHHHBTT-------------BSSCCEEEEEEEEETTTTEEEEEECSCSCCCEEEC--CEEECCC-----------
T ss_pred HHHHHHHHHHhc-------------CCCCEEEEEEEEEECCCCEEEEEeCCCCCceEEEeCCeEEEeCCCCce-------
Confidence 444444444321 12479999999996 67899999999 56899999999999877621
Q ss_pred HHHHcCCeeeeccCcceeCCCcceeccccCCCCCCCCcccCCceEEEEeCCCCeEEEEEcCCcccCCChHH-------HH
Q 005427 578 RVVSAGGNVNWQVDTWRVGPPALQVTRSIGDDDLKPAVTAEPEITETIMTPEDEYLVMASDGLWDVVSHVE-------AV 650 (697)
Q Consensus 578 ri~~~g~~~~~~~~~~~~~~~~~~ltralG~~~~k~~v~~~p~v~~~~l~~~d~~lvl~SDGl~d~~~~~e-------i~ 650 (697)
+|... ..+++...+.+.+|| .|+||||||++.++.++ +.
T Consensus 171 ----------------------------lG~~~-----~~~~~~~~~~l~~gd-~lll~TDGl~e~~~~~~~~~g~~~l~ 216 (255)
T 3f79_A 171 ----------------------------VGLFD-----DATYDDRVMELPPSF-SLSLFSDGILDVLPGATLKEKEASLP 216 (255)
T ss_dssp -----------------------------CCSS-----CCCCCC---BCCSSE-EEEEECSCCCCCSCC---CCTTTSSH
T ss_pred ----------------------------EEEcC-----CCceEEEEEEECCCC-EEEEECCCcCcccCCCcchhhHHHHH
Confidence 34332 235666778899998 77799999999998887 88
Q ss_pred HHHHhhcCChhHHHHHHHHHHHhcCCCCCcEEEEEEeC
Q 005427 651 GIIKDTVKEPGMCSKRLATEAAERGSKDNITVIVVFLQ 688 (697)
Q Consensus 651 ~~~~~~~~~~~~~a~~L~~~a~~~g~~DNiT~ivv~l~ 688 (697)
+++......++.+++.|. .+..++..||||+++|+..
T Consensus 217 ~~l~~~~~~~~~~~~~l~-~~~~~~~~DDiTvl~v~~~ 253 (255)
T 3f79_A 217 EQVAAAGGTLDGLRQVFG-LANLAEMPDDIALLVLSRN 253 (255)
T ss_dssp HHHHHHSCSSHHHHHHC------CCSSSCEEEEEEEEC
T ss_pred HHHHhcCCCHHHHHHHHH-hccCCCCCCCEEEEEEEec
Confidence 888765556788888887 5677788899999999864
|
| >3zt9_A Serine phosphatase; hydrolase, signal transduction, protein protein interaction,; HET: PEG; 1.75A {Moorella thermoacetica} | Back alignment and structure |
|---|
Probab=99.72 E-value=2.1e-16 Score=150.22 Aligned_cols=189 Identities=13% Similarity=0.113 Sum_probs=139.1
Q ss_pred cccceEeeeccCC-CCCCCceeEEcccccCCCceEEEEEecCCCChHHHHHHHHHhHHHHHhcCCCCChHHHHHHHHHHH
Q 005427 427 PVLSWGSFATCGR-RETMEDTHFLMPHMYNQKEIHMFGIFDGHRGSAAAEFSARALPGFLQNLGSTTRPTDALLEAFIRT 505 (697)
Q Consensus 427 ~~~~~~~~s~~G~-R~~neD~~~~~~~~~~~~~~~~~~V~DG~GG~~~~~~as~~~~~~l~~~~~~~~~~~~l~~~~~~~ 505 (697)
..++++..+.... +..+.|.+.+.. .++..+++|+||+|....|..++..+...+... ....+.+ .+..+
T Consensus 2 ~~~~~~~~~~p~~~~~v~GD~y~~~~----~~~~~~~~v~Dv~GhG~~Aa~~s~~~~~~l~~~-~~~~p~~----il~~l 72 (193)
T 3zt9_A 2 EKLEVGIYTRAREGEIACGDACLVKR----VEGVIFLAVGDGIGHGPEAARAAEIAIASMESS-MNTGLVN----IFQLC 72 (193)
T ss_dssp CCCCEEEEEECCTTCSSCSEEEEEEE----ETTEEEEEEEEESSSHHHHHHHHHHHHHHHHHH-TTSCHHH----HHHHH
T ss_pred CccEEEEEEeccCCCCCCCCeEEEEE----eCCEEEEEEEeCCCCCHHHHHHHHHHHHHHHHc-ccCCHHH----HHHHH
Confidence 3577888888865 788999998854 235679999999998888888888888888764 2223322 23333
Q ss_pred HHHHHHHHHHHHhhhhcccCCCCCCceEEEEEEe--cCeEEEEEcCCeEEEEEECCeeeecCCCCCCCCHHHHHHHHHcC
Q 005427 506 DVAFRNELDSLRKSKRVVQKDWHPGCTAIAALIV--RNRLFVANAGDCRAILCRGGHPFALSRDHVASCLEERERVVSAG 583 (697)
Q Consensus 506 ~~~~~~~~~~~~~~~~~~~~~~~~GtT~~~~~i~--~~~l~~anvGDSr~~l~~~~~~~~lt~dH~~~~~~e~~ri~~~g 583 (697)
+..+.. ..|+|++++.++ .+++.++|+|+++.|++|++....+...+
T Consensus 73 n~~l~~----------------~~~~t~~~~~id~~~~~l~~~~aGh~~~~l~~~~~~~~l~~~~--------------- 121 (193)
T 3zt9_A 73 HRELRG----------------TRGAVAALCRVDRRQGLWQAAIVGNIHVKILSAKGIITPLATP--------------- 121 (193)
T ss_dssp HHHHTT----------------SSCEEEEEEEEETTTTEEEEEEESSCEEEEEETTEEECCCCBC---------------
T ss_pred HHHHhc----------------cCceEEEEEEEECCCCEEEEEecCCceEEEEcCCcEEEecCCC---------------
Confidence 333321 137888888887 56899999999999999998766553222
Q ss_pred CeeeeccCcceeCCCcceeccccCCCCCCCCcccCCceEEEEeCCCCeEEEEEcCCcccCCChHHHHHHHHhhcCChhHH
Q 005427 584 GNVNWQVDTWRVGPPALQVTRSIGDDDLKPAVTAEPEITETIMTPEDEYLVMASDGLWDVVSHVEAVGIIKDTVKEPGMC 663 (697)
Q Consensus 584 ~~~~~~~~~~~~~~~~~~ltralG~~~~k~~v~~~p~v~~~~l~~~d~~lvl~SDGl~d~~~~~ei~~~~~~~~~~~~~~ 663 (697)
+ .+|... ..+++...+.+.++| .|+||||||++.++.+++..++. .+++++
T Consensus 122 --------------g------~lG~~~-----~~~~~~~~~~l~~gd-~l~l~sDGl~e~~~~~~~~~~~~---~~~~~~ 172 (193)
T 3zt9_A 122 --------------G------ILGYNY-----PHQLLIAKGSYQEGD-LFLIHSDGIQEGAVPLALLANYR---LTAEEL 172 (193)
T ss_dssp --------------C------BBTTBC-----CSSCCCEEEECCTTC-EEEEECTTSCTTCSCGGGGGCTT---SCHHHH
T ss_pred --------------C------ceeccC-----CccceeEEeccCCCC-EEEEECCCCCCccChhhhhchhc---CCHHHH
Confidence 0 133221 225667788999999 77799999999999998877652 389999
Q ss_pred HHHHHHHHHhcCCCCCcEEEEEE
Q 005427 664 SKRLATEAAERGSKDNITVIVVF 686 (697)
Q Consensus 664 a~~L~~~a~~~g~~DNiT~ivv~ 686 (697)
|+.|++.+ .++.||+|++|++
T Consensus 173 a~~l~~~~--~~~~Dd~tvlv~r 193 (193)
T 3zt9_A 173 VRLIGEKY--GRRDDDVAVIVAR 193 (193)
T ss_dssp HHHHHHHH--CCTTSCEEEEEEC
T ss_pred HHHHHHHh--CcCCCCeEEEEEC
Confidence 99999998 4578999999985
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.69 E-value=1.1e-17 Score=173.55 Aligned_cols=133 Identities=19% Similarity=0.214 Sum_probs=97.6
Q ss_pred cccccccccCCceEEEEEEE-CCeeEEEEeccCCCh-----------------HH-----HHHHHHHHHHHHhcCCCCc-
Q 005427 68 YTLLSPIARGAESVVYEATL-DGRKVAVKKPILSTS-----------------EE-----LDNFHKELQLLCKLDHPGL- 123 (697)
Q Consensus 68 y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~-----------------~~-----~~~~~~E~~~l~~l~hpni- 123 (697)
|++..+||+|+||.||+|.+ +|+.||||+...... .. .-...+|...|.+|.++++
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~ 176 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP 176 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 89999999999999999987 688999997543210 00 0112356666666644433
Q ss_pred -eEEeeccccCCceEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCC--
Q 005427 124 -AKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLC-- 200 (697)
Q Consensus 124 -v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~-- 200 (697)
...++. ...++||||++|+.|..+... +....++.|++.+|.|||+.|||||||||.|||++.++.
T Consensus 177 vp~p~~~----~~~~LVME~i~G~~L~~l~~~-------~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~ 245 (397)
T 4gyi_A 177 VPEPIAQ----SRHTIVMSLVDALPMRQVSSV-------PDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAE 245 (397)
T ss_dssp CCCEEEE----ETTEEEEECCSCEEGGGCCCC-------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSS
T ss_pred CCeeeec----cCceEEEEecCCccHhhhccc-------HHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcc
Confidence 222222 234799999999888765422 234578899999999999999999999999999987763
Q ss_pred --------Ceeeeeccchh
Q 005427 201 --------PHLADFGLAEY 211 (697)
Q Consensus 201 --------~kL~Dfg~a~~ 211 (697)
+.|+||+.+..
T Consensus 246 d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 246 DPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp CTTSEEEEEEECCCTTCEE
T ss_pred cccccccceEEEEeCCccc
Confidence 78999997753
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.30 E-value=2.8e-12 Score=128.62 Aligned_cols=138 Identities=12% Similarity=0.141 Sum_probs=111.7
Q ss_pred CcccccccccCCceEEEEEEECCeeEEEEeccCCChHHHHHHHHHHHHHHhcC-CCCceEEeeccccCCceEEEEeecCC
Q 005427 67 SYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLD-HPGLAKFVAAHAKPPNYMFFFEFYES 145 (697)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lv~e~~~~ 145 (697)
.|++...++.|+++.||++...++.+++|............+.+|+.+|+.|. +.+++++++++.+.+..++||||++|
T Consensus 15 ~~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G 94 (263)
T 3tm0_A 15 KYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADG 94 (263)
T ss_dssp TSEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSS
T ss_pred cceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCC
Confidence 58889999999999999998878899999865421122345889999999994 67788899988888899999999999
Q ss_pred CCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHh---------------------------------------------
Q 005427 146 RNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHN--------------------------------------------- 180 (697)
Q Consensus 146 g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~--------------------------------------------- 180 (697)
.+|.+.+. +......++.++..+|..||+
T Consensus 95 ~~l~~~~~------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (263)
T 3tm0_A 95 VLCSEEYE------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPR 168 (263)
T ss_dssp EEHHHHCC------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHH
T ss_pred eehhhccC------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHH
Confidence 99887632 112344678899999999998
Q ss_pred --------------CCcccccCCCCceeecCCCCCeeeeeccch
Q 005427 181 --------------LGIVHRDVKPANVLLDRNLCPHLADFGLAE 210 (697)
Q Consensus 181 --------------~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~ 210 (697)
..++|+|++|.|||++.+..+.|+||+.+.
T Consensus 169 ~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 169 ELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 448999999999999876666799999774
|
| >3ke6_A Protein RV1364C/MT1410; anti-sigma factor, anti-sigma factor antagonist, phosphatase serine kinase, ATPase, unknown function; 2.60A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.20 E-value=9.1e-10 Score=116.70 Aligned_cols=201 Identities=13% Similarity=0.108 Sum_probs=125.6
Q ss_pred cccceEeeeccCC--CCCCCceeEEcccccCCCceEEEEEecCCCChHHHHHHHHHhHHHHHhcC-CCCChHHHHHHHHH
Q 005427 427 PVLSWGSFATCGR--RETMEDTHFLMPHMYNQKEIHMFGIFDGHRGSAAAEFSARALPGFLQNLG-STTRPTDALLEAFI 503 (697)
Q Consensus 427 ~~~~~~~~s~~G~--R~~neD~~~~~~~~~~~~~~~~~~V~DG~GG~~~~~~as~~~~~~l~~~~-~~~~~~~~l~~~~~ 503 (697)
+.++++....... ....=|.|-+.. .++..+++|+|++|....|.+++..+...+.... ....+.+ .+.
T Consensus 34 ~~~~~~~~y~P~~~~~~vgGD~y~~~~----~~~~~~~~v~Dv~GhGv~AA~~~~~~~~~l~~~~~~~~~p~~----il~ 105 (399)
T 3ke6_A 34 PGADIAAEYLVAAEDTAAGGDWFDALA----LGDRLVLVVGDVVGHGVEAAAVMSQLRTALRMQISAGYTVVE----ALE 105 (399)
T ss_dssp TTEEEEEEEECSSSSCSCCSEEEEEEE----CSSEEEEEEEECSSCSHHHHHHHHHHHHHHHHHHHTTCCHHH----HHH
T ss_pred CCeEEEEEEEECCCCCCCCCceEEEEE----ECCEEEEEEEEecCCCHHHHHHHHHHHHHHHHHHhcCCCHHH----HHH
Confidence 3455555555544 245568877654 2237789999999955555555555555555432 1223322 222
Q ss_pred HHHHHHHHHHHHHHhhhhcccCCCCCCceEEEEEEe--cCeEEEEEcCCeEEEEEE-CCeeeecCCCCCCCCHHHHHHHH
Q 005427 504 RTDVAFRNELDSLRKSKRVVQKDWHPGCTAIAALIV--RNRLFVANAGDCRAILCR-GGHPFALSRDHVASCLEERERVV 580 (697)
Q Consensus 504 ~~~~~~~~~~~~~~~~~~~~~~~~~~GtT~~~~~i~--~~~l~~anvGDSr~~l~~-~~~~~~lt~dH~~~~~~e~~ri~ 580 (697)
.++. +... ....+++|++++.++ .+++.++|+|..+.|+++ +|....+..++.+
T Consensus 106 ~ln~-~~~~------------~~~~~~~t~~~~~id~~~~~l~~~~aGh~~~~l~~~~g~~~~l~~~~~~---------- 162 (399)
T 3ke6_A 106 AVDR-FHKQ------------VPGSKSATMCVGSLDFTSGEFQYCTAGHPPPLLVTADASARYVEPTGAG---------- 162 (399)
T ss_dssp HHHH-HGGG------------STTCTTCEEEEEEEETTTCEEEEEEESSCCCEEECTTSCEEECCCCSCC----------
T ss_pred HHHH-HHHh------------cCCCcEEEEEEEEEECCCCEEEEECCCCChhEEEeCCCCEEEeecCCCc----------
Confidence 2222 1110 012368999999996 578999999999999998 6777777665410
Q ss_pred HcCCeeeeccCcceeCCCcceeccccCCCCCCCCcccCCceEEEEeCCCCeEEEEEcCCcccCCCh------HHHHHHHH
Q 005427 581 SAGGNVNWQVDTWRVGPPALQVTRSIGDDDLKPAVTAEPEITETIMTPEDEYLVMASDGLWDVVSH------VEAVGIIK 654 (697)
Q Consensus 581 ~~g~~~~~~~~~~~~~~~~~~ltralG~~~~k~~v~~~p~v~~~~l~~~d~~lvl~SDGl~d~~~~------~ei~~~~~ 654 (697)
.+|... ..+...+.+.++| .|+|+||||.|.... +.+.+++.
T Consensus 163 ------------------------plG~~~-------~~~~~~~~l~~Gd-~l~l~TDGl~e~~~~~~~~g~~~l~~~l~ 210 (399)
T 3ke6_A 163 ------------------------PLGSGT-------GFPVRSEVLNIGD-AILFYTDGLIERPGRPLEASTAEFADLAA 210 (399)
T ss_dssp ------------------------CTTSSC-------CCCCEEEECCTTC-EEEEECTTTTSCTTCCHHHHHHHHHHHHH
T ss_pred ------------------------ceECCC-------CceeEEEEECCCC-EEEEECCCcccCCCCCcchhHHHHHHHHH
Confidence 123211 2445678999999 677999999998765 56677765
Q ss_pred hhcC--------ChhHHHHHHHHHHHh-----cCCCCCcEEEEEEeCCC
Q 005427 655 DTVK--------EPGMCSKRLATEAAE-----RGSKDNITVIVVFLQPV 690 (697)
Q Consensus 655 ~~~~--------~~~~~a~~L~~~a~~-----~g~~DNiT~ivv~l~~~ 690 (697)
.... ++...+++|++.+++ .+..||+|++++++.+.
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~DDitvl~vr~~~~ 259 (399)
T 3ke6_A 211 SIASGSGGFVLDAPARPIDRLCSDTLELLLRSTGYNDDVTLLAMQRRAP 259 (399)
T ss_dssp HHTC----------CCHHHHHHHHHHHHHHHTTCCSSCEEEEEEEECCC
T ss_pred HhhcccccccccChhhHHHHHHHHHHHHhccCCCCCCceEEEEEEeeCC
Confidence 5321 234455555555543 35679999999999864
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.07 E-value=1.7e-10 Score=115.18 Aligned_cols=132 Identities=16% Similarity=0.208 Sum_probs=98.0
Q ss_pred CcccccccccCCceEEEEEEE-CCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCC--ceEEeeccccCCceEEEEeec
Q 005427 67 SYTLLSPIARGAESVVYEATL-DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPG--LAKFVAAHAKPPNYMFFFEFY 143 (697)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn--iv~l~~~~~~~~~~~lv~e~~ 143 (697)
.|.+....+.|..+.||++.. +++.+++|..... ....+.+|+.+|+.+.+.+ +.+++.+....+..++||||+
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i 97 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV 97 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred CCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEec
Confidence 455554445666799999976 4678999985443 2245778999999985444 556888888778899999999
Q ss_pred CCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------------------
Q 005427 144 ESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLG----------------------------------------- 182 (697)
Q Consensus 144 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~----------------------------------------- 182 (697)
+|.+|. ... .. ...++.++...|..||+..
T Consensus 98 ~G~~l~--~~~----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (264)
T 1nd4_A 98 PGQDLL--SSH----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPA 168 (264)
T ss_dssp SSEETT--TSC----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHH
T ss_pred CCcccC--cCc----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHH
Confidence 998874 211 11 2256677777888888643
Q ss_pred -----------------cccccCCCCceeecCCCCCeeeeeccch
Q 005427 183 -----------------IVHRDVKPANVLLDRNLCPHLADFGLAE 210 (697)
Q Consensus 183 -----------------ivHrDlkp~Nill~~~~~~kL~Dfg~a~ 210 (697)
++|+|++|.|||++.++.+.|+|||.+.
T Consensus 169 ~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 169 ELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 9999999999999877667799999874
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.06 E-value=3.4e-10 Score=118.94 Aligned_cols=142 Identities=15% Similarity=0.207 Sum_probs=107.9
Q ss_pred ccccccccCCceEEEEEEECCeeEEEEecc--CCC-hHHHHHHHHHHHHHHhcC--CCCceEEeeccccC---CceEEEE
Q 005427 69 TLLSPIARGAESVVYEATLDGRKVAVKKPI--LST-SEELDNFHKELQLLCKLD--HPGLAKFVAAHAKP---PNYMFFF 140 (697)
Q Consensus 69 ~~~~~lg~G~~g~V~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--hpniv~l~~~~~~~---~~~~lv~ 140 (697)
.-.+.|+.|.++.||+....+..+++|+.. ... ......+.+|+.+|+.|. +.++++++.++.+. +..++||
T Consensus 41 ~~~~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp CEEEECCC-CCSCEEEEECSSCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred ceEEEcCCcccceEEEEEECCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 346788999999999998877889999765 222 123456889999999996 45678888887766 4589999
Q ss_pred eecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------
Q 005427 141 EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHN---------------------------------------- 180 (697)
Q Consensus 141 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~---------------------------------------- 180 (697)
||++|..+.+... ..++..+...++.++...|..||+
T Consensus 121 e~v~G~~l~~~~~---~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (359)
T 3dxp_A 121 EFVSGRVLWDQSL---PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAM 197 (359)
T ss_dssp ECCCCBCCCCTTC---TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHH
T ss_pred EecCCeecCCCcc---ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHH
Confidence 9999977754221 135778888999999999999997
Q ss_pred ------------------CCcccccCCCCceeecCCCC--Ceeeeeccchhhh
Q 005427 181 ------------------LGIVHRDVKPANVLLDRNLC--PHLADFGLAEYRE 213 (697)
Q Consensus 181 ------------------~~ivHrDlkp~Nill~~~~~--~kL~Dfg~a~~~~ 213 (697)
..++|+|++|.|||++.++. +.|+||+.+..-.
T Consensus 198 ~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g~ 250 (359)
T 3dxp_A 198 DSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLGH 250 (359)
T ss_dssp HHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEEC
T ss_pred HHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccCC
Confidence 35899999999999987653 5899999986443
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.92 E-value=1.2e-09 Score=111.79 Aligned_cols=197 Identities=19% Similarity=0.207 Sum_probs=123.3
Q ss_pred ccccccCCceEEEEEEECCeeEEEEeccCCChHHHHHHHHHHHHHHhc-CCCC--ceEEeeccccCC---ceEEEEeecC
Q 005427 71 LSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKL-DHPG--LAKFVAAHAKPP---NYMFFFEFYE 144 (697)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpn--iv~l~~~~~~~~---~~~lv~e~~~ 144 (697)
.+.++.|....||+.. ..+++|+.. .......+.+|+.+|+.+ .+.. +.+.+....... ..|+||++++
T Consensus 25 i~~~~~G~~n~v~~v~---~~~vlR~~~--~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~ 99 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN---RDFIFKFPK--HSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK 99 (304)
T ss_dssp CCEEEECSSEEEEEST---TSEEEEEES--SHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred eEecCCCCcceEEEEC---CEEEEEecC--CcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence 4568999999999874 568899753 224467789999999888 3332 344555443333 3578999999
Q ss_pred CCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------------
Q 005427 145 SRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHN-------------------------------------------- 180 (697)
Q Consensus 145 ~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~-------------------------------------------- 180 (697)
|..|.+.... .++.++...++.++...+..||+
T Consensus 100 G~~l~~~~~~---~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 176 (304)
T 3sg8_A 100 GVPLTPLLLN---NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDF 176 (304)
T ss_dssp CEECCHHHHH---TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHH
T ss_pred CeECCccccc---cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHH
Confidence 9887653321 45677778888888888888885
Q ss_pred --------------CCcccccCCCCceeecC--CCCCeeeeeccchhhhhhhhhhcccccCCCCCCCCccccccccCccc
Q 005427 181 --------------LGIVHRDVKPANVLLDR--NLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIY 244 (697)
Q Consensus 181 --------------~~ivHrDlkp~Nill~~--~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 244 (697)
..++|+|++|.||+++. ...+.|+||+.+..-....+........ ...+.............
T Consensus 177 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~--~~~~~~~~~~~l~~Y~~ 254 (304)
T 3sg8_A 177 YRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDD--EEYGMEFVSKILNHYKH 254 (304)
T ss_dssp HHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTT--TSCCHHHHHHHHHHHTC
T ss_pred HHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhc--cccCHHHHHHHHHHcCC
Confidence 13699999999999988 4567899999886533222211100000 00000000000000011
Q ss_pred cc-hhhhcccCCCchhhHHHHHHHHHHHHhCCCCCC
Q 005427 245 MA-PEILKKEIHSEKSDVYSFGISINELLTGVVPYT 279 (697)
Q Consensus 245 ~a-PE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~ 279 (697)
.. |+..... ....+.|+++.++|.+.+|..+|-
T Consensus 255 ~~~~~~~~r~--~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 255 KDIPTVLEKY--RMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp SCHHHHHHHH--HHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred CCcHHHHHHH--HHHHHHHHHHHHHHHHHcCCHHHH
Confidence 12 2222111 223689999999999999988874
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.38 E-value=2.1e-06 Score=87.57 Aligned_cols=133 Identities=20% Similarity=0.228 Sum_probs=92.5
Q ss_pred ccccccCCceEEEEEEECCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCC---CceEEeeccc-cCCceEEEEeecCCC
Q 005427 71 LSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP---GLAKFVAAHA-KPPNYMFFFEFYESR 146 (697)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp---niv~l~~~~~-~~~~~~lv~e~~~~g 146 (697)
.+.++.|....||+. +..+++|+. ........+.+|+.+|+.|.+. .+.+.+.+.. ..+..+++|++++|.
T Consensus 24 v~~l~~G~~n~v~~v---g~~~VlR~~--~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~ 98 (306)
T 3tdw_A 24 VESLGEGFRNYAILV---NGDWVFRFP--KSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ 98 (306)
T ss_dssp EEEEEECSSEEEEEE---TTTEEEEEE--SSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred eeecCCCcceeEEEE---CCEEEEEec--CCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence 456788999999988 678899974 2334467889999999999652 3455555553 445678999999998
Q ss_pred CHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---------------------------------------------
Q 005427 147 NLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL--------------------------------------------- 181 (697)
Q Consensus 147 ~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~--------------------------------------------- 181 (697)
.+.+..-. .++..+...++.++...|..||+.
T Consensus 99 ~l~~~~~~---~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~ 175 (306)
T 3tdw_A 99 ILGEDGMA---VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLR 175 (306)
T ss_dssp ECHHHHHT---TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHH
T ss_pred ECchhhhh---hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHH
Confidence 77653211 234444555555555555555532
Q ss_pred ---------------CcccccCCCCceeecC---CCCC-eeeeeccchh
Q 005427 182 ---------------GIVHRDVKPANVLLDR---NLCP-HLADFGLAEY 211 (697)
Q Consensus 182 ---------------~ivHrDlkp~Nill~~---~~~~-kL~Dfg~a~~ 211 (697)
.++|+|++|.|||++. ++.+ .|+||+.+..
T Consensus 176 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 176 FQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 3589999999999987 4554 7999998753
|
| >3eq2_A Probable two-component response regulator; adaptor sigmas, signaling protein; 3.40A {Pseudomonas aeruginosa} PDB: 3f7a_A | Back alignment and structure |
|---|
Probab=98.38 E-value=2.4e-06 Score=90.56 Aligned_cols=183 Identities=17% Similarity=0.128 Sum_probs=98.2
Q ss_pred CCCceeEEcccccCCCceEEEEEecCCC-ChHHHHHHH---HHhHHHHHhcCC-----CCChHHHHHHHHHHHHHHHHHH
Q 005427 442 TMEDTHFLMPHMYNQKEIHMFGIFDGHR-GSAAAEFSA---RALPGFLQNLGS-----TTRPTDALLEAFIRTDVAFRNE 512 (697)
Q Consensus 442 ~neD~~~~~~~~~~~~~~~~~~V~DG~G-G~~~~~~as---~~~~~~l~~~~~-----~~~~~~~l~~~~~~~~~~~~~~ 512 (697)
..-|.+-+.. ...+...++|+|+.| |-.+|-.++ ..+...+..... ...+. +.+..++..+...
T Consensus 189 vgGD~yd~~~---~~~~~~~~~i~Dv~GhGv~aa~~~~~~~~~~~~~~~~~~~~~~~~~~~p~----~~l~~ln~~l~~~ 261 (394)
T 3eq2_A 189 LSGDFVDYFR---VDERRVAFYLADVSGHGASSAFVTVLLKFMTTRLLYESRRNGTLPEFKPS----EVLAHINRGLINT 261 (394)
T ss_dssp -CCCEEECCE---ETTTEEEEEEEEESSCSTTTHHHHHHHHHHHHHHHHHSCSSCSSSSCCHH----HHHHHHHHHHHHT
T ss_pred cCccEEeEEE---eCCCcEEEEEEECCCCChHHHHHHHHHHHHHHHHHHhhhccCCcccCCHH----HHHHHHHHHHhcc
Confidence 3446664432 133567899999888 555543322 122222222111 11222 2333344444321
Q ss_pred HHHHHhhhhcccCCCCCCceEEEEEEe--cCeEEEEEcCCeE-EEEEECCeeeecCCCCCCCCHHHHHHHHHcCCeeeec
Q 005427 513 LDSLRKSKRVVQKDWHPGCTAIAALIV--RNRLFVANAGDCR-AILCRGGHPFALSRDHVASCLEERERVVSAGGNVNWQ 589 (697)
Q Consensus 513 ~~~~~~~~~~~~~~~~~GtT~~~~~i~--~~~l~~anvGDSr-~~l~~~~~~~~lt~dH~~~~~~e~~ri~~~g~~~~~~ 589 (697)
...+..|++.++++ .+++.++|+|-.. .++.++|.+..+.....
T Consensus 262 -------------~~~~~~t~~~~~~d~~~~~l~~~~aGh~p~~~~~~~g~~~~l~~~~~-------------------- 308 (394)
T 3eq2_A 262 -------------KLGKHVTMLGGVIDLEKNSLTYSIGGHLPLPVLFVEGQAGYLEGRGL-------------------- 308 (394)
T ss_dssp -------------TCCCCEEEEEEEEETTTTEEEEEECSSSCCCEEEETTEEEECCCC----------------------
T ss_pred -------------CcCcEEEEEEEEEECCCCEEEEEcCCCCCCcEEecCCceEecCCCCc--------------------
Confidence 11357899999987 5689999999754 67778888776653320
Q ss_pred cCcceeCCCcceeccccCCCCCCCCcccCCceEEEEeCCCCeEEEEEcCCcccCCCh-------HHHHHHHHhhcCChhH
Q 005427 590 VDTWRVGPPALQVTRSIGDDDLKPAVTAEPEITETIMTPEDEYLVMASDGLWDVVSH-------VEAVGIIKDTVKEPGM 662 (697)
Q Consensus 590 ~~~~~~~~~~~~ltralG~~~~k~~v~~~p~v~~~~l~~~d~~lvl~SDGl~d~~~~-------~ei~~~~~~~~~~~~~ 662 (697)
.+|-.. ........+.+.+|| .|+|.||||.|.... +.+.+++......+
T Consensus 309 ---------------plG~~~-----~~~~~~~~~~l~~gd-~l~l~TDG~~e~~~~~~~~~~~~~l~~~l~~~~~~~-- 365 (394)
T 3eq2_A 309 ---------------PVGLFD-----DATYDDRVMELPPSF-SLSLFSDGILDVLPGATLKEKEASLPEQVAAAGGTL-- 365 (394)
T ss_dssp ---------------CCSCCC-----CC--CCEEEECCSSC-EEEECSSCCCC-----CCSTTTTTSHHHHHTTC--C--
T ss_pred ---------------eeEecC-----CCceEEEEEEeCCCC-EEEEECCCcccccCcccchhhHHHHHHHHHhcchhH--
Confidence 123222 223445678999999 777999999997433 45566665533223
Q ss_pred HHHHHHHHHHhc---CCCCCcEEEEEEeCC
Q 005427 663 CSKRLATEAAER---GSKDNITVIVVFLQP 689 (697)
Q Consensus 663 ~a~~L~~~a~~~---g~~DNiT~ivv~l~~ 689 (697)
+.|.+..... ...||+|+++++..+
T Consensus 366 --~~l~~~~~~~~~~~~~DDit~l~i~~~~ 393 (394)
T 3eq2_A 366 --DGLRQVFGLANLAEMPDDIALLVLSRNL 393 (394)
T ss_dssp --HHHHHHHSCCCSCC--CCCEEEEEC---
T ss_pred --HHHHHHhcccCCCCCCCceEEEEEeccc
Confidence 3333333222 235999999998653
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.20 E-value=5.1e-06 Score=82.98 Aligned_cols=129 Identities=17% Similarity=0.133 Sum_probs=93.2
Q ss_pred cccCCce-EEEEEEE--CCeeEEEEeccCCChHHHHHHHHHHHHHHhcC-CCCceEEeeccccCCceEEEEeecCCCCHh
Q 005427 74 IARGAES-VVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLD-HPGLAKFVAAHAKPPNYMFFFEFYESRNLA 149 (697)
Q Consensus 74 lg~G~~g-~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lv~e~~~~g~L~ 149 (697)
+..|..| .||+... .+..+++|.... .....+.+|...|+.|. +-.+.+++.++.+++..++|||+++|.++.
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~ 108 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAF 108 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHH
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccc
Confidence 4445555 6898765 356789997532 24456889999999884 334677888888888999999999998877
Q ss_pred hhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC------------------------------------------------
Q 005427 150 EKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL------------------------------------------------ 181 (697)
Q Consensus 150 ~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~------------------------------------------------ 181 (697)
+...... .....+..++...|..||..
T Consensus 109 ~~~~~~~-----~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 183 (272)
T 4gkh_A 109 QVLEEYP-----DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEM 183 (272)
T ss_dssp HHHHHCG-----GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHH
T ss_pred ccccCCH-----HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHH
Confidence 7653221 22334556666666666631
Q ss_pred ----------CcccccCCCCceeecCCCCCeeeeeccch
Q 005427 182 ----------GIVHRDVKPANVLLDRNLCPHLADFGLAE 210 (697)
Q Consensus 182 ----------~ivHrDlkp~Nill~~~~~~kL~Dfg~a~ 210 (697)
.++|+|+.+.|||++.++.+-|+||+.+.
T Consensus 184 ~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 184 HKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 16899999999999987777799999874
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.15 E-value=2.2e-06 Score=89.59 Aligned_cols=80 Identities=9% Similarity=0.074 Sum_probs=55.4
Q ss_pred ccccc-ccCCceEEEEEEEC--------CeeEEEEeccCCC---hHHHHHHHHHHHHHHhcC-C--CCceEEeeccccC-
Q 005427 70 LLSPI-ARGAESVVYEATLD--------GRKVAVKKPILST---SEELDNFHKELQLLCKLD-H--PGLAKFVAAHAKP- 133 (697)
Q Consensus 70 ~~~~l-g~G~~g~V~~~~~~--------~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h--pniv~l~~~~~~~- 133 (697)
..+.| +.|....+|+.... +..+++|...... ......+.+|+.+|+.|. + -.+.+++.++.+.
T Consensus 24 ~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~ 103 (357)
T 3ats_A 24 VESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGD 103 (357)
T ss_dssp EEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSST
T ss_pred EEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCC
Confidence 45677 88889999998764 6788999754321 001245678999988884 2 3567777776554
Q ss_pred --CceEEEEeecCCCCHh
Q 005427 134 --PNYMFFFEFYESRNLA 149 (697)
Q Consensus 134 --~~~~lv~e~~~~g~L~ 149 (697)
+..++|||+++|..+.
T Consensus 104 ~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 104 VLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TTSSCEEEEECCCCBCCC
T ss_pred ccCCceEEEEecCCCChh
Confidence 3578999999986654
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=98.04 E-value=5.8e-05 Score=70.50 Aligned_cols=135 Identities=19% Similarity=0.110 Sum_probs=93.7
Q ss_pred CHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhcccccC
Q 005427 147 NLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHN-LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRS 225 (697)
Q Consensus 147 ~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~ 225 (697)
+|.++|...+.+++++++|.++.|.+.+|.-+-. +.-..+=+.|..|++..+|.|.+.+ ..+.
T Consensus 34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~--------------- 97 (229)
T 2yle_A 34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD--------------- 97 (229)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C------------------
T ss_pred cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc---------------
Confidence 7999999999999999999999999999887722 1212334456889999999887664 1110
Q ss_pred CCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHHHHHHH
Q 005427 226 SGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVV 305 (697)
Q Consensus 226 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (697)
.....+.+||... ...+.+.=|||||+++|..+--..|-+
T Consensus 98 -------------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e~-------------------------- 137 (229)
T 2yle_A 98 -------------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKEN-------------------------- 137 (229)
T ss_dssp ----------------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCTT--------------------------
T ss_pred -------------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCcc--------------------------
Confidence 1123456787763 345678899999999999987433321
Q ss_pred hCCCCCcccccccCChHHHHHHHHHhccC-------------------------CCCCCCCHHHHHH
Q 005427 306 SGGLRPILASLELGLPASILSLIQRCWDG-------------------------NPHNRPSFSDIAL 347 (697)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~-------------------------dP~~Rpt~~ell~ 347 (697)
.+..+|+.|.+||..|... .+..|+++++|++
T Consensus 138 ----------eE~eLS~~LE~LL~~Mt~~~~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~ 194 (229)
T 2yle_A 138 ----------EERELSPPLEQLIDHMANTVEADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMK 194 (229)
T ss_dssp ----------EEECCCHHHHHHHHHHTTCCC--------------------CCSCCCCCCSHHHHHH
T ss_pred ----------cchhhCHHHHHHHHHHHhcccccccccccccccccccccccccccccCcCCHHHHHH
Confidence 2457899999999999755 3568889998874
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.95 E-value=1.3e-05 Score=84.95 Aligned_cols=75 Identities=13% Similarity=0.135 Sum_probs=49.7
Q ss_pred cccccccCCceEEEEEEE--CCeeEEEEeccCCCh-------HHHHHHHHHHHHHHhcCC--CC-ceEEeeccccCCceE
Q 005427 70 LLSPIARGAESVVYEATL--DGRKVAVKKPILSTS-------EELDNFHKELQLLCKLDH--PG-LAKFVAAHAKPPNYM 137 (697)
Q Consensus 70 ~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h--pn-iv~l~~~~~~~~~~~ 137 (697)
-.+.||.|.++.||++.. .++.++||....... ...+++..|.++|+.+.. |. +.+++.+ ++...+
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~ 111 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV 111 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence 356899999999999954 567899997432211 123456789999988742 33 4455543 345678
Q ss_pred EEEeecCCC
Q 005427 138 FFFEFYESR 146 (697)
Q Consensus 138 lv~e~~~~g 146 (697)
+|||++.+.
T Consensus 112 lvmE~l~g~ 120 (397)
T 2olc_A 112 TVMEDLSHL 120 (397)
T ss_dssp EEECCCTTS
T ss_pred EEEEeCCCc
Confidence 999999864
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.92 E-value=6.8e-05 Score=77.48 Aligned_cols=136 Identities=13% Similarity=0.141 Sum_probs=79.3
Q ss_pred ccccccCCceEEEEEEECCeeEEEEeccCCChHHHHHHHHHHHHHHhcC--CCCceEEeec------cccCCceEEEEee
Q 005427 71 LSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLD--HPGLAKFVAA------HAKPPNYMFFFEF 142 (697)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--hpniv~l~~~------~~~~~~~~lv~e~ 142 (697)
.+.|+.|..+.||++...+..+++|+... .. ..+..|..+++.|. .-.+++++.. ....+..+++|+|
T Consensus 37 ~~~l~gG~~n~~~~v~~~~~~~vlk~~~~-~~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTDSGAVCLKRIHR-PE---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EEECC----CEEEEEEETTEEEEEEEECS-CH---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeeccccccCcEEEEEeCCCCEEEEecCC-CH---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 34566677889999988777799998654 22 23445666666553 1133344331 1235678899999
Q ss_pred cCCCCHh--------------hhhhhcC--C--C---------CCHHH-------------------------------H
Q 005427 143 YESRNLA--------------EKLHVEE--W--S---------PSVDQ-------------------------------V 164 (697)
Q Consensus 143 ~~~g~L~--------------~~l~~~~--~--~---------~~~~~-------------------------------~ 164 (697)
++|..+. ..++... . . ..+.. .
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9985432 1122110 0 0 01111 0
Q ss_pred HHHHHHHHHHHHHHHh-------------CCcccccCCCCceeecCCCCCeeeeeccch
Q 005427 165 LMIAAQLAKALQYLHN-------------LGIVHRDVKPANVLLDRNLCPHLADFGLAE 210 (697)
Q Consensus 165 ~~i~~qi~~~l~~LH~-------------~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~ 210 (697)
..+..++..++.+|++ .+++|+|+++.|||++.++.+.|+||+.+.
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 1111223345666652 579999999999999888889999999774
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.61 E-value=0.00014 Score=77.51 Aligned_cols=74 Identities=9% Similarity=0.119 Sum_probs=45.8
Q ss_pred cccccccCCceEEEEEEECCeeEEEEeccC-----CCh----HHHHHHHHHHHHHHh-cCCCCceEEeeccccCCceEEE
Q 005427 70 LLSPIARGAESVVYEATLDGRKVAVKKPIL-----STS----EELDNFHKELQLLCK-LDHPGLAKFVAAHAKPPNYMFF 139 (697)
Q Consensus 70 ~~~~lg~G~~g~V~~~~~~~~~vavK~~~~-----~~~----~~~~~~~~E~~~l~~-l~hpniv~l~~~~~~~~~~~lv 139 (697)
-.+.||.|..+.||++...++.++||.... ... .....+..|+..+.. .....+++++.+. ++..++|
T Consensus 38 ~i~~l~~G~~n~vyrv~~~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~lv 115 (420)
T 2pyw_A 38 VIKEVGDGNLNFVFIVVGSSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALIG 115 (420)
T ss_dssp EEEECCCSSSCEEEEEECSSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEEE
T ss_pred EEEEccCCCcEEEEEEEcCCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEEE
Confidence 356789999999999987778899993211 110 122233334333221 2234566666654 5678999
Q ss_pred Eeec-CC
Q 005427 140 FEFY-ES 145 (697)
Q Consensus 140 ~e~~-~~ 145 (697)
|||+ ++
T Consensus 116 ~e~l~~g 122 (420)
T 2pyw_A 116 MRYLEPP 122 (420)
T ss_dssp ECCCCTT
T ss_pred EeecCCc
Confidence 9999 76
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.54 E-value=0.00025 Score=71.88 Aligned_cols=76 Identities=13% Similarity=0.050 Sum_probs=60.9
Q ss_pred cccccccCCceEEEEEEECCeeEEEEeccCCChHHHHHHHHHHHHHHhcC---CCCceEEeeccccCCceEEEEeecCCC
Q 005427 70 LLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLD---HPGLAKFVAAHAKPPNYMFFFEFYESR 146 (697)
Q Consensus 70 ~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~l~~~~~~~~~~~lv~e~~~~g 146 (697)
-.+.|+.|....+|+....+..+++|..... ....+..|+..|+.|. ...+++.+.+....+..++||||++|.
T Consensus 40 ~~~~l~gG~~n~~y~v~~~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~ 116 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLINDEVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS 116 (312)
T ss_dssp EEEEECCSSSSEEEEEESSSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred eeEEeCCccceeeeEEEECCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence 3567899999999999887888999975432 3567889999999883 356788888877778899999999987
Q ss_pred CH
Q 005427 147 NL 148 (697)
Q Consensus 147 ~L 148 (697)
.+
T Consensus 117 ~~ 118 (312)
T 3jr1_A 117 KN 118 (312)
T ss_dssp CC
T ss_pred CC
Confidence 54
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.14 E-value=0.001 Score=66.79 Aligned_cols=78 Identities=15% Similarity=0.116 Sum_probs=56.3
Q ss_pred CCcccccccccCCceEEEEEEE-CCeeEEEEeccCCChHHHHHHHHHHHHHHhcCC---CCceEEeeccccCCceEEEEe
Q 005427 66 SSYTLLSPIARGAESVVYEATL-DGRKVAVKKPILSTSEELDNFHKELQLLCKLDH---PGLAKFVAAHAKPPNYMFFFE 141 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---pniv~l~~~~~~~~~~~lv~e 141 (697)
.+..-++.+|.|..+.||+.+. +|+.|.+|+...........+..|+..|+.|.- -.+++.+++. ..++|||
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e 90 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAME 90 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEE
T ss_pred CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEE
Confidence 4556678899999999999987 688999998554433334467899999998842 2345555542 3478999
Q ss_pred ecCCCC
Q 005427 142 FYESRN 147 (697)
Q Consensus 142 ~~~~g~ 147 (697)
|+.++.
T Consensus 91 ~l~~~~ 96 (288)
T 3f7w_A 91 WVDERP 96 (288)
T ss_dssp CCCCCC
T ss_pred eecccC
Confidence 988754
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.05 E-value=0.00075 Score=68.91 Aligned_cols=139 Identities=18% Similarity=0.189 Sum_probs=78.8
Q ss_pred cccccccCCceEEEEEEECCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCC--ceEEeecc------ccCCceEEEEe
Q 005427 70 LLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPG--LAKFVAAH------AKPPNYMFFFE 141 (697)
Q Consensus 70 ~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn--iv~l~~~~------~~~~~~~lv~e 141 (697)
-.+.|+.|....+|+....+..+++|..... ...+.+..|+.+++.|.... +.+++... ...+..+++++
T Consensus 26 ~~~~i~~G~~n~~~~v~~~~g~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~ 103 (322)
T 2ppq_A 26 SYKGIAEGVENSNFLLHTTKDPLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALIS 103 (322)
T ss_dssp EEEEECC---EEEEEEEESSCCEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEE
T ss_pred EeeccCCCcccceEEEEeCCccEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEE
Confidence 3567788888999999876668889976542 12234567888887773212 33333221 12356789999
Q ss_pred ecCCCCHhh--------------hhhhc--CCC------CC---HHHHHH------------HHHHHHHHHHHHHh----
Q 005427 142 FYESRNLAE--------------KLHVE--EWS------PS---VDQVLM------------IAAQLAKALQYLHN---- 180 (697)
Q Consensus 142 ~~~~g~L~~--------------~l~~~--~~~------~~---~~~~~~------------i~~qi~~~l~~LH~---- 180 (697)
|++|..+.. .++.. ... .. +..... +...+...+..+..
T Consensus 104 ~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~ 183 (322)
T 2ppq_A 104 FLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPK 183 (322)
T ss_dssp CCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCC
T ss_pred eCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcc
Confidence 998854311 12211 100 01 111000 00113344555542
Q ss_pred ---CCcccccCCCCceeecCCCCCeeeeeccch
Q 005427 181 ---LGIVHRDVKPANVLLDRNLCPHLADFGLAE 210 (697)
Q Consensus 181 ---~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~ 210 (697)
.+++|+|+++.|||++.++.+.|+||+.+.
T Consensus 184 ~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 184 DLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp SSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 368999999999999887666899999774
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.88 E-value=0.0014 Score=67.25 Aligned_cols=135 Identities=15% Similarity=0.133 Sum_probs=69.9
Q ss_pred cccccCCceE-EEEEEEC-CeeEEEEeccCCChHHHHHHHHHHHHHHhcCC--CCceEEeeccccCCceEEEEeecCCCC
Q 005427 72 SPIARGAESV-VYEATLD-GRKVAVKKPILSTSEELDNFHKELQLLCKLDH--PGLAKFVAAHAKPPNYMFFFEFYESRN 147 (697)
Q Consensus 72 ~~lg~G~~g~-V~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--pniv~l~~~~~~~~~~~lv~e~~~~g~ 147 (697)
+.|+.|.... +|+.... +..+++|....... ..+..|+.+++.|.. -.+.+++.+....+ +++||++.+..
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcc
Confidence 3555554444 6677653 66777776433211 234567777777632 23455665533332 78999997766
Q ss_pred Hhhhhhhc---------------------C----CCCCHHHHHH--------HH------------HHHHHHHHHH----
Q 005427 148 LAEKLHVE---------------------E----WSPSVDQVLM--------IA------------AQLAKALQYL---- 178 (697)
Q Consensus 148 L~~~l~~~---------------------~----~~~~~~~~~~--------i~------------~qi~~~l~~L---- 178 (697)
+.+.+... . ..+....... +. ..+...+..+
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 54332210 0 0111111100 00 0111222333
Q ss_pred --HhCCcccccCCCCceeecCC----CCCeeeeeccchh
Q 005427 179 --HNLGIVHRDVKPANVLLDRN----LCPHLADFGLAEY 211 (697)
Q Consensus 179 --H~~~ivHrDlkp~Nill~~~----~~~kL~Dfg~a~~ 211 (697)
+...++|+|+.+.|||++.+ +.+.|+||+.+..
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 23469999999999999874 6789999998854
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.87 E-value=0.0016 Score=65.84 Aligned_cols=71 Identities=15% Similarity=0.216 Sum_probs=44.6
Q ss_pred ccccccCCceEEEEEEECCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCc-eEEeeccccCCceEEEEeec-CCCCH
Q 005427 71 LSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGL-AKFVAAHAKPPNYMFFFEFY-ESRNL 148 (697)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpni-v~l~~~~~~~~~~~lv~e~~-~~g~L 148 (697)
.+.|+.|....+|+. ..+++|+..... ...-...+|+.+++.+....+ .+++..+ +..-++++||+ +|..+
T Consensus 23 i~~l~gG~tN~~~~~----~~~vlR~~~~~~-~~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~~l 95 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA----GDLCLRIPGKGT-EEYINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQTM 95 (301)
T ss_dssp CEEEESCSSEEEEEE----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCEEC
T ss_pred eeEcCCcccccccee----eeEEEECCCCCc-cceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCccC
Confidence 778999999999999 678888754321 111123568888887742222 4555543 33457899999 65443
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.80 E-value=0.0023 Score=68.13 Aligned_cols=71 Identities=17% Similarity=0.169 Sum_probs=48.5
Q ss_pred ccccccCCceEEEEEEEC---------CeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCC-ceEEeeccccCCceEEEE
Q 005427 71 LSPIARGAESVVYEATLD---------GRKVAVKKPILSTSEELDNFHKELQLLCKLDHPG-LAKFVAAHAKPPNYMFFF 140 (697)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn-iv~l~~~~~~~~~~~lv~ 140 (697)
++.|+.|....||++... ++.+++|+...... .+.+..|..+++.|...+ .+++++.+.+ .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~--~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET--ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC--HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc--HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 457888888999999864 46889998633221 134557999999884333 3567766543 3899
Q ss_pred eecCCCC
Q 005427 141 EFYESRN 147 (697)
Q Consensus 141 e~~~~g~ 147 (697)
||++|..
T Consensus 152 e~l~G~~ 158 (429)
T 1nw1_A 152 EYIPSRP 158 (429)
T ss_dssp CCCCEEE
T ss_pred EEeCCcc
Confidence 9998643
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.68 E-value=0.0026 Score=66.17 Aligned_cols=134 Identities=19% Similarity=0.241 Sum_probs=80.2
Q ss_pred cccccCCceEEEEEEEC---------CeeEEEEeccCCChHHHHHHHHHHHHHHhcC-CCCceEEeeccccCCceEEEEe
Q 005427 72 SPIARGAESVVYEATLD---------GRKVAVKKPILSTSEELDNFHKELQLLCKLD-HPGLAKFVAAHAKPPNYMFFFE 141 (697)
Q Consensus 72 ~~lg~G~~g~V~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lv~e 141 (697)
+.|.-|-...+|++... ++.+.+|+.-. .......+.+|..+++.|. +.-..++++.+.+ .+|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~-~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA-ILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC-ccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 45666777889998763 36788987422 1223455678999998884 3333566776654 28999
Q ss_pred ecCCCCHhh--------------h---hhhcC----CCCC--HHHHHHHHHHHHH-------------------HHHHHH
Q 005427 142 FYESRNLAE--------------K---LHVEE----WSPS--VDQVLMIAAQLAK-------------------ALQYLH 179 (697)
Q Consensus 142 ~~~~g~L~~--------------~---l~~~~----~~~~--~~~~~~i~~qi~~-------------------~l~~LH 179 (697)
|++|..|.. . ++... ..+. +.++..++.++-. .+..|.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 998854421 0 12111 1122 3455555544322 233332
Q ss_pred ----hC----CcccccCCCCceeecCC----CCCeeeeeccch
Q 005427 180 ----NL----GIVHRDVKPANVLLDRN----LCPHLADFGLAE 210 (697)
Q Consensus 180 ----~~----~ivHrDlkp~Nill~~~----~~~kL~Dfg~a~ 210 (697)
.. .++|+|+.+.|||++.+ +.+.|+||..+.
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 22 48999999999999876 789999999875
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.54 E-value=0.0033 Score=65.48 Aligned_cols=72 Identities=14% Similarity=0.114 Sum_probs=43.7
Q ss_pred ccccccCCceEEEEEEECC----------eeEEEEeccCCChHHHHHHHHHHHHHHhcCCCC-ceEEeeccccCCceEEE
Q 005427 71 LSPIARGAESVVYEATLDG----------RKVAVKKPILSTSEELDNFHKELQLLCKLDHPG-LAKFVAAHAKPPNYMFF 139 (697)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~~----------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn-iv~l~~~~~~~~~~~lv 139 (697)
.+.|+.|....+|+....+ ..+++|+.... .........|..+++.|...+ ..++++.+. -++|
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~-~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~~----~~~v 112 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKH-VDELYNTISEFEVYKTMSKYKIAPQLLNTFN----GGRI 112 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTT-GGGTSCHHHHHHHHHHHHHTTSSCCEEEEET----TEEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCC-ccceecHHHHHHHHHHHHhcCCCCceEEecC----CcEE
Confidence 4567788888999998754 67888875432 122112367888888884333 445665542 3689
Q ss_pred EeecCCCC
Q 005427 140 FEFYESRN 147 (697)
Q Consensus 140 ~e~~~~g~ 147 (697)
|+|++|..
T Consensus 113 ~e~i~G~~ 120 (369)
T 3c5i_A 113 EEWLYGDP 120 (369)
T ss_dssp EECCCSEE
T ss_pred EEEecCCc
Confidence 99998743
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.36 E-value=0.0076 Score=64.43 Aligned_cols=73 Identities=18% Similarity=0.171 Sum_probs=47.0
Q ss_pred ccccccCCceEEEEEEECC--eeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCc-eEEeeccccCCceEEEEeecCCCC
Q 005427 71 LSPIARGAESVVYEATLDG--RKVAVKKPILSTSEELDNFHKELQLLCKLDHPGL-AKFVAAHAKPPNYMFFFEFYESRN 147 (697)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpni-v~l~~~~~~~~~~~lv~e~~~~g~ 147 (697)
++.|+.|-...+|++...+ ..+++|+...... ..-.-.+|..+|+.|...++ +++++++.. .+|+||++|..
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~-~~idR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTD-EIINREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CC-SCSCHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChh-hhcCHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCCcc
Confidence 4567888889999999865 8899997532211 11112589999999965444 567776632 35999998744
Q ss_pred H
Q 005427 148 L 148 (697)
Q Consensus 148 L 148 (697)
|
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.18 E-value=0.01 Score=60.46 Aligned_cols=135 Identities=21% Similarity=0.226 Sum_probs=76.4
Q ss_pred cccccCCceEEEEEEE-CCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCC--CceEEeec-----cccCCceEEEEeec
Q 005427 72 SPIARGAESVVYEATL-DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP--GLAKFVAA-----HAKPPNYMFFFEFY 143 (697)
Q Consensus 72 ~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp--niv~l~~~-----~~~~~~~~lv~e~~ 143 (697)
..|+ |....||+... +|+.+++|...... .....+..|..+++.|... .+++++.. ....+..+++|+++
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 3456 77889999876 45679999865321 1234566788888887422 23444433 11234567899999
Q ss_pred CCCCHh-----h------h---hhhc--C------CCCCHHHH----------------------HHHHHHHHHHHHHH-
Q 005427 144 ESRNLA-----E------K---LHVE--E------WSPSVDQV----------------------LMIAAQLAKALQYL- 178 (697)
Q Consensus 144 ~~g~L~-----~------~---l~~~--~------~~~~~~~~----------------------~~i~~qi~~~l~~L- 178 (697)
+|..+. . . ++.. . ...+.... ...+..++..+.-+
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 874321 0 0 1110 0 01111110 11111222222222
Q ss_pred ---HhCCcccccCCCCceeecCCCCCeeeeeccch
Q 005427 179 ---HNLGIVHRDVKPANVLLDRNLCPHLADFGLAE 210 (697)
Q Consensus 179 ---H~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~ 210 (697)
....++|+|+++.|||++ + .+.|+||+.+.
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~ 222 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDAR 222 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence 123589999999999998 4 78999999774
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.05 E-value=0.014 Score=59.99 Aligned_cols=68 Identities=10% Similarity=0.097 Sum_probs=43.2
Q ss_pred ccCCceEEEEEEECCeeEEEEeccCCChHHHHHHHHHHHHHHhcC---CCCceEEeec------cccCCceEEEEeecCC
Q 005427 75 ARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLD---HPGLAKFVAA------HAKPPNYMFFFEFYES 145 (697)
Q Consensus 75 g~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~l~~~------~~~~~~~~lv~e~~~~ 145 (697)
|.|....||+....+..+++|+...... ..|+.+++.|. -|++++.+.. ....+..+++|+|++|
T Consensus 32 G~g~~N~vy~v~~~~g~~vLK~~~~~~~------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G 105 (339)
T 3i1a_A 32 GADTNAFAYQADSESKSYFIKLKYGYHD------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHA 105 (339)
T ss_dssp TSCSSCEEEEEECSSCEEEEEEEECSSC------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCC
T ss_pred cCccccceEEEEeCCCCEEEEEecCccc------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCC
Confidence 4444679999986545899997554331 35666666662 2224454432 1234678899999998
Q ss_pred CCH
Q 005427 146 RNL 148 (697)
Q Consensus 146 g~L 148 (697)
..+
T Consensus 106 ~~~ 108 (339)
T 3i1a_A 106 PNG 108 (339)
T ss_dssp CBT
T ss_pred CcC
Confidence 655
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.02 E-value=0.028 Score=59.28 Aligned_cols=72 Identities=11% Similarity=0.080 Sum_probs=46.8
Q ss_pred ccccccCCceEEEEEEEC---------CeeEEEEeccCCChHHHHHHHHHHHHHHhcC-CCCceEEeeccccCCceEEEE
Q 005427 71 LSPIARGAESVVYEATLD---------GRKVAVKKPILSTSEELDNFHKELQLLCKLD-HPGLAKFVAAHAKPPNYMFFF 140 (697)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lv~ 140 (697)
++.|..|-...+|+.... ++.+++++..... ...-...+|..+++.|. +.-..++++.+. -++|+
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEE
Confidence 456667888899999875 5789999753322 11112357888888884 333455665442 37899
Q ss_pred eecCCCC
Q 005427 141 EFYESRN 147 (697)
Q Consensus 141 e~~~~g~ 147 (697)
+|++|..
T Consensus 150 efI~G~~ 156 (424)
T 3mes_A 150 EFIDGEP 156 (424)
T ss_dssp ECCCSEE
T ss_pred EEeCCcc
Confidence 9999854
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=90.07 E-value=0.2 Score=52.51 Aligned_cols=29 Identities=31% Similarity=0.521 Sum_probs=24.8
Q ss_pred cccccCCCCceee------cCCCCCeeeeeccchh
Q 005427 183 IVHRDVKPANVLL------DRNLCPHLADFGLAEY 211 (697)
Q Consensus 183 ivHrDlkp~Nill------~~~~~~kL~Dfg~a~~ 211 (697)
++|+|+.+.|||+ +.+..++++||.+|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6899999999999 4467799999998853
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=82.94 E-value=2.9 Score=38.94 Aligned_cols=117 Identities=9% Similarity=0.108 Sum_probs=76.8
Q ss_pred CCCCceEEeeccccCCceEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCC
Q 005427 119 DHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRN 198 (697)
Q Consensus 119 ~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~ 198 (697)
.||++++. .+-.+.+.+.+.++.-..+.=+..++ ..+....++++.+|+....+++. =+|--|+|+|++++.+
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik----~~~~~eKlr~l~ni~~l~~~~~~--r~tf~L~P~NL~f~~~ 115 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIK----SFTKNEKLRYLLNIKNLEEVNRT--RYTFVLAPDELFFTRD 115 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGG----GSCHHHHHHHHHHGGGGGGGGGS--SEECCCSGGGEEECTT
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHHHH----hcCHHHHHHHHHHHHHHHHHhcC--ceEEEEecceEEEcCC
Confidence 68888876 45555566666555543222222232 35678899999999887755443 4678899999999999
Q ss_pred CCCeeeeeccchhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCC
Q 005427 199 LCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY 278 (697)
Q Consensus 199 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf 278 (697)
+.+++.=.|+-.. ++|. ..+...=.-.+=|++..+++++..|
T Consensus 116 ~~p~i~~RGik~~---------------------------------l~P~-----~~~ee~fL~qyKAliiall~~K~~F 157 (215)
T 4ann_A 116 GLPIAKTRGLQNV---------------------------------VDPL-----PVSEAEFLTRYKALVICAFNEKQSF 157 (215)
T ss_dssp SCEEESCCEETTT---------------------------------BSCC-----CCCHHHHHHHHHHHHHHHHCTTCCH
T ss_pred CCEEEEEccCccC---------------------------------CCCC-----CCCHHHHHHHHHHHHHHHHcCCCCH
Confidence 9999988775321 1221 1122222334778889999998888
Q ss_pred CC
Q 005427 279 TD 280 (697)
Q Consensus 279 ~~ 280 (697)
..
T Consensus 158 e~ 159 (215)
T 4ann_A 158 DA 159 (215)
T ss_dssp HH
T ss_pred HH
Confidence 54
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 697 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-63 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-53 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-52 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-52 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-51 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-50 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 6e-50 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-49 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-49 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-49 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 4e-49 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 6e-49 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-48 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-48 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-48 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-48 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-47 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-47 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-47 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 5e-47 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 5e-47 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-46 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-46 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-46 | |
| d1a6qa2 | 295 | d.219.1.1 (A:2-296) Protein serine/threonine phosp | 2e-46 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-46 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-46 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-45 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-45 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-45 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-44 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-44 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 5e-44 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-43 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 5e-43 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-42 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 4e-42 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-41 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-41 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 4e-41 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 4e-41 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-41 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-39 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-39 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 4e-39 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 7e-39 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 8e-39 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-38 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-38 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 7e-38 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-37 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 5e-37 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 6e-37 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-36 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-36 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-35 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-35 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-35 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-34 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 6e-33 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 5e-32 | |
| d1txoa_ | 235 | d.219.1.1 (A:) putative serine/threonine phosphata | 2e-30 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 7e-30 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-26 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-18 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (533), Expect = 4e-63
Identities = 80/298 (26%), Positives = 135/298 (45%), Gaps = 34/298 (11%)
Query: 63 LPPSSYTLLSPIARGAESVVYEATLDGRKVAVK--KPILSTSEELDNFHKELQLLCKLDH 120
+P T+ I G+ VY+ G VAVK T ++L F E+ +L K H
Sbjct: 5 IPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRH 63
Query: 121 PGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHN 180
+ F+ P + ++ E +L LH+ E + +++ IA Q A+ + YLH
Sbjct: 64 VNILLFMGYSTAPQLAIVT-QWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 122
Query: 181 LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
I+HRD+K N+ L +L + DFGLA + +G + + G
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGLA--------------TVKSRWSGSHQFEQLSG 168
Query: 241 TLIYMAPEILK---KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTE 297
++++MAPE+++ K +S +SDVY+FGI + EL+TG +PY+++
Sbjct: 169 SILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN-------------NR 215
Query: 298 QQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH 355
Q+ V G L P L+ + P ++ L+ C RP F I ++L+
Sbjct: 216 DQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (464), Expect = 2e-53
Identities = 67/296 (22%), Positives = 116/296 (39%), Gaps = 42/296 (14%)
Query: 63 LPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPG 122
L LL I +G V G KVAVK + F E ++ +L H
Sbjct: 4 LNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVK--CIKNDATAQAFLAEASVMTQLRHSN 61
Query: 123 LAKFVAAHAKPPNYMFF-FEFYESRNLAEKLHVEEWSP-SVDQVLMIAAQLAKALQYLHN 180
L + + + ++ E+ +L + L S D +L + + +A++YL
Sbjct: 62 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 121
Query: 181 LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
VHRD+ NVL+ + ++DFGL + + +
Sbjct: 122 NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS-------------------TQDTGKL 162
Query: 241 TLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQ 299
+ + APE L+++ S KSDV+SFGI + E+ + G VPY + +
Sbjct: 163 PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI--------------PLKD 208
Query: 300 LTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH 355
+ V G G P ++ +++ CW + RPSF + +L+ + H
Sbjct: 209 VVPRVEKGYKMDAPD----GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 181 bits (459), Expect = 3e-52
Identities = 69/305 (22%), Positives = 124/305 (40%), Gaps = 36/305 (11%)
Query: 63 LPPSSYTLLSPIARGAESVVYEATL-----DGRKVAVKKPILSTSE-ELDNFHKELQLLC 116
+ S + I G V L VA+K +E + +F E ++
Sbjct: 23 IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMG 82
Query: 117 KLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQ 176
+ DHP + K M EF E+ +L L + +V Q++ + +A ++
Sbjct: 83 QFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMK 142
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
YL ++ VHRD+ N+L++ NL ++DFGL+ +
Sbjct: 143 YLADMNYVHRDLAARNILVNSNLVCKVSDFGLS-----------RFLEDDTSDPTYTSAL 191
Query: 237 NMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNY 295
+ + APE ++ + SDV+S+GI + E+++ G PY D+
Sbjct: 192 GGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM-------------- 237
Query: 296 TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH 355
T Q + A+ P + P+++ L+ CW + ++RP F I LD ++ +
Sbjct: 238 TNQDVINAIEQDYRLPP----PMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293
Query: 356 RKSLK 360
SLK
Sbjct: 294 PNSLK 298
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 3e-52
Identities = 61/289 (21%), Positives = 114/289 (39%), Gaps = 39/289 (13%)
Query: 64 PPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP 121
P + ++ + GA VY+A A K + EEL+++ E+ +L DHP
Sbjct: 10 PEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHP 69
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL 181
+ K + A N EF + + E + Q+ ++ Q AL YLH+
Sbjct: 70 NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN 129
Query: 182 GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGT 241
I+HRD+K N+L + LADFG++ + + +GT
Sbjct: 130 KIIHRDLKAGNILFTLDGDIKLADFGVSAK----------------NTRTIQRRDSFIGT 173
Query: 242 LIYMAPEIL-----KKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYT 296
+MAPE++ K + K+DV+S GI++ E+ P+ +L
Sbjct: 174 PYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHEL--------------N 219
Query: 297 EQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
++ + + + ++ +++C + N R + S +
Sbjct: 220 PMRVLLKIAKSEPPTL--AQPSRWSSNFKDFLKKCLEKNVDARWTTSQL 266
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 4e-51
Identities = 70/291 (24%), Positives = 123/291 (42%), Gaps = 38/291 (13%)
Query: 63 LPPSSYTLLSPIARGAESVVYEATL-DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP 121
+P + L+ + G V+ KVAVK + S D F E L+ +L H
Sbjct: 10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKS-LKQGSMSPDAFLAEANLMKQLQHQ 68
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSP-SVDQVLMIAAQLAKALQYLHN 180
L + A + P Y+ E+ E+ +L + L +++++L +AAQ+A+ + ++
Sbjct: 69 RLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127
Query: 181 LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
+HRD++ AN+L+ L +ADFGLA E ++
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIE---------------DNEYTAREGAKF 172
Query: 241 TLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQ 299
+ + APE + + KSDV+SFGI + E++T G +PY + +
Sbjct: 173 PIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER------- 225
Query: 300 LTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350
G R + P + L++ CW P +RP+F + L+
Sbjct: 226 --------GYRMVRPD---NCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 3e-50
Identities = 61/284 (21%), Positives = 118/284 (41%), Gaps = 36/284 (12%)
Query: 64 PPSSYTLLSPIARGAESVVYEAT--LDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP 121
P YT I +GA VY A G++VA+++ L + + E+ ++ + +P
Sbjct: 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNP 77
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL 181
+ ++ ++ E+ +L + + E Q+ + + +AL++LH+
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALEFLHSN 135
Query: 182 GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGT 241
++HRD+K N+LL + L DFG +I+ + + S MVGT
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFC------AQITPEQSKRS----------TMVGT 179
Query: 242 LIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLT 301
+MAPE++ ++ + K D++S GI E++ G PY + +
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN--------------ENPLRAL 225
Query: 302 AAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
+ + G + L A + RC D + R S ++
Sbjct: 226 YLIATNGTPEL--QNPEKLSAIFRDFLNRCLDMDVEKRGSAKEL 267
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 6e-50
Identities = 57/283 (20%), Positives = 101/283 (35%), Gaps = 43/283 (15%)
Query: 68 YTLLSPIARGAESVVYEATL--DGRKVAVK---KPILSTSEELDNFHKELQLLCKLDHPG 122
+ + P+ +G VY A +A+K K L + +E+++ L HP
Sbjct: 8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 67
Query: 123 LAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLG 182
+ + E+ + +L + + +LA AL Y H+
Sbjct: 68 ILRLYGYFHDATRVYLILEYAPLGTVYRELQ-KLSKFDEQRTATYITELANALSYCHSKR 126
Query: 183 IVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTL 242
++HRD+KP N+LL +ADFG + + + GTL
Sbjct: 127 VIHRDIKPENLLLGSAGELKIADFGWS------------------VHAPSSRRTTLCGTL 168
Query: 243 IYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTA 302
Y+ PE+++ +H EK D++S G+ E L G P+ + + + +T
Sbjct: 169 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF-- 226
Query: 303 AVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
+ LI R NP RP ++
Sbjct: 227 -----------------VTEGARDLISRLLKHNPSQRPMLREV 252
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 1e-49
Identities = 69/289 (23%), Positives = 115/289 (39%), Gaps = 34/289 (11%)
Query: 63 LPPSSYTLLSPIARGAESVVYEATL-DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP 121
+P S L + +G V+ T +VA+K + + + F +E Q++ KL H
Sbjct: 14 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKT-LKPGTMSPEAFLQEAQVMKKLRHE 72
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL 181
L + A ++ P Y+ + L + Q++ +AAQ+A + Y+ +
Sbjct: 73 KLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 132
Query: 182 GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGT 241
VHRD++ AN+L+ NL +ADFGLA E ++
Sbjct: 133 NYVHRDLRAANILVGENLVCKVADFGLARLIE---------------DNEYTARQGAKFP 177
Query: 242 LIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLT 301
+ + APE + KSDV+SFGI + EL T +++
Sbjct: 178 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP-------------GMVNREVL 224
Query: 302 AAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350
V G P P S+ L+ +CW P RP+F + L+
Sbjct: 225 DQVERGYRMPCPP----ECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 269
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (436), Expect = 1e-49
Identities = 61/293 (20%), Positives = 118/293 (40%), Gaps = 34/293 (11%)
Query: 63 LPPSSYTLLSPIARGAESVVYEATL-DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHP 121
+ PS T + I G +V+ + KVA+K I + ++F +E +++ KL HP
Sbjct: 2 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKT-IREGAMSEEDFIEEAEVMMKLSHP 60
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL 181
L + + FEF E L++ L + + + +L + + + + YL
Sbjct: 61 KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 120
Query: 182 GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGT 241
++HRD+ N L+ N ++DFG+ + +
Sbjct: 121 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD---------------DQYTSSTGTKFP 165
Query: 242 LIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLT 301
+ + +PE+ +S KSDV+SFG+ + E+ + + R+ ++
Sbjct: 166 VKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--------------V 211
Query: 302 AAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE 354
+S G R L + ++ CW P +RP+FS + +L + E
Sbjct: 212 VEDISTGFRLYKPRL---ASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 1e-49
Identities = 65/309 (21%), Positives = 120/309 (38%), Gaps = 36/309 (11%)
Query: 67 SYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKF 126
+ L I +G V+ G +VAVK S E E+ L H + F
Sbjct: 4 TIVLQESIGKGRFGEVWRGKWRGEEVAVKI-FSSREERSWFREAEIYQTVMLRHENILGF 62
Query: 127 VAA----HAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLH--- 179
+AA + +++E +L + L+ ++ +V+ ++ +A A L +LH
Sbjct: 63 IAADNKDNGTWTQLWLVSDYHEHGSLFDYLN--RYTVTVEGMIKLALSTASGLAHLHMEI 120
Query: 180 -----NLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFH 234
I HRD+K N+L+ +N +AD G L S T
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG------------LAVRHDSATDTIDIA 168
Query: 235 KKNMVGTLIYMAPEILKKEIH------SEKSDVYSFGISINELLTGVVPY-TDLRAEAQA 287
+ VGT YMAPE+L I+ +++D+Y+ G+ E+ +
Sbjct: 169 PNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY 228
Query: 288 HTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPAS--ILSLIQRCWDGNPHNRPSFSDI 345
+ ++ + + +++ V LRP + + A + +++ CW N R + I
Sbjct: 229 YDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRI 288
Query: 346 ALELDLVLE 354
L + +
Sbjct: 289 KKTLSQLSQ 297
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 4e-49
Identities = 59/283 (20%), Positives = 102/283 (36%), Gaps = 36/283 (12%)
Query: 65 PSSYTLLSPIARGAESVVYEATL-DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGL 123
P T L + G VV VA+K I S D F +E +++ L H L
Sbjct: 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKM-IKEGSMSEDEFIEEAKVMMNLSHEKL 61
Query: 124 AKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGI 183
+ K E+ + L L Q+L + + +A++YL +
Sbjct: 62 VQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQF 121
Query: 184 VHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLI 243
+HRD+ N L++ ++DFGL+ Y + +
Sbjct: 122 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLD---------------DEYTSSVGSKFPVR 166
Query: 244 YMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTA 302
+ PE+L S KSD+++FG+ + E+ + G +PY A + +
Sbjct: 167 WSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ---------- 216
Query: 303 AVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
GLR L + +++ CW RP+F +
Sbjct: 217 -----GLRLYRPHL---ASEKVYTIMYSCWHEKADERPTFKIL 251
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 172 bits (436), Expect = 6e-49
Identities = 64/309 (20%), Positives = 109/309 (35%), Gaps = 47/309 (15%)
Query: 64 PPSSYTLLSPIARGAESVVYEATL--DGRKVAVK---KPILSTSEELDNFHKELQLLCKL 118
P ++ L I G+ VY A + VA+K ++E+ + KE++ L KL
Sbjct: 13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL 72
Query: 119 DHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYL 178
HP ++ + + E+ + ++ + + L YL
Sbjct: 73 RHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV-HKKPLQEVEIAAVTHGALQGLAYL 131
Query: 179 HNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNM 238
H+ ++HRDVK N+LL L DFG A +
Sbjct: 132 HSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--------------------ANSF 171
Query: 239 VGTLIYMAPEIL---KKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNY 295
VGT +MAPE++ + + K DV+S GI+ EL P ++ A + + + +
Sbjct: 172 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES 231
Query: 296 TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH 355
Q + + C P +RP+ + L+ VL
Sbjct: 232 PALQ-----------------SGHWSEYFRNFVDSCLQKIPQDRPTSEVL-LKHRFVLRE 273
Query: 356 RKSLKEEDL 364
R DL
Sbjct: 274 RPPTVIMDL 282
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 172 bits (437), Expect = 1e-48
Identities = 62/292 (21%), Positives = 104/292 (35%), Gaps = 43/292 (14%)
Query: 68 YTLLSPIARGAESVVYEAT--LDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAK 125
Y + + GA VV+ T G A K + + + KE+Q + L HP L
Sbjct: 28 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVN 87
Query: 126 FVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVH 185
A + +EF L EK+ E S D+ + Q+ K L ++H VH
Sbjct: 88 LHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVH 147
Query: 186 RDVKPANVLLDRNLCPH--LADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLI 243
D+KP N++ L DFGL + + K GT
Sbjct: 148 LDLKPENIMFTTKRSNELKLIDFGLTAHLD-----------------PKQSVKVTTGTAE 190
Query: 244 YMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAA 303
+ APE+ + + +D++S G+ LL+G+ P+ + V ++
Sbjct: 191 FAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDW-------- 242
Query: 304 VVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH 355
+ S G+ I++ +P+ R + LEH
Sbjct: 243 -------NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQA-------LEH 280
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (430), Expect = 1e-48
Identities = 72/305 (23%), Positives = 125/305 (40%), Gaps = 37/305 (12%)
Query: 63 LPPSSYTLLSPIARGAESVVYEATLDG------RKVAVKK-PILSTSEELDNFHKELQLL 115
+ PS T I G VY+ L VA+K T ++ +F E ++
Sbjct: 4 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIM 63
Query: 116 CKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKAL 175
+ H + + +K M E+ E+ L + L ++ SV Q++ + +A +
Sbjct: 64 GQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGM 123
Query: 176 QYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHK 235
+YL N+ VHRD+ N+L++ NL ++DFGL+ E+ P +
Sbjct: 124 KYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED-------------DPEATYTT 170
Query: 236 KNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNY 295
+ + APE + + SDV+SFGI + E++T
Sbjct: 171 SGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP-------------YWEL 217
Query: 296 TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH 355
+ ++ A+ G P + P++I L+ +CW RP F+DI LD ++
Sbjct: 218 SNHEVMKAINDGFRLPT----PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273
Query: 356 RKSLK 360
SLK
Sbjct: 274 PDSLK 278
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (433), Expect = 2e-48
Identities = 63/314 (20%), Positives = 114/314 (36%), Gaps = 48/314 (15%)
Query: 61 LHLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEEL-DNFHKELQLLCK 117
+ L + +S + G VV++ + G +A K L + + +ELQ+L +
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 118 LDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQY 177
+ P + F A E + +L + L + + ++ + K L Y
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK-KAGRIPEQILGKVSIAVIKGLTY 119
Query: 178 LHN-LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
L I+HRDVKP+N+L++ L DFG++ +
Sbjct: 120 LREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM------------------AN 161
Query: 237 NMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY------------------ 278
+ VGT YM+PE L+ +S +SD++S G+S+ E+ G P
Sbjct: 162 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEG 221
Query: 279 --TDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILS-----LIQRC 331
+ + +Y + L I+ LP+ + S + +C
Sbjct: 222 DAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKC 281
Query: 332 WDGNPHNRPSFSDI 345
NP R +
Sbjct: 282 LIKNPAERADLKQL 295
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 171 bits (434), Expect = 3e-48
Identities = 54/282 (19%), Positives = 95/282 (33%), Gaps = 36/282 (12%)
Query: 68 YTLLSPIARGAESVVYEAT--LDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAK 125
Y +L + GA VV+ GR K + E+ ++ +L HP L
Sbjct: 31 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLIN 90
Query: 126 FVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVH 185
A + EF L +++ E++ S +V+ Q + L+++H IVH
Sbjct: 91 LHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVH 150
Query: 186 RDVKPANVLLDRNLCPH--LADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLI 243
D+KP N++ + + DFGLA K T
Sbjct: 151 LDIKPENIMCETKKASSVKIIDFGLATKLNP-----------------DEIVKVTTATAE 193
Query: 244 YMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAA 303
+ APEI+ +E +D+++ G+ LL+G+ P+ V ++
Sbjct: 194 FAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDW-------- 245
Query: 304 VVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
+ I+ P R + D
Sbjct: 246 -------EFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDA 280
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 1e-47
Identities = 74/301 (24%), Positives = 118/301 (39%), Gaps = 45/301 (14%)
Query: 68 YTLLSPIARGAESVVYEATL--DGRKVAVKK-PILSTSEELDNFHKELQLLCKLDHPGLA 124
+ L+ + GA V A VAVK + + +N KE+ + L+H +
Sbjct: 7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 66
Query: 125 KFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIV 184
KF + F E+ L +++ + QL + YLH +GI
Sbjct: 67 KFYGHRREGNIQYLFLEYCSGGELFDRIE-PDIGMPEPDAQRFFHQLMAGVVYLHGIGIT 125
Query: 185 HRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIY 244
HRD+KP N+LLD ++DFGLA L N M GTL Y
Sbjct: 126 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN--------------KMCGTLPY 171
Query: 245 MAPEILK-KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAA 303
+APE+LK +E H+E DV+S GI + +L G +P+ Q ++ +
Sbjct: 172 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK--------- 222
Query: 304 VVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH---RKSLK 360
+ + ++ L+L+ + NP R + DI + K LK
Sbjct: 223 -------KTYLNPWKKIDSAPLALLHKILVENPSARITIPDI-------KKDRWYNKPLK 268
Query: 361 E 361
+
Sbjct: 269 K 269
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 3e-47
Identities = 71/302 (23%), Positives = 122/302 (40%), Gaps = 39/302 (12%)
Query: 63 LPPSSYTLLSPIARGAESVVYEATL-----DGRKVAVKKPILSTSEEL-DNFHKELQLLC 116
+ L I G V++ VA+K TS+ + + F +E +
Sbjct: 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMR 63
Query: 117 KLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQ 176
+ DHP + K + + P ++ E L L V ++S + +++ A QL+ AL
Sbjct: 64 QFDHPHIVKLIGVITENPVWIIM-ELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALA 122
Query: 177 YLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
YL + VHRD+ NVL+ N C L DFGL+ Y E + +
Sbjct: 123 YLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME---------------DSTYYKAS 167
Query: 237 NMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYT 296
+ +MAPE + + SDV+ FG+ + E+L V
Sbjct: 168 KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ-------------GVK 214
Query: 297 EQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHR 356
+ + +G P+ P ++ SL+ +CW +P RP F+++ +L +LE
Sbjct: 215 NNDVIGRIENGERLPMPP----NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 270
Query: 357 KS 358
K+
Sbjct: 271 KA 272
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (420), Expect = 3e-47
Identities = 72/302 (23%), Positives = 116/302 (38%), Gaps = 55/302 (18%)
Query: 68 YTLLSPIARGAESVVYEATL--DGRKVAVK--KPILSTSEELDNFHKELQLLCKLDHPGL 123
Y +L I G+ + DG+ + K T E E+ LL +L HP +
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 65
Query: 124 AKFVAAHAKPPNYMFF--FEFYESRNLAEKLH---VEEWSPSVDQVLMIAAQLAKALQYL 178
++ N + E+ E +LA + E + VL + QL AL+
Sbjct: 66 VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC 125
Query: 179 HNLG-----IVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGF 233
H ++HRD+KPANV LD L DFGLA + F
Sbjct: 126 HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA-----------RILNHDTSFAKAF 174
Query: 234 HKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEM 293
T YM+PE + + ++EKSD++S G + EL + P+T
Sbjct: 175 VG-----TPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA------------- 216
Query: 294 NYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL 353
+++++L + G R I + +I R + ++RPS +I L
Sbjct: 217 -FSQKELAGKIREGKFRRI----PYRYSDELNEIITRMLNLKDYHRPSVEEI-------L 264
Query: 354 EH 355
E+
Sbjct: 265 EN 266
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 5e-47
Identities = 68/296 (22%), Positives = 111/296 (37%), Gaps = 40/296 (13%)
Query: 63 LPPSSYTLLSPIARGAESVVYEATLD-----GRKVAVK---KPILSTSEELDNFHKELQL 114
+ LL + G+ VV D VAVK +LS E +D+F +E+
Sbjct: 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 64
Query: 115 LCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKA 174
+ LDH L + PP M E +L ++L + + + A Q+A+
Sbjct: 65 MHSLDHRNLIRLYGVVLTPPMKMVT-ELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 123
Query: 175 LQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFH 234
+ YL + +HRD+ N+LL + DFGL
Sbjct: 124 MGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRA-------------LPQNDDHYVM 170
Query: 235 KKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEM 293
+++ + APE LK S SD + FG+++ E+ T G P+ L
Sbjct: 171 QEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL------------ 218
Query: 294 NYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALEL 349
Q+ + G R P I +++ +CW P +RP+F + L
Sbjct: 219 --NGSQILHKIDKEGERLPRPE---DCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 269
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 166 bits (420), Expect = 5e-47
Identities = 71/303 (23%), Positives = 125/303 (41%), Gaps = 37/303 (12%)
Query: 63 LPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDH 120
+ + T+ + G VYE VAVK + + E++ F KE ++ ++ H
Sbjct: 14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKT-LKEDTMEVEEFLKEAAVMKEIKH 72
Query: 121 PGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSP-SVDQVLMIAAQLAKALQYLH 179
P L + + + P + EF NL + L S +L +A Q++ A++YL
Sbjct: 73 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 132
Query: 180 NLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMV 239
+HRD+ N L+ N +ADFGL+ +
Sbjct: 133 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA---------------HAGAK 177
Query: 240 GTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQ 299
+ + APE L S KSDV++FG+ + E+ T + +Q + +LE +Y ++
Sbjct: 178 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER 237
Query: 300 LTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHRKSL 359
G P + L++ CW NP +RPSF++I + + + S+
Sbjct: 238 PE-----------------GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE-SSI 279
Query: 360 KEE 362
+E
Sbjct: 280 SDE 282
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 165 bits (418), Expect = 1e-46
Identities = 71/326 (21%), Positives = 122/326 (37%), Gaps = 64/326 (19%)
Query: 61 LHLPPSSYTLLSPIARGAESVVYEATL-------DGRKVAVKKPILSTSEEL-DNFHKEL 112
L P ++ + I GA V++A VAVK S ++ +F +E
Sbjct: 8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREA 67
Query: 113 QLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLH------------------- 153
L+ + D+P + K + A FE+ +L E L
Sbjct: 68 ALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRA 127
Query: 154 ----VEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLA 209
S + L IA Q+A + YL VHRD+ N L+ N+ +ADFGL+
Sbjct: 128 RVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLS 187
Query: 210 EYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISIN 269
R+ N + +M PE + ++ +SDV+++G+ +
Sbjct: 188 --------------RNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLW 233
Query: 270 ELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLI 328
E+ + G+ PY + +++ V G + + P + +L+
Sbjct: 234 EIFSYGLQPYYGM--------------AHEEVIYYVRDGNILACPEN----CPLELYNLM 275
Query: 329 QRCWDGNPHNRPSFSDIALELDLVLE 354
+ CW P +RPSF I L + E
Sbjct: 276 RLCWSKLPADRPSFCSIHRILQRMCE 301
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (417), Expect = 1e-46
Identities = 55/282 (19%), Positives = 103/282 (36%), Gaps = 38/282 (13%)
Query: 74 IARGAESVVYEATL----DGRKVAVKK-PILSTSEELDNFHKELQLLCKLDHPGLAKFVA 128
+ G V + VA+K + + + +E Q++ +LD+P + + +
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 76
Query: 129 AHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDV 188
+ M E L + L + V V + Q++ ++YL VHRD+
Sbjct: 77 VC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDL 135
Query: 189 KPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPE 248
NVLL ++DFGL++ + + L + APE
Sbjct: 136 AARNVLLVNRHYAKISDFGLSK-------------ALGADDSYYTARSAGKWPLKWYAPE 182
Query: 249 ILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSG 307
+ S +SDV+S+G+++ E L+ G PY + ++ A + G
Sbjct: 183 CINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM--------------KGPEVMAFIEQG 228
Query: 308 GLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALEL 349
P + +L+ CW +RP F + +
Sbjct: 229 KRMECPP----ECPPELYALMSDCWIYKWEDRPDFLTVEQRM 266
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 164 bits (417), Expect = 2e-46
Identities = 59/302 (19%), Positives = 106/302 (35%), Gaps = 29/302 (9%)
Query: 68 YTLLSPIARGAESVVYEAT--LDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAK 125
Y + I G+ V++E T L+ ++VA+K + E + L
Sbjct: 7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIK--FEPRRSDAPQLRDEYRTYKLLAGCTGIP 64
Query: 126 FVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVH 185
V + + +L + L + SV V M A Q+ +Q +H +V+
Sbjct: 65 NVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVY 124
Query: 186 RDVKPANVLLDRNLCPH-----LADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
RD+KP N L+ R + + DFG+ ++ + + + KKN+ G
Sbjct: 125 RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD---------PVTKQHIPYREKKNLSG 175
Query: 241 TLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQL 300
T YM+ S + D+ + G L G +P+ L+A + +Q
Sbjct: 176 TARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ-- 233
Query: 301 TAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHRKSLK 360
L L G P + + P + + VLE + +
Sbjct: 234 ---------STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTE 284
Query: 361 EE 362
+E
Sbjct: 285 DE 286
|
| >d1a6qa2 d.219.1.1 (A:2-296) Protein serine/threonine phosphatase 2C, catalytic domain {Human (Homo sapiens) [TaxId: 9606]} Length = 295 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: PP2C-like superfamily: PP2C-like family: PP2C-like domain: Protein serine/threonine phosphatase 2C, catalytic domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 2e-46
Identities = 65/277 (23%), Positives = 112/277 (40%), Gaps = 21/277 (7%)
Query: 429 LSWGSFATCGRRETMEDTHFLMPHMYNQKE-IHMFGIFDGHRGSAAAEFSARALPGFLQN 487
L +G + G R MED H + + + E F ++DGH GS A++ L + N
Sbjct: 21 LRYGLSSMQGWRVEMEDAHTAVIGLPSGLESWSFFAVYDGHAGSQVAKYCCEHLLDHITN 80
Query: 488 LGSTTRPTDALLEAFIRTDV--AFRNELDSLRKSKRVVQKDWHPGCTAIAALIVRNRLFV 545
A ++ + F + +R G TA+ LI +
Sbjct: 81 NQDFKGSAGAPSVENVKNGIRTGFLEIDEHMRVMSEKKHGADRSGSTAVGVLISPQHTYF 140
Query: 546 ANAGDCRAILCRGGHPFALSRDHVASCLEERERVVSAGGNVNWQVDTWRVGPPALQVTRS 605
N GD R +LCR ++DH S E+ER+ +AGG + +L V+R+
Sbjct: 141 INCGDSRGLLCRNRKVHFFTQDHKPSNPLEKERIQNAGG-----SVMIQRVNGSLAVSRA 195
Query: 606 IGDDDLKPAVTAEPEITETIMTPED----------EYLVMASDGLWDVVSHVEAVGIIKD 655
+GD D K P PE +++++A DG+WDV+ + E ++
Sbjct: 196 LGDFDYKCVHGKGPTEQLVSPEPEVHDIERSEEDDQFIILACDGIWDVMGNEELCDFVRS 255
Query: 656 TV---KEPGMCSKRLATEAAERGSKDNITVIVVFLQP 689
+ + + +GS+DN++VI++
Sbjct: 256 RLEVTDDLEKVCNEVVDTCLYKGSRDNMSVILICFPN 292
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 2e-46
Identities = 60/312 (19%), Positives = 118/312 (37%), Gaps = 42/312 (13%)
Query: 60 PLHLPPSSYTLLSPIARGAESVVYEAT--LDGRKVAVK---KPILSTSEELDNFHKELQL 114
P P + + G+ S V A R+ A+K K + ++ +E +
Sbjct: 2 PRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDV 61
Query: 115 LCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKA 174
+ +LDHP K F + ++ L + + + S A++ A
Sbjct: 62 MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVSA 120
Query: 175 LQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFH 234
L+YLH GI+HRD+KP N+LL+ ++ + DFG A + +
Sbjct: 121 LEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTA--------------KVLSPESKQAR 166
Query: 235 KKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMN 294
+ VGT Y++PE+L ++ + SD+++ G I +L+ G+ P+ ++++
Sbjct: 167 ANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE 226
Query: 295 YTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE 354
Y L+++ + R ++ +
Sbjct: 227 Y-------------------DFPEKFFPKARDLVEKLLVLDATKRLGCEEM-EGYGPLKA 266
Query: 355 HR--KSLKEEDL 364
H +S+ E+L
Sbjct: 267 HPFFESVTWENL 278
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (417), Expect = 3e-46
Identities = 71/320 (22%), Positives = 114/320 (35%), Gaps = 63/320 (19%)
Query: 63 LPPSSYTLLSPIARGAESVVYEATL-------DGRKVAVKK-PILSTSEELDNFHKELQL 114
P + + GA V AT +VAVK + S E + EL++
Sbjct: 34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKM 93
Query: 115 LCKL-DHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVD----------- 162
+ +L H + + A FE+ +L L + S D
Sbjct: 94 MTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 153
Query: 163 -----------QVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEY 211
+L A Q+AK +++L VHRD+ NVL+ + DFGLA
Sbjct: 154 EEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLA-- 211
Query: 212 RENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINEL 271
R + + N + +MAPE L + I++ KSDV+S+GI + E+
Sbjct: 212 ------------RDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEI 259
Query: 272 LT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQR 330
+ GV PY + ++ G + I ++Q
Sbjct: 260 FSLGVNPYPGI--------------PVDANFYKLIQNGFKM---DQPFYATEEIYIIMQS 302
Query: 331 CWDGNPHNRPSFSDIALELD 350
CW + RPSF ++ L
Sbjct: 303 CWAFDSRKRPSFPNLTSFLG 322
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 1e-45
Identities = 64/283 (22%), Positives = 109/283 (38%), Gaps = 40/283 (14%)
Query: 74 IARGAESVVYEATL----DGRKVAVK--KPILSTSEELDNFHKELQLLCKLDHPGLAKFV 127
+ G V + + VAVK K + D E ++ +LD+P + + +
Sbjct: 15 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 128 AAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRD 187
+ ++M E E L + L + ++ + Q++ ++YL VHRD
Sbjct: 75 GIC-EAESWMLVMEMAELGPLNKYLQ-QNRHVKDKNIIELVHQVSMGMKYLEESNFVHRD 132
Query: 188 VKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAP 247
+ NVLL ++DFGL+ K + + G + + AP
Sbjct: 133 LAARNVLLVTQHYAKISDFGLS------KALRADENYYKAQTHG-------KWPVKWYAP 179
Query: 248 EILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVS 306
E + S KSDV+SFG+ + E + G PY + ++TA +
Sbjct: 180 ECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM--------------KGSEVTAMLEK 225
Query: 307 GGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALEL 349
G A G P + L+ CW + NRP F+ + L L
Sbjct: 226 GERMGCPA----GCPREMYDLMNLCWTYDVENRPGFAAVELRL 264
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 1e-45
Identities = 76/334 (22%), Positives = 129/334 (38%), Gaps = 57/334 (17%)
Query: 63 LPPSSYTLLSPIARGAESVVYEATLDG----RKVAVKK-PILSTSEELDNFHKELQLLCK 117
L + I G V +A + A+K+ ++ ++ +F EL++LCK
Sbjct: 7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCK 66
Query: 118 L-DHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSP---------------SV 161
L HP + + A E+ NL + L S
Sbjct: 67 LGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 126
Query: 162 DQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLK 221
Q+L AA +A+ + YL +HRD+ N+L+ N +ADFGL+ +E
Sbjct: 127 QQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV------- 179
Query: 222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTD 280
K + +MA E L +++ SDV+S+G+ + E+++ G PY
Sbjct: 180 ----------YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG 229
Query: 281 LRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRP 340
+ T +L + G L + L+++CW P+ RP
Sbjct: 230 M--------------TCAELYEKLPQGYRLEK----PLNCDDEVYDLMRQCWREKPYERP 271
Query: 341 SFSDIALELDLVLEHRKSLKEEDLCAGKSYVTYD 374
SF+ I + L+ +LE RK+ L +Y D
Sbjct: 272 SFAQILVSLNRMLEERKTYVNTTLYEKFTYAGID 305
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 162 bits (410), Expect = 2e-45
Identities = 53/283 (18%), Positives = 104/283 (36%), Gaps = 27/283 (9%)
Query: 68 YTLLSPIARGAESVVYEAT--LDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAK 125
Y L I G+ +Y T G +VA+K + + H E ++ +
Sbjct: 9 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIK--LECVKTKHPQLHIESKIYKMMQGGVGIP 66
Query: 126 FVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVH 185
+ +Y +L + + S+ VL++A Q+ ++Y+H+ +H
Sbjct: 67 TIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIH 126
Query: 186 RDVKPANVL---LDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTL 242
RDVKP N L + ++ DFGLA+ + + + KN+ GT
Sbjct: 127 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD---------ARTHQHIPYRENKNLTGTA 177
Query: 243 IYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTA 302
Y + S + D+ S G + G +P+ L+A + ++ +
Sbjct: 178 RYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK----- 232
Query: 303 AVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
+ + L G P+ + + C ++P +S +
Sbjct: 233 ------MSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYL 269
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 1e-44
Identities = 64/289 (22%), Positives = 105/289 (36%), Gaps = 47/289 (16%)
Query: 68 YTLLSPIARGAESVVYEATL--DGRKVAVKK--PILSTSEELDNFHKELQLLCKLDHPGL 123
I RG+ VY+ +VA + T E F +E ++L L HP +
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70
Query: 124 AKFVAAHAKP----PNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLH 179
+F + + E S L L + + Q+ K LQ+LH
Sbjct: 71 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK-RFKVMKIKVLRSWCRQILKGLQFLH 129
Query: 180 NLG--IVHRDVKPANVLL-DRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKK 236
I+HRD+K N+ + + D GLA + K
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR------------------ASFAK 171
Query: 237 NMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYT 296
++GT +MAPE+ +++ + E DVY+FG+ + E+ T PY++
Sbjct: 172 AVIGTPEFMAPEMYEEK-YDESVDVYAFGMCMLEMATSEYPYSE-------------CQN 217
Query: 297 EQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
Q+ V SG S + + +I+ C N R S D+
Sbjct: 218 AAQIYRRVTSGVKPA---SFDKVAIPEVKEIIEGCIRQNKDERYSIKDL 263
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 3e-44
Identities = 57/296 (19%), Positives = 116/296 (39%), Gaps = 41/296 (13%)
Query: 63 LPPSSYTLLSPIARGAESVVYEATL------DGRKVAVKKPILSTSEE-LDNFHKELQLL 115
L + + + + GA VY+ VA+K+ +TS + E ++
Sbjct: 6 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 65
Query: 116 CKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKAL 175
+D+P + + + + + L + + + + +L Q+AK +
Sbjct: 66 ASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 124
Query: 176 QYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHK 235
YL + +VHRD+ NVL+ + DFGLA + G +H
Sbjct: 125 NYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA--------------KLLGAEEKEYHA 170
Query: 236 KNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMN 294
+ + +MA E + I++ +SDV+S+G+++ EL+T G PY
Sbjct: 171 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG-------------- 216
Query: 295 YTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350
++++ + G P + ++ +CW + +RP F ++ +E
Sbjct: 217 IPASEISSILEKGERLPQPP----ICTIDVYMIMVKCWMIDADSRPKFRELIIEFS 268
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 5e-44
Identities = 45/282 (15%), Positives = 101/282 (35%), Gaps = 37/282 (13%)
Query: 68 YTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAK 125
Y + + RG +V+ + K + + KE+ +L H +
Sbjct: 7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKF-VKVKGTDQVLVKKEISILNIARHRNILH 65
Query: 126 FVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVH 185
+ + FEF ++ E+++ + + +++ Q+ +ALQ+LH+ I H
Sbjct: 66 LHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGH 125
Query: 186 RDVKPANVLLDRNLCPH--LADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLI 243
D++P N++ + +FG A + G + + +
Sbjct: 126 FDIRPENIIYQTRRSSTIKIIEFGQARQLKP-----------------GDNFRLLFTAPE 168
Query: 244 YMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAA 303
Y APE+ + ++ S +D++S G + LL+G+ P+ + ++ YT
Sbjct: 169 YYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYT------- 221
Query: 304 VVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
+ + + R +R + S+
Sbjct: 222 --------FDEEAFKEISIEAMDFVDRLLVKERKSRMTASEA 255
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 3e-43
Identities = 69/306 (22%), Positives = 119/306 (38%), Gaps = 40/306 (13%)
Query: 74 IARGAESVVYEATLD-----GRKVAVKK-PILSTSEELDNFHKELQLLCKLDHPGLAKFV 127
I RG VY TL AVK ++ E+ F E ++ HP + +
Sbjct: 35 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 94
Query: 128 AAHAKPPNYMFF-FEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHR 186
+ + + +L + E +P+V ++ Q+AK +++L + VHR
Sbjct: 95 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHR 154
Query: 187 DVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMA 246
D+ N +LD +ADFGLA + +K + +MA
Sbjct: 155 DLAARNCMLDEKFTVKVADFGLA------------RDMYDKEFDSVHNKTGAKLPVKWMA 202
Query: 247 PEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVV 305
E L+ + + KSDV+SFG+ + EL+T G PY D+ +L+
Sbjct: 203 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ------------- 249
Query: 306 SGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHRKSLKEEDLC 365
G R + P + ++ +CW RPSFS++ + + + E +
Sbjct: 250 --GRRLLQPE---YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS--TFIGEHYVH 302
Query: 366 AGKSYV 371
+YV
Sbjct: 303 VNATYV 308
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 5e-43
Identities = 60/287 (20%), Positives = 109/287 (37%), Gaps = 42/287 (14%)
Query: 68 YTLLSPIARGAESVVYEATL--DGRKVAVK---KPILSTSEELDNFHKELQLL-CKLDHP 121
+ L + +G+ V+ A + A+K K ++ ++++ E ++L +HP
Sbjct: 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63
Query: 122 GLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL 181
L N F E+ +L + + + AA++ LQ+LH+
Sbjct: 64 FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ-SCHKFDLSRATFYAAEIILGLQFLHSK 122
Query: 182 GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGT 241
GIV+RD+K N+LLD++ +ADFG+ + G GT
Sbjct: 123 GIVYRDLKLDNILLDKDGHIKIADFGMCKENM----------------LGDAKTNTFCGT 166
Query: 242 LIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLT 301
Y+APEIL + ++ D +SFG+ + E+L G P+ E H++ N +
Sbjct: 167 PDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPR-- 224
Query: 302 AAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALE 348
L L+ + + P R +
Sbjct: 225 -----------------WLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 2e-42
Identities = 64/314 (20%), Positives = 115/314 (36%), Gaps = 56/314 (17%)
Query: 63 LPPSSYTLLSPIARGAESVVYEATL-------DGRKVAVKK-PILSTSEELDNFHKELQL 114
P + + + GA V EAT VAVK + E + EL++
Sbjct: 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKV 79
Query: 115 LCKL-DHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLH-----------------VEE 156
L L +H + + A + E+ +L L +E
Sbjct: 80 LSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139
Query: 157 WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLK 216
+ ++ +L + Q+AK + +L + +HRD+ N+LL + DFGLA +N
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 217 EISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVV 276
+K + +MAPE + +++ +SDV+S+GI + EL +
Sbjct: 200 NYVVKGN--------------ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGS 245
Query: 277 PYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNP 336
++ G R + PA + +++ CWD +P
Sbjct: 246 SP-------------YPGMPVDSKFYKMIKEGFRMLSPE---HAPAEMYDIMKTCWDADP 289
Query: 337 HNRPSFSDIALELD 350
RP+F I ++
Sbjct: 290 LKRPTFKQIVQLIE 303
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 152 bits (384), Expect = 4e-42
Identities = 70/292 (23%), Positives = 115/292 (39%), Gaps = 39/292 (13%)
Query: 68 YTLLSPIARGAESVVYEAT--LDGRKVAVK---KPILSTSEELDNFHKELQLLCKLDHPG 122
Y L + G S V+ A R VAVK + F +E Q L+HP
Sbjct: 9 YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 68
Query: 123 LAK----FVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYL 178
+ A P E+ + L + +H E + + + + A +AL +
Sbjct: 69 IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH-TEGPMTPKRAIEVIADACQALNFS 127
Query: 179 HNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNM 238
H GI+HRDVKPAN+++ + DFG+A + +
Sbjct: 128 HQNGIIHRDVKPANIMISATNAVKVMDFGIA-------------RAIADSGNSVTQTAAV 174
Query: 239 VGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQ 298
+GT Y++PE + + +SDVYS G + E+LTG P+T +
Sbjct: 175 IGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG--------------DSPV 220
Query: 299 QLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRP-SFSDIALEL 349
+ V P A E GL A + +++ + NP NR + +++ +L
Sbjct: 221 SVAYQHVREDPIPPSARHE-GLSADLDAVVLKALAKNPENRYQTAAEMRADL 271
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 152 bits (384), Expect = 1e-41
Identities = 62/293 (21%), Positives = 110/293 (37%), Gaps = 46/293 (15%)
Query: 68 YTLLSPIARGAESVVYEATL--DGRKVAVK---KPILSTSEELDNFHKELQLLCKLDHPG 122
+ +L + G+ V+ +GR A+K K I+ +++++ + E +L + HP
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65
Query: 123 LAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLG 182
+ + ++ E L L + AA++ AL+YLH+
Sbjct: 66 IIRMWGTFQDAQQIFMIMDYIEGGELFS-LLRKSQRFPNPVAKFYAAEVCLALEYLHSKD 124
Query: 183 IVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTL 242
I++RD+KP N+LLD+N + DFG A+Y + + GT
Sbjct: 125 IIYRDLKPENILLDKNGHIKITDFGFAKYVPD-------------------VTYTLCGTP 165
Query: 243 IYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTA 302
Y+APE++ + +++ D +SFGI I E+L G P+ D +L
Sbjct: 166 DYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPP--- 222
Query: 303 AVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH 355
+ L+ R + R E V H
Sbjct: 223 ----------------FFNEDVKDLLSRLITRDLSQRLGNLQNGTE--DVKNH 257
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 149 bits (378), Expect = 2e-41
Identities = 62/296 (20%), Positives = 108/296 (36%), Gaps = 51/296 (17%)
Query: 68 YTLLSPIARGAESVVYEAT--LDGRKVAVKK---------PILSTSEELDNFHKELQLLC 116
Y + RG SVV ++ AVK E + KE+ +L
Sbjct: 5 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64
Query: 117 KL-DHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKAL 175
K+ HP + + + + F+ + L + L E+ + S + I L + +
Sbjct: 65 KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT-EKVTLSEKETRKIMRALLEVI 123
Query: 176 QYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHK 235
LH L IVHRD+KP N+LLD ++ L DFG + + G
Sbjct: 124 CALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP-----------------GEKL 166
Query: 236 KNMVGTLIYMAPEIL------KKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHT 289
+ + GT Y+APEI+ + ++ D++S G+ + LL G P+ +
Sbjct: 167 REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRM 226
Query: 290 VLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
++ NY + ++ L+ R P R + +
Sbjct: 227 IMSGNY---------------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEA 267
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 150 bits (379), Expect = 4e-41
Identities = 60/284 (21%), Positives = 108/284 (38%), Gaps = 39/284 (13%)
Query: 68 YTLLSPIARGAESVVYEAT--LDGRKVAVKK-PILSTSEELDNFHKELQLLCKLDHPGLA 124
Y + GA S V A + VA+K + + + E+ +L K+ HP +
Sbjct: 11 YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIV 70
Query: 125 KFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIV 184
+ + + L +++ E+ + + Q+ A++YLH+LGIV
Sbjct: 71 ALDDIYESGGHLYLIMQLVSGGELFDRIV-EKGFYTERDASRLIFQVLDAVKYLHDLGIV 129
Query: 185 HRDVKPANVLL---DRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGT 241
HRD+KP N+L D + ++DFGL++ + G GT
Sbjct: 130 HRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP-----------------GSVLSTACGT 172
Query: 242 LIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLT 301
Y+APE+L ++ +S+ D +S G+ LL G P+ D +L+ Y
Sbjct: 173 PGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEY------ 226
Query: 302 AAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
+ + S I+ + +P R +
Sbjct: 227 ---------EFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQA 261
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 4e-41
Identities = 63/310 (20%), Positives = 121/310 (39%), Gaps = 50/310 (16%)
Query: 63 LPPSSYTLLSPIARGAESVVYEATL-------DGRKVAVKKPILSTSE-ELDNFHKELQL 114
+ T+ + +G+ +VYE +VA+K + S E F E +
Sbjct: 17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 76
Query: 115 LCKLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWS---------PSVDQVL 165
+ + + + + + ++ + E +L L + PS+ +++
Sbjct: 77 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 136
Query: 166 MIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRS 225
+A ++A + YL+ VHRD+ N ++ + + DFG+ R
Sbjct: 137 QMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGM--------------TRD 182
Query: 226 SGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGV-VPYTDLRAE 284
+ + + +M+PE LK + + SDV+SFG+ + E+ T PY L
Sbjct: 183 IYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL--- 239
Query: 285 AQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSD 344
+ +Q+ V+ GGL + P + L++ CW NP RPSF +
Sbjct: 240 -----------SNEQVLRFVMEGGLLDKPDN----CPDMLFELMRMCWQYNPKMRPSFLE 284
Query: 345 IALELDLVLE 354
I + +E
Sbjct: 285 IISSIKEEME 294
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 149 bits (377), Expect = 4e-41
Identities = 68/302 (22%), Positives = 112/302 (37%), Gaps = 38/302 (12%)
Query: 68 YTLLSPIARGAESVVYEATL-DGRKVAVKKPILSTSEE--LDNFHKELQLLCKLDHPGLA 124
Y L I G VVY+A G A+KK L +E +E+ +L +L H +
Sbjct: 4 YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIV 63
Query: 125 KFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIV 184
K + FE + ++L + L V E QL + Y H+ ++
Sbjct: 64 KLYDVIHTKKRLVLVFE-HLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVL 122
Query: 185 HRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIY 244
HRD+KP N+L++R +ADFGLA + + TL Y
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAFGI----------------PVRKYTHEIVTLWY 166
Query: 245 MAPEIL-KKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTAA 303
AP++L + +S D++S G E++ G + + Q + + T
Sbjct: 167 RAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWP 226
Query: 304 VVSGGLR----------PILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL 353
V+ + S GL S + L+ + +P+ R + L
Sbjct: 227 NVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA-------L 279
Query: 354 EH 355
EH
Sbjct: 280 EH 281
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 1e-39
Identities = 67/308 (21%), Positives = 118/308 (38%), Gaps = 45/308 (14%)
Query: 68 YTLLSPIARGAESVVYEAT--LDGRKVAVK---KPILSTSEELDNFHKELQLLCKLDHPG 122
+ L + +G V GR A+K K ++ +E+ + E ++L HP
Sbjct: 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 123 LAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLG 182
L A F E+ L L E + ++ A++ AL+YLH+
Sbjct: 67 LTALKYAFQTHDRLCFVMEYANGGELFFHLS-RERVFTEERARFYGAEIVSALEYLHSRD 125
Query: 183 IVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTL 242
+V+RD+K N++LD++ + DFGL K S G K GT
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLC-----------KEGISDGATM-----KTFCGTP 169
Query: 243 IYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTA 302
Y+APE+L+ + D + G+ + E++ G +P+ + ++L
Sbjct: 170 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN--------------QDHERLFE 215
Query: 303 AVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHR--KSLK 360
++ +R L SL+ +P R + V+EHR S+
Sbjct: 216 LILMEEIR-----FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAK--EVMEHRFFLSIN 268
Query: 361 EEDLCAGK 368
+D+ K
Sbjct: 269 WQDVVQKK 276
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 2e-39
Identities = 70/319 (21%), Positives = 119/319 (37%), Gaps = 59/319 (18%)
Query: 63 LPPSSYTLLSPIARGAESVVYEATL---------DGRKVAVKK-PILSTSEELDNFHKEL 112
LP L P+ GA V A KVAVK +T ++L + E+
Sbjct: 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEM 69
Query: 113 QLLCKL-DHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSP------------ 159
+++ + H + + A + E+ NL E L
Sbjct: 70 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 129
Query: 160 ---SVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLK 216
S ++ A Q+A+ ++YL + +HRD+ NVL+ + +ADFGLA
Sbjct: 130 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA------- 182
Query: 217 EISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GV 275
R N + +MAPE L I++ +SDV+SFG+ + E+ T G
Sbjct: 183 -------RDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG 235
Query: 276 VPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGN 335
PY + ++L + G + + +++ CW
Sbjct: 236 SPYPGV--------------PVEELFKLLKEGHRMDKPS----NCTNELYMMMRDCWHAV 277
Query: 336 PHNRPSFSDIALELDLVLE 354
P RP+F + +LD ++
Sbjct: 278 PSQRPTFKQLVEDLDRIVA 296
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 4e-39
Identities = 65/293 (22%), Positives = 105/293 (35%), Gaps = 31/293 (10%)
Query: 68 YTLLSPIARGAESVVYEAT--LDGRKVAVK--KPILSTSEELDNFHKELQLLCKLDHPGL 123
+ + I G VVY+A L G VA+K + T +E+ LL +L+HP +
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 124 AKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGI 183
K + FEF + + QL + L + H+ +
Sbjct: 64 VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 123
Query: 184 VHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLI 243
+HRD+KP N+L++ LADFGLA + V TL
Sbjct: 124 LHRDLKPQNLLINTEGAIKLADFGLARAFG----------------VPVRTYTHEVVTLW 167
Query: 244 YMAPEIL-KKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTA 302
Y APEIL + +S D++S G E++T + Q + T ++
Sbjct: 168 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVW 227
Query: 303 AVVSG----------GLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
V+ R + + L SL+ + +P+ R S
Sbjct: 228 PGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 7e-39
Identities = 61/290 (21%), Positives = 106/290 (36%), Gaps = 45/290 (15%)
Query: 68 YTLLSPIARGAESVVYEATL--DGRKVAVK--KPILSTSEE----LDNFHKELQLLCKLD 119
Y + G +VV + G + A K K + S ++ +E+ +L ++
Sbjct: 12 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLH 179
HP + + + + E L + E+ S + ++ Q+ + YLH
Sbjct: 72 HPNVITLHEVYENKTDVILILELVAGGELFDF-LAEKESLTEEEATEFLKQILNGVYYLH 130
Query: 180 NLGIVHRDVKPANVLLDRNLCP----HLADFGLAEYRENLKEISLKNWRSSGKPTGGFHK 235
+L I H D+KP N++L P + DFGLA + G
Sbjct: 131 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF-----------------GNEF 173
Query: 236 KNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNY 295
KN+ GT ++APEI+ E ++D++S G+ LL+G P+ + V +NY
Sbjct: 174 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNY 233
Query: 296 TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
A I+R +P R + D
Sbjct: 234 ---------------EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDS 268
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 8e-39
Identities = 62/298 (20%), Positives = 108/298 (36%), Gaps = 58/298 (19%)
Query: 60 PLHLPPSSYTLLSPIARGAESVVYEAT--LDGRKVAVK---KPILSTSEELDN---FHKE 111
PL S Y + + G VY D VA+K K +S EL N E
Sbjct: 1 PLE---SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPME 57
Query: 112 LQLLCKLD--HPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAA 169
+ LL K+ G+ + + +P +++ E E E + +
Sbjct: 58 VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFW 117
Query: 170 QLAKALQYLHNLGIVHRDVKPANVLLDRN-LCPHLADFGLAEYRENLKEISLKNWRSSGK 228
Q+ +A+++ HN G++HRD+K N+L+D N L DFG ++
Sbjct: 118 QVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD-------------- 163
Query: 229 PTGGFHKKNMVGTLIYMAPEILKKE-IHSEKSDVYSFGISINELLTGVVPYTDLRAEAQA 287
+ GT +Y PE ++ H + V+S GI + +++ G +P+ +
Sbjct: 164 ----TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG 219
Query: 288 HTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
+ + LI+ C P +RP+F +I
Sbjct: 220 QVFFRQR-------------------------VSSECQHLIRWCLALRPSDRPTFEEI 252
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (360), Expect = 1e-38
Identities = 63/299 (21%), Positives = 104/299 (34%), Gaps = 38/299 (12%)
Query: 68 YTLLSPIARGAESVVYEAT---LDGRKVAVKKPILSTSEELDNFH-----KELQLLCKLD 119
Y ++ I GA V++A GR VA+K+ + T EE L+ L +
Sbjct: 9 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 68
Query: 120 HPGLAKFVAAHAKPPN-----YMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKA 174
HP + + FE + V E + + + QL +
Sbjct: 69 HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRG 128
Query: 175 LQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFH 234
L +LH+ +VHRD+KP N+L+ + LADFGLA
Sbjct: 129 LDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM-----------------A 171
Query: 235 KKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMN 294
++V TL Y APE+L + ++ D++S G E+ + Q +L++
Sbjct: 172 LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI 231
Query: 295 YT--------EQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
+ L + + L+ +C NP R S
Sbjct: 232 GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (360), Expect = 2e-38
Identities = 67/304 (22%), Positives = 110/304 (36%), Gaps = 39/304 (12%)
Query: 68 YTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEE--LDNFHKELQLLCKLDHPGL 123
Y L+ I +G V++A G+KVA+KK ++ +E +E+++L L H +
Sbjct: 12 YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 71
Query: 124 AKFVAAHAKPPNYMF--------FFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKAL 175
+ + F+F E +V ++ ++ + L L
Sbjct: 72 VNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK-FTLSEIKRVMQMLLNGL 130
Query: 176 QYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHK 235
Y+H I+HRD+K ANVL+ R+ LADFGLA S K +
Sbjct: 131 YYIHRNKILHRDMKAANVLITRDGVLKLADFGLARA------------FSLAKNSQPNRY 178
Query: 236 KNMVGTLIYMAPEILKKEI-HSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMN 294
N V TL Y PE+L E + D++ G + E+ T + Q + ++
Sbjct: 179 TNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLC 238
Query: 295 YTEQQLTAAVVSGGLRPILASLELGLPASI-------------LSLIQRCWDGNPHNRPS 341
+ V L G + L LI + +P R
Sbjct: 239 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRID 298
Query: 342 FSDI 345
D
Sbjct: 299 SDDA 302
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 7e-38
Identities = 71/317 (22%), Positives = 116/317 (36%), Gaps = 55/317 (17%)
Query: 63 LPPSSYTLLSPIARGAESVVYEATL-------DGRKVAVKK-PILSTSEELDNFHKELQL 114
P L P+ RGA V EA R VAVK +T E EL++
Sbjct: 10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKI 69
Query: 115 LCK-LDHPGLAKFVAAHAKPPNY-MFFFEFYESRNLAEKLHVEEWSP------------- 159
L H + + A KP M EF + NL+ L +
Sbjct: 70 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 129
Query: 160 --SVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKE 217
+++ ++ + Q+AK +++L + +HRD+ N+LL + DFGLA
Sbjct: 130 FLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA-------- 181
Query: 218 ISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVP 277
R K K + L +MAPE + +++ +SDV+SFG+ + E+ +
Sbjct: 182 ------RDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS 235
Query: 278 YTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPH 337
+ + G R + + CW G P
Sbjct: 236 PYP-------------GVKIDEEFCRRLKEGTRMRAPD---YTTPEMYQTMLDCWHGEPS 279
Query: 338 NRPSFSDIALELDLVLE 354
RP+FS++ L +L+
Sbjct: 280 QRPTFSELVEHLGNLLQ 296
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 2e-37
Identities = 54/290 (18%), Positives = 102/290 (35%), Gaps = 45/290 (15%)
Query: 68 YTLLS-PIARGAESVVYEAT--LDGRKVAVKKPILSTSEELDNFHKELQLLCKL-DHPGL 123
Y + S + G V + K A+K ++ +E++L + P +
Sbjct: 13 YKVTSQVLGLGINGKVLQIFNKRTQEKFALKM-----LQDCPKARREVELHWRASQCPHI 67
Query: 124 AKFV----AAHAKPPNYMFFFEFYESRNLAEKLHVEEWSP-SVDQVLMIAAQLAKALQYL 178
+ V +A + E + L ++ + + I + +A+QYL
Sbjct: 68 VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 127
Query: 179 HNLGIVHRDVKPANVLLDRNLCP---HLADFGLAEYRENLKEISLKNWRSSGKPTGGFHK 235
H++ I HRDVKP N+L L DFG A+ + ++ +
Sbjct: 128 HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY------------ 175
Query: 236 KNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNY 295
T Y+APE+L E + + D++S G+ + LL G P+ A + +
Sbjct: 176 -----TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR-- 228
Query: 296 TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
+ G + + LI+ P R + ++
Sbjct: 229 ---------IRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEF 269
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 5e-37
Identities = 68/293 (23%), Positives = 108/293 (36%), Gaps = 34/293 (11%)
Query: 70 LLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELD-----NFHKELQLLCKLDHPG 122
L + G + VY+A + VA+KK L E +E++LL +L HP
Sbjct: 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPN 61
Query: 123 LAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLG 182
+ + A N F+F E+ + + + + L+YLH
Sbjct: 62 IIGLLDAFGHKSNISLVFDFMETDLE-VIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 120
Query: 183 IVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTL 242
I+HRD+KP N+LLD N LADFGLA+ + + V T
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLAKSFGS----------------PNRAYTHQVVTR 164
Query: 243 IYMAPEILKK-EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLT 301
Y APE+L ++ D+++ G + ELL V Q + E T +
Sbjct: 165 WYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQ 224
Query: 302 AAVVSGGLRPI---------LASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
+ + L + +L LIQ + NP R + +
Sbjct: 225 WPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 139 bits (352), Expect = 6e-37
Identities = 62/297 (20%), Positives = 105/297 (35%), Gaps = 46/297 (15%)
Query: 68 YTLLSPIARGAESVVYEATL--DGRKVAVKK------PILSTSEELDNFHKELQLLCKLD 119
+++ I RG VY G+ A+K + N L L+ D
Sbjct: 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65
Query: 120 HPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLH 179
P + A P F + +L L + S + AA++ L+++H
Sbjct: 66 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS-QHGVFSEADMRFYAAEIILGLEHMH 124
Query: 180 NLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMV 239
N +V+RD+KPAN+LLD + ++D GLA K V
Sbjct: 125 NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK------------------PHASV 166
Query: 240 GTLIYMAPEILKKEI-HSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQ 298
GT YMAPE+L+K + + +D +S G + +LL G P+ + + +
Sbjct: 167 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV 226
Query: 299 QLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH 355
+L + SL++ + + R + V E
Sbjct: 227 ELPD----------------SFSPELRSLLEGLLQRDVNRRLGCLGRGAQ--EVKES 265
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 1e-36
Identities = 67/294 (22%), Positives = 109/294 (37%), Gaps = 33/294 (11%)
Query: 68 YTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEE--LDNFHKELQLLCKLDHPGL 123
Y L I G V++A VA+K+ L +E + +E+ LL +L H +
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 124 AKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGI 183
+ FEF + + V QL K L + H+ +
Sbjct: 64 VRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDP-EIVKSFLFQLLKGLGFCHSRNV 122
Query: 184 VHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLI 243
+HRD+KP N+L++RN LA+FGLA R+ G P V TL
Sbjct: 123 LHRDLKPQNLLINRNGELKLANFGLA--------------RAFGIPVR--CYSAEVVTLW 166
Query: 244 YMAPEIL-KKEIHSEKSDVYSFGISINELLTGVVP-YTDLRAEAQAHTVLEMNYTEQQLT 301
Y P++L +++S D++S G EL P + + Q + + T +
Sbjct: 167 YRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQ 226
Query: 302 AAVVSG----------GLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
++ L ++ L A+ L+Q NP R S +
Sbjct: 227 WPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 2e-36
Identities = 60/298 (20%), Positives = 108/298 (36%), Gaps = 35/298 (11%)
Query: 68 YTLLSPIARGAESVVYEAT--LDGRKVAVKK-PILSTSEELDNFHKELQLLCKLDHPGLA 124
YT LS I GA +V A ++ +VA+KK +E+++L + H +
Sbjct: 10 YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 69
Query: 125 KFVAAHAKPP----NYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHN 180
P ++ +L + L + S D + Q+ + L+Y+H+
Sbjct: 70 GINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSN--DHICYFLYQILRGLKYIHS 127
Query: 181 LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVG 240
++HRD+KP+N+LL+ + DFGLA + V
Sbjct: 128 ANVLHRDLKPSNLLLNTTCDLKICDFGLARV-------------ADPDHDHTGFLTEYVA 174
Query: 241 TLIYMAPEILKKEIH-SEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQ 299
T Y APEI+ ++ D++S G + E+L+ + Q + +L + + Q
Sbjct: 175 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 234
Query: 300 LTAAVVSG------------GLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345
+ + L + L L+ + NPH R
Sbjct: 235 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 136 bits (342), Expect = 1e-35
Identities = 49/294 (16%), Positives = 106/294 (36%), Gaps = 46/294 (15%)
Query: 68 YTLLSPIARGAESVVYEAT--LDGRKVAVK---KPILSTSEELDNFHKELQLLCKLDHPG 122
+ + + G+ V G A+K K + +++++ E ++L ++ P
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 123 LAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLG 182
L K + N E+ + L S AAQ+ +YLH+L
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFSEPHARFYAAQIVLTFEYLHSLD 161
Query: 183 IVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTL 242
+++RD+KP N+L+D+ + DFG A+ + + GT
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-------------------RTWTLCGTP 202
Query: 243 IYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTA 302
+APEI+ + +++ D ++ G+ I E+ G P+ + ++
Sbjct: 203 EALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS--- 259
Query: 303 AVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHR 356
+ + L++ + R F ++ ++ + H+
Sbjct: 260 ----------------HFSSDLKDLLRNLLQVDLTKR--FGNLKNGVNDIKNHK 295
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 1e-35
Identities = 70/301 (23%), Positives = 115/301 (38%), Gaps = 43/301 (14%)
Query: 67 SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLA 124
SYT I G+ VVY+A L G VA+KK +L ++ELQ++ KLDH +
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK-VLQDKRF---KNRELQIMRKLDHCNIV 76
Query: 125 KFV-----AAHAKPPNYMFF-FEFYESRNLAEKLHV--EEWSPSVDQVLMIAAQLAKALQ 176
+ + K Y+ ++ H + + V V + QL ++L
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 177 YLHNLGIVHRDVKPANVLLDRN-LCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHK 235
Y+H+ GI HRD+KP N+LLD + L DFG A+ G
Sbjct: 137 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-----------------GEPN 179
Query: 236 KNMVGTLIYMAP-EILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMN 294
+ + + Y AP I ++ DV+S G + ELL G + Q ++++
Sbjct: 180 VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL 239
Query: 295 YTEQQLTAAVVSGGL----------RPILASLELGLPASILSLIQRCWDGNPHNRPSFSD 344
T + ++ P P ++L R + P R + +
Sbjct: 240 GTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLE 299
Query: 345 I 345
Sbjct: 300 A 300
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 2e-35
Identities = 59/301 (19%), Positives = 111/301 (36%), Gaps = 39/301 (12%)
Query: 65 PSSYTLLSPIARGAESVVYEAT--LDGRKVAVK--KPILSTSEELDNFHKELQLLCKLDH 120
+ Y L P+ GA V A G KVA+K + ++EL+LL + H
Sbjct: 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRH 76
Query: 121 PGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLH---VEEWSPSVDQVLMIAAQLAKALQY 177
+ + F +FY ++ D++ + Q+ K L+Y
Sbjct: 77 ENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRY 136
Query: 178 LHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKN 237
+H GI+HRD+KP N+ ++ + + DFGLA ++
Sbjct: 137 IHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS-------------------EMTG 177
Query: 238 MVGTLIYMAPE-ILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYT 296
V T Y APE IL +++ D++S G + E++TG + Q ++++ T
Sbjct: 178 YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGT 237
Query: 297 EQQLTAAVVSGGL------------RPILASLELGLPASILSLIQRCWDGNPHNRPSFSD 344
+ + AS+ ++L+++ + R + +
Sbjct: 238 PPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGE 297
Query: 345 I 345
Sbjct: 298 A 298
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 2e-34
Identities = 69/315 (21%), Positives = 116/315 (36%), Gaps = 47/315 (14%)
Query: 68 YTLLSPIARGAESVVYEATL-----DGRKVAVKK----PILSTSEELDNFHKELQLLCKL 118
+ LL + GA V+ G+ A+K I+ ++ ++ E Q+L +
Sbjct: 26 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 85
Query: 119 DH-PGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQY 177
P L A ++ L L + + +V + ++ AL++
Sbjct: 86 RQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLS-QRERFTEHEVQIYVGEIVLALEH 144
Query: 178 LHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKN 237
LH LGI++RD+K N+LLD N L DFGL++ +
Sbjct: 145 LHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV---------------ADETERAYD 189
Query: 238 MVGTLIYMAPEIL--KKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNY 295
GT+ YMAP+I+ H + D +S G+ + ELLTG P+T + +
Sbjct: 190 FCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL 249
Query: 296 TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH 355
+ + A LIQR +P R + + EH
Sbjct: 250 KSEP---------------PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDAD--EIKEH 292
Query: 356 R--KSLKEEDLCAGK 368
+ + +DL A K
Sbjct: 293 LFFQKINWDDLAAKK 307
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (321), Expect = 6e-33
Identities = 68/353 (19%), Positives = 124/353 (35%), Gaps = 51/353 (14%)
Query: 68 YTLLSPIARGAESVVYEAT--LDGRKVAVKK--PILSTSEELDNFHKELQLLCKLDHPGL 123
Y L PI GA+ +V A + R VA+KK ++EL L+ ++H +
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78
Query: 124 AKFVAAHAKPPNYMFFFEFYESRNLAE--KLHVEEWSPSVDQVLMIAAQLAKALQYLHNL 181
+ F + Y L + V + +++ + Q+ +++LH+
Sbjct: 79 ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA 138
Query: 182 GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGT 241
GI+HRD+KP+N+++ + + DFGLA F V T
Sbjct: 139 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-----------------SFMMTPYVVT 181
Query: 242 LIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYT----- 296
Y APE++ + E D++S G + E++ + + Q + V+E T
Sbjct: 182 RYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF 241
Query: 297 ------------------EQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHN 338
+ L P + + L+ + +P
Sbjct: 242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAK 301
Query: 339 RPSFSDIALELDLVLEHRKSLKEEDLCAGKSYVTYDDKLINSGNNMHTYHESI 391
R S D AL+ + + E YD +L + + + E I
Sbjct: 302 RISVDD-ALQHPYINVWYDPAEVEAPPP----QIYDKQLDEREHTIEEWKELI 349
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 5e-32
Identities = 65/301 (21%), Positives = 114/301 (37%), Gaps = 39/301 (12%)
Query: 65 PSSYTLLSPIARGAESVVYEA--TLDGRKVAVK--KPILSTSEELDNFHKELQLLCKLDH 120
P Y LSP+ GA V A T G +VAVK + ++EL+LL + H
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 121 PGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEW---SPSVDQVLMIAAQLAKALQY 177
+ + + F + Y +L + D V + Q+ + L+Y
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 136
Query: 178 LHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKN 237
+H+ I+HRD+KP+N+ ++ + + DFGLA +
Sbjct: 137 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT-------------------DDEMTG 177
Query: 238 MVGTLIYMAPEI-LKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYT 296
V T Y APEI L +++ D++S G + ELLTG + Q +L + T
Sbjct: 178 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 237
Query: 297 EQQLTAAVVSGGL------------RPILASLELGLPASILSLIQRCWDGNPHNRPSFSD 344
+S + A++ +G + L+++ + R + +
Sbjct: 238 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQ 297
Query: 345 I 345
Sbjct: 298 A 298
|
| >d1txoa_ d.219.1.1 (A:) putative serine/threonine phosphatase pstp/ppp {Mycobacterium tuberculosis [TaxId: 1773]} Length = 235 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: PP2C-like superfamily: PP2C-like family: PP2C-like domain: putative serine/threonine phosphatase pstp/ppp species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 117 bits (294), Expect = 2e-30
Identities = 55/262 (20%), Positives = 95/262 (36%), Gaps = 30/262 (11%)
Query: 428 VLSWGSFATCGR-RETMEDTHFLMPHMYNQKEIHMFGIFDGHRGSAAAEFSARALPGFLQ 486
VL + + + G R ED+ + + + DG G AA E +++ + L
Sbjct: 2 VLRYAARSDRGLVRANNEDSVYAGARL--------LALADGMGGHAAGEVASQLVIAALA 53
Query: 487 NLGSTTRPTDALLEAFIRTDVAFRNELDSLRKSKRVVQKDWHPGCTAIAALIVRNRLFVA 546
+L D + D A R ++ + G T A L NRL +
Sbjct: 54 HLDDDEPGGDL----LAKLDAAVRAGNSAIAAQVEMEPDLEGMGTTLTAILFAGNRLGLV 109
Query: 547 NAGDCRAILCRGGHPFALSRDHVASCLEERERVVSAGGNVNWQVDTWRVGPPALQVTRSI 606
+ GD R L R G +++D V + + P + R++
Sbjct: 110 HIGDSRGYLLRDGELTQITKDD--------TFVQTLVDEGRITPEEAHSHPQRSLIMRAL 161
Query: 607 GDDDLKPAVTAEPEITETIMTPEDEYLVMASDGLWDVVSHVEAVGIIKDTVKEPGMCSKR 666
+++P +T + ++ SDGL D VS + ++ E + R
Sbjct: 162 TGHEVEPTLTMRE-------ARAGDRYLLCSDGLSDPVSDETILEALQI--PEVAESAHR 212
Query: 667 LATEAAERGSKDNITVIVVFLQ 688
L A G DN+TV+V L+
Sbjct: 213 LIELALRGGGPDNVTVVVADLE 234
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 118 bits (296), Expect = 7e-30
Identities = 58/314 (18%), Positives = 114/314 (36%), Gaps = 57/314 (18%)
Query: 68 YTLLSPIARGAESVVYEAT--LDGRKVAVKKPILSTSEELDNFHKELQLLCKL-DHPGLA 124
Y L+ + RG S V+EA + KV VK + +E+++L L P +
Sbjct: 37 YQLVRKLGRGKYSEVFEAINITNNEKVVVKI---LKPVKKKKIKREIKILENLRGGPNII 93
Query: 125 KFVAAHAKPPNYMFF--FEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLG 182
P + FE + + + + + + ++ KAL Y H++G
Sbjct: 94 TLADIVKDPVSRTPALVFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHSMG 149
Query: 183 IVHRDVKPANVLLDR-NLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGT 241
I+HRDVKP NV++D + L D+GLAE+ +E + V +
Sbjct: 150 IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYN-----------------VRVAS 192
Query: 242 LIYMAPEI-LKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAE-AQAHTVLEMNYTEQQ 299
+ PE+ + +++ D++S G + ++ P+ Q + ++ TE
Sbjct: 193 RYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDL 252
Query: 300 ------------------LTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPS 341
L R + + + + L + + + +R +
Sbjct: 253 YDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLT 312
Query: 342 FSDIALELDLVLEH 355
+ +EH
Sbjct: 313 AREA-------MEH 319
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 110 bits (274), Expect = 1e-26
Identities = 71/374 (18%), Positives = 122/374 (32%), Gaps = 77/374 (20%)
Query: 68 YTLLSPIARGAESVVYEA--TLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAK 125
Y L+ + G S V+ A ++ VA+K + + E++LL +++ K
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKI-VRGDKVYTEAAEDEIKLLQRVNDADNTK 73
Query: 126 ---------------FVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQ 170
F + + FE LA E + V I+ Q
Sbjct: 74 EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133
Query: 171 LAKALQYLH-NLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKP 229
L L Y+H GI+H D+KP NVL++ P I +K
Sbjct: 134 LLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPE-------------NLIQIKIADLGNAC 180
Query: 230 TGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY---------TD 280
H N + T Y +PE+L +D++S I EL+TG + D
Sbjct: 181 WYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 240
Query: 281 LRAEAQAHTVL-----EMNYTEQQLTAAVVSGGLRPILASLEL---------------GL 320
AQ +L + + S GL ++ L+
Sbjct: 241 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDE 300
Query: 321 PASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH---RKSLKEEDLCAGKSYVTYDDKL 377
I + +P R + + H + +L E++ D +L
Sbjct: 301 AKEISDFLSPMLQLDPRKRADAGGL-------VNHPWLKDTLGMEEI------RVPDREL 347
Query: 378 INSGNNMHTYHESI 391
SG+++ + E +
Sbjct: 348 YGSGSDIPGWFEEV 361
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 82.1 bits (202), Expect = 1e-18
Identities = 23/154 (14%), Positives = 49/154 (31%), Gaps = 18/154 (11%)
Query: 68 YTLLSPIARGAESVVYEATL-DGRKVAVKKPILSTSE----------ELDNFHKELQLLC 116
+ + G ES V+ + VK + + +F
Sbjct: 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSA 61
Query: 117 KLDHPGLAKFVAAHAKPPNYMFFFEFYESRNLAEKLHVEEWS-PSVDQVLMIAAQLAKAL 175
+ + L K + + + + L E + +E V+ + + + +
Sbjct: 62 RNEFRALQKL-----QGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEV 116
Query: 176 QYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLA 209
++ GIVH D+ NVL+ + DF +
Sbjct: 117 AKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQS 149
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 697 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1a6qa2 | 295 | Protein serine/threonine phosphatase 2C, catalytic | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1txoa_ | 235 | putative serine/threonine phosphatase pstp/ppp {My | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.89 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.35 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.5 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.43 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.11 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 95.65 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.05 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-54 Score=436.55 Aligned_cols=267 Identities=29% Similarity=0.510 Sum_probs=222.5
Q ss_pred cCCCCCCCcccccccccCCceEEEEEEECCeeEEEEeccCC--ChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceE
Q 005427 60 PLHLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYM 137 (697)
Q Consensus 60 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 137 (697)
.|+++.++|++.++||+|+||+||+|++.+ .||||++... .....+.|.+|+.+|++++|||||++++++.. +.++
T Consensus 2 dwei~~~~~~~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~ 79 (276)
T d1uwha_ 2 DWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLA 79 (276)
T ss_dssp CCBCCTTCCCCCSEEEECSSCEEEEEESSS-EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCE
T ss_pred CcccccccEEEEEEEeeCCCcEEEEEEECC-EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEE
Confidence 468889999999999999999999998765 5999987543 34567889999999999999999999998754 5789
Q ss_pred EEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhh
Q 005427 138 FFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKE 217 (697)
Q Consensus 138 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~ 217 (697)
+|||||++|+|.+++...+..+++.+++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+|+.......
T Consensus 80 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~ 159 (276)
T d1uwha_ 80 IVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG 159 (276)
T ss_dssp EEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC------
T ss_pred EEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCC
Confidence 99999999999999987777899999999999999999999999999999999999999999999999999976543111
Q ss_pred hhcccccCCCCCCCCccccccccCccccchhhhcc---cCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhcc
Q 005427 218 ISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK---EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMN 294 (697)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~ 294 (697)
........||+.|||||++.+ ..++.++|||||||+||||+||+.||.+..........
T Consensus 160 --------------~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~---- 221 (276)
T d1uwha_ 160 --------------SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFM---- 221 (276)
T ss_dssp --------------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHH----
T ss_pred --------------cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHH----
Confidence 112345689999999999964 35799999999999999999999999876544333222
Q ss_pred ccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 005427 295 YTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH 355 (697)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~ 355 (697)
+..+...|.+...+..+|+++.+||.+||+.||++|||+.||+++|+.+.+.
T Consensus 222 ---------~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~ 273 (276)
T d1uwha_ 222 ---------VGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273 (276)
T ss_dssp ---------HHHTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ---------HhcCCCCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence 2223345556666778999999999999999999999999999999988653
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-54 Score=440.21 Aligned_cols=253 Identities=23% Similarity=0.375 Sum_probs=218.9
Q ss_pred CCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEee
Q 005427 65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF 142 (697)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 142 (697)
.++|+++++||+|+||+||+|++ +++.||||++........+.+.+|+.+|+.++|||||++++++.+++.+|+||||
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy 98 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence 46899999999999999999987 5899999987665555567899999999999999999999999999999999999
Q ss_pred cCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhccc
Q 005427 143 YESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKN 222 (697)
Q Consensus 143 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 222 (697)
|+||+|.+++... .+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.+...
T Consensus 99 ~~gg~L~~~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~------- 169 (293)
T d1yhwa1 99 LAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE------- 169 (293)
T ss_dssp CTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCST-------
T ss_pred cCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeeccc-------
Confidence 9999999987654 5899999999999999999999999999999999999999999999999999765421
Q ss_pred ccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHHHH
Q 005427 223 WRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTA 302 (697)
Q Consensus 223 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 302 (697)
.......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.........+....
T Consensus 170 ---------~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~-------- 232 (293)
T d1yhwa1 170 ---------QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG-------- 232 (293)
T ss_dssp ---------TCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHC--------
T ss_pred ---------cccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCC--------
Confidence 112345689999999999999999999999999999999999999998766554444333211
Q ss_pred HHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 005427 303 AVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL 351 (697)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~ 351 (697)
. +.+ ..+..+|+++.+||.+||+.||++|||+.|+++|.|+
T Consensus 233 -----~--~~~-~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~ 273 (293)
T d1yhwa1 233 -----T--PEL-QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFL 273 (293)
T ss_dssp -----S--CCC-SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGG
T ss_pred -----C--CCC-CCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhh
Confidence 1 111 2245689999999999999999999999999999876
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-54 Score=433.18 Aligned_cols=250 Identities=22% Similarity=0.368 Sum_probs=218.1
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccCCC---hHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEE
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST---SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFF 140 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 140 (697)
++|++++.||+|+||+||+|++ +++.||+|++.... ....+.+.+|+.+|+.++|||||++++++.++..+++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 5899999999999999999998 57899999865322 223567899999999999999999999999999999999
Q ss_pred eecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhc
Q 005427 141 EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL 220 (697)
Q Consensus 141 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~ 220 (697)
|||++|+|.+++...+ .+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|.....
T Consensus 86 Ey~~~g~L~~~l~~~~-~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~------ 158 (263)
T d2j4za1 86 EYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS------ 158 (263)
T ss_dssp ECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC------
T ss_pred eecCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCC------
Confidence 9999999999997655 689999999999999999999999999999999999999999999999999965432
Q ss_pred ccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHH
Q 005427 221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQL 300 (697)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 300 (697)
.......||+.|||||++.+..++.++|||||||++|+|++|..||.+.+.......+.+...
T Consensus 159 ------------~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~----- 221 (263)
T d2j4za1 159 ------------SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF----- 221 (263)
T ss_dssp ------------CCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC-----
T ss_pred ------------CcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-----
Confidence 113456899999999999999999999999999999999999999988766555544433221
Q ss_pred HHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 005427 301 TAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL 353 (697)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~ 353 (697)
..+..+|+++.+||.+||+.||++|||++|+++|+|+..
T Consensus 222 --------------~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 222 --------------TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp --------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred --------------CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence 134568999999999999999999999999999998754
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-54 Score=439.94 Aligned_cols=254 Identities=24% Similarity=0.366 Sum_probs=220.2
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEeec
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFY 143 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 143 (697)
+.|+++++||+|+||+||+|++ +++.||||++........+.+.+|+++|++++|||||++++++.+++.+++|||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 4699999999999999999998 57899999987666667788999999999999999999999999999999999999
Q ss_pred CCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhcccc
Q 005427 144 ESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNW 223 (697)
Q Consensus 144 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~ 223 (697)
++|+|.+++......+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.......
T Consensus 92 ~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~------ 165 (288)
T d2jfla1 92 AGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ------ 165 (288)
T ss_dssp TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH------
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCcc------
Confidence 99999999877666799999999999999999999999999999999999999999999999999976543221
Q ss_pred cCCCCCCCCccccccccCccccchhhhc-----ccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHH
Q 005427 224 RSSGKPTGGFHKKNMVGTLIYMAPEILK-----KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQ 298 (697)
Q Consensus 224 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~ 298 (697)
...+.+||+.|+|||++. +..|+.++|||||||++|||++|..||.+.+.......+....
T Consensus 166 ----------~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~---- 231 (288)
T d2jfla1 166 ----------RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSE---- 231 (288)
T ss_dssp ----------HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSC----
T ss_pred ----------cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCC----
Confidence 134568999999999984 5568899999999999999999999998876655544443321
Q ss_pred HHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 005427 299 QLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL 351 (697)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~ 351 (697)
.+.+ ..+..+|+++.+||.+||+.||++|||++|+++|.|.
T Consensus 232 -----------~~~~-~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~ 272 (288)
T d2jfla1 232 -----------PPTL-AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFV 272 (288)
T ss_dssp -----------CCCC-SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGG
T ss_pred -----------CCCC-CccccCCHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence 1111 2245689999999999999999999999999998876
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-54 Score=434.24 Aligned_cols=255 Identities=26% Similarity=0.368 Sum_probs=211.4
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccCCCh-HHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEee
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTS-EELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF 142 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 142 (697)
++|+++++||+|+||+||+|++ +++.||||++..... ...+.+.+|+.+|+.++|||||++++++.+++.+|+||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 5799999999999999999998 588999998765433 3356789999999999999999999999999999999999
Q ss_pred cCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhccc
Q 005427 143 YESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKN 222 (697)
Q Consensus 143 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 222 (697)
|++|+|.+++.... .+++.+++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+.......
T Consensus 85 ~~gg~L~~~l~~~~-~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~----- 158 (271)
T d1nvra_ 85 CSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR----- 158 (271)
T ss_dssp CTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTE-----
T ss_pred cCCCcHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCc-----
Confidence 99999999997544 789999999999999999999999999999999999999999999999999986643211
Q ss_pred ccCCCCCCCCccccccccCccccchhhhcccCC-CchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHHH
Q 005427 223 WRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIH-SEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLT 301 (697)
Q Consensus 223 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 301 (697)
.......+||+.|||||++.+..+ +.++|||||||++|||++|..||...............
T Consensus 159 ---------~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~-------- 221 (271)
T d1nvra_ 159 ---------ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE-------- 221 (271)
T ss_dssp ---------ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHT--------
T ss_pred ---------cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhc--------
Confidence 012345689999999999988775 67899999999999999999999765433222221111
Q ss_pred HHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 005427 302 AAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL 351 (697)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~ 351 (697)
. +........+|+++.+||.+||+.||++|||++|+++|.|+
T Consensus 222 -----~---~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf 263 (271)
T d1nvra_ 222 -----K---KTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWY 263 (271)
T ss_dssp -----T---CTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTT
T ss_pred -----C---CCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhh
Confidence 1 11112234688999999999999999999999999999886
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-54 Score=429.67 Aligned_cols=251 Identities=28% Similarity=0.404 Sum_probs=204.8
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccCC--ChHHHHHHHHHHHHHHhcCCCCceEEeecccc--CCceEEE
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAK--PPNYMFF 139 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~--~~~~~lv 139 (697)
++|++++.||+|+||+||+|++ +++.||||++... .....+.+.+|+++|++++|||||++++++.+ ...+|+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 6799999999999999999987 5889999987654 34456789999999999999999999998864 4568999
Q ss_pred EeecCCCCHhhhhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC-----cccccCCCCceeecCCCCCeeeeeccchh
Q 005427 140 FEFYESRNLAEKLHV---EEWSPSVDQVLMIAAQLAKALQYLHNLG-----IVHRDVKPANVLLDRNLCPHLADFGLAEY 211 (697)
Q Consensus 140 ~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~-----ivHrDlkp~Nill~~~~~~kL~Dfg~a~~ 211 (697)
||||++|+|.+++.. ....+++.+++.++.|++.||+|||++| |+||||||+|||++.++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 999999999999864 3457899999999999999999999976 99999999999999999999999999987
Q ss_pred hhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHH
Q 005427 212 RENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVL 291 (697)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~ 291 (697)
+..... .....+||+.|||||++.+..++.++|||||||++|||++|..||.+.+.......+.
T Consensus 164 ~~~~~~----------------~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~ 227 (269)
T d2java1 164 LNHDTS----------------FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR 227 (269)
T ss_dssp C---------------------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred cccCCC----------------ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHH
Confidence 643111 2345689999999999999999999999999999999999999998876555444433
Q ss_pred hccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 005427 292 EMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350 (697)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~ 350 (697)
. +... ..+..+|+++.+||.+||+.||++|||++|+++|+|
T Consensus 228 ~--------------~~~~----~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~ 268 (269)
T d2java1 228 E--------------GKFR----RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL 268 (269)
T ss_dssp H--------------TCCC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred c--------------CCCC----CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCc
Confidence 2 2222 234578999999999999999999999999998876
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-54 Score=433.49 Aligned_cols=255 Identities=22% Similarity=0.345 Sum_probs=216.3
Q ss_pred CCCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCC---hHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceE
Q 005427 63 LPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST---SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYM 137 (697)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 137 (697)
..+++|++++.||+|+||+||+|++ +++.||||++.... ....+.+.+|+++|++++||||+++++++.+++.+|
T Consensus 5 ~~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 84 (288)
T d1uu3a_ 5 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLY 84 (288)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEE
T ss_pred CCCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEE
Confidence 3457899999999999999999998 58899999865322 223567999999999999999999999999999999
Q ss_pred EEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhh
Q 005427 138 FFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKE 217 (697)
Q Consensus 138 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~ 217 (697)
+|||||+||+|.+++...+ .+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+.+.....
T Consensus 85 ivmEy~~gg~L~~~~~~~~-~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~ 163 (288)
T d1uu3a_ 85 FGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 163 (288)
T ss_dssp EEECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred EEEEccCCCCHHHhhhccC-CCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCc
Confidence 9999999999999987665 799999999999999999999999999999999999999999999999999986542111
Q ss_pred hhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccH
Q 005427 218 ISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTE 297 (697)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~ 297 (697)
.....+.+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+.......+....+
T Consensus 164 --------------~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~-- 227 (288)
T d1uu3a_ 164 --------------QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY-- 227 (288)
T ss_dssp --------------------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCC--
T ss_pred --------------ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCC--
Confidence 1123456899999999999999999999999999999999999999998766655555443221
Q ss_pred HHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 005427 298 QQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL 351 (697)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~ 351 (697)
..+..+++++.+||++||+.||++|||++|++++.+.
T Consensus 228 -----------------~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i 264 (288)
T d1uu3a_ 228 -----------------DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPL 264 (288)
T ss_dssp -----------------CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHH
T ss_pred -----------------CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHH
Confidence 1345789999999999999999999999998776553
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-53 Score=422.21 Aligned_cols=259 Identities=23% Similarity=0.414 Sum_probs=211.6
Q ss_pred CCCCCcccccccccCCceEEEEEEE-CCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEe
Q 005427 63 LPPSSYTLLSPIARGAESVVYEATL-DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFE 141 (697)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 141 (697)
+++++|++.++||+|+||+||+|++ +++.||||++.... ...+.+.+|+.++++++||||+++++++..++.+++|||
T Consensus 2 idp~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E 80 (263)
T d1sm2a_ 2 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFE 80 (263)
T ss_dssp BCCSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred CChHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEE
Confidence 4578999999999999999999998 57789999876433 334679999999999999999999999999999999999
Q ss_pred ecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhcc
Q 005427 142 FYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLK 221 (697)
Q Consensus 142 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~ 221 (697)
|+++|+|.+++......++++.++.++.|++.||+|||+++|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~---- 156 (263)
T d1sm2a_ 81 FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY---- 156 (263)
T ss_dssp CCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC--------------
T ss_pred ecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCc----
Confidence 9999999999987777889999999999999999999999999999999999999999999999999976643211
Q ss_pred cccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCCchhHHHHHHHHhccccHHHH
Q 005427 222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQL 300 (697)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 300 (697)
.......||+.|+|||++.+..++.++|||||||++|||+| |.+||...........+..
T Consensus 157 -----------~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~-------- 217 (263)
T d1sm2a_ 157 -----------TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST-------- 217 (263)
T ss_dssp -------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHH--------
T ss_pred -----------eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHh--------
Confidence 11234578999999999999999999999999999999999 5777766554443333321
Q ss_pred HHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 005427 301 TAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH 355 (697)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~ 355 (697)
+.++. .+..+++++.+||.+||+.||++|||++||+++|..+.+.
T Consensus 218 -------~~~~~---~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 218 -------GFRLY---KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp -------TCCCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -------cCCCC---CccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 11221 2456789999999999999999999999999999988753
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.2e-53 Score=431.06 Aligned_cols=268 Identities=25% Similarity=0.401 Sum_probs=214.1
Q ss_pred CCCCCCcccccccccCCceEEEEEEEC--C---eeEEEEeccCC-ChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCc
Q 005427 62 HLPPSSYTLLSPIARGAESVVYEATLD--G---RKVAVKKPILS-TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPN 135 (697)
Q Consensus 62 ~~~~~~y~~~~~lg~G~~g~V~~~~~~--~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 135 (697)
++..++|++.++||+|+||+||+|++. + ..||||++... .....+.|.+|+.+|++++|||||++++++.++..
T Consensus 22 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~ 101 (299)
T d1jpaa_ 22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTP 101 (299)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred hhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCE
Confidence 466678999999999999999999873 2 25888876544 34456789999999999999999999999999999
Q ss_pred eEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhh
Q 005427 136 YMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL 215 (697)
Q Consensus 136 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~ 215 (697)
+++|||||++|+|.+++......+++.+++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++.+...
T Consensus 102 ~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 181 (299)
T d1jpaa_ 102 VMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181 (299)
T ss_dssp CEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccCC
Confidence 99999999999999998877768999999999999999999999999999999999999999999999999999876532
Q ss_pred hhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCCchhHHHHHHHHhcc
Q 005427 216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMN 294 (697)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~~~~~~~~~~~~~~~ 294 (697)
.... .........||+.|||||++.+..++.++|||||||++|||+| |..||.+.........+.
T Consensus 182 ~~~~-----------~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~--- 247 (299)
T d1jpaa_ 182 TSDP-----------TYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIE--- 247 (299)
T ss_dssp -------------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH---
T ss_pred CCcc-----------eeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHH---
Confidence 2110 0011223468999999999999999999999999999999998 899998876554433332
Q ss_pred ccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHhcc
Q 005427 295 YTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHRKS 358 (697)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~~~~ 358 (697)
. +.++ ..+..+|+++.+||.+||+.||++|||+.||++.|+.+++...+
T Consensus 248 -----------~-~~~~---~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~p~s 296 (299)
T d1jpaa_ 248 -----------Q-DYRL---PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNPNS 296 (299)
T ss_dssp -----------T-TCCC---CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGG
T ss_pred -----------c-CCCC---CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcChhh
Confidence 1 2222 13457899999999999999999999999999999988875443
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-53 Score=436.46 Aligned_cols=270 Identities=23% Similarity=0.316 Sum_probs=217.3
Q ss_pred CCCCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCC-hHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEE
Q 005427 62 HLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST-SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMF 138 (697)
Q Consensus 62 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 138 (697)
++..++|+++++||+|+||+||+|++ +++.||+|++.... ....+.+.+|+.+|+.++|||||+++++|.++.++++
T Consensus 2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~i 81 (322)
T d1s9ja_ 2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 81 (322)
T ss_dssp CCCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEE
T ss_pred CCCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 45678999999999999999999998 58899999876543 3345788999999999999999999999999999999
Q ss_pred EEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccccCCCCceeecCCCCCeeeeeccchhhhhhhh
Q 005427 139 FFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNL-GIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKE 217 (697)
Q Consensus 139 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~ 217 (697)
|||||+||+|.+++...+ .+++..++.++.|++.||.|||++ ||+||||||+|||++.++.+||+|||+|+.....
T Consensus 82 VmEy~~gg~L~~~l~~~~-~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-- 158 (322)
T d1s9ja_ 82 CMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 158 (322)
T ss_dssp EEECCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred EEEcCCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC--
Confidence 999999999999997665 689999999999999999999975 9999999999999999999999999999876431
Q ss_pred hhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHH-hcccc
Q 005427 218 ISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVL-EMNYT 296 (697)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~-~~~~~ 296 (697)
...+.+||+.|+|||++.+..|+.++||||+||++|||++|+.||.+.+......... .....
T Consensus 159 ----------------~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~ 222 (322)
T d1s9ja_ 159 ----------------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGD 222 (322)
T ss_dssp ----------------TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------
T ss_pred ----------------ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCC
Confidence 1345689999999999999999999999999999999999999998754332211110 00000
Q ss_pred ---------------------------HHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 005427 297 ---------------------------EQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALEL 349 (697)
Q Consensus 297 ---------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l 349 (697)
..+....... ...|.+ ....+|.++.+||.+||+.||.+|||++|+++|+
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~--~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hp 299 (322)
T d1s9ja_ 223 AAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVN-EPPPKL--PSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA 299 (322)
T ss_dssp -----------------------CCCCHHHHHHHHHT-SCCCCC--CBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred cccCCcccccccccccccccccccchhHHHHHhhhhc-cCCccC--ccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCH
Confidence 0001111111 111111 1234689999999999999999999999999999
Q ss_pred HHHH
Q 005427 350 DLVL 353 (697)
Q Consensus 350 ~~~~ 353 (697)
|...
T Consensus 300 f~~~ 303 (322)
T d1s9ja_ 300 FIKR 303 (322)
T ss_dssp HHHH
T ss_pred hhCc
Confidence 8754
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=5e-53 Score=439.64 Aligned_cols=255 Identities=24% Similarity=0.323 Sum_probs=223.7
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEeec
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFY 143 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 143 (697)
++|+++++||+|+||.||+|++ +|+.||||++........+.+.+|+.+|++++|||||++++++.+++.+|+|||||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 105 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 5899999999999999999997 58999999987777777788999999999999999999999999999999999999
Q ss_pred CCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecC--CCCCeeeeeccchhhhhhhhhhcc
Q 005427 144 ESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDR--NLCPHLADFGLAEYRENLKEISLK 221 (697)
Q Consensus 144 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~--~~~~kL~Dfg~a~~~~~~~~~~~~ 221 (697)
+||+|.+++......+++.+++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++.+....
T Consensus 106 ~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~----- 180 (350)
T d1koaa2 106 SGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ----- 180 (350)
T ss_dssp CSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS-----
T ss_pred CCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheeccccc-----
Confidence 999999999766667999999999999999999999999999999999999954 6789999999997654311
Q ss_pred cccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHHH
Q 005427 222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLT 301 (697)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 301 (697)
...+..||+.|||||++.+..++.++|||||||++|+|++|..||.+.+.......+....+.
T Consensus 181 ------------~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~----- 243 (350)
T d1koaa2 181 ------------SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWN----- 243 (350)
T ss_dssp ------------CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC-----
T ss_pred ------------ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-----
Confidence 234578999999999999999999999999999999999999999987766666555443321
Q ss_pred HHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 302 AAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
........+|+++.+||.+||+.||++|||++|+++|.|..
T Consensus 244 ----------~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~ 284 (350)
T d1koaa2 244 ----------MDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLT 284 (350)
T ss_dssp ----------SCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTS
T ss_pred ----------CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccC
Confidence 11223346899999999999999999999999999998763
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.3e-53 Score=431.45 Aligned_cols=254 Identities=22% Similarity=0.307 Sum_probs=203.2
Q ss_pred CCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCCh-HHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEe
Q 005427 65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTS-EELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFE 141 (697)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 141 (697)
.++|++.++||+|+||+||+|++ +++.||||++..... .....+.+|+.+|+.++|||||++++++.++..+|+|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 35799999999999999999998 588999998764432 234568899999999999999999999999999999999
Q ss_pred ecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeec---CCCCCeeeeeccchhhhhhhhh
Q 005427 142 FYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLD---RNLCPHLADFGLAEYRENLKEI 218 (697)
Q Consensus 142 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~---~~~~~kL~Dfg~a~~~~~~~~~ 218 (697)
||+||+|.+++...+ .+++.++..++.||+.||+|||++||+||||||+|||+. .++.+||+|||+++......
T Consensus 88 ~~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~-- 164 (307)
T d1a06a_ 88 LVSGGELFDRIVEKG-FYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS-- 164 (307)
T ss_dssp CCCSCBHHHHHHTCS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC------------
T ss_pred ccCCCcHHHhhhccc-CCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCC--
Confidence 999999999997654 799999999999999999999999999999999999994 57899999999997654211
Q ss_pred hcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHH
Q 005427 219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQ 298 (697)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~ 298 (697)
...+.+||+.|||||++.+..++.++|||||||++|||++|..||.+.........+.....
T Consensus 165 ---------------~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~--- 226 (307)
T d1a06a_ 165 ---------------VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEY--- 226 (307)
T ss_dssp -----------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCC---
T ss_pred ---------------eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCC---
Confidence 23456899999999999999999999999999999999999999998766655555443222
Q ss_pred HHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 005427 299 QLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL 351 (697)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~ 351 (697)
+.....+..+|+++.+||.+||+.||++|||++|+++|+|.
T Consensus 227 ------------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~ 267 (307)
T d1a06a_ 227 ------------EFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWI 267 (307)
T ss_dssp ------------CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTT
T ss_pred ------------CCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhh
Confidence 11222345789999999999999999999999999999876
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=8.1e-53 Score=438.42 Aligned_cols=254 Identities=22% Similarity=0.306 Sum_probs=223.8
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEeec
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFY 143 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 143 (697)
++|+++++||+|+||.||+|++ +++.||||++......+...+.+|+.+|++|+|||||+++++|.++..+|+|||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 4799999999999999999997 58899999987776667778999999999999999999999999999999999999
Q ss_pred CCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeec--CCCCCeeeeeccchhhhhhhhhhcc
Q 005427 144 ESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLD--RNLCPHLADFGLAEYRENLKEISLK 221 (697)
Q Consensus 144 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~--~~~~~kL~Dfg~a~~~~~~~~~~~~ 221 (697)
+||+|.+.+......+++.+++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||+|..+...
T Consensus 109 ~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~------ 182 (352)
T d1koba_ 109 SGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD------ 182 (352)
T ss_dssp CCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT------
T ss_pred CCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCC------
Confidence 99999998877777899999999999999999999999999999999999997 5789999999999765421
Q ss_pred cccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHHH
Q 005427 222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLT 301 (697)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 301 (697)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+....+.
T Consensus 183 -----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~----- 246 (352)
T d1koba_ 183 -----------EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWE----- 246 (352)
T ss_dssp -----------SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCC-----
T ss_pred -----------CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-----
Confidence 1234568999999999999999999999999999999999999999987766665555443321
Q ss_pred HHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 005427 302 AAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL 351 (697)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~ 351 (697)
.....+..+|+++.+||.+||+.||.+|||+.|+++|.|+
T Consensus 247 ----------~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~ 286 (352)
T d1koba_ 247 ----------FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWL 286 (352)
T ss_dssp ----------CCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTT
T ss_pred ----------CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhh
Confidence 1122345789999999999999999999999999998876
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-52 Score=419.99 Aligned_cols=249 Identities=26% Similarity=0.377 Sum_probs=206.9
Q ss_pred CcccccccccCCceEEEEEEE--CCeeEEEEeccCC--ChHHHHHHHHHHHHHHhcCCCCceEEeecccc----CCceEE
Q 005427 67 SYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAK----PPNYMF 138 (697)
Q Consensus 67 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~----~~~~~l 138 (697)
.|++.++||+|+||+||+|++ +++.||+|++... ...+.+.+.+|+++|++++|||||++++++.+ ...+++
T Consensus 10 y~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~i 89 (270)
T d1t4ha_ 10 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 89 (270)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred EEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEE
Confidence 357888999999999999998 4778999986543 34556789999999999999999999999864 456899
Q ss_pred EEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccccCCCCceeec-CCCCCeeeeeccchhhhhh
Q 005427 139 FFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLG--IVHRDVKPANVLLD-RNLCPHLADFGLAEYRENL 215 (697)
Q Consensus 139 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~Nill~-~~~~~kL~Dfg~a~~~~~~ 215 (697)
|||||++|+|.+++.... .+++.+++.++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||+++....
T Consensus 90 vmE~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~- 167 (270)
T d1t4ha_ 90 VTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA- 167 (270)
T ss_dssp EEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT-
T ss_pred EEeCCCCCcHHHHHhccc-cccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC-
Confidence 999999999999997654 7899999999999999999999998 99999999999996 578999999999975332
Q ss_pred hhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccc
Q 005427 216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNY 295 (697)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~ 295 (697)
....+.+||+.|||||++.+ .++.++|||||||++|||++|+.||.+..........+
T Consensus 168 -----------------~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i---- 225 (270)
T d1t4ha_ 168 -----------------SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRV---- 225 (270)
T ss_dssp -----------------TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHH----
T ss_pred -----------------CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHH----
Confidence 12345689999999999876 58999999999999999999999998654433322221
Q ss_pred cHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 005427 296 TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL 351 (697)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~ 351 (697)
. .+.+| ...+..+++++.+||.+||+.||++|||++|+++|.|+
T Consensus 226 ---------~-~~~~~--~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~f 269 (270)
T d1t4ha_ 226 ---------T-SGVKP--ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 269 (270)
T ss_dssp ---------T-TTCCC--GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred ---------H-cCCCC--cccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCccc
Confidence 1 11111 22345688999999999999999999999999998774
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.9e-52 Score=426.60 Aligned_cols=249 Identities=24% Similarity=0.311 Sum_probs=212.8
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccCCC---hHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEE
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST---SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFF 140 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 140 (697)
+.|+++++||+|+||+||+|++ +++.||||++.... ....+.+.+|+.+|++++|||||++++++.++..+|+||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 4699999999999999999987 58899999876443 334567999999999999999999999999999999999
Q ss_pred eecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhc
Q 005427 141 EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL 220 (697)
Q Consensus 141 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~ 220 (697)
|||.+|+|..++... ..+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 95 E~~~~g~l~~~~~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~------ 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ 167 (309)
T ss_dssp ECCSEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS------
T ss_pred EecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC------
Confidence 999999887666544 4789999999999999999999999999999999999999999999999999975431
Q ss_pred ccccCCCCCCCCccccccccCccccchhhhcc---cCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccH
Q 005427 221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK---EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTE 297 (697)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~ 297 (697)
.....||+.|||||++.+ ..|+.++|||||||++|||++|..||.+.........+...
T Consensus 168 --------------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~---- 229 (309)
T d1u5ra_ 168 --------------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN---- 229 (309)
T ss_dssp --------------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS----
T ss_pred --------------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC----
Confidence 345679999999999864 45889999999999999999999999876655544443322
Q ss_pred HHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 298 QQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
...+ + .+..+|+++.+||.+||+.||.+|||++|+++|.|..
T Consensus 230 ----------~~~~-~--~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~ 271 (309)
T d1u5ra_ 230 ----------ESPA-L--QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL 271 (309)
T ss_dssp ----------CCCC-C--SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHH
T ss_pred ----------CCCC-C--CCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhc
Confidence 1111 1 2346899999999999999999999999999998875
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.9e-52 Score=421.97 Aligned_cols=260 Identities=26% Similarity=0.399 Sum_probs=218.0
Q ss_pred cCCCCCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceE
Q 005427 60 PLHLPPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYM 137 (697)
Q Consensus 60 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 137 (697)
.|+++.++|++.++||+|+||+||+|++ +++.||||++... ....+.+.+|+.+|++++|||||++++++.+++.++
T Consensus 11 ~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (287)
T d1opja_ 11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 89 (287)
T ss_dssp TTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred ccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeE
Confidence 5788899999999999999999999998 5889999986543 334677999999999999999999999999999999
Q ss_pred EEEeecCCCCHhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhh
Q 005427 138 FFFEFYESRNLAEKLHVE-EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLK 216 (697)
Q Consensus 138 lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~ 216 (697)
+|||||++|+|.+++... ...+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 90 iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~ 169 (287)
T d1opja_ 90 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 169 (287)
T ss_dssp EEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS
T ss_pred EEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCCC
Confidence 999999999999998653 4568999999999999999999999999999999999999999999999999997654211
Q ss_pred hhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCC-CCchhHHHHHHHHhccc
Q 005427 217 EISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPY-TDLRAEAQAHTVLEMNY 295 (697)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf-~~~~~~~~~~~~~~~~~ 295 (697)
........||+.|+|||++.+..++.++|||||||++|||++|..|| .+.+.... ..++
T Consensus 170 ---------------~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~-~~~i---- 229 (287)
T d1opja_ 170 ---------------YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV-YELL---- 229 (287)
T ss_dssp ---------------SEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH-HHHH----
T ss_pred ---------------ceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHH-HHHH----
Confidence 11223456899999999999999999999999999999999966555 44333222 2211
Q ss_pred cHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 005427 296 TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL 353 (697)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~ 353 (697)
..+.++ ..+..+|+++.+||.+||+.||++|||+.||++.|..+.
T Consensus 230 ----------~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 230 ----------EKDYRM---ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp ----------HTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred ----------hcCCCC---CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 122222 234578999999999999999999999999998776654
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-51 Score=409.87 Aligned_cols=254 Identities=22% Similarity=0.369 Sum_probs=218.8
Q ss_pred CCCCCcccccccccCCceEEEEEEE-CCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEe
Q 005427 63 LPPSSYTLLSPIARGAESVVYEATL-DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFE 141 (697)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 141 (697)
+++++|+++++||+|+||+||+|++ +++.||||++..... ..+.+.+|+.++++++||||+++++++.++..+++|||
T Consensus 1 ~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~E 79 (258)
T d1k2pa_ 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE 79 (258)
T ss_dssp CCCCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEE
T ss_pred CChHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEE
Confidence 3567999999999999999999998 567899998765433 34679999999999999999999999999999999999
Q ss_pred ecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhcc
Q 005427 142 FYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLK 221 (697)
Q Consensus 142 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~ 221 (697)
|+.+|+|..++......+++..++.++.|++.||+|||+.||+||||||+|||++.++.+||+|||+++.......
T Consensus 80 y~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~---- 155 (258)
T d1k2pa_ 80 YMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY---- 155 (258)
T ss_dssp CCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC----
T ss_pred ccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCc----
Confidence 9999999999877777889999999999999999999999999999999999999999999999999976543111
Q ss_pred cccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCCchhHHHHHHHHhccccHHHH
Q 005427 222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQL 300 (697)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 300 (697)
.......||+.|+|||++.+..++.++|||||||++|||+| |+.||.+.........+..
T Consensus 156 -----------~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~-------- 216 (258)
T d1k2pa_ 156 -----------TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ-------- 216 (258)
T ss_dssp -----------CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHT--------
T ss_pred -----------eeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHh--------
Confidence 12334679999999999999999999999999999999998 8999998766554443322
Q ss_pred HHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 005427 301 TAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELD 350 (697)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~ 350 (697)
+.++. .|..+++++.+||.+||+.||++|||+++|+++|.
T Consensus 217 -------~~~~~---~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~ 256 (258)
T d1k2pa_ 217 -------GLRLY---RPHLASEKVYTIMYSCWHEKADERPTFKILLSNIL 256 (258)
T ss_dssp -------TCCCC---CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred -------CCCCC---CcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhh
Confidence 22222 34578899999999999999999999999999874
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-52 Score=428.50 Aligned_cols=263 Identities=27% Similarity=0.399 Sum_probs=218.3
Q ss_pred CccCCCCCCCcccccccccCCceEEEEEEECC-------eeEEEEeccCC-ChHHHHHHHHHHHHHHhc-CCCCceEEee
Q 005427 58 SIPLHLPPSSYTLLSPIARGAESVVYEATLDG-------RKVAVKKPILS-TSEELDNFHKELQLLCKL-DHPGLAKFVA 128 (697)
Q Consensus 58 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~l~~ 128 (697)
...|+++.++|++.++||+|+||+||+|++.+ ..||+|.+... .......+.+|+.+|+++ +|||||++++
T Consensus 29 ~~kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~ 108 (325)
T d1rjba_ 29 DLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLG 108 (325)
T ss_dssp CGGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CccccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEE
Confidence 35678899999999999999999999998732 36899976543 233456789999999998 8999999999
Q ss_pred ccccCCceEEEEeecCCCCHhhhhhhcC----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccc
Q 005427 129 AHAKPPNYMFFFEFYESRNLAEKLHVEE----------------------WSPSVDQVLMIAAQLAKALQYLHNLGIVHR 186 (697)
Q Consensus 129 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------------------~~~~~~~~~~i~~qi~~~l~~LH~~~ivHr 186 (697)
++.+++.+++|||||++|+|.++++... ..+++..++.++.|++.||+|||+++|+||
T Consensus 109 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHR 188 (325)
T d1rjba_ 109 ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHR 188 (325)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred EEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeec
Confidence 9999999999999999999999997543 247889999999999999999999999999
Q ss_pred cCCCCceeecCCCCCeeeeeccchhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHH
Q 005427 187 DVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGI 266 (697)
Q Consensus 187 Dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ 266 (697)
||||+|||++.++.+||+|||+|+....... .....+..||+.|||||++.+..++.++|||||||
T Consensus 189 DlKp~Nill~~~~~~Kl~DFGla~~~~~~~~--------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gv 254 (325)
T d1rjba_ 189 DLAARNVLVTHGKVVKICDFGLARDIMSDSN--------------YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGI 254 (325)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTT--------------SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHH
T ss_pred cCchhccccccCCeEEEeeccccccccCCCc--------------eeeeccccCCCccCChHHHcCCCCCcceeccchhH
Confidence 9999999999999999999999976553221 11234567899999999999999999999999999
Q ss_pred HHHHHHh-CCCCCCCchhHHHHHHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHH
Q 005427 267 SINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDI 345 (697)
Q Consensus 267 ~l~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~el 345 (697)
++|||++ |..||.+.........++. .+.++ ..+..+|+++.+||.+||+.||++|||++||
T Consensus 255 il~emlt~g~~Pf~~~~~~~~~~~~~~--------------~~~~~---~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei 317 (325)
T d1rjba_ 255 LLWEIFSLGVNPYPGIPVDANFYKLIQ--------------NGFKM---DQPFYATEEIYIIMQSCWAFDSRKRPSFPNL 317 (325)
T ss_dssp HHHHHTTTSCCSSTTCCCSHHHHHHHH--------------TTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHHHHHhCCCCCCCCCCHHHHHHHHHh--------------cCCCC---CCCCcCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 9999998 8999987655444333332 23332 2345789999999999999999999999999
Q ss_pred HHHHHH
Q 005427 346 ALELDL 351 (697)
Q Consensus 346 l~~l~~ 351 (697)
+++|..
T Consensus 318 ~~~L~~ 323 (325)
T d1rjba_ 318 TSFLGC 323 (325)
T ss_dssp HHHHHH
T ss_pred HHHHhC
Confidence 999853
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-52 Score=428.21 Aligned_cols=251 Identities=23% Similarity=0.319 Sum_probs=218.5
Q ss_pred CCCcccccccccCCceEEEEEEE--CCeeEEEEeccCC---ChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEE
Q 005427 65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFF 139 (697)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 139 (697)
-++|++++.||+|+||.||+|++ +++.||||++... .....+.+.+|+.+|+.++||||+++++++.++..+|+|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 45899999999999999999997 6889999986532 122457789999999999999999999999999999999
Q ss_pred EeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhh
Q 005427 140 FEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEIS 219 (697)
Q Consensus 140 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~ 219 (697)
||||+||+|.+++...+ .++++.++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.....
T Consensus 84 ~ey~~gg~L~~~~~~~~-~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~---- 158 (337)
T d1o6la_ 84 MEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD---- 158 (337)
T ss_dssp EECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT----
T ss_pred eeccCCCchhhhhhccc-CCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccC----
Confidence 99999999999987665 7899999999999999999999999999999999999999999999999999754321
Q ss_pred cccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHH
Q 005427 220 LKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQ 299 (697)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~ 299 (697)
+......+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+.......+.....
T Consensus 159 ------------~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~---- 222 (337)
T d1o6la_ 159 ------------GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI---- 222 (337)
T ss_dssp ------------TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC----
T ss_pred ------------CcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCC----
Confidence 1124567899999999999999999999999999999999999999998776655544433221
Q ss_pred HHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCC-----HHHHHHHHHH
Q 005427 300 LTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPS-----FSDIALELDL 351 (697)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt-----~~ell~~l~~ 351 (697)
..|..+|+++.+||++||+.||.+||+ ++|+++|.|+
T Consensus 223 ---------------~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f 264 (337)
T d1o6la_ 223 ---------------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264 (337)
T ss_dssp ---------------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGG
T ss_pred ---------------CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCccc
Confidence 234578999999999999999999994 8999999876
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-51 Score=415.47 Aligned_cols=261 Identities=25% Similarity=0.432 Sum_probs=216.4
Q ss_pred ccCCCCCCCcccccccccCCceEEEEEEEC-CeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceE
Q 005427 59 IPLHLPPSSYTLLSPIARGAESVVYEATLD-GRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYM 137 (697)
Q Consensus 59 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 137 (697)
..|+++.++|++.++||+|+||+||+|++. ++.||||++.... ...+.+.+|+.+|++++|||||++++++.+ +.++
T Consensus 6 ~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~ 83 (272)
T d1qpca_ 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIY 83 (272)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred CCeecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeE
Confidence 467888999999999999999999999984 6789999875433 345679999999999999999999998754 5678
Q ss_pred EEEeecCCCCHhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhh
Q 005427 138 FFFEFYESRNLAEKLHVEE-WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLK 216 (697)
Q Consensus 138 lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~ 216 (697)
+||||+++|+|.+++.... ..+++.+++.++.||+.||+|||+++|+||||||+||||+.++.+||+|||+|+......
T Consensus 84 iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~ 163 (272)
T d1qpca_ 84 IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (272)
T ss_dssp EEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred EEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCCc
Confidence 9999999999999775433 358999999999999999999999999999999999999999999999999998654211
Q ss_pred hhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhC-CCCCCCchhHHHHHHHHhccc
Q 005427 217 EISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTG-VVPYTDLRAEAQAHTVLEMNY 295 (697)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g-~~Pf~~~~~~~~~~~~~~~~~ 295 (697)
. .......||+.|+|||++.+..++.++|||||||++|||+|| .+||...........+.
T Consensus 164 ~---------------~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~---- 224 (272)
T d1qpca_ 164 Y---------------TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE---- 224 (272)
T ss_dssp E---------------ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH----
T ss_pred c---------------ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHH----
Confidence 1 123445789999999999999999999999999999999995 55555544433332221
Q ss_pred cHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 005427 296 TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE 354 (697)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~ 354 (697)
.+.++. .+..+|+++.+||.+||+.||++|||+++|++.|+.+..
T Consensus 225 -----------~~~~~~---~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 225 -----------RGYRMV---RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp -----------TTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----------hcCCCC---CcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 222332 345789999999999999999999999999998887654
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-51 Score=415.81 Aligned_cols=261 Identities=21% Similarity=0.321 Sum_probs=217.8
Q ss_pred CCCCCCcccccc-cccCCceEEEEEEE----CCeeEEEEeccCC-ChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCc
Q 005427 62 HLPPSSYTLLSP-IARGAESVVYEATL----DGRKVAVKKPILS-TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPN 135 (697)
Q Consensus 62 ~~~~~~y~~~~~-lg~G~~g~V~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 135 (697)
-+..++|.+.+. ||+|+||+||+|.+ ++..||||++... .....+.|.+|+++|++++|||||++++++.+ +.
T Consensus 4 ~l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~ 82 (285)
T d1u59a_ 4 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EA 82 (285)
T ss_dssp BCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SS
T ss_pred eecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-Ce
Confidence 355567888884 99999999999976 3457999987544 34557889999999999999999999999865 56
Q ss_pred eEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhh
Q 005427 136 YMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL 215 (697)
Q Consensus 136 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~ 215 (697)
+++|||||++|+|.+++......+++.+++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.+...
T Consensus 83 ~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~ 162 (285)
T d1u59a_ 83 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 162 (285)
T ss_dssp EEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred EEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccccc
Confidence 89999999999999998776668999999999999999999999999999999999999999999999999999866432
Q ss_pred hhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCCchhHHHHHHHHhcc
Q 005427 216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMN 294 (697)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~~~~~~~~~~~~~~~ 294 (697)
.. .........||+.|+|||++.+..++.++|||||||++|||+| |..||.+.........+.
T Consensus 163 ~~-------------~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~--- 226 (285)
T d1u59a_ 163 DS-------------YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE--- 226 (285)
T ss_dssp SC-------------EECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHH---
T ss_pred cc-------------ccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHH---
Confidence 11 0112334578999999999999999999999999999999998 999998765544333322
Q ss_pred ccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 005427 295 YTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE 354 (697)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~ 354 (697)
.+.++ ..+..+|+++.+||.+||+.||++|||+.+|++.|.....
T Consensus 227 ------------~~~~~---~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~ 271 (285)
T d1u59a_ 227 ------------QGKRM---ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271 (285)
T ss_dssp ------------TTCCC---CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------------cCCCC---CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 12222 2345799999999999999999999999999988876654
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-51 Score=421.15 Aligned_cols=253 Identities=23% Similarity=0.308 Sum_probs=218.5
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccCCC------hHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceE
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST------SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYM 137 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 137 (697)
++|+++++||+|+||+||+|++ +|+.||||++.... ....+.+.+|+.+|++++|||||++++++.++..+|
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 5799999999999999999997 58899999864322 123578999999999999999999999999999999
Q ss_pred EEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCC----CCeeeeeccchhhh
Q 005427 138 FFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNL----CPHLADFGLAEYRE 213 (697)
Q Consensus 138 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~----~~kL~Dfg~a~~~~ 213 (697)
+|||||++|+|.+++...+ .+++.+++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||++....
T Consensus 90 iv~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~ 168 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 168 (293)
T ss_dssp EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECT
T ss_pred EEEEcCCCccccchhcccc-ccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcC
Confidence 9999999999999997665 799999999999999999999999999999999999998766 58999999997654
Q ss_pred hhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhc
Q 005427 214 NLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEM 293 (697)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~ 293 (697)
... ...+..||+.|+|||++.+..++.++|||||||++|||++|..||.+.+.......+...
T Consensus 169 ~~~-----------------~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~ 231 (293)
T d1jksa_ 169 FGN-----------------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 231 (293)
T ss_dssp TSC-----------------BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTT
T ss_pred CCc-----------------cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhc
Confidence 211 234568999999999999999999999999999999999999999987766665555443
Q ss_pred cccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 005427 294 NYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL 351 (697)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~ 351 (697)
... .....+..+|+++.+||++||+.||++|||++|+++|.|+
T Consensus 232 ~~~---------------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~ 274 (293)
T d1jksa_ 232 NYE---------------FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 274 (293)
T ss_dssp CCC---------------CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTT
T ss_pred CCC---------------CCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence 322 1223345789999999999999999999999999998876
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-51 Score=413.01 Aligned_cols=263 Identities=27% Similarity=0.411 Sum_probs=212.5
Q ss_pred CCCCCCcccccccccCCceEEEEEEECC------eeEEEEeccCCC-hHHHHHHHHHHHHHHhcCCCCceEEeeccccCC
Q 005427 62 HLPPSSYTLLSPIARGAESVVYEATLDG------RKVAVKKPILST-SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPP 134 (697)
Q Consensus 62 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~------~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 134 (697)
++.++.|++.++||+|+||.||+|.+.+ ..||||++.... ......|.+|+.+|++++|||||++++++.+..
T Consensus 3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~ 82 (283)
T d1mqba_ 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK 82 (283)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCC
Confidence 5677899999999999999999998632 369999876543 344567999999999999999999999999999
Q ss_pred ceEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhh
Q 005427 135 NYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYREN 214 (697)
Q Consensus 135 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~ 214 (697)
..++|||||.++++.+.+......+++.+++.++.|++.||+|||+.+|+||||||+||||+.++.+||+|||+++....
T Consensus 83 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 162 (283)
T d1mqba_ 83 PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 162 (283)
T ss_dssp SEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred ceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcccC
Confidence 99999999999999999887777899999999999999999999999999999999999999999999999999987653
Q ss_pred hhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCC-CCCCchhHHHHHHHHhc
Q 005427 215 LKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVV-PYTDLRAEAQAHTVLEM 293 (697)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~-Pf~~~~~~~~~~~~~~~ 293 (697)
.... ........||+.|+|||++.+..++.++|||||||++|||++|.. ||.+.........+
T Consensus 163 ~~~~-------------~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i--- 226 (283)
T d1mqba_ 163 DPEA-------------TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI--- 226 (283)
T ss_dssp ------------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH---
T ss_pred CCcc-------------ceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHH---
Confidence 2211 112334568999999999999999999999999999999999544 45444333322221
Q ss_pred cccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 005427 294 NYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH 355 (697)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~ 355 (697)
. .+.++ ..+..+|.++.+||.+||+.||++|||+.||++.|+.+.+.
T Consensus 227 -----------~-~~~~~---~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 227 -----------N-DGFRL---PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp -----------H-TTCCC---CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred -----------h-ccCCC---CCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 1 22232 23457899999999999999999999999999999888764
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-51 Score=414.32 Aligned_cols=261 Identities=26% Similarity=0.455 Sum_probs=212.1
Q ss_pred CCCCCCCcccccccccCCceEEEEEEEC-----CeeEEEEeccCC-ChHHHHHHHHHHHHHHhcCCCCceEEeeccccCC
Q 005427 61 LHLPPSSYTLLSPIARGAESVVYEATLD-----GRKVAVKKPILS-TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPP 134 (697)
Q Consensus 61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 134 (697)
|+++.++|++.+.||+|+||.||+|++. +..||||.+... .....+.+.+|+.+|++++||||+++++++. .+
T Consensus 2 ~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~ 80 (273)
T d1mp8a_ 2 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN 80 (273)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SS
T ss_pred CCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cC
Confidence 6788899999999999999999999873 245888876543 3444678999999999999999999999985 46
Q ss_pred ceEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhh
Q 005427 135 NYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYREN 214 (697)
Q Consensus 135 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~ 214 (697)
.+++||||+.+|+|.+++......+++.+++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~ 160 (273)
T d1mp8a_ 81 PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 160 (273)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred eEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccC
Confidence 78999999999999999887777899999999999999999999999999999999999999999999999999986543
Q ss_pred hhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCCchhHHHHHHHHhc
Q 005427 215 LKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEM 293 (697)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~~~~~~~~~~~~~~ 293 (697)
... .......||+.|+|||++.+..++.++|||||||++|||++ |.+||.+.........+..
T Consensus 161 ~~~---------------~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~- 224 (273)
T d1mp8a_ 161 STY---------------YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN- 224 (273)
T ss_dssp -------------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT-
T ss_pred Ccc---------------eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHc-
Confidence 211 12344578999999999999999999999999999999998 8999988765544433322
Q ss_pred cccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 005427 294 NYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH 355 (697)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~ 355 (697)
+. ++ ..+..+|+++.+||.+||+.||++|||+.||+++|..+++.
T Consensus 225 -------------~~-~~---~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 225 -------------GE-RL---PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp -------------TC-CC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -------------CC-CC---CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 21 21 23557899999999999999999999999999999988765
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.3e-51 Score=421.59 Aligned_cols=247 Identities=23% Similarity=0.361 Sum_probs=216.6
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccCC---ChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEE
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFF 140 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 140 (697)
++|+++++||+|+||+||+|++ +|+.||||++... .....+.+.+|+.+|+.++|||||++++++.++..+|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 5799999999999999999997 5889999986532 1223577899999999999999999999999999999999
Q ss_pred eecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhc
Q 005427 141 EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL 220 (697)
Q Consensus 141 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~ 220 (697)
|||.||+|..++.... .+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus 84 E~~~gg~l~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~------ 156 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD------ 156 (316)
T ss_dssp CCCCSCBHHHHHHHTS-SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS------
T ss_pred eecCCccccccccccc-cccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEecc------
Confidence 9999999999887655 788899999999999999999999999999999999999999999999999976542
Q ss_pred ccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHH
Q 005427 221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQL 300 (697)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 300 (697)
...+.+||+.|||||++.+..++.++|||||||++|+|++|..||.+.+.......+.....
T Consensus 157 -------------~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~----- 218 (316)
T d1fota_ 157 -------------VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL----- 218 (316)
T ss_dssp -------------CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCC-----
T ss_pred -------------ccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCC-----
Confidence 13456899999999999999999999999999999999999999998776665555543221
Q ss_pred HHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCC-----CHHHHHHHHHH
Q 005427 301 TAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRP-----SFSDIALELDL 351 (697)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~ell~~l~~ 351 (697)
..+..+|+++.+++.+||..||.+|+ |++++++|+|+
T Consensus 219 --------------~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f 260 (316)
T d1fota_ 219 --------------RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWF 260 (316)
T ss_dssp --------------CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGG
T ss_pred --------------CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCccc
Confidence 12456899999999999999999996 99999999876
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-51 Score=420.19 Aligned_cols=254 Identities=18% Similarity=0.283 Sum_probs=221.2
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEeec
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFY 143 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~ 143 (697)
++|++++.||+|+||+||+|.+ +++.||||++.... .+...+.+|+++|+.++|||||++++++.++..+|+|||||
T Consensus 5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~ 83 (321)
T d1tkia_ 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecC
Confidence 6899999999999999999997 58899999876654 34456889999999999999999999999999999999999
Q ss_pred CCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCC--CCCeeeeeccchhhhhhhhhhcc
Q 005427 144 ESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRN--LCPHLADFGLAEYRENLKEISLK 221 (697)
Q Consensus 144 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~--~~~kL~Dfg~a~~~~~~~~~~~~ 221 (697)
.||+|.+++...+..+++++++.++.||+.||+|||++||+||||||+|||++.+ ..+||+|||+++.....
T Consensus 84 ~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~------ 157 (321)
T d1tkia_ 84 SGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG------ 157 (321)
T ss_dssp CCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT------
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccC------
Confidence 9999999998777689999999999999999999999999999999999999754 57999999998754321
Q ss_pred cccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHHH
Q 005427 222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLT 301 (697)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 301 (697)
.......||+.|+|||.+.+..++.++|||||||++|+|++|..||.+.+.......+....+..
T Consensus 158 -----------~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~---- 222 (321)
T d1tkia_ 158 -----------DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTF---- 222 (321)
T ss_dssp -----------CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCC----
T ss_pred -----------CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC----
Confidence 12345679999999999999999999999999999999999999999887766666665443321
Q ss_pred HHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 302 AAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
....+..+|+++.+||.+||..||++|||++|+++|.|+.
T Consensus 223 -----------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~ 262 (321)
T d1tkia_ 223 -----------DEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLK 262 (321)
T ss_dssp -----------CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHH
T ss_pred -----------ChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhc
Confidence 1123356899999999999999999999999999999864
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.1e-51 Score=423.72 Aligned_cols=247 Identities=19% Similarity=0.282 Sum_probs=216.9
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccCCC---hHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEE
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST---SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFF 140 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 140 (697)
++|+++++||+|+||.||+|++ +++.||||++.... ....+.+.+|+.+|+.++|||||++++++.+...+++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 5899999999999999999998 58899999864321 223567899999999999999999999999999999999
Q ss_pred eecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhc
Q 005427 141 EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISL 220 (697)
Q Consensus 141 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~ 220 (697)
||+.+|+|..++...+ .+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.+..
T Consensus 121 e~~~~g~l~~~l~~~~-~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~------ 193 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------ 193 (350)
T ss_dssp ECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS------
T ss_pred ccccccchhhhHhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeeccc------
Confidence 9999999999997665 799999999999999999999999999999999999999999999999999976542
Q ss_pred ccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHH
Q 005427 221 KNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQL 300 (697)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 300 (697)
...+..||+.|||||++.+..++.++|||||||++|||++|..||.+.+.......+.....
T Consensus 194 -------------~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~----- 255 (350)
T d1rdqe_ 194 -------------RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV----- 255 (350)
T ss_dssp -------------CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-----
T ss_pred -------------ccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCC-----
Confidence 13456899999999999999999999999999999999999999998766555554433221
Q ss_pred HHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCC-----CHHHHHHHHHH
Q 005427 301 TAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRP-----SFSDIALELDL 351 (697)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~ell~~l~~ 351 (697)
..+..+|+++.+||++||+.||.+|+ |++++++|.|+
T Consensus 256 --------------~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f 297 (350)
T d1rdqe_ 256 --------------RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297 (350)
T ss_dssp --------------CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGG
T ss_pred --------------CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccc
Confidence 12457899999999999999999994 99999999886
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-51 Score=405.83 Aligned_cols=256 Identities=26% Similarity=0.404 Sum_probs=212.1
Q ss_pred CCCCCCCcccccccccCCceEEEEEEECCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeecccc-CCceEEE
Q 005427 61 LHLPPSSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAK-PPNYMFF 139 (697)
Q Consensus 61 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~~lv 139 (697)
|++..++|++.++||+|+||.||+|+++++.||||++... ...+.+.+|+++|++++||||+++++++.+ ++.+++|
T Consensus 2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv 79 (262)
T d1byga_ 2 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 79 (262)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEE
T ss_pred CccCHHHeEEeEEEecCCCeEEEEEEECCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEE
Confidence 6788899999999999999999999999999999987543 345779999999999999999999998854 5678999
Q ss_pred EeecCCCCHhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhh
Q 005427 140 FEFYESRNLAEKLHVEE-WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI 218 (697)
Q Consensus 140 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~ 218 (697)
|||+++|+|.+++.... ..+++..++.++.||+.||.|||+.+|+||||||+|||++.++.+||+|||+++....
T Consensus 80 ~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~---- 155 (262)
T d1byga_ 80 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS---- 155 (262)
T ss_dssp ECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred EeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCC----
Confidence 99999999999996543 3489999999999999999999999999999999999999999999999999975432
Q ss_pred hcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCCchhHHHHHHHHhccccH
Q 005427 219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTE 297 (697)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~ 297 (697)
......+|+.|+|||++.+..++.++|||||||++|||+| |.+||...........+.
T Consensus 156 ---------------~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~------ 214 (262)
T d1byga_ 156 ---------------TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE------ 214 (262)
T ss_dssp ---------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHT------
T ss_pred ---------------CCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHH------
Confidence 1234568899999999999999999999999999999998 798988765544433332
Q ss_pred HHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 005427 298 QQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH 355 (697)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~ 355 (697)
.+.++. .+..+++++.+||.+||+.||.+|||+.+++++|+.+..+
T Consensus 215 ---------~~~~~~---~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~ 260 (262)
T d1byga_ 215 ---------KGYKMD---APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260 (262)
T ss_dssp ---------TTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---------cCCCCC---CCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence 223332 3457899999999999999999999999999999887643
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.7e-50 Score=407.02 Aligned_cols=254 Identities=24% Similarity=0.322 Sum_probs=216.3
Q ss_pred CCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCCh---------HHHHHHHHHHHHHHhcC-CCCceEEeecccc
Q 005427 65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTS---------EELDNFHKELQLLCKLD-HPGLAKFVAAHAK 132 (697)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~ 132 (697)
.++|++.+.||+|+||+||+|++ +++.||||++..... ...+.+.+|+.+|++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 36899999999999999999998 689999998654321 12456889999999997 9999999999999
Q ss_pred CCceEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhh
Q 005427 133 PPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYR 212 (697)
Q Consensus 133 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~ 212 (697)
++.+|+|||||++|+|.+++...+ .+++++++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 160 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL 160 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred CcceEEEEEcCCCchHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEc
Confidence 999999999999999999997655 7899999999999999999999999999999999999999999999999999765
Q ss_pred hhhhhhhcccccCCCCCCCCccccccccCccccchhhhcc------cCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHH
Q 005427 213 ENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK------EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQ 286 (697)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~ 286 (697)
... .......||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+....
T Consensus 161 ~~~-----------------~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~ 223 (277)
T d1phka_ 161 DPG-----------------EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM 223 (277)
T ss_dssp CTT-----------------CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred cCC-----------------CceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHH
Confidence 421 12345689999999999863 3467899999999999999999999998776665
Q ss_pred HHHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 005427 287 AHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL 351 (697)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~ 351 (697)
...+..... .+ .......+|+++.+||.+||+.||++|||++|+++|.|+
T Consensus 224 ~~~i~~~~~--------------~~-~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~ 273 (277)
T d1phka_ 224 LRMIMSGNY--------------QF-GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFF 273 (277)
T ss_dssp HHHHHHTCC--------------CC-CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGG
T ss_pred HHHHHhCCC--------------CC-CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHH
Confidence 555543322 11 111234689999999999999999999999999998775
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-50 Score=407.64 Aligned_cols=249 Identities=24% Similarity=0.375 Sum_probs=203.6
Q ss_pred cccccCCceEEEEEEEC----CeeEEEEeccCC--ChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEeecCC
Q 005427 72 SPIARGAESVVYEATLD----GRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEFYES 145 (697)
Q Consensus 72 ~~lg~G~~g~V~~~~~~----~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~ 145 (697)
++||+|+||+||+|.+. ++.||||++... .....+.+.+|+++|++++|||||++++++.+ +.+++|||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 46999999999999762 467999987543 23346789999999999999999999999865 567899999999
Q ss_pred CCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhcccccC
Q 005427 146 RNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRS 225 (697)
Q Consensus 146 g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~ 225 (697)
|+|.+++.... .+++.+++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++........
T Consensus 92 g~L~~~l~~~~-~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~------- 163 (277)
T d1xbba_ 92 GPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY------- 163 (277)
T ss_dssp EEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE-------
T ss_pred CcHHHHHhhcc-CCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccccc-------
Confidence 99999987654 7899999999999999999999999999999999999999999999999999765421110
Q ss_pred CCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCCchhHHHHHHHHhccccHHHHHHHH
Q 005427 226 SGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAV 304 (697)
Q Consensus 226 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (697)
........||+.|+|||++.+..++.++|||||||++|||++ |..||.+.........+..
T Consensus 164 ------~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~------------ 225 (277)
T d1xbba_ 164 ------YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK------------ 225 (277)
T ss_dssp ------EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT------------
T ss_pred ------cccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHc------------
Confidence 111234579999999999999999999999999999999998 9999998765443333221
Q ss_pred HhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 005427 305 VSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL 353 (697)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~ 353 (697)
+.++ ..+..+|+++.+||.+||+.||++|||+++|++.|....
T Consensus 226 ---~~~~---~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 268 (277)
T d1xbba_ 226 ---GERM---GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268 (277)
T ss_dssp ---TCCC---CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred ---CCCC---CCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence 2222 234578999999999999999999999999987765543
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.5e-49 Score=402.19 Aligned_cols=260 Identities=26% Similarity=0.355 Sum_probs=210.2
Q ss_pred CCCcccccccccCCceEEEEEEE--CCeeEEEEeccCC---ChHHHHHHHHHHHHHHhcCCCCceEEeeccccCC----c
Q 005427 65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS---TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPP----N 135 (697)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~----~ 135 (697)
.++|++.+.||+|+||+||+|++ +++.||||++... .......+.+|+.+|+.++||||+++++++.... .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 36899999999999999999997 5899999987543 3344678999999999999999999999987654 3
Q ss_pred eEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhh
Q 005427 136 YMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL 215 (697)
Q Consensus 136 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~ 215 (697)
+|+|||||+|++|.+++...+ .+++.+++.++.||+.||+|||++||+||||||+|||++.++.++|+|||.+......
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~-~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~ 164 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS 164 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC--
T ss_pred EEEEEECCCCCEehhhhcccC-CCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhccc
Confidence 889999999999999887655 7899999999999999999999999999999999999999999999999988654321
Q ss_pred hhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccc
Q 005427 216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNY 295 (697)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~ 295 (697)
.. ........+||+.|+|||++.+..++.++|||||||++|||++|.+||.+.+.......+....
T Consensus 165 ~~-------------~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~- 230 (277)
T d1o6ya_ 165 GN-------------SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVRED- 230 (277)
T ss_dssp ---------------------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCC-
T ss_pred cc-------------cccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcC-
Confidence 11 1112445689999999999999999999999999999999999999999876655544443322
Q ss_pred cHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCC-CHHHHHHHHHHHH
Q 005427 296 TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRP-SFSDIALELDLVL 353 (697)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-t~~ell~~l~~~~ 353 (697)
..+ .......+|+++.+||.+||+.||.+|| |+++++..|..+.
T Consensus 231 -------------~~~-~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 231 -------------PIP-PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp -------------CCC-GGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred -------------CCC-CchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 111 1223467999999999999999999999 8999988776653
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.7e-49 Score=406.54 Aligned_cols=262 Identities=26% Similarity=0.384 Sum_probs=219.3
Q ss_pred cCCCCCCCcccccccccCCceEEEEEEEC-------CeeEEEEeccCCChH-HHHHHHHHHHHHHhcCCCCceEEeeccc
Q 005427 60 PLHLPPSSYTLLSPIARGAESVVYEATLD-------GRKVAVKKPILSTSE-ELDNFHKELQLLCKLDHPGLAKFVAAHA 131 (697)
Q Consensus 60 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~ 131 (697)
.++++.++|++.++||+|+||+||+|++. ++.||||++...... ..+.+.+|+.+|++++||||+++++++.
T Consensus 7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 86 (301)
T d1lufa_ 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 86 (301)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence 46778889999999999999999999864 368999987654433 4678999999999999999999999999
Q ss_pred cCCceEEEEeecCCCCHhhhhhhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccC
Q 005427 132 KPPNYMFFFEFYESRNLAEKLHVEE-----------------------WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDV 188 (697)
Q Consensus 132 ~~~~~~lv~e~~~~g~L~~~l~~~~-----------------------~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDl 188 (697)
.....+++|||+.+|+|.+++.... ..+++.+++.++.|++.||+|||+.+|+||||
T Consensus 87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDl 166 (301)
T d1lufa_ 87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDL 166 (301)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEE
Confidence 9999999999999999999986432 24788899999999999999999999999999
Q ss_pred CCCceeecCCCCCeeeeeccchhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHH
Q 005427 189 KPANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISI 268 (697)
Q Consensus 189 kp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l 268 (697)
||+|||++.++.+||+|||+++.+...... ....+..||+.|+|||++.+..++.++|||||||++
T Consensus 167 Kp~NILld~~~~~Kl~DFGls~~~~~~~~~--------------~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl 232 (301)
T d1lufa_ 167 ATRNCLVGENMVVKIADFGLSRNIYSADYY--------------KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVL 232 (301)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGCB--------------C----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred cccceEECCCCcEEEccchhheeccCCccc--------------cccCCCCcCcCcCCHHHHccCCCChhhhhccchhhH
Confidence 999999999999999999999866432211 123456789999999999999999999999999999
Q ss_pred HHHHhC-CCCCCCchhHHHHHHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHH
Q 005427 269 NELLTG-VVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIAL 347 (697)
Q Consensus 269 ~ell~g-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 347 (697)
|||++| .+||.+.........+. .+. + +..+..+|+++.+||.+||+.||++|||+.||++
T Consensus 233 ~ell~~~~~p~~~~~~~e~~~~v~--------------~~~-~---~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 233 WEIFSYGLQPYYGMAHEEVIYYVR--------------DGN-I---LACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp HHHHTTTCCTTTTSCHHHHHHHHH--------------TTC-C---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHccCCCCCCCCCHHHHHHHHH--------------cCC-C---CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 999997 46888766555443332 222 2 2235578999999999999999999999999998
Q ss_pred HHHHHH
Q 005427 348 ELDLVL 353 (697)
Q Consensus 348 ~l~~~~ 353 (697)
.|+.+.
T Consensus 295 ~L~~i~ 300 (301)
T d1lufa_ 295 ILQRMC 300 (301)
T ss_dssp HHHHTT
T ss_pred HHHHhc
Confidence 887653
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-50 Score=403.57 Aligned_cols=260 Identities=28% Similarity=0.399 Sum_probs=209.5
Q ss_pred ccCCCCCCCcccccccccCCceEEEEEEE-CCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceE
Q 005427 59 IPLHLPPSSYTLLSPIARGAESVVYEATL-DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYM 137 (697)
Q Consensus 59 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 137 (697)
-.|+++.++|++.+.||+|+||+||+|++ .++.||||++.... ...+.|.+|+.+|++++|||||++++++.+ +.++
T Consensus 10 ~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~ 87 (285)
T d1fmka3 10 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 87 (285)
T ss_dssp TCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred cceEcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeE
Confidence 35788889999999999999999999998 45689999875443 334679999999999999999999999854 5688
Q ss_pred EEEeecCCCCHhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhh
Q 005427 138 FFFEFYESRNLAEKLHVE-EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLK 216 (697)
Q Consensus 138 lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~ 216 (697)
+|||||++|+|..++... ...+++.+++.++.||+.||+|||+.||+||||||+||||+.++.+||+|||+++......
T Consensus 88 lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~ 167 (285)
T d1fmka3 88 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 167 (285)
T ss_dssp EEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred EEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCCC
Confidence 999999999999988653 3468999999999999999999999999999999999999999999999999997654211
Q ss_pred hhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCC-CCCCCchhHHHHHHHHhccc
Q 005427 217 EISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGV-VPYTDLRAEAQAHTVLEMNY 295 (697)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~-~Pf~~~~~~~~~~~~~~~~~ 295 (697)
. .......||+.|+|||++.+..++.++|||||||++|||++|. +||.+.........+.
T Consensus 168 ~---------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~---- 228 (285)
T d1fmka3 168 Y---------------TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE---- 228 (285)
T ss_dssp -----------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH----
T ss_pred c---------------eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHH----
Confidence 1 1234467999999999999999999999999999999999954 5555544433333222
Q ss_pred cHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 005427 296 TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVL 353 (697)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~ 353 (697)
.+.++ ..+..+|+++.+||.+||+.||++|||+++|++.|+...
T Consensus 229 -----------~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~ 272 (285)
T d1fmka3 229 -----------RGYRM---PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272 (285)
T ss_dssp -----------TTCCC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred -----------hcCCC---CCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence 12222 234578999999999999999999999999987766654
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-50 Score=413.77 Aligned_cols=250 Identities=24% Similarity=0.364 Sum_probs=213.7
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccCCC---hHHHHHHHHHHHHHH-hcCCCCceEEeeccccCCceEEE
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST---SEELDNFHKELQLLC-KLDHPGLAKFVAAHAKPPNYMFF 139 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~---~~~~~~~~~E~~~l~-~l~hpniv~l~~~~~~~~~~~lv 139 (697)
++|+++++||+|+||+||+|++ +++.||||++.... ....+.+..|..++. .++|||||++++++.+++.+|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 5799999999999999999998 68999999865321 223456677777765 68999999999999999999999
Q ss_pred EeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhh
Q 005427 140 FEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEIS 219 (697)
Q Consensus 140 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~ 219 (697)
||||++|+|.+++.... .+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 82 mEy~~~g~L~~~i~~~~-~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~---- 156 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG---- 156 (320)
T ss_dssp EECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT----
T ss_pred EeecCCCcHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccc----
Confidence 99999999999997655 7899999999999999999999999999999999999999999999999999754321
Q ss_pred cccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHH
Q 005427 220 LKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQ 299 (697)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~ 299 (697)
........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+....
T Consensus 157 ------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~----- 219 (320)
T d1xjda_ 157 ------------DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN----- 219 (320)
T ss_dssp ------------TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-----
T ss_pred ------------cccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-----
Confidence 112345689999999999999999999999999999999999999999877665554443221
Q ss_pred HHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHH-HHHHHHHH
Q 005427 300 LTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFS-DIALELDL 351 (697)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~-ell~~l~~ 351 (697)
+ ..+..+|+++.+||.+||+.||++|||+. ++++|+|+
T Consensus 220 -----------~---~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff 258 (320)
T d1xjda_ 220 -----------P---FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLF 258 (320)
T ss_dssp -----------C---CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGG
T ss_pred -----------C---CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchh
Confidence 1 23457899999999999999999999995 89888775
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-49 Score=408.52 Aligned_cols=258 Identities=21% Similarity=0.372 Sum_probs=211.1
Q ss_pred CCCCcccccccccCCceEEEEEEEC--Ce----eEEEEeccCC-ChHHHHHHHHHHHHHHhcCCCCceEEeeccccCCce
Q 005427 64 PPSSYTLLSPIARGAESVVYEATLD--GR----KVAVKKPILS-TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNY 136 (697)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 136 (697)
..++|+++++||+|+||+||+|.+. ++ +||+|++... .....+.+.+|+++|++++|||||++++++.++ ..
T Consensus 7 k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~ 85 (317)
T d1xkka_ 7 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV 85 (317)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SE
T ss_pred CHHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Ce
Confidence 3467999999999999999999873 33 5888876543 233467899999999999999999999999764 56
Q ss_pred EEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhh
Q 005427 137 MFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLK 216 (697)
Q Consensus 137 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~ 216 (697)
++++|++.+|+|.+.+......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 86 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~ 165 (317)
T d1xkka_ 86 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 165 (317)
T ss_dssp EEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTC
T ss_pred eEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceeccccc
Confidence 78899999999999998887789999999999999999999999999999999999999999999999999998764311
Q ss_pred hhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCCchhHHHHHHHHhccc
Q 005427 217 EISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEMNY 295 (697)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~~~~~~~~~~~~~~~~ 295 (697)
. ........||+.|+|||++.+..++.++|||||||++|||+| |.+||.+.........+..
T Consensus 166 ~--------------~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~--- 228 (317)
T d1xkka_ 166 K--------------EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK--- 228 (317)
T ss_dssp C----------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHH---
T ss_pred c--------------cccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc---
Confidence 1 112334578999999999999999999999999999999998 8999987654443322221
Q ss_pred cHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 005427 296 TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE 354 (697)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~ 354 (697)
+.++ ..+..+|+++.+||.+||+.||.+|||+.||+++++.+..
T Consensus 229 ------------~~~~---~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 229 ------------GERL---PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp ------------TCCC---CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------------CCCC---CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 1222 2345789999999999999999999999999999988764
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-49 Score=407.68 Aligned_cols=266 Identities=27% Similarity=0.409 Sum_probs=210.5
Q ss_pred ccCCCCCCCcccccccccCCceEEEEEEEC-------CeeEEEEeccCC-ChHHHHHHHHHHHHHHhc-CCCCceEEeec
Q 005427 59 IPLHLPPSSYTLLSPIARGAESVVYEATLD-------GRKVAVKKPILS-TSEELDNFHKELQLLCKL-DHPGLAKFVAA 129 (697)
Q Consensus 59 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~l~~~ 129 (697)
.+|+++.++|++.++||+|+||.||+|++. ++.||||++... .....+.+.+|..++.++ +||||+.++++
T Consensus 6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~ 85 (299)
T d1ywna1 6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 85 (299)
T ss_dssp HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeee
Confidence 457788899999999999999999999862 367999987543 334566788888888777 68999999998
Q ss_pred cccC-CceEEEEeecCCCCHhhhhhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCce
Q 005427 130 HAKP-PNYMFFFEFYESRNLAEKLHVEE---------------WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANV 193 (697)
Q Consensus 130 ~~~~-~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Ni 193 (697)
+..+ ..+++|||||++|+|.+++.... ..+++.+++.++.||+.||+|||+++|+||||||+||
T Consensus 86 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NI 165 (299)
T d1ywna1 86 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 165 (299)
T ss_dssp ECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred eccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccce
Confidence 7654 56899999999999999986532 2478999999999999999999999999999999999
Q ss_pred eecCCCCCeeeeeccchhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh
Q 005427 194 LLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT 273 (697)
Q Consensus 194 ll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~ 273 (697)
|++.++.+||+|||+|+....... ........||+.|+|||++.+..++.++|||||||++|||++
T Consensus 166 Ll~~~~~~Kl~DFGla~~~~~~~~--------------~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt 231 (299)
T d1ywna1 166 LLSEKNVVKICDFGLARDIYKDPD--------------YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 231 (299)
T ss_dssp EECGGGCEEECC------CCSCTT--------------SCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred eECCCCcEEEccCcchhhcccccc--------------ccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHh
Confidence 999999999999999976542111 112345689999999999999999999999999999999998
Q ss_pred C-CCCCCCchhHHHHHHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 274 G-VVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 274 g-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
| .+||.+..........+. .+.++ ..+..+|+++.+||.+||+.||++|||+.|+++||+.+
T Consensus 232 ~~~~p~~~~~~~~~~~~~~~--------------~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i 294 (299)
T d1ywna1 232 LGASPYPGVKIDEEFCRRLK--------------EGTRM---RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294 (299)
T ss_dssp TSCCSSTTCCCSHHHHHHHH--------------HTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHh--------------cCCCC---CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 5 678876544333222221 12222 23457899999999999999999999999999999988
Q ss_pred HHH
Q 005427 353 LEH 355 (697)
Q Consensus 353 ~~~ 355 (697)
++.
T Consensus 295 lq~ 297 (299)
T d1ywna1 295 LQA 297 (299)
T ss_dssp HHH
T ss_pred HhC
Confidence 764
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2e-49 Score=415.04 Aligned_cols=252 Identities=23% Similarity=0.285 Sum_probs=206.6
Q ss_pred CCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCCh---HHHHHH---HHHHHHHHhcCCCCceEEeeccccCCce
Q 005427 65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTS---EELDNF---HKELQLLCKLDHPGLAKFVAAHAKPPNY 136 (697)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~---~~~~~~---~~E~~~l~~l~hpniv~l~~~~~~~~~~ 136 (697)
-++|++.++||+|+||.||+|++ +|+.||||++..... .....+ ..|+.+++.++|||||++++++.+++.+
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 35899999999999999999998 588999998643211 112223 3456777788999999999999999999
Q ss_pred EEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhh
Q 005427 137 MFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLK 216 (697)
Q Consensus 137 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~ 216 (697)
|+|||||+||+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.+...
T Consensus 83 ~ivmE~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~- 160 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK- 160 (364)
T ss_dssp EEEECCCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSS-
T ss_pred EEEEEecCCCcHHHHHHhcc-cccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCC-
Confidence 99999999999999997654 7899999999999999999999999999999999999999999999999999755321
Q ss_pred hhhcccccCCCCCCCCccccccccCccccchhhhc-ccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccc
Q 005427 217 EISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILK-KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNY 295 (697)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~ 295 (697)
.....+||+.|+|||++. +..++.++|||||||+||||++|..||.+........ +....
T Consensus 161 -----------------~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~-~~~~~- 221 (364)
T d1omwa3 161 -----------------KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMT- 221 (364)
T ss_dssp -----------------CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHH-HHHHS-
T ss_pred -----------------cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHhc-
Confidence 134568999999999997 4568999999999999999999999998754322111 11000
Q ss_pred cHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCC-----HHHHHHHHHH
Q 005427 296 TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPS-----FSDIALELDL 351 (697)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt-----~~ell~~l~~ 351 (697)
.......+..+|+++.+||.+||+.||++||| ++|+++|.|+
T Consensus 222 --------------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f 268 (364)
T d1omwa3 222 --------------LTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF 268 (364)
T ss_dssp --------------SSCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGG
T ss_pred --------------ccCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccc
Confidence 01112234578999999999999999999999 7999998876
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-49 Score=407.64 Aligned_cols=270 Identities=24% Similarity=0.252 Sum_probs=213.1
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccCCChH--HHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEe
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSE--ELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFE 141 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 141 (697)
++|+++++||+|+||+||+|++ +++.||||++...... ..+.+.+|+++|++++|||||++++++.++.++|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 5899999999999999999998 5889999987554322 25678999999999999999999999999999999999
Q ss_pred ecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhcc
Q 005427 142 FYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLK 221 (697)
Q Consensus 142 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~ 221 (697)
|+.++.+..........+++.+++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~----- 156 (298)
T d1gz8a_ 82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV----- 156 (298)
T ss_dssp CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS-----
T ss_pred ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCc-----
Confidence 998754444444455579999999999999999999999999999999999999999999999999997654211
Q ss_pred cccCCCCCCCCccccccccCccccchhhhcccC-CCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHH
Q 005427 222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEI-HSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQL 300 (697)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~ 300 (697)
.......||+.|+|||++.... ++.++|||||||++|+|++|+.||.+.+.......+........+.
T Consensus 157 -----------~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~ 225 (298)
T d1gz8a_ 157 -----------RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEV 225 (298)
T ss_dssp -----------BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred -----------ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchh
Confidence 1234568999999999987665 5789999999999999999999999877666655554332221111
Q ss_pred HHHHH--hCCCC--------CcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 005427 301 TAAVV--SGGLR--------PILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL 351 (697)
Q Consensus 301 ~~~~~--~~~~~--------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~ 351 (697)
..... ..... .........+++++.+||.+||+.||++|||+.|+++|.|+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff 286 (298)
T d1gz8a_ 226 VWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286 (298)
T ss_dssp TSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGG
T ss_pred hccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhh
Confidence 00000 00000 11111234678999999999999999999999999999775
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-49 Score=400.19 Aligned_cols=258 Identities=25% Similarity=0.376 Sum_probs=206.8
Q ss_pred CCCCCcccccccccCCceEEEEEEEC-----CeeEEEEeccCC---ChHHHHHHHHHHHHHHhcCCCCceEEeeccccCC
Q 005427 63 LPPSSYTLLSPIARGAESVVYEATLD-----GRKVAVKKPILS---TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPP 134 (697)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 134 (697)
+..++|++.+.||+|+||.||+|++. ...||||++... .....+.|.+|+.+|++++||||+++++++.+ +
T Consensus 5 i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~ 83 (273)
T d1u46a_ 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-P 83 (273)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred EchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-c
Confidence 45678999999999999999999862 236899976533 23446789999999999999999999999976 4
Q ss_pred ceEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhh
Q 005427 135 NYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYREN 214 (697)
Q Consensus 135 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~ 214 (697)
.+++|||||++|++.+++......+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 84 ~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~ 163 (273)
T d1u46a_ 84 PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 163 (273)
T ss_dssp SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred chheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhccc
Confidence 77899999999999999877766799999999999999999999999999999999999999999999999999986543
Q ss_pred hhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh-CCCCCCCchhHHHHHHHHhc
Q 005427 215 LKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT-GVVPYTDLRAEAQAHTVLEM 293 (697)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~-g~~Pf~~~~~~~~~~~~~~~ 293 (697)
... .........||+.|+|||++.+..++.++|||||||++|||+| |..||.+.+.......+..
T Consensus 164 ~~~-------------~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~- 229 (273)
T d1u46a_ 164 NDD-------------HYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK- 229 (273)
T ss_dssp -CC-------------EEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT-
T ss_pred CCC-------------cceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHh-
Confidence 111 1112334568899999999999999999999999999999998 8999998766655444432
Q ss_pred cccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 005427 294 NYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL 351 (697)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~ 351 (697)
.+.++ ..+..+|+++.+||.+||+.||++|||+.+|++.|..
T Consensus 230 -------------~~~~~---~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 230 -------------EGERL---PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp -------------SCCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -------------CCCCC---CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 23333 2345789999999999999999999999999876654
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-50 Score=408.61 Aligned_cols=265 Identities=26% Similarity=0.262 Sum_probs=207.8
Q ss_pred cccccccCCceEEEEEEE--CCeeEEEEeccCCChHH-----HHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEee
Q 005427 70 LLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEE-----LDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF 142 (697)
Q Consensus 70 ~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~-----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 142 (697)
.+++||+|+||+||+|++ +++.||||++....... ...+.+|+.+|+.++|||||++++++.++.++++||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 568999999999999987 58899999875443221 34688999999999999999999999999999999999
Q ss_pred cCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhccc
Q 005427 143 YESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKN 222 (697)
Q Consensus 143 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 222 (697)
+.++++..+.. ....+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~~~~~~~-~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~------ 154 (299)
T d1ua2a_ 82 METDLEVIIKD-NSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN------ 154 (299)
T ss_dssp CSEEHHHHHTT-CCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC------
T ss_pred hcchHHhhhhh-cccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCc------
Confidence 99877766654 44578999999999999999999999999999999999999999999999999997554211
Q ss_pred ccCCCCCCCCccccccccCccccchhhhcc-cCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHHH
Q 005427 223 WRSSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLT 301 (697)
Q Consensus 223 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 301 (697)
......+||+.|+|||++.+ ..++.++|||||||++|||++|.+||.+.........+.+.........
T Consensus 155 ----------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~ 224 (299)
T d1ua2a_ 155 ----------RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQ 224 (299)
T ss_dssp ----------CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred ----------ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhh
Confidence 12345689999999999875 4679999999999999999999999998877776666554322111000
Q ss_pred HH-HHh----CCC--C--CcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 005427 302 AA-VVS----GGL--R--PILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL 351 (697)
Q Consensus 302 ~~-~~~----~~~--~--~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~ 351 (697)
.. ... ... . ..+......+++++.+||.+||+.||++|||++|+++|.|+
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f 283 (299)
T d1ua2a_ 225 WPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYF 283 (299)
T ss_dssp SSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGG
T ss_pred ccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhh
Confidence 00 000 000 0 00111224678999999999999999999999999999876
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-48 Score=398.96 Aligned_cols=263 Identities=26% Similarity=0.401 Sum_probs=217.6
Q ss_pred cCCCCCCCcccccccccCCceEEEEEEEC---------CeeEEEEeccCCCh-HHHHHHHHHHHHHHhc-CCCCceEEee
Q 005427 60 PLHLPPSSYTLLSPIARGAESVVYEATLD---------GRKVAVKKPILSTS-EELDNFHKELQLLCKL-DHPGLAKFVA 128 (697)
Q Consensus 60 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~---------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpniv~l~~ 128 (697)
.|+++.++|++.++||+|+||.||+|++. +..||||++..... .....+.+|...+.++ +|||||++++
T Consensus 7 ~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~ 86 (299)
T d1fgka_ 7 RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLG 86 (299)
T ss_dssp TTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccc
Confidence 47888999999999999999999999852 24699998765543 4467889999999888 7999999999
Q ss_pred ccccCCceEEEEeecCCCCHhhhhhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCce
Q 005427 129 AHAKPPNYMFFFEFYESRNLAEKLHVEE---------------WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANV 193 (697)
Q Consensus 129 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Ni 193 (697)
++.++...++|||||.+|+|.+++.... ..+++.+++.++.||+.||+|||+.+|+||||||+||
T Consensus 87 ~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~Ni 166 (299)
T d1fgka_ 87 ACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 166 (299)
T ss_dssp EECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred ccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccce
Confidence 9999999999999999999999996543 3579999999999999999999999999999999999
Q ss_pred eecCCCCCeeeeeccchhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHh
Q 005427 194 LLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLT 273 (697)
Q Consensus 194 ll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~ 273 (697)
|++.++.+||+|||+++....... ........||+.|+|||++.+..|+.++|||||||++|||++
T Consensus 167 Ll~~~~~~kl~dfg~~~~~~~~~~--------------~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~ 232 (299)
T d1fgka_ 167 LVTEDNVMKIADFGLARDIHHIDY--------------YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 232 (299)
T ss_dssp EECTTCCEEECSTTCCCCGGGCCT--------------TCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred eecCCCCeEeccchhhcccccccc--------------ccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhcc
Confidence 999999999999999986653211 112345678999999999999999999999999999999998
Q ss_pred -CCCCCCCchhHHHHHHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 274 -GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 274 -g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
|.+||.+.........+ . .+.++ ..+..+|+++.+||.+||+.||++|||+.||++.|+.+
T Consensus 233 ~g~~p~~~~~~~~~~~~i--------------~-~~~~~---~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i 294 (299)
T d1fgka_ 233 LGGSPYPGVPVEELFKLL--------------K-EGHRM---DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294 (299)
T ss_dssp TSCCSSTTCCHHHHHHHH--------------H-TTCCC---CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHH--------------H-cCCCC---CCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 79999876554433222 1 22233 23457899999999999999999999999999999888
Q ss_pred HH
Q 005427 353 LE 354 (697)
Q Consensus 353 ~~ 354 (697)
.+
T Consensus 295 ~a 296 (299)
T d1fgka_ 295 VA 296 (299)
T ss_dssp HH
T ss_pred hh
Confidence 65
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-49 Score=410.75 Aligned_cols=254 Identities=21% Similarity=0.285 Sum_probs=203.9
Q ss_pred CCccccc-ccccCCceEEEEEEE--CCeeEEEEeccCCChHHHHHHHHHHHHHHhc-CCCCceEEeecccc----CCceE
Q 005427 66 SSYTLLS-PIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKL-DHPGLAKFVAAHAK----PPNYM 137 (697)
Q Consensus 66 ~~y~~~~-~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~----~~~~~ 137 (697)
++|.++. .||+|+||+||+|++ +++.||||++.. ...+.+|+.++.++ +|||||+++++|.+ ...+|
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ 85 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 85 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence 5799875 599999999999997 588999998642 24567899987654 89999999999865 46789
Q ss_pred EEEeecCCCCHhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecC---CCCCeeeeeccchhhh
Q 005427 138 FFFEFYESRNLAEKLHVEE-WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDR---NLCPHLADFGLAEYRE 213 (697)
Q Consensus 138 lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~---~~~~kL~Dfg~a~~~~ 213 (697)
+|||||+||+|.+++...+ ..+++.+++.++.||+.||+|||++||+||||||+|||++. .+.+||+|||+++...
T Consensus 86 ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~ 165 (335)
T d2ozaa1 86 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 165 (335)
T ss_dssp EEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECC
T ss_pred EEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeeecc
Confidence 9999999999999997653 46899999999999999999999999999999999999975 5679999999997554
Q ss_pred hhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhc
Q 005427 214 NLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEM 293 (697)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~ 293 (697)
... .....+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.........+...
T Consensus 166 ~~~-----------------~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~ 228 (335)
T d2ozaa1 166 SHN-----------------SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR 228 (335)
T ss_dssp CCC-----------------CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------C
T ss_pred CCC-----------------ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHH
Confidence 211 234568999999999999999999999999999999999999999876443332222111
Q ss_pred cccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 294 NYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
.. .+.. .+.......+|+++.+||++||+.||++|||+.|+++|.|+.
T Consensus 229 i~----------~~~~-~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~ 276 (335)
T d2ozaa1 229 IR----------MGQY-EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM 276 (335)
T ss_dssp CC----------SCSS-SCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHH
T ss_pred Hh----------cCCC-CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhh
Confidence 00 0000 111112235889999999999999999999999999999875
|
| >d1a6qa2 d.219.1.1 (A:2-296) Protein serine/threonine phosphatase 2C, catalytic domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: PP2C-like superfamily: PP2C-like family: PP2C-like domain: Protein serine/threonine phosphatase 2C, catalytic domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-48 Score=391.23 Aligned_cols=253 Identities=27% Similarity=0.481 Sum_probs=211.5
Q ss_pred cccceEeeeccCCCCCCCceeEEcccccCC-CceEEEEEecCCCChHHHHHHHHHhHHHHHhc-----CCCCC----hHH
Q 005427 427 PVLSWGSFATCGRRETMEDTHFLMPHMYNQ-KEIHMFGIFDGHRGSAAAEFSARALPGFLQNL-----GSTTR----PTD 496 (697)
Q Consensus 427 ~~~~~~~~s~~G~R~~neD~~~~~~~~~~~-~~~~~~~V~DG~GG~~~~~~as~~~~~~l~~~-----~~~~~----~~~ 496 (697)
..+.||++|.+|+|.+|||++.+..++... .+..||||||||||+.+|++|++.+++.|.+. ..... ..+
T Consensus 19 ~~~~~g~~s~~G~R~~~ED~~~~~~~~~~~~~~~~lf~V~DGhGG~~~s~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~ 98 (295)
T d1a6qa2 19 NGLRYGLSSMQGWRVEMEDAHTAVIGLPSGLESWSFFAVYDGHAGSQVAKYCCEHLLDHITNNQDFKGSAGAPSVENVKN 98 (295)
T ss_dssp TTEEEEEEEEEETSSSCCEEEEEEEEETTTEEEEEEEEEEEEESCSHHHHHHHHHHHHHHHTSHHHHCSSSSCCHHHHHH
T ss_pred CceEEEEEeCccCCCcccCeeEEEcccCCCCCceEEEEEEeCCCChHHHHHHHHHHHHHHHHhhhhccccccchHHHHHH
Confidence 468899999999999999999987655432 45789999999999999999999999988764 11112 334
Q ss_pred HHHHHHHHHHHHHHHHHHHHHhhhhcccCCCCCCceEEEEEEecCeEEEEEcCCeEEEEEECCeeeecCCCCCCCCHHHH
Q 005427 497 ALLEAFIRTDVAFRNELDSLRKSKRVVQKDWHPGCTAIAALIVRNRLFVANAGDCRAILCRGGHPFALSRDHVASCLEER 576 (697)
Q Consensus 497 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GtT~~~~~i~~~~l~~anvGDSr~~l~~~~~~~~lt~dH~~~~~~e~ 576 (697)
++.++|.+++..+..... .......||||+++++|.++++|+|||||||+|+++++.+++||+||+|.++.|+
T Consensus 99 al~~a~~~~~~~~~~~~~-------~~~~~~~~GtTa~~~~i~~~~l~vanvGDSR~~l~~~~~~~~lT~dH~~~~~~E~ 171 (295)
T d1a6qa2 99 GIRTGFLEIDEHMRVMSE-------KKHGADRSGSTAVGVLISPQHTYFINCGDSRGLLCRNRKVHFFTQDHKPSNPLEK 171 (295)
T ss_dssp HHHHHHHHHHHHHHHHHH-------HTTCCCCCEECEEEEEECSSEEEEEEESSCEEEEEETTEEEEECCCCCTTSHHHH
T ss_pred HHHHHHHHHHHHHhhhhh-------hccCcCCCCCeEEEEEeeCCEEEEEecCCCeEEEeecccceeeccccCcccHHHH
Confidence 556666666555543321 1223345899999999999999999999999999999999999999999999999
Q ss_pred HHHHHcCCeeeeccCcceeCCCcceeccccCCCCCCC---------CcccCCceEEEEeC-CCCeEEEEEcCCcccCCCh
Q 005427 577 ERVVSAGGNVNWQVDTWRVGPPALQVTRSIGDDDLKP---------AVTAEPEITETIMT-PEDEYLVMASDGLWDVVSH 646 (697)
Q Consensus 577 ~ri~~~g~~~~~~~~~~~~~~~~~~ltralG~~~~k~---------~v~~~p~v~~~~l~-~~d~~lvl~SDGl~d~~~~ 646 (697)
+|+.+.||.+.. .+.. +.+++||+|||..+|. .|+++|++..+.+. ++|+|||||||||||+|++
T Consensus 172 ~Ri~~~gg~v~~----~r~~-g~l~~tRa~Gd~~~k~~~~~~~~~~~v~~~Pdi~~~~~~~~~~~flvL~SDGl~d~l~~ 246 (295)
T d1a6qa2 172 ERIQNAGGSVMI----QRVN-GSLAVSRALGDFDYKCVHGKGPTEQLVSPEPEVHDIERSEEDDQFIILACDGIWDVMGN 246 (295)
T ss_dssp HHHHHTTCCEET----TEET-TTBSCSBCEECGGGSCCTTCCGGGSSSBCCCEEEEEECCTTTEEEEEEECHHHHTTSCH
T ss_pred hhHhhcCCcccc----cccC-CceeeeeccCcHHhhhccccCcccccccccccceEEEeecccceeEeeecCcccccCCH
Confidence 999999997743 3444 6899999999998873 59999999999885 5677999999999999999
Q ss_pred HHHHHHHHhhc---CChhHHHHHHHHHHHhcCCCCCcEEEEEEeCCCC
Q 005427 647 VEAVGIIKDTV---KEPGMCSKRLATEAAERGSKDNITVIVVFLQPVS 691 (697)
Q Consensus 647 ~ei~~~~~~~~---~~~~~~a~~L~~~a~~~g~~DNiT~ivv~l~~~~ 691 (697)
+||+++++... .+++.+|+.|++.|+.+|+.||||||||+|+..+
T Consensus 247 ~ei~~~v~~~~~~~~~~~~~a~~Lv~~A~~~gs~DNiTvivv~~~~~~ 294 (295)
T d1a6qa2 247 EELCDFVRSRLEVTDDLEKVCNEVVDTCLYKGSRDNMSVILICFPNAP 294 (295)
T ss_dssp HHHHHHHHHHHTTCCCHHHHHHHHHHHHHHTTCCSCEEEEEEECTTSC
T ss_pred HHHHHHHHHHhhcCCCHHHHHHHHHHHHHhcCCCCCeEEEEEeccCCC
Confidence 99999997643 4799999999999999999999999999998654
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-48 Score=398.57 Aligned_cols=268 Identities=25% Similarity=0.398 Sum_probs=223.7
Q ss_pred CCCccCCCCCCCcccccccccCCceEEEEEEE-------CCeeEEEEeccCC-ChHHHHHHHHHHHHHHhc-CCCCceEE
Q 005427 56 SQSIPLHLPPSSYTLLSPIARGAESVVYEATL-------DGRKVAVKKPILS-TSEELDNFHKELQLLCKL-DHPGLAKF 126 (697)
Q Consensus 56 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~l 126 (697)
+...+|+++.++|++.++||+|+||.||+|++ .++.||||++... ...+...+.+|+.+++.+ +|||||++
T Consensus 13 ~~~~~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~ 92 (311)
T d1t46a_ 13 PYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNL 92 (311)
T ss_dssp CCCGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEE
Confidence 33447889999999999999999999999985 2468999987654 344566899999999999 69999999
Q ss_pred eeccccCCceEEEEeecCCCCHhhhhhhcC-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCC
Q 005427 127 VAAHAKPPNYMFFFEFYESRNLAEKLHVEE-----------------WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVK 189 (697)
Q Consensus 127 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----------------~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlk 189 (697)
++++.++..++++||||++|+|.++++... ..+++..+..++.||+.||+|||+++++|||||
T Consensus 93 ~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLK 172 (311)
T d1t46a_ 93 LGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLA 172 (311)
T ss_dssp EEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred EEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccc
Confidence 999999999999999999999999987543 257899999999999999999999999999999
Q ss_pred CCceeecCCCCCeeeeeccchhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHH
Q 005427 190 PANVLLDRNLCPHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISIN 269 (697)
Q Consensus 190 p~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ 269 (697)
|+|||++.++.+||+|||+++....... ........||+.|+|||++.+..++.++|||||||++|
T Consensus 173 p~NIl~~~~~~~ki~DfG~~~~~~~~~~--------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ 238 (311)
T d1t46a_ 173 ARNILLTHGRITKICDFGLARDIKNDSN--------------YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLW 238 (311)
T ss_dssp GGGEEEETTTEEEECCCGGGSCTTSCTT--------------SEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred cccccccccCcccccccchheeccCCCc--------------ceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHH
Confidence 9999999999999999999976543211 11234568999999999999999999999999999999
Q ss_pred HHHh-CCCCCCCchhHHHHHHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 005427 270 ELLT-GVVPYTDLRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALE 348 (697)
Q Consensus 270 ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 348 (697)
||+| |.+||...........++. .+.++. .+..+|+++.+||.+||+.||++|||+++|++.
T Consensus 239 ellt~g~p~~~~~~~~~~~~~~i~--------------~~~~~~---~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~ 301 (311)
T d1t46a_ 239 ELFSLGSSPYPGMPVDSKFYKMIK--------------EGFRML---SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (311)
T ss_dssp HHHTTTCCSSTTCCSSHHHHHHHH--------------HTCCCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhCCCCCCCCCCHHHHHHHHHh--------------cCCCCC---CcccccHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 9999 6777766554443333322 223332 234689999999999999999999999999999
Q ss_pred HHHHHH
Q 005427 349 LDLVLE 354 (697)
Q Consensus 349 l~~~~~ 354 (697)
|+.++.
T Consensus 302 L~~~i~ 307 (311)
T d1t46a_ 302 IEKQIS 307 (311)
T ss_dssp HHHHHH
T ss_pred HHHhhc
Confidence 987664
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-49 Score=403.31 Aligned_cols=259 Identities=28% Similarity=0.460 Sum_probs=212.7
Q ss_pred CCCCCcccccccccCCceEEEEEEE--CCe--eEEEEeccCC-ChHHHHHHHHHHHHHHhc-CCCCceEEeeccccCCce
Q 005427 63 LPPSSYTLLSPIARGAESVVYEATL--DGR--KVAVKKPILS-TSEELDNFHKELQLLCKL-DHPGLAKFVAAHAKPPNY 136 (697)
Q Consensus 63 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~ 136 (697)
++.++|++.++||+|+||.||+|++ ++. .||||++... .....+.+.+|+++|+++ +|||||++++++.+.+.+
T Consensus 7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~ 86 (309)
T d1fvra_ 7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL 86 (309)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEE
T ss_pred cCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCee
Confidence 4557899999999999999999987 454 4677765433 334566899999999999 799999999999999999
Q ss_pred EEEEeecCCCCHhhhhhhc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCC
Q 005427 137 MFFFEFYESRNLAEKLHVE---------------EWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCP 201 (697)
Q Consensus 137 ~lv~e~~~~g~L~~~l~~~---------------~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~ 201 (697)
++||||+++|+|.++++.. ...+++.+++.++.||+.||.|||+.+|+||||||+|||++.++.+
T Consensus 87 ~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 87 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCE
T ss_pred EEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCce
Confidence 9999999999999998653 3468999999999999999999999999999999999999999999
Q ss_pred eeeeeccchhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhC-CCCCCC
Q 005427 202 HLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTG-VVPYTD 280 (697)
Q Consensus 202 kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g-~~Pf~~ 280 (697)
||+|||+++...... ......||+.|+|||.+.+..++.++|||||||++|||++| .+||.+
T Consensus 167 kl~DfG~a~~~~~~~-----------------~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~ 229 (309)
T d1fvra_ 167 KIADFGLSRGQEVYV-----------------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG 229 (309)
T ss_dssp EECCTTCEESSCEEC-----------------CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred EEccccccccccccc-----------------cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCC
Confidence 999999997543211 12345689999999999999999999999999999999995 567877
Q ss_pred chhHHHHHHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHh
Q 005427 281 LRAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHR 356 (697)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~~ 356 (697)
.+.......+.. +.++ ..+..+|+++.+||.+||+.||++|||+.||+++|..+.+..
T Consensus 230 ~~~~~~~~~i~~---------------~~~~---~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~ 287 (309)
T d1fvra_ 230 MTCAELYEKLPQ---------------GYRL---EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 287 (309)
T ss_dssp CCHHHHHHHGGG---------------TCCC---CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred CCHHHHHHHHHh---------------cCCC---CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 655554433322 1222 234578999999999999999999999999999999987643
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-49 Score=405.08 Aligned_cols=269 Identities=23% Similarity=0.263 Sum_probs=213.5
Q ss_pred CCcccccccccCCceEEEEEEEC---CeeEEEEeccCCCh--HHHHHHHHHHHHHHhc---CCCCceEEeecccc-----
Q 005427 66 SSYTLLSPIARGAESVVYEATLD---GRKVAVKKPILSTS--EELDNFHKELQLLCKL---DHPGLAKFVAAHAK----- 132 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~---~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~hpniv~l~~~~~~----- 132 (697)
++|+++++||+|+||+||+|++. ++.||||++..... .....+.+|+.+|+.| +||||++++++|..
T Consensus 7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~ 86 (305)
T d1blxa_ 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 86 (305)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccccc
Confidence 68999999999999999999972 56799998654321 1233456788877766 79999999999853
Q ss_pred CCceEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhh
Q 005427 133 PPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYR 212 (697)
Q Consensus 133 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~ 212 (697)
...++++|||+.++.+..........+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 87 ~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~~ 166 (305)
T d1blxa_ 87 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY 166 (305)
T ss_dssp EEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCC
T ss_pred CceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhhh
Confidence 35789999999998777666666667899999999999999999999999999999999999999999999999998754
Q ss_pred hhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHh
Q 005427 213 ENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLE 292 (697)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~ 292 (697)
.... ......||+.|+|||++.+.+++.++|||||||++|||++|.+||.+.+.......+..
T Consensus 167 ~~~~-----------------~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~ 229 (305)
T d1blxa_ 167 SFQM-----------------ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILD 229 (305)
T ss_dssp CGGG-----------------GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred cccc-----------------cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHH
Confidence 3211 24567899999999999999999999999999999999999999998877776666554
Q ss_pred ccccHHHHHH--------HHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 005427 293 MNYTEQQLTA--------AVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL 351 (697)
Q Consensus 293 ~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~ 351 (697)
.........+ .................+++++.+||.+||+.||++|||++|+++|+|+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff 296 (305)
T d1blxa_ 230 VIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 296 (305)
T ss_dssp HHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGG
T ss_pred hhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhh
Confidence 3221110000 0000111112233445789999999999999999999999999999875
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1e-48 Score=398.36 Aligned_cols=269 Identities=23% Similarity=0.253 Sum_probs=212.7
Q ss_pred CCcccccccccCCceEEEEEEE-CCeeEEEEeccCCChHH--HHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEee
Q 005427 66 SSYTLLSPIARGAESVVYEATL-DGRKVAVKKPILSTSEE--LDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFEF 142 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~ 142 (697)
++|+++++||+|+||+||+|++ +++.||||++......+ .+.+.+|+.+|++++||||+++++++.+++..+++||+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 5899999999999999999998 57899999876654332 57899999999999999999999999999999999999
Q ss_pred cCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhccc
Q 005427 143 YESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKN 222 (697)
Q Consensus 143 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 222 (697)
+.++.+..+.. ....+++.+++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~~~~~~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~------ 154 (286)
T d1ob3a_ 82 LDQDLKKLLDV-CEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV------ 154 (286)
T ss_dssp CSEEHHHHHHT-STTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--------
T ss_pred ehhhhHHHHHh-hcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCc------
Confidence 98766666554 44579999999999999999999999999999999999999999999999999997654211
Q ss_pred ccCCCCCCCCccccccccCccccchhhhcc-cCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHHH
Q 005427 223 WRSSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLT 301 (697)
Q Consensus 223 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 301 (697)
.......|++.|+|||.+.+ ..++.++|||||||++|||++|+.||.+.+......++...........
T Consensus 155 ----------~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~ 224 (286)
T d1ob3a_ 155 ----------RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKN 224 (286)
T ss_dssp -----------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred ----------cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhh
Confidence 12344578999999999875 4568999999999999999999999998776666555543222110000
Q ss_pred HH--HHhC--------CCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 005427 302 AA--VVSG--------GLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL 351 (697)
Q Consensus 302 ~~--~~~~--------~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~ 351 (697)
.. .... ............+++++.+||++||+.||++|||++|+++|+|+
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f 284 (286)
T d1ob3a_ 225 WPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284 (286)
T ss_dssp STTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGG
T ss_pred ccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence 00 0000 00111122345688999999999999999999999999998775
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-48 Score=395.87 Aligned_cols=261 Identities=23% Similarity=0.390 Sum_probs=220.0
Q ss_pred cCCCCCCCcccccccccCCceEEEEEEEC-------CeeEEEEeccCC-ChHHHHHHHHHHHHHHhcCCCCceEEeeccc
Q 005427 60 PLHLPPSSYTLLSPIARGAESVVYEATLD-------GRKVAVKKPILS-TSEELDNFHKELQLLCKLDHPGLAKFVAAHA 131 (697)
Q Consensus 60 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~ 131 (697)
.|+++.++|++.++||+|+||+||+|.+. ++.||||++... ...+...+.+|+.++++++||||+++++++.
T Consensus 14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~ 93 (308)
T d1p4oa_ 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 93 (308)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred ceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEe
Confidence 47899999999999999999999999863 468999987643 3445667999999999999999999999999
Q ss_pred cCCceEEEEeecCCCCHhhhhhhcC---------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCe
Q 005427 132 KPPNYMFFFEFYESRNLAEKLHVEE---------WSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPH 202 (697)
Q Consensus 132 ~~~~~~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~k 202 (697)
.+...++||||+.+|+|.+++.... ..+++..+..++.|++.||.|||+++|+||||||+|||++.++++|
T Consensus 94 ~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~K 173 (308)
T d1p4oa_ 94 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVK 173 (308)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEE
T ss_pred cCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEE
Confidence 9999999999999999999886432 2468899999999999999999999999999999999999999999
Q ss_pred eeeeccchhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhC-CCCCCCc
Q 005427 203 LADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTG-VVPYTDL 281 (697)
Q Consensus 203 L~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g-~~Pf~~~ 281 (697)
|+|||+++........ .......||+.|+|||.+.+..++.++|||||||++|||++| .+||.+.
T Consensus 174 l~DFGla~~~~~~~~~--------------~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~ 239 (308)
T d1p4oa_ 174 IGDFGMTRDIYETDYY--------------RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL 239 (308)
T ss_dssp ECCTTCCCGGGGGGCE--------------EGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS
T ss_pred EeecccceeccCCcce--------------eeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCC
Confidence 9999999876542211 123445789999999999999999999999999999999997 6888876
Q ss_pred hhHHHHHHHHhccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 282 RAEAQAHTVLEMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
+.......+. .+.. ...+..+|+.+.+||.+||+.||++|||+.+|+++|...
T Consensus 240 ~~~~~~~~i~--------------~~~~----~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~ 292 (308)
T d1p4oa_ 240 SNEQVLRFVM--------------EGGL----LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292 (308)
T ss_dssp CHHHHHHHHH--------------TTCC----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred CHHHHHHHHH--------------hCCC----CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 6554443332 2221 123457899999999999999999999999999877554
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-49 Score=399.99 Aligned_cols=243 Identities=22% Similarity=0.358 Sum_probs=203.1
Q ss_pred CCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCCh------HHHHHHHHHHHHHHhcC--CCCceEEeeccccCC
Q 005427 65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTS------EELDNFHKELQLLCKLD--HPGLAKFVAAHAKPP 134 (697)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--hpniv~l~~~~~~~~ 134 (697)
.++|++.++||+|+||+||+|++ +++.||||++..... .....+.+|+.+|++++ ||||+++++++.+++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 36899999999999999999998 588999997643211 11234678999999996 899999999999999
Q ss_pred ceEEEEeecCC-CCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecC-CCCCeeeeeccchhh
Q 005427 135 NYMFFFEFYES-RNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDR-NLCPHLADFGLAEYR 212 (697)
Q Consensus 135 ~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~-~~~~kL~Dfg~a~~~ 212 (697)
.+++||||+.+ +++.+++.... .+++++++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+|+..
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~-~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~ 161 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL 161 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred eEEEEEEeccCcchHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceec
Confidence 99999999986 57778776554 7899999999999999999999999999999999999985 478999999999754
Q ss_pred hhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCC-CchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHH
Q 005427 213 ENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIH-SEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVL 291 (697)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~ 291 (697)
.. ....+..||+.|+|||++.+..+ +.++|||||||++|||++|..||.+... +.
T Consensus 162 ~~------------------~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------i~ 217 (273)
T d1xwsa_ 162 KD------------------TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------II 217 (273)
T ss_dssp CS------------------SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HH
T ss_pred cc------------------ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH------Hh
Confidence 32 12345689999999999987665 6779999999999999999999976421 11
Q ss_pred hccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 005427 292 EMNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL 351 (697)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~ 351 (697)
. +. ...+..+|+++.+||++||+.||++|||++|+++|+|.
T Consensus 218 ~--------------~~-----~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~ 258 (273)
T d1xwsa_ 218 R--------------GQ-----VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 258 (273)
T ss_dssp H--------------CC-----CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred h--------------cc-----cCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhh
Confidence 1 11 11345789999999999999999999999999998875
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-47 Score=390.47 Aligned_cols=257 Identities=25% Similarity=0.373 Sum_probs=209.7
Q ss_pred cccccccCCceEEEEEEECC-----eeEEEEeccC-CChHHHHHHHHHHHHHHhcCCCCceEEeecccc-CCceEEEEee
Q 005427 70 LLSPIARGAESVVYEATLDG-----RKVAVKKPIL-STSEELDNFHKELQLLCKLDHPGLAKFVAAHAK-PPNYMFFFEF 142 (697)
Q Consensus 70 ~~~~lg~G~~g~V~~~~~~~-----~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~~lv~e~ 142 (697)
+.++||+|+||+||+|++.. ..||||++.. ......+.|.+|+++|++++||||+++++++.. +..+++||||
T Consensus 31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~ 110 (311)
T d1r0pa_ 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY 110 (311)
T ss_dssp EEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEEC
T ss_pred cceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEE
Confidence 46789999999999998732 3589998753 455667889999999999999999999999765 5678999999
Q ss_pred cCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhccc
Q 005427 143 YESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLKN 222 (697)
Q Consensus 143 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~ 222 (697)
|++|+|.+++......+++..++.++.|++.||.|||+.+|+||||||+|||++.++.+||+|||+++.......
T Consensus 111 ~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~----- 185 (311)
T d1r0pa_ 111 MKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF----- 185 (311)
T ss_dssp CTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC-----
T ss_pred eecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcccccc-----
Confidence 999999999988777888999999999999999999999999999999999999999999999999986653211
Q ss_pred ccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHHHHH
Q 005427 223 WRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQLTA 302 (697)
Q Consensus 223 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 302 (697)
..........||+.|+|||++.+..++.++||||||+++|||++|..||......... ..
T Consensus 186 -------~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~-------------~~ 245 (311)
T d1r0pa_ 186 -------DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI-------------TV 245 (311)
T ss_dssp -------CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------C-------------HH
T ss_pred -------ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHH-------------HH
Confidence 1111233457999999999999999999999999999999999977777653222111 11
Q ss_pred HHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 005427 303 AVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH 355 (697)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~ 355 (697)
.+. .+.++. .+..+++++.+||.+||+.||++|||+.||+++|..+++.
T Consensus 246 ~i~-~g~~~~---~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 246 YLL-QGRRLL---QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp HHH-TTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHH-cCCCCC---CcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 112 222332 3457899999999999999999999999999999988753
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-47 Score=396.61 Aligned_cols=266 Identities=22% Similarity=0.320 Sum_probs=209.9
Q ss_pred CCCcccccccccCCceEEEEEEE--CCeeEEEEeccCC--ChHHHHHHHHHHHHHHhcCCCCceEEeeccccCC------
Q 005427 65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPP------ 134 (697)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~------ 134 (697)
.++|+++++||+|+||+||+|++ +++.||||++... .....+.+.+|+.+|+.++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 57899999999999999999997 5899999987643 3345678999999999999999999999987654
Q ss_pred ceEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhh
Q 005427 135 NYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYREN 214 (697)
Q Consensus 135 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~ 214 (697)
.+|+||||| +.+|..+.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~ 173 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS 173 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred eEEEEEecc-cccHHHHHHhc--cccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccCC
Confidence 579999999 55777776543 689999999999999999999999999999999999999999999999999975432
Q ss_pred hhhhhcccccCCCCCCCCccccccccCccccchhhhcc-cCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhc
Q 005427 215 LKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEM 293 (697)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~ 293 (697)
......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+...........
T Consensus 174 -------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~ 234 (346)
T d1cm8a_ 174 -------------------EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKV 234 (346)
T ss_dssp -------------------SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred -------------------ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhc
Confidence 2345689999999999876 45789999999999999999999999987766655544432
Q ss_pred cccHHH------------HHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 294 NYTEQQ------------LTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 294 ~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
...... .............+......+++++.+||.+||..||++|||+.|+++|+|+-
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~ 305 (346)
T d1cm8a_ 235 TGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFE 305 (346)
T ss_dssp HCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGT
T ss_pred cCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhC
Confidence 221111 11111112222333344567899999999999999999999999999998763
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-47 Score=388.53 Aligned_cols=275 Identities=23% Similarity=0.293 Sum_probs=210.7
Q ss_pred CCcccccccccCCceEEEEEEECCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeeccccCC----ceEEEEe
Q 005427 66 SSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPP----NYMFFFE 141 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~----~~~lv~e 141 (697)
++|.+.++||+|+||.||+|+++|+.||||++..... .......|+..++.++||||+++++++.+.. .+++|||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~E 81 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEETTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEe
Confidence 4788999999999999999999999999998754322 1222334555556789999999999987654 5899999
Q ss_pred ecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHh--------CCcccccCCCCceeecCCCCCeeeeeccchhhh
Q 005427 142 FYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHN--------LGIVHRDVKPANVLLDRNLCPHLADFGLAEYRE 213 (697)
Q Consensus 142 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~--------~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~ 213 (697)
||++|+|.++++.. .+++++++.++.|++.||+|||+ .||+||||||+||||+.++.+||+|||++....
T Consensus 82 y~~~g~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~ 159 (303)
T d1vjya_ 82 YHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD 159 (303)
T ss_dssp CCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEE
T ss_pred cccCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccccc
Confidence 99999999999764 58899999999999999999996 599999999999999999999999999997654
Q ss_pred hhhhhhcccccCCCCCCCCccccccccCccccchhhhcccC------CCchhhHHHHHHHHHHHHhCCCCCCCchhHHH-
Q 005427 214 NLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEI------HSEKSDVYSFGISINELLTGVVPYTDLRAEAQ- 286 (697)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~- 286 (697)
.... .........+||+.|+|||++.+.. ++.++|||||||+||||+||..||........
T Consensus 160 ~~~~------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~ 227 (303)
T d1vjya_ 160 SATD------------TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 227 (303)
T ss_dssp TTTT------------EECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCT
T ss_pred CCCc------------ceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccc
Confidence 3211 1111234568999999999987643 56789999999999999999988854322111
Q ss_pred HHHHHhccccHHHHHHHHHhCCCCCcccccc--cCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 005427 287 AHTVLEMNYTEQQLTAAVVSGGLRPILASLE--LGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEH 355 (697)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~ 355 (697)
....................+..+|.++... ...+..+.+|+.+||+.||++|||+.||+++|..+.+.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 298 (303)
T d1vjya_ 228 YYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp TTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hhhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence 1111122233444455555566666554432 23446799999999999999999999999999887754
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-46 Score=391.91 Aligned_cols=271 Identities=23% Similarity=0.284 Sum_probs=210.0
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccCC-ChHHHHHHHHHHHHHHhcCCCCceEEeeccccCC----ceEE
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS-TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKPP----NYMF 138 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~----~~~l 138 (697)
++|+++++||+|+||+||+|++ +++.||||++... .....+.+.+|+.+|++++||||+++++++..+. ..++
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~ 87 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 87 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence 5799999999999999999987 5899999987644 3445678999999999999999999999987653 3455
Q ss_pred EEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhh
Q 005427 139 FFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEI 218 (697)
Q Consensus 139 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~ 218 (697)
+++++.+|+|.+++... .+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus 88 l~~~~~~g~L~~~l~~~--~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~- 164 (345)
T d1pmea_ 88 LVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD- 164 (345)
T ss_dssp EEEECCCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGC-
T ss_pred EEEeecCCchhhhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCc-
Confidence 56677799999999654 689999999999999999999999999999999999999999999999999976543211
Q ss_pred hcccccCCCCCCCCccccccccCccccchhhhc-ccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccH
Q 005427 219 SLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILK-KEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTE 297 (697)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~ 297 (697)
........+||+.|+|||++. +..++.++||||+||++|+|++|..||.+.................
T Consensus 165 ------------~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~ 232 (345)
T d1pmea_ 165 ------------HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP 232 (345)
T ss_dssp ------------BCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSC
T ss_pred ------------cceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCC
Confidence 011234568999999999985 4567899999999999999999999998876555444433221111
Q ss_pred HHH----------HHHHH--hCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 005427 298 QQL----------TAAVV--SGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL 351 (697)
Q Consensus 298 ~~~----------~~~~~--~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~ 351 (697)
... ..... ..............+++++.+||.+||+.||.+|||++|+++|.|.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~ 298 (345)
T d1pmea_ 233 SQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 298 (345)
T ss_dssp CHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGG
T ss_pred ChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhh
Confidence 000 00000 0111122233345788999999999999999999999999999875
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=4e-46 Score=379.55 Aligned_cols=270 Identities=21% Similarity=0.276 Sum_probs=216.7
Q ss_pred CCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCChHHHHHHHHHHHHHHhcCC-CCceEEeeccccCCceEEEE
Q 005427 64 PPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDH-PGLAKFVAAHAKPPNYMFFF 140 (697)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~l~~~~~~~~~~~lv~ 140 (697)
.+++|++.++||+|+||+||+|++ +++.||||+..... ....+.+|++.++.|+| +|++.+++++......++||
T Consensus 3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vm 80 (293)
T d1csna_ 3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 80 (293)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred CCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEE
Confidence 357999999999999999999997 58899999764432 23457789999999975 89999999999999999999
Q ss_pred eecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecC-----CCCCeeeeeccchhhhhh
Q 005427 141 EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDR-----NLCPHLADFGLAEYRENL 215 (697)
Q Consensus 141 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~-----~~~~kL~Dfg~a~~~~~~ 215 (697)
||+ +++|.+++...+..+++.++..++.|++.||+|||++||+||||||+|||++. ++.+||+|||+|+.+...
T Consensus 81 e~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~ 159 (293)
T d1csna_ 81 DLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP 159 (293)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred Eec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccC
Confidence 998 67999999877778999999999999999999999999999999999999964 578999999999876532
Q ss_pred hhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccc
Q 005427 216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNY 295 (697)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~ 295 (697)
... ...........+||+.|||||++.+..++.++|||||||++|||++|..||.+...............
T Consensus 160 ~~~---------~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~ 230 (293)
T d1csna_ 160 VTK---------QHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGE 230 (293)
T ss_dssp TTC---------CBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHH
T ss_pred ccc---------cceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHh
Confidence 211 11111234567899999999999999999999999999999999999999986543322211111000
Q ss_pred cHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHh
Q 005427 296 TEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLEHR 356 (697)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~~~ 356 (697)
. ...+....+...+|+++.+++..||..+|++||+++.+.+.+..+++..
T Consensus 231 ~-----------~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~ 280 (293)
T d1csna_ 231 K-----------KQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 280 (293)
T ss_dssp H-----------HHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred c-----------cCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHc
Confidence 0 0011223344578999999999999999999999999988888877643
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-46 Score=389.80 Aligned_cols=273 Identities=23% Similarity=0.243 Sum_probs=206.6
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccCCCh--HHHHHHHHHHHHHHhcCCCCceEEeecccc--------C
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTS--EELDNFHKELQLLCKLDHPGLAKFVAAHAK--------P 133 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~--------~ 133 (697)
++|+++++||+|+||+||+|++ +++.||||++..... .....+.+|+.+|+.++||||+++++++.. .
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 6999999999999999999997 588999998654422 235678899999999999999999998755 4
Q ss_pred CceEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhh
Q 005427 134 PNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRE 213 (697)
Q Consensus 134 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~ 213 (697)
...+++|||+.++.+... ......+++..++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||++..+.
T Consensus 90 ~~~~iv~e~~~~~~~~~~-~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~ 168 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLL-SNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFS 168 (318)
T ss_dssp -CEEEEEECCCEEHHHHH-TCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred ceEEEEEeccCCCccchh-hhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeecc
Confidence 568999999987665544 4445578999999999999999999999999999999999999999999999999997654
Q ss_pred hhhhhhcccccCCCCCCCCccccccccCccccchhhhccc-CCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHh
Q 005427 214 NLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKE-IHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLE 292 (697)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~ 292 (697)
.... .......+.+||+.|+|||++.+. .++.++|||||||++|||++|..||.+.........+..
T Consensus 169 ~~~~------------~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~ 236 (318)
T d3blha1 169 LAKN------------SQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ 236 (318)
T ss_dssp C-----------------CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred cccc------------cccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHH
Confidence 3211 111123456899999999998765 689999999999999999999999998776665555443
Q ss_pred ccccHHH----------HHHHHHhC-CCCCcccc--cccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 005427 293 MNYTEQQ----------LTAAVVSG-GLRPILAS--LELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL 351 (697)
Q Consensus 293 ~~~~~~~----------~~~~~~~~-~~~~~~~~--~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~ 351 (697)
....... ........ ...+.... .....++++.+||.+||+.||++|||++|+++|+|+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff 308 (318)
T d3blha1 237 LCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 308 (318)
T ss_dssp HHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred hcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhh
Confidence 3221110 00000000 00000000 011246788999999999999999999999999986
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1e-45 Score=378.59 Aligned_cols=266 Identities=21% Similarity=0.293 Sum_probs=206.6
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceE-EeeccccCCceEEEEee
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAK-FVAAHAKPPNYMFFFEF 142 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~-l~~~~~~~~~~~lv~e~ 142 (697)
++|++.++||+|+||.||+|++ +++.||||+...... ...+..|+++++.++|+|++. +..++.+...+++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 5799999999999999999997 588999998655432 245789999999998776554 55666777888999999
Q ss_pred cCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeec---CCCCCeeeeeccchhhhhhhhhh
Q 005427 143 YESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLD---RNLCPHLADFGLAEYRENLKEIS 219 (697)
Q Consensus 143 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~---~~~~~kL~Dfg~a~~~~~~~~~~ 219 (697)
+. ++|.+.+......+++.++..++.|++.||+|||++||+||||||+|||++ .+..+||+|||+|+.+.......
T Consensus 85 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~ 163 (299)
T d1ckia_ 85 LG-PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ 163 (299)
T ss_dssp CC-CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCC
T ss_pred cC-CchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecccccccc
Confidence 85 577777776677899999999999999999999999999999999999975 45679999999998765422211
Q ss_pred cccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccccHHH
Q 005427 220 LKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNYTEQQ 299 (697)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~ 299 (697)
...........||+.|||||++.+..++.++|||||||++|||++|..||.+.........+......
T Consensus 164 ---------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~--- 231 (299)
T d1ckia_ 164 ---------HIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK--- 231 (299)
T ss_dssp ---------BCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHH---
T ss_pred ---------ceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcc---
Confidence 11112245668999999999999999999999999999999999999999876544433322111100
Q ss_pred HHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 005427 300 LTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLVLE 354 (697)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~~~ 354 (697)
...+..+....++|+++.+||..||+.||++||++.++.+.|..+..
T Consensus 232 --------~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 232 --------KMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp --------HHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred --------cCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence 00112233445789999999999999999999999999877776654
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-46 Score=390.86 Aligned_cols=265 Identities=25% Similarity=0.310 Sum_probs=206.6
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCceEEeecccc------CCceE
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGLAKFVAAHAK------PPNYM 137 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~------~~~~~ 137 (697)
.+|+.+++||+|+||+||+|++ +++.||||++..... ...+|+.+|++++||||++++++|.. ..+++
T Consensus 20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~ 95 (350)
T d1q5ka_ 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 95 (350)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEE
T ss_pred CCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEE
Confidence 3799999999999999999998 588999998754332 23479999999999999999998843 33578
Q ss_pred EEEeecCCCCHhhhhh--hcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCC-CCeeeeeccchhhhh
Q 005427 138 FFFEFYESRNLAEKLH--VEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNL-CPHLADFGLAEYREN 214 (697)
Q Consensus 138 lv~e~~~~g~L~~~l~--~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~-~~kL~Dfg~a~~~~~ 214 (697)
+|||||+++.+..+.. .....+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.....
T Consensus 96 lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~ 175 (350)
T d1q5ka_ 96 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 175 (350)
T ss_dssp EEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCT
T ss_pred EEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhccC
Confidence 9999998754433332 3445789999999999999999999999999999999999999775 899999999876542
Q ss_pred hhhhhcccccCCCCCCCCccccccccCccccchhhhcc-cCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhc
Q 005427 215 LKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKK-EIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEM 293 (697)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~ 293 (697)
.. ...+.+||+.|+|||++.+ ..++.++|||||||++|||++|..||...........+...
T Consensus 176 ~~-----------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~ 238 (350)
T d1q5ka_ 176 GE-----------------PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV 238 (350)
T ss_dssp TS-----------------CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHH
T ss_pred Cc-----------------ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHH
Confidence 11 2345689999999998875 56899999999999999999999999988777666665543
Q ss_pred cccHHHHHHHHHhCCC-C---------CcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 005427 294 NYTEQQLTAAVVSGGL-R---------PILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL 351 (697)
Q Consensus 294 ~~~~~~~~~~~~~~~~-~---------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~ 351 (697)
................ . +........+++++.+||.+||+.||++|||+.|+++|.|+
T Consensus 239 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f 306 (350)
T d1q5ka_ 239 LGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 306 (350)
T ss_dssp HCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred hCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhh
Confidence 2222111111111110 0 11111234578999999999999999999999999999876
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=8.8e-46 Score=384.34 Aligned_cols=262 Identities=21% Similarity=0.285 Sum_probs=204.2
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccCCChHHHHHHHHHHHHHHhcC-CCCceEEeecccc--CCceEEEE
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLD-HPGLAKFVAAHAK--PPNYMFFF 140 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~--~~~~~lv~ 140 (697)
++|+++++||+|+||+||+|++ +++.||||++.... .+.+.+|+.+|+.++ ||||+++++++.. ...+++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 5799999999999999999998 58999999875433 456889999999995 9999999999874 45699999
Q ss_pred eecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCC-CCeeeeeccchhhhhhhhhh
Q 005427 141 EFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNL-CPHLADFGLAEYRENLKEIS 219 (697)
Q Consensus 141 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~-~~kL~Dfg~a~~~~~~~~~~ 219 (697)
|||.+++|....+ .+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+......
T Consensus 112 e~~~~~~L~~~~~----~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~--- 184 (328)
T d3bqca1 112 EHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ--- 184 (328)
T ss_dssp ECCCSCBGGGTTT----SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC---
T ss_pred eecCCCcHHHHhc----CCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCCC---
Confidence 9999999987642 689999999999999999999999999999999999998755 58999999997654211
Q ss_pred cccccCCCCCCCCccccccccCccccchhhhccc-CCCchhhHHHHHHHHHHHHhCCCCCCCchhHH-HHHHHHhccccH
Q 005427 220 LKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKE-IHSEKSDVYSFGISINELLTGVVPYTDLRAEA-QAHTVLEMNYTE 297 (697)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~-~~~~~~~~~~~~ 297 (697)
.....+||+.|+|||++.+. .++.++||||+||++|+|++|..||....... ....+......+
T Consensus 185 --------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~ 250 (328)
T d3bqca1 185 --------------EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTE 250 (328)
T ss_dssp --------------CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHH
T ss_pred --------------cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCc
Confidence 23456799999999998765 47999999999999999999999997654332 222222211111
Q ss_pred HHHHHHHHh-CCCC------------C-----cccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 005427 298 QQLTAAVVS-GGLR------------P-----ILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL 351 (697)
Q Consensus 298 ~~~~~~~~~-~~~~------------~-----~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~ 351 (697)
......... .... . ........+++++.+||++||+.||++|||++|+++|+|+
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F 322 (328)
T d3bqca1 251 DLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 322 (328)
T ss_dssp HHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred hhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence 111110000 0000 0 0011123478999999999999999999999999999886
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-46 Score=387.66 Aligned_cols=267 Identities=23% Similarity=0.324 Sum_probs=212.0
Q ss_pred CCCcccccccccCCceEEEEEEE--CCeeEEEEeccCC--ChHHHHHHHHHHHHHHhcCCCCceEEeeccccC-----Cc
Q 005427 65 PSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAKP-----PN 135 (697)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-----~~ 135 (697)
+++|+++++||+|+||+||+|++ +++.||||++... .....+.+.+|+.+|+.++|||||++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 47899999999999999999987 5899999987543 344567889999999999999999999988643 34
Q ss_pred eEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhh
Q 005427 136 YMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL 215 (697)
Q Consensus 136 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~ 215 (697)
.+++++++.+|+|.+++... .+++.+++.++.||+.||+|||++||+||||||+|||++.++.+|++|||++.....
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~--~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~- 173 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD- 173 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCTG-
T ss_pred eEEEEEeecCCchhhhcccc--cccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccCc-
Confidence 56777888899999998643 699999999999999999999999999999999999999999999999999865432
Q ss_pred hhhhcccccCCCCCCCCccccccccCccccchhhhccc-CCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhcc
Q 005427 216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKE-IHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMN 294 (697)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~ 294 (697)
...+..||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+.......+....
T Consensus 174 ------------------~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~ 235 (348)
T d2gfsa1 174 ------------------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 235 (348)
T ss_dssp ------------------GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred ------------------ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 23456899999999987765 46899999999999999999999999887776666655433
Q ss_pred ccHHHH---------HHHHHh---CCCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 295 YTEQQL---------TAAVVS---GGLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 295 ~~~~~~---------~~~~~~---~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
...... ...... ......+......+++++.+||++||+.||.+|||+.|+++|.|+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~ 305 (348)
T d2gfsa1 236 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 305 (348)
T ss_dssp CCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGT
T ss_pred CCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhC
Confidence 221110 000000 0111111223356889999999999999999999999999998864
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-46 Score=385.27 Aligned_cols=256 Identities=25% Similarity=0.344 Sum_probs=210.8
Q ss_pred CCCcccccccccCCceEEEEEEE-----CCeeEEEEeccCC----ChHHHHHHHHHHHHHHhcCC-CCceEEeeccccCC
Q 005427 65 PSSYTLLSPIARGAESVVYEATL-----DGRKVAVKKPILS----TSEELDNFHKELQLLCKLDH-PGLAKFVAAHAKPP 134 (697)
Q Consensus 65 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h-pniv~l~~~~~~~~ 134 (697)
-++|+++++||+|+||+||+|++ +++.||||++... .....+.+.+|+++|++++| |||+++++++.++.
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~ 102 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 102 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence 36899999999999999999986 4688999986432 22335678899999999976 89999999999999
Q ss_pred ceEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhh
Q 005427 135 NYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYREN 214 (697)
Q Consensus 135 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~ 214 (697)
.++++|||+.+|+|.+++.... .+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++.+..
T Consensus 103 ~~~~v~e~~~~~~L~~~i~~~~-~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~ 181 (322)
T d1vzoa_ 103 KLHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA 181 (322)
T ss_dssp EEEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCG
T ss_pred ceeeeeecccccHHHHHHHhcc-cccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhcc
Confidence 9999999999999999997665 678899999999999999999999999999999999999999999999999976543
Q ss_pred hhhhhcccccCCCCCCCCccccccccCccccchhhhccc--CCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHh
Q 005427 215 LKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKE--IHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLE 292 (697)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~ 292 (697)
... ....+..|++.|+|||.+.+. .++.++|||||||+||+|++|..||.+.........+..
T Consensus 182 ~~~---------------~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~ 246 (322)
T d1vzoa_ 182 DET---------------ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR 246 (322)
T ss_dssp GGG---------------GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHH
T ss_pred ccc---------------ccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 221 123456899999999999764 468899999999999999999999987654433333222
Q ss_pred ccccHHHHHHHHHhCCCCCcccccccCChHHHHHHHHHhccCCCCCCC-----CHHHHHHHHHH
Q 005427 293 MNYTEQQLTAAVVSGGLRPILASLELGLPASILSLIQRCWDGNPHNRP-----SFSDIALELDL 351 (697)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~ell~~l~~ 351 (697)
.. ... . +..+..+|+++.+||++||+.||.+|| |++|+++|.|+
T Consensus 247 ~~----------~~~--~---~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff 295 (322)
T d1vzoa_ 247 RI----------LKS--E---PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF 295 (322)
T ss_dssp HH----------HHC--C---CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGG
T ss_pred hc----------ccC--C---CCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhh
Confidence 11 111 1 123457899999999999999999999 58999998885
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-45 Score=387.10 Aligned_cols=266 Identities=22% Similarity=0.276 Sum_probs=201.9
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccCC--ChHHHHHHHHHHHHHHhcCCCCceEEeecccc------CCc
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILS--TSEELDNFHKELQLLCKLDHPGLAKFVAAHAK------PPN 135 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~------~~~ 135 (697)
++|+++++||+|+||+||+|++ +++.||||++... .......+.+|+.+|++++||||++++++|.. ..+
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 5799999999999999999998 5899999987543 34456789999999999999999999999854 467
Q ss_pred eEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhh
Q 005427 136 YMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENL 215 (697)
Q Consensus 136 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~ 215 (697)
+|+|||||.++ +.+.+. ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+|++|||+++.....
T Consensus 97 ~~iv~Ey~~~~-l~~~~~---~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~ 172 (355)
T d2b1pa1 97 VYLVMELMDAN-LCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 172 (355)
T ss_dssp EEEEEECCSEE-HHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred eEEEEeccchH-HHHhhh---cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhccccc
Confidence 89999999765 444443 25899999999999999999999999999999999999999999999999998654321
Q ss_pred hhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHhccc
Q 005427 216 KEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYTDLRAEAQAHTVLEMNY 295 (697)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~~~~~~~~~~~~~~~~~ 295 (697)
......+||+.|+|||++.+..++.++||||+||++|+|++|.+||.+.+.......+.....
T Consensus 173 -----------------~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~ 235 (355)
T d2b1pa1 173 -----------------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLG 235 (355)
T ss_dssp -------------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred -----------------cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhcc
Confidence 123456799999999999999999999999999999999999999998776666555543222
Q ss_pred cHHH--------HHHHHHhCCC-C--------------CcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 005427 296 TEQQ--------LTAAVVSGGL-R--------------PILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 296 ~~~~--------~~~~~~~~~~-~--------------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
.... .......... . +.........++++.+||++||..||++|||++|+++|+|+-
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~ 315 (355)
T d2b1pa1 236 TPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN 315 (355)
T ss_dssp CCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTG
T ss_pred CCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccC
Confidence 1100 0011111110 0 000111123577899999999999999999999999999885
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-46 Score=378.84 Aligned_cols=269 Identities=23% Similarity=0.226 Sum_probs=211.4
Q ss_pred CCcccccccccCCceEEEEEEE--CCeeEEEEeccCCC--hHHHHHHHHHHHHHHhcCCCCceEEeeccccCCceEEEEe
Q 005427 66 SSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILST--SEELDNFHKELQLLCKLDHPGLAKFVAAHAKPPNYMFFFE 141 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e 141 (697)
++|+++++||+|+||+||+|++ +++.||||++.... ......+.+|+.+|+.++||||+++++++.++..++++++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 5899999999999999999998 57889999875443 3446789999999999999999999999999999999999
Q ss_pred ecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeeccchhhhhhhhhhcc
Q 005427 142 FYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGLAEYRENLKEISLK 221 (697)
Q Consensus 142 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~ 221 (697)
++.+++|..++... ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||.+.......
T Consensus 82 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~----- 155 (292)
T d1unla_ 82 FCDQDLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV----- 155 (292)
T ss_dssp CCSEEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC-----
T ss_pred eccccccccccccc-cccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCC-----
Confidence 99998888877644 478999999999999999999999999999999999999999999999999997654211
Q ss_pred cccCCCCCCCCccccccccCccccchhhhcccC-CCchhhHHHHHHHHHHHHhCCCCCCCc-hhHHHHHHHHhccccHHH
Q 005427 222 NWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEI-HSEKSDVYSFGISINELLTGVVPYTDL-RAEAQAHTVLEMNYTEQQ 299 (697)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~~l~ell~g~~Pf~~~-~~~~~~~~~~~~~~~~~~ 299 (697)
.......+++.|+|||++.+.. ++.++|||||||++|||++|..||... +.......+.........
T Consensus 156 -----------~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 224 (292)
T d1unla_ 156 -----------RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTE 224 (292)
T ss_dssp -----------SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred -----------ccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCCh
Confidence 1223446788999999987665 689999999999999999999886443 333333333221111100
Q ss_pred HH--HHHHhC--------CCCCcccccccCChHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 005427 300 LT--AAVVSG--------GLRPILASLELGLPASILSLIQRCWDGNPHNRPSFSDIALELDL 351 (697)
Q Consensus 300 ~~--~~~~~~--------~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~l~~ 351 (697)
.. ...... ............+++++.+||++||+.||.+|||++|+++|.|+
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f 286 (292)
T d1unla_ 225 EQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF 286 (292)
T ss_dssp TTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGG
T ss_pred hhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhh
Confidence 00 000000 00111122334678999999999999999999999999999876
|
| >d1txoa_ d.219.1.1 (A:) putative serine/threonine phosphatase pstp/ppp {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: PP2C-like superfamily: PP2C-like family: PP2C-like domain: putative serine/threonine phosphatase pstp/ppp species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=8e-43 Score=343.40 Aligned_cols=229 Identities=25% Similarity=0.300 Sum_probs=197.6
Q ss_pred ccceEeeeccCC-CCCCCceeEEcccccCCCceEEEEEecCCCChHHHHHHHHHhHHHHHhc---CCCCChHHHHHHHHH
Q 005427 428 VLSWGSFATCGR-RETMEDTHFLMPHMYNQKEIHMFGIFDGHRGSAAAEFSARALPGFLQNL---GSTTRPTDALLEAFI 503 (697)
Q Consensus 428 ~~~~~~~s~~G~-R~~neD~~~~~~~~~~~~~~~~~~V~DG~GG~~~~~~as~~~~~~l~~~---~~~~~~~~~l~~~~~ 503 (697)
.++||+.|++|. |++|||++++.. .+|+|||||||+.+|++||+.+++.+.+. .........+.+++.
T Consensus 2 ~~~~~~~s~~G~~R~~nEDa~~~~~--------~l~~V~DG~GG~~~g~~as~~~~~~l~~~~~~~~~~~~~~~l~~~~~ 73 (235)
T d1txoa_ 2 VLRYAARSDRGLVRANNEDSVYAGA--------RLLALADGMGGHAAGEVASQLVIAALAHLDDDEPGGDLLAKLDAAVR 73 (235)
T ss_dssp EEEEEEEEECCSSCSSCCEEEEECS--------SEEEEEEEECTTTHHHHHHHHHHHHHGGGGSSCCCSCHHHHHHHHHH
T ss_pred EEEEEEECCCCCCCCCCCCccccCC--------CEEEEEeCCCCcHHHHHHHHHHHHHHHHHhhccCcccHHHHHHHHHH
Confidence 478999999996 999999998843 38999999999999999999999999875 334556778888998
Q ss_pred HHHHHHHHHHHHHHhhhhcccCCCCCCceEEEEEEecCeEEEEEcCCeEEEEEECCeeeecCCCCCCCCHHHHHHHHHcC
Q 005427 504 RTDVAFRNELDSLRKSKRVVQKDWHPGCTAIAALIVRNRLFVANAGDCRAILCRGGHPFALSRDHVASCLEERERVVSAG 583 (697)
Q Consensus 504 ~~~~~~~~~~~~~~~~~~~~~~~~~~GtT~~~~~i~~~~l~~anvGDSr~~l~~~~~~~~lt~dH~~~~~~e~~ri~~~g 583 (697)
+++..+...... ......+|||++++++.+++++++||||||+|++|+|++++||+|| +..+++...|
T Consensus 74 ~~~~~l~~~~~~-------~~~~~~~gtt~~~~~~~~~~l~~anvGDSr~~l~r~g~~~~lt~dH-----~~~~~~~~~g 141 (235)
T d1txoa_ 74 AGNSAIAAQVEM-------EPDLEGMGTTLTAILFAGNRLGLVHIGDSRGYLLRDGELTQITKDD-----TFVQTLVDEG 141 (235)
T ss_dssp HHHHHHHHHHHH-------CGGGTTCEECEEEEEEETTEEEEEEESSCEEEEEETTEEEECSCCC-----BHHHHHHHTT
T ss_pred HHHHHHHHHhhc-------ccccccceeeeeeeeeccceeEEEecCCccEEEecCCEEEEecCCC-----cHHHHhhhhc
Confidence 888888765332 1223357999999999999999999999999999999999999999 4566677777
Q ss_pred CeeeeccCcceeCCCcceeccccCCCCCCCCcccCCceEEEEeCCCCeEEEEEcCCcccCCChHHHHHHHHhhcCChhHH
Q 005427 584 GNVNWQVDTWRVGPPALQVTRSIGDDDLKPAVTAEPEITETIMTPEDEYLVMASDGLWDVVSHVEAVGIIKDTVKEPGMC 663 (697)
Q Consensus 584 ~~~~~~~~~~~~~~~~~~ltralG~~~~k~~v~~~p~v~~~~l~~~d~~lvl~SDGl~d~~~~~ei~~~~~~~~~~~~~~ 663 (697)
. ......+.+|.++.+||++|+.. .+|++..+++.++| +||||||||||++++++|.+++... +++++
T Consensus 142 ~---~~~~~~~~~~~~~~lt~~~g~~~------~~pdi~~~~l~~~D-~llL~SDGl~d~l~~~ei~~i~~~~--~~~~~ 209 (235)
T d1txoa_ 142 R---ITPEEAHSHPQRSLIMRALTGHE------VEPTLTMREARAGD-RYLLCSDGLSDPVSDETILEALQIP--EVAES 209 (235)
T ss_dssp S---SCTTGGGGCTTTTCBCCCBSSSC------CCCEEEEEECCTTC-EEEEECHHHHTTSCHHHHHHHHTSS--SHHHH
T ss_pred c---cchhhhhhccccchhhccccccc------ccceEEEEecCCCC-EEEEcCcchhcCCCHHHHHHHHhCC--CHHHH
Confidence 6 45556677888999999999876 57999999999998 6679999999999999999999754 89999
Q ss_pred HHHHHHHHHhcCCCCCcEEEEEEeC
Q 005427 664 SKRLATEAAERGSKDNITVIVVFLQ 688 (697)
Q Consensus 664 a~~L~~~a~~~g~~DNiT~ivv~l~ 688 (697)
|+.|++.|+++|+.||+|||||+|+
T Consensus 210 a~~Lv~~A~~~gs~DNiTvivv~l~ 234 (235)
T d1txoa_ 210 AHRLIELALRGGGPDNVTVVVADLE 234 (235)
T ss_dssp HHHHHHHHHHTTCCSCEEEEEEEEE
T ss_pred HHHHHHHHHhcCCCCCEEEEEEEEe
Confidence 9999999999999999999999985
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.6e-39 Score=342.39 Aligned_cols=269 Identities=21% Similarity=0.251 Sum_probs=193.8
Q ss_pred CCCCcccccccccCCceEEEEEEE--CCeeEEEEeccCCChHHHHHHHHHHHHHHhcC-----------CCCceEEeecc
Q 005427 64 PPSSYTLLSPIARGAESVVYEATL--DGRKVAVKKPILSTSEELDNFHKELQLLCKLD-----------HPGLAKFVAAH 130 (697)
Q Consensus 64 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------hpniv~l~~~~ 130 (697)
..+||+++++||+|+||+||+|++ +++.||||++... ....+.+.+|+.+|+.++ ||||+++++++
T Consensus 11 ~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~-~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~ 89 (362)
T d1q8ya_ 11 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 89 (362)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred cCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc-ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEe
Confidence 346799999999999999999997 5899999987643 334567889999998885 57899998887
Q ss_pred cc--CCceEEEEeecCCCCHhh--hhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCCCceeecCCCC-----
Q 005427 131 AK--PPNYMFFFEFYESRNLAE--KLHVEEWSPSVDQVLMIAAQLAKALQYLHN-LGIVHRDVKPANVLLDRNLC----- 200 (697)
Q Consensus 131 ~~--~~~~~lv~e~~~~g~L~~--~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivHrDlkp~Nill~~~~~----- 200 (697)
.. ....+++++++..+.... ........+++..++.++.|++.||+|||+ .||+||||||+|||++.++.
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~ 169 (362)
T d1q8ya_ 90 NHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLI 169 (362)
T ss_dssp EEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred eeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccc
Confidence 54 455666777665543322 223344578999999999999999999998 89999999999999976654
Q ss_pred -CeeeeeccchhhhhhhhhhcccccCCCCCCCCccccccccCccccchhhhcccCCCchhhHHHHHHHHHHHHhCCCCCC
Q 005427 201 -PHLADFGLAEYRENLKEISLKNWRSSGKPTGGFHKKNMVGTLIYMAPEILKKEIHSEKSDVYSFGISINELLTGVVPYT 279 (697)
Q Consensus 201 -~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell~g~~Pf~ 279 (697)
+||+|||.+..... .....+||+.|+|||++.+..++.++||||+||++++|++|+.||.
T Consensus 170 ~~kl~dfg~s~~~~~-------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~ 230 (362)
T d1q8ya_ 170 QIKIADLGNACWYDE-------------------HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFE 230 (362)
T ss_dssp EEEECCCTTCEETTB-------------------CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-
T ss_pred eeeEeeccccccccc-------------------ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCC
Confidence 89999999865432 2345679999999999999999999999999999999999999997
Q ss_pred CchhHH------HHHHHHhcccc-HHHHHHH------HHh-C----CCC-----Cc------ccccccCChHHHHHHHHH
Q 005427 280 DLRAEA------QAHTVLEMNYT-EQQLTAA------VVS-G----GLR-----PI------LASLELGLPASILSLIQR 330 (697)
Q Consensus 280 ~~~~~~------~~~~~~~~~~~-~~~~~~~------~~~-~----~~~-----~~------~~~~~~~~~~~l~~li~~ 330 (697)
...... ........... ....... ... . ... +. ....+...++++.+||.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~ 310 (362)
T d1q8ya_ 231 PDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSP 310 (362)
T ss_dssp --------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGG
T ss_pred CCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHH
Confidence 543211 11111111000 0010000 000 0 000 00 000122357889999999
Q ss_pred hccCCCCCCCCHHHHHHHHHHH
Q 005427 331 CWDGNPHNRPSFSDIALELDLV 352 (697)
Q Consensus 331 ~l~~dP~~Rpt~~ell~~l~~~ 352 (697)
||++||.+|||++|+++|.|+-
T Consensus 311 mL~~dP~~Rpta~e~L~Hp~f~ 332 (362)
T d1q8ya_ 311 MLQLDPRKRADAGGLVNHPWLK 332 (362)
T ss_dssp GGCSSTTTCBCHHHHHTCGGGT
T ss_pred HCCCChhHCcCHHHHhcCcccC
Confidence 9999999999999999998774
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.89 E-value=8.4e-24 Score=199.64 Aligned_cols=133 Identities=19% Similarity=0.202 Sum_probs=106.1
Q ss_pred cccccccccCCceEEEEEEE-CCeeEEEEeccCCCh------------------HHHHHHHHHHHHHHhcCCCCceEEee
Q 005427 68 YTLLSPIARGAESVVYEATL-DGRKVAVKKPILSTS------------------EELDNFHKELQLLCKLDHPGLAKFVA 128 (697)
Q Consensus 68 y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~hpniv~l~~ 128 (697)
+.+.++||+|+||+||+|++ +|+.||||+...... ........|...+.++.|++++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 46789999999999999987 789999997543211 11234567899999999999999887
Q ss_pred ccccCCceEEEEeecCCCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCCCceeecCCCCCeeeeecc
Q 005427 129 AHAKPPNYMFFFEFYESRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHNLGIVHRDVKPANVLLDRNLCPHLADFGL 208 (697)
Q Consensus 129 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kL~Dfg~ 208 (697)
+.. .+++|||++++.+.. ++...+..++.|++.+|.|||++||+||||||+|||++.++ ++|+|||+
T Consensus 82 ~~~----~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~-~~liDFG~ 148 (191)
T d1zara2 82 WEG----NAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQ 148 (191)
T ss_dssp EET----TEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTE-EEECCCTT
T ss_pred ecC----CEEEEEeeccccccc--------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCCC-EEEEECCC
Confidence 642 379999999865543 23345678999999999999999999999999999998765 89999999
Q ss_pred chhhh
Q 005427 209 AEYRE 213 (697)
Q Consensus 209 a~~~~ 213 (697)
|....
T Consensus 149 a~~~~ 153 (191)
T d1zara2 149 SVEVG 153 (191)
T ss_dssp CEETT
T ss_pred cccCC
Confidence 86543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.35 E-value=4.5e-07 Score=87.89 Aligned_cols=139 Identities=13% Similarity=0.148 Sum_probs=95.7
Q ss_pred CCcccccccccCCceEEEEEEECCeeEEEEeccCCChHHHHHHHHHHHHHHhcC-CCCceEEeeccccCCceEEEEeecC
Q 005427 66 SSYTLLSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLD-HPGLAKFVAAHAKPPNYMFFFEFYE 144 (697)
Q Consensus 66 ~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lv~e~~~ 144 (697)
+.|++.+..+-++.+.||+...+++.+.+|+...........+.+|...+..|. +-.+.+++.+..+++..++||++++
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~ 93 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEAD 93 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEECSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCS
T ss_pred hceEEEEcCCCCCCCcEEEEEeCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecc
Confidence 356666665545557899998888888899755443333445678888888774 4346677777778888999999999
Q ss_pred CCCHhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------------
Q 005427 145 SRNLAEKLHVEEWSPSVDQVLMIAAQLAKALQYLHN-------------------------------------------- 180 (697)
Q Consensus 145 ~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~-------------------------------------------- 180 (697)
|..+.+...... ....++.++...+..||+
T Consensus 94 G~~~~~~~~~~~------~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (263)
T d1j7la_ 94 GVLCSEEYEDEQ------SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDP 167 (263)
T ss_dssp SEEHHHHTTTCS------CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSH
T ss_pred cccccccccccc------cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHH
Confidence 987765442211 122233444444444542
Q ss_pred ---------------CCcccccCCCCceeecCCCCCeeeeeccch
Q 005427 181 ---------------LGIVHRDVKPANVLLDRNLCPHLADFGLAE 210 (697)
Q Consensus 181 ---------------~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~ 210 (697)
..++|+|+.|.|||++.++.+.|+||+.+.
T Consensus 168 ~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 168 RELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 127899999999999987667799999874
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.50 E-value=8.9e-05 Score=70.63 Aligned_cols=74 Identities=14% Similarity=0.143 Sum_probs=51.0
Q ss_pred ccccCCc-eEEEEEEEC-CeeEEEEeccCCChHHHHHHHHHHHHHHhcC--CCCceEEeeccccCCceEEEEeecCCCCH
Q 005427 73 PIARGAE-SVVYEATLD-GRKVAVKKPILSTSEELDNFHKELQLLCKLD--HPGLAKFVAAHAKPPNYMFFFEFYESRNL 148 (697)
Q Consensus 73 ~lg~G~~-g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--hpniv~l~~~~~~~~~~~lv~e~~~~g~L 148 (697)
.+..|.. +.||+...+ +..+.+|...... ...+..|...|+.|. .-.+.+++.+..+++..++||++++|.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 3344543 689999874 5568888754433 234678888888773 33466678887888889999999988654
Q ss_pred h
Q 005427 149 A 149 (697)
Q Consensus 149 ~ 149 (697)
.
T Consensus 94 ~ 94 (255)
T d1nd4a_ 94 L 94 (255)
T ss_dssp T
T ss_pred c
Confidence 3
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.43 E-value=9.5e-05 Score=75.39 Aligned_cols=75 Identities=13% Similarity=0.105 Sum_probs=48.7
Q ss_pred ccccccCCceEEEEEEE--CCeeEEEEeccC----C---ChHHHHHHHHHHHHHHhcC-C--CCceEEeeccccCCceEE
Q 005427 71 LSPIARGAESVVYEATL--DGRKVAVKKPIL----S---TSEELDNFHKELQLLCKLD-H--PGLAKFVAAHAKPPNYMF 138 (697)
Q Consensus 71 ~~~lg~G~~g~V~~~~~--~~~~vavK~~~~----~---~~~~~~~~~~E~~~l~~l~-h--pniv~l~~~~~~~~~~~l 138 (697)
.+.||.|....||+++. .++.++||.... . -....++...|.+.|+.+. + ..+++++.+ ++...++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 45789999999999975 466789995321 1 0112345667888888772 2 345556654 4556789
Q ss_pred EEeecCCCC
Q 005427 139 FFEFYESRN 147 (697)
Q Consensus 139 v~e~~~~g~ 147 (697)
|||++.+..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997654
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.11 E-value=0.0062 Score=61.51 Aligned_cols=71 Identities=17% Similarity=0.166 Sum_probs=47.0
Q ss_pred ccccccCCceEEEEEEEC---------CeeEEEEeccCCChHHHHHHHHHHHHHHhcC-CCCceEEeeccccCCceEEEE
Q 005427 71 LSPIARGAESVVYEATLD---------GRKVAVKKPILSTSEELDNFHKELQLLCKLD-HPGLAKFVAAHAKPPNYMFFF 140 (697)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lv~ 140 (697)
++.|+-|-.-.+|++... .+.|.+++.- .... .....+|..+++.+. +.-..++++++.+ .+|+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~~~-~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ 120 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NPET-ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 120 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SCCC-HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Ccch-hhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence 356777888899999863 2456676643 2222 234568999999884 4444577777753 6889
Q ss_pred eecCCCC
Q 005427 141 EFYESRN 147 (697)
Q Consensus 141 e~~~~g~ 147 (697)
||++|..
T Consensus 121 efi~g~~ 127 (395)
T d1nw1a_ 121 EYIPSRP 127 (395)
T ss_dssp CCCCEEE
T ss_pred EEecccc
Confidence 9998743
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=95.65 E-value=0.0047 Score=60.59 Aligned_cols=67 Identities=25% Similarity=0.172 Sum_probs=42.2
Q ss_pred ceEEEEEEE-CCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCCc--eEEee-----ccccCCceEEEEeecCCC
Q 005427 79 ESVVYEATL-DGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPGL--AKFVA-----AHAKPPNYMFFFEFYESR 146 (697)
Q Consensus 79 ~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpni--v~l~~-----~~~~~~~~~lv~e~~~~g 146 (697)
--.||+++. +|+.+++|+.+... ...+.+..|...|..|....+ +..+. .+...+..+.+++++.|.
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred cceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 458999986 68889999865432 234557788888888742222 11111 123355678889988763
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.05 E-value=0.0062 Score=59.35 Aligned_cols=138 Identities=18% Similarity=0.116 Sum_probs=72.0
Q ss_pred ccccccCCceEEEEEEECCeeEEEEeccCCChHHHHHHHHHHHHHHhcCCCC--ceEEeec------cccCCceEEEEee
Q 005427 71 LSPIARGAESVVYEATLDGRKVAVKKPILSTSEELDNFHKELQLLCKLDHPG--LAKFVAA------HAKPPNYMFFFEF 142 (697)
Q Consensus 71 ~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn--iv~l~~~------~~~~~~~~lv~e~ 142 (697)
.+.|..|---+.|+.+.++..+++|+.... ...+.+..|+++|..|...+ +...+.. .........++.+
T Consensus 23 ~~~i~~G~~N~ny~v~t~~g~yVLri~~~~--~~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~~~~~~~ 100 (316)
T d2ppqa1 23 YKGIAEGVENSNFLLHTTKDPLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISF 100 (316)
T ss_dssp EEEECC---EEEEEEEESSCCEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEEC
T ss_pred eecCCCCcccCeEEEEECCCcEEEEEcCCC--CCHHHHHHHHHHHHhhhhccccccccceecCCCcceeeecccceeeee
Confidence 345667777889999887778999986432 22344556777777773222 1111111 1112345556666
Q ss_pred cCCCCHhh--------------hhhhcC--------CCCCH------------------HHHHHHHHHHHHHHHHHH---
Q 005427 143 YESRNLAE--------------KLHVEE--------WSPSV------------------DQVLMIAAQLAKALQYLH--- 179 (697)
Q Consensus 143 ~~~g~L~~--------------~l~~~~--------~~~~~------------------~~~~~i~~qi~~~l~~LH--- 179 (697)
..+..... .++... ..... ......+..+...+...+
T Consensus 101 ~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 180 (316)
T d2ppqa1 101 LEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKD 180 (316)
T ss_dssp CCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCS
T ss_pred cccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhhhccCccc
Confidence 55532110 011000 00000 011222222233333322
Q ss_pred -hCCcccccCCCCceeecCCCCCeeeeeccch
Q 005427 180 -NLGIVHRDVKPANVLLDRNLCPHLADFGLAE 210 (697)
Q Consensus 180 -~~~ivHrDlkp~Nill~~~~~~kL~Dfg~a~ 210 (697)
..|++|+|+.++||+++.+...-|+||+.+.
T Consensus 181 L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 181 LPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp SCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccccCCcchhhhhcccccceeEecccccc
Confidence 2379999999999999988777899999874
|